Citrus Sinensis ID: 003436

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820
Protein Sequence
MMVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEGHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMREM
Secondary Structure (PSIPRED)
ccccccccEEHHHHHHHHHHHHccccccccccEEEcccccccccccccEEEcccccccccccccccEEEEEcccccccccccccccEEEEcccccEEEEEEcccccEEEEEEEcccccccccccccEEEEEEccEEEEEEcccccccEEEEEEEEEEcccEEEEEEEcccccEEEEEEEEccccccccccccccccccccccccccccccccEEEEEEEccccccccccccccEEEccccccEEEcccEEEEccccEEEEccccccccccHHHHHHcccccccccccccccEEEEEEccccccEEEEEEEEEEEEcccccEEEEEEEccccccccccccccccccccccEEEEEEEEcccccEEEEEEEccccccccccccccccEEEEcccccccccccccccccccccEEEEEEEEEHHHHHHHHHHHEEEEEEEEEcccccccccccccccccccccccccccccccccccHHHHHHHcccccccccEEEccccEEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccccccccccccccccHHHHHHHHHHHcHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccEEEEEEccccccccHHHHHccccccccccccHHHHHHHHHccccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccHHcccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHccccccccccEEEEccccccccccccEEEEcccccccccccccccEEEcccccccccccccccEEEEEEccccEEEEEccccccEEEEEEEEEcccccccccccEEEEEEccEEEEcccccccccEEEEEEEEccccEEEEEEEcccccEEEEEEEEEEccccHcccccccccccccccccccccccccEEEEEEEEcccccccccccccEEEEcccccHccccccccccccccEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEEcccccEEEEEEEEEEEEEcccccEEEEEEEcccEEcccccHHHEccccccEEEEEEEEEEEccccEEEEEEcccccccccccccccccEEEEEcccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccEEcHHHHHHHHcccccccEEEccccccEEEEEEccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHEEccccccccEEEEEHHHccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccHHHEEEEHHHEEEEccccHHHHcccHHHHEEEEEEEcccccccHHHHHHHHccccccHHHHHHEHHHHHcccccccccccHHHHHHHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
MMVNVRNFELLLWLSSVLCLVSvstafdpvdnylidcgsftntsagnrvfaadhtstftnlsspqnisiNASLnsissgnysrlyhtariftgpsnysfSIKKQARHFIrlhffpfvhetynmstakfsvssQSFTLIKDYqsqegssvkeYSLNIasdrlvlsftpfansfAFINALEVislpdelipqsaktidpqgsstgnqsLQRQALETVARVnmggkdvppqndvlwrrwvsddaylkhsNLVMFVSNTSivnftdsvteniaprdvygtativnsgsdpnsnvnvtwnfdvdpgfefLVRFHFCDIYFNNISSLAFNVYINSrsaqldfdlhklpsyaagnpyymdfitresdnpklhvsigrstlvdtfpnailNGLEIMKINnsrgdfdvaestspkssktrVGLIVGVASGSCISVGLALVLVLLCRRRNRLArghlkadeqfavkeghisaifssskigyrfpfVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAvkrggtqshqgLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMengtlkdhlyasnfpslsWRKRLEICIGAArglhylhtgstkaIIHRDVKSANILLDENLMAKVADfglskigpdldqthvstavkgsfgyldpeyltkqqlteksdvysFGVVMFEILcgrpvidpslprekVNLVEWAMKCqetgqledivdptltgqikpdsLNKFVEIAEKCLAqcgidrpsmgDVLWNLEYALQLqgdegksspkgetsspnnhshsqtgvsntefstasvgdlagvSMSKVFAQMVREEMREM
Flexible Loop (DISEMBL)
MMVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKtidpqgsstgnqsLQRQALETVARvnmggkdvppqndvLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVnsgsdpnsnVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVaestspkssktrvGLIVGVASGSCISVGLALVLVLLCRRRNRLArghlkadeqfavkegHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKvavkrggtqshqglaEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKsspkgetsspnnhshsqtgvsnTEFSTASVGDLAGVSMSKVFAQMVREEMREM
Low Complexity Region (SEG)
MMVNVRNFElllwlssvlclvsvsTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQnisinaslnsissGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGlalvlvllcrrrnrlarGHLKADEQFAVKEGHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMREM
Disordered region (IsUnstruct)
***NVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNL*****ISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDY*******VKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDEL****************************************QNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINN******************RVGLIVGVASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEGHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL***********************************************************
Disordered Region (DISOPRED)
*****RNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFT************************LYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATI*****DPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINN************************GVASGSCISVGLALVLVLLCR**********************************RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAV**************RTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA*****************************************************MVREEM***
Disordered Region (DISEMBL)
MMVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAK**************QRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDF*************RVGLIVGVASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEGHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ***************************TEFSTASVGDLAGVSMSKVFAQMVREEMREM
Disordered Region (DISPRO)
*MVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINAS*NSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGD*************TRVGLIVGVASGSCISVGLALVLVLLCRRRN***************************KIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDE*******************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MMVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEGHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMREM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	820	2.2.26 [Sep-21-2011]
Q9LX66	830	Receptor-like protein kin	yes	no	0.982	0.971	0.538	0.0
Q9FN92	829	Probable receptor-like pr	no	no	0.967	0.956	0.536	0.0
O80623	815	Probable receptor-like pr	no	no	0.965	0.971	0.520	0.0
Q9LK35	855	Receptor-like protein kin	no	no	0.984	0.943	0.452	0.0
Q9FLJ8	842	Probable receptor-like pr	no	no	0.892	0.869	0.471	0.0
Q9T020	878	Probable receptor-like pr	no	no	0.925	0.864	0.460	0.0
Q9FLW0	824	Probable receptor-like pr	no	no	0.953	0.949	0.456	0.0
Q9SJT0	871	Probable receptor-like pr	no	no	0.885	0.833	0.457	0.0
Q9SA72	849	Probable receptor-like pr	no	no	0.868	0.838	0.424	1e-173
Q9SR05	850	Receptor-like protein kin	no	no	0.869	0.838	0.412	1e-164

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  866 bits (2238), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/840 (53%), Positives = 567/840 (67%), Gaps = 34/840 (4%)

Query: 3   VNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLS 62
           + +  FE  + +S++  L+ +   F PVDNYLI+CGS TN +   R+F +D       LS
Sbjct: 1   MGIEKFETFILISTISILLCICHGFTPVDNYLINCGSPTNGTLMGRIFLSDK------LS 54

Query: 63  SPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYN 122
           S    S    L S+   + S +YHTAR+FT  S+Y FS+ +  RH++RL+F PF ++ + 
Sbjct: 55  SKLLTSSKEILASVGGNSGSDIYHTARVFTEVSSYKFSVTR-GRHWVRLYFNPFDYQNFK 113

Query: 123 MSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVIS 182
           M +AKF+VSSQS  L+ D+       VKEYSLN+ ++ LVL+FTP + SFAF+NA+EVIS
Sbjct: 114 MGSAKFAVSSQSHVLLSDFTVTSSKVVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVIS 173

Query: 183 LPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAY 242
           +PD LI  S + +   G+      +  Q LET+ RVNMGG  V   ND L R WV D  +
Sbjct: 174 IPDTLITGSPRFV---GNPAQFPDMSMQGLETIHRVNMGGPLVASNNDTLTRTWVPDSEF 230

Query: 243 LKHSNLVMFVSNTSIVNFTDS-VTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPG 301
           L   NL   +S  S VNF     TE+ APR VYG+ T +NS  +PNS  NVTW FDVDPG
Sbjct: 231 LLEKNLAKSMSKFSTVNFVPGYATEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPG 290

Query: 302 FEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDN 361
           F++  RFHFCDI   +++ L FN+Y++S  A  D DL  L        Y MDF+T+    
Sbjct: 291 FQYYFRFHFCDIVSLSLNQLYFNLYVDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKG 350

Query: 362 P-KLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAE--STSPKSSKTRVGLIVGV 418
             K+ VSIG ST+   +PNAI+NGLEIMK+NNS+G          S  SSK+ +GLIVG 
Sbjct: 351 SNKVRVSIGPSTVHTDYPNAIVNGLEIMKMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGS 410

Query: 419 ASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEGHISAIFS--------SSKIG 470
           A GS ++V       +L ++R R   GH K    F++    + + +S        ++   
Sbjct: 411 AIGSLLAVVFLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTTLTSITTNAN 470

Query: 471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEI 530
           YR PF A+++AT+NF ES  IG+GGFGKVY+G L D TKVAVKRG  +S QGLAEFRTEI
Sbjct: 471 YRIPFAAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEI 530

Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
           EMLSQFRHRHLVSLIGYCDE NEMI+IYEYMENGT+K HLY S  PSL+W++RLEICIGA
Sbjct: 531 EMLSQFRHRHLVSLIGYCDENNEMILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGA 590

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           ARGLHYLHTG +K +IHRDVKSANILLDEN MAKVADFGLSK GP+LDQTHVSTAVKGSF
Sbjct: 591 ARGLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSF 650

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
           GYLDPEY  +QQLT+KSDVYSFGVV+FE+LC RPVIDP+LPRE VNL EWAMK Q+ GQL
Sbjct: 651 GYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQL 710

Query: 711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSP 770
           + I+D +L G I+PDSL KF E  EKCLA  G+DRPSMGDVLWNLEYALQLQ       P
Sbjct: 711 DQIIDQSLRGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEP 770

Query: 771 KGETSSP--------NNHSHSQTGV----SNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
           +  +++         NN S   T V    +   F  +S+ DL+GVSMSKVF+Q+V+ E R
Sbjct: 771 EDNSTNMIGELPPQINNFSQGDTSVNVPGTAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1

 Score =  848 bits (2192), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 452/842 (53%), Positives = 571/842 (67%), Gaps = 49/842 (5%)

Query: 8   FELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNI 67
           F  L+W+ S+ CL+ +   + PVDNYLI+CGS TN +  +RVF +D+ ++   L+SP  I
Sbjct: 6   FGFLIWILSIPCLIFLCYGYVPVDNYLINCGSSTNVTVTSRVFISDNLAS-NFLTSPNEI 64

Query: 68  SINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAK 127
              ++ NS S      +Y TARIFTG S Y FS+ +  RH+IRLHF PF ++ + M +AK
Sbjct: 65  LAASNRNSNSD-----IYQTARIFTGISKYRFSVAR-GRHWIRLHFNPFQYQNFQMVSAK 118

Query: 128 FSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDEL 187
           FSVSS++  L+ D+ +     +KEYSLN+A+D L L+FTP  +SFAF+NALEV+S+PD L
Sbjct: 119 FSVSSETHVLLSDF-TVSSRVMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTL 177

Query: 188 IPQSAKTIDPQ--GSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKH 245
                 + DP   GS    Q L  QALETV RVNMGG  V P ND L R W  D  +L  
Sbjct: 178 F-----SGDPSFAGSPGKFQGLSWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVE 232

Query: 246 SNLVMFVSNTSIVNFTDS-VTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEF 304
            NLV  VS  + V++     TE  APR VYGT T +NS  +P+SN NVTW+FDVDPGF++
Sbjct: 233 KNLVKSVSKIASVDYVPGFATEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQY 292

Query: 305 LVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESD-NPK 363
            +RFHFCDI    ++ L FN+Y++S     + DL    S      Y MDF+T  +    +
Sbjct: 293 FLRFHFCDIVSKALNQLYFNLYVDSMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKR 352

Query: 364 LHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAE---STSPKSSKTRVGLIVGVAS 420
           + VSIGRS++   +P AILNGLEIMK+NNS+    +     S S  ++K  VG+I+G+  
Sbjct: 353 IRVSIGRSSVHTDYPTAILNGLEIMKMNNSKSQLSIGTFLPSGSSSTTKKNVGMIIGLTI 412

Query: 421 GSCISVGLALVLVLLCRRRNRLARGHLKA-------DEQFAVKEGHISAIFSSSKIGYRF 473
           GS +++ +     +L ++R R   G+ K            +     +++I S+S   YR 
Sbjct: 413 GSLLALVVLGGFFVLYKKRGRDQDGNSKTWIPLSSNGTTSSSNGTTLASIASNSS--YRI 470

Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
           P VA++EAT++F E+  IG+GGFGKVY+G L D TKVAVKR   +S QGLAEFRTEIEML
Sbjct: 471 PLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEML 530

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           SQFRHRHLVSLIGYCDE NEMI++YEYMENGTLK HLY S   SLSW++RLEICIG+ARG
Sbjct: 531 SQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARG 590

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           LHYLHTG  K +IHRDVKSANILLDENLMAKVADFGLSK GP++DQTHVSTAVKGSFGYL
Sbjct: 591 LHYLHTGDAKPVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYL 650

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
           DPEY  +QQLTEKSDVYSFGVVMFE+LC RPVIDP+L RE VNL EWAMK Q+ GQLE I
Sbjct: 651 DPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHI 710

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGE 773
           +DP+L G+I+PDSL KF E  EKCLA  G+DRPSMGDVLWNLEYALQLQ       P+  
Sbjct: 711 IDPSLRGKIRPDSLRKFGETGEKCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDPEDS 770

Query: 774 TSSP-------NNHSHSQTGVSNTEFSTASVGDL----------AGVSMSKVFAQMVREE 816
           T+         N+++H  T V+   FS A  G            +GVSMSKVF+Q+++ E
Sbjct: 771 TNMIGELPLRFNDYNHGDTSVN---FSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSE 827

Query: 817 MR 818
            R
Sbjct: 828 GR 829

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O80623|Y2393_ARATH Probable receptor-like protein kinase At2g39360 OS=Arabidopsis thaliana GN=At2g39360 PE=1 SV=1

 Score =  835 bits (2157), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/840 (52%), Positives = 579/840 (68%), Gaps = 48/840 (5%)

Query: 2   MVNVRNF-EL-LLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFT 59
           M+N++ F EL L +L ++LC   +S+     D + I+CGS TN +  NR F +D+     
Sbjct: 1   MINLKLFLELKLCFLITLLCSSHISSV---SDTFFINCGSPTNVTVNNRTFVSDN----- 52

Query: 60  NLSSPQNISINASLNSISSGNYSRLYHTARIFT--GPSNYSFSIKKQARHFIRLHFFPFV 117
           NL   Q  S+  +    +SG+ S L+ TAR+F+    S Y F I++     IR++F P V
Sbjct: 53  NLV--QGFSVGTT--DSNSGDESTLFQTARVFSDESSSTYRFPIEEHGWFLIRIYFLPLV 108

Query: 118 HETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINA 177
             + +++TA+FSVS+Q+FTLI++Y+    S V+EY LN+ +D L+L F P   S +FINA
Sbjct: 109 SASQDLTTARFSVSAQNFTLIREYKPSTTSVVREYILNVTTDSLLLQFLPRTGSVSFINA 168

Query: 178 LEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWV 237
           LEV+ LP+ LIP+ AK I  Q     +  L   A+ETV+RVNMG   V    D LWR+W 
Sbjct: 169 LEVLRLPETLIPEDAKLIGTQK----DLKLSSHAMETVSRVNMGNLSVSRDQDKLWRQWD 224

Query: 238 SDDAYLKHSNLVMFVSNTSIVNFT-DSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNF 296
           SD AY  H      V N   VNF+   +T++IAP  VYGTAT +NS  DPN+N N+TW F
Sbjct: 225 SDSAYKAHFGTP--VMNLKAVNFSAGGITDDIAPVYVYGTATRLNSDLDPNTNANLTWTF 282

Query: 297 DVDPGFEFLVRFHFCDIY---FNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMD 353
            V+PGF++ VRFHFC+I    F     + F++++NS   +   D+ ++ +   G P+++D
Sbjct: 283 KVEPGFDYFVRFHFCNIIVDPFGFERQIRFDIFVNSEKVR-TIDMTEVLNGTFGAPFFVD 341

Query: 354 FITRESDNPK--LHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTR 411
            + R++ + +  L++SIG    V ++P + +NG EI K++N +   D  ++  P  S + 
Sbjct: 342 AVMRKAKSREGFLNLSIGLVMDVSSYPVSFINGFEISKLSNDKRSLDAFDAILPDGSSSN 401

Query: 412 ------VGLIVGVASGSCISVGLALVLVLLCRRRNRLARGHLKA------DEQFAVKEGH 459
                 VGLI G+++  C+++   +V+   C R+ R     ++       D Q    E  
Sbjct: 402 KSSNTSVGLIAGLSAALCVALVFGVVVSWWCIRKRRRRNRQMQTVHSRGDDHQIKKNETG 461

Query: 460 ISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS 519
            S IFSSSKIGYR+P   I+EATD+F ESLVIG+GGFGKVY+GVLRD+T+VAVKRG  QS
Sbjct: 462 ESLIFSSSKIGYRYPLALIKEATDDFDESLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQS 521

Query: 520 HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSL 578
            QGLAEF+TE+EML+QFRHRHLVSLIGYCDE +EMII+YEYME GTLKDHLY   + P L
Sbjct: 522 RQGLAEFKTEVEMLTQFRHRHLVSLIGYCDENSEMIIVYEYMEKGTLKDHLYDLDDKPRL 581

Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
           SWR+RLEIC+GAARGLHYLHTGST+AIIHRDVKSANILLD+N MAKVADFGLSK GPDLD
Sbjct: 582 SWRQRLEICVGAARGLHYLHTGSTRAIIHRDVKSANILLDDNFMAKVADFGLSKTGPDLD 641

Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           QTHVSTAVKGSFGYLDPEYLT+QQLTEKSDVYSFGVVM E++CGRPVIDPSLPREKVNL+
Sbjct: 642 QTHVSTAVKGSFGYLDPEYLTRQQLTEKSDVYSFGVVMLEVVCGRPVIDPSLPREKVNLI 701

Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA 758
           EWAMK  + G+LEDI+DP L G++K + + K+ E+ EKCL+Q GI+RP+MGD+LWNLE+ 
Sbjct: 702 EWAMKLVKKGKLEDIIDPFLVGKVKLEEVKKYCEVTEKCLSQNGIERPAMGDLLWNLEFM 761

Query: 759 LQLQGDEGKSSPKGETSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
           LQ+Q  + K+      +  ++   +    S  +FS   VGD+AGVSMSKVFAQMVREE R
Sbjct: 762 LQVQAKDEKA------AMVDDKPEASVVGSTMQFSVNGVGDIAGVSMSKVFAQMVREETR 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1

 Score =  703 bits (1814), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 391/865 (45%), Positives = 526/865 (60%), Gaps = 58/865 (6%)

Query: 2   MVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAAD--HTSTFT 59
           MV  ++  +LLW  S     + S  F+P DNYLI CGS  N +  NR+F  D  H+S   
Sbjct: 1   MVFTKSLLVLLWFLSCYTTTTSSALFNPPDNYLISCGSSQNITFQNRIFVPDSLHSSLVL 60

Query: 60  NLSSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHE 119
            + +      + + ++ S+ + + +Y TAR+F+  ++Y F I    RH+IRLHF P  + 
Sbjct: 61  KIGNS-----SVATSTTSNNSTNSIYQTARVFSSLASYRFKITSLGRHWIRLHFSPINNS 115

Query: 120 TYNMSTAKFSVSSQSFTLIKDYQSQE--GSSV-KEYSLNIASDRLVLSFTPFANSFAFIN 176
           T+N+++A  +V ++ F L+ ++      GS + KEY++N+ S+ L LSF P  NS  F+N
Sbjct: 116 TWNLTSASITVVTEDFVLLNNFSFNNFNGSYIFKEYTVNVTSEFLTLSFIPSNNSVVFVN 175

Query: 177 ALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRW 236
           A+EV+S+PD LIP  A  ++P   ST    L   A ETV R+NMGG  +  QND L R+W
Sbjct: 176 AIEVVSVPDNLIPDQALALNP---STPFSGLSLLAFETVYRLNMGGPLLTSQNDTLGRQW 232

Query: 237 VSDDAYLK-HSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWN 295
            +D  YL  +S++++  +N S + ++ SVT+  AP  VY TA  +   +  + + NVTW 
Sbjct: 233 DNDAEYLHVNSSVLVVTANPSSIKYSPSVTQETAPNMVYATADTMGDANVASPSFNVTWV 292

Query: 296 FDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFI 355
             VDP F + VR HFCDI    +++L FN+Y+N   A    DL  L +     PY+ DFI
Sbjct: 293 LPVDPDFRYFVRVHFCDIVSQALNTLVFNLYVNDDLALGSLDLSTL-TNGLKVPYFKDFI 351

Query: 356 TRES--DNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSP------KS 407
           +  S   +  L VS+G  +  D   NA +NGLE++KI+N         S          S
Sbjct: 352 SNGSVESSGVLTVSVGPDSQAD-ITNATMNGLEVLKISNEAKSLSGVSSVKSLLPGGSGS 410

Query: 408 SKTRVGLIVGVASGSCISVGLALVLVLLCRRRNRLAR---------GH------LKADEQ 452
              +  +I+G   G+   + L  V    C   +R  R         GH      L    Q
Sbjct: 411 KSKKKAVIIGSLVGAVTLILLIAVCCYCCLVASRKQRSTSPQEGGNGHPWLPLPLYGLSQ 470

Query: 453 FAVKE--GHISAI-----FSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLR 505
              K    H SA       +S+ +G  F F  I +AT+ F ES ++G+GGFG+VY+G L 
Sbjct: 471 TLTKSTASHKSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLE 530

Query: 506 DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGT 565
           D TKVAVKRG  +S QG+AEFRTEIEMLS+ RHRHLVSLIGYCDER+EMI++YEYM NG 
Sbjct: 531 DGTKVAVKRGNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGP 590

Query: 566 LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV 625
           L+ HLY ++ P LSW++RLEICIGAARGLHYLHTG++++IIHRDVK+ NILLDENL+AKV
Sbjct: 591 LRSHLYGADLPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKV 650

Query: 626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
           ADFGLSK GP LDQTHVSTAVKGSFGYLDPEY  +QQLTEKSDVYSFGVV+ E+LC RP 
Sbjct: 651 ADFGLSKTGPSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPA 710

Query: 686 IDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDR 745
           ++P LPRE+VN+ EWAM  Q+ G L+ I+D  LTG++ P SL KF E AEKCLA+ G+DR
Sbjct: 711 LNPVLPREQVNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDR 770

Query: 746 PSMGDVLWNLEYALQLQGDEGKSSPKGETSS------------PNNHSHSQTGVSNTEFS 793
           PSMGDVLWNLEYALQL+          + S+            P ++S S          
Sbjct: 771 PSMGDVLWNLEYALQLEETSSALMEPDDNSTNHIPGIPMAPMEPFDNSMSIIDRGGVNSG 830

Query: 794 TASVGDLAGVSMSKVFAQMVREEMR 818
           T +  D    + S VF+Q+V    R
Sbjct: 831 TGTDDDAEDATTSAVFSQLVHPRGR 855

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1

 Score =  671 bits (1732), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/798 (47%), Positives = 483/798 (60%), Gaps = 66/798 (8%)

Query: 20  LVSVSTAFDPVDNYLIDCGSFTNTS-AGNRVFAADHTSTFTNLSSPQNISINASLNSISS 78
           +V  S++F P DNYLIDCGS   T  +  R F +D  S    L + ++I  +     I+ 
Sbjct: 21  IVKSSSSFTPADNYLIDCGSSDETKLSDGRNFKSDQQSV-AFLQTDEDIKTSVDSIPITD 79

Query: 79  GNYSRL--YHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFT 136
            N S L  Y TARIF G S YSF I +  RH+IRLHF+P  H  YN++ + FSV++ +  
Sbjct: 80  SNASTLPLYLTARIFAGKSTYSFYISRPGRHWIRLHFYPLNHPLYNLTNSVFSVTTDTTV 139

Query: 137 LIKDYQSQEGSSV--KEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKT 194
           L+ D+ + + SS+  KEY L  A+++L L F P   S AFINA+E++S+PDEL+P SA +
Sbjct: 140 LLHDFSAGDTSSIVFKEY-LIYAAEKLSLYFKPHKGSTAFINAVEIVSVPDELVPDSASS 198

Query: 195 IDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAY--LKHSNLVMFV 252
           + PQ      + L   +LE + R+N+GG  + P+ D L R W+SD  Y      +  + V
Sbjct: 199 V-PQAPDF--KGLSSFSLEILHRINIGGDLISPKIDPLSRTWLSDKPYNTFPEGSRNVTV 255

Query: 253 SNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCD 312
             ++I       T  IAP  VY TA  +        N N++W   VD G ++ +R HFCD
Sbjct: 256 DPSTITYPDGGATALIAPNPVYATAEEMADAQTSQPNFNLSWRMSVDFGHDYFIRLHFCD 315

Query: 313 IYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRES--DNPKLHVSIGR 370
           I   +++ L FNV+IN  SA    DL  L S A G  YY DF+   S   N  + V +G 
Sbjct: 316 IVSKSLNDLIFNVFINKLSAISALDLSSLTS-ALGTAYYADFVLNASTITNGSILVQVGP 374

Query: 371 S-TLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGLA 429
           +  L    PNAILNGLEIMK+NN+ G  D       K      G I G++S      G+ 
Sbjct: 375 TPNLQSGKPNAILNGLEIMKLNNAAGSLDGLFGVDGKYK----GPIGGMSSKKLAIAGIG 430

Query: 430 LVL---------VLLCRRRNR-------------LARGHLKADEQFAVKEGH-------- 459
            V+         VLL R + R             L   H       + K G         
Sbjct: 431 FVMALTAFLGVVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYISSKGGSTSRRMSIF 490

Query: 460 ---------ISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKV 510
                     S+ FS+  +G  FPF  +Q AT NF E+ V G+GGFGKVY G +   T+V
Sbjct: 491 GSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQV 550

Query: 511 AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL 570
           A+KRG   S QG+ EF+TEI+MLS+ RHRHLVSLIG+CDE  EMI++YEYM NG L+DHL
Sbjct: 551 AIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHL 610

Query: 571 YASN------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAK 624
           Y S        P+LSW++RLEICIG+ARGLHYLHTG+ + IIHRDVK+ NILLDENL+AK
Sbjct: 611 YGSKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAK 670

Query: 625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           V+DFGLSK  P +D+ HVSTAVKGSFGYLDPEY  +QQLT+KSDVYSFGVV+FE+LC RP
Sbjct: 671 VSDFGLSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARP 729

Query: 685 VIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID 744
           VI+P LPRE+VNL E+AM     G LE I+DP + G I   SL KFVE AEKCLA+ G+D
Sbjct: 730 VINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVD 789

Query: 745 RPSMGDVLWNLEYALQLQ 762
           RP MGDVLWNLEYALQLQ
Sbjct: 790 RPGMGDVLWNLEYALQLQ 807

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  658 bits (1697), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/803 (46%), Positives = 488/803 (60%), Gaps = 44/803 (5%)

Query: 25  TAFDPVDNYLIDCGSFTNTSAGN-RVFAADHTSTFTNLSSPQNISINASLNSISSGNYSR 83
           T F P D+ LIDCGS +++   + RVF +D   T   + + ++I ++A     S    S 
Sbjct: 50  TGFKPADDILIDCGSKSSSKTPDGRVFKSDQ-ETIQYIEAKEDIQVSAP---PSDKVASP 105

Query: 84  LYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQ- 142
           +Y TARIF   + Y F + +   H++RLHF  F ++ +++  A FSV ++ + L+ +++ 
Sbjct: 106 IYLTARIFREEATYKFHLTRPGWHWVRLHFLAFPNDKFDLQQATFSVLTEKYVLLHNFKI 165

Query: 143 -----SQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDP 197
                  + +  KEY +N+   +  L F P  +S AFINA+EV+S PDELI  S   + P
Sbjct: 166 SNNNNDSQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTALFP 225

Query: 198 QGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNT-S 256
                G   L   A ++V RVN+GG  + PQND L R W+ D  +LK  NL   V  T S
Sbjct: 226 ---VIGFSGLSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKTTPS 282

Query: 257 IVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFN 316
            + +   VT  IAP+ VY TA  + +    + N NV+WNF  +P F +L+R HFCDI   
Sbjct: 283 AIKYPPEVTPLIAPQTVYATAVEMANSLTIDPNFNVSWNFPSNPSFNYLIRLHFCDIVSK 342

Query: 317 NISSLAFNVYINSRSAQLDFDLHKLPSYAAGN---PYYMDFITRES-DNPKLHVSIGRST 372
           +++ L FNVYIN ++A    DL    S  AGN   PYY D +   +   P+L V IG   
Sbjct: 343 SLNDLYFNVYINGKTAISGLDL----STVAGNLAAPYYKDIVVNATLMGPELQVQIGPMG 398

Query: 373 LVDTFPNAILNGLEIMKINNS----RGDFDVAESTSPKSSKTRVGLIVGVAS-GSCISVG 427
                 NAILNG+E++K++NS     G+F V   T+       V     V   G+ I +G
Sbjct: 399 EDTGTKNAILNGVEVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIGLG 458

Query: 428 LALVLVLLCR-----RRNRLARGHLK---ADEQFAVKEG--HISAIFSSS-KIGYRFPFV 476
            A+V     R     +RN  +   L     D  F   +G    S  ++S+  +G  F   
Sbjct: 459 -AMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSLS 517

Query: 477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
            +QEAT NF  S +IG+GGFG VY G L D TKVAVKRG  QS QG+ EF+TEI+MLS+ 
Sbjct: 518 ELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSKL 577

Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
           RHRHLVSLIGYCDE +EMI++YE+M NG  +DHLY  N   L+W++RLEICIG+ARGLHY
Sbjct: 578 RHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLHY 637

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LHTG+ + IIHRDVKS NILLDE L+AKVADFGLSK      Q HVSTAVKGSFGYLDPE
Sbjct: 638 LHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-DVAFGQNHVSTAVKGSFGYLDPE 696

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP 716
           Y  +QQLT+KSDVYSFGVV+ E LC RP I+P LPRE+VNL EWAM+ +  G LE I+DP
Sbjct: 697 YFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIIDP 756

Query: 717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG--DEGKSSPKGET 774
            L G I P+S+ KF E AEKCL   G+DRP+MGDVLWNLEYALQLQ    +GK+  + E 
Sbjct: 757 HLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAE-ETEN 815

Query: 775 SSPNNHSHSQTGVSNTEFSTASV 797
           + P+  +     VS+    T SV
Sbjct: 816 AKPDVVTPGSVPVSDPSPITPSV 838

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1

 Score =  653 bits (1684), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 370/811 (45%), Positives = 494/811 (60%), Gaps = 29/811 (3%)

Query: 26  AFDPVDNYLIDCGSFTNTSA-GNRVFAADHTSTFTN-LSSPQNISINASLNSISSGNYSR 83
           AF P DNYLI+ GS TNTS    R F +D +   ++ LS+ ++ISI+   ++  S +   
Sbjct: 25  AFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISIS---DTNPSPDSPV 81

Query: 84  LYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQS 143
           LY+TAR+F    +Y F +  +  HFIRLHF PF    +N+ +AKF V    F++I  + S
Sbjct: 82  LYNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSF-S 140

Query: 144 QEGSSVKEYSLNIASDRLVLSFTPF-ANSFAFINALEVISLP-DELIPQSAKTIDPQGSS 201
                VKE+ L I    L +SF PF A+ F F+NA+EV S P D ++ Q  K + P  S+
Sbjct: 141 TSSVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPN-SA 199

Query: 202 TGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFT 261
               +L  Q LETV R+N+GG  + P ND LWR WV DD YL           T   N+ 
Sbjct: 200 QIFSNLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQ 259

Query: 262 DS-VTENIAPRDVYGTATIVN-SGSDPNSNVNVTWNFDVDPGFEF-LVRFHFCDIYFNNI 318
           +   T  IAP +VY TA  ++    +  +  N++W F VD      LVR HFCDI  +++
Sbjct: 260 NGGATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSL 319

Query: 319 SSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVD-TF 377
           + L FNV+IN   A  D DL  L  +   +P Y+DF+     +  L +S+G S L +   
Sbjct: 320 NQLYFNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPAR 379

Query: 378 PNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGLALVLVL-LC 436
            NA+LNG+EIM+I           S      +  V ++VG   G  + + L  + VL LC
Sbjct: 380 VNALLNGVEIMRI------LSPVSSEVVSGKRNVVWIVVGSVLGGFVFLSLFFLSVLCLC 433

Query: 437 RRRNRLARGHLKAD----EQFAVKEGHISAIFSSSKIGY---RFPFVAIQEATDNFSESL 489
           RR+N   R           +F       +   + S  GY   R  F  +Q  T+NF  SL
Sbjct: 434 RRKNNKTRSSESTGWTPLRRFRGSSNSRTTERTVSSSGYHTLRISFAELQSGTNNFDRSL 493

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           VIG+GGFG V+RG L+D TKVAVKRG   S QGL EF +EI +LS+ RHRHLVSL+GYC+
Sbjct: 494 VIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCE 553

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           E++EMI++YEYM+ G LK HLY S  P LSW++RLE+CIGAARGLHYLHTGS++ IIHRD
Sbjct: 554 EQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRD 613

Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           +KS NILLD N +AKVADFGLS+ GP +D+THVST VKGSFGYLDPEY  +QQLT+KSDV
Sbjct: 614 IKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDV 673

Query: 670 YSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNK 729
           YSFGVV+FE+LC RP +DP L RE+VNL EWA++ Q  G L+ IVDP +  +IKP SL K
Sbjct: 674 YSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKK 733

Query: 730 FVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQTGVSN 789
           F E AEKC A  G+DRP++GDVLWNLE+ LQLQ     + P+ +     +   ++ G+SN
Sbjct: 734 FAETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDVTDPRTARQGLSN 793

Query: 790 TEFSTASVGDLAG--VSMSKVFAQMVREEMR 818
                   GD     +S ++VF+Q++    R
Sbjct: 794 GSNIERDYGDGTSGIISSTQVFSQLMTNAGR 824

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SJT0|Y2214_ARATH Probable receptor-like protein kinase At2g21480 OS=Arabidopsis thaliana GN=At2g21480 PE=3 SV=1

 Score =  645 bits (1664), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 353/771 (45%), Positives = 470/771 (60%), Gaps = 45/771 (5%)

Query: 22  SVSTAFDPVDNYLIDCGSFTNT-SAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGN 80
           S +  F P D+ LIDCGS ++T +   RVF +D + T   + +  +I ++A     S   
Sbjct: 46  SPTAGFKPADDILIDCGSKSSTKTPEGRVFKSD-SETVQYIEAKDDIQVSAP---PSDKL 101

Query: 81  YSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKD 140
            S +Y TA+IF   + Y F + +   H++RLHFF F ++ +++  A FSV ++ + L+ +
Sbjct: 102 PSPIYLTAKIFREEAIYKFHLTRPGWHWVRLHFFAFPNDKFDLQQATFSVLTEKYVLLHN 161

Query: 141 YQ------SQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKT 194
           ++        + +  KEY LN+   +  L F P   S AFIN +E++S PDELI  +  +
Sbjct: 162 FKLSNDNNDSQATVQKEYLLNMTDAQFALRFKPMKGSAAFINGIELVSAPDELISDAGTS 221

Query: 195 IDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFV-S 253
           + P    +G   L   A ++V RVN+GG  + PQND L R W  D  YLK  NL   V +
Sbjct: 222 LFPVNGFSG---LSDYAYQSVYRVNVGGPLITPQNDTLGRTWTPDKEYLKDENLAKDVKT 278

Query: 254 NTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDI 313
           N + + +   VT  IAP+ VY T   +      + N NVTWNF  +P F + +R HFCDI
Sbjct: 279 NPTAIIYPPGVTPLIAPQTVYATGAEMADSQTIDPNFNVTWNFPSNPSFHYFIRLHFCDI 338

Query: 314 YFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGN---PYYMDFITRES-DNPKLHVSIG 369
              +++ L FNVYIN ++A    DL    S  AG+   PYY D +   +    +L V IG
Sbjct: 339 ISKSLNDLYFNVYINGKTAISGLDL----STVAGDLSAPYYKDIVVNSTLMTSELQVQIG 394

Query: 370 RSTLVDTFPNAILNGLEIMKINNS----RGDFDVAESTSPKSSKTRVGLIV--GVASGSC 423
                    NAILNG+E++K++NS     G+F V      ++S  + G++   G      
Sbjct: 395 PMGEDTGKKNAILNGVEVLKMSNSVNSLDGEFGV---DGQRASMGKQGMVATAGFVMMFG 451

Query: 424 ISVGLALVLVLLCRR------RNRLARGHL---KADEQFAVKE--GHISAIFSSS-KIGY 471
             VGL  ++    +R      RN  +   L     D  F   +   H S +++S+  +G 
Sbjct: 452 AFVGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTGSHKSNLYNSALGLGR 511

Query: 472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
            F    +QE T NF  S +IG+GGFG VY G + D T+VA+KRG  QS QG+ EF TEI+
Sbjct: 512 YFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGNPQSEQGITEFHTEIQ 571

Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           MLS+ RHRHLVSLIGYCDE  EMI++YEYM NG  +DHLY  N   L+W++RLEICIGAA
Sbjct: 572 MLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLSPLTWKQRLEICIGAA 631

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           RGLHYLHTG+ + IIHRDVKS NILLDE L+AKVADFGLSK      Q HVSTAVKGSFG
Sbjct: 632 RGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-DVAFGQNHVSTAVKGSFG 690

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE 711
           YLDPEY  +QQLT+KSDVYSFGVV+ E LC RP I+P LPRE+VNL EWAM  ++ G LE
Sbjct: 691 YLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMLWKQKGLLE 750

Query: 712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ 762
            I+DP L G + P+S+ KF E AEKCLA  G+DRP+MGDVLWNLEYALQLQ
Sbjct: 751 KIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLEYALQLQ 801

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SA72|Y1357_ARATH Probable receptor-like protein kinase At1g30570 OS=Arabidopsis thaliana GN=At1g30570 PE=1 SV=1

 Score =  610 bits (1572), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 333/785 (42%), Positives = 473/785 (60%), Gaps = 73/785 (9%)

Query: 32  NYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISI---NASLNSISSGN--YSRLYH 86
           ++L+DCGS   T    R +  D       LS  +++++   +A   S S G+  Y+ +Y 
Sbjct: 32  SFLVDCGSNATTEVDGRTWVGD-------LSPNKSVTLQGFDAITASTSKGSSVYAEIYK 84

Query: 87  TARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKD------ 140
           TAR+F    NY+F    Q  +F+RLHF PF  E +N++ + FSV +    L+ D      
Sbjct: 85  TARVFDAVLNYTFEGITQGNYFVRLHFSPFAIENHNVNESSFSVFADGLRLMLDINIAGE 144

Query: 141 ------------YQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELI 188
                       + +   S VKE+ L     +LVLSF P   SF F+NA+E++S+ D+L 
Sbjct: 145 IAHKNLILESTGHNATASSLVKEFLLPTGPGKLVLSFIPEKGSFGFVNAIEIVSVDDKLF 204

Query: 189 PQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDV-LWRRWVSDDAYLKHSN 247
            +S   +   G S     L  + +ET+ R+N+GG  + P  D+ L+R W +D +Y+   N
Sbjct: 205 KESVTKV---GGSEVELGLGGRGIETMYRLNVGGPKLGPSKDLKLYRTWETDLSYMVIEN 261

Query: 248 LVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVR 307
             + V N+S + +  +    +AP  VY TA ++++        N++W F+VDP F++LVR
Sbjct: 262 AGVEVKNSSNITYALADDSPVAPLLVYETARMMSNTEVLEKRFNISWKFEVDPNFDYLVR 321

Query: 308 FHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGN--PYYMDFITR-ESDNPKL 364
            HFC++  +  +   F +YIN+++A  +FD+    ++A G     Y D++    S N  L
Sbjct: 322 LHFCELLVDKQNQRIFRIYINNQTAAGNFDIF---AHAGGKNKGIYQDYLDPVSSKNDVL 378

Query: 365 HVSIGRSTLVDTFPNAILNGLEIMKI--NNSRGDFDVAESTSPKSSKTRVGLI-VGVASG 421
            + +G  + V    +A+L+GLEI K+  N +       +ST    S +++ +I + V +G
Sbjct: 379 WIQLGPDSSVGASGDALLSGLEIFKLSKNGNLAHLIRFDSTGHSVSDSKMRIIWISVGAG 438

Query: 422 SCIS---VGLALVLVLLCRRRNRLARGHLKADEQFAVKEG------HISA---------- 462
             I    V L +++V LC++R        K+DE      G      H++           
Sbjct: 439 IAIIIFFVFLGILVVCLCKKRRS------KSDESKNNPPGWRPLFLHVNNSTANAKATGG 492

Query: 463 -----IFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGT 517
                  ++S +G +F    I+ AT NF + L IG+GGFGKVYRG L D T +A+KR   
Sbjct: 493 SLRLNTLAASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATP 552

Query: 518 QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS 577
            S QGLAEF TEI MLS+ RHRHLVSLIG+CDE NEMI++YEYM NGTL+ HL+ SN P 
Sbjct: 553 HSQQGLAEFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPP 612

Query: 578 LSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL 637
           LSW++RLE CIG+ARGLHYLHTGS + IIHRDVK+ NILLDEN +AK++DFGLSK GP +
Sbjct: 613 LSWKQRLEACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSM 672

Query: 638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNL 697
           D THVSTAVKGSFGYLDPEY  +QQLTEKSDVYSFGVV+FE +C R VI+P+LP++++NL
Sbjct: 673 DHTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINL 732

Query: 698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY 757
            EWA+  Q+   LE I+D  L G   P+SL K+ EIAEKCLA  G +RP MG+VLW+LEY
Sbjct: 733 AEWALSWQKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEY 792

Query: 758 ALQLQ 762
            LQ+ 
Sbjct: 793 VLQIH 797

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1

 Score =  579 bits (1492), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 328/795 (41%), Positives = 466/795 (58%), Gaps = 82/795 (10%)

Query: 85  YHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQ 144
           Y TARIFT P+ Y   IK   RH +RL+F+P  +   N+S + F+V +   TL+ ++ + 
Sbjct: 77  YMTARIFTAPATYEIPIKGDKRHLLRLYFYPSTYTGLNISNSYFTVEANDVTLLSNFSAA 136

Query: 145 -------EGSSVKEYSLNIASDRLVLS--FTP---FANSFAFINALEVISLPD-----EL 187
                  +   VKEYSL   +D+ VLS  FTP   + ++FAFIN +EVI +P+      L
Sbjct: 137 ITCQALTQAYLVKEYSL-APTDKDVLSIKFTPSDKYRDAFAFINGIEVIQMPELFDTAAL 195

Query: 188 IPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDV--LWRRWVSDDAYLKH 245
           +  + +T+D   + T N       L+++ R+N+GG+D+P   D   L R W +D  Y+  
Sbjct: 196 VGFTDQTMD---AKTAN-------LQSMFRLNVGGQDIPGSQDSGGLTRTWYNDAPYIFS 245

Query: 246 SNL--VMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFE 303
           + L   +  SN   +N+ + +  +IAP D+Y TA       D N   N+TW F +D  F 
Sbjct: 246 AGLGVTLQASNNFRINYQN-MPVSIAPADIYKTARSQGPNGDINLKSNLTWMFQIDKNFT 304

Query: 304 FLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAA--GNPYYMDF-ITRESD 360
           +++R HFC+   + I+   FN+YIN+R+AQ D     +  +    G P Y D+ I  +++
Sbjct: 305 YILRLHFCEFQLSKINQKVFNIYINNRTAQADTTPADIIGWTGEKGIPMYKDYAIYVDAN 364

Query: 361 NPKLHVSIGRSTLVDTFP---NAILNGLEIMKINNSRGDFDVAESTSPKSSKTRV----- 412
           N    +++  +      P   ++ LNGLEI K++  +         SP  ++  V     
Sbjct: 365 NGGEEITLQMTPSTFGQPEYYDSSLNGLEIFKMDTMKNLAGPNPEPSPMQAEEEVKKEFK 424

Query: 413 -----GLIVGVASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFA---------VKEG 458
                  I+G A G      LA+++  LC    +  +G+   D   +            G
Sbjct: 425 NEKRHAFIIGSAGGV-----LAVLIGALCFTAYKKKQGYQGGDSHTSSWLPIYGNSTTSG 479

Query: 459 HISAIFSSSKIG-----------YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDE 507
             S I   S  G            RF    I+  T NF +S VIG+GGFGKVY+GV+   
Sbjct: 480 TKSTISGKSNNGSHLSNLAAGLCRRFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGT 539

Query: 508 TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLK 567
           TKVAVK+    S QGL EF TEIE+LS+ RH+HLVSLIGYCDE  EM ++Y+YM  GTL+
Sbjct: 540 TKVAVKKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLR 599

Query: 568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD 627
           +HLY +  P L+W++RLEI IGAARGLHYLHTG+   IIHRDVK+ NIL+DEN +AKV+D
Sbjct: 600 EHLYNTKKPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSD 659

Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
           FGLSK GP+++  HV+T VKGSFGYLDPEY  +QQLTEKSDVYSFGVV+FEILC RP ++
Sbjct: 660 FGLSKTGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPALN 719

Query: 688 PSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS 747
           PSLP+E+V+L +WAM C+  G LEDI+DP L G+I  + L KF + AEKCL   G++RP+
Sbjct: 720 PSLPKEQVSLGDWAMNCKRKGNLEDIIDPNLKGKINAECLKKFADTAEKCLNDSGLERPT 779

Query: 748 MGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQT----GVSNTEFSTASVGDLAGV 803
           MGDVLWNLE+ALQLQ    +++      +PNN   S+     G++        V DL+  
Sbjct: 780 MGDVLWNLEFALQLQ----ETADGTRHRTPNNGGSSEDLGRGGMAVNVAGRDDVSDLSSE 835

Query: 804 SMSKVFAQMVREEMR 818
             +++F+Q+V  + R
Sbjct: 836 DNTEIFSQIVNPKGR 850

Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	820
224109624	819	predicted protein [Populus trichocarpa]	0.989	0.990	0.663	0.0
255568229	813	kinase, putative [Ricinus communis] gi|2	0.978	0.986	0.654	0.0
359486440	827	PREDICTED: probable receptor-like protei	0.990	0.981	0.638	0.0
356542591	837	PREDICTED: receptor-like protein kinase	0.990	0.970	0.584	0.0
224054892	832	predicted protein [Populus trichocarpa]	0.987	0.973	0.586	0.0
359478665	1006	PREDICTED: receptor-like protein kinase	0.953	0.777	0.591	0.0
224104501	833	predicted protein [Populus trichocarpa]	0.973	0.957	0.592	0.0
449451880	815	PREDICTED: probable receptor-like protei	0.973	0.979	0.587	0.0
449461015	839	PREDICTED: receptor-like protein kinase	0.984	0.961	0.560	0.0
147816692	802	hypothetical protein VITISV_009237 [Viti	0.909	0.930	0.591	0.0

>gi|224109624|ref|XP_002315260.1| predicted protein [Populus trichocarpa] gi|222864300|gb|EEF01431.1| predicted protein [Populus trichocarpa]

 Score = 1060 bits (2742), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 547/825 (66%), Positives = 640/825 (77%), Gaps = 14/825 (1%)

Query: 2   MVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNL 61
           MVN+ + ELL+ + S+LCLV VS  + P DNYLIDCGS TN+S G+RVF AD + +   L
Sbjct: 1   MVNIYSCELLILIGSILCLVCVSLEYVPEDNYLIDCGSSTNSSVGDRVFVADQSYSDV-L 59

Query: 62  SSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETY 121
           S+P +IS N S +S SS   S LY TA+IF   S+Y+F IKK  RH+IRLHFFPFV+  Y
Sbjct: 60  STPHSISANTSSDSTSSTYDSALYQTAKIFNESSHYTFPIKKPGRHWIRLHFFPFVYRNY 119

Query: 122 NMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVI 181
           N S AKFSVS+Q+FTLI++Y+ +    VKEYS+N+ S  LVL+FTP  NSFAFINALEV 
Sbjct: 120 NSSMAKFSVSAQNFTLIREYRLESPPIVKEYSVNVTSGSLVLTFTPSVNSFAFINALEVF 179

Query: 182 SLPDELIPQSAKTIDPQGSSTGN-QSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDD 240
           SLPDELIP  A+TI    S  GN ++L +QALETV RVNMG + V PQND LWR WVSD+
Sbjct: 180 SLPDELIPAGARTIS---SLQGNYKNLWKQALETVERVNMGNQTVFPQNDTLWRLWVSDN 236

Query: 241 AYLKHSNLVMFVSNTSIVNFTDS-VTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVD 299
            YL H+NLV FVSN + VNFT    TENIAP  VYGTAT +NS SDPN N NVTW FDVD
Sbjct: 237 EYLIHNNLVTFVSNVTAVNFTGGGPTENIAPSLVYGTATRLNSDSDPNINANVTWLFDVD 296

Query: 300 PGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRES 359
           PGFE+LVRFHFCDI  N    L FNVYI S     + DL KL +++ G PY+MD ITR S
Sbjct: 297 PGFEYLVRFHFCDILSNPHPKLYFNVYIGSWLVYQNLDLLKL-TFSLGAPYFMDVITRAS 355

Query: 360 DNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVA 419
           D   L+VS+G S +   +PNAILNGLEIMKI+NS    DV +S S +SS+ +V ++VG+ 
Sbjct: 356 DTRLLNVSVGPSNVGVPYPNAILNGLEIMKISNSEDSLDVLDSISSRSSEVKVIIVVGLT 415

Query: 420 SGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEG------HISAIFSSSKIGYRF 473
            G  + V LA VL LLCRRR       LK++  F    G      + + IFS+SK GYRF
Sbjct: 416 VGLFLVVVLAFVLFLLCRRRKLDHADPLKSEGHFPTSGGGNNRYFNGANIFSTSKFGYRF 475

Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
           PF+ IQEATDNF+ESLV+G+GGFGKVYRGVLRDET VAVKRG +QS QG+AEFRTEIEML
Sbjct: 476 PFMVIQEATDNFTESLVLGVGGFGKVYRGVLRDETMVAVKRGTSQS-QGIAEFRTEIEML 534

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           SQFRHRHLVSLIGYCDER+EMIIIYE+MENGTLKDHLY SN PSLSWR+RLEICIGAA+G
Sbjct: 535 SQFRHRHLVSLIGYCDERDEMIIIYEFMENGTLKDHLYGSNHPSLSWRQRLEICIGAAKG 594

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           LHYLHTGST+AIIHRDVKSANILLDEN MAKVADFGLSK GP++DQ+HVSTAVKGSFGYL
Sbjct: 595 LHYLHTGSTRAIIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQSHVSTAVKGSFGYL 654

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
           DPEYL +QQLTEKSDVYSFGVVMFE++CGRPVIDPS+ RE+VNLV+WA+K    G+LE+I
Sbjct: 655 DPEYLIRQQLTEKSDVYSFGVVMFEVVCGRPVIDPSVSRERVNLVDWALKSIRGGKLEEI 714

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGE 773
           VDP L GQIKPDSL KFVEIAEKCLA+CG+DRPSMGDVLWNLE +LQLQG+E  S+    
Sbjct: 715 VDPRLEGQIKPDSLKKFVEIAEKCLAECGVDRPSMGDVLWNLECSLQLQGEERSSNNCQI 774

Query: 774 TSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
           ++  N  ++ +T VS  EFS     DL GVSMSKVFAQMVREEMR
Sbjct: 775 STQFNRGNNFETRVSAREFSLGGGDDLDGVSMSKVFAQMVREEMR 819

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255568229|ref|XP_002525090.1| kinase, putative [Ricinus communis] gi|223535671|gb|EEF37337.1| kinase, putative [Ricinus communis]

 Score = 1046 bits (2706), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 542/828 (65%), Positives = 632/828 (76%), Gaps = 26/828 (3%)

Query: 2   MVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNL 61
           MVN        W++S+LCL+ +S+ +DP D YLIDCGS +N S GNRVF +D    ++NL
Sbjct: 1   MVNSGGSGFFFWVASILCLICISSGYDPKDKYLIDCGSSSNQSVGNRVFVSDQF--YSNL 58

Query: 62  SSPQNISI-NASLNSISSGNYSR-LYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHE 119
            S  NIS  NAS + I S +Y   L+ TA IFT  S Y+F+I K  RH+IRL+F+PFV  
Sbjct: 59  LSTPNISTANASSSPIPSSSYDPSLFQTAIIFTETSQYTFTINKSGRHWIRLYFYPFVSR 118

Query: 120 TYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALE 179
             N+STA FSVS+Q+FTLIK+Y+S+ G  V EYSLN+ S  LVL+FTPFA SFAF+NALE
Sbjct: 119 NLNLSTANFSVSAQNFTLIKEYKSKIGPEVTEYSLNVTSSTLVLTFTPFAKSFAFVNALE 178

Query: 180 VISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSD 239
           V SLPDELIP  A  +     +  N SLQ +ALETV RVNMG + V PQND LWR W  D
Sbjct: 179 VFSLPDELIPPGATIV----GNHDNYSLQNRALETVERVNMGNETVSPQNDTLWRLWNYD 234

Query: 240 DAYLKHSNLVMFVSNTSIVNFT-DSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDV 298
             YL H N+  F SN   VNFT    TENIAP  VYGTATI+NS  DPN+N NVTW F+V
Sbjct: 235 GQYLTHGNIGKFESNVKAVNFTTGGPTENIAPSSVYGTATILNSAGDPNTNANVTWLFNV 294

Query: 299 DPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRE 358
           DPGFE+LVRFHFCDI   N     FNVYI S       DL K  S+  G PY++D ITR 
Sbjct: 295 DPGFEYLVRFHFCDILSGNHERFYFNVYIGSFLVVQYLDLLKETSHV-GAPYFLDVITRV 353

Query: 359 SDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGV 418
           S +  L++S+G S+  +++P AILNGLEIMKI+NS+   D+ +S S ++SK+RV LIVG+
Sbjct: 354 SHSRMLNISVGPSS-SNSYPMAILNGLEIMKISNSKDSLDILDSVSVENSKSRVILIVGL 412

Query: 419 ASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEGHI-------SAIFSSSKIGY 471
           A G  I +   L+L LLCRR+ RLA  HLKA+  FA+  G         + IFS+SK GY
Sbjct: 413 AVGLSILIVFTLILFLLCRRK-RLA--HLKAENHFAMNGGDTESKFSNGATIFSTSKFGY 469

Query: 472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           RFPF AIQEATDNFSESLV+G+GGFGKVY+G+LRDET+VAVKRG +QS QG+AEF+TEIE
Sbjct: 470 RFPFGAIQEATDNFSESLVLGVGGFGKVYKGLLRDETRVAVKRGTSQS-QGIAEFQTEIE 528

Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY SN PSLSWR+RLEICIGAA
Sbjct: 529 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYGSNQPSLSWRQRLEICIGAA 588

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +GLHYLHTGS KAIIHRDVKSANILLDEN MAKVADFGLSK GP++DQ+HVSTAVKGSFG
Sbjct: 589 KGLHYLHTGSAKAIIHRDVKSANILLDENFMAKVADFGLSKTGPEIDQSHVSTAVKGSFG 648

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE 711
           YLDPEYL +QQLTEKSDVYSFGVVMFE+LCGRPVIDPSL REKVNLVEWA+KC   GQLE
Sbjct: 649 YLDPEYLIRQQLTEKSDVYSFGVVMFEVLCGRPVIDPSLSREKVNLVEWALKCHRRGQLE 708

Query: 712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSP- 770
           +IVDP L GQIKPDSL KF EIAEKCLA+CGI RPSMGDVLWNLEYALQLQG E +SS  
Sbjct: 709 EIVDPLLEGQIKPDSLKKFGEIAEKCLAECGIYRPSMGDVLWNLEYALQLQGQEERSSHI 768

Query: 771 KGETSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
           + +T+  N  +  +  VS  +    S+GDL+GVSMSKVFAQMVREEMR
Sbjct: 769 RRQTAEINRVNSFEASVSAAQ---VSMGDLSGVSMSKVFAQMVREEMR 813

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359486440|ref|XP_002275845.2| PREDICTED: probable receptor-like protein kinase At5g59700-like [Vitis vinifera]

 Score = 1028 bits (2658), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 531/831 (63%), Positives = 635/831 (76%), Gaps = 19/831 (2%)

Query: 3   VNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLS 62
           + V  F+LL W+SS+ CL+ VS  FDP DNYLIDCGS  NTS GNR FA+D++ ++T +S
Sbjct: 1   MTVGKFDLLFWVSSIFCLMYVSLGFDPTDNYLIDCGSSKNTSVGNRTFASDNSDSYT-VS 59

Query: 63  SPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYN 122
           +P+ +  + + N+ISS   S LY TARI    ++Y+FSIK    H+IRLHFFPFV++ +N
Sbjct: 60  TPERLFASTNSNTISSNYDSSLYQTARILNETTHYTFSIKAPGWHWIRLHFFPFVYQEFN 119

Query: 123 MSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVIS 182
           +S AKFSVS ++FTLI++YQ Q  + VKEYSLNI+S  LVL+FTP ANSFAF+NALEV+S
Sbjct: 120 LSAAKFSVSVKNFTLIREYQPQNDAEVKEYSLNISSGPLVLTFTPSANSFAFVNALEVLS 179

Query: 183 LPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAY 242
           LPD LIP  A  +   GS    Q+L++QALETV RVNMG + V PQND LWR W+SD +Y
Sbjct: 180 LPDGLIPDGASVVHQPGSY---QNLEKQALETVIRVNMGNQTVFPQNDTLWRLWISDYSY 236

Query: 243 LKHSNLVMFVSNTSIVNFTDS-VTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPG 301
           LKH+NL  FVS    VN+T    T++ APR VYGTAT +N  SDP   VNVTW FDVDP 
Sbjct: 237 LKHNNLGTFVSKEDKVNYTSGGPTQDTAPRSVYGTATTINDDSDPRIMVNVTWLFDVDPE 296

Query: 302 FEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDN 361
           FE+LVRFHFCDI  ++   L FNVYIN+ +   DFDL    S   G PYYMD I +  D+
Sbjct: 297 FEYLVRFHFCDIVSSSPKMLFFNVYINALAVVTDFDLSNRTSNILGAPYYMDVIIKMGDS 356

Query: 362 PKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAES---TSPKSSKTRVGLIVGV 418
             L+VSIGRST+      AILNGLEIMK+NNS+G  DV +S   +S  SSK +V ++VG+
Sbjct: 357 RALNVSIGRSTVDSRRTMAILNGLEIMKMNNSKGSLDVLDSEVKSSKTSSKVKVWVMVGL 416

Query: 419 ASGS-CISVGLALVLVLLCRRRNRLAR-GHLKADEQFAVKEGHI-------SAIFSSSKI 469
           A G  C    LALVL LLCRRR +L+  GH   D       G++       SAIFS SKI
Sbjct: 417 AGGVLCTVAVLALVLFLLCRRRRKLSHVGHSVQDRFGENGGGNLRSRNMDGSAIFSVSKI 476

Query: 470 GYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTE 529
           GYRFPFVAIQ+ATDNFSE++V+G+GGFGKVY+G L DETKVAVKRG  QS QGLAEFRTE
Sbjct: 477 GYRFPFVAIQQATDNFSENMVLGVGGFGKVYKGTLGDETKVAVKRGLAQSRQGLAEFRTE 536

Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           IEMLSQFRHRHLVSLIGYCDER EMIIIYEYMENGTLK+HLY S+ P+LSW++RLEICIG
Sbjct: 537 IEMLSQFRHRHLVSLIGYCDERKEMIIIYEYMENGTLKNHLYGSDLPALSWKQRLEICIG 596

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
           +ARGLHYLHTG+ KAIIHRDVKSANILLDENLMAKVADFGLSKIGP++D+THVSTAVKGS
Sbjct: 597 SARGLHYLHTGTAKAIIHRDVKSANILLDENLMAKVADFGLSKIGPEIDETHVSTAVKGS 656

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ 709
           FGYLDPEYLT+QQLTEKSDVYS GVVMFE+LCGRPVIDPSLPRE+VNLVEWAMK Q  GQ
Sbjct: 657 FGYLDPEYLTRQQLTEKSDVYSLGVVMFEVLCGRPVIDPSLPREEVNLVEWAMKWQRKGQ 716

Query: 710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSS 769
           LE+I+DP L G+IKPDSL KF E AEKCLA+ G DRP+MGDVLWNLEYALQLQ    +S+
Sbjct: 717 LEEIIDPRLAGKIKPDSLKKFGETAEKCLAEYGSDRPAMGDVLWNLEYALQLQVSGERSN 776

Query: 770 PKGETSSPNNHSHSQ--TGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
             G   S    S ++  +G S   FS  S+ D+AG+SMS VF+++V+ +MR
Sbjct: 777 VNGGEMSQEAGSINRLPSGFSTAHFSMGSIDDIAGISMSAVFSELVKADMR 827

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542591|ref|XP_003539750.1| PREDICTED: receptor-like protein kinase HERK 1-like [Glycine max]

 Score =  946 bits (2445), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 492/842 (58%), Positives = 600/842 (71%), Gaps = 30/842 (3%)

Query: 2   MVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTN- 60
           M + R   L + + S+L LV  S  F P DNYLIDCGS TNT   +R F AD  S + N 
Sbjct: 1   MRDCREICLFICVLSILPLVCFSANFVPTDNYLIDCGSPTNTPIDSRNFTAD--SFYKNF 58

Query: 61  LSSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHET 120
           LS+ Q+I  + SL SI+S + S LY TARIFT PS Y+F I K+ RH+IRL+FFPF +E 
Sbjct: 59  LSTQQDIVASTSLKSITSTSDSPLYSTARIFTAPSKYTFPINKKGRHWIRLYFFPFAYEK 118

Query: 121 YNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEV 180
           YN+S AKF+VS+Q++ L+ D+  Q+   +KEYSLN+ SD LV++F+P  NS AF+NA+EV
Sbjct: 119 YNLSAAKFAVSTQNYNLLSDFSVQKNPVMKEYSLNVTSDTLVITFSPSDNSIAFVNAIEV 178

Query: 181 ISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDD 240
           +S+PD+LI   A T++P GS +G   L  QALETV RVNMGG  +   +D L R WV D+
Sbjct: 179 VSVPDDLIIDDANTLNPAGSYSG---LFAQALETVFRVNMGGPTISSGSDTLQRTWVPDE 235

Query: 241 AYLKHSNLVMFVSNTSIVNFTDS-VTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVD 299
            +L   NL    +N   V + D   TEN AP  VYGT T +NS  DP SN NVTW FDV+
Sbjct: 236 KFLIQPNLARNFTNIGAVKYVDGGPTENTAPPSVYGTLTQMNSADDPRSNFNVTWQFDVE 295

Query: 300 PGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRES 359
           P F++LVR HFCDI   +++ L FNVYINS     D DL  + +     P++ D IT  S
Sbjct: 296 PQFQYLVRLHFCDIISKSLNELYFNVYINSWFVAKDLDLSTINNNILAAPFFKDMITAPS 355

Query: 360 DNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFD----VAESTSPKSSKTRVGLI 415
            + K+ +SIG ST+   +PNAILNGLEIMK+NNS         V  S++  S   +VGLI
Sbjct: 356 ASTKIFISIGPSTVNSNYPNAILNGLEIMKMNNSVSSLSSSTAVPLSSTSGSGSKKVGLI 415

Query: 416 VGVASGSCISVGL-ALVLVLLCRRRNRLAR-GHLKADEQFAVKEGHISAIFS-------- 465
           VGV+ G+ ++V +  +   LLCR+R RL + GH K     ++ +G    + S        
Sbjct: 416 VGVSVGAFLAVVIVGVFFFLLCRKRKRLEKEGHSKTWVPLSINDGTSHTMGSKYSNATTG 475

Query: 466 --SSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGL 523
             +S  GYRFPFV +QEAT+NF ES VIGIGGFGKVY+G L D TKVAVKRG  +S QGL
Sbjct: 476 SAASNFGYRFPFVTVQEATNNFDESWVIGIGGFGKVYKGELNDGTKVAVKRGNPRSQQGL 535

Query: 524 AEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKR 583
           AEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI+IYEYME GTLK HLY S FPSLSW++R
Sbjct: 536 AEFRTEIEMLSQFRHRHLVSLIGYCDERNEMILIYEYMEKGTLKSHLYGSGFPSLSWKER 595

Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
           LEICIGAARGLHYLHTG  KA+IHRDVKSANILLDENLMAKVADFGLSK GP++DQTHVS
Sbjct: 596 LEICIGAARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVS 655

Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK 703
           TAVKGSFGYLDPEY  +QQLTEKSDVYSFGVV+FE+LC RPVIDP+LPRE VNL EW+MK
Sbjct: 656 TAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWSMK 715

Query: 704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL-- 761
            Q+ GQLE I+DPTL G+I+PDSL KF E AEKCLA  G+DRPSMGDVLWNLEYALQL  
Sbjct: 716 LQKRGQLEQIIDPTLAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQE 775

Query: 762 ---QGD--EGKSSPKGETSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREE 816
              QGD  E  ++  GE S   N+ + +  VS  +F   S+ DL+GVSMS+VF+Q+V+ E
Sbjct: 776 AVVQGDPEENSTNMIGELSPQVNNFNHEVSVSAAQFEATSLDDLSGVSMSRVFSQLVKSE 835

Query: 817 MR 818
            R
Sbjct: 836 GR 837

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224054892|ref|XP_002298383.1| predicted protein [Populus trichocarpa] gi|222845641|gb|EEE83188.1| predicted protein [Populus trichocarpa]

 Score =  946 bits (2445), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 492/839 (58%), Positives = 608/839 (72%), Gaps = 29/839 (3%)

Query: 2   MVNVRNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNL 61
           M +V +   +  L S+L LV +S+ F PVDNYLIDCGS TNT+ GNRVF AD++++   L
Sbjct: 1   MGSVGSRRFICVLLSILSLVCLSSGFTPVDNYLIDCGSLTNTTVGNRVFVADNSAS-NFL 59

Query: 62  SSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETY 121
           S+P+N   NAS+ S++SG+ S LY TARIF G S Y+F I +  RH+IRL+F+PFV  +Y
Sbjct: 60  STPKNTFANASI-SVTSGDDSPLYQTARIFDGTSKYTFLINQPGRHWIRLYFYPFVSGSY 118

Query: 122 NMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVI 181
           NMS A F VS+ ++  + ++ S + S VKE+S+N+ S  LV++ TP  NSFAF+NALEV+
Sbjct: 119 NMSNASFGVSTLNYAFLSNF-SVKASVVKEFSVNVTSKNLVITITPSGNSFAFLNALEVV 177

Query: 182 SLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDA 241
           S+PDELI   A+T +P G   G   L  QALETV RVNMGG  V  +ND L R WV D +
Sbjct: 178 SVPDELITDDAETFNPVGRFKG---LSWQALETVHRVNMGGPTVSFENDTLGRTWVPDQS 234

Query: 242 YLKHSNLVMFVSNTSIVNFT-DSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDP 300
           +L  +NL + VSN + V +     T++ AP  VYGTA+ +NS ++P+SN NVTW F+V P
Sbjct: 235 FLIQNNLAINVSNIAAVKYVVGGATQDSAPNAVYGTASRMNSDNNPSSNFNVTWEFNVQP 294

Query: 301 GFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESD 360
           GF++LVRFHFCDI   N++ L F+VYI+S     + D   + +  A   +YMDF+T  + 
Sbjct: 295 GFQYLVRFHFCDIVSRNLNELYFDVYIDSWLVAENVDPSTIANTLA-VAFYMDFVTAATV 353

Query: 361 NPKLHVSIGRS-TLVDTFPNAILNGLEIMKINNSRGDFD-VAESTSPKSSKTRVGLIVGV 418
           + KL VSIG + T+   +PNAILNGLEIMK+NNS G     A + +  SSK  VG+IVG+
Sbjct: 354 SNKLRVSIGPTNTISSAYPNAILNGLEIMKMNNSLGSLSGTAPAVANSSSKKNVGVIVGL 413

Query: 419 ASGSCISVGLALVLVLLCRRRNRLAR-GHLKADEQFAVKEGHISAIFS----------SS 467
           + G+ I   LA +  + CR+R RLAR GH K    F++  G+   + S            
Sbjct: 414 SIGALILAVLAGIFFMFCRKRRRLARQGHSKTWIPFSINGGNSHTMGSKYSNGTATSLGY 473

Query: 468 KIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR 527
            +GYR PFVA+QEAT++F ES VIGIGGFGKVYRGVL D TKVAVKRG  +S QGLAEF+
Sbjct: 474 NLGYRIPFVAVQEATNSFDESWVIGIGGFGKVYRGVLNDGTKVAVKRGNPRSQQGLAEFQ 533

Query: 528 TEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
           TEIEMLSQFRHRHLVSLIGYCDE+NEMI+IYEYMENGTLK HLY S  P+LSW+ RLEIC
Sbjct: 534 TEIEMLSQFRHRHLVSLIGYCDEKNEMILIYEYMENGTLKSHLYGSGSPTLSWKDRLEIC 593

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           IGAARGLHYLHTG  KA+IHRDVKSANILLDENLMAKVADFGLSK GP++DQTHVSTAVK
Sbjct: 594 IGAARGLHYLHTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVK 653

Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
           GSFGYLDPEY  +QQLTEKSDVYSFGVV+ E+LC RPVIDPSLPRE VNL EWAMK Q+ 
Sbjct: 654 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLLEVLCARPVIDPSLPREMVNLAEWAMKWQKR 713

Query: 708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ----- 762
           GQLE I+D  L G+I+PDSL KF E AEKCLA  G+DRPSMGD+LWNLEYALQLQ     
Sbjct: 714 GQLEQIIDAALAGKIRPDSLRKFGETAEKCLADFGVDRPSMGDILWNLEYALQLQEAVLP 773

Query: 763 GD--EGKSSPKGETSSP-NNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
           GD  E  ++  GE S   NN SHS   VS  +F  +SV  L+GVSMS+VF+Q+V+ E R
Sbjct: 774 GDPEENSTNMIGELSPQINNFSHSDDSVSAAQFEASSVDGLSGVSMSRVFSQLVKSEGR 832

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359478665|ref|XP_002281617.2| PREDICTED: receptor-like protein kinase HERK 1-like [Vitis vinifera]

 Score =  936 bits (2420), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 478/808 (59%), Positives = 585/808 (72%), Gaps = 26/808 (3%)

Query: 31   DNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARI 90
            D+YLIDCGS TNTS   RVF AD TS++  LS+P+ +  N +  S SS +   LY TARI
Sbjct: 205  DDYLIDCGSTTNTSVAGRVFLAD-TSSY--LSTPEKLLANTATKSDSSSDDLPLYQTARI 261

Query: 91   FTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVK 150
            FTG S Y+FS+    R++IRL+FFPFV++TYNMSTA FSVS+Q+  LI ++  + GS++K
Sbjct: 262  FTGTSKYTFSVGSNRRYWIRLYFFPFVYDTYNMSTANFSVSTQNHVLISNFSPKAGSAMK 321

Query: 151  EYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQ 210
            E+S N+ SD LV++F P +NSFAF+NALEV+S+P+ELI   A TI P G   G   L  Q
Sbjct: 322  EFSENVTSDTLVITFAPSSNSFAFLNALEVVSVPNELISDDAITITPSGKFKG---LVTQ 378

Query: 211  ALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDS-VTENIA 269
            ALETVARVNMGG  V  +ND LWR W+ D  +L  +NL   VS    V +     T+ IA
Sbjct: 379  ALETVARVNMGGPTVTSENDTLWRTWLPDQNFLVENNLATNVSKIGAVIYAKGGPTKLIA 438

Query: 270  PRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINS 329
            P  VYGTAT +NS ++P  N NVTW FDVDPGF++LVR+HFCDI   +++ L FNVY++S
Sbjct: 439  PASVYGTATKMNSDANPQYNFNVTWEFDVDPGFQYLVRYHFCDIVSISLNQLYFNVYLDS 498

Query: 330  RSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMK 389
                 + DL  L     G PYY+D +T      KL VSIG S++   +P+AILNGLEIMK
Sbjct: 499  YLVYEELDLSTLAFNILGAPYYLDVVTGTRVGSKLRVSIGPSSIHTEYPDAILNGLEIMK 558

Query: 390  INNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGLALVLVLLCRRRNRLAR-GHLK 448
            +N+S G    +   S  SSK  V +++G + G   ++ LA V  L+ RRR +LAR GH K
Sbjct: 559  MNSSMGSLSGSVIVSNPSSKKNVAVVIGASVGVFAALILAGVFFLVYRRRRKLARQGHSK 618

Query: 449  ADEQFAVKEGHISAIFS----------SSKIGYRFPFVAIQEATDNFSESLVIGIGGFGK 498
                F+   G+   + S           S  GYR PF+A+QEAT+NF ES VIGIGGFGK
Sbjct: 619  TWMAFSTNGGNSHTMGSKYSNGTIASAGSNFGYRIPFLAVQEATNNFDESWVIGIGGFGK 678

Query: 499  VYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY 558
            VY+G L D TKVAVKRG  +S QGLAEF+TEIEMLSQFRHRHLVSLIGYCDE+NEMI+IY
Sbjct: 679  VYKGTLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHRHLVSLIGYCDEKNEMILIY 738

Query: 559  EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD 618
            EYMENGT+K HLY S  PSL W++RLEICIGAARGLHYLHTG  KA+IHRDVKSANILLD
Sbjct: 739  EYMENGTVKSHLYGSGLPSLDWKERLEICIGAARGLHYLHTGYAKAVIHRDVKSANILLD 798

Query: 619  ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
            ENLMAKVADFGLSK GP++DQTHVSTAVKGSFGYLDPEY  +QQLTEKSDVYSFGVV+FE
Sbjct: 799  ENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFE 858

Query: 679  ILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCL 738
            +LC RPVIDP+LPRE VNL EWAMK Q+ GQLE I+DP L G+I+PDSL KF E AEKCL
Sbjct: 859  VLCARPVIDPTLPREMVNLAEWAMKWQKRGQLEQIIDPNLVGKIRPDSLRKFGETAEKCL 918

Query: 739  AQCGIDRPSMGDVLWNLEYALQLQ-----GD--EGKSSPKGETSSP-NNHSHSQTGVSNT 790
            +  G+DRPSMGD+LWNLEYALQLQ     GD  E  ++  GE +   NN +H+ T VS  
Sbjct: 919  SDFGVDRPSMGDILWNLEYALQLQEAVLVGDPEENSTNLIGELAPQVNNFNHADTSVSAA 978

Query: 791  EFSTASVGDLAGVSMSKVFAQMVREEMR 818
            +F  +SV DL+G+SMS+VF+Q+V+ E R
Sbjct: 979  QFEVSSVDDLSGISMSRVFSQLVKSEGR 1006

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104501|ref|XP_002313457.1| predicted protein [Populus trichocarpa] gi|222849865|gb|EEE87412.1| predicted protein [Populus trichocarpa]

 Score =  932 bits (2408), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 490/827 (59%), Positives = 600/827 (72%), Gaps = 29/827 (3%)

Query: 14  LSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASL 73
           L +VL L  +S+ F PVDNYLIDCGS TNT+ G RVF AD +++   LS+P++ ++ +S 
Sbjct: 14  LLTVLILAFLSSGFTPVDNYLIDCGSPTNTTVGGRVFVADDSASIF-LSTPKS-TLASSS 71

Query: 74  NSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQ 133
            S++SG+ S LY TARIF G S YSFSI++  RH+IRL+F PFV  +Y+MS A F VS+ 
Sbjct: 72  KSVTSGDDSPLYQTARIFDGTSKYSFSIRQPGRHWIRLYFNPFVSGSYDMSGASFDVSTP 131

Query: 134 SFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAK 193
           +   + ++ S + S VKE+S N+ S  LV++FTP  NSFAF+NALEV+S+PDELI   A+
Sbjct: 132 NHVFLSNF-SVKTSVVKEFSANVTSKDLVITFTPSGNSFAFLNALEVVSVPDELITDDAE 190

Query: 194 TIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVS 253
           T +P G   G   L  QALETV RVNMGG  V  +ND L R WV D +YL  +NL   VS
Sbjct: 191 TFNPAGRFKG---LSWQALETVYRVNMGGPTVSFENDTLGRTWVPDKSYLVGNNLATNVS 247

Query: 254 NTSIVNF-TDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCD 312
           N + V +     T++ AP  VYGTA  +NS +DPNSN NVTW F+V+PGF++LVRFHFCD
Sbjct: 248 NIAAVKYVAGGATQDSAPNAVYGTAIRMNSENDPNSNFNVTWEFNVNPGFQYLVRFHFCD 307

Query: 313 IYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRS- 371
           I  +++++L FNVYI+S     D D     + A    +Y DF+T  + + KL VSIG + 
Sbjct: 308 IVSSSLNNLYFNVYIDSWLVAEDEDPSSFAN-ALAVAFYKDFVTAATVSNKLRVSIGPTN 366

Query: 372 TLVDTFPNAILNGLEIMKINNSRGDFD-VAESTSPKSSKTRVGLIVGVASGSCISVGLAL 430
           T+   +PNAILNGLEIMK+NNS G     A   S  SSK  VG+IVG++ G+ I V LA 
Sbjct: 367 TIAVAYPNAILNGLEIMKMNNSLGSLSGPAPDVSDSSSKKNVGVIVGLSIGAVILVVLAG 426

Query: 431 VLVLLCRRRNRLAR-GHLKADEQFAVKEGHISAIFSS----------SKIGYRFPFVAIQ 479
           +  + CR+R RLAR G+ K     ++  G+   + +           S +GY  PF A+ 
Sbjct: 427 IFFVFCRKRRRLARQGNSKMWIPLSINGGNSHTMGTKYSNGTTATLDSNLGYCIPFAAVH 486

Query: 480 EATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR 539
           EAT+NF ES VIGIGGFGKVY+GVL D TKVAVKRG  +S QGLAEF+TEIEMLSQFRHR
Sbjct: 487 EATNNFDESWVIGIGGFGKVYKGVLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFRHR 546

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           HLVSLIGYCDE+NEMI+IYEYMENGTLK HLY S  PSL W+ RLEICIGAARGLHYLHT
Sbjct: 547 HLVSLIGYCDEKNEMILIYEYMENGTLKSHLYGSGSPSLCWKDRLEICIGAARGLHYLHT 606

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
           G  KA+IHRDVKSANILLDENLMAKVADFGLSK GP++DQTHVSTAVKGSFGYLDPEY  
Sbjct: 607 GYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFR 666

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           +QQLTEKSD+YSFGVV+FE+LC RPVIDPSLPRE VNL EWAMK Q+ GQLE+I+DPTL 
Sbjct: 667 RQQLTEKSDIYSFGVVLFEVLCARPVIDPSLPREMVNLAEWAMKWQKRGQLEEIIDPTLV 726

Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ-----GDEGKSSPK--G 772
           G+I+PDSL KF E AEKCLA  G+DRPSMGDVLWNLEYALQLQ     GD   +S    G
Sbjct: 727 GKIRPDSLRKFGETAEKCLADFGVDRPSMGDVLWNLEYALQLQEAVVLGDPEDNSINMIG 786

Query: 773 ETSSP-NNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
           E S   NN SH+ + VS  +F  +SV DL+GVSMS+VF+Q+V+ E R
Sbjct: 787 ELSPQINNFSHTDSSVSAAKFEASSVDDLSGVSMSRVFSQLVKSEGR 833

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449451880|ref|XP_004143688.1| PREDICTED: probable receptor-like protein kinase At2g39360-like [Cucumis sativus] gi|449507582|ref|XP_004163073.1| PREDICTED: probable receptor-like protein kinase At2g39360-like [Cucumis sativus]

 Score =  919 bits (2376), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 485/825 (58%), Positives = 603/825 (73%), Gaps = 27/825 (3%)

Query: 7   NFELLLWLSSVLCLVSVSTA-FDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQ 65
           N   L+W+   LCL S   + F P DN+LIDCGS +N + G+R+F +D      +LSS  
Sbjct: 5   NANFLIWILCALCLSSSLLSEFTPDDNFLIDCGSSSNNTVGDRLFLSDDNPNGKSLSSTS 64

Query: 66  NISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMST 125
            +S ++ L+  SS     L+ TA++F     Y+F IKKQ RH+IRL+F PFV   +N+S 
Sbjct: 65  KVSTSSELDMFSS-----LFQTAKVFETTFQYNFKIKKQGRHWIRLYFDPFVSGNFNLSL 119

Query: 126 AKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPD 185
           AKFSVS+Q+ TL+K++Q + GS +KEYSLN+ S  LVL+FTP  NSFAFINALEV+S+P+
Sbjct: 120 AKFSVSAQNITLLKEFQIESGSIIKEYSLNLTSSNLVLTFTPIVNSFAFINALEVVSVPN 179

Query: 186 ELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKH 245
           ELIP +  +++   +S GN+     ALETVARVNMG + + P +D L R WV+D  YL H
Sbjct: 180 ELIPLTVTSVEKVENSLGNR-----ALETVARVNMGNRTMLPDDDTLSRLWVADGPYLMH 234

Query: 246 SNLVM---FVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGF 302
           +N V+   FVSN + VN T  + E  APR VYGTAT +    D   NVNV+W+FDVDPG+
Sbjct: 235 NNQVVVGKFVSNLTKVNMTGGL-EIKAPRFVYGTATQLGVDGDTFVNVNVSWSFDVDPGY 293

Query: 303 EFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNP 362
           E+L+R+HFCDI  ++   + FNVY+NS    +  DL  + S   G PY +D I    D+ 
Sbjct: 294 EYLIRYHFCDIIDHSFGPMVFNVYVNSWKV-VHLDLDNVTSNIRGAPYVLDTIASPIDSS 352

Query: 363 KLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAE--STSPKSSKTRVGLIVGVAS 420
           K  +S+G +   D F  AILNGLEIMKI++SR   D       S K S  +VGLI G+ +
Sbjct: 353 KFKISVGPTNFHD-FSTAILNGLEIMKISDSRRSLDEPPFGLDSKKGSNVKVGLIAGLVA 411

Query: 421 GSCISVGLALVLVLLCRRR--NRLARGHLKADEQFAV--KEGHI---SAIFSSSKIGYRF 473
           G  +   LA ++++LCRRR  + L R HLK +E   V  +E +    S  FS+SK GYR+
Sbjct: 412 GLVVLAILATLVIVLCRRRRRSALVR-HLKEEENLGVNGRESNYTIGSVAFSNSKFGYRY 470

Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
              AIQEATDNFSESL IG+GGFGKVY+G+LRD T+VAVKRG ++S QGLAEF+TEIEML
Sbjct: 471 SLAAIQEATDNFSESLAIGVGGFGKVYKGMLRDNTEVAVKRGTSKSMQGLAEFQTEIEML 530

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           SQFRHRHLVSLIGYCDE+NEMIIIYEYME GTLKDHLY S  PSLSW++RL+ICIG+ARG
Sbjct: 531 SQFRHRHLVSLIGYCDEQNEMIIIYEYMEKGTLKDHLYGSELPSLSWKQRLDICIGSARG 590

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           LHYLHTGSTKAIIHRDVK+ANILLD+N MAKVADFGLSKIGP+ D+THVSTAVKGSFGYL
Sbjct: 591 LHYLHTGSTKAIIHRDVKTANILLDQNYMAKVADFGLSKIGPEFDKTHVSTAVKGSFGYL 650

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
           DPEYLT QQLTEKSDVYSFGVVMFE+LCGRPVIDPSLPREKVNL+EW M+ ++  QLE I
Sbjct: 651 DPEYLTMQQLTEKSDVYSFGVVMFEVLCGRPVIDPSLPREKVNLIEWVMRRKDKDQLEAI 710

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGE 773
           VD  +  QIK +SL K+VE AEKCLA+CG+DRP+MG+VLWNLE ALQLQGDE     K  
Sbjct: 711 VDARIVEQIKLESLKKYVETAEKCLAECGMDRPTMGNVLWNLECALQLQGDEKSRHGKES 770

Query: 774 TSSPNNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
           +S  +  +H +  VS T+FST S  D+A +SMSKVFAQMVRE+MR
Sbjct: 771 SSQADLSNHWEASVSTTQFSTGSAVDIASMSMSKVFAQMVREDMR 815

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461015|ref|XP_004148239.1| PREDICTED: receptor-like protein kinase HERK 1-like [Cucumis sativus] gi|449523606|ref|XP_004168814.1| PREDICTED: receptor-like protein kinase HERK 1-like [Cucumis sativus]

 Score =  907 bits (2343), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 471/841 (56%), Positives = 577/841 (68%), Gaps = 34/841 (4%)

Query: 6   RNFELLLWLSSVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQ 65
           R F LL W+  +  L S+   F+PVDNYLIDCGS  N S GNRVF AD       LS+PQ
Sbjct: 5   RRFGLLSWVLFISLLPSIFCLFNPVDNYLIDCGSAANVSVGNRVFMADDNLASKFLSTPQ 64

Query: 66  NISINASLNSI--SSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNM 123
            I  + + +S+  +S N S L+ TAR+FTG S Y F IK   RH+IRL+FFPFV   YNM
Sbjct: 65  VIMADTNTSSLLATSSNDSLLFKTARVFTGTSKYKFPIKA-GRHWIRLYFFPFVFSVYNM 123

Query: 124 STAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISL 183
           S A FSVS+Q F L++D    +   +KE+S+N+ASD L + F P   S A++NA+EVIS+
Sbjct: 124 SAANFSVSTQDFVLLRDLAGGKNPIIKEFSVNLASDTLEVIFAPVNGSIAYVNAIEVISV 183

Query: 184 PDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYL 243
           PD LI   A  ++P G     Q L  QA ETVARVNMGG  V P ND L R WVSDD+++
Sbjct: 184 PDILIGDEAILLEPSGKF---QGLSNQAYETVARVNMGGPKVAPDNDPLTRSWVSDDSFI 240

Query: 244 KHSNLVMFVSNTSIVNFT-DSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGF 302
            + NL    SN + V ++ +     IAP  VYGT + +NS  DPNSN NVTW F VDP F
Sbjct: 241 VNKNLATSFSNIAAVKYSAEGAAPEIAPNVVYGTLSEMNSKDDPNSNFNVTWKFKVDPEF 300

Query: 303 EFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNP 362
           ++LVRFHFCDI   ++  L FNVYI+S       DL    + A    YY+D ++   +N 
Sbjct: 301 QYLVRFHFCDIVSKSLHELYFNVYIDSWLVVGGLDLSVPLNNALSTAYYIDSVSGVINND 360

Query: 363 KLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAEST----SPKSSKTRVGLIVGV 418
           +L VSIG + + + +PNAILNGLEIMK+NNS G     +S        SS   +G+IVGV
Sbjct: 361 ELLVSIGPANIANVYPNAILNGLEIMKMNNSVGSLSGKDSVISFPDSNSSSKHIGVIVGV 420

Query: 419 ASGSCISVGLALVLVLLCRRRNR-------------LARGHLKADEQFAVKEGHISAIFS 465
             G+ ++  L  +L +L +RR +                G +          G I++  +
Sbjct: 421 CVGAFVAALLVGILFILHKRRRKGMHQATSKTWISISTAGEMSHTMGSKYSNGTITS--A 478

Query: 466 SSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE 525
           +S  GYR PF  +QEAT+NF ES VIGIGGFGKVY+GVL D TKVAVKRG  +S QGLAE
Sbjct: 479 ASNYGYRIPFATVQEATNNFDESWVIGIGGFGKVYKGVLNDGTKVAVKRGNPRSQQGLAE 538

Query: 526 FRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE 585
           F+TEIEMLSQFRHRHLVSLIGYCDERNEMI+IYEYME GTLK HLY S+FPSLSW++RLE
Sbjct: 539 FQTEIEMLSQFRHRHLVSLIGYCDERNEMILIYEYMEQGTLKSHLYGSDFPSLSWKERLE 598

Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +CIGAARGLHYLHTG  K +IHRDVKSANILLDE LMAKVADFGLSK GP++DQTHVSTA
Sbjct: 599 VCIGAARGLHYLHTGYAKPVIHRDVKSANILLDETLMAKVADFGLSKTGPEIDQTHVSTA 658

Query: 646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ 705
           VKGSFGYLDPEY  +QQLTEKSDVYSFGVV+FE+LC RPVIDP+LPRE VNL EWAMK Q
Sbjct: 659 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQ 718

Query: 706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDE 765
           + GQL+ I+D TL G+I+  SL KF E AEKCLA  G+DRPSMGDVLWNLEYALQLQ   
Sbjct: 719 KKGQLDQIIDSTLVGKIRSTSLRKFGETAEKCLADYGVDRPSMGDVLWNLEYALQLQEAV 778

Query: 766 GKSSPKGETS------SP--NNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEM 817
            ++ P+  ++      SP  NN ++ + GVS T F    V DL+GVSMS+VF+Q+V+ E 
Sbjct: 779 IETDPEDNSTNMIGELSPQINNFNNIEAGVSATRFDIPGVDDLSGVSMSRVFSQLVKSEG 838

Query: 818 R 818
           R
Sbjct: 839 R 839

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147816692|emb|CAN77769.1| hypothetical protein VITISV_009237 [Vitis vinifera]

 Score =  900 bits (2326), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/769 (59%), Positives = 557/769 (72%), Gaps = 23/769 (2%)

Query: 70  NASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFS 129
           N +  S SS +   LY TARIFTG S Y+FS+    R++IRL+FFPFV++TYNMSTA FS
Sbjct: 37  NTATKSDSSSDDLPLYQTARIFTGTSKYTFSVGSNRRYWIRLYFFPFVYDTYNMSTANFS 96

Query: 130 VSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIP 189
           VS+Q+  LI ++  + GS++KE+S N+ SD LV++F P ++SFAF+NALEV+S+P+ELI 
Sbjct: 97  VSTQNHVLISNFSPKAGSAMKEFSENVTSDTLVITFAPSSDSFAFLNALEVVSVPNELIS 156

Query: 190 QSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLV 249
             A TI P G   G   L  QALETVARVNMGG  V  +ND LWR W+ D  +L  +NL 
Sbjct: 157 DDAITITPSGKFKG---LVTQALETVARVNMGGPTVTSENDTLWRTWLPDQNFLVENNLA 213

Query: 250 MFVSNTSIVNFTDS-VTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRF 308
             VS    V +     T+ IAP  VYGTAT +NS ++P  N NVTW FDVDPGF++LVR+
Sbjct: 214 TNVSKIGAVIYAKGGPTKLIAPASVYGTATKMNSDANPQYNFNVTWEFDVDPGFQYLVRY 273

Query: 309 HFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSI 368
           HFCDI   +++ L FNVY++S     + DL  L     G PYY+D +T      KL VSI
Sbjct: 274 HFCDIVSISLNQLYFNVYLDSYLVYEELDLSTLAFNILGAPYYLDVVTGTRVGSKLRVSI 333

Query: 369 GRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGL 428
           G S++   +P+AILNGLEIMK+N+S G    +   S  SSK  V +++G + G   ++ L
Sbjct: 334 GPSSIHTEYPDAILNGLEIMKMNSSMGSLSGSVIVSNPSSKKNVAVVIGASVGVFAALIL 393

Query: 429 ALVLVLLCRRRNRLAR-GHLKADEQFAVKEGHISAIFSS----------SKIGYRFPFVA 477
           A V  L+ RRR +LAR GH K    F+   G+   + S           S  GYR PF+A
Sbjct: 394 AGVFFLVYRRRRKLARQGHSKTWMAFSTNGGNSHTMGSKYSNGTXASAGSNFGYRIPFLA 453

Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR 537
           +QEAT+NF ES VIGIGGFGKVY+G L D TKVAVKRG  +S QGLAEF+TEIEMLSQFR
Sbjct: 454 VQEATNNFDESWVIGIGGFGKVYKGTLNDGTKVAVKRGNPRSQQGLAEFQTEIEMLSQFR 513

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           HRHLVSLIGYCDE+NEMI+IYEYMENGT+K HLY S  PSL W++RLEICIGAARGLHYL
Sbjct: 514 HRHLVSLIGYCDEKNEMILIYEYMENGTVKSHLYGSGLPSLDWKERLEICIGAARGLHYL 573

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           HTG  KA+IHRDVKSANILLDENLMAKVADFGLSK GP++DQTHVSTAVKGSFGYLDPEY
Sbjct: 574 HTGYAKAVIHRDVKSANILLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEY 633

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT 717
             +QQLTEKSDVYSFGVV+FE+LC RPVIDP+LPRE VNL EWAMK Q+ GQLE I+DP 
Sbjct: 634 FRRQQLTEKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKRGQLEQIIDPN 693

Query: 718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ-----GD--EGKSSP 770
           L G+I+PDSL KF E AEKCL+  G+DRPSMGD+LWNLEYALQLQ     GD  E  ++ 
Sbjct: 694 LVGKIRPDSLRKFGETAEKCLSDFGVDRPSMGDILWNLEYALQLQEAVLVGDPEENSTNL 753

Query: 771 KGETSSP-NNHSHSQTGVSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
            GE +   NN +H+ T VS  +F  +SV DL+G+SMS+VF+Q+V+ E R
Sbjct: 754 IGELAPQVNNFNHADTSVSAAQFEVSSVDDLSGISMSRVFSQLVKSEGR 802

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	820
TAIR|locus:2075346	830	HERK1 "hercules receptor kinas	0.952	0.940	0.548	1.8e-222
TAIR|locus:2174249	829	AT5G59700 [Arabidopsis thalian	0.946	0.936	0.543	2.8e-217
TAIR|locus:2039717	815	AT2G39360 [Arabidopsis thalian	0.930	0.936	0.501	2.8e-192
TAIR|locus:2151349	855	THE1 "THESEUS1" [Arabidopsis t	0.393	0.377	0.665	2.1e-182
TAIR|locus:2163158	842	AT5G61350 [Arabidopsis thalian	0.373	0.363	0.654	1.5e-175
TAIR|locus:2178707	824	AT5G24010 [Arabidopsis thalian	0.948	0.944	0.443	2.9e-167
TAIR|locus:2081895	895	FER "FERONIA" [Arabidopsis tha	0.371	0.340	0.638	3.3e-157
TAIR|locus:2204564	849	HERK2 "hercules receptor kinas	0.396	0.382	0.607	1e-156
TAIR|locus:2136338	878	AT4G39110 [Arabidopsis thalian	0.924	0.863	0.440	4.9e-156
TAIR|locus:2050080	871	AT2G21480 [Arabidopsis thalian	0.802	0.755	0.470	8.5e-152

TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2148 (761.2 bits), Expect = 1.8e-222, P = 1.8e-222
 Identities = 448/817 (54%), Positives = 551/817 (67%)

Query:    27 FDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQXXXXXXXXXXXXXGNY-SRLY 85
             F PVDNYLI+CGS TN +   R+F +D  S+    SS +             GN  S +Y
Sbjct:    25 FTPVDNYLINCGSPTNGTLMGRIFLSDKLSSKLLTSSKEILASVG-------GNSGSDIY 77

Query:    86 HTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQE 145
             HTAR+FT  S+Y FS+ +  RH++RL+F PF ++ + M +AKF+VSSQS  L+ D+    
Sbjct:    78 HTARVFTEVSSYKFSVTR-GRHWVRLYFNPFDYQNFKMGSAKFAVSSQSHVLLSDFTVTS 136

Query:   146 GSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQ 205
                VKEYSLN+ ++ LVL+FTP + SFAF+NA+EVIS+PD LI  S + +   G+     
Sbjct:   137 SKVVKEYSLNVTTNDLVLTFTPSSGSFAFVNAIEVISIPDTLITGSPRFV---GNPAQFP 193

Query:   206 SLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDS-V 264
              +  Q LET+ RVNMGG  V   ND L R WV D  +L   NL   +S  S VNF     
Sbjct:   194 DMSMQGLETIHRVNMGGPLVASNNDTLTRTWVPDSEFLLEKNLAKSMSKFSTVNFVPGYA 253

Query:   265 TENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFN 324
             TE+ APR VYG+ T +NS  +PNS  NVTW FDVDPGF++  RFHFCDI   +++ L FN
Sbjct:   254 TEDSAPRTVYGSCTEMNSADNPNSIFNVTWEFDVDPGFQYYFRFHFCDIVSLSLNQLYFN 313

Query:   325 VYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRE-SDNPKLHVSIGRSTLVDTFPNAILN 383
             +Y++S  A  D DL  L        Y MDF+T+    + K+ VSIG ST+   +PNAI+N
Sbjct:   314 LYVDSMVAATDIDLSTLVDNTLAGAYSMDFVTQTPKGSNKVRVSIGPSTVHTDYPNAIVN 373

Query:   384 GLEIMKINNSRGDFDVAEST--SPKSSKTRVGLIVGVASGSCISVGXXXXXXXXXXXXXX 441
             GLEIMK+NNS+G          S  SSK+ +GLIVG A GS ++V               
Sbjct:   374 GLEIMKMNNSKGQLSTGTFVPGSSSSSKSNLGLIVGSAIGSLLAVVFLGSCFVLYKKRKR 433

Query:   442 XXXGHLKADEQFAVKEGHISAIFSS--------SKIGYRFPFVAIQEATDNFSESLVIGI 493
                GH K    F++    + + +S+        +   YR PF A+++AT+NF ES  IG+
Sbjct:   434 GQDGHSKTWMPFSINGTSMGSKYSNGTTLTSITTNANYRIPFAAVKDATNNFDESRNIGV 493

Query:   494 GGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE 553
             GGFGKVY+G L D TKVAVKRG  +S QGLAEFRTEIEMLSQFRHRHLVSLIGYCDE NE
Sbjct:   494 GGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNE 553

Query:   554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSA 613
             MI+IYEYMENGT+K HLY S  PSL+W++RLEICIGAARGLHYLHTG +K +IHRDVKSA
Sbjct:   554 MILIYEYMENGTVKSHLYGSGLPSLTWKQRLEICIGAARGLHYLHTGDSKPVIHRDVKSA 613

Query:   614 NILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFG 673
             NILLDEN MAKVADFGLSK GP+LDQTHVSTAVKGSFGYLDPEY  +QQLT+KSDVYSFG
Sbjct:   614 NILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFG 673

Query:   674 VVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEI 733
             VV+FE+LC RPVIDP+LPRE VNL EWAMK Q+ GQL+ I+D +L G I+PDSL KF E 
Sbjct:   674 VVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQIIDQSLRGNIRPDSLRKFAET 733

Query:   734 AEKCLAQCGIDRPSMGDVLWNLEYALQLQ-----GDEGKSSPK--GETSSP-NNHSHSQT 785
              EKCLA  G+DRPSMGDVLWNLEYALQLQ     G+   +S    GE     NN S   T
Sbjct:   734 GEKCLADYGVDRPSMGDVLWNLEYALQLQEAVIDGEPEDNSTNMIGELPPQINNFSQGDT 793

Query:   786 GVS--NT--EFSTASVGDLAGVSMSKVFAQMVREEMR 818
              V+   T   F  +S+ DL+GVSMSKVF+Q+V+ E R
Sbjct:   794 SVNVPGTAGRFEESSIDDLSGVSMSKVFSQLVKSEGR 830

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2174249 AT5G59700 [Arabidopsis thaliana (taxid:3702)]

 Score = 2099 (743.9 bits), Expect = 2.8e-217, P = 2.8e-217
 Identities = 444/817 (54%), Positives = 550/817 (67%)

Query:    29 PVDNYLIDCGSFTNTSAGNRVFAADH-TSTFTNLSSPQXXXXXXXXXXXXXGNYSRLYHT 87
             PVDNYLI+CGS TN +  +RVF +D+  S F  L+SP               + S +Y T
Sbjct:    27 PVDNYLINCGSSTNVTVTSRVFISDNLASNF--LTSPNEILAASNR-----NSNSDIYQT 79

Query:    88 ARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGS 147
             ARIFTG S Y FS+ +  RH+IRLHF PF ++ + M +AKFSVSS++  L+ D+ +    
Sbjct:    80 ARIFTGISKYRFSVAR-GRHWIRLHFNPFQYQNFQMVSAKFSVSSETHVLLSDF-TVSSR 137

Query:   148 SVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQ--GSSTGNQ 205
              +KEYSLN+A+D L L+FTP  +SFAF+NALEV+S+PD L        DP   GS    Q
Sbjct:   138 VMKEYSLNVATDHLELTFTPSGDSFAFLNALEVVSVPDTLFSG-----DPSFAGSPGKFQ 192

Query:   206 SLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDS-V 264
              L  QALETV RVNMGG  V P ND L R W  D  +L   NLV  VS  + V++     
Sbjct:   193 GLSWQALETVYRVNMGGPRVTPSNDTLSRIWEPDSEFLVEKNLVKSVSKIASVDYVPGFA 252

Query:   265 TENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFN 324
             TE  APR VYGT T +NS  +P+SN NVTW+FDVDPGF++ +RFHFCDI    ++ L FN
Sbjct:   253 TEETAPRTVYGTCTEMNSADNPSSNFNVTWDFDVDPGFQYFLRFHFCDIVSKALNQLYFN 312

Query:   325 VYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPK-LHVSIGRSTLVDTFPNAILN 383
             +Y++S     + DL    S      Y MDF+T  +   K + VSIGRS++   +P AILN
Sbjct:   313 LYVDSMDVVENLDLSSYLSNTLSGAYAMDFVTGSAKLTKRIRVSIGRSSVHTDYPTAILN 372

Query:   384 GLEIMKINNSRGDFDVAE---STSPKSSKTRVGLIVGVASGSCISVGXXXXXXXXXXXXX 440
             GLEIMK+NNS+    +     S S  ++K  VG+I+G+  GS +++              
Sbjct:   373 GLEIMKMNNSKSQLSIGTFLPSGSSSTTKKNVGMIIGLTIGSLLALVVLGGFFVLYKKRG 432

Query:   441 XXXXGHLKA----DEQFAVKEGHISAIFS-SSKIGYRFPFVAIQEATDNFSESLVIGIGG 495
                 G+ K              + + + S +S   YR P VA++EAT++F E+  IG+GG
Sbjct:   433 RDQDGNSKTWIPLSSNGTTSSSNGTTLASIASNSSYRIPLVAVKEATNSFDENRAIGVGG 492

Query:   496 FGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI 555
             FGKVY+G L D TKVAVKR   +S QGLAEFRTEIEMLSQFRHRHLVSLIGYCDE NEMI
Sbjct:   493 FGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMI 552

Query:   556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI 615
             ++YEYMENGTLK HLY S   SLSW++RLEICIG+ARGLHYLHTG  K +IHRDVKSANI
Sbjct:   553 LVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANI 612

Query:   616 LLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVV 675
             LLDENLMAKVADFGLSK GP++DQTHVSTAVKGSFGYLDPEY  +QQLTEKSDVYSFGVV
Sbjct:   613 LLDENLMAKVADFGLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVV 672

Query:   676 MFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAE 735
             MFE+LC RPVIDP+L RE VNL EWAMK Q+ GQLE I+DP+L G+I+PDSL KF E  E
Sbjct:   673 MFEVLCARPVIDPTLTREMVNLAEWAMKWQKKGQLEHIIDPSLRGKIRPDSLRKFGETGE 732

Query:   736 KCLAQCGIDRPSMGDVLWNLEYALQLQ-----GD-EGKSSPKGETSSP-NNHSHSQTGVS 788
             KCLA  G+DRPSMGDVLWNLEYALQLQ     GD E  ++  GE     N+++H  T V+
Sbjct:   733 KCLADYGVDRPSMGDVLWNLEYALQLQEAVVDGDPEDSTNMIGELPLRFNDYNHGDTSVN 792

Query:   789 NT-------EFSTASVGDLAGVSMSKVFAQMVREEMR 818
              +       +   +SV D +GVSMSKVF+Q+++ E R
Sbjct:   793 FSVAKEGRFDEEESSVDDSSGVSMSKVFSQLIKSEGR 829

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0007062 "sister chromatid cohesion" evidence=RCA

GO:0007131 "reciprocal meiotic recombination" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0033044 "regulation of chromosome organization" evidence=RCA

GO:0042138 "meiotic DNA double-strand break formation" evidence=RCA

GO:0045132 "meiotic chromosome segregation" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2039717 AT2G39360 [Arabidopsis thaliana (taxid:3702)]

 Score = 1863 (660.9 bits), Expect = 2.8e-192, P = 2.8e-192
 Identities = 407/812 (50%), Positives = 530/812 (65%)

Query:    31 DNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQXXXXXXXXXXXXXGNYSRLYHTARI 90
             D + I+CGS TN +  NR F +D+     NL                 G+ S L+ TAR+
Sbjct:    29 DTFFINCGSPTNVTVNNRTFVSDN-----NLVQ----GFSVGTTDSNSGDESTLFQTARV 79

Query:    91 FTGPSN--YSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSS 148
             F+  S+  Y F I++     IR++F P V  + +++TA+FSVS+Q+FTLI++Y+    S 
Sbjct:    80 FSDESSSTYRFPIEEHGWFLIRIYFLPLVSASQDLTTARFSVSAQNFTLIREYKPSTTSV 139

Query:   149 VKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQ 208
             V+EY LN+ +D L+L F P   S +FINALEV+ LP+ LIP+ AK I  Q     +  L 
Sbjct:   140 VREYILNVTTDSLLLQFLPRTGSVSFINALEVLRLPETLIPEDAKLIGTQK----DLKLS 195

Query:   209 RQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNL-VMFVS--NTSIVNFTDSVT 265
               A+ETV+RVNMG   V    D LWR+W SD AY  H    VM +   N S    TD + 
Sbjct:   196 SHAMETVSRVNMGNLSVSRDQDKLWRQWDSDSAYKAHFGTPVMNLKAVNFSAGGITDDIA 255

Query:   266 ENIAPRDVYGTATIVNSGSDPNSNVNVTWN----FDVDPGFEFLVRFHFCDIYFNNISSL 321
                       T    +   + N+N+  T+     FD    F F    +     F     +
Sbjct:   256 PVYVYGTA--TRLNSDLDPNTNANLTWTFKVEPGFDYFVRFHFC---NIIVDPFGFERQI 310

Query:   322 AFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPK--LHVSIGRSTLVDTFPN 379
              F++++NS   +   D+ ++ +   G P+++D + R++ + +  L++SIG    V ++P 
Sbjct:   311 RFDIFVNSEKVRT-IDMTEVLNGTFGAPFFVDAVMRKAKSREGFLNLSIGLVMDVSSYPV 369

Query:   380 AILNGLEIMKINNSRGDFDVAE------STSPKSSKTRVGLIVGVASGSCISV--GXXXX 431
             + +NG EI K++N +   D  +      S+S KSS T VGLI G+++  C+++  G    
Sbjct:   370 SFINGFEISKLSNDKRSLDAFDAILPDGSSSNKSSNTSVGLIAGLSAALCVALVFGVVVS 429

Query:   432 ---XXXXXXXXXXXXXGHLKADE-QFAVKEGHISAIFSSSKIGYRFPFVAIQEATDNFSE 487
                              H + D+ Q    E   S IFSSSKIGYR+P   I+EATD+F E
Sbjct:   430 WWCIRKRRRRNRQMQTVHSRGDDHQIKKNETGESLIFSSSKIGYRYPLALIKEATDDFDE 489

Query:   488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
             SLVIG+GGFGKVY+GVLRD+T+VAVKRG  QS QGLAEF+TE+EML+QFRHRHLVSLIGY
Sbjct:   490 SLVIGVGGFGKVYKGVLRDKTEVAVKRGAPQSRQGLAEFKTEVEMLTQFRHRHLVSLIGY 549

Query:   548 CDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             CDE +EMII+YEYME GTLKDHLY   + P LSWR+RLEIC+GAARGLHYLHTGST+AII
Sbjct:   550 CDENSEMIIVYEYMEKGTLKDHLYDLDDKPRLSWRQRLEICVGAARGLHYLHTGSTRAII 609

Query:   607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
             HRDVKSANILLD+N MAKVADFGLSK GPDLDQTHVSTAVKGSFGYLDPEYLT+QQLTEK
Sbjct:   610 HRDVKSANILLDDNFMAKVADFGLSKTGPDLDQTHVSTAVKGSFGYLDPEYLTRQQLTEK 669

Query:   667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
             SDVYSFGVVM E++CGRPVIDPSLPREKVNL+EWAMK  + G+LEDI+DP L G++K + 
Sbjct:   670 SDVYSFGVVMLEVVCGRPVIDPSLPREKVNLIEWAMKLVKKGKLEDIIDPFLVGKVKLEE 729

Query:   727 LNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQTG 786
             + K+ E+ EKCL+Q GI+RP+MGD+LWNLE+ LQ+Q  + K++   +   P     S  G
Sbjct:   730 VKKYCEVTEKCLSQNGIERPAMGDLLWNLEFMLQVQAKDEKAAMVDD--KPEA---SVVG 784

Query:   787 VSNTEFSTASVGDLAGVSMSKVFAQMVREEMR 818
              S  +FS   VGD+AGVSMSKVFAQMVREE R
Sbjct:   785 -STMQFSVNGVGDIAGVSMSKVFAQMVREETR 815

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2151349 THE1 "THESEUS1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1144 (407.8 bits), Expect = 2.1e-182, Sum P(2) = 2.1e-182
 Identities = 217/326 (66%), Positives = 261/326 (80%)

Query:   456 KEGHISAI-FSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKR 514
             K    S I  +S+ +G  F F  I +AT+ F ES ++G+GGFG+VY+G L D TKVAVKR
Sbjct:   480 KSATASCISLASTHLGRCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKR 539

Query:   515 GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN 574
             G  +S QG+AEFRTEIEMLS+ RHRHLVSLIGYCDER+EMI++YEYM NG L+ HLY ++
Sbjct:   540 GNPRSEQGMAEFRTEIEMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGAD 599

Query:   575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG 634
              P LSW++RLEICIGAARGLHYLHTG++++IIHRDVK+ NILLDENL+AKVADFGLSK G
Sbjct:   600 LPPLSWKQRLEICIGAARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTG 659

Query:   635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK 694
             P LDQTHVSTAVKGSFGYLDPEY  +QQLTEKSDVYSFGVV+ E+LC RP ++P LPRE+
Sbjct:   660 PSLDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQ 719

Query:   695 VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN 754
             VN+ EWAM  Q+ G L+ I+D  LTG++ P SL KF E AEKCLA+ G+DRPSMGDVLWN
Sbjct:   720 VNIAEWAMAWQKKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWN 779

Query:   755 LEYALQLQGDEGKSSPKGETSSPNNH 780
             LEYALQL+  E  S+      +  NH
Sbjct:   780 LEYALQLE--ETSSALMEPDDNSTNH 803

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2163158 AT5G61350 [Arabidopsis thaliana (taxid:3702)]

 Score = 1085 (387.0 bits), Expect = 1.5e-175, Sum P(2) = 1.5e-175
 Identities = 205/313 (65%), Positives = 244/313 (77%)

Query:   456 KEGHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRG 515
             K    S+ FS+  +G  FPF  +Q AT NF E+ V G+GGFGKVY G +   T+VA+KRG
Sbjct:   496 KSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFGKVYIGEIDGGTQVAIKRG 555

Query:   516 GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN- 574
                S QG+ EF+TEI+MLS+ RHRHLVSLIG+CDE  EMI++YEYM NG L+DHLY S  
Sbjct:   556 SQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILVYEYMSNGPLRDHLYGSKE 615

Query:   575 -----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG 629
                   P+LSW++RLEICIG+ARGLHYLHTG+ + IIHRDVK+ NILLDENL+AKV+DFG
Sbjct:   616 NDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDVKTTNILLDENLVAKVSDFG 675

Query:   630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPS 689
             LSK  P +D+ HVSTAVKGSFGYLDPEY  +QQLT+KSDVYSFGVV+FE+LC RPVI+P 
Sbjct:   676 LSKDAP-MDEGHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVINPQ 734

Query:   690 LPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMG 749
             LPRE+VNL E+AM     G LE I+DP + G I   SL KFVE AEKCLA+ G+DRP MG
Sbjct:   735 LPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISKGSLRKFVEAAEKCLAEYGVDRPGMG 794

Query:   750 DVLWNLEYALQLQ 762
             DVLWNLEYALQLQ
Sbjct:   795 DVLWNLEYALQLQ 807

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2178707 AT5G24010 [Arabidopsis thaliana (taxid:3702)]

 Score = 1627 (577.8 bits), Expect = 2.9e-167, P = 2.9e-167
 Identities = 357/805 (44%), Positives = 478/805 (59%)

Query:    26 AFDPVDNYLIDCGSFTNTSA-GNRVFAADHTSTFTNLSSPQXXXXXXXXXXXXXGNYSRL 84
             AF P DNYLI+ GS TNTS    R F +D +   ++  S                    L
Sbjct:    25 AFTPTDNYLINSGSNTNTSFFTTRSFLSDSSEPGSSFLSTDRSISISDTNPSPDSPV--L 82

Query:    85 YHTARIFTGPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQ 144
             Y+TAR+F    +Y F +  +  HFIRLHF PF    +N+ +AKF V    F++I  + S 
Sbjct:    83 YNTARVFPVGGSYKFQVTTKGTHFIRLHFAPFKASRFNLRSAKFRVLINGFSVINSF-ST 141

Query:   145 EGSSVKEYSLNIASDRLVLSFTPF-ANSFAFINALEVISLP-DELIPQSAKTIDPQGSST 202
                 VKE+ L I    L +SF PF A+ F F+NA+EV S P D ++ Q  K + P  +  
Sbjct:   142 SSVVVKEFILKIDDPVLEISFLPFKASGFGFVNAVEVFSAPKDYIMDQGTKLVIPNSAQI 201

Query:   203 GNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTD 262
              + +L  Q LETV R+N+GG  + P ND LWR WV DD YL           T   N+ +
Sbjct:   202 FS-NLSSQVLETVHRINVGGSKLTPFNDTLWRTWVVDDNYLLLRAAARRAWTTHSPNYQN 260

Query:   263 S-VTENIAPRDVYGTATIVN-SGSDPNSNVNVTWNFDVDPGFEF-LVRFHFCDIYFNNIS 319
                T  IAP +VY TA  ++    +  +  N++W F VD      LVR HFCDI  ++++
Sbjct:   261 GGATREIAPDNVYMTAQEMDRDNQELQARFNISWGFQVDEKRVLHLVRLHFCDIVSSSLN 320

Query:   320 SLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFP- 378
              L FNV+IN   A  D DL  L  +   +P Y+DF+     +  L +S+G S L +    
Sbjct:   321 QLYFNVFINEYLAFKDVDLSTLTFHVLASPLYIDFVAESDRSGMLRISVGPSDLSNPARV 380

Query:   379 NAILNGLEIMKINNSRGDFDVAESTSPKSSKTRVGLIVGVASGSCISVGXXXXXXXXXXX 438
             NA+LNG+EIM+I +       +E  S K  +  V ++VG   G  + +            
Sbjct:   381 NALLNGVEIMRILSPVS----SEVVSGK--RNVVWIVVGSVLGGFVFLSLFFLSVLCLCR 434

Query:   439 XXXXXXGHLKAD-----EQFAVKEGHISAIFSSSKIGY---RFPFVAIQEATDNFSESLV 490
                      ++       +F       +   + S  GY   R  F  +Q  T+NF  SLV
Sbjct:   435 RKNNKTRSSESTGWTPLRRFRGSSNSRTTERTVSSSGYHTLRISFAELQSGTNNFDRSLV 494

Query:   491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
             IG+GGFG V+RG L+D TKVAVKRG   S QGL EF +EI +LS+ RHRHLVSL+GYC+E
Sbjct:   495 IGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVSLVGYCEE 554

Query:   551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
             ++EMI++YEYM+ G LK HLY S  P LSW++RLE+CIGAARGLHYLHTGS++ IIHRD+
Sbjct:   555 QSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGLHYLHTGSSQGIIHRDI 614

Query:   611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
             KS NILLD N +AKVADFGLS+ GP +D+THVST VKGSFGYLDPEY  +QQLT+KSDVY
Sbjct:   615 KSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRRQQLTDKSDVY 674

Query:   671 SFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKF 730
             SFGVV+FE+LC RP +DP L RE+VNL EWA++ Q  G L+ IVDP +  +IKP SL KF
Sbjct:   675 SFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNIADEIKPCSLKKF 734

Query:   731 VEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQTGVSNT 790
              E AEKC A  G+DRP++GDVLWNLE+ LQLQ     + P+ +     +   ++ G+SN 
Sbjct:   735 AETAEKCCADYGVDRPTIGDVLWNLEHVLQLQESGPLNIPEEDYGDVTDPRTARQGLSNG 794

Query:   791 EFSTASVGD-LAGV-SMSKVFAQMV 813
                    GD  +G+ S ++VF+Q++
Sbjct:   795 SNIERDYGDGTSGIISSTQVFSQLM 819

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2081895 FER "FERONIA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1039 (370.8 bits), Expect = 3.3e-157, Sum P(3) = 3.3e-157
 Identities = 196/307 (63%), Positives = 238/307 (77%)

Query:   467 SKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAE 525
             S +   F F  I+ AT NF ES V+G+GGFGKVYRG +    TKVA+KRG   S QG+ E
Sbjct:   518 SNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHE 577

Query:   526 FRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE 585
             F+TEIEMLS+ RHRHLVSLIGYC+E  EMI++Y+YM +GT+++HLY +  PSL W++RLE
Sbjct:   578 FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQNPSLPWKQRLE 637

Query:   586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
             ICIGAARGLHYLHTG+   IIHRDVK+ NILLDE  +AKV+DFGLSK GP LD THVST 
Sbjct:   638 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 697

Query:   646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ 705
             VKGSFGYLDPEY  +QQLTEKSDVYSFGVV+FE LC RP ++P+L +E+V+L EWA  C 
Sbjct:   698 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPALNPTLAKEQVSLAEWAPYCY 757

Query:   706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDE 765
             + G L+ IVDP L G+I P+   KF E A KC+   GI+RPSMGDVLWNLE+ALQLQ + 
Sbjct:   758 KKGMLDQIVDPYLKGKITPECFKKFAETAMKCVLDQGIERPSMGDVLWNLEFALQLQ-ES 816

Query:   766 GKSSPKG 772
              + + KG
Sbjct:   817 AEENGKG 823

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0010483 "pollen tube reception" evidence=IMP

GO:0043680 "filiform apparatus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009791 "post-embryonic development" evidence=IMP

GO:0050832 "defense response to fungus" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0000902 "cell morphogenesis" evidence=RCA

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0010193 "response to ozone" evidence=RCA

GO:0016049 "cell growth" evidence=RCA

GO:0030244 "cellulose biosynthetic process" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048193 "Golgi vesicle transport" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2204564 HERK2 "hercules receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1056 (376.8 bits), Expect = 1.0e-156, Sum P(2) = 1.0e-156
 Identities = 198/326 (60%), Positives = 245/326 (75%)

Query:   465 SSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLA 524
             ++S +G +F    I+ AT NF + L IG+GGFGKVYRG L D T +A+KR    S QGLA
Sbjct:   500 AASTMGRKFTLAEIRAATKNFDDGLAIGVGGFGKVYRGELEDGTLIAIKRATPHSQQGLA 559

Query:   525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
             EF TEI MLS+ RHRHLVSLIG+CDE NEMI++YEYM NGTL+ HL+ SN P LSW++RL
Sbjct:   560 EFETEIVMLSRLRHRHLVSLIGFCDEHNEMILVYEYMANGTLRSHLFGSNLPPLSWKQRL 619

Query:   585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
             E CIG+ARGLHYLHTGS + IIHRDVK+ NILLDEN +AK++DFGLSK GP +D THVST
Sbjct:   620 EACIGSARGLHYLHTGSERGIIHRDVKTTNILLDENFVAKMSDFGLSKAGPSMDHTHVST 679

Query:   645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC 704
             AVKGSFGYLDPEY  +QQLTEKSDVYSFGVV+FE +C R VI+P+LP++++NL EWA+  
Sbjct:   680 AVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEAVCARAVINPTLPKDQINLAEWALSW 739

Query:   705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD 764
             Q+   LE I+D  L G   P+SL K+ EIAEKCLA  G +RP MG+VLW+LEY LQ+  +
Sbjct:   740 QKQRNLESIIDSNLRGNYSPESLEKYGEIAEKCLADEGKNRPMMGEVLWSLEYVLQIH-E 798

Query:   765 EGKSSPKGETSSPNNHSHSQTGVSNT 790
                    GE S  ++ +  +   S T
Sbjct:   799 AWLRKQNGENSFSSSQAVEEAPESFT 824

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2136338 AT4G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
 Identities = 354/804 (44%), Positives = 462/804 (57%)

Query:    25 TAFDPVDNYLIDCGSFTNTSAGN-RVFAADHTSTFTNLSSPQXXXXXXXXXXXXXGN-Y- 81
             T F P D+ LIDCGS +++   + RVF +D   T   + + +                Y 
Sbjct:    50 TGFKPADDILIDCGSKSSSKTPDGRVFKSDQ-ETIQYIEAKEDIQVSAPPSDKVASPIYL 108

Query:    82 -SRLYHTARIF----TGPSNYSFSIKKQARHFIRL--HFFPFVHETYNMSTAKFSVSSQS 134
              +R++     +    T P  +   +     HF+      F     T+++ T K+ V   +
Sbjct:   109 TARIFREEATYKFHLTRPGWHWVRL-----HFLAFPNDKFDLQQATFSVLTEKY-VLLHN 162

Query:   135 FTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKT 194
             F +  +    + +  KEY +N+   +  L F P  +S AFINA+EV+S PDELI  S   
Sbjct:   163 FKISNNNNDSQAAVQKEYLVNMTDAQFALRFRPMKSSAAFINAIEVVSAPDELISDSGTA 222

Query:   195 IDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSN 254
             + P     G   L   A ++V RVN+GG  + PQND L R W+ D  +LK  NL   V  
Sbjct:   223 LFPV---IGFSGLSDYAYQSVYRVNVGGPLIMPQNDTLGRTWIPDKEFLKDENLAKDVKT 279

Query:   255 T-SIVNFTDSVTENIAPRDVYGTAT-IVNSGS-DPNSNVNVTWNFDVDPGFEFLVRFHFC 311
             T S + +   VT  IAP+ VY TA  + NS + DPN   NV+WNF  +P F +L+R HFC
Sbjct:   280 TPSAIKYPPEVTPLIAPQTVYATAVEMANSLTIDPN--FNVSWNFPSNPSFNYLIRLHFC 337

Query:   312 DIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRES-DNPKLHVSIGR 370
             DI   +++ L FNVYIN ++A    DL  +    A  PYY D +   +   P+L V IG 
Sbjct:   338 DIVSKSLNDLYFNVYINGKTAISGLDLSTVAGNLAA-PYYKDIVVNATLMGPELQVQIGP 396

Query:   371 STLVDTFPNAILNGLEIMKINNS----RGDFDVAESTSPKSSKTRVGLIVGVAS-GSCIS 425
                     NAILNG+E++K++NS     G+F V   T+       V     V   G+ I 
Sbjct:   397 MGEDTGTKNAILNGVEVLKMSNSVNSLDGEFGVDGRTTGMGKHGMVATAGFVMMFGAFIG 456

Query:   426 VGXXXXXXXXXXXXXXXXXGHLK-------ADEQFAVKEG--HISAIFSSSK-IGYRFPF 475
             +G                             D  F   +G    S  ++S+  +G  F  
Sbjct:   457 LGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKGGSQKSNFYNSTLGLGRYFSL 516

Query:   476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
               +QEAT NF  S +IG+GGFG VY G L D TKVAVKRG  QS QG+ EF+TEI+MLS+
Sbjct:   517 SELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQMLSK 576

Query:   536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
              RHRHLVSLIGYCDE +EMI++YE+M NG  +DHLY  N   L+W++RLEICIG+ARGLH
Sbjct:   577 LRHRHLVSLIGYCDENSEMILVYEFMSNGPFRDHLYGKNLAPLTWKQRLEICIGSARGLH 636

Query:   596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
             YLHTG+ + IIHRDVKS NILLDE L+AKVADFGLSK      Q HVSTAVKGSFGYLDP
Sbjct:   637 YLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-DVAFGQNHVSTAVKGSFGYLDP 695

Query:   656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
             EY  +QQLT+KSDVYSFGVV+ E LC RP I+P LPRE+VNL EWAM+ +  G LE I+D
Sbjct:   696 EYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLLEKIID 755

Query:   716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG--DEGKSSPKGE 773
             P L G I P+S+ KF E AEKCL   G+DRP+MGDVLWNLEYALQLQ    +GK+  + E
Sbjct:   756 PHLAGTINPESMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQGKAE-ETE 814

Query:   774 TSSPNNHSHSQTGVSNTEFSTASV 797
              + P+  +     VS+    T SV
Sbjct:   815 NAKPDVVTPGSVPVSDPSPITPSV 838

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

GO:0030048 "actin filament-based movement" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2050080 AT2G21480 [Arabidopsis thaliana (taxid:3702)]

 Score = 1481 (526.4 bits), Expect = 8.5e-152, P = 8.5e-152
 Identities = 322/684 (47%), Positives = 413/684 (60%)

Query:   114 FPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFA 173
             F     T+++ T K+ V   +F L  D    + +  KEY LN+   +  L F P   S A
Sbjct:   142 FDLQQATFSVLTEKY-VLLHNFKLSNDNNDSQATVQKEYLLNMTDAQFALRFKPMKGSAA 200

Query:   174 FINALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLW 233
             FIN +E++S PDELI  +  ++ P    +G   L   A ++V RVN+GG  + PQND L 
Sbjct:   201 FINGIELVSAPDELISDAGTSLFPVNGFSG---LSDYAYQSVYRVNVGGPLITPQNDTLG 257

Query:   234 RRWVSDDAYLKHSNLVMFV-SNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNV 292
             R W  D  YLK  NL   V +N + + +   VT  IAP+ VY T   +      + N NV
Sbjct:   258 RTWTPDKEYLKDENLAKDVKTNPTAIIYPPGVTPLIAPQTVYATGAEMADSQTIDPNFNV 317

Query:   293 TWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYM 352
             TWNF  +P F + +R HFCDI   +++ L FNVYIN ++A    DL  +    +  PYY 
Sbjct:   318 TWNFPSNPSFHYFIRLHFCDIISKSLNDLYFNVYINGKTAISGLDLSTVAGDLSA-PYYK 376

Query:   353 DFITRES-DNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNS----RGDFDV---AESTS 404
             D +   +    +L V IG         NAILNG+E++K++NS     G+F V     S  
Sbjct:   377 DIVVNSTLMTSELQVQIGPMGEDTGKKNAILNGVEVLKMSNSVNSLDGEFGVDGQRASMG 436

Query:   405 PKSSKTRVGLIV--G--VASGSCISVGXXXXXXXXXXXXXXXXXGHLKA-DEQFAV-KEG 458
              +      G ++  G  V  G+ +                      + A D  F   K G
Sbjct:   437 KQGMVATAGFVMMFGAFVGLGAMVYKWKKRPQDWQKRNSFSSWLLPIHAGDSTFMTSKTG 496

Query:   459 -HISAIFSSSK-IGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGG 516
              H S +++S+  +G  F    +QE T NF  S +IG+GGFG VY G + D T+VA+KRG 
Sbjct:   497 SHKSNLYNSALGLGRYFSLSELQEVTKNFDASEIIGVGGFGNVYIGTIDDGTQVAIKRGN 556

Query:   517 TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP 576
              QS QG+ EF TEI+MLS+ RHRHLVSLIGYCDE  EMI++YEYM NG  +DHLY  N  
Sbjct:   557 PQSEQGITEFHTEIQMLSKLRHRHLVSLIGYCDENAEMILVYEYMSNGPFRDHLYGKNLS 616

Query:   577 SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD 636
              L+W++RLEICIGAARGLHYLHTG+ + IIHRDVKS NILLDE L+AKVADFGLSK    
Sbjct:   617 PLTWKQRLEICIGAARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSK-DVA 675

Query:   637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVN 696
               Q HVSTAVKGSFGYLDPEY  +QQLT+KSDVYSFGVV+ E LC RP I+P LPRE+VN
Sbjct:   676 FGQNHVSTAVKGSFGYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVN 735

Query:   697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
             L EWAM  ++ G LE I+DP L G + P+S+ KF E AEKCLA  G+DRP+MGDVLWNLE
Sbjct:   736 LAEWAMLWKQKGLLEKIIDPHLVGAVNPESMKKFAEAAEKCLADYGVDRPTMGDVLWNLE 795

Query:   757 YALQLQG--DEGKSSPKG-ETSSP 777
             YALQLQ    +GK+  +  ET  P
Sbjct:   796 YALQLQEAFSQGKAEAEEVETPKP 819

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LX66	HERK_ARATH	2, ., 7, ., 1, 1, ., -	0.5380	0.9829	0.9710	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	820
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	3e-62
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-54
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-54
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-40
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-34
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-32
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-30
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-30
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-29
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-27
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-27
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-26
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-25
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-25
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-25
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-24
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	9e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-23
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-23
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-23
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-23
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-23
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-22
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	9e-22
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-21
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-21
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-21
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-20
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-17
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-17
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-14
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	8e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	8e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	9e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.002
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.002

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  212 bits (542), Expect = 3e-62
 Identities = 102/375 (27%), Positives = 155/375 (41%), Gaps = 59/375 (15%)

Query: 35  IDCGSFTNTS----AGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARI 90
           IDCG  +N S    +    + +D  + F +     NIS   S     S   S+ Y T R 
Sbjct: 1   IDCGLPSNESYTDPSTGITWVSD--AGFIDTGKSGNISKENS-----SSFLSKPYKTLRS 53

Query: 91  FT-GPSN-YSFSIKKQA--RHFIRLHFFPFVHETYNMSTA--KFSVS---SQSFTLIKDY 141
           F  G  N Y+  +      ++ IR  F    ++  N  ++   F +    +   T+    
Sbjct: 54  FPDGKRNCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSN 113

Query: 142 QSQEGSSVKEYSLNIA-SDRLVLSFTPFANSFAFINALEVISLPDELIPQSAKTIDPQGS 200
            S + S VKEY +++  SD L +          FI+ALE+  LPD L P S         
Sbjct: 114 DSGD-SVVKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSS--------- 163

Query: 201 STGNQSLQRQALETVARVNMG--GKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIV 258
                S   QAL+ VAR+N G     +   +DV  R W    +    S +    S +  V
Sbjct: 164 ---GGS---QALKLVARLNFGGSEGTIRYPDDVYDRIWEPFFSSPGWSQI----STSLSV 213

Query: 259 NFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNI 318
           + + +    I P  V  TA    + S P   +N TW+   DP FE+ V  HF +I   ++
Sbjct: 214 DISSNNAPYIPPSAVLQTAVTPTNASAP---LNFTWDLV-DPNFEYYVYLHFAEI--QSL 267

Query: 319 SSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGR---STLVD 375
            +  F++YIN ++   D     L         Y+DF    S    L++S+     STL  
Sbjct: 268 ETREFDIYINGKTVYGDVSPKYL--GTDTGALYLDFPVNVSGGGLLNISLVPTSGSTL-- 323

Query: 376 TFPNAILNGLEIMKI 390
                +LN LEI K+
Sbjct: 324 ---PPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  189 bits (482), Expect = 1e-54
 Identities = 72/210 (34%), Positives = 111/210 (52%), Gaps = 19/210 (9%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
            +G G FG+VY+G L+      T+VAVK  +    S +   +F  E  ++ +  H ++V 
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA-SEEERKDFLKEARVMKKLGHPNVVR 60

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHL-------YASNFPSLSWRKRLEICIGAARGLHY 596
           L+G C E   + ++ EYME G L D+L        +    +LS +  L   I  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           L    +K  +HRD+ + N L+ E+L+ K++DFGLS+   D D     T  K    ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 657 YLTKQQLTEKSDVYSFGVVMFEI--LCGRP 684
            L     T KSDV+SFGV+++EI  L   P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  188 bits (479), Expect = 2e-54
 Identities = 70/200 (35%), Positives = 109/200 (54%), Gaps = 12/200 (6%)

Query: 490 VIGIGGFGKVYRGVLRD-----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FG+VY+G L+      ETKVAVK  + G  S +   EF  E  ++ +  H ++V
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-SEEEREEFLEEASIMKKLSHPNIV 64

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C +   + I+ EYM  G L D L       L+ +  L++ +  A+G+ YL    +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           K  +HRD+ + N L+ ENL+ K++DFGLS+   + D        K    ++ PE L   +
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 663 LTEKSDVYSFGVVMFEILCG 682
            T KSDV+SFGV+++EI   
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  187 bits (477), Expect = 5e-54
 Identities = 75/204 (36%), Positives = 112/204 (54%), Gaps = 15/204 (7%)

Query: 490 VIGIGGFGKVYRGVLRD-----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FG+VY+G L+      + +VAVK  +      Q + EF  E  ++ +  H ++V
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHPNVV 64

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C E   + I+ EYME G L  +L   N P LS    L   +  ARG+ YL    +
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           K  IHRD+ + N L+ ENL+ K++DFGLS+   D D  +     K    ++ PE L + +
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 663 LTEKSDVYSFGVVMFEI--LCGRP 684
            T KSDV+SFGV+++EI  L  +P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  186 bits (476), Expect = 6e-54
 Identities = 74/207 (35%), Positives = 112/207 (54%), Gaps = 20/207 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FG+VY+G L+      E +VAVK  +      Q + EF  E  ++ +  H ++V
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ-IEEFLREARIMRKLDHPNIV 64

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C E   ++I+ EYM  G L D+L  +    LS    L   +  ARG+ YL    +
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA---VKGSFGYLDPEYLT 659
           K  IHRD+ + N L+ ENL+ K++DFGLS+   D D   V      ++    ++ PE L 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLK 177

Query: 660 KQQLTEKSDVYSFGVVMFEI--LCGRP 684
           + + T KSDV+SFGV+++EI  L   P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (440), Expect = 2e-49
 Identities = 74/193 (38%), Positives = 104/193 (53%), Gaps = 10/193 (5%)

Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G GGFG VY    +    KVA+K    +    L E    EIE+L +  H ++V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           ++ N + ++ EY E G+LKD L   N   LS  + L I +    GL YLH   +  IIHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 609 DVKSANILLDE-NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTEK 666
           D+K  NILLD  N   K+ADFGLSK+            + G+  Y+ PE L  K   +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 667 SDVYSFGVVMFEI 679
           SD++S GV+++E+
Sbjct: 175 SDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  167 bits (425), Expect = 7e-47
 Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FGKVY     +    VA+K     +  +       EI++L + +H ++V L   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL--EICIGAARGLHYLHTGSTKAI 605
            ++ +++ ++ EY E G L D L      S    +    +I       L YLH+   K I
Sbjct: 66  FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLHS---KGI 118

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           +HRD+K  NILLDE+   K+ADFGL++    LD     T   G+  Y+ PE L  +   +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 666 KSDVYSFGVVMFEILCGRP 684
             D++S GV+++E+L G+P
Sbjct: 176 AVDIWSLGVILYELLTGKP 194

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (403), Expect = 8e-44
 Identities = 83/273 (30%), Positives = 133/273 (48%), Gaps = 33/273 (12%)

Query: 490 VIGIGGFGKVYRGVLRDE-TKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            +G G FG VY+   +     VAVK    +S   +     R EI +L +  H ++V LI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             ++++ + ++ EY E G L D+L       LS  +  +I +   RGL YLH+     II
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHS---NGII 120

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL-TE 665
           HRD+K  NILLDEN + K+ADFGL+K       + ++T V G+  Y+ PE L        
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP 178

Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           K DV+S GV+++E+L G+P   P      ++            QL+ ++   L   ++ D
Sbjct: 179 KVDVWSLGVILYELLTGKP---PFSGENILD------------QLQ-LIRRILGPPLEFD 222

Query: 726 SLNK------FVEIAEKCLAQCGIDRPSMGDVL 752
                       ++ +KCL +    RP+  ++L
Sbjct: 223 EPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (375), Expect = 5e-40
 Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 14/203 (6%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           ++G G FG VY  + +D  + +AVK       S + L     EI +LS  +H ++V   G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 547 -YCDERNEMIIIY-EYMENGTLKDHLYASNFPSLSWR--KRLEICIGAARGLHYLHTGST 602
              DE    + I+ EY+  G+L   L    F  L     ++    I    GL YLH+   
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEPVIRKYTRQI--LEGLAYLHS--- 119

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             I+HRD+K ANIL+D + + K+ADFG +K   D++    + +V+G+  ++ PE +  ++
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 663 LTEKSDVYSFGVVMFEILCGRPV 685
               +D++S G  + E+  G+P 
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  133 bits (336), Expect = 9e-35
 Identities = 72/197 (36%), Positives = 112/197 (56%), Gaps = 11/197 (5%)

Query: 490 VIGIGGFGKVYRGVL----RDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG+V RG L    + E  VA+K  + G+   Q L +F TE  ++ QF H +++ 
Sbjct: 11  VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIMGQFDHPNIIR 69

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G   +   ++II EYMENG+L D     N    +  + + +  G A G+ YL   S  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
             +HRD+ + NIL++ NL+ KV+DFGLS+   D + T+ +   K    +  PE +  ++ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 664 TEKSDVYSFGVVMFEIL 680
           T  SDV+SFG+VM+E++
Sbjct: 186 TSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (333), Expect = 2e-34
 Identities = 76/222 (34%), Positives = 121/222 (54%), Gaps = 17/222 (7%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG V  G  R + KVAVK    +     A+ F  E  +++  RH +LV L+G   
Sbjct: 14  IGKGEFGDVMLGDYRGQ-KVAVKC--LKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           + N + I+ EYM  G+L D+L +     ++  ++L   +    G+ YL     K  +HRD
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127

Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           + + N+L+ E+L+AKV+DFGL+K   +  Q   S   K    +  PE L +++ + KSDV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---EASQGQDSG--KLPVKWTAPEALREKKFSTKSDV 182

Query: 670 YSFGVVMFEILC-GRPVIDPSLP-REKVNLVE--WAMKCQET 707
           +SFG++++EI   GR V  P +P ++ V  VE  + M+  E 
Sbjct: 183 WSFGILLWEIYSFGR-VPYPRIPLKDVVPHVEKGYRMEAPEG 223

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  128 bits (322), Expect = 5e-33
 Identities = 69/191 (36%), Positives = 109/191 (57%), Gaps = 10/191 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+ G   ++ KVA+K  R G  S +   +F  E +++ +  H  LV L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ER+ + +++E+ME+G L D+L A      S    L +C+    G+ YL + +   +IHR
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  + + KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 669 VYSFGVVMFEI 679
           V+SFGV+M+E+
Sbjct: 184 VWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  125 bits (315), Expect = 4e-32
 Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 8/201 (3%)

Query: 485 FSESLVIGIGGFGKVYRG-VLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           F     IG GGFG+VY+    R   +VA+K    +S +   +   EI++L + +H ++V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
             G   +++E+ I+ E+   G+LKD L  S   +L+  +   +C    +GL YLH+    
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYLHS---N 117

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            IIHRD+K+ANILL  +   K+ DFGLS    D    +      G+  ++ PE +  +  
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVINGKPY 174

Query: 664 TEKSDVYSFGVVMFEILCGRP 684
             K+D++S G+   E+  G+P
Sbjct: 175 DYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  124 bits (314), Expect = 7e-32
 Identities = 60/189 (31%), Positives = 106/189 (56%), Gaps = 5/189 (2%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G FG+V+ G+ ++  +VA+K   +       +F+ E++ L + RH+HL+SL   C  
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
              + II E ME G+L   L +     L     +++    A G+ YL     +  IHRD+
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDL 130

Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + NIL+ E+L+ KVADFGL+++    +  ++S+  K  + +  PE  +    + KSDV+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIK--EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188

Query: 671 SFGVVMFEI 679
           SFG++++E+
Sbjct: 189 SFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 1e-31
 Identities = 68/191 (35%), Positives = 108/191 (56%), Gaps = 7/191 (3%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG VY+GVL+  T+VAVK   +     L  +F  E E+L Q+ H ++V LIG C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           ++  + I+ E +  G+L   L       L+ +K L++ + AA G+ YL    +K  IHRD
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG-SFGYLDPEYLTKQQLTEKSD 668
           + + N L+ EN + K++DFG+S+       T VS  +K     +  PE L   + T +SD
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYT-VSDGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 669 VYSFGVVMFEI 679
           V+S+G++++E 
Sbjct: 178 VWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (307), Expect = 5e-31
 Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 16/207 (7%)

Query: 484 NFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRH 540
           N+    +IG G FG VY+G+ L     VA+K+   +    + L     EI++L   +H +
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA---RGLHYL 597
           +V  IG  +  + + II EY ENG+L+  +    F          + +      +GL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII--KKFGPFP---ESLVAVYVYQVLQGLAYL 115

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H    + +IHRD+K+ANIL  ++ + K+ADFG++    D+ +     +V G+  ++ PE 
Sbjct: 116 HE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEV 170

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +     +  SD++S G  + E+L G P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 5e-31
 Identities = 68/191 (35%), Positives = 102/191 (53%), Gaps = 9/191 (4%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + GT S      F  E +++ + RH  LV L   C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L +     L   + +++    A G+ YL +   +  IHR
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + NIL+ ENL+ K+ADFGL+++  D D+       K    +  PE     + T KSD
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIED-DEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 669 VYSFGVVMFEI 679
           V+SFG+++ EI
Sbjct: 187 VWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  120 bits (303), Expect = 2e-30
 Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 40/275 (14%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR----GGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
            IG G FGKVY      D     +K       ++  +   +   E+++L +  H +++  
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER--EDALNEVKILKKLNHPNIIKY 64

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
               +E+ ++ I+ EY + G L   +             + L+  +     L YLH+   
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS--- 121

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--HVSTAVKGSFGYLDPEYLTK 660
           + I+HRD+K  NI L  N + K+ DFG+SK+   L  T     T V G+  YL PE    
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKV---LSSTVDLAKTVV-GTPYYLSPELCQN 177

Query: 661 QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG 720
           +    KSD++S G V++E+   +       P E  NL+E A+K              L G
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKH------PFEGENLLELALK-------------ILKG 218

Query: 721 QIKPDSL---NKFVEIAEKCLAQCGIDRPSMGDVL 752
           Q  P      ++   +    L +   +RPS+  +L
Sbjct: 219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQIL 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  119 bits (299), Expect = 6e-30
 Identities = 77/212 (36%), Positives = 116/212 (54%), Gaps = 20/212 (9%)

Query: 490 VIGIGGFGKVYRGVL----RDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           VIG G FG+V+RG+L    R E  VA+K    G T+  +   +F +E  ++ QF H +++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNII 69

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLHTG 600
            L G   +    +II EYMENG L  +L  +   F S      L    G A G+ YL   
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL--- 123

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ-THVSTAVKGSFGYLDPEYLT 659
           S    +HRD+ + NIL++ NL  KV+DFGLS++  D  + T+ ++  K    +  PE + 
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 660 KQQLTEKSDVYSFGVVMFEILC--GRPVIDPS 689
            ++ T  SDV+SFG+VM+E++    RP  D S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 1e-29
 Identities = 64/191 (33%), Positives = 99/191 (51%), Gaps = 10/191 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V+ G  R +  VA+K  R G  S     +F  E +++ +  H +LV L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + I+ EYM NG L ++L       L     L++C      + YL    +   IHR
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHR 124

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ E+ + KV+DFGL++   D DQ   S   K    +  PE     + + KSD
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSD 183

Query: 669 VYSFGVVMFEI 679
           V+SFGV+M+E+
Sbjct: 184 VWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  113 bits (285), Expect = 6e-28
 Identities = 79/284 (27%), Positives = 128/284 (45%), Gaps = 34/284 (11%)

Query: 484 NFSESLVIGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQF 536
           N  E   +G G FG+V+    +       ET V VK    T+     +EFR E++M  + 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-------NFPSLSWRKRLEICIG 589
            H+++V L+G C E     +I EY + G LK  L A+         P LS ++++ +C  
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A G+ +L   S    +HRD+ + N L+      KV+   LSK      + +        
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIP 181

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ 709
             +L PE + +   + KSDV+SFGV+M+E+          LP   ++  E   + Q  G+
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----QGELPFYGLSDEEVLNRLQA-GK 235

Query: 710 LE-DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           LE  + +        P  L K   +  +C A    DRPS  +++
Sbjct: 236 LELPVPEGC------PSRLYK---LMTRCWAVNPKDRPSFSELV 270

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  113 bits (285), Expect = 6e-28
 Identities = 69/214 (32%), Positives = 112/214 (52%), Gaps = 32/214 (14%)

Query: 490 VIGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FGKV+ G         D+  VAVK    T S+    +F  E E+L+ F+H ++V
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS-------------LSWRKRLEICIG 589
              G C E +  I+++EYME+G L   L  S+ P              L+  + L+I + 
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDLNKFL-RSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A G+ YL   +++  +HRD+ + N L+  +L+ K+ DFG+S+   D+  T     V G 
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYR-VGGH 183

Query: 650 ----FGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
                 ++ PE +  ++ T +SDV+SFGVV++EI
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (284), Expect = 1e-27
 Identities = 76/275 (27%), Positives = 129/275 (46%), Gaps = 24/275 (8%)

Query: 491 IGIGGFGKVYRG---VLRDET--KVAVKRGGT-QSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV       L D T  +VAVK        Q  ++F  EIE+L    H ++V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 545 IGYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            G C++     + +I EY+ +G+L+D+L   +   ++ ++ L       +G+ YL +   
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLGS--- 127

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS--FGYLDPEYLTK 660
           +  IHRD+ + NIL++   + K++DFGL+K+ P+    +       S  F Y  PE L  
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186

Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
            + +  SDV+SFGV ++E+   G P   P         +      Q    +  +++    
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPP-----AEFLRMIGIAQGQMIVTRLLELLKE 241

Query: 720 GQ--IKPDSLNKFV-EIAEKCLAQCGIDRPSMGDV 751
           G+   +P S    V ++ + C      DRPS  D+
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (286), Expect = 2e-27
 Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 24/277 (8%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRH-RHLVSLI 545
            +G G FG+VY    RD   VA+K          + +  F  EI++L+   H  ++V L 
Sbjct: 7   KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
            +  +   + ++ EY++ G+L+D L        LS  + L I       L YLH+   K 
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KG 121

Query: 605 IIHRDVKSANILLDENLM-AKVADFGLSKIGPDLDQT----HVSTAVKGSFGYLDPEYLT 659
           IIHRD+K  NILLD +    K+ DFGL+K+ PD   T     + +   G+ GY+ PE L 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 660 KQQL---TEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
              L   +  SD++S G+ ++E+L G  P             ++  ++         +  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                           ++ +K LA+   +R S    L
Sbjct: 242 -----SNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  111 bits (279), Expect = 2e-27
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 9/192 (4%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G   + TKVAVK  + GT S Q   E   E  ++   +H  LV L    
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVV 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYM  G+L D L +     +   K ++     A G+ Y+     K  IHR
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++AN+L+ E+LM K+ADFGL+++  D ++       K    +  PE +     T KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 669 VYSFGVVMFEIL 680
           V+SFG++++EI+
Sbjct: 187 VWSFGILLYEIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  111 bits (279), Expect = 3e-27
 Identities = 59/192 (30%), Positives = 101/192 (52%), Gaps = 9/192 (4%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G+  + T VAVK  + GT       +F  E +++ + RH  L+ L   C
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
                + I+ E M+ G+L ++L      +L   + +++    A G+ YL   +    IHR
Sbjct: 71  TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N+L+ EN + KVADFGL+++  + D        K    +  PE     + + KSD
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 187 VWSFGILLTEIV 198

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  110 bits (277), Expect = 4e-27
 Identities = 68/192 (35%), Positives = 103/192 (53%), Gaps = 10/192 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVA+K  + G+ S      F  E  ++ Q +H  LV L    
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             +  + II EYMENG+L D L       L+  K +++    A G+ ++     K  IHR
Sbjct: 71  -TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHR 126

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ E L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSD 185

Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 186 VWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  108 bits (272), Expect = 3e-26
 Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 25/212 (11%)

Query: 489 LVIGIGGFGKVYRGVLRD-------ETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
             +G G FG+VY G   D         +VAVK   +G T   +   EF  E  ++S F H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNF-----PSLSWRKRLEICIGAARG 593
            ++V L+G C       II E ME G L  +L  +       P L+ ++ L+IC+  A+G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDE-----NLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
             YL        IHRD+ + N L+ E     + + K+ DFGL++     D          
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175

Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
              ++ PE L   + T +SDV+SFGV+M+EIL
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  108 bits (271), Expect = 4e-26
 Identities = 77/223 (34%), Positives = 120/223 (53%), Gaps = 21/223 (9%)

Query: 490 VIGIGGFGKVYRGVL----RDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG+V RG L    + E  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGS 601
           L G   +   ++II E+MENG L   L  ++  F  +     L    G A G+ YL   S
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYL---S 123

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD--LDQTHVST-AVKGSFGYLDPEYL 658
               +HRD+ + NIL++ NL+ KV+DFGLS+   D   D T+ S+   K    +  PE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 659 TKQQLTEKSDVYSFGVVMFEILC--GRPVIDPSLPREKVNLVE 699
             ++ T  SDV+S+G+VM+E++    RP  D S  ++ +N +E
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVINAIE 225

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  107 bits (268), Expect = 5e-26
 Identities = 67/212 (31%), Positives = 116/212 (54%), Gaps = 12/212 (5%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLA-EFRTEIEMLSQFRHRHLVSLIGYC 548
           ++G G FG+V++G L+D+T VAVK       Q L  +F +E  +L Q+ H ++V LIG C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +R  + I+ E +  G     L       L  ++ ++  + AA G+ YL    +K  IHR
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG-SFGYLDPEYLTKQQLTEKS 667
           D+ + N L+ EN + K++DFG+S+   + D  + S+ +K     +  PE L   + + +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 668 DVYSFGVVMFEI----LCGRPVIDPSLPREKV 695
           DV+S+G++++E     +C  P +     RE+V
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  107 bits (269), Expect = 6e-26
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 33/212 (15%)

Query: 491 IGIGGFGKVYRGVLRDETKV-AVK-----RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           IG G FGKVY  V  D  ++ AVK         ++ + +A+   E+++L   +H +LV  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIAD---EMKVLELLKHPNLVKY 64

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHL-YASNFPSLSWRKRLEICIGA-----ARGLHYLH 598
            G    R ++ I  EY   GTL++ L +             E  I         GL YLH
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILD--------EHVIRVYTLQLLEGLAYLH 116

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDP 655
           +     I+HRD+K ANI LD N + K+ DFG +    + + T +   V+   G   Y+ P
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-NTTTMGEEVQSLAGTPAYMAP 172

Query: 656 EYLTKQQLTEK---SDVYSFGVVMFEILCGRP 684
           E +T  +       +D++S G V+ E+  G+ 
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 2e-25
 Identities = 72/271 (26%), Positives = 117/271 (43%), Gaps = 42/271 (15%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           V+G G  G VY+   +   K  A+K+    G +  +       E++ L      ++V   
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL--LRELKTLRSCESPYVVKCY 65

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNF---PSLSWRKRLEICIGAARGLHYLHTGST 602
           G   +  E+ I+ EYM+ G+L D L        P L+      I     +GL YLHT   
Sbjct: 66  GAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLHT--K 118

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVSTAVKGSFGYLDPEYLT 659
           + IIHRD+K +N+L++     K+ADFG+SK+     D   T V T       Y+ PE + 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT-----YMSPERIQ 173

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD---P 716
            +  +  +D++S G+ + E   G+    P LP  + +   + +          I D   P
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK---FPFLPPGQPSF--FELMQA-------ICDGPPP 221

Query: 717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS 747
           +L  +        F+     CL +    RPS
Sbjct: 222 SLPAEEFSPEFRDFI---SACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  105 bits (264), Expect = 4e-25
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 20/207 (9%)

Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     S     +F  E E+L+  +H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYA----------SNFPS-LSWRKRLEICIGAARG 593
            G C E + +I+++EYM++G L   L A           N P+ L+  + L I    A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           + YL   +++  +HRD+ + N L+ ENL+ K+ DFG+S+     D   V         ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T +SDV+S GVV++EI 
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  105 bits (265), Expect = 4e-25
 Identities = 66/228 (28%), Positives = 117/228 (51%), Gaps = 29/228 (12%)

Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRHLV 542
           +G G FG+V +            + VAVK      + + L++  +E+EM+    +H++++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSLSWRKRL------EICI 588
           +L+G C +   + ++ EY  +G L+D L        YAS        + L          
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
             ARG+ +L   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  + 
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196

Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREK 694
              ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E+
Sbjct: 197 PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY--PGIPVEE 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  104 bits (262), Expect = 4e-25
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 16/200 (8%)

Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGL--AEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G FG V++ V + + +V A+K+            E   E  +L++    +++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLS----WRKRLEICIGAARGLHYLHTGSTK 603
             ++ ++ I+ EY ENG L   L       L     WR  ++I +G    L +LH+   K
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHS---K 120

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            I+HRD+KS N+ LD     K+ D G++K+    D T+ +  + G+  YL PE    +  
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 664 TEKSDVYSFGVVMFEILCGR 683
            EKSDV++ GVV++E   G+
Sbjct: 179 NEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  104 bits (262), Expect = 5e-25
 Identities = 66/191 (34%), Positives = 101/191 (52%), Gaps = 10/191 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++ +  H  LV L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + I+ EYM NG L ++L   +       + LE+C     G+ YL +   K  IHR
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHR 124

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+D+    KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183

Query: 669 VYSFGVVMFEI 679
           V++FGV+M+E+
Sbjct: 184 VWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 2e-24
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 25/210 (11%)

Query: 490 VIGIGGFGKVYRGVLRDET----KVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G FG V  G L  +     KVAVK  +    ++  + EF +E   +  F H +++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 544 LIGYCDERNEM------IIIYEYMENGTLKDHLYASNFPSLSW----RKRLEICIGAARG 593
           LIG C E + +      ++I  +M++G L   L  S    L      +  L+  +  A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVSTAVKGSF 650
           + YL   S +  IHRD+ + N +L E++   VADFGLSK    G    Q  ++   K   
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPV 179

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            ++  E L  +  T KSDV++FGV M+EI 
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  103 bits (258), Expect = 2e-24
 Identities = 74/219 (33%), Positives = 114/219 (52%), Gaps = 13/219 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + GT S +   E   E +++ + RH  LV L    
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE---EAQIMKKLRHDKLVQLYAVV 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L      +L     +++    A G+ Y+   +    IHR
Sbjct: 71  SEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D++SANIL+ + L+ K+ADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 185

Query: 669 VYSFGVVMFEILCGRPVIDPSL-PREKVNLVE--WAMKC 704
           V+SFG+++ E++    V  P +  RE +  VE  + M C
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (257), Expect = 2e-24
 Identities = 70/217 (32%), Positives = 112/217 (51%), Gaps = 15/217 (6%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGY- 547
            IG G FG V  G  R   KVAVK      +   A+ F  E  +++Q RH +LV L+G  
Sbjct: 13  TIGKGEFGDVMLGDYRG-NKVAVK---CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +E+  + I+ EYM  G+L D+L +     L     L+  +     + YL   +    +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+ + N+L+ E+ +AKV+DFGL+K     + +      K    +  PE L +++ + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 668 DVYSFGVVMFEILCGRPVIDPSLP-REKVNLVEWAMK 703
           DV+SFG++++EI     V  P +P ++ V  VE   K
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 217

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  103 bits (258), Expect = 2e-24
 Identities = 65/198 (32%), Positives = 109/198 (55%), Gaps = 12/198 (6%)

Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG+V  G L+     E  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G   +   ++I+ EYMENG+L D     +    +  + + +  G A G+ YL   S  
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    +  PE +  ++
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+S+G+VM+E++
Sbjct: 186 FTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-24
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G+ +       ET+VA+K      S +   EF  E  ++ +F   H+V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSLSWRKRLEICIGAARGLH 595
           L+G        +++ E M  G LK +L                + +K +++    A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL-- 653
           YL     K  +HRD+ + N ++ E+L  K+ DFG+++   D+ +T      KG  G L  
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYR--KGGKGLLPV 185

Query: 654 ---DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
               PE L     T KSDV+SFGVV++E+ 
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  102 bits (256), Expect = 3e-24
 Identities = 72/219 (32%), Positives = 114/219 (52%), Gaps = 13/219 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 71  SEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T      K    +  PE     + T KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 669 VYSFGVVMFEILCGRPVIDPSL-PREKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 4e-24
 Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 19/202 (9%)

Query: 491 IGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G G FGKV     +D  K+     +K+      + +    TE  +LS+  H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLS-WRKRL---EICIGAARGLHYLHTGST 602
                 ++ ++ EY   G L  HL  S     S  R R    EI +     L YLH+   
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA----LEYLHS--- 111

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             II+RD+K  NILLD +   K+ DFGL+K     + +  +T   G+  YL PE L  + 
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC-GTPEYLAPEVLLGKG 169

Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
             +  D +S GV+++E+L G+P
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  103 bits (257), Expect = 4e-24
 Identities = 86/302 (28%), Positives = 147/302 (48%), Gaps = 48/302 (15%)

Query: 491 IGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+    +H++
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P + +              K L  C
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D    +T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMKC 704
           +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P      VE   K 
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIP------VEELFKL 251

Query: 705 QETGQLEDIVDPTLTGQIKP-DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG 763
            + G   D          KP +  N+   +   C       RP+   ++ +L+  L L  
Sbjct: 252 LKEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301

Query: 764 DE 765
           +E
Sbjct: 302 NE 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  101 bits (254), Expect = 6e-24
 Identities = 63/190 (33%), Positives = 98/190 (51%), Gaps = 6/190 (3%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +G G +G+VY GV +  +  VAVK     + + + EF  E  ++ + +H +LV L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
                 II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 129

Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           + + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188

Query: 670 YSFGVVMFEI 679
           ++FGV+++EI
Sbjct: 189 WAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  101 bits (254), Expect = 9e-24
 Identities = 73/230 (31%), Positives = 110/230 (47%), Gaps = 33/230 (14%)

Query: 472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVL------RDETKVAVKR-GGTQSHQGLA 524
             P  A++     F E L  G G FGKVY+G L         T VA+K        +   
Sbjct: 1   EIPLSAVR-----FLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ 53

Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-------- 576
           EFR E E++S  +H ++V L+G C +     +++EY+ +G L + L   N P        
Sbjct: 54  EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFL-VRNSPHSDVGAES 112

Query: 577 -------SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG 629
                  SL     L I I  A G+ YL   S+   +HRD+ + N L+ E L  K++DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFG 169

Query: 630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
           LS+     D   V +       ++ PE +   + T +SD++SFGVV++EI
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  101 bits (252), Expect = 1e-23
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V+ G  R + KVA+K    G  S +   +F  E +++ +  H  LV L G C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + I+ E+MENG L ++L       LS    L +C     G+ YL   S    IHR
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+    + KV+DFG+++   D D+   S+  K    +  PE     + + KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 669 VYSFGVVMFEI 679
           V+SFGV+M+E+
Sbjct: 184 VWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-23
 Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 32/224 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           V+G G FG VY+GV   E +     VA+K  R  T S +   E   E  +++   H H+V
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAARGLHYL 597
            L+G C   +++ +I + M  G L D++  +  N  S   L+W      C+  A+G+ YL
Sbjct: 73  RLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPE 656
                K ++HRD+ + N+L+      K+ DFGL+K +  D  + H     K    ++  E
Sbjct: 126 ---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG-KVPIKWMALE 181

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVE 699
            +  +  T KSDV+S+GV ++E++  G        P E +  VE
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGA------KPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  101 bits (252), Expect = 2e-23
 Identities = 70/231 (30%), Positives = 125/231 (54%), Gaps = 31/231 (13%)

Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +++    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEI 586
           +++L+G C +   + +I EY   G L+++L A   P               LS++  +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 251

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 99.8 bits (249), Expect = 3e-23
 Identities = 66/198 (33%), Positives = 95/198 (47%), Gaps = 15/198 (7%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG VY+GV       +  VAVK     +   + E F  E  ++ QF H H+V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + I+ E    G L+ +L   N  SL     +      +  L YL +   K 
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES---KR 127

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF--GYLDPEYLTKQQ 662
            +HRD+ + N+L+      K+ DFGLS+    L+      A KG     ++ PE +  ++
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+ FGV M+EIL
Sbjct: 185 FTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G G +G VY+ + ++  + VA+K       + L E   EI +L Q    ++V   G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKV--VPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +  ++ I+ EY   G++ D +  +N  +L+  +   I     +GL YLH+      IHR
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHR 123

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST-AVKGSFGYLDPEYLTKQQLTEKS 667
           D+K+ NILL+E   AK+ADFG+S     L  T      V G+  ++ PE + +     K+
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQ---LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180

Query: 668 DVYSFGVVMFEILCGRP 684
           D++S G+   E+  G+P
Sbjct: 181 DIWSLGITAIEMAEGKP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  100 bits (250), Expect = 4e-23
 Identities = 71/224 (31%), Positives = 113/224 (50%), Gaps = 43/224 (19%)

Query: 490 VIGIGGFGKVYRGVLRDE-------TKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHL 541
           VIG G FG+V R +++ +        K+  +      H+   +F  E+E+L +   H ++
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR---DFAGELEVLCKLGHHPNI 65

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEIC 587
           ++L+G C+ R  + I  EY   G L D L  S                 +L+ ++ L+  
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
              A G+ YL   S K  IHRD+ + N+L+ ENL +K+ADFGLS+ G ++        VK
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-GEEV-------YVK 174

Query: 648 GSFGYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRP 684
            + G L   ++  + L     T KSDV+SFGV+++EI  L G P
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.6 bits (249), Expect = 4e-23
 Identities = 71/250 (28%), Positives = 107/250 (42%), Gaps = 52/250 (20%)

Query: 490 VIGIGGFGKVYRGVLRDET-KVAVKRG------GTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            IG G FG V + V R    K+ V +         +  Q L    +E+ +L + +H ++V
Sbjct: 7   TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIV 62

Query: 543 SLIGYCDE----RNEMIIIY-EYMENGTL--------KDHLYASNFP-SLSWRKRLEICI 588
               Y D      N+ + I  EY E G L        K+  Y         WR   ++ +
Sbjct: 63  ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY---IEEEFIWRILTQLLL 116

Query: 589 GAARGLHYLHTGSTK--AIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVS 643
                L+  H  S     ++HRD+K ANI LD N   K+ DFGL+KI        +T+V 
Sbjct: 117 A----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172

Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK 703
           T       Y+ PE L      EKSD++S G +++E+    P      P    N ++ A K
Sbjct: 173 TPY-----YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP------PFTARNQLQLASK 221

Query: 704 CQETGQLEDI 713
            +E G+   I
Sbjct: 222 IKE-GKFRRI 230

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =   99 bits (249), Expect = 5e-23
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 30/216 (13%)

Query: 491 IGIGGFGKVYR----GVL--RDETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G FG+V++    G+L     T VAVK    + S    A+F+ E  ++++F H ++V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHL--------------------YASNFPSLSWRKR 583
           L+G C     M +++EYM  G L + L                       N   LS  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
           L I    A G+ YL   S +  +HRD+ + N L+ EN++ K+ADFGLS+     D    S
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
                   ++ PE +   + T +SDV+++GVV++EI
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.0 bits (246), Expect = 6e-23
 Identities = 70/221 (31%), Positives = 115/221 (52%), Gaps = 13/221 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVA+K  + GT   +    F  E +++ + RH  LV L    
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYAVV 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ E+M  G+L D L   +   L   + +++    A G+ Y+   +    IHR
Sbjct: 71  SEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHR 126

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ +NL+ K+ADFGL+++  D + T      K    +  PE     + T KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 669 VYSFGVVMFEILCGRPVIDPSL-PREKVNLVE--WAMKCQE 706
           V+SFG+++ E++    V  P +  RE +  VE  + M C +
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ 226

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 99.0 bits (247), Expect = 6e-23
 Identities = 82/300 (27%), Positives = 125/300 (41%), Gaps = 45/300 (15%)

Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLR------DETKVAVK-RGGTQSHQGLAEFRTEIE 531
           +   D+ +    +G G FG+VY G+ R       E +VAVK    + S Q  ++F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL-----YASNFPSLSWRKRLEI 586
           ++S+F H+++V LIG   ER    I+ E M  G LK  L           SL+ +  L  
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVS 643
               A+G  YL        IHRD+ + N LL       +AK+ADFG+++     D    S
Sbjct: 122 ARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRAS 173

Query: 644 TAVKGS-----FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
              KG        ++ PE       T K+DV+SFGV+++EI     +  P    ++V   
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233

Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSL-NKFVEIAEKCLAQCGIDRPSMGDVLWNLEY 757
                    G+L+            P         I   C      DRP+   +L  ++Y
Sbjct: 234 -----VTGGGRLD-----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 98.7 bits (246), Expect = 7e-23
 Identities = 67/203 (33%), Positives = 113/203 (55%), Gaps = 20/203 (9%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK        + + +F  E  ++  F H +++SL
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 545 IGYC--DERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIG--AARGLHYLHT 599
           +G C   E + ++++  YM++G L++ + + ++ P++   K L I  G   A+G+ YL  
Sbjct: 62  LGICLPSEGSPLVVL-PYMKHGDLRNFIRSETHNPTV---KDL-IGFGLQVAKGMEYL-- 114

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEY 657
            ++K  +HRD+ + N +LDE+   KVADFGL++     +    H  T  K    ++  E 
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           L  Q+ T KSDV+SFGV+++E++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 98.6 bits (246), Expect = 7e-23
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 37/212 (17%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKR-----GGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FG VY G+  D+    AVK       G    + + +   EI +LS+ +H ++V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHL--YASNFP----SLSWRKRLEICIGAARGLHYLH 598
           +G   E + + I  E +  G+L   L  Y S FP     L  R+ L        GL YLH
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGS-FPEPVIRLYTRQILL-------GLEYLH 119

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST-----AVKGSFGYL 653
               +  +HRD+K ANIL+D N + K+ADFG++K         V       + KGS  ++
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWM 168

Query: 654 DPEYLTKQQL-TEKSDVYSFGVVMFEILCGRP 684
            PE + +Q      +D++S G  + E+  G+P
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKP 200

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  100 bits (249), Expect = 7e-23
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 31/231 (13%)

Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V R    G+ +        VAVK      + + LA+  +E+E++    +H++
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEI 586
           +++L+G C +   + +I EY   G L++ L A   P               LS++  +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL    ++  IHRD+ + N+L+ E+ + K+ADFGL++   D+D    ++  
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFG++M+EI  L G P   P +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY--PGIPVEEL 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 7e-23
 Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 12/196 (6%)

Query: 491 IGIGGFGKVYRGVLR----DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V +GV       E +VAVK         G  EF  E  +++Q  H  +V LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
           G C     ++++ E    G L  +L       +      E+    A G+ YL +   K  
Sbjct: 63  GVCKG-EPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYLES---KHF 116

Query: 606 IHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           +HRD+ + N+LL     AK++DFG+S+ +G   D    +TA +    +  PE +   + +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 665 EKSDVYSFGVVMFEIL 680
            KSDV+S+GV ++E  
Sbjct: 177 SKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 10/195 (5%)

Query: 491 IGIGGFGKVYRG----VLRDETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V RG           VAVK   +      + +F  E  ++    H +L+ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
           G     + ++++ E    G+L D L              +  +  A G+ YL +   K  
Sbjct: 63  GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRF 118

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-VKGSFGYLDPEYLTKQQLT 664
           IHRD+ + NILL  +   K+ DFGL +  P  +  +V    +K  F +  PE L  +  +
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178

Query: 665 EKSDVYSFGVVMFEI 679
             SDV+ FGV ++E+
Sbjct: 179 HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 67/200 (33%), Positives = 95/200 (47%), Gaps = 16/200 (8%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVKRGGTQSH---QGLAEFRTEIEMLSQFRHRHLVSL- 544
           VIG G FGKV     RD  K+ A+K    Q       +     E  +L +  H  LV+L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC-IGAARGLHYLHTGSTK 603
             + DE N M ++ + +  G L+ HL +        + +  IC I  A  L YLH+   K
Sbjct: 67  YSFQDEEN-MYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLA--LEYLHS---K 119

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            IIHRD+K  NILLDE     + DF ++        T   T+  G+ GY+ PE L +Q  
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGY 176

Query: 664 TEKSDVYSFGVVMFEILCGR 683
           +   D +S GV  +E L G+
Sbjct: 177 SVAVDWWSLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 98.1 bits (244), Expect = 2e-22
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     S     +F+ E E+L+  +H+H+V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASN-------------FPSLSWRKRLEICIGAA 591
            G C E   +++++EYM +G L   L +                  L+  + L I    A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
            G+ YL   ++   +HRD+ + N L+ + L+ K+ DFG+S+     D   V         
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++ PE +  ++ T +SD++SFGVV++EI 
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 22/202 (10%)

Query: 491 IGIGGFGKV----YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FG V    Y   L+D T   VAVK+    + + L +F  EIE+L   +H ++V  
Sbjct: 12  LGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 545 IGYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL----EICIGAARGLHYLH 598
            G C    R  + ++ EY+  G+L+D+L   +   L  RK L    +IC    +G+ YL 
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQIC----KGMEYL- 124

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEY 657
              +K  +HRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE 
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182

Query: 658 LTKQQLTEKSDVYSFGVVMFEI 679
           LT+ + +  SDV+SFGVV++E+
Sbjct: 183 LTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.0 bits (245), Expect = 2e-22
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT---EIEMLSQFRHRHLVSLI 545
           IG G +G+VY+    +    VA+K+       +G     T   EI++L + RH ++V L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP--ITAIREIKLLQKLRHPNIVRLK 64

Query: 546 GYC--DERNEMIIIYEYME---NGTLKDHLYASNFPSL-SWRKRLEICIGAARGLHYLHT 599
                  +  + +++EYM+    G L           +  + K+L        GL YLH+
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------LEGLQYLHS 118

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYL 658
                I+HRD+K +NIL++ + + K+ADFGL+          + +  +  +  Y  PE L
Sbjct: 119 ---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPELL 173

Query: 659 TKQ-QLTEKSDVYSFGVVMFEILCGRPV 685
               +   + D++S G ++ E+  G+P+
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGKPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.2 bits (242), Expect = 2e-22
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKR-----GGTQSHQGLAEFRTEIEMLSQFR 537
           N+    ++G G FG+VY     D  + +AVK+        ++ + +     EI++L   +
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 538 HRHLVSLIGYCDERNEMIIIY-EYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
           H  +V   G C   +E + I+ EYM  G++KD L  Y +   +++ +   +I      G+
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST----AVKGSF 650
            YLH+     I+HRD+K ANIL D     K+ DFG SK    L     S     +V G+ 
Sbjct: 118 EYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICSSGTGMKSVTGTP 171

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            ++ PE ++ +    K+DV+S G  + E+L  +P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 97.8 bits (243), Expect = 2e-22
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 491 IGIGGFGKVYRG------VLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     +     +F+ E E+L+  +H H+V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEICIGA 590
            G C + + +I+++EYM++G L   L A    +              L   + L I    
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A G+ YL   +++  +HRD+ + N L+  NL+ K+ DFG+S+     D   V        
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            ++ PE +  ++ T +SDV+SFGV+++EI 
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.8 bits (238), Expect = 5e-22
 Identities = 71/221 (32%), Positives = 118/221 (53%), Gaps = 22/221 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +IG G FG V +G    + KVAVK    +       F  E  ++++  H++LV L+G   
Sbjct: 13  IIGEGEFGAVLQGEYTGQ-KVAVKN--IKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI- 68

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
             N + I+ E M  G L + L       +S  + L+  +  A G+ YL +   K ++HRD
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRD 125

Query: 610 VKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           + + NIL+ E+ +AKV+DFGL+++G   +D + +   VK    +  PE L  ++ + KSD
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVK----WTAPEALKHKKFSSKSD 179

Query: 669 VYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETG 708
           V+S+GV+++E+   GR       P  K++L E   +C E G
Sbjct: 180 VWSYGVLLWEVFSYGRA------PYPKMSLKE-VKECVEKG 213

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 95.9 bits (238), Expect = 7e-22
 Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 43/224 (19%)

Query: 490 VIGIGGFGKVYRGVLRDE-------TKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHL 541
           VIG G FG+V +  ++ +        K   +      H+   +F  E+E+L +   H ++
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNI 58

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEIC 587
           ++L+G C+ R  + +  EY  +G L D L  S                 +LS ++ L   
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
              ARG+ YL   S K  IHRD+ + NIL+ EN +AK+ADFGLS+ G ++        VK
Sbjct: 119 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVK 167

Query: 648 GSFGYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRP 684
            + G L   ++  + L     T  SDV+S+GV+++EI  L G P
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.5 bits (237), Expect = 9e-22
 Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 10/192 (5%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+       TKVAVK  + G+ S   +  F  E  ++   +H  LV L    
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             +  + II E+M  G+L D L +         K ++     A G+ ++     +  IHR
Sbjct: 71  -TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 126

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+  +L+ K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSD 185

Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 186 VWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 97.0 bits (241), Expect = 1e-21
 Identities = 63/229 (27%), Positives = 121/229 (52%), Gaps = 27/229 (11%)

Query: 491 IGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+      VAVK      + + L++  +E+EM+    +H++
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP--------------SLSWRKRLEI 586
           +++L+G C +   + ++ EY   G L+++L A   P               L+++  +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   +++  IHRD+ + N+L+ E+ + K+ADFGL++   ++D    +T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI        P +P E++
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.7 bits (239), Expect = 1e-21
 Identities = 59/210 (28%), Positives = 109/210 (51%), Gaps = 20/210 (9%)

Query: 482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
            + +     IG G  G+VY+   R    +VA+K  R   Q+ + +     EI ++   +H
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V         +E+ ++ EYM+ G+L D +   NF  ++  +   +C    +GL YLH
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFG----LSKIGPDLDQTHVSTAVKGSFGYLD 654
           +   + +IHRD+KS NILL ++   K+ADFG    L+K     +++  ++ V G+  ++ 
Sbjct: 134 S---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK-----EKSKRNSVV-GTPYWMA 184

Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           PE + ++    K D++S G++  E+  G P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 94.7 bits (235), Expect = 1e-21
 Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 18/196 (9%)

Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG+V+ G LR D T VAVK         L A+F  E  +L Q+ H ++V LIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + I+ E ++ G     L  +  P L  ++ +++   AA G+ YL    +K  IHR
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHR 118

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA------VKGSFGYLDPEYLTKQQ 662
           D+ + N L+ E  + K++DFG+S+   + D  + ST       VK    +  PE L   +
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVK----WTAPEALNYGR 172

Query: 663 LTEKSDVYSFGVVMFE 678
            + +SDV+SFG++++E
Sbjct: 173 YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 94.7 bits (235), Expect = 2e-21
 Identities = 81/284 (28%), Positives = 124/284 (43%), Gaps = 33/284 (11%)

Query: 491 IGIGGFGKVYRGVLRDET---KVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V  G L  +    KVAVK  +    +   + +F +E   + +F H +++ LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 546 GYCDERNEM------IIIYEYMENGTLKDHLYASNFPS----LSWRKRLEICIGAARGLH 595
           G C +  E       ++I  +M++G L   L  S        L  +  ++     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           YL   S+K+ IHRD+ + N +L+EN+   VADFGLSK   + D        K    ++  
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
           E L  +  T KSDV+SFGV M+EI        P +               E  ++ D + 
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---------------ENSEIYDYLR 228

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL 759
                +  PD L+    +   C      DRPS   +   LE AL
Sbjct: 229 QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 39/272 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKRGG-TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            IG G FG+VY+ + +   + VA+K     ++   + + + EI+ LSQ R  ++    G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFP--SLSWRKRLEICIGAARGLHYLHTGSTKAI 605
             + +++ II EY   G+  D L         +++  R E+      GL YLH       
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-EVL----LGLEYLHEEGK--- 119

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV--STAVKGSFGYLDPEYLTKQQL 663
           IHRD+K+ANILL E    K+ADFG+S     L  T    +T V   F ++ PE + +   
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPF-WMAPEVIKQSGY 175

Query: 664 TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD---PTLTG 720
            EK+D++S G+   E+  G P      P   ++     M+      L  I     P+L G
Sbjct: 176 DEKADIWSLGITAIELAKGEP------PLSDLH----PMRV-----LFLIPKNNPPSLEG 220

Query: 721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                    FV     CL +   +RPS  ++L
Sbjct: 221 NKFSKPFKDFV---SLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 93.4 bits (233), Expect = 6e-21
 Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           +IG G F  V     ++  K  A+K    +     + +   + E E+L++   H  ++ L
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 545 IG-YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG--AAR---GLHYLH 598
              + DE N +  + EY  NG L  ++    + SL      E C    AA     L YLH
Sbjct: 68  YYTFQDEEN-LYFVLEYAPNGELLQYI--RKYGSLD-----EKCTRFYAAEILLALEYLH 119

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--------------QTHVST 644
           +   K IIHRD+K  NILLD+++  K+ DFG +K+                   Q   + 
Sbjct: 120 S---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 645 AVKGSF-G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
               SF G   Y+ PE L ++   + SD+++ G +++++L G+P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 93.5 bits (232), Expect = 8e-21
 Identities = 72/221 (32%), Positives = 112/221 (50%), Gaps = 37/221 (16%)

Query: 490 VIGIGGFGKVYRGVLRDE---TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G FG+V +  ++ +      A+KR     S     +F  E+E+L +   H ++++L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGA 590
           +G C+ R  + +  EY  +G L D L  S                 +LS ++ L      
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           ARG+ YL   S K  IHRD+ + NIL+ EN +AK+ADFGLS+ G ++        VK + 
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 182

Query: 651 GYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRP 684
           G L   ++  + L     T  SDV+S+GV+++EI  L G P
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 70/268 (26%), Positives = 126/268 (47%), Gaps = 26/268 (9%)

Query: 491 IGIGGFGKVYRGVLRDET-KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +G G FGKVY+   ++     A K    +S + L +F  EI++LS+ +H ++V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
             N++ I+ E+ + G L   +       L+  +   +C      L++LH+     +IHRD
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHS---HKVIHRD 128

Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE---- 665
           +K+ NILL  +   K+ADFG+S       Q    T + G+  ++ PE +  +   +    
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPYD 186

Query: 666 -KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP 724
            K+D++S G+ + E+    P      P  ++N +   +K  ++        PTL    K 
Sbjct: 187 YKADIWSLGITLIELAQMEP------PHHELNPMRVLLKILKSEP------PTLDQPSKW 234

Query: 725 DSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            S   F +  + CL +   DRP+  ++L
Sbjct: 235 SS--SFNDFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 83/289 (28%), Positives = 122/289 (42%), Gaps = 36/289 (12%)

Query: 485 FSESLVIGIGGFGKVYRGVLRDE----TKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           F+   ++G G FG V    L+ E     KVAVK  +    S   + EF  E   + +F H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 539 RHLVSLIGYCDERNEM------IIIYEYMENGTLKDHLYAS----NFPSLSWRKRLEICI 588
            +++ LIG              ++I  +M++G L   L  S       +L  +  +   I
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
             A G+ YL   S+K  IHRD+ + N +L+EN+   VADFGLSK     D      A K 
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQET 707
              +L  E L     T  SDV++FGV M+EI+  G+    P    E   +  + +K    
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ---TPYAGVENSEIYNYLIKGNRL 234

Query: 708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
            Q              PD L    E+  +C +     RPS   +   LE
Sbjct: 235 KQ-------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 28/209 (13%)

Query: 491 IGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++ +F   H+V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSLS---WRKRLEICIGAARGLH 595
           L+G   +    ++I E M  G LK +L +      N P  +    +K +++    A G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T      KG  G    
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR--KGGKGLLPV 185

Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SDV+SFGVV++EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.7 bits (238), Expect = 3e-20
 Identities = 93/363 (25%), Positives = 156/363 (42%), Gaps = 55/363 (15%)

Query: 414 LIVGVASGSCISVGLALVLVLLCRRRNRLARGHLKADEQFAVKEGHISAIFSSSKIGYRF 473
             +    G+ + + L     +  R RN L    LK  E    ++G     F  SK+    
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNL---ELKRVEN---EDGTWELQFFDSKVSKSI 683

Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRG-VLRDETKVAVKRGGTQSHQGLAEFRTEIEM 532
               I +   +  E  VI  G  G  Y+G  +++  +  VK         +    +EI  
Sbjct: 684 ---TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE--INDVNSIPS--SEIAD 736

Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR 592
           + + +H ++V LIG C       +I+EY+E   L + L      +LSW +R +I IG A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAK 791

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF-- 650
            L +LH   + A++  ++    I++D                   D+ H+  ++ G    
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGK-----------------DEPHLRLSLPGLLCT 834

Query: 651 --------GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVN--LVEW 700
                    Y+ PE    + +TEKSD+Y FG+++ E+L G+    P+     V+  +VEW
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK---SPADAEFGVHGSIVEW 891

Query: 701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEI---AEKCLAQCGIDRPSMGDVLWNLEY 757
           A  C     L+  +DP++ G +  +  N+ VE+   A  C A     RP   DVL  LE 
Sbjct: 892 ARYCYSDCHLDMWIDPSIRGDVSVNQ-NEIVEVMNLALHCTATDPTARPCANDVLKTLES 950

Query: 758 ALQ 760
           A +
Sbjct: 951 ASR 953

Length = 968

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 69/267 (25%), Positives = 117/267 (43%), Gaps = 26/267 (9%)

Query: 490 VIGIGGFGK--VYRGVLRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           V+G G FG+  +YR    D++ V  K       S +   +   EI +LS  +H ++++  
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
            +  + N ++I  EY   GTL D +             L         + Y+H      I
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---I 122

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           +HRD+K+ NI L +  + K+ DFG+SKI    + +   T V G+  Y+ PE     +   
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAETVV-GTPYYMSPELCQGVKYNF 180

Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           KSD+++ G V++E+L  +   D + P   +NLV   ++   T     +V    +  I   
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNP---LNLVVKIVQGNYT----PVVSVYSSELI--- 230

Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                  +    L Q    RP+  +VL
Sbjct: 231 ------SLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 66/233 (28%), Positives = 110/233 (47%), Gaps = 26/233 (11%)

Query: 529 EIEMLSQFRHRHLVSLIG-YCDERNEMI-IIYEYMENGTLKDHLYA---SNFPSLSWRKR 583
           E+E+    +  ++V   G + DE +  I I  EY E G+L D +Y         +  +  
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL 107

Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHV 642
            +I     +GL YLH+   + IIHRD+K +NILL      K+ DFG+S ++   L  T  
Sbjct: 108 GKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT 164

Query: 643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-PVI-DPSLPREKVNLVEW 700
            T    SF Y+ PE +  +  +  SDV+S G+ + E+   R P   +   P   + L+ +
Sbjct: 165 GT----SF-YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY 219

Query: 701 AMKCQETGQLEDIVDPTLTGQIK-PDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +      +L+D  +P     IK  +    F+   ++CL +    RP+  D+L
Sbjct: 220 IVN-MPNPELKD--EPGN--GIKWSEEFKDFI---KQCLEKDPTRRPTPWDML 264

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.7 bits (225), Expect = 5e-20
 Identities = 70/223 (31%), Positives = 109/223 (48%), Gaps = 35/223 (15%)

Query: 490 VIGIGGFGKV--YR-GVLRDETK--VAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           V+G G FGKV  Y      D T   VAVK   R   Q +   + ++ EI +L    H ++
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENI 68

Query: 542 VSLIGYCDERNEMII--IYEYMENGTLKDHLYASNFPSLSWRKRL----EICIGAARGLH 595
           V   G C E+    +  I EY+  G+L+D+L       L+  + L    +IC     G+ 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQIC----EGMA 121

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VSTAVKGSFGYLD 654
           YLH+   +  IHRD+ + N+LLD + + K+ DFGL+K  P+  + + V         +  
Sbjct: 122 YLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEIL--CGRPVIDPSL-PREK 694
            E L + + +  SDV+SFGV ++E+L  C     D    P +K
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHC-----DSKQSPPKK 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 90.9 bits (226), Expect = 6e-20
 Identities = 70/244 (28%), Positives = 104/244 (42%), Gaps = 41/244 (16%)

Query: 484 NFSESLVIGIGGFGKVY-----------------RGVLRDETKVAVK--RGGTQSHQGLA 524
           NF E L  G G FG+V+                          VAVK  R     +    
Sbjct: 8   NFVEKL--GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-ARE 64

Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS---------NF 575
           +F  E+++LS+    ++  L+G C     + +I EYMENG L   L            N 
Sbjct: 65  DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124

Query: 576 PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP 635
            SLS+   L +    A G+ YL    +   +HRD+ + N L+ +N   K+ADFG+S+   
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 636 DLDQTHVSTAVKGSFGYLDPE--YLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLP 691
             D   V         ++  E   L K   T KSDV++FGV ++EI  LC     +  L 
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFGVTLWEILTLCREQPYE-HLT 238

Query: 692 REKV 695
            ++V
Sbjct: 239 DQQV 242

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 50/142 (35%), Positives = 74/142 (52%), Gaps = 5/142 (3%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           IG G +G VY+   +     VA+K    +        + EI ML + RH ++V+  G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
            R+++ I+ EY   G+L+D +Y      LS  +   +C    +GL YLH       IHRD
Sbjct: 71  RRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRD 126

Query: 610 VKSANILLDENLMAKVADFGLS 631
           +K ANILL E+   K+ADFG+S
Sbjct: 127 IKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 88.4 bits (219), Expect = 2e-19
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 20/219 (9%)

Query: 483 DNFSESL--VIGIGGFGKVYRGVL----RDETKVAVK--RGGTQSHQGLAEFRTEIEMLS 534
           DN S  +  ++G G FG++ RG L    + E  VA+   R G    Q    F  E   L 
Sbjct: 3   DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLG 61

Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
           QF H ++V L G     N M+I+ EYM NG L D     +   L   + + +  G A G+
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGM 120

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL- 653
            YL   S    +H+ + +  +L++ +L+ K++ F       +     + T + G    L 
Sbjct: 121 KYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLW 174

Query: 654 -DPEYLTKQQLTEKSDVYSFGVVMFEILC--GRPVIDPS 689
             PE +     +  SDV+SFG+VM+E++    RP  D S
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 37/215 (17%)

Query: 491 IGIGGFGKVY---RGVLRDETKVAVK-------RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           I  G +G+V+   +    D    A+K           Q  Q L    TE ++LSQ +  +
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVL----TERDILSQAQSPY 54

Query: 541 LVSLI-GYCDERNEMIIIYEYMENGTLKDHLYASNFPSL--SWRKRL--EICIGAARGLH 595
           +V L   +  ++N + ++ EY+  G L   L   N  SL     +    EI +     L 
Sbjct: 55  VVKLYYSFQGKKN-LYLVMEYLPGGDLASLL--ENVGSLDEDVARIYIAEIVLA----LE 107

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK------GS 649
           YLH+     IIHRD+K  NIL+D N   K+ DFGLSK+G    Q +++   K      G+
Sbjct: 108 YLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             Y+ PE +  Q  ++  D +S G +++E L G P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 48/277 (17%)

Query: 491 IGIGGFGKVYRGVLR--DETKVAVKRG--GTQSHQGLAEFRTEIEMLSQFRHRHLVS--- 543
           +G G +G VY+ V R  D    A+K    G+ S +   +   EI +L+   H +++S   
Sbjct: 8   LGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 544 --LIGYCDERNEMIIIYEYMENGTL-----KDHLYASNFPS-LSWRKRLEICIGAARGLH 595
             L G     N++ I+ EY   G L     K        P    WR  +++     RGL 
Sbjct: 67  AFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQ 117

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
            LH    + I+HRD+KSANILL  N + K+ D G+SK+   L +    T + G+  Y+ P
Sbjct: 118 ALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNMAKTQI-GTPHYMAP 170

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
           E    +  + KSD++S G +++E+    P      P E  ++ +   K Q  G+   I  
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAP------PFEARSMQDLRYKVQ-RGKYPPI-- 221

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                 I    L  F+      L      RP+   +L
Sbjct: 222 ----PPIYSQDLQNFI---RSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 87.3 bits (216), Expect = 9e-19
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 28/209 (13%)

Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL   + K  +HRD+ + N ++  +   K+ DFG+++   D+ +T      KG  G    
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR---DIYETDYYR--KGGKGLLPV 185

Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.5 bits (214), Expect = 1e-18
 Identities = 53/200 (26%), Positives = 105/200 (52%), Gaps = 17/200 (8%)

Query: 490 VIGIGGFGKVYRGVLRDE-----TKVAVK----RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           ++G G FG V++G+   E       VA+K    R G Q+ Q + +    +  L    H +
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD---HAY 70

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V L+G C     + ++ +    G+L DH+   +  SL  ++ L  C+  A+G++YL   
Sbjct: 71  IVRLLGIC-PGASLQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMYYLEE- 127

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
               ++HR++ + NILL  + + ++ADFG++ +    D+ +  +  K    ++  E +  
Sbjct: 128 --HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 661 QQLTEKSDVYSFGVVMFEIL 680
            + T +SDV+S+GV ++E++
Sbjct: 186 GRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 24/202 (11%)

Query: 491 IGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQGLA-EFRTEIEMLSQFRHRHLVSLIG 546
           +G G FG V +GV +   K   VA+K    ++ + +  E   E E++ Q  + ++V +IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 547 YCDERNEMIIIYEYMENGTL-------KDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
            C+    M+++ E    G L       KD +  SN         +E+    + G+ YL  
Sbjct: 63  VCEAEALMLVM-EMASGGPLNKFLSGKKDEITVSNV--------VELMHQVSMGMKYLEG 113

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYL 658
              K  +HRD+ + N+LL     AK++DFGLSK +G D       +A K    +  PE +
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170

Query: 659 TKQQLTEKSDVYSFGVVMFEIL 680
             ++ + +SDV+S+G+ M+E  
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 17/206 (8%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLA------EFRTEIEMLSQFRHRHLVS 543
           V+G G +G VY G+      +AVK+    +   LA      + + E+++L   +H ++V 
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            +G C + N + I  E++  G++   L      P   + K  +  +    G+ YLH    
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL---DGVAYLHNNC- 122

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK----IGPDLDQTHVSTAVKGSFGYLDPEYL 658
             ++HRD+K  N++L  N + K+ DFG ++    +G     +++  ++ G+  ++ PE +
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
            +     KSD++S G  +FE+  G+P
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.1 bits (213), Expect = 1e-18
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 490 VIGIGGFGKVYRGVLRD---ETKVAVKR----GGTQSHQG--LAEFRTEIEMLSQFRHRH 540
            +G G F   Y+   RD    T +AVK+      T S Q   +   R EI ++++  H H
Sbjct: 7   QLGTGAFSSCYQA--RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           ++ ++G   E +   +  E+M  G++   L  S + +      +       RGL YLH  
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLSYLHE- 121

Query: 601 STKAIIHRDVKSANILLDEN-LMAKVADFGLS-KIGPDLDQT-HVSTAVKGSFGYLDPEY 657
               IIHRDVK AN+L+D      ++ADFG + ++             + G+  ++ PE 
Sbjct: 122 --NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L  +Q     DV+S G V+ E+   +P
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 16/204 (7%)

Query: 484 NFSESLVIGIGGFGKVY--RGVLRDETKVAVKR----GGTQSHQGLAEFRTEIEMLSQFR 537
            + +  V+G G FG V+  R    D+  V +K+      T+  +  A+   E ++L    
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQ--NECQVLKLLS 57

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H +++       E   ++I+ EY   GTL +++       L     L   +     LH++
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 598 HTGSTKAIIHRDVKSANILLDENLM-AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           HT   K I+HRD+K+ NILLD++ M  K+ DFG+SKI   L     +  V G+  Y+ PE
Sbjct: 118 HT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPE 171

Query: 657 YLTKQQLTEKSDVYSFGVVMFEIL 680
               +   +KSD+++ G V++E+ 
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELA 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 30/213 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVK----------RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +IG G +G+VY  +     ++ AVK          R  ++    +   R+EIE L    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 539 RHLVSLIGYCDERNEMIIIY-EYMENGTLKDHL--YASNFPSLS---WRKRLEICIGAAR 592
            ++V  +G  +   E + I+ EY+  G++   L  Y      L      + LE       
Sbjct: 68  LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE------- 119

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
           GL YLH+   K I+HRD+K+ N+L+D + + K++DFG+SK   D+     + +++GS  +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 653 LDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGR 683
           + PE +       + K D++S G V+ E+  GR
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 26/264 (9%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ    ++    G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +  ++ II EY+  G+  D L A  F        L+  +   +GL YLH+   +  IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS---EKKIHR 125

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+K+AN+LL E    K+ADFG++    D  Q   +T V   F ++ PE + +     K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPF-WMAPEVIQQSAYDSKAD 183

Query: 669 VYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLN 728
           ++S G+   E+  G P      P   + L+                 PTLTG+       
Sbjct: 184 IWSLGITAIELAKGEPPNSDMHPMRVLFLI------------PKNNPPTLTGEFS----K 227

Query: 729 KFVEIAEKCLAQCGIDRPSMGDVL 752
            F E  + CL +    RP+  ++L
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 86.8 bits (216), Expect = 2e-18
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 36/215 (16%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
            IG G +G V   V  R   KVA+K+          A+ R   EI++L   RH +++ L+
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK-RILREIKLLRHLRHENIIGLL 65

Query: 546 -----GYCDERNEMIIIYEYMENGT-LKDHLYASNFPSLSWRKRL--EICIGAARGLHYL 597
                   ++ N++ I+ E ME  T L   + +    +    +    +I     RGL YL
Sbjct: 66  DILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQPLTDDHIQYFLYQIL----RGLKYL 119

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYL--- 653
           H+ +   +IHRD+K +NIL++ N   K+ DFGL++ + PD D+    T       Y+   
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYVVTR 170

Query: 654 ---DPE-YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
               PE  L+  + T+  D++S G +  E+L  +P
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.3 bits (211), Expect = 3e-18
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 29/213 (13%)

Query: 490 VIGIGGFGKVY------RGVLRDETKVAVKRGGTQS---HQGLAE-FRTEIEMLSQFRHR 539
           +IG G FG VY       G L    +V +      S    + + +    EI +L + +H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYL 597
           ++V  +G   + + + I  EY+  G++   L  Y + F     R  +   +   +GL+YL
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQIL---KGLNYL 122

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-------VKGSF 650
           H    + IIHRD+K ANIL+D     K++DFG+SK    L+   +ST        ++GS 
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARPSLQGSV 176

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
            ++ PE + +   T K+D++S G ++ E+L G+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 25/224 (11%)

Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDET--KVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N S    +G G FGKV      G+ + +   KVAVK     +H    E   +E++++S 
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
              H ++V+L+G C     +++I EY   G L + L       L+    L      A+G+
Sbjct: 95  LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST-AVKGS---- 649
            +L   ++K  IHRD+ + N+LL    + K+ DFGL++     D  + S   VKG+    
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLP 206

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLP 691
             ++ PE +     T +SDV+S+G++++EI  L   P   P +P
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY--PGMP 248

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 19/206 (9%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           VIG+G    VY  + L +  KVA+KR    +    + E R E++ +SQ  H ++V     
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL-EICIGAA-----RGLHYLHTGS 601
               +E+ ++  Y+  G+L D +  S++P    R  L E  I        +GL YLH+  
Sbjct: 68  FVVGDELWLVMPYLSGGSLLD-IMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHS-- 120

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTH-VSTAVKGSFGYLDPEYLT 659
               IHRD+K+ NILL E+   K+ADFG+S  +    D+T  V     G+  ++ PE + 
Sbjct: 121 -NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 660 KQQ-LTEKSDVYSFGVVMFEILCGRP 684
           +      K+D++SFG+   E+  G  
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAA 205

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.6 bits (209), Expect = 7e-18
 Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 27/206 (13%)

Query: 491 IGIGGFGKVY------RGVLRDET--KVAVK-----RGGTQSHQGLAEFRTEIEMLSQFR 537
           +G G FGKV        G   D T  +VAVK      GG       A+ + EIE+L    
Sbjct: 12  LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHI----ADLKKEIEILRNLY 64

Query: 538 HRHLVSLIGYCDER--NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
           H ++V   G C E   N + +I E++ +G+LK++L   N   ++ +++L+  +   +G+ 
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMD 123

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLD 654
           YL    ++  +HRD+ + N+L++     K+ DFGL+K I  D +   V   +     +  
Sbjct: 124 YL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180

Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEIL 680
           PE L + +    SDV+SFGV ++E+L
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 8e-18
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 36/215 (16%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI- 545
            IG G +G V          KVA+K+     HQ   + RT  EI++L +F+H +++ ++ 
Sbjct: 12  YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQ-RTLREIKILRRFKHENIIGILD 70

Query: 546 ----GYCDERNEMIIIYEYMENGTLK---------DHLYASNFPSLSWRKRLEICIGAAR 592
                  +  N++ I+ E ME    K         DH+    +  L             R
Sbjct: 71  IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL-------------R 117

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFG 651
           GL Y+H+ +   ++HRD+K +N+LL+ N   K+ DFGL++I  P+ D T   T    +  
Sbjct: 118 GLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
           Y  PE  L  +  T+  D++S G ++ E+L  RP+
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLIGY 547
           IG G +G VY+         VA+K+   +            EI++L +  H +++ L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
              + ++ +++E+M+   L   +       L             +GL + H+     I+H
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHSHG---ILH 121

Query: 608 RDVKSANILLDENLMAKVADFGLSK-IGPDLDQ-TH-VSTAVKGSFGYLDPEYL-TKQQL 663
           RD+K  N+L++   + K+ADFGL++  G  +   TH V T       Y  PE L   +  
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY 176

Query: 664 TEKSDVYSFGVVMFEILCGRP 684
           +   D++S G +  E+L  RP
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 81/315 (25%), Positives = 133/315 (42%), Gaps = 85/315 (26%)

Query: 490 VIGIGGFGKVYRGV------LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
            +G G FGKV +            T VAVK      + S   L +  +E  +L Q  H H
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLKQVNHPH 64

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS--------------------------- 573
           ++ L G C +   +++I EY + G+L+  L  S                           
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 574 ---NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL 630
              +  S +W    +I     RG+ YL   +   ++HRD+ + N+L+ E    K++DFGL
Sbjct: 125 TMGDLISFAW----QIS----RGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGL 173

Query: 631 SKIGPDLDQTHVSTAVKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGR 683
           S+     D     + VK S G     ++  E L     T +SDV+SFGV+++EI  L G 
Sbjct: 174 SR-----DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228

Query: 684 PVIDPSLPREKV-NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFV-EIAEKCLAQC 741
           P   P +  E++ NL+       +TG   +          +P++ ++ +  +   C  Q 
Sbjct: 229 PY--PGIAPERLFNLL-------KTGYRME----------RPENCSEEMYNLMLTCWKQE 269

Query: 742 GIDRPSMGDVLWNLE 756
              RP+  D+   LE
Sbjct: 270 PDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 49/169 (28%), Positives = 89/169 (52%), Gaps = 15/169 (8%)

Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL----------YASN 574
           +F  EI+++S+ ++ +++ L+G C   + + +I EYMENG L   L          +A+N
Sbjct: 63  DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122

Query: 575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG 634
            PS+S    L + +  A G+ YL   ++   +HRD+ + N L+  +   K+ADFG+S+  
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LC 681
              D   +         ++  E +   + T  SDV++FGV ++E+  LC
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.1 bits (208), Expect = 2e-17
 Identities = 86/274 (31%), Positives = 122/274 (44%), Gaps = 43/274 (15%)

Query: 491 IGIGGFGKVY--RGVLRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           IG G FG VY  R V  +E  VA+K+    G QS++   +   E+  L Q RH + +   
Sbjct: 23  IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81

Query: 546 G-YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           G Y  E    +++ EY   G+  D L     P L   +   IC GA +GL YLH+     
Sbjct: 82  GCYLREHTAWLVM-EYCL-GSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHSHER-- 136

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY---LTKQ 661
            IHRD+K+ NILL E    K+ADFG + +      + V T       ++ PE    + + 
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL-VSPANSFVGTPY-----WMAPEVILAMDEG 189

Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD---PTL 718
           Q   K DV+S G+   E+   +P      P   +N    AM       L  I     PTL
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP------PLFNMN----AMSA-----LYHIAQNDSPTL 234

Query: 719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           +     D    FV   + CL +   DRPS  ++L
Sbjct: 235 SSNDWSDYFRNFV---DSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 491 IGIGGFGKVY-----RGVLRDETKV--AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY     + V  +  KV   +  G    ++ + +   E ++LS+  H  +V 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV-QANQEAQLLSKLDHPAIVK 66

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
                 ER+   II EY E   L   L        +LS  +  E  I    G+HY+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
            + I+HRD+K+ NI L  NL+ K+ DFG+S++   +    ++T   G+  Y+ PE L  Q
Sbjct: 125 -RRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 662 QLTEKSDVYSFGVVMFEILC 681
               KSD++S G +++E+ C
Sbjct: 181 GYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 18/212 (8%)

Query: 484 NFSESLVIGIGGFGKVY------RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR 537
           N+    ++G G FG+VY       G      +V       ++ + ++    EI++L   +
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 538 HRHLVSLIGYCDERNE--MIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARG 593
           H  +V   G   +R E  + I  EYM  G++KD L  Y +   S++ +   +I      G
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EG 118

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST-AVKGSFGY 652
           + YLH+     I+HRD+K ANIL D     K+ DFG SK    +  +     +V G+  +
Sbjct: 119 MSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE ++ +    K+DV+S G  + E+L  +P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 38/221 (17%)

Query: 494 GGFGKVYRGVLRDETKV--------AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           G FG+++ G+L DE            VK   ++    +     E  +L    H++++ ++
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQNILPIL 74

Query: 546 GYCDERNEM-IIIYEYMENGTLKDHLY------ASNFPSLSWRKRLEICIGAARGLHYLH 598
             C E  E   ++Y YM  G LK  L       A+N  +LS ++ + + I  A G+ YLH
Sbjct: 75  HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL--DQTHV-----STAVKGSFG 651
               + +IH+D+ + N ++DE L  K+ D  LS+   DL     H      +  VK    
Sbjct: 135 K---RGVIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNENRPVK---- 184

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPV--IDP 688
           ++  E L  ++ +  SDV+SFGV+++E+  L   P   IDP
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 50/201 (24%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 491 IGIGGFGKVYRGVLRDETKV-AVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G GGFG+V    ++   K+ A K   +   +  +G      E ++L +   R +VSL  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL----EICIGAARGLHYLHTGST 602
             + ++++ ++   M  G LK H+Y    P     + +    +I  G    L +LH    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ--- 113

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + I++RD+K  N+LLD++   +++D GL+       +        G+ GY+ PE L  + 
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170

Query: 663 LTEKSDVYSFGVVMFEILCGR 683
                D ++ G  ++E++ GR
Sbjct: 171 YDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 82.1 bits (204), Expect = 4e-17
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 31/208 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAE---FRT---EIEMLSQFRHRHLVS 543
           +G G +G VY+    +    VA+K    +      E     T   EI +L + +H ++V 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALK----KIRLDNEEEGIPSTALREISLLKELKHPNIVK 62

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFP---SLSWRKRLEICIGAARGLHYLHTG 600
           L+       ++ +++EY +   LK +L     P   S +  K +   +   RGL Y H+ 
Sbjct: 63  LLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQL--LRGLAYCHSH 117

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQ-TH-VSTAVKGSFGYLDPEY 657
               I+HRD+K  NIL++ + + K+ADFGL++  G  L   TH V T       Y  PE 
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT-----LWYRAPEI 169

Query: 658 LTKQQLTEKS-DVYSFGVVMFEILCGRP 684
           L   +    + D++S G +  E++ G+P
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 82.8 bits (204), Expect = 4e-17
 Identities = 64/223 (28%), Positives = 114/223 (51%), Gaps = 24/223 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETK-----VAVK-RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FG VY+G+   E +     VA+K    T   +   EF  E  +++   H HLV 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 544 LIGYCDERNEMIIIYEYMENGTLKD--HLYASNFPS---LSWRKRLEICIGAARGLHYLH 598
           L+G C     + ++ + M +G L D  H +  N  S   L+W      C+  A+G+ YL 
Sbjct: 74  LLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
               + ++HRD+ + N+L+      K+ DFGL+++    ++ + +   K    ++  E +
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183

Query: 659 TKQQLTEKSDVYSFGVVMFEILC--GRPVIDPSLPREKVNLVE 699
             ++ T +SDV+S+GV ++E++   G+P  D    RE  +L+E
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPY-DGIPTREIPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 82.1 bits (203), Expect = 5e-17
 Identities = 64/270 (23%), Positives = 123/270 (45%), Gaps = 40/270 (14%)

Query: 499 VYRGVLRDETKVAVKRGGTQSHQG----LAEFRTEIEMLSQFRHRHLVSLIGY----CDE 550
           +Y+G+  +  +V ++    + H+G    +     EI+ L +    +++ + G+     D+
Sbjct: 36  IYKGIF-NNKEVIIRTF-KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
              + +I EY   G L++ L       LS++ +L++ I   +GL+ L+  + K   ++++
Sbjct: 94  LPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK--QQLTEKSD 668
            S + L+ EN   K+   GL KI       +V+  V     Y   + L     + T K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDD 204

Query: 669 VYSFGVVMFEILCGRPVIDPSLPREKVNLVE-WAMKCQETGQLE-DIVDPTLTGQIKPDS 726
           +YS GVV++EI  G+      +P E +   E + +   +   L+  +  P     IK   
Sbjct: 205 IYSLGVVLWEIFTGK------IPFENLTTKEIYDLIINKNNSLKLPLDCPLE---IK--- 252

Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                 I E C +   I RP++ ++L+NL 
Sbjct: 253 -----CIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 73/273 (26%), Positives = 112/273 (41%), Gaps = 45/273 (16%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGLAEFR---TEIEMLSQFRHRHLVSLI 545
            +G G  G V + + R   K+ AVK    +     A  +    E+++L +    ++V   
Sbjct: 8   ELGAGNSGVVSKVLHRPTGKIMAVKT--IRLEINEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 546 GYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G      ++ I  EYM+ G+L   L       P     K   I +   +GL YLH     
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK---IAVAVLKGLTYLH--EKH 120

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
            IIHRDVK +NIL++     K+ DFG+S ++   L +T V T+      Y+ PE +    
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS-----YMAPERIQGND 175

Query: 663 LTEKSDVYSFGVVMFEILCGR-----PVIDPSLPREKVNLVEWAMKCQETGQLEDIVD-- 715
            + KSD++S G+ + E+  GR         P    E                L+ IV+  
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE---------------LLQYIVNEP 220

Query: 716 -PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS 747
            P L           FV     CL +   +RPS
Sbjct: 221 PPRLPSGKFSPDFQDFV---NLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 26/217 (11%)

Query: 485 FSESLVIGIGGFGKVYRGVL----RDETK-VAVKR-GGTQSHQGLAEFRTEIEMLSQFRH 538
           F E L  G   FGK+Y+G L     D  + VA+K      + Q   EF+ E  ++++  H
Sbjct: 9   FMEEL--GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN---------------FPSLSWRKR 583
            ++V L+G   +   + +++EY+  G L + L   +                 SL     
Sbjct: 67  PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126

Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
           L I I  A G+ YL   S+   +H+D+ + NIL+ E L  K++D GLS+     D   V 
Sbjct: 127 LHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183

Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
                   ++ PE +   + +  SD++SFGVV++EI 
Sbjct: 184 PKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 38/222 (17%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
            D   E +V+G G +G VY    L  + ++A+K    +  + +     EI + S  +HR+
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTL-----------KDHLYASNFPSLSWRKRLEICIG 589
           +V  +G   E     I  E +  G+L           KD+     F +   ++ LE    
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT---KQILE---- 119

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSK----IGPDLDQTHVST 644
              GL YLH      I+HRD+K  N+L++  + + K++DFG SK    I P       + 
Sbjct: 120 ---GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTE 167

Query: 645 AVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRP 684
              G+  Y+ PE + K        +D++S G  + E+  G+P
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 20/213 (9%)

Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKR-----GGTQSHQGLAEFRTEIEMLSQFR 537
           N+    ++G G FG+VY     D  + +AVK+        ++ + +     EI++L   R
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 538 HRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAAR 592
           H  +V   G C    E  ++ I  EYM  G++KD L  Y +   +++ R   +I     +
Sbjct: 63  HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----Q 117

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS-TAVKGSFG 651
           G+ YLH+     I+HRD+K ANIL D     K+ DFG SK    +  +     +V G+  
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           ++ PE ++ +    K+DV+S    + E+L  +P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 10/196 (5%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE---FRTEIEMLSQFRHRHLVSLIG 546
            IG G FGK+Y    + +++  V +    +   + E    + E+ +L++ +H ++V+   
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
              E   + I+ EY + G L   +        S  + L   +  + GL ++H    + I+
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKIL 123

Query: 607 HRDVKSANILLDENLM-AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           HRD+KS NI L +N M AK+ DFG+++   D     ++    G+  YL PE    +    
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 666 KSDVYSFGVVMFEILC 681
           K+D++S G V++E LC
Sbjct: 182 KTDIWSLGCVLYE-LC 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 80.0 bits (197), Expect = 3e-16
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 20/173 (11%)

Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL-------------- 570
           +F  E+++LS+ +  +++ L+G C + + + +I EYMENG L   L              
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124

Query: 571 ---YASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD 627
               A   P++S+   L + +  A G+ YL   S+   +HRD+ + N L+ ENL  K+AD
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181

Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           FG+S+     D   +         ++  E +   + T  SDV++FGV ++EIL
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 83.0 bits (205), Expect = 4e-16
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 21/192 (10%)

Query: 509 KVAVK----RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI--GYCDERNEMIIIYEYME 562
           +VA+K        + HQ  A FR E  + ++  H ++V+L+  G       +  ++EY+ 
Sbjct: 5   EVAIKLLRTDAPEEEHQ-RARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVP 62

Query: 563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DE 619
             TL++ L A          RL       + L  L     + I+HRD+K  NI++     
Sbjct: 63  GRTLREVLAADGALPAGETGRL-----MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117

Query: 620 NLMAKVADFGLSKIGPDLDQTHVSTA-----VKGSFGYLDPEYLTKQQLTEKSDVYSFGV 674
              AKV DFG+  + P +    V+T      V G+  Y  PE L  + +T  SD+Y++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177

Query: 675 VMFEILCGRPVI 686
           +  E L G+ V+
Sbjct: 178 IFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 24/209 (11%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKR-----GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G FG+VY     D  + +AVK+        ++ + +     EI++L    H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 544 LIGYCDERNE--MIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLHT 599
             G   +  E  + I  E+M  G++KD L  Y +   +++ +   +I      G+ YLH+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHS 124

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS----TAVKGSFGYLDP 655
                I+HRD+K ANIL D     K+ DFG SK    L    +S     +V G+  ++ P
Sbjct: 125 ---NMIVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSGTGMKSVTGTPYWMSP 178

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           E ++ +    K+D++S G  + E+L  +P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.1 bits (196), Expect = 4e-16
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 20/202 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAE-FRTEIEMLSQFRHRHLVSLI 545
            +G G FG+V     +   K  A+K             E    E  +L   RH  LV+L 
Sbjct: 8   TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67

Query: 546 G-YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRK--RLEICIGAARGLHYLHTGST 602
           G + D+ N + ++ EY+  G L  HL  S        +    ++ +     L YLH+   
Sbjct: 68  GSFQDDSN-LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLA----LEYLHS--- 119

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             I++RD+K  N+LLD +   K+ DFG +K       T   T       YL PE +  + 
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTP-----EYLAPEIILSKG 174

Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
             +  D ++ G++++E+L G P
Sbjct: 175 YGKAVDWWALGILIYEMLAGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 12/200 (6%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQ-FRHRHLVSL 544
           V+G G FGKV    L+   ++     +K+        +    TE  +L+   +H  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
                 ++ +  + EY+  G L  H+  S        +     I    GL +LH    + 
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEI--VLGLQFLHE---RG 116

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           II+RD+K  N+LLD     K+ADFG+ K G     T  ++   G+  Y+ PE L+ Q   
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYG 174

Query: 665 EKSDVYSFGVVMFEILCGRP 684
              D ++ GV+++E+L G+ 
Sbjct: 175 PAVDWWALGVLLYEMLAGQS 194

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 12/194 (6%)

Query: 491 IGIGGFGKVYRGVL---RDETKVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V +G+    + E  VAVK     ++      E   E  ++ Q  + ++V +I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
           G C+  + M+++ E  E G L  + +      ++ +   E+    + G+ YL   +    
Sbjct: 63  GICEAESWMLVM-ELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---F 116

Query: 606 IHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           +HRD+ + N+LL     AK++DFGLSK +G D +     T  K    +  PE +   + +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 665 EKSDVYSFGVVMFE 678
            KSDV+SFGV+M+E
Sbjct: 177 SKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.1 bits (195), Expect = 8e-16
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 29/217 (13%)

Query: 480 EATDNFSESLVIGIGGFGKV--YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQ 535
           E T+ + +   +G+G FG V   R  L  +  VA+K+        +   RT  E+++L  
Sbjct: 7   EITNRYVDLQPVGMGAFGLVCSARDQLTGQN-VAIKKIMKPFSTPVLAKRTYRELKLLKH 65

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICIG 589
            RH +++SL    D      I    +E+      L  ++   L   + LE          
Sbjct: 66  LRHENIISL---SD------IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ 116

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
             RGL Y+H+     ++HRD+K +NIL++EN   K+ DFGL++I     Q    T    +
Sbjct: 117 ILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168

Query: 650 FGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             Y  PE  LT Q+   + D++S G +  E+L G+P+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL 205

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 38/213 (17%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRT---EIEMLSQFRHRHLVSLI 545
           V+G G +G V +   +   + VA+K    +S       +T   E+++L Q RH ++V+L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIK-KFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFP---------SLSWRKRLEICIGAARGLHY 596
                +  + +++EY+E  TL + L AS  P         S  W+          + + Y
Sbjct: 67  EAFRRKGRLYLVFEYVER-TLLELLEAS--PGGLPPDAVRSYIWQ--------LLQAIAY 115

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQT-HVSTAVKGSFGY 652
            H+     IIHRD+K  NIL+ E+ + K+ DFG ++     P    T +V+T       Y
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WY 167

Query: 653 LDPEYLTKQQLTEKS-DVYSFGVVMFEILCGRP 684
             PE L       K  DV++ G +M E+L G P
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKR-------GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           IG G  G V++   R+  + VA+K+       GG   +Q L     EI+ L   +H ++V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQAL----REIKALQACQHPYVV 62

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRLEICIGAARGLHYLHTGS 601
            L+      +  +++ EYM    L + L     P   +  K     +   +G+ Y+H   
Sbjct: 63  KLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMHA-- 117

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL-TK 660
              I+HRD+K AN+L+  + + K+ADFGL+++  + +    S  V  +  Y  PE L   
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGA 175

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
           ++     D+++ G +  E+L G P
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 25/207 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTE---IEMLSQFRHRHLV 542
           V+G G FGKV     +   ++    A+K+G   +   +     E    E  +  RH  LV
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL-----EICIGAARGLHYL 597
           +L       + +  + EY   G L  H++   F       R       + +G    L YL
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS----EPRAVFYAACVVLG----LQYL 117

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H      I++RD+K  N+LLD     K+ADFGL K G        ST   G+  +L PE 
Sbjct: 118 HE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TSTFC-GTPEFLAPEV 172

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           LT+   T   D +  GV+++E+L G  
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGES 199

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 26/205 (12%)

Query: 491 IGIGGFGKVY---------RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           +G+GGFG+V             L+   K  +   G Q H       +E E+L +  H  +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH-----IFSEKEILEECNHPFI 55

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEI-CIGAARGLHYLHT 599
           V L     ++  + ++ EY   G L   L     F    +  R  I C+  A    YLH 
Sbjct: 56  VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARFYIACVVLA--FEYLHN 111

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
              + II+RD+K  N+LLD N   K+ DFG +K      +T   T   G+  Y+ PE + 
Sbjct: 112 ---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIIL 165

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRP 684
            +      D +S G++++E+L GRP
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 1e-15
 Identities = 74/235 (31%), Positives = 106/235 (45%), Gaps = 27/235 (11%)

Query: 491 IGIGGFGKVYRGVLRDETK--VAVKRGGTQSHQGLAEFR---TEIEMLSQFRHRHLVSLI 545
           +G GG+G+V+    +D T   VA+KR        L E R   TE ++L+  +   LV L+
Sbjct: 9   VGQGGYGQVFLAKKKD-TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRK-RLEIC--IGAARGLHYLHTGST 602
               +   + +  EY+  G  +  L  +N   LS    R  +     A   LH L     
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHEL----- 120

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              IHRD+K  N L+D +   K+ DFGLSK       T+ ++ V GS  Y+ PE L  + 
Sbjct: 121 -GYIHRDLKPENFLIDASGHIKLTDFGLSKGI----VTYANSVV-GSPDYMAPEVLRGKG 174

Query: 663 LTEKSDVYSFGVVMFEILCGRPVIDPSLPREK-VNLVEWAMKCQETGQLEDIVDP 716
                D +S G +++E LCG P    S P E   NL  W    +ET Q     DP
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW----KETLQRPVYDDP 225

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 14/196 (7%)

Query: 491 IGIGGFGKVYRGVLRDETKV--AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FGKVY+   + ET    A K   T+S + L ++  EIE+L+   H ++V L+G  
Sbjct: 20  LGDGAFGKVYKAKNK-ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
               ++ I+ E+   G + D +       L+  +   IC      L YLH+     IIHR
Sbjct: 79  YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHR 134

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE--- 665
           D+K+ N+LL  +   K+ADFG+S    ++       +  G+  ++ PE +  + + +   
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192

Query: 666 --KSDVYSFGVVMFEI 679
             K+D++S G+ + E+
Sbjct: 193 DYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 22/232 (9%)

Query: 485 FSESLVIGIGGFGKVYRGVLRDETKV-AVKR---GGTQSHQGLAEFRTEIEMLSQFRHRH 540
           F +  V+G GGFG+V    +R   K+ A KR      +  +G +    E ++L +   + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL----EICIGAARGLHY 596
           +V+L    + ++ + ++   M  G LK H+Y    P     + L    EI  G    L  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LED 117

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    +  ++RD+K  NILLD+    +++D GL+   P+ +         G+ GY+ PE
Sbjct: 118 LHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPE 171

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR-EKVNLVEWAMKCQET 707
            L  Q+ T   D +  G +++E++ G+    P   R EKV   E   +  ET
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ---SPFRGRKEKVKREEVDRRVLET 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 55/212 (25%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGL-AEFRT----EIEMLSQ 535
             NF     IG G F  VY+ +   + + VA+K+   Q  + + A+ R     EI++L Q
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKK--VQIFEMMDAKARQDCLKEIDLLKQ 58

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLK---DHLYASN--FPSLS-WRKRLEICIG 589
             H +++  +    E NE+ I+ E  + G L     H        P  + W+  +++C  
Sbjct: 59  LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC-- 116

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
               L ++H+   K I+HRD+K AN+ +    + K+ D GL +      +T  + ++ G+
Sbjct: 117 --SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGT 169

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC 681
             Y+ PE + +     KSD++S G +++E+  
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 77/265 (29%), Positives = 121/265 (45%), Gaps = 28/265 (10%)

Query: 491 IGIGGFGKVYRGVL-RDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG+VY+G+  R +  VA+K     ++   + + + EI +LSQ    ++    G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +  ++ II EY+  G+  D L             L   +   +GL YLH+   +  IHR
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHS---ERKIHR 125

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+K+AN+LL E    K+ADFG++    D  Q   +T V   F ++ PE + +     K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPF-WMAPEVIKQSAYDFKAD 183

Query: 669 VYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI-KPDSL 727
           ++S G+   E+  G P      P   + L+                 PTL GQ  KP   
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------PTLEGQYSKP--- 228

Query: 728 NKFVEIAEKCLAQCGIDRPSMGDVL 752
             F E  E CL +    RP+  ++L
Sbjct: 229 --FKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 76.7 bits (188), Expect = 3e-15
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 10/202 (4%)

Query: 485 FSESLVIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           F++   IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ    ++ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
              G   +  ++ II EY+  G+  D L       L   +   I     +GL YLH+   
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS--- 119

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           +  IHRD+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE + +  
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
              K+D++S G+   E+  G P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 22/200 (11%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVKRG---GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G FGK      +++ K  V +       S +   E R E+ +LS  +H ++V     
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASN---FPS---LSWRKRLEICIGAARGLHYLHTGS 601
            +E   + I+ +Y E G L   + A     FP    L W   ++IC+     L ++H   
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICLA----LKHVHD-- 119

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HVSTAVKGSFGYLDPEYLTK 660
            + I+HRD+KS NI L ++   K+ DFG++++   L+ T  ++    G+  YL PE    
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIARV---LNSTVELARTCIGTPYYLSPEICEN 175

Query: 661 QQLTEKSDVYSFGVVMFEIL 680
           +    KSD+++ G V++E+ 
Sbjct: 176 RPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.8 bits (186), Expect = 7e-15
 Identities = 65/250 (26%), Positives = 121/250 (48%), Gaps = 27/250 (10%)

Query: 485 FSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           F +  V+G GGFG+V    +R   K+     +++   +  +G +    E ++L +   R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL----EICIGAARGLHY 596
           +VSL    + ++ + ++   M  G LK H+Y          + +    EIC G    L  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LED 117

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + I++RD+K  NILLD++   +++D GL+   P+  QT +   V G+ GY+ PE
Sbjct: 118 LHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTVGYMAPE 171

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP 716
            +  ++ T   D ++ G +++E++ G+    P   R+K       +K +E  +L   V  
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ---SPFQQRKK------KIKREEVERLVKEVQE 222

Query: 717 TLTGQIKPDS 726
             + +  PD+
Sbjct: 223 EYSEKFSPDA 232

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 64/222 (28%), Positives = 111/222 (50%), Gaps = 26/222 (11%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAE----FRTEIEMLSQFRHRHLVSLI 545
           IG G FG V+     RD  +VA+K+      Q L      FR E++ML  F+H +++S +
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65

Query: 546 -----GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAARGLHYL 597
                 + D   E+ ++ E M++   K  +  S  P  S   ++   +I     RGL YL
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQSDLHK--IIVSPQPLSSDHVKVFLYQIL----RGLKYL 119

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     I+HRD+K  N+L++ N + K+ DFGL+++    +  H++  V   + Y  PE 
Sbjct: 120 HSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEI 175

Query: 658 LT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           L   +  T   D++S G +  E+L  R +     P ++++L+
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 8e-15
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 30/211 (14%)

Query: 491 IGIGGFGKVYRGVLRDETK---VAVKRGGTQ-SHQG--LAEFRTEIEMLSQ---FRHRHL 541
           IG G +G VY+   RD      VA+K+     S +G  L+  R EI +L Q   F H ++
Sbjct: 7   IGEGAYGTVYKA--RDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63

Query: 542 VSLIGYC----DERNEMI-IIYEYMENGTLKD-HLYASNFPS--LSWRKRLEICIGAARG 593
           V L+  C     +R   + +++E+++    +D   Y S  P   L      ++     RG
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           + +LH+     I+HRD+K  NIL+  +   K+ADFGL++I          T+V  +  Y 
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTLWYR 173

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE L +       D++S G +  E+   RP
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRRP 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 44/165 (26%), Positives = 85/165 (51%), Gaps = 12/165 (7%)

Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL---------KDHLYASNF 575
           +F  EI+++S+ +  +++ L+  C   + + +I EYMENG L         ++    ++ 
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 576 PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP 635
            ++S+   + +    A G+ YL   S+   +HRD+ + N L+ +N   K+ADFG+S+   
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Query: 636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             D   +         ++  E +   + T  SDV++FGV ++EIL
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 21/204 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           ++G G +G V +   ++  + VA+K+               R EI ML Q RH +LV+LI
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66

Query: 546 GYCDERNEMIIIYEYMENGTLKD-HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
                +  + +++E++++  L D   Y +       RK L   +   RG+ + H+ +   
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL---RGIEFCHSHN--- 120

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQT-HVSTAVKGSFGYLDPEYLTKQ 661
           IIHRD+K  NIL+ ++ + K+ DFG ++    P    T +V+T       Y  PE L   
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLVGD 175

Query: 662 QLTEKS-DVYSFGVVMFEILCGRP 684
               ++ D+++ G ++ E+L G P
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 57/204 (27%), Positives = 106/204 (51%), Gaps = 15/204 (7%)

Query: 485 FSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQFR 537
           F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++   
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           + H+  L+G C   + + +I + M  G L D++   +  ++  +  L  C+  A+G++YL
Sbjct: 68  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPE 656
                + ++HRD+ + N+L+      K+ DFGL+K +G D  + H     K    ++  E
Sbjct: 126 EE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG-KVPIKWMALE 181

Query: 657 YLTKQQLTEKSDVYSFGVVMFEIL 680
            +  +  T +SDV+S+GV ++E++
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 79/270 (29%), Positives = 120/270 (44%), Gaps = 35/270 (12%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FG VY        + VAVK+    G Q+++   +   E++ L Q +H + +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
              + +   ++ EY   G+  D L     P L   +   I  GA +GL YLH+     +I
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHS---HNMI 143

Query: 607 HRDVKSANILLDENLMAKVADFG-LSKIGPDLDQTHVSTAVKGSFGYLDPEY---LTKQQ 662
           HRD+K+ NILL E    K+ADFG  SK  P       + +  G+  ++ PE    + + Q
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQ 196

Query: 663 LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI 722
              K DV+S G+   E+   +P      P   +N    AM         D   PTL    
Sbjct: 197 YDGKVDVWSLGITCIELAERKP------PLFNMN----AMSALYHIAQND--SPTLQSNE 244

Query: 723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
             DS   FV+    CL +   +RP+  ++L
Sbjct: 245 WTDSFRGFVDY---CLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 11/196 (5%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           IG G  G VY  + +    +VA+K+   Q          EI ++ + +H ++V+ +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
             +E+ ++ EY+  G+L D +  +    +   +   +C    + L +LH+     +IHRD
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRD 140

Query: 610 VKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           +KS NILL  +   K+ DFG  ++I P  +Q+  ST V G+  ++ PE +T++    K D
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197

Query: 669 VYSFGVVMFEILCGRP 684
           ++S G++  E++ G P
Sbjct: 198 IWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 38/232 (16%)

Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC- 587
           E++++ + R  ++VS  G     N + +  E+M+ G+L D +Y    P       +EI  
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPI-----PVEILG 106

Query: 588 ---IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVS 643
              +    GL YL+  +   I+HRD+K +NIL++     K+ DFG+S ++   +  T V 
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVG 164

Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-----PVIDPSLPREKVNLV 698
           T+      Y+ PE +   + T KSDV+S G+ + E+  G+       ID     + + ++
Sbjct: 165 TST-----YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219

Query: 699 EWAMKCQETGQLEDIVD---PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS 747
           +          L+ IV    P L     P+ L  FV   + CL +   +RP+
Sbjct: 220 DL---------LQQIVQEPPPRLPSSDFPEDLRDFV---DACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-14
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 54/235 (22%)

Query: 490 VIGIGGFGKVYRGVLRDET-------KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           VIG G FG+V+  ++RD+        KV  K    + +Q +A  R E ++L+      +V
Sbjct: 8   VIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRK----RLEICIGAARGLHYL 597
            L     +   + ++ EYM  G L + L   + FP     +     L + + +   L + 
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-ETARFYIAELVLALDSVHKLGF- 122

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK------------------------- 632
                   IHRD+K  NIL+D +   K+ADFGL K                         
Sbjct: 123 --------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 633 -IGPDLDQTHV--STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
               D  Q  V  ++ V G+  Y+ PE L       + D +S GV+++E+L G P
Sbjct: 175 VRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 491 IGIGGFGKVYRGVLRD-----------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR 539
           +G G F  +Y+GVLR            E  V +K  G+     LA F T   ++SQ  H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHK 61

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLH 598
           HLV L G C  R+E I++ EY++ G L   L+   N  SL W  +L++    A  LHYL 
Sbjct: 62  HLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 599 TGSTKAIIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
               K ++H +V   NIL+         V    LS  G  +        V+    ++ PE
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-PWIAPE 174

Query: 657 YL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
            +   +  LT  +D +SFG  + EI     
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 26/206 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGLAEFRTEIEMLSQ------FRHRHLV 542
           V+G G FGKV    L+   +  A+K    +    L +   E  M+ +      + H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIK--ALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 543 SLIGYC--DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAARGLHYL 597
            L  +C    +  +  + EY+  G L  H+ +S     + R R    EI  G    L +L
Sbjct: 60  HL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-RARFYAAEIICG----LQFL 112

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H    K II+RD+K  N+LLD++   K+ADFG+ K   + +    ++   G+  Y+ PE 
Sbjct: 113 HK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEI 167

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGR 683
           L  Q+  E  D +SFGV+++E+L G+
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 21/198 (10%)

Query: 491 IGIGGFGKVY--RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G +G VY  R V   E   A+K    +  +  A  + EI M+   +H ++V+  G  
Sbjct: 17  IGSGTYGDVYKARNVNTGEL-AAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             R+++ I  E+   G+L+D +Y    P LS  +   +     +GL+YLH+   K  +HR
Sbjct: 76  LRRDKLWICMEFCGGGSLQD-IYHVTGP-LSESQIAYVSRETLQGLYYLHS---KGKMHR 130

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF----GYLDPEYLT---KQ 661
           D+K ANILL +N   K+ADFG+S       Q   + A + SF     ++ PE      K 
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSA------QITATIAKRKSFIGTPYWMAPEVAAVERKG 184

Query: 662 QLTEKSDVYSFGVVMFEI 679
              +  D+++ G+   E+
Sbjct: 185 GYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 28/208 (13%)

Query: 490 VIGIGGFGKVYRGVLRDETKV---------AVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           VIG G FGKV     + + K          A+ +   Q H  +AE      +L   +H  
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHI-MAERNV---LLKNVKHPF 57

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRL---EICIGAARGLHY 596
           LV L       +++  + +Y+  G L  HL    +FP    R R    EI    A  L Y
Sbjct: 58  LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP--RARFYAAEI----ASALGY 111

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+     II+RD+K  NILLD      + DFGL K G +  +T  ++   G+  YL PE
Sbjct: 112 LHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPE 166

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            L KQ      D +  G V++E+L G P
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 29/213 (13%)

Query: 487 ESLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFR 537
           ESL  G G F K+++G+ R+        +T+V +K    +SH+  +E F     M+SQ  
Sbjct: 1   ESL--GQGTFTKIFKGIRREVGDYGELHKTEVLLKVL-DKSHRNYSESFFEAASMMSQLS 57

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHY 596
           H+HLV   G C   +E I++ EY++ G+L  +L  + N  ++SW  +LE+    A  LH+
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHF 115

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD-- 654
           L     K + H +V + N+LL      K  +    K    L    +S  V      L+  
Sbjct: 116 LE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIK----LSDPGISITVLPKEILLERI 168

Query: 655 ----PEYLTK-QQLTEKSDVYSFGVVMFEILCG 682
               PE +   Q L+  +D +SFG  ++EI  G
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 63/260 (24%), Positives = 124/260 (47%), Gaps = 18/260 (6%)

Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLS 534
           V+I +    ++    IG G  G V+  + +    +VA+K+   Q          EI ++ 
Sbjct: 12  VSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMK 71

Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
           + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + L
Sbjct: 72  ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQAL 128

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYL 653
            +LH      +IHRD+KS N+LL  +   K+ DFG  ++I P  +Q+  ST V G+  ++
Sbjct: 129 EFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWM 182

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
            PE +T++    K D++S G++  E++ G P      P   + L+        T    ++
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGTPEL 235

Query: 714 VDPTLTGQIKPDSLNKFVEI 733
            +P     I  D LN+ +E+
Sbjct: 236 QNPEKLSPIFRDFLNRCLEM 255

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 71/291 (24%), Positives = 131/291 (45%), Gaps = 39/291 (13%)

Query: 484 NFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGL-AEFR----TEIEMLSQFR 537
           NF     IG G F +VYR   L D   VA+K+   Q  + + A+ R     EI++L Q  
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK--VQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-----FPSLS-WRKRLEICIGAA 591
           H +++  +    E NE+ I+ E  + G L   +          P  + W+  +++C    
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC---- 116

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             + ++H+   + ++HRD+K AN+ +    + K+ D GL +      +T  + ++ G+  
Sbjct: 117 SAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPY 171

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE 711
           Y+ PE + +     KSD++S G +++E+      +      +K+NL      CQ+  Q +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSL---CQKIEQCD 224

Query: 712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ 762
               P L  +   +   K  E+   C+      RP +G V    + A Q+ 
Sbjct: 225 ---YPPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYV---HQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 63/260 (24%), Positives = 125/260 (48%), Gaps = 18/260 (6%)

Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLS 534
           V++ +    ++    IG G  G VY  + +    +VA+K+   Q          EI ++ 
Sbjct: 12  VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMR 71

Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
           + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + L
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 128

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYL 653
            +LH+     +IHRD+KS NILL  +   K+ DFG  ++I P  +Q+  ST V G+  ++
Sbjct: 129 DFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWM 182

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
            PE +T++    K D++S G++  E++ G P      P   + L+        T    ++
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGTPEL 235

Query: 714 VDPTLTGQIKPDSLNKFVEI 733
            +P     +  D LN+ +E+
Sbjct: 236 QNPERLSAVFRDFLNRCLEM 255

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 7e-14
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 35/227 (15%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGVLRDETK-VAVK-RGGTQSHQGLAEFRTEIEMLSQF- 536
           + T  F    VIG G +GKVY+   +   + VA+K     +  +   E + E  +L ++ 
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE--EEIKEEYNILRKYS 60

Query: 537 RHRHLVSLIGYCDERN------EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE----- 585
            H ++ +  G   ++N      ++ ++ E    G++ D +           KRL+     
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL----RKKGKRLKEEWIA 116

Query: 586 -ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--HV 642
            I     RGL YLH      +IHRD+K  NILL +N   K+ DFG+S     LD T    
Sbjct: 117 YILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRR 170

Query: 643 STAVKGSFGYLDPEYLT-KQQLTE----KSDVYSFGVVMFEILCGRP 684
           +T + G+  ++ PE +   +Q       +SDV+S G+   E+  G+P
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 51/208 (24%), Positives = 106/208 (50%), Gaps = 14/208 (6%)

Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFR 537
           +E  D+F   + IG G  G V     +   K VAVK+   +  Q       E+ ++  + 
Sbjct: 21  REYLDSF---IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H ++V +       +E+ ++ E++E G L D +  +    ++  +   +C+   R L YL
Sbjct: 78  HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALSYL 134

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPE 656
           H    + +IHRD+KS +ILL  +   K++DFG  +++  ++ +     ++ G+  ++ PE
Sbjct: 135 HN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPE 188

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            +++     + D++S G+++ E++ G P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 73.3 bits (180), Expect = 9e-14
 Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 22/163 (13%)

Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD-HLYASNFPSLSWRKRLEIC 587
           EIE+L    H ++V      D   E+ ++ E+M+ G+L+  H+    F +   R+ L   
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-- 179

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH--VSTA 645
                G+ YLH    + I+HRD+K +N+L++     K+ADFG+S+I   L QT    +++
Sbjct: 180 -----GIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRI---LAQTMDPCNSS 228

Query: 646 VKGSFGYLDPEYLTKQQLTEK-----SDVYSFGVVMFEILCGR 683
           V G+  Y+ PE +              D++S GV + E   GR
Sbjct: 229 V-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETK------VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G FGKV   ++R++          +K+    +   +A   TE  +L   RH  L S
Sbjct: 2   LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHYLHTGS 601
           L      ++ +  + EY+  G L  HL      S   R R     GA     L YLH+G 
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-RTRF---YGAEIVSALDYLHSGK 115

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
              I++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE L   
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFCGTPEYLAPEVLEDN 170

Query: 662 QLTEKSDVYSFGVVMFEILCGR 683
                 D +  GVVM+E++CGR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 72.1 bits (176), Expect = 1e-13
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 30/240 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYC 548
           ++G G +G+VY+G      ++A  +    +     E + EI ML ++  HR++ +  G  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 549 DERN------EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            ++N      ++ ++ E+   G++ D +  +   +L       IC    RGL +LH    
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--- 129

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+LL EN   K+ DFG+S     LD+T        G+  ++ PE +   
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 662 QLTE-----KSDVYSFGVVMFEILCGRP-----------VIDPSLPREKVNLVEWAMKCQ 705
           +  +     KSD++S G+   E+  G P            + P  P  ++   +W+ K Q
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 246

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQG---LAEFR--TEIEMLSQFRHRHLVSL 544
           IG+G +G VY+         VA+K    Q+++    L+  R    ++ L  F H ++V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 545 IGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           +  C     D   ++ +++E+++   L+ +L     P L      ++     RGL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS-TAVKGSFGYLDPEYL 658
                I+HRD+K  NIL+      K+ADFGL++I        ++ T V  +  Y  PE L
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPEVL 179

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRPV 685
            +       D++S G +  E+   +P+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEMFRRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 81/279 (29%), Positives = 121/279 (43%), Gaps = 38/279 (13%)

Query: 485 FSESLVIGIGGFGKVY--RGVLRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHR 539
           FS+   IG G FG VY  R V   E  VA+K+    G QS++   +   E+  L + RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           + +   G     +   ++ EY   G+  D L     P L   +   +  GA +GL YLH+
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS 133

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY-- 657
            +   +IHRDVK+ NILL E  + K+ DFG + I         +    G+  ++ PE   
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 184

Query: 658 -LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC-QETGQLEDIVD 715
            + + Q   K DV+S G+   E+   +P      P   +N    AM       Q E    
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKP------PLFNMN----AMSALYHIAQNE---S 231

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN 754
           P L      +    FV   + CL +   DRP+  +VL  
Sbjct: 232 PALQSGHWSEYFRNFV---DSCLQKIPQDRPT-SEVLLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 25/206 (12%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLA----EFRTEIEMLSQFRHRHLVSLI 545
           IG G +G V++   R+  + VA+K+   +S           R EI ML Q +H +LV+LI
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALR-EIRMLKQLKHPNLVNLI 66

Query: 546 GYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
                + ++ +++EY ++ T+ + L       P    +K   I     + +++ H     
Sbjct: 67  EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCHK---H 119

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQT-HVSTAVKGSFGYLDPEYLT- 659
             IHRDVK  NIL+ +    K+ DFG ++I  GP  D T +V+T       Y  PE L  
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPELLVG 174

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRPV 685
             Q     DV++ G V  E+L G+P+
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 71/257 (27%), Positives = 120/257 (46%), Gaps = 28/257 (10%)

Query: 491 IGIGGFGKVYRGVLRDETKV--AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FGKVY+     ET V  A K   T+S + L ++  EI++L+   H ++V L+   
Sbjct: 13  LGDGAFGKVYKA-QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
              N + I+ E+   G +   +     P    + R+ +C      L+YLH      IIHR
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHENK---IIHR 127

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE--- 665
           D+K+ NIL   +   K+ADFG+S       Q   S    G+  ++ PE +  +   +   
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 185

Query: 666 --KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK 723
             K+DV+S G+ + E+      I+P  P  ++N +   +K  ++        PTL    +
Sbjct: 186 DYKADVWSLGITLIEM----AQIEP--PHHELNPMRVLLKIAKSEP------PTLAQPSR 233

Query: 724 PDSLNKFVEIAEKCLAQ 740
             S  +F +  +KCL +
Sbjct: 234 WSS--EFKDFLKKCLEK 248

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 484 NFSESLVIGIGGFGKVYRGV-LRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHR 539
           NF     IG G F +VYR   L D   VA+K+         +  A+   EI++L Q  H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKD---HLYASN--FPSLS-WRKRLEICIGAARG 593
           +++       E NE+ I+ E  + G L     H        P  + W+  +++C      
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L ++H+   + ++HRD+K AN+ +    + K+ D GL +      +T  + ++ G+  Y+
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYM 173

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEI 679
            PE + +     KSD++S G +++E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 60/234 (25%), Positives = 106/234 (45%), Gaps = 42/234 (17%)

Query: 481 ATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQG----LAEFRTEIEMLSQ 535
              ++     +G G FG+VY+   ++    VA+K+     ++     +   R EI++L +
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALR-EIKILKK 63

Query: 536 FRHRHLVSLI--------GYCDERNEMIIIYEYME---NGTLKD---HLYASNFPSLSWR 581
            +H ++V LI            +R  + ++  YM+   +G L++    L  S        
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI-KCYML 122

Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-------- 633
           + LE       G++YLH      I+HRD+K+ANIL+D   + K+ADFGL++         
Sbjct: 123 QLLE-------GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172

Query: 634 -GPDLDQTHVSTAVKGSFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            G     T   T +  +  Y  PE  L +++ T   D++  G V  E+   RP+
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 38/92 (41%), Positives = 56/92 (60%), Gaps = 5/92 (5%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A  L +LH+     II+RD+K  NILLDE    K+ DFGLSK    +D    + +  G+ 
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 162

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            Y+ PE + ++  T+ +D +SFGV+MFE+L G
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 49/204 (24%), Positives = 105/204 (51%), Gaps = 14/204 (6%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           DNF   + IG G  G V    ++   K VAVK+   +  Q       E+ ++  ++H ++
Sbjct: 23  DNF---IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +       +E+ ++ E++E G L D +  +    ++  +   +C+   + L  LH   
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALSVLHA-- 134

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            + +IHRD+KS +ILL  +   K++DFG  +++  ++ +     ++ G+  ++ PE +++
Sbjct: 135 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKSLVGTPYWMAPELISR 190

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                + D++S G+++ E++ G P
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 35/101 (34%), Positives = 49/101 (48%), Gaps = 9/101 (8%)

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
           G+  LH    + IIHRD+K  N+L+D+    K+ DFGLS+ G        +    G+  Y
Sbjct: 109 GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDY 159

Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
           L PE +      + SD +S G V+FE L G P      P  
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 72/290 (24%), Positives = 132/290 (45%), Gaps = 36/290 (12%)

Query: 477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
           A+++    F    V+G G +G+VY+G      ++A  +    +     E + EI ML ++
Sbjct: 10  ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKY 69

Query: 537 -RHRHLVSLIGYCDER------NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
             HR++ +  G   ++      +++ ++ E+   G++ D +  +   +L       IC  
Sbjct: 70  SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--HVSTAVK 647
             RGL +LH      +IHRD+K  N+LL EN   K+ DFG+S     LD+T    +T + 
Sbjct: 130 ILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI- 182

Query: 648 GSFGYLDPEYLTKQQLTE-----KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM 702
           G+  ++ PE +   +  +     +SD++S G+   E+  G P +    P   + L+    
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--- 239

Query: 703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                       +P    + K  S  KF++  E CL +  + RPS   +L
Sbjct: 240 -----------RNPPPKLKSKKWS-KKFIDFIEGCLVKNYLSRPSTEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 43/223 (19%)

Query: 484 NFSESLVIGIGGFGKVY----RG-----------VLRDETKVAVKRGGTQSHQGLAEFRT 528
           NF    V+G G +GKV+     G           VL+  T   V++  T  H      RT
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKAT--IVQKAKTAEHT-----RT 53

Query: 529 EIEMLSQFRHR-HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
           E ++L   R    LV+L        ++ +I +Y+  G L  HLY     + S    + + 
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVY 110

Query: 588 IG----AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH 641
           I     A   LH L       II+RD+K  NILLD      + DFGLSK     + ++ +
Sbjct: 111 IAEIVLALDHLHQL------GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY 164

Query: 642 VSTAVKGSFGYLDPEYLTKQQLTEKS--DVYSFGVVMFEILCG 682
              +  G+  Y+ PE +           D +S GV+ FE+L G
Sbjct: 165 ---SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 53/163 (32%), Positives = 77/163 (47%), Gaps = 14/163 (8%)

Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL-YASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   I 
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK---IS 105

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-- 645
           I   RGL YL       I+HRDVK +NIL++     K+ DFG+S       Q   S A  
Sbjct: 106 IAVLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANS 157

Query: 646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDP 688
             G+  Y+ PE L     T +SD++S G+ + E+  GR  I P
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 23/204 (11%)

Query: 490 VIGIGGFGKVYRGVLRDETKVA-------VKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           ++G G FGKV   +L  E           +K+    +   +A   TE  +L   RH  L 
Sbjct: 2   LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAARGLHYLHT 599
           +L       + +  + EY   G L  HL      S   R R    EI + A   L YLH+
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGAEI-VSA---LGYLHS 113

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                +++RD+K  N++LD++   K+ DFGL K    +          G+  YL PE L 
Sbjct: 114 CD---VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLE 168

Query: 660 KQQLTEKSDVYSFGVVMFEILCGR 683
                   D +  GVVM+E++CGR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 33/212 (15%)

Query: 490 VIGIGGFGKVYRGVLRDET--------KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           V+G GG+GKV++               KV  K    ++ +  A  + E  +L   +H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHL---------YASNFPSLSWRKRLEICIGAAR 592
           V LI       ++ +I EY+  G L  HL          A  + S       EI +    
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-------EISLA--- 112

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
            L +LH    + II+RD+K  NILLD     K+ DFGL K    + +  V+    G+  Y
Sbjct: 113 -LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEY 166

Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE L +    +  D +S G +M+++L G P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.1 bits (171), Expect = 6e-13
 Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 35/276 (12%)

Query: 485 FSESLVIGIGGFGKVYRGV-LRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRH 540
           F++   IG G FG VY    +R    VA+K+    G QS++   +   E++ L + +H +
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
            +   G     +   ++ EY   G+  D L     P L   +   I  GA +GL YLH+ 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAITHGALQGLAYLHSH 144

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY--- 657
           +   +IHRD+K+ NILL E    K+ADFG + I         + +  G+  ++ PE    
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVILA 195

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC-QETGQLEDIVDP 716
           + + Q   K DV+S G+   E+   +P      P   +N    AM       Q E    P
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKP------PLFNMN----AMSALYHIAQNE---SP 242

Query: 717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           TL      D    FV   + CL +   DRP+  ++L
Sbjct: 243 TLQSNEWSDYFRNFV---DSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 40/177 (22%), Positives = 95/177 (53%), Gaps = 10/177 (5%)

Query: 509 KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD 568
           +VAVK+   +  Q       E+ ++  ++H ++V +       +E+ ++ E++E G L D
Sbjct: 46  QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105

Query: 569 HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF 628
            +  +    ++  +   +C+   + L +LH    + +IHRD+KS +ILL  +   K++DF
Sbjct: 106 IVTHTR---MNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDF 159

Query: 629 GL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           G  +++  ++ +     ++ G+  ++ PE +++     + D++S G+++ E++ G P
Sbjct: 160 GFCAQVSKEVPR---RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.8 bits (170), Expect = 7e-13
 Identities = 54/211 (25%), Positives = 108/211 (51%), Gaps = 11/211 (5%)

Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLS 534
           V++ +    ++    IG G  G VY  + +    +VA+++   Q          EI ++ 
Sbjct: 13  VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
           + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + L
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 129

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYL 653
            +LH+     +IHRD+KS NILL  +   K+ DFG  ++I P  +Q+  ST V G+  ++
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWM 183

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE +T++    K D++S G++  E++ G P
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 7e-13
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 485 FSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           F    V+G GGFG+V    +R   K+     +++   +  +G A    E  +L +   R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL----EICIGAARGLHY 596
           +VSL    + ++ + ++   M  G LK H+Y    P    ++ +    E+C G    L  
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG----LED 117

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           L     + I++RD+K  NILLD+    +++D GL+   P+ +         G+ GY+ PE
Sbjct: 118 LQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV---GTVGYMAPE 171

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            +  ++ T   D +  G +++E++ G+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 43/280 (15%)

Query: 491 IGIGGFGKVYRGVLRDE------------TKVAVKRGGTQSHQGLAEFRTEIEML-SQFR 537
           +G G FG VY+   ++                A  +   +  + + +  +E+ ++  Q R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSLS-WRKRLEICIGAA 591
           H ++V       E + + I+ + +E   L +H  +       F     W   +++ +   
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             L YLH    K I+HRD+   NI+L E+    + DFGL+K           T+V G+  
Sbjct: 126 --LRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTIL 178

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE 711
           Y  PE +  +   EK+DV++FG +++++   +P      P    N++  A K  E    E
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP------PFYSTNMLSLATKIVE-AVYE 231

Query: 712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDV 751
            + +   +  +         ++   CL      RP +  V
Sbjct: 232 PLPEGMYSEDVT--------DVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 51/194 (26%), Positives = 94/194 (48%), Gaps = 9/194 (4%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT---EIEMLSQFRHRHLVSLI- 545
           V+G G +G+V     R + K  V +     +    E +    E ++LSQ +H ++V+   
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
            +  E   + I+  + E G L   L       L   + +E  +  A  L YLH    K I
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           +HRD+K+ N+ L    + KV D G++++    +Q  +++ + G+  Y+ PE  + +    
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPELFSNKPYNY 181

Query: 666 KSDVYSFGVVMFEI 679
           KSDV++ G  ++E+
Sbjct: 182 KSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 15/199 (7%)

Query: 490 VIGIGGFGKVYRGV-------LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           V+G G FG VY+G+       ++    + V R  T S +   E   E  +++     ++ 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C   + + ++ + M  G L D++   N   +  +  L  C+  A+G+ YL     
Sbjct: 73  RLLGIC-LTSTVQLVTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLEE--- 127

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYLTKQ 661
             ++HRD+ + N+L+      K+ DFGL+++  D+D+T   +   K    ++  E +  +
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARL-LDIDETEYHADGGKVPIKWMALESILHR 186

Query: 662 QLTEKSDVYSFGVVMFEIL 680
           + T +SDV+S+GV ++E++
Sbjct: 187 RFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.1 bits (170), Expect = 1e-12
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 36/212 (16%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAE------FRTEIEMLSQFRHRHLVS 543
           +G G +  VY+         VA+K+      +   +       R EI++L + +H +++ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66

Query: 544 LIG-YCDERNEMIIIYEYMEN---GTLKDH---LYASNFPSLSWRKRLEICIGAARGLHY 596
           L+  +  + N + +++E+ME      +KD    L  ++  S              RGL Y
Sbjct: 67  LLDVFGHKSN-INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLM--------TLRGLEY 117

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VSTAVKGSFGYL 653
           LH+     I+HRD+K  N+L+  + + K+ADFGL++    P+   TH V T       Y 
Sbjct: 118 LHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YR 169

Query: 654 DPEYL-TKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE L   +      D++S G +  E+L   P
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 33/224 (14%)

Query: 491 IGIGGFGKVYRGVLRDETK---VAVKRGGT-QSHQGL--AEFRTEIEMLSQFRHRHLVSL 544
           IG G +G VYR   RD T    VA+K+        G+  +  R EI +L   RH ++V L
Sbjct: 15  IGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVEL 71

Query: 545 ----IGYCDERNEMIIIYEYMEN--GTLKDHLYASNFPS-LSWRKRLEICIGAARGLHYL 597
               +G     + + ++ EY E    +L D     N P+  S  +   + +   RGL YL
Sbjct: 72  KEVVVG--KHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQYL 124

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H      IIHRD+K +N+LL +    K+ADFGL++      +      V  +  Y  PE 
Sbjct: 125 HE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPEL 179

Query: 658 L---TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           L   T    T   D+++ G ++ E+L  +P++      E+++L+
Sbjct: 180 LLGCTTY--TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 31/208 (14%)

Query: 490 VIGIGGFGKVY------------RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR 537
           ++G G FGKV               +LR E  +A           +A   TE  +L   R
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--------VAHTVTESRVLQNTR 53

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLH 595
           H  L +L       + +  + EY   G L  HL      +   R R     GA     L 
Sbjct: 54  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARF---YGAEIVSALE 109

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           YLH+   + +++RD+K  N++LD++   K+ DFGL K G   D   + T   G+  YL P
Sbjct: 110 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFC-GTPEYLAP 164

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGR 683
           E L         D +  GVVM+E++CGR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 48/142 (33%), Positives = 75/142 (52%), Gaps = 6/142 (4%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +G G +G VY+   L      AVK    +     +  + EI M+ + +H ++V+  G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
            R ++ I  EY   G+L+D +Y    P LS  +   +C    +GL YLH+   K  +HRD
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGP-LSELQIAYVCRETLQGLAYLHS---KGKMHRD 131

Query: 610 VKSANILLDENLMAKVADFGLS 631
           +K ANILL +N   K+ADFG++
Sbjct: 132 IKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 69.5 bits (170), Expect = 3e-12
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 32/216 (14%)

Query: 547 YCDERNE-----MIIIYEYMENGTLKDHLYASNFPSLSWRKRLE--ICIGAARGLHYLHT 599
             D RN      + ++ +Y   G L+  + +    + ++R+     + I     +H++H+
Sbjct: 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS 161

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
              K +IHRD+KSANILL  N + K+ DFG SK+        V     G+  Y+ PE   
Sbjct: 162 ---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           ++  ++K+D++S GV+++E+L  +   D                      +E+++  TL 
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGE-------------------NMEEVMHKTLA 259

Query: 720 GQIK--PDSLNK-FVEIAEKCLAQCGIDRPSMGDVL 752
           G+    P S++    EI    L+     RPS   +L
Sbjct: 260 GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295

Length = 496

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 64/203 (31%), Positives = 91/203 (44%), Gaps = 20/203 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETKVA-------VKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           ++G G FGKV   +L  E           +K+    +   +A   TE  +L   RH  L 
Sbjct: 2   LLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHYLHTG 600
           +L       + +  + EY   G L  HL      S   R R     GA     L YLH  
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAEIVSALDYLH-- 112

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           S K +++RD+K  N++LD++   K+ DFGL K G   D   + T   G+  YL PE L  
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKTFC-GTPEYLAPEVLED 170

Query: 661 QQLTEKSDVYSFGVVMFEILCGR 683
                  D +  GVVM+E++CGR
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 10/166 (6%)

Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 109

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   RGL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 110 IAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163

Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 9/103 (8%)

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
           +I +   + L YLH  S  ++IHRDVK +N+L++ N   K+ DFG+S     L  +   T
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKT 161

Query: 645 AVKGSFGYLDPEY----LTKQQLTEKSDVYSFGVVMFEILCGR 683
              G   Y+ PE     L ++    KSDV+S G+ M E+  GR
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 56/239 (23%)

Query: 491 IGIGGFGKVYRGVL---RDETKVAVKRGGTQSHQG----LAEFRTEIEMLSQFRHRHLVS 543
           IG G +G+VY+      +D  + A+K+      Q      +  R EI +L + +H ++VS
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLRELKHENVVS 66

Query: 544 LIGYCDERNEMII--IYEYMEN---GTLKDH-------LYASNFPSLSWRKRLEICIGAA 591
           L+    E  +  +  +++Y E+     +K H       +  S   SL W+          
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ--------IL 118

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLSKI--GP-----DLDQT 640
            G+HYLH+     ++HRD+K ANIL+     E  + K+ D GL+++   P     DLD  
Sbjct: 119 NGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 641 HVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV-------IDPSLP 691
            V      +  Y  PE L   +  T+  D+++ G +  E+L   P+       I  S P
Sbjct: 176 VV------TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 30/209 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETK--VAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIG 546
           +IG G +G VYRG     T   VA+K     +    +++ + E+ +LSQ R     ++  
Sbjct: 8   LIGRGAYGAVYRGK-HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 547 YCD---ERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWRKRLEICIGAARGLHYLHT 599
           Y     +   + II EY E G+++  + A      + S+  R+ L         L Y+H 
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-------ALKYIHK 119

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLS---KIGPDLDQTHVSTAVKGSFGYLDPE 656
                +IHRD+K+ANIL+      K+ DFG++           T V T       ++ PE
Sbjct: 120 ---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-----WMAPE 171

Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGRP 684
            +T+ +    K+D++S G+ ++E+  G P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLS-QFRHRHLVSL 544
           ++G G FGKV+   L+   +     A+K+        +     E  +LS  + H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYAS---NFPSLSWRKRLEICIGAARGLHYLHTGS 601
                 +  +  + EY+  G L  H+ +    + P  ++     IC     GL +LH+  
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIIC-----GLQFLHS-- 114

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
            K I++RD+K  NILLD +   K+ADFG+ K    L      T   G+  Y+ PE L  Q
Sbjct: 115 -KGIVYRDLKLDNILLDTDGHIKIADFGMCKENM-LGDAKTCTFC-GTPDYIAPEILLGQ 171

Query: 662 QLTEKSDVYSFGVVMFEILCGR 683
           +     D +SFGV+++E+L G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 43/177 (24%), Positives = 94/177 (53%), Gaps = 10/177 (5%)

Query: 509 KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD 568
           +VAVK    +  Q       E+ ++  ++H+++V +        E+ ++ E+++ G L D
Sbjct: 48  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107

Query: 569 HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF 628
            +  +    L+  +   +C    + L YLH+   + +IHRD+KS +ILL  +   K++DF
Sbjct: 108 IVSQTR---LNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDF 161

Query: 629 GL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           G  ++I  D+ +     ++ G+  ++ PE +++     + D++S G+++ E++ G P
Sbjct: 162 GFCAQISKDVPK---RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 18/207 (8%)

Query: 485 FSESLVIGIGGFGKVYRGVLRDETKV-AVKR---GGTQSHQGLAEFRTEIEMLSQFRHRH 540
           F    V+G GGFG+V    +R   K+ A K+      +  +G A    E ++L +   R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL----EICIGAARGLHY 596
           +VSL    + ++ + ++   M  G LK H+Y    P     + +    EI  G    L  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG----LED 117

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + I++RD+K  NILLD+    +++D GL+   P+ +   +   V G+ GY+ PE
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPE 171

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            +  ++ T   D +  G +++E++ G+
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 60/230 (26%), Positives = 108/230 (46%), Gaps = 33/230 (14%)

Query: 491 IGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV------- 542
           +G G  G V+  V  D + +VAVK+      Q +     EI+++ +  H ++V       
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 543 -------SLIGYCDERNEMIIIYEYMENG---TLKDHLYASNFPSLSWRKRLEICIGAAR 592
                    +G   E N + I+ EYME      L+    +     L   + L       R
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL-------R 125

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKG--S 649
           GL Y+H+ +   ++HRD+K AN+ ++ E+L+ K+ DFGL++I  D   +H     +G  +
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI-VDPHYSHKGYLSEGLVT 181

Query: 650 FGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
             Y  P   L+    T+  D+++ G +  E+L G+P+   +   E++ L+
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 59/215 (27%), Positives = 111/215 (51%), Gaps = 18/215 (8%)

Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQG--LAEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +  V++G  +  E  VA+K    +  +G      R E+ +L   +H ++V+L   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI-GAARGLHYLHTGSTKAII 606
                 + +++EY+++  LK +L   N  +L     ++I +    RGL Y H    + I+
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKIL 125

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HRD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P+ L     TE 
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS--TEY 181

Query: 667 S---DVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           S   D++  G +++E+  GRP+   S  +E+++L+
Sbjct: 182 STPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 491 IGIGGFGKVYRGVLRDETK----VAVKRGGTQSHQGLAEFRT--EIEMLSQ---FRHRHL 541
           IG G +GKV++   RD       VA+KR   Q+ +      T  E+ +L     F H ++
Sbjct: 9   IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 542 VSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
           V L   C     D   ++ +++E+++   L  +L     P +      ++     RGL +
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+     ++HRD+K  NIL+  +   K+ADFGL++I          T+V  +  Y  PE
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 179

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            L +       D++S G +  E+   +P+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 67.0 bits (163), Expect = 8e-12
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSL 544
           VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   +  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWR-KRLEICIGAARGLHYLHTGST 602
                  + + ++ EY+  G L  H+      P    R    EICI     L++LH    
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA----LNFLHE--- 114

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + II+RD+K  N+LLD +   K+ D+G+ K G  L     ++   G+  Y+ PE L  ++
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTFCGTPNYIAPEILRGEE 172

Query: 663 LTEKSDVYSFGVVMFEILCGRPVID 687
                D ++ GV+MFE++ GR   D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 15/201 (7%)

Query: 491 IGIGGFGKVY------RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G GGFG+V        G L    K+  KR   +  +G      E  +L++   R +VSL
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKR--LKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGST 602
                 + ++ ++   M  G L+ H+Y      P     +          GL +LH    
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + II+RD+K  N+LLD +   +++D GL+      D    +    G+ G++ PE L  ++
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEE 173

Query: 663 LTEKSDVYSFGVVMFEILCGR 683
                D ++ GV ++E++  R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 26/224 (11%)

Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGL-AEFRTEI 530
           I  +T  F E L  G   FGKVY+G L           VA+K    ++   L  EF+ E 
Sbjct: 2   INLSTVRFMEEL--GEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59

Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSLSWRK 582
            M S+ +H ++V L+G   +   + +I+ Y  +  L + L          S     + + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 583 RLE------ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD 636
            LE      I    A G+ +L   S+  ++H+D+ + N+L+ + L  K++D GL +    
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            D   +         ++ PE +   + +  SD++S+GVV++E+ 
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 67/250 (26%), Positives = 116/250 (46%), Gaps = 45/250 (18%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQG---LAEFRTEIEMLSQFRH 538
           D F     IG G +G+VY+   +D  + VA+K+    + +    +   R EI++L Q  H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNH 65

Query: 539 RHLVSL-------IGYCDERNE---MIIIYEYMEN---GTLKDHLYASNFPSL-SWRKRL 584
           R++V+L           D + +     +++EYM++   G L+  L   +   + S+ K+L
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
                   GL+Y H    K  +HRD+K +NILL+     K+ADFGL+++    +    + 
Sbjct: 126 ------LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTN 176

Query: 645 AVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK 703
            V  +  Y  PE L  +++     DV+S G ++ E+   +P+   +              
Sbjct: 177 KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN-------------- 221

Query: 704 CQETGQLEDI 713
            QE  QLE I
Sbjct: 222 -QELAQLELI 230

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 67.0 bits (163), Expect = 2e-11
 Identities = 53/198 (26%), Positives = 100/198 (50%), Gaps = 7/198 (3%)

Query: 527 RTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEI 586
           R+E+  L+   H  +V         +++++I EY   G L   +       L + +  E+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEV 171

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
            +   + +  L    ++ ++HRD+KSANI L    + K+ DFG SK   D     V+++ 
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWA---- 701
            G+  YL PE   +++ ++K+D++S GV+++E+L   RP   PS  RE +  V +     
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-QREIMQQVLYGKYDP 290

Query: 702 MKCQETGQLEDIVDPTLT 719
             C  +  ++ ++DP L+
Sbjct: 291 FPCPVSSGMKALLDPLLS 308

Length = 478

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 10/166 (6%)

Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 109

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 110 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163

Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 36/211 (17%)

Query: 491 IGIGGFGKVYRGVLRD-ETKVAVKRGGT--QSHQGLAEF--RT--EIEMLSQFRHRHLVS 543
           +G G +G+V          KVA+K+     QS    A    RT  E+ +L    H +++ 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS----AIHAKRTYRELRLLKHMDHENVIG 78

Query: 544 LIG-YC--DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGA---ARGL 594
           L+  +       +   +Y       L  HL  ++  ++   ++L    I        RGL
Sbjct: 79  LLDVFTPASSLEDFQDVY-------LVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGL 131

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
            Y+H+     IIHRD+K +NI ++E+   K+ DFGL++   D    +V+T       Y  
Sbjct: 132 KYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 183

Query: 655 PE-YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           PE  L      +  D++S G +M E+L G+ 
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 14/199 (7%)

Query: 491 IGIGGFGKV------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G GGFG+V        G +    K+  KR   +S + +A    EI  L +     +V+L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
               + +  + ++   M  G LK H+Y      L   + +        G+ +LH+     
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           I++RD+K  N+LLD+    +++D GL+    D       T   G+ GY+ PE L ++  +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYS 172

Query: 665 EKSDVYSFGVVMFEILCGR 683
              D ++ G  ++E++ GR
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 20/200 (10%)

Query: 490 VIGIGGFGK--VYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           V+G G FG+  + + V  D+     +    +S   + + R E  +L++ +H ++V+    
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASN---FPS---LSWRKRLEICIGAARGLHYLHTGS 601
            +    + I+ EY + G L   +       FP    L W   +++C+G    + ++H   
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF--VQMCLG----VQHIHE-- 118

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
            K ++HRD+KS NI L +N   K+ DFG +++       +  T V G+  Y+ PE     
Sbjct: 119 -KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYV-GTPYYVPPEIWENM 175

Query: 662 QLTEKSDVYSFGVVMFEILC 681
               KSD++S G +++E LC
Sbjct: 176 PYNNKSDIWSLGCILYE-LC 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 24/206 (11%)

Query: 490 VIGIGGFGKV----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR 539
           VIG G FGKV             V   + K+ + R   Q H  +AE      +L   +H 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK-EQKHI-MAERNV---LLKNVKHP 56

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHYLH 598
            LV L        ++  + +++  G L  HL    +FP    R R       A  L YLH
Sbjct: 57  FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP--RARFYAA-EIASALGYLH 113

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           + +   I++RD+K  NILLD      + DFGL K G  + Q+  +T   G+  YL PE +
Sbjct: 114 SIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG--IAQSDTTTTFCGTPEYLAPEVI 168

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
            KQ      D +  G V++E+L G P
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.9 bits (159), Expect = 3e-11
 Identities = 53/202 (26%), Positives = 102/202 (50%), Gaps = 21/202 (10%)

Query: 494 GGFGKVYRGVLRDETK---VAVKRGGTQSH-QG--LAEFRTEIEMLSQFRHRHLVSL--I 545
           G +G VYR   RD+     VA+K+   +   +G  +   R EI +L + +H ++V++  +
Sbjct: 16  GTYGVVYRA--RDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEV 72

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRLEICIGAARGLHYLHTGSTKA 604
                 +++ ++ EY+E+  LK  +     P   S  K L + +    G+ +LH      
Sbjct: 73  VVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQL--LSGVAHLHD---NW 126

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE-YLTKQQL 663
           I+HRD+K++N+LL+   + K+ DFGL++      + +    V  +  Y  PE  L  ++ 
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPELLLGAKEY 184

Query: 664 TEKSDVYSFGVVMFEILCGRPV 685
           +   D++S G +  E+L  +P+
Sbjct: 185 STAIDMWSVGCIFAELLTKKPL 206

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 43/134 (32%), Positives = 65/134 (48%), Gaps = 12/134 (8%)

Query: 552 NEMIIIYEYMENGTLKDHL-YASNFPSLSWRKRLEICIGA-ARGLHYLHTGSTKAIIHRD 609
           +++ ++ +YM  G L  HL     F       R +  I      L +LH      I++RD
Sbjct: 69  SDLYLVTDYMSGGELFWHLQKEGRFS----EDRAKFYIAELVLALEHLHKYD---IVYRD 121

Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ-LTEKSD 668
           +K  NILLD      + DFGLSK   +L     +    G+  YL PE L  ++  T+  D
Sbjct: 122 LKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179

Query: 669 VYSFGVVMFEILCG 682
            +S GV++FE+ CG
Sbjct: 180 FWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 11/100 (11%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVK 647
           A GL +LH+   K II+RD+K  N++LD     K+ADFG+ K    G    +T   T   
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP-- 165

Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
               Y+ PE +  Q   +  D ++FGV+++E+L G+P  D
Sbjct: 166 ---DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 64.5 bits (158), Expect = 5e-11
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 57/225 (25%)

Query: 491 IGIGGFGKVYRGVLRDETK--VAVKR-----GGTQSHQGLAEFRT--EIEMLSQFR-HRH 540
           +G G +G V++ + R  TK  VA+K+           Q     RT  EI  L +   H +
Sbjct: 15  LGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQ-----RTFREIMFLQELGDHPN 68

Query: 541 LVSLIGYCDERNEMII--IYEYMEN--------GTLKD-HLYASNFPSLSWRKRLEICIG 589
           +V L+      N+  I  ++EYME           L+D H            KR  I   
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY-IMYQ 115

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-------- 641
             + L Y+H+G+   +IHRD+K +NILL+ +   K+ADFGL++   +L++          
Sbjct: 116 LLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 642 VSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPV 685
           V+T       Y  PE L    + T+  D++S G ++ E+L G+P+
Sbjct: 173 VATR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 64.2 bits (156), Expect = 6e-11
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 32/217 (14%)

Query: 484 NFSESLVIGIGGFGKVY--RGVLRDET----------KVA-VKRGGTQSHQGLAEFRTEI 530
           NF    V+G G +GKV+  R V   +T          K A V++  T  H      RTE 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-----RTER 55

Query: 531 EMLSQFRHR-HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICI 588
            +L   R    LV+L        ++ +I +Y+  G +  HLY   NF     R      I
Sbjct: 56  NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEII 115

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAV 646
            A   LH L       I++RD+K  NILLD      + DFGLSK  +  + ++T+   + 
Sbjct: 116 LALEHLHKL------GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SF 166

Query: 647 KGSFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
            G+  Y+ PE +  +    K+ D +S G+++FE+L G
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.2 bits (156), Expect = 6e-11
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 20/204 (9%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVK--------RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           VIG G FGKV     + D +  AVK        +   Q+H  +AE      +L   +H  
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHI-MAERNV---LLKNLKHPF 57

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           LV L        ++  + +Y+  G L  HL       L  R R       A  + YLH+ 
Sbjct: 58  LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC-FLEPRARF-YAAEVASAIGYLHSL 115

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           +   II+RD+K  NILLD      + DFGL K G + ++T  ++   G+  YL PE L K
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRK 170

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
           +      D +  G V++E+L G P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 24/204 (11%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           V+G G FGKV    L++  ++     +K+        +    TE  +LS  R+   ++ +
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 546 GYCDERNE-MIIIYEYMENGTLKDHLYASNFPSLSWRKRLE---ICIGAAR---GLHYLH 598
             C +  + +  + E++  G L  H+  S        +R +       AA     L +LH
Sbjct: 62  YCCFQTPDRLFFVMEFVNGGDLMFHIQKS--------RRFDEARARFYAAEITSALMFLH 113

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
               K II+RD+K  N+LLD     K+ADFG+ K G  +     ++   G+  Y+ PE L
Sbjct: 114 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTFCGTPDYIAPEIL 168

Query: 659 TKQQLTEKSDVYSFGVVMFEILCG 682
            +       D ++ GV+++E+LCG
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 64.2 bits (156), Expect = 7e-11
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 32/209 (15%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQ------FRHRHLV 542
           V+G G FGKV    L+ + +  AVK    +    L +   E  M+ +      + +  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVK--ALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDH--------LYASNFPSLSWRKRLEICIGAARGL 594
            L      +  +  + E++  G L  H        LY + F +        +C     GL
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEI-----VC-----GL 109

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
            +LH+   K II+RD+K  N++LD +   K+ADFG+ K   ++   + ++   G+  Y+ 
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIA 164

Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
           PE L   + T   D +SFGV+++E+L G+
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQG--LAEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +  V++G  +  E  VA+K    +  +G      R E+ +L   +H ++V+L   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72

Query: 548 CDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
                 + +++EY++   LK ++    N  S+   K     I   RGL Y H    + ++
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQI--LRGLAYCHR---RKVL 126

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTE 665
           HRD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P+ L    + + 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184

Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           + D++  G + FE+  GRP+   S   ++++L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 33/227 (14%)

Query: 491 IGIGGFGKVYRG---VLRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FGKV  G       + +V VK    + +      F  E++   +  H +++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNF-------PSLSWRKRLEICIGAARGLHYLHT 599
            C E    +++ E+   G LK++L ++           +  R   E+  G    LH    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL-WLHQAD- 120

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGL--SKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                 IH D+   N  L  +L  K+ D+GL   +   D   T    AV     +L PE 
Sbjct: 121 -----FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV--PLRWLAPEL 173

Query: 658 LTKQQ-------LTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +  +         T+KS+++S GV M+E+     +P   P L  E+V
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQV 218

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 41/213 (19%)

Query: 490 VIGIGGFGKVYRGVLR------------DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR 537
           +IG GGFG+VY G  +            D+ ++ +K+G T +   L E R  + ++S   
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNE-RIMLSLVSTGD 55

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR---GL 594
              +V +       +++  I + M  G L  HL      S +     E+   AA    GL
Sbjct: 56  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----EMRFYAAEIILGL 110

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL----SKIGPDLDQTHVSTAVKGSF 650
            ++H    + +++RD+K ANILLDE+   +++D GL    SK  P     H S    G+ 
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTH 159

Query: 651 GYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           GY+ PE L K    + S D +S G ++F++L G
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 484 NFSESLVIGIGGFGKVY--RGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           NF    V+G G +GKV+  R V   ++      KV  K    Q  +     RTE ++L  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 536 FRHRHLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKR-----LEICIG 589
            R    +  + Y  + + ++ +I +Y+  G L        F  LS R+R     ++I  G
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--------FTHLSQRERFKEQEVQIYSG 112

Query: 590 A-ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                L +LH      II+RD+K  NILLD N    + DFGLSK   + D+   + +  G
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCG 168

Query: 649 SFGYLDPEYLTKQQLTEKS--DVYSFGVVMFEILCG 682
           +  Y+ P+ +           D +S GV+M+E+L G
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.9 bits (155), Expect = 8e-11
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 16/205 (7%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   H  LV L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWR-KRLEICIGAARGLHYLHTGST 602
                  + +  + EY+  G L  H+      P    R    EI +     L+YLH    
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHE--- 114

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + II+RD+K  N+LLD     K+ D+G+ K G  L     ++   G+  Y+ PE L  + 
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 663 LTEKSDVYSFGVVMFEILCGRPVID 687
                D ++ GV+MFE++ GR   D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 38/218 (17%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRD---ETKVAVK--------RGGTQSHQGLAEFRTEIE 531
           D+      +G G FG+V+  ++RD   E   A+K        R   + H        E  
Sbjct: 1   DDLERIKTVGTGTFGRVH--LVRDRISEHYYALKVMAIPEVIRLKQEQH-----VHNEKR 53

Query: 532 MLSQFRHRHLVSLI-GYCDERNEMIIIYEYMENGTLKDHLYA----SNFPSLSWRKRLEI 586
           +L +  H  ++ L     D+R  + ++ EY+  G L  +L      SN   L +   + +
Sbjct: 54  VLKEVSHPFIIRLFWTEHDQRF-LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI-V 111

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
           C      L YLH   +K I++RD+K  NILLD+    K+ DFG +K   D   T     +
Sbjct: 112 C-----ALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----L 158

Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE +  +   +  D ++ G++++E+L G P
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.9 bits (155), Expect = 9e-11
 Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQ-------FRHRHL 541
           VIG G FGKV     + +E   AVK       + + + + E  ++S+        +H  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVK---VLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAARGLHYLH 598
           V L       +++  + +Y+  G L  HL       L  R R    EI    A  L YLH
Sbjct: 59  VGLHFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEI----ASALGYLH 113

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           + +   I++RD+K  NILLD      + DFGL K   +++    ++   G+  YL PE L
Sbjct: 114 SLN---IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
            KQ      D +  G V++E+L G P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 32/223 (14%)

Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  D + +   +G G +G V   +  R   KVA+K+        L   R   E+ +L 
Sbjct: 10  IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 69

Query: 535 QFRHRHLVSLIGY------CDERNEMIIIYEYM--ENGTLKDHLYASNFPSLSWRKRLEI 586
             +H +++ L+         D  ++  ++  +M  + G L  H        LS  +   +
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH------EKLSEDRIQFL 123

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
                +GL Y+H      IIHRD+K  N+ ++E+   K+ DFGL++           + +
Sbjct: 124 VYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEM 172

Query: 647 KG---SFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            G   +  Y  PE  L     T+  D++S G +M E+L G+P+
Sbjct: 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL 215

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 35/210 (16%)

Query: 490 VIGIGGFGKVYRGVLR------------DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR 537
           +IG GGFG+VY G  +            D+ ++ +K+G T +   L E R  + ++S   
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNE-RIMLSLVSTGD 55

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
              +V +       +++  I + M  G L  HL  S     S ++          GL ++
Sbjct: 56  CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILGLEHM 113

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGL----SKIGPDLDQTHVSTAVKGSFGYL 653
           H    + +++RD+K ANILLDE+   +++D GL    SK  P     H S    G+ GY+
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HASV---GTHGYM 162

Query: 654 DPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
            PE L K    + S D +S G ++F++L G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 64/231 (27%), Positives = 114/231 (49%), Gaps = 33/231 (14%)

Query: 528 TEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
           +E+E+L +    +++   G     N + I  E+M+ G+L   +Y      +  R    I 
Sbjct: 48  SELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD--VYRKIPEHVLGR----IA 101

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAV 646
           +   +GL YL   S K I+HRDVK +N+L++     K+ DFG+S ++   + +T+V    
Sbjct: 102 VAVVKGLTYLW--SLK-ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---- 154

Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKCQ 705
            G+  Y+ PE ++ +Q    SDV+S G+   E+  GR P   P + + + +L+   +   
Sbjct: 155 -GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY--PQIQKNQGSLMPLQL--- 208

Query: 706 ETGQLEDIVD---PTL-TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
               L+ IVD   P L  GQ       KFV    +C+ +   +RP+  +++
Sbjct: 209 ----LQCIVDEDPPVLPVGQFSE----KFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 53/213 (24%), Positives = 105/213 (49%), Gaps = 14/213 (6%)

Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQG--LAEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +  VY+G  +  +  VA+K    +  +G      R E+ +L   +H ++V+L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72

Query: 548 CDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
                 + +++EY++   LK +L    N  ++   K     +   RGL+Y H    + ++
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQL--LRGLNYCHR---RKVL 126

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTE 665
           HRD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P+ L      + 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184

Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           + D++  G + +E+  GRP+   S   E+++ +
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 42/226 (18%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKR--------GGTQSHQGLAE----FRT--EIEMLSQ 535
           +G G +GKV +         VA+K+          T+  Q +      F T  E++++++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 536 FRHRHLVSLIG-YCDERNEMI-IIYEYMENGTLKDHLYASNFPSLSWRKRLEICI--GAA 591
            +H +++ L+  Y +   + I ++ + M    LK  +      + S  K    CI     
Sbjct: 77  IKHENIMGLVDVYVEG--DFINLVMDIMA-SDLKKVVDRKIRLTESQVK----CILLQIL 129

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-------IGPDLDQTHVS- 643
            GL+ LH       +HRD+  ANI ++   + K+ADFGL++                +  
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 644 ----TAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRP 684
               T+   +  Y  PE L   ++     D++S G +  E+L G+P
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 35/91 (38%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGS 649
           ARG+ +L   +++  IHRD+ + NILL EN + K+ DFGL++ I  D D     +A +  
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA-RLP 239

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 84/322 (26%), Positives = 134/322 (41%), Gaps = 48/322 (14%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----------AVKRGGTQSHQGLAEFRTEIEM 532
           ++F    VIG G FG+V    L++  KV           +KR  T      A FR E ++
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET------ACFREERDV 54

Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGA 590
           L    ++ + +L     + N + ++ +Y   G L   L  +    P    R  L   + A
Sbjct: 55  LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA 114

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
              +H LH       +HRD+K  NIL+D N   ++ADFG S +    D T  S+   G+ 
Sbjct: 115 IDSVHQLH------YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTP 167

Query: 651 GYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKC 704
            Y+ PE L      K +   + D +S GV M+E+L G  P    SL      ++    + 
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 227

Query: 705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID----RPSMGDVLWNLEYALQ 760
           Q   Q+ D+ +         D + + +   E  L Q GI+     P    + W+      
Sbjct: 228 QFPAQVTDVSEDA------KDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD-----N 276

Query: 761 LQGDEGKSSPKGETSSPNNHSH 782
           ++  E    P  E SSP + S+
Sbjct: 277 IRNCEAPYIP--EVSSPTDTSN 296

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 9/102 (8%)

Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           + +   + LHYL       +IHRDVK +NILLD +   K+ DFG+S    D  +    +A
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAKTRSA 175

Query: 646 VKGSFGYLDPEYLTKQQLTEK----SDVYSFGVVMFEILCGR 683
             G   Y+ PE +       K    +DV+S G+ + E+  G+
Sbjct: 176 --GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 30/206 (14%)

Query: 491 IGIGGFGKV----YRG-----VLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           +G G FG+V    ++G      ++   K  + +     H        E  +L +  H  +
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-----VAQEKSILMELSHPFI 80

Query: 542 VSLI-GYCDERNEMIIIYEYMENGTLKDHLY-ASNFPS-LSWRKRLEICIGAARGLHYLH 598
           V+++  + DE N +  + E++  G L  HL  A  FP+ ++     E+ +       YLH
Sbjct: 81  VNMMCSFQDE-NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA----FEYLH 135

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +   K II+RD+K  N+LLD     KV DFG +K  PD   T     + G+  YL PE +
Sbjct: 136 S---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVI 187

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             +   +  D ++ GV+++E + G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 35/90 (38%), Positives = 56/90 (62%), Gaps = 5/90 (5%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGS 649
           ARG+ +L   +++  IHRD+ + NILL EN + K+ DFGL++ I  D D      A +  
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RLP 238

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
             ++ PE +  +  T +SDV+SFGV+++EI
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.1 bits (151), Expect = 3e-10
 Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G + KV    L+   ++     +K+      + +   +TE  +      H  LV L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWR-KRLEICIGAARGLHYLHTGST 602
                  + +  + E++  G L  H+      P    R    EI +     L++LH    
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNFLHE--- 114

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + II+RD+K  N+LLD     K+ D+G+ K G  +     ++   G+  Y+ PE L  + 
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYIAPEILRGED 172

Query: 663 LTEKSDVYSFGVVMFEILCGRPVID 687
                D ++ GV+MFE++ GR   D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 34/95 (35%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           + L+YL       IIHRDVK +NILLD N   K+ DFG+S     L  +   T   G   
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRP 172

Query: 652 YLDPEYLTKQQLTE---KSDVYSFGVVMFEILCGR 683
           Y+ PE +          +SDV+S G+ ++E+  G+
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 25/216 (11%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET-------KVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
            +F    ++G G FG+V   V+R++        KV +K+    + + ++ F  E ++LS 
Sbjct: 1   KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKV-MKKSVLLAQETVSFFEEERDILSI 57

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARG 593
                +  L     +++ + ++ EY   G L   L  Y   F     +  L   + A   
Sbjct: 58  SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLA--- 114

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           +H +H       +HRD+K  N+L+D     K+ADFG S      ++   S    G+  Y+
Sbjct: 115 IHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYI 170

Query: 654 DPEYLTKQQLTEKS------DVYSFGVVMFEILCGR 683
            PE LT      K       D +S GV+ +E++ GR
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L +LH      +I+RD+K  NILLD     K+ADFG+ K G     T  +T   G+  Y+
Sbjct: 109 LMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE L + +     D ++ GV+M+E++ G+P
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQP 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 34/91 (37%), Positives = 56/91 (61%), Gaps = 5/91 (5%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGS 649
           A+G+ +L   +++  IHRD+ + NILL EN + K+ DFGL++ I  D D      A +  
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA-RLP 244

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQSH--QGLAEFRTEIEMLSQF-RHRHLVSLIG 546
           +G G FG VY    ++    VA+K+   + +  +     R E++ L +   H ++V L  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLKE 65

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHTGST 602
              E +E+  ++EYME       L        F     R    I     +GL ++H    
Sbjct: 66  VFRENDELYFVFEYMEGNLY--QLMKDRKGKPFSESVIRS---IIYQILQGLAHIHK--- 117

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQT-HVSTAVKGSFGYLDPEYLTK 660
               HRD+K  N+L+    + K+ADFGL++ I      T +VST       Y  PE L +
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEILLR 172

Query: 661 QQL-TEKSDVYSFGVVMFEILCGRP 684
               +   D+++ G +M E+   RP
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 40/272 (14%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT---EIEMLSQFRHRHLVSLIGY 547
           +G G +G VY+ VL   T V +     +     ++F     E+++L +    ++V   G 
Sbjct: 9   LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA--RGLHYLHTGSTKAI 605
                 + +  EYM+ G+L D LYA    +    + +   I  A  +GL +L       I
Sbjct: 68  FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNI 124

Query: 606 IHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           IHRDVK  N+L++ N   K+ DFG+S  +   L +T++     G   Y+ PE +      
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPN 179

Query: 665 E------KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD--- 715
           +      +SDV+S G+ + E+  GR    P  P    N+           QL  IVD   
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRY---PYPPETYANIF---------AQLSAIVDGDP 227

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS 747
           PTL      D+   FV    KCL +    RP+
Sbjct: 228 PTLPSGYSDDA-QDFV---AKCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 15/200 (7%)

Query: 491 IGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FGKV +   RD  ++     +++    S   +     E  +L+Q     +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC--IGAARGLHYLHTGSTKA 604
                 ++ ++  ++  G L  HL       LS R R      + A   LH  +      
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLS-RARFYTAELLCALENLHKFN------ 113

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           +I+RD+K  NILLD      + DFGL K+  ++     +    G+  YL PE L     T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 665 EKSDVYSFGVVMFEILCGRP 684
           +  D ++ GV+++E+L G P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 25/207 (12%)

Query: 491 IGIGGFGKVYRGVLR--DETKVAVKRGGTQSHQGLAEFRT-EIEMLSQFRHRHLVSL--I 545
           IG G +G VY+   R  +ET    K    Q  +G+      EI +L + +H ++V L  +
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL--EICIGAARGLHYLHTGSTK 603
            + ++R  + +++EY++   LK H+ +S  P  +   RL         RG+ Y H+    
Sbjct: 70  VHSEKR--LYLVFEYLDL-DLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS---H 121

Query: 604 AIIHRDVKSANILLDENLMA-KVADFGLSK-IG-PDLDQTH-VSTAVKGSFGYLDPEYLT 659
            ++HRD+K  N+L+D    A K+ADFGL++  G P    TH V T       Y  PE L 
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVT-----LWYRAPEILL 176

Query: 660 -KQQLTEKSDVYSFGVVMFEILCGRPV 685
             +  +   D++S G +  E++  +P+
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPL 203

Length = 294

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 81/312 (25%), Positives = 128/312 (41%), Gaps = 71/312 (22%)

Query: 483 DNFSESL-VIGIGGFGKVYRGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           D+F ES+ VIG G FG+V R V + +T      K   K    +  Q +A  R E ++L++
Sbjct: 1   DDF-ESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAE 57

Query: 536 FRHRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAA 591
             +  +V L  Y    DE   + +I EY+  G +   L   + F     R  +   I A 
Sbjct: 58  ADNPWVVKL--YYSFQDENY-LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAI 114

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK------------------- 632
             +H L        IHRD+K  N+LLD     K++DFGL                     
Sbjct: 115 DSIHKL------GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168

Query: 633 -IGPDLDQTHVSTAVK----------------GSFGYLDPEYLTKQQLTEKSDVYSFGVV 675
               D     +S+  K                G+  Y+ PE   +    ++ D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228

Query: 676 MFEILCGRPVIDPSLPRE---KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVE 732
           M+E+L G P      P+E   K+      +  +ET Q  D  +  L+ + K D + +   
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKI------INWKETLQFPD--EVPLSPEAK-DLIKRLCC 279

Query: 733 IAEKCLAQCGID 744
            AE+ L   G++
Sbjct: 280 EAERRLGNNGVN 291

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 43/217 (19%)

Query: 491 IGIGGFGKVYRGVLRDET-KVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLIGY 547
           IG G +G V      +   KVA+K+        +   RT  EI++L    H +++++   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 548 C-----DERNEMIIIYEYME---------NGTL-KDHLYASNFPSLSWRKRLEICIGAAR 592
                 +  N++ I+YE M+         + TL  DH     +  L             R
Sbjct: 73  MPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL-------------R 119

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ---THVSTAVKGS 649
           GL Y+H+ +   ++HRD+K +N+LL+ N   K+ DFGL++   +       +V T     
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---- 172

Query: 650 FGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             Y  PE  L   + T   DV+S G +  E+L  +P+
Sbjct: 173 -WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 27/219 (12%)

Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLRDETKV----------AVKRGGTQSHQGLAEFR 527
           +Q   +++    VIG G FG+V     +   KV           +KR  +      A F 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS------AFFW 91

Query: 528 TEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
            E ++++      +V L     +   + ++ EYM  G L + +   + P   W K     
Sbjct: 92  EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAE 150

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           +  A  L  +H+     +IHRDVK  N+LLD++   K+ADFG      +       TAV 
Sbjct: 151 VVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204

Query: 648 GSFGYLDPEYLTKQ----QLTEKSDVYSFGVVMFEILCG 682
           G+  Y+ PE L  Q        + D +S GV +FE+L G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGL--AEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +  VY+G+ R   + VA+K    ++ +G+     R E  +L   +H ++V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPS--LSWRKRLEICIGAARGLHYLHTGSTKAI 605
              +  +  ++EYM     +   Y    P     +  RL       RGL Y+H    + I
Sbjct: 72  IHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRL-FMFQLLRGLAYIHG---QHI 124

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLT 664
           +HRD+K  N+L+      K+ADFGL++      QT+ S  V  +  Y  P+ L      +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182

Query: 665 EKSDVYSFGVVMFEILCGRPV 685
              D++  G +  E+L G+P 
Sbjct: 183 SALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 58.9 bits (142), Expect = 5e-09
 Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 19/142 (13%)

Query: 558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL 617
           Y        +     +  P+LS+   +      A G+ +L   ++K  +HRD+ + N+L+
Sbjct: 216 YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLI 272

Query: 618 DENLMAKVADFGLSKIGPDL--DQTHVSTAVKGS----FGYLDPEYLTKQQLTEKSDVYS 671
            E  + K+ DFGL++   D+  D  ++S   KGS      ++ PE +     T  SDV+S
Sbjct: 273 CEGKLVKICDFGLAR---DIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWS 326

Query: 672 FGVVMFEI--LCGRPVIDPSLP 691
           FG++++EI  L G P   P LP
Sbjct: 327 FGILLWEIFTLGGTPY--PELP 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)

Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 12  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71

Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 72  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 128 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 181

Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 182 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 31/97 (31%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           + GL +LH    + II+RD+K  N++LD     K+ADFG+ K    +     +    G+ 
Sbjct: 111 SVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
            Y+ PE +  Q   +  D +++GV+++E+L G+P  D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 49/219 (22%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSH-QGLAEFRT-EIEMLSQFRHRHLVSLIGY 547
           IG G +G VY+G  +   + VA+K+   +S  +G+      EI +L + +H ++V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 548 CDERNEMIIIYE-----------------YMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
             + + + +I+E                 YM+   +K +LY             +I    
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY-------------QI---- 110

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IG-PDLDQTH-VSTAVK 647
            +G+ + H+   + ++HRD+K  N+L+D   + K+ADFGL++  G P    TH V T   
Sbjct: 111 LQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVT--- 164

Query: 648 GSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
               Y  PE L    + +   D++S G +  E+   +P+
Sbjct: 165 --LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 28/155 (18%)

Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQS-HQGLAEFRT-EIEMLSQFRHRHLVSLIGY 547
           IG G +G V++   R+  + VA+KR       +G+      EI +L + +H+++V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 548 CDERNEMIIIYEYME----------NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
                ++ +++EY +          NG +   +  S    L             +GL + 
Sbjct: 68  LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------------LKGLAFC 115

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK 632
           H+     ++HRD+K  N+L+++N   K+ADFGL++
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 54/215 (25%), Positives = 105/215 (48%), Gaps = 28/215 (13%)

Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRT-EIEMLSQFRHRHL 541
           NF +   +G G +  VY+G  R   + VA+K     + +G       EI ++ + +H ++
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDH---------LYASNFPSLSWRKRLEICIGAAR 592
           V L       N++++++EYM+   LK +         L  +   S +++          +
Sbjct: 61  VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQ--------LLK 111

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFG 651
           G+ + H      ++HRD+K  N+L+++    K+ADFGL++  G  ++ T  +  V  +  
Sbjct: 112 GIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-TFSNEVV--TLW 165

Query: 652 YLDPEYLTKQQLTEKS-DVYSFGVVMFEILCGRPV 685
           Y  P+ L   +    S D++S G +M E++ GRP+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 65/254 (25%), Positives = 99/254 (38%), Gaps = 60/254 (23%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
           ++F    VIG G FG+V R V + +T      K  +K    +  Q LA  + E ++L++ 
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQ-LAHVKAERDVLAES 58

Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLH 595
               +VSL     +   + +I E++  G L   L   + F     R  +  C+ A   +H
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS------------------KIGPDL 637
            L        IHRD+K  NIL+D     K++DFGLS                  K   + 
Sbjct: 119 KL------GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172

Query: 638 DQTHVSTAVK---------------------------GSFGYLDPEYLTKQQLTEKSDVY 670
                S AV                            G+  Y+ PE   +Q   ++ D +
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232

Query: 671 SFGVVMFEILCGRP 684
           S G +MFE L G P
Sbjct: 233 SLGAIMFECLIGWP 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 57.8 bits (140), Expect = 8e-09
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 41/184 (22%)

Query: 471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRT- 528
           Y FPF    +    + +   IG G FG+V++   +  +  VA+K+        L E    
Sbjct: 3   YEFPFC---DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-------LMENEKE 52

Query: 529 --------EIEMLSQFRHRHLVSLIGYCDERNEMI-----IIYEYMENGTLKDHLYA--- 572
                   EI++L   +H ++V+LI  C  +           Y   E     +H  A   
Sbjct: 53  GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFE---FCEHDLAGLL 109

Query: 573 SN----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF 628
           SN    F +LS  K++   +    GL+Y+H      I+HRD+K+ANIL+ ++ + K+ADF
Sbjct: 110 SNKNVKF-TLSEIKKVMKML--LNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163

Query: 629 GLSK 632
           GL++
Sbjct: 164 GLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.2 bits (141), Expect = 8e-09
 Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 13/144 (9%)

Query: 606 IHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ--- 661
           IHRDVK  N+LLD++   K+ADFG   K+  +       TAV G+  Y+ PE L  Q   
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAV-GTPDYISPEVLKSQGGD 221

Query: 662 -QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG 720
                + D +S GV ++E+L G     P      V      M  + +    D  D  ++ 
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDT---PFYADSLVGTYSKIMDHKNSLTFPD--DIEISK 276

Query: 721 QIKPDSLNKFVEIAEKCLAQCGID 744
           Q K D +  F+   E  L + G+D
Sbjct: 277 QAK-DLICAFLTDREVRLGRNGVD 299

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)

Query: 491 IGIGGFGKVYRGVLR---DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FGKV  G +       +V VK    + S Q   +F  E +     +H +L+  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSLSWRKRLEICIGAARGLHYLHTGS 601
            C E    +++ E+   G LK +L +        P  +  +R+   I  A GL +LH  +
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI--ALGLLHLHKNN 120

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
               IH D+   N LL  +L  K+ D+GLS      D       +     ++ PE + + 
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 662 Q-------LTEKSDVYSFGVVMFEIL 680
                    T++S+V+S GV ++E+ 
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 70/280 (25%), Positives = 116/280 (41%), Gaps = 37/280 (13%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----------AVKRGGTQSHQGLAEFRTEIEM 532
           D+F    VIG G FG+V    ++   ++           +KR  T      A FR E  +
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAET------ACFREERNV 54

Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGA 590
           L     + + +L     + N + ++ +Y   G L   L  +    P    R  +   + A
Sbjct: 55  LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
              +H LH       +HRD+K  N+LLD N   ++ADFG S +  + D T  S+   G+ 
Sbjct: 115 IHSIHQLH------YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167

Query: 651 GYLDPEYLTKQQ-----LTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKC 704
            Y+ PE L   +        + D +S GV M+E+L G  P    SL      ++    + 
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227

Query: 705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID 744
           Q    + D+ +         D + + +   E+ L Q GI+
Sbjct: 228 QFPSHITDVSEEA------KDLIQRLICSRERRLGQNGIE 261

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 57.7 bits (139), Expect = 9e-09
 Identities = 32/97 (32%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A GL +LH+   K II+RD+K  N++LD     K+ADFG+ K   ++     +    G+ 
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
            Y+ PE +  Q   +  D ++FGV+++E+L G+   +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.4 bits (139), Expect = 9e-09
 Identities = 50/194 (25%), Positives = 97/194 (50%), Gaps = 24/194 (12%)

Query: 506 DETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFR-HRHLVSL----IGYCDERNEMIIIY 558
           +E  VA+K+      + +   R   E+++L  FR H+++  L    I +    NE+ +  
Sbjct: 26  EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85

Query: 559 EYME---NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI 615
           E ME   +  ++     ++    S+  ++ +C     GL Y+H+ +   ++HRD+K  N+
Sbjct: 86  ELMEADLHQIIRSGQPLTDAHFQSFIYQI-LC-----GLKYIHSAN---VLHRDLKPGNL 136

Query: 616 LLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFGYLDPE-YLTKQQLTEKSDVYS 671
           L++ +   K+ DFGL++     P  +   ++  V  +  Y  PE  L+ Q  T+  DV+S
Sbjct: 137 LVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWS 195

Query: 672 FGVVMFEILCGRPV 685
            G ++ E+L  +PV
Sbjct: 196 VGCILAELLGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 32/218 (14%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----------AVKRGGTQSHQGLAEFRTEIEM 532
           D+F    VIG G FG+V    +++  +V           +KR  T      A FR E ++
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET------ACFREERDV 54

Query: 533 LSQFRHRHLVSL-IGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIG 589
           L     R + +L   + DE N + ++ +Y   G L   L  +    P    R  L   + 
Sbjct: 55  LVNGDRRWITNLHYAFQDENN-LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL 113

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
           A   +H L        +HRD+K  N+LLD+N   ++ADFG S +    D T  S    G+
Sbjct: 114 AIDSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGT 166

Query: 650 FGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCG 682
             Y+ PE L      K +   + D +S GV M+E+L G
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 51/190 (26%), Positives = 77/190 (40%), Gaps = 14/190 (7%)

Query: 494 GGFGKVYRGVLRDE---TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           G  G+V+      +    KV VK        G      EI++L    HR +++LI     
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRW 157

Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
           ++ + ++   M         Y      L   + + I       L YLH    + IIHRDV
Sbjct: 158 KSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDV 211

Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
           K+ NI LDE   A + DFG +        T       G+     PE L       K+D++
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIW 271

Query: 671 SFGVVMFEIL 680
           S G+V+FE+ 
Sbjct: 272 SAGLVLFEMS 281

Length = 392

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 12/92 (13%)

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKG 648
            GL YLH    + IIHRDVK+ NI +++     + D G ++   + P          + G
Sbjct: 168 EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF------LGLAG 218

Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +     PE L + +   K+D++S G+V+FE+L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 13/128 (10%)

Query: 558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL 617
           Y+   +  +K+ L       L+    L      ARG+ +L   ++K  +HRD+ + N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 618 DENLMAKVADFGLSKIGPDLDQTHVSTAV-KGS----FGYLDPEYLTKQQLTEKSDVYSF 672
            +  + K+ DFGL++     D  H S  V KGS      ++ PE +     T  SDV+S+
Sbjct: 271 AQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325

Query: 673 GVVMFEIL 680
           G++++EI 
Sbjct: 326 GILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 16/207 (7%)

Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           NF +   IG G +G VY+   +   + VA+K  R  T++    +    EI +L +  H +
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V L+      N++ +++E++ +  LK  + AS    +             +GL + H+ 
Sbjct: 61  IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS- 118

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IG-PDLDQTH-VSTAVKGSFGYLDPEY 657
               ++HRD+K  N+L++     K+ADFGL++  G P    TH V T       Y  PE 
Sbjct: 119 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT-----LWYRAPEI 171

Query: 658 LTKQQL-TEKSDVYSFGVVMFEILCGR 683
           L   +  +   D++S G +  E++  R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 44/227 (19%)

Query: 487 ESLVIGIGGFGKVYRGVLRD---ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           E   +G G +G VY+   +D   +   A+K+  GT           EI +L + +H +++
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR---EIALLRELKHPNVI 61

Query: 543 SL----IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR------ 592
           SL    + + D +  + ++++Y E+     H+   +  S + +K +++  G  +      
Sbjct: 62  SLQKVFLSHADRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQI 117

Query: 593 --GLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLSKI--GP-----DLDQ 639
             G+HYLH      ++HRD+K ANIL+     E    K+AD G +++   P     DLD 
Sbjct: 118 LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 640 THVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
             V      +F Y  PE L   +  T+  D+++ G +  E+L   P+
Sbjct: 175 VVV------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.5 bits (136), Expect = 2e-08
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET--KVAVKR---GGTQSHQGLAEFRTEIEMLSQFR 537
           ++F+    +G G FG+V     ++E    VA+KR         + +    +E ++L+   
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEI---CIGAARGL 594
           H   V+L G   + + + ++ E++  G          F  L   KR      C  AA+ +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEF--------FTFLRRNKRFPNDVGCFYAAQIV 141

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
                  +  I++RD+K  N+LLD++   K+ DFG +K+      T   T + G+  Y+ 
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYT-LCGTPEYIA 196

Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           PE L      + +D ++ G+ ++EIL G P
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCP 226

Length = 340

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 40/213 (18%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKR-------GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           IG G +G VY+         VA+K+        G  S       R EI +L +  H ++V
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS----TAIR-EISLLKELNHPNIV 61

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL------EICIGAARGLHY 596
            L+      N++ +++E++ +  LK ++ +S  P       L      ++     +G+ Y
Sbjct: 62  RLLDVVHSENKLYLVFEFL-DLDLKKYMDSS--PLTGLDPPLIKSYLYQLL----QGIAY 114

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQ-TH-VSTAVKGSFGYL 653
            H+     ++HRD+K  N+L+D     K+ADFGL++  G  +   TH V T       Y 
Sbjct: 115 CHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT-----LWYR 166

Query: 654 DPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE L  ++Q  T   D++S G +  E++  RP
Sbjct: 167 APEILLGSRQYST-PVDIWSIGCIFAEMVNRRP 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.1 bits (138), Expect = 3e-08
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 46/226 (20%)

Query: 491 IGIGGFGKVYRGVLRDET---KVAVKRGGTQSHQGLAE-------FRTEIEMLSQFRHRH 540
           IG GG G+VY     D     +VA+K+      + L+E       F  E ++ +   H  
Sbjct: 10  IGKGGMGEVYLA--YDPVCSRRVALKK----IREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEI--CIGA-------- 590
           +V +   C + + +     Y+E  TLK  L  S +   S  K L     +GA        
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG--LSKIGPDLDQTHVSTAVKG 648
              + Y+H+   K ++HRD+K  NILL       + D+G  + K   + D   +    + 
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 649 SF--------------GYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
                            Y+ PE L     +E +D+Y+ GV+++++L
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 21/194 (10%)

Query: 494 GGFGKVYRGVLRDETKVAVKRGG--TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER 551
                + +    + T VAVK+    + S + L   + EI    Q +H +++  +      
Sbjct: 13  LMIVHLAKHKPTN-TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI---GAARGLHYLHTGSTKAIIHR 608
           +E+ ++   M  G+ +D L  ++FP       L I          L Y+H+   K  IHR
Sbjct: 72  SELYVVSPLMAYGSCED-LLKTHFPE--GLPELAIAFILKDVLNALDYIHS---KGFIHR 125

Query: 609 DVKSANILLDENLMAKVADF--GLSKIGPDLDQTHVSTAVKGS---FGYLDPEYLTKQQL 663
            VK+++ILL  +    ++     +S I     Q  V    K S     +L PE L +Q L
Sbjct: 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL-QQNL 184

Query: 664 ---TEKSDVYSFGV 674
               EKSD+YS G+
Sbjct: 185 QGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT---EIEMLSQFRHRHLVSLIG 546
           +G G +G V      R   KVAVK+  ++  Q L   R    E+ +L   +H +++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 547 Y------CDERNEMIIIYEYME---NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
                   +  NE+ ++   M    N  +K          LS      +     RGL Y+
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVK-------CQKLSDEHVQFLIYQLLRGLKYI 134

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE- 656
           H+     IIHRD+K +N+ ++E+   ++ DFGL++   D    +V+T       Y  PE 
Sbjct: 135 HSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEI 186

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L      +  D++S G +M E+L G+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 67/248 (27%), Positives = 111/248 (44%), Gaps = 50/248 (20%)

Query: 464 FSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH--- 520
           ++SS +G      ++ + TD +     IG G +GKVY        KV  K+ G+ +    
Sbjct: 7   YNSSMLGLE----SLGDPTDTWEIIETIGKGTYGKVY--------KVTNKKDGSLAAVKI 54

Query: 521 -QGLAEFRTEIE-----MLSQFRHRHLVSLIGYCDERNEMI-----IIYEYMENGTLKDH 569
              +++   EIE     + S   H ++V   G   + ++++     ++ E    G++ + 
Sbjct: 55  LDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL 114

Query: 570 LYASNFPSLSWRKRLE------ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA 623
           +       L   +RL+      I  GA  GL +LH      IIHRDVK  NILL      
Sbjct: 115 VKGL----LICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167

Query: 624 KVADFGLSKIGPDLDQTHV--STAVKGSFGYLDPEYLTKQQLTEKS-----DVYSFGVVM 676
           K+ DFG+S     L  T +  +T+V   F ++ PE +  +Q  + S     DV+S G+  
Sbjct: 168 KLVDFGVSA---QLTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITA 223

Query: 677 FEILCGRP 684
            E+  G P
Sbjct: 224 IELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 6e-08
 Identities = 53/236 (22%), Positives = 87/236 (36%), Gaps = 56/236 (23%)

Query: 490 VIGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           ++G G  G+V+   L+        KV  K+   + ++ +    TE E+L+   H  L +L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDHPFLPTL 66

Query: 545 IGYCDERNEMIIIY--EYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GL 594
             Y   + E  +    +Y   G L        F  L  +    +    AR         L
Sbjct: 67  --YASFQTETYLCLVMDYCPGGEL--------FRLLQRQPGKCLSEEVARFYAAEVLLAL 116

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG--- 651
            YLH      I++RD+K  NILL E+    ++DF LSK              KGS     
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 652 ------------------------YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
                                   Y+ PE ++        D ++ G++++E+L G 
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 38/225 (16%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET--KVAVKRGGTQS-------HQGLAEFRTEIEML 533
           ++F    +I  G +G VY  V   ET  + A+K+   Q+        Q   E     ++L
Sbjct: 1   EDFETIKLISNGAYGAVYL-VRHKETRQRFAMKKINKQNLILRNQIQQVFVER----DIL 55

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENG---TLKDHLYASNFPSLSWRKRLEICIGA 590
           +   +  +VS+    + +  + ++ EY+E G   TL  ++ A   P    R      + A
Sbjct: 56  TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMYFAETVLA 113

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-----PDLDQTHVSTA 645
              L YLH      I+HRD+K  N+L+      K+ DFGLSKIG      +L + H+   
Sbjct: 114 ---LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167

Query: 646 VK--------GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            +        G+  Y+ PE + +Q   +  D ++ G++++E L G
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 54.7 bits (131), Expect = 8e-08
 Identities = 57/227 (25%), Positives = 106/227 (46%), Gaps = 44/227 (19%)

Query: 487 ESLVIGIGGFGKVYRGVLRD---ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           E   +G G +G VY+   +D   E + A+K+  GT           EI +L + +H +++
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR---EIALLRELKHPNVI 61

Query: 543 SL----IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR------ 592
           +L    + + D +  + ++++Y E+     H+   +  S + +K +++     +      
Sbjct: 62  ALQKVFLSHSDRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 593 --GLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLSKI--GP-----DLDQ 639
             G+HYLH      ++HRD+K ANIL+     E    K+AD G +++   P     DLD 
Sbjct: 118 LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 640 THVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
             V      +F Y  PE L   +  T+  D+++ G +  E+L   P+
Sbjct: 175 VVV------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETK--VAVKR-GGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLI 545
           V+G G +G V +     ETK  VA+K+   ++ ++ + E    E++ML   +  ++V L 
Sbjct: 8   VVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK 66

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI-GAARGLHYLHTGSTKA 604
                R ++ +++EY+E   L+        P+    +++   I    + +H+ H      
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--- 120

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQT-HVSTAVKGSFGYLDPEYLTK 660
           I+HRD+K  N+L+  N + K+ DFG ++    G + + T +V+T       Y  PE L  
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR-----WYRSPELLLG 175

Query: 661 QQLTEKSDVYSFGVVMFEILCGRPV 685
               +  D++S G ++ E+  G+P+
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQPL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 30/180 (16%)

Query: 511 AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG-YCDERNEMIIIYEYMENGTLKDH 569
           A +RGGT          TE  +L    H  ++ L G +   +   +I+  Y      K  
Sbjct: 124 AGQRGGTA---------TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY------KTD 168

Query: 570 LYASNFPSLSWRKRLEICIGAA------RGLHYLHTGSTKAIIHRDVKSANILLDENLMA 623
           LY      L+ ++ + IC   A      R + YLH      IIHRD+K+ NI ++     
Sbjct: 169 LYCY----LAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDV 221

Query: 624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
            + DFG +    D++         G+     PE L +       D++S G+V+FE+    
Sbjct: 222 CLGDFGAACFPVDINANKY-YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.9 bits (130), Expect = 2e-07
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 34/215 (15%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLIG 546
            IG G +G V   +  R   KVA+K+            RT  E+++L  F+H +++++  
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71

Query: 547 -YCDERNEMIIIY---EYME---------NGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
                  +   +Y   + ME         +  L +         L             RG
Sbjct: 72  ILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL------------LRG 119

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFG 651
           L Y+H+ +   +IHRD+K +N+L++E+   ++ DFG+++       +  +  T    +  
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
           Y  PE  L+  + T   D++S G +  E+L  R +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.0 bits (128), Expect = 2e-07
 Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 53/219 (24%)

Query: 491 IGIGGFGKVYRG-VLRDETKVAVKRGGTQSHQGLAE---FRTEIEMLSQFR-HRHLVSLI 545
           IG G F +V +    +     A+K    +  + L +    R EI+ L +   H +++ LI
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLI 64

Query: 546 GYCDERN-----------EMIIIYEYMENGTLKDHLYASNFPSLSWRKRL-EICIGAARG 593
               +R            +M + YE +     K        P    +  + ++     + 
Sbjct: 65  EVLFDRKTGRLALVFELMDMNL-YELI-----KGRKRP--LPEKRVKSYMYQLL----KS 112

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-- 651
           L ++H      I HRD+K  NIL+ ++++ K+ADFG  +              K  +   
Sbjct: 113 LDHMHR---NGIFHRDIKPENILIKDDIL-KLADFGSCR----------GIYSKPPYTEY 158

Query: 652 -----YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                Y  PE  LT      K D+++ G V FEIL   P
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 34/95 (35%), Positives = 59/95 (62%), Gaps = 15/95 (15%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL--DQTHVSTAVKG 648
           A+G+ +L   ++K  IHRDV + N+LL +  +AK+ DFGL++   D+  D  +V   VKG
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSNYV---VKG 272

Query: 649 S----FGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
           +      ++ PE +     T +SDV+S+G++++EI
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLIG 546
            +G G +  VY+G  +     VA+K    +  +G A F    E  +L   +H ++V+L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPS-LSWRKRLEICIGAARGLHYLHTGSTKAI 605
               +  + +++EY++   LK   Y  +    LS            RGL Y H    + +
Sbjct: 71  IIHTKKTLTLVFEYLDT-DLKQ--YMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRV 124

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           +HRD+K  N+L+ E    K+ADFGL++      +T+ +  V  +  Y  P+ L     TE
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGS--TE 180

Query: 666 KS---DVYSFGVVMFEILCGRPV 685
            S   D++  G + +E+  GRP+
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPL 203

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 15/96 (15%)

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL--DQTHVSTAVKG 648
           A+G+ +L   ++K  IHRD+ + NILL    + K+ DFGL++   D+  D  +V   VKG
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYV---VKG 274

Query: 649 S----FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +      ++ PE +     T +SDV+S+G++++EI 
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.8 bits (125), Expect = 4e-07
 Identities = 36/146 (24%), Positives = 60/146 (41%), Gaps = 12/146 (8%)

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           + + + L          ++I +Y+++G L D L       LS  +  +I       L+ L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 598 HTGSTKAIIHRDVKSANILLDENLM-AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           H      IIH D+K  N+L D       + D+GL KI          +   G+  Y  PE
Sbjct: 126 HK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI------IGTPSCYDGTLDYFSPE 176

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCG 682
            +         D ++ GV+ +E+L G
Sbjct: 177 KIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQG--LAEFRTEIEMLSQFRHR 539
           D++ +   +G G +  VY+G  +   K VA+K    Q  +G      R E  +L   +H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI-GAARGLHYLH 598
           ++V L      +  + +++EY+     +   Y    P     + +++ +    RGL Y+H
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
               + I+HRD+K  N+L+ +    K+ADFGL++       T+ +  V  +  Y  P+ L
Sbjct: 121 Q---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVL 175

Query: 659 TKQQLTEKS---DVYSFGVVMFEILCG 682
                TE S   D++  G +  E++ G
Sbjct: 176 LGS--TEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.3 bits (125), Expect = 6e-07
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 27/207 (13%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----------AVKRGGTQSHQGLAEFRTEIEMLSQFRHR 539
           VIG G FG+V     +   KV           +KR  +      A F  E ++++     
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS------AFFWEERDIMAFANSP 103

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
            +V L     +   + ++ EYM  G L + +   + P    R      + A   +H +  
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM-- 161

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                 IHRDVK  N+LLD++   K+ADFG              TAV G+  Y+ PE L 
Sbjct: 162 ----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLK 216

Query: 660 KQ----QLTEKSDVYSFGVVMFEILCG 682
            Q        + D +S GV ++E+L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 70/237 (29%), Positives = 106/237 (44%), Gaps = 34/237 (14%)

Query: 469 IGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVL--RDETKVAVKRGGTQSHQGLAEF 526
            G    F +  + +D +     IG G +GKV++ VL  ++ +K AVK      H    E 
Sbjct: 4   SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKIL-DPIHDIDEEI 61

Query: 527 RTEIEMLSQFR-HRHLVSLIGYC---DERN--EMIIIYEYMENGTLKDHLYASNFPSLSW 580
             E  +L     H ++V   G     D +N  ++ ++ E    G++ D      F  L  
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD--LVKGF--LKR 117

Query: 581 RKRLE------ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG 634
            +R+E      I   A  GL +LH   T   IHRDVK  NILL      K+ DFG+S   
Sbjct: 118 GERMEEPIIAYILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSA-- 172

Query: 635 PDLDQTHV--STAVKGSFGYLDPEYLT-KQQL----TEKSDVYSFGVVMFEILCGRP 684
             L  T +  +T+V   F ++ PE +  +QQL      + DV+S G+   E+  G P
Sbjct: 173 -QLTSTRLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ------FRHRHLVSL 544
           IG G FGKV    +  +T VA  R   +  +  A  + + E L Q       +H +++  
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVA--RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHL------YASNFPSLSWRKRLEICIGAARGLHYLH 598
           +G C E    ++++EY E G LK +L        ++   L  R   EI  G    +H  +
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH-MHKHN 119

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFG--YLDP 655
                  +H D+   N  L  +L  KV D+G   IGP    + ++ T         +L P
Sbjct: 120 ------FLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLRWLAP 170

Query: 656 EYLTKQQ-------LTEKSDVYSFGVVMFEIL 680
           E + +          T+ S+V++ GV ++E+ 
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 55/272 (20%), Positives = 110/272 (40%), Gaps = 57/272 (20%)

Query: 491 IGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +GIG FG+V      D   +     +++    +   +A  + E ++L++  +  +V L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
              +++ +  + +Y+  G +   L     FP +  R  +     A   +H +        
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM------GF 122

Query: 606 IHRDVKSANILLDENLMAKVADFGL--------------------------SKIGPDLD- 638
           IHRD+K  NIL+D +   K+ DFGL                          S +  D+  
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 639 ------------------QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
                             Q  ++ ++ G+  Y+ PE L ++  T+  D +S GV++FE+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 681 CGR-PVIDPSLPREKVNLVEWAMKCQETGQLE 711
            G+ P + P+    ++ ++ W        Q++
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVK 274

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 9e-07
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 490 VIGIGGFGKVYRGVLRDET-KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY- 547
           +IG G FG VY  +  D + KVA+K+      Q       E+ ++    H +++ L  Y 
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128

Query: 548 ---CDERNE----MIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLH 598
              C ++NE    + ++ E++   T+  ++  YA N  +L             R L Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 599 TGSTKAIIHRDVKSANILLDENLMA-KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE- 656
           +   K I HRD+K  N+L+D N    K+ DFG +K   +L     S +   S  Y  PE 
Sbjct: 188 S---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQRSVSYICSRFYRAPEL 241

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            L     T   D++S G ++ E++ G P+
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPI 270

Length = 440

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 31/99 (31%), Positives = 50/99 (50%), Gaps = 10/99 (10%)

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSF 650
           R L Y+HT +   + HRD+K  NIL + +   K+ DFGL+++   D       T    + 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 651 GYLDPE----YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            Y  PE    + +K   T   D++S G +  E+L G+P+
Sbjct: 171 WYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 57/268 (21%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
           D+F    VIG G FG+V R V + +T      K+  K    +  Q +A  R E ++L + 
Sbjct: 1   DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQ-VAHIRAERDILVEA 58

Query: 537 RHRHLVSLI-GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKR---LEICIGAAR 592
               +V +   + D+RN + +I E++  G +   L   +  +LS       +   + A  
Sbjct: 59  DGAWVVKMFYSFQDKRN-LYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAID 115

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL---------------------- 630
            +H L        IHRD+K  N+LLD     K++DFGL                      
Sbjct: 116 AIHQL------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 631 --------SKIGPDL---DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
                   SK   +    ++  ++ +  G+  Y+ PE   +    +  D +S GV+M+E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 680 LCGRPVIDPSLPREKVNLVEWAMKCQET 707
           L G P      P+E    V   M  +ET
Sbjct: 230 LIGYPPFCSETPQETYRKV---MNWKET 254

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 51.8 bits (124), Expect = 1e-06
 Identities = 44/149 (29%), Positives = 69/149 (46%), Gaps = 13/149 (8%)

Query: 491 IGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           I  G FGKVY G  ++ +K+     VK+    +   + + + E + L+  +   +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 547 YCDERNEMIIIYEYMENGTLKD--HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
                N + ++ EY+  G +K   H+Y   F      K +      A  L YLH      
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYIS---EVALALDYLHRHG--- 124

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKI 633
           IIHRD+K  N+L+      K+ DFGLSK+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 71/280 (25%), Positives = 117/280 (41%), Gaps = 58/280 (20%)

Query: 519 SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS- 577
           + + L   + E+ +   FRH ++++        + + +I  +M  G+  + L  + FP  
Sbjct: 39  TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLLKTYFPEG 97

Query: 578 LSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE----------NLMAKVAD 627
           +S      I  GA RGL+YLH       IHR++K+++IL+            +L + V +
Sbjct: 98  MSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN 154

Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL---TEKSDVYSFGVVMFEILCGR- 683
              +K+  D  Q   ST+V     +L PE L +Q L     KSD+YS G+   E+  GR 
Sbjct: 155 GQKAKVVYDFPQ--FSTSV---LPWLSPELL-RQDLYGYNVKSDIYSVGITACELATGRV 208

Query: 684 PVIDPSLPREKVNLV------------------EWAMKCQETGQ----LEDIVDPTLTGQ 721
           P  D  + R ++ L                   E  MK  ++G      E +V   +T  
Sbjct: 209 PFQD--MLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQT 266

Query: 722 IKPDSLNK---------FVEIAEKCLAQCGIDRPSMGDVL 752
           +  + L           F  + E CL Q    RPS   +L
Sbjct: 267 MTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87

Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 142

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGR 683
           +      E  D++S G +M E++ G 
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 34/224 (15%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQ------GLAEFRTEIEML 533
           D + +   IG G +GKVY+   RD+     VA+K+   +  +       L E  + ++ML
Sbjct: 1   DAYEKLEKIGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREI-SLLQML 57

Query: 534 SQFRHRHLVSLIG--YCDERNEMIIIY---EYMENGTLK--DHLYASNFPSLSWRKRLEI 586
           S+    ++V L+   + +E+N    +Y   EY+++   K  D         L  +     
Sbjct: 58  SE--SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA-KVADFGLSKIG--PDLDQTH-V 642
                +G+ + H      ++HRD+K  N+L+D+     K+AD GL +    P    TH +
Sbjct: 116 MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 643 STAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
            T       Y  PE L      +   D++S G +  E+   +P+
Sbjct: 173 VT-----LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.5 bits (118), Expect = 4e-06
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 25/204 (12%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +G V   +  R   KVA+K+     QS         E+ +L   +H +++ L+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 548 ------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
                  DE  +  ++  YM+    K   +      LS  K   +      GL Y+H+  
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSA- 136

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HVSTAVKGSFGYLDPEY-LT 659
              IIHRD+K  N+ ++E+   K+ DFGL++   D + T +V T       Y  PE  L 
Sbjct: 137 --GIIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTR-----WYRAPEVILN 188

Query: 660 KQQLTEKSDVYSFGVVMFEILCGR 683
                +  D++S G +M E+L G+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 58/268 (21%), Positives = 105/268 (39%), Gaps = 59/268 (22%)

Query: 485 FSESLVIGIGGFGKVYRGVLRDE-----TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR 539
           F +   +GIG FG+V      D       K   K+     +Q +A  + E ++L++  + 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-VAHVKAERDILAEADNE 61

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLH 598
            +V L     +++ +  + +Y+  G +   L     FP    R  +     A   +H + 
Sbjct: 62  WVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM- 120

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGL---------------------------- 630
                  IHRD+K  NIL+D +   K+ DFGL                            
Sbjct: 121 -----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175

Query: 631 -------SKIGPDLD----------QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFG 673
                   + G  L           Q  ++ ++ G+  Y+ PE L +   T+  D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235

Query: 674 VVMFEILCGRPVIDPSLPRE-KVNLVEW 700
           V+++E+L G+P      P E ++ ++ W
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 6e-06
 Identities = 90/409 (22%), Positives = 157/409 (38%), Gaps = 75/409 (18%)

Query: 10  LLLWLSSVLCLVSVSTAFDPVDNYL--IDCGSFTN--TSAGNRVFAADHTST---FTNLS 62
           L LWL +   L++V  +    + +   I CG+  N  T+  N ++  D   T     N +
Sbjct: 1   LRLWLLAASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTGGIPANAT 60

Query: 63  SPQNISINASLNSISSGNYSRLYHTARIF---TGPSN-YSFSIKKQARHFIRLHFFPFVH 118
            P  I+    L             T R F    GP N Y+ +   +  + +R+ FF  V 
Sbjct: 61  RPSFIA--PPLK------------TLRYFPLSDGPENCYNINRVPKGHYSVRV-FFGLVA 105

Query: 119 ETYNMSTAKFSVS---SQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFI 175
           E    S   F VS   +Q  +L   + S +     E  + +      + F    +    I
Sbjct: 106 EPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAI 165

Query: 176 NALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVL--- 232
            ++E++             +D +  + G    Q   L T  R++ G        D     
Sbjct: 166 LSIEILQ------------VDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDH 213

Query: 233 W---RRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSN 289
           W   R W     +   S+  +   N  I     S   N  P  +Y +A +V++ + P+  
Sbjct: 214 WGGDRFWNRMQTFGSGSDQAISTEN-VIKKA--SNAPNFYPESLYQSA-LVSTDTQPD-- 267

Query: 290 VNVTWNFDVDPGFEFLVRFHFCDIYFNNISSL---AFNVYINSRSAQLDFDLHKLPSYAA 346
             +++  DVDP   + V  HF +I  N+I++     F+V IN  +A  D D+ K+    +
Sbjct: 268 --LSYTMDVDPNRNYSVWLHFAEID-NSITAEGKRVFDVLINGDTAFKDVDIVKM----S 320

Query: 347 GNPYYMDFITRESDNPKLHVSIGRSTLVDTF-----PNAILNGLEIMKI 390
           G  Y    + +        V++   TL          +AI+N +E+ +I
Sbjct: 321 GERYTALVLNKT-------VAVSGRTLTIVLQPKKGTHAIINAIEVFEI 362

Length = 623

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 10/93 (10%)

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQT-HVSTAVKGSF 650
           G+ +LH+     IIHRD+K +NI++  +   K+ DFGL++  G     T +V T      
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182

Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
            Y  PE +      E  D++S G +M E++ G 
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 46.2 bits (110), Expect = 9e-06
 Identities = 28/148 (18%), Positives = 58/148 (39%), Gaps = 16/148 (10%)

Query: 491 IGIGGFGKVYRGVLRDET-KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS--LIGY 547
           +  G   +VY   L  +     +K   ++     A+   E+ +L     + L    ++  
Sbjct: 6   LKGGLTNRVYL--LGTKDEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLAS 61

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +      ++ E++E  TL +         +S  ++ +I    A  L  LH      + H
Sbjct: 62  GESDGWSYLLMEWIEGETLDE---------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGP 635
            D+   NIL+D+  +  + D+  +  GP
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 28/203 (13%)

Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  VL  +  VA+K+       Q+H   A +R E+ ++    H++++S
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIS 80

Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ ++ E M+    +      +   +S+     +C     G+ +L
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 135

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 136 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 189

Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           +      E  D++S G +M E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 23/183 (12%)

Query: 510 VAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYE 559
           VAVK+       Q+H   A +R E+ +L    H++++SL+         +E  ++ ++ E
Sbjct: 49  VAVKKLSRPFQNQTHAKRA-YR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106

Query: 560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE 619
            M+    +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  
Sbjct: 107 LMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKS 158

Query: 620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
           +   K+ DFGL++         + T    +  Y  PE +      E  D++S G +M E+
Sbjct: 159 DCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215

Query: 680 LCG 682
           + G
Sbjct: 216 VKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 51/249 (20%), Positives = 98/249 (39%), Gaps = 44/249 (17%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    VIG G FG+V     +D   V     +++      + +   R E ++L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYL 597
             +V +     ++  + +I E++  G +   L   +       +  +   + A   +H L
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGL---------SKIGPDLDQT-------- 640
                   IHRD+K  N+LLD     K++DFGL         ++   +L+ +        
Sbjct: 121 ------GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 641 ----------------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                            ++ +  G+  Y+ PE   +    +  D +S GV+M+E+L G P
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 685 VIDPSLPRE 693
                 P+E
Sbjct: 235 PFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 3e-05
 Identities = 54/233 (23%), Positives = 104/233 (44%), Gaps = 53/233 (22%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQ--------SHQGLAE-----FRTEIEMLSQFR 537
           IG G FG+V+           VK   TQ        S++GL E        E+ ++ + +
Sbjct: 21  IGNGRFGEVF----------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70

Query: 538 HRHLVSLIG-YCDERNE-MIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARG 593
           H+++V  I  + ++ N+ + I+ E+ + G L  ++      F  +     ++I       
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130

Query: 594 LHYLHT----GSTKAIIHRDVKSANILLDENL-----------------MAKVADFGLSK 632
           L Y H      + + ++HRD+K  NI L   +                 +AK+ DFGLSK
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190

Query: 633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT--EKSDVYSFGVVMFEILCGR 683
              ++    ++ +  G+  Y  PE L  +  +  +KSD+++ G +++E+  G+
Sbjct: 191 ---NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 36/147 (24%), Positives = 62/147 (42%), Gaps = 16/147 (10%)

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG--AARGLHYL 597
           ++V L  Y    + + ++ ++ E G L  H+         +    E C+   AA  +  L
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-------SKFLNIPEECVKRWAAEMVVAL 98

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFG-LSKIGPDLDQTHVSTAVKGSFGYLDPE 656
                + I+ RD+   NILLD+    ++  F   S++    D   V         Y  PE
Sbjct: 99  DALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPE 152

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
                + TE  D +S G ++FE+L G+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.6 bits (108), Expect = 8e-05
 Identities = 32/137 (23%), Positives = 58/137 (42%), Gaps = 42/137 (30%)

Query: 606 IHRDVKSANILLDENLMAKVADFGL------------------------------SKIGP 635
           IHRD+K  NIL+D +   K+ DFGL                              S+I  
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 636 D----LDQTHV-------STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR- 683
                L++          + ++ G+  Y+ PE L +   T+  D +S GV+++E+L G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 684 PVIDPSLPREKVNLVEW 700
           P +  +    ++ ++ W
Sbjct: 243 PFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 34/140 (24%), Positives = 52/140 (37%), Gaps = 21/140 (15%)

Query: 564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA 623
            +L D L     P L+  +   +C+     L  LH         R  KS NILL  + + 
Sbjct: 1   VSLADILEVRGRP-LNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWDGLL 50

Query: 624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
           K+      K            A         PE +  Q  TEK+D+YS G+ ++E L   
Sbjct: 51  KLDGSVAFKTPEQSRPDPYFMA---------PEVIQGQSYTEKADIYSLGITLYEALDYE 101

Query: 684 PVIDPSLPREKVNLVEWAMK 703
                +  RE   ++E  + 
Sbjct: 102 L--PYNEERELSAILEILLN 119

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 27/208 (12%)

Query: 491 IGIGGFGKVYRGVLRD-------------ETKVAVKRGGTQSHQ--GLAEFRTEIEMLSQ 535
           +G G   ++Y G+L               E KV +K     SH+   LA F T   M+ Q
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP-SHRDISLAFFETA-SMMRQ 60

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRLEICIGAARGL 594
             H+H+V L G C    E I++ E++E G L   ++  +   +  W  + ++    A  L
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASAL 118

Query: 595 HYLHTGSTKAIIHRDVKSANILL-DENLMAKVADF-GLSKIGPDLDQTHVSTAVKGSFGY 652
            YL     K ++H +V + NILL  E +  +   F  LS  G  +        V+    +
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-RIPW 174

Query: 653 LDPEYLT-KQQLTEKSDVYSFGVVMFEI 679
           + PE +   + L+  +D +SFG  ++EI
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 7/85 (8%)

Query: 596 YLHTGSTKAIIHRDVKSANILLD--ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           Y+H    + IIHRD+K+ N+L++  E++   + DFG +        T     + G+    
Sbjct: 275 YIHG---EGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFE 678
            PE L     T   D++S G+V+FE
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 41.7 bits (98), Expect = 0.002
 Identities = 41/166 (24%), Positives = 60/166 (36%), Gaps = 36/166 (21%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHRHL 541
           D+F     +G G FG VY+  L        K+ G    +   E+   EI M  + R    
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASL---VNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACP 188

Query: 542 VSLIGYC---------DERNEMIIIYEYMENGTLKDHLYASNFP----SLSWRKRLEICI 588
            S   +           + +E  +++ Y    TL D + +  FP         K  ++  
Sbjct: 189 NSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248

Query: 589 GAAR--------------GLHYLH-TGSTKAIIHRDVKSANILLDE 619
           G  R               L  LH TG    I+HRDVK  NI+  E
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSE 290

Length = 566

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 18/90 (20%)

Query: 552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC--IGAARGLHYLHTGSTKAIIHRD 609
              II+ EY+E   LKD + ++        + LE+   IG   G   LH+     IIH D
Sbjct: 72  ENFIIVMEYIEGEPLKDLINSNG------MEELELSREIGRLVGK--LHSAG---IIHGD 120

Query: 610 VKSANILLDENLMAKV--ADFGLSKIGPDL 637
           + ++N++L      K+   DFGL++   DL
Sbjct: 121 LTTSNMILSGG---KIYLIDFGLAEFSKDL 147

Length = 211

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 24/214 (11%)

Query: 519 SHQ--GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL-----KDHLY 571
           SH+   LA F T   ++SQ  H HL  + G C   +E I++ E++E+G L     K+   
Sbjct: 55  SHRDIALAFFETA-SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR 113

Query: 572 ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS 631
                 ++W  ++ +    A  L YL     K ++H +V + NILL    +A+     + 
Sbjct: 114 V----PVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIK 164

Query: 632 KIGPDLDQTHVSTAVK-GSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILC--GRPVID 687
              P +  T +S   +     ++ PE +     L+  +D +SFG  + EI C  G   + 
Sbjct: 165 LSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-CFDGEVPLK 223

Query: 688 PSLPREKVNLVEWAMKCQETG--QLEDIVDPTLT 719
              P EK    E   +  E    +L  ++   LT
Sbjct: 224 ERTPSEKERFYEKKHRLPEPSCKELATLISQCLT 257

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	820
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	100.0
PLN03150	623	hypothetical protein; Provisional	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.98
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.76
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.73
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.73
PRK10345	210	hypothetical protein; Provisional	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
smart00090	237	RIO RIO-like kinase.	99.65
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.64
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.63
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.56
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.47
PF11721	174	Malectin: Di-glucose binding within endoplasmic re	99.47
PLN03150	623	hypothetical protein; Provisional	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.16
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.14
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.13
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.09
KOG1243	690	consensus Protein kinase [General function predict	99.03
KOG3087	229	consensus Serine/threonine protein kinase [General	98.98
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.98
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.94
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.94
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	98.92
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.78
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.73
KOG3593	355	consensus Predicted receptor-like serine/threonine	98.71
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.68
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.67
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.52
COG4248	637	Uncharacterized protein with protein kinase and he	98.47
PRK09902	216	hypothetical protein; Provisional	98.43
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.41
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.39
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.33
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.25
PF01636	239	APH: Phosphotransferase enzyme family This family	98.09
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.99
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.96
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.96
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.95
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.88
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.88
PLN02876	822	acyl-CoA dehydrogenase	97.88
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.77
PRK10593	297	hypothetical protein; Provisional	97.63
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.59
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.46
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.41
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.4
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.29
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.26
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.05
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.02
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.96
PRK05231	319	homoserine kinase; Provisional	96.93
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.73
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.69
PLN02236	344	choline kinase	96.59
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.59
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.36
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.18
PLN02756	418	S-methyl-5-thioribose kinase	95.98
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.79
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.37
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.37
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.97
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.58
COG2334	331	Putative homoserine kinase type II (protein kinase	94.51
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.4
PRK12396	409	5-methylribose kinase; Reviewed	94.37
KOG1093	725	consensus Predicted protein kinase (contains TBC a	94.22
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.09

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=100.00  E-value=5.2e-59  Score=508.81  Aligned_cols=324  Identities=33%  Similarity=0.499  Sum_probs=249.9

Q ss_pred             EecCCCcccC-----CCCceeecCCCCcccccCCCCccccccccccCCCCCCccccceeeeec--cCceeeEecc--cCc
Q 003436           35 IDCGSFTNTS-----AGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFT--GPSNYSFSIK--KQA  105 (820)
Q Consensus        35 i~cG~~~~~~-----~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~t~R~f~--~~~~y~~~~~--~~~  105 (820)
                      ||||++.+..     .+||+|++|.++..++.+  ..+   ++.....++..+++|+|||+|+  .++||+||+.  +|+
T Consensus         1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~--~~i---~~~~~~~~~~~~~~y~taR~F~~g~r~cY~l~~~~~~~~   75 (347)
T PF12819_consen    1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKS--GNI---SSQPDSSSSDSSPPYQTARIFPEGSRNCYTLPVTPPGGG   75 (347)
T ss_pred             CcCCCCCCCcccccCCCCcEEeCCCCcccCCCc--ccc---ccccCCcCCccccccceEEEcCCCCccEEEeeccCCCCc
Confidence            8999776644     359999999987665443  222   1112223456688999999997  7899999998  466


Q ss_pred             eEEEEEEecCCCCCCCC----cccceEEEEeCc-EEEEeecccc-CCceEEEEEEecc-CCcEEEEEeeCCCcc-ceeee
Q 003436          106 RHFIRLHFFPFVHETYN----MSTAKFSVSSQS-FTLIKDYQSQ-EGSSVKEYSLNIA-SDRLVLSFTPFANSF-AFINA  177 (820)
Q Consensus       106 ~~~~R~~f~~~~~~~~~----~~~~~f~v~~~~-~~~~~~~~~~-~~~~~~e~~~~~~-~~~~~v~~~~~~~~~-~fi~~  177 (820)
                      ||||||||+|++|++.+    .+.+.||+++++ +|...+.... ..++++||++.+. ++.+.|||+|++.+. ||||+
T Consensus        76 ~yliRl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsa  155 (347)
T PF12819_consen   76 KYLIRLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISA  155 (347)
T ss_pred             eEEEEEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeE
Confidence            99999999999999764    235679999954 5555555441 2569999999999 699999999999776 99999


Q ss_pred             eEEEEcCCccccccccccCCCCCCCCCcchhhhheeeeEEeecCCcc--cCCCCCcccccccc--CccccccCCcceeec
Q 003436          178 LEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKD--VPPQNDVLWRRWVS--DDAYLKHSNLVMFVS  253 (820)
Q Consensus       178 ~e~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~--~~d~~dr~wr~w~~--d~~~~~~~~~~~~~~  253 (820)
                      |||||||+++|++...             ..+++|++++|+||||..  ++.++|.+||.|.+  +.+-|...++...+.
T Consensus       156 iEl~~lp~~ly~~~~~-------------~~s~~L~~~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~  222 (347)
T PF12819_consen  156 IELRPLPDSLYPDTDA-------------NSSQALETVYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNIN  222 (347)
T ss_pred             EEEEECCccceecccc-------------CCCceeEEEEeecCCCcccccCCCCCcceeeccccccCccccccccceeee
Confidence            9999999999964211             237899999999999998  88888888888874  234455544432221


Q ss_pred             CceeeeecCCcccccCchhhhhhhhccCCCCCCCCcceeEEEeecCCCCeeEEEEeecceee--cccccEEEEEEEcccc
Q 003436          254 NTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYF--NNISSLAFNVYINSRS  331 (820)
Q Consensus       254 ~~~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~~tw~~~~~~~~~y~v~lhFaEi~~--~~~~~R~FdI~in~~~  331 (820)
                            .....+.+.||..|||||+++..   .+.+++|+|.+ ++++..|+||||||||+.  +..++|+|||||||+.
T Consensus       223 ------~~~~~~~~~~P~~V~~TA~~~~~---~s~~~nltw~~-~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~  292 (347)
T PF12819_consen  223 ------INSSNNPYDAPSAVYQTARTPSN---SSDPLNLTWSF-VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQT  292 (347)
T ss_pred             ------cccCCccCcChHHHHHhhhcccc---cccceEEEecc-CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeE
Confidence                  12234445699999999996644   33459999999 999999999999999997  4556899999999999


Q ss_pred             ccCccCccccccccCCCceeeeeeeecCCCCceeEEEcccccccCCcccccccceeeec
Q 003436          332 AQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKI  390 (820)
Q Consensus       332 ~~~~~di~~~~~~~~~~~~y~~~~v~~~~~~~~~vsl~~s~~~~~~~~~ilNg~EI~~i  390 (820)
                      +.++++...  .+..+.++|.+|++.....+.+.+++++...+..  ||||||+|||+|
T Consensus       293 ~~~~~~~~~--~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~l--ppiLNalEIy~v  347 (347)
T PF12819_consen  293 AYSDVSPPY--LGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTL--PPILNALEIYKV  347 (347)
T ss_pred             ccCccCccc--ccCcceEeecceEEEecCCCEEEEEEEeCCCCCc--CceeEeeeeEeC
Confidence            997554422  3344567899999999887788899998777643  999999999986

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-57  Score=535.50  Aligned_cols=331  Identities=21%  Similarity=0.274  Sum_probs=261.2

Q ss_pred             ccccCCCccEEEecCCCcccC--CCCceeecCCCCcccccCCCCccccccccccCCCCCCccccceeeeecc----Ccee
Q 003436           24 STAFDPVDNYLIDCGSFTNTS--AGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFTG----PSNY   97 (820)
Q Consensus        24 ~~~~~~~~~~~i~cG~~~~~~--~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~t~R~f~~----~~~y   97 (820)
                      +.+....|+|+||||++.+.+  .+||+|++|..+..       +......    .+...+++|+|||+|+.    ++||
T Consensus        17 ~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~-------~~~~~~~----~~~~~~~~~~t~R~F~~~~g~~~cY   85 (623)
T PLN03150         17 SLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTG-------GIPANAT----RPSFIAPPLKTLRYFPLSDGPENCY   85 (623)
T ss_pred             ccccCCCccEEEeCCCCCCcccCCCCCEEcCCccccc-------Ccccccc----CcccccchhhccccCCcccccccce
Confidence            334448899999999887764  68999999955432       1111100    12234678999999975    8899


Q ss_pred             eEecccCceEEEEEEecCCCCCCCCcccceEEEEeCc---EEEEeeccccCCceEEEEEEeccCCcEEEEEeeCCCccce
Q 003436           98 SFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQS---FTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAF  174 (820)
Q Consensus        98 ~~~~~~~~~~~~R~~f~~~~~~~~~~~~~~f~v~~~~---~~~~~~~~~~~~~~~~e~~~~~~~~~~~v~~~~~~~~~~f  174 (820)
                      +||++++|+||||+||+|++|++++ ..+.|||+++|   ++++.+|+..+..+++|++++++++.+.|||+|+++++||
T Consensus        86 ~~~~~~~g~ylVRl~F~~~~y~~~~-~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pF  164 (623)
T PLN03150         86 NINRVPKGHYSVRVFFGLVAEPNFD-SEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPA  164 (623)
T ss_pred             EeeecCCCcEEEEEEeecCCcCCCC-CCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCc
Confidence            9999999999999999999999999 67899999999   7888888777778999999999999999999999999999


Q ss_pred             eeeeEEEEcCCccccccccccCCCCCCCCCcchhhhheeeeEEeecCCcccC----CCCCcc--ccccccCccccccCCc
Q 003436          175 INALEVISLPDELIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVP----PQNDVL--WRRWVSDDAYLKHSNL  248 (820)
Q Consensus       175 i~~~e~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~l~~~~R~n~Gg~~~~----d~~dr~--wr~w~~d~~~~~~~~~  248 (820)
                      ||+|||||+|+++|......    +        .+++|+++||+||||++++    -++|.+  ||.|.+|.+|......
T Consensus       165 Is~iEv~~l~~~~y~~~~~~----~--------~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~  232 (623)
T PLN03150        165 ILSIEILQVDDKAYNFGPSW----G--------QGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQ  232 (623)
T ss_pred             eeEEEEEEcCcccccccccc----c--------CceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCCCccc
Confidence            99999999999999532111    0        1567999999999998764    233443  6888888887643211


Q ss_pred             ceeecCceeeeecCCcccccCchhhhhhhhccCCCCCCCCcceeEEEeecCCCCeeEEEEeecceee--cccccEEEEEE
Q 003436          249 VMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYF--NNISSLAFNVY  326 (820)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~~tw~~~~~~~~~y~v~lhFaEi~~--~~~~~R~FdI~  326 (820)
                      .  ......+++. +.+++.+|+.||||||.+...     ..+++|.++++++++|+||||||||+.  ...++|+||||
T Consensus       233 ~--~st~~~I~~~-~~~~~~~P~~VyqTA~~~~~~-----~~~lty~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~  304 (623)
T PLN03150        233 A--ISTENVIKKA-SNAPNFYPESLYQSALVSTDT-----QPDLSYTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVL  304 (623)
T ss_pred             c--cccccccccc-cCCCccChHHHhhhhccccCC-----CCceEEEeecCCCCCEEEEEEEEeccCccCCCceEEEEEE
Confidence            1  1222234444 346668999999999966431     147899999999999999999999974  46689999999


Q ss_pred             EccccccCccCccccccccCCCceeeeeeeecCCCCceeEEEcccccccCCcccccccceeeeccC
Q 003436          327 INSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINN  392 (820)
Q Consensus       327 in~~~~~~~~di~~~~~~~~~~~~y~~~~v~~~~~~~~~vsl~~s~~~~~~~~~ilNg~EI~~i~~  392 (820)
                      |||+.+.+++|+..+ +++...+++.+|.+.+.+ +.+.+++.+...+    +||+||+||+++..
T Consensus       305 ing~~~~~~~di~~~-~g~~~~~~~~~~~v~~~~-g~l~isl~p~~~s----~pilNaiEI~~~~~  364 (623)
T PLN03150        305 INGDTAFKDVDIVKM-SGERYTALVLNKTVAVSG-RTLTIVLQPKKGT----HAIINAIEVFEIIT  364 (623)
T ss_pred             ECCEEeecccChhhh-cCCcccceEEEeEEeecC-CeEEEEEeeCCCC----cceeeeeeeeeccc
Confidence            999999999999877 555567999999988775 7788999886532    69999999999975

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-56  Score=491.36  Aligned_cols=292  Identities=52%  Similarity=0.860  Sum_probs=260.0

Q ss_pred             CCCCCCHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEe
Q 003436          469 IGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC  548 (820)
Q Consensus       469 ~~~~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~  548 (820)
                      ....|++.+++.||++|...++||+|+||.||+|.+.++..||||++.....+..++|.+|+++|.+++|||||+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34679999999999999999999999999999999999999999987765543146699999999999999999999999


Q ss_pred             ecCc-eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          549 DERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       549 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                      .+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 599999999999999999986544889999999999999999999999888999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      ||+|+..+.. .....+...||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....+++|++...+.
T Consensus       221 FGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            9999865542 222222118999999999999999999999999999999999999999876666666799999999999


Q ss_pred             CccccccCcccc-CCCCh-hhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          708 GQLEDIVDPTLT-GQIKP-DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       708 ~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      +.+.+++||++. ..+.. ++..++.+++.+|++.+|++||+|.||++.|+.+...
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            999999999998 55554 6888999999999999999999999999999655443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=399.30  Aligned_cols=256  Identities=35%  Similarity=0.535  Sum_probs=214.2

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCCCCChh--hHHHHHHHHHHHHcCCCCceeeEEeEeecCc-eEEEEEeeccC
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ--GLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-EMIIIYEYMEN  563 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~  563 (820)
                      ..+.||+|+||+||+|.+++...||||++......  ..++|.+|+.+|.+++|||||+++|.|.+.. .+++|+|||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            33469999999999999987666999987754422  2569999999999999999999999999887 79999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc-EEeccCCCCcEEEcCCC-CeeEeeccccccCCCCCCcc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA-IIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~-iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~~~~~~~  641 (820)
                      |+|.++|+......+++..+++|+.+||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++......  .
T Consensus       125 GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~  199 (362)
T KOG0192|consen  125 GSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T  199 (362)
T ss_pred             CcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence            99999998865678999999999999999999999   566 99999999999999997 99999999998644321  2


Q ss_pred             ccccccCCccccCccccc--cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          642 VSTAVKGSFGYLDPEYLT--KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      ..+...||..|||||++.  ...++.|+||||||++||||+||+.||....+.   .....+..            ...+
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~------------~~~R  264 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVV------------GGLR  264 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHh------------cCCC
Confidence            334478999999999999  569999999999999999999999999865441   12221111            1112


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      ..++..++..+..++.+||+.||.+||++.+++..|+.+....
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            2334457788999999999999999999999999999887643

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=390.45  Aligned_cols=253  Identities=32%  Similarity=0.483  Sum_probs=215.5

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ..+.||+|.||.||.|.+++...||+|.+.... ...+.|.+|+++|.+|+|+|||+++|+|..++.++||+|||++|+|
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            345899999999999999988899999876653 3347899999999999999999999999998899999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccc
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV  646 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (820)
                      .++|.......+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+||||||...+ +........
T Consensus       289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~~~~~  364 (468)
T KOG0197|consen  289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTASEGG  364 (468)
T ss_pred             HHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCC-CceeecCCC
Confidence            99999877778999999999999999999999   89999999999999999999999999999995443 333344455


Q ss_pred             cCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChh
Q 003436          647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD  725 (820)
Q Consensus       647 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  725 (820)
                      .-+..|.|||.+....++.|||||||||+||||+| |+.|+......+....++       .|         .+-..++.
T Consensus       365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-------~G---------yRlp~P~~  428 (468)
T KOG0197|consen  365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-------RG---------YRLPRPEG  428 (468)
T ss_pred             CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------cc---------CcCCCCCC
Confidence            66789999999999999999999999999999999 777766544333322221       11         11133567


Q ss_pred             hHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       726 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      |+..+.+|+..||+.+|++|||+..+...|+....
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            89999999999999999999999999998887754

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=368.62  Aligned_cols=249  Identities=27%  Similarity=0.383  Sum_probs=209.0

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc-eEEEEEeec
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-EMIIIYEYM  561 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~  561 (820)
                      ++..+.||+|..|+|||++++ .++.+|+|.+... +....+++.+|++++++.+||+||.++|.|...+ +..++||||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM  160 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM  160 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence            445568999999999999998 4678899987433 4556788999999999999999999999999888 599999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|||++.+...  .++++...-+|+.++++||.|||+  .++||||||||+|||++..|++||||||.++...+.    
T Consensus       161 DgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  161 DGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             CCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            999999998765  469999999999999999999995  589999999999999999999999999999865432    


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCC--chhhhhHHHHHHHhhccCccccccCcccc
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSL--PREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      ......||..|||||.+.+..|+.++||||||+.++|+.+|+-|+.+..  ......+..++            ++.. .
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I------------v~~p-p  299 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI------------VDEP-P  299 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH------------hcCC-C
Confidence            4456789999999999999999999999999999999999999887641  12233333332            1211 1


Q ss_pred             CCCCh-hhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKP-DSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~-~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...+. .+..+++.++..||++||.+||++.|++++
T Consensus       300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            12233 367889999999999999999999999876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-43  Score=402.67  Aligned_cols=259  Identities=31%  Similarity=0.491  Sum_probs=221.9

Q ss_pred             CCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      +....+.||+|+||+||+|+..+      .+.||||.++..... ..++|++|+++|..++|||||+|+|.|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            44556689999999999999543      467999998766554 78999999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCee
Q 003436          557 IYEYMENGTLKDHLYASN------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAK  624 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~k  624 (820)
                      |+|||..|+|.++|....            ..+|+..+.+.||.|||.||+||-   ++.+|||||..+|+|+.++..+|
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEE
Confidence            999999999999997432            234889999999999999999998   78999999999999999999999


Q ss_pred             EeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHH
Q 003436          625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      |+||||+|.....++........-.++|||||.+..+++|.+||||||||+|||+++ |+.|+......+.++       
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe-------  716 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE-------  716 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH-------
Confidence            999999997766666555545566789999999999999999999999999999999 788887665544332       


Q ss_pred             hhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      +++.+++.         ..++.|+.++.+|+..||+.+|++||++.||-..|+...+.
T Consensus       717 ~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 CIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            23333332         45678999999999999999999999999999999877553

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-42  Score=357.42  Aligned_cols=205  Identities=29%  Similarity=0.519  Sum_probs=183.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  ..+..+-...|+++|++++|||||.+++++..++.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            356778888999999999999987 4789999987766  5666677889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC------CCeeEeeccccc
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN------LMAKVADFGLSK  632 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~------~~~kl~DFGla~  632 (820)
                      |||.+|+|.++|+..+  .+++.....+..|+|.||++||   +++||||||||.||||+..      -.+||+|||+||
T Consensus        89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999998765  6899999999999999999999   8999999999999999764      568999999999


Q ss_pred             cCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                      ....   .......+|++-|||||+++.++|+.|+|+||.|++|||+++|++||+.....+-
T Consensus       164 ~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  164 FLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             hCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            7653   3445578999999999999999999999999999999999999999987765543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-41  Score=368.17  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=211.6

Q ss_pred             cCCccceeEeeecceEEEEEEE-cCccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ..|...++||+|||..||+++. ..|..||+|.+...   .....+...+||++.++|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4588889999999999999998 77999999986542   3344567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      |+|++++|..++.+  ...+++.++..+..||+.||.|||   +++|+|||||..|+||+++.++||+|||||.......
T Consensus        98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            99999999998873  458999999999999999999999   7999999999999999999999999999998765432


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        ......+||+.|.|||++.....+..+||||+||+||-||.|+|||+...-++..+.+.       ..   +-     
T Consensus       173 --Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------~~---~Y-----  235 (592)
T KOG0575|consen  173 --ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------LN---EY-----  235 (592)
T ss_pred             --cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-------hc---Cc-----
Confidence              33456899999999999999999999999999999999999999998654333322111       11   11     


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                        ..+.....+..+|+.++|+.+|.+||++.+|+.+=
T Consensus       236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence              12224446788999999999999999999998753

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=376.71  Aligned_cols=259  Identities=27%  Similarity=0.439  Sum_probs=218.3

Q ss_pred             ccceeEeeecceEEEEEEEcC----ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          486 SESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .+.++||.|.||.|++|+++-    ...||||.++... .+...+|+.|+.+|.+.+||||++|.|+.......++|.||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            467799999999999999863    3579999887654 45578899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      |+||+|+.+|..+. .++++.++..+..+||.||.||-   +.++|||||.++|||++.+...|++||||+|...+....
T Consensus       712 MENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  712 MENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            99999999998776 45999999999999999999999   899999999999999999999999999999977654322


Q ss_pred             -cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          641 -HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       641 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                       ......+-..+|.|||.+..+++|.++||||||++|||.++ |.+|+......+..+.++                ...
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe----------------~gy  851 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE----------------QGY  851 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH----------------hcc
Confidence             22223344679999999999999999999999999999988 777776554443332221                112


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                      +-..+.+|+..|.+|++.||++|-.+||.+.+++..|.+++..+..
T Consensus       852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            2234668999999999999999999999999999999998765443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-42  Score=340.20  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=208.1

Q ss_pred             CCccceeEeeecceEEEEEEE-cCccEEEEEeCC--CCChhhHHHHHHHHHHHHcCCCCceeeEEeE-eecCce-EEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGG--TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY-CDERNE-MIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~--~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~-~~~~~~-~~lV~  558 (820)
                      +|.+.++||+|.||+|||+.. .+|..+|.|.+.  ..+.+..+....|+.+|++|+|||||+++++ +.++.+ ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            477888999999999999985 478899999865  3345667789999999999999999999994 555555 89999


Q ss_pred             eeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      ||+..|+|...+..  ++.+.++++.++++..|++.||..+|+.... -|+||||||.||+|+.+|.+||+||||++...
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999999964  4557799999999999999999999953222 39999999999999999999999999999876


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..  .......+||+.||+||.+.+..|+.||||||+||+++||+.-++||...      ++.+. ...++.+....+. 
T Consensus       180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L-~~KI~qgd~~~~p-  249 (375)
T KOG0591|consen  180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL-CKKIEQGDYPPLP-  249 (375)
T ss_pred             ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH-HHHHHcCCCCCCc-
Confidence            42  33455688999999999999999999999999999999999999999865      22221 1222333222111 


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                             ..-....+.+|+..|+..||+.||+...++..+..
T Consensus       250 -------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  250 -------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                   13446788999999999999999996555555443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-41  Score=348.26  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=201.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-------hhHHHHHHHHHHHHcCCCCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-------QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  553 (820)
                      .+.|...+.||+|+||.|-+|..+ .|+.||||.+.....       .......+|+++|++|+|||||++++++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            345677789999999999999865 689999997653321       112335699999999999999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC---CCeeEeeccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN---LMAKVADFGL  630 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~---~~~kl~DFGl  630 (820)
                      .|+|+|||+||.|.+.+..+.  .+.+.....++.|++.|+.|||   +.||+||||||+||||..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999997765  4666667889999999999999   8999999999999999655   8999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCC---CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL---TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      |+...   ....+...+||+.|.|||++.+...   ..+.|+||+||+||-+++|.+||.......  .+.+.    +..
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQ----I~~  396 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQ----ILK  396 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHH----Hhc
Confidence            99754   3456678999999999999976543   347899999999999999999996543322  11111    112


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      |+...  -|    .......++..+++.+||..||++||++.|++++
T Consensus       397 G~y~f--~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  397 GRYAF--GP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             Ccccc--cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            22111  11    1122445778999999999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=343.65  Aligned_cols=255  Identities=28%  Similarity=0.404  Sum_probs=205.8

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc--eEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN--EMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E~  560 (820)
                      ++...+.||+|+||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+++|......  .+++.|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            45666799999999999999765 8899999876654334677899999999999999999999754444  68999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeeccccccCCC-CC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKIGPD-LD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~~~~-~~  638 (820)
                      +++|+|.+++.+.+. .|++..+.....|+++||+|||   +++|+||||||+|||++. ++.+||+|||+++.... ..
T Consensus        98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999999988776 7999999999999999999999   899999999999999999 79999999999986543 11


Q ss_pred             CccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .........||+.|||||++..+ ....++|||||||+++||+||++||...     ....++..........       
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-------  241 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-------  241 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-------
Confidence            22223457899999999999853 3445999999999999999999999742     1111222111111111       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                        ..++...+.+..+++.+|+..+|++|||+.+++++.-
T Consensus       242 --P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  242 --PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             --CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence              1344556678899999999999999999999998753

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=346.14  Aligned_cols=263  Identities=27%  Similarity=0.389  Sum_probs=219.0

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhh-HHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      .....++||+|-||.|.+...+++.+||||.++...... .++|.+|+++|.+|+||||+.|+|.|..++.+++|+|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            445677999999999999999989999999998776544 5899999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.++|..+..+.+.-....+||.|||.||+||.   +..+|||||.++|+|++.++++||+|||++|-....+..+.
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            999999999887666667778899999999999999   79999999999999999999999999999997666555555


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc--CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC--GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .....-+++|||+|.+..++++.++|||+||+.|||+++  ...|+.....++.   ++....+...+....      ..
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~------~l  766 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQV------VL  766 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcce------ec
Confidence            556667899999999999999999999999999999865  5677754433222   222222222211111      11


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      .-+.-|+..+.+++.+||..+-++||+++++...|++.
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            23457888999999999999999999999999888653

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-39  Score=355.62  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC-c
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER-N  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~  552 (820)
                      .++|...++||+|+||.||+|.+.      .+..||||++.... ....+.+.+|+++|.++ +||||++++++|... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            456888899999999999999742      24679999876433 33456789999999999 899999999988664 4


Q ss_pred             eEEEEEeeccCCchhhHhhhcC----------------------------------------------------------
Q 003436          553 EMIIIYEYMENGTLKDHLYASN----------------------------------------------------------  574 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  574 (820)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6889999999999999986532                                                          


Q ss_pred             --CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccc
Q 003436          575 --FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY  652 (820)
Q Consensus       575 --~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  652 (820)
                        ...+++.+++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134888899999999999999999   789999999999999999999999999999854332221122234467889


Q ss_pred             cCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHH
Q 003436          653 LDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFV  731 (820)
Q Consensus       653 ~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  731 (820)
                      +|||++.+..++.++|||||||+||||++ |+.||......+.  ..   .. ...+..     .    ..+..++..+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~---~~-~~~~~~-----~----~~~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC---QR-LKDGTR-----M----RAPENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH---HH-HhcCCC-----C----CCCCCCCHHHH
Confidence            99999999999999999999999999997 9999865432221  11   11 111111     0    11234456789


Q ss_pred             HHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          732 EIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       732 ~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      +++.+||+.+|.+||++.|+++.|+.+++
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=337.67  Aligned_cols=242  Identities=27%  Similarity=0.384  Sum_probs=201.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|+..++||+|+||+||.++.++ ++.+|+|.++..   .....+...+|..+|.+++||.||+++-.+++.+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4679999999999999999999765 778899976543   344567788999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+.||.|..+|.+.+  .+++..+.-.+..|+.||.|||   +++||||||||+|||||++|+++|+||||++..-. 
T Consensus       104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-  177 (357)
T ss_pred             EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence            99999999999997654  6888888888889999999999   89999999999999999999999999999995433 


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                       ........+||+.|||||++.+..++..+|.||+|+++|||++|.+||......+.      .....+ +++       
T Consensus       178 -~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~------~~~I~~-~k~-------  242 (357)
T KOG0598|consen  178 -DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM------YDKILK-GKL-------  242 (357)
T ss_pred             -CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH------HHHHhc-CcC-------
Confidence             22334458999999999999999999999999999999999999999986543322      222111 110       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCC
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRP  746 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  746 (820)
                        ...+.-...+..+++.+.+..+|++|-
T Consensus       243 --~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 --PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              011222446788999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.2e-40  Score=328.22  Aligned_cols=265  Identities=23%  Similarity=0.344  Sum_probs=209.0

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      +.|+...++|+|+||.|||.+.++ |+.||||++....  ..-.+-.++|+++|++++|+|+|.|+..|..+..++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            457778899999999999999875 8999999865433  3345567899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ||+.--|++ |... ...++.....+++.|++.|+.|+|   ++++|||||||+|||++.++.+||||||+||.....  
T Consensus        82 ~~dhTvL~e-Le~~-p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--  154 (396)
T KOG0593|consen   82 YCDHTVLHE-LERY-PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--  154 (396)
T ss_pred             ecchHHHHH-HHhc-cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--
Confidence            998754444 4333 235888999999999999999999   789999999999999999999999999999976542  


Q ss_pred             ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH---------HhhccC-
Q 003436          640 THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM---------KCQETG-  708 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~---------~~~~~~-  708 (820)
                      ....+..+.|..|.|||++.+ .+|....||||.||++.||++|.+.|-...+-++...+.-..         -+...+ 
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            233455678999999999987 689999999999999999999999987776666554443211         111111 


Q ss_pred             ----ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 ----QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          .+.+.-++.......+....-+++++..|++.||.+|++-++++.+
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                1222222222222223445578899999999999999999998754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=380.30  Aligned_cols=260  Identities=33%  Similarity=0.483  Sum_probs=217.1

Q ss_pred             CCccceeEeeecceEEEEEEEcC--c----cEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD--E----TKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~--~----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      +.+....||+|.||.||.|...+  +    ..||||.+... +.+...+|.+|..+|++++||||++++|.|.+....++
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i  772 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI  772 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence            44556689999999999999764  3    34899987654 46678899999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC-----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          557 IYEYMENGTLKDHLYASN-----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      ++|||++|+|..+|.+.+     ...|+..+.+.++.|||+|+.||+   ++++|||||.++|+||++...+||+|||+|
T Consensus       773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999998763     356899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      |.....+........+-..+|||||.+..+.++.|+|||||||+|||++| |..|+......+...      ...+.+++
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ggRL  923 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGGRL  923 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCCcc
Confidence            95554444433333455679999999999999999999999999999999 677776544333221      11223322


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                                ..+..|+..+.+|+..||+.+|++||++..+++.++.+.+..
T Consensus       924 ----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  924 ----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             ----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence                      345688899999999999999999999999999998887643

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=356.44  Aligned_cols=254  Identities=29%  Similarity=0.456  Sum_probs=210.2

Q ss_pred             eeEeeecceEEEEEEEcCc----cE-EEEEeCCC---CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          489 LVIGIGGFGKVYRGVLRDE----TK-VAVKRGGT---QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~----~~-vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++||+|+||.||+|++...    .. ||||....   .....+++|.+|+++|++++|||||+++|++..+..+++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            5999999999999997642    23 89998764   3467789999999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      |+||+|.++|..... .++..+++.++.++|+||+|||   ++++|||||.++|+|++.++.+||+|||+++....  ..
T Consensus       243 ~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~~  316 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--YV  316 (474)
T ss_pred             cCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCCcc--ee
Confidence            999999999987653 6999999999999999999999   89999999999999999999999999999986541  11


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .......-+.+|+|||.+....++.++|||||||++||+++ |..|+......+   +..++.   ..         ...
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~---~~---------~~r  381 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIV---KN---------GYR  381 (474)
T ss_pred             eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHH---hc---------Ccc
Confidence            11112246789999999999999999999999999999999 788886554332   222221   11         111


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      ...+...+..+..++.+||..+|++||+|.++.+.|+.+.....
T Consensus       382 ~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  382 MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            23344667888999999999999999999999999998876544

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=351.41  Aligned_cols=249  Identities=26%  Similarity=0.432  Sum_probs=211.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      .|....+||+|+.|.||.++.. .++.||||++........+-+.+|+.+|+..+|+|||.++..+..+++++.|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            4566668999999999999854 578899999887776666778999999999999999999999988899999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.|.+....   +++.++..||.++++||+|||   .++|+|||||.+||||+.++.+||+|||++.......  ..
T Consensus       354 ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~--~K  425 (550)
T KOG0578|consen  354 GGSLTDVVTKTR---MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ--SK  425 (550)
T ss_pred             CCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc--Cc
Confidence            999999987653   899999999999999999999   8999999999999999999999999999998665422  24


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....||+.|||||+.....|.+|.||||||++++||+.|.+||-...+.....++.      ..+.      |.+  ..
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng~------P~l--k~  491 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGT------PKL--KN  491 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcCC------CCc--CC
Confidence            456789999999999999999999999999999999999999997654433322221      1111      111  23


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ++.....|.+++.+||+.|+++||++.|+|++
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            44556789999999999999999999999976

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=347.33  Aligned_cols=250  Identities=30%  Similarity=0.513  Sum_probs=210.1

Q ss_pred             CCCCHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec
Q 003436          471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE  550 (820)
Q Consensus       471 ~~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  550 (820)
                      +.+||++|.       +++-||.|+-|.||+|++.+ +.||||+++.-.       ..+|+-|++|+||||+.+.|+|..
T Consensus       119 WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  119 WEIPFEEIS-------ELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             ccCCHHHhh-------hhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence            567887764       34579999999999999974 679999865332       257899999999999999999999


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      ..-+|+|||||+.|.|.+.|...+  .++-.....+..+||.||+|||   .+.|||||||+-||||..+-.+||+|||.
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccc
Confidence            999999999999999999997654  6888889999999999999999   79999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ++...+.   .....++||..|||||+++..+.++|.|||||||||||||||..|+..-....    +-|     .    
T Consensus       259 S~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw-----G----  322 (904)
T KOG4721|consen  259 SKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW-----G----  322 (904)
T ss_pred             hHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE-----e----
Confidence            9865443   33346789999999999999999999999999999999999999986432111    111     1    


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                        +-...|.-..+..|+.-|.-|++.||+..|..||++++++.+|+.+
T Consensus       323 --VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  323 --VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             --ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence              1112233345678899999999999999999999999999998654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-39  Score=341.41  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=208.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV  557 (820)
                      +.|+.+++||+|.||.||||+.. .|+.||+|++....  ........+||.+|++|+||||++|.+...+.  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            44777789999999999999954 68999999876554  33445567899999999999999999998776  789999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +|||++ +|.-++... .-.++..++..++.|++.||+|+|   ..+|+|||||.+|||||.+|.+||+|||||+++...
T Consensus       197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999987 888777643 346899999999999999999999   899999999999999999999999999999976553


Q ss_pred             CCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh-----hccCccc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC-----QETGQLE  711 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~-----~~~~~~~  711 (820)
                      . ....+..+-|+.|.|||++.+. .|+.+.|+||.||||.||++|++.+....+.++...+--..-.     +...++.
T Consensus       272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            3 2335667789999999999875 7999999999999999999999999888776665544211100     0101111


Q ss_pred             --cccCcc------ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 --DIVDPT------LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 --~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ..+.+.      +... ....+...++|+..+|..||.+|.|+.++++.
T Consensus       351 ~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence              111111      1100 11334567889999999999999999988864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.7e-38  Score=337.17  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=202.5

Q ss_pred             ccceeEeeecceEEEEEEEcCccEEEEEeCCCCChh---hHHHHHHHHHHHHcCCCCceeeEEeEeec----CceEEEEE
Q 003436          486 SESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ---GLAEFRTEIEMLSQFRHRHLVSLIGYCDE----RNEMIIIY  558 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  558 (820)
                      .....||+|++|.||+|++ +++.||||++......   ..+.|.+|+++|++++||||++++|++.+    ....++||
T Consensus        23 ~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~  101 (283)
T PHA02988         23 YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL  101 (283)
T ss_pred             CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence            3345899999999999998 5789999987654332   25778899999999999999999999866    35689999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++...  ..++|...++++.+++.||+|||+  ..+++||||||+|||+++++.+||+|||+++..... 
T Consensus       102 Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        102 EYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-  176 (283)
T ss_pred             EeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-
Confidence            999999999999764  368999999999999999999993  247889999999999999999999999999854321 


Q ss_pred             CccccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                          .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+..   ..   ....+.       
T Consensus       177 ----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~---~~---i~~~~~-------  239 (283)
T PHA02988        177 ----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---DL---IINKNN-------  239 (283)
T ss_pred             ----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH---HH---HHhcCC-------
Confidence                123457889999999976  68999999999999999999999999755332211   11   111110       


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                        ....+..++..+.+++.+||+.||++||++.|+++.|++..+
T Consensus       240 --~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        240 --SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             --CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence              011233466789999999999999999999999999987654

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=350.06  Aligned_cols=257  Identities=30%  Similarity=0.511  Sum_probs=208.1

Q ss_pred             CccceeEeeecceEEEEEEEcCccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          485 FSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +.....||+|.||+||+|++-+  .||||.+...  ..+..+.|.+|+.+|++-+|.||+-+.|||..... .+|..+|+
T Consensus       394 v~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe  470 (678)
T KOG0193|consen  394 VLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE  470 (678)
T ss_pred             hhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence            4456699999999999999864  4899987654  35567899999999999999999999999988776 99999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      |-+|+.+|+..+ ..++..+.+.|+.|+|+||.|||   .++|||||||+.||+|.+++++||+||||+.....-.....
T Consensus       471 GsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q  546 (678)
T KOG0193|consen  471 GSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ  546 (678)
T ss_pred             Cchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence            999999998765 46888999999999999999999   89999999999999999999999999999864322222222


Q ss_pred             cccccCCccccCccccccC---CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          643 STAVKGSFGYLDPEYLTKQ---QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .....|...|||||+++.+   +++..+||||||+|+|||+||..|+... ..++.-   |   +...|-+  ..|.   
T Consensus       547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIi---f---mVGrG~l--~pd~---  614 (678)
T KOG0193|consen  547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQII---F---MVGRGYL--MPDL---  614 (678)
T ss_pred             cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheE---E---Eeccccc--Cccc---
Confidence            2334578889999999754   6899999999999999999999999733 222211   1   0111111  1111   


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ......+++++.+|+..||..++++||.+.+++..|+.++.
T Consensus       615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            12345788899999999999999999999999999988866

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.7e-38  Score=340.03  Aligned_cols=262  Identities=26%  Similarity=0.402  Sum_probs=204.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-----------------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-----------------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSL  544 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l  544 (820)
                      ++|...++||+|+||.||++.+++                 +..||+|.+.... ....++|.+|+++|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            457788899999999999998643                 3369999876543 4446789999999999999999999


Q ss_pred             EeEeecCceEEEEEeeccCCchhhHhhhcC-----------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEe
Q 003436          545 IGYCDERNEMIIIYEYMENGTLKDHLYASN-----------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH  607 (820)
Q Consensus       545 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiH  607 (820)
                      ++++.+.+..++|+||+++|+|.+++....                 ...++|.++++++.|++.||+|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999986432                 134788999999999999999999   789999


Q ss_pred             ccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc--CCCC
Q 003436          608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC--GRPV  685 (820)
Q Consensus       608 rDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt--G~~p  685 (820)
                      |||||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999975433222222233456789999999998899999999999999999987  4566


Q ss_pred             CCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          686 IDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       686 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      +......+   ....+..........      .....++.++..+.+++.+||+.+|++||++.+|.+.|+
T Consensus       242 ~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQ---VIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHH---HHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            65433222   222222211111000      001123355678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.2e-38  Score=332.93  Aligned_cols=250  Identities=36%  Similarity=0.557  Sum_probs=198.8

Q ss_pred             cceeEeeecceEEEEEEEc-----CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          487 ESLVIGIGGFGKVYRGVLR-----DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ..+.||.|.||.||+|.+.     .+..|+||.+... .....++|.+|++.+++++||||++++|+|...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999987     3678999998654 344578999999999999999999999999988889999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.++|.......+++.++++|+.|+++||+|||   +.+++|+||+++||++++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999886678999999999999999999999   688999999999999999999999999999865332222


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      ...........|+|||.+....++.++||||||+++|||++ |+.|+......+   +..   .. ..+..         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~---~~-~~~~~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIE---KL-KQGQR---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHH---HH-HTTEE---------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc---cc-ccccc---------
Confidence            33344557789999999999999999999999999999999 678875442222   111   11 11111         


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ...+..++..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            112234567799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=389.85  Aligned_cols=265  Identities=28%  Similarity=0.492  Sum_probs=219.7

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .....+...++||+|+||.||+|+.. ++..||||++......    ...|++++++++||||++++|+|.+.+..++||
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            33456778889999999999999974 6889999987644322    234688999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      |||++|+|.++++     .++|.++.+|+.|+|+||+|||+.++++|+||||||+||+++.++.+++. ||.......  
T Consensus       763 Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        763 EYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             eCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            9999999999995     38999999999999999999998777899999999999999999988876 666543211  


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          .....++..|+|||++.+..++.|+|||||||++|||+||+.|++.... ......+|++..........++|+.+
T Consensus       835 ----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        835 ----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             ----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence                1223678999999999999999999999999999999999999864332 23456778777666666677778777


Q ss_pred             cCC--CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          719 TGQ--IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       719 ~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ...  ...++..++.+++.+|++.+|++||+|.||++.|+.+.+.
T Consensus       910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            543  3446677889999999999999999999999999887653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.4e-38  Score=350.31  Aligned_cols=259  Identities=24%  Similarity=0.362  Sum_probs=204.6

Q ss_pred             hcCCccceeEeeecceEEEEEEE------cCccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL------RDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  553 (820)
                      .++|...++||+|+||.||+|+.      +.+..||||++.... ....+.+.+|+++|..+ +||||++++++|..++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34688888999999999999974      235679999876433 33456788999999999 89999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC-----------------------------------------------------------
Q 003436          554 MIIIYEYMENGTLKDHLYASN-----------------------------------------------------------  574 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  574 (820)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986432                                                           


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          575 --------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       575 --------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                                    ...++|..+++++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124789999999999999999999   789999999999999999999999999999865432221


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......  ....+..    .+..         
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~---------  335 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGYR---------  335 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCcc---------
Confidence            22222345678999999999999999999999999999998 788886432221  1111111    1110         


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      ...+...+.++.+++.+||+.+|++||++.|+++.|++.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            011122346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.4e-37  Score=332.60  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=203.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .|...+.||+|+||.||++... +++.||+|.+....   ......+.+|++++++++|+||+++++++.+++..++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677889999999999999975 68899999865432   2334567899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++|+|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999998887655557999999999999999999999   7899999999999999999999999999997643211 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||............   .......          .
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~----------~  221 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKED----------Q  221 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhcc----------c
Confidence              123456899999999999999999999999999999999999999754332211111   0101110          0


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                      ..++......+.+|+.+||+.+|.+||+     +.+++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            1223344567889999999999999997     7777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-38  Score=336.06  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=209.5

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  555 (820)
                      ..++|...+.||.|+|++|++|+.. .++++|||++...   .....+-...|-++|.+| .||.|++|+--|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3456888889999999999999966 5789999986432   122234566788999999 8999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||++||+|.++|.+-+  .+++......+.+|+.||+|||   +.|||||||||+|||||+|+++||+|||-|+...
T Consensus       151 FvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~  225 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS  225 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence            9999999999999998764  6888888899999999999999   8999999999999999999999999999999765


Q ss_pred             CCCCc---------cc--cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          636 DLDQT---------HV--STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       636 ~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      .....         ..  ....+||..|.+||++.....+..+|+|+|||+||.|+.|++||....+.-..   +-+.. 
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF---qkI~~-  301 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF---QKIQA-  301 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH---HHHHH-
Confidence            42222         11  14578999999999999999999999999999999999999999765432211   11111 


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                   +.-.+++..++.+.+|+.+.|..||.+|++..++.++
T Consensus       302 -------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  302 -------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                         1124555666889999999999999999999999876

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=327.30  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=210.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .+.|+..++||.|..+.||+|+.. .+..||||++..+. ....+.+.+|+..|+.++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            456888999999999999999964 57899999987554 3346889999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ||.+||+.+.+...-...+++..+..|.+++++||.|||   .+|.||||||+.||||+.+|.+||+|||.+....+...
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999998766667999999999999999999999   89999999999999999999999999998764433221


Q ss_pred             c-ccc-ccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          640 T-HVS-TAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       640 ~-~~~-~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      . ... ....||+.|||||+++.  ..|+.|+||||||+..+||.+|..||....+.+..     .+.+........  -
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL-----l~tLqn~pp~~~--t  254 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL-----LLTLQNDPPTLL--T  254 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH-----HHHhcCCCCCcc--c
Confidence            1 111 45689999999999644  46999999999999999999999999766544321     112222111111  0


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+..+-.......+.+++..||++||.+||++.++++.
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            111111122334578999999999999999999999865

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-37  Score=347.81  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=205.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  553 (820)
                      .++|...+.||+|+||.||+|+..      ++..||+|++.... ......+.+|+++++.+ +|+||++++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            346888899999999999998842      23579999886543 33456788999999999 89999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC-----------------------------------------------------------
Q 003436          554 MIIIYEYMENGTLKDHLYASN-----------------------------------------------------------  574 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  574 (820)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999986421                                                           


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccccc
Q 003436          575 ---------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA  645 (820)
Q Consensus       575 ---------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (820)
                               ...+++.++++++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     124788999999999999999999   78999999999999999999999999999975433221112223


Q ss_pred             ccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||........  ..    .....+         .....+.
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~---------~~~~~~~  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG---------YQMSRPD  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc---------cCccCCC
Confidence            345678999999999999999999999999999997 9999865432211  11    011111         0001112


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      ..+.++.+++.+||+.+|.+||++.++++.|++++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            23467899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.7e-37  Score=326.19  Aligned_cols=254  Identities=27%  Similarity=0.448  Sum_probs=208.8

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|+..++||+|++|.||+|...++..||+|+..... ...+.+.+|+.++++++|+||+++++.+...+..++|+||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4688889999999999999998888899999876543 235788999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++.......+++.+++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++....... ..
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~  160 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA  160 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence            999999998766667899999999999999999999   78999999999999999999999999999986543211 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||++....++.++|||||||++|||++ |+.||......+   ...+...    +.     ..    .
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~~-----~~----~  224 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR----GY-----RM----P  224 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc----CC-----CC----C
Confidence            223346778999999998899999999999999999998 888886433222   1111111    10     00    1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            112345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.1e-37  Score=327.22  Aligned_cols=255  Identities=24%  Similarity=0.373  Sum_probs=205.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...+.||+|+||.||+|.+.    .+..||+|...... ......|.+|+.++++++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            45788889999999999999864    35689999876543 33456799999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++.... ..++|.+++.++.|++.||+|||   +.+++||||||+||+++.++.+|++|||.+......
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999987643 46899999999999999999999   789999999999999999999999999987643221


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      . ........++..|+|||.+.+..++.++|||||||++||+++ |++||......+.   ....    ..+..      
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~~------  226 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV----EDGFR------  226 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCCCC------
Confidence            1 111122345678999999999999999999999999999775 9999865433221   1111    11110      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                         ...+..++..+.+++.+||+.+|.+||++.++++.|+..
T Consensus       227 ---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 ---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               112345667899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=332.11  Aligned_cols=266  Identities=29%  Similarity=0.403  Sum_probs=203.5

Q ss_pred             CccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHH--cCCCCceeeEEeEeecCc----eEEEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLS--QFRHRHLVSLIGYCDERN----EMIIIY  558 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~--~l~H~nIv~l~g~~~~~~----~~~lV~  558 (820)
                      ....++||+|+||.||||.+.+ +.||||++....   .+.|.+|-++.+  .++|+||+++++.-..+.    +++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhccC-ceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3445589999999999999975 899999976544   457788888776  458999999999876555    899999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcC------CCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG------STKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~------~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ||.++|+|.++|..+   .++|....+|+..+++||+|||+.      ..++|+|||||++|||+.+|++..|+|||||.
T Consensus       288 ~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            999999999999876   599999999999999999999963      46789999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccCC------CCCcceeeehhhhHHHHhcCCCCCCCC------Cchh-------
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ------LTEKSDVYSFGVVMFEILCGRPVIDPS------LPRE-------  693 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~SfGvll~ElltG~~p~~~~------~~~~-------  693 (820)
                      ...........-..+||.+|||||++.+.-      .-.+.||||+|.|||||++.-...++.      .+.+       
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            766544334444578999999999997642      224789999999999999964333211      1111       


Q ss_pred             -hhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          694 -KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       694 -~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                       ..++.+.+.+...+..+.+.       -.....+..+.+.++.||+.|++.|-|+.-|-+++.++..+...
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~-------W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDA-------WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhh-------hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence             00111222221111111111       11125567899999999999999999999999999888766543

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.5e-37  Score=330.35  Aligned_cols=256  Identities=30%  Similarity=0.470  Sum_probs=208.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcCc------cEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDE------TKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|...+.||+|+||.||+|.....      ..+++|.+.... .....+|.+|++++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            3577888999999999999986532      578999876443 344567899999999999999999999999989999


Q ss_pred             EEEeeccCCchhhHhhhcCC--------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC
Q 003436          556 IIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL  621 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~  621 (820)
                      +++||+++|+|.+++.....              ..+++.+++.++.|++.||+|||   ..+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            99999999999999975421              45889999999999999999999   78999999999999999999


Q ss_pred             CeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHH
Q 003436          622 MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       622 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~  700 (820)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+.   ...
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---IEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence            999999999986443222222333456788999999998899999999999999999998 9999875443321   111


Q ss_pred             HHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       701 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      +    ..+..         ...+..++.++.+|+.+||+.+|.+||++.||++.|+.
T Consensus       239 i----~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 I----RSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1    11111         12234567889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.5e-37  Score=334.86  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=205.7

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc----EEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET----KVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .+|+..+.||+|+||.||+|++.. +.    .||+|...... ....++|.+|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            358889999999999999998642 33    48999876443 34567899999999999999999999999765 5679


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++|+|.+++.... ..+++..+++++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999987643 45889999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |+.|++.....+.   ....    ..+.      
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~------  228 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL----EKGE------  228 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----hCCC------
Confidence            222222223345678999999999999999999999999999998 9999865432221   1111    1110      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                         ....+..+...+.+++.+||+.+|.+||++.+++..|..+...
T Consensus       229 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         229 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence               0011233456789999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.6e-38  Score=336.10  Aligned_cols=247  Identities=27%  Similarity=0.457  Sum_probs=211.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|...+.||+|.||.||||+-+ ..+.||+|.+...  ..+..+.+.+|++++++++||||+.++++++...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888889999999999999976 4678999976543  34557789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+.+ +|..+|...+  .+++..+..|+.+++.||.|||   +.+|+|||+||.||||+.++.+|+||||+||....  .
T Consensus        82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N  153 (808)
T ss_pred             hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence            9976 9999997654  6999999999999999999999   89999999999999999999999999999997653  4


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      +...+.++||+-|||||+..+++++..+|+||+||+|||+.+|+|||...   ....++   .....        ||.  
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv---~~I~~--------d~v--  217 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLV---KSILK--------DPV--  217 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHH---HHHhc--------CCC--
Confidence            56677889999999999999999999999999999999999999999643   222222   22211        111  


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+......+..++...+.+||.+|-+-.+++.+
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence             1233566789999999999999999999988765

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-37  Score=306.85  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=210.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChh--hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ--GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...++||+|.||.||+|++. .|+.||||+++.....  ......+|++.|++++|+||+.+++.+...+.+.||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            4667779999999999999965 5899999997765432  234678999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      |+. +|+..+..+. ..++..+...++.++.+||+|||   .+.|+||||||.|+|++.+|.+||+|||+|+.....+..
T Consensus        83 m~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             ccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            975 8888886554 46888899999999999999999   789999999999999999999999999999987654433


Q ss_pred             cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc---cC-
Q 003436          641 HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI---VD-  715 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~d-  715 (820)
                      .  +..+-|..|.|||.+.+ +.|+...|+||.||++.||+-|.|.+.+..+-++...+-.+.-.....++.++   .| 
T Consensus       158 ~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  158 Q--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             c--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            3  33367899999999976 47999999999999999999999888776665555444322222222221111   11 


Q ss_pred             -------ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 -------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 -------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                             +......-+.+.....+++.+++..||.+|.++.|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                   111112334556677999999999999999999999875

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-37  Score=323.42  Aligned_cols=255  Identities=27%  Similarity=0.431  Sum_probs=208.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...+.||+|++|.||+|..+++..||+|...... ...++|.+|++++++++|+||+++++++...+..++|+||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            45688889999999999999998888889999876543 23567899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.......++|.++..++.+++.||+|||   ..+++||||||+||++++++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997665567899999999999999999999   78999999999999999999999999999986542111 1


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......+..|+|||++.+..++.++||||||++++||++ |+.|+........   ....   .....          .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~~~~~----------~  223 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV---LQQV---DQGYR----------M  223 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH---HcCCC----------C
Confidence            1112223468999999999999999999999999999999 8888865432211   1111   01000          0


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      ......+..+.+++.+|++.+|.+||++.++++.|++
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            1123445779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4e-37  Score=325.73  Aligned_cols=255  Identities=28%  Similarity=0.469  Sum_probs=213.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ..+|...++||.|+||.||+|...++..+++|.+.........++..|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45678888999999999999999888999999987766656678999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.......+++.+++.++.+++.||+|||   +.+++|+||||+||++++++.+||+|||++.......  .
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~--~  159 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--Y  159 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc--c
Confidence            9999999998766667999999999999999999999   7899999999999999999999999999997653321  1


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......++..|+|||.+.+..++.++||||||++++||++ |+.|+......+   .......    +         ...
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~----~---------~~~  223 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA----G---------YRM  223 (261)
T ss_pred             cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh----C---------CcC
Confidence            1223446778999999998899999999999999999998 888886543222   1111111    0         011


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      ..+..++..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            1233555778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=322.07  Aligned_cols=257  Identities=29%  Similarity=0.458  Sum_probs=208.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|+..+.||+|+||.||+|.+..    ...|++|...... .....+|.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568888999999999999999753    3578999876543 3445679999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++++|.+++.... ..+++.++++++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999997643 36899999999999999999999   78999999999999999999999999999986542


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........++..|+|||.+.+..++.++||||||++++||++ |..|+......+   ......    .+..     
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~-----  226 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVE----DGYR-----  226 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCC-----
Confidence            222222223345678999999998999999999999999999998 988885433221   111111    1100     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                          ......++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       227 ----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 ----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                011234557789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-37  Score=336.25  Aligned_cols=252  Identities=25%  Similarity=0.362  Sum_probs=205.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+.. .++.||+|++....   ....+.+..|++++.+++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999986 47899999875432   234567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            9999999999996543  6889999999999999999999   78999999999999999999999999999975432  


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH-HHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV-EWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~d~~  717 (820)
                         ......||..|+|||++.+..++.++|||||||++|||++|++||......+..... .|.    .  .+.   .+.
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----~--~~~---~~~  221 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK----E--TLQ---RPV  221 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc----c--ccc---CCC
Confidence               223456899999999999999999999999999999999999999765443322111 110    0  000   010


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      . .........++.+++.+|+..+|.+||++.+++++
T Consensus       222 ~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 Y-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             C-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0 00012345678899999999999999999999876

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.5e-36  Score=327.35  Aligned_cols=259  Identities=27%  Similarity=0.430  Sum_probs=211.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...+.||+|+||.||+|+..      ++..+++|+.........+.+.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            34777789999999999999853      345688998877666666789999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC
Q 003436          557 IYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM  622 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~  622 (820)
                      ||||+++++|.+++....              ...++|..+++++.|++.||+|||   +++|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999997532              234899999999999999999999   789999999999999999999


Q ss_pred             eeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHH
Q 003436          623 AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWA  701 (820)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~  701 (820)
                      +||+|||+++...............++..|+|||++.+..++.++||||||+++|||+| |+.|+......+.   .+. 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~-  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IEC-  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-
Confidence            99999999975443222222334556788999999999999999999999999999999 9999865433221   111 


Q ss_pred             HHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          702 MKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       702 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                         ...+...         .....++..+.+++.+|++.+|.+||++.+|++.|+.+..
T Consensus       238 ---~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         238 ---ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             ---HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence               1111111         1122345678999999999999999999999999988855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-36  Score=321.67  Aligned_cols=251  Identities=28%  Similarity=0.449  Sum_probs=203.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...+.||+|+||.||++.++++..+|+|...... ...++|.+|+++|++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4577888999999999999999888889999865432 234678899999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++.... ..++|..++.++.+++.||+|||   +.+++||||||+||++++++.+||+|||+++....... ..
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS  157 (256)
T ss_pred             CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence            999999987543 35899999999999999999999   78999999999999999999999999999875432111 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   .......    +..  ...      
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~~----~~~--~~~------  222 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMISR----GFR--LYR------  222 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----CCC--CCC------
Confidence            223345678999999998899999999999999999999 888886543222   1221111    110  011      


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                       +...+..+.+++.+||+.+|.+||++.++++.|
T Consensus       223 -~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 -PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             112345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-36  Score=325.13  Aligned_cols=257  Identities=26%  Similarity=0.422  Sum_probs=205.0

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE  553 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  553 (820)
                      ++++|+..+.||+|+||.||+|.+.      .+..+|+|+..... .....+|.+|+.++++++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4567999999999999999999864      24679999875432 3345678999999999999999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC--------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeE
Q 003436          554 MIIIYEYMENGTLKDHLYASN--------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl  625 (820)
                      .++|+||+++|+|.+++....        ...+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532        134688999999999999999999   789999999999999999999999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHh
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      +|||+++...............++..|+|||++.+..++.++|||||||+++||++ |..|+......+.   .+..   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~~~---  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LRFV---  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---
Confidence            99999875433222222222345788999999999999999999999999999999 6788865432221   1111   


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                       ......         ..+..++..+.+++.+|++.+|++||++.|+++.|+
T Consensus       235 -~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 -MEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -HcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence             111111         122345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.1e-36  Score=341.96  Aligned_cols=260  Identities=25%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~  553 (820)
                      .++|...++||+|+||.||+|+...      +..||||++.... ....+.|.+|+++|++++ ||||++++++|.+.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            4567888899999999999998632      3469999886543 333567999999999996 9999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC-----------------------------------------------------------
Q 003436          554 MIIIYEYMENGTLKDHLYASN-----------------------------------------------------------  574 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  574 (820)
                      .+|||||+++|+|.++|....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886431                                                           


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          575 -----------------------------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       575 -----------------------------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                                                         ...+++.++++++.|++.||+|||   ..+|+||||||+|||+++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                               124788899999999999999999   789999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHH
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLV  698 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~  698 (820)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+..  .
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--Y  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--H
Confidence            99999999999986433222222223456788999999999999999999999999999997 88888643322111  1


Q ss_pred             HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      ..    ...+.         ....+..++..+.+++.+||+.+|++||++.+|.+.|+.+.
T Consensus       351 ~~----~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 NK----IKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HH----HhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            11    11110         01122345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.2e-36  Score=325.99  Aligned_cols=260  Identities=26%  Similarity=0.473  Sum_probs=208.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      ..++|+..+.||+|+||.||++...+      ...+|+|..... ......++.+|++++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            44568888999999999999998642      357899987643 334456789999999999 8999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhc--------------CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc
Q 003436          553 EMIIIYEYMENGTLKDHLYAS--------------NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD  618 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~  618 (820)
                      ..+++|||+++|+|.+++...              ....+++..+++++.|++.||+|||   +.+|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999998642              2356899999999999999999999   78999999999999999


Q ss_pred             CCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhH
Q 003436          619 ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNL  697 (820)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l  697 (820)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+....
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            999999999999986543322222233345678999999998999999999999999999998 8888764432221111


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                             ...+.         ....+..+...+.+++.+|++.+|++||++.|+++.|+.++
T Consensus       247 -------~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 -------LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -------HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                   11110         11123345577999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.7e-36  Score=321.76  Aligned_cols=254  Identities=29%  Similarity=0.418  Sum_probs=207.8

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +|...+.||+|++|.||+|..++ ++.+++|..... ....+++.+|++++++++|+||++++++|...+..++||||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            47778899999999999999764 778999987644 3345789999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.......+++..++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++....... ..
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~~  161 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TA  161 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-ec
Confidence            999999997766567999999999999999999999   78999999999999999999999999999986543211 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......+.   .   ... ..+         ....
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~---~~~-~~~---------~~~~  225 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---Y---ELL-EKG---------YRME  225 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H---HHH-HCC---------CCCC
Confidence            112234668999999999999999999999999999998 8888864332211   1   111 110         1112


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      .+...+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            2334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-36  Score=324.76  Aligned_cols=255  Identities=27%  Similarity=0.440  Sum_probs=204.8

Q ss_pred             cCCccceeEeeecceEEEEEEE-----cCccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVL-----RDETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|+..++||+|+||.||+|..     ..+..+++|..... .......|.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577788999999999999985     24578999987643 34455789999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC---------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC
Q 003436          557 IYEYMENGTLKDHLYASN---------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL  621 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~  621 (820)
                      ||||+++++|.+++....               ...+++.+.+.++.|++.||+|||   +.+++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985322               235889999999999999999999   78999999999999999999


Q ss_pred             CeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHH
Q 003436          622 MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       622 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~  700 (820)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |.+|+......+.   .+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~---~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV---IEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH
Confidence            999999999986443222222333446778999999988889999999999999999998 8888865432221   111


Q ss_pred             HHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       701 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      .    ......         ..+..++..+.+++.+|++.+|++||++.++++.|.
T Consensus       239 ~----~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         239 V----RKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             H----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence            1    111111         122345577899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-36  Score=334.33  Aligned_cols=264  Identities=24%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|+..+.||+|+||.||+++.. .+..+|+|.+.... ....+.+.+|+++|++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            367899999999999999999976 47788999876542 3445679999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++|+|.+++....  .+++..+..++.|++.||.|||+  ..+|+||||||+|||+++++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999997643  58899999999999999999994  346999999999999999999999999998754321  


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc--cCcc-------
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE--TGQL-------  710 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~-------  710 (820)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.......  ....  .+..       
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCccc
Confidence              12335689999999999999999999999999999999999999965433221111000  0000  0000       


Q ss_pred             ------------------------ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          711 ------------------------EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       711 ------------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                                              ..+...............++.+++.+||+.||++||++.|++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                    000000000000112356789999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-36  Score=325.75  Aligned_cols=260  Identities=28%  Similarity=0.436  Sum_probs=210.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...+.||+|+||.||++...      ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            56888889999999999999852      245689998877666667889999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC-----------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeE
Q 003436          557 IYEYMENGTLKDHLYASN-----------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl  625 (820)
                      |+||+++++|.+++....           ...+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999986432           235899999999999999999999   789999999999999999999999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHh
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      +|||+++...............++..|+|||++.+..++.++|||||||+++||++ |++||......+.   ...    
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~~----  234 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IEC----  234 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----
Confidence            99999975433222222233445778999999999999999999999999999998 8888865433221   111    


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ...+...         ..+...+..+.+++.+|++.+|.+||++.++++.|+.+...
T Consensus       235 i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1111111         11123446789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-36  Score=325.71  Aligned_cols=255  Identities=29%  Similarity=0.477  Sum_probs=207.0

Q ss_pred             cCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|...+.||+|+||.||+|...+      +..+|+|........ ..+.|.+|+++|++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457778899999999999998743      468999987655443 5678999999999999999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcC------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          556 IIYEYMENGTLKDHLYASN------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      +||||+++++|.+++....            ...+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            9999999999999997542            245889999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+...
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence            9999999975433222222233446788999999999999999999999999999998 999886443322   122111


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                          .+...         ..+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus       239 ----~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 ----QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ----cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                11111         112244577899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-36  Score=333.92  Aligned_cols=242  Identities=24%  Similarity=0.304  Sum_probs=197.7

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      ++||+|+||.||+++.. +++.+|+|.+...   .......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            37999999999999975 5788999986543   2334567889999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST  644 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (820)
                      +|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~  153 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCccc
Confidence            999998754  36899999999999999999999   789999999999999999999999999998753221  12223


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||........   .....    .+.      .    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~~~----~~~------~----~~p~  216 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---FELIL----MEE------I----RFPR  216 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH---HHHHH----cCC------C----CCCC
Confidence            45699999999999999999999999999999999999999965432211   11110    110      1    1223


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      ....++.+++.+||+.||++||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            3456788999999999999999     78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=332.83  Aligned_cols=266  Identities=21%  Similarity=0.309  Sum_probs=208.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHH--HHHHHHHHHcCC-CCceeeEEeEeecCc-eEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE--FRTEIEMLSQFR-HRHLVSLIGYCDERN-EMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~--f~~Ei~~l~~l~-H~nIv~l~g~~~~~~-~~~  555 (820)
                      ..++|...++||.|.||.||+|+-. .+..||||+++..-.. +++  =++|++.|++|+ ||||++|.+.+.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            3456888889999999999999954 6888999987654332 233  357999999998 999999999998877 999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|||||+ .+|.+++..+ .+.+++.++..|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+||...
T Consensus        87 fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccc
Confidence            9999996 5999999877 678999999999999999999999   8999999999999999999999999999999654


Q ss_pred             CCCCccccccccCCccccCccccc-cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc-----
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ-----  709 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----  709 (820)
                      ..   ...+..+.|..|.|||++. ...|+.+.|+||+||+++||.+-++.|-+..+-++..-+.-+.-......     
T Consensus       162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            42   3345667899999999884 56899999999999999999999988876655554433322111100000     


Q ss_pred             -cccccC-------ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          710 -LEDIVD-------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       710 -~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                       +...+.       +.-...+-+.+..+.++++.+|+.-||.+||++.|.+++-
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             111111       0001122234678899999999999999999999998863

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-36  Score=327.82  Aligned_cols=261  Identities=23%  Similarity=0.329  Sum_probs=197.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc--CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcC---CCCceeeEEeEee-----c
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR--DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQF---RHRHLVSLIGYCD-----E  550 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~-----~  550 (820)
                      ++|...+.||+|+||.||+|+..  ++..||+|++....  ......+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999863  46789999765432  22234566777777665   6999999999884     3


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      ....++|+||++ ++|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 69999997766567999999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc---
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET---  707 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---  707 (820)
                      ++.....   .......||..|+|||++.+..++.++|||||||++|||++|++||......+.....   ......   
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i---~~~~~~~~~  230 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LDVIGLPGE  230 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH---HHHhCCCCh
Confidence            9764332   2233456899999999999889999999999999999999999999765443322111   111000   


Q ss_pred             Ccc-------ccccCcccc---CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          708 GQL-------EDIVDPTLT---GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       708 ~~~-------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ...       .....+...   ....+.....+.+++.+|++.+|++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000       000000000   0111234566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.1e-36  Score=324.63  Aligned_cols=258  Identities=27%  Similarity=0.413  Sum_probs=206.1

Q ss_pred             CCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      +|...+.||+|+||.||+|+...      ...+++|...... ....+++.+|+++++.++||||+++++.|..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46677899999999999998642      3568888766443 3445779999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC----------------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCc
Q 003436          557 IYEYMENGTLKDHLYASN----------------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSAN  614 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~N  614 (820)
                      |+||+++|+|.+++....                      ...+++.+++.++.|++.||+|||   ..+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986421                      135889999999999999999999   7899999999999


Q ss_pred             EEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchh
Q 003436          615 ILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPRE  693 (820)
Q Consensus       615 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~  693 (820)
                      ||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |+.||....+.+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999975433222112223446778999999988899999999999999999999 998886543322


Q ss_pred             hhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          694 KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       694 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .   .++.    ..+         .....+......+.+++.+|++.+|++||++.++++.|+++..
T Consensus       238 ~---~~~~----~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 L---FNLL----KTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H---HHHH----hCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1   1111    111         0111123445679999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-36  Score=333.71  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=201.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+.. +++.+|+|.+...   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46888899999999999999986 4788999986532   2233567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999997643  5788899999999999999999   789999999999999999999999999999864331 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+..   +   . ...+..        
T Consensus       172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~---~-i~~~~~--------  232 (329)
T PTZ00263        172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY---E---K-ILAGRL--------  232 (329)
T ss_pred             ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH---H---H-HhcCCc--------
Confidence                12356899999999999999999999999999999999999999654332211   1   1 111111        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                        .++......+.+++.+||+.||.+||+     +.+++.+
T Consensus       233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              112223456889999999999999986     6777654

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.7e-36  Score=347.47  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=205.4

Q ss_pred             CccceeEeeecceEEEEEEEc-C-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-D-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      |...+.||+|+||.||+|... + +..||+|+...........+..|+.+|+.++||||+++++++..++..+|||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            888899999999999999864 3 57788888766666666778899999999999999999999999999999999999


Q ss_pred             CCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          563 NGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       563 ~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +|+|.++|...  ....+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            99999988643  2346889999999999999999999   789999999999999999999999999999865433222


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ....   . .+...         
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~---~~~~---~-~~~~~---------  289 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI---MQQV---L-YGKYD---------  289 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---H-hCCCC---------
Confidence            233456799999999999999999999999999999999999999965432221   1111   0 11110         


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+......+.+++.+||+.+|++||++.+++..
T Consensus       290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            1122344678999999999999999999998753

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=333.45  Aligned_cols=254  Identities=29%  Similarity=0.418  Sum_probs=214.3

Q ss_pred             ccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          486 SESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      ...++||-|-||.||.|+++. ...||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|..+..+|+|.|||..|
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG  348 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG  348 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence            445689999999999999975 5679999877554 34689999999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST  644 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (820)
                      +|.++|.+.+...++-.-++.++.||+.||+||.   .+.+|||||.++|+|+.++..+||+||||++++.....+ ...
T Consensus       349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT-AHA  424 (1157)
T KOG4278|consen  349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT-AHA  424 (1157)
T ss_pred             cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee-ccc
Confidence            9999999988888888889999999999999999   789999999999999999999999999999987654332 233


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ...-.+.|.|||.+....++.|+|||+|||+||||.| |..|+-...      +.+ +..+.++         ..+-+.+
T Consensus       425 GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSq-VY~LLEk---------gyRM~~P  488 (1157)
T KOG4278|consen  425 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQ-VYGLLEK---------GYRMDGP  488 (1157)
T ss_pred             CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHH-HHHHHhc---------cccccCC
Confidence            3455788999999999999999999999999999999 445553321      111 1122222         2223456


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      +.|+..+.+|++.||+-+|.+||+++|+-+.+|.+.+
T Consensus       489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            7899999999999999999999999999999988763

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-37  Score=330.20  Aligned_cols=245  Identities=25%  Similarity=0.319  Sum_probs=201.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+|+.. +++.+|+|++....   ....+.+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888899999999999999976 57889999875432   234567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            9999999999987643  6899999999999999999999   789999999999999999999999999999754321 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+..   +..    ..+..        
T Consensus       155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~---~~i----~~~~~--------  215 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY---EKI----LAGKL--------  215 (291)
T ss_pred             ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----HhCCc--------
Confidence                22356899999999999999999999999999999999999999754332211   111    11110        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                        .++......+.+++.+||+.||.+||+     +.+++++
T Consensus       216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence              112233457889999999999999995     7777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-36  Score=334.53  Aligned_cols=260  Identities=26%  Similarity=0.392  Sum_probs=205.0

Q ss_pred             cCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeec-Cce
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDE-RNE  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~-~~~  553 (820)
                      ++|+..++||+|+||.||+|+..+      ++.||+|++.... ....+.+..|++++.++ +|+||++++++|.. +..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            358888899999999999997432      4689999876443 33456788999999999 89999999998864 456


Q ss_pred             EEEEEeeccCCchhhHhhhcC-----------------------------------------------------------
Q 003436          554 MIIIYEYMENGTLKDHLYASN-----------------------------------------------------------  574 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  574 (820)
                      .++++||+++|+|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999999986422                                                           


Q ss_pred             CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccC
Q 003436          575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD  654 (820)
Q Consensus       575 ~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  654 (820)
                      ...++|..+.+++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||+++...............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            126899999999999999999999   78999999999999999999999999999986533222122223456778999


Q ss_pred             ccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHH
Q 003436          655 PEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEI  733 (820)
Q Consensus       655 PE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  733 (820)
                      ||++.+..++.++|||||||+++||++ |+.||......+.  +..    ....+..         ...+.....++.++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~---------~~~~~~~~~~~~~l  308 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTR---------MRAPEYATPEIYSI  308 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCC---------CCCCccCCHHHHHH
Confidence            999999999999999999999999998 9999865332221  111    1111100         01122345678999


Q ss_pred             HHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          734 AEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       734 ~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      +.+||+.+|++||++.|++++|+.+++
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-36  Score=325.84  Aligned_cols=265  Identities=19%  Similarity=0.263  Sum_probs=202.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..+.||+|+||.||+++.+ +++.+|+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888999999999999999986 47789999865432  2335678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |++++.|..+...  ...+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9998877654432  246899999999999999999999   78999999999999999999999999999986533211


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH---------HHhhccCcc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA---------MKCQETGQL  710 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~  710 (820)
                       .......|+..|+|||++.+..++.++|||||||++|||++|++||......+........         .........
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence             1223456899999999999989999999999999999999999999764433222111110         000011111


Q ss_pred             ccccCcccc------CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          711 EDIVDPTLT------GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       711 ~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .....+...      ..........+.+++.+||+.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111110      0111124567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.9e-36  Score=321.31  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=203.6

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc----EEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET----KVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|+..+.||+|+||.||+|++.. +.    .+++|...... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            357778899999999999999742 33    47888765433 3345678889999999999999999998864 45788


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ++||+++|+|.+++.... ..++|..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999997543 46899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........++..|+|||++.+..++.++||||||+++|||++ |+.|+....+....   +..    ..+...  . 
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~---~~~----~~~~~~--~-  231 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP---DLL----EKGERL--A-  231 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHH----HCCCcC--C-
Confidence            322222334567789999999998899999999999999999998 99998654332221   111    111110  0 


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                            .+..+...+.+++.+|+..+|.+||++.|+++.|..+.+
T Consensus       232 ------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         232 ------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                  111234567889999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.4e-36  Score=326.32  Aligned_cols=262  Identities=28%  Similarity=0.462  Sum_probs=209.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcC--------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      ++|...+.||+|+||.||+++..+        ...+|+|..... ......++..|++++.++ +|+||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            568888999999999999998532        346999987654 234456788999999999 7999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCC--------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD  618 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~  618 (820)
                      ..++|+||+++|+|.+++.....              ..++|.++++++.|++.||+|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            99999999999999999976421              35899999999999999999999   78999999999999999


Q ss_pred             CCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhH
Q 003436          619 ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNL  697 (820)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l  697 (820)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |++|+......+... 
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~-  253 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-  253 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-
Confidence            999999999999875433221111222334578999999998899999999999999999998 888886443222111 


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                           .. ..+.         ....+.....++.+++.+|++.+|.+||++.++++.|+++.....
T Consensus       254 -----~~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         254 -----LL-KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             -----HH-HcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence                 11 1111         012233455788899999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-36  Score=325.27  Aligned_cols=264  Identities=27%  Similarity=0.448  Sum_probs=211.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc--------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR--------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER  551 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  551 (820)
                      .++|...+.||+|+||.||+|+..        ++..+|+|..... .....+++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            356778889999999999999742        2347899987643 244567899999999999 899999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          552 NEMIIIYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      ...++||||+++|+|.+++....              ...++|.+++.++.|++.||+|||   +.+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999997542              235889999999999999999999   7899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~  696 (820)
                      ++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+......+.  
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--  248 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--  248 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH--
Confidence            9999999999999986544322222233446778999999998889999999999999999998 7777754432221  


Q ss_pred             HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                          .........          ...+..++..+.+++.+||+.+|.+||++.|+++.|+++..+..+
T Consensus       249 ----~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         249 ----FKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             ----HHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence                111111110          011234567899999999999999999999999999998877544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.4e-36  Score=318.31  Aligned_cols=252  Identities=30%  Similarity=0.435  Sum_probs=203.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...+.||+|+||.||+|...++..+|+|.+.... ...++|.+|+.++.+++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            3477778999999999999998877789999876443 234678999999999999999999999999899999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++..... .+++.++++++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~  157 (256)
T cd05113          83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS  157 (256)
T ss_pred             CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence            9999999876433 6899999999999999999999   78999999999999999999999999999875433211 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+   ......    .+...         .
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~---------~  221 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS----QGLRL---------Y  221 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh----cCCCC---------C
Confidence            122345678999999998889999999999999999999 888886443222   111111    11000         1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      ........+.+++.+||+.+|.+||++.++++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            11223467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.9e-36  Score=321.62  Aligned_cols=257  Identities=29%  Similarity=0.419  Sum_probs=204.5

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE  553 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  553 (820)
                      .+++|...+.||+|++|.||+|.+.+      +..|++|...... ......|..|+.++++++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            34678889999999999999999864      4678899876443 3345679999999999999999999999999899


Q ss_pred             EEEEEeeccCCchhhHhhhcCC-----CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---CeeE
Q 003436          554 MIIIYEYMENGTLKDHLYASNF-----PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---MAKV  625 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---~~kl  625 (820)
                      .++|+||+++++|.+++.....     ..++|.++++++.|++.||+|||   +.+++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999976432     35899999999999999999999   78999999999999998654   6999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHh
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      +|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......+..   .   ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~---~~  234 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E---FV  234 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---HH
Confidence            99999986532221111122234568999999999999999999999999999997 88888654332211   1   11


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      ....          ....+...+..+.+++.+|++.+|++||++.+|+++|+
T Consensus       235 ~~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111          11123345578899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.2e-36  Score=317.30  Aligned_cols=253  Identities=29%  Similarity=0.432  Sum_probs=204.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...++||+|+||.||+|..+++..+|+|....... ..+.|.+|+.++++++|+|++++++++.+ ...++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence            35777889999999999999988888899998765433 34678999999999999999999998854 56789999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.......+++.+++.++.+++.||+|||   +.+++||||||+||++++++.+||+|||++........ ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence            999999998765567899999999999999999999   78999999999999999999999999999976433211 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||++.+..++.++|+||||++++||++ |++||......+   ..+...   . .         ....
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~-~---------~~~~  223 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVE---R-G---------YRMP  223 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH---c-C---------CCCC
Confidence            122345678999999988899999999999999999999 888886433221   111111   1 0         0111


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .+...+..+.+++.+|++.+|.+||++.++.+.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            223455679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=329.59  Aligned_cols=239  Identities=23%  Similarity=0.271  Sum_probs=194.1

Q ss_pred             EeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       491 LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ||+|+||.||+++.. +++.+|+|.+...   .......+..|++++.+++||||+++++++...+..++|+||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999976 4778999986532   234456788999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccc
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV  646 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (820)
                      .+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .......
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~  153 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF  153 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence            9999764  36899999999999999999999   789999999999999999999999999999753321  1223345


Q ss_pred             cCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       647 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      .||..|+|||++.+..++.++|||||||+++||++|++||......+      ....... +.          ..++...
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~-~~----------~~~~~~~  216 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQ-EP----------LRFPDGF  216 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHc-CC----------CCCCCcC
Confidence            79999999999999999999999999999999999999996543221      1111111 10          0122334


Q ss_pred             HHHHHHHHHHHhhcCCCCCCC---HHHHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRPS---MGDVLW  753 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RPs---~~evl~  753 (820)
                      ...+.+++.+||+.+|.+||+   +.|++.
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            567889999999999999985   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.6e-36  Score=317.73  Aligned_cols=255  Identities=29%  Similarity=0.446  Sum_probs=206.0

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...++||+|+||.||+|++.+...||+|+...... ..++|.+|++++++++|+||+++++.+.+ ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            45888899999999999999988777899998764332 34678999999999999999999998754 55799999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++........ .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~  159 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-A  159 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccc-c
Confidence            999999998655556899999999999999999999   789999999999999999999999999999755432211 1


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||+..+..++.++||||||++++||++ |+.||......+...      . ...+.         ...
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~------~-~~~~~---------~~~  223 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------Q-VERGY---------RMP  223 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH------H-HhcCC---------CCC
Confidence            123346778999999998899999999999999999999 778886543322111      1 11110         001


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      ...+.+..+.+++.+|++.+|++||++.++++.|++..
T Consensus       224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            12345677899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=330.71  Aligned_cols=249  Identities=29%  Similarity=0.421  Sum_probs=205.4

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC----Ch-hhHHHHHHHHHHHHcCC-CCceeeEEeEeecCce
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ----SH-QGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNE  553 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~----~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~  553 (820)
                      ..++|...+.||+|.||+|++|... .+..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            4567888899999999999999865 5799999975543    12 23456678999999999 9999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeeccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLSK  632 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla~  632 (820)
                      .++||||+.+|+|.+++...  .++.+.+..+++.|++.|++|||   +++|+||||||+|||++.+ +++||+|||++.
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999873  46888999999999999999999   8999999999999999999 999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccCC-CC-CcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ-LT-EKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+......   +.   +. +..++.
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~---~k-i~~~~~  240 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY---RK-IRKGEF  240 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH---HH-HhcCCc
Confidence            763  2223445678999999999999877 75 78999999999999999999998632211   11   11 111111


Q ss_pred             ccccCccccCCCChhh-HHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDS-LNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                                .++... ..++..++.+|+..+|.+|+++.++++
T Consensus       241 ----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 ----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                      122222 567899999999999999999999984

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-36  Score=329.99  Aligned_cols=242  Identities=25%  Similarity=0.320  Sum_probs=197.7

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      ++||+|+||.||+++.. +++.+|+|.+...   .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            37999999999999975 5789999987543   2334567889999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST  644 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (820)
                      +|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  153 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK  153 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence            999888654  36899999999999999999999   789999999999999999999999999998753221  11223


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....      . ...      +.    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~------~-~~~------~~----~~p~  216 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------I-LME------DI----KFPR  216 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH------h-ccC------Cc----cCCC
Confidence            45799999999999999999999999999999999999999965432221111      0 000      01    1223


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      .....+.+++.+||+.+|.+||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            3456788999999999999997     88888865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.1e-36  Score=320.36  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=210.1

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-Cce
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-RNE  553 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~  553 (820)
                      ..++|...++||+|+||.||+|.+.+     +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678888999999999999999876     678999987643 34446778999999999999999999998866 567


Q ss_pred             EEEEEeeccCCchhhHhhhcCC------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          554 MIIIYEYMENGTLKDHLYASNF------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                      .++++||+++|+|.+++.....      ..+++.+++.++.+++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            8999999999999999875432      46899999999999999999999   78999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhc
Q 003436          628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      ||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.|+....+.+   +..+...   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~---  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD---  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc---
Confidence            999985443222222233456778999999998899999999999999999999 999986543322   2222111   


Q ss_pred             cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       707 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ....          .....++..+.+++.+|++.+|++||++.++++.|+.+..
T Consensus       235 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 GYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1000          1122345678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.5e-36  Score=322.75  Aligned_cols=255  Identities=22%  Similarity=0.356  Sum_probs=204.3

Q ss_pred             CCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      +|...+.||+|+||.||+|...+      +..||+|++..... .....|.+|+.++++++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35666789999999999998643      46799999875543 334678899999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC
Q 003436          557 IYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM  622 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~  622 (820)
                      ++||+++++|.+++....              ...+++..+++++.|++.||+|||   +.+|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            999999999999985321              235889999999999999999999   789999999999999999999


Q ss_pred             eeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHH
Q 003436          623 AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWA  701 (820)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~  701 (820)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..|+......+   ..+..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~i  239 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEMI  239 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence            99999999886543222222233446788999999988889999999999999999998 778876543222   11111


Q ss_pred             HHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          702 MKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       702 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                          ..+..         ...+.+++..+.+++.+|++.+|.+||++.+++..|+.
T Consensus       240 ----~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 ----RNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----HcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                11111         12234567789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-36  Score=324.55  Aligned_cols=265  Identities=21%  Similarity=0.353  Sum_probs=201.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888899999999999999976 57889999875432 22345678999999999999999999999998999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++ +|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++......  
T Consensus        85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            974 8998886543 35789999999999999999999   7899999999999999999999999999997543211  


Q ss_pred             cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh---------ccCcc
Q 003436          641 HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ---------ETGQL  710 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~---------~~~~~  710 (820)
                      .......++..|+|||++.+ ..++.++||||+||++|||++|++||......+............         .....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            11233467899999999865 568999999999999999999999997655443322211110000         00000


Q ss_pred             ccccCccccC----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTG----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .....+....    ...+....++.+++.+|++.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1111111100    0112234568899999999999999999999853

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-36  Score=316.51  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=201.6

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      +|+..+.||+|+||.||+|.++++..+|+|....... ....|.+|++++++++||||+++++++...+..++|+||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4677789999999999999988777899998654322 335788999999999999999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      ++|.+++.... ..++|..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...... ....
T Consensus        84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~  158 (256)
T cd05059          84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSS  158 (256)
T ss_pred             CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-cccc
Confidence            99999997644 36899999999999999999999   7899999999999999999999999999987543211 1111


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ...   . ..+     ..    ...
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~---~-~~~-----~~----~~~  222 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VES---V-SAG-----YR----LYR  222 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHH---H-HcC-----Cc----CCC
Confidence            12234568999999999999999999999999999999 7888865433221   111   1 111     00    111


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      +...+..+.+++.+|++.+|++||++.|+++.|
T Consensus       223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            223567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.7e-36  Score=320.40  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=205.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++...++||+|+||.||++...      .+..+++|..........+.|.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            35667789999999999999742      356789998877777777889999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCC-------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          557 IYEYMENGTLKDHLYASNF-------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      |+||+++|+|.+++.....             ..+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            9999999999999875431             35899999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |++||......+..   ... 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~-  237 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECI-  237 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HHH-
Confidence            9999999875433222122223345688999999999999999999999999999998 88888644332221   111 


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                         ..+..         ...+..++..+.+++.+||+.+|.+||++.++++.|+
T Consensus       238 ---~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 ---TQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ---HcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence               01100         0112234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3e-36  Score=332.20  Aligned_cols=245  Identities=22%  Similarity=0.319  Sum_probs=200.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC--ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD--ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...+.||+|+||.||+|++.+  +..||+|++...   .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            468889999999999999998654  357999976432   233456788999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999997643  6899999999999999999999   789999999999999999999999999999864321


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                           .....||+.|+|||++.+..++.++|||||||++|||++|++||....+....   .   . ...+..       
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~---~---~-i~~~~~-------  245 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY---Q---K-ILEGII-------  245 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH---H---H-HhcCCC-------
Confidence                 23457899999999999988999999999999999999999999754332111   1   1 111110       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                         .++......+.+++.+|++.+|++|+     ++.+++++
T Consensus       246 ---~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 ---YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               11223345678999999999999995     78888765

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.4e-36  Score=326.23  Aligned_cols=242  Identities=26%  Similarity=0.356  Sum_probs=195.6

Q ss_pred             eeEeeecceEEEEEEEc----CccEEEEEeCCCC----ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          489 LVIGIGGFGKVYRGVLR----DETKVAVKRGGTQ----SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++||+|+||.||+++..    .++.+|+|.+...    .......+..|+++|++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            58999999999999853    4678999986532    223345678899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.+++....  .+.+..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  154 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--G  154 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--C
Confidence            99999999986543  5788888999999999999999   789999999999999999999999999998743221  1


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......||..|+|||++.+..++.++|||||||++|||++|+.||.........      .... .+.          .
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~-~~~----------~  217 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKIL-KGK----------L  217 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHH-cCC----------C
Confidence            1223456999999999999988999999999999999999999999754332211      1111 111          1


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      ..+......+.+++.+|++.+|++||     ++.+++++
T Consensus       218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            12334456789999999999999999     78887764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.7e-36  Score=317.51  Aligned_cols=254  Identities=31%  Similarity=0.457  Sum_probs=199.3

Q ss_pred             ccceeEeeecceEEEEEEEcCcc---EEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------ceE
Q 003436          486 SESLVIGIGGFGKVYRGVLRDET---KVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------NEM  554 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~~~---~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~  554 (820)
                      ...++||+|+||.||+|++.+..   .+|+|.....  .....+.|..|++++++++|+||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            34568999999999999976532   5899976543  345567899999999999999999999987432      246


Q ss_pred             EEEEeeccCCchhhHhhhc----CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          555 IIIYEYMENGTLKDHLYAS----NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      ++++||+++|+|.+++...    ....+++...+.++.|++.||+|||   .++|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999987532    2245899999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      ++...............++..|++||++.+..++.++||||||+++|||++ |+.||......+   ..+.    ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----LRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHcCC
Confidence            986543221111223346678999999999999999999999999999999 788886433221   1111    11111


Q ss_pred             cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       710 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      ..         ......+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10         11234556789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3e-36  Score=330.13  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=197.1

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      +.||+|+||.||+++.. ++..||+|.+...   .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            37999999999999975 5789999986543   2334567788999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST  644 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (820)
                      +|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  153 (323)
T cd05595          81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMK  153 (323)
T ss_pred             cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCccc
Confidence            9998886543  6899999999999999999999   789999999999999999999999999998753221  11223


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+.....       ....      .    .++.
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~-------~~~~------~----~~p~  216 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-------LMEE------I----RFPR  216 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCC------C----CCCC
Confidence            456899999999999999999999999999999999999998654332211110       0000      0    1223


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      .....+.+++.+||+.+|.+||     ++.+++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            3456788999999999999998     78888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=316.64  Aligned_cols=255  Identities=29%  Similarity=0.443  Sum_probs=202.6

Q ss_pred             CccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce-----
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE-----  553 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----  553 (820)
                      |...+.||+|+||.||+|.+..    +..+|+|++...  .......+.+|++.++.++|+||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4566789999999999999753    367999987643  33446789999999999999999999998866554     


Q ss_pred             -EEEEEeeccCCchhhHhhhcC----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          554 -MIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       554 -~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                       .++|+||+++|+|..++....    ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             799999999999999986532    246899999999999999999999   789999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      |+++...............++..|+|||.+.+..++.++|||||||+++||++ |.+|+......+   ..++...    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~----  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRH----  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence            99986543222222222345678999999988899999999999999999999 888886433221   2222111    


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      +..         ...+..+...+.+++.+|++.+|.+||++.|+++.|+++
T Consensus       231 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110         112234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.4e-36  Score=324.93  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=207.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  553 (820)
                      .++|...+.||+|+||.||++...      .+..+|+|...... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            356888999999999999999752      24579999876543 33456789999999999 79999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++|+||+++|+|.+++.......+++.+++.++.+++.||+|||   +.+|+|+||||+|||+++++.+||+|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            999999999999999997655455899999999999999999999   78999999999999999999999999999985


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ..............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+..  ....    ..+.   
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~----~~~~---  261 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLI----KEGY---  261 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHH----HcCC---
Confidence            443222112223346778999999999999999999999999999998 89888644332211  1111    1110   


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                            ....+.....++.+++.+|++.+|++||++.|+++.|+++
T Consensus       262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  0011123346789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-36  Score=322.54  Aligned_cols=265  Identities=27%  Similarity=0.420  Sum_probs=204.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-----CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-----DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~  555 (820)
                      +.|+..+.||+|+||.||++..+     ++..|++|++........+.|.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            45777889999999999999853     477899999877777777889999999999999999999998743  34688


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||+++|+|.+++.... ..++|..++.++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999997543 35899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCcc-ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc-----
Q 003436          636 DLDQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ-----  709 (820)
Q Consensus       636 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-----  709 (820)
                      ...... ......++..|+|||++.+..++.++||||||++++||++|..++..... .      +.........     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~  232 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-E------FMRMMGNDKQGQMIV  232 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-h------hhhhcccccccccch
Confidence            322211 11122344569999999988999999999999999999998766532211 0      0000000000     


Q ss_pred             --cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          710 --LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       710 --~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                        +.+.+............+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence              0001111111112234567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.3e-36  Score=314.11  Aligned_cols=247  Identities=29%  Similarity=0.456  Sum_probs=197.6

Q ss_pred             eEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchh
Q 003436          490 VIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLK  567 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  567 (820)
                      .||+|+||.||+|++. +++.+|+|..... .......|.+|++++++++||||++++++|..+...++|+||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            6899999999999975 6788999976543 3344567999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccccccc
Q 003436          568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK  647 (820)
Q Consensus       568 ~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  647 (820)
                      +++.... ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...............
T Consensus        82 ~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          82 TFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9986543 46899999999999999999999   7899999999999999999999999999987543211111111122


Q ss_pred             CCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       648 gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      .+..|+|||.+.+..++.++||||||++++||++ |..|+......+....       ....         .....+...
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~-------~~~~---------~~~~~~~~~  221 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA-------IEQG---------VRLPCPELC  221 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH-------HHcC---------CCCCCcccC
Confidence            3467999999999899999999999999999998 8888864432221111       1110         011122344


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      +..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-36  Score=320.47  Aligned_cols=268  Identities=24%  Similarity=0.371  Sum_probs=204.6

Q ss_pred             CccceeEeeecceEEEEEEE-----cCccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVL-----RDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMII  556 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  556 (820)
                      |...+.||+|+||.||++..     .++..||+|...... ......|.+|+++|++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37778999999999988653     346789999876543 33457788999999999999999999988653  45789


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++...   .+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999998754   4899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCcc-ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..... ......++..|+|||.+.+..++.++||||||++++||++|+.|+....... .....+.........+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence            22111 1122345667999999998899999999999999999999998875432211 111111110011111112222


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      .......+..++..+.+++.+|++.+|++||++.++++.|+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            22222234456688999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-36  Score=322.74  Aligned_cols=262  Identities=23%  Similarity=0.359  Sum_probs=202.7

Q ss_pred             cCCccceeEeeecceEEEEEEEcC---------------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD---------------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIG  546 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~---------------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g  546 (820)
                      ++|+..+.||+|+||.||+++..+               ...||+|..... .......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888899999999999987643               124899987654 3344567999999999999999999999


Q ss_pred             EeecCceEEEEEeeccCCchhhHhhhcC----------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEE
Q 003436          547 YCDERNEMIIIYEYMENGTLKDHLYASN----------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANIL  616 (820)
Q Consensus       547 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIl  616 (820)
                      ++......++||||+++++|.+++....          ...++|.+++.++.|++.||+|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986432          134789999999999999999999   789999999999999


Q ss_pred             EcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc--CCCCCCCCCchhh
Q 003436          617 LDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC--GRPVIDPSLPREK  694 (820)
Q Consensus       617 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt--G~~p~~~~~~~~~  694 (820)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++|||||||+++||++  |..|+......+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999975433222222223345778999999998899999999999999999998  5567654433221


Q ss_pred             hhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          695 VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       695 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      .   ...........      .......++..+..+.+++.+|++.+|.+||++.+|++.|+
T Consensus       242 ~---~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 I---ENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H---HHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1   11111111100      00001112234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-35  Score=321.51  Aligned_cols=258  Identities=29%  Similarity=0.461  Sum_probs=205.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-c--cEEEEEeCCC-CChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-E--TKVAVKRGGT-QSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~--~~vavK~~~~-~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|+..++||+|+||.||+|+..+ +  ..+++|.+.. ......+.|.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            467888899999999999999764 3  2468887664 3344567799999999999 799999999999999999999


Q ss_pred             EeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          558 YEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      +||+++|+|.+++....              ...+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999996532              135889999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||+++||++ |+.||......+..   +   
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~---~---  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY---E---  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---
Confidence            99999998642211   11111233567999999998899999999999999999997 99998654332211   1   


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      .... +         .....+..+...+.+++.+|++.+|.+||++.++++.|+.+.+..
T Consensus       230 ~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         230 KLPQ-G---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             HHhc-C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1110 0         111122345567899999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-35  Score=314.42  Aligned_cols=253  Identities=30%  Similarity=0.441  Sum_probs=206.0

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...++||+|+||.||+|..++++.+|+|.+..... ...+|.+|++++++++|+|++++++++. .+..++|+||++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            46888889999999999999988889999998765433 3467899999999999999999999874 457899999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-cc
Confidence            999999997766667999999999999999999999   78999999999999999999999999999976442111 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||++....++.++||||||++++||++ |++||......+.   ....    ..+.         ...
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~---------~~~  223 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNL----ERGY---------RMP  223 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH----HcCC---------CCC
Confidence            223346778999999998899999999999999999999 9999865432221   1111    1110         001


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .+...+.++.+++.+|++.+|++||++.+++..|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            122345679999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-37  Score=325.75  Aligned_cols=248  Identities=29%  Similarity=0.431  Sum_probs=207.8

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .|...++||+|.||.||||.+. .++.||+|.+.... ...+.++.+|+.+|.+++++||.+.+|.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            3666679999999999999976 47889999987654 445788899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      .+|++.+.|....  .+++....-|..++..||.|||   ..+.+|||||+.|||+..+|.+||+|||++........  
T Consensus        94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--  166 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--  166 (467)
T ss_pred             cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh--
Confidence            9999999997654  3477777888999999999999   78999999999999999999999999999976554222  


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......||+-|||||++....|+.|+||||||++.+||++|.||+....+.....+            +.+-..|.+.+ 
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~-  233 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG-  233 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc-
Confidence            22567899999999999988999999999999999999999999976554322111            12222344433 


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .+...+.+++..||+++|+.||++.+++++
T Consensus       234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ---ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence               455678999999999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-36  Score=330.74  Aligned_cols=265  Identities=23%  Similarity=0.339  Sum_probs=197.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ceEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NEMI  555 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~  555 (820)
                      +|+..++||+|+||.||+|+.. ++..||||++...  .......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778889999999999999976 5789999987532  223446788999999999999999999987433     3479


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||++ ++|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 68998886543  5899999999999999999999   7899999999999999999999999999998543


Q ss_pred             CCCC-ccccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH--------Hh
Q 003436          636 DLDQ-THVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM--------KC  704 (820)
Q Consensus       636 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~--------~~  704 (820)
                      .... ........||..|+|||++.+  ..++.++|||||||+++||++|++||................        ..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2111 112234568999999999866  678999999999999999999999996543322211110000        00


Q ss_pred             hccCccccc---cCccc---cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QETGQLEDI---VDPTL---TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~~~~~~~~---~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......+.   +.+..   .....+.....+.+++.+||+.+|++||++.|++++
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000000   00000   000111234567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.5e-36  Score=345.40  Aligned_cols=258  Identities=25%  Similarity=0.335  Sum_probs=207.4

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc--
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN--  552 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--  552 (820)
                      .+...++|...++||+|+||.||+|+.. +++.||||.+...  .......+.+|+.++..++|+|+++++..+....  
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            3445578999999999999999999865 6889999986543  3455677889999999999999999988764332  


Q ss_pred             ------eEEEEEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCee
Q 003436          553 ------EMIIIYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAK  624 (820)
Q Consensus       553 ------~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~k  624 (820)
                            ..++||||+++|+|.+++...  ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEE
Confidence                  368999999999999998653  2356899999999999999999999   78999999999999999999999


Q ss_pred             EeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ....
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~~  257 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHKT  257 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH
Confidence            9999999865433222333456799999999999999999999999999999999999999975432211      1111


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      . .+..         ...+...+.++.+++.+||+.+|.+||++.+++.+
T Consensus       258 ~-~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 L-AGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             h-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1 1111         11233455779999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.3e-35  Score=326.55  Aligned_cols=261  Identities=24%  Similarity=0.372  Sum_probs=202.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|+..++||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+||++++++|.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            367888999999999999999987 4778888876654 33345678999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++|+|.+++....  .+++.....++.+++.||+|||+  ..+|+||||||+|||+++++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999997643  58899999999999999999993  347999999999999999999999999998754321  


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc--------
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE--------  711 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--------  711 (820)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||......+.....    .....+...        
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF----GCPVEGDPAESETSPRP  231 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh----cCcccCCccccccCccc
Confidence              122346899999999999989999999999999999999999998754332211110    000000000        


Q ss_pred             ---------------------cccCcccc---CCCC-hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 ---------------------DIVDPTLT---GQIK-PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ---------------------~~~d~~l~---~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                           .+.+....   .... .....++.+++.+||+.||++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                 00000000   0000 1124568899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=319.82  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=203.3

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      +|+..++||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778889999999999999975 57899999875432   2223567889999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++|+|.+++.......+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999999987655567999999999999999999999   7899999999999999999999999999987643211 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                        ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........   +.......          .
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~---~~~~~~~~----------~  221 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE---VERRVKED----------Q  221 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH---HHHHhhhc----------c
Confidence              12234689999999999989999999999999999999999999975433221111   11111110          0


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      ..++......+.+++.+|++.||.+||     ++.+++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            112233456788999999999999999     78788664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.2e-36  Score=335.29  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=205.1

Q ss_pred             cCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~  554 (820)
                      +++...++||+|+||.||+|++.+      +..||+|++.... ....+.+..|+++|.++. ||||++++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            457777899999999999998642      4579999987543 233457889999999997 99999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcC------------------------------------------------------------
Q 003436          555 IIIYEYMENGTLKDHLYASN------------------------------------------------------------  574 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------  574 (820)
                      ++|+||+++|+|.++++...                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999996532                                                            


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc
Q 003436          575 ------------------------------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD  618 (820)
Q Consensus       575 ------------------------------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~  618 (820)
                                                          ...++|.++++++.|++.||+|||   ..+++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                124788889999999999999999   78999999999999999


Q ss_pred             CCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhH
Q 003436          619 ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNL  697 (820)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l  697 (820)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+..  
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~--  351 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF--  351 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--
Confidence            999999999999985432221111223456788999999998889999999999999999998 88887543222211  


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      .    .....+         .....+..+...+.+++.+||+.+|.+||++.++++.|+.++
T Consensus       352 ~----~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         352 Y----NAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             H----HHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0    111111         011122344578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-35  Score=325.11  Aligned_cols=245  Identities=25%  Similarity=0.359  Sum_probs=194.4

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHH---HcCCCCceeeEEeEeecCceEEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEML---SQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l---~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      |...++||+|+||.||+|... +++.||||.+...   .....+.+..|++++   ++++||||+++++++..++..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566789999999999999976 5789999987532   122345566676655   567899999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|..++...   .+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            9999999999887543   5899999999999999999999   789999999999999999999999999998743221


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        ........|+..|+|||.+.+..++.++|||||||++|||++|+.||......+...      .... +.      + 
T Consensus       155 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~i~~-~~------~-  218 (324)
T cd05589         155 --GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVN-DE------V-  218 (324)
T ss_pred             --CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-CC------C-
Confidence              122234678999999999999999999999999999999999999997554322211      1111 10      0 


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                         ..+......+.+++.+||+.||.+||+     +.+++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence               122334567889999999999999994     5555543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-35  Score=312.32  Aligned_cols=250  Identities=27%  Similarity=0.397  Sum_probs=205.9

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...+.||+|++|.||+|+.. ++..+++|.+...  .....+.+.+|++++++++|||++++++++.+++..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999976 5788999986532  345567899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++.......+++.+++.++.+++.||.|||   +.+++|+||||+||++++++.+||+|||+++......  
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--  155 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--  155 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence            99999999998765567999999999999999999999   7899999999999999999999999999988654321  


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......|+..|+|||++.+..++.++|+||||++++||++|+.|+......+   .....    ..+...         
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~~---------  219 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKI----IRGVFP---------  219 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HcCCCC---------
Confidence            12233468889999999999999999999999999999999999986543211   11111    111111         


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .........+.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1122345678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-35  Score=319.40  Aligned_cols=260  Identities=24%  Similarity=0.411  Sum_probs=205.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE  553 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  553 (820)
                      ..++|+..++||+|+||.||+|..++      +..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45678899999999999999997542      4579999865443 2334568899999999999999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC--------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeE
Q 003436          554 MIIIYEYMENGTLKDHLYASN--------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl  625 (820)
                      .++||||+++|+|.+++....        ...+++..+++++.|++.||+|||   +++|+||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996532        245678889999999999999999   789999999999999999999999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHh
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      +|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |+.|+......+   .....   
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~---  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV---  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence            99999985433222222222345678999999999899999999999999999998 678886443222   11111   


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      .. +..         ...+..++..+.+++.+|++.+|++||++.++++.|+..+
T Consensus       235 ~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 MD-GGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             Hc-CCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11 110         0112344578999999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.7e-35  Score=313.49  Aligned_cols=253  Identities=28%  Similarity=0.419  Sum_probs=204.1

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...+.||+|++|.||+|...++..+++|...... ...+.+.+|++++++++|+|++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            3477788999999999999998877789999876443 234678899999999999999999998854 56789999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++.......++|..+..++.+++.||+|||   +.+++|+||||+||++++++.+||+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999998765566899999999999999999999   78999999999999999999999999999976433211 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||...+..++.++||||||++++||++ |+.|+......+.   .++..   ....          ..
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~---~~~~----------~~  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQVE---RGYR----------MP  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH---cCCC----------CC
Confidence            122346778999999998899999999999999999999 8888865433221   11111   1100          01


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .+...+..+.+++.+|++.+|.+||++.++++.|++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            123445779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.7e-35  Score=314.79  Aligned_cols=257  Identities=29%  Similarity=0.450  Sum_probs=206.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-c---cEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-E---TKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|+..+.||+|+||.||+|++.. +   ..+++|...... ....+++..|++++++++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3468888999999999999999753 2   368999876543 3445779999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999987543 46899999999999999999999   78999999999999999999999999999875543


Q ss_pred             CCCccc-cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          637 LDQTHV-STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       637 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ...... ......+..|+|||++....++.++|||||||++|||++ |+.|+......+   ...   ......      
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~---~i~~~~------  227 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMK---AINDGF------  227 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH---HHhcCC------
Confidence            221111 112223567999999998899999999999999999997 999986443221   111   111100      


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                          ......+++..+.+++.+|++.+|.+||++.+|++.|+++
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                0111224557789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=332.24  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+.. +++.||+|++....   ......+..|++++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999976 58899999875432   234567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999765  46899999999999999999999   7999999999999999999999999999997544322


Q ss_pred             ---------------------------CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCc
Q 003436          639 ---------------------------QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLP  691 (820)
Q Consensus       639 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~  691 (820)
                                                 .........||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                       00112345689999999999999999999999999999999999999976543


Q ss_pred             hhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC-HHHHHHH
Q 003436          692 REKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-MGDVLWN  754 (820)
Q Consensus       692 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~~  754 (820)
                      .+...      .....  .     ..+.-.........+.+++.+|+. +|.+||+ +.+++++
T Consensus       236 ~~~~~------~i~~~--~-----~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETYN------KIINW--K-----ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHH------HHhcc--C-----CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            22111      11000  0     000000111245678899999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=302.55  Aligned_cols=236  Identities=25%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||.|+||+|.+++.+ ++..+|+|.++...-   ...+...+|..+|+.+.||.++++.+.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888999999999999999987 478899998765542   33455678999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||++||-|..+|++.+  +++.+...-++.+|+.||+|||   +..|++|||||+|||||.+|.+||+|||+|+....  
T Consensus       124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            9999999999998765  6899999999999999999999   89999999999999999999999999999996543  


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                         ..-..+||+.|+|||.+....+..++|.|||||++|||+.|.+||....+....+       .+-.+++        
T Consensus       197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~-------KI~~~~v--------  258 (355)
T KOG0616|consen  197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE-------KILEGKV--------  258 (355)
T ss_pred             ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH-------HHHhCcc--------
Confidence               2456899999999999999999999999999999999999999998765532211       1111111        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCC
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDR  745 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~R  745 (820)
                        .++.-....+.+|+.+.++.|-.+|
T Consensus       259 --~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 --KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence              2333444668899999999999888

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=316.42  Aligned_cols=256  Identities=25%  Similarity=0.440  Sum_probs=206.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|...+.||+|+||.||+|...+      +..+++|...... ......+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3568888999999999999998753      3679999876443 34456789999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcC--------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEe
Q 003436          555 IIIYEYMENGTLKDHLYASN--------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA  626 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~  626 (820)
                      ++|+||+++|+|.+++....        ...++|..++.++.|++.||+|||   +.+++||||||+||++++++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999996532        234789999999999999999999   7899999999999999999999999


Q ss_pred             eccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhh
Q 003436          627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |++|+......+.   ..+..   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~~~---  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---LKFVI---  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---HHHHh---
Confidence            9999975443222222233456789999999998899999999999999999998 8888864433221   11111   


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                       .+...         ..+..++..+.+++.+|++.+|++||++.++++.|+
T Consensus       236 -~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 -DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             11111         122334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.8e-36  Score=327.63  Aligned_cols=243  Identities=24%  Similarity=0.315  Sum_probs=196.6

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      +.||+|+||.||+++.. .+..+|+|.+...   .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            37999999999999875 5788999986542   2334567788999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST  644 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (820)
                      +|.+++....  .+++.++..++.|++.||+|||+  ..+|+||||||+|||+++++.+||+|||+++.....  .....
T Consensus        81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (325)
T cd05594          81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMK  154 (325)
T ss_pred             cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Ccccc
Confidence            9999886543  68999999999999999999993  279999999999999999999999999998743221  11223


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      ...||..|+|||++.+..++.++|||||||++|||++|+.||......+.....       ....      .    .++.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i-------~~~~------~----~~p~  217 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------LMEE------I----RFPR  217 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH-------hcCC------C----CCCC
Confidence            456999999999999999999999999999999999999999754332211111       0000      0    1222


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      .....+.+++.+||+.||++|+     ++.+++++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            3446788999999999999996     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-35  Score=316.71  Aligned_cols=258  Identities=23%  Similarity=0.370  Sum_probs=204.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-Ccc----EEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DET----KVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|+..++||+|+||.||+|++. ++.    .||+|..... .....+++.+|+.++..++|+||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            46888899999999999999854 333    4899987643 334467889999999999999999999999754 5779


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ++||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++....
T Consensus        86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999987543 46899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |++|+.......   +..+...    +...    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~~~----  230 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEK----GERL----  230 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----CCcC----
Confidence            222212222345678999999999999999999999999999998 888886543222   2222111    1000    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                           .....++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus       231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence                 11223456788999999999999999999999988776543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-35  Score=312.25  Aligned_cols=249  Identities=29%  Similarity=0.467  Sum_probs=206.6

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|+..+.||+|+||.||+|... ++.|++|....... ..+++.+|+.++++++|+||+++++++......++|+||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            46788889999999999999875 68899999876554 56789999999999999999999999998999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.......+++..+..++.|++.||.|||   ..+++||||||+||++++++.+||+|||+++......    
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----  156 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----  156 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence            999999997765557999999999999999999999   7899999999999999999999999999998643211    


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                       .....+..|+|||++....++.++||||||++++||++ |+.|+......+   +.....    .+.         ...
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~~---------~~~  219 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVE----KGY---------RME  219 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHh----cCC---------CCC
Confidence             12345678999999998899999999999999999997 998886543222   111111    110         011


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            123345778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-35  Score=319.43  Aligned_cols=263  Identities=26%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-----------------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-----------------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVS  543 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-----------------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~  543 (820)
                      .++|+..+.||+|+||.||++...+                 +..||+|.+.... ....+++.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3468888899999999999998643                 2458899876543 345678999999999999999999


Q ss_pred             EEeEeecCceEEEEEeeccCCchhhHhhhcC---------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCc
Q 003436          544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN---------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSAN  614 (820)
Q Consensus       544 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~N  614 (820)
                      +++++..++..++|+||+++++|.+++....         ...+++..++.++.|++.||+|||   +.+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999997543         236899999999999999999999   7899999999999


Q ss_pred             EEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc--CCCCCCCCCch
Q 003436          615 ILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC--GRPVIDPSLPR  692 (820)
Q Consensus       615 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt--G~~p~~~~~~~  692 (820)
                      |++++++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..|+......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876443322223334556789999999988899999999999999999998  56676543222


Q ss_pred             hhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          693 EKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       693 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      +   ................      ....+...+.++.+++.+|++.+|.+||++.|+++.|+
T Consensus       241 ~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q---VIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H---HHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1   2222222111111110      01112334578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-35  Score=326.02  Aligned_cols=252  Identities=24%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             CCccceeEeeecceEEEEEEEc----CccEEEEEeCCCC----ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQ----SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~----~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  554 (820)
                      +|+..++||+|+||.||+++..    .++.+|+|.+...    .....+.+..|++++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998853    4788999986432    223345678899999999 599999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++||||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            99999999999999987543  5899999999999999999999   789999999999999999999999999999754


Q ss_pred             CCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ..... .......||..|+|||++.+. .++.++|||||||++|||++|+.||............  ......       
T Consensus       156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~-------  225 (332)
T cd05614         156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK-------  225 (332)
T ss_pred             cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-------
Confidence            32211 122345799999999999765 4789999999999999999999999643322111111  111110       


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      .++    ..+......+.+++.+||+.||++||     ++.+++++
T Consensus       226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            111    12223446788999999999999999     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.5e-35  Score=309.92  Aligned_cols=246  Identities=27%  Similarity=0.461  Sum_probs=199.4

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchhh
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD  568 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  568 (820)
                      +||+|+||.||+|...++..+|+|...... ......|.+|++++++++||||++++++|...+..++||||+++++|.+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            689999999999998888999999876544 3334578899999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccC
Q 003436          569 HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG  648 (820)
Q Consensus       569 ~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  648 (820)
                      ++.... ..+++.+++.++.+++.+|.|||   ..+++||||||+||++++++.+||+|||+++...... ........+
T Consensus        82 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          82 FLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             HHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            886543 45899999999999999999999   7899999999999999999999999999987533211 111112234


Q ss_pred             CccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhH
Q 003436          649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSL  727 (820)
Q Consensus       649 t~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  727 (820)
                      +..|+|||++.+..++.++||||||+++||+++ |..||........   ...    ...+.         ....+...+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~----~~~~~---------~~~~~~~~~  220 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQ----VEKGY---------RMSCPQKCP  220 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHH----HHcCC---------CCCCCCCCC
Confidence            678999999998899999999999999999998 8888864432211   111    11110         111223456


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          728 NKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       728 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      ..+.+++.+|++.+|++||++.|+++.|.
T Consensus       221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         221 DDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            78999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.2e-35  Score=320.30  Aligned_cols=258  Identities=30%  Similarity=0.463  Sum_probs=204.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc--EEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET--KVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|+..+.||+|+||.||+|.+.. +.  .+++|+.... .....+.|.+|++++.++ +|+||+++++++..++..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            468888899999999999999753 43  4677776543 344567889999999999 899999999999999999999


Q ss_pred             EeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          558 YEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      +||+++|+|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            99999999999997542              235889999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||+++....   ........++..|+|||++.+..++.++|||||||+++||+| |.+||......+.   .+   
T Consensus       164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~---  234 (303)
T cd05088         164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE---  234 (303)
T ss_pred             EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HH---
Confidence            9999999863211   111112234678999999988889999999999999999998 9999864432221   11   


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      .. ..+         .....+...+..+.+++.+|++.+|++||++.++++.|+.+++..
T Consensus       235 ~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         235 KL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             HH-hcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11 000         000112234467899999999999999999999999998876644

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.2e-35  Score=311.76  Aligned_cols=248  Identities=29%  Similarity=0.445  Sum_probs=201.7

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEe-ecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC-DERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E~~  561 (820)
                      ++|...+.||+|+||.||++... +..+++|......  ..+.|.+|+.++++++|+|++++++++ ..+...++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            45788889999999999999875 6778999875433  346789999999999999999999976 4556789999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.......+++..++.++.+++.||+|||   ..+++||||||+||++++++.+||+|||+++.....    
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~----  155 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  155 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc----
Confidence            9999999998766566899999999999999999999   789999999999999999999999999998753321    


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                       .....++..|+|||++.+..++.++|||||||++|||++ |+.|+......+   +..+..    .+.         ..
T Consensus       156 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~----~~~---------~~  218 (256)
T cd05082         156 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGY---------KM  218 (256)
T ss_pred             -CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cCC---------CC
Confidence             122345678999999999899999999999999999997 888886432211   111111    110         11


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .....++..+.+++.+|++.+|++||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1223456788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-35  Score=324.46  Aligned_cols=238  Identities=25%  Similarity=0.320  Sum_probs=193.0

Q ss_pred             eeEeeecceEEEEEEE----cCccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          489 LVIGIGGFGKVYRGVL----RDETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +.||+|+||.||+++.    ..++.+|+|++....  ......+..|+++|++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    257889999875432  2234567789999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ..
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~  154 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK  154 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence            99999998654  36899999999999999999999   7899999999999999999999999999987543221  12


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+..   ..   .. ...          ...
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---~~---i~-~~~----------~~~  217 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---TM---IL-KAK----------LGM  217 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH---HH---HH-cCC----------CCC
Confidence            23457899999999999888999999999999999999999999754332211   11   11 110          012


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGD  750 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~e  750 (820)
                      +......+.+++.+||+.||++||++.+
T Consensus       218 p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            2334567889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-35  Score=313.52  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=204.4

Q ss_pred             CCccceeEeeecceEEEEEEEcC-c---cEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-E---TKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .|...+.||+|+||.||+|.+.. +   ..|++|..... .....++|..|+.++++++||||+++++++..+...++|+
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778899999999999999763 2   36999987654 3445678999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999987543 46899999999999999999999   7899999999999999999999999999987543322


Q ss_pred             Cccccc-cc--cCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          639 QTHVST-AV--KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       639 ~~~~~~-~~--~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ...... ..  ..+..|+|||++.+..++.++|||||||++|||++ |+.||......+   ...++...   ..     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~---~~-----  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQD---YR-----  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcC---Cc-----
Confidence            111111 11  12457999999999999999999999999999886 999886543322   22222110   00     


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                           ...+.+++..+.+++.+|++.+|.+||++.+++..|+.+
T Consensus       230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 -----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 011234567789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-35  Score=330.79  Aligned_cols=252  Identities=23%  Similarity=0.373  Sum_probs=197.3

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .|...+.||+|+||+||+|+.. .++.+|+|++...   .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999875 4788999987543   23445678999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++|+|.+++....  .+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999987643  5888999999999999999999   78999999999999999999999999999763211000


Q ss_pred             ---------------------------------------------ccccccccCCccccCccccccCCCCCcceeeehhh
Q 003436          640 ---------------------------------------------THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGV  674 (820)
Q Consensus       640 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGv  674 (820)
                                                                   ........||..|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                         00012346999999999999989999999999999


Q ss_pred             hHHHHhcCCCCCCCCCchhhh-hHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHH--HhhcCCCCCCCHHHH
Q 003436          675 VMFEILCGRPVIDPSLPREKV-NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEK--CLAQCGIDRPSMGDV  751 (820)
Q Consensus       675 ll~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPs~~ev  751 (820)
                      ++|||++|++||....+.+.. ....|      .....      .  ........++.+++.+  |+..++..||++.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~------~--~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINW------ENTLH------I--PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHcc------ccccC------C--CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999765432211 11111      00000      0  0011233566777777  556677779999999


Q ss_pred             HHH
Q 003436          752 LWN  754 (820)
Q Consensus       752 l~~  754 (820)
                      +.+
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.1e-36  Score=331.35  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=194.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +|+..++||+|+||.||+|+.. +++.||||.+.... ....+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4556679999999999999976 57899999875433 334567899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+..      ..++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  .
T Consensus       155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        155 DGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             CCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            999986532      3567788899999999999999   7899999999999999999999999999998643211  1


Q ss_pred             ccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          642 VSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+.....    ...       
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~-------  292 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----MSQ-------  292 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----ccC-------
Confidence            1234568999999998743     234568999999999999999999997432222111111100    000       


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ..........++.+++.+||+.+|++||++.|++++
T Consensus       293 --~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 --PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011223445678999999999999999999999875

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.1e-35  Score=321.96  Aligned_cols=261  Identities=25%  Similarity=0.443  Sum_probs=207.3

Q ss_pred             CCccceeEeeecceEEEEEEEcC--------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCce
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNE  553 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  553 (820)
                      +|...+.||+|+||.||++...+        ...+|+|..... .....+++.+|+++++++ +||||++++++|...+.
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            57888899999999999997531        236899987643 334567899999999999 89999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          554 MIIIYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                      .++++||+++|+|.+++....              ...++|.+++.++.|++.||+|||   ..+++||||||+|||+++
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~  169 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcC
Confidence            999999999999999987532              235889999999999999999999   789999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHH
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLV  698 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~  698 (820)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.    
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----  245 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL----  245 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH----
Confidence            99999999999986543222222222344578999999999999999999999999999998 7888764432221    


Q ss_pred             HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                        ..... .+..         ...+..++..+.+++.+|++.+|.+||++.|+++.|+.+.....
T Consensus       246 --~~~~~-~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         246 --FKLLK-EGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             --HHHHH-cCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence              11111 1110         11223445678999999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=312.36  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=208.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...++||+|+||.||+|..+++..++||.+.... ...+++.+|++++++++|+||+++++++......++|+||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            45788889999999999999998888889999876443 23467899999999999999999999999989999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.......+++.++..++.+++.||+|||   ..+++|+||||+||++++++.+||+|||+++...... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999998766567999999999999999999999   7899999999999999999999999999987654311 11


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......+..|+|||.+.+..++.++|+||||++++||++ |+.|+.......   ..+...   ..          ...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~---~~----------~~~  223 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE---RG----------YRM  223 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---cC----------CCC
Confidence            1122334578999999998899999999999999999998 899886443221   111111   00          001


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      ..+...+..+.+++.+|++.+|.+||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4e-35  Score=319.84  Aligned_cols=261  Identities=26%  Similarity=0.464  Sum_probs=206.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc--------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR--------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      ++|...++||+|+||.||+++..        ....+|+|..... ......++..|+++++++ +||||++++++|..++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            45778889999999999999752        2456889987643 334567789999999999 6999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc
Q 003436          553 EMIIIYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD  618 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~  618 (820)
                      ..++|+||+++|+|.+++....              ...++|.++++++.|++.||+|||   +.+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            9999999999999999996532              235899999999999999999999   78999999999999999


Q ss_pred             CCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhH
Q 003436          619 ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNL  697 (820)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l  697 (820)
                      +++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..  
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--  246 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF--  246 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            999999999999986543222111122234567999999999999999999999999999999 88888644322211  


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                       ...    ..+..         ...+..++..+.+++.+|++.+|++||++.++++.|+.+....
T Consensus       247 -~~~----~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         247 -KLL----REGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             -HHH----HcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence             111    11110         1122345567889999999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.9e-35  Score=324.58  Aligned_cols=249  Identities=23%  Similarity=0.326  Sum_probs=197.2

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+++.. +++.||+|.+...   .....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            37999999999999976 5788999987542   233456688999999988 799999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~  153 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTT  153 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCcc
Confidence            9999888654  36999999999999999999999   789999999999999999999999999998742211  1222


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh--hhhHHHHHHHhhccCccccccCccccCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE--KVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||+.....+  .....++..+.......          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence            34578999999999999999999999999999999999999996432111  11112222222221111          1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCC------HHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPS------MGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs------~~evl~~  754 (820)
                      .+......+.+++.+||+.+|.+||+      +.+++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            22334567889999999999999997      5666543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.9e-35  Score=310.44  Aligned_cols=248  Identities=25%  Similarity=0.423  Sum_probs=197.7

Q ss_pred             eEeeecceEEEEEEEc---CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCc
Q 003436          490 VIGIGGFGKVYRGVLR---DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      .||+|+||.||+|++.   .+..||+|...... ....++|.+|+.++++++|+||++++++|.. ...++|+||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999864   34569999876553 3345679999999999999999999999864 57899999999999


Q ss_pred             hhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc-ccc
Q 003436          566 LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VST  644 (820)
Q Consensus       566 L~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~  644 (820)
                      |.+++.... ..+++.++++++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++......... ...
T Consensus        81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999986532 46899999999999999999999   7899999999999999999999999999997543322111 112


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ...++..|+|||++.+..++.++||||||+++|||++ |++||......+.   ...+    ..+.         ....+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~---------~~~~~  220 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFI----EQGK---------RLDCP  220 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCCC---------CCCCC
Confidence            2334678999999988889999999999999999996 9999875433221   1111    1111         11223


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      ..++.++.+++.+||..+|++||++.+|.+.|+..
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            45567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.7e-35  Score=311.45  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=197.0

Q ss_pred             eEeeecceEEEEEEEc---CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          490 VIGIGGFGKVYRGVLR---DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      .||+|+||.||+|.+.   ++..+|+|++....  ....+++..|+.++++++|+||+++++++.. ...++|+||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   46789999875433  3346789999999999999999999999864 5678999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc-cc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VS  643 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~  643 (820)
                      +|.+++...  ..+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++......... ..
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999998654  36899999999999999999999   7899999999999999999999999999998654322111 11


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      ....++..|+|||.+....++.++|+|||||++|||++ |++||......+.   ...    .+.+.         ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----i~~~~---------~~~~  219 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQM----IESGE---------RMEC  219 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHCCC---------CCCC
Confidence            22334678999999988889999999999999999998 9999875433221   111    11111         1122


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      +..++.++.+++.+|++.+|++||++.+|.+.|++
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            33456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=329.88  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..++||+|+||.||+++.. .++.||||++...   .......+.+|+++|..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999976 5788999987542   2334566889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999997643  5899999999999999999999   7899999999999999999999999999987532211


Q ss_pred             Ccc------------------------------------ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcC
Q 003436          639 QTH------------------------------------VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG  682 (820)
Q Consensus       639 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG  682 (820)
                      ...                                    ......||+.|+|||++.+..++.++|||||||+++||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            000                                    01124699999999999999999999999999999999999


Q ss_pred             CCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 003436          683 RPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS---MGDVLWN  754 (820)
Q Consensus       683 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~~  754 (820)
                      ++||......+..   ......  ...+.   -+     ........+.+++.+|+. +|.+|++   +.+++++
T Consensus       236 ~~Pf~~~~~~~~~---~~i~~~--~~~~~---~~-----~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         236 YPPFCSDNPQETY---RKIINW--KETLQ---FP-----DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCHHHHH---HHHHcC--CCccC---CC-----CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999765433221   111100  00000   00     011234567888899996 8999997   8888764

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.3e-35  Score=324.02  Aligned_cols=249  Identities=25%  Similarity=0.354  Sum_probs=196.1

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+++.. +++.+|+|.+...   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            37999999999999976 4678999986542   334456678899988877 899999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|..++...  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~  153 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT  153 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence            9999888654  36899999999999999999999   7899999999999999999999999999987532211  122


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh--hhhHHHHHHHhhccCccccccCccccCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE--KVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||.......  ......+..........          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence            34578999999999999999999999999999999999999995321111  11112222222211111          1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCC------HHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPS------MGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs------~~evl~~  754 (820)
                      ++......+.+++.+||+.||++||+      +.+++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            23344567889999999999999998      4566544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.9e-35  Score=312.34  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=193.9

Q ss_pred             eEeeecceEEEEEEEcC---ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCc
Q 003436          490 VIGIGGFGKVYRGVLRD---ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      .||+|+||.||+|...+   +..+++|++.... ......|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            68999999999998653   3578999876543 3344578899999999999999999999999999999999999999


Q ss_pred             hhhHhhhcC---CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          566 LKDHLYASN---FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       566 L~~~l~~~~---~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      |.+++....   ....++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999997533   235678888899999999999999   78999999999999999999999999999875433222122


Q ss_pred             cccccCCccccCccccccC-------CCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          643 STAVKGSFGYLDPEYLTKQ-------QLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      .....++..|+|||++.+.       .++.++|+||||+++|||++ |+.||......+..   ...    ..+......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~----~~~~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT----VREQQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH----hhcccCCCC
Confidence            2334578889999998642       35789999999999999996 99998654332211   110    011111222


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      ++.+    .......+.+++..|+ .+|.+||++.||++.|+
T Consensus       232 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222    1223456788999998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-35  Score=319.95  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ..++|+.+..||+|+||.||+++-++ |..+|+|+++....   ...+..+.|-++|...++|.||+|+-.|++...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45789999999999999999999764 88999999876543   335567889999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||++||++..+|...+  .|++......+.+++.|++-||   ..|+|||||||+|+|||..|++||+||||+.-...
T Consensus       219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999997765  6888888888999999999999   89999999999999999999999999999852110


Q ss_pred             ----------------------CCCcc----c-------------------cccccCCccccCccccccCCCCCcceeee
Q 003436          637 ----------------------LDQTH----V-------------------STAVKGSFGYLDPEYLTKQQLTEKSDVYS  671 (820)
Q Consensus       637 ----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S  671 (820)
                                            .+...    .                   .-...||+-|||||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                  00000    0                   01246999999999999999999999999


Q ss_pred             hhhhHHHHhcCCCCCCCCCchhh-hhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC---
Q 003436          672 FGVVMFEILCGRPVIDPSLPREK-VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS---  747 (820)
Q Consensus       672 fGvll~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---  747 (820)
                      +||++||||.|-|||....+.+. ..++.|...+....              ...+..+..+|+.+|+. ||++|--   
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG~~G  438 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLGSKG  438 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcCccc
Confidence            99999999999999998887764 34555643332211              11233678899999998 9999964   


Q ss_pred             HHHHHH
Q 003436          748 MGDVLW  753 (820)
Q Consensus       748 ~~evl~  753 (820)
                      +.||-+
T Consensus       439 ~~EIK~  444 (550)
T KOG0605|consen  439 AEEIKK  444 (550)
T ss_pred             HHHHhc
Confidence            555543

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-36  Score=296.59  Aligned_cols=250  Identities=27%  Similarity=0.406  Sum_probs=211.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|+..+.||+|.||.||.|+.+ ++-.||+|.+....   .+..+++.+|+++-+.|+||||+++++|+.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            356899999999999999999976 46789999865432   23356789999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||.++|+|...|......+++......++.|+|.||.|+|   .+++|||||||+|+|++.++..||+|||-+...+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999999777778999999999999999999999   8999999999999999999999999999987543  


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .......+||.-|.+||...+...+...|+|++|++.+|++.|.+||+.....+.   ...+.+       .++.+  
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et---YkrI~k-------~~~~~--  241 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET---YKRIRK-------VDLKF--  241 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH---HHHHHH-------ccccC--
Confidence              2334567899999999999999999999999999999999999999986542221   111111       11222  


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                           +........+++.+|+..+|.+|.+..|++.+-
T Consensus       242 -----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  242 -----PSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             -----CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                 234456788999999999999999999998753

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.5e-35  Score=316.57  Aligned_cols=262  Identities=22%  Similarity=0.331  Sum_probs=202.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-----------------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-----------------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSL  544 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-----------------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l  544 (820)
                      ++|+..++||+|+||.||++...                 +...+|+|..... .....++|.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999998543                 2346899987654 34445789999999999999999999


Q ss_pred             EeEeecCceEEEEEeeccCCchhhHhhhcCC---------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcE
Q 003436          545 IGYCDERNEMIIIYEYMENGTLKDHLYASNF---------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI  615 (820)
Q Consensus       545 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NI  615 (820)
                      ++++...+..++|+||+++|+|.+++.....         ..+++.+++.++.|++.||+|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            9999999999999999999999999875421         24788899999999999999999   78999999999999


Q ss_pred             EEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc--CCCCCCCCCchh
Q 003436          616 LLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC--GRPVIDPSLPRE  693 (820)
Q Consensus       616 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt--G~~p~~~~~~~~  693 (820)
                      |+++++.+||+|||+++...............++..|++||...++.++.++|||||||++|||++  |..|+......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999875433221111222344678999999988899999999999999999998  667775443322


Q ss_pred             hhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          694 KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       694 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      .....   ......... ....     ..+..++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       242 ~~~~~---~~~~~~~~~-~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIENT---GEFFRDQGR-QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHH---HHHHhhccc-cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21111   111110000 0000     112345578999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.5e-35  Score=317.06  Aligned_cols=256  Identities=28%  Similarity=0.443  Sum_probs=204.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|+..+.||+|+||.||++...      .+..+|+|.+.... ....++|.+|+.++++++||||++++++|..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888899999999999999864      35789999876543 34457799999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcC--------------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCc
Q 003436          555 IIIYEYMENGTLKDHLYASN--------------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSAN  614 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~N  614 (820)
                      ++|+||+++|+|.+++....                    ...+++.+++.++.|++.||+|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999996421                    235789999999999999999999   7899999999999


Q ss_pred             EEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchh
Q 003436          615 ILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPRE  693 (820)
Q Consensus       615 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~  693 (820)
                      |++++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875433222111222335678999999998899999999999999999998 777775433222


Q ss_pred             hhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          694 KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       694 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      .   .   .. ...+...         ..+...+.++.+++.+|++.+|.+||++.|+++.|+
T Consensus       241 ~---~---~~-~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 V---I---YY-VRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H---H---HH-HhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1   1   11 1111111         112244577999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.2e-35  Score=323.36  Aligned_cols=241  Identities=24%  Similarity=0.339  Sum_probs=194.5

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCC-ceeeEEeEeecCceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHR-HLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~  558 (820)
                      +|...+.||+|+||.||+|+..+ ++.||+|.+...   .....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            47788899999999999999764 678999986532   233456788899999999764 5888999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   ..+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence            9999999999986543  5889999999999999999999   789999999999999999999999999998743211 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                       ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.   .....    ...         
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~----~~~---------  217 (324)
T cd05587         155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSIM----EHN---------  217 (324)
T ss_pred             -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cCC---------
Confidence             1122345689999999999999999999999999999999999999975543221   11111    000         


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                       ..++......+.+++.+|++.+|.+|++.
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence             11222345678899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.4e-35  Score=321.87  Aligned_cols=253  Identities=20%  Similarity=0.279  Sum_probs=201.8

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+++.. +++.+|+|.+....   ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999976 57889999875432   234567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999987652 36899999999999999999999   7899999999999999999999999999998654322


Q ss_pred             CccccccccCCccccCccccc------cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLT------KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      . .......||..|+|||++.      ...++.++|||||||++|||++|+.||......+..      ...........
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~  229 (330)
T cd05601         157 M-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQRFLK  229 (330)
T ss_pred             c-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCCCccC
Confidence            1 1233456899999999986      456789999999999999999999999754432211      11111111000


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .       .........+.+++.+|++ +|.+||++.+++.+
T Consensus       230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0       0112344678899999997 99999999998864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.9e-35  Score=308.84  Aligned_cols=254  Identities=27%  Similarity=0.421  Sum_probs=205.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...++||+|+||.||+|.+.++..+++|...... ...+.|.+|++++++++|+|++++++.+.+ ...++++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            35688889999999999999998888889999876443 345678999999999999999999999877 7789999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.......+++.+++.++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||++....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-cc
Confidence            9999999998765567899999999999999999999   7899999999999999999999999999987543321 11


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......++..|+|||++....++.++|+|||||+++|+++ |+.|+......+   +..+.    ..+..         .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~---------~  222 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYR---------M  222 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCCC---------C
Confidence            1222345678999999998889999999999999999999 888886443221   11111    11100         0


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      ......+..+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1122345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=336.88  Aligned_cols=259  Identities=22%  Similarity=0.306  Sum_probs=211.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCc-cEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeE-eec------Cc
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGY-CDE------RN  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~-~~~------~~  552 (820)
                      ..+.++.+.|.+|||+.||.|.+..+ ..+|+|++-..+....+...+|+++|++|+ |+|||.+++. ...      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34567788999999999999998876 999999988888889999999999999997 9999999993 211      24


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      +.+|.||||++|+|-|++.......|++.++++|+.++++|+++||. +..+|||||||-+||||..++..||||||-|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            78999999999999999987666679999999999999999999995 46789999999999999999999999999986


Q ss_pred             cCCCCCCcccc-------ccccCCccccCcccc---ccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH
Q 003436          633 IGPDLDQTHVS-------TAVKGSFGYLDPEYL---TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       633 ~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ...........       -...-|+-|.|||.+   .+..+++|+|||||||+||-|+-...||+.....          
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----------  264 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----------  264 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence            32211111100       012358899999987   5788999999999999999999999999754211          


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                               .|++....-...+.....|.+||..||+.+|.+||++-+|+..+-++..
T Consensus       265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                     1222222212224677899999999999999999999999998877764

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-35  Score=323.06  Aligned_cols=242  Identities=24%  Similarity=0.331  Sum_probs=195.3

Q ss_pred             eeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|+..+ ++.+|+|.+...   .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            369999999999999764 688999986543   233445677899999866 799999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|...+....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (321)
T cd05591          81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT  153 (321)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence            99999886543  6899999999999999999999   7899999999999999999999999999987532211  222


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..   +..   .. +.   .       ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~---~~i---~~-~~---~-------~~p  216 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF---ESI---LH-DD---V-------LYP  216 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH---HHH---Hc-CC---C-------CCC
Confidence            3456899999999999999999999999999999999999999765432211   111   11 10   0       112


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCC-------CHHHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRP-------SMGDVLWN  754 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RP-------s~~evl~~  754 (820)
                      .....++.+++.+||+.+|++||       ++.+++++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            22346788999999999999999       77777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=312.33  Aligned_cols=284  Identities=24%  Similarity=0.352  Sum_probs=215.8

Q ss_pred             cCCCCCCCCHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHH--cCCCCceee
Q 003436          466 SSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLS--QFRHRHLVS  543 (820)
Q Consensus       466 ~~~~~~~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~--~l~H~nIv~  543 (820)
                      .++.+.-.|+...+...++....+.||+|.||.||+|.++ |+.||||.+...++   +.+.+|.++.+  .|+|+||+.
T Consensus       194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhh
Confidence            3455566777777778888999999999999999999997 57899999875554   45667777776  459999999


Q ss_pred             EEeEeecC----ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhc-----CCCCcEEeccCCCCc
Q 003436          544 LIGYCDER----NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT-----GSTKAIIHRDVKSAN  614 (820)
Q Consensus       544 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~-----~~~~~iiHrDIkp~N  614 (820)
                      +++.-..+    .+++||.+|.++|||.|+|.+.   .++....++++..+|.||++||.     +..+.|.|||||++|
T Consensus       270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             hhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            99875332    3789999999999999999874   68999999999999999999994     356789999999999


Q ss_pred             EEEcCCCCeeEeeccccccCCCCCC--ccccccccCCccccCccccccC------CCCCcceeeehhhhHHHHhcC----
Q 003436          615 ILLDENLMAKVADFGLSKIGPDLDQ--THVSTAVKGSFGYLDPEYLTKQ------QLTEKSDVYSFGVVMFEILCG----  682 (820)
Q Consensus       615 Ill~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvll~ElltG----  682 (820)
                      ||+..++...|+|+|||-.......  .......+||.+|||||++...      +.-..+||||||.++||+...    
T Consensus       347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g  426 (513)
T KOG2052|consen  347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG  426 (513)
T ss_pred             EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence            9999999999999999976544321  1223456799999999999653      123468999999999999862    


Q ss_pred             ------CCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          683 ------RPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       683 ------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                            ++||..-.+.+..  .+-+++..-..+++..++.+   ....+++..+.+|++.||..+|.-|-++-.+-+.|.
T Consensus       427 gi~eey~~Pyyd~Vp~DPs--~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~  501 (513)
T KOG2052|consen  427 GIVEEYQLPYYDVVPSDPS--FEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA  501 (513)
T ss_pred             CEehhhcCCcccCCCCCCC--HHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence                  3566543322211  11122222222222222221   223477889999999999999999999999999988


Q ss_pred             HHHhh
Q 003436          757 YALQL  761 (820)
Q Consensus       757 ~~~~~  761 (820)
                      ++.+.
T Consensus       502 ~l~~~  506 (513)
T KOG2052|consen  502 KLSNS  506 (513)
T ss_pred             HHhcC
Confidence            87653

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=329.11  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=197.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+++.. +++.||+|.+...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888899999999999999875 5788999986542   2334567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999998754  36888999999999999999999   7899999999999999999999999999986322100


Q ss_pred             Cc---------------------------------------------cccccccCCccccCccccccCCCCCcceeeehh
Q 003436          639 QT---------------------------------------------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFG  673 (820)
Q Consensus       639 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfG  673 (820)
                      ..                                             .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            00                                             000124699999999999999999999999999


Q ss_pred             hhHHHHhcCCCCCCCCCchhhhh-HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCC---CCHH
Q 003436          674 VVMFEILCGRPVIDPSLPREKVN-LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDR---PSMG  749 (820)
Q Consensus       674 vll~ElltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Ps~~  749 (820)
                      |++|||++|++||......+... ...|      ...+. .  |     .......++.+++.+|+. +|.+|   +++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~------~~~~~-~--p-----~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINW------RETLY-F--P-----DDIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHcc------CCccC-C--C-----CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            99999999999997554322211 1111      00000 0  0     011234568899999997 66665   6999


Q ss_pred             HHHHH
Q 003436          750 DVLWN  754 (820)
Q Consensus       750 evl~~  754 (820)
                      |++++
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5e-35  Score=311.20  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=205.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...+.||+|+||.||+|...    .+..+|+|.+.... ....+.|..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778889999999999999864    23478999876533 33457899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999997643 46899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCcc-ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          638 DQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       638 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .... ......++..|+|||++.+..++.++||||||++++|+++ |+.||......+   .......   ...      
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~---~~~------  227 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE---GYR------  227 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC---CCc------
Confidence            2111 1112234568999999998899999999999999999886 999986543322   1111111   000      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                          .......+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ----LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                011223456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-35  Score=311.37  Aligned_cols=258  Identities=22%  Similarity=0.343  Sum_probs=207.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCC---CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGT---QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||.||+|+.. +++.+|||.+..   ........+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            46888899999999999999975 678999997543   23344567899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          559 EYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||+++|+|.+++...  ....+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988532  2345889999999999999999999   78999999999999999999999999999886543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ..  .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......    ..++...... ..     .+
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~-~~-----~~  226 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQ-CD-----YP  226 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhc-CC-----CC
Confidence            21  1122346888999999999888999999999999999999999998543221    1111111111 00     11


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      .   .........+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       227 ~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 P---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             C---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            1   11223456789999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.7e-35  Score=330.22  Aligned_cols=254  Identities=22%  Similarity=0.263  Sum_probs=200.6

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ..++|+..++||+|+||.||+++.. .+..+|+|.+...   .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999976 5788999987532   22334567889999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++...   .++...+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++....
T Consensus       121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999988653   4788888999999999999999   78999999999999999999999999999975432


Q ss_pred             CCCccccccccCCccccCccccccC----CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQ----QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      .. ........||+.|+|||.+.+.    .++.++|||||||++|||++|++||........   ..   .......  .
T Consensus       195 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~---~i~~~~~--~  265 (370)
T cd05596         195 NG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YS---KIMDHKN--S  265 (370)
T ss_pred             CC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---HH---HHHcCCC--c
Confidence            21 1122345799999999998653    478999999999999999999999975433211   11   1111000  0


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID--RPSMGDVLWN  754 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  754 (820)
                           +.-.........+.+++.+|++.+|.+  ||++.+++.+
T Consensus       266 -----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 -----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                 000011134567889999999988987  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-35  Score=326.46  Aligned_cols=260  Identities=24%  Similarity=0.380  Sum_probs=202.3

Q ss_pred             cCCccceeEeeecceEEEEEEE------cCccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC-ce
Q 003436          483 DNFSESLVIGIGGFGKVYRGVL------RDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER-NE  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~  553 (820)
                      ++|...++||+|+||.||+|+.      ..++.||||++.... ....+.+.+|+.+|.++ +|+||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            4688889999999999999974      246789999876533 33456788999999999 689999999988654 56


Q ss_pred             EEEEEeeccCCchhhHhhhcC-----------------------------------------------------------
Q 003436          554 MIIIYEYMENGTLKDHLYASN-----------------------------------------------------------  574 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~-----------------------------------------------------------  574 (820)
                      .++|+||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999999986432                                                           


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccC
Q 003436          575 ------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG  648 (820)
Q Consensus       575 ------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  648 (820)
                            ...++|.++.+++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...............+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  123788899999999999999999   78999999999999999999999999999976432221111222345


Q ss_pred             CccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhH
Q 003436          649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSL  727 (820)
Q Consensus       649 t~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  727 (820)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+......+.  ..    .....+...         ..+....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~~---------~~~~~~~  308 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTRM---------RAPDYTT  308 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCCC---------CCCCCCC
Confidence            678999999999899999999999999999997 8888864322211  11    111111110         0111233


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          728 NKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       728 ~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+.+++.+||+.+|.+||++.|+++.|+.+++
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            568899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.6e-35  Score=321.71  Aligned_cols=241  Identities=25%  Similarity=0.351  Sum_probs=191.4

Q ss_pred             eeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|+..+ ++.||+|.+...   .....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            379999999999999764 678999986542   123344556677777654 899999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~  153 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA  153 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence            99999886543  5889999999999999999999   7899999999999999999999999999997543211  223


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+...      .... .          ...++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~-~----------~~~~~  216 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SILN-D----------RPHFP  216 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHc-C----------CCCCC
Confidence            34578999999999999999999999999999999999999997544322111      1110 0          01122


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHH-HHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMG-DVLW  753 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl~  753 (820)
                      .....++.+++.+||+.+|.+||++. ++++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            33446788999999999999999875 4433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.5e-35  Score=310.09  Aligned_cols=249  Identities=25%  Similarity=0.383  Sum_probs=202.0

Q ss_pred             eeEeeecceEEEEEEEcC--c--cEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD--E--TKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~--~--~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|++|.||+|.+..  +  ..+|+|.+..... ...+.|..|++++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999999753  2  3689999876655 567889999999999999999999999988 889999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc-cc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HV  642 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~  642 (820)
                      |+|.+++.......++|...+.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||+++........ ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997654357899999999999999999999   789999999999999999999999999999865432211 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||++.+..++.++|||||||+++||++ |+.|+......+.   ......   ....         ..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~~~---------~~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EGER---------LE  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cCCc---------CC
Confidence            223457789999999999999999999999999999999 9999865433221   111111   0000         01


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      .+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            12234567999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.7e-35  Score=329.14  Aligned_cols=252  Identities=21%  Similarity=0.296  Sum_probs=194.8

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .|...++||+|+||.||+|+.. +++.+|+|.+....   ....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888899999999999999975 57889999875432   2345678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC-
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD-  638 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~-  638 (820)
                      |+++|+|.+++....  .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999987643  5788888999999999999999   7899999999999999999999999999975321000 


Q ss_pred             --------------------------------------------CccccccccCCccccCccccccCCCCCcceeeehhh
Q 003436          639 --------------------------------------------QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGV  674 (820)
Q Consensus       639 --------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGv  674 (820)
                                                                  .........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                        000012346899999999999999999999999999


Q ss_pred             hHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC---HHHH
Q 003436          675 VMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS---MGDV  751 (820)
Q Consensus       675 ll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~ev  751 (820)
                      ++|||++|++||....+.+...      ......       ..+..........++.+++.+|+ .+|++|++   +.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~------~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQM------KVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHH------HHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            9999999999997654332211      000000       00000001122345667777765 59999987   7777


Q ss_pred             HHH
Q 003436          752 LWN  754 (820)
Q Consensus       752 l~~  754 (820)
                      +++
T Consensus       303 ~~h  305 (382)
T cd05625         303 KAH  305 (382)
T ss_pred             hcC
Confidence            654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-36  Score=324.13  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=212.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce-EEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE-MIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-~~lV~  558 (820)
                      ++|...+++|+|+||.++..+++ ++..+++|++....  ....+..++|+.++++++|||||.+.+.+.+++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788889999999999998876 46789999865443  3334567899999999999999999999988888 99999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      +|++||+|.+.|...+...+++.+++++..|++.|++|||   +..|+|||||+.||+++.+..+||+|||+|+......
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999887778999999999999999999999   7899999999999999999999999999999865532


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......||+.||.||.+.+.+|..|+|+|||||+++||++-+++|.......   ++.   +..          +..
T Consensus       161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~---ki~----------~~~  222 (426)
T KOG0589|consen  161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL---KIN----------RGL  222 (426)
T ss_pred             --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH---HHh----------hcc
Confidence              24456789999999999999999999999999999999999999997654322   211   110          011


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....+.....++..++..|++.+|..||++.+++.+
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            123345566789999999999999999999999987

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=322.02  Aligned_cols=254  Identities=31%  Similarity=0.466  Sum_probs=212.8

Q ss_pred             CccceeEeeecceEEEEEEEcC---c--cEEEEEeCCC-CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD---E--TKVAVKRGGT-QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~---~--~~vavK~~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ....++||.|-||.||+|++.+   |  -.||||..+. ......+.|+.|+.+|++++||||++|+|.|.+ ...++||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            3445689999999999999643   2  3588887654 344557889999999999999999999999977 4689999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      |.++-|-|+.+|.... ..|+.......|.|++.+|+|||   +..+|||||..+|||+...-.+||+||||+|...+..
T Consensus       470 EL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             ecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            9999999999997654 46888999999999999999999   8999999999999999999999999999999887654


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      ... .+..+-++.|||||.+.-++++.++|||.|||++||++. |..||..-...+...       .++.|         
T Consensus       546 yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnG---------  608 (974)
T KOG4257|consen  546 YYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENG---------  608 (974)
T ss_pred             hhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCC---------
Confidence            433 335567889999999999999999999999999999987 888987554333211       11111         


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      -+-..++.|+..+..|+.+||+.+|.+||.+.|+...|+.+++
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            1224577899999999999999999999999999999998887

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.6e-35  Score=326.98  Aligned_cols=254  Identities=23%  Similarity=0.355  Sum_probs=195.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||+||+++.. .++.+|+|.+....   ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999876 47899999875432   233456888999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999764  36899999999999999999999   7899999999999999999999999999987543211


Q ss_pred             Cc---------------------------------cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCC
Q 003436          639 QT---------------------------------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV  685 (820)
Q Consensus       639 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p  685 (820)
                      ..                                 .......||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            00                                 001235799999999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhh--cCCCCCCCHHHHHHH
Q 003436          686 IDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLA--QCGIDRPSMGDVLWN  754 (820)
Q Consensus       686 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~--~dp~~RPs~~evl~~  754 (820)
                      |......+....   +...  ...+  .+.+.      .....++.+++.+++.  .++..||++.|++++
T Consensus       236 f~~~~~~~~~~~---i~~~--~~~~--~~p~~------~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETYKK---VMNW--KETL--IFPPE------VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHHHH---HHcC--cCcc--cCCCc------CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            976543322111   1100  0000  01110      0122445566665332  344467999999876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-35  Score=311.25  Aligned_cols=248  Identities=31%  Similarity=0.495  Sum_probs=196.8

Q ss_pred             eEeeecceEEEEEEEcC-cc--EEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          490 VIGIGGFGKVYRGVLRD-ET--KVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~-~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      .||+|+||.||+|++.+ +.  .+++|..... .....+.+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            68999999999999864 33  4688876643 344556889999999999 8999999999999999999999999999


Q ss_pred             chhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          565 TLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       565 sL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      +|.+++....              ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999997532              135889999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      ++....   .........+..|+|||++....++.++||||||++++||++ |+.||......+   ..+   .... + 
T Consensus       159 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~~~~-~-  227 (270)
T cd05047         159 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---KLPQ-G-  227 (270)
T ss_pred             ccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH---HHhC-C-
Confidence            863221   111112234567999999988899999999999999999997 999986432211   111   1111 0 


Q ss_pred             cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       710 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                              ............+.+++.+|++.+|.+||++.++++.|+.++
T Consensus       228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                    000112234467899999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.1e-35  Score=318.11  Aligned_cols=264  Identities=21%  Similarity=0.287  Sum_probs=198.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...++||+|+||.||+|+.. +++.+|+|.+..... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            367889999999999999999986 578899998764432 223467789999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |++ ++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            996 68888776543 45888999999999999999999   7899999999999999999999999999987533211 


Q ss_pred             ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc---ccc---
Q 003436          640 THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ---LED---  712 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~---  712 (820)
                       .......+++.|+|||++.+ ..++.++|||||||+++||++|++||.......  ...+..........   ...   
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence             12234568899999999865 457889999999999999999999997543211  11111111100000   000   


Q ss_pred             --ccCccccCCCC----------hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 --IVDPTLTGQIK----------PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 --~~d~~l~~~~~----------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ..++.-.....          ......+.+++.+|++.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence              00000000000          0123467899999999999999999999863

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-35  Score=307.84  Aligned_cols=249  Identities=33%  Similarity=0.523  Sum_probs=204.7

Q ss_pred             eeEeeecceEEEEEEEcC----ccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|....    +..+++|........ ..+.+.+|+++++.++|+|++++++++..+...++|+||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            379999999999999764    778999987655443 367899999999999999999999999999999999999999


Q ss_pred             CchhhHhhhcC-------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          564 GTLKDHLYASN-------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       564 gsL~~~l~~~~-------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ++|.+++....       ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997652       357999999999999999999999   79999999999999999999999999999986654


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........++..|+|||.+....++.++||||||++++||++ |+.|+......+   ..+..   .. +.      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~---~~-~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL---RK-GY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---Hc-CC------
Confidence            332222334567889999999988899999999999999999999 588887553222   11111   11 10      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                         ....+...+.++.+++.+|++.+|.+||++.++++.|+
T Consensus       225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               01122344678999999999999999999999998773

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-35  Score=307.84  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=198.6

Q ss_pred             eeEeeecceEEEEEEEcC----ccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|++..    +..+|+|....... ...+++.+|++++++++|+||+++++++. ....++|+||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            379999999999998643    26799998765543 34578999999999999999999999876 4568999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc-c
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-V  642 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~  642 (820)
                      |+|.+++....  .+++..++.++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++......... .
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999997654  6899999999999999999999   7899999999999999999999999999998553322111 1


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |++||......   .+..+....    ..         ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~----~~---------~~  218 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESG----ER---------LP  218 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcC----Cc---------CC
Confidence            112234568999999999999999999999999999998 99998654332   222222111    00         01


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      .+..++..+.+++.+|+..+|.+||++.++++.|+..
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            2234457789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.2e-35  Score=313.08  Aligned_cols=247  Identities=22%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             EeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       491 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ||+|+||.||+++.. +++.+|+|.+....   ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999976 58899999875322   12234566799999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccc
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV  646 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (820)
                      .+++.......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            99987766667999999999999999999999   789999999999999999999999999998754331   122335


Q ss_pred             cCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       647 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||........  ..+....... ...    .  .   .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-~~~----~--~---~~~~~  222 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-DEV----K--F---EHQNF  222 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-ccc----c--c---ccccC
Confidence            689999999999988899999999999999999999999864332111  1111111111 000    0  0   01123


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ..++.+++.+||+.+|++||++.|+++.+
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            46689999999999999999998776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.2e-35  Score=321.05  Aligned_cols=241  Identities=23%  Similarity=0.317  Sum_probs=194.4

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      +|...++||+|+||.||+|+... ++.+|+|.+....   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            47788899999999999999764 6789999865432   23345567788888877 5899999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence            9999999999886543  5889999999999999999999   789999999999999999999999999998743221 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   .....   . ..         
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~~~i~---~-~~---------  217 (323)
T cd05616         155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIM---E-HN---------  217 (323)
T ss_pred             -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---HHHHH---h-CC---------
Confidence             1122345789999999999999999999999999999999999999975543221   11111   1 10         


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                       ..++.....++.+++.+|++.+|.+|++.
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             01223345678899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.5e-35  Score=313.67  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=201.4

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |+..++||+|+||+||+|... +++.+|+|.+....   ......+.+|+++|++++|+|++++.+.+..++..++|+||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999975 57889999875432   22345578899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999999987665567999999999999999999999   7899999999999999999999999999987543211  


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                       ......|+..|+|||++.+..++.++|+||||++++||++|+.||.............  ... ....          .
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~-~~~~----------~  222 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRV-LETE----------E  222 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhh-hccc----------c
Confidence             1233568999999999998999999999999999999999999997543322211111  111 1100          0


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                      .+.......+.+++.+|++.+|++||+     +.+++.+
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            122334467889999999999999999     5666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-35  Score=321.96  Aligned_cols=237  Identities=25%  Similarity=0.331  Sum_probs=192.0

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|+.+ +++.||+|.+...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            37999999999999976 4788999986532   223456677899988876 699999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~  153 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT  153 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence            99999887553  6899999999999999999999   789999999999999999999999999998753221  1223


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   .+..    ..+..          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i----~~~~~----------~~~  216 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAI----LNDEV----------VYP  216 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHH----hcCCC----------CCC
Confidence            345799999999999999999999999999999999999999975543221   1111    11110          112


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMG  749 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~  749 (820)
                      ......+.+++.+|++.||++||++.
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence            23446788999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-35  Score=327.35  Aligned_cols=255  Identities=21%  Similarity=0.258  Sum_probs=198.5

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ...++|+..++||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++++..+...+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34568999999999999999999986 4778999986432   2233456889999999999999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||+++|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999998653   4788899999999999999999   7899999999999999999999999999998653


Q ss_pred             CCCCccccccccCCccccCccccccC----CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQ----QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|++||.........      ......... 
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~~-  265 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKNS-  265 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCcc-
Confidence            3211 122345799999999999754    3788999999999999999999999754332211      111110000 


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID--RPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  754 (820)
                            +.-.........+.+++.+|+..++.+  ||++.|++++
T Consensus       266 ------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 ------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                  000001123456788889999755543  8899998876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-35  Score=311.44  Aligned_cols=258  Identities=22%  Similarity=0.322  Sum_probs=206.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|++|.||+++.. ++..++||.+...   .....+++.+|+++++.++|+||+++++++.+++..++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            35777889999999999999964 6889999976532   2334568899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          559 EYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||+++++|.+++...  ....+++.+++.++.+++.||+|||   +.+++|+||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988642  2346899999999999999999999   78999999999999999999999999999875433


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ..  .......++..|+|||++.+..++.++|+||||+++|||++|+.||...... .   .+.....      .....+
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~---~~~~~~~------~~~~~~  226 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-L---YSLCKKI------EQCDYP  226 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-H---HHHhhhh------hcCCCC
Confidence            21  1122346889999999999889999999999999999999999998643221 1   1111111      111111


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      .+   ........+.+++.+|++.+|.+||+|.+|++.++++
T Consensus       227 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11   1123456789999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-35  Score=307.97  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=203.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-----hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-----HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...++||+|++|.||++... +++.+++|......     ....+.+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56888999999999999999875 57899999764322     2234678899999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++++|.+++....  .+++..+.+++.+++.||+|||   ..+++||||+|+||++++++.++|+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999987543  5888999999999999999999   78999999999999999999999999999875433


Q ss_pred             CCCccc-cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHV-STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...... .....++..|+|||++.+..++.++||||||+++|||++|+.||......+.   .....   .         
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~---~---------  221 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFKIA---T---------  221 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHHHh---c---------
Confidence            211111 1234578899999999999999999999999999999999999864322211   11100   0         


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......+......+.+++.+|++.+|.+||++.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            001112233455678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.6e-35  Score=320.66  Aligned_cols=243  Identities=23%  Similarity=0.338  Sum_probs=193.8

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+++.. +++.+|+|.+...   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            37999999999999976 4688999987643   223456688999999888 699999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (327)
T cd05617          81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTT  153 (327)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCce
Confidence            99998886543  6899999999999999999999   789999999999999999999999999998743221  1122


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||............++..........          ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence            3457999999999999999999999999999999999999999653332222222222222111111          122


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                      ......+.+++.+||+.||.+|+++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2344668899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.3e-35  Score=314.21  Aligned_cols=246  Identities=22%  Similarity=0.330  Sum_probs=195.7

Q ss_pred             EeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       491 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ||+|+||+||++... +++.+|+|.+....   ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999976 57899999875432   22345678899999999999999999999999999999999999999


Q ss_pred             hhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccc
Q 003436          567 KDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST  644 (820)
Q Consensus       567 ~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (820)
                      .+++...  ....+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......  ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence            9888542  3356899999999999999999999   7899999999999999999999999999997543321  1223


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      ...||..|+|||.+.+..++.++|||||||++|||++|+.||.........  .......         ....  ...+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~---------~~~~--~~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRI---------LNDS--VTYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhh---------cccC--CCCcc
Confidence            456899999999999999999999999999999999999999654322111  0000000         0000  12233


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      ..+..+.+++.+|++.+|++||     ++.+++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            4557789999999999999999     66777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.4e-35  Score=328.75  Aligned_cols=252  Identities=21%  Similarity=0.281  Sum_probs=197.2

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      +|+..+.||+|+||.||+++.. .++.+|+|.+....   ......+.+|+++|.+++|+||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999976 47889999875432   2234568899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC-
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD-  638 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~-  638 (820)
                      |+++|+|.+++....  .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++....... 
T Consensus        82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            999999999997643  5788888999999999999999   7899999999999999999999999999975321000 


Q ss_pred             ----------------------------------------CccccccccCCccccCccccccCCCCCcceeeehhhhHHH
Q 003436          639 ----------------------------------------QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE  678 (820)
Q Consensus       639 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~E  678 (820)
                                                              .........||+.|+|||++.+..++.++|||||||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0000123469999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCC---CHHHHHHH
Q 003436          679 ILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP---SMGDVLWN  754 (820)
Q Consensus       679 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---s~~evl~~  754 (820)
                      |++|+.||....+.+....      ......       .+...........+.+++.+|+ .+|.+|+   ++.+++++
T Consensus       237 ll~G~~Pf~~~~~~~~~~~------i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         237 MLVGQPPFLADTPAETQLK------VINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhhCCCCCCCCCHHHHHHH------HhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            9999999976544322111      000000       0000011123456777888876 5999999   88888866

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=336.02  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=215.0

Q ss_pred             CccceeEeeecceEEEEEEEc-Cc----cEEEEEeCC-CCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DE----TKVAVKRGG-TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~----~~vavK~~~-~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ....++||+|+||+||||.+- .+    .+||+|.+. ....+...++++|+-+|.+|+||||++|+|+|.... +.||.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            455679999999999999863 23    468888754 345566789999999999999999999999998766 88999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      +||+.|+|.++++.++ ..+.-+..+.|+.|||+||.|||   .+.++||||.++|||+.....+||.|||+++......
T Consensus       777 q~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            9999999999998754 46888999999999999999999   7999999999999999999999999999999877766


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      ........+-.+.|||-|.+....++.++|||||||.+|||+| |..|++....++..++.+       .+.        
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~ge--------  917 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KGE--------  917 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------ccc--------
Confidence            5555556667789999999999999999999999999999999 888887765555444332       221        


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                       +-..++.|...+..++.+||..|+..||.++++...+....
T Consensus       918 -RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  918 -RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             -cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence             11346678889999999999999999999999998886654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=309.65  Aligned_cols=267  Identities=23%  Similarity=0.340  Sum_probs=206.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCC--CCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-----Cce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGG--TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-----RNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~--~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~  553 (820)
                      ...|...+.||+|++|.|.+++.. +|..||+|++.  .......++-.+|+++|+.++|+||+.+...+..     -..
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            344555678999999999999976 57999999987  4455667888999999999999999999998744     357


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .|+|+|+|+ -+|.+.++...  .|+.....-+..|+++||.|+|   +.+++||||||+|+|++.+..+||+|||+||.
T Consensus       101 vYiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence            899999994 58888886543  4888889999999999999999   78999999999999999999999999999997


Q ss_pred             CCCCCCccccccccCCccccCccccc-cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ..........+....|..|.|||.+. ...|+...||||.||++.||++|++.|.+...-++..++........+..+..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            65433334456677899999999885 46899999999999999999999998876654444433321111110001111


Q ss_pred             cc--------C------ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 IV--------D------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 ~~--------d------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +-        .      +......-+......++|+++||..||.+|+|+.|.+++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            10        0      000011122445678899999999999999999999875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-35  Score=328.73  Aligned_cols=260  Identities=22%  Similarity=0.239  Sum_probs=196.5

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...++||+|+||.||++... .++.||+|...      .+.+.+|+++|++++||||+++++++..+...++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999975 57889999743      23567899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +. ++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... .
T Consensus       165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~  237 (391)
T PHA03212        165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A  237 (391)
T ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence            95 6888888654  36899999999999999999999   7899999999999999999999999999997533211 1


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh----hhhHHHHHHHhhccC--------
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE----KVNLVEWAMKCQETG--------  708 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~----~~~l~~~~~~~~~~~--------  708 (820)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.|+......+    .......+.......        
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            12234579999999999999999999999999999999999997764321100    000000000000000        


Q ss_pred             --ccccc---------cCccccCC--CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 --QLEDI---------VDPTLTGQ--IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 --~~~~~---------~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .+.+.         ..+.....  .....+.++.+++.+||+.||++||++.|++++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              00000         00000000  001235678899999999999999999999864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.7e-35  Score=314.40  Aligned_cols=262  Identities=24%  Similarity=0.420  Sum_probs=203.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-----CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-----DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  554 (820)
                      +.|...+.||+|+||.||++++.     ++..||+|.+.... ....+.+.+|++++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            34678889999999999999853     46789999876543 34456799999999999999999999998765  568


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++++|.+++.... ..++|.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            89999999999999986543 35899999999999999999999   789999999999999999999999999999864


Q ss_pred             CCCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCch---------hhhhHHHHHHHh
Q 003436          635 PDLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR---------EKVNLVEWAMKC  704 (820)
Q Consensus       635 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~---------~~~~l~~~~~~~  704 (820)
                      ...... .......++..|+|||++.+..++.++||||||++++||++++.|.......         .......+. ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RV  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HH
Confidence            432211 1122345677899999998889999999999999999999987654321110         000011111 11


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      ...+.         .......++..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            11111         0112234567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-34  Score=305.85  Aligned_cols=250  Identities=21%  Similarity=0.345  Sum_probs=204.0

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +|+..++||+|+||.||++... ++..+++|..... .....+.+.+|+.++++++|+||+++++.+..++..++|+||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677889999999999999976 5788999986432 3345677889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.......+++...+.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            9999999987655556899999999999999999999   7899999999999999999999999999987543321  1


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......++..|+|||++.+..++.++|+||||++++||++|+.||.........      ... ..+...         .
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~---------~  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------LKV-CQGSYK---------P  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH------HHH-hcCCCC---------C
Confidence            223456888999999999989999999999999999999999999754322111      111 111111         1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+......+.+++.+||+.+|++||++.+++..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            122334568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-35  Score=312.88  Aligned_cols=238  Identities=26%  Similarity=0.382  Sum_probs=189.1

Q ss_pred             eEeeecceEEEEEEEcC-------------------------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeE
Q 003436          490 VIGIGGFGKVYRGVLRD-------------------------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL  544 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~-------------------------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l  544 (820)
                      +||+|+||.||+|.+..                         ...|++|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998521                         13588898776555556788999999999999999999


Q ss_pred             EeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---
Q 003436          545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---  621 (820)
Q Consensus       545 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---  621 (820)
                      +++|.+....++||||+++|+|..++... ...+++..++.++.|+++||+|||   +.+|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999988653 346899999999999999999999   78999999999999997643   


Q ss_pred             ----CeeEeeccccccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHH-hcCCCCCCCCCchhhh
Q 003436          622 ----MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEI-LCGRPVIDPSLPREKV  695 (820)
Q Consensus       622 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~El-ltG~~p~~~~~~~~~~  695 (820)
                          .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.|+....+.+..
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                4799999987643221      12346788999998865 5689999999999999998 4788888654332221


Q ss_pred             hHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          696 NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       696 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .   +...   ..            ..+......+.+++.+||+.+|.+||++.++++.|
T Consensus       232 ~---~~~~---~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 R---FYEK---KH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             H---HHHh---cc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            1   1110   00            01112234688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.9e-35  Score=315.88  Aligned_cols=258  Identities=24%  Similarity=0.414  Sum_probs=202.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-Ccc----EEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DET----KVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|+..+.||+|+||.||+|++. ++.    .+|+|...... .....++.+|+.++++++||||++++|+|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            45778889999999999999864 333    47888776543 23345788999999999999999999998754 4679


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ++||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999987543 35889999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........++..|+|||++.+..++.++||||||+++|||++ |+.|+......+   ..++..    .+...    
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~~----  230 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLE----KGERL----  230 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----CCCCC----
Confidence            222212223345778999999999999999999999999999997 888886443222   122211    11100    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                           .....+...+.+++.+|+..+|++||++.++++.|+.+...
T Consensus       231 -----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         231 -----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                 11123446788999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=304.84  Aligned_cols=248  Identities=30%  Similarity=0.465  Sum_probs=199.9

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchh
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLK  567 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  567 (820)
                      ++||+|+||.||++.+.+++.|++|....... ...+.|.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            37899999999999987789999998765443 35678999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccccccc
Q 003436          568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK  647 (820)
Q Consensus       568 ~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  647 (820)
                      +++.... ..+++..++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++...............
T Consensus        81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9987543 36889999999999999999999   7899999999999999999999999999987543211111111223


Q ss_pred             CCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       648 gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      .+..|+|||.+.+..++.++|+||||++++||++ |..|+.........   ...    ...         .....+...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~~~----~~~---------~~~~~~~~~  220 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---ERI----ESG---------YRMPAPQLC  220 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---HHH----hcC---------CCCCCCccC
Confidence            4567999999998899999999999999999999 77887544322111   111    100         001122344


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      +..+.+++.+|++.+|.+||++.|+++.|+
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-34  Score=317.41  Aligned_cols=237  Identities=25%  Similarity=0.328  Sum_probs=188.2

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHH-HHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIE-MLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|+.. +++.+|+|.+....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            37999999999999986 57889999865321   222344555554 67889999999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETT  153 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCcc
Confidence            9999888654  35788889999999999999999   789999999999999999999999999998753221  1222


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|++||......+   ..+.   ... ..          ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~---i~~-~~----------~~~~  216 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDN---ILH-KP----------LQLP  216 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHH---Hhc-CC----------CCCC
Confidence            34568999999999999999999999999999999999999997543221   1111   111 00          1122


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMG  749 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~  749 (820)
                      ......+.+++.+|++.+|.+||+..
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            34456788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=309.56  Aligned_cols=257  Identities=24%  Similarity=0.385  Sum_probs=205.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-c----cEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-E----TKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~----~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .+|...+.||+|+||.||+|...+ +    ..+++|...... .....++.+|+.++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            457778899999999999998653 2    258899866544 3455788999999999999999999999987 78899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997643 35899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........++..|+|||.+....++.++|+||||++++||++ |+.||......+.   .+...    .+..     
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~~~-----  229 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDLLE----KGER-----  229 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHh----CCCC-----
Confidence            222111222334678999999988899999999999999999999 9999875433221   11111    1110     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                          ...+..+...+.+++.+||..+|.+||++.++++.|..+..
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                01122344678899999999999999999999999988755

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-34  Score=317.99  Aligned_cols=237  Identities=28%  Similarity=0.367  Sum_probs=189.5

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHH-HHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIE-MLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|+.. +++.||+|.+....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            37999999999999986 58899999875332   222345555555 56789999999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTT  153 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCcc
Confidence            9999988754  36889999999999999999999   789999999999999999999999999998753221  1223


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+..      ..... +..          ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~-~~~----------~~~  216 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNILN-KPL----------RLK  216 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHHc-CCC----------CCC
Confidence            3456899999999999999999999999999999999999999754322211      11111 100          112


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMG  749 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~  749 (820)
                      +.....+.+++.+|++.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            23456788999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=9.1e-35  Score=312.61  Aligned_cols=251  Identities=23%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |+..++||+|+||.||++... .++.+|+|.+....   ....+.+..|+.++++++|+|++++++.+..++..++|+||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677789999999999999976 57889999865432   22345678899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++.......+++.+++.++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999997665567999999999999999999999   7899999999999999999999999999987543211  


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                       ......|+..|+|||++.+..++.++||||||+++|||++|+.||.............   .....  .        ..
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~--~--------~~  222 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE--V--------QE  222 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh--h--------hh
Confidence             1123468999999999999999999999999999999999999997543221111111   00000  0        01


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                      .........+.+++.+||+.+|++||+     +.|++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            122334466889999999999999999     7888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.4e-35  Score=310.68  Aligned_cols=254  Identities=24%  Similarity=0.343  Sum_probs=201.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|+..+.||+|+||.||+|+.. +++.+|+|+...........+.+|+.++++++||||+++++++..++..++|+||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888899999999999999974 57889999876555455567889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......  .
T Consensus        89 ~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          89 GGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            999999998654  36899999999999999999999   7899999999999999999999999999998543211  1


Q ss_pred             ccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          642 VSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ......++..|+|||.+.   ...++.++|||||||+++||++|++|+....+.+...  .     .....   ...+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-----~~~~~---~~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-----MSKSN---FQPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-----eecCC---CCCCCC
Confidence            122346888999999884   3457889999999999999999999885432221110  0     00000   001111


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .  ........+.+++.+||+.+|++||++.++++.|
T Consensus       232 ~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 K--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1  1123346789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-35  Score=325.02  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=206.1

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |...+.||+|+-|.|-+|++. .|+.+|||.+....   ......+.+|+-+|+.+.|||++++++.++++.++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            556678999999999999975 69999999876542   22245678899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|-|.++|..++  ++++++..+++.||+.|+.|+|   ..+|+||||||+|+|||..+.+||+|||+|.+...   .
T Consensus        94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---g  165 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP---G  165 (786)
T ss_pred             cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC---C
Confidence            99999999998765  6899999999999999999999   78999999999999999999999999999986432   2


Q ss_pred             cccccccCCccccCccccccCCCC-CcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      ..-.+-+|.+.|.|||.+++.+|. .++||||+||+|+.||||+.||+...-   ..+..    ..+.|..+        
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLl----KV~~G~f~--------  230 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLL----KVQRGVFE--------  230 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHH----HHHcCccc--------
Confidence            233456899999999999999874 789999999999999999999984322   12221    22233222        


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                        .+...+.+..+|+.+|+..||.+|-+++||+++-
T Consensus       231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             --CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence              2345567788999999999999999999999874

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.7e-35  Score=326.45  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=200.3

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc-----eEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-----EMI  555 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  555 (820)
                      +|+..++||+|+||.||++... +++.||+|++...  .....+.+.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778889999999999999975 6889999987543  2344577899999999999999999999997766     789


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||+. ++|.+.+...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999997 5788877543  36899999999999999999999   7899999999999999999999999999998643


Q ss_pred             CCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH-------------
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA-------------  701 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~-------------  701 (820)
                      ... ........++..|+|||++.+. .++.++|||||||+++||++|++||....+.+....+...             
T Consensus       155 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         155 PDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             cCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            321 1222334578899999999774 5789999999999999999999999765543332221110             


Q ss_pred             ---HHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          702 ---MKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       702 ---~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ..............+. ..........++.+++.+|++.||++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPSLPV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCchHH-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               0000000000000000 001122335678899999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-34  Score=307.17  Aligned_cols=258  Identities=23%  Similarity=0.351  Sum_probs=208.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCC---CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGT---QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|++|.||+|... +++.+++|.+..   ......+.+.+|++++++++|+|++++++++...+..++|+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999999999999987 688999997643   22334578899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          559 EYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||+++|+|.+++...  ....+++.+++.++.+++.||+|||   +.+++||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642  2346899999999999999999999   78999999999999999999999999999875433


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ..  .......++..|+|||.+.+..++.++|||||||++|||++|+.|+.....    ...+..... ..+...    +
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~----~  227 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-EKCDYP----P  227 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhh-hcCCCC----C
Confidence            21  112234588899999999988999999999999999999999999854321    111111111 111111    0


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                          .........+.+++.+|++.+|.+||++.++++.|+++
T Consensus       228 ----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 ----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                01113456788999999999999999999999999765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-34  Score=311.01  Aligned_cols=250  Identities=23%  Similarity=0.335  Sum_probs=198.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|+..++||+|+||.||+|+.. +++.+|+|..... .....+++.+|++++++++||||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999864 5788999986543 334456799999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|..+.      .+++..+..++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||++......   
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            9999996542      4788899999999999999999   789999999999999999999999999998754321   


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh-hHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV-NLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                       ......++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ....+..... ...     .+.+ 
T Consensus       149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~-  220 (279)
T cd06619         149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DED-----PPVL-  220 (279)
T ss_pred             -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccC-----CCCC-
Confidence             123356899999999999999999999999999999999999998653322111 1111111110 000     0111 


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .......++.+++.+|++.+|++||++.|++++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              111234568899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=325.66  Aligned_cols=245  Identities=27%  Similarity=0.370  Sum_probs=205.3

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCce
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNE  553 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  553 (820)
                      ....++|...++||+|.||+|+++.+++ ++.+|||.++..   ...+.+..+.|.+++... +||.|+.|+..++.+++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            3455789999999999999999999874 678899977654   345567788899888877 59999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      +++||||+.||++..+.+   ...+++..+.-++..|+.||+|||   +++||+||||.+|||||.+|.+||+|||+++.
T Consensus       444 l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence            999999999999544433   346899999999999999999999   89999999999999999999999999999996


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ...  ....+.+.+||+.|||||++.++.|+...|.|||||+|||||.|+.||....+++..+.+.              
T Consensus       518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--------------  581 (694)
T KOG0694|consen  518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--------------  581 (694)
T ss_pred             cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--------------
Confidence            442  2234567899999999999999999999999999999999999999998776555433221              


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                      .|.   ..++..+..+.+.|+.+++.++|++|--+
T Consensus       582 ~d~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 NDE---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cCC---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            011   12445667889999999999999999765

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.7e-35  Score=310.71  Aligned_cols=248  Identities=32%  Similarity=0.490  Sum_probs=197.7

Q ss_pred             eEeeecceEEEEEEEcC-------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          490 VIGIGGFGKVYRGVLRD-------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~-------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .||+|+||.||+|+..+       +..+++|...... .....+|.+|++++++++||||++++++|...+..++|+||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999998653       2578889765433 234678899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcC-----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-----CeeEeecccc
Q 003436          562 ENGTLKDHLYASN-----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-----MAKVADFGLS  631 (820)
Q Consensus       562 ~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-----~~kl~DFGla  631 (820)
                      ++++|.+++....     ...++|.+++.++.|++.||+|||   +.+++|+||||+||+++.+.     .+||+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            9999999997532     234889999999999999999999   78999999999999998877     8999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |+.|+......+   ......   ...  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~~---~~~--  230 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHVT---AGG--  230 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHHh---cCC--
Confidence            75433222222223345788999999999999999999999999999998 998886433221   111111   100  


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                              ........+..+.+++.+||..+|.+||++.++++.|+
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    00122345577899999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.7e-34  Score=307.44  Aligned_cols=257  Identities=28%  Similarity=0.406  Sum_probs=205.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcCc----cEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDE----TKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...++||+|+||.||+|.+.+.    ..+++|...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577788999999999999986532    468899876554 4556789999999999999999999999875 457899


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+++|+|.+++.... ..+++.+++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999997543 35899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      . ........++..|+|||.+....++.++||||||++++||++ |+.||......+.   ..+..   .....      
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~---~~~~~------  227 (270)
T cd05056         161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIE---NGERL------  227 (270)
T ss_pred             c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH---cCCcC------
Confidence            1 111222334568999999988889999999999999999986 9999865533221   11111   10000      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                          ..+..++..+.+++.+|+..+|.+||++.++++.|+++...
T Consensus       228 ----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         228 ----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                12234557899999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.2e-35  Score=308.56  Aligned_cols=238  Identities=24%  Similarity=0.377  Sum_probs=189.9

Q ss_pred             eEeeecceEEEEEEEcC-------------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          490 VIGIGGFGKVYRGVLRD-------------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~-------------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .||+|+||.||+|+...             ...|++|.+..........|.+|+.+++.++||||+++++++..+...++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            68999999999998532             23588898776655566788999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC-------eeEeecc
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM-------AKVADFG  629 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~-------~kl~DFG  629 (820)
                      |+||+++|+|..++.... ..+++..+++++.|+++||+|||   +.+|+||||||+|||++.++.       +|++|||
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999998886543 45899999999999999999999   789999999999999987664       8999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccc-cCCCCCcceeeehhhhHHHHh-cCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEIL-CGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvll~Ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      ++.....      .....++..|+|||++. +..++.++|||||||++|||+ +|+.|+......+....       . .
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~-~  223 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y-E  223 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H-h
Confidence            9864322      12245788899999986 567899999999999999998 57777754322211110       0 0


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      +..          .........+.+++.+||+.+|.+||++.++++.|
T Consensus       224 ~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 GQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             cCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            000          01112345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.1e-34  Score=308.73  Aligned_cols=257  Identities=23%  Similarity=0.366  Sum_probs=205.2

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++.+++++....+||+|+||.||+|++. ++..|++|..........+.+.+|++++++++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4567788888889999999999999966 467899998877766677889999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCC--CHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeecccccc
Q 003436          557 IYEYMENGTLKDHLYASNFPSL--SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKI  633 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l--~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~  633 (820)
                      |+||+++++|.+++.... ..+  ++..+..++.|++.||+|||   ..+|+||||||+||+++. ++.+||+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            999999999999997643 234  78889999999999999999   789999999999999976 67999999999875


Q ss_pred             CCCCCCccccccccCCccccCccccccC--CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQ--QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      .....  .......++..|+|||++.+.  .++.++||||||+++|||++|++|+........   ..+......     
T Consensus       159 ~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~-----  228 (268)
T cd06624         159 LAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK-----  228 (268)
T ss_pred             cccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-----
Confidence            43211  112234578999999998654  378999999999999999999999864321111   111110000     


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                            .....+.....++.+++.+|++.+|.+||++.|++++
T Consensus       229 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 ------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                  0112233445678899999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-35  Score=313.62  Aligned_cols=261  Identities=24%  Similarity=0.401  Sum_probs=205.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-----CccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeec--CceEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-----DETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEMI  555 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~  555 (820)
                      .|...+.||+|+||.||+|++.     .+..+|||........ ..+.|.+|++++++++|+||+++++++..  +...+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            4666789999999999999864     3578999987655443 56789999999999999999999999877  56789


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||+++++|.+++.... ..+++.+++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++....
T Consensus        85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999997643 35999999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh---------hHHHHHHHhh
Q 003436          636 DLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV---------NLVEWAMKCQ  705 (820)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~---------~l~~~~~~~~  705 (820)
                      ..... .......++..|++||.+.+..++.++||||||++++||++|+.|+.........         ....+...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL--  238 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH--
Confidence            32211 1112234566799999998889999999999999999999999887543221100         00111111  


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                              +........+..++.++.+++.+|++.+|.+||++.|++++|+.+
T Consensus       239 --------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 --------LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             --------HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                    111111112234557899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-35  Score=312.06  Aligned_cols=257  Identities=23%  Similarity=0.342  Sum_probs=201.5

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh--------------hhHHHHHHHHHHHHcCCCCceeeE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH--------------QGLAEFRTEIEMLSQFRHRHLVSL  544 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--------------~~~~~f~~Ei~~l~~l~H~nIv~l  544 (820)
                      ...++|+....||+|.||.|-+|+.. +++.||+|.+.....              ..++...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            44577999999999999999999965 588999997643321              113578899999999999999999


Q ss_pred             EeEeec--CceEEEEEeeccCCchhhHhhhcCCCC-CCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC
Q 003436          545 IGYCDE--RNEMIIIYEYMENGTLKDHLYASNFPS-LSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL  621 (820)
Q Consensus       545 ~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~  621 (820)
                      +.+..+  .+.+|||+|||..|.+...   ..... ++..+..+++.++..||+|||   .++||||||||+|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            999855  4679999999999887543   22233 899999999999999999999   79999999999999999999


Q ss_pred             CeeEeeccccccCCCC---CCccccccccCCccccCccccccCC----CCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          622 MAKVADFGLSKIGPDL---DQTHVSTAVKGSFGYLDPEYLTKQQ----LTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       622 ~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                      ++||+|||.+......   +....-....||+.|+|||.+.++.    .+.+.||||+||.||.|+-|+.||......+.
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999998754221   1111123468999999999997743    45688999999999999999999965432221


Q ss_pred             hhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          695 VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       695 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                                     ..+++...|.-...++..+.+.+|++++|++||++|-+..+|..+..-
T Consensus       328 ---------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  328 ---------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             ---------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence                           112223333222233556789999999999999999999999877643

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.3e-35  Score=319.25  Aligned_cols=241  Identities=25%  Similarity=0.339  Sum_probs=192.1

Q ss_pred             eeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      +.||+|+||.||+|+..+ ++.||+|.+....   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            379999999999999864 6789999865431   22345567788888764 899999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKT  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCce
Confidence            9999998754  36889999999999999999999   789999999999999999999999999998743221  1122


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+.   .+...    ..      .+.    ++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~i~----~~------~~~----~~  216 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQSIR----MD------NPC----YP  216 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hC------CCC----CC
Confidence            345689999999999999999999999999999999999999975443221   11111    00      011    11


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHH-HHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMG-DVLW  753 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl~  753 (820)
                      ......+.+++.+|++.+|.+||++. ++++
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            22345688999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-35  Score=307.94  Aligned_cols=257  Identities=25%  Similarity=0.346  Sum_probs=197.0

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc-----eEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-----EMIII  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~lV  557 (820)
                      .|...+++|.|+||.||+|++.. ++.||||+.-.+.+.    -.+|+++|++++|||||+|+-++....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            46777899999999999999764 689999987654432    136899999999999999998874332     34589


Q ss_pred             EeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeeccccccC
Q 003436          558 YEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLSKIG  634 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla~~~  634 (820)
                      +||||. +|.+.+..  .....++...+.-+..|+.+||+|||   ..+|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999986 99988874  23456777778889999999999999   7999999999999999876 99999999999976


Q ss_pred             CCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc---
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL---  710 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---  710 (820)
                      .....+   .....|.-|.|||++.+. .|+.+.||||.||++.||+-|++.|.+....++...+-   ++......   
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi---k~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII---KVLGTPTREDI  250 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH---HHhCCCCHHHH
Confidence            543222   234467789999999875 79999999999999999999999998765555443331   11111111   


Q ss_pred             -------ccccCccccC-----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 -------EDIVDPTLTG-----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 -------~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                             .+...|.+..     -+......+.++++.++++.+|.+|.++.|++.+
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                   1111222221     1334556789999999999999999999999865

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.9e-35  Score=344.36  Aligned_cols=262  Identities=24%  Similarity=0.305  Sum_probs=206.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+|+.. .++.||+|++...   .....++|.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888999999999999999976 4789999987543   2334567999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcC---------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          559 EYMENGTLKDHLYASN---------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~---------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                      ||+++|+|.+++....         ...+++..+++++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421         234678889999999999999999   7899999999999999999999999999


Q ss_pred             ccccCCCCCC----------------ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh
Q 003436          630 LSKIGPDLDQ----------------THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE  693 (820)
Q Consensus       630 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~  693 (820)
                      +++.......                ........||+.|+|||++.+..++.++|||||||+++||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986421100                001123469999999999999999999999999999999999999996532211


Q ss_pred             hhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHHhh
Q 003436          694 KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-SMGDVLWNLEYALQL  761 (820)
Q Consensus       694 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~~~~  761 (820)
                      ..    +.      .   .+.++.-. ....+.+..+.+++.+|++.+|++|| ++.++++.|+..++.
T Consensus       239 i~----~~------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 IS----YR------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh----hh------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            10    00      0   00111100 00123456788999999999999995 677888888877654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=325.34  Aligned_cols=250  Identities=24%  Similarity=0.379  Sum_probs=209.2

Q ss_pred             cceeEeeecceEEEEEEEcC--c--cEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          487 ESLVIGIGGFGKVYRGVLRD--E--TKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~--~--~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ..++||+|.||.|++|.++.  |  ..||||.++..... ...+|++|+.+|.+|+|+|+++|+|...+ ....+|+|++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            44589999999999999873  3  35899988766544 68899999999999999999999999887 6788999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      +.|||.+.|+......|-...+..++.|||.||+||.   .+++|||||..+|+||-....+||+||||.|.....+...
T Consensus       193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y  269 (1039)
T KOG0199|consen  193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY  269 (1039)
T ss_pred             ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence            9999999999866667888889999999999999999   8999999999999999999999999999999766544444


Q ss_pred             cc-ccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          642 VS-TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       642 ~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .. ....-.+.|+|||.++...++.++|||+|||.||||+| |..||-.....+....+                |..-+
T Consensus       270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i----------------D~~er  333 (1039)
T KOG0199|consen  270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI----------------DAGER  333 (1039)
T ss_pred             EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc----------------ccccc
Confidence            33 33456788999999999999999999999999999999 56888766543332222                21111


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      -.-++.|++.+.++++.||..+|++||++..+.+.+-
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            2345688999999999999999999999999986543

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.7e-34  Score=305.77  Aligned_cols=251  Identities=27%  Similarity=0.463  Sum_probs=195.3

Q ss_pred             eeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEee-cCceEEEEEeecc
Q 003436          489 LVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD-ERNEMIIIYEYME  562 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~~~~lV~E~~~  562 (820)
                      +.||+|+||.||+|.+.+    ...+|+|+.... .....+.+.+|+.+++.++|||+++++++|. .++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998642    357899987543 3445678899999999999999999999875 4556889999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc--
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--  640 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~--  640 (820)
                      +|+|.+++.... ..+++..++.++.|++.||+|||   ..+++||||||+|||+++++.+||+|||+++........  
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999987543 34678889999999999999999   789999999999999999999999999999754321111  


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcC-CCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG-RPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .......++..|+|||.+.+..++.++||||||+++|||++| .+|+......   .+.....   . +..     +   
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~---~-~~~-----~---  221 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL---Q-GRR-----L---  221 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh---c-CCC-----C---
Confidence            111234467789999999888999999999999999999995 4555433221   1222111   1 100     0   


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                       ..+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       222 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 -LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             111233467889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.3e-35  Score=312.41  Aligned_cols=262  Identities=22%  Similarity=0.327  Sum_probs=195.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcC---CCCceeeEEeEeec-----Cc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQF---RHRHLVSLIGYCDE-----RN  552 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~-----~~  552 (820)
                      +|+..+.||+|+||.||+|+.. +++.+|+|.+....  ......+.+|+++++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778889999999999999976 57889999865432  11223456677777655   79999999998754     34


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++|+||++ ++|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5799999997 48999887765567999999999999999999999   7899999999999999999999999999997


Q ss_pred             cCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhh-HHHHHHHhhccCccc
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVN-LVEWAMKCQETGQLE  711 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~  711 (820)
                      .....   .......+|..|+|||++.+..++.++|||||||+++||++|++||......+... ...+.. ......+.
T Consensus       157 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~~  232 (288)
T cd07863         157 IYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDWP  232 (288)
T ss_pred             cccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCChhhCc
Confidence            64321   11233568899999999999899999999999999999999999986554332211 111100 00000000


Q ss_pred             -------cccCccc---cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          712 -------DIVDPTL---TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       712 -------~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                             ....+..   .....+.....+.+++.+|++.||++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   0000000   01112244567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.3e-35  Score=319.45  Aligned_cols=240  Identities=27%  Similarity=0.343  Sum_probs=190.4

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHH-HHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIE-MLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|+.. +++.+|+|.+...   .....+.+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36999999999999975 5789999986533   2233445566655 46789999999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~  153 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTT  153 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCc
Confidence            9999888654  36899999999999999999999   789999999999999999999999999998753221  1122


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|++||......+..      ..... ..+          ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~~-~~~----------~~~  216 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNILH-KPL----------VLR  216 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHHc-CCc----------cCC
Confidence            3456999999999999999999999999999999999999999754322211      11111 100          112


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVL  752 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  752 (820)
                      +.....+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            23446688999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-34  Score=313.36  Aligned_cols=250  Identities=23%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .+|...+.||+|++|.||+|+.. +++.+++|.+........+.+.+|+.++++++|+|++++++.+..+...++|+||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            46888889999999999999864 57889999877655555678899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++...   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~  171 (296)
T cd06654         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (296)
T ss_pred             CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence            999999998643   4789999999999999999999   7899999999999999999999999999987543211  1


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......++..|+|||.+.+..++.++|||||||+++||++|++||....+.+..  ..+    ...+.      +.+  .
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~----~~~~~------~~~--~  237 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLI----ATNGT------PEL--Q  237 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHH----hcCCC------CCC--C
Confidence            122346888999999999888999999999999999999999999654332211  111    01110      000  1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+......+.+++.+|+..+|++||++.++++.
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            122344678899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=289.21  Aligned_cols=264  Identities=21%  Similarity=0.320  Sum_probs=209.3

Q ss_pred             HhcCCccceeEeeecceEEEEEE-EcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ceE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NEM  554 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  554 (820)
                      ..++|...+.||+|||.-||.++ +.++..+|+|++...+.++.+..++|++..++++|||++++++++..+     .+.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34578889999999999999998 456788999999888888889999999999999999999999987433     358


Q ss_pred             EEEEeeccCCchhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          555 IIIYEYMENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ||+++|...|||.+.+....  +..+++.+.+.|+.++++||++||+. ..++.||||||.|||+.+.+.++|.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            99999999999999997643  34699999999999999999999953 2359999999999999999999999999987


Q ss_pred             cCCCCCCcc-------ccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH
Q 003436          633 IGPDLDQTH-------VSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       633 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ..+-.-...       .......|..|.|||++.   +...++++|||||||+||+|+-|..||+.....          
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------  247 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ----------  247 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc----------
Confidence            543211110       012335788999999984   557899999999999999999999999743221          


Q ss_pred             HhhccCccc-cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          703 KCQETGQLE-DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       703 ~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                          -+.+. .+..+.+.-.-.....+.+.+++++|++.||.+||++.+++..++.+.
T Consensus       248 ----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                11111 111111111112235678999999999999999999999999987653

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.3e-35  Score=319.27  Aligned_cols=240  Identities=25%  Similarity=0.331  Sum_probs=191.9

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|+.. .+..||+|.+....   ......+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            37999999999999986 47889999865431   22345567788888754 899999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~  153 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRA  153 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCce
Confidence            9999988654  36889999999999999999999   789999999999999999999999999998743211  1223


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.||......+.   .+..    ...      .+    ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~~~----~~~------~~----~~~  216 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FESI----RVD------TP----HYP  216 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH----HhC------CC----CCC
Confidence            346789999999999999999999999999999999999999975433221   1111    100      01    112


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHH-HHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMG-DVL  752 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl  752 (820)
                      .....++.+++.+||+.||.+||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            23446788999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.4e-35  Score=319.46  Aligned_cols=242  Identities=25%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             eeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+++... ++.+|+|.+...   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            379999999999999864 678999986543   223456677899999888 799999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......  ...
T Consensus        81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~  153 (318)
T cd05570          81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT  153 (318)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence            99999886543  6899999999999999999999   7899999999999999999999999999987432211  122


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.   ....    ....      .    .++
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~~i----~~~~------~----~~~  216 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQSI----LEDE------V----RYP  216 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HHHH----HcCC------C----CCC
Confidence            335689999999999999999999999999999999999999975432221   1111    1110      0    112


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCH-----HHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSM-----GDVLWN  754 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl~~  754 (820)
                      ......+.+++.+||+.||.+||++     .+++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            2345678999999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-34  Score=307.46  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=190.8

Q ss_pred             eEeeecceEEEEEEEcC---ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCc
Q 003436          490 VIGIGGFGKVYRGVLRD---ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      .||+|+||.||+|...+   ...+++|...... ......|.+|+++++.++|+||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997643   3468888765443 3345678999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCC---CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          566 LKDHLYASNF---PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       566 L~~~l~~~~~---~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      |.+++.....   ...++...+.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999976432   33567888999999999999999   78999999999999999999999999999875332211111


Q ss_pred             cccccCCccccCcccccc-------CCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          643 STAVKGSFGYLDPEYLTK-------QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |+.|+....+.+.   ..   ...... ...+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~~~~-~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LK---QVVREQ-DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH---HHhhcc-CccCC
Confidence            223346778999998743       456889999999999999999 6777754432221   11   111111 11122


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ++.    ........+.+++..|+ .+|++||++.+|++.|
T Consensus       232 ~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         232 KPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            222    22344566778888898 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.8e-34  Score=319.31  Aligned_cols=259  Identities=21%  Similarity=0.249  Sum_probs=201.1

Q ss_pred             HHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc
Q 003436          477 AIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN  552 (820)
Q Consensus       477 ~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  552 (820)
                      ++....++|...+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.+++.++||||+++++.+.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445678999999999999999999987 4678999986432   2233456788999999999999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++||||+++|+|.+++...   .++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            999999999999999998653   4788889999999999999999   7899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccC----CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQ----QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      ...... ........||+.|+|||++.+.    .++.++|||||||++|||++|++||.........      .......
T Consensus       191 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~  263 (371)
T cd05622         191 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMNHK  263 (371)
T ss_pred             EcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHcCC
Confidence            653321 1122345799999999999754    3789999999999999999999999754332111      1111110


Q ss_pred             ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCC--CCCHHHHHHHH
Q 003436          709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID--RPSMGDVLWNL  755 (820)
Q Consensus       709 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L  755 (820)
                      .....       .........+.+++.+|+...+.+  ||++.+++++.
T Consensus       264 ~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 NSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            00000       011234567889999999744433  78999888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.9e-35  Score=319.19  Aligned_cols=241  Identities=27%  Similarity=0.354  Sum_probs=189.7

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHH-HHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEI-EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei-~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      +.||+|+||.||+++.. +++.+|+|.+....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            37999999999999976 46789999865322   12233444444 456889999999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++....  .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~  153 (325)
T cd05602          81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT  153 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence            99999987543  5778888899999999999999   789999999999999999999999999998743221  1223


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....||..|+|||++.+..++.++|||||||++|||++|++||......+.   .....   . ..          ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~---~-~~----------~~~~  216 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNIL---N-KP----------LQLK  216 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHHH---h-CC----------cCCC
Confidence            345799999999999999999999999999999999999999975433221   11111   1 00          0122


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      +.....+.+++.+|++.+|.+||++.+.+.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence            344567889999999999999998775443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.3e-35  Score=310.89  Aligned_cols=253  Identities=25%  Similarity=0.408  Sum_probs=200.5

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC------
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER------  551 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~------  551 (820)
                      .+++.|+..+.||+|+||.||+|... .++.+|+|...... .....+..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888889999999999999976 47789999875443 3346788999999998 799999999998642      


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      ...++|+||+++|+|.+++.......+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46899999999999999998765567999999999999999999999   789999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      +......  .......|+..|+|||++.     +..++.++|||||||++|||++|+.|+....+.....     .  ..
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~--~~  229 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----L--IP  229 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----H--Hh
Confidence            7543211  1223456889999999986     3457889999999999999999999986433221111     0  00


Q ss_pred             cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       707 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ....     +.+   .....+..+.+++.+||..+|.+||++.++++
T Consensus       230 ~~~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNPA-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCCC-----CCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000     111   11234467899999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-34  Score=304.31  Aligned_cols=251  Identities=31%  Similarity=0.528  Sum_probs=201.8

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      .+|+..+.||+|+||.||+|.+.++..+++|....... ...+|.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            35777889999999999999987788899998764332 34678999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.... ..+++..+..++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||+++....... ..
T Consensus        83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~  157 (256)
T cd05112          83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS  157 (256)
T ss_pred             CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence            999999987543 35889999999999999999999   78999999999999999999999999999875432111 11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++.+|+|||++.+..++.++||||||+++|||++ |+.|+......+   ..+   .. ..+  .....+     
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~-~~~--~~~~~~-----  223 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE---TI-NAG--FRLYKP-----  223 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HH-hCC--CCCCCC-----
Confidence            122335678999999998899999999999999999998 888886543222   111   11 111  011111     


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                        ...+..+.+++.+|++.+|++||++.++++.|
T Consensus       224 --~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 --RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              12346799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6e-35  Score=332.63  Aligned_cols=262  Identities=21%  Similarity=0.290  Sum_probs=194.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--------c
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--------N  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~  552 (820)
                      .++|...++||+|+||.||+|+.. .++.||||++....    ....+|+.+|++++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            457999999999999999999975 57899999875432    2335799999999999999998876321        2


Q ss_pred             eEEEEEeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeecc
Q 003436          553 EMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFG  629 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFG  629 (820)
                      .+++||||+++ +|.+++..  .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999985 77777653  23456899999999999999999999   78999999999999998654 79999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc--
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE--  706 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~--  706 (820)
                      +++......   ......||..|+|||++.+. .++.++|||||||++|||++|++||......+.............  
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            998643321   12235689999999998664 689999999999999999999999976544332211110000000  


Q ss_pred             -----cCc-----cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          707 -----TGQ-----LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       707 -----~~~-----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                           ...     ...+....+...++...+.++.+++.+||+.+|.+||++.|++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                 000     001111111112233445688999999999999999999999866

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.9e-35  Score=317.75  Aligned_cols=265  Identities=21%  Similarity=0.353  Sum_probs=200.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+|+.. .+..+|+|.+..... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            46888899999999999999976 567899998764332 2334678899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++ +|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  158 (309)
T cd07872          86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--  158 (309)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence            975 8888876543 35889999999999999999999   7899999999999999999999999999987543211  


Q ss_pred             cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc------
Q 003436          641 HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI------  713 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------  713 (820)
                      .......++..|+|||.+.+ ..++.++|||||||+++||+||++||......+...................+      
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            11223457899999998865 46889999999999999999999999765443332222111100000000000      


Q ss_pred             ---cCccccC----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 ---VDPTLTG----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ---~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ..+....    ...+....++.+++.+|++.||.+||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence               0000000    0112344678899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-34  Score=315.25  Aligned_cols=262  Identities=25%  Similarity=0.351  Sum_probs=202.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|+..++||+|+||.||++... .+..+++|..... ......++.+|++++.+++||||+++++++..++..++|+||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888999999999999999976 4677888876544 233456788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||+++.....   
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999765  468899999999999999999993  358999999999999999999999999998754321   


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc---------
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE---------  711 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---------  711 (820)
                       ......++..|+|||++.+..++.++||||||++++||++|+.|+........   ..+...........         
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccccCC
Confidence             12335688999999999888899999999999999999999999864332111   11110000000000         


Q ss_pred             -----------cccCccc---cCCCC-hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          712 -----------DIVDPTL---TGQIK-PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       712 -----------~~~d~~l---~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                                 +..+...   ....+ ......+.+++.+|++.+|++||++.+++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                       0000000   00000 11345688999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.6e-34  Score=303.27  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=206.0

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|+..++||+|+||.||.++.. ++..+++|.....  .....+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4778889999999999998865 4788999975543  345567889999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++.......+++.++..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            99999999998765567899999999999999999999   78999999999999999999999999999986543221 


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                       ......++..|+|||++.+...+.++||||||++++||++|+.|+......+..      .... .+...         
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~-~~~~~---------  219 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKIV-QGNYT---------  219 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-cCCCC---------
Confidence             223456889999999998888999999999999999999999998754332211      1111 11111         


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .........+.+++.+|++.+|.+||++.++++++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11133456788999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-35  Score=298.29  Aligned_cols=265  Identities=23%  Similarity=0.303  Sum_probs=204.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChh-hH-HHHHHHHHHHHcCCCCceeeEEeEee--cCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ-GL-AEFRTEIEMLSQFRHRHLVSLIGYCD--ERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-~~-~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV  557 (820)
                      ++|+..+.|++|.||.||+|+++ .++.||+|+++..... +. =.-++||.+|.+++|||||.+..+..  +-+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45888889999999999999976 5788999998755422 11 13478999999999999999988763  34579999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      ||||+. +|..++.... .++...+..-+..|+++|++|||   ...|+|||||++|+|+++.|.+||+|||+||.+...
T Consensus       156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999987 8999887655 57888999999999999999999   788999999999999999999999999999976543


Q ss_pred             CCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC-
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD-  715 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-  715 (820)
                        ....+..+-|..|.|||.+.+. .|+...|+||+||++.||++++|.|....+.++.+.+-...-...+..+....+ 
T Consensus       231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence              2345667889999999999875 689999999999999999999999877666555443321111100101111100 


Q ss_pred             -------------ccccCCCChh-hHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 -------------PTLTGQIKPD-SLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 -------------~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                   ..+.+.+... ..+.-.+++...+..||++|-|+.|.+++
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                         1111122211 23566789999999999999999998864

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.3e-34  Score=317.31  Aligned_cols=241  Identities=23%  Similarity=0.336  Sum_probs=193.9

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      +|+..+.||+|+||.||+++.. +++.||+|.+...   .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677889999999999999976 5788999986532   2233456788999998885 577888999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence            9999999999986543  5899999999999999999999   789999999999999999999999999998753221 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                       ........||..|+|||++.+..++.++|||||||++|||++|++||........   .+....    ...        
T Consensus       155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~~----~~~--------  218 (323)
T cd05615         155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---FQSIME----HNV--------  218 (323)
T ss_pred             -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHh----CCC--------
Confidence             1122345689999999999999999999999999999999999999976543221   111111    110        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                        .++......+.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              1222344678899999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-35  Score=310.10  Aligned_cols=238  Identities=25%  Similarity=0.418  Sum_probs=190.7

Q ss_pred             eEeeecceEEEEEEEcC--------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          490 VIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .||+|+||.||+|....        ..++++|..........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            68999999999998642        2347888876655566678999999999999999999999999988999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC--------eeEeecccccc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM--------AKVADFGLSKI  633 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~--------~kl~DFGla~~  633 (820)
                      ++|+|.+++.... ..+++..+++++.|++.||+|||   +++|+||||||+||+++.++.        ++++|||++..
T Consensus        82 ~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          82 KFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999987654 36899999999999999999999   789999999999999987765        59999998864


Q ss_pred             CCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCC-CCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      ...      .....++..|+|||++.+ ..++.++||||||+++|||++|. +|+....+.......      ...    
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------~~~----  221 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------EDR----  221 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH------Hcc----
Confidence            322      123457889999999976 45799999999999999999995 555433222111110      000    


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                              ...+.....++.+++.+||+.+|++||++.++++.|
T Consensus       222 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 --------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                    012223335789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-34  Score=304.70  Aligned_cols=247  Identities=29%  Similarity=0.446  Sum_probs=200.0

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...+.||+|+||.||+|.. .++.+|+|......  ..+.+.+|+.++++++|||++++++++... ..++|+||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            3477888999999999999975 56779999876443  236788999999999999999999998665 4789999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.......+++.+++.++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++.....     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999998765567899999999999999999999   789999999999999999999999999998753321     


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......+..|+|||.+.+..++.++|+||||++++||++ |++||......+..   ..    ...+.         ...
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~---------~~~  217 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK---EC----VEKGY---------RME  217 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH---HH----HhCCC---------CCC
Confidence            112234567999999998899999999999999999997 89988654332211   11    11111         011


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .....+..+.+++.+|++.+|.+||++.++++.|++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            123445778999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.5e-34  Score=306.94  Aligned_cols=255  Identities=29%  Similarity=0.467  Sum_probs=203.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|.....||+|+||.||+|+.+      +...+++|........ ..+++.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888889999999999999964      2457899987654443 4678999999999999999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCC-------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          556 IIYEYMENGTLKDHLYASNF-------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                      +|+||+++|+|.+++.....       ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999975441       26899999999999999999999   789999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      |+++...... ........++..|+|||.+.+...+.++||||||++++||++ |..|+.......   ....    ...
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~----~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR----LQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH----HHc
Confidence            9987432211 111223346778999999988889999999999999999999 777875332211   1111    111


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      +...        .......+..+.+++.+|++.+|.+||++.|++..|.
T Consensus       234 ~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111        1112345578999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-34  Score=329.18  Aligned_cols=262  Identities=20%  Similarity=0.231  Sum_probs=196.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ..+|...+.||+|+||.||++++.. ++.||||....      ..+.+|+++|++++|+||+++++++..++..++|+|+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3468889999999999999999864 67899996332      3456899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +. ++|.+++.... ..++|.+++.|+.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++........
T Consensus       242 ~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        242 YR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             cC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            95 78888886533 36999999999999999999999   789999999999999999999999999999865432222


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCC-chh----hhhHHHHHHHhhcc-Ccccccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSL-PRE----KVNLVEWAMKCQET-GQLEDIV  714 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~-~~~----~~~l~~~~~~~~~~-~~~~~~~  714 (820)
                      .......||..|+|||++.+..++.++|||||||+||||++|..++.... ...    ...+.+.+...... .......
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            22334679999999999999999999999999999999999886542211 100    01111111111000 0000000


Q ss_pred             Cccc------------cCCCC-------hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTL------------TGQIK-------PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l------------~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..++            .....       ......+.+|+.+||+.||.+||++.|++++
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000            00000       0112367889999999999999999999874

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=316.35  Aligned_cols=244  Identities=28%  Similarity=0.427  Sum_probs=201.7

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |...+.||.|+||.||-|++. +...||||++....+   ..+.++..|+..|++++|||++.+.|++......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            667778999999999999975 567899999875544   4577899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      |- ||-.|+|.-.. +++-+.++..|+.+.+.||+|||   +++.||||||+.||||++.|.+||+|||.|.+..+    
T Consensus       108 Cl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----  178 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----  178 (948)
T ss_pred             Hh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence            95 68888776543 46888999999999999999999   89999999999999999999999999999876432    


Q ss_pred             cccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          641 HVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .....||+.|||||++.   .++|+-|+||||||+...||...+||.-........      .+.....      .|.
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL------YHIAQNe------sPt  244 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE------SPT  244 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH------HHHHhcC------CCC
Confidence              34578999999999984   578999999999999999999999987644322211      1111111      122


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      |.   ..+....++.++..||++-|.+|||..+++++
T Consensus       245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            32   34567789999999999999999999887665

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3e-34  Score=307.74  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=200.3

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      |+..+.||+|+||.||+|.... +..+++|..........+.+.+|+++++.++|||++++++++..+...++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            4666789999999999999874 677888888766666778899999999999999999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      ++|..++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....  ....
T Consensus        87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~  160 (282)
T cd06643          87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR  160 (282)
T ss_pred             CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence            99998876533 46899999999999999999999   789999999999999999999999999998754321  1122


Q ss_pred             ccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          644 TAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ....++..|+|||++.     +..++.++|||||||++|||++|++|+....+.+.  ....    .. ...     +.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~----~~-~~~-----~~~  228 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKI----AK-SEP-----PTL  228 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHH----hh-cCC-----CCC
Confidence            3356889999999984     45578899999999999999999999865432221  1111    00 000     000


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ..+......+.+++.+||+.+|.+||++.+++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0112334678999999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.3e-34  Score=311.53  Aligned_cols=254  Identities=23%  Similarity=0.271  Sum_probs=197.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+++.. .++.+|+|.+...   .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999976 4678999986532   2233456888999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999997632 36889999999999999999999   7999999999999999999999999999997543321


Q ss_pred             CccccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc-Ccccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET-GQLED  712 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~  712 (820)
                       ........||+.|+|||++.+     ..++.++|||||||+||||++|+.||......+..      ...... .+.. 
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~~-  228 (331)
T cd05624         157 -TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEERFQ-  228 (331)
T ss_pred             -ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCCccc-
Confidence             112233569999999999875     46789999999999999999999999754332211      111110 0000 


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID--RPSMGDVLWN  754 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  754 (820)
                           +. ....+...++.+++.+|+...+++  |+++.+++++
T Consensus       229 -----~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 -----FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -----CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                 00 111234567888999998765544  4678888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.5e-34  Score=302.37  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=202.2

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-CceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-RNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E  559 (820)
                      +|+..+.||+|++|.||+++.. +++.+++|++...  .....+.+.+|++++++++|+|++++++.+.. ....++|+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778889999999999999976 4678999987543  23445678899999999999999999988764 446789999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++.......+++.++..++.+++.||++||   +.+++||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999998755567899999999999999999999   7899999999999999999999999999998653321 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                       .......++..|+|||++.+..++.++||||||++++||++|+.|+........      ..... .+.+.        
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~--------  220 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGKLP--------  220 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcCCC--------
Confidence             122345688999999999999999999999999999999999999864432211      11111 11111        


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+......+.+++.+|++.+|++||++.+++++
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 -PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             1223445678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-34  Score=306.22  Aligned_cols=252  Identities=31%  Similarity=0.490  Sum_probs=200.8

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhH--HHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGL--AEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~--~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      |+..++||+|+||+||+++... ++.+|+|..........  .....|+.++++++||||+++++++..+...++|+||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999999875 56899998776654432  23456999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++...  ..+++..++.++.|+++||++||   +.+++|+||||+||++++++.++|+|||.+....  ....
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNE  153 (260)
T ss_dssp             TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTS
T ss_pred             cccccccccccc--ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccc
Confidence            999999999832  36899999999999999999999   6899999999999999999999999999987531  1222


Q ss_pred             ccccccCCccccCccccc-cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......++..|+|||++. +...+.++||||+|++++||++|+.|+......+............    ...   .   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~---~---~  223 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP----LPS---S---S  223 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH----HHH---H---T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc----ccc---c---c
Confidence            334567899999999998 8899999999999999999999999997652222222221111100    000   0   0


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .........+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001112378999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.5e-34  Score=302.26  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=204.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|+..+.||+|+||.+|+++.. +++.+++|++...  .....+++.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778889999999999999875 5788999986532  234456889999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++.......+++.++++++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--  155 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--  155 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence            99999999997655556899999999999999999999   7899999999999999999999999999997543321  


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......|+..|+|||++.+...+.++|+|||||+++||++|+.|+......+.      ..... .+...         
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~---------  219 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKII-RGSYP---------  219 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHh-cCCCC---------
Confidence            112234578899999999998999999999999999999999999865432221      11111 11110         


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+......+.+++.+|++.+|.+||++.+|+++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1223445678999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-34  Score=305.75  Aligned_cols=237  Identities=26%  Similarity=0.432  Sum_probs=189.3

Q ss_pred             eeEeeecceEEEEEEEcCcc-----------EEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          489 LVIGIGGFGKVYRGVLRDET-----------KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~-----------~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++||+|+||.||+|.+.+..           .+++|........ ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            36899999999999986533           4777876544433 6789999999999999999999999988 778999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-------CeeEeeccc
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-------MAKVADFGL  630 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-------~~kl~DFGl  630 (820)
                      +||+++|+|.+++..... .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999876432 6899999999999999999999   78999999999999999887       799999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccC--CCCCcceeeehhhhHHHHhcC-CCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ--QLTEKSDVYSFGVVMFEILCG-RPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvll~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      ++....      .....++..|+|||++.+.  .++.++||||||+++|||++| ..|+......+...   +..   ..
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~---~~  222 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ---DQ  222 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh---cC
Confidence            875432      1223466789999999876  789999999999999999994 66665432221111   110   00


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ..            .+......+.+++.+|++.+|.+||++.++++.|
T Consensus       223 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         223 HR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            00            0111126788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-34  Score=303.81  Aligned_cols=249  Identities=29%  Similarity=0.433  Sum_probs=203.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|+..++||+|+||.||+|+..+ +..+++|.+.....  .+++.+|++++++++|+||+++++++..+...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            568888899999999999999875 78899998765433  678999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.... ..+++..+..++.|++.||.|||   ..+++||||+|+||++++++.+||+|||++.......  .
T Consensus        81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            9999999986533 46899999999999999999999   7899999999999999999999999999988654321  1


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......++..|+|||++.+..++.++||||||+++|||++|++|+....+.+....       ....     ..+.+  .
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~--~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------IPNK-----PPPTL--S  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------hccC-----CCCCC--C
Confidence            22334578899999999998999999999999999999999999875433221100       0000     00000  1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .+......+.+++.+|++.+|.+||++.|+++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            12233467899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.7e-34  Score=321.07  Aligned_cols=253  Identities=22%  Similarity=0.329  Sum_probs=196.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||.||+++.. .++.+|+|.+...   .......+..|++++.+++|+||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888899999999999999976 4788999987532   2334567888999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            9999999999987543  5889999999999999999999   7999999999999999999999999999987432211


Q ss_pred             Cc---------------------------------cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCC
Q 003436          639 QT---------------------------------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV  685 (820)
Q Consensus       639 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p  685 (820)
                      ..                                 .......||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                                 001234699999999999999999999999999999999999999


Q ss_pred             CCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 003436          686 IDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS---MGDVLWN  754 (820)
Q Consensus       686 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~~  754 (820)
                      |....+.+....      ...... ...+.+      ......++.+++.+|+ .+|.+|++   +.+++++
T Consensus       236 f~~~~~~~~~~~------i~~~~~-~~~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         236 FCSETPQETYRK------VMNWKE-TLVFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCHHHHHHH------HHcCCC-ceecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            976544322111      110000 000011      0113356777777776 49999985   5565544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-34  Score=324.51  Aligned_cols=262  Identities=23%  Similarity=0.244  Sum_probs=199.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC---ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ..+|...+.||+|+||.||++...+   +..|++|.+...     +.+.+|+++|++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            3579999999999999999997543   567899986543     23467999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      |++. ++|.+++..  ...+++.+++.++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++......
T Consensus       166 e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        166 PKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             hhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            9996 688888843  346999999999999999999999   7899999999999999999999999999997654332


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc-----
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI-----  713 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-----  713 (820)
                      .........||..|+|||++.+..++.++|||||||++|||++|+.||.............-+............     
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  319 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST  319 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence            222233567999999999999999999999999999999999999998654332211111111111110000000     


Q ss_pred             --------cCccccCCC-------ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 --------VDPTLTGQI-------KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 --------~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                              ........+       .......+.+++.+|+..+|++||++.|++.+
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    000000000       01223567889999999999999999999875

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.3e-34  Score=303.65  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=190.9

Q ss_pred             eEeeecceEEEEEEEcCc---cEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCc
Q 003436          490 VIGIGGFGKVYRGVLRDE---TKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      .||+|+||.||+|...++   ..+++|...... ....+.|.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            689999999999986543   345677655433 3456789999999999999999999999999999999999999999


Q ss_pred             hhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          566 LKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       566 L~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |.+++....  ...+++.....++.|+++||+|||   +.+++||||||+|||++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997642  235677788899999999999999   789999999999999999999999999998643221111222


Q ss_pred             ccccCCccccCcccccc-------CCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          644 TAVKGSFGYLDPEYLTK-------QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |.+|+....+.+.      ...... +......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~-~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIK-DQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHh-hcccccCC
Confidence            34567889999998843       245789999999999999997 4667754332221      111111 11222333


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      +.+..    .....+.+++..|+ .+|.+||++.+|++.|.
T Consensus       232 ~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33322    23456788899999 67999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3e-34  Score=310.30  Aligned_cols=250  Identities=22%  Similarity=0.376  Sum_probs=204.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .+|...+.||.|++|.||+|+.. +++.|++|.+........+.+.+|+++++.++|||++++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888899999999999999864 68899999876555555678899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++...   .+++.++..++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++.......  
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            999999988643   5899999999999999999999   78999999999999999999999999999875433211  


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.+....   ..   . .....     +  .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~---~-~~~~~-----~--~  236 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA---T-NGTPE-----L--Q  236 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---h-cCCcc-----c--C
Confidence            12234688899999999988899999999999999999999999976543222111   10   0 00000     0  1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+......+.+++.+||..+|.+||++.+++.+
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            122345678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-34  Score=306.89  Aligned_cols=248  Identities=29%  Similarity=0.420  Sum_probs=202.8

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +|+..+.||.|++|.||+|+.. +++.+++|...... ......+.+|++++++++|+|++++++++.++...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5777789999999999999976 57889999876543 344567889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++...   .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++......  .
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            999999998754   6899999999999999999999   7899999999999999999999999999998654321  1


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......++..|+|||++.+..++.++||||||+++|||+||++|+....+.+..      .. .....     .+.+...
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~~-~~~~~-----~~~~~~~  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------FL-IPKNN-----PPSLEGN  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------HH-hhhcC-----CCCCccc
Confidence            223456788999999999888999999999999999999999999654322111      00 01111     1111111


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ..+..+.+++.+|+..+|++||++.+++++
T Consensus       222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence               144578899999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.3e-34  Score=303.39  Aligned_cols=251  Identities=23%  Similarity=0.432  Sum_probs=201.0

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCC------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      +|...+.||+|+||.||+|...+++.+|+|.+....      ....+.+.+|++++++++|+||++++++|.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            366778999999999999998888899999765332      22345688999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+++++|.+++....  .+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||+++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999996543  5789999999999999999999   788999999999999999999999999998754221


Q ss_pred             C----CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          638 D----QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       638 ~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      .    .........++..|+|||++.+..++.++||||||++++||++|+.||.........  ..   .....+.    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~---~~~~~~~----  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--FY---IGAHRGL----  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--HH---hhhccCC----
Confidence            1    111123356889999999999888999999999999999999999999643221111  00   0000011    


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                       .+    ..+......+.+++.+|++.+|.+||++.++++
T Consensus       227 -~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 -MP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -CC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             11    122334567899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.8e-34  Score=304.24  Aligned_cols=255  Identities=31%  Similarity=0.443  Sum_probs=199.7

Q ss_pred             CccceeEeeecceEEEEEEEc----CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc------
Q 003436          485 FSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN------  552 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  552 (820)
                      |...++||+|+||.||+|.+.    .++.+|+|++...  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            455678999999999999864    2578999986543  3445678899999999999999999999885432      


Q ss_pred             eEEEEEeeccCCchhhHhhhcC----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          553 EMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                      ..++++||+++|+|.+++....    ...+++...++++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            3478999999999998875432    235789999999999999999999   789999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      |+++...............++..|++||.+....++.++||||||+++|||++ |++|+......   .+..+...   .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~---~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK---G  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc---C
Confidence            99986433221112223345678999999998889999999999999999999 88888644321   22222111   1


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      ...          ......+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus       232 ~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111          11224457899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-33  Score=309.77  Aligned_cols=255  Identities=23%  Similarity=0.278  Sum_probs=196.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+++.+. ++.+|+|.+...   .......+..|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            468889999999999999999874 677899986532   2223445888999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999999997532 35899999999999999999999   7899999999999999999999999999987543211


Q ss_pred             CccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                       ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......+..      ........  ..
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~--~~  227 (332)
T cd05623         157 -TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKE--RF  227 (332)
T ss_pred             -cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCc--cc
Confidence             12223456999999999986     346789999999999999999999999754322211      11111100  00


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCC--CCCCCHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCG--IDRPSMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp--~~RPs~~evl~~  754 (820)
                      .-+    .........+.+++.+|+..++  ..|+++.|++++
T Consensus       228 ~~p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFP----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCC----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000    1112345677888888875544  346899998876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.5e-34  Score=311.48  Aligned_cols=265  Identities=22%  Similarity=0.368  Sum_probs=200.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...+.||+|+||.||+|+.. .++.||+|.+.... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888899999999999999976 47889999865432 22345677899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++ ++|.+++.... ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++......  
T Consensus        86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--  158 (301)
T cd07873          86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--  158 (301)
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence            97 58988886543 35889999999999999999999   7899999999999999999999999999987533211  


Q ss_pred             cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC----
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD----  715 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----  715 (820)
                      .......++..|+|||.+.+. .++.++|||||||++|||++|++||......+................+..+.+    
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            112234568899999998654 578899999999999999999999976543322211110000000000111100    


Q ss_pred             -----ccccC----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 -----PTLTG----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 -----~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                           +....    ...+.....+.+++.+|++.||.+||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                 10000    1112345678899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3e-34  Score=310.45  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=204.5

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ..+|...+.||+|++|.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            367888899999999999999964 6889999987665555567788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++...   .+++.++..++.+++.||.|||   +.+++||||||+|||++.++.+||+|||++.......  
T Consensus        98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--  169 (297)
T cd06656          98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  169 (297)
T ss_pred             cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--
Confidence            9999999998653   4789999999999999999999   7899999999999999999999999999987543321  


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......++..|+|||.+.+..++.++|+|||||+++||++|+.||....+......      ....+      .+.  .
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~------~~~--~  235 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPE--L  235 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC------CCC--C
Confidence            112334688899999999998899999999999999999999999965433211100      00000      000  0


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+......+.+++.+|++.+|.+||++.+++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1122344668899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.9e-34  Score=300.24  Aligned_cols=250  Identities=33%  Similarity=0.536  Sum_probs=202.3

Q ss_pred             ccceeEeeecceEEEEEEEcC-----ccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          486 SESLVIGIGGFGKVYRGVLRD-----ETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ...+.||+|+||.||+++..+     +..+|+|........ ..+.+..|++++.+++|+||+++++++.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            456789999999999999764     378999998655443 56789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++.......+++.++..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++.......
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            999999999997655434899999999999999999999   78999999999999999999999999999986544322


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      .. .....++..|+|||.+.+..++.++||||||++++||++ |++|+......+   ..+...    .+...       
T Consensus       159 ~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~----~~~~~-------  223 (258)
T smart00219      159 YK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLK----KGYRL-------  223 (258)
T ss_pred             cc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cCCCC-------
Confidence            11 112347789999999988889999999999999999998 778876532211   122111    11110       


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                        ......+.++.+++.+|+..+|++||++.++++.|
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              11223556789999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-34  Score=308.39  Aligned_cols=246  Identities=28%  Similarity=0.404  Sum_probs=200.7

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      |+..+.||+|+||.||+|.+. ++..||+|...... ....+.+.+|++++++++||||+++++++..+...++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            556678999999999999875 46789999876433 3445788999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++..   ..+++..+..++.|+++||+|||   ..+++|+||+|+||++++++.++|+|||+++......  ..
T Consensus        86 ~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          86 GGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            9999998854   35899999999999999999999   7899999999999999999999999999987543321  12


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....++..|+|||++.+..++.++||||||++++||++|+.|+....+....   .+    ....     ..+    ..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~----~~~~-----~~~----~~  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FL----IPKN-----SPP----TL  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hh----hhcC-----CCC----CC
Confidence            22346788999999999989999999999999999999999998643322111   00    0000     011    22


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....+..+.+++.+|++.+|.+||++.+++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            23445678999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.6e-35  Score=302.06  Aligned_cols=248  Identities=27%  Similarity=0.417  Sum_probs=210.0

Q ss_pred             cCCccceeEeeecceEEEEEEE-cCccEEEEEeCCC---CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGGT---QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .+|+..+.||+|.||.|-+|.. ..|+.||||.++.   .+.+++-.+.+||++|+.|+||||++++.+|++++.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4577778999999999999985 6799999997653   45666777899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||..+|.|.|++.+.+  .|++.+...++.||..|+.|+|   .++++|||||.+|||||+++++||+||||+-++..  
T Consensus       133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--  205 (668)
T KOG0611|consen  133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--  205 (668)
T ss_pred             EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence            9999999999997654  7999999999999999999999   89999999999999999999999999999976543  


Q ss_pred             CccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                       ....+..+|++-|.+||.+.+.+| .+..|-|||||+||-|+.|..||+...-   ..++..    +..|...      
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQ----Is~GaYr------  271 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQ----ISRGAYR------  271 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHH----hhccccc------
Confidence             234567899999999999999887 5789999999999999999999986532   222221    1222222      


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                           .++.+....-|+++||..+|++|.|+.+|..+..
T Consensus       272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  272 -----EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             -----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                 1233456778999999999999999999987753

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.5e-34  Score=302.77  Aligned_cols=248  Identities=27%  Similarity=0.440  Sum_probs=199.0

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh---------hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH---------QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~---------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      |.....||+|++|.||+|... +++.+++|.......         ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            556679999999999999875 578899997653321         2235688999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999999654  36889999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCC----ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          635 PDLDQ----THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       635 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      .....    ........|+..|+|||.+.+..++.++||||||++++||++|+.||........   .   .....    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~----  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---I---FKIGE----  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---H---HHHhc----
Confidence            42111    1111234578899999999988899999999999999999999999975422111   1   00000    


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                        ...+    ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       227 --~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 --NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              1111    222344577889999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.9e-34  Score=303.64  Aligned_cols=253  Identities=23%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             CCccceeEeeecceEEEEEEEcC--ccEEEEEeCCCC----------ChhhHHHHHHHHHHHHc-CCCCceeeEEeEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD--ETKVAVKRGGTQ----------SHQGLAEFRTEIEMLSQ-FRHRHLVSLIGYCDE  550 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~----------~~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~  550 (820)
                      +|+..+.||+|+||.||+|.+..  ++.+|+|.+...          ......++..|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            36777899999999999999875  678999975422          23345667889998875 799999999999999


Q ss_pred             CceEEEEEeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          551 RNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                      ++..++|+||+++++|.+++..  .....+++..+++++.|++.||.|||+  ..+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999998854  233568999999999999999999993  367999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      |++.......   ......++..|+|||.+.+..++.++||||||+++|||++|++|+........   .   ... ..+
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~---~~~-~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---A---TKI-VEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---H---HHH-hhc
Confidence            9998644322   23345688999999999988899999999999999999999999864432211   1   111 111


Q ss_pred             ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       709 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      ...    +.    ........+.+++.+|++.+|++||++.|+..+++
T Consensus       229 ~~~----~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYE----PL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCC----cC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111    10    11123467889999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.9e-34  Score=305.76  Aligned_cols=252  Identities=26%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|+..++||+|+||.||+|+... +..+++|..........+.+.+|++++++++|+|++++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            457788899999999999999864 7889999987777777788999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|..++.... ..+++..+..++.|++.+|+|||   ..+++||||||+||+++.++.+||+|||++......  ..
T Consensus        92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            9999988876543 46899999999999999999999   789999999999999999999999999998753221  11


Q ss_pred             ccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          642 VSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ......++..|+|||++.     ...++.++|||||||++|||++|++|+......+.      ....... .     .+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~-~-----~~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS-E-----PP  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcC-C-----Cc
Confidence            123345788999999984     34568899999999999999999999864332111      1111111 0     01


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+  ..+......+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            10  1122344578899999999999999999999763

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-34  Score=312.41  Aligned_cols=255  Identities=23%  Similarity=0.266  Sum_probs=196.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||.||+++.. +++.+|+|.+...   .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999976 4789999987532   2233466889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++.......
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999653 245889999999999999999999   7899999999999999999999999999987543321


Q ss_pred             CccccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                       ........||+.|+|||++..     ..++.++|||||||++|||++|+.||......+..      ...........+
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~~~  229 (331)
T cd05597         157 -TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHFQF  229 (331)
T ss_pred             -CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcccC
Confidence             112223468999999999863     45788999999999999999999999654322211      111111100000


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhc--CCCCCCCHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQ--CGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPs~~evl~~  754 (820)
                        +    ......+..+.+++.+|+..  ++..||++.+++++
T Consensus       230 --~----~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 --P----PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --C----CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              0    01112445677888887754  33447899988876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-34  Score=308.07  Aligned_cols=256  Identities=22%  Similarity=0.322  Sum_probs=204.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|+..++||+|+||+||++... +++.+|+|...... ....+.+.+|+++++.++||||+++++++......++|+||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45777789999999999999976 57889999765432 34467899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++...  ..+++..+..++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++......   
T Consensus        85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            9999999988654  368999999999999999999994  358999999999999999999999999998643221   


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh-----hhhHHHHHHHhhccCccccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE-----KVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                       ......|+..|+|||++.+..++.++|||||||+++||++|+.||......+     ...+.++........      .
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  230 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P  230 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence             1123568999999999988899999999999999999999999997544321     111222222221110      0


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      +.+.   ....+..+.+++.+|++.+|.+||++.|++++.
T Consensus       231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1111   112456789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-34  Score=331.06  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=195.1

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC------CceeeEEeEeecC
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH------RHLVSLIGYCDER  551 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H------~nIv~l~g~~~~~  551 (820)
                      ...+++|...++||+|+||.||+|++. .++.||||++.... ...+++..|++++++++|      .+++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            345678999999999999999999975 47789999875432 223456667777777754      4588899988654


Q ss_pred             -ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---------
Q 003436          552 -NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---------  621 (820)
Q Consensus       552 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---------  621 (820)
                       ...++|+|++ +++|.+++...  ..+++..+..|+.|++.||+|||+  ..+||||||||+|||++.++         
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~  278 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNR  278 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccc
Confidence             5788999988 67898888754  368999999999999999999993  25999999999999998665         


Q ss_pred             -------CeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          622 -------MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       622 -------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                             .+||+|||++....     .......||..|+|||++.+..++.++|||||||++|||++|++||......+.
T Consensus       279 ~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  353 (467)
T PTZ00284        279 ALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH  353 (467)
T ss_pred             ccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                   49999999876322     223456799999999999999999999999999999999999999976554433


Q ss_pred             hhHHH---------HHHHhh---------ccCccccccCcccc----C-C-C-ChhhHHHHHHHHHHHhhcCCCCCCCHH
Q 003436          695 VNLVE---------WAMKCQ---------ETGQLEDIVDPTLT----G-Q-I-KPDSLNKFVEIAEKCLAQCGIDRPSMG  749 (820)
Q Consensus       695 ~~l~~---------~~~~~~---------~~~~~~~~~d~~l~----~-~-~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~  749 (820)
                      ...+.         |...+.         ..+.+....++...    . . . .......+.+|+.+||+.||++||++.
T Consensus       354 ~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence            32221         111000         00000000011000    0 0 0 001134578999999999999999999


Q ss_pred             HHHHH
Q 003436          750 DVLWN  754 (820)
Q Consensus       750 evl~~  754 (820)
                      |++++
T Consensus       434 e~L~H  438 (467)
T PTZ00284        434 QMTTH  438 (467)
T ss_pred             HHhcC
Confidence            99974

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-34  Score=307.15  Aligned_cols=261  Identities=21%  Similarity=0.275  Sum_probs=198.0

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...+.||+|++|.||+|+.. ++..||+|++....  ....+.+.+|+.++++++||||+++++++..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999976 57899999865432  22346788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ++ ++|.+++.... ...+++.++..++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++...... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 68988886533 356899999999999999999999   7899999999999999999999999999987543211 


Q ss_pred             ccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc--c---------
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE--T---------  707 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~--~---------  707 (820)
                       .......++..|+|||.+.+. .++.++||||||++++||+||++|+......+..  .........  .         
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhh
Confidence             112234568899999988654 5789999999999999999999999754332211  000000000  0         


Q ss_pred             Cc----cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          708 GQ----LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       708 ~~----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ..    ........+. ........++.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         233 PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00    0000000000 011124567789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.1e-34  Score=302.14  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=195.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-----SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~  554 (820)
                      .+|...+.||+|+||.||+|... .+..+++|+....     .....+.+.+|+.++++++||||+++++++.+  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888899999999999999875 4788999976432     22345678899999999999999999998865  3577


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++++||+++++|.+++....  .+++...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            89999999999999997543  5889999999999999999999   789999999999999999999999999998754


Q ss_pred             CCCCC-ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          635 PDLDQ-THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       635 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ..... ........++..|+|||++.+..++.++|||||||++|||++|+.||......+..      .......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~-----  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQP-----  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCC-----
Confidence            32111 11122345889999999999989999999999999999999999998754222111      1111100     


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ..+    ..+......+.+++ +||..+|++||++.|+++
T Consensus       226 ~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            011    12223334556666 688899999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=4.3e-34  Score=313.64  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=194.9

Q ss_pred             ceeEeee--cceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          488 SLVIGIG--GFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       488 ~~~LG~G--~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      .++||+|  +||+||+++.. +++.||+|++....  ....+.+.+|+++++.++||||++++++|..++..++|+||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4589999  78999999875 57889999876542  3344567789999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc--
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--  640 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~--  640 (820)
                      +|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.++++||+...........  
T Consensus        83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            999999997655556899999999999999999999   789999999999999999999999999865432111100  


Q ss_pred             ---cccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          641 ---HVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       641 ---~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                         .......++..|+|||++.+  ..++.++|||||||+++||++|+.||........  .....     .+......+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-----~~~~~~~~~  232 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-----NGTVPCLLD  232 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-----cCCcccccc
Confidence               01122346778999999976  4689999999999999999999999964322111  00000     000000000


Q ss_pred             -------------------ccc-----------------cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 -------------------PTL-----------------TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 -------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                         ...                 ...........+.+++.+||+.||++||++.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                               000                 001112234578899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.4e-34  Score=302.80  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=199.9

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC----------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS----------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN  552 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~----------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  552 (820)
                      +|...+.||+|+||.||+|... +++.+|+|......          ....+.+..|++++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3566779999999999999865 57889999764321          112356888999999999999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++|+||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999998765  36899999999999999999999   7899999999999999999999999999997


Q ss_pred             cCCCCCCccccccccCCccccCccccccCC--CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ...............++..|+|||.+....  ++.++|+||||++++||++|+.|+......+.  .    ...... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~----~~~~~~-~~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--M----FKLGNK-RS  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--H----HHhhcc-cc
Confidence            644322222233456889999999987654  88999999999999999999999853322111  0    111111 11


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...++    .......+..+.+++.+|++.+|.+||++.+|+++
T Consensus       230 ~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111    12223445788999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.1e-34  Score=305.81  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=206.4

Q ss_pred             CCCHHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEee
Q 003436          472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCD  549 (820)
Q Consensus       472 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~  549 (820)
                      +.++.++....+.|+..+.||+|+||.||+|+.. .++.+|+|...... ....++..|+.++.++ +|+||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            3456667777889999999999999999999975 57889999865443 3346788899999998 7999999999984


Q ss_pred             c------CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          550 E------RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       550 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      .      ....+++|||+++|+|.+++.......+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence            3      457899999999999999997655566889999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV  698 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~  698 (820)
                      +|+|||+++......  .......|+..|+|||.+.     +..++.++|||||||++|||++|+.||....+.+.....
T Consensus       161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            999999987543211  1123356889999999985     346788999999999999999999998654322211100


Q ss_pred             HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                            .+      ...+.   ......+..+.+++.+||+.+|.+||++.|+++
T Consensus       239 ------~~------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 ------PR------NPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------hh------CCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                  00      00111   111234567999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.3e-34  Score=303.72  Aligned_cols=252  Identities=26%  Similarity=0.374  Sum_probs=200.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|...++||+|+||.||+|+.. +++.+|+|............+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            45777789999999999999875 57889999876665555667889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++....  .+++.+++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||++......  ..
T Consensus        89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06645          89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA  161 (267)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence            9999999886543  6899999999999999999999   789999999999999999999999999998754321  11


Q ss_pred             ccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          642 VSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|++|+....+.......       .....   ..+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~-------~~~~~---~~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------TKSNF---QPPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh-------hccCC---CCCcc
Confidence            223456899999999974   456889999999999999999999988544322211100       00000   01111


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ..  ....+..+.+++.+|++.+|++||++.++++
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            10  1123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-34  Score=298.67  Aligned_cols=267  Identities=21%  Similarity=0.289  Sum_probs=203.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChh--hHHHHHHHHHHHHcCCCCc-eeeEEeEeecCc-----
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ--GLAEFRTEIEMLSQFRHRH-LVSLIGYCDERN-----  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~-----  552 (820)
                      ...|...++||+|.||+||+|+.. .|+.||+|+++.....  .-....+|+.+|++|+|+| |+.|++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            344666778999999999999965 5789999987765442  2345678999999999999 999999997766     


Q ss_pred             -eEEEEEeeccCCchhhHhhhcCC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          553 -EMIIIYEYMENGTLKDHLYASNF--PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       553 -~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                       .+++|+||++. +|.+++.....  ..++-..+..+..|+++||+|||   +++|+||||||.|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             78999999964 99999976543  35777889999999999999999   8999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      +|+...-..  ...+...+|..|.|||++.+. .|+...|+||+||++.||+++++.|....+.++...+-.........
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence            999654222  223456789999999999887 79999999999999999999999887766544332221111111111


Q ss_pred             ccccc---cCcc--ccC-----CCCh---hhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 QLEDI---VDPT--LTG-----QIKP---DSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ~~~~~---~d~~--l~~-----~~~~---~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+..+   .+-.  ...     .+..   .......+++.+|++.+|.+|.++..++.+
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111   1111  000     0001   111467899999999999999999999875

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.8e-34  Score=306.40  Aligned_cols=262  Identities=25%  Similarity=0.333  Sum_probs=204.6

Q ss_pred             CCHHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeec
Q 003436          473 FPFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDE  550 (820)
Q Consensus       473 ~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~  550 (820)
                      ++..++..++++|...+.||+|+||.||++... +++.+|+|...... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344566677899999999999999999999975 57889999875432 2245678899999999 89999999999864


Q ss_pred             C-----ceEEEEEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          551 R-----NEMIIIYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       551 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      .     +..++|+||+++|+|.+++...  ....+++..+..++.|++.||+|||   ..+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     3589999999999999988642  3356899999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccC-----CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-----QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV  698 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~  698 (820)
                      ||+|||+++.......  ......|+..|+|||++...     .++.++|||||||++|||++|++|+....+.+.  +.
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~  243 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF  243 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence            9999999875433211  12234688899999998543     368999999999999999999999865432211  11


Q ss_pred             HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+     .......+.+       .+.....+.+++.+|++.+|++||++.|++++
T Consensus       244 ~~-----~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KI-----PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH-----hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11     0111111111       12334578999999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-34  Score=305.56  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=200.8

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +|+..+.||+|+||.||+++.. .+..+|+|.+... .......+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5777889999999999999986 6789999987543 3344578999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          562 ENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       562 ~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++++|..++.... ...+++..+..++.+++.||.|||+  ..+++||||||+||+++.++.+||+|||+++.....   
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  156 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---  156 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---
Confidence            9999999887542 2368999999999999999999994  358999999999999999999999999998754221   


Q ss_pred             cccccccCCccccCccccccC------CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ------QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                       ......++..|+|||++.+.      .++.++|+|||||++|||++|+.||............   ... ..+.     
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~-~~~~-----  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---SAI-VDGD-----  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---HHH-hhcC-----
Confidence             12234578899999998554      3588999999999999999999998654322111111   000 0010     


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          ....+......+.+++.+|++.+|.+||++.+++..
T Consensus       227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 ----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             ----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                012233456778999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.3e-34  Score=306.90  Aligned_cols=261  Identities=24%  Similarity=0.334  Sum_probs=202.6

Q ss_pred             HHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEee---
Q 003436          475 FVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCD---  549 (820)
Q Consensus       475 ~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~---  549 (820)
                      +..+..+.++|+..+.||+|+||.||+++.. .++.+++|...... ....++.+|+.+++++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3445667889999999999999999999875 47889999865432 2235688899999999 6999999999873   


Q ss_pred             --cCceEEEEEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeE
Q 003436          550 --ERNEMIIIYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       550 --~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl  625 (820)
                        .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999988642  2346889999999999999999999   789999999999999999999999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHH
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~  700 (820)
                      +|||+++......  .......|+..|+|||++..     ..++.++|||||||++|||++|+.|+....+....  .. 
T Consensus       166 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~-  240 (286)
T cd06638         166 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK-  240 (286)
T ss_pred             ccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh-
Confidence            9999987543321  12233468999999999853     45788999999999999999999998654322111  00 


Q ss_pred             HHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       701 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                         .. ........+       +......+.+++.+|++.+|.+||++.|+++++
T Consensus       241 ---~~-~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         241 ---IP-RNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ---cc-ccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence               00 000001111       112345688999999999999999999998754

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.4e-34  Score=303.97  Aligned_cols=247  Identities=26%  Similarity=0.395  Sum_probs=203.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .|+..+.||+|+||.||+|+.. .+..+|+|...... ....+.+.+|++++++++|+||+++++.+.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3666778999999999999976 47889999865432 445678999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++...   .+++.+...++.+++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            999999998643   5889999999999999999999   7899999999999999999999999999997543321  1


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......++..|+|||++.+...+.++|+|||||+++||++|++|+....+......       ..         ......
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~---------~~~~~~  220 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------IP---------KNNPPT  220 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------hh---------cCCCCC
Confidence            22334678899999999988899999999999999999999999875433221110       00         001112


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .....+..+.+++.+||+.+|++||++.+++.+
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            334566789999999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.4e-34  Score=315.92  Aligned_cols=263  Identities=20%  Similarity=0.266  Sum_probs=198.2

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------  551 (820)
                      ..++|...+.||+|+||.||++... .++.+|||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4568999999999999999999875 4788999987643  333456788999999999999999999987543      


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      ...++||||+++ +|.+.+..    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            357999999975 67666643    4888999999999999999999   789999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH-------------
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV-------------  698 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~-------------  698 (820)
                      +....   ........||..|+|||++.+..++.++|||||||+++||++|+.||......+.....             
T Consensus       167 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            75432   11223456899999999999999999999999999999999999999754322211100             


Q ss_pred             ---HHHHHhhc-cCccccccCccc--------cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          699 ---EWAMKCQE-TGQLEDIVDPTL--------TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       699 ---~~~~~~~~-~~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .......+ .........+..        ...........+.+++.+|++.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               00000000 000000000000        001112234578899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-34  Score=305.88  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=204.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|...+.||+|++|.||+|... ++..+|+|..........+.|..|++++++++|+||+++++.+..+...++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            45788889999999999999975 57889999987776667788999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.... ..+++.++..++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||++.......  .
T Consensus        85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            9999999886543 36899999999999999999999   7899999999999999999999999999987543221  1


Q ss_pred             ccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          642 VSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ......++..|+|||.+.     ...++.++||||||+++|||++|++|+......+..      .... .+..     +
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~-----~  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL------LKIL-KSEP-----P  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH------HHHh-cCCC-----C
Confidence            223456889999999975     345778999999999999999999998654322111      1111 1100     1


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+  ..+......+.+++.+||+.+|.+||++.+++++
T Consensus       227 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11  1122344678899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.7e-34  Score=317.47  Aligned_cols=264  Identities=21%  Similarity=0.266  Sum_probs=197.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc-----
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-----  552 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----  552 (820)
                      ..++|...+.||+|+||.||+++.. .+..+|+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999975 4789999987533  3344567889999999999999999999885443     


Q ss_pred             -eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          553 -EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       553 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                       ..++||||+++ +|.+.+..    .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999975 56666542    4788999999999999999999   789999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH-------------
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV-------------  698 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~-------------  698 (820)
                      +....   ........||..|+|||++.+..++.++|||||||++|||++|+.||......+.....             
T Consensus       171 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         171 RTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            75322   12223456899999999999999999999999999999999999999754322111000             


Q ss_pred             ---HHHHHhhc-cCcc-----ccccCcccc---CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          699 ---EWAMKCQE-TGQL-----EDIVDPTLT---GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       699 ---~~~~~~~~-~~~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                         ........ ....     .+.......   ..........+.+++.+||+.||++||++.|++++-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence               00000000 0000     000000000   001112245688999999999999999999998753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.1e-34  Score=299.37  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=201.0

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-----hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-----HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      +|...+.||+|++|.||+|... ++..+++|.+....     .+..+.+.+|++++++++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3566779999999999999987 68899999764332     33567899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999998754  35889999999999999999999   789999999999999999999999999998764332


Q ss_pred             CCccccccccCCccccCccccccCC-CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQ-LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .   ......++..|++||.+.... ++.++|+||||++++||++|++||......+..      .........      
T Consensus       156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~------  220 (258)
T cd06632         156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSKEL------  220 (258)
T ss_pred             c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcccC------
Confidence            2   223456889999999997766 899999999999999999999998654321111      111110111      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                         ...+......+.+++.+|++.+|.+||++.+++.
T Consensus       221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               1122334567889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-34  Score=316.30  Aligned_cols=192  Identities=23%  Similarity=0.322  Sum_probs=163.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ...+|...+.||+|+||.||+|+... +..||+|.....      ....|+.++++++|+||+++++++......++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            34579999999999999999999864 578889874322      23569999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ++. ++|.+++.... ..++|.+++.|+.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            995 68888886533 46899999999999999999999   789999999999999999999999999998743221  


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCC
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVI  686 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~  686 (820)
                       .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             1223456899999999999999999999999999999999865443

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=298.95  Aligned_cols=253  Identities=27%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|+..+.||+|+||.||+|... ++..+++|..........+.+.+|++++++++||||+++++++..+...+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            56888899999999999999975 46789999877665556788999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.... ..+++.++..++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++.......  .
T Consensus        83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999886542 46899999999999999999999   7899999999999999999999999999987543211  1


Q ss_pred             ccccccCCccccCccccccC---CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          642 VSTAVKGSFGYLDPEYLTKQ---QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ......++..|+|||.+.+.   .++.++||||||++++||++|++|+....+.+.....       .....   ..+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-------~~~~~---~~~~~  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-------SKSNF---PPPKL  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhccC---CCccc
Confidence            22345678899999999776   8899999999999999999999998754432221110       00000   00111


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                        ......+..+.+++.+|+..+|.+||++.+++.
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              112234567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-33  Score=297.99  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=202.5

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...+.||+|++|.||++... .++.+++|.+...  .....+.+.+|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778889999999999999875 5788999986543  234467899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla~~~~~~~~  639 (820)
                      +++++|.+++.......+++..+.+++.+++.||+|||   +.+++|+||||+||+++++ +.+||+|||+++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999998765567899999999999999999999   7899999999999999754 468999999998654321 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                        ......++..|+|||.+.+...+.++||||||+++|||++|+.|+.......   ......   . +...        
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~---~-~~~~--------  219 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM---S-GTFA--------  219 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHH---h-cCCC--------
Confidence              1223467889999999998889999999999999999999999986543221   111111   1 1111        


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       .........+.+++.+||+.+|.+||++.|++++
T Consensus       220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence             1122345678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-33  Score=298.28  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=206.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|+..+.||.|+||+||+|... ++..+++|+..... ....+.+.+|+++++.++|+|++++++.+..+...++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888899999999999999965 57789999875432 33567899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      +++++|.+++..... ..+++.....++.|++.||+|||   +.+++||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999976433 56899999999999999999999   78999999999999999999999999999876544322


Q ss_pred             cc--ccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          640 TH--VSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       640 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ..  ......++..|+|||++... ..+.++|+||||++++||++|+.||......+.  ..+..    ..      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~----~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL----QN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh----cC------CCC
Confidence            21  22344688999999998777 789999999999999999999999865433211  11111    10      011


Q ss_pred             cccCCC-ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQI-KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+.... ....+..+.+++.+|++.+|++||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111111 12445778999999999999999999999863

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-33  Score=297.85  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=207.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|+..+.||+|++|.||+++... ++.+++|+...... ...+.+.+|++++.+++|+|++++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999999875 88999998766544 4567899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCC-CcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST-KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~-~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      +++++|.+++...  ..+++..++.++.|+++||+|||   + .+++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999999999765  46899999999999999999999   7 9999999999999999999999999999886533221


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                        ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.............+...   . ..     +   
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~-~~-----~---  221 (264)
T cd06623         156 --QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---G-PP-----P---  221 (264)
T ss_pred             --cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---C-CC-----C---
Confidence              11234678899999999999999999999999999999999999875542222222222211   0 00     1   


Q ss_pred             CCCChh-hHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPD-SLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+.. .+..+.+++.+|++.+|.+||++.+++++
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         222 -SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             11222 55789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-33  Score=303.55  Aligned_cols=264  Identities=23%  Similarity=0.312  Sum_probs=200.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+...+||+|++|.||+|+.. +++.+|+|+.....  ....+.+.+|++++++++|+|++++++++......++|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788889999999999999987 47899999765332  2234568899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|..++...  ..+++.+++.++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99998888876543  35899999999999999999999   78999999999999999999999999999986543221


Q ss_pred             ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH-HHHHh-------hccC-c
Q 003436          640 THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE-WAMKC-------QETG-Q  709 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~-~~~~~-------~~~~-~  709 (820)
                        ......++..|+|||++.+ ..++.++||||||++++||++|++||......+...... .....       .... .
T Consensus       156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence              1223457888999999876 567899999999999999999999997554332211110 00000       0000 0


Q ss_pred             cccccCccccCC-----CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          710 LEDIVDPTLTGQ-----IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       710 ~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ......+.....     ..+.....+.+++.+|++.+|++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            000001111000     01123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=316.19  Aligned_cols=244  Identities=27%  Similarity=0.429  Sum_probs=201.7

Q ss_pred             eEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchhh
Q 003436          490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD  568 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  568 (820)
                      +||+|.||+||.|++.+ ...+|||.+........+-+++||.+.++|+|.|||+.+|.|.+++.+-+.||.+|||||.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            89999999999999775 45789999887777777888999999999999999999999999999999999999999999


Q ss_pred             HhhhcCCCCC--CHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-CCCCeeEeeccccccCCCCCCcccccc
Q 003436          569 HLYASNFPSL--SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTA  645 (820)
Q Consensus       569 ~l~~~~~~~l--~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (820)
                      +|...= .++  .+.+.--...||++||.|||   ...|||||||-+|||++ -.|.+||+|||-++.....  +.....
T Consensus       662 LLrskW-GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET  735 (1226)
T KOG4279|consen  662 LLRSKW-GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET  735 (1226)
T ss_pred             HHHhcc-CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence            997542 334  66777778899999999999   78999999999999995 5799999999999865432  334456


Q ss_pred             ccCCccccCccccccC--CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          646 VKGSFGYLDPEYLTKQ--QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       646 ~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ..||+.|||||++..+  .|..++|||||||.+.||.||+|||........      ++  .+.|-.      .....++
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AM--FkVGmy------KvHP~iP  801 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AM--FKVGMY------KVHPPIP  801 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hh--hhhcce------ecCCCCc
Confidence            7899999999999765  588999999999999999999999964322111      11  111111      1123456


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ++...+...++++|+.++|.+||++.++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            777888999999999999999999999875

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.6e-34  Score=307.38  Aligned_cols=265  Identities=23%  Similarity=0.376  Sum_probs=200.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..++||+|+||.||+|... +++.+|+|+.....  ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46788899999999999999986 47889999754332  2235678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.++....  ..++|.+++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99999998876543  34899999999999999999999   7899999999999999999999999999987643322 


Q ss_pred             ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh-hHHHHHHHhh-------ccCc-
Q 003436          640 THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV-NLVEWAMKCQ-------ETGQ-  709 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~-~l~~~~~~~~-------~~~~-  709 (820)
                       .......++..|+|||++.+ ..++.++||||||++++||++|++|+......+.. ....+.....       .... 
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence             22233457889999999875 45788999999999999999999988654332211 1111100000       0000 


Q ss_pred             cccccCcccc-----CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 LEDIVDPTLT-----GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 ~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...+..+...     ....+..+..+.+++.+||+.+|.+||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000000     01112345679999999999999999999998863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-33  Score=305.75  Aligned_cols=258  Identities=22%  Similarity=0.330  Sum_probs=202.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||++.... ++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368888999999999999999764 6789999876443   234567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++...  ..+++..+..++.+++.||+|||   +.+++||||||+||++++++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999654  36899999999999999999999   7899999999999999999999999999987421100


Q ss_pred             -------------CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          639 -------------QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       639 -------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                                   .........++..|+|||.+.+..++.++|+||||+++|||++|+.||......+.      .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~------~~~~~  229 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVI  229 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence                         00011224578899999999888999999999999999999999999865432211      11111


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      . +.   ...+..    ....+..+.+++.+|++.+|++||++.++.+.|+..+
T Consensus       230 ~-~~---~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         230 S-DD---IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             h-cc---cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence            1 10   111111    1134567899999999999999999776666665543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-33  Score=308.84  Aligned_cols=196  Identities=24%  Similarity=0.385  Sum_probs=159.2

Q ss_pred             ceeEeeecceEEEEEEEc---CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceEEEEEeecc
Q 003436          488 SLVIGIGGFGKVYRGVLR---DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEMIIIYEYME  562 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~E~~~  562 (820)
                      .++||+|+||.||+|+..   .++.+|+|.+.....  ...+.+|+++|++++||||+++++++..  +...++|+||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            358999999999999965   357899998754322  3457789999999999999999998843  456889999996


Q ss_pred             CCchhhHhhhcC-------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE----cCCCCeeEeecccc
Q 003436          563 NGTLKDHLYASN-------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLS  631 (820)
Q Consensus       563 ~gsL~~~l~~~~-------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll----~~~~~~kl~DFGla  631 (820)
                       ++|.+++....       ...+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             58888775321       235889999999999999999999   7899999999999999    45679999999999


Q ss_pred             ccCCCCCC-ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCC
Q 003436          632 KIGPDLDQ-THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPS  689 (820)
Q Consensus       632 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~  689 (820)
                      +....... ........||..|+|||++.+ ..++.++||||+||+++||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            86543211 112234568999999999976 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=308.75  Aligned_cols=253  Identities=22%  Similarity=0.273  Sum_probs=202.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|++|.||++...+ +..+|+|.......   ...+.+..|++++++++|+||+++++.+......++|+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999999875 88999998764432   34567899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999997665567999999999999999999999   7899999999999999999999999999987543211


Q ss_pred             Cc---------------------------cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCc
Q 003436          639 QT---------------------------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLP  691 (820)
Q Consensus       639 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~  691 (820)
                      ..                           .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011123578899999999998999999999999999999999999865432


Q ss_pred             hhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC----HHHHHH
Q 003436          692 REKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS----MGDVLW  753 (820)
Q Consensus       692 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs----~~evl~  753 (820)
                      ....     .. ..         +....-......+..+.+++.+|++.+|++||+    +.|++.
T Consensus       238 ~~~~-----~~-~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DETF-----SN-IL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHH-----HH-Hh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2111     00 00         111100111124578999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=314.06  Aligned_cols=240  Identities=24%  Similarity=0.305  Sum_probs=186.8

Q ss_pred             EeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC---CCCceeeEEeEeecCceEEEEEeeccC
Q 003436          491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF---RHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       491 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ||+|+||.||+|+.. .++.||+|++....   ......+..|..++.++   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999976 47899999865321   22334456677777665   699999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ...
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~  153 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT  153 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence            9999988654  36899999999999999999999   7899999999999999999999999999987532211  122


Q ss_pred             ccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      ....||..|+|||++.+. .++.++|||||||++|||++|+.||......+..       .....+..      .+.   
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~------~~~---  217 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-------RNIAFGKV------RFP---  217 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-------HHHHcCCC------CCC---
Confidence            345799999999998764 4899999999999999999999999754322211       11111111      010   


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCC----HHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPS----MGDVLW  753 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs----~~evl~  753 (820)
                      .......+.+++.+||+.+|.+||+    +.++++
T Consensus       218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0123456789999999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-33  Score=302.55  Aligned_cols=262  Identities=23%  Similarity=0.327  Sum_probs=202.5

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...+.||+|++|.||+|+.. ++..+++|+.....  ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999975 57899999865443  33456789999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      + +++|.+++.... ..+++.+++.++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-  154 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence            9 999999987544 56999999999999999999999   78999999999999999999999999999986543221 


Q ss_pred             cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC-----------
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG-----------  708 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----------  708 (820)
                      .......++..|+|||.+.+. .++.++||||+|++++||++|++++......+.   ..+........           
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL  231 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence            112335688999999998654 468999999999999999999888765433221   11111111100           


Q ss_pred             -ccccccCccc----cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 -QLEDIVDPTL----TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 -~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ....+..+..    .....++....+.+++.+|++.+|.+||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000000000    001112345788999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-33  Score=297.52  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=196.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-----SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  554 (820)
                      .+|...++||+|+||.||+|+.. ++..|++|.+...     .....+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999975 4789999976432     123456788999999999999999999988653  467


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++++|.+++....  .+++...++++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999987543  5788999999999999999999   789999999999999999999999999998754


Q ss_pred             CCCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          635 PDLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       635 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ...... .......++..|+|||++.+..++.++||||||+++|||++|+.||.........      .......     
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~-----  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQP-----  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHhcCC-----
Confidence            321111 1122345889999999998888999999999999999999999998643221111      0110000     


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          .....+......+.+++.+|+. +|++||++.+++++
T Consensus       226 ----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 ----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                0111233444667888899984 89999999998863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=302.80  Aligned_cols=265  Identities=21%  Similarity=0.319  Sum_probs=201.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..++||+|++|.||+|... +++.|++|++...  .....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888899999999999999986 4788999986543  23345778999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |++++.|..++...  ..+++.++..++.+++.||+|||   ..+++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99987776555432  35899999999999999999999   78999999999999999999999999999886544222


Q ss_pred             ccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHH---------hhccCc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK---------CQETGQ  709 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~---------~~~~~~  709 (820)
                       .......++..|+|||++.+. .++.++||||||+++|||++|++|+......+..........         ......
T Consensus       156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence             122345678899999999888 889999999999999999999999865433221111110000         000000


Q ss_pred             -----cccccCcc-ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          710 -----LEDIVDPT-LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       710 -----~~~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                           ..+..++. +...++...+.++.+++++||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                 00000000 000122233678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-33  Score=313.97  Aligned_cols=263  Identities=20%  Similarity=0.275  Sum_probs=197.4

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------  551 (820)
                      ..++|...+.||+|+||.||+++.. .++.+|||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3467999999999999999999975 4788999987643  233456788999999999999999999987543      


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      ...++||||+++ +|.+.+..    .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            357999999975 77776643    4788999999999999999999   789999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH---------HH-
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE---------WA-  701 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~---------~~-  701 (820)
                      +.....   .......+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+.         +. 
T Consensus       174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            754321   12234568999999999999999999999999999999999999997544322111100         00 


Q ss_pred             ------HHh-hccCccc-----cccCccc---cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          702 ------MKC-QETGQLE-----DIVDPTL---TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       702 ------~~~-~~~~~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                            ... .......     +.....+   ...........+.+++.+|++.||.+|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                  000 0000000     0000000   001111223568899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-34  Score=297.41  Aligned_cols=254  Identities=25%  Similarity=0.318  Sum_probs=208.7

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      +.|+..+.||+|.-|+||++.+++ +...|+|.+....   .+...+...|-+||+.++||-++.|++.++.+...+|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            346777799999999999999986 4889999876543   344567788999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC--
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD--  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~--  636 (820)
                      |||+||+|..+++++..+.+++..+.-.+..++.||+|||   -.|||.|||||+||||.++|++.|+||.|+.....  
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999999988889999999999999999999999   89999999999999999999999999999753210  


Q ss_pred             -------------------------------CCCc---------------------cccccccCCccccCccccccCCCC
Q 003436          637 -------------------------------LDQT---------------------HVSTAVKGSFGYLDPEYLTKQQLT  664 (820)
Q Consensus       637 -------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~t  664 (820)
                                                     ....                     ..+...+||..|+|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                           0000                     011235699999999999999999


Q ss_pred             CcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCC
Q 003436          665 EKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID  744 (820)
Q Consensus       665 ~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~  744 (820)
                      .+.|.|+|||+||||+.|+.||.....++...               .++-..+.-...+.....+.+|+++.|.+||.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            99999999999999999999998776544322               122222211122245678899999999999999


Q ss_pred             CCC----HHHHHHH
Q 003436          745 RPS----MGDVLWN  754 (820)
Q Consensus       745 RPs----~~evl~~  754 (820)
                      |-.    +.||-++
T Consensus       379 Rlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRH  392 (459)
T ss_pred             hhccccchHHhhcC
Confidence            987    6776544

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.6e-33  Score=296.35  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=203.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  558 (820)
                      +|+..+.||+|+||.||++... ++..+++|.+...  .....+.+..|++++++++|+||+++++++..  +...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4677889999999999999865 5788999986532  34456778899999999999999999998753  45679999


Q ss_pred             eeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCC--CCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          559 EYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGS--TKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       559 E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~--~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ||+++++|.+++...  ....+++..++.++.+++.||+|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653  2357899999999999999999999543  578999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      .....  ......++..|+|||.+.+..++.++|+||||+++++|++|+.|+......   ...+..    ..+..    
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~----  227 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI----KEGKF----  227 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH----hcCCC----
Confidence            43221  123346889999999999888999999999999999999999998754321   111111    11111    


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                           ...+......+.+++.+|++.+|.+||++.+|+++
T Consensus       228 -----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 -----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 12233455778999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-33  Score=306.88  Aligned_cols=195  Identities=25%  Similarity=0.396  Sum_probs=158.8

Q ss_pred             eeEeeecceEEEEEEEcC---ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEee--cCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD--ERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~lV~E~~~~  563 (820)
                      .+||+|+||.||+|+..+   +..+|+|.+.....  ...+.+|+++|++++||||+++++++.  .+...++|+||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            589999999999999753   46899998764432  346788999999999999999999884  45678999999975


Q ss_pred             CchhhHhhhc-------CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE----cCCCCeeEeeccccc
Q 003436          564 GTLKDHLYAS-------NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLSK  632 (820)
Q Consensus       564 gsL~~~l~~~-------~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll----~~~~~~kl~DFGla~  632 (820)
                       +|.+++...       ....+++..+..++.|++.||+|||   +.+|+||||||+|||+    ++++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             777776432       1235889999999999999999999   7899999999999999    567899999999998


Q ss_pred             cCCCCCCc-cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCC
Q 003436          633 IGPDLDQT-HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPS  689 (820)
Q Consensus       633 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~  689 (820)
                      ........ .......+|..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            65432211 12234568999999999876 45899999999999999999999998643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-33  Score=297.43  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=200.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      +|+..+.||+|++|.||+|... +++.+|+|.+....      ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4677789999999999999864 57889999875432      1235788999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGP  635 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~  635 (820)
                      |+||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999998754  36889999999999999999999   78999999999999998775 69999999987544


Q ss_pred             CCCC--ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          636 DLDQ--THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       636 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ....  ........++..|+|||.+.+..++.++||||+|++++||++|+.|+............   ......      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~------  226 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---FKIASA------  226 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH---HHHhcc------
Confidence            3211  11122345788999999998888999999999999999999999998643322111111   110000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                         ......+......+.+++.+|++.+|.+||++.++++
T Consensus       227 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 ---TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               0011233344577889999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.6e-33  Score=297.81  Aligned_cols=246  Identities=26%  Similarity=0.412  Sum_probs=201.1

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      |...+.||+|+||.||+|... ++..+|+|...... ....+.+.+|++++++++||||+++++++..+...++|+||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            667789999999999999875 57889999865432 3445678999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++...   .+++..+..++.+++.||+|||   ..+++|+||||+||+++.++.++|+|||+++......  ..
T Consensus        86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          86 GGSALDLLEPG---PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            99999988643   5899999999999999999999   7899999999999999999999999999987543321  11


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....++..|+|||.+.+...+.++|+|||||+++||++|+.|+.........      .. .....         ....
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~~~---------~~~~  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL------FL-IPKNN---------PPTL  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH------HH-HhcCC---------CCCC
Confidence            23346788999999998888999999999999999999999998643321111      11 01110         1112


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....+..+.+++.+|++.+|.+||++.+++++
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            23445678899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-34  Score=314.49  Aligned_cols=259  Identities=23%  Similarity=0.343  Sum_probs=195.8

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----  551 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----  551 (820)
                      +..++|...+.||+|+||.||+|... .+..||||++....  ....+.+.+|+++|++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            44578999999999999999999975 57889999876432  23345678899999999999999999887432     


Q ss_pred             -ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          552 -NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       552 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                       ...++++|++ +++|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence             4578999988 7799887753   35899999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC-
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG-  708 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-  708 (820)
                      ++.....     .....||..|+|||++.+ ..++.++|||||||+++||++|+.||......+...  .+ ....... 
T Consensus       165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~-~~~~~~~~  236 (343)
T cd07878         165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK--RI-MEVVGTPS  236 (343)
T ss_pred             ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HH-HHHhCCCC
Confidence            9854321     233468999999999876 578999999999999999999999986543222111  10 0000000 


Q ss_pred             -----------------ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 -----------------QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 -----------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                       .+.......+. .........+.+++.+|++.||.+||++.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         237 PEVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                             00000000000 0001223457899999999999999999999875

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.2e-33  Score=303.15  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=199.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|+..+.||+|++|.||+|+.. +++.++||++....  ....+.+.+|++++++++||||+++++++.+++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788889999999999999976 57889999876433  22345788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +. ++|.+++.......+++..+..++.|++.||+|||   ..+++||||+|+||++++++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            96 68999987766667999999999999999999999   7899999999999999999999999999987543211  


Q ss_pred             cccccccCCccccCccccccCC-CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc------------
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQ-LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET------------  707 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~------------  707 (820)
                      .......++..|+|||++.+.. ++.++||||||++++||+||+.||......+.  ..+........            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence            1122335688999999887644 68899999999999999999999865433221  11111100000            


Q ss_pred             ---CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          708 ---GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       708 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                         ..........+. ...+.....+.+++.+|++.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               000000000000 011123356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=301.77  Aligned_cols=264  Identities=21%  Similarity=0.338  Sum_probs=196.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|++|.||+|+.+ +++.||+|....... .....+.+|++++++++|+||+++++++.++...++|+||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            56888899999999999999976 578899998654322 2234567899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++ +|.+++.... ..+++.....++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++......  
T Consensus        85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--  157 (291)
T cd07844          85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--  157 (291)
T ss_pred             CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence            984 9999887544 36899999999999999999999   7899999999999999999999999999987532211  


Q ss_pred             cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCc-hhhhhHHHHHHHhhccCccccc-----
Q 003436          641 HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLP-REKVNLVEWAMKCQETGQLEDI-----  713 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~-----  713 (820)
                      .......++..|+|||++.+ ..++.++||||||+++|||++|++||..... .+...................+     
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            11122346788999999865 4588999999999999999999999865431 1111111000000000000000     


Q ss_pred             ---------cCccccCCCC-hhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 ---------VDPTLTGQIK-PDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ---------~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                               ....+..... ......+.+++.+|++.+|++||++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                     0000000000 011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-33  Score=331.30  Aligned_cols=256  Identities=21%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEM  554 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~  554 (820)
                      ...++|...++||+|+||.||+++... +..+|+|.+...  .......|..|+.+|++|+||||+++++++..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            345679999999999999999999764 667888876533  33445778999999999999999999998743  4568


Q ss_pred             EEEEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCC----CCcEEeccCCCCcEEEcC---------
Q 003436          555 IIIYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGS----TKAIIHRDVKSANILLDE---------  619 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~----~~~iiHrDIkp~NIll~~---------  619 (820)
                      +|||||+++|+|.++|...  ....+++..++.|+.||+.||+|||+..    ..+||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999999753  2346999999999999999999999532    146999999999999964         


Q ss_pred             --------CCCeeEeeccccccCCCCCCccccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCC
Q 003436          620 --------NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPS  689 (820)
Q Consensus       620 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~  689 (820)
                              ...+||+|||+++.....   .......||+.|+|||++.+  ..++.++|||||||+||||+||+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    345899999999754321   12234578999999999854  45889999999999999999999999643


Q ss_pred             CchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          690 LPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       690 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....     .........        +.+.   .......+.+|+..||+.+|.+||++.|++..
T Consensus       247 ~~~~-----qli~~lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        247 NNFS-----QLISELKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CcHH-----HHHHHHhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            3211     111111111        1110   11234678999999999999999999999853

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=299.55  Aligned_cols=254  Identities=27%  Similarity=0.401  Sum_probs=200.8

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc-----
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN-----  552 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~-----  552 (820)
                      .++++|+..+.||+|++|.||+|..+ +++.+++|....... ..+++.+|+++++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35678999999999999999999986 467899998765443 346789999999999 7999999999986544     


Q ss_pred             -eEEEEEeeccCCchhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          553 -EMIIIYEYMENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       553 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                       ..++|+||+++++|.+++....  ...+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999987543  457899999999999999999999   7899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      ++......  ........++..|+|||.+..     ..++.++||||||++++||++|++||........  +.+    .
T Consensus       159 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~  230 (275)
T cd06608         159 VSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----I  230 (275)
T ss_pred             cceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----h
Confidence            98754321  122234568899999998753     3567899999999999999999999864322111  111    0


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                       .....     +.+  .........+.+++.+|+..||.+||++.++++
T Consensus       231 -~~~~~-----~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 -PRNPP-----PTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -hccCC-----CCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             11111     111  111224567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-33  Score=303.68  Aligned_cols=262  Identities=21%  Similarity=0.304  Sum_probs=199.5

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChh-----hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ-----GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      +|...+.||+|++|.||+|... +++.|++|++......     ....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3677789999999999999976 5789999987654322     345677899999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+ +|+|.+++.... ..+++..++.++.|+++||+|||   ..+++|+||||+||+++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 899999987654 46999999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh--------ccC
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ--------ETG  708 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~--------~~~  708 (820)
                      ..  ......++..|+|||.+.+ ..++.++|||||||+++||++|.+++....+.+.....  .....        ...
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI--FEALGTPTEENWPGVT  231 (298)
T ss_pred             Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH--HHHcCCCchhhhhhcc
Confidence            21  1223356788999998854 46789999999999999999998887654332211111  00000        000


Q ss_pred             ccccccCccccC-----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 QLEDIVDPTLTG-----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ............     .........+.+++.+|++.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000000     1112335678999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.9e-33  Score=290.75  Aligned_cols=250  Identities=28%  Similarity=0.471  Sum_probs=205.0

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +|...+.||+|++|.||++... ++..+++|+.........+.+.+|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3677789999999999999986 578899999876655566889999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.... ..+++..+..++.+++.||++||   ..+++||||+|+||++++++.++|+|||.+........   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---  153 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---  153 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence            999999987653 46899999999999999999999   78999999999999999999999999999876543221   


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....++..|++||.+.+...+.++||||||++++||++|+.|+......+.....      .. .......+       
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-~~~~~~~~-------  219 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI------AT-NGPPGLRN-------  219 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH------Hh-cCCCCcCc-------
Confidence            23456888999999998888999999999999999999999998654322211110      00 11111110       


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......+.+++.+|++.+|.+||++.+++++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11124678999999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.3e-34  Score=306.25  Aligned_cols=247  Identities=21%  Similarity=0.371  Sum_probs=199.5

Q ss_pred             ccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          486 SESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      .....||+|+||.||++... .+..+|||++........+.+.+|+.++++++|+||+++++.+..++..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            33457999999999999875 57889999876655566678999999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST  644 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  644 (820)
                      +|.+++...   .+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.......  ....
T Consensus       105 ~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  176 (292)
T cd06658         105 ALTDIVTHT---RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK  176 (292)
T ss_pred             cHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence            999988543   5889999999999999999999   7899999999999999999999999999987543221  1122


Q ss_pred             cccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       645 ~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      ...++..|+|||.+.+..++.++||||||++++||++|+.|+......+....   ..         ....+.+..  ..
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~---------~~~~~~~~~--~~  242 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IR---------DNLPPRVKD--SH  242 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---------hcCCCcccc--cc
Confidence            34588999999999888899999999999999999999999865433221111   00         011111111  11


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .....+.+++.+|+..+|.+||++.+++++
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            234568889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=296.06  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      |.+.++||+|+||.|||+.++ .|+.+|+|++...+  +.+++..|+.+|++++.|++|+++|.+.....+++|||||-.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            777889999999999999987 58999999976554  468899999999999999999999999888999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+..+.+...+ ++|++.++..|....+.||+|||   ...-||||||+.||||+.+|.+||+|||.|....+  .....
T Consensus       113 GSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKR  186 (502)
T KOG0574|consen  113 GSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKR  186 (502)
T ss_pred             CcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhh
Confidence            99999887554 67999999999999999999999   68889999999999999999999999999975432  22334


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ..+.||+-|||||++..-.|..++||||+|+...||..|++|+..-.+....-       ++.       ..|...-..+
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIP-------T~PPPTF~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIP-------TKPPPTFKKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------ecc-------CCCCCCCCCh
Confidence            45789999999999999999999999999999999999999986543322110       000       0111111234


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +....++-++++.||-++|++|-++-+++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            5667889999999999999999999888765

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-33  Score=305.82  Aligned_cols=246  Identities=22%  Similarity=0.351  Sum_probs=199.1

Q ss_pred             cceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCc
Q 003436          487 ESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      ....||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            3447999999999999875 578999998765554556778899999999999999999999999999999999999999


Q ss_pred             hhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccccc
Q 003436          566 LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA  645 (820)
Q Consensus       566 L~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  645 (820)
                      |.+++..   ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++......  .....
T Consensus       105 L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~  176 (297)
T cd06659         105 LTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKS  176 (297)
T ss_pred             HHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccc
Confidence            9998754   35899999999999999999999   7899999999999999999999999999987543221  11234


Q ss_pred             ccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChh
Q 003436          646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD  725 (820)
Q Consensus       646 ~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  725 (820)
                      ..++..|+|||++.+..++.++|||||||+++||++|+.||......+..   ....    ....     +..  .....
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~----~~~~-----~~~--~~~~~  242 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLR----DSPP-----PKL--KNAHK  242 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHh----ccCC-----CCc--cccCC
Confidence            56889999999999889999999999999999999999998754332221   1111    0000     000  11122


Q ss_pred             hHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       726 ~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....+.+++.+|++.+|.+||++.+++++
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            34568899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-33  Score=299.31  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=202.2

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +|+..+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677789999999999999987 57889999876543 345577899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCC-CcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST-KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~-~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++++|.+++.... ..+++....+++.|++.||+|||   + .+++|+||||+||++++++.+||+|||++......   
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---  154 (265)
T cd06605          82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---  154 (265)
T ss_pred             CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence            9999999987653 56889999999999999999999   6 89999999999999999999999999998643221   


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                       ......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ....+.........      .+.+. 
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~~-  225 (265)
T cd06605         155 -LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRLP-  225 (265)
T ss_pred             -HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCCC-
Confidence             1112568889999999999999999999999999999999999986442111 11111111111110      01111 


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .......+.+++.+|+..+|++||++.+++.+
T Consensus       226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 --SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             --hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence              11145678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2e-33  Score=296.40  Aligned_cols=250  Identities=24%  Similarity=0.410  Sum_probs=202.0

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|+..+.||+|+||.||+|..+ ++..+|+|.+....  ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778889999999999999986 47889999865431  23346788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~~~~~  639 (820)
                      +++++|.+++.......+++..+..++.|++.||+|||   +.+++|+||||+||++++++ .+||+|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence            99999999997765556899999999999999999999   78999999999999998875 56999999987654321 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                       .......|+..|+|||++.+..++.++|+||||++++||++|+.|+......+      +...... +...        
T Consensus       157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~--------  220 (257)
T cd08225         157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYFA--------  220 (257)
T ss_pred             -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccCC--------
Confidence             11223458889999999988889999999999999999999999986443221      1211111 1111        


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ...+.....+.+++.+|++.+|++||++.+++++
T Consensus       221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             1122344678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.2e-33  Score=299.61  Aligned_cols=247  Identities=21%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      |...++||+|++|.||++... +++.+++|+.........+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            455669999999999999965 5788999987665555567789999999999999999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      ++|.+++..   ..+++.++..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||++......  ....
T Consensus       101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~  172 (285)
T cd06648         101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR  172 (285)
T ss_pred             CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence            999999876   35899999999999999999999   789999999999999999999999999988754321  1112


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....|+..|+|||.+.+..++.++||||||++++||++|+.|+....+.+..      ...... .     .+.+.  ..
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~------~~~~~~-~-----~~~~~--~~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------KRIRDN-L-----PPKLK--NL  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHhc-C-----CCCCc--cc
Confidence            2345889999999999888999999999999999999999998654322111      111111 0     01111  11


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ......+.+++.+|++.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            124467899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.4e-33  Score=297.90  Aligned_cols=258  Identities=24%  Similarity=0.319  Sum_probs=202.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV~  558 (820)
                      ++|...+.||.|++|.||++... .++.+|+|...... .....++.+|++++++++||||++++++|..  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888899999999999999985 47889999876433 2445778999999999999999999998854  34689999


Q ss_pred             eeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          559 EYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||+++++|.+++..  .....+++.....++.|++.||+|||   ..+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998754  23346889999999999999999999   78999999999999999999999999999875332


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCc--hhhhhHHHHHHHhhccCcccccc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLP--REKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      .    ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....  ........+....    ....+.
T Consensus       158 ~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~  229 (287)
T cd06621         158 S----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELK  229 (287)
T ss_pred             c----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhc
Confidence            1    11234578899999999999999999999999999999999999875422  1122233332211    111110


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +. .  .........+.+++.+|++.+|.+||++.|+++.
T Consensus       230 ~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         230 DE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             cC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00 0  0011235678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.7e-33  Score=292.79  Aligned_cols=252  Identities=26%  Similarity=0.408  Sum_probs=206.5

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  558 (820)
                      +|...+.||+|++|.||+|... ++..+++|......  ....+.+.+|++++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3677789999999999999987 68889999876544  24567899999999999999999999999888  8899999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++....  .+++.+++.++.+++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999997654  7999999999999999999999   6899999999999999999999999999998655432


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      .........++..|+|||.+.+...+.++||||||++++||++|+.|+.....     ..........         ...
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~---------~~~  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGS---------SGE  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccc---------cCC
Confidence            21112345688899999999888899999999999999999999999875541     1111111111         111


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....+......+.+++.+|++.+|.+||++.+++.+
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            112333446789999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-33  Score=301.80  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=203.8

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|...+.||+|+||.||+|... ++..+++|..........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999864 57889999876555555678899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++...   .+++.++..++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||++........  
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            999999998653   4789999999999999999999   78999999999999999999999999999875443221  


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......++..|+|||.+.+..++.++||||||+++||+++|+.||......+....      ....+        .....
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~~  236 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPELQ  236 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCCC
Confidence            12234688899999999888899999999999999999999999965433221110      00000        00001


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ........+.+++.+||+.+|.+||++.+++.+
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122334578899999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.3e-33  Score=298.58  Aligned_cols=251  Identities=26%  Similarity=0.355  Sum_probs=193.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHH-HHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEM-LSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..+.||+|+||.||+++.. ++..||+|+..... .....++..|+.. ++.++||||+++++++..++..++|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999976 58899999876442 2233455666665 566789999999999999999999999


Q ss_pred             eccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |++ |+|.+++...  ....+++..++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6888887642  2356899999999999999999999   55 899999999999999999999999999875432


Q ss_pred             CCCccccccccCCccccCcccccc----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTK----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      .   ...+...++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+...... ...+.    .... +.   
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~-~~---  224 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLK----QVVE-EP---  224 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHH----HHHh-cC---
Confidence            1   11223457889999998865    45688999999999999999999998642211 01111    1111 00   


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .+.+.   ....+..+.+++.+||..+|.+||++.+++++
T Consensus       225 --~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         225 --SPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             --CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              01110   11234678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-33  Score=297.75  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=199.5

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .|+..+.||+|+||.||+|.+. ++..+++|.+... .....+++.+|++++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4667789999999999999975 5788999987543 3344577889999999997   999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++...   .+++...+.++.+++.||.|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999988653   6899999999999999999999   7899999999999999999999999999997654322


Q ss_pred             CccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .......|+..|+|||.+.+ ..++.++||||||+++|||++|++||........      ... ...     ...+.
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-~~~-----~~~~~  221 (277)
T cd06917         156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-IPK-----SKPPR  221 (277)
T ss_pred             --cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-ccc-----CCCCC
Confidence              12233468899999999865 4578999999999999999999999975432111      110 000     01111


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +..   ...+..+.+++.+|++.+|.+||++.++++.
T Consensus       222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            111   1245678899999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.3e-33  Score=299.43  Aligned_cols=254  Identities=25%  Similarity=0.403  Sum_probs=206.8

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ..+++|...+.||+|++|.||+|.++ ++..+++|....... ..+.+.+|++++++++|+|++++++.+......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45667888889999999999999987 578899998765544 5677899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++.... ..+++..++.++.+++.||+|||   ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999997654 46999999999999999999999   7999999999999999999999999999986543221


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......++..|++||.+.+..++.++||||||+++|||++|+.|+....+.....  ...     .......     
T Consensus       171 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~-----~~~~~~~-----  236 (286)
T cd06614         171 --SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LIT-----TKGIPPL-----  236 (286)
T ss_pred             --hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-----hcCCCCC-----
Confidence              12233457889999999998889999999999999999999999986543322111  100     0011100     


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ......+..+.+++.+|++.+|.+||++.++++.
T Consensus       237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 --KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              1111245678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.4e-33  Score=293.27  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=200.8

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH--QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...+.||+|+||.||+|+.. +++.+++|.+.....  ...+.+..|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4677789999999999999975 578899998654433  3678899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++....  .+++..+..++.+++.||+|||   +.+++|+||+|+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            99999999987643  5789999999999999999999   789999999999999999999999999998865432221


Q ss_pred             cc--cccccCCccccCccccccCC---CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          641 HV--STAVKGSFGYLDPEYLTKQQ---LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       641 ~~--~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..  .....++..|+|||++.+..   .+.++||||||++++||++|+.||........  .   ...... +.     .
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~~~-~~-----~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHVGA-GH-----K  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHHhc-CC-----C
Confidence            11  11346788999999998766   89999999999999999999999964432111  1   111000 10     1


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      +.+.  ........+.+++.+|++.+|.+||++.+++.
T Consensus       225 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111  01123567889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-33  Score=304.60  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=206.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeC--CCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRG--GTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~--~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ...|+.+++||+||.+.|||+.-.+.+.+|+|++  ...+.+....|.+|+..|.+|+ |.+|++|++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3457888899999999999999888888888874  3456677889999999999994 999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||=+ -+|..+|.........| .+..+..|++.++.++|   ..+|||.||||.|+|+- .|.+||+|||+|.......
T Consensus       440 E~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            9864 58999998766555556 67778899999999999   79999999999999995 5799999999999887766


Q ss_pred             CccccccccCCccccCccccccC-----------CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQ-----------QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      ........+||+.||+||.+...           +.++++||||+||+||+|+-|++||...     .+  .|.      
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n--~~a------  580 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----IN--QIA------  580 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HH--HHH------
Confidence            66667788999999999998532           3678999999999999999999999522     11  111      


Q ss_pred             CccccccCccccCCCChhh-HHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDS-LNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~-~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ++..+.||...-+++.-- ..+++++++.||+.||++||+..|+|++
T Consensus       581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             244555664433333211 2339999999999999999999999875

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.2e-33  Score=299.58  Aligned_cols=245  Identities=24%  Similarity=0.337  Sum_probs=200.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|++|.||++... +++.+|+|.....   .....+.+.+|++++++++||||+++++++.+++..++|+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788899999999999999976 4788999976532   2234567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++...  ..+++..+..++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999998765  36899999999999999999999   789999999999999999999999999998865432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          .....++..|+|||.+.+...+.++||||||++++||++|+.|+......+.   ...    ...+..        
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~----~~~~~~--------  215 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI---YEK----ILEGKV--------  215 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HhcCCc--------
Confidence                2344688999999999888899999999999999999999999865432111   110    001110        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                        .++......+.+++.+||+.+|.+||     ++.|++++
T Consensus       216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence              12223346788999999999999998     66666543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=8.8e-33  Score=297.74  Aligned_cols=266  Identities=22%  Similarity=0.304  Sum_probs=196.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++++|...+.||+|+||.||+|... ++..+++|+...... .....+.+|++++++++|+||+++++++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3567899999999999999999875 578999998754432 22346788999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+. ++|.+++.... ..+++.++..++.|++.||+|||   ..+|+|+||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9996 67777765433 45788899999999999999999   7899999999999999999999999999987543221


Q ss_pred             CccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh----------hcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC----------QET  707 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~----------~~~  707 (820)
                      .  ......++..|+|||++.+. .++.++||||||+++|||++|+.||+........-...|....          ...
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            1  12234578899999998764 5788999999999999999999999754332111000010000          000


Q ss_pred             Ccc-ccccCccccCCC-----ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          708 GQL-EDIVDPTLTGQI-----KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       708 ~~~-~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ... ............     .......+.+++.+|++.+|.+|||+.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000 000000000000     0012457889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-33  Score=300.66  Aligned_cols=262  Identities=20%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...+.||+|+||.||+|+.. .|..+++|++....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999976 57889999865432  22235677899999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++ ++|.+++.... ..+++..++.++.|+++||+|||   ..+++||||||+||+++.++.+||+|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--  153 (284)
T cd07839          81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--  153 (284)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence            97 58888776543 45899999999999999999999   7899999999999999999999999999987543211  


Q ss_pred             cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC------ccccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG------QLEDI  713 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~  713 (820)
                      .......++..|+|||++.+. .++.++|||||||+++||++|+.|+......+.  ..+.........      .+...
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhc
Confidence            112234578899999998765 468999999999999999999987644332211  111110000000      00000


Q ss_pred             cCc----ccc-----CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 VDP----TLT-----GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ~d~----~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+.    ...     ....+....++.+++.+||+.+|.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000    000     01112345678899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=299.39  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=198.5

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      |+..+.||.|++|.||+|... ++..+++|++....  ......+.+|++++++++|||++++++++.+++..++|+||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566779999999999999975 68899999875433  223457889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      + ++|.+++.......+++..+++++.|+++||+|||   +.+++||||+|+||++++++.++|+|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 69999987665457899999999999999999999   78999999999999999999999999999875432111  


Q ss_pred             ccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc-----------Cc
Q 003436          642 VSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET-----------GQ  709 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------~~  709 (820)
                      ......++..|+|||++.+. .++.++||||||+++|||++|++||......+.  +..........           ..
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence            11223468899999988654 578999999999999999999999865433221  11111100000           00


Q ss_pred             ----cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          710 ----LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       710 ----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                          ......+.+ ....+.....+.+++.+|++.+|.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                000000000 1112234467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-33  Score=305.65  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=210.3

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~  555 (820)
                      ..+.|...+.||+|.||.||+++.+. |+.+|+|.+.....   .....+.+|+.+|+++. ||||+.+.+.++.....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34567777899999999999999876 89999998754433   24468899999999998 999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC----CCCeeEeecccc
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE----NLMAKVADFGLS  631 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~----~~~~kl~DFGla  631 (820)
                      +|||++.||.|.+.+...   .+++.....++.|++.+++|||   +.+|+||||||+|+|+..    ++.+|++|||++
T Consensus       113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            999999999999999876   3999999999999999999999   799999999999999943    358999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      .....   .......+||+.|+|||++....++..+|+||+||++|.|++|.+||...........       ...+.. 
T Consensus       187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~-------i~~~~~-  255 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA-------ILRGDF-  255 (382)
T ss_pred             eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH-------HHcCCC-
Confidence            87654   3344568899999999999999999999999999999999999999987654333221       111111 


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                           ......-+.....+.+++..|+..||.+|+++.+++++
T Consensus       256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                 11222233456778899999999999999999999984

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.7e-33  Score=300.15  Aligned_cols=264  Identities=21%  Similarity=0.284  Sum_probs=199.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV  557 (820)
                      ++|+..+.||+|+||.||+|... +++.+++|.+....  ......+.+|++++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888889999999999999986 47889999875433  22234577899999999999999999998776  889999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||++ ++|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99997 59999887543 36899999999999999999999   789999999999999999999999999998865432


Q ss_pred             CCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH-H---------HHHH---
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV-E---------WAMK---  703 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~-~---------~~~~---  703 (820)
                      .  .......++..|+|||.+.+. ..+.++|+||||++++||++|++|+......+..... .         |...   
T Consensus       160 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         160 L--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             c--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            1  112234578899999998754 4689999999999999999999999755433221111 0         0000   


Q ss_pred             -hhccCccccccCccccCCCChh-hHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          704 -CQETGQLEDIVDPTLTGQIKPD-SLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       704 -~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                       ..............+...++.. ....+.+++.+|++.+|++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence             0000001111111111222222 3567889999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-33  Score=300.72  Aligned_cols=254  Identities=25%  Similarity=0.350  Sum_probs=196.3

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...++||+|+||.||+++.. .++.+|+|+..... ......+.+|+.++.++. |+||+++++++...+..++++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555668999999999999976 47899999876433 344567889999999996 99999999999988999999999


Q ss_pred             ccCCchhhH---hhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          561 MENGTLKDH---LYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       561 ~~~gsL~~~---l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      ++. +|.++   +.......+++..+.+++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 55443   333334579999999999999999999994  358999999999999999999999999998754321


Q ss_pred             CCccccccccCCccccCccccccC---CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQ---QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      .   ......|+..|+|||++.+.   .++.++|||||||++|||++|+.||.....     ..+....... +     .
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~-----~  227 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-G-----D  227 (288)
T ss_pred             C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-C-----C
Confidence            1   12234588899999999766   689999999999999999999999864321     1111111111 0     1


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+.+........+..+.+++.+|++.+|.+||++.+++++
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1222222223456789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.7e-33  Score=309.36  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=204.9

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-C-----CceeeEEeEeecCceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-H-----RHLVSLIGYCDERNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H-----~nIv~l~g~~~~~~~~~l  556 (820)
                      +|++.+.||+|.||.|-|+.+.. ++.||||+++... .-..+-..|+.+|..|+ |     -|+|++++++..++++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            68889999999999999999764 8999999987553 33456678999999996 4     499999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC--CCCeeEeeccccccC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE--NLMAKVADFGLSKIG  634 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~--~~~~kl~DFGla~~~  634 (820)
                      |+|.++ -+|.++|..++...++...+..|+.||+.||..||   ..+|||+||||+||||.+  ...+||+|||.+...
T Consensus       266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999996 59999999999889999999999999999999999   799999999999999964  348999999999864


Q ss_pred             CCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH--------HHh--
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA--------MKC--  704 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~--------~~~--  704 (820)
                      ...-.     ...-+.-|.|||++.+.+|+.+.|+|||||++.||++|.+.|.+..+.++...+.-+        ...  
T Consensus       342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            32211     334567799999999999999999999999999999999888777665554433211        100  


Q ss_pred             -----hcc-Cc-c-----ccc----------------cCcc-cc-------CCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          705 -----QET-GQ-L-----EDI----------------VDPT-LT-------GQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       705 -----~~~-~~-~-----~~~----------------~d~~-l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                           ... .. +     .+.                .+.. ..       .......-..+.+++++|++.||.+|++.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                 000 00 0     000                0000 00       00111334578999999999999999999


Q ss_pred             HHHHHH
Q 003436          749 GDVLWN  754 (820)
Q Consensus       749 ~evl~~  754 (820)
                      .+.+++
T Consensus       497 ~qal~H  502 (586)
T KOG0667|consen  497 AQALNH  502 (586)
T ss_pred             HHHhcC
Confidence            999876

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-32  Score=299.29  Aligned_cols=247  Identities=29%  Similarity=0.424  Sum_probs=197.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      +.|...+.||+|+||.||+|+.. +++.|++|.+...   .....+++.+|+++++.++||||++++++|..++..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45778889999999999999976 5788999986533   2334567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||++ |+|.+++.... ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++..... 
T Consensus        95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            9997 57777775433 35899999999999999999999   789999999999999999999999999998754321 


Q ss_pred             CccccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          639 QTHVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                           ....++..|+|||++.   ...++.++||||||+++|||++|++|+.........      ....... .     
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~~~-~-----  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND-S-----  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhcCC-C-----
Confidence                 2345788999999884   456889999999999999999999998644322111      1111000 0     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      +.+   ........+.+++.+||+.+|.+||++.+++.+.
T Consensus       232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            111   1123456789999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.7e-33  Score=298.66  Aligned_cols=265  Identities=22%  Similarity=0.317  Sum_probs=197.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..+.||+|++|.||+|+.. +++.+++|+.....  ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999976 57889999865432  2334678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeeccccccCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~~~~~~  638 (820)
                      |++ ++|.+++.......+++.....++.|++.||+|||   +.+++||||+|+||++++ ++.+||+|||+++..... 
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            996 58888876555445788889999999999999999   789999999999999985 567999999999754321 


Q ss_pred             CccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhh-HHHHHHHhhccCc------c
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVN-LVEWAMKCQETGQ------L  710 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~------~  710 (820)
                       ........++..|+|||++.+ ..++.++||||||+++|||+||++||......+... ...+... .....      +
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (294)
T PLN00009        157 -VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGT-PNEETWPGVTSL  234 (294)
T ss_pred             -ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChhhccccccc
Confidence             111223457889999999866 457899999999999999999999997543322211 1100000 00000      0


Q ss_pred             ccccC--cccc----CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVD--PTLT----GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d--~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+...  +...    ....+....++.+++.+|++.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000  0000    01112345668899999999999999999999864

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-33  Score=301.55  Aligned_cols=266  Identities=20%  Similarity=0.276  Sum_probs=196.6

Q ss_pred             CCccceeEeeecceEEEEEEEcC---ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMI  555 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  555 (820)
                      +|...++||+|+||.||+|+...   +..+|+|.+....   ....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            36778899999999999999754   6889999876532   33346778899999999999999999999887  7899


Q ss_pred             EEEeeccCCchhhHhhhcC---CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC----CCCeeEeec
Q 003436          556 IIYEYMENGTLKDHLYASN---FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE----NLMAKVADF  628 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~----~~~~kl~DF  628 (820)
                      +|+||+++ +|.+++....   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6777664322   236889999999999999999999   789999999999999999    999999999


Q ss_pred             cccccCCCCCC-ccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchh-------hhhHHH
Q 003436          629 GLSKIGPDLDQ-THVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE-------KVNLVE  699 (820)
Q Consensus       629 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~-------~~~l~~  699 (820)
                      |+++....... ........++..|+|||.+.+. .++.++||||||++++||++|++||.......       ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543222 1122334678899999988764 57899999999999999999999987543322       011111


Q ss_pred             HHHHhh-----------ccCccccccCccccCCCC---------h--hhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          700 WAMKCQ-----------ETGQLEDIVDPTLTGQIK---------P--DSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       700 ~~~~~~-----------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .+..+.           +........+.......+         .  ....++.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            111000           000000000000000111         0  23456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.5e-33  Score=305.03  Aligned_cols=267  Identities=23%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC--ceE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER--NEM  554 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~--~~~  554 (820)
                      ..++|...+.||+|+||.||+|... ++..+|+|++...  .......+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888889999999999999976 5788999986432  233445678899999999 999999999998543  468


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||++ ++|.+++...   .++|..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            99999997 5998888654   6889999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCCc---cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh------
Q 003436          635 PDLDQT---HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC------  704 (820)
Q Consensus       635 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~------  704 (820)
                      ......   .......|+..|+|||.+.+ ...+.++||||||+++|||++|++||......+...........      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432221   12233468899999998855 46789999999999999999999998654433221111100000      


Q ss_pred             --hccCccccccC----cc--ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 --QETGQLEDIVD----PT--LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 --~~~~~~~~~~d----~~--l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ........+++    ..  ......+.....+.+++.+|++.+|.+||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              00000000000    00  0001112345778999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.4e-33  Score=299.33  Aligned_cols=267  Identities=23%  Similarity=0.341  Sum_probs=198.8

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc----
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN----  552 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----  552 (820)
                      ...++|+..+.||+|+||.||+|... +++.|++|++....  ......+.+|++++++++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34577899999999999999999986 47889999875432  223456778999999999999999999986654    


Q ss_pred             ------eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEe
Q 003436          553 ------EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA  626 (820)
Q Consensus       553 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~  626 (820)
                            ..++|+||+++ +|.+.+... ...+++.++..++.|++.||+|||   +.+|+|+||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999986 777776543 346899999999999999999999   7899999999999999999999999


Q ss_pred             eccccccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      |||++........ .......++..|+|||.+.+ ...+.++|||||||+++||++|++|+......+....+.......
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (302)
T cd07864         159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP  237 (302)
T ss_pred             cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999986543221 11222346778999998865 457899999999999999999999997543322221111100000


Q ss_pred             ccCccccccC--------c------cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          706 ETGQLEDIVD--------P------TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       706 ~~~~~~~~~d--------~------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .......+..        +      ... ......+..+.+++.+||+.+|.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             Chhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000111100        0      000 011124577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-32  Score=295.46  Aligned_cols=264  Identities=22%  Similarity=0.332  Sum_probs=199.0

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +|+..++||+|++|.||+|+.. ++..+|+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999986 578899998765432 23466788999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          562 ENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       562 ~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++ +|.+++.... ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            85 8888886543 346899999999999999999999   7899999999999999999999999999997543211  


Q ss_pred             cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC------ccccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG------QLEDI  713 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~  713 (820)
                      .......++..|++||++.+. .++.++||||||+++|||++|++||......+......-........      .....
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            112234568899999998654 56889999999999999999999987654332211110000000000      00000


Q ss_pred             cC--ccc----cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 VD--PTL----TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ~d--~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ..  +..    .....+.....+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00  000    00111233567889999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-33  Score=296.81  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEEEEEe
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMIIIYE  559 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~E  559 (820)
                      |+..+.||+|++|.||+|+..+ ++.+++|++....  ....+.+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            4567799999999999999764 7889999876552  33346788999999999999999999999887  88999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++ +|.+++.... ..+++.+++.++.|++.||+|||   ..+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9975 8988886543 46899999999999999999999   78999999999999999999999999999986543221


Q ss_pred             ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc------
Q 003436          640 THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED------  712 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------  712 (820)
                       .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..........................      
T Consensus       156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence             11233456788999998765 4678999999999999999999999876543322211110000000000000      


Q ss_pred             --------ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          713 --------IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       713 --------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                              .....+.......++..+.+++.+|++.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    00000111111123567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-33  Score=310.67  Aligned_cols=244  Identities=25%  Similarity=0.412  Sum_probs=193.5

Q ss_pred             ceeEeeecceEEEEEEEc-CccEEEE---EeCC-CCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc--eEEEEEee
Q 003436          488 SLVIGIGGFGKVYRGVLR-DETKVAV---KRGG-TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN--EMIIIYEY  560 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~-~~~~vav---K~~~-~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~E~  560 (820)
                      ..+||+|+|-+||||.+. .|.+||-   |.-. .......+.|..|+.+|+.|+||||++++.++.+..  ...+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            348999999999999976 3666653   3211 223455688999999999999999999999886554  47899999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~~~~~~~  639 (820)
                      |..|+|+.++.+.+  .++.+...+||.||++||.|||+. .++|||||||.+||+|+. -|.+||+|+|||.....   
T Consensus       125 ~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~---  198 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK---  198 (632)
T ss_pred             ccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc---
Confidence            99999999997765  688899999999999999999975 579999999999999964 58999999999987543   


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                       .....+.||+.|||||++. ..|.+..||||||++++||+|+..|+.......+  +..-+....+...+.++-|    
T Consensus       199 -s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~kV~d----  270 (632)
T KOG0584|consen  199 -SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSKVKD----  270 (632)
T ss_pred             -cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhccCC----
Confidence             2234478999999999997 7899999999999999999999999865433221  1111222222222333333    


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                              .++.+++.+|+.. ..+||++.|+|..
T Consensus       271 --------Pevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  271 --------PEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             --------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                    4578999999998 8999999999874

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.1e-33  Score=298.00  Aligned_cols=262  Identities=21%  Similarity=0.281  Sum_probs=195.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCce-----
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNE-----  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~-----  553 (820)
                      ++|+..+.||+|+||.||+|... +++.||+|+.....  ......+.+|+.++++++ |+||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999976 57899999865432  223467888999999995 6999999999876655     


Q ss_pred             EEEEEeeccCCchhhHhhhcC---CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeecc
Q 003436          554 MIIIYEYMENGTLKDHLYASN---FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFG  629 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFG  629 (820)
                      .++||||+++ +|.+++....   ...+++..++.++.|++.||+|||   ..+++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8988886532   246899999999999999999999   789999999999999998 8999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      +++......  .......+++.|+|||.+.+ ..++.++||||||+++|||++|++||....+.+..  .... ......
T Consensus       157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~-~~~~~~  231 (295)
T cd07837         157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIF-KLLGTP  231 (295)
T ss_pred             cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHH-HHhCCC
Confidence            987543211  11122346788999998865 45789999999999999999999998654322211  1000 000000


Q ss_pred             c---cccccC-------c----cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          709 Q---LEDIVD-------P----TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       709 ~---~~~~~d-------~----~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .   .....+       +    .......+....++.+++.+|++.+|.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   000000       0    0000111234567889999999999999999999885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.9e-33  Score=293.42  Aligned_cols=247  Identities=27%  Similarity=0.329  Sum_probs=202.3

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      +|...+.||+|+||.||++... ++..+++|......   ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778889999999999999986 47889999865432   2456789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++...  ..+++.++..++.|+++||.|||   ..+++|+||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999998765  46899999999999999999999   7899999999999999999999999999987644321 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                        ......|+..|+|||.+.+..++.++|+||||++++||++|+.|+........    .+.......          ..
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~~  218 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------AD  218 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------cc
Confidence              22345688899999999988899999999999999999999999876543211    111111111          01


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCH--HHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSM--GDVL  752 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~--~evl  752 (820)
                      ...+...+..+.+++.+|++.+|.+||+.  .|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            12233445788999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.9e-32  Score=288.24  Aligned_cols=250  Identities=25%  Similarity=0.413  Sum_probs=205.7

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...+.||+|++|.||++... ++..+++|++....  ....+++.+|++++++++|+|++++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4777889999999999999976 57889999876543  35567889999999999999999999999988999999999


Q ss_pred             ccCCchhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      +++++|.+++....  ...+++.++..++.+++.||+|||   ..+++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997653  467999999999999999999999   7899999999999999999999999999997654322


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......|+..|+|||.+.+..++.++|+||+|++++||++|+.|+......+.      ...... ...        
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~~~--------  220 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALKILK-GQY--------  220 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------HHHHhc-CCC--------
Confidence              122334688899999999988999999999999999999999999865432211      111111 111        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ...+......+.+++.+|+..+|.+||++.++++.
T Consensus       221 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 -PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             11223445778999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-32  Score=281.81  Aligned_cols=264  Identities=23%  Similarity=0.306  Sum_probs=215.9

Q ss_pred             HHHHHHhcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCC-CChhhHHHHHHHHHHHHcCCCCceeeEEeEe
Q 003436          476 VAIQEATDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGT-QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC  548 (820)
Q Consensus       476 ~~l~~at~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~  548 (820)
                      .++.....++....++-+|.||.||.|.+.      +.+.|.||.++. .+.-....++.|.-++..+.|||+.++.+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            345555567788888999999999999764      345677776543 3455567899999999999999999999998


Q ss_pred             ecC-ceEEEEEeeccCCchhhHhhh------cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC
Q 003436          549 DER-NEMIIIYEYMENGTLKDHLYA------SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL  621 (820)
Q Consensus       549 ~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~  621 (820)
                      .+. ...+.+|.++.-|+|..+|..      +..+.++..+...++.|++.||+|||   .+++||.||.++|++||+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            654 567899999999999999973      22356788889999999999999999   89999999999999999999


Q ss_pred             CeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHH
Q 003436          622 MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       622 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~  700 (820)
                      .+||+|=.++|..-..+.......-..+..||+||.+....++..+|||||||+||||+| |+.|+..-.+.+....   
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y---  510 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY---  510 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH---
Confidence            999999999997665555555555667889999999999999999999999999999998 8888876665543322   


Q ss_pred             HHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       701 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                          .++|.         +-..+-.|+.++..++.-||...|++||++++++.-|.+-
T Consensus       511 ----lkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  511 ----LKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ----Hhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                12221         1123557899999999999999999999999999988764

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3e-32  Score=297.67  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=197.2

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |...+.||+|+||.||+|+.. ++..+|+|++...   .....+.+..|++++++++|+|++++++++.++...++|+||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            677779999999999999975 5788999986533   233456788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++ |+|.+.+.... ..++|.++..++.+++.||.|||   ..+++||||+|+||+++.++.+||+|||++.....    
T Consensus       107 ~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         107 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            97 58877775443 45899999999999999999999   78999999999999999999999999999875332    


Q ss_pred             cccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          641 HVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .....++..|+|||++.   .+.++.++|||||||+++||++|++|+.........  ..+    ...+.      + 
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~----~~~~~------~-  242 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHI----AQNES------P-  242 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHH----HhccC------C-
Confidence              12345788999999973   457899999999999999999999988644222111  111    11100      0 


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                        ..........+.+++.+|++.+|.+||++.++++++..
T Consensus       243 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         243 --TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             --CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence              01122345678999999999999999999999987644

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-33  Score=305.58  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=196.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  554 (820)
                      +++|...++||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467999999999999999999865 57899999876432 33456788999999999999999999987543     357


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++ +|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            999999974 88777754   35899999999999999999999   789999999999999999999999999998754


Q ss_pred             CCCCC-ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC---c
Q 003436          635 PDLDQ-THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG---Q  709 (820)
Q Consensus       635 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~  709 (820)
                      ..... ........|+..|+|||.+.+ ..++.++|||||||+++||++|++||........   ..+........   .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~  233 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQED  233 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHH
Confidence            32211 111223468899999998754 5689999999999999999999999864332111   11111111100   0


Q ss_pred             cccccCccc---------cC-----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 LEDIVDPTL---------TG-----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 ~~~~~d~~l---------~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +..+.+...         ..     ...+....++.+++.+||+.+|++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000         00     0011234568899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-32  Score=285.52  Aligned_cols=247  Identities=26%  Similarity=0.437  Sum_probs=202.7

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH--QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|+..+.||+|++|.||+++.. +++.+++|.......  ...+.+.+|++++++++|+|++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677889999999999999876 578899998765543  4567899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999999998765  46899999999999999999999   789999999999999999999999999999865432221


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                        .....++..|+|||...+...+.++||||||++++||++|+.|+........    .|...  . ..         ..
T Consensus       156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~--~-~~---------~~  217 (254)
T cd06627         156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIV--Q-DD---------HP  217 (254)
T ss_pred             --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHh--c-cC---------CC
Confidence              2334688899999999888889999999999999999999999864332111    11111  0 00         01


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ..+......+.+++.+|++.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            122334567889999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-32  Score=298.02  Aligned_cols=268  Identities=21%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN------  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  552 (820)
                      -++|+..++||+|+||.||+|+.. +++.+|+|.+....  ......+.+|++++++++||||++++++|....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            346889999999999999999976 57899999765332  222345678999999999999999999986543      


Q ss_pred             --eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          553 --EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       553 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                        ..++|+||+. ++|.+.+.... ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence              4599999997 48888776543 36899999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCc--cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          631 SKIGPDLDQT--HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       631 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      +.........  .......++..|+|||.+.+. .++.++||||||++++||++|++|+.....................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9754332211  112234578889999988664 4788999999999999999999998765443333222221110000


Q ss_pred             Cccccc-----cCc-cccCC--------C-ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 GQLEDI-----VDP-TLTGQ--------I-KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ~~~~~~-----~d~-~l~~~--------~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +.....     .+. .+...        . .......+.+++.+|++.+|.+||++.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000000     000 00000        0 00123456799999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-32  Score=294.00  Aligned_cols=244  Identities=23%  Similarity=0.349  Sum_probs=193.8

Q ss_pred             EeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       491 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ||+|+||+||++... +++.+++|.+....   ......+..|+++|++++||||+++++++...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999865 57889999865322   22345677899999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccc
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV  646 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (820)
                      .+++.......+++.+++.++.|++.||.|||   ..+++||||+|+||++++++.+||+|||++.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            99998766567999999999999999999999   78999999999999999999999999999875432   1112234


Q ss_pred             cCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       647 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      .++..|+|||.+.+..++.++||||||++++||++|+.||............   ...    ...      .....+...
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~----~~~------~~~~~~~~~  221 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KRR----TLE------MAVEYPDKF  221 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hhc----ccc------ccccCCccC
Confidence            5788999999998888999999999999999999999998654331111100   000    000      011122334


Q ss_pred             HHHHHHHHHHHhhcCCCCCC-----CHHHHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRP-----SMGDVLW  753 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  753 (820)
                      ...+.+++.+||+.+|.+||     ++.+++.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            56789999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-32  Score=298.70  Aligned_cols=263  Identities=25%  Similarity=0.303  Sum_probs=196.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l  556 (820)
                      .++|...++||+|+||.||+|+.. .++.||+|+.....  ......+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            457889999999999999999976 48899999865332  12223566899999999999999999998654  56899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||++ ++|.+++.... ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999997 48888886543 46899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC---cccc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG---QLED  712 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~  712 (820)
                      ..  .......++..|+|||.+.+ ..++.++||||||+++|||++|++||....+.+......   ......   ....
T Consensus       161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (309)
T cd07845         161 PA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII---QLLGTPNESIWPG  235 (309)
T ss_pred             cc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCChhhchh
Confidence            22  11223345788999999865 457899999999999999999999997654433222111   110000   0000


Q ss_pred             ccC------ccccCC-------CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 IVD------PTLTGQ-------IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 ~~d------~~l~~~-------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+      -.+...       ........+.+++.+|++.||++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000      000000       001124567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.9e-32  Score=290.23  Aligned_cols=242  Identities=22%  Similarity=0.296  Sum_probs=195.2

Q ss_pred             EeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          491 IGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       491 LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ||+|++|.||+++... ++.+++|......   ....+.+.+|++++++++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999864 7889999865432   23456799999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccc
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV  646 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (820)
                      .+++....  .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++......   .....
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~  152 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF  152 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence            99997643  5899999999999999999999   7899999999999999999999999999998654321   12234


Q ss_pred             cCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       647 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      .++..|++||.+.+..++.++|+||||+++|||++|+.|+.......    .+......         +.......+...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~  219 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL---------KGNGKLEFPNYI  219 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh---------ccCCCCCCCccc
Confidence            67889999999988889999999999999999999999997554211    11111111         000111223333


Q ss_pred             HHHHHHHHHHHhhcCCCCCCC-----HHHHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRPS-----MGDVLW  753 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  753 (820)
                      ...+.+++.+||+.+|.+||+     +.|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            578999999999999999999     555554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-32  Score=291.03  Aligned_cols=244  Identities=26%  Similarity=0.373  Sum_probs=197.1

Q ss_pred             EeeecceEEEEEEEcC-ccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          491 IGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       491 LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ||+|+||.||+++... ++.+++|.......   ...+.+.+|++++++++|+||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999874 88999998764433   4567789999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC------c
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ------T  640 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~------~  640 (820)
                      .+++....  .+++..+..++.|+++||+|||   ..+++|+||+|+||++++++.+||+|||++........      .
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99997644  6899999999999999999999   78999999999999999999999999999875433211      1


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......++..|++||...+...+.++||||||++++||++|+.|+......+..   .   .... +...         
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~---~~~~-~~~~---------  219 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF---Q---NILN-GKIE---------  219 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHhc-CCcC---------
Confidence            1223455788999999998888999999999999999999999998755432211   1   1111 1110         


Q ss_pred             CCChh--hHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          721 QIKPD--SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       721 ~~~~~--~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                       .+..  .+..+.+++.+|++.+|.+||++.++.+.|+
T Consensus       220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 -WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             1111  2567899999999999999999966655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-32  Score=288.34  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=203.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|+..++||+|++|.||+++.. +++.+++|.....  ......++.+|++++++++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4777889999999999999865 5778999986543  234456788999999999999999999999989999999999


Q ss_pred             ccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      +++++|.+++...  ....+++..++.++.+++.||+|||   +.+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998652  2356899999999999999999999   789999999999999999999999999999865442 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                         ......++..|++||.+.+..++.++|+||||++++||++|+.|+......+.   ...    ...+...       
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~~----~~~~~~~-------  219 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RYK----VQRGKYP-------  219 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH----HhcCCCC-------
Confidence               22234578899999999999999999999999999999999999975433211   111    1111111       


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .........+.+++.+|++.+|++||++.++++.
T Consensus       220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              1223445678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-32  Score=293.30  Aligned_cols=242  Identities=24%  Similarity=0.311  Sum_probs=187.1

Q ss_pred             eEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHH---cCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          490 VIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLS---QFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~---~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +||+|+||.||++... +++.+|+|......   ......+.+|..+++   ..+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 47889999764321   122233445544443   4479999999999999899999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++......    .
T Consensus        81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~  151 (279)
T cd05633          81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (279)
T ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence            999999886543  6999999999999999999999   789999999999999999999999999998744321    1


Q ss_pred             cccccCCccccCccccc-cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....|+..|+|||.+. +..++.++|||||||+++||++|+.||..........+...    ..          .....
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~~----------~~~~~  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TL----------TVNVE  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH----hh----------cCCcC
Confidence            12346899999999986 45689999999999999999999999965432221111110    00          00112


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      .+.....++.+++.+|++.+|.+||     ++.|++++
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2334456789999999999999999     59888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-32  Score=303.33  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=198.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  553 (820)
                      .++|...+.||+|+||.||+|+.. .+..||||++...  .....+.+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            356888999999999999999975 5789999986542  233456778899999999999999999987544     35


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++|+||+. ++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            799999996 6898888654  36899999999999999999999   78999999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH--------Hh
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM--------KC  704 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~--------~~  704 (820)
                      .....  .......++..|+|||.+.+ ..++.++|||||||+++||++|++||.............-..        ..
T Consensus       158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            54321  12233457889999998865 468999999999999999999999986543211111110000        00


Q ss_pred             hccCcccc-------ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QETGQLED-------IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~~~~~~~-------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......+       ..++... ...+.....+.+++.+|++.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000       0001000 1122455778999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-32  Score=291.50  Aligned_cols=258  Identities=22%  Similarity=0.279  Sum_probs=193.2

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecC--ceEEEEEe
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDER--NEMIIIYE  559 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~E  559 (820)
                      |+..++||+|+||.||+|... +++.+|+|+..... .........|+.++.++. |+|++++++++.++  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456778999999999999975 57889999865432 222234457899999885 99999999999877  88999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |++ |+|.+.+.... ..++|.+++.++.|++.||+|||   ..+++||||||+||+++. +.+||+|||+++.......
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~  154 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP  154 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence            997 58888876533 46899999999999999999999   789999999999999999 9999999999976433211


Q ss_pred             ccccccccCCccccCccccc-cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc-----------
Q 003436          640 THVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET-----------  707 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-----------  707 (820)
                         .....++..|+|||++. +..++.++|||||||++|||++|++||......+.   ..+.......           
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhcc
Confidence               12345788999999764 45678999999999999999999999965543221   1111111100           


Q ss_pred             CccccccCccccC----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 GQLEDIVDPTLTG----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ........+....    ...+..+..+.+++.+||+.+|++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000000000    0112446789999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=291.95  Aligned_cols=260  Identities=23%  Similarity=0.317  Sum_probs=195.7

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC--hhhHHHHHHHHHHHHcC---CCCceeeEEeEeecCce-----
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS--HQGLAEFRTEIEMLSQF---RHRHLVSLIGYCDERNE-----  553 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~~~~~-----  553 (820)
                      |+..+.||+|+||.||+|+.+. ++.+|+|+.....  ......+.+|++++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5567899999999999999874 8899999876432  22234566788777666   59999999999987766     


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++++||++ ++|.+++.......+++.++..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999997 48999887655556999999999999999999999   78999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc--
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE--  711 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  711 (820)
                      .....   ......++..|+|||.+.+..++.++|+|||||+++||++|++|+......+..  ..............  
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  231 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEWP  231 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhcC
Confidence            43321   112334788999999999999999999999999999999999998754433221  11111110000000  


Q ss_pred             -------cccCcccc---CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          712 -------DIVDPTLT---GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       712 -------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                             ........   ....+.....+.+++.+||+.+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                   00000000   1111233467789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-32  Score=320.86  Aligned_cols=259  Identities=28%  Similarity=0.463  Sum_probs=207.6

Q ss_pred             CCccceeEeeecceEEEEEEEcC--------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCce
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNE  553 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  553 (820)
                      +....+.||+|.||.|++|...+        ...||||.++.. .....+.+..|+++|..+ +|+||+.++|+|..++.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            33444599999999999998541        456899987644 335678899999999999 69999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC------C--------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          554 MIIIYEYMENGTLKDHLYASN------F--------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                      .++|.||++.|+|.++|...+      .        ..++..+.+.++.|||.||+||+   +.++|||||.++|||+.+
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITK  453 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecC
Confidence            999999999999999998765      0        13889999999999999999999   789999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCcccc-ccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhH
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVS-TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNL  697 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l  697 (820)
                      +..+||+|||+||.....+..... ....-...|||||.+....++.|+|||||||+||||+| |..|+......+  ++
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--~l  531 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--EL  531 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--HH
Confidence            999999999999965543332211 11113566999999999999999999999999999999 567775422111  22


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .++    .+.|..         -..+..|..++.++++.||+.+|++||++.++++.|+..++
T Consensus       532 ~~~----l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  532 LEF----LKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             HHH----HhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            222    222221         13355677889999999999999999999999999998543

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=306.06  Aligned_cols=251  Identities=26%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             CCccceeEeeecceEEEEEEEcCcc-EEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDET-KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~-~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      -|.++..||.|+||.||||+.++.. ..|.|.+...+...+.+|+-||++|..++||+|++|++.|...+.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            3566778999999999999977533 346788888888889999999999999999999999998888899999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      ||-.+..+..-+ ..|+..++.-+|.+++.||.|||   +..|||||||+.|||++-+|.++|+|||.+....  .....
T Consensus       113 GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk  186 (1187)
T KOG0579|consen  113 GGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK  186 (1187)
T ss_pred             CchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence            999988776543 47999999999999999999999   8999999999999999999999999999975321  12223


Q ss_pred             cccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          643 STAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .....||+.|||||+..     ..+|+.++||||||+.|.||..+.||-....+.      +...+..+. ..     |.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKS-eP-----PT  254 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS-EP-----PT  254 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhc-CC-----Cc
Confidence            34678999999999874     568999999999999999999999987543322      111111111 11     11


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      |.  -+......+.+++.+||.+||..||++.+++++
T Consensus       255 Ll--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 LL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            11  122445679999999999999999999998765

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-32  Score=319.09  Aligned_cols=268  Identities=19%  Similarity=0.226  Sum_probs=189.1

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC--ccEEEEE------------------eCCCCChhhHHHHHHHHHHHHcCCCCc
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD--ETKVAVK------------------RGGTQSHQGLAEFRTEIEMLSQFRHRH  540 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK------------------~~~~~~~~~~~~f~~Ei~~l~~l~H~n  540 (820)
                      ..++|...++||+|+||+||++.++.  +...++|                  +.. ........+.+|+++|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            35689999999999999999987642  1111111                  111 12223456889999999999999


Q ss_pred             eeeEEeEeecCceEEEEEeeccCCchhhHhhhcC---CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN---FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       541 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      |+++++++...+..++|+|++. ++|.+++....   .......+...|+.|++.||+|||   +++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999985 57777775432   122345667889999999999999   7899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCC-CCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP-VIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~-p~~~~~~~~~~~  696 (820)
                      +.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|+. |+..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            999999999999998654321 122234579999999999999999999999999999999999884 443322222222


Q ss_pred             HHHHHHHhhc-cCcc-------ccccCcc-c---cCCC-----ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          697 LVEWAMKCQE-TGQL-------EDIVDPT-L---TGQI-----KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       697 l~~~~~~~~~-~~~~-------~~~~d~~-l---~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +.+....... ...+       .+.++.. +   ....     .......+.+++.+||+.||.+||++.|++.+
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            2111110000 0000       0000000 0   0000     00123457788999999999999999999875

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.7e-32  Score=301.56  Aligned_cols=263  Identities=20%  Similarity=0.290  Sum_probs=198.4

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------  551 (820)
                      ..++|...+.||+|+||.||+|+.. .++.+|+|.+...  .....+++.+|++++++++|+||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4577999999999999999999975 5789999987532  333456778899999999999999999987543      


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      ...++|+||++ ++|.+.+...    +++.++..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999996 5888877542    888999999999999999999   789999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH---------HHHH
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV---------EWAM  702 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~---------~~~~  702 (820)
                      +.....   .......++..|+|||++.+..++.++|||||||+++||++|+.||......+....+         ++..
T Consensus       166 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         166 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            864331   1123345788999999999999999999999999999999999998654322111000         0000


Q ss_pred             H-------hhc-cC-----ccccccCccc----cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          703 K-------CQE-TG-----QLEDIVDPTL----TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       703 ~-------~~~-~~-----~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .       ... ..     .+.++....+    ...........+.+++.+||+.||++||++.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0       000 00     0011111110    001112345678899999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=293.84  Aligned_cols=259  Identities=20%  Similarity=0.304  Sum_probs=199.7

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH--QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      |...+.||+|++|.||+++.. +++.+++|+......  .....+..|++++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456678999999999999975 678899998664432  24567889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++ +|.+++.... ..+++.+++.++.+++.||+|||   ..+++|+||||+||++++++.+||+|||.+.......  .
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R  153 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence            75 8888876643 47899999999999999999999   7899999999999999999999999999987654422  1


Q ss_pred             ccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc---CccccccC--
Q 003436          642 VSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET---GQLEDIVD--  715 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~d--  715 (820)
                      ......++..|+|||.+.+. ..+.++|+||||++++||++|++||......+.....   ......   .......+  
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI---FRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCchHhcccchhhh
Confidence            12234578889999999776 7899999999999999999999998654432221111   000000   00000000  


Q ss_pred             -------cc----ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          716 -------PT----LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       716 -------~~----l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                             +.    ......+....++.+++.+|++.+|.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   00    000112245678999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.2e-32  Score=293.28  Aligned_cols=255  Identities=15%  Similarity=0.171  Sum_probs=184.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcCc----cEEEEEeCCCCChhhH-----------HHHHHHHHHHHcCCCCceeeEEeE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDE----TKVAVKRGGTQSHQGL-----------AEFRTEIEMLSQFRHRHLVSLIGY  547 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~l~g~  547 (820)
                      ++|...++||+|+||.||+|...+.    ..+++|..........           .....+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788899999999999999997653    4556665332221110           112334455667789999999997


Q ss_pred             eecCc----eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          548 CDERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       548 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      +....    ..++++|++. .++.+.+...  ...++..+..|+.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            65433    3467777764 3666665432  23578889999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh-hhH
Q 003436          624 KVADFGLSKIGPDLDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK-VNL  697 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~-~~l  697 (820)
                      ||+|||+++........     .......||+.|+|||++.+..++.++|||||||+++||++|+.||........ ...
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999865321111     112234699999999999999999999999999999999999999975522211 111


Q ss_pred             H--HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          698 V--EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       698 ~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .  ++.... ..        +.+   ....++..+.+++..|++.+|++||++.++++.|
T Consensus       246 ~~~~~~~~~-~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRL-HE--------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHh-hh--------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1  111111 11        111   1124457799999999999999999999999876

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.8e-32  Score=294.40  Aligned_cols=244  Identities=21%  Similarity=0.369  Sum_probs=198.0

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchh
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLK  567 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  567 (820)
                      .+||+|+||.||++... ++..+|+|+.........+.+.+|+.++++++|+|++++++++..++..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            47999999999999875 67899999876655556678999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccccccc
Q 003436          568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK  647 (820)
Q Consensus       568 ~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  647 (820)
                      +++...   .+++.....++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++.......  .......
T Consensus       106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         106 DIVTHT---RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            987543   5899999999999999999999   7899999999999999999999999999987543321  1123356


Q ss_pred             CCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhH
Q 003436          648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSL  727 (820)
Q Consensus       648 gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  727 (820)
                      ++..|+|||.+.+..++.++|+||||++++||++|++|+......+...   .....         ..+.+.  ......
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~~---------~~~~~~--~~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDN---------LPPKLK--NLHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhh---------CCcccC--CcccCC
Confidence            8899999999988889999999999999999999999986543322211   11110         001110  011234


Q ss_pred             HHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          728 NKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       728 ~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+.+++.+|++.+|.+||++.+++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            568899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-32  Score=286.55  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=197.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-----SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  554 (820)
                      .+|...+.||+|+||.||+|... ++..+++|.....     .....+.+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888899999999999999975 4789999975322     234456889999999999999999999998653  468


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++++|.+++....  .+++....+++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999987543  4889999999999999999999   789999999999999999999999999999754


Q ss_pred             CCCCC-ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          635 PDLDQ-THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       635 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ..... ........++..|+|||++.+..++.++|+|||||+++||++|++||......+..  .+    ....      
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~~~------  224 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--FK----IATQ------  224 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--HH----HHcC------
Confidence            32111 11112345889999999999888999999999999999999999998643222111  11    0000      


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                         ......+......+.+++.+|++ +|.+||+..+++.
T Consensus       225 ---~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 ---PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               01112334455778999999998 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.1e-33  Score=278.13  Aligned_cols=256  Identities=23%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--------hhhHHHHHHHHHHHHcC-CCCceeeEEeEe
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--------HQGLAEFRTEIEMLSQF-RHRHLVSLIGYC  548 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~  548 (820)
                      +.-.++|...+.||+|..+.|-+..++ .+.+.|+|++....        ....+.-.+|+.+|+++ .||+|+++.+.+
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888889999999999888766 57788888754322        12234456799999998 699999999999


Q ss_pred             ecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       549 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                      +.....++|+|.|+.|-|.|+|...-  .+++++..+|+.|+.+|++|||   ...|+||||||+|||++++.++||+||
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence            99999999999999999999997653  6899999999999999999999   799999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccc------cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT------KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~  702 (820)
                      |++...+.   ...-+..+||++|+|||.+.      ...|+...|.||+||++|-|+.|.+||.....   .    .+.
T Consensus       168 GFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---m----lML  237 (411)
T KOG0599|consen  168 GFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---M----LML  237 (411)
T ss_pred             ceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---H----HHH
Confidence            99986544   23456789999999999884      23578899999999999999999999964311   1    112


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .++..|+.+-      ...--.+......+|+.+||+.||.+|-|+.|++++=
T Consensus       238 R~ImeGkyqF------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  238 RMIMEGKYQF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             HHHHhccccc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            2223333221      0111123445678999999999999999999999864

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=3.7e-32  Score=298.45  Aligned_cols=260  Identities=23%  Similarity=0.303  Sum_probs=194.7

Q ss_pred             eEeee--cceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          490 VIGIG--GFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       490 ~LG~G--~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      .||+|  +||+||++++. .++.||+|.....  .....+.+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            56666  89999999975 6899999986543  2334578899999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc---
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH---  641 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~---  641 (820)
                      +|.+++.......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+|++||+.+..........   
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (328)
T cd08226          85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV  161 (328)
T ss_pred             CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence            9999988765556899999999999999999999   7899999999999999999999999998654221111100   


Q ss_pred             --ccccccCCccccCccccccC--CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh-------------
Q 003436          642 --VSTAVKGSFGYLDPEYLTKQ--QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC-------------  704 (820)
Q Consensus       642 --~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~-------------  704 (820)
                        ......++..|+|||++.+.  .++.++|||||||+++||++|++||......+..  .......             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccchh
Confidence              01112346679999999764  4789999999999999999999999754322111  0000000             


Q ss_pred             ----------h---------ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 ----------Q---------ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ----------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                .         .......+.+..+.......+...+.+++.+||+.||++||++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                      0         0000001111112222233456788999999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-32  Score=291.19  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=197.3

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEeec
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      |...+.||+|++|.||+|+..+ ++.+++|+...... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            4567799999999999999864 77899998654322 22334567999999999 999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                       +|+|.+++.......+++.+++.++.|++.+|+|||   +.+++|+||+|+||++++++.++|+|||+++......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             889999987765567899999999999999999999   7899999999999999999999999999987543311   


Q ss_pred             ccccccCCccccCccccc-cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH----------HHHHHhhccCcc
Q 003436          642 VSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV----------EWAMKCQETGQL  710 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~----------~~~~~~~~~~~~  710 (820)
                      ......++..|+|||.+. ...++.++|+||||++++||++|++|+......+.....          .|..........
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            112345788999999885 456799999999999999999999988655432221100          011000000000


Q ss_pred             ccccCccc---cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTL---TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...+....   .....+.....+.+++.+|++.+|++||++.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000000   001111224678999999999999999999998753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.4e-32  Score=302.57  Aligned_cols=267  Identities=19%  Similarity=0.294  Sum_probs=199.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeec----CceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE----RNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~  555 (820)
                      ++|+..+.||+|++|.||+|... .+..|++|++....  ....+.+.+|+.+|++++||||+++++++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888899999999999999976 58899999876432  2345677889999999999999999988753    35689


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||+. |+|.+++...  ..+++..+..++.|++.||+|||   ..+|+||||||+||++++++.+||+|||+++...
T Consensus        85 lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            9999996 6899988654  35899999999999999999999   7899999999999999999999999999997543


Q ss_pred             CCCCc--cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH--------Hh
Q 003436          636 DLDQT--HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM--------KC  704 (820)
Q Consensus       636 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~--------~~  704 (820)
                      .....  .......++..|+|||.+.+ ..++.++||||||+++|||++|++||................        ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211  11223468889999999865 468999999999999999999999996543322211110000        00


Q ss_pred             hccCccccccC---ccc---cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          705 QETGQLEDIVD---PTL---TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       705 ~~~~~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .....+.+..+   ...   .....+..+..+.+++.+|++.+|.+||++.+++.+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            00000000000   000   0011123467799999999999999999999988753

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=7.1e-34  Score=277.74  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=198.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      +++|+.-+.||+|.|+.||+.... .|+..|+|.+...  +..+.+++.+|+.+-+.|+||||++|.....+.+..+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            345666779999999999988754 5778888765322  2335678889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFGla~~~~  635 (820)
                      |+|+|+.|..-+...  .-.++...-..+.||+++|.|+|   ..+|||||+||.|++|.   ..--+||+|||+|....
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999998766543  23566677888999999999999   89999999999999993   34579999999998765


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                         .........||++|||||+++..+++..+|||+.||+|+-|+.|.+||....   ...+.+.+.    .+...  ++
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~----~g~yd--~~  232 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIK----AGAYD--YP  232 (355)
T ss_pred             ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHh----ccccC--CC
Confidence               2334456789999999999999999999999999999999999999997532   222222221    11111  11


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +.    .-+...++..+|+.+||..||.+|.|+.|.+.+
T Consensus       233 ~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  233 SP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             Cc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            11    122344678899999999999999999988764

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=6.8e-32  Score=285.67  Aligned_cols=243  Identities=23%  Similarity=0.317  Sum_probs=189.6

Q ss_pred             eeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHH-HcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEML-SQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      +.||+|+||.||+|... +++.+|+|......   ......+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999875 57899999875432   22233445555544 455899999999999999999999999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      ++|.+++....  .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++....      .
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~  150 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N  150 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence            99999987543  5889999999999999999999   78999999999999999999999999999875322      2


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                      ....++..|+|||.+.+..++.++||||||++++||++|++|+......+.....       ......      ......
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~------~~~~~~  217 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-------LSRRIN------WPEEVK  217 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhcccC------CCCccc
Confidence            2345788999999998888999999999999999999999999754332211110       011100      011122


Q ss_pred             hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       724 ~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ..++..+.+++.+|++.+|++||++.++.+.|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            24457789999999999999999776554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=4.5e-32  Score=293.14  Aligned_cols=253  Identities=22%  Similarity=0.339  Sum_probs=194.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|...+.||+|++|.||+|+.+. ++.+|||++.... .....++..|+.++.++. |+||++++++|......++|+|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            557888899999999999999875 8899999876432 234566777888777775 9999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |++ ++|.+++.... ..+++..+..++.+++.||+|||+  ..+|+||||+|+||++++++.+||+|||++....... 
T Consensus        95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-  169 (296)
T cd06618          95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-  169 (296)
T ss_pred             ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence            985 47777665433 378999999999999999999993  3589999999999999999999999999987543211 


Q ss_pred             ccccccccCCccccCccccccCC----CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQ----LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                        ......++..|+|||++.+..    ++.++||||||+++|||++|+.||......  .......   ... ...    
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~---~~~-~~~----  237 (296)
T cd06618         170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKI---LQE-EPP----  237 (296)
T ss_pred             --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHH---hcC-CCC----
Confidence              122335788999999987554    789999999999999999999998643211  1111111   111 000    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                       .+  ........++.+++.+|++.+|.+||++.+++++-
T Consensus       238 -~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         238 -SL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             -CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence             00  01113456789999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.3e-32  Score=300.59  Aligned_cols=260  Identities=22%  Similarity=0.340  Sum_probs=193.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------c
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------N  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  552 (820)
                      .++|...+.||+|+||.||+|+.. +++.+|+|++...  .......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            378999999999999999999965 5889999986542  222345688999999999999999999988654      3


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++|+||+.. +|.+++.    ..+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            46899999964 6766542    35889999999999999999999   7899999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH--------H
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM--------K  703 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~--------~  703 (820)
                      ....     ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||................        .
T Consensus       166 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         166 HADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            5322     1223457888999999876 468899999999999999999999997543222111111000        0


Q ss_pred             hhccCccccccC--ccc-cC---CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          704 CQETGQLEDIVD--PTL-TG---QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       704 ~~~~~~~~~~~d--~~l-~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ............  +.. ..   ...+.....+.+++.+|++.+|.+||++.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000000  000 00   0011234568899999999999999999999865

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=8.1e-33  Score=274.36  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=195.7

Q ss_pred             ccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEeecc
Q 003436          486 SESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +.+..||.|..|.|+|.+.+. |..+|||.+... .....++++..++++.+.+ .|.||+.+|||..+...++.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            445579999999999999875 788999987654 4556788888888887664 8999999999999999999999994


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                       ..++.+|.+. ..++++.-+-++...+..||.||.+  .++|+|||+||+|||+|+.|.+|+||||++...-+   ...
T Consensus       175 -~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---SkA  247 (391)
T KOG0983|consen  175 -TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---SKA  247 (391)
T ss_pred             -HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec---ccc
Confidence             3455555443 3468888888999999999999986  78999999999999999999999999999875433   233


Q ss_pred             cccccCCccccCcccccc---CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          643 STAVKGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .+...|.+.|||||.+.-   ..|+.++||||||+.|+||.||+.|+.....+-.  ...   +...+.      .|.|.
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~lt---kvln~e------PP~L~  316 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLT---KVLNEE------PPLLP  316 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHH---HHHhcC------CCCCC
Confidence            455679999999999953   4789999999999999999999999976543211  111   111110      13332


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..  ......+.+++..||.+|+.+||...+++++
T Consensus       317 ~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  317 GH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            21  1255779999999999999999999998875

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=1.4e-31  Score=285.05  Aligned_cols=248  Identities=20%  Similarity=0.256  Sum_probs=190.8

Q ss_pred             HHHHHhcCCccceeE--eeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          477 AIQEATDNFSESLVI--GIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       477 ~l~~at~~f~~~~~L--G~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      ++....++|...+.+  |+|+||.||++... ++..+|+|.........     .|+.....+ +|+|++++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445566666665  99999999999975 56778888765432111     122222222 7999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeecccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLS  631 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla  631 (820)
                      ..++||||+++++|.+++....  .++|.++..++.|+++||+|||   +.+++||||||+||+++.++ .++|+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            9999999999999999997653  7999999999999999999999   78999999999999999988 9999999998


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      +.....      ....++..|+|||++.+..++.++||||||++++||++|+.||..... +......+.......  . 
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~--~-  227 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQQKK--L-  227 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhhccc--C-
Confidence            754321      224588999999999998999999999999999999999999974332 222222332221100  0 


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC-HHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-MGDVLW  753 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~  753 (820)
                               .........+.+++.+||+.+|.+||+ +.++++
T Consensus       228 ---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 ---------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ---------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                     111234567899999999999999995 688774

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.98  E-value=3.5e-32  Score=298.63  Aligned_cols=262  Identities=24%  Similarity=0.346  Sum_probs=201.9

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc-----eEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-----EMI  555 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-----~~~  555 (820)
                      +|...+.||+|++|.||+|+... +..+++|++....  ....+.+.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            47778899999999999999764 7899999876543  344578899999999999999999999987765     789


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||++ ++|.+++....  .+++..++.++.+++.||+|||   +.+|+||||||.|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999998 58988886543  7999999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC-----
Q 003436          636 DLDQT-HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG-----  708 (820)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~-----  708 (820)
                      ..... .......++..|+|||.+.+. .++.++|+||||++++||++|++||......+.....   .......     
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI---VEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH---HHhcCCCChhHh
Confidence            42210 112334578899999999887 8899999999999999999999999765433221111   1100000     


Q ss_pred             ------ccccccC---cc---ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 ------QLEDIVD---PT---LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ------~~~~~~d---~~---l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                            ...+.+.   ..   -.....+.....+.+++.+||+.+|.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  0000000   00   0001122345678999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=289.71  Aligned_cols=247  Identities=24%  Similarity=0.364  Sum_probs=202.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .+.|..-++||+||||.||-.+.+ .|+.+|.|++...   .+++....++|-.+|.+++.+.||.+--.++.++.++||
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            356888899999999999988866 4778888865432   234455678899999999999999998888999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +..|.||+|.-||...+.+.+++..+.-.+.+|+.||++||   ...||.||+||+|||||+.|+++|+|+|||...+..
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999999988889999999999999999999999   799999999999999999999999999999866542


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                         ...+..+||.+|||||++.++.|+...|.||+||+||||+.|+.||.....+....-++.   ...       -|+ 
T Consensus       341 ---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r~~-------~~~-  406 (591)
T KOG0986|consen  341 ---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---RTL-------EDP-  406 (591)
T ss_pred             ---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---HHh-------cch-
Confidence               223345899999999999999999999999999999999999999975544332211111   000       011 


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCC
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPS  747 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs  747 (820)
                        .++++...++...|.+..|++||.+|-.
T Consensus       407 --~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  407 --EEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             --hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence              1344455667888888999999999964

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=5.5e-32  Score=289.00  Aligned_cols=249  Identities=24%  Similarity=0.379  Sum_probs=202.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...+.||+|++|.||+|+.. +++.+++|.....   .....+.+..|++++++++ |+||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36788889999999999999976 6889999986542   2334567889999999998 99999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++++|.+++....  .+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999997653  6999999999999999999999   789999999999999999999999999998754332


Q ss_pred             CCc------------------cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH
Q 003436          638 DQT------------------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE  699 (820)
Q Consensus       638 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~  699 (820)
                      ...                  .......++..|+|||.+.+...+.++|+||||++++|+++|+.|+........   ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---FQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---HH
Confidence            211                  112234578899999999888899999999999999999999999875532111   11


Q ss_pred             HHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCH----HHHHH
Q 003436          700 WAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM----GDVLW  753 (820)
Q Consensus       700 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~----~evl~  753 (820)
                      ...   .           .....+...+..+.+++.+|++.+|.+||++    .++++
T Consensus       233 ~~~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 KIL---K-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH---h-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111   0           0112223335678999999999999999999    66664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=6.8e-32  Score=298.48  Aligned_cols=268  Identities=22%  Similarity=0.328  Sum_probs=200.1

Q ss_pred             CHHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeec
Q 003436          474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE  550 (820)
Q Consensus       474 ~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  550 (820)
                      ...++...+++|...+.||+|+||.||+|... +++.||+|++....  ....+.+.+|++++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34567778899999999999999999999864 68899999876432  2334678889999999999999999998753


Q ss_pred             C------ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCee
Q 003436          551 R------NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAK  624 (820)
Q Consensus       551 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~k  624 (820)
                      .      ...+++++++ +++|.+++...   .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            3      3467888877 78998877543   5899999999999999999999   78999999999999999999999


Q ss_pred             EeeccccccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH-HHH-
Q 003436          625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV-EWA-  701 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~-~~~-  701 (820)
                      |+|||+++....     ......++..|+|||.+.+ ..++.++|||||||+++||++|++||............ ... 
T Consensus       161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999875322     1223467889999999866 56889999999999999999999998644322211111 000 


Q ss_pred             ------HHhhccCc-------cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          702 ------MKCQETGQ-------LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       702 ------~~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                            ........       +......... .........+.+++.+|++.+|.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                  00000000       0000000000 0011234568899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=1.9e-31  Score=290.15  Aligned_cols=245  Identities=27%  Similarity=0.405  Sum_probs=194.6

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCC---CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGT---QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |...+.||+|+||.||+|+.. ++..+++|....   ......+++.+|+++++.++|+|++++++++......++|+||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            666778999999999999976 467899998653   2334456788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +. |+|.+.+.... ..+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++.....    
T Consensus        97 ~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----  167 (308)
T cd06634          97 CL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----  167 (308)
T ss_pred             cC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence            96 68888775433 45899999999999999999999   78999999999999999999999999999875432    


Q ss_pred             cccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          641 HVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .....++..|+|||++.   ...++.++|||||||++|||++|+.|+......+..      ....+. ..     +.
T Consensus       168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~-~~-----~~  233 (308)
T cd06634         168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN-ES-----PA  233 (308)
T ss_pred             --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHhhc-CC-----CC
Confidence              12345788999999974   356788999999999999999999987543221111      111110 00     11


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                         .........+.+++.+||+.+|.+||++.++++..
T Consensus       234 ---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 ---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence               11123446788999999999999999999998764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=7.2e-32  Score=293.96  Aligned_cols=260  Identities=22%  Similarity=0.240  Sum_probs=192.3

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchh
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLK  567 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  567 (820)
                      .+|.|+++.||++.. +++.+|+|+....  .....+.+..|++++++++|+||+++++++.+.+..+++|||+++|+|.
T Consensus         9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   87 (314)
T cd08216           9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE   87 (314)
T ss_pred             hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence            345555555555554 5889999987543  4455678999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC-----ccc
Q 003436          568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ-----THV  642 (820)
Q Consensus       568 ~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~-----~~~  642 (820)
                      +++.......+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+........     ...
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence            9998765556899999999999999999999   78999999999999999999999999998864432111     111


Q ss_pred             cccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh----ccC-------c
Q 003436          643 STAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ----ETG-------Q  709 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~----~~~-------~  709 (820)
                      .....++..|+|||++..  ..++.++|+|||||++|||++|+.||........  ..+......    ...       .
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCC
Confidence            223457788999999866  3588999999999999999999999975432211  111100000    000       0


Q ss_pred             ccc----ccCcccc----CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          710 LED----IVDPTLT----GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       710 ~~~----~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ...    ..++...    .........++.+++.+||+.+|++||++.+++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            000    0001000    011122345788999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=1.7e-31  Score=287.55  Aligned_cols=251  Identities=24%  Similarity=0.295  Sum_probs=194.9

Q ss_pred             CCccceeEeeecceEEEEEEEc----CccEEEEEeCCCCC----hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQS----HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  554 (820)
                      +|+..+.||+|+||.||+++..    ++..+|+|.+....    ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4677889999999999999863    57889999875432    22346678899999999 599999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++++|.+++....  .+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            99999999999999987643  5888999999999999999999   789999999999999999999999999999764


Q ss_pred             CCCCCccccccccCCccccCccccccC--CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQ--QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ..... .......|+..|+|||.+.+.  .++.++||||||++++||++|+.|+.......  .............    
T Consensus       156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~----  228 (290)
T cd05613         156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE----  228 (290)
T ss_pred             ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC----
Confidence            33211 112234588999999998753  46789999999999999999999986432211  1111111111100    


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLW  753 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~  753 (820)
                         +    ..+......+.+++.+|++.+|.+||     +..+++.
T Consensus       229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               0    12233456788999999999999997     5565554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=1.2e-31  Score=288.35  Aligned_cols=256  Identities=24%  Similarity=0.277  Sum_probs=198.9

Q ss_pred             CCccceeEeeecceEEEEEEEc----CccEEEEEeCCCCC----hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQS----HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  554 (820)
                      +|...+.||+|++|.||+++..    ++..+|||......    ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677789999999999999853    46789999765322    22346788999999999 599999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++|+|.+++...  ..+++..+..++.|+++||+|||   ..+++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999999998654  35889999999999999999999   789999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCccccCccccccCC--CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ..... .......|+..|+|||.+.+..  .+.++||||||++++||++|+.|+.......  ...+........     
T Consensus       156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~-----  227 (288)
T cd05583         156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS-----  227 (288)
T ss_pred             ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc-----
Confidence            33211 1122345889999999987655  7889999999999999999999985332111  111111111110     


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                        .+    ..+......+.+++.+|++.+|++||++.++.+.|+..
T Consensus       228 --~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 --KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             --CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence              01    12223445688999999999999999998887766543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.7e-31  Score=286.02  Aligned_cols=242  Identities=24%  Similarity=0.291  Sum_probs=187.1

Q ss_pred             eEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHH---HHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          490 VIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIE---MLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~---~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +||+|+||.||+++.. .++.||+|.+....   ......+..|..   .++...||||+++++++...+..++|+||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 47899999765432   122223444443   3445579999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.....    .
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~  151 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K  151 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----C
Confidence            99999988654  36999999999999999999999   789999999999999999999999999998754321    1


Q ss_pred             cccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....|+..|+|||++.++ .++.++||||||++++||++|+.||............ .   ...      ..++    .
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~---~~~------~~~~----~  217 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-R---MTL------TMAV----E  217 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-H---Hhh------ccCC----C
Confidence            1234689999999999754 6899999999999999999999999754322211111 0   000      0111    1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                      .+......+.+++.+|+..+|.+||     ++.+++++
T Consensus       218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            2223456789999999999999999     88888753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=3e-31  Score=289.23  Aligned_cols=244  Identities=26%  Similarity=0.400  Sum_probs=193.5

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |...+.||+|+||.||+|+.. ++..+++|++...   .....+.+.+|++++++++|||++++++++.+....++|+||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999999975 5788999986533   233456788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +. |+|.+++.... ..+++.+++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++.....    
T Consensus       103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            96 57877775433 46899999999999999999999   78999999999999999999999999999864221    


Q ss_pred             cccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          641 HVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .....|+..|+|||++.   ...++.++|||||||++|||++|++|+.........   .   ..... ...     .
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~---~~~~~-~~~-----~  239 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y---HIAQN-DSP-----T  239 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---H---HHHhc-CCC-----C
Confidence              22346888999999984   456889999999999999999999998654322211   1   11111 011     0


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .........+.+++.+|++.+|.+||++.+++.+
T Consensus       240 ---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 ---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1112233568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.4e-31  Score=294.67  Aligned_cols=261  Identities=20%  Similarity=0.293  Sum_probs=194.9

Q ss_pred             CCcc-ceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhh--------------HHHHHHHHHHHHcCCCCceeeEEeE
Q 003436          484 NFSE-SLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQG--------------LAEFRTEIEMLSQFRHRHLVSLIGY  547 (820)
Q Consensus       484 ~f~~-~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~--------------~~~f~~Ei~~l~~l~H~nIv~l~g~  547 (820)
                      +|.. .+.||+|+||.||+|+.. .++.||+|.........              ...+.+|++++++++|+||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            4443 457999999999999976 58899999765432211              1257789999999999999999999


Q ss_pred             eecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       548 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                      +..++..++|+||++ |+|.+++...  ..+++.....++.|++.||+|||   +.+++|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECC
Confidence            999999999999997 6899988653  35889999999999999999999   78999999999999999999999999


Q ss_pred             ccccccCCCCC------------CccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          628 FGLSKIGPDLD------------QTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       628 FGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                      ||+++......            .........++..|+|||++.+. .++.++|||||||+++||++|++||......+.
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99997543110            01111223467889999998764 468999999999999999999999975543322


Q ss_pred             hhHHHHHHHhhccCc---cccc------------cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          695 VNLVEWAMKCQETGQ---LEDI------------VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       695 ~~l~~~~~~~~~~~~---~~~~------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .   ..+........   +...            ..+... .........+.+++.+|++.+|++||++.|++.+
T Consensus       243 ~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        243 L---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             H---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1   11111111110   0000            000000 1112335678899999999999999999999864

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-32  Score=287.38  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=205.5

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChh--hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ--GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      |...+.||+|.|..|-+|++- .|..||||.+....-.  ....+.+|++.|+.++|||||+|+.+...+..+|||+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            566678999999999988854 6899999998765432  3456788999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE-cCCCCeeEeeccccccCCCCCCc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL-DENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll-~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++|+|.++|.++. ..+.+....+.+.||+.|+.|+|   +..+|||||||+||.+ ..-|.+||.|||++-.+..   .
T Consensus       100 D~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G  172 (864)
T KOG4717|consen  100 DGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---G  172 (864)
T ss_pred             CCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC---c
Confidence            9999999997664 45888999999999999999999   7889999999999977 5678999999999865443   2


Q ss_pred             cccccccCCccccCccccccCCCC-CcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      ...+..+|.+.|.|||.+.+..|+ ++.|||||||+||.|+||++||+...+.+.               +..++|... 
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY-  236 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY-  236 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc-
Confidence            334567899999999999998876 678999999999999999999975543332               333444433 


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+.....+..+|+..||..||++|.+..|++..
T Consensus       237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence             3455667889999999999999999999888653

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=301.59  Aligned_cols=269  Identities=23%  Similarity=0.362  Sum_probs=200.3

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------ceEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------NEMII  556 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l  556 (820)
                      +...+.||+|+||.||+|+.+ .|+.||||..+... ....+...+|+++|++++|+|||++++.=++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            445568999999999999955 69999999876544 23356678999999999999999999875443      36789


Q ss_pred             EEeeccCCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE--cC--CCCeeEeecccc
Q 003436          557 IYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL--DE--NLMAKVADFGLS  631 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll--~~--~~~~kl~DFGla  631 (820)
                      |||||.+|||+..|.... ...|++.+.+.+..+++.||.|||   .++|+||||||.||++  .+  .-.-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999997643 467999999999999999999999   7999999999999999  23  335899999999


Q ss_pred             ccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      |..++.   ...+...||..|++||++.+ +.++..+|.|||||++||++||..||.+........-+.|.....+....
T Consensus       172 rel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            976543   35667899999999999985 88999999999999999999999999765443322223343322222211


Q ss_pred             ccccCccccC------------CCChhhHHHHHHHHHHHhhcCCCCCC--CHHHHHHHHHHHH
Q 003436          711 EDIVDPTLTG------------QIKPDSLNKFVEIAEKCLAQCGIDRP--SMGDVLWNLEYAL  759 (820)
Q Consensus       711 ~~~~d~~l~~------------~~~~~~~~~l~~l~~~Cl~~dp~~RP--s~~evl~~L~~~~  759 (820)
                      .-..++...+            .........+...+..++.-+|++|-  ...+....+..++
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            1111111111            11223334555666667777888887  5555544444444

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=9.9e-32  Score=291.95  Aligned_cols=267  Identities=23%  Similarity=0.290  Sum_probs=194.5

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-------  551 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-------  551 (820)
                      .++|+..++||+|+||.||+|+.. +++.+++|++....  ......+.+|++++++++|+||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999976 57889999764332  12234567899999999999999999887443       


Q ss_pred             -ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          552 -NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       552 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                       ...++|+||+++ +|...+... ...+++.++..++.|+++||+|||   +.+|+|+||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             346999999975 677766543 346999999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCc---------cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHH
Q 003436          631 SKIGPDLDQT---------HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       631 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~  700 (820)
                      ++........         ...+...++..|+|||.+.+ ..++.++||||||++++||++|++||..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9754322111         11123456888999998865 4588999999999999999999999975544332221111


Q ss_pred             HHHhhccC------ccccccCccccCCC-------ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          701 AMKCQETG------QLEDIVDPTLTGQI-------KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       701 ~~~~~~~~------~~~~~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ........      .+....+.......       .......+.+++.+|++.+|.+||++.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            10000000      00000000000000       0122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.3e-31  Score=293.96  Aligned_cols=265  Identities=22%  Similarity=0.310  Sum_probs=198.2

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-Cce
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-RNE  553 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~  553 (820)
                      +...+++|...+.||+|+||.||++... ++..+|+|++...  .....+.+..|++++++++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999866 6889999976432  22335678899999999999999999998865 567


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++|+||+ +++|.+++...   .+++.....++.|++.||+|||   ..+++||||+|+||++++++.+||+|||+++.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            89999998 56898887543   4788888999999999999999   78999999999999999999999999999874


Q ss_pred             CCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhH-H--------HHHHH
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNL-V--------EWAMK  703 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l-~--------~~~~~  703 (820)
                      ...     ......++..|+|||.+.+ ..++.++||||||++++||++|++||........... .        +|...
T Consensus       158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            322     1123456888999998866 5689999999999999999999999865433211111 0        01111


Q ss_pred             hhccCccccccCccccC-----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          704 CQETGQLEDIVDPTLTG-----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .........+..-....     ...+.....+.+++.+|++.+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000000000     1112345778999999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-31  Score=287.17  Aligned_cols=261  Identities=23%  Similarity=0.313  Sum_probs=198.0

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      |+..++||+|++|.||+|+... ++.+++|......  ....+.+..|++++++++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            4456689999999999999874 8899999876543  333467889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      + ++|.+++.... ..+++..++.++.+++.||+|||   ..+|+||||+|+||++++++.+||+|||+++.......  
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  153 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--  153 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence            8 59999997653 36899999999999999999999   78999999999999999999999999999876433211  


Q ss_pred             ccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhH-HHHH-------HHhh-c----c
Q 003436          642 VSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNL-VEWA-------MKCQ-E----T  707 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l-~~~~-------~~~~-~----~  707 (820)
                      ......++..|+|||.+.+. .++.++||||||++++||++|++|+......+.... .+..       +... .    .
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            12233457789999998776 889999999999999999999999865432221110 0000       0000 0    0


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ........... ....+.....+.+++.+|++.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            00000000000 0111122567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-33  Score=323.85  Aligned_cols=253  Identities=29%  Similarity=0.360  Sum_probs=199.2

Q ss_pred             HHhcCCccceeEeeecceEEEEEEE-cCccEEEEEeCC--CCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGG--TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~--~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ..+-++....+||.|.||.||-|.. +.|...|+|-+.  .......+...+|+.+|..|+|||+|+.+|+-..+++.++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3445667777999999999999985 458888999643  3345567788899999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      .||||++|+|.+++...+  -+++.....+..|++.|++|||   ..+||||||||.||+|+.+|.+|++|||.|.....
T Consensus      1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999987653  2444445556789999999999   79999999999999999999999999999986654


Q ss_pred             CCCc--cccccccCCccccCccccccC---CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHH-hhccCcc
Q 003436          637 LDQT--HVSTAVKGSFGYLDPEYLTKQ---QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK-CQETGQL  710 (820)
Q Consensus       637 ~~~~--~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~-~~~~~~~  710 (820)
                      ..++  ..-...+||+.|||||++.+.   ....++||||+|||++||+||+.||.....       +|+.. ....|..
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHK 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCC
Confidence            3211  122356799999999999654   356789999999999999999999964322       22211 1112221


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                               .++++....+-.+++.+|++.||++|.++.|+++
T Consensus      1460 ---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 ---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             ---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                     1334445566789999999999999988877665

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=2.1e-31  Score=281.96  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=192.8

Q ss_pred             CCccceeEeeecceEEEEEEEcC-ccEEEEEeC---CCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRG---GTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~---~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      +|...++||+|+||.||+++... +..+++|..   ...  ......++..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            36777899999999999998753 233434432   221  222334577899999999999999999999988999999


Q ss_pred             EeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          558 YEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||+++++|.+++..  .....+++.+++.++.|++.||.|||   +.+++|+||||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864  23357999999999999999999999   789999999999999975 569999999987643


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...  .......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......      ........ +.     .
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~-~~-----~  222 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIVE-GP-----T  222 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHc-CC-----C
Confidence            321  1223345788999999998888999999999999999999999998643211      11111111 11     1


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +    ..+......+.+++.+|++.+|++||++.+++++
T Consensus       223 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 P----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             C----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            1    1223445678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=2.6e-31  Score=292.18  Aligned_cols=264  Identities=23%  Similarity=0.301  Sum_probs=192.6

Q ss_pred             CCccceeEeeecceEEEEEEEcC---ccEEEEEeCCCC--ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC----ce
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER----NE  553 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~----~~  553 (820)
                      +|...+.||+|+||.||+++...   +..+|+|++...  .....+.+.+|+++++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47778899999999999999763   678999986542  223356788999999999 599999999875332    45


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++++||+. ++|.+++...  ..+++..+..++.|++.||+|||   ..+++||||||+||++++++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            688889886 6899888643  36899999999999999999999   78999999999999999999999999999985


Q ss_pred             CCCCCCc--cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH---------HH
Q 003436          634 GPDLDQT--HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE---------WA  701 (820)
Q Consensus       634 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~---------~~  701 (820)
                      .......  .......|+..|+|||++.+ ..++.++|+||||++++||++|++||.............         +.
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            4332111  11223468899999998765 468999999999999999999999987543222111000         00


Q ss_pred             HHhhccC------ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          702 MKCQETG------QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       702 ~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......      .........+ ....+.....+.+++.+|++.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000      0000000000 01112234678999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.2e-31  Score=294.22  Aligned_cols=263  Identities=23%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc---
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN---  552 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~---  552 (820)
                      ....++|...+.||+|+||.||++... ++..||||+....  .....+.+.+|+++|++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            345678999999999999999999865 5889999986432  2334467889999999999999999999886543   


Q ss_pred             ---eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          553 ---EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       553 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                         ..++|+||+ +++|.+++..   ..+++..+..++.|+++||+|||   ..+|+||||||+||++++++.+||+|||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence               458999999 6799888754   35899999999999999999999   7899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh-hHH--------H
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV-NLV--------E  699 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~-~l~--------~  699 (820)
                      +++....     ......++..|+|||.+.+ ..++.++|+||||++++||++|++||......... ...        +
T Consensus       164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07880         164 LARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE  238 (343)
T ss_pred             ccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence            9875432     1223457889999999876 45889999999999999999999999754322111 000        0


Q ss_pred             HHHHhhcc------CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          700 WAMKCQET------GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       700 ~~~~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +.......      ..+.......+ ....+.....+.+++.+|++.+|.+||++.+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000      00000000000 01122345568899999999999999999999853

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.1e-31  Score=296.30  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=195.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC----------
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER----------  551 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~----------  551 (820)
                      .+|...+.||.|+||.||+|... .+..||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57888999999999999999975 4789999987666556667889999999999999999999766443          


Q ss_pred             ----ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-CCCCeeEe
Q 003436          552 ----NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVA  626 (820)
Q Consensus       552 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-~~~~~kl~  626 (820)
                          ...++|+||++ ++|.+++...   .+++.....++.|++.||+|||   +.+|+||||||+||+++ +++.+||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                35789999997 5898887542   5889999999999999999999   78999999999999997 56688999


Q ss_pred             eccccccCCCCCC-ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          627 DFGLSKIGPDLDQ-THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       627 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      |||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.+...........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999875432111 111123357889999998754 56888999999999999999999999755432221111000000


Q ss_pred             hcc---Cc----ccc-cc----Ccc-ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QET---GQ----LED-IV----DPT-LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~~---~~----~~~-~~----d~~-l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...   ..    ... ..    .+. ......+....++.+++.+|++.+|++||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000   00    000 00    000 0000112344678899999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-31  Score=294.64  Aligned_cols=260  Identities=22%  Similarity=0.336  Sum_probs=197.1

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce---
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE---  553 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~---  553 (820)
                      ...++|.....||+|++|.||+|+.. +++.+|+|++...  .....+.+.+|+.++++++|+|++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999986 4788999987543  23344667889999999999999999987765554   


Q ss_pred             ---EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          554 ---MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       554 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                         .++|+||+ +++|.+++..   ..+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999999 5699998865   35899999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc--
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET--  707 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~--  707 (820)
                      +......     .....++..|+|||.+.+ ..++.++||||||++++||++|+.||......+...   ........  
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~---~i~~~~~~~~  236 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK---RIMNLVGTPD  236 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHhcCCCC
Confidence            8754321     233457888999999865 367899999999999999999999986543322111   10000000  


Q ss_pred             ---------CccccccCc---cccC---CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 ---------GQLEDIVDP---TLTG---QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ---------~~~~~~~d~---~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                               ......+..   ....   .........+.+++.+|++.+|.+||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                     000000000   0000   0011235678999999999999999999998864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=6.3e-31  Score=288.63  Aligned_cols=247  Identities=24%  Similarity=0.345  Sum_probs=205.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      -...|.....||+|.|+.|.+|++. .+..||+|.+....  ....+.+.+|+++|..|+|||||+++.+......+++|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467888899999999999999976 58899999876553  23345588999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+.+|.+.++|....  .+.......+..|+..+++|||   ++.|||||||++||||+.+.++||+|||++..+.  
T Consensus       134 ~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             EEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec--
Confidence            99999999999998765  4556888889999999999999   8999999999999999999999999999997653  


Q ss_pred             CCccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                       ........+|++.|.|||++.+.++ .+++|+||+|++||-|++|..||+...-.+-                   -++
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-------------------r~r  266 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-------------------RPR  266 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------cch
Confidence             3344567899999999999998765 6899999999999999999999986532221                   111


Q ss_pred             cccCC--CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQ--IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+.+.  ++.-...+..+++++++-.+|.+|+++.++.+.
T Consensus       267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             heeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            22221  222334567789999999999999999999775

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=274.38  Aligned_cols=236  Identities=25%  Similarity=0.326  Sum_probs=192.7

Q ss_pred             EeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       491 LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      ||+|+||.||++... +++.+++|.+....   ......+..|++++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999976 47889999865432   23456889999999999999999999999999999999999999999


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccc
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV  646 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  646 (820)
                      .+++....  .+++.....++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~  153 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF  153 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence            99997653  5899999999999999999999   7899999999999999999999999999987643321  122345


Q ss_pred             cCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       647 ~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      .++..|++||...+...+.++|+||||++++||++|+.|+......   ......   .. ..          ...+...
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~-~~----------~~~~~~~  216 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKI---LK-DP----------LRFPEFL  216 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---hc-CC----------CCCCCCC
Confidence            6888999999998888999999999999999999999998644321   111111   11 10          1122233


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRPSMGD  750 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RPs~~e  750 (820)
                      +..+.+++.+|+..+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            567889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=294.10  Aligned_cols=262  Identities=24%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             CCHHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEee-
Q 003436          473 FPFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCD-  549 (820)
Q Consensus       473 ~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~-  549 (820)
                      ..+..+..-++.|++.++||+|.+|.||+++.. +++..|+|++...... .+++..|.++|+.+ .|||++.++|++. 
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            345555666788999999999999999999954 5788899987665443 36778899999988 6999999999873 


Q ss_pred             ----cCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeE
Q 003436          550 ----ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       550 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl  625 (820)
                          .+++++||||||.+||.-|++.+.....+.|..+..|+..++.||++||   ...++|||||-.||||+.++.+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence                3568999999999999999998877788999999999999999999999   789999999999999999999999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHH
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~  700 (820)
                      +|||++.....  .........||+.|||||++.-     ..|+.++|+||||++..||.-|.+|+....+....     
T Consensus       165 vDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-----  237 (953)
T KOG0587|consen  165 VDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----  237 (953)
T ss_pred             eeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-----
Confidence            99999875433  1222334679999999999953     35778999999999999999999998655442211     


Q ss_pred             HHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       701 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          ...   .  -.|...-.-+..-.+++.+++..|+.+|.++||++.+++++
T Consensus       238 ----F~I---p--RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 ----FLI---P--RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----ccC---C--CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                110   0  11222222344567889999999999999999999998764

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=8e-33  Score=273.62  Aligned_cols=251  Identities=25%  Similarity=0.308  Sum_probs=193.3

Q ss_pred             cceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHc-CCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          487 ESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQ-FRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~-l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ....||.|.||+|+|-.++ .|+..|||+++... ....++++.|.+...+ -+.||||+++|.+..++..++.||+|+ 
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence            4458999999999999876 58999999987654 3667888888886554 478999999999999999999999995 


Q ss_pred             CchhhHh---hhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          564 GTLKDHL---YASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       564 gsL~~~l---~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      -||+.+-   +......+++.-.-+|....+.||.||.+  ...||||||||+||||+..|.+||||||++....+   .
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S  221 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S  221 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence            4665543   33445678888888999999999999986  67899999999999999999999999999875432   2


Q ss_pred             cccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ...+.-.|...|||||.+..  ..++.+|||||||+.|+|+.||+-|+..-..     +.+...... .+..     |.+
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdp-----p~l  290 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDP-----PIL  290 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCC-----Cee
Confidence            33455678899999999954  3589999999999999999999998853221     122111111 1111     111


Q ss_pred             cCC-CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQ-IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ... -.......+..++..|+.+|-.+||...++.+.
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            111 112345678899999999999999999998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=3.2e-31  Score=307.93  Aligned_cols=256  Identities=25%  Similarity=0.391  Sum_probs=191.0

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec------
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE------  550 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------  550 (820)
                      ..-..+|++.++||+||||.|||++.+ ||+.+|||++... +......+.+|+++|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345567999999999999999999976 8999999997755 34445678899999999999999998732100      


Q ss_pred             -----------------------------------------------------------C--------------------
Q 003436          551 -----------------------------------------------------------R--------------------  551 (820)
Q Consensus       551 -----------------------------------------------------------~--------------------  551 (820)
                                                                                 +                    
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                       0                    


Q ss_pred             ----------------------------------ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhh
Q 003436          552 ----------------------------------NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL  597 (820)
Q Consensus       552 ----------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yL  597 (820)
                                                        ..+|+=||||+.-.|++++..+.... .-...++++.+|++||+|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence                                              02467789998877777776554211 3456789999999999999


Q ss_pred             hcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC----C------------CCCccccccccCCccccCccccccC
Q 003436          598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP----D------------LDQTHVSTAVKGSFGYLDPEYLTKQ  661 (820)
Q Consensus       598 H~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~  661 (820)
                      |   +.+||||||||.||+|+++..+||+|||+|....    .            .......+...||.-|+|||++.+.
T Consensus       714 H---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 H---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             H---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9   7899999999999999999999999999998611    0            0111234567899999999999765


Q ss_pred             ---CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHh
Q 003436          662 ---QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCL  738 (820)
Q Consensus       662 ---~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl  738 (820)
                         .|+.|+|+||+|||++||+.   ||....+  .....    ...+.+.+..-      ..+.......-..++.+++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~iL----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASIL----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHH--HHHHH----HhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence               49999999999999999986   4544322  11111    11223333322      1222233345568999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 003436          739 AQCGIDRPSMGDVLW  753 (820)
Q Consensus       739 ~~dp~~RPs~~evl~  753 (820)
                      +.||.+|||+.|++.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999875

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=269.74  Aligned_cols=250  Identities=26%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ..++|...++||+|.||.|.+.+-+ .++.+|+|+++..   .+.....-+.|-++|+..+||.+..|.-.++..+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            3467899999999999999999866 5788999987644   23334455679999999999999999888999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||..||.|.-+|.+.+  .+++....-....|+.||.|||   +.+||.||||.+|.|||.+|++||+||||++..- 
T Consensus       246 VMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc-
Confidence            999999999998886643  5777777778889999999999   7999999999999999999999999999998533 


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                       .........+||+.|+|||++....|....|.|.+||++|||+||+.||..........++   ..       .++   
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---l~-------ed~---  385 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---LM-------EDL---  385 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---Hh-------hhc---
Confidence             2334456789999999999999999999999999999999999999999765433222221   10       111   


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                          .++.....+...|+...|.+||.+|-     ++.||.++
T Consensus       386 ----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  386 ----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                22333445677888899999999994     34555443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=3.5e-30  Score=307.21  Aligned_cols=145  Identities=29%  Similarity=0.406  Sum_probs=130.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+|++. .++.||+|++...   .......+..|+.++..++|+||+++++.+......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999987 5789999987543   2334567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ||+++++|.+++....  .+++..++.|+.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999987543  5888999999999999999999   6899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=2.5e-30  Score=270.28  Aligned_cols=222  Identities=20%  Similarity=0.193  Sum_probs=177.5

Q ss_pred             ecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchhhHhhh
Q 003436          494 GGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA  572 (820)
Q Consensus       494 G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  572 (820)
                      |.+|.||+++.. +++.+|+|++....     .+..|...+....|||++++++++.+....++|+||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999976 57889999876543     234455566667899999999999999999999999999999999865


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccc
Q 003436          573 SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY  652 (820)
Q Consensus       573 ~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  652 (820)
                      ..  .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||++......     .....++..|
T Consensus        79 ~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y  148 (237)
T cd05576          79 FL--NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY  148 (237)
T ss_pred             hc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence            43  5899999999999999999999   789999999999999999999999999987643321     1233456789


Q ss_pred             cCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHH
Q 003436          653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVE  732 (820)
Q Consensus       653 ~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  732 (820)
                      +|||.+.+..++.++||||+|++++||++|+.|+.......            .     ...    ....+......+.+
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~-----~~~----~~~~~~~~~~~~~~  207 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N-----THT----TLNIPEWVSEEARS  207 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c-----ccc----ccCCcccCCHHHHH
Confidence            99999988889999999999999999999998764321100            0     000    00122234467889


Q ss_pred             HHHHHhhcCCCCCCCHHHH
Q 003436          733 IAEKCLAQCGIDRPSMGDV  751 (820)
Q Consensus       733 l~~~Cl~~dp~~RPs~~ev  751 (820)
                      ++.+|++.||.+||++.+.
T Consensus       208 li~~~l~~dp~~R~~~~~~  226 (237)
T cd05576         208 LLQQLLQFNPTERLGAGVA  226 (237)
T ss_pred             HHHHHccCCHHHhcCCCcc
Confidence            9999999999999997433

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-30  Score=270.24  Aligned_cols=258  Identities=25%  Similarity=0.384  Sum_probs=197.3

Q ss_pred             hcCCccceeEeeecceEEEEEEE-cCccEEEEEeC--CCCChhh-----HHHHHHHHHHHHcCCCCceeeEEeEee-cCc
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRG--GTQSHQG-----LAEFRTEIEMLSQFRHRHLVSLIGYCD-ERN  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~--~~~~~~~-----~~~f~~Ei~~l~~l~H~nIv~l~g~~~-~~~  552 (820)
                      .++|-.+++||+|||+.||||.+ ...+.||||+-  .......     .+...+|.++.+.|+||.||++++|+. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            34567778999999999999985 45678999963  2222221     244678999999999999999999984 556


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeecc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFG  629 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFG  629 (820)
                      .+|-|+|||+|.+|+-+|..+.  .++++++..|+.||+.||.||.+. ..+|||-||||.||||.   ..|.+||.|||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            7899999999999999887654  689999999999999999999853 57899999999999994   56899999999


Q ss_pred             ccccCCCCCCc-----cccccccCCccccCcccccc----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHH
Q 003436          630 LSKIGPDLDQT-----HVSTAVKGSFGYLDPEYLTK----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       630 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~  700 (820)
                      |++++.+....     .......||..|++||++.-    ..++.|.||||.||++|.++-|+.||.........  .+.
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lqe  696 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQE  696 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hhh
Confidence            99987664433     23445689999999999843    36789999999999999999999999876543321  111


Q ss_pred             HHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       701 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                             ..+.+...-..  ...+....+...++++||+..-++|.+..++..
T Consensus       697 -------NTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  697 -------NTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             -------hchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                   11111000000  112233456778999999999999988776653

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.7e-29  Score=287.19  Aligned_cols=260  Identities=20%  Similarity=0.266  Sum_probs=183.0

Q ss_pred             HhcCCccceeEeeecceEEEEEEE-----------------cCccEEEEEeCCCCChhhHHHH--------------HHH
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVL-----------------RDETKVAVKRGGTQSHQGLAEF--------------RTE  529 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~-----------------~~~~~vavK~~~~~~~~~~~~f--------------~~E  529 (820)
                      ..++|...++||+|+||.||+|.+                 ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999974                 2346799999865544333333              347


Q ss_pred             HHHHHcCCCCce-----eeEEeEeec--------CceEEEEEeeccCCchhhHhhhcC----------------------
Q 003436          530 IEMLSQFRHRHL-----VSLIGYCDE--------RNEMIIIYEYMENGTLKDHLYASN----------------------  574 (820)
Q Consensus       530 i~~l~~l~H~nI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~----------------------  574 (820)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++|+|.++|+...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777788876654     677887743        356899999999999999987431                      


Q ss_pred             CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccC
Q 003436          575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD  654 (820)
Q Consensus       575 ~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  654 (820)
                      ...++|..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++...... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence            123567888999999999999999   7899999999999999999999999999997543211 111122345789999


Q ss_pred             ccccccCCC----------------------CCcceeeehhhhHHHHhcCCC-CCCCCCchh------hhhHHHHHHHhh
Q 003436          655 PEYLTKQQL----------------------TEKSDVYSFGVVMFEILCGRP-VIDPSLPRE------KVNLVEWAMKCQ  705 (820)
Q Consensus       655 PE~~~~~~~----------------------t~ksDV~SfGvll~ElltG~~-p~~~~~~~~------~~~l~~~~~~~~  705 (820)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.......      ...+..|..  .
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--Y  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--h
Confidence            998854321                      234799999999999999874 553211100      011112211  1


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCC---CCCCCHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCG---IDRPSMGDVLWN  754 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPs~~evl~~  754 (820)
                      .....    +-    ...........+++.+|+..+|   .+|+|+.|++++
T Consensus       457 ~~~~~----~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        457 KGQKY----DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             cccCC----Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            11110    00    1112334667899999998766   689999999864

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-30  Score=258.96  Aligned_cols=259  Identities=22%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             HHHHHHHhcCCccceeEeeecceEEEEEE-EcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          475 FVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       475 ~~~l~~at~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      +.++-..|+     ++||+|+++.|--.+ +..+.++|||++.........+..+|++++.+. .|+||++|+.+++++.
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            455544443     389999999998776 567899999998887777788899999999998 5999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---CeeEeecc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---MAKVADFG  629 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---~~kl~DFG  629 (820)
                      .+|||||.|.||+|..+|++..  .+++.++-++..+||.||.+||   .++|.||||||+|||.....   -+|||||.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccc
Confidence            9999999999999999998764  6899999999999999999999   89999999999999996543   58999999


Q ss_pred             ccccCCCCC-----CccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh-----
Q 003436          630 LSKIGPDLD-----QTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK-----  694 (820)
Q Consensus       630 la~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~-----  694 (820)
                      |..-.....     .+......+|+..|||||+..     ...|+.++|+|||||+||-|++|.+||...=..+.     
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            976322111     111123467899999999873     34688999999999999999999999965321110     


Q ss_pred             --h-hHHHHHHHhhccCccccccCccccCCCCh----hhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          695 --V-NLVEWAMKCQETGQLEDIVDPTLTGQIKP----DSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       695 --~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                        - .-.+-.-..+++|..          ++++    ....+..+++...+..++.+|-++.+++.
T Consensus       305 e~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              0 000001111222221          1222    23456677888888899999999988876

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1.6e-30  Score=262.19  Aligned_cols=270  Identities=22%  Similarity=0.293  Sum_probs=196.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-----ccEEEEEeCCCCChh--hHHHHHHHHHHHHcCCCCceeeEEeEeec-Cce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-----ETKVAVKRGGTQSHQ--GLAEFRTEIEMLSQFRHRHLVSLIGYCDE-RNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~  553 (820)
                      ...|+....||+|.||.||||+-.+     ...+|+|+++.....  ......+|+.++++++||||+.|..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            4568889999999999999996432     236899987654321  23456789999999999999999998866 778


Q ss_pred             EEEEEeeccCCchhhHhhhcC---CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC----CCeeEe
Q 003436          554 MIIIYEYMENGTLKDHLYASN---FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN----LMAKVA  626 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~----~~~kl~  626 (820)
                      .+|++||.+. +|...|+-++   .+.++-..+..|..||+.|++|||   +.=|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999987 8888775432   356888899999999999999999   6779999999999999776    999999


Q ss_pred             eccccccCCCCCCcc-ccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchh------hhhHH
Q 003436          627 DFGLSKIGPDLDQTH-VSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE------KVNLV  698 (820)
Q Consensus       627 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~------~~~l~  698 (820)
                      |+|++|...+.-... ....++-|+.|.|||++.+. .||.+.||||.||++.||+|-+|.|.....+-      ..+..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999876533222 23456789999999999875 68999999999999999999888775432211      11111


Q ss_pred             HHHHHhhccCccccccC----ccc-------c-CCCChh-----------hHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          699 EWAMKCQETGQLEDIVD----PTL-------T-GQIKPD-----------SLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d----~~l-------~-~~~~~~-----------~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      +.+.+........++-|    |..       . .....-           -.....+|+.++|..||.+|-++.+.++..
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            21222111111110000    000       0 000000           012266889999999999999999988764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.9e-29  Score=262.23  Aligned_cols=238  Identities=27%  Similarity=0.361  Sum_probs=193.5

Q ss_pred             cceEEEEEEEcC-ccEEEEEeCCCCChhh-HHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchhhHhhh
Q 003436          495 GFGKVYRGVLRD-ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA  572 (820)
Q Consensus       495 ~fG~Vykg~~~~-~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~  572 (820)
                      +||.||+|+..+ ++.+++|+........ .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            589999999874 8899999977655444 68899999999999999999999999998999999999999999999876


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccc
Q 003436          573 SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY  652 (820)
Q Consensus       573 ~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  652 (820)
                      ..  .+++..++.++.+++++|+|||   ..+++|+||+|+||++++++.++|+|||.+.......   ......++..|
T Consensus        81 ~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~  152 (244)
T smart00220       81 RG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY  152 (244)
T ss_pred             cc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence            44  3899999999999999999999   6899999999999999999999999999998654321   22345678899


Q ss_pred             cCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHH
Q 003436          653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVE  732 (820)
Q Consensus       653 ~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  732 (820)
                      ++||.+.+...+.++||||||++++||++|+.|+......  ....++..    .+....       ..........+.+
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~----~~~~~~-------~~~~~~~~~~~~~  219 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG----KPKPPF-------PPPEWKISPEAKD  219 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh----ccCCCC-------ccccccCCHHHHH
Confidence            9999999888999999999999999999999998653211  11121111    111100       0000114567899


Q ss_pred             HHHHHhhcCCCCCCCHHHHHH
Q 003436          733 IAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       733 l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ++.+|+..+|.+||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=6.4e-30  Score=272.50  Aligned_cols=244  Identities=24%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             ceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          488 SLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      .++||+|-||+||-|+++ .|+.||||.+....  .+...+.++|+.+|++++||.||.+..-|+..+..+.|||.+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            568999999999999986 68999999865432  334477899999999999999999999999999999999999 46


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC---CCeeEeeccccccCCCCCCcc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN---LMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~  641 (820)
                      +..+.|..+...+|+++.-.-++.||+.||.|||   -++|+|+||||+||||...   -.+||||||+||+...   ..
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ks  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KS  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch---hh
Confidence            7777777777778999888889999999999999   7999999999999999543   4799999999998654   34


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ..+.+.||+.|+|||+++++.|...-|+||.||++|--++|.-||....+  ..+.++.         ..-+..+.... 
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQN---------AaFMyPp~PW~-  789 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQN---------AAFMYPPNPWS-  789 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhc---------cccccCCCchh-
Confidence            45678899999999999999999999999999999999999999964422  1111111         11222232222 


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                         +.....++++...|+..-++|-+..+-+.
T Consensus       790 ---eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  790 ---EISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ---hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence               33356778899999999999998876544

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=3.2e-31  Score=260.09  Aligned_cols=266  Identities=23%  Similarity=0.401  Sum_probs=197.0

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC-hhh-HHHHHHHHHHHHcCCCCceeeEEeEeecC--------ce
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS-HQG-LAEFRTEIEMLSQFRHRHLVSLIGYCDER--------NE  553 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--------~~  553 (820)
                      |+...+||+|.||.||+|+.++ ++.||+|+..... +.+ -....+|+++|..|+|+|++.++..|...        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t   98 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT   98 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence            4555689999999999999764 6778988743322 222 23457899999999999999999988432        35


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ++||+.+|+. +|.-+|... ..+++..++.++..++..||.|+|   ...|+|||+|+.|+||+.++.+||+|||+++.
T Consensus        99 ~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   99 FYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            8999999986 787777543 246888999999999999999999   78999999999999999999999999999986


Q ss_pred             CCCCCC--ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          634 GPDLDQ--THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       634 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ....+.  ....+..+-|+.|.+||.+.+ ++++++.|||+-||++.||+|+.+-+....+.....++.........+.+
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            443221  122345567999999999876 57999999999999999999999988877666655555422211111111


Q ss_pred             ccc--------c--CccccCCCC--hhhH------HHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          711 EDI--------V--DPTLTGQIK--PDSL------NKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       711 ~~~--------~--d~~l~~~~~--~~~~------~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .++        +  .|...+.+.  ++..      .+.++|+++++..||.+|+++.+++.+-
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            111        1  111111110  1111      2577899999999999999999988764

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=255.17  Aligned_cols=254  Identities=27%  Similarity=0.357  Sum_probs=198.4

Q ss_pred             HhcCCccc-eeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeec----Cce
Q 003436          481 ATDNFSES-LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDE----RNE  553 (820)
Q Consensus       481 at~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~  553 (820)
                      .|++|.+. ++||-|--|.|-....+ .++++|+|.+...     ...++|+++.-.. .|||||++++++++    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666553 58999999999988876 4788999987544     3346788766555 69999999998743    456


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeeccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGL  630 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFGl  630 (820)
                      +++|||.|+||.|...+..++...++++++-+|..||+.|+.|||   +..|.||||||+|+|..   .|..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999999999988888999999999999999999999   89999999999999995   456899999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      |+....   .......+-|+.|.|||++...+++..+|+||+||++|-|+||.+||......   .+.--++..+..++.
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy  284 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY  284 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc
Confidence            986432   22334567899999999999999999999999999999999999999754321   111112222333332


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .- -+|     --....+...++++.+|..+|.+|-++.+++.+
T Consensus       285 ~F-P~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  285 EF-PEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             cC-CCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            20 000     011345677889999999999999999999865

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=5e-29  Score=290.26  Aligned_cols=260  Identities=22%  Similarity=0.273  Sum_probs=169.0

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-----ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeE------ee
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-----ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CD  549 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~------~~  549 (820)
                      ..++|...++||+|+||.||+|++.+     +..||+|++......  +.+..|  .+....+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            46789999999999999999999864     588999986543221  111111  1122222222222111      34


Q ss_pred             cCceEEEEEeeccCCchhhHhhhcCCC------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCC
Q 003436          550 ERNEMIIIYEYMENGTLKDHLYASNFP------------------SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVK  611 (820)
Q Consensus       550 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIk  611 (820)
                      .+.+.++|+||+++++|.+++......                  ......+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            567899999999999999998754311                  1112345578999999999999   7899999999


Q ss_pred             CCcEEEcC-CCCeeEeeccccccCCCCCCccccccccCCccccCccccccC----------------------CCCCcce
Q 003436          612 SANILLDE-NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ----------------------QLTEKSD  668 (820)
Q Consensus       612 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksD  668 (820)
                      |+|||+++ ++.+||+|||+++..... .........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 689999999999854321 22233456789999999966322                      2345679


Q ss_pred             eeehhhhHHHHhcCCCCCCCCCchh-------hhhHHHHHHHhhccCccccccCccccC--CCChhhHHHHHHHHHHHhh
Q 003436          669 VYSFGVVMFEILCGRPVIDPSLPRE-------KVNLVEWAMKCQETGQLEDIVDPTLTG--QIKPDSLNKFVEIAEKCLA  739 (820)
Q Consensus       669 V~SfGvll~ElltG~~p~~~~~~~~-------~~~l~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~  739 (820)
                      ||||||+||||+++..+.+.....-       ......|.......      ..+.+..  +..........+|+.+||+
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence            9999999999999765543211000       00111221111000      0000000  0001112345689999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 003436          740 QCGIDRPSMGDVLWN  754 (820)
Q Consensus       740 ~dp~~RPs~~evl~~  754 (820)
                      .||++||++.+++++
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=280.20  Aligned_cols=240  Identities=19%  Similarity=0.281  Sum_probs=193.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++.|.....+|.|+|+.|-++... .++..+||++.....    +-.+|+.++... +|||++++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567777778999999999988865 467889998765522    234577666666 79999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE-cCCCCeeEeeccccccCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL-DENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll-~~~~~~kl~DFGla~~~~~~~  638 (820)
                      .+.++-|.+.+.....  .. .++..|+.+++.++.|||   .++++||||||+|||+ ++.++++|+|||.++..... 
T Consensus       397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            9999988887765432  22 777889999999999999   7999999999999999 69999999999999865442 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          ....+-|..|.|||++....+++++|+||||++||||++|+.|+......  .+    .......+          
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~----------  529 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMP----------  529 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCC----------
Confidence                22346788999999999999999999999999999999999999755433  11    12222222          


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .+.........+|+.+||+.||.+||+|.++..+
T Consensus       530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             --ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence              2224445678899999999999999999999764

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=262.90  Aligned_cols=240  Identities=25%  Similarity=0.354  Sum_probs=193.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .+|..+.+||+|+||.|.+|.-++ .+.+|||.++.+-   ..+.+--+.|-++|... +-|.+++++.+++.-+.+++|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            358888899999999999998765 4678999765432   12223334577777766 568899999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+.||+|--++..-+  .+.+..+.-.+..||-||-+||   +++||.||||.+|||||.+|++||+|||+++..-- 
T Consensus       429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-  502 (683)
T ss_pred             EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence            99999999988886544  5777888889999999999999   89999999999999999999999999999985322 


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                       ........+||+.|+|||.+..++|...+|.|||||+||||+.|++||+...+.+....+   .            +..
T Consensus       503 -~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---~------------ehn  566 (683)
T KOG0696|consen  503 -DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---M------------EHN  566 (683)
T ss_pred             -CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H------------Hcc
Confidence             223345689999999999999999999999999999999999999999876554432211   1            111


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCC
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRP  746 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  746 (820)
                        -.++.....+...+....+.+.|.+|-
T Consensus       567 --vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 --VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence              134445567788999999999999994

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=292.53  Aligned_cols=257  Identities=25%  Similarity=0.285  Sum_probs=203.3

Q ss_pred             HHHHHHhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC
Q 003436          476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER  551 (820)
Q Consensus       476 ~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  551 (820)
                      .+++-..++|.+.++||+|+||.|...+++. ++.+|.|++...   ......-|..|-++|.--+.+=|++++-.|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            3455566899999999999999999999875 678899987652   234456799999999999999999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      ..+|+|||||+||+|-.++....  .++...+.-.+..|+.||.-||   +.|+|||||||+|||||..|++||+|||.+
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence            99999999999999999997655  6888888888889999999999   899999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCccccCccccc----c-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLT----K-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      -.... +..-.....+||+-|.+||++.    + +.|.+.+|.||+||++|||+.|..||....      +++-..+...
T Consensus       223 lkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~  295 (1317)
T KOG0612|consen  223 LKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMN  295 (1317)
T ss_pred             HhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhc
Confidence            76554 3344455678999999999995    2 578999999999999999999999997542      2221111111


Q ss_pred             cCccccccCccccCCCC--hhhHHHHHHHHHHHhhcCCCCCCC---HHHHHHH
Q 003436          707 TGQLEDIVDPTLTGQIK--PDSLNKFVEIAEKCLAQCGIDRPS---MGDVLWN  754 (820)
Q Consensus       707 ~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPs---~~evl~~  754 (820)
                      ....       +  .++  .+.+++..+|+++.+. +|+.|-.   +.++..+
T Consensus       296 hk~~-------l--~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  296 HKES-------L--SFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             hhhh-------c--CCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            1000       0  112  2345677888887774 6777766   7777654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=261.50  Aligned_cols=263  Identities=20%  Similarity=0.303  Sum_probs=203.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC--C----ceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH--R----HLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~----nIv~l~g~~~~~~~~  554 (820)
                      +++|....++|+|.||.|-+..+.. +..||||+++..... .+.-+-|+++|+++.+  |    -++++.+|+...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6778888899999999999988664 578999987654332 3445679999999932  2    467888999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---------------
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---------------  619 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---------------  619 (820)
                      ++|+|.| |-|+.++|..++..+++...+..|+.|+++++++||   +.+++|-||||+|||+.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999 459999999888888999999999999999999999   899999999999999932               


Q ss_pred             -----CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          620 -----NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       620 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                           +..+||+|||-|.....     ....+..|..|.|||++.+-.++..+||||+||+|.||.||...|+.....+.
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 34689999999975322     22557789999999999999999999999999999999999998887765555


Q ss_pred             hhHHHHHHH--------------hhccCccc-----------cccCccc--c--CCCChhhHHHHHHHHHHHhhcCCCCC
Q 003436          695 VNLVEWAMK--------------CQETGQLE-----------DIVDPTL--T--GQIKPDSLNKFVEIAEKCLAQCGIDR  745 (820)
Q Consensus       695 ~~l~~~~~~--------------~~~~~~~~-----------~~~d~~l--~--~~~~~~~~~~l~~l~~~Cl~~dp~~R  745 (820)
                      ....+.+..              ....+++.           .+.++..  .  -.....+..+|.+|++++|..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            444432211              01111100           0000000  0  01122445679999999999999999


Q ss_pred             CCHHHHHHH
Q 003436          746 PSMGDVLWN  754 (820)
Q Consensus       746 Ps~~evl~~  754 (820)
                      +|+.|++++
T Consensus       398 iTl~EAL~H  406 (415)
T KOG0671|consen  398 ITLREALSH  406 (415)
T ss_pred             ccHHHHhcC
Confidence            999999864

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=5.9e-29  Score=232.60  Aligned_cols=263  Identities=21%  Similarity=0.277  Sum_probs=196.8

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH--QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +|...++||+|.+|+||||+.. .++.||+|+.+.++.  ..-....+|+-+|+.++|.|||++++....+..+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4556679999999999999965 468899998654432  2245678999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      |. .+|..+...- ...++...+..++.|+++||.++|   ++.+.|||+||.|.|++.+|+.|++|||+++...-.  .
T Consensus        83 cd-qdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--v  155 (292)
T KOG0662|consen   83 CD-QDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--V  155 (292)
T ss_pred             hh-HHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--e
Confidence            96 4787776543 356888999999999999999999   789999999999999999999999999999865431  1


Q ss_pred             cccccccCCccccCccccccCC-CCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccc---cccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQ-LTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLE---DIVD  715 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d  715 (820)
                      .......-|..|.+|.++.+.+ |+...|+||-||++.|+.. |++.|......++...+-|......+.++.   .+-|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            1233456789999999998764 7889999999999999987 555555444444444444443333333322   2223


Q ss_pred             ccccCCCCh---------hhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          716 PTLTGQIKP---------DSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~---------~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      -.....++.         .....=++++.+.+.-+|.+|.++.+.++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            222222221         11122356777788888999999987765

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.95  E-value=8.3e-29  Score=278.70  Aligned_cols=246  Identities=30%  Similarity=0.408  Sum_probs=187.9

Q ss_pred             CccceeEeeecceE-EEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeecc
Q 003436          485 FSESLVIGIGGFGK-VYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       485 f~~~~~LG~G~fG~-Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      |...+++|.|+-|+ ||+|..+ ++.||||++-....   +-..+|+..|+.- .|||||++++.-.++...|++.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            55566889999876 8999985 67999999764432   3456899999988 69999999988888899999999995


Q ss_pred             CCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-----CCCeeEeeccccccCC
Q 003436          563 NGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-----NLMAKVADFGLSKIGP  635 (820)
Q Consensus       563 ~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-----~~~~kl~DFGla~~~~  635 (820)
                       .+|.+++...  ......-...+.+..|++.||++||   +.+||||||||.||||+.     ..+++|+|||+++...
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             6999999874  1111111345778889999999999   799999999999999965     3589999999999765


Q ss_pred             CCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcC-CCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          636 DLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG-RPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ..... .......||.||+|||++....-+..+|+||+||++|..++| +.||......+. ++.      .....+..+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl------~~~~~L~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NIL------TGNYTLVHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhh------cCccceeee
Confidence            53322 223457799999999999998888999999999999999997 789875433221 111      111111111


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                             .-.+++  +..+|+.+|++++|..||++.+|+.+
T Consensus       736 -------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  736 -------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                   011122  78899999999999999999999754

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=233.24  Aligned_cols=201  Identities=25%  Similarity=0.335  Sum_probs=165.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      +.......||+|++|.|=+-++. +|+..|+|++... ..+..++.+.|+++..+. .+|.+|.++|.....+..++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            34455568999999999888765 6889999987644 345567788888877655 79999999999888899999999


Q ss_pred             eccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          560 YMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       560 ~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      .|. -||+.+-..  .....+++.-.-+|+..+.+||.|||+  ...+||||+||+|||++.+|++|+||||++....+ 
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d-  201 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD-  201 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehh-
Confidence            996 477766543  234578888899999999999999996  77899999999999999999999999999876433 


Q ss_pred             CCccccccccCCccccCcccccc----CCCCCcceeeehhhhHHHHhcCCCCCCCC
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTK----QQLTEKSDVYSFGVVMFEILCGRPVIDPS  689 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SfGvll~ElltG~~p~~~~  689 (820)
                        .-..+...|...|||||.+..    ..|+-|+||||||+.+.||.+++.|++..
T Consensus       202 --SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  202 --SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             --hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence              122334568889999998853    37899999999999999999999998643

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.2e-27  Score=257.92  Aligned_cols=215  Identities=24%  Similarity=0.401  Sum_probs=173.6

Q ss_pred             HHHHHHHh---cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeE
Q 003436          475 FVAIQEAT---DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGY  547 (820)
Q Consensus       475 ~~~l~~at---~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~  547 (820)
                      |..|+.+.   .-|..++.||-|+||+|.++...+ ...+|.|.++..+   +........|-+||...+.+=||+|+-.
T Consensus       618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS  697 (1034)
T KOG0608|consen  618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS  697 (1034)
T ss_pred             HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence            34444443   457778899999999999997544 4567888765443   2334456789999999999999999999


Q ss_pred             eecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       548 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                      |.+++.+|+||||++||++-.+|.+.+  -+.+..+.-.+..+.+|+++.|   ..|+|||||||+|||||.+|++||.|
T Consensus       698 FQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  698 FQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             eccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeee
Confidence            999999999999999999999987765  3556666667778999999999   89999999999999999999999999


Q ss_pred             ccccccC---------CCCCC---c--c--------------------------ccccccCCccccCccccccCCCCCcc
Q 003436          628 FGLSKIG---------PDLDQ---T--H--------------------------VSTAVKGSFGYLDPEYLTKQQLTEKS  667 (820)
Q Consensus       628 FGla~~~---------~~~~~---~--~--------------------------~~~~~~gt~~y~aPE~~~~~~~t~ks  667 (820)
                      |||+.-+         ...+.   .  .                          .....+||..|+|||++....++..+
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            9998521         10000   0  0                          01135699999999999999999999


Q ss_pred             eeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          668 DVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       668 DV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                      |.||.||+|+||+-|++||-...+.+.
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            999999999999999999987766543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1.2e-26  Score=234.69  Aligned_cols=210  Identities=37%  Similarity=0.592  Sum_probs=182.9

Q ss_pred             EeeecceEEEEEEEcC-ccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchhh
Q 003436          491 IGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD  568 (820)
Q Consensus       491 LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  568 (820)
                      ||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999875 888999987655442 35678999999999999999999999999899999999999999999


Q ss_pred             HhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeeccccccCCCCCCcccccccc
Q 003436          569 HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKIGPDLDQTHVSTAVK  647 (820)
Q Consensus       569 ~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~  647 (820)
                      ++.... ..+++..+..++.+++++|++||   ..+++|+||+|.||+++. ++.++|+|||.+........  ......
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~  154 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV  154 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence            987653 36899999999999999999999   689999999999999999 89999999999986543221  123345


Q ss_pred             CCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhh
Q 003436          648 GSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS  726 (820)
Q Consensus       648 gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  726 (820)
                      +...|++||..... ..+.+.|+|++|++++||                                               
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------  187 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------  187 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence            78889999999877 888999999999999998                                               


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          727 LNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       727 ~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+.+++.+|++.+|.+||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             357789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=242.40  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=196.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCC---CChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGT---QSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~---~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|....+||+|+|.+|..+++.. .+.+|+|.++.   .+..+++..+.|-.+..+. +||.+|.+..++..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            4679999999999999999999864 67788876543   3445566777888888776 79999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |.||+++|+|--++.+.  +.|++..+.-....|+.||.|||   +.+||.||||..|||||..|++||.|+|+++..-.
T Consensus       329 vieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999997766544  46888888888889999999999   89999999999999999999999999999985433


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCc-hhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLP-REKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                        ........+||+.|.|||.+++..|....|.|++||+++||+.|+.||+--.. ....+-.++.-+.+-+.+++    
T Consensus       404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----  477 (593)
T KOG0695|consen  404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----  477 (593)
T ss_pred             --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc----
Confidence              23345678999999999999999999999999999999999999999964221 11122223333322222221    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCC
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP  746 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  746 (820)
                            ++.....+...+++.-+.+||++|-
T Consensus       478 ------iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 ------IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ------ccceeehhhHHHHHHhhcCCcHHhc
Confidence                  2223335567788899999999984

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.6e-28  Score=257.36  Aligned_cols=249  Identities=20%  Similarity=0.284  Sum_probs=201.4

Q ss_pred             CCccceeEeeecceEEEEEEEcCccE-EEEEeC---CCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRG---GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~-vavK~~---~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++..+..||-||||.|=+...++... .|+|.+   ...+....+....|-++|.+++.|.||+++--+.+....|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            45556689999999999988765443 565543   33344455667889999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      -|-||.|...|...+  .++..+..-++..+.+|++|||   .++||.|||||+|.+|+.+|-+||.|||+|+.....  
T Consensus       501 aClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--  573 (732)
T KOG0614|consen  501 ACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--  573 (732)
T ss_pred             hhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC--
Confidence            999999999997654  5777888888899999999999   899999999999999999999999999999976442  


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                       ..+-..+||+.|.|||.+.++..+.++|.||||++++||++|+|||....+....+++--....+              
T Consensus       574 -~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--------------  638 (732)
T KOG0614|consen  574 -RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--------------  638 (732)
T ss_pred             -CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--------------
Confidence             33446899999999999999999999999999999999999999998877655544432111111              


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWNL  755 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~L  755 (820)
                       .++........+++++.+..+|.+|-.     +.++-++-
T Consensus       639 -~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  639 -EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             -hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence             122334456788999999999999965     56666553

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.4e-28  Score=240.26  Aligned_cols=264  Identities=26%  Similarity=0.360  Sum_probs=194.7

Q ss_pred             CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ceEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NEMII  556 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~~l  556 (820)
                      .+..+.||.|+||.||...+. +|+.|+.|++...-  -...+.+.+|+++|...+|.|++..++...-.     .++|.
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            445668999999999998865 78999999865432  23457889999999999999999988765433     35688


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      +.|.|.. +|++.+...  ..++-..+.-+..||++||.|||   +.+|.||||||.|.|++.+..+||||||++|....
T Consensus       135 ~TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            8898854 777776543  35777777788999999999999   78999999999999999999999999999997544


Q ss_pred             CCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH--------HHhhcc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA--------MKCQET  707 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~--------~~~~~~  707 (820)
                       +....++...-|..|.|||.+++. .|+.+.||||.||++.||+..+..|....+-++.+++.-.        .+..-+
T Consensus       209 -d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 -RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             -hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence             334445555678899999999875 6899999999999999999998888777666665544211        111111


Q ss_pred             CccccccC-----c---cccC-CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          708 GQLEDIVD-----P---TLTG-QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       708 ~~~~~~~d-----~---~l~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      |....++.     |   .+.. .-+...-.+...+..+++..+|.+|.+..+.+..+
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            11111111     1   1100 01112234556777888999999999988877654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-26  Score=227.83  Aligned_cols=252  Identities=20%  Similarity=0.329  Sum_probs=185.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeE-eecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGY-CDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~-~~~~~~~~lV~  558 (820)
                      .+.|.+.+.||+|.||.+.++.++. .+.+++|-.. ......++|.+|..---.| .|.||+.-++. ++..+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            3568888999999999999999985 5677788654 3344578999998766566 58999988775 56677888999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE--cCCCCeeEeeccccccCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL--DENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll--~~~~~~kl~DFGla~~~~~  636 (820)
                      ||+|.|+|..-+...   .+.+....+++.|++.||.|+|   ++.+||||||.+|||+  .+..++||||||+.+....
T Consensus       102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999887654   4777888899999999999999   8999999999999999  3445899999999874221


Q ss_pred             CCCccccccccCCccccCccccccC-----CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQ-----QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                           ......-+..|.+||.+...     ...+.+|+|.||++++.++||++||+.....+ ....+|..-.  .+.. 
T Consensus       176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~--~rk~-  246 (378)
T KOG1345|consen  176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWL--KRKN-  246 (378)
T ss_pred             -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHh--cccC-
Confidence                 11223456679999988543     45778999999999999999999998443322 2233333211  1111 


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          +++...+. ...+.+..+.++-+..++++|-...++.++
T Consensus       247 ----~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  247 ----PALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             ----ccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence                12222222 223456677788899999999555555444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.5e-25  Score=230.62  Aligned_cols=199  Identities=32%  Similarity=0.467  Sum_probs=172.4

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      |...+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556789999999999999875 788999997765544 57789999999999999999999999999899999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++..... .+++.....++.+++.+|.+||   ..+++|+||+|+||+++.++.++|+|||++......... .
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~  155 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L  155 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence            9999999876542 2889999999999999999999   679999999999999999999999999999865443211 2


Q ss_pred             cccccCCccccCcccc-ccCCCCCcceeeehhhhHHHHhcCCCCCCC
Q 003436          643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPVIDP  688 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvll~ElltG~~p~~~  688 (820)
                      .....++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2334677889999998 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=5.6e-27  Score=257.50  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=203.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      -.++|+....+|.|.+|.|||++.. .+...|+|.++.......+-..+|+-+++..+||||+.++|.+.....++++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3457888889999999999999976 578889998887777777888899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ||.+|+|.+.-+...  .+++.+...+|+...+||+|||   +.+-+|||||-.|||+++.+.+|++|||.+.....  .
T Consensus        93 ycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--t  165 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--T  165 (829)
T ss_pred             ecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--h
Confidence            999999999776554  7899999999999999999999   78999999999999999999999999999764321  1


Q ss_pred             ccccccccCCccccCcccc---ccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC-
Q 003436          640 THVSTAVKGSFGYLDPEYL---TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD-  715 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-  715 (820)
                      -.......||+.|||||+.   +.+.|..++|||+.|+...|+-.-++|.....+.....+..      +.     ..+ 
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------kS-----~~qp  234 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------KS-----GFQP  234 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------cc-----CCCC
Confidence            2233457899999999987   45678999999999999999988777764433322221110      10     111 


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      |.+.  -...-.+.+.++++.|+.++|++||++..++.
T Consensus       235 p~lk--Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTLK--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             Cccc--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1111  11233467889999999999999999987765

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-25  Score=237.38  Aligned_cols=131  Identities=27%  Similarity=0.416  Sum_probs=113.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC--------CCceeeEEeEeec---
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR--------HRHLVSLIGYCDE---  550 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~~---  550 (820)
                      .+|...++||-|.|++||++.+. ..+.||+|+.+..... .+..+.||++|++++        ..+||+|+++|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            57889999999999999999976 4578999987654433 355678999999884        2489999999854   


Q ss_pred             -CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          551 -RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       551 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                       +.+.++|+|++ |-+|..+|.....+.++...+.+||.||+.||.|||.  ..+|||-||||+||||
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence             55899999999 6699999999888899999999999999999999997  5589999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-25  Score=228.59  Aligned_cols=259  Identities=20%  Similarity=0.267  Sum_probs=187.9

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------ceE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------NEM  554 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~  554 (820)
                      +|.....+|.|.- .|--+.+. .++.||+|+....  .....++..+|..++..++|+|+++++.++.-.      .+.
T Consensus        18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~   96 (369)
T KOG0665|consen   18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV   96 (369)
T ss_pred             eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence            3555556777776 44444432 4788999975432  334467788999999999999999999988433      367


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|||+|. ++|.+.++.    .++-.+...|..|++.|++|||   +.+|+||||||+||++..++.+||.|||+|+..
T Consensus        97 y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   97 YLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence            99999995 599988873    4777889999999999999999   899999999999999999999999999999853


Q ss_pred             CCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh----------------hHH
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV----------------NLV  698 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~----------------~l~  698 (820)
                      ..   .-..+....|..|.|||++.+..+.+.+||||.||++.||++|+-.|.+..--++.                .+.
T Consensus       169 ~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  169 DT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             Cc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            22   13455667889999999999988999999999999999999999766533211111                111


Q ss_pred             HHHHHhhcc-C-----cccccc-CccccC--CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          699 EWAMKCQET-G-----QLEDIV-DPTLTG--QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       699 ~~~~~~~~~-~-----~~~~~~-d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .-++...+. +     ...+.+ |.....  +.++-....+.+++.+||-.+|++|-+++++|++
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            111111110 0     001111 111110  1112334567899999999999999999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=3.1e-25  Score=215.35  Aligned_cols=259  Identities=19%  Similarity=0.317  Sum_probs=189.6

Q ss_pred             hcCCccceeEeeecceEEEEEE-EcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecC--ceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDER--NEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV  557 (820)
                      .++|+..+++|+|.++.||.|. ..+.++++||.+++...   +.+.+|+++|+.|. ||||++|++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4578888899999999999998 45678999999876544   56778999999997 99999999988554  457899


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeeccccccCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKIGPD  636 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~~~~  636 (820)
                      +||+.+.+...+.     +.|+...+.....+++.||.|+|   +.||.|||+||.|+++|. ...++|+|+|||.....
T Consensus       114 FE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999987766544     34777788889999999999999   899999999999999985 56899999999986543


Q ss_pred             CCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCch-hhhh-H---------HHHHHHh
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR-EKVN-L---------VEWAMKC  704 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~-~~~~-l---------~~~~~~~  704 (820)
                      .....   ....+..|.-||++.. +.++..-|+|||||+|.+|+..+.||-..... ++.- +         ..+..+.
T Consensus       186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            22211   2234556788999854 56788899999999999999999887544322 2211 1         1111111


Q ss_pred             hc--cCccccccCccccC--------CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QE--TGQLEDIVDPTLTG--------QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~--~~~~~~~~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .-  ..+...++....+.        +-..-...+.++++.+.|..|-.+|+|+.|.+.+
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            00  01111111111111        0011123678899999999999999999998865

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.91  E-value=7.5e-25  Score=237.12  Aligned_cols=196  Identities=21%  Similarity=0.396  Sum_probs=164.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCCh--------hhHHHHHHHHHHHHcCC---CCceeeEEeEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH--------QGLAEFRTEIEMLSQFR---HRHLVSLIGYCDE  550 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~  550 (820)
                      .+|...+.+|.|+||.|+.+.++. ...|+||.+....-        ...-....||.+|..|+   |+||++++.++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            457888999999999999999875 56788887654321        11123556999999997   9999999999999


Q ss_pred             CceEEEEEeec-cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          551 RNEMIIIYEYM-ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       551 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                      ++.++|++|-. ++-+|.+++..+  +.+++.+..-|..|++.|+++||   +.+|||||||-+||.++.+|-+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            99999999975 456888888765  47999999999999999999999   8999999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccCCCC-CcceeeehhhhHHHHhcCCCCCC
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGRPVID  687 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvll~ElltG~~p~~  687 (820)
                      .+.....    ..-...+||..|.|||++.+.+|- ..-|||++|++||-++-...|+.
T Consensus       716 saa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9875332    233457899999999999988764 45799999999999998877764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=3.2e-24  Score=229.44  Aligned_cols=265  Identities=20%  Similarity=0.263  Sum_probs=199.8

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC------CCceeeEEeEeecCce
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR------HRHLVSLIGYCDERNE  553 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~------H~nIv~l~g~~~~~~~  553 (820)
                      .-..|.+....|+|-|++|-+|.+. .|+.||||++..... ..+.=+.|+++|++|.      ..|+++|+..|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            4467888889999999999999976 377999999875532 3345578999999995      3588999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeecccc
Q 003436          554 MIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLS  631 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla  631 (820)
                      +|||+|-+. .+|.+.|..-+ .-.|....+..++.|+.-||..|.   ..+|+|.||||.|||+++. ..+||||||.|
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence            999999884 59999997643 346888899999999999999999   7899999999999999865 67899999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH-----Hhhc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM-----KCQE  706 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~-----~~~~  706 (820)
                      ........+    ...-+.-|.|||.+.+..|+...|+||.||+||||.||+..|.+....+...+..-+.     ++++
T Consensus       585 ~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  585 SFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             ccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            765543222    1223456999999999999999999999999999999998886655544443321110     1111


Q ss_pred             cCccc-cccC--------------------------c------cccC--CCC---hhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          707 TGQLE-DIVD--------------------------P------TLTG--QIK---PDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       707 ~~~~~-~~~d--------------------------~------~l~~--~~~---~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                      .++.. .-+|                          |      .|.+  .++   +....+|.+|+.+|+..||++|-+.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            11110 0111                          1      0000  122   2345678899999999999999999


Q ss_pred             HHHHHH
Q 003436          749 GDVLWN  754 (820)
Q Consensus       749 ~evl~~  754 (820)
                      .+.|++
T Consensus       741 nqAL~H  746 (752)
T KOG0670|consen  741 NQALKH  746 (752)
T ss_pred             HHHhcC
Confidence            988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=1.2e-23  Score=222.23  Aligned_cols=266  Identities=24%  Similarity=0.338  Sum_probs=195.5

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      +....+.|...++||.|.|++||++.+..    +..||+|.+...+..  ..+.+|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            33445678889999999999999998643    578999998776654  4578999999999 5999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeecccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLS  631 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla  631 (820)
                      ...+|+||++...-.+++..     ++..++....+.+..||+++|   ..|||||||||+|+|.+. -+.-.|+|||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhH
Confidence            99999999999888887753     667888899999999999999   899999999999999964 467899999999


Q ss_pred             ccCCCCC------C------c------------------------------cccccccCCccccCcccccc-CCCCCcce
Q 003436          632 KIGPDLD------Q------T------------------------------HVSTAVKGSFGYLDPEYLTK-QQLTEKSD  668 (820)
Q Consensus       632 ~~~~~~~------~------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ksD  668 (820)
                      .......      .      .                              .......||+||.|||++.. ...+.+.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7210000      0      0                              00112469999999999965 46788999


Q ss_pred             eeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH--------HHhhc-cCc--ccc------c---------cC-ccccC-
Q 003436          669 VYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA--------MKCQE-TGQ--LED------I---------VD-PTLTG-  720 (820)
Q Consensus       669 V~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~--------~~~~~-~~~--~~~------~---------~d-~~l~~-  720 (820)
                      |||.||+++-+++++.||-....+ ...+.+.+        +++.. .|.  +.+      +         ++ ..+.+ 
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             eeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            999999999999999888543221 11111111        11100 011  000      0         00 00000 


Q ss_pred             --------CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          721 --------QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       721 --------~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                              ...+..+..+.+++.+|++.||.+|-++++.|++
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                    1111223478899999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=1.4e-24  Score=265.25  Aligned_cols=196  Identities=18%  Similarity=0.220  Sum_probs=138.8

Q ss_pred             cCCC-CceeeEEeEe-------ecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEE
Q 003436          535 QFRH-RHLVSLIGYC-------DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII  606 (820)
Q Consensus       535 ~l~H-~nIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~ii  606 (820)
                      .++| +||.+++++|       .+...+++++|++ +++|.++|... ...+++.+++.++.||++||+|||   +++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            4456 6888888877       2234567889988 56999999753 346999999999999999999999   78999


Q ss_pred             eccCCCCcEEEcC-------------------CCCeeEeeccccccCCCCCC--------------ccccccccCCcccc
Q 003436          607 HRDVKSANILLDE-------------------NLMAKVADFGLSKIGPDLDQ--------------THVSTAVKGSFGYL  653 (820)
Q Consensus       607 HrDIkp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  653 (820)
                      ||||||+||||+.                   ++.+|++|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   44566666666653211000              00011245788999


Q ss_pred             CccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHH
Q 003436          654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEI  733 (820)
Q Consensus       654 aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  733 (820)
                      |||++.+..++.++|||||||+||||++|.+|+....    .........         ...+..     .........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChhh-----hhcCHHHHHH
Confidence            9999999999999999999999999999988754211    001111000         011111     0112345678


Q ss_pred             HHHHhhcCCCCCCCHHHHHH
Q 003436          734 AEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       734 ~~~Cl~~dp~~RPs~~evl~  753 (820)
                      +.+||+++|.+||+|.|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            88999999999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=2e-22  Score=220.44  Aligned_cols=264  Identities=20%  Similarity=0.231  Sum_probs=201.3

Q ss_pred             CCccceeEeeecceEEEEEEEcCc--cEEEEEeCCCCChhhHHHHHHHHHHHHcCCC----CceeeEEeEe-ecCceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDE--TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH----RHLVSLIGYC-DERNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~--~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H----~nIv~l~g~~-~~~~~~~l  556 (820)
                      +|...++||+|+||.||++.....  ..+|+|............+..|..++..+.+    .++..++... ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  4788887654433322267778999988863    6888998888 57778899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-----CCeeEeecccc
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-----LMAKVADFGLS  631 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-----~~~kl~DFGla  631 (820)
                      ||+.+ |.+|.++........++..+.++|+.|++.+|++||   +.+++||||||.|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 779999886665678999999999999999999999   8999999999999999754     46999999999


Q ss_pred             ccCC--CCCCc---cc---cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh-hHHHHHH
Q 003436          632 KIGP--DLDQT---HV---STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV-NLVEWAM  702 (820)
Q Consensus       632 ~~~~--~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~-~l~~~~~  702 (820)
                      +...  .....   ..   .....||.+|.++..+.+.+.+++.|+||++.++.|++.|..||......... ...+...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            8322  21111   11   12356999999999999999999999999999999999999999654432221 1111111


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                      .        .....     .....+.++.++...+-..+..++|....+...|++.....+.
T Consensus       255 ~--------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~  303 (322)
T KOG1164|consen  255 K--------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS  303 (322)
T ss_pred             h--------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence            0        00110     2233456677777777779999999999999998888765533

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=5.1e-23  Score=204.51  Aligned_cols=169  Identities=22%  Similarity=0.238  Sum_probs=126.3

Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      |+|.+++...+ ..++|.+++.|+.|++.||+|||   ..+      ||+|||++.++.+|+  ||+++.....      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc------
Confidence            78999997543 46999999999999999999999   444      999999999999999  9998864331      


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK  723 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  723 (820)
                       ...||..|||||++.+..++.++|||||||++|||++|+.|+........ .+..+.......       ++.. ....
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~-------~~~~-~~~~  132 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPAD-------DPRD-RSNL  132 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhccC-------Cccc-cccH
Confidence             12588999999999999999999999999999999999999864322111 111111111000       0000 0011


Q ss_pred             hhhHH--HHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          724 PDSLN--KFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       724 ~~~~~--~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .....  .+.+++.+|++.+|.+||++.|+++++.....
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            12222  68999999999999999999999999876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1.6e-22  Score=198.08  Aligned_cols=262  Identities=17%  Similarity=0.226  Sum_probs=205.2

Q ss_pred             hcCCccceeEeeecceEEEEEE-EcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC-CceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH-RHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ..+|..+++||.|+||.+|.|. +.+|.+||+|..+....  ..++.-|.++.+.|+| ..|..+..|..++..-.|||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            3568999999999999999998 45799999998654433  2466789999999976 677777888889999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFGla~~~~~  636 (820)
                      .+ |-||++++.- +.+.++.++.+.++-|++.-++|+|   .+++|||||||+|+|..   ....+.++|||+|+...+
T Consensus        92 LL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             cc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            98 6789887653 3357899999999999999999999   79999999999999995   345789999999997665


Q ss_pred             CCCcc-----ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          637 LDQTH-----VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       637 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      .....     ..+...||.+|.+-..+.+...+.+.|+-|+|.+|..+.-|..||+...+.....-.+-+...    ++ 
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----K~-  241 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----KM-  241 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----hc-
Confidence            43322     234577999999999988888999999999999999999999999876654443322221111    11 


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                          .......+...+.++...+.-|-..--++-|+..-+.+.+.-+.
T Consensus       242 ----s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  242 ----STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             ----CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence                11111234455678888999999999999999887777665554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-23  Score=206.84  Aligned_cols=245  Identities=20%  Similarity=0.338  Sum_probs=190.9

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchh
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLK  567 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~  567 (820)
                      +|.+...|..|+|++.++. +++|.+...  .....++|..|.-.|+-..||||++++|.|.....+.++..||+.|||.
T Consensus       197 kl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly  275 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY  275 (448)
T ss_pred             hhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence            7888999999999997554 455554332  2333468999999999999999999999999999999999999999999


Q ss_pred             hHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccccccc
Q 003436          568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK  647 (820)
Q Consensus       568 ~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  647 (820)
                      ..|++...-..+..+..+++.++|+|++|||+.. +-|.---|.+..|++|++.+++|+- +-+++      ........
T Consensus       276 nvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kf------sfqe~gr~  347 (448)
T KOG0195|consen  276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEVGRA  347 (448)
T ss_pred             HHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-cccee------eeeccccc
Confidence            9999877667888999999999999999999632 2344446899999999999998852 11111      01112233


Q ss_pred             CCccccCccccccCCC---CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCCh
Q 003436          648 GSFGYLDPEYLTKQQL---TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP  724 (820)
Q Consensus       648 gt~~y~aPE~~~~~~~---t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  724 (820)
                      -.+.||+||.++..+.   -+.+|+|||+++||||.|..-||..-.+.+..      .         ++.-..++-.+++
T Consensus       348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------m---------kialeglrv~ipp  412 (448)
T KOG0195|consen  348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------M---------KIALEGLRVHIPP  412 (448)
T ss_pred             cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------h---------hhhhccccccCCC
Confidence            5678999999987654   35789999999999999999999765544321      1         1112234445677


Q ss_pred             hhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          725 DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       725 ~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      .....+.+|+.-|+..||.+||.+..++-.||..
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            7788899999999999999999999999999875

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=1e-21  Score=200.63  Aligned_cols=266  Identities=17%  Similarity=0.221  Sum_probs=206.6

Q ss_pred             cCCccceeEeeecceEEEEEE-EcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~-~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      -+|.+.++||+|.||..+.|+ +-+++.||||.....++  ..+++.|.+..+.| ..++|...+-+..++.+-.||+|+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            358889999999999999998 45789999998554433  35677888888888 468999999888888889999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-----CCCeeEeeccccccCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-----NLMAKVADFGLSKIGP  635 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-----~~~~kl~DFGla~~~~  635 (820)
                      + |-||+|++.- +.+.++.++++.||.|+..-++|+|   .+.+|.|||||+|+||..     ...+.|+|||+|+...
T Consensus       106 L-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  106 L-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             h-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            9 6799887654 4567999999999999999999999   789999999999999954     3478999999999876


Q ss_pred             CCCCcc-----ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          636 DLDQTH-----VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       636 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      +.....     ......||.+||+-..+.+++.+++.|+-|+|-+++..|-|..||............+-+-...+...+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            644322     234577999999999999999999999999999999999999999876543322221111111111111


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                               ..+.+..+.++..-+.-.-..+-.+-|+..-+...+..++...+.
T Consensus       261 ---------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  261 ---------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             ---------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence                     122334566777777777778899999999888888777765443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.1e-22  Score=217.02  Aligned_cols=169  Identities=22%  Similarity=0.188  Sum_probs=130.6

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc--CccEEEEEeCCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR--DETKVAVKRGGTQ-----SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE  550 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  550 (820)
                      .....++|...++||+|+||+||+|++.  +++.+|||++...     .....+.|.+|+++|++++|+|+++.+..+  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            4455678999999999999999999875  4677899985432     223356799999999999999998533222  


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccC-CCCcEEEcCCCCeeEeecc
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV-KSANILLDENLMAKVADFG  629 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDI-kp~NIll~~~~~~kl~DFG  629 (820)
                       +..+|||||+++++|... . ..    .   ...++.+++++|+|||   +.+|+|||| ||+|||++.++.+||+|||
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~-~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-R-PH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-C-cc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence             457999999999999632 1 11    1   1467889999999999   789999999 9999999999999999999


Q ss_pred             ccccCCCCCCccc------cccccCCccccCccccccC
Q 003436          630 LSKIGPDLDQTHV------STAVKGSFGYLDPEYLTKQ  661 (820)
Q Consensus       630 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  661 (820)
                      +|+..........      -+...+++.|+|||.+...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9986544321111      1356788899999998644

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1.5e-19  Score=194.91  Aligned_cols=260  Identities=28%  Similarity=0.437  Sum_probs=196.4

Q ss_pred             CccceeEeeecceEEEEEEEcCccEEEEEeCCCCChh---hHHHHHHHHHHHHcCCCC-ceeeEEeEeecCceEEEEEee
Q 003436          485 FSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ---GLAEFRTEIEMLSQFRHR-HLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~-nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      |.....||.|+||.||++...  ..+++|.+......   ....|.+|+.+++.+.|+ +++++...+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566778999999999999987  67888876544332   467899999999999988 799999999777778999999


Q ss_pred             ccCCchhhHhhhcCC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~~~~  638 (820)
                      +.+++|.+++..... ..+.......+..+++.++.|+|   ..+++||||||+||+++... .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966654332 26888999999999999999999   78899999999999999988 79999999998544332


Q ss_pred             Ccc----ccccccCCccccCcccccc---CCCCCcceeeehhhhHHHHhcCCCCCCCCCch-hhhhHHHHHHHhhccCcc
Q 003436          639 QTH----VSTAVKGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR-EKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       639 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~  710 (820)
                      ...    ......|+..|++||.+.+   .......|+||+|++++++++|..|+...... ......+........ ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~  235 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL  235 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence            221    2356779999999999987   68899999999999999999999986544321 011111111111100 00


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .    ..............+.+++.+|+..+|..|.++.+....
T Consensus       236 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         236 A----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c----cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0    000000002223578899999999999999998887765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=1.7e-19  Score=200.58  Aligned_cols=218  Identities=27%  Similarity=0.397  Sum_probs=166.0

Q ss_pred             HHcCCCCceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCC
Q 003436          533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKS  612 (820)
Q Consensus       533 l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp  612 (820)
                      |+.+.|.|+.+++|.|.++...+.|.+|+..|+|.|.+... ...++|.-...++.+++.||+|||+  +....|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            45789999999999999999999999999999999999873 3579999999999999999999995  44459999999


Q ss_pred             CcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccC-------CCCCcceeeehhhhHHHHhcCCCC
Q 003436          613 ANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-------QLTEKSDVYSFGVVMFEILCGRPV  685 (820)
Q Consensus       613 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~SfGvll~ElltG~~p  685 (820)
                      +|+++|..+.+||+|||+.................-..-|.|||.++..       ..+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998765431111222223345679999999763       257789999999999999999999


Q ss_pred             CCCCCchhh-hhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          686 IDPSLPREK-VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       686 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      |........ ..++.++..     ......-|.+....  +....+..++..||..+|.+||++.+|-..++.+..
T Consensus       158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            976432221 233333222     11112222222111  344578999999999999999999999888766544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=3.4e-20  Score=215.75  Aligned_cols=253  Identities=21%  Similarity=0.235  Sum_probs=185.6

Q ss_pred             cceeEeeecceEEEEEEEcC-ccEEEEEeCC-----CCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          487 ESLVIGIGGFGKVYRGVLRD-ETKVAVKRGG-----TQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~-----~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ...++|.|++|.|+...... ....+.|...     ... .+....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            45689999999777665432 2222333211     111 1222236678888888999999888887777777666799


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++ +|..++...  ..+...++..+..|+..|++|||   ..+|.|||||++|+++..++.+||+|||.+....-...
T Consensus       402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            9999 999988664  25777888999999999999999   89999999999999999999999999999986544333


Q ss_pred             c--cccccccCCccccCccccccCCCCCc-ceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          640 T--HVSTAVKGSFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       640 ~--~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .  ......+|...|+|||.+.+.++.+. .||||.|+++..|++|+.||......+... .       .........+.
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~-------~~~~~~~~~~~  547 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K-------TNNYSDQRNIF  547 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h-------hhccccccccc
Confidence            3  55667889999999999999998775 799999999999999999997544332211 0       00000000000


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .-...+....+.+...++.++++.+|.+|-++.+|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0011122345667788999999999999999999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=3e-19  Score=181.92  Aligned_cols=171  Identities=16%  Similarity=0.149  Sum_probs=132.0

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhh---HHH------HHHHHHHHHcCCCCceeeEEeEeecC
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQG---LAE------FRTEIEMLSQFRHRHLVSLIGYCDER  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~---~~~------f~~Ei~~l~~l~H~nIv~l~g~~~~~  551 (820)
                      ..++|...++||.|+||.||.... ++..+|+|.+.......   ...      +.+|++.+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            467899999999999999999655 56789999876443222   222      67999999999999999998875422


Q ss_pred             --------ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          552 --------NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       552 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                              +..+|||||++|.+|.++..      ++.    ....+++.+|..||   ..+++||||||+||+++.++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence                    35789999999999988732      222    34568999999999   79999999999999999888 9


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHh
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL  680 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ell  680 (820)
                      +|+|||..+........              ..+.....+..++|+|+||+.+.-+.
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999987643221100              11344556678999999999988664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.78  E-value=4.1e-19  Score=178.58  Aligned_cols=138  Identities=15%  Similarity=0.130  Sum_probs=106.8

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChh--h-------HHH-----------------HHHHHHHHHcCCCCce
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ--G-------LAE-----------------FRTEIEMLSQFRHRHL  541 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~H~nI  541 (820)
                      ...||+|+||.||+|...+|+.||||.++.....  .       ...                 ...|++.|.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3589999999999999888999999986543210  0       112                 2349999999988776


Q ss_pred             eeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhh-hcCCCCcEEeccCCCCcEEEcCC
Q 003436          542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL-HTGSTKAIIHRDVKSANILLDEN  620 (820)
Q Consensus       542 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yL-H~~~~~~iiHrDIkp~NIll~~~  620 (820)
                      .....+..  ...+|||||+++++|...+...  ..+++.+..+++.|++.+|.+| |   ..+|+||||||+|||++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-C
Confidence            43332222  2238999999988776553322  3688999999999999999999 6   67999999999999998 4


Q ss_pred             CCeeEeecccccc
Q 003436          621 LMAKVADFGLSKI  633 (820)
Q Consensus       621 ~~~kl~DFGla~~  633 (820)
                      +.++|+|||+|..
T Consensus       154 ~~v~LiDFG~a~~  166 (190)
T cd05147         154 GKLYIIDVSQSVE  166 (190)
T ss_pred             CcEEEEEcccccc
Confidence            7899999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.76  E-value=6.1e-18  Score=170.50  Aligned_cols=140  Identities=16%  Similarity=0.113  Sum_probs=109.4

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChh--------------------------hHHHHHHHHHHHHcCCCCce
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ--------------------------GLAEFRTEIEMLSQFRHRHL  541 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~--------------------------~~~~f~~Ei~~l~~l~H~nI  541 (820)
                      ...||+|++|.||+|...+|+.||||........                          ....+..|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            3589999999999999888999999986543210                          01224578999999999987


Q ss_pred             eeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCC-CcEEeccCCCCcEEEcCC
Q 003436          542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST-KAIIHRDVKSANILLDEN  620 (820)
Q Consensus       542 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~-~~iiHrDIkp~NIll~~~  620 (820)
                      .....+...  ..+|||||++++++.......  ..++..+..+++.+++.+|.+||   . .+|+||||||.|||++ +
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            544443322  248999999988654432222  35778889999999999999999   5 8999999999999998 8


Q ss_pred             CCeeEeeccccccCC
Q 003436          621 LMAKVADFGLSKIGP  635 (820)
Q Consensus       621 ~~~kl~DFGla~~~~  635 (820)
                      +.++|+|||+++...
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1e-17  Score=167.08  Aligned_cols=185  Identities=17%  Similarity=0.115  Sum_probs=137.3

Q ss_pred             ccceeEeeecceEEEEEEEcCccEEEEEeCCCCChh----hHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEee
Q 003436          486 SESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ----GLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~----~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .+...|++|+||+||.+.- ++.+++.+.+......    ....|.+|+++|++|+ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4456899999999997665 5677777765544321    1235889999999995 5889999886    346999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccC-CCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV-KSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDI-kp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ++|.+|.+.+..         ....+..+++++|+++|   ..+|+|||| ||.|||++.++.++|+|||++........
T Consensus        80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ecCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999998754321         12457788999999999   789999999 79999999999999999999985443221


Q ss_pred             c----cc-------cccccCCccccCccccccC-CCC-CcceeeehhhhHHHHhcCCCCCC
Q 003436          640 T----HV-------STAVKGSFGYLDPEYLTKQ-QLT-EKSDVYSFGVVMFEILCGRPVID  687 (820)
Q Consensus       640 ~----~~-------~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~SfGvll~ElltG~~p~~  687 (820)
                      .    ..       ....+.++.|++|+...-. ..+ .+.+.++-|+-+|.++|++.+..
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            0    00       0112367778888765322 222 56799999999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.73  E-value=7.7e-19  Score=203.18  Aligned_cols=247  Identities=22%  Similarity=0.275  Sum_probs=176.2

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCC-CChhhHHHHHHHHHH--HHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGT-QSHQGLAEFRTEIEM--LSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~-~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++...+.||++.|=+|.+|+++.|. |+||..-. ......+.|.++++-  ...++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5677789999999999999998887 77776433 223334455444433  4556899999998777777777889899


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC--CCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG--PDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~--~~~~  638 (820)
                      ..+ +|.|.|..+  +-+...+..-|+.|++.||.-+|   ..+|+|||||.+|||++.=.-+.|+||.--+-.  +..+
T Consensus       103 vkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             Hhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            865 888877543  34666777789999999999999   799999999999999998888999999876522  1111


Q ss_pred             Ccc---ccccccCCccccCccccccC----------C-CCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHH
Q 003436          639 QTH---VSTAVKGSFGYLDPEYLTKQ----------Q-LTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       639 ~~~---~~~~~~gt~~y~aPE~~~~~----------~-~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      ...   .-..-..-..|.|||.+...          . .+++.||||+||++.||++ |+|+|+.+      ++..+...
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~~  250 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRSG  250 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhcc
Confidence            111   01111233469999988431          2 6789999999999999988 68888633      22222111


Q ss_pred             hhc--cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          704 CQE--TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       704 ~~~--~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ...  +.-++++-|            ..+++++..|++.||.+|-++.+.++.-
T Consensus       251 ~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  251 NADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             CccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence            000  001222222            2477999999999999999999999883

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.73  E-value=1.8e-18  Score=170.57  Aligned_cols=143  Identities=22%  Similarity=0.357  Sum_probs=85.5

Q ss_pred             eeEEeecCCcccCCCCCccccccccCccccccCCcc-eeecCceeeeecCCcccccCchhhhhhhhccCCCCCCCCccee
Q 003436          214 TVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLV-MFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNV  292 (820)
Q Consensus       214 ~~~R~n~Gg~~~~d~~dr~wr~w~~d~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~~  292 (820)
                      +++||||||+..+|..+..   |.+|..|-.+...- .................++.++.||||+|....        +|
T Consensus         1 ~~~~IN~Gg~~~~~~~g~~---w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~--------~f   69 (174)
T PF11721_consen    1 VVLRINAGGPAYTDSSGIV---WEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPS--------SF   69 (174)
T ss_dssp             EEEEEEETSSSEEETTTEE---E-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SS--------SE
T ss_pred             CEEEEECCCCcccCCCCCE---EcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCC--------ce
Confidence            4789999999997777777   55577664443300 000000000011223334577789999995422        69


Q ss_pred             EEEeecCCCCeeEEEEeecceeecc------cccEEEEEEEccccccCccCccccccccCCCceeeee-eeecCCCCcee
Q 003436          293 TWNFDVDPGFEFLVRFHFCDIYFNN------ISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDF-ITRESDNPKLH  365 (820)
Q Consensus       293 tw~~~~~~~~~y~v~lhFaEi~~~~------~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~y~~~-~v~~~~~~~~~  365 (820)
                      +|.+|+.++|.|.|+|||||++...      .|+|+|||+|||+++.++|||... +++...+.+..+ .+.+.+ +.+.
T Consensus        70 ~Y~ip~~~~G~Y~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~-~G~~~~~~~~~~~~v~v~d-g~L~  147 (174)
T PF11721_consen   70 SYDIPVVPNGTYTVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAE-AGGFNKAAVRRFFNVTVTD-GTLN  147 (174)
T ss_dssp             EEEEE--S-EEEEEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHH-HSSSS---EEEEEEEEEET-TEEE
T ss_pred             EEEEecCCCcEEEEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHH-cCCCceEEEEEEEEEEEeC-CcEE
Confidence            9999988899999999999999877      999999999999999999999988 666656777666 565544 5565


Q ss_pred             EEEc
Q 003436          366 VSIG  369 (820)
Q Consensus       366 vsl~  369 (820)
                      +.+.
T Consensus       148 i~f~  151 (174)
T PF11721_consen  148 IQFV  151 (174)
T ss_dssp             TTEE
T ss_pred             EEEE
Confidence            5554

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>PRK10345 hypothetical protein; Provisional

Probab=99.71  E-value=7.3e-17  Score=163.95  Aligned_cols=137  Identities=18%  Similarity=0.219  Sum_probs=106.0

Q ss_pred             CccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-----CCCceeeEEeEeecCc---e-EE
Q 003436          485 FSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-----RHRHLVSLIGYCDERN---E-MI  555 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-----~H~nIv~l~g~~~~~~---~-~~  555 (820)
                      ....++||+|+||.||.  +......+||+.........+++.+|+++++.+     +||||++++|++.++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34556999999999996  443333468887655444567899999999999     5799999999997763   3 34


Q ss_pred             EEEee--ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHh-hhhhcCCCCcEEeccCCCCcEEEcC----CCCeeEeec
Q 003436          556 IIYEY--MENGTLKDHLYASNFPSLSWRKRLEICIGAARGL-HYLHTGSTKAIIHRDVKSANILLDE----NLMAKVADF  628 (820)
Q Consensus       556 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL-~yLH~~~~~~iiHrDIkp~NIll~~----~~~~kl~DF  628 (820)
                      +|+||  +++|+|.+++...   .+++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    +..++|+||
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            78999  6689999999653   25544  35677777777 9999   799999999999999963    348999995


Q ss_pred             ccc
Q 003436          629 GLS  631 (820)
Q Consensus       629 Gla  631 (820)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=3.2e-17  Score=194.20  Aligned_cols=201  Identities=21%  Similarity=0.219  Sum_probs=160.4

Q ss_pred             HHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCc
Q 003436          476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERN  552 (820)
Q Consensus       476 ~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~  552 (820)
                      .+.+...+.|.+.+.||+|+||.||+|...+++.||+|..++....   +|.--.+++.+|+   -+.|..+...+.-.+
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~  767 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQN  767 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence            3444555788899999999999999999999999999997766543   3333445556666   123333334445567


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-------CCCCeeE
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-------ENLMAKV  625 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-------~~~~~kl  625 (820)
                      ..+||+||.+-|+|.+++.  ..+.++|.-.+.++.++++-++.||   ..+|||+||||+|+||.       +...++|
T Consensus       768 ~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEE
Confidence            7899999999999999997  3457999999999999999999999   79999999999999993       3457999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCC
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP  684 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~  684 (820)
                      +|||.+-.+........-...++|-.+-.+|...++.++.+.|.|.++.+++-||-|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999864333222233455678899999999999999999999999999999999973

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.70  E-value=8.4e-17  Score=168.90  Aligned_cols=231  Identities=19%  Similarity=0.279  Sum_probs=148.7

Q ss_pred             CccceeEeeecceEEEEEEEcC-ccEEEEEeCC---CCChhhHHHHHHHHHHHHcCCC----------CceeeEEeEe--
Q 003436          485 FSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGG---TQSHQGLAEFRTEIEMLSQFRH----------RHLVSLIGYC--  548 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~---~~~~~~~~~f~~Ei~~l~~l~H----------~nIv~l~g~~--  548 (820)
                      ......||.|+++.||.+.+.. ++++|||...   .......+++.+|.-....+.+          -.++..++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            4456689999999999999875 7899999632   2233456777777765555322          2222222221  


Q ss_pred             -------ecC---c-----eEEEEEeeccCCchhhHhhh---cCC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEec
Q 003436          549 -------DER---N-----EMIIIYEYMENGTLKDHLYA---SNF--PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR  608 (820)
Q Consensus       549 -------~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~--~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHr  608 (820)
                             ..+   .     ..+++|+-+ .++|.+++..   ...  ..+....++.+..|+++.+++||   ..+++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                   111   1     236788887 4688887642   221  23455667888899999999999   7999999


Q ss_pred             cCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCcccccc--------CCCCCcceeeehhhhHHHHh
Q 003436          609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK--------QQLTEKSDVYSFGVVMFEIL  680 (820)
Q Consensus       609 DIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~SfGvll~Ell  680 (820)
                      ||||+|++++++|.++|+||+.......    .... ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999998764322    1111 344577999997743        25788999999999999999


Q ss_pred             cCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCC
Q 003436          681 CGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDR  745 (820)
Q Consensus       681 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R  745 (820)
                      ||+.|++...+......                    .-.... +.++.+..|+..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999976533221110                    111223 677889999999999999988

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=2.8e-16  Score=161.03  Aligned_cols=134  Identities=25%  Similarity=0.355  Sum_probs=112.6

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCCh--------hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH--------QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +.||+|++|.||+|.. .+..+++|+......        .....+.+|++++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4799999999999987 566788887543221        1124578899999999999998877777777788999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      +++++|.+++....     + ++..++.+++.+|.+||   ..+++|||++|.|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999886432     2 88899999999999999   78999999999999999 78999999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.67  E-value=1.8e-17  Score=183.97  Aligned_cols=225  Identities=22%  Similarity=0.248  Sum_probs=169.9

Q ss_pred             eEeeecceEEEEEE----EcCccEEEEEeCCCCChh--hHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEeecc
Q 003436          490 VIGIGGFGKVYRGV----LRDETKVAVKRGGTQSHQ--GLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       490 ~LG~G~fG~Vykg~----~~~~~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|+|.||.|++.+    .+.+..+|.|.+......  .......|..++..++ ||.++++.-.++.+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            36899999998754    233555666654433211  1113456788888887 9999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|.|...+....  ..+..........+|-+++++|   +.+|+|||+|++||+++.+|++|+.|||+++..-...    
T Consensus        81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----  151 (612)
T ss_pred             cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence            999988876543  4556666667778889999999   8999999999999999999999999999998543211    


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                        ..+||..|||||.+.  .....+|.||||++++||+||..||..    +..      ....+           ..-..
T Consensus       152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~------~~Il~-----------~~~~~  206 (612)
T KOG0603|consen  152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTM------KRILK-----------AELEM  206 (612)
T ss_pred             --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHH------HHHhh-----------hccCC
Confidence              128999999999998  567889999999999999999999875    111      11100           01123


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                      +.+.......++..+...+|..|--.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            44555667778888888999998644

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=3.2e-16  Score=183.12  Aligned_cols=141  Identities=23%  Similarity=0.296  Sum_probs=113.7

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCC-CC------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGT-QS------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER  551 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~-~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  551 (820)
                      ......|...++||+|+||.||+|.+.+...++.++... ..      ....+.+.+|++++.+++|++++....++...
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            334455567789999999999999886554333222211 11      11235688999999999999999888888777


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      ...++||||+++++|.+++.          ....++.+++++|.+||   +.+++||||||+|||+ +++.++|+|||++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            78899999999999999874          45779999999999999   7899999999999999 6789999999998


Q ss_pred             cc
Q 003436          632 KI  633 (820)
Q Consensus       632 ~~  633 (820)
                      +.
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            75

>smart00090 RIO RIO-like kinase

Probab=99.65  E-value=5.5e-16  Score=161.29  Aligned_cols=140  Identities=16%  Similarity=0.126  Sum_probs=109.3

Q ss_pred             CCccceeEeeecceEEEEEE--EcCccEEEEEeCCCCChh------------------------hHHHHHHHHHHHHcCC
Q 003436          484 NFSESLVIGIGGFGKVYRGV--LRDETKVAVKRGGTQSHQ------------------------GLAEFRTEIEMLSQFR  537 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~--~~~~~~vavK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~  537 (820)
                      -|...+.||+|++|.||+|+  ..+|+.||+|........                        ....+..|++++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46677899999999999998  557899999976533210                        1123568999999997


Q ss_pred             CC--ceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc-EEeccCCCCc
Q 003436          538 HR--HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA-IIHRDVKSAN  614 (820)
Q Consensus       538 H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~-iiHrDIkp~N  614 (820)
                      +.  .+.+++++.    ..++||||+++++|...+...  ..+...+...++.|++.+|++||   ..+ ++||||||+|
T Consensus       109 ~~~i~~p~~~~~~----~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAWR----RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEec----CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhh
Confidence            53  344555432    348999999998887654322  23556667899999999999999   788 9999999999


Q ss_pred             EEEcCCCCeeEeecccccc
Q 003436          615 ILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       615 Ill~~~~~~kl~DFGla~~  633 (820)
                      |+++ ++.++|+|||.+..
T Consensus       180 Ili~-~~~i~LiDFg~a~~  197 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             EEEE-CCCEEEEEChhhhc
Confidence            9999 88999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.64  E-value=7.8e-16  Score=156.28  Aligned_cols=130  Identities=27%  Similarity=0.353  Sum_probs=105.7

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEeCCCCC--------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQS--------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .||+|++|.||+|.+ ++..+++|......        .....++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            479999999999986 45778888743321        112356788999999999887665555555666779999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ++++|.+++.....         .++.+++.+|.+||   ..+++|+|++|.||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998754321         78999999999999   78999999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=6.4e-17  Score=176.49  Aligned_cols=173  Identities=25%  Similarity=0.385  Sum_probs=128.6

Q ss_pred             eEEEEEeeccCCchhhHhhhc-CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          553 EMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      .+++.|++|...+|.+||.+. .....+|...+.++.|++.|+.|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999754 34567889999999999999998      57999999999999999999999999998


Q ss_pred             ccCCCCC----CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhc
Q 003436          632 KIGPDLD----QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       632 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      .......    .....+...||..||+||++.+++|+.|+||||||++|+||+. =...++      ....    ..-.+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t----~~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIAT----LTDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHHh----hhhhh
Confidence            7554432    1223456789999999999999999999999999999999987 111111      1000    00111


Q ss_pred             cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHH
Q 003436          707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGD  750 (820)
Q Consensus       707 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~e  750 (820)
                      .+.+.    |....+++     +=..++.+++.+.|.+||++.+
T Consensus       474 ~g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  474 DGIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             cCCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence            22221    11111111     2247889999999999994433

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.63  E-value=1.3e-15  Score=154.55  Aligned_cols=142  Identities=19%  Similarity=0.162  Sum_probs=109.8

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCCh----------------------hhHHHHHHHHHHHHc
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH----------------------QGLAEFRTEIEMLSQ  535 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~----------------------~~~~~f~~Ei~~l~~  535 (820)
                      +......|...+.||+|+||.||++...+++.||||+......                      .....+..|+.++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            3333334677789999999999999988899999997543220                      011236678999999


Q ss_pred             CCCC--ceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCC
Q 003436          536 FRHR--HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSA  613 (820)
Q Consensus       536 l~H~--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~  613 (820)
                      +.|+  .++..++.    ...++||||+++++|.+....        .....++.+++.++.++|   ..+++||||||.
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~  154 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEF  154 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcc
Confidence            9877  44555543    345899999999998765421        235678899999999999   689999999999


Q ss_pred             cEEEcCCCCeeEeeccccccC
Q 003436          614 NILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       614 NIll~~~~~~kl~DFGla~~~  634 (820)
                      ||++++++.++|+|||++...
T Consensus       155 Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             cEEEcCCCcEEEEECCccccC
Confidence            999999999999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=2.3e-15  Score=157.54  Aligned_cols=198  Identities=21%  Similarity=0.239  Sum_probs=140.9

Q ss_pred             CCCceeeEEeEeec---------------------------CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHH
Q 003436          537 RHRHLVSLIGYCDE---------------------------RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG  589 (820)
Q Consensus       537 ~H~nIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~  589 (820)
                      +|||||++.+.|.+                           ...+|+||...+. +|++++...   ..+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC---CCchHHHHHHHHH
Confidence            59999998876532                           2357899988864 999998754   3667778889999


Q ss_pred             HHHHhhhhhcCCCCcEEeccCCCCcEEE--cCCC--CeeEeeccccccCCC----CCCccccccccCCccccCccccccC
Q 003436          590 AARGLHYLHTGSTKAIIHRDVKSANILL--DENL--MAKVADFGLSKIGPD----LDQTHVSTAVKGSFGYLDPEYLTKQ  661 (820)
Q Consensus       590 ia~gL~yLH~~~~~~iiHrDIkp~NIll--~~~~--~~kl~DFGla~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~  661 (820)
                      +++|+.|||   .++|.|||+|++|||+  |+|.  .+.|+|||++-....    ..........-|...-||||.....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   8999999999999999  3443  578899999853222    0111112234577889999998643


Q ss_pred             C------CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHH
Q 003436          662 Q------LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAE  735 (820)
Q Consensus       662 ~------~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~  735 (820)
                      +      --.|+|.|+.|.+.||+++...||...... ..+.-.     .++.++.         ..++.++..+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~qLP---------alp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQESQLP---------ALPSRVPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhhhCC---------CCcccCChHHHHHHH
Confidence            2      235899999999999999999998752110 111100     1122222         234556677899999


Q ss_pred             HHhhcCCCCCCCHHHHHHHHH
Q 003436          736 KCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       736 ~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      ..++.||.+|++..=....|.
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999998765555443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=2e-14  Score=137.80  Aligned_cols=135  Identities=19%  Similarity=0.225  Sum_probs=114.9

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC--CceeeEEeEeecCceEEEEEeeccCC
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH--RHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+..+..++|  .++++++++...++..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            34689999999999999865 7789998765443  4678899999999976  58999999988888899999999988


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .+..+         ++.....++.+++++|++||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77654         5567788899999999999964446899999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.56  E-value=3.5e-15  Score=173.42  Aligned_cols=209  Identities=24%  Similarity=0.320  Sum_probs=144.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ..+|..+++|..|++|.||..+++. .+..|.|. ....     .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee------------------
Confidence            3579999999999999999998874 45666643 2111     00000  22222333322                  


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                         |+-...+...+  .++-        +++.+++|||   +.+|+|||+||+|.+++.-|++|+.|||+.+.......+
T Consensus       136 ---gDc~tllk~~g--~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNIG--PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccCC--CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               44444444332  2221        2277899999   899999999999999999999999999999853221110


Q ss_pred             -------------cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          641 -------------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       641 -------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                                   .....++||+.|.|||++..+.|....|.|++|+++||.+-|..||....+++....+-  ..    
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--sd----  273 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--SD----  273 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh--hh----
Confidence                         11234689999999999999999999999999999999999999998887665432221  00    


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCC
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP  746 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP  746 (820)
                              .....+..+..+.+..+++.+.|+.+|..|-
T Consensus       274 --------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  274 --------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             --------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                    0001111334456788999999999999994

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=6.1e-14  Score=140.78  Aligned_cols=136  Identities=19%  Similarity=0.156  Sum_probs=97.3

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChh--hHHH----------------------HHHHHHHHHcCCCC--ce
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ--GLAE----------------------FRTEIEMLSQFRHR--HL  541 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~--~~~~----------------------f~~Ei~~l~~l~H~--nI  541 (820)
                      .+.||+|+||.||+|...+++.||||........  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999888999999976543211  1111                      13566666666443  34


Q ss_pred             eeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCC-CcEEeccCCCCcEEEcCC
Q 003436          542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST-KAIIHRDVKSANILLDEN  620 (820)
Q Consensus       542 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~-~~iiHrDIkp~NIll~~~  620 (820)
                      .+.++.    ...++||||++++.+.........  .. .+...++.+++.++.++|   . .+|+||||||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            445443    235899999999654322111110  11 567889999999999999   5 8999999999999999 8


Q ss_pred             CCeeEeeccccccC
Q 003436          621 LMAKVADFGLSKIG  634 (820)
Q Consensus       621 ~~~kl~DFGla~~~  634 (820)
                      +.++|+|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            99999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.47  E-value=3e-13  Score=141.10  Aligned_cols=135  Identities=20%  Similarity=0.183  Sum_probs=104.0

Q ss_pred             ceeEe-eecceEEEEEEEcCccEEEEEeCCCCC-------------hhhHHHHHHHHHHHHcCCCCce--eeEEeEeecC
Q 003436          488 SLVIG-IGGFGKVYRGVLRDETKVAVKRGGTQS-------------HQGLAEFRTEIEMLSQFRHRHL--VSLIGYCDER  551 (820)
Q Consensus       488 ~~~LG-~G~fG~Vykg~~~~~~~vavK~~~~~~-------------~~~~~~f~~Ei~~l~~l~H~nI--v~l~g~~~~~  551 (820)
                      ...|| .||.|+||+.... +..++||+.....             ......+.+|++++.+|+|+++  +..++++..+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34788 8999999999875 5678888653211             1223567889999999998775  6777765433


Q ss_pred             c----eEEEEEeeccC-CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEe
Q 003436          552 N----EMIIIYEYMEN-GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA  626 (820)
Q Consensus       552 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~  626 (820)
                      .    ..++|+|++++ .+|.+++...   .++..    .+.+++.+|.+||   ..+|+||||||.|||++.++.++|+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence            2    23599999997 6898887542   34433    3568899999999   7999999999999999998999999


Q ss_pred             ecccccc
Q 003436          627 DFGLSKI  633 (820)
Q Consensus       627 DFGla~~  633 (820)
                      |||.++.
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998874

>PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan

Probab=99.47  E-value=2.4e-13  Score=134.24  Aligned_cols=147  Identities=20%  Similarity=0.247  Sum_probs=90.0

Q ss_pred             cEEEecCCCcccCCCCceeecCCCCcccccC---C-CCccccccccccCCCCCCccccceeeeeccCceeeEecccCceE
Q 003436           32 NYLIDCGSFTNTSAGNRVFAADHTSTFTNLS---S-PQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARH  107 (820)
Q Consensus        32 ~~~i~cG~~~~~~~~~~~~~~D~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~y~t~R~f~~~~~y~~~~~~~~~~  107 (820)
                      .++||||+...++.++..|.+|..+......   + ..+........+...-..+.+|+|.|.-+...+|.+|+.+.|.|
T Consensus         2 ~~~IN~Gg~~~~~~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~~~f~Y~ip~~~~G~Y   81 (174)
T PF11721_consen    2 VLRINAGGPAYTDSSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGPSSFSYDIPVVPNGTY   81 (174)
T ss_dssp             EEEEEETSSSEEETTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----SSSEEEEEE--S-EEE
T ss_pred             EEEEECCCCcccCCCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCCCceEEEEecCCCcEE
Confidence            3799999888877899999999876433220   0 00000001111112223357999999976688999998899999


Q ss_pred             EEEEEecCCCCCC----CCcccceEEEEeCcEEEEeeccc-----cC-CceEEEE-EEeccCCcEEEEEee---------
Q 003436          108 FIRLHFFPFVHET----YNMSTAKFSVSSQSFTLIKDYQS-----QE-GSSVKEY-SLNIASDRLVLSFTP---------  167 (820)
Q Consensus       108 ~~R~~f~~~~~~~----~~~~~~~f~v~~~~~~~~~~~~~-----~~-~~~~~e~-~~~~~~~~~~v~~~~---------  167 (820)
                      .|||||....+..    ...+...|||.++|..++.||.-     .. .+.++++ -+.+.++.|.|+|..         
T Consensus        82 ~V~L~FaE~~~~~~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~~~~i~  161 (174)
T PF11721_consen   82 TVRLHFAELYFGASGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKGTLCIP  161 (174)
T ss_dssp             EEEEEEE-SSS--------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--SEEEEE
T ss_pred             EEEEEeccccccccccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCCcEEee
Confidence            9999999887775    23456789999999999999962     33 3788888 677889999999997         


Q ss_pred             --CCCccceeeee
Q 003436          168 --FANSFAFINAL  178 (820)
Q Consensus       168 --~~~~~~fi~~~  178 (820)
                        ...+.|.||+|
T Consensus       162 ~~~~~~~p~IsaI  174 (174)
T PF11721_consen  162 FIGSYGNPLISAI  174 (174)
T ss_dssp             EESSSSSSSEEEE
T ss_pred             ccccCCCcEEeeC
Confidence              33455777765

It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A.

>PLN03150 hypothetical protein; Provisional

Probab=99.46  E-value=3.2e-13  Score=159.75  Aligned_cols=151  Identities=19%  Similarity=0.258  Sum_probs=111.6

Q ss_pred             cEEEecCCCccc---C-C-----CCceeecCCCCcc---cccCCCCccccccccccCCCCCCccccceeeeecc---Cce
Q 003436           32 NYLIDCGSFTNT---S-A-----GNRVFAADHTSTF---TNLSSPQNISINASLNSISSGNYSRLYHTARIFTG---PSN   96 (820)
Q Consensus        32 ~~~i~cG~~~~~---~-~-----~~~~~~~D~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~y~t~R~f~~---~~~   96 (820)
                      .||||||+....   + .     -+|.|.+|..+..   ...+....|  ... ...+-..|..+|+|||.+..   .-+
T Consensus       193 ~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~~~~~~~st~~~I--~~~-~~~~~~~P~~VyqTA~~~~~~~~~lt  269 (623)
T PLN03150        193 AKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGSGSDQAISTENVI--KKA-SNAPNFYPESLYQSALVSTDTQPDLS  269 (623)
T ss_pred             EEEEEecCcccccccCCCCCcccCccccCcCcccCCCccccccccccc--ccc-cCCCccChHHHhhhhccccCCCCceE
Confidence            479999975432   1 1     1799999976321   112221222  111 11111224669999999975   568


Q ss_pred             eeEecccCceEEEEEEecCCCCCCCCcccceEEEEeCcEEEEeeccc------cCCceEEEEEEeccCCcEEEEEeeCCC
Q 003436           97 YSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQS------QEGSSVKEYSLNIASDRLVLSFTPFAN  170 (820)
Q Consensus        97 y~~~~~~~~~~~~R~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~------~~~~~~~e~~~~~~~~~~~v~~~~~~~  170 (820)
                      |.|++.++++|+|||||++............|||++||..++.+|+.      ...++++++.++++++.+.|+|+|+.+
T Consensus       270 y~~~v~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~~di~~~~g~~~~~~~~~~~v~~~~g~l~isl~p~~~  349 (623)
T PLN03150        270 YTMDVDPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKDVDIVKMSGERYTALVLNKTVAVSGRTLTIVLQPKKG  349 (623)
T ss_pred             EEeecCCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecccChhhhcCCcccceEEEeEEeecCCeEEEEEeeCCC
Confidence            99999999999999999999765445566789999999999999853      235789999999988999999999988


Q ss_pred             ccceeeeeEEEEcCC
Q 003436          171 SFAFINALEVISLPD  185 (820)
Q Consensus       171 ~~~fi~~~e~~~~~~  185 (820)
                      +.||||+|||+.+-.
T Consensus       350 s~pilNaiEI~~~~~  364 (623)
T PLN03150        350 THAIINAIEVFEIIT  364 (623)
T ss_pred             Ccceeeeeeeeeccc
Confidence            889999999999876

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.40  E-value=1.5e-12  Score=147.55  Aligned_cols=140  Identities=21%  Similarity=0.226  Sum_probs=100.3

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCChhhH----------------------------------------HHHHH
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGL----------------------------------------AEFRT  528 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~----------------------------------------~~f~~  528 (820)
                      +.||.|++|.||+|++.+|+.||||...+......                                        -+|..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999999999999998765432111                                        02455


Q ss_pred             HHHHHHcCC-----CCceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHH-HhhhhhcCCC
Q 003436          529 EIEMLSQFR-----HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR-GLHYLHTGST  602 (820)
Q Consensus       529 Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~-gL~yLH~~~~  602 (820)
                      |++.+.+++     ++++.-..-+....+..+|||||++|++|.+....... ..   .+.+++..++. .+..+|   .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHH---h
Confidence            666665552     33332222222334557999999999999987653211 12   24556666665 467788   6


Q ss_pred             CcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       603 ~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      .+++|+|++|.||++++++.++++|||++....
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            899999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=3.8e-13  Score=138.32  Aligned_cols=204  Identities=24%  Similarity=0.335  Sum_probs=140.3

Q ss_pred             HHHHHcCCCCceeeEEeEeec-----CceEEEEEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCC
Q 003436          530 IEMLSQFRHRHLVSLIGYCDE-----RNEMIIIYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGST  602 (820)
Q Consensus       530 i~~l~~l~H~nIv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~  602 (820)
                      ...|-++.|.||++++.|+.+     ..+..++.|||+.|+|..+|.+.  +...+......+++.||..||.|||+ |.
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            345566789999999998744     34578999999999999999864  34567777788999999999999996 67


Q ss_pred             CcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC--CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHh
Q 003436          603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL--DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL  680 (820)
Q Consensus       603 ~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ell  680 (820)
                      ++|+|+++..+-|++..++-+|++--.-.......  ..........+-++|.+||+=.....+..+|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            89999999999999999999988422111110000  0011112334678999999887778888999999999999998


Q ss_pred             cCCCC-CCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          681 CGRPV-IDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       681 tG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      -+.-- -......+.......+....+        +            ..-+.++.+|++..|..||+|++++.+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~le--------n------------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGLE--------N------------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeecc--------C------------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            87632 111110000000000000000        0            011346678999999999999988755

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=1.4e-13  Score=160.73  Aligned_cols=256  Identities=22%  Similarity=0.287  Sum_probs=185.6

Q ss_pred             CCccceeEeeecceEEEEEEEcC--ccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD--ETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .|...+.||+|.|+.|-......  ...+++|.+....  .........|..+-..+. |+|++.+++...+....++..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            35556679999999987776533  3456667655443  222333445777667776 999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccCCC-
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPD-  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~~-  636 (820)
                      ||..++++.+-+........+....-....|+..++.|+|.  ..++.||||||+|.+++..+ ..|++|||+|..... 
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999988842222245556677788999999999995  57899999999999999999 999999999987665 


Q ss_pred             CCCccccccccC-CccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          637 LDQTHVSTAVKG-SFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       637 ~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+. ....|....   +.    .
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~----~  250 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GR----F  250 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cc----c
Confidence            333333445667 9999999999874 556789999999999999999999876544331 112222111   00    0


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ..    ...........++..+++..+|..|.+..++..
T Consensus       251 ~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  251 TQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cc----CccccCChhhhhcccccccCCchhccccccccc
Confidence            01    111122345677888888899999998877653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.16  E-value=1.1e-10  Score=114.97  Aligned_cols=131  Identities=21%  Similarity=0.164  Sum_probs=95.2

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCcee-eEEeEeecCceEEEEEeeccCCch
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV-SLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      .+.|+.|.++.||++... +..+++|....... ....+..|+++++.+.+.+++ +++.+..  ...++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            357889999999999875 67799998654432 123467899999988665544 4555443  235799999999887


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCC--CCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS--TKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~--~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .+..       .   ....+..+++++|+.||...  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6430       1   11245678999999999432  22369999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=7.2e-11  Score=132.05  Aligned_cols=247  Identities=21%  Similarity=0.187  Sum_probs=175.3

Q ss_pred             CccceeEee--ecceEEEEEEE--c-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEE
Q 003436          485 FSESLVIGI--GGFGKVYRGVL--R-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       485 f~~~~~LG~--G~fG~Vykg~~--~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  556 (820)
                      |...+.+|.  |.+|.||++..  . ++..+|+|+-+...  ......=.+|+....++ .|+|.++....+..++..++
T Consensus       116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi  195 (524)
T KOG0601|consen  116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI  195 (524)
T ss_pred             cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence            566678999  99999999987  3 56788998733222  22222334566666666 49999998888889999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHH----HhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeecccc
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR----GLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLS  631 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~----gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla  631 (820)
                      -.|++. .+|..+.+... ..++....+.+..+...    ||.++|   ...++|-|+||.||++..+ ...+++|||+.
T Consensus       196 qtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  196 QTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            999985 68888876543 23556667777777777    999999   7899999999999999999 89999999998


Q ss_pred             ccCCCCCCc---cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          632 KIGPDLDQT---HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       632 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      ....+....   .......|...|++||...+ -++..+|+|++|.+.+|..++.........      ..|..      
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~------  337 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ------  337 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc------
Confidence            866543321   11223367888999998854 568899999999999999998754322210      01111      


Q ss_pred             ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       709 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                       ++.+.   +..++......++...+..+++.+|..|++.+.+..
T Consensus       338 -~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 -LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             11111   111222233345556888899999999998876654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.13  E-value=1.7e-10  Score=132.23  Aligned_cols=147  Identities=16%  Similarity=0.151  Sum_probs=93.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhh----------------------------------HH--
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQG----------------------------------LA--  524 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~----------------------------------~~--  524 (820)
                      ...|+. +.||+|++|.||+|++++ |+.||||..++.....                                  .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 689999999999999987 9999999876542110                                  01  


Q ss_pred             ----HHHHHHHHHHcCC----CCceeeEEeEe-ecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHH-h
Q 003436          525 ----EFRTEIEMLSQFR----HRHLVSLIGYC-DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG-L  594 (820)
Q Consensus       525 ----~f~~Ei~~l~~l~----H~nIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~g-L  594 (820)
                          +|.+|+..+.+++    +.+.+.+=..+ .-....+|||||++|++|.+.-.-.. ...+..   .++...++. +
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~---~la~~~v~~~~  273 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMK---LLAERGVEVFF  273 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHH---HHHHHHHHHHH
Confidence                1444555555442    33323222222 22456789999999999987422111 112222   222222211 1


Q ss_pred             hhhhcCCCCcEEeccCCCCcEEEcCCC----CeeEeeccccccCCC
Q 003436          595 HYLHTGSTKAIIHRDVKSANILLDENL----MAKVADFGLSKIGPD  636 (820)
Q Consensus       595 ~yLH~~~~~~iiHrDIkp~NIll~~~~----~~kl~DFGla~~~~~  636 (820)
                      .-++   ..+++|+|+||.||+++.++    .++++|||++.....
T Consensus       274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2223   57899999999999999888    999999999876543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.09  E-value=8.7e-10  Score=113.45  Aligned_cols=142  Identities=18%  Similarity=0.288  Sum_probs=110.9

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCC--CceeeEEeEeecCc---eEEEEEeecc
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRH--RHLVSLIGYCDERN---EMIIIYEYME  562 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~---~~~lV~E~~~  562 (820)
                      +.|+.|..+.||++...+|..+++|....... .....+..|+++++.+++  .++.+++.++....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            47899999999999987778899998654332 134578899999999976  44677888876643   5689999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcC------------------------------------------
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG------------------------------------------  600 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~------------------------------------------  600 (820)
                      +.+|.+.+..   ..++..++..++.++++.|..||+.                                          
T Consensus        84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            9988776532   2467777888888888888888842                                          


Q ss_pred             -----------CCCcEEeccCCCCcEEEcC--CCCeeEeecccccc
Q 003436          601 -----------STKAIIHRDVKSANILLDE--NLMAKVADFGLSKI  633 (820)
Q Consensus       601 -----------~~~~iiHrDIkp~NIll~~--~~~~kl~DFGla~~  633 (820)
                                 ....++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       1356899999999999988  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.03  E-value=3.7e-09  Score=119.44  Aligned_cols=164  Identities=15%  Similarity=0.202  Sum_probs=121.7

Q ss_pred             CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHH
Q 003436          506 DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE  585 (820)
Q Consensus       506 ~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~  585 (820)
                      ++.+|.|...+...........+-++.|+.++||||++++...+..+..|||.|-+  -.|..++....     -....-
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHH
Confidence            56677666654444433445667889999999999999999999999999999998  46777775432     344555


Q ss_pred             HHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCC
Q 003436          586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE  665 (820)
Q Consensus       586 i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~  665 (820)
                      .+.||+.||.+||+  ..+++|++|.-..|++++.|..||++|.++........  ......--..|..|+.+....  -
T Consensus       109 Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence            67899999999996  67899999999999999999999999998864332211  111112223466666553222  3


Q ss_pred             cceeeehhhhHHHHhcC
Q 003436          666 KSDVYSFGVVMFEILCG  682 (820)
Q Consensus       666 ksDV~SfGvll~ElltG  682 (820)
                      ..|.|-||++++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            46999999999999999

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.98  E-value=8.1e-09  Score=99.25  Aligned_cols=143  Identities=21%  Similarity=0.230  Sum_probs=104.3

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEe-CCCC-------ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKR-GGTQ-------SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~-~~~~-------~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ...+|-||+-+.|+++.+. |+..+||. ....       ..-..++-.+|++.|.+++--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5668999999999999886 45556664 2211       1223456778999999887545544433444555567899


Q ss_pred             eeccC-CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---CeeEeecccccc
Q 003436          559 EYMEN-GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---MAKVADFGLSKI  633 (820)
Q Consensus       559 E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---~~kl~DFGla~~  633 (820)
                      ||+++ -++.+++...............++..+-+.+.-||   ...|||+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99976 47888887655444444444788889999999999   78999999999999996543   458999999864

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.98  E-value=4.5e-09  Score=105.18  Aligned_cols=135  Identities=14%  Similarity=0.104  Sum_probs=95.9

Q ss_pred             eeEeeecceEEEEEEEcC-------ccEEEEEeCCCCC----------------------hhhHHHHH----HHHHHHHc
Q 003436          489 LVIGIGGFGKVYRGVLRD-------ETKVAVKRGGTQS----------------------HQGLAEFR----TEIEMLSQ  535 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~-------~~~vavK~~~~~~----------------------~~~~~~f~----~Ei~~l~~  535 (820)
                      ..||.|--+.||.|...+       +..+|||..+...                      ....+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            478999999999998653       4789999421100                      01122333    79999999


Q ss_pred             CCC--CceeeEEeEeecCceEEEEEeeccCCchhh-HhhhcCCCCCCHHHHHHHHHHHHHHhhhh-hcCCCCcEEeccCC
Q 003436          536 FRH--RHLVSLIGYCDERNEMIIIYEYMENGTLKD-HLYASNFPSLSWRKRLEICIGAARGLHYL-HTGSTKAIIHRDVK  611 (820)
Q Consensus       536 l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~l~i~~~ia~gL~yL-H~~~~~~iiHrDIk  611 (820)
                      +..  -++.+++++    ..-+|||||+.+..+.. .|..   ..++..+..++..+++.+|..| |   ..+++|+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            853  466667764    45689999997654422 1211   1244456677889999999999 7   6899999999


Q ss_pred             CCcEEEcCCCCeeEeeccccccC
Q 003436          612 SANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       612 p~NIll~~~~~~kl~DFGla~~~  634 (820)
                      +.|||+. ++.+.|+|||.+...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.94  E-value=7.3e-09  Score=100.20  Aligned_cols=130  Identities=26%  Similarity=0.341  Sum_probs=98.8

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEe-CCCC-Ch------hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKR-GGTQ-SH------QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~-~~~~-~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .+++|+-..+|.+.+.+. .+++|. +... ..      -....-.+|+++|.+++--.|...+=+..+.....++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            578999999999976543 466663 2211 11      11234667999999997666655555666777788999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ++..|.+.+...         +..++..+-.-+.-||   ..+|+|+||.++||++..+. +.++||||+..
T Consensus        82 ~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888654         2566777777788899   78999999999999997665 99999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.94  E-value=1.3e-09  Score=122.17  Aligned_cols=247  Identities=19%  Similarity=0.199  Sum_probs=170.1

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc--CccEEEEEeCCCCChhhHHH--HHHHHHHHHcC-CCCceeeEEeEeecCceEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR--DETKVAVKRGGTQSHQGLAE--FRTEIEMLSQF-RHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~~~~~~~~--f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  555 (820)
                      -+.+|..+..||.|.|+.|++...+  ++..+++|...........+  -..|+-+...+ .|.+++.....+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            3567889999999999999987754  57788888754433222111  12355555555 4777777666555556677


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeeccccccC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLSKIG  634 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla~~~  634 (820)
                      +=-||++++++...+.-  ...++...++++..+++.++.++|   ++.++|+|+||+||++..+ +.-+++|||+....
T Consensus       343 ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             CchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            99999999998776622  234677788999999999999999   8999999999999999775 88999999987531


Q ss_pred             CCCCCccccccccCCcccc--CccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          635 PDLDQTHVSTAVKGSFGYL--DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ...     .......-+++  +++......+-.+.|++|||.-+.|.+++.+.-...        .+|.  .+..+.+. 
T Consensus       418 ~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~--~i~~~~~p-  481 (524)
T KOG0601|consen  418 AFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSL--TIRSGDTP-  481 (524)
T ss_pred             cee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccce--eeeccccc-
Confidence            111     11112233344  556666677889999999999999999987532211        1111  11111111 


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                              ..+ ....++..+++.++.+++..||.+.+.....+.
T Consensus       482 --------~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  482 --------NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             --------CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                    111 222667788889999999999999887765543

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=98.92  E-value=4.3e-09  Score=115.76  Aligned_cols=148  Identities=22%  Similarity=0.335  Sum_probs=100.6

Q ss_pred             cEEEecCCCc--cc---CCCCceeecCCC-CcccccCCCCccc-cccccccCCCCCCccccceeeeeccC-----ceeeE
Q 003436           32 NYLIDCGSFT--NT---SAGNRVFAADHT-STFTNLSSPQNIS-INASLNSISSGNYSRLYHTARIFTGP-----SNYSF   99 (820)
Q Consensus        32 ~~~i~cG~~~--~~---~~~~~~~~~D~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~y~t~R~f~~~-----~~y~~   99 (820)
                      .+|+|||+..  ..   +.-+|.|.+... ......+....+. ......   --.|..+|+|||.-...     -+|.|
T Consensus       180 ~~R~n~G~~~~~iryp~D~~dR~W~~~~~~~~~~~ist~~~i~~~~~~~~---~~~P~~V~~TA~~~~~~s~~~nltw~~  256 (347)
T PF12819_consen  180 VYRLNVGGSSSFIRYPDDTYDRIWQPYSSSPGWSNISTTSNININSSNNP---YDAPSAVYQTARTPSNSSDPLNLTWSF  256 (347)
T ss_pred             EEeecCCCcccccCCCCCcceeeccccccCccccccccceeeecccCCcc---CcChHHHHHhhhcccccccceEEEecc
Confidence            6899999765  22   234999997421 1111222222222 111111   12236699999987433     35777


Q ss_pred             ecccCceEEEEEEecCCCCCCCCcccceEEEEeCcEEEEeeccc-----cCCceEEEEEEeccC-CcEEEEEeeCCCcc-
Q 003436          100 SIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQS-----QEGSSVKEYSLNIAS-DRLVLSFTPFANSF-  172 (820)
Q Consensus       100 ~~~~~~~~~~R~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~-----~~~~~~~e~~~~~~~-~~~~v~~~~~~~~~-  172 (820)
                       +.++..|+|||||+.......+.....|+|++||.....++..     ...++++.+++.++. +.+.|+++++..+. 
T Consensus       257 -~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~isL~~t~~S~l  335 (347)
T PF12819_consen  257 -VDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSDVSPPYLGADTVPYYSDYVVNVPDSGFLNISLGPTPDSTL  335 (347)
T ss_pred             -CCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCccCcccccCcceEeecceEEEecCCCEEEEEEEeCCCCCc
Confidence             7778899999999999765444446789999999887766654     234468889998876 58999999998774 


Q ss_pred             -ceeeeeEEEEc
Q 003436          173 -AFINALEVISL  183 (820)
Q Consensus       173 -~fi~~~e~~~~  183 (820)
                       |+|||+||+.+
T Consensus       336 ppiLNalEIy~v  347 (347)
T PF12819_consen  336 PPILNALEIYKV  347 (347)
T ss_pred             CceeEeeeeEeC
Confidence             99999999864

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.78  E-value=6e-08  Score=106.36  Aligned_cols=166  Identities=14%  Similarity=0.234  Sum_probs=125.6

Q ss_pred             eEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEee----cCceEEEEEeeccC-CchhhHh
Q 003436          497 GKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD----ERNEMIIIYEYMEN-GTLKDHL  570 (820)
Q Consensus       497 G~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~l  570 (820)
                      .+.||+..+ +|..+++||+.....+.......-+++++++.|.|+|++...+.    .+..++|||+|.|+ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            578999865 78999999984433333323345678899999999999988775    23468999999986 5777765


Q ss_pred             hhc-------------CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          571 YAS-------------NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       571 ~~~-------------~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      ...             .....++..++.++.|+..||.++|   +.|+..+-|.+++||++.+.+++|+..|........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            421             1245778899999999999999999   788888999999999999999999988876654332


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCC
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP  684 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~  684 (820)
                      ..                |-+.+   -.+-|.=.||.+++.|.||..
T Consensus       447 ~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  447 PT----------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            20                11211   235688889999999999964

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.73  E-value=1.3e-07  Score=99.96  Aligned_cols=140  Identities=16%  Similarity=0.092  Sum_probs=99.5

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEeCCCCChh-hHH----------HHHHHHHHHHcCCCCc--eeeEEeEeec-----C
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ-GLA----------EFRTEIEMLSQFRHRH--LVSLIGYCDE-----R  551 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~-~~~----------~f~~Ei~~l~~l~H~n--Iv~l~g~~~~-----~  551 (820)
                      .+-......|.+..+ +|+.+.||+....... ..+          .+.+|...+.+|...+  .+.++++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            444444445667665 4678999975433211 112          3778999998885433  3445555533     2


Q ss_pred             ceEEEEEeeccCC-chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-------CCCe
Q 003436          552 NEMIIIYEYMENG-TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-------NLMA  623 (820)
Q Consensus       552 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-------~~~~  623 (820)
                      ..-+||+|++++- +|.+++........+...+..++.+++..+.-||   ..+|+|+|++++|||++.       +..+
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceE
Confidence            3578999999986 8999885422234556677889999999999999   899999999999999975       5789


Q ss_pred             eEeecccccc
Q 003436          624 KVADFGLSKI  633 (820)
Q Consensus       624 kl~DFGla~~  633 (820)
                      .++||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998753

>KOG3593 consensus Predicted receptor-like serine/threonine kinase [Signal transduction mechanisms]

Probab=98.71  E-value=4.9e-09  Score=105.61  Aligned_cols=132  Identities=11%  Similarity=0.180  Sum_probs=97.6

Q ss_pred             eeeeEEeecCCcccCCCCCccccccccCccccccCCcceeecCceeeeecCCcccccCchhhhhhhhccCCCCCCCCcce
Q 003436          212 LETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVN  291 (820)
Q Consensus       212 l~~~~R~n~Gg~~~~d~~dr~wr~w~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~  291 (820)
                      .+++|.+||||+...|-|+..++     .|.+.+..-. +.....   +......+.-...+|||+|....        .
T Consensus        58 ~svI~aVncGgdaavd~ygI~f~-----aD~~~~VGra-sd~G~~---l~i~~raeeed~ily~ter~nee--------t  120 (355)
T KOG3593|consen   58 SSVIPAVNCGGDAAVDNYGIRFA-----ADPLEGVGRA-SDYGMV---LGIGCRAEEEDIILYQTERYNEE--------T  120 (355)
T ss_pred             hhhhheeccCChhhhcccceEee-----cccccccccc-CCccce---eeccccCChhhhhhhhhcccchh--------h
Confidence            45889999999999999988774     3545552211 111111   11111222334459999995433        6


Q ss_pred             eEEEeecCCCCeeEEEEeecceeecccccEEEEEEEc-cccccCccCcccccc-ccCCCceeeeeeeecCC
Q 003436          292 VTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYIN-SRSAQLDFDLHKLPS-YAAGNPYYMDFITRESD  360 (820)
Q Consensus       292 ~tw~~~~~~~~~y~v~lhFaEi~~~~~~~R~FdI~in-~~~~~~~~di~~~~~-~~~~~~~y~~~~v~~~~  360 (820)
                      |.|+.|.++.+.|-+.|.|||++|...+..+|||-+| ++.+.+++||+...+ .+.++..+..+....+.
T Consensus       121 Fgyd~pik~dgdyalvlkfaevyF~~~q~kvfdvrln~sh~vVk~ldi~~~vg~rg~AhDe~i~~~i~~gk  191 (355)
T KOG3593|consen  121 FGYDVPIKEDGDYALVLKFAEVYFKTCQHKVFDVRLNCSHCVVKALDIFDQVGDRGKAHDEIIPCLIGQGK  191 (355)
T ss_pred             hcccccccCCCceehhhhHHHHHHHhhhhhheeeeeccceeEEeccchhhhcCCCcccccceEEEEEcCce
Confidence            8899999999999999999999999999999999999 999999999998866 57788888777665553

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.68  E-value=6.8e-09  Score=121.93  Aligned_cols=250  Identities=19%  Similarity=0.230  Sum_probs=160.2

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-ccEEEEEe---CCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~---~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ..+.|...+-+-+|.++.++.+.-.. +...+.|.   .........+....+-.++-..+||-++...--+.-.....|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            44567777778889999988765332 21112221   111111112222223333333344555544333445667899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |++|..+++|...|+...  ..+..-....+..+...++|||   ...+.|+|++|.|.+...++..++.|||.......
T Consensus       882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccccccc
Confidence            999999999999988765  2333333344556778899999   66699999999999999999999999984332110


Q ss_pred             C----------------------C-------CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCC
Q 003436          637 L----------------------D-------QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID  687 (820)
Q Consensus       637 ~----------------------~-------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~  687 (820)
                      .                      .       .........||..|.+||...+......+|.|+.|++++|.++|.+|+.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                      0       0001123568999999999999999999999999999999999999998


Q ss_pred             CCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHH
Q 003436          688 PSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMG  749 (820)
Q Consensus       688 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~  749 (820)
                      ...+.....-            +....-+  ......+...+..+++.+.+..+|.+|-.|.
T Consensus      1037 a~tpq~~f~n------------i~~~~~~--~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFEN------------ILNRDIP--WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhhhc------------cccCCCC--CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            7655433211            1100001  1122334445667788888889999996654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.67  E-value=2.4e-07  Score=92.40  Aligned_cols=124  Identities=24%  Similarity=0.246  Sum_probs=81.6

Q ss_pred             EEEEEEEcCccEEEEEeCCCCC--------------------------hhhHHHHHHHHHHHHcCCCC--ceeeEEeEee
Q 003436          498 KVYRGVLRDETKVAVKRGGTQS--------------------------HQGLAEFRTEIEMLSQFRHR--HLVSLIGYCD  549 (820)
Q Consensus       498 ~Vykg~~~~~~~vavK~~~~~~--------------------------~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~  549 (820)
                      .||.|...++..+|||.-+...                          ........+|++.|.++..-  ++.+++.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999522110                          01123467899999999765  566676553 


Q ss_pred             cCceEEEEEeecc--CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhh-hhcCCCCcEEeccCCCCcEEEcCCCCeeEe
Q 003436          550 ERNEMIIIYEYME--NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY-LHTGSTKAIIHRDVKSANILLDENLMAKVA  626 (820)
Q Consensus       550 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~y-LH~~~~~~iiHrDIkp~NIll~~~~~~kl~  626 (820)
                         .-.|||||++  +..+..+....    ++......++.+++..+.. +|   ..+|+|+||.+.||+++++ .+.|+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEE
Confidence               3479999999  65565443221    1134456677777775555 56   7899999999999999888 99999


Q ss_pred             ecccccc
Q 003436          627 DFGLSKI  633 (820)
Q Consensus       627 DFGla~~  633 (820)
                      |||.+..
T Consensus       149 Df~qav~  155 (188)
T PF01163_consen  149 DFGQAVD  155 (188)
T ss_dssp             -GTTEEE
T ss_pred             ecCccee
Confidence            9998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=6.1e-08  Score=110.18  Aligned_cols=151  Identities=21%  Similarity=0.295  Sum_probs=103.6

Q ss_pred             HHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC-------ccccccccCCccccCcccccc
Q 003436          588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ-------THVSTAVKGSFGYLDPEYLTK  660 (820)
Q Consensus       588 ~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~  660 (820)
                      .+++.||.|+|.  +.++||++|.|++|.++.++.+||+.|+.+........       ............|.|||++.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345699999996  77899999999999999999999999998764333111       011111234567999999999


Q ss_pred             CCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhh
Q 003436          661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLA  739 (820)
Q Consensus       661 ~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  739 (820)
                      ...+.++|+||+|++++-+.. |+.-+............             ...+..-...+....+.++.+=+.+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-------------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-------------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh-------------hcccccccccccccCcHHHHHHHHHHhc
Confidence            889999999999999999994 54433322111110000             0001111112234566788888899999


Q ss_pred             cCCCCCCCHHHHHH
Q 003436          740 QCGIDRPSMGDVLW  753 (820)
Q Consensus       740 ~dp~~RPs~~evl~  753 (820)
                      .++..||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998776654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.47  E-value=6.3e-06  Score=88.60  Aligned_cols=259  Identities=15%  Similarity=0.166  Sum_probs=154.1

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeE------eecCc-eEEEEEe
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGY------CDERN-EMIIIYE  559 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~------~~~~~-~~~lV~E  559 (820)
                      ...||+|+-+.+|----- +. .+.|+..........   +.+..|... .||-+-.-+.|      ..+++ ..-+.|.
T Consensus        16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecchh-hc-hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            447899999999853211 11 233443322222111   223344444 56644332222      12222 3667788


Q ss_pred             eccCC-chhhHhh----hcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          560 YMENG-TLKDHLY----ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       560 ~~~~g-sL~~~l~----~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      .+++. ...+++.    +...+..+|.-.++++..+|.+.+-||   ..|.+-+|+.++|+|+.+++.+.|.|=.--.+.
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeec
Confidence            77664 2333332    123456899999999999999999999   788999999999999999999999885433221


Q ss_pred             CCCCCccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcC-CCCCCCCCchh-hhhHHHHHHHhhcc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCG-RPVIDPSLPRE-KVNLVEWAMKCQET  707 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG-~~p~~~~~~~~-~~~l~~~~~~~~~~  707 (820)
                         ..........|...|.+||...     +..-+...|.|.+|+++++|+.| +.|+....... .-.-.+-   -+-.
T Consensus       168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---~Ia~  241 (637)
T COG4248         168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---DIAH  241 (637)
T ss_pred             ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh---hhhc
Confidence               1122233456888999999765     44567889999999999999887 78885432100 0000000   0000


Q ss_pred             CccccccCccc-----cCCCC-hhhHHHHHHHHHHHhhcC--CCCCCCHHHHHHHHHHHHh
Q 003436          708 GQLEDIVDPTL-----TGQIK-PDSLNKFVEIAEKCLAQC--GIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       708 ~~~~~~~d~~l-----~~~~~-~~~~~~l~~l~~~Cl~~d--p~~RPs~~evl~~L~~~~~  760 (820)
                      +.....-|...     ....+ .-.+..+..+..+|+...  +.-||+++.++..|..+.+
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            11111111000     00111 123455677778888644  5689999999988876654

>PRK09902 hypothetical protein; Provisional

Probab=98.43  E-value=2.5e-06  Score=85.70  Aligned_cols=137  Identities=15%  Similarity=0.124  Sum_probs=103.6

Q ss_pred             eeecceEEEEEEEcCccEEEEEeCCCCC------hhhHHHHHHHHHHHHcCCCC--ceeeEEeEee-c----CceEEEEE
Q 003436          492 GIGGFGKVYRGVLRDETKVAVKRGGTQS------HQGLAEFRTEIEMLSQFRHR--HLVSLIGYCD-E----RNEMIIIY  558 (820)
Q Consensus       492 G~G~fG~Vykg~~~~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~-~----~~~~~lV~  558 (820)
                      |+||-+.|++-.+.+. .+.+|+...--      +.....|.+|+..|.+|..-  .+.+.+ ++. .    .-.-+||.
T Consensus        27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence            7788888998776544 68889754111      23567899999999998532  344555 332 1    12468999


Q ss_pred             eeccC-CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC--eeEeecccccc
Q 003436          559 EYMEN-GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM--AKVADFGLSKI  633 (820)
Q Consensus       559 E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~--~kl~DFGla~~  633 (820)
                      |-+++ -+|.+++......+.+..++..+..+++..+.-||   ..++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97764 58888886655556677888899999999999999   899999999999999986666  99999987653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.41  E-value=1.6e-06  Score=99.12  Aligned_cols=147  Identities=20%  Similarity=0.277  Sum_probs=96.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhH------------------------------H--------
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGL------------------------------A--------  524 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~------------------------------~--------  524 (820)
                      ..|+. +-|+.++-|.||+|++.+|+.||||..++.-....                              +        
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            34443 47999999999999999999999998765432211                              1        


Q ss_pred             --HHHHHHHHHHcCC-----CCceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhh
Q 003436          525 --EFRTEIEMLSQFR-----HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL  597 (820)
Q Consensus       525 --~f~~Ei~~l~~l~-----H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yL  597 (820)
                        ++..|+..+.+++     .+++.-..=|.+-.+...|+|||++|-.+.+...... ..++-+.......++.  +.-+
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~  281 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQL  281 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHH
Confidence              1444555555552     3333322223334567799999999999988753222 2345333332222222  1111


Q ss_pred             hcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       598 H~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      -   ..++.|.|..|.||+++.++++.+.|||+......
T Consensus       282 ~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 L---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             H---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            1   35899999999999999999999999999875443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.39  E-value=1.7e-06  Score=88.81  Aligned_cols=132  Identities=23%  Similarity=0.204  Sum_probs=92.2

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCCC--CC--------------------hhhHHHHHHHHHHHHcCCCC--cee
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGGT--QS--------------------HQGLAEFRTEIEMLSQFRHR--HLV  542 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~--~~--------------------~~~~~~f~~Ei~~l~~l~H~--nIv  542 (820)
                      ....||.|--+.||.|....|.++|||.-+.  .+                    ........+|.+.|.+|...  .+.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            3458999999999999999999999994211  10                    01123466899999999655  777


Q ss_pred             eEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC
Q 003436          543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM  622 (820)
Q Consensus       543 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~  622 (820)
                      +.+++    +.-.+|||++++-.|...-.    ......+++   ..|++-+.-+-   ..|+||+|+.+-||+++++|.
T Consensus       175 ~P~~~----nRHaVvMe~ieG~eL~~~r~----~~en~~~il---~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg~  240 (304)
T COG0478         175 KPIAW----NRHAVVMEYIEGVELYRLRL----DVENPDEIL---DKILEEVRKAY---RRGIVHGDLSEFNILVTEDGD  240 (304)
T ss_pred             Ccccc----ccceeeeehcccceeecccC----cccCHHHHH---HHHHHHHHHHH---HcCccccCCchheEEEecCCC
Confidence            77664    34589999999876654321    112223333   33333333222   368999999999999999999


Q ss_pred             eeEeeccccc
Q 003436          623 AKVADFGLSK  632 (820)
Q Consensus       623 ~kl~DFGla~  632 (820)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999998664

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.33  E-value=2.8e-06  Score=86.75  Aligned_cols=105  Identities=24%  Similarity=0.290  Sum_probs=83.1

Q ss_pred             HHHHHHHHHHHcCCC--CceeeEEeEeecCc----eEEEEEeeccCC-chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhh
Q 003436          524 AEFRTEIEMLSQFRH--RHLVSLIGYCDERN----EMIIIYEYMENG-TLKDHLYASNFPSLSWRKRLEICIGAARGLHY  596 (820)
Q Consensus       524 ~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~y  596 (820)
                      ....+|...+.+|..  -..++.+++.....    ..+||+|++++. +|.+++.....  ++......++.+++..++-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            457788888887753  33456666665432    458999999984 79998876332  5556778899999999999


Q ss_pred             hhcCCCCcEEeccCCCCcEEEcCCC---CeeEeecccccc
Q 003436          597 LHTGSTKAIIHRDVKSANILLDENL---MAKVADFGLSKI  633 (820)
Q Consensus       597 LH~~~~~~iiHrDIkp~NIll~~~~---~~kl~DFGla~~  633 (820)
                      ||   ..+|+|+|++++|||++.+.   .+.++||+-++.
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99   79999999999999998877   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.25  E-value=1.3e-05  Score=82.87  Aligned_cols=139  Identities=13%  Similarity=0.145  Sum_probs=85.6

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc--eeeEEeEeecCceEEEEEeeccCCc-
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH--LVSLIGYCDERNEMIIIYEYMENGT-  565 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~~~~gs-  565 (820)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.++++...+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            47899999999984   24467788765433  2245678999999886433  4677888877777889999999863 


Q ss_pred             hhhHh---------------------hhcCCCCCCHHHHHHHHH-----------HHHH-Hhhhhhc-CCCCcEEeccCC
Q 003436          566 LKDHL---------------------YASNFPSLSWRKRLEICI-----------GAAR-GLHYLHT-GSTKAIIHRDVK  611 (820)
Q Consensus       566 L~~~l---------------------~~~~~~~l~~~~~l~i~~-----------~ia~-gL~yLH~-~~~~~iiHrDIk  611 (820)
                      +...+                     |.-.........+..-..           .+.. ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111                     111011111111111000           0011 1122221 123467999999


Q ss_pred             CCcEEEcCCCCeeEeecccccc
Q 003436          612 SANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       612 p~NIll~~~~~~kl~DFGla~~  633 (820)
                      |.||++++++ +.|+||+.+..
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcCc
Confidence            9999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.09  E-value=3.2e-05  Score=79.89  Aligned_cols=143  Identities=19%  Similarity=0.198  Sum_probs=85.6

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC--ceeeEEeEeec---CceEEEEEeecc
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR--HLVSLIGYCDE---RNEMIIIYEYME  562 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~~~---~~~~~lV~E~~~  562 (820)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+...  .+.+++.++..   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999999877 58899985544  4456778899998888533  35667765422   335789999999


Q ss_pred             CCchhh----------------Hh---hhc--CCCCCCHHH---------HHHH------------HHHHHH-Hhhhhhc
Q 003436          563 NGTLKD----------------HL---YAS--NFPSLSWRK---------RLEI------------CIGAAR-GLHYLHT  599 (820)
Q Consensus       563 ~gsL~~----------------~l---~~~--~~~~l~~~~---------~l~i------------~~~ia~-gL~yLH~  599 (820)
                      +..+..                .+   +..  ......+..         ....            ...+.+ .++.++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                11   111  111111111         0000            011122 2333331


Q ss_pred             ----CCCCcEEeccCCCCcEEEc-CCCCeeEeecccccc
Q 003436          600 ----GSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKI  633 (820)
Q Consensus       600 ----~~~~~iiHrDIkp~NIll~-~~~~~kl~DFGla~~  633 (820)
                          .....++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                2357899999999999999 666668999987653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.99  E-value=1.3e-06  Score=98.26  Aligned_cols=189  Identities=20%  Similarity=0.120  Sum_probs=134.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc-eeeEEeEeecCceEEEEEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH-LVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E  559 (820)
                      .+.-+..-+-+++|++++++|.+....+...++.+...     ....-++++|.+++||| .+..++-++.+...+++++
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            33334444467899999999988655555556654433     33456899999999999 6666777777788899999


Q ss_pred             eccCC-chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          560 YMENG-TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       560 ~~~~g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ++..+ +-....... ...+...+...++..-.++|++||   +..=+|+|    ||+..+ ...|..||+........ 
T Consensus       315 i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~-  384 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT-  384 (829)
T ss_pred             hhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCcc-
Confidence            99877 222111111 012333455667777889999999   44458888    777765 68899999988654332 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCC
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVI  686 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~  686 (820)
                        ...+...++..|+|||+..+..+..+.|+|+.|+-..++.-|-+|-
T Consensus       385 --~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  385 --MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             --cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence              1344567899999999999999999999999999877777776654

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.96  E-value=4e-05  Score=87.53  Aligned_cols=139  Identities=19%  Similarity=0.225  Sum_probs=90.6

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCChhhH---------------------------H----------HHHHHHH
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGL---------------------------A----------EFRTEIE  531 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~---------------------------~----------~f~~Ei~  531 (820)
                      +.||..+.|.||+|++++|+.||||..++.-+...                           +          +|..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            46999999999999999999999998665432221                           0          1445555


Q ss_pred             HHHcC----CCCc------eeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCC
Q 003436          532 MLSQF----RHRH------LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS  601 (820)
Q Consensus       532 ~l~~l----~H~n------Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~  601 (820)
                      ...+.    +|-+      |.+++-  .-.....|+||||+|..+.|.-.-.. ..++-..   |+..+.++  |++...
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~---i~~~l~~~--~~~qIf  318 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHD---ILNKLVEA--YLEQIF  318 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHHH---HHHHHHHH--HHHHHH
Confidence            44444    3444      333332  22346799999999998876543211 1244443   33333332  222112


Q ss_pred             CCcEEeccCCCCcEEEc----CCCCeeEeeccccccCC
Q 003436          602 TKAIIHRDVKSANILLD----ENLMAKVADFGLSKIGP  635 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll~----~~~~~kl~DFGla~~~~  635 (820)
                      ..|++|+|=.|.||+++    .++.+.+-|||+.....
T Consensus       319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             hcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            45899999999999998    36789999999987543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.96  E-value=3.2e-05  Score=77.50  Aligned_cols=103  Identities=21%  Similarity=0.317  Sum_probs=82.7

Q ss_pred             HHHHHHHHcCCC-CceeeEEeEeecCceEEEEEeeccCCchhhHhhh-cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc
Q 003436          527 RTEIEMLSQFRH-RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKA  604 (820)
Q Consensus       527 ~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~  604 (820)
                      ..|.-+|+.+++ +++++++|+|-.    ++|.||...+++...-.. .....-+|..|.+||.++++.+++|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888898976 699999999944    778999987766432000 11124689999999999999999999766566


Q ss_pred             EEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          605 IIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       605 iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      +...|++++|+-+++++++|++|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            99999999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.95  E-value=7.9e-05  Score=78.09  Aligned_cols=139  Identities=17%  Similarity=0.162  Sum_probs=85.3

Q ss_pred             Eeeecc-eEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEeeccCCchhh
Q 003436          491 IGIGGF-GKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKD  568 (820)
Q Consensus       491 LG~G~f-G~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~  568 (820)
                      |-.|.. ..||+...++ ..+++|+.....   ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            344444 7789987654 678888865443   235667899888884 4446677887776667899999999987764


Q ss_pred             Hh-------------------hhcCCC--CCC--HHHHHHHHHH--------------------HHHHhhhhh----cCC
Q 003436          569 HL-------------------YASNFP--SLS--WRKRLEICIG--------------------AARGLHYLH----TGS  601 (820)
Q Consensus       569 ~l-------------------~~~~~~--~l~--~~~~l~i~~~--------------------ia~gL~yLH----~~~  601 (820)
                      ..                   +.....  ...  +...+..+..                    +...++.|-    ...
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   111000  111  0011110000                    111111221    112


Q ss_pred             CCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          602 TKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ...++|+|+.|.|||++++....|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            46699999999999999987788999998754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.88  E-value=0.00013  Score=74.48  Aligned_cols=151  Identities=17%  Similarity=0.162  Sum_probs=96.2

Q ss_pred             CCHHHHHHHhcCCccce---eEeeecceEEEEEEEcCccEEEEEeCCCCChhh------------------------HHH
Q 003436          473 FPFVAIQEATDNFSESL---VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQG------------------------LAE  525 (820)
Q Consensus       473 ~~~~~l~~at~~f~~~~---~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~------------------------~~~  525 (820)
                      .++..|......-....   .|..|--..||+|.-.++..+|||+........                        ...
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            45555666555555544   455666778999998889999999754322110                        012


Q ss_pred             HHHHHHHHHcCC--CCceeeEEeEeecCceEEEEEeeccCCchh-hHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCC
Q 003436          526 FRTEIEMLSQFR--HRHLVSLIGYCDERNEMIIIYEYMENGTLK-DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST  602 (820)
Q Consensus       526 f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~  602 (820)
                      ...|+..|.++.  +-.+.+.+++..    -.|||||+....+. -.|..-   ++...+...+..++++.+.-|-.  .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~--~  185 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK--E  185 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--h
Confidence            345777777773  444555555443    37999999654111 111111   12222455566667777776652  4


Q ss_pred             CcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          603 KAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       603 ~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||+||+.-|||+. ++.+.|+|+|-|..
T Consensus       186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             cCcccccchhhheEEE-CCeEEEEECccccc
Confidence            6899999999999999 88999999998764

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.88  E-value=0.00015  Score=73.28  Aligned_cols=137  Identities=16%  Similarity=0.164  Sum_probs=89.2

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHH---------HHHHHHHHcCCC---CceeeEEeEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF---------RTEIEMLSQFRH---RHLVSLIGYC  548 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f---------~~Ei~~l~~l~H---~nIv~l~g~~  548 (820)
                      ...+|...+++-......|.+-.. ++..+++|..+.......+.|         .+++..+.+++.   -....++..+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346777777787777666766555 457788897655443322222         234444444432   2222322222


Q ss_pred             -----ecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          549 -----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       549 -----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                           ......+|+|||++|..|.+...      ++.    .++..+++++.-||   ..|+.|+|..|.|++++++ .+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC-cE
Confidence                 22245679999999988876532      221    24456777899999   7999999999999999855 49


Q ss_pred             eEeeccccc
Q 003436          624 KVADFGLSK  632 (820)
Q Consensus       624 kl~DFGla~  632 (820)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PLN02876 acyl-CoA dehydrogenase

Probab=97.88  E-value=0.00016  Score=89.22  Aligned_cols=148  Identities=15%  Similarity=0.246  Sum_probs=92.4

Q ss_pred             ceeEeeecceEEEEEEEcCc---cEEEEEeCCCCC-hhhHHHHHHHHHHHHcCC-CCce--eeEEeEeecC---ceEEEE
Q 003436          488 SLVIGIGGFGKVYRGVLRDE---TKVAVKRGGTQS-HQGLAEFRTEIEMLSQFR-HRHL--VSLIGYCDER---NEMIII  557 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~nI--v~l~g~~~~~---~~~~lV  557 (820)
                      ...|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++++|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            55788999999999877654   367777754322 122356889999999995 6655  7888888764   467899


Q ss_pred             EeeccCCchhh--------------------H---hhhcCC---------CCCCHH--HHHHHH---------------H
Q 003436          558 YEYMENGTLKD--------------------H---LYASNF---------PSLSWR--KRLEIC---------------I  588 (820)
Q Consensus       558 ~E~~~~gsL~~--------------------~---l~~~~~---------~~l~~~--~~l~i~---------------~  588 (820)
                      |||+++..+.+                    .   ||.-..         .+..+.  ++-.+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99999865322                    1   111100         011111  111110               1


Q ss_pred             HHHHHhhhhhcCC--------CCcEEeccCCCCcEEEcCC-C-CeeEeeccccccCC
Q 003436          589 GAARGLHYLHTGS--------TKAIIHRDVKSANILLDEN-L-MAKVADFGLSKIGP  635 (820)
Q Consensus       589 ~ia~gL~yLH~~~--------~~~iiHrDIkp~NIll~~~-~-~~kl~DFGla~~~~  635 (820)
                      .+.+.+++|....        ...+||+|+++.||+++.+ . ..-|.||.++....
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence            1333456664211        2469999999999999742 3 35799999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.77  E-value=0.00034  Score=70.50  Aligned_cols=129  Identities=21%  Similarity=0.295  Sum_probs=90.5

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCCCCC----------------hhhHHHHHHHHHHHHcCC------CCceeeE
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS----------------HQGLAEFRTEIEMLSQFR------HRHLVSL  544 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~----------------~~~~~~f~~Ei~~l~~l~------H~nIv~l  544 (820)
                      ....||+|+.-.||.  +.+.....||......                ....++..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345899999999995  5555667788765554                223466777777666665      8899999


Q ss_pred             EeEeecCceEEEEEeeccC------CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc
Q 003436          545 IGYCDERNEMIIIYEYMEN------GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD  618 (820)
Q Consensus       545 ~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~  618 (820)
                      +|+.+.+.-..+|+|.+.+      -+|.+++...   .++. +..+.+.+.   .+||-   ...|+.+|++|.||++.
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQ  152 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEE
Confidence            9999999889999998754      2577777543   2444 444444444   34554   56799999999999994


Q ss_pred             CC---C-CeeEee
Q 003436          619 EN---L-MAKVAD  627 (820)
Q Consensus       619 ~~---~-~~kl~D  627 (820)
                      ..   . .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            32   2 567776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.63  E-value=0.00094  Score=72.21  Aligned_cols=79  Identities=10%  Similarity=0.045  Sum_probs=57.6

Q ss_pred             CccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC---CceeeEEeEeec---CceEEEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH---RHLVSLIGYCDE---RNEMIIIY  558 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~---~~~~~lV~  558 (820)
                      ....+.||.|..+.||+....++ .+++|..+...  ....|..|++.|+.|..   -.+.+++++|..   .+..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            34456899999999999876555 46666633211  22478899999998853   467888988854   36689999


Q ss_pred             eeccCCch
Q 003436          559 EYMENGTL  566 (820)
Q Consensus       559 E~~~~gsL  566 (820)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.59  E-value=0.00044  Score=72.05  Aligned_cols=139  Identities=19%  Similarity=0.245  Sum_probs=77.5

Q ss_pred             eeEeeecce-EEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC---ceeeEEeEeecC---ceEEEEEeec
Q 003436          489 LVIGIGGFG-KVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR---HLVSLIGYCDER---NEMIIIYEYM  561 (820)
Q Consensus       489 ~~LG~G~fG-~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~~~---~~~~lV~E~~  561 (820)
                      +.|+.|+.. .||+.    +..+++|.....  .....+..|+++|..+...   .+.+.++.+...   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467777776 48874    234677764432  2235788899999887532   344555544332   2358899999


Q ss_pred             cCCchhhH------------------hhhcCCCC--------------C-CHHHHH--HHH-------HHHHHH-hh-hh
Q 003436          562 ENGTLKDH------------------LYASNFPS--------------L-SWRKRL--EIC-------IGAARG-LH-YL  597 (820)
Q Consensus       562 ~~gsL~~~------------------l~~~~~~~--------------l-~~~~~l--~i~-------~~ia~g-L~-yL  597 (820)
                      +|.++.+.                  ||.-....              + .|....  .+.       .+.... ++ ++
T Consensus        77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  156 (235)
T cd05155          77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL  156 (235)
T ss_pred             cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence            98776422                  11110000              0 121110  000       011111 11 11


Q ss_pred             hc--CCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          598 HT--GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       598 H~--~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      +.  .....++|+|+.+.||+++++...-|+||+.+..
T Consensus       157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            11  1245699999999999998776667999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.46  E-value=0.00057  Score=66.22  Aligned_cols=128  Identities=18%  Similarity=0.204  Sum_probs=86.2

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCcee-eEEeEeecCceEEEEEeeccCCc
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV-SLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      ..+.|++|.+|.||+|.+.++ .+|+|..+.++.  ...+..|+++|..+.-.++. +++.|..+    .+.|||+.|-+
T Consensus        26 v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWRGG-EVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeeccCc-eEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            445899999999999998755 788887655543  35778899999999876664 34444333    45599999888


Q ss_pred             hhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCC-CCcEEEcCCCCeeEeecccccc
Q 003436          566 LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVK-SANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       566 L~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIk-p~NIll~~~~~~kl~DFGla~~  633 (820)
                      |.++-...     +-.+.+.    +++.---|.   ..+|-|+.|. |...+|..+..+.|+||.-|..
T Consensus        99 L~~~~~~~-----~rk~l~~----vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG-----DRKHLLR----VLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc-----cHHHHHH----HHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            87764321     2223333    333322233   5688888886 4445555555999999998863

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.41  E-value=0.0014  Score=68.19  Aligned_cols=140  Identities=19%  Similarity=0.219  Sum_probs=80.8

Q ss_pred             eeEeeecceEEEEEEEcC--ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce-eeEEeEeecCceEEEEEeeccCCc
Q 003436          489 LVIGIGGFGKVYRGVLRD--ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL-VSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      +.|..|-...+|+....+  +..+++|......... -+-.+|+.++..+...++ +++++.+. +   .+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCCc
Confidence            467778888999987664  5678888765432221 223468888888854333 44444432 2   47999999877


Q ss_pred             hhhH-----------------hhhcCC---------CCCC-HHHHHHHH-------------------------HHHHHH
Q 003436          566 LKDH-----------------LYASNF---------PSLS-WRKRLEIC-------------------------IGAARG  593 (820)
Q Consensus       566 L~~~-----------------l~~~~~---------~~l~-~~~~l~i~-------------------------~~ia~g  593 (820)
                      +...                 +|....         .... |..+..+.                         .+.+..
T Consensus        79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  158 (235)
T cd05157          79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW  158 (235)
T ss_pred             CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence            6321                 111110         0111 22211111                         111111


Q ss_pred             hh-hhhc-CCCCcEEeccCCCCcEEEcC-CCCeeEeecccccc
Q 003436          594 LH-YLHT-GSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKI  633 (820)
Q Consensus       594 L~-yLH~-~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~  633 (820)
                      |. .+.. .....++|+|+.+.|||+++ +..+.|+||..|..
T Consensus       159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            11 1111 12457999999999999997 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.40  E-value=0.00073  Score=71.38  Aligned_cols=137  Identities=15%  Similarity=0.113  Sum_probs=78.1

Q ss_pred             EeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce-eeEEeEeecCceEEEEEeeccCCchhhH
Q 003436          491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL-VSLIGYCDERNEMIIIYEYMENGTLKDH  569 (820)
Q Consensus       491 LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gsL~~~  569 (820)
                      +..|-.+.+|+.. .++..+++|..........-...+|.++++.+....+ .++++.+.    -.+|+||++|..+...
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence            4557778899876 4566788887544322211134678889988864333 34454442    3689999998765421


Q ss_pred             -----------------hhhcC--CCCCCHHHHH-HHHHH---------HHHHhhhhhc-----CCCCcEEeccCCCCcE
Q 003436          570 -----------------LYASN--FPSLSWRKRL-EICIG---------AARGLHYLHT-----GSTKAIIHRDVKSANI  615 (820)
Q Consensus       570 -----------------l~~~~--~~~l~~~~~l-~i~~~---------ia~gL~yLH~-----~~~~~iiHrDIkp~NI  615 (820)
                                       ||...  ..+++...++ +...+         +...+..+-.     .....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111  1122222111 11000         1111111111     1235699999999999


Q ss_pred             EEcCCCCeeEeecccccc
Q 003436          616 LLDENLMAKVADFGLSKI  633 (820)
Q Consensus       616 ll~~~~~~kl~DFGla~~  633 (820)
                      ++++++ +.|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.29  E-value=0.0039  Score=69.58  Aligned_cols=75  Identities=21%  Similarity=0.190  Sum_probs=54.4

Q ss_pred             eeEeeecceEEEEEEEcCc-cEEEEEeCCCC------C-hhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCceEEEE
Q 003436          489 LVIGIGGFGKVYRGVLRDE-TKVAVKRGGTQ------S-HQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~-~~vavK~~~~~------~-~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV  557 (820)
                      +.||.|.+..||+....+| +.++||.-.+.      . ....+.+..|.+.|..+.   ..++++++.+..  ...++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence            4789999999999998877 58999974321      1 224466778888888763   346777777743  457899


Q ss_pred             EeeccCCc
Q 003436          558 YEYMENGT  565 (820)
Q Consensus       558 ~E~~~~gs  565 (820)
                      ||++++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.26  E-value=0.0027  Score=63.63  Aligned_cols=125  Identities=23%  Similarity=0.274  Sum_probs=88.7

Q ss_pred             cCCccceeEeeecc-eEEEEEEEcCccEEEEEeCCC---CCh------------------hhHHHHHHHHHHHHcCC---
Q 003436          483 DNFSESLVIGIGGF-GKVYRGVLRDETKVAVKRGGT---QSH------------------QGLAEFRTEIEMLSQFR---  537 (820)
Q Consensus       483 ~~f~~~~~LG~G~f-G~Vykg~~~~~~~vavK~~~~---~~~------------------~~~~~f~~Ei~~l~~l~---  537 (820)
                      .+++..+.||.|.- |.|||+++. |+.+|+|....   ...                  .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            77888999999999 999999986 56899998211   100                  11235888998888875   


Q ss_pred             CCce--eeEEeEeecC------------------ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhh
Q 003436          538 HRHL--VSLIGYCDER------------------NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL  597 (820)
Q Consensus       538 H~nI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yL  597 (820)
                      +.++  ++++||..-.                  ....+|.||++...           .+.    .+-+.++.+-|.-+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHHHHHHHH
Confidence            5566  9999997211                  12467888876533           122    22344566667788


Q ss_pred             hcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       598 H~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      |   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---HCCeeeccCcccccc-----CCEEEecccC
Confidence            9   789999999999986     4589999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.05  E-value=0.0021  Score=77.97  Aligned_cols=198  Identities=20%  Similarity=0.229  Sum_probs=132.6

Q ss_pred             HHHHHHHHHHHcCCCCceeeEEeEeecCceE----EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhc
Q 003436          524 AEFRTEIEMLSQFRHRHLVSLIGYCDERNEM----IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT  599 (820)
Q Consensus       524 ~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~  599 (820)
                      ..-..|.+.+.++.|+|++.+++|..++...    .+..|++..-++...+....  .++..+...+..+..+||.|+|.
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence            3344577888899999999999987554332    24456777777777776543  57778888889999999999994


Q ss_pred             CCCCcEEeccCCCC---cEEEcCCCCeeEe--eccccccCCCCCCccccccccCCccccCccccccCCCCC--cceeeeh
Q 003436          600 GSTKAIIHRDVKSA---NILLDENLMAKVA--DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE--KSDVYSF  672 (820)
Q Consensus       600 ~~~~~iiHrDIkp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDV~Sf  672 (820)
                         ....|.-+..+   +.-.+.++...++  ||+..+...+.....   ...-+..+.++|......+..  ..|+|.+
T Consensus       305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             ---hccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence               44445444444   4444566677777  888877655433221   223445677888776655544  4799999


Q ss_pred             hhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHH
Q 003436          673 GVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL  752 (820)
Q Consensus       673 Gvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  752 (820)
                      |.++..+..|..+-.....                  ...+.+        ......+.+...+|+..++++|++..+++
T Consensus       379 gll~~~~~~~~~i~~~~~~------------------~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAV------------------PVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHhhhhhcCcccccccc------------------hhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhh
Confidence            9999999988754321100                  000011        11111466778899999999999999998


Q ss_pred             HHH
Q 003436          753 WNL  755 (820)
Q Consensus       753 ~~L  755 (820)
                      .+.
T Consensus       433 ~~~  435 (1351)
T KOG1035|consen  433 THP  435 (1351)
T ss_pred             hch
Confidence            764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.02  E-value=0.0039  Score=67.60  Aligned_cols=140  Identities=25%  Similarity=0.311  Sum_probs=82.5

Q ss_pred             eeEeeecceEEEEEEEcC-------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce-eeEEeEeecCceEEEEEee
Q 003436          489 LVIGIGGFGKVYRGVLRD-------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL-VSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~-------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~  560 (820)
                      +.|..|-...+|+....+       ++.+++|....... ......+|.+++..+....+ .++++++..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            355666667899888655       47788888554332 22344678888888753333 455655542    358999


Q ss_pred             ccCCchhhH-----------------hhhcCCC-------CCC--HHHHHH--------------------------HHH
Q 003436          561 MENGTLKDH-----------------LYASNFP-------SLS--WRKRLE--------------------------ICI  588 (820)
Q Consensus       561 ~~~gsL~~~-----------------l~~~~~~-------~l~--~~~~l~--------------------------i~~  588 (820)
                      ++|.++...                 +|.....       ..+  |....+                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998776431                 1111111       000  111101                          011


Q ss_pred             HHHHHhhhhh------cCCCCcEEeccCCCCcEEEcCC----CCeeEeecccccc
Q 003436          589 GAARGLHYLH------TGSTKAIIHRDVKSANILLDEN----LMAKVADFGLSKI  633 (820)
Q Consensus       589 ~ia~gL~yLH------~~~~~~iiHrDIkp~NIll~~~----~~~kl~DFGla~~  633 (820)
                      .+..-+..|.      ......++|+|+.+.|||++++    +.++++||..|..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            1222233332      1245689999999999999875    8899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.96  E-value=0.0069  Score=65.34  Aligned_cols=142  Identities=18%  Similarity=0.168  Sum_probs=84.6

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC--ceeeEEeEe------ecCceEEEEEe
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR--HLVSLIGYC------DERNEMIIIYE  559 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~------~~~~~~~lV~E  559 (820)
                      .+.|..|....+|+....++ .+++|+....   .......|++++..+.+.  .+.+++...      ...+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~-~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG-RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCC-cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            45677777789998876544 6788876542   234556688888777433  244544321      22345689999


Q ss_pred             eccCCchhh----H----------hhhc--C--C-----CCCCHHHHHH----------HHHHHHHHhhhhhc----CCC
Q 003436          560 YMENGTLKD----H----------LYAS--N--F-----PSLSWRKRLE----------ICIGAARGLHYLHT----GST  602 (820)
Q Consensus       560 ~~~~gsL~~----~----------l~~~--~--~-----~~l~~~~~l~----------i~~~ia~gL~yLH~----~~~  602 (820)
                      |++|..+..    .          +|..  .  .     ....|.....          ....+...++++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    1          1110  0  0     1123332211          11112333444432    124


Q ss_pred             CcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          603 KAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       603 ~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||+|+.|.||+++++....|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987788999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=96.93  E-value=0.016  Score=63.30  Aligned_cols=141  Identities=13%  Similarity=0.163  Sum_probs=76.3

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC--ceeeEEe------EeecCceEEEEEee
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR--HLVSLIG------YCDERNEMIIIYEY  560 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g------~~~~~~~~~lV~E~  560 (820)
                      +.|+.|....+|+...+++ .+++|+......   +....|+.++..|...  .+.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4566777788999876655 578887542222   2333455555554321  2333332      11234567899999


Q ss_pred             ccCCchhh-----------H---hhhcC---------CCCCCH-HHHHHHH------------HH-HHHHhhhhhc----
Q 003436          561 MENGTLKD-----------H---LYASN---------FPSLSW-RKRLEIC------------IG-AARGLHYLHT----  599 (820)
Q Consensus       561 ~~~gsL~~-----------~---l~~~~---------~~~l~~-~~~l~i~------------~~-ia~gL~yLH~----  599 (820)
                      ++|..+..           .   +|...         ...+.| .+...-.            .+ +...++.+..    
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99875421           1   11110         011222 2211111            11 1112222221    


Q ss_pred             CCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       600 ~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ....++||+|+.+.||+++.+...-|+||+.+..
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            1246899999999999998776668999998753

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.73  E-value=0.0016  Score=68.82  Aligned_cols=146  Identities=16%  Similarity=0.186  Sum_probs=94.8

Q ss_pred             CCHHHHHHHhc---CCccceeEeeecceEEEEEEEcCccEEEEEe--CCCCChh--------------------hHHHHH
Q 003436          473 FPFVAIQEATD---NFSESLVIGIGGFGKVYRGVLRDETKVAVKR--GGTQSHQ--------------------GLAEFR  527 (820)
Q Consensus       473 ~~~~~l~~at~---~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~--~~~~~~~--------------------~~~~f~  527 (820)
                      +.|..|+....   -+...+.||-|--+.+|.+-..+|++.++|.  +...+-.                    ..-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            34555554433   2456779999999999999999899988883  2111100                    011244


Q ss_pred             HHHHHHHcCCC--CceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcE
Q 003436          528 TEIEMLSQFRH--RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI  605 (820)
Q Consensus       528 ~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~i  605 (820)
                      +|...|+.|..  --+.+.++++    .-++|||++.+-.|.+.-+-.     +..++..-+.++   +--|.   .+|+
T Consensus       159 kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~lm~~---Iv~la---~~Gl  223 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHVE-----DPPTLYDDLMGL---IVRLA---NHGL  223 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeecC-----ChHHHHHHHHHH---HHHHH---HcCc
Confidence            67778877742  3445555443    458999999988886643322     223333322222   22333   6799


Q ss_pred             EeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          606 IHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       606 iHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ||+|..--||+++++..++++||--...
T Consensus       224 IHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  224 IHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eecccchheeEEecCCCEEEeechHhhc
Confidence            9999999999999999999999976543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.69  E-value=0.019  Score=62.48  Aligned_cols=154  Identities=14%  Similarity=0.163  Sum_probs=86.5

Q ss_pred             HHHHHHhcCCcc-----ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC--ceeeEEeEe
Q 003436          476 VAIQEATDNFSE-----SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR--HLVSLIGYC  548 (820)
Q Consensus       476 ~~l~~at~~f~~-----~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~~  548 (820)
                      .+|....+.|..     ...++.|.-..+|+...+++ .+++|+......  ..+...|++++..|...  .+.+++...
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            445444444433     34566676688998876555 566786543221  23445567777766422  234444421


Q ss_pred             ------ecCceEEEEEeeccCCchhh----H----------hhhcCC----------CCCCHHHHHH------------H
Q 003436          549 ------DERNEMIIIYEYMENGTLKD----H----------LYASNF----------PSLSWRKRLE------------I  586 (820)
Q Consensus       549 ------~~~~~~~lV~E~~~~gsL~~----~----------l~~~~~----------~~l~~~~~l~------------i  586 (820)
                            ...+..++++||++|..+..    .          +|....          ..-.|.....            .
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                  22456789999999855321    0          111000          0112221111            0


Q ss_pred             HHHHHHHhhhhhc----CCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          587 CIGAARGLHYLHT----GSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       587 ~~~ia~gL~yLH~----~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ...+.+.++++..    ....++||+|+.+.||++++++...|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            1122334555532    235789999999999999988877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.59  E-value=0.016  Score=64.09  Aligned_cols=139  Identities=16%  Similarity=0.200  Sum_probs=80.6

Q ss_pred             eEeeecceEEEEEEEcC-----ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCcee-eEEeEeecCceEEEEEeeccC
Q 003436          490 VIGIGGFGKVYRGVLRD-----ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV-SLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      .|-.|-.-.+|+....+     +..+++|............ .+|..+++.+..-++. ++++.+.. +   .|+||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence            44446667888876532     3578888866544333333 5788888888654443 45565533 2   58999987


Q ss_pred             CchhhH-----------------hhhcCC---C-CCCHHHHHHHHHH-----------------HHHHhhh----hhc-C
Q 003436          564 GTLKDH-----------------LYASNF---P-SLSWRKRLEICIG-----------------AARGLHY----LHT-G  600 (820)
Q Consensus       564 gsL~~~-----------------l~~~~~---~-~l~~~~~l~i~~~-----------------ia~gL~y----LH~-~  600 (820)
                      .+|...                 +|....   . ...|.+..++..+                 +...+..    +.. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            776421                 111110   1 1112222222211                 1111111    221 2


Q ss_pred             CCCcEEeccCCCCcEEEcC-CCCeeEeecccccc
Q 003436          601 STKAIIHRDVKSANILLDE-NLMAKVADFGLSKI  633 (820)
Q Consensus       601 ~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~  633 (820)
                      ....++|+|+++.|||+++ ++.++++||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2457999999999999976 47899999998764

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.59  E-value=0.023  Score=61.42  Aligned_cols=138  Identities=15%  Similarity=0.266  Sum_probs=78.5

Q ss_pred             EEEEEEEcCccEEEEEeCC-CCChhhHHHHHHHHHHHHcCCC--CceeeEEeEeecCc--eEEEEEeeccCCchhhHhhh
Q 003436          498 KVYRGVLRDETKVAVKRGG-TQSHQGLAEFRTEIEMLSQFRH--RHLVSLIGYCDERN--EMIIIYEYMENGTLKDHLYA  572 (820)
Q Consensus       498 ~Vykg~~~~~~~vavK~~~-~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~--~~~lV~E~~~~gsL~~~l~~  572 (820)
                      .+|..... +++.++.+-. ...........+|+++|+.+.-  --+...+++|.++.  ..+.||+|++|..+.+.+..
T Consensus        40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~  118 (321)
T COG3173          40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP  118 (321)
T ss_pred             ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence            34444433 6667777321 1222233455678888877743  33455677887665  77999999998433222211


Q ss_pred             cC------------------------------------CCCCCHHHHHHHHH--------HHHHHhhhhhc-----CCCC
Q 003436          573 SN------------------------------------FPSLSWRKRLEICI--------GAARGLHYLHT-----GSTK  603 (820)
Q Consensus       573 ~~------------------------------------~~~l~~~~~l~i~~--------~ia~gL~yLH~-----~~~~  603 (820)
                      ..                                    .+-..|...++.+.        ....-..||+.     ....
T Consensus       119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~  198 (321)
T COG3173         119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP  198 (321)
T ss_pred             ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence            00                                    00011222221110        11122333332     2356


Q ss_pred             cEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       604 ~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      .++|+|+.+.|++++.+.-+-|.||+++.....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            799999999999999888899999999986543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.36  E-value=0.033  Score=59.50  Aligned_cols=33  Identities=27%  Similarity=0.579  Sum_probs=26.9

Q ss_pred             CCcEEeccCCCCcEEEcCCCC-eeEeeccccccC
Q 003436          602 TKAIIHRDVKSANILLDENLM-AKVADFGLSKIG  634 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll~~~~~-~kl~DFGla~~~  634 (820)
                      ...++|+|+++.|||+++++. .-|+||+.+...
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            346999999999999987555 469999988653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.18  E-value=0.014  Score=62.59  Aligned_cols=140  Identities=21%  Similarity=0.248  Sum_probs=74.3

Q ss_pred             ccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCceEEEEEeecc
Q 003436          486 SESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ...+.|+.|....+|+.. .+++.+.||...   ......|..|++-|+.|.   --.+++.+++...++..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345578888899999877 667889999754   233356888999888883   4567788998877777899999998


Q ss_pred             CCc--------hhh---Hhhh-cCC-------------------CCCCHHHH-----HHHHH--------------HHHH
Q 003436          563 NGT--------LKD---HLYA-SNF-------------------PSLSWRKR-----LEICI--------------GAAR  592 (820)
Q Consensus       563 ~gs--------L~~---~l~~-~~~-------------------~~l~~~~~-----l~i~~--------------~ia~  592 (820)
                      .+.        |-.   .||. ...                   ..-+|.+.     +.-..              .+.+
T Consensus        96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~  175 (288)
T PF03881_consen   96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE  175 (288)
T ss_dssp             -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence            771        111   1233 110                   11334321     11111              1122


Q ss_pred             Hh-hhhhcC-CCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          593 GL-HYLHTG-STKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       593 gL-~yLH~~-~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                      .+ ..|+.. ..+.++|+||-+.|++.+.++.+.|.|=.
T Consensus       176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence            22 223311 24579999999999999999989998743

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.98  E-value=0.086  Score=58.88  Aligned_cols=73  Identities=16%  Similarity=0.134  Sum_probs=49.8

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCC-----C--hhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCceEEEE
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQ-----S--HQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~-----~--~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .+.||.|....||+.... +..++||+-...     .  .....+-..|++.|+.+.   ..++.+++.+|.+  ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEE
Confidence            457899999999997764 456899974411     1  112334445677776653   3578889998874  46788


Q ss_pred             EeeccC
Q 003436          558 YEYMEN  563 (820)
Q Consensus       558 ~E~~~~  563 (820)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.79  E-value=0.088  Score=57.79  Aligned_cols=73  Identities=14%  Similarity=0.143  Sum_probs=47.7

Q ss_pred             eEeeecceEEEEEEEcCc-cEEEEEeCC----C---CChhhHHHHHHHHHHHHcCC--CC-ceeeEEeEeecCceEEEEE
Q 003436          490 VIGIGGFGKVYRGVLRDE-TKVAVKRGG----T---QSHQGLAEFRTEIEMLSQFR--HR-HLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~-~~vavK~~~----~---~~~~~~~~f~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV~  558 (820)
                      .||-|-...||++...++ +.|+||+-.    .   ..+....+..-|.+.|+...  -| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            468899999999998754 589999632    1   12334455567778886653  24 45555544  344567999


Q ss_pred             eeccCC
Q 003436          559 EYMENG  564 (820)
Q Consensus       559 E~~~~g  564 (820)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.37  E-value=0.088  Score=57.84  Aligned_cols=139  Identities=17%  Similarity=0.230  Sum_probs=77.9

Q ss_pred             eEeeecceEEEEEEEcC----ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCcee-eEEeEeecCceEEEEEeeccCC
Q 003436          490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV-SLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~----~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      .|..|-...+|+....+    +..+++|.........+. -.+|..+++.+..-++. ++++++. ++   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            34446667788876543    237888876554332222 25788888888655553 5566553 22   589999876


Q ss_pred             chhhH-----------------hhhcCC---CCC-CHHHHHHHHHHH----------------------HHHhh----hh
Q 003436          565 TLKDH-----------------LYASNF---PSL-SWRKRLEICIGA----------------------ARGLH----YL  597 (820)
Q Consensus       565 sL~~~-----------------l~~~~~---~~l-~~~~~l~i~~~i----------------------a~gL~----yL  597 (820)
                      +|...                 ||....   ... -|....++..++                      .+-+.    .+
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            65320                 111111   111 133222221111                      11111    11


Q ss_pred             hc-CCCCcEEeccCCCCcEEEcC-CCCeeEeecccccc
Q 003436          598 HT-GSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKI  633 (820)
Q Consensus       598 H~-~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~  633 (820)
                      .. .....++|.|+.+.|||+++ ++.++++||..|..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 12346899999999999974 57899999998753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.37  E-value=0.044  Score=55.96  Aligned_cols=32  Identities=25%  Similarity=0.426  Sum_probs=22.9

Q ss_pred             CCcEEeccCCCCcEEE-cCCCCeeEeecccccc
Q 003436          602 TKAIIHRDVKSANILL-DENLMAKVADFGLSKI  633 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll-~~~~~~kl~DFGla~~  633 (820)
                      ...++|+|+.+.|||+ +.++.++++||..|..
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            4579999999999999 8899999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.97  E-value=0.23  Score=50.56  Aligned_cols=74  Identities=19%  Similarity=0.296  Sum_probs=51.8

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      .+.-|..-..|... .+..++.||.-   .......|..|+.-|..|.   --++.+.+.+..+.+..+||+||++-|.+
T Consensus        23 ~v~gG~inea~~v~-dg~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~   98 (286)
T COG3001          23 EVSGGDINEAWRLR-DGTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL   98 (286)
T ss_pred             ccCCccccceeEee-cCCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence            34444444445433 24567888873   2334567888888777764   45678889998999999999999998776


Q ss_pred             h
Q 003436          567 K  567 (820)
Q Consensus       567 ~  567 (820)
                      .
T Consensus        99 d   99 (286)
T COG3001          99 D   99 (286)
T ss_pred             C
Confidence            5

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.58  E-value=0.33  Score=52.72  Aligned_cols=32  Identities=16%  Similarity=0.291  Sum_probs=28.9

Q ss_pred             CCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          602 TKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ..++||+|+.+.|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45899999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.51  E-value=0.28  Score=53.64  Aligned_cols=139  Identities=22%  Similarity=0.252  Sum_probs=79.1

Q ss_pred             eEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc------eeeEEeE----eecCceEEEEEe
Q 003436          490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH------LVSLIGY----CDERNEMIIIYE  559 (820)
Q Consensus       490 ~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~----~~~~~~~~lV~E  559 (820)
                      .|.+ .-..+|+....+|+. ++|.....  ....+...|+..|..|.-..      +..+=|-    .......+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 456789988877776 88876654  22345566777777663211      2222221    111137788999


Q ss_pred             eccCCchhh-H----h----------hh--cC--------CCCCCHHH---H----------HHHHHHHHHHhhhhhc--
Q 003436          560 YMENGTLKD-H----L----------YA--SN--------FPSLSWRK---R----------LEICIGAARGLHYLHT--  599 (820)
Q Consensus       560 ~~~~gsL~~-~----l----------~~--~~--------~~~l~~~~---~----------l~i~~~ia~gL~yLH~--  599 (820)
                      |++|..+.. .    +          |.  .+        .....|..   .          .....++...+..+.+  
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988772 1    1          11  11        11244431   0          1112222233333322  


Q ss_pred             --CCCCc---EEeccCCCCcEEEcCCCC-eeEeeccccc
Q 003436          600 --GSTKA---IIHRDVKSANILLDENLM-AKVADFGLSK  632 (820)
Q Consensus       600 --~~~~~---iiHrDIkp~NIll~~~~~-~kl~DFGla~  632 (820)
                        .....   +||+|+.|.||+++.+.. ..++||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence              11223   999999999999998885 8999999775

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.40  E-value=0.72  Score=49.94  Aligned_cols=30  Identities=30%  Similarity=0.413  Sum_probs=26.2

Q ss_pred             CCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          602 TKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            468999999999999987 678999999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.37  E-value=0.2  Score=55.79  Aligned_cols=74  Identities=18%  Similarity=0.189  Sum_probs=49.6

Q ss_pred             ceeEeeecceEEEEEEEcC-ccEEEEEeCC------CCChhhHHHHHHHHHHHHcCC--CC-ceeeEEeEeecCceEEEE
Q 003436          488 SLVIGIGGFGKVYRGVLRD-ETKVAVKRGG------TQSHQGLAEFRTEIEMLSQFR--HR-HLVSLIGYCDERNEMIII  557 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~-~~~vavK~~~------~~~~~~~~~f~~Ei~~l~~l~--H~-nIv~l~g~~~~~~~~~lV  557 (820)
                      .+.||-|--.-||++.+.. +..|+||+-.      ...+-..++..-|.+.|+...  -| ++++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            3478999999999999753 5679999622      222344566677888887663  34 45556544  34456789


Q ss_pred             EeeccC
Q 003436          558 YEYMEN  563 (820)
Q Consensus       558 ~E~~~~  563 (820)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999864

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=94.22  E-value=0.035  Score=62.32  Aligned_cols=49  Identities=16%  Similarity=0.366  Sum_probs=38.2

Q ss_pred             HHHHHHHHHHHcCCCCceeeEEeEeecCc-eEEEEEeeccCCchhhHhhhc
Q 003436          524 AEFRTEIEMLSQFRHRHLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYAS  573 (820)
Q Consensus       524 ~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~  573 (820)
                      .++.....+++.+.|+|+.+.+.+..... ...+|+|++ +.||.+.+..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            45667788999999999999998875543 357889998 56999887654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.09  E-value=0.0088  Score=74.30  Aligned_cols=159  Identities=16%  Similarity=0.041  Sum_probs=109.6

Q ss_pred             HHHHHHHHHcCCCCceeeEEeEe--ecCceEEEEEeeccCCchhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcC-
Q 003436          526 FRTEIEMLSQFRHRHLVSLIGYC--DERNEMIIIYEYMENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTG-  600 (820)
Q Consensus       526 f~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~-  600 (820)
                      ...|.+.+++..|+++.....-.  .+..+.+.+++|+..|.+.+.|-+..  .+.++..-+...-.+...+..-+|.. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            34455566667898877655433  23456788999999999999886542  22333333332223324444444432 


Q ss_pred             -CCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHH
Q 003436          601 -STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI  679 (820)
Q Consensus       601 -~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~El  679 (820)
                       .+.--+|+++|+-|.+|..+..+|++++|+.+...+  .........+++-|+.|+....-.++.++|+|..|+.++++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence             234578999999999999999999999999983222  11112234567789999999888999999999999999999


Q ss_pred             hcCCCCC
Q 003436          680 LCGRPVI  686 (820)
Q Consensus       680 ltG~~p~  686 (820)
                      --|.+++
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8877654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	820
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-108
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-107
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-56
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-55
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-37
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-27
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-26
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-26
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-25
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-25
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-24
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-24
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-24
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-24
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-24
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-24
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-23
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-22
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-22
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-22
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-22
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		6e-22
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-22
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-22
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-22
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-22
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-22
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-22
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-21
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-21
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-21
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-21
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-21
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-21
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-21
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-21
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-21
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-21
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-21
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-21
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-21
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-21
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-21
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-21
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-21
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-21
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-21
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-21
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-21
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-21
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-21
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-21
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-21
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-20
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-18
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-18
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-18
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-18
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-18
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-18
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-18
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		8e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-17
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-17
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-17
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-17
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-17
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-17
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-17
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-17
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-17
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-17
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-17
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-15
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-15
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-14
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-14
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		7e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		9e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-10
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		9e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-09
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-07
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		1e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-07
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-07
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-07
3soa_A	444	Full-Length Human Camkii Length = 444		5e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		9e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		9e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-06
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-06
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-06
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-05
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		2e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-05

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  388 bits (996), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 194/294 (65%), Positives = 226/294 (76%), Gaps = 5/294 (1%)
Query: 471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEI 530
           YR P V ++EAT+NF    +IG G FGKVY+GVLRD  KVA+KR   +S QG+ EF TEI
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP--SLSWRKRLEICI 588
           E LS  RH HLVSLIG+CDERNEMI+IY+YMENG LK HLY S+ P  S+SW +RLEICI
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
           GAARGLHYLHT   +AIIHRDVKS NILLDEN + K+ DFG+SK G +LDQTH+   VKG
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG 708
           + GY+DPEY  K +LTEKSDVYSFGVV+FE+LC R  I  SLPRE VNL EWA++    G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ 762
           QLE IVDP L  +I+P+SL KF + A KCLA    DRPSMGDVLW LEYAL+LQ
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  385 bits (989), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 193/294 (65%), Positives = 225/294 (76%), Gaps = 5/294 (1%)
Query: 471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEI 530
           YR P V ++EAT+NF    +IG G FGKVY+GVLRD  KVA+KR   +S QG+ EF TEI
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP--SLSWRKRLEICI 588
           E LS  RH HLVSLIG+CDERNEMI+IY+YMENG LK HLY S+ P  S+SW +RLEICI
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
           GAARGLHYLHT   +AIIHRDVKS NILLDEN + K+ DFG+SK G +L QTH+   VKG
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG 708
           + GY+DPEY  K +LTEKSDVYSFGVV+FE+LC R  I  SLPRE VNL EWA++    G
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ 762
           QLE IVDP L  +I+P+SL KF + A KCLA    DRPSMGDVLW LEYAL+LQ
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  218 bits (555), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 121/292 (41%), Positives = 176/292 (60%), Gaps = 10/292 (3%)
Query: 472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQG-LAEFRTEI 530
           RF    +Q A+DNFS   ++G GGFGKVY+G L D T VAVKR   +  QG   +F+TE+
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICI 588
           EM+S   HR+L+ L G+C    E +++Y YM NG++   L     + P L W KR  I +
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
           G+ARGL YLH      IIHRDVK+ANILLDE   A V DFGL+K+  D    HV  AV+G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRG 205
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR----EKVNLVEWAMKC 704
           + G++ PEYL+  + +EK+DV+ +GV++ E++ G+   D  L R    + V L++W    
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVMLLDWVKGL 263
Query: 705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
            +  +LE +VD  L G  K + + + +++A  C     ++RP M +V+  LE
Sbjct: 264 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  213 bits (542), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 119/292 (40%), Positives = 173/292 (59%), Gaps = 10/292 (3%)
Query: 472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQG-LAEFRTEI 530
           RF    +Q A+DNF    ++G GGFGKVY+G L D   VAVKR   +  QG   +F+TE+
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICI 588
           EM+S   HR+L+ L G+C    E +++Y YM NG++   L     + P L W KR  I +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
           G+ARGL YLH      IIHRDVK+ANILLDE   A V DFGL+K+  D    HV  AV+G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRG 197
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR----EKVNLVEWAMKC 704
             G++ PEYL+  + +EK+DV+ +GV++ E++ G+   D  L R    + V L++W    
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD--LARLANDDDVMLLDWVKGL 255
Query: 705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
            +  +LE +VD  L G  K + + + +++A  C     ++RP M +V+  LE
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 162/293 (55%), Gaps = 20/293 (6%)
Query: 471 YRFPFVAIQEATDNFSESLV------IGIGGFGKVYRGVLRDETKVAVKRGGTQ----SH 520
           + F F  ++  T+NF E  +      +G GGFG VY+G + + T VAVK+        + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 71
Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLS 579
           +   +F  EI+++++ +H +LV L+G+  + +++ ++Y YM NG+L D L      P LS
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
           W  R +I  GAA G+++LH       IHRD+KSANILLDE   AK++DFGL++      Q
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE-KVNLV 698
           T + + + G+  Y+ PE L + ++T KSD+YSFGVV+ EI+ G P +D    RE ++ L 
Sbjct: 189 TVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLD 245
Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDV 751
                  E   +ED +D  +       S+     +A +CL +    RP +  V
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  160 bits (406), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/293 (34%), Positives = 161/293 (54%), Gaps = 20/293 (6%)
Query: 471 YRFPFVAIQEATDNFSESLV------IGIGGFGKVYRGVLRDETKVAVKRGGTQ----SH 520
           + F F  ++  T+NF E  +      +G GGFG VY+G + + T VAVK+        + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 71
Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLS 579
           +   +F  EI+++++ +H +LV L+G+  + +++ ++Y YM NG+L D L      P LS
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
           W  R +I  GAA G+++LH       IHRD+KSANILLDE   AK++DFGL++      Q
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE-KVNLV 698
           T +   + G+  Y+ PE L + ++T KSD+YSFGVV+ EI+ G P +D    RE ++ L 
Sbjct: 189 TVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLD 245
Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDV 751
                  E   +ED +D  +       S+     +A +CL +    RP +  V
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  158 bits (400), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 101/293 (34%), Positives = 160/293 (54%), Gaps = 20/293 (6%)
Query: 471 YRFPFVAIQEATDNFSESLV------IGIGGFGKVYRGVLRDETKVAVKRGGTQ----SH 520
           + F F  ++  T+NF E  +      +G GGFG VY+G + + T VAVK+        + 
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 65
Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLS 579
           +   +F  EI+++++ +H +LV L+G+  + +++ ++Y YM NG+L D L      P LS
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
           W  R +I  GAA G+++LH       IHRD+KSANILLDE   AK++DFGL++      Q
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE-KVNLV 698
             +   + G+  Y+ PE L + ++T KSD+YSFGVV+ EI+ G P +D    RE ++ L 
Sbjct: 183 XVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLD 239
Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDV 751
                  E   +ED +D  +       S+     +A +CL +    RP +  V
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKV 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  152 bits (383), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 86/228 (37%), Positives = 132/228 (57%), Gaps = 16/228 (7%)
Query: 471 YRFPFVAIQEATDNFSESLV------IGIGGFGKVYRGVLRDETKVAVKRGGTQ----SH 520
           + F F  ++  T+NF E  +       G GGFG VY+G + + T VAVK+        + 
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTE 62
Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLS 579
           +   +F  EI++ ++ +H +LV L+G+  + +++ ++Y Y  NG+L D L      P LS
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
           W  R +I  GAA G+++LH       IHRD+KSANILLDE   AK++DFGL++      Q
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
               + + G+  Y  PE L + ++T KSD+YSFGVV+ EI+ G P +D
Sbjct: 180 XVXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  120 bits (302), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 143/277 (51%), Gaps = 20/277 (7%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 78
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
           + ++ I+ ++ E  +L  HL+AS       +K ++I    ARG+ YLH    K+IIHRD+
Sbjct: 79  KPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDL 134
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTEKS 667
           KS NI L E+   K+ DFGL+ +      +H    + GS  ++ PE +  Q     + +S
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 194
Query: 668 DVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSL 727
           DVY+FG+V++E++ G+      LP   +N  +  ++    G L     P L+ +++ +  
Sbjct: 195 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSL----SPDLS-KVRSNCP 243
Query: 728 NKFVEIAEKCLAQCGIDRPSMGDVLWNL-EYALQLQG 763
            +   +  +CL +   +RPS   +L  + E A +L G
Sbjct: 244 KRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  118 bits (295), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 142/277 (51%), Gaps = 20/277 (7%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
           + ++ I+ ++ E  +L  HL+AS       +K ++I    ARG+ YLH    K+IIHRD+
Sbjct: 91  KPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDL 146
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTEKS 667
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE +  Q     + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 668 DVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSL 727
           DVY+FG+V++E++ G+      LP   +N  +  ++    G L     P L+ +++ +  
Sbjct: 207 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSL----SPDLS-KVRSNCP 255
Query: 728 NKFVEIAEKCLAQCGIDRPSMGDVLWNL-EYALQLQG 763
            +   +  +CL +   +RPS   +L  + E A +L G
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEIEELARELSG 292

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  116 bits (291), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 137/269 (50%), Gaps = 19/269 (7%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
             ++ I+ ++ E  +L  HL+AS       +K ++I    ARG+ YLH    K+IIHRD+
Sbjct: 92  -PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDL 146
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTEKS 667
           KS NI L E+   K+ DFGL+        +H    + GS  ++ PE +  Q     + +S
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQS 206
Query: 668 DVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSL 727
           DVY+FG+V++E++ G+      LP   +N  +  ++    G L     P L+ +++ +  
Sbjct: 207 DVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSL----SPDLS-KVRSNCP 255
Query: 728 NKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
            +   +  +CL +   +RPS   +L  +E
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+ G   ++ KVA+K  R G  S +   +F  E E++ +  H  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E+  + +++E+ME+G L D+L        +    L +C+    G+ YL   S   +IHR
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAS---VIHR 127
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  + + KSD
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 669 VYSFGVVMFEIL 680
           V+SFGV+M+E+ 
Sbjct: 187 VWSFGVLMWEVF 198

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 70/199 (35%), Positives = 114/199 (57%), Gaps = 13/199 (6%)
Query: 490 VIGIGGFGKVYRGVLR-----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           VIG G FG+VY+G+L+      E  VA+K  + G    Q + +F  E  ++ QF H +++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHNII 109
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L G   +   M+II EYMENG L   L   +    S  + + +  G A G+ YL   + 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
              +HRD+ + NIL++ NL+ KV+DFGLS++   D + T+ ++  K    +  PE ++ +
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 662 QLTEKSDVYSFGVVMFEIL 680
           + T  SDV+SFG+VM+E++
Sbjct: 226 KFTSASDVWSFGIVMWEVM 244

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+ G   ++ KVA+K  R G  S +   +F  E E++ +  H  LV L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E+  + +++E+ME+G L D+L        +    L +C+    G+ YL       +IHR
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 125
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  + + KSD
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 669 VYSFGVVMFEIL 680
           V+SFGV+M+E+ 
Sbjct: 185 VWSFGVLMWEVF 196

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+ G   ++ KVA+K  R G  S +   +F  E E++ +  H  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E+  + +++E+ME+G L D+L        +    L +C+    G+ YL       +IHR
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 127
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  + + KSD
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 669 VYSFGVVMFEIL 680
           V+SFGV+M+E+ 
Sbjct: 187 VWSFGVLMWEVF 198

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+ G   ++ KVA+K  R G  S +   +F  E E++ +  H  LV L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E+  + +++E+ME+G L D+L        +    L +C+    G+ YL       +IHR
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 130
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  + + KSD
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 669 VYSFGVVMFEIL 680
           V+SFGV+M+E+ 
Sbjct: 190 VWSFGVLMWEVF 201

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 133
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 194 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDLS-KVRSN 242
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 243 CPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 76
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 77  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 130
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 191 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSN 239
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQILASIE 270

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  110 bits (276), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 79
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 80  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 133
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 194 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDLS-KVRSN 242
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 243 CPKAMKRLMAECLKKKRDERPLFPQILASIE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 189 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSN 237
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 101
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 102 KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 155
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 216 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDLS-KVRSN 264
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 265 CPKAMKRLMAECLKKKRDERPLFPQILASIE 295

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  110 bits (275), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 138/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 156
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 217 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDLS-KVRSN 265
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 266 CPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 28/209 (13%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSH--QGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +IGIGGFGKVYR   + DE  V   R        Q +   R E ++ +  +H ++++L G
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPS---LSWRKRLEICIGAARGLHYLHTGSTK 603
            C +   + ++ E+   G L   L     P    ++W       +  ARG++YLH  +  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAIV 127
Query: 604 AIIHRDVKSANILLDE--------NLMAKVADFGLSKIGPDLDQTHVST--AVKGSFGYL 653
            IIHRD+KS+NIL+ +        N + K+ DFGL++      + H +T  +  G++ ++
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAGAYAWM 181
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            PE +     ++ SDV+S+GV+++E+L G
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 104/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+ G   ++ KVA+K  R G  S +   +F  E E++ +  H  LV L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E+  + ++ E+ME+G L D+L        +    L +C+    G+ YL       +IHR
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  + + KSD
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 669 VYSFGVVMFEIL 680
           V+SFGV+M+E+ 
Sbjct: 188 VWSFGVLMWEVF 199

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+ G   ++ KVA+K  + G+ S     +F  E E++ +  H  LV L G C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED---DFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E+  + +++E+ME+G L D+L        +    L +C+    G+ YL       +IHR
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHR 147
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  + + KSD
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 669 VYSFGVVMFEIL 680
           V+SFGV+M+E+ 
Sbjct: 207 VWSFGVLMWEVF 218

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  109 bits (272), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 189 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSN 237
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 103/192 (53%), Gaps = 7/192 (3%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQG--LAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+R      + VAVK    Q      + EF  E+ ++ + RH ++V  +G  
Sbjct: 45  IGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +   + I+ EY+  G+L   L+ S     L  R+RL +    A+G++YLH      I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+KS N+L+D+    KV DFGLS++         S    G+  ++ PE L  +   EKS
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 668 DVYSFGVVMFEI 679
           DVYSFGV+++E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 105/192 (54%), Gaps = 7/192 (3%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQG--LAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG V+R      + VAVK    Q      + EF  E+ ++ + RH ++V  +G  
Sbjct: 45  IGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +   + I+ EY+  G+L   L+ S     L  R+RL +    A+G++YLH      I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           R++KS N+L+D+    KV DFGLS++      +  S A  G+  ++ PE L  +   EKS
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKS 220
Query: 668 DVYSFGVVMFEI 679
           DVYSFGV+++E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 94
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 95  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 148
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+        +H    + GS  ++ PE +  Q     + 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 209 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDLS-KVRSN 257
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 258 CPKAMKRLMAECLKKKRDERPLFPQILASIE 288

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 102
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 103 KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 156
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+        +H    + GS  ++ PE +  Q     + 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 217 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYLS----PDLS-KVRSN 265
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 266 CPKAMKRLMAECLKKKRDERPLFPQILASIE 296

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74
Query: 551 RNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           + ++ I+ ++ E  +L  HL+   + F  +   K ++I    A+G+ YLH    K+IIHR
Sbjct: 75  KPQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTE 665
           D+KS NI L E+L  K+ DFGL+        +H    + GS  ++ PE +  Q     + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  +     G L     P L+ +++ +
Sbjct: 189 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRGYL----SPDLS-KVRSN 237
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                  +  +CL +   +RP    +L ++E
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G   + TKVAVK  + GT S Q   E   E  ++   +H  LV L    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVV 77
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
                + II EYM  G+L D L +     +   K ++     A G+ Y+     K  IHR
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 134
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++AN+L+ E+LM K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGCFTIKSD 193
Query: 669 VYSFGVVMFEIL 680
           V+SFG++++EI+
Sbjct: 194 VWSFGILLYEIV 205

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 85
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 86  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 141
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 200
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 201 VWSFGILLTEIV 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 86
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 87  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 142
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 201
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 202 VWSFGILLTEIV 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 83
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 139
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 198
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 199 VWSFGILLTEIV 210

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 79
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 80  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 135
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 194
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 195 VWSFGILLTEIV 206

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 77
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 192
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 193 VWSFGILLTEIV 204

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 78
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 79  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 134
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 193
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 194 VWSFGILLTEIV 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 77
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 192
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 193 VWSFGILLTEIV 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 104/192 (54%), Gaps = 9/192 (4%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G   + TKVAVK  + GT S Q   E   E  ++   +H  LV L    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAVV 76
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II E+M  G+L D L +     +   K ++     A G+ Y+     K  IHR
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 133
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++AN+L+ E+LM K+ADFGL+++  D + T    A K    +  PE +     T KS+
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGCFTIKSN 192
Query: 669 VYSFGVVMFEIL 680
           V+SFG++++EI+
Sbjct: 193 VWSFGILLYEIV 204

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 83  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSD 197
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 198 VWSFGILLTEIV 209

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 83
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 84  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 139
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSD 198
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 199 VWSFGILLTEIV 210

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 120/234 (51%), Gaps = 25/234 (10%)
Query: 470 GYRFPFVAIQEATDNFSE-SLVIGIGGFGKVYRG-VLRDETKVAVK-------RGGTQSH 520
           G  FP   +    DN  E    IG GGFG V++G +++D++ VA+K        G T+  
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSW 580
           +   EF+ E+ ++S   H ++V L G       M++  E++  G L   L     P + W
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKW 121
Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DEN--LMAKVADFGLSKIGP 635
             +L + +  A G+ Y+       I+HRD++S NI L   DEN  + AKVADFGLS+   
Sbjct: 122 SVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--- 177
Query: 636 DLDQTHVSTAVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRPVID 687
                H  + + G+F ++ PE +  ++   TEK+D YSF ++++ IL G    D
Sbjct: 178 --QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 77
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSD 192
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 193 VWSFGILLTEIV 204

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 104/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 87
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 88  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 143
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T      K    +  PE +     T KSD
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 203 VWSFGILLTEIV 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G FG+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 135
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P IDPS                   Q+ ++++     +     
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPS-------------------QVYELLEKDYRMERPEGC 235
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  103 bits (257), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/192 (35%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 72
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 73  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSD 187
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 188 VWSFGILLTEIV 199

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 129/271 (47%), Gaps = 23/271 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           IG G FG VY+G    +  V + +    + +    FR E+ +L + RH +++  +GY  +
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
            N + I+ ++ E  +L  HL+          + ++I    A+G+ YLH    K IIHRD+
Sbjct: 104 DN-LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDM 158
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTEKS 667
           KS NI L E L  K+ DFGL+ +      +       GS  ++ PE +  Q     + +S
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 668 DVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK--PD 725
           DVYS+G+V++E++ G       LP   +N  +  +     G       P L+   K  P 
Sbjct: 219 DVYSYGIVLYELMTG------ELPYSHINNRDQIIFMVGRG----YASPDLSKLYKNCPK 268
Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
           ++ + V     C+ +   +RP    +L ++E
Sbjct: 269 AMKRLV---ADCVKKVKEERPLFPQILSSIE 296

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 12/200 (6%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           V+G G FG V +   R +  VA+K+  ++S +    F  E+  LS+  H ++V L G C 
Sbjct: 16  VVGRGAFGVVCKAKWRAK-DVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC- 71
Query: 550 ERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             N + ++ EY E G+L + L+ A   P  +    +  C+  ++G+ YLH+   KA+IHR
Sbjct: 72  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 609 DVKSANILL-DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           D+K  N+LL     + K+ DFG +    D+ QTH+ T  KGS  ++ PE       +EK 
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTAC---DI-QTHM-TNNKGSAAWMAPEVFEGSNYSEKC 185
Query: 668 DVYSFGVVMFEILCGRPVID 687
           DV+S+G++++E++  R   D
Sbjct: 186 DVFSWGIILWEVITRRKPFD 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  103 bits (256), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 20/207 (9%)
Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     S     +F  E E+L+  +H H+V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYA----------SNFPS-LSWRKRLEICIGAARG 593
            G C E + +I+++EYM++G L   L A           N P+ L+  + L I    A G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           + YL   +++  +HRD+ + N L+ ENL+ K+ DFG+S+     D   V         ++
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T +SDV+S GVV++EI 
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIF 224

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/239 (29%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP--------------SL 578
               +H+++++L+G C +   + +I EY   G L+++L A   P               +
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
           +++  +      ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 135
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P IDPS                   Q+ ++++     +     
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPS-------------------QVYELLEKDYRMERPEGC 235
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/200 (33%), Positives = 111/200 (55%), Gaps = 12/200 (6%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           V+G G FG V +   R +  VA+K+  ++S +    F  E+  LS+  H ++V L G C 
Sbjct: 15  VVGRGAFGVVCKAKWRAK-DVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 550 ERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             N + ++ EY E G+L + L+ A   P  +    +  C+  ++G+ YLH+   KA+IHR
Sbjct: 71  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 609 DVKSANILL-DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           D+K  N+LL     + K+ DFG +    D+ QTH+ T  KGS  ++ PE       +EK 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC---DI-QTHM-TNNKGSAAWMAPEVFEGSNYSEKC 184
Query: 668 DVYSFGVVMFEILCGRPVID 687
           DV+S+G++++E++  R   D
Sbjct: 185 DVFSWGIILWEVITRRKPFD 204

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  102 bits (254), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 149/310 (48%), Gaps = 48/310 (15%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVN 696
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P     
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIP----- 310
Query: 697 LVEWAMKCQETGQLEDIVDPTLTGQIKP-DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL 755
            VE   K  + G   D          KP +  N+   +   C       RP+   ++ +L
Sbjct: 311 -VEELFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359
Query: 756 EYALQLQGDE 765
           +  L L  +E
Sbjct: 360 DRILTLTTNE 369

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 260

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 104/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G  G+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 77
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGA-KFPIKWTAPEAINYGTFTIKSD 192
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 193 VWSFGILLTEIV 204

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 126/239 (52%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H++++ L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 261

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 331
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T      K    +  PE     + T KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 669 VYSFGVVMFEILCGRPVIDPSL-PREKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 485

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 257

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 470 GYRFPFVAIQEATDNFSE-SLVIGIGGFGKVYRG-VLRDETKVAVK-------RGGTQSH 520
           G  FP   +    DN  E    IG GGFG V++G +++D++ VA+K        G T+  
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSW 580
           +   EF+ E+ ++S   H ++V L G       M++  E++  G L   L     P + W
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKW 121
Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DEN--LMAKVADFGLSKIGP 635
             +L + +  A G+ Y+       I+HRD++S NI L   DEN  + AKVADFG S+   
Sbjct: 122 SVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--- 177
Query: 636 DLDQTHVSTAVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRPVID 687
                H  + + G+F ++ PE +  ++   TEK+D YSF ++++ IL G    D
Sbjct: 178 --QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 255

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 302

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L    
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA---FLAEANLMKQLQHQRLVRLYAVV 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     +  IHR
Sbjct: 74  TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 129
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           ++++ANIL+ + L  K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKSD 188
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 189 VWSFGILLTEIV 200

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 127/239 (53%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I EY   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + ++ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 135
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P IDPS                   Q+ ++++     +     
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPS-------------------QVYELLEKDYRMERPEGC 235
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 261

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 119/234 (50%), Gaps = 25/234 (10%)
Query: 470 GYRFPFVAIQEATDNFSE-SLVIGIGGFGKVYRG-VLRDETKVAVK-------RGGTQSH 520
           G  FP   +    DN  E    IG GGFG V++G +++D++ VA+K        G T+  
Sbjct: 5   GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSW 580
           +   EF+ E+ ++S   H ++V L G       M++  E++  G L   L     P + W
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP-IKW 121
Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DEN--LMAKVADFGLSKIGP 635
             +L + +  A G+ Y+       I+HRD++S NI L   DEN  + AKVADF LS+   
Sbjct: 122 SVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--- 177
Query: 636 DLDQTHVSTAVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRPVID 687
                H  + + G+F ++ PE +  ++   TEK+D YSF ++++ IL G    D
Sbjct: 178 --QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 254

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 261

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T      K    +  PE     + T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 253

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-------------KRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 250

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T      K    +  PE     + T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSW-------------RKRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 246

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 110/198 (55%), Gaps = 12/198 (6%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG+G FG+V  G L+     E  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 36  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNIIH 94
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G   +   ++II EYMENG+L D     N    +  + + +  G   G+ YL   S  
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 150
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + +HRD+ + NIL++ NL+ KV+DFG+S++   D +  + +   K    +  PE +  ++
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+S+G+VM+E++
Sbjct: 211 FTSASDVWSYGIVMWEVM 228

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 125/231 (54%), Gaps = 31/231 (13%)
Query: 491 IGIGGFGKVYR----GVLRDE----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +G G FG+V      G+ +D+    TKVAVK      + + L++  +E+EM+    +H++
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSW-------------RKRLEIC 587
           +++L+G C +   + +I EY   G L+++L A   P L +              K L  C
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 588 I-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++    +D    +T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
           +    ++ PE L  +  T +SDV+SFGV+++EI  L G P   P +P E++
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 261

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  100 bits (250), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 115/211 (54%), Gaps = 16/211 (7%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG+V RG L+     E+ VA+K  +GG    Q   EF +E  ++ QF H +++ 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIR 79
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G       ++I+ E+MENG L D     N    +  + + +  G A G+ YL   +  
Sbjct: 80  LEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 135
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPD--LDQTHVST-AVKGSFGYLDPEYLTK 660
           + +HRD+ + NIL++ NL+ KV+DFGLS+   +   D T+ S+   K    +  PE +  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 661 QQLTEKSDVYSFGVVMFEILC--GRPVIDPS 689
           ++ T  SD +S+G+VM+E++    RP  D S
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERPYWDMS 226

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 91
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 148
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 149 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVM 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 137/273 (50%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ +L   ++
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---AS 152
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++  +  + D  H  T  K    ++  E L  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 259
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 260 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 289

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 72
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 73  SE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGA-KFPIKWTAPEAALYGRFTIKSD 187
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 188 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 226

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 249 SE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T      K    +  PE     + T KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 126/239 (52%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I  Y   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 113/214 (52%), Gaps = 22/214 (10%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG+V RG L+     E+ VA+K  +GG    Q   EF +E  ++ QF H +++ 
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIR 81
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G       ++I+ E+MENG L D     N    +  + + +  G A G+ YL   +  
Sbjct: 82  LEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMRYL---AEM 137
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG------YLDPEY 657
           + +HRD+ + NIL++ NL+ KV+DFGLS+    L++         S G      +  PE 
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRF---LEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 658 LTKQQLTEKSDVYSFGVVMFEILC--GRPVIDPS 689
           +  ++ T  SD +S+G+VM+E++    RP  D S
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMS 228

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 110/198 (55%), Gaps = 12/198 (6%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG+G FG+V  G L+     E  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 21  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNIIH 79
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G   +   ++II EYMENG+L D     N    +  + + +  G   G+ YL   S  
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 135
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + +HRD+ + NIL++ NL+ KV+DFG+S++   D +  + +   K    +  PE +  ++
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+S+G+VM+E++
Sbjct: 196 FTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 110/198 (55%), Gaps = 12/198 (6%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG+G FG+V  G L+     E  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 15  VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNIIH 73
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G   +   ++II EYMENG+L D     N    +  + + +  G   G+ YL   S  
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 129
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + +HRD+ + NIL++ NL+ KV+DFG+S++   D +  + +   K    +  PE +  ++
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+S+G+VM+E++
Sbjct: 190 FTSASDVWSYGIVMWEVM 207

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 14/205 (6%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 101
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H +++ L G   +   ++I+ EYMENG+L D     +    +  + + +  G A G+ Y
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDP 655
           L   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    +  P
Sbjct: 161 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 656 EYLTKQQLTEKSDVYSFGVVMFEIL 680
           E +  ++ T  SDV+S+G+V++E++
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVM 242

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 75
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 76  SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 131
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 190
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 191 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 229

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 79
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 80  SE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGA-KFPIKWTAPEAALYGRFTIKSD 194
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 233

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 74/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E    I+I EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +HR
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 669 VYSFGVVMFEI 679
           +++FGV+M+EI
Sbjct: 204 IWAFGVLMWEI 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 126/239 (52%), Gaps = 31/239 (12%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEML 533
           D  +    +G G FG+V      G+ +D+ K    VAVK      + + L++  +E+EM+
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR----------- 581
               +H+++++L+G C +   + +I  Y   G L+++L A   P + +            
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 582 --KRLEICI-GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             K L  C    ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++   ++D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKV 695
               +T  +    ++ PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL 268

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ +L   ++
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---AS 151
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++     + D  H  T  K    ++  E L  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 258
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 259 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 288

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 79
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 80  SE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 194
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ +L   ++
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---AS 210
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++     + D  H  T  K    ++  E L  
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 317
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 318 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 347

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGL+++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G C
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +HR
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 669 VYSFGVVMFEI 679
           +++FGV+M+EI
Sbjct: 204 IWAFGVLMWEI 214

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ +L   ++
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---AS 156
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++     + D  H  T  K    ++  E L  
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 263
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 264 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 293

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ +L   ++
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---AS 152
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++     + D  H  T  K    ++  E L  
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 259
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 260 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ +L   ++
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---AS 151
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++     + D  H  T  K    ++  E L  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 258
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 259 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 288

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E    I+I EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 74  SE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 129
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 188
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 189 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 227

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ +L   ++
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---AS 149
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++     + D  H  T  K    ++  E L  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 256
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 257 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 286

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G C
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +HR
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 669 VYSFGVVMFEI 679
           +++FGV+M+EI
Sbjct: 188 IWAFGVLMWEI 198

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 71
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 72  SE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 127
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 186
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 187 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 225

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +HR
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 124
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 669 VYSFGVVMFEI 679
           +++FGV+M+EI
Sbjct: 184 IWAFGVLMWEI 194

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G C
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +HR
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 135
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 669 VYSFGVVMFEI 679
           +++FGV+M+EI
Sbjct: 195 IWAFGVLMWEI 205

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +HR
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 129
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 669 VYSFGVVMFEI 679
           +++FGV+M+EI
Sbjct: 189 IWAFGVLMWEI 199

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ EYMENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGL ++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 115/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKIRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 10/191 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G C
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +HR
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 129
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   + + KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 669 VYSFGVVMFEI 679
           +++FGV+M+EI
Sbjct: 189 IWAFGVLMWEI 199

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 237
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 237
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 471 YRFPFVAIQEATDNFSESL-----VIGIGGFGKVYRGVLR----DETKVAVKR---GGTQ 518
           Y  P  A+ E       S      VIG G FG+V  G L+     E  VA+K    G T+
Sbjct: 5   YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTE 64
Query: 519 SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSL 578
             +   +F  E  ++ QF H +++ L G   +   ++I+ EYMENG+L D     N    
Sbjct: 65  KQR--RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQF 121
Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDL 637
           +  + + +  G + G+ YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D 
Sbjct: 122 TVIQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 178
Query: 638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +  + +   K    +  PE +  ++ T  SDV+S+G+VM+E++
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV 221

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 142
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 202 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 242
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 237
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNL 344
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 444
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 445 PEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 112/219 (51%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + G  S +    F  E +++ + RH  LV L    
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 249
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 250 SE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 305
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+ ENL+ KVADFGL ++  D + T      K    +  PE     + T KSD
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 403

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   +S    L +    +  + YL     K  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDL 137
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 237
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 114/219 (52%), Gaps = 13/219 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L    
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAVV 82
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L       L   + +++    A G+ Y+   +    +HR
Sbjct: 83  SE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ +ANIL+ ENL+ KVADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSD 197
Query: 669 VYSFGVVMFEILCGRPVIDPSLP-REKVNLVE--WAMKC 704
           V+SFG+++ E+     V  P +  RE ++ VE  + M C
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 236

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ E MENG+L   L  + + F  +     L    G A G+
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 131
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 132 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVM 215

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +IG G  G+V  G LR     +  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNIIR 114
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G        +I+ EYMENG+L D    ++    +  + + +  G   G+ YL   S  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + N+L+D NL+ KV+DFGLS++   D D  + +T  K    +  PE +  + 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 663 LTEKSDVYSFGVVMFEILC 681
            +  SDV+SFGVVM+E+L 
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 142
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 202 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 242
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 170
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 277
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 278 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 307

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 169
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 276
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 277 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 306

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 150
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 257
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 258 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 287

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 142
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 202 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 242
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 142
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 202 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 242
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 151
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 258
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 259 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 288

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ E MENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 138
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 198 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 238
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 151
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 258
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 259 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 288

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 150
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 257
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 258 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 287

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 137
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 237
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 143
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 250
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 251 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 280

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 138
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 198 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 238
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 149
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 256
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 257 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 286

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 141
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 201 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 241
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 137
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 197 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 237
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 148
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 255
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 256 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 285

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/273 (29%), Positives = 136/273 (49%), Gaps = 31/273 (11%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G L D    +   AVK     +  G +++F TE  ++  F H +++SL
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 545 IGYC-DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +G C       +++  YM++G L++ +   ++ P++  +  +   +  A+G+ YL   ++
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---AS 146
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD--QTHVSTAVKGSFGYLDPEYLTK 660
           K  +HRD+ + N +LDE    KVADFGL++   D +    H  T  K    ++  E L  
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 661 QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
           Q+ T KSDV+SFGV+++E++  G P      P   VN  +  +   +  +L       L 
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRL-------LQ 253
Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            +  PD L    E+  KC       RPS  +++
Sbjct: 254 PEYCPDPL---YEVMLKCWHPKAEMRPSFSELV 283

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 110/207 (53%), Gaps = 18/207 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQF 536
           N S   V+G G FG+V  G L+     E  VA+K    G T+  +   +F  E  ++ QF
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQF 103
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGL 594
            H +++ L G   +   ++I+ E MENG+L   L  + + F  +     L    G A G+
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYL 653
            YL   S    +HRD+ + NIL++ NL+ KV+DFGLS++   D +  + +   K    + 
Sbjct: 161 KYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            PE +  ++ T  SDV+S+G+V++E++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVM 244

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 150
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 209
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 210 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 250
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 251 PEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 139
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 199 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 239
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDL 142
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 202 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 242
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +IG G  G+V  G LR     +  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNIIR 114
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G        +I+ EYMENG+L D    ++    +  + + +  G   G+ YL   S  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + N+L+D NL+ KV+DFGLS++   D D    +T  K    +  PE +  + 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 663 LTEKSDVYSFGVVMFEILC 681
            +  SDV+SFGVVM+E+L 
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 139
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 199 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 239
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRDL 139
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 199 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 239
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     +     +F+ E E+L+  +H H+V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEICIGA 590
            G C + + +I+++EYM++G L   L A    +              L   + L I    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A G+ YL   +++  +HRD+ + N L+  NL+ K+ DFG+S+     D   V        
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            ++ PE +  ++ T +SDV+SFGV+++EI 
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L A +   +   K L+      +G+ YL    TK
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQA-HAERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 13/221 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+ G     TKVA+K  + GT S +   E   E +++ + +H  LV L    
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLE---EAQIMKKLKHDKLVQLYAVV 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            E   + I+ EYM  G+L D L      +L     +++    A G+ Y+   +    IHR
Sbjct: 74  SE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 129
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D++SANIL+   L+ K+ADFGL+++  D + T    A K    +  PE     + T KSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGA-KFPIKWTAPEAALYGRFTIKSD 188
Query: 669 VYSFGVVMFEILCGRPVIDPSL-PREKVNLVE--WAMKCQE 706
           V+SFG+++ E++    V  P +  RE +  VE  + M C +
Sbjct: 189 VWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQ 229

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 27/264 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                I+ EYM  G L D+L   N   ++    L +    +  + YL     K  IHRD+
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYL---EKKNFIHRDL 156
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L     + KSDV+
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ D+++     +     
Sbjct: 216 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYDLLEKGYRMEQPEGC 256
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGD 750
             K  E+   C      DRPS  +
Sbjct: 257 PPKVYELMRACWKWSPADRPSFAE 280

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 116/265 (43%), Gaps = 27/265 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 550
           +G G +G+VY GV +  +     +   +    + EF  E  ++ + +H +LV L+G C  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV 610
                II E+M  G L D+L   N   ++    L +    +  + YL     K  IHR++
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL---EKKNFIHRNL 383
Query: 611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
            + N L+ EN + KVADFGLS++    D        K    +  PE L   + + KSDV+
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 442
Query: 671 SFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +FGV+++EI    +   P ID S                   Q+ ++++     +     
Sbjct: 443 AFGVLLWEIATYGMSPYPGIDLS-------------------QVYELLEKDYRMERPEGC 483
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDV 751
             K  E+   C      DRPS  ++
Sbjct: 484 PEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 118/227 (51%), Gaps = 25/227 (11%)
Query: 473 FPFVAIQEATDNFSESL---------VIGIGGFGKVYRGVLR----DETKVAVK---RGG 516
           F F    EA   F++ +         VIG G FG+V  G L+     E  VA+K    G 
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 517 TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP 576
           T+  +   +F +E  ++ QF H +++ L G   +   ++II E+MENG+L D     N  
Sbjct: 74  TEKQR--RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDG 130
Query: 577 SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD 636
             +  + + +  G A G+ YL   +    +HRD+ + NIL++ NL+ KV+DFGLS+   D
Sbjct: 131 QFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 637 --LDQTHVST-AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
              D T+ S    K    +  PE +  ++ T  SDV+S+G+VM+E++
Sbjct: 188 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           VIG G FG+V  G L+     +  VA+K    G T+  +   +F  E  ++ QF H ++V
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR--RDFLCEASIMGQFDHPNVV 107
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L G       ++I+ E+MENG L D     +    +  + + +  G A G+ YL   + 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL---AD 163
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
              +HRD+ + NIL++ NL+ KV+DFGLS+ I  D +  + +T  K    +  PE +  +
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 662 QLTEKSDVYSFGVVMFEILC--GRPVIDPS 689
           + T  SDV+S+G+VM+E++    RP  D S
Sbjct: 224 KFTSASDVWSYGIVMWEVMSYGERPYWDMS 253

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 164
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 224
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 225 FSVASDVWSFGVVLYELF 242

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 137
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 197
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 198 FSVASDVWSFGVVLYELF 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 132
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 192
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 193 FSVASDVWSFGVVLYELF 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 139
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 199
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 200 FSVASDVWSFGVVLYELF 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L       +   K L+      +G+ YL    TK
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTK 138
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 198
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 199 FSVASDVWSFGVVLYELF 216

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 140
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 200
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 201 FSVASDVWSFGVVLYELF 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY-CD 549
           IG G FG V  G  R   KVAVK    ++      F  E  +++Q RH +LV L+G   +
Sbjct: 201 IGKGEFGDVMLGDYRG-NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           E+  + I+ EYM  G+L D+L +     L     L+  +     + YL   +    +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 314
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           + + N+L+ E+ +AKV+DFGL+K     + +      K    +  PE L +++ + KSDV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 670 YSFGVVMFEILCGRPVIDPSLPREKV 695
           +SFG++++EI     V  P +P + V
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKDV 395

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 131
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 191
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 192 FSVASDVWSFGVVLYELF 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 193
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY-CD 549
           IG G FG V  G  R   KVAVK    ++      F  E  +++Q RH +LV L+G   +
Sbjct: 29  IGKGEFGDVMLGDYRG-NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           E+  + I+ EYM  G+L D+L +     L     L+  +     + YL   +    +HRD
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 142
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           + + N+L+ E+ +AKV+DFGL+K     + +      K    +  PE L +++ + KSDV
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 670 YSFGVVMFEILCGRPVIDPSLPREKV 695
           +SFG++++EI     V  P +P + V
Sbjct: 198 WSFGILLWEIYSFGRVPYPRIPLKDV 223

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 151
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 212 FSVASDVWSFGVVLYELF 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 151
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 211
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 212 FSVASDVWSFGVVLYELF 229

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY-CD 549
           IG G FG V  G  R   KVAVK    ++      F  E  +++Q RH +LV L+G   +
Sbjct: 14  IGKGEFGDVMLGDYRG-NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           E+  + I+ EYM  G+L D+L +     L     L+  +     + YL   +    +HRD
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 127
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           + + N+L+ E+ +AKV+DFGL+K     + +      K    +  PE L +++ + KSDV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 670 YSFGVVMFEILCGRPVIDPSLPREKV 695
           +SFG++++EI     V  P +P + V
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDV 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG V  G  + +  VAVK  + G+ S     EF  E + + +  H  LV   G C
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   + I+ EY+ NG L ++L  S+   L   + LE+C     G+ +L    +   IHR
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+D +L  KV+DFG+++   D DQ   S   K    +  PE     + + KSD
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 669 VYSFGVVMFEIL 680
           V++FG++M+E+ 
Sbjct: 188 VWAFGILMWEVF 199

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 12/206 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY-CD 549
           IG G FG V  G  R   KVAVK    ++      F  E  +++Q RH +LV L+G   +
Sbjct: 20  IGKGEFGDVMLGDYRG-NKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           E+  + I+ EYM  G+L D+L +     L     L+  +     + YL   +    +HRD
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 133
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           + + N+L+ E+ +AKV+DFGL+K     + +      K    +  PE L +   + KSDV
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 670 YSFGVVMFEILCGRPVIDPSLPREKV 695
           +SFG++++EI     V  P +P + V
Sbjct: 189 WSFGILLWEIYSFGRVPYPRIPLKDV 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L       +   K L+      +G+ YL    TK
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTK 133
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 194 FSVASDVWSFGVVLYELF 211

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     S     +F+ E E+L+  +H+H+V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEICIGA 590
            G C E   +++++EYM +G L   L  S+ P               L   + L +    
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A G+ YL   +    +HRD+ + N L+ + L+ K+ DFG+S+     D   V        
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            ++ PE +  ++ T +SDV+SFGVV++EI 
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     S     +F+ E E+L+  +H+H+V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEICIGA 590
            G C E   +++++EYM +G L   L  S+ P               L   + L +    
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A G+ YL   +    +HRD+ + N L+ + L+ K+ DFG+S+     D   V        
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            ++ PE +  ++ T +SDV+SFGVV++EI 
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIF 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV+          +D+  VAVK     S     +F+ E E+L+  +H+H+V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEICIGA 590
            G C E   +++++EYM +G L   L  S+ P               L   + L +    
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFL-RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A G+ YL   +    +HRD+ + N L+ + L+ K+ DFG+S+     D   V        
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE +  ++ T +SDV+SFGVV++EI
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           VIG G FG+V  G L+     E  VA+K    G T+  +   +F +E  ++ QF H +++
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNVI 71
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L G   +   ++II E+MENG+L D     N    +  + + +  G A G+ YL   + 
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---AD 127
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPD--LDQTHVST-AVKGSFGYLDPEYLT 659
              +HR + + NIL++ NL+ KV+DFGLS+   D   D T+ S    K    +  PE + 
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+S+G+VM+E++
Sbjct: 188 YRKFTSASDVWSYGIVMWEVM 208

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL    TK
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL---GTK 134
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHR++ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 194
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 195 FSVASDVWSFGVVLYELF 212

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L+D T   VAVK+    + + L +F  EIE+L   +H ++V   
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 546 GYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G C    R  + +I E++  G+L+++L       +   K L+      +G+ YL    TK
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHK-ERIDHIKLLQYTSQICKGMEYL---GTK 136
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             IHRD+ + NIL++     K+ DFGL+K+ P D +   V    +    +  PE LT+ +
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK 196
Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVV++E+ 
Sbjct: 197 FSVASDVWSFGVVLYELF 214

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 109/219 (49%), Gaps = 32/219 (14%)
Query: 491 IGIGGFGKVYR----GVLRDE--TKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVS 543
           IG G FG+V++    G+L  E  T VAVK    ++   + A+F+ E  ++++F + ++V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA----------------------SNFPSLSWR 581
           L+G C     M +++EYM  G L + L +                         P LS  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH 641
           ++L I    A G+ YL   S +  +HRD+ + N L+ EN++ K+ADFGLS+     D   
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
                     ++ PE +   + T +SDV+++GVV++EI 
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 59
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 117
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +S    G+
Sbjct: 118 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GT 170
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
             YL PE +  +   EK D++S GV+ +E L G+P  +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 137 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIXETDXXR- 189
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 190 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 128 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIXETDXXR- 180
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 181 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 117 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
             YL PE +  +   EK D++S GV+ +E L G+P  +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG+V+ G LR D T VAVK         L A+F  E  +L Q+ H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + I+ E ++ G     L       L  +  L++   AA G+ YL    +K  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYL---ESKCCIHR 237
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ E  + K++DFG+S+   D          +    +  PE L   + + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 669 VYSFGVVMFE 678
           V+SFG++++E
Sbjct: 298 VWSFGILLWE 307

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 84
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 142
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +   T + G+
Sbjct: 143 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 195
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
             YL PE +  +   EK D++S GV+ +E L G+P  +
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 60/300 (20%)
Query: 490 VIGIGGFGKVYRGVLRDE---TKVAVKRGGT-QSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G FG+V +  ++ +      A+KR     S     +F  E+E+L +   H ++++L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGA 590
           +G C+ R  + +  EY  +G L D L  S                 +LS ++ L      
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           ARG+ YL   S K  IHRD+ + NIL+ EN +AK+ADFGLS+ G ++        VK + 
Sbjct: 142 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 190
Query: 651 GYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMK 703
           G L   ++  + L     T  SDV+S+GV+++EI  L G P                 M 
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--------------GMT 236
Query: 704 CQETGQLEDIVDPTLTGQIKPDSLN---KFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           C E      + +    G      LN   +  ++  +C  +   +RPS   +L +L   L+
Sbjct: 237 CAE------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 290

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 136/300 (45%), Gaps = 60/300 (20%)
Query: 490 VIGIGGFGKVYRGVLRDE---TKVAVKRGGT-QSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G FG+V +  ++ +      A+KR     S     +F  E+E+L +   H ++++L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGA 590
           +G C+ R  + +  EY  +G L D L  S                 +LS ++ L      
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           ARG+ YL   S K  IHRD+ + NIL+ EN +AK+ADFGLS+ G ++        VK + 
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 200
Query: 651 GYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMK 703
           G L   ++  + L     T  SDV+S+GV+++EI  L G P                 M 
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--------------GMT 246
Query: 704 CQETGQLEDIVDPTLTGQIKPDSLN---KFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           C E      + +    G      LN   +  ++  +C  +   +RPS   +L +L   L+
Sbjct: 247 CAE------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGL-AEFRTEIEMLSQFR 537
           +D +    ++G GG  +V+    LRD   VAVK  R            FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 538 HRHLVSLIGYCDERNEM----IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H  +V++    +          I+ EY++  TL+D ++      ++ ++ +E+   A + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-VKGSFGY 652
           L++ H      IIHRDVK ANIL+      KV DFG+++   D   +   TA V G+  Y
Sbjct: 129 LNFSHQ---NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE      +  +SDVYS G V++E+L G P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +     +N P L   S  K ++
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 195
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 196 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 21  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 75
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 133
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +   T + G+
Sbjct: 134 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 186
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
             YL PE +  +   EK D++S GV+ +E L G+P  +
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 117 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 117 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 98/190 (51%), Gaps = 6/190 (3%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG+V+ G LR D T VAVK         L A+F  E  +L Q+ H ++V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            ++  + I+ E ++ G     L       L  +  L++   AA G+ YL    +K  IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYL---ESKCCIHR 237
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N L+ E  + K++DFG+S+   D          +    +  PE L   + + +SD
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 669 VYSFGVVMFE 678
           V+SFG++++E
Sbjct: 298 VWSFGILLWE 307

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 63
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 122 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 174
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +    A+ G+
Sbjct: 117 LANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 59
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 117
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 118 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 170
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 63
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 122 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 174
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 111/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +     +N P L   S  K ++
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 133 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 185
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 186 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 61
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 119
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +    A+ G+
Sbjct: 120 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGT 172
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 61
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 119
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 120 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 172
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 117 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 117 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 63
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +   T + G+
Sbjct: 122 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 174
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
             YL PE +  +   EK D++S GV+ +E L G+P  +
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 62
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 120
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 121 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 173
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+       TKVAVK  + G+ S +    F  E  ++   +H  LV L    
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 79
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             +  + II E+M  G+L D L +         K ++     A G+ ++     +  IHR
Sbjct: 80  T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 135
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+  +L+ K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSD 194
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 195 VWSFGILLMEIV 206

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 136 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 188
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 189 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 57
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 58  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 115
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 116 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 168
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +    A+ G+
Sbjct: 117 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALCGT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 134 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 186
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 187 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 63
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   G +   L          ++       
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 122 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 174
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGL-AEFRTEIEMLSQFR 537
           +D +    ++G GG  +V+    LRD   VAVK  R            FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 538 HRHLVSLIGYCDERNEM----IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H  +V++    +          I+ EY++  TL+D ++      ++ ++ +E+   A + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-VKGSFGY 652
           L++ H      IIHRDVK ANI++      KV DFG+++   D   +   TA V G+  Y
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE      +  +SDVYS G V++E+L G P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 14/212 (6%)
Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGL-AEFRTEIEMLSQFR 537
           +D +    ++G GG  +V+    LRD   VAVK  R            FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 538 HRHLVSLIGYCDERNEM----IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H  +V++    +          I+ EY++  TL+D ++      ++ ++ +E+   A + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-VKGSFGY 652
           L++ H      IIHRDVK ANI++      KV DFG+++   D   +   TA V G+  Y
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE      +  +SDVYS G V++E+L G P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 195
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 196 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 137 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 189
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 190 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE-HQ----LRRE 55
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 56  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 113
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +   T + G+
Sbjct: 114 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 166
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 201

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 61
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 119
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +T +     G+
Sbjct: 120 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GT 172
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 136 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 188
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 189 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 130 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 182
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 183 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 118/257 (45%), Gaps = 47/257 (18%)
Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G GGFG V R + +D   +VA+K+   + S +    +  EI+++ +  H ++VS     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 549 DERNEM------IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG--------- 593
           D   ++      ++  EY E G L+ +L            + E C G   G         
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-----------NQFENCCGLKEGPIRTLLSDI 130
Query: 594 ---LHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
              L YLH      IIHRD+K  NI+L    + L+ K+ D G +K   +LDQ  + T   
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV 184
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG-RPVIDPSLPREKVNLVEWAMKCQE 706
           G+  YL PE L +++ T   D +SFG + FE + G RP +    P      V+W  K +E
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVRE 238
Query: 707 TGQLEDIVDPTLTGQIK 723
                 +V   LTG +K
Sbjct: 239 KSNEHIVVYDDLTGAVK 255

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 110/219 (50%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 105 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 164
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   D+ +T     
Sbjct: 165 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR- 217
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 218 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 118/257 (45%), Gaps = 47/257 (18%)
Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G GGFG V R + +D   +VA+K+   + S +    +  EI+++ +  H ++VS     
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 549 DERNEM------IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG--------- 593
           D   ++      ++  EY E G L+ +L            + E C G   G         
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-----------NQFENCCGLKEGPIRTLLSDI 131
Query: 594 ---LHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
              L YLH      IIHRD+K  NI+L    + L+ K+ D G +K   +LDQ  + T   
Sbjct: 132 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV 185
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG-RPVIDPSLPREKVNLVEWAMKCQE 706
           G+  YL PE L +++ T   D +SFG + FE + G RP +    P      V+W  K +E
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVRE 239
Query: 707 TGQLEDIVDPTLTGQIK 723
                 +V   LTG +K
Sbjct: 240 KSNEHIVVYDDLTGAVK 256

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDET---------KVAVKRGGTQSHQGLAEFRTE 529
           Q   ++F     +G G FG VY    R            K  +++ G + HQ     R E
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQ----LRRE 62
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITE 120
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL  N   K+ADFG S   P    +   T + G+
Sbjct: 121 LANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLCGT 173
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G P
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 136/300 (45%), Gaps = 60/300 (20%)
Query: 490 VIGIGGFGKVYRGVLRDE---TKVAVKRGGT-QSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G FG+V +  ++ +      A+KR     S     +F  E+E+L +   H ++++L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGA 590
           +G C+ R  + +  EY  +G L D L  S                 +LS ++ L      
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           ARG+ YL   S K  IHR++ + NIL+ EN +AK+ADFGLS+ G ++        VK + 
Sbjct: 149 ARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR-GQEV-------YVKKTM 197
Query: 651 GYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMK 703
           G L   ++  + L     T  SDV+S+GV+++EI  L G P                 M 
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--------------GMT 243
Query: 704 CQETGQLEDIVDPTLTGQIKPDSLN---KFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           C E      + +    G      LN   +  ++  +C  +   +RPS   +L +L   L+
Sbjct: 244 CAE------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 297

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLA 524
           P  + Q A ++F     +G G FG VY            L+   K  +++ G + HQ   
Sbjct: 2   PLGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ--- 57
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
             R E+E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++  
Sbjct: 58  -LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA 114
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
                 A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +  +  
Sbjct: 115 TYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC- 170
Query: 645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
              G+  YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 171 ---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+       TKVAVK  + G+ S +    F  E  ++   +H  LV L    
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 252
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             +  + II E+M  G+L D L +         K ++     A G+ ++     +  IHR
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 308
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+  +L+ K+ADFGL+++  D + T    A K    +  PE +     T KSD
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSD 367
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 368 VWSFGILLMEIV 379

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 23/218 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 84
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 142
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +  +     G+
Sbjct: 143 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GT 195
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
             YL PE +  +   EK D++S GV+ +E L G+P  +
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 60
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 118
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +  +     G+
Sbjct: 119 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 171
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 491 IGIGGFGKVYRGVLRDET---KVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G+G FGKV  G  + E    KVAVK   R   +S   + + R EI+ L  FRH H++ L
Sbjct: 24  LGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
                  +++ ++ EY+  G L D++  +        +RL   I +  G+ Y H      
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYCHR---HM 136
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           ++HRD+K  N+LLD ++ AK+ADFGLS +  D +    S    GS  Y  PE ++ +   
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPEVISGRLYA 193
Query: 665 -EKSDVYSFGVVMFEILCGR-PVIDPSLP 691
             + D++S GV+++ +LCG  P  D  +P
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVP 222

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 60
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 118
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+A+FG S   P   +T +     G+
Sbjct: 119 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GT 171
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 206

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 61
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 119
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+A+FG S   P   +T +     G+
Sbjct: 120 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLC----GT 172
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 63
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   G +   L          ++       
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +     + G+
Sbjct: 122 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLXGT 174
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 209

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 58
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 116
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +  +     G+
Sbjct: 117 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 204

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 491 IGIGGFGKVYRGVLRDET----KVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G GG   VY   L ++T    KVA+K       +  + L  F  E+   SQ  H+++VS
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           +I   +E +   ++ EY+E  TL +  Y  +   LS    +        G+ + H     
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSE--YIESHGPLSVDTAINFTNQILDGIKHAHD---M 130
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            I+HRD+K  NIL+D N   K+ DFG++K   +   T  +  V G+  Y  PE    +  
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEAT 189
Query: 664 TEKSDVYSFGVVMFEILCGRP 684
            E +D+YS G+V++E+L G P
Sbjct: 190 DECTDIYSIGIVLYEMLVGEP 210

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 61
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 119
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P   +  +     G+
Sbjct: 120 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GT 172
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 207

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 28/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVY----RGVLRDE--TKVAVKR-GGTQSHQGLAEFRTEIEML 533
           A +  + S  +G G FG VY    +GV++DE  T+VA+K      S +   EF  E  ++
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-----SNFPSL---SWRKRLE 585
            +F   H+V L+G   +    ++I E M  G LK +L +      N P L   S  K ++
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +    A G+ YL+       +HRD+ + N  + E+   K+ DFG+++   D+ +T     
Sbjct: 130 MAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTR---DIYETDYYR- 182
Query: 646 VKGSFG-----YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            KG  G     ++ PE L     T  SDV+SFGVV++EI
Sbjct: 183 -KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTE 529
           Q A ++F     +G G FG VY            L+   K  +++ G + HQ     R E
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-HQ----LRRE 59
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITE 117
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL      K+ADFG S   P    +     + G+
Sbjct: 118 LANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDTLCGT 170
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G+P
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 20/192 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FG+V+       TKVAVK  + G+ S +    F  E  ++   +H  LV L    
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKLHAVV 246
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             +  + II E+M  G+L D L +         K ++     A G+ ++     +  IHR
Sbjct: 247 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHR 302
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+++ANIL+  +L+ K+ADFGL+++G            K    +  PE +     T KSD
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVG-----------AKFPIKWTAPEAINFGSFTIKSD 351
Query: 669 VYSFGVVMFEIL 680
           V+SFG+++ EI+
Sbjct: 352 VWSFGILLMEIV 363

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 490 VIGIGGFGKVYRGVLRDE----TKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G FG V  G L+ E     KVAVK  +    S + + EF +E   +  F H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 544 LIGYCDERNEM-----IIIYEYMENGTLKDHLYASNFPS----LSWRKRLEICIGAARGL 594
           L+G C E +       ++I  +M+ G L  +L  S   +    +  +  L+  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
            YL   S +  +HRD+ + N +L +++   VADFGLSK     D        K    ++ 
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV 714
            E L  +  T KSDV++FGV M+EI        P +  +   + ++ +      Q ED +
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV--QNHEMYDYLLHGHRLKQPEDCL 275
Query: 715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           D             +  EI   C     +DRP+   +   LE  L+
Sbjct: 276 D-------------ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HRD+ + N ++  +   K+ DFG+++     D        KG  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 196
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HRD+ + N ++  +   K+ DFG+++     D        KG  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 196
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDET---------KVAVKRGGTQSHQGLAEFRTE 529
           Q   ++F     +G G FG VY    R            K  +++ G + HQ     R E
Sbjct: 8   QWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE-HQ----LRRE 62
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           +E+ S  RH +++ L GY  +   + +I EY   GT+   L          ++       
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITE 120
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A  L Y H+   K +IHRD+K  N+LL  N   K+ADFG S   P    +     + G+
Sbjct: 121 LANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRDTLCGT 173
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             YL PE +  +   EK D++S GV+ +E L G P
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP 208

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HRD+ + N ++  +   K+ DFG+++     D        KG  G    
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIXETDXXRKGGKGLLPV 193
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGL-AEFRTEIEMLSQFR 537
           +D +    ++G GG  +V+    LR    VAVK  R            FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 538 HRHLVSLIGYCDERNEM----IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H  +V++    +          I+ EY++  TL+D ++      ++ ++ +E+   A + 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-VKGSFGY 652
           L++ H      IIHRDVK ANI++      KV DFG+++   D   +   TA V G+  Y
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE      +  +SDVYS G V++E+L G P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGL-AEFRTEIEMLSQFR 537
           +D +    ++G GG  +V+    LR    VAVK  R            FR E +  +   
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 538 HRHLVSLIGYCDERNEM----IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H  +V++    +          I+ EY++  TL+D ++      ++ ++ +E+   A + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-VKGSFGY 652
           L++ H      IIHRDVK ANI++      KV DFG+++   D   +   TA V G+  Y
Sbjct: 129 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE      +  +SDVYS G V++E+L G P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HRD+ + N ++  +   K+ DFG+++     D    +   KG  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETAYYRKGGKGLLPV 196
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 29/222 (13%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           V+G G FG+  +   R+  +V V +   +   +    F  E++++    H +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 549 DERNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
            +   +  I EY++ GTL+  + +  S +P   W +R+      A G+ YLH+ +   II
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYP---WSQRVSFAKDIASGMAYLHSMN---II 130
Query: 607 HRDVKSANILLDENLMAKVADFGLSKI---------------GPDLDQTHVSTAVKGSFG 651
           HRD+ S N L+ EN    VADFGL+++                PD  + +    V G+  
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY---TVVGNPY 187
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPS-LPR 692
           ++ PE +  +   EK DV+SFG+V+ EI+ GR   DP  LPR
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPR 228

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HRD+ + N ++  +   K+ DFG+++     D        KG  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 196
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGL-AEFRTEIEMLSQFR 537
           +D +    ++G GG  +V+    LR    VAVK  R            FR E +  +   
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 538 HRHLVSLIGYCDERNEM----IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H  +V++    +          I+ EY++  TL+D ++      ++ ++ +E+   A + 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQA 145
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA-VKGSFGY 652
           L++ H      IIHRDVK ANI++      KV DFG+++   D   +   TA V G+  Y
Sbjct: 146 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE      +  +SDVYS G V++E+L G P
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    F SL     +      +  L YL +   K 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KR 131
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STXXKASKGKLPIKWMAPESIN 185
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HRD+ + N ++  +   K+ DFG+++     D        KG  G    
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 195
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 491 IGIGGFGKVYRGVLRDE-----TKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV       E      +VAVK    +S    +A+ + EIE+L    H ++V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 545 IGYCDER--NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            G C E   N + +I E++ +G+LK++L   N   ++ +++L+  +   +G+ YL    +
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL---GS 144
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
           +  +HRD+ + N+L++     K+ DFGL+K I  D +   V         +  PE L + 
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 662 QLTEKSDVYSFGVVMFEIL 680
           +    SDV+SFGV + E+L
Sbjct: 205 KFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 491 IGIGGFGKVYRGVLRDE-----TKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G FGKV       E      +VAVK    +S    +A+ + EIE+L    H ++V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 545 IGYCDER--NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            G C E   N + +I E++ +G+LK++L   N   ++ +++L+  +   +G+ YL    +
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL---GS 132
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
           +  +HRD+ + N+L++     K+ DFGL+K I  D +   V         +  PE L + 
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 662 QLTEKSDVYSFGVVMFEIL 680
           +    SDV+SFGV + E+L
Sbjct: 193 KFYIASDVWSFGVTLHELL 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G+G FGKV  G  +    KVAVK   R   +S   + + + EI+ L  FRH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
                 +  ++ EY+  G L D++        +  R+  +  + A    H         +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH------RHMV 132
Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT- 664
           +HRD+K  N+LLD ++ AK+ADFGLS +  D +    S    GS  Y  PE ++ +    
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYAG 189
Query: 665 EKSDVYSFGVVMFEILCGR-PVIDPSLP 691
            + D++S GV+++ +LCG  P  D  +P
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 10/229 (4%)
Query: 477 AIQEATDNFSESLVIGIGGFGKVYRG-VLRDETKVAVKRGGTQS--HQGLAE-FRTEIEM 532
            I E  ++F    ++G G F  VYR   +    +VA+K    ++    G+ +  + E+++
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR 592
             Q +H  ++ L  Y ++ N + ++ E   NG +  +L     P  S  +          
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP-FSENEARHFMHQIIT 123
Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
           G+ YLH+     I+HRD+  +N+LL  N+  K+ADFGL+       + H +    G+  Y
Sbjct: 124 GMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNY 178
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA 701
           + PE  T+     +SDV+S G + + +L GRP  D    +  +N V  A
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HR++ + N ++  +   K+ DFG+++     D        KG  G    
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 196
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    F SL     +      +  L YL +   K 
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KR 511
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 565
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 483 DNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
           D+F     +G G FG VY            L+   K  +++ G + HQ     R EIE+ 
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQ----LRREIEIQ 69
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           S  RH +++ +  Y  +R  + ++ E+   G L   L          ++        A  
Sbjct: 70  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADA 127
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           LHY H    + +IHRD+K  N+L+      K+ADFG S   P L +  +     G+  YL
Sbjct: 128 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL 180
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
            PE +  +   EK D++  GV+ +E L G P  D
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 491 IGIGGFGKVYRGVLRD------ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG VY G  RD      ET+VAVK    + S +   EF  E  ++  F   H+V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--------SNFPSLSWRKRLEICIGAARGLH 595
           L+G   +    +++ E M +G LK +L +           P  + ++ +++    A G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
           YL+    K  +HR++ + N ++  +   K+ DFG+++     D        KG  G    
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLPV 197
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            ++ PE L     T  SD++SFGVV++EI
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 34/206 (16%)
Query: 491 IGIGGFGKVY------------RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           +G G FG+V+              VL+ E  V +K+    + + L        MLS   H
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL--------MLSIVTH 65
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPS-LSWRKRLEICIGAARGLHY 596
             ++ + G   +  ++ +I +Y+E G L   L  S  FP+ ++     E+C+     L Y
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA----LEY 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   K II+RD+K  NILLD+N   K+ DFG +K  PD     V+  + G+  Y+ PE
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPE 173
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCG 682
            ++ +   +  D +SFG++++E+L G
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G+G FGKV  G  +    KVAVK   R   +S   + + + EI+ L  FRH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
                 +  ++ EY+  G L D++        +  R+  +  + A    H         +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH------RHMV 132
Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT- 664
           +HRD+K  N+LLD ++ AK+ADFGLS +  D +    S    GS  Y  PE ++ +    
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVISGRLYAG 189
Query: 665 EKSDVYSFGVVMFEILCGR-PVIDPSLP 691
            + D++S GV+++ +LCG  P  D  +P
Sbjct: 190 PEVDIWSCGVILYALLCGTLPFDDEHVP 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 490 VIGIGGFGKVYRGVLRDETK-----VAVK-RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FG VY+G+   E +     VA+K    T   +   EF  E  +++   H HLV 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 544 LIGYCDERNEMIIIYEYMENGTLKD--HLYASNFPS---LSWRKRLEICIGAARGLHYLH 598
           L+G C     + ++ + M +G L +  H +  N  S   L+W      C+  A+G+ YL 
Sbjct: 82  LLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL- 133
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
               + ++HRD+ + N+L+      K+ DFGL+++    ++ + +   K    ++  E +
Sbjct: 134 --EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 659 TKQQLTEKSDVYSFGVVMFEILC--GRP 684
             ++ T +SDV+S+GV ++E++   G+P
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 23/214 (10%)
Query: 483 DNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
           D+F     +G G FG VY            L+   K  +++ G + HQ     R EIE+ 
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-HQ----LRREIEIQ 68
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           S  RH +++ +  Y  +R  + ++ E+   G L   L          ++        A  
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADA 126
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           LHY H    + +IHRD+K  N+L+      K+ADFG S   P L +  +     G+  YL
Sbjct: 127 LHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC----GTLDYL 179
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
            PE +  +   EK D++  GV+ +E L G P  D
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    + SL     +      +  L YL +   K 
Sbjct: 105 IGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 159
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 213
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 214 FRRFTSASDVWMFGVCMWEIL 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    + SL     +      +  L YL +   K 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 131
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 185
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    + SL     +      +  L YL +   K 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 131
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 185
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRDETK----VAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    + SL     +      +  L YL +   K 
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 128
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 182
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 183 FRRFTSASDVWMFGVCMWEIL 203

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 490 VIGIGGFGKVYRGVLRDETK-----VAVK-RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FG VY+G+   E +     VA+K    T   +   EF  E  +++   H HLV 
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 544 LIGYCDERNEMIIIYEYMENGTLKD--HLYASNFPS---LSWRKRLEICIGAARGLHYLH 598
           L+G C     + ++ + M +G L +  H +  N  S   L+W      C+  A+G+ YL 
Sbjct: 105 LLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYL- 156
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
               + ++HRD+ + N+L+      K+ DFGL+++    ++ + +   K    ++  E +
Sbjct: 157 --EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 659 TKQQLTEKSDVYSFGVVMFEILC--GRP 684
             ++ T +SDV+S+GV ++E++   G+P
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRDETK----VAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    + SL     +      +  L YL +   K 
Sbjct: 80  IGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 134
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 188
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 189 FRRFTSASDVWMFGVCMWEIL 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    + SL     +      +  L YL +   K 
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 136
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 190
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRDETK----VAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    + SL     +      +  L YL +   K 
Sbjct: 79  IGVITE-NPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLES---KR 133
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+  N   K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 187
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 188 FRRFTSASDVWMFGVCMWEIL 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 491 IGIGGFGKVYRGVLRDETK---VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V +GV R   K   VA+K  + GT+      E   E +++ Q  + ++V LI
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLI 76
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-AARGLHYLHTG---- 600
           G C +   ++++ E    G L   L           KR EI +   A  LH +  G    
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYL 126
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLT 659
             K  +HRD+ + N+LL     AK++DFGLSK +G D       +A K    +  PE + 
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ + +SDV+S+GV M+E L
Sbjct: 187 FRKFSSRSDVWSYGVTMWEAL 207

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGY- 547
            +G G +G+V+RG+   E+ VAVK   ++  Q    FR TEI      RH +++  I   
Sbjct: 15  CVGKGRYGEVWRGLWHGES-VAVKIFSSRDEQSW--FRETEIYNTVLLRHDNILGFIASD 71
Query: 548 CDERN---EMIIIYEYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLH----- 598
              RN   ++ +I  Y E+G+L D L      P L+    L + + AA GL +LH     
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEIFG 127
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVSTAVKGSFGYLDP 655
           T    AI HRD KS N+L+  NL   +AD GL+ +   G D      +  V G+  Y+ P
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAP 186
Query: 656 EYLTKQQLTE------KSDVYSFGVVMFEI 679
           E L +Q  T+       +D+++FG+V++EI
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    F SL     +      +  L YL +   K 
Sbjct: 77  IGVITE-NPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KR 131
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+      K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 185
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 106
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  L  HL  ++   L   + L    IC       RGL Y+
Sbjct: 107 ------NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 26/277 (9%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVL-RDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQ 535
           I +  + F++   IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ
Sbjct: 18  IADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ 77
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
               ++    G   + +++ II EY+  G+  D L A  F        L+  +   +GL 
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLD 134
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           YLH+      IHRD+K+AN+LL E    K+ADFG++    D  Q   +T V   F ++ P
Sbjct: 135 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-TQIKRNTFVGTPF-WMAP 189
Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
           E + +     K+D++S G+   E+  G P      P   + L+                 
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------------PKNNP 237
Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           PTL G    D    F E  + CL +    RP+  ++L
Sbjct: 238 PTLVG----DFTKSFKEFIDACLNKDPSFRPTAKELL 270

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+  L    F SL     +      +  L YL +   K 
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLES---KR 511
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG-----YLDPEYLT 659
            +HRD+ + N+L+      K+ DFGLS+   D      ST  K S G     ++ PE + 
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPESIN 565
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ T  SDV+ FGV M+EIL
Sbjct: 566 FRRFTSASDVWMFGVCMWEIL 586

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 484 NFSESLVIGIGGFGKV---YRGVLRDETKVAV---KRGGTQSHQGLAEFRTEIEMLSQFR 537
           N+     +G G FGKV   Y      +  + +   K       QG  E   EI  L   R
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H H++ L      ++E+I++ EY  N      +          R+  +  I A    H  
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 129
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                  I+HRD+K  N+LLDE+L  K+ADFGLS I  D +    S    GS  Y  PE 
Sbjct: 130 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 182
Query: 658 LT-KQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLP 691
           ++ K     + DV+S GV+++ +LC R P  D S+P
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 484 NFSESLVIGIGGFGKV---YRGVLRDETKVAV---KRGGTQSHQGLAEFRTEIEMLSQFR 537
           N+     +G G FGKV   Y      +  + +   K       QG  E   EI  L   R
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H H++ L      ++E+I++ EY  N      +          R+  +  I A    H  
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 130
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                  I+HRD+K  N+LLDE+L  K+ADFGLS I  D +    S    GS  Y  PE 
Sbjct: 131 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 183
Query: 658 LT-KQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLP 691
           ++ K     + DV+S GV+++ +LC R P  D S+P
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 219

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDE----TKVAVK--RGGTQSHQGLAEFRTEIEMLSQFR 537
            F+   ++G G FG V    L+ E     KVAVK  +    +   + EF  E   + +F 
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD 83
Query: 538 HRHLVSLIGYCDERNEM------IIIYEYMENGTLKDHLYAS----NFPSLSWRKRLEIC 587
           H H+  L+G              ++I  +M++G L   L AS    N  +L  +  +   
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFM 143
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           +  A G+ YL   S++  IHRD+ + N +L E++   VADFGLS+     D      A K
Sbjct: 144 VDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK 200
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
               +L  E L     T  SDV++FGV M+EI+
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 127/276 (46%), Gaps = 53/276 (19%)
Query: 494 GGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN- 552
           G FG V++  L +E  VAVK    Q  Q   +   E+  L   +H +++  IG  ++R  
Sbjct: 35  GRFGCVWKAQLLNEY-VAVKIFPIQDKQSW-QNEYEVYSLPGMKHENILQFIG-AEKRGT 91
Query: 553 ----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT-------GS 601
               ++ +I  + E G+L D L A+    +SW +   I    ARGL YLH        G 
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLS---KIGPDLDQTHVSTAVKGSFGYLDPEYL 658
             AI HRD+KS N+LL  NL A +ADFGL+   + G     TH      G+  Y+ PE L
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV---GTRRYMAPEVL 205
Query: 659 T-----KQQLTEKSDVYSFGVVMFEILCGR------PVIDPSLPREKVNLVEWAMKCQET 707
                 ++    + D+Y+ G+V++E L  R      PV +  LP E           +E 
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWE-LASRCTAADGPVDEYMLPFE-----------EEI 253
Query: 708 GQ---LEDIVDPTLTGQIKP---DSLNKFVEIAEKC 737
           GQ   LED+ +  +  + +P   D   K   +A  C
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 484 NFSESLVIGIGGFGKV---YRGVLRDETKVAV---KRGGTQSHQGLAEFRTEIEMLSQFR 537
           N+     +G G FGKV   Y      +  + +   K       QG  E   EI  L   R
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H H++ L      ++E+I++ EY  N      +          R+  +  I A    H  
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 120
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                  I+HRD+K  N+LLDE+L  K+ADFGLS I  D +    S    GS  Y  PE 
Sbjct: 121 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 173
Query: 658 LT-KQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLP 691
           ++ K     + DV+S GV+++ +LC R P  D S+P
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 209

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 491 IGIGGFGKVYRGVLRDETK---VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V +GV R   K   VA+K  + GT+      E   E +++ Q  + ++V LI
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRLI 402
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-AARGLHYLHTG---- 600
           G C +   ++++ E    G L   L           KR EI +   A  LH +  G    
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG---------KREEIPVSNVAELLHQVSMGMKYL 452
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLT 659
             K  +HR++ + N+LL     AK++DFGLSK +G D       +A K    +  PE + 
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 512
Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
            ++ + +SDV+S+GV M+E L
Sbjct: 513 FRKFSSRSDVWSYGVTMWEAL 533

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 23/218 (10%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDET--KVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N      +G G FGKV      G+ +++   KVAVK   + +H    E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL------------YASNFPSLSWRK 582
             +H ++V+L+G C     +++I EY   G L + L            +A    +LS R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 583 RLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV 642
            L      A+G+ +L   ++K  IHRDV + N+LL    +AK+ DFGL++   +     V
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
               +    ++ PE +     T +SDV+S+G++++EI 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 484 NFSESLVIGIGGFGKV---YRGVLRDETKVAV---KRGGTQSHQGLAEFRTEIEMLSQFR 537
           N+     +G G FGKV   Y      +  + +   K       QG  E   EI  L   R
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H H++ L      ++E+I++ EY  N      +          R+  +  I A    H  
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH-- 124
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                  I+HRD+K  N+LLDE+L  K+ADFGLS I  D +    S    GS  Y  PE 
Sbjct: 125 ----RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEV 177
Query: 658 LT-KQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLP 691
           ++ K     + DV+S GV+++ +LC R P  D S+P
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 483 DNFSESLVIGIGGFGKVYRG---------VLRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
           D+F     +G G FG VY            L+   K  +++ G + HQ     R EIE+ 
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVE-HQ----LRREIEIQ 77
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           +   H +++ L  Y  +R  + +I EY   G L   L  S   +   ++   I    A  
Sbjct: 78  AHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEELADA 135
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L Y H    K +IHRD+K  N+LL      K+ADFG S   P L +  +     G+  YL
Sbjct: 136 LMYCHG---KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC----GTLDYL 188
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE +  +   EK D++  GV+ +E+L G P
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVGNP 219

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDET--KVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N      +G G FGKV      G+ +++   KVAVK   + +H    E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSW-------------- 580
             +H ++V+L+G C     +++I EY   G L + L     P L +              
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT 640
           R  L      A+G+ +L   ++K  IHRDV + N+LL    +AK+ DFGL++   +    
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            V    +    ++ PE +     T +SDV+S+G++++EI 
Sbjct: 223 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 262

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 490 VIGIGGFGKVYRGVLRDE---------TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           V+G G FG V++GV   E          KV   + G QS Q + +    I  L    H H
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD---HAH 94
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V L+G C   + + ++ +Y+  G+L DH+      +L  +  L   +  A+G++YL   
Sbjct: 95  IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYL--- 149
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
               ++HR++ + N+LL      +VADFG++ + P  D+  + +  K    ++  E +  
Sbjct: 150 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 661 QQLTEKSDVYSFGVVMFEIL 680
            + T +SDV+S+GV ++E++
Sbjct: 210 GKYTHQSDVWSYGVTVWELM 229

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 23/203 (11%)
Query: 491 IGIGGFGKVYRGVLRDETK------VAVKR----GGTQSHQGLAEFRTEIEMLSQFRHRH 540
           +G G FGKV      D T       VAVK      G Q   G   ++ EI++L    H H
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEH 77
Query: 541 LVSLIGYCDERNE--MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
           ++   G C+++ E  + ++ EY+  G+L+D+L      S+   + L        G+ YLH
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH 134
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VSTAVKGSFGYLDPEY 657
           +   +  IHR++ + N+LLD + + K+ DFGL+K  P+  + + V         +  PE 
Sbjct: 135 S---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           L + +    SDV+SFGV ++E+L
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELL 214

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 38/274 (13%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGY-- 547
           IG G +G+V+ G  R E KVAVK   T        FR TEI      RH +++  I    
Sbjct: 45  IGKGRYGEVWMGKWRGE-KVAVKVFFTTEEASW--FRETEIYQTVLMRHENILGFIAADI 101
Query: 548 --CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG--STK 603
                  ++ +I +Y ENG+L D+L ++   +L  +  L++   +  GL +LHT   ST+
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 604 ---AIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVK-GSFGYLDPEYL 658
              AI HRD+KS NIL+ +N    +AD GL+ K   D ++  +    + G+  Y+ PE L
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 659 TKQ------QLTEKSDVYSFGVVMFEI----LCGRPVIDPSLPREKVNLVEWAMKCQETG 708
            +       Q    +D+YSFG++++E+    + G  V +  LP    +LV          
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH--DLVP------SDP 270
Query: 709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCG 742
             ED+ +     +++P   N++   +++CL Q G
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWS--SDECLRQMG 302

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 490 VIGIGGFGKVYRGVLRDE---------TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           V+G G FG V++GV   E          KV   + G QS Q + +    I  L    H H
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD---HAH 76
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V L+G C   + + ++ +Y+  G+L DH+   +  +L  +  L   +  A+G++YL   
Sbjct: 77  IVRLLGLCPG-SSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
               ++HR++ + N+LL      +VADFG++ + P  D+  + +  K    ++  E +  
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 661 QQLTEKSDVYSFGVVMFEIL 680
            + T +SDV+S+GV ++E++
Sbjct: 192 GKYTHQSDVWSYGVTVWELM 211

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 23/203 (11%)
Query: 491 IGIGGFGKVYRGVLRDETK------VAVKR----GGTQSHQGLAEFRTEIEMLSQFRHRH 540
           +G G FGKV      D T       VAVK      G Q   G   ++ EI++L    H H
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSG---WKQEIDILRTLYHEH 77
Query: 541 LVSLIGYCDERNE--MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
           ++   G C+++ E  + ++ EY+  G+L+D+L      S+   + L        G+ YLH
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH 134
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VSTAVKGSFGYLDPEY 657
               +  IHR++ + N+LLD + + K+ DFGL+K  P+  + + V         +  PE 
Sbjct: 135 A---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           L + +    SDV+SFGV ++E+L
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELL 214

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L D T   VAVK+          +F+ EI++L       +V   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 546 G--YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G  Y   R E+ ++ EY+ +G L+D L   +   L   + L       +G+ YL    ++
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL---GSR 130
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + NIL++     K+ADFGL+K+ P D D   V    +    +  PE L+   
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 663 LTEKSDVYSFGVVMFEI 679
            + +SDV+SFGVV++E+
Sbjct: 191 FSRQSDVWSFGVVLYEL 207

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 491 IGIGGFGKVYRGVLRDETK------VAVKR----GGTQSHQGLAEFRTEIEMLSQFRHRH 540
           +G G FGKV      D T       VAVK      G Q   G   ++ EI++L    H H
Sbjct: 39  LGEGHFGKVSL-YCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTLYHEH 94
Query: 541 LVSLIGYCDERN--EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
           ++   G C++     + ++ EY+  G+L+D+L      S+   + L        G+ YLH
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH 151
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VSTAVKGSFGYLDPEY 657
               +  IHRD+ + N+LLD + + K+ DFGL+K  P+  + + V         +  PE 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           L + +    SDV+SFGV ++E+L
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELL 231

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +G G +G VY+ + ++  + VA+K+   +S   L E   EI ++ Q    H+V   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           +  ++ I+ EY   G++ D +   N  +L+  +   I     +GL YLH       IHRD
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRK---IHRD 150
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDV 669
           +K+ NILL+    AK+ADFG++  G   D       V G+  ++ PE + +      +D+
Sbjct: 151 IKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADI 208
Query: 670 YSFGVVMFEILCGRP 684
           +S G+   E+  G+P
Sbjct: 209 WSLGITAIEMAEGKP 223

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 138/304 (45%), Gaps = 65/304 (21%)
Query: 491 IGIGGFGKVYRGV---LRDE---TKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FGKV +     L+     T VAVK      S   L +  +E  +L Q  H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS-------------------NFP---SLSWR 581
           L G C +   +++I EY + G+L+  L  S                   + P   +L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH 641
             +      ++G+ YL   +  +++HRD+ + NIL+ E    K++DFGLS+     D   
Sbjct: 151 DLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYE 202
Query: 642 VSTAVKGSFGYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRPVIDPSLPREK 694
             + VK S G +  +++  + L     T +SDV+SFGV+++EI  L G P   P +P E+
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPPER 260
Query: 695 V-NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLN-KFVEIAEKCLAQCGIDRPSMGDVL 752
           + NL++   + +                 +PD+ + +   +  +C  Q    RP   D+ 
Sbjct: 261 LFNLLKTGHRME-----------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 753 WNLE 756
            +LE
Sbjct: 304 KDLE 307

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 93/176 (52%), Gaps = 17/176 (9%)
Query: 511 AVKRG-GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE--MIIIYEYMENGTLK 567
           A+K G G Q   G   ++ EIE+L    H H+V   G C+++ E  + ++ EY+  G+L+
Sbjct: 45  ALKEGCGPQLRSG---WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR 101
Query: 568 DHL--YASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV 625
           D+L  +      L    + +IC G A    YLH    +  IHR + + N+LLD + + K+
Sbjct: 102 DYLPRHCVGLAQLLLFAQ-QICEGMA----YLHA---QHYIHRALAARNVLLDNDRLVKI 153
Query: 626 ADFGLSKIGPDLDQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            DFGL+K  P+  + + V         +  PE L + +    SDV+SFGV ++E+L
Sbjct: 154 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 209

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 23/218 (10%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDET--KVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N      +G G FGKV      G+ +++   KVAVK   + +H    E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL------------YASNFPSLSWRK 582
             +H ++V+L+G C     +++I EY   G L + L            +A    + S R 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 583 RLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV 642
            L      A+G+ +L   ++K  IHRDV + N+LL    +AK+ DFGL++   +     V
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
               +    ++ PE +     T +SDV+S+G++++EI 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 37/233 (15%)
Query: 477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
           +++ A+D F E  V+G G FG+V +     +++    +    + + L+   +E+ +L+  
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 537 RHRHLVSLIGYCDERNEMI-------------IIYEYMENGTLKDHLYASNFPSLS---W 580
            H+++V       ER   +             I  EY ENGTL D +++ N        W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQ 639
           R   +I       L Y+H+   + IIHRD+K  NI +DE+   K+ DFGL+K +   LD 
Sbjct: 120 RLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 640 THVS-----------TAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEIL 680
             +            T+  G+  Y+  E L       EK D+YS G++ FE++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 93/176 (52%), Gaps = 17/176 (9%)
Query: 511 AVKRG-GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE--MIIIYEYMENGTLK 567
           A+K G G Q   G   ++ EIE+L    H H+V   G C+++ E  + ++ EY+  G+L+
Sbjct: 44  ALKEGCGPQLRSG---WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR 100
Query: 568 DHL--YASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV 625
           D+L  +      L    + +IC G A    YLH    +  IHR + + N+LLD + + K+
Sbjct: 101 DYLPRHCVGLAQLLLFAQ-QICEGMA----YLHA---QHYIHRALAARNVLLDNDRLVKI 152
Query: 626 ADFGLSKIGPDLDQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            DFGL+K  P+  + + V         +  PE L + +    SDV+SFGV ++E+L
Sbjct: 153 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELL 208

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 137/304 (45%), Gaps = 65/304 (21%)
Query: 491 IGIGGFGKVYRGV---LRDE---TKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FGKV +     L+     T VAVK      S   L +  +E  +L Q  H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS-------------------NFP---SLSWR 581
           L G C +   +++I EY + G+L+  L  S                   + P   +L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH 641
             +      ++G+ YL   +   ++HRD+ + NIL+ E    K++DFGLS+     D   
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYE 202
Query: 642 VSTAVKGSFGYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRPVIDPSLPREK 694
             + VK S G +  +++  + L     T +SDV+SFGV+++EI  L G P   P +P E+
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPPER 260
Query: 695 V-NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLN-KFVEIAEKCLAQCGIDRPSMGDVL 752
           + NL++   + +                 +PD+ + +   +  +C  Q    RP   D+ 
Sbjct: 261 LFNLLKTGHRME-----------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 753 WNLE 756
            +LE
Sbjct: 304 KDLE 307

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDET--KVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N      +G G FGKV      G+ +++   KVAVK   + +H    E   +E++++S 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--------ASNFPSLSWRKRLEI 586
             +H ++V+L+G C     +++I EY   G L + L           +   L  R  L  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               A+G+ +L   ++K  IHRDV + N+LL    +AK+ DFGL++   +     V    
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +    ++ PE +     T +SDV+S+G++++EI 
Sbjct: 215 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 248

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGY 547
           V+G G F +V      R +  VA+K    ++ +G       EI +L + +H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +    + +I + +  G L D +    F   + R    +       + YLH      I+H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHD---LGIVH 139
Query: 608 RDVKSANIL---LDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           RD+K  N+L   LDE+    ++DFGLSK+    D   V +   G+ GY+ PE L ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 665 EKSDVYSFGVVMFEILCGRP 684
           +  D +S GV+ + +LCG P
Sbjct: 197 KAVDCWSIGVIAYILLCGYP 216

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGY 547
           V+G G F +V      R +  VA+K    ++ +G       EI +L + +H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +    + +I + +  G L D +    F   + R    +       + YLH      I+H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHD---LGIVH 139
Query: 608 RDVKSANIL---LDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           RD+K  N+L   LDE+    ++DFGLSK+    D   V +   G+ GY+ PE L ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 665 EKSDVYSFGVVMFEILCGRP 684
           +  D +S GV+ + +LCG P
Sbjct: 197 KAVDCWSIGVIAYILLCGYP 216

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGY 547
           V+G G F +V      R +  VA+K    ++ +G       EI +L + +H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +    + +I + +  G L D +    F   + R    +       + YLH      I+H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHD---LGIVH 139
Query: 608 RDVKSANIL---LDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           RD+K  N+L   LDE+    ++DFGLSK+    D   V +   G+ GY+ PE L ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 665 EKSDVYSFGVVMFEILCGRP 684
           +  D +S GV+ + +LCG P
Sbjct: 197 KAVDCWSIGVIAYILLCGYP 216

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L D T   VAVK+          +F+ EI++L       +V   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 546 G--YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G  Y   R  + ++ EY+ +G L+D L   +   L   + L       +G+ YL    ++
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL---GSR 133
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + NIL++     K+ADFGL+K+ P D D   V    +    +  PE L+   
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 663 LTEKSDVYSFGVVMFEIL 680
            + +SDV+SFGVV++E+ 
Sbjct: 194 FSRQSDVWSFGVVLYELF 211

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 86
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 87  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 137/304 (45%), Gaps = 65/304 (21%)
Query: 491 IGIGGFGKVYRGV---LRDE---TKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FGKV +     L+     T VAVK      S   L +  +E  +L Q  H H++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS-------------------NFP---SLSWR 581
           L G C +   +++I EY + G+L+  L  S                   + P   +L+  
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH 641
             +      ++G+ YL   +   ++HRD+ + NIL+ E    K++DFGLS+     D   
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR-----DVYE 202
Query: 642 VSTAVKGSFGYLDPEYLTKQQL-----TEKSDVYSFGVVMFEI--LCGRPVIDPSLPREK 694
             + VK S G +  +++  + L     T +SDV+SFGV+++EI  L G P   P +P E+
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPPER 260
Query: 695 V-NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLN-KFVEIAEKCLAQCGIDRPSMGDVL 752
           + NL++   + +                 +PD+ + +   +  +C  Q    RP   D+ 
Sbjct: 261 LFNLLKTGHRME-----------------RPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 753 WNLE 756
            +LE
Sbjct: 304 KDLE 307

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDET--KVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N      +G G FGKV      G+ +++   KVAVK   + +H    E   +E++++S 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--------ASNFPSLSWRKRLEI 586
             +H ++V+L+G C     +++I EY   G L + L           +   L  R  L  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               A+G+ +L   ++K  IHRDV + N+LL    +AK+ DFGL++   +     V    
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +    ++ PE +     T +SDV+S+G++++EI 
Sbjct: 223 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 256

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 88
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 89  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L D T   VAVK+          +F+ EI++L       +V   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 546 G--YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G  Y   R  + ++ EY+ +G L+D L   +   L   + L       +G+ YL    ++
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL---GSR 134
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + NIL++     K+ADFGL+K+ P D D   V    +    +  PE L+   
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 663 LTEKSDVYSFGVVMFEIL 680
            + +SDV+SFGVV++E+ 
Sbjct: 195 FSRQSDVWSFGVVLYELF 212

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 94
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 95  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 148
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 149 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 86
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 87  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 13/200 (6%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVSLIGY 547
           V+G G F +V      R +  VA+K    ++ +G       EI +L + +H ++V+L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +    + +I + +  G L D +    F   + R    +       + YLH      I+H
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHD---LGIVH 139
Query: 608 RDVKSANIL---LDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           RD+K  N+L   LDE+    ++DFGLSK+    D   V +   G+ GY+ PE L ++  +
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 665 EKSDVYSFGVVMFEILCGRP 684
           +  D +S GV+ + +LCG P
Sbjct: 197 KAVDCWSIGVIAYILLCGYP 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 491 IGIGGFGKV---YRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V       L D T   VAVK+          +F+ EI++L       +V   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 546 G--YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           G  Y   R  + ++ EY+ +G L+D L   +   L   + L       +G+ YL    ++
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL---GSR 146
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGP-DLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + NIL++     K+ADFGL+K+ P D D   V    +    +  PE L+   
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 663 LTEKSDVYSFGVVMFEIL 680
            + +SDV+SFGVV++E+ 
Sbjct: 207 FSRQSDVWSFGVVLYELF 224

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 86
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 87  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 86
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 87  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G G FGKV      + + KVA+K   R   +          EI  L   RH H++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
                 +++++ EY   G L D++      +    +R    I  A  + Y H      I+
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHR---HKIV 130
Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTE 665
           HRD+K  N+LLD+NL  K+ADFGLS I  D +    S    GS  Y  PE +  K     
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGKLYAGP 187
Query: 666 KSDVYSFGVVMFEILCGR-PVIDPSLPR--EKVNLVEWAM 702
           + DV+S G+V++ +L GR P  D  +P   +KVN   + M
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 106
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 107 ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 86
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 87  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L  FRH +++ + 
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLAFRHENIIGI- 88
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 89  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
           ++G G FG+VY GV      ++  VAVK           E F +E  ++    H H+V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 545 IGYCDERNEMII--IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           IG  +E    II  +Y Y E G    H    N  SL     +   +   + + YL + + 
Sbjct: 75  IGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              +HRD+   NIL+      K+ DFGLS+   D D  + ++  +    ++ PE +  ++
Sbjct: 131 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRR 186
Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+ F V M+EIL
Sbjct: 187 FTTASDVWMFAVCMWEIL 204

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 24/232 (10%)
Query: 466 SSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE 525
           +S  G   PF+  +      +    +G G +G+V+RG  + E  VAVK   ++  +  + 
Sbjct: 20  TSGSGSGLPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEK--SW 76
Query: 526 FR-TEIEMLSQFRHRHLVSLIGY----CDERNEMIIIYEYMENGTLKDHLYASNFPSLSW 580
           FR TE+      RH +++  I           ++ +I  Y E G+L D+L  +   ++S 
Sbjct: 77  FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS- 135
Query: 581 RKRLEICIGAARGLHYLH-----TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-G 634
              L I +  A GL +LH     T    AI HRD+KS NIL+ +N    +AD GL+ +  
Sbjct: 136 --CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 193
Query: 635 PDLDQTHVSTAVK-GSFGYLDPEYLTKQQLTE------KSDVYSFGVVMFEI 679
              +Q  V    + G+  Y+ PE L +    +      + D+++FG+V++E+
Sbjct: 194 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
           ++G G FG+VY GV      ++  VAVK           E F +E  ++    H H+V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 545 IGYCDERNEMII--IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           IG  +E    II  +Y Y E G    H    N  SL     +   +   + + YL + + 
Sbjct: 91  IGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              +HRD+   NIL+      K+ DFGLS+   D D  + ++  +    ++ PE +  ++
Sbjct: 147 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRR 202
Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+ F V M+EIL
Sbjct: 203 FTTASDVWMFAVCMWEIL 220

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 84
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 85  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 490 VIGIGGFGKVYRGVLR----DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
           ++G G FG+VY GV      ++  VAVK           E F +E  ++    H H+V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 545 IGYCDERNEMII--IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           IG  +E    II  +Y Y E G    H    N  SL     +   +   + + YL + + 
Sbjct: 79  IGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              +HRD+   NIL+      K+ DFGLS+   D D  + ++  +    ++ PE +  ++
Sbjct: 135 ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRR 190
Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+ F V M+EIL
Sbjct: 191 FTTASDVWMFAVCMWEIL 208

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 84
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 85  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 91
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 92  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 37  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 92
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 93  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 146
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 147 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 28  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 83
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 84  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 137
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 138 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 90
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 91  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSL- 544
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGIN 91
Query: 545 ----IGYCDERNEMIIIYEYMENGTLK----DHLYASNFPSLSWRKRLEICIGAARGLHY 596
                   ++  ++ I+ + ME    K     HL   +     ++          RGL Y
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ--------ILRGLKY 143
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDP 655
           +H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  P
Sbjct: 144 IHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 656 E-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
           E  L  +  T+  D++S G ++ E+L  RP+
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 90
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 91  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  V  ++ +VA+K+     HQ   + RT  EI++L  FRH +++ + 
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLAFRHENIIGI- 88
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 89  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 115/247 (46%), Gaps = 27/247 (10%)
Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGVLRDE--------TKVAVKRGGTQSHQGLAEF 526
           + A +E    +    VIG G    V R V R           +V  +R   +  + + E 
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 527 -RTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
            R E  +L Q   H H+++LI   +  + M ++++ M  G L D  Y +   +LS ++  
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD--YLTEKVALSEKETR 203
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
            I       + +LH  +   I+HRD+K  NILLD+N+  +++DFG S     L+      
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLR 257
Query: 645 AVKGSFGYLDPEYL------TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
            + G+ GYL PE L      T     ++ D+++ GV++F +L G P   P   R ++ ++
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP---PFWHRRQILML 314
Query: 699 EWAMKCQ 705
              M+ Q
Sbjct: 315 RMIMEGQ 321

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQ-RTLREIKILLRFRHENIIGI- 90
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 91  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 107/233 (45%), Gaps = 37/233 (15%)
Query: 477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
           +++ A+D F E  V+G G FG+V +     +++    +    + + L+   +E+ +L+  
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL 59
Query: 537 RHRHLVSLIGYCDERNEMI-------------IIYEYMENGTLKDHLYASNFPSLS---W 580
            H+++V       ER   +             I  EY EN TL D +++ N        W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQ 639
           R   +I       L Y+H+   + IIHRD+K  NI +DE+   K+ DFGL+K +   LD 
Sbjct: 120 RLFRQIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 640 THVS-----------TAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEIL 680
             +            T+  G+  Y+  E L       EK D+YS G++ FE++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+++     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 90
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 91  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T   T    +  Y  PE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 484 NFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRH 538
            +++   IG G +G V   Y  V +  T+VA+K+     HQ   + RT  EI++L +FRH
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQ-RTLREIQILLRFRH 100
Query: 539 RHLVSL-----IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
            +++ +         +   ++ I+ + ME    K  L  S    LS            RG
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK--LLKSQ--QLSNDHICYFLYQILRG 156
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGY 652
           L Y+H+ +   ++HRD+K +N+L++     K+ DFGL++I  P+ D T   T    +  Y
Sbjct: 157 LKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 653 LDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             PE  L  +  T+  D++S G ++ E+L  RP+
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 490 VIGIGGFGKVY--RGVLRDET----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FGKV+  R V R ++     + V +  T   +     + E ++L+   H  +V 
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA-ARGLHYLHTGST 602
           L        ++ +I +++  G L   L       +   + ++  +   A GL +LH+   
Sbjct: 95  LHYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALGLDHLHS--- 148
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             II+RD+K  NILLDE    K+ DFGLSK   D ++   S    G+  Y+ PE + +Q 
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC--GTVEYMAPEVVNRQG 206
Query: 663 LTEKSDVYSFGVVMFEILCG 682
            +  +D +S+GV+MFE+L G
Sbjct: 207 HSHSADWWSYGVLMFEMLTG 226

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 32/227 (14%)
Query: 483 DNFSESLVIGIGGFGKVYR----GVLRDET--KVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N      +G G FGKV      G+ +++   KVAVK   + +H    E   +E++++S 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY----ASNFPSLS----------- 579
             +H ++V+L+G C     +++I EY   G L + L     A   PSL+           
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 580 ------WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
                  R  L      A+G+ +L   ++K  IHRDV + N+LL    +AK+ DFGL++ 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             +     V    +    ++ PE +     T +SDV+S+G++++EI 
Sbjct: 208 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 254

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 108/212 (50%), Gaps = 11/212 (5%)
Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
            V++ +    ++    IG G  G VY  + +    +VA+++   Q          EI ++
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
            + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGY 652
           L +LH+     +IHRD+KS NILL  +   K+ DFG  ++I P  +Q+  ST V G+  +
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 182
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE +T++    K D++S G++  E++ G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K +     D       K+  K    + HQ   +   EI +     H+H+V   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 107
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R +I +G      YLH    
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRNR- 161
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L+E+L  K+ DFGL +K+  D ++  V   + G+  Y+ PE L+K+
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 216
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + DV+S G +M+ +L G+P  + S  +E
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K +     D       K+  K    + HQ   +   EI +     H+H+V   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 105
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R +I +G      YLH    
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRNR- 159
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L+E+L  K+ DFGL +K+  D ++  V   + G+  Y+ PE L+K+
Sbjct: 160 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 214
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + DV+S G +M+ +L G+P  + S  +E
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 246

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 270
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 271 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 319

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 10/202 (4%)
Query: 485 FSESLVIGIGGFGKVYRGVL-RDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           F++   IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ    ++ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
              G   +  ++ II EY+  G+  D L       L   +   I     +GL YLH+   
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK 145
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              IHRD+K+AN+LL E+   K+ADFG++    D  Q   +T V   F ++ PE + +  
Sbjct: 146 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPF-WMAPEVIKQSA 200
Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
              K+D++S G+   E+  G P
Sbjct: 201 YDSKADIWSLGITAIELARGEP 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 90
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 91  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T        +  Y  PE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 28/210 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V   Y  +  ++ +VA+K+     HQ   + RT  EI++L +FRH +++ + 
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENIIGI- 91
Query: 546 GYCDERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI---GAARGLHYL 597
                 N++I     E M++  +   L  ++   L   + L    IC       RGL Y+
Sbjct: 92  ------NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSFGYLDPE 656
           H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD D T        +  Y  PE
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 657 -YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             L  +  T+  D++S G ++ E+L  RP+
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG+V+RG  R E +VAVK   ++  +    FR  EI      RH +++  I   +
Sbjct: 50  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADN 106
Query: 550 ERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
           + N    ++ ++ +Y E+G+L D+L   N  +++    +++ +  A GL +LH     T 
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEY 657
              AI HRD+KS NIL+ +N    +AD GL+ +  D     +  A     G   Y+ PE 
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 658 LTKQ------QLTEKSDVYSFGVVMFEI 679
           L         +  +++D+Y+ G+V +EI
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 78
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 79  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 132 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 75
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 76  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 128
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 129 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K +     D       K+  K    + HQ   +   EI +     H+H+V   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 81
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R +I +G      YLH    
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRNR- 135
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L+E+L  K+ DFGL +K+  D ++  V   + G+  Y+ PE L+K+
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSKK 190
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + DV+S G +M+ +L G+P  + S  +E
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG+V+RG  R E +VAVK   ++  +    FR  EI      RH +++  I   +
Sbjct: 12  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADN 68
Query: 550 ERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
           + N    ++ ++ +Y E+G+L D+L   N  +++    +++ +  A GL +LH     T 
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEY 657
              AI HRD+KS NIL+ +N    +AD GL+ +  D     +  A     G   Y+ PE 
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 658 LTKQ------QLTEKSDVYSFGVVMFEI 679
           L         +  +++D+Y+ G+V +EI
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTE 529
           P + I+   ++F    ++G G FGKV+    +   +     A+K+        +     E
Sbjct: 9   PSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 68
Query: 530 IEMLS-QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
             +LS  + H  L  +      +  +  + EY+  G L  H+ + +   LS         
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATF 123
Query: 589 GAAR---GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
            AA    GL +LH+   K I++RD+K  NILLD++   K+ADFG+ K   ++     +  
Sbjct: 124 YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNE 178
Query: 646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
             G+  Y+ PE L  Q+     D +SFGV+++E+L G+
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG+V+RG  R E +VAVK   ++  +    FR  EI      RH +++  I   +
Sbjct: 17  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADN 73
Query: 550 ERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
           + N    ++ ++ +Y E+G+L D+L   N  +++    +++ +  A GL +LH     T 
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEY 657
              AI HRD+KS NIL+ +N    +AD GL+ +  D     +  A     G   Y+ PE 
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 658 LTKQ------QLTEKSDVYSFGVVMFEI 679
           L         +  +++D+Y+ G+V +EI
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG+V+RG  R E +VAVK   ++  +    FR  EI      RH +++  I   +
Sbjct: 37  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADN 93
Query: 550 ERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
           + N    ++ ++ +Y E+G+L D+L   N  +++    +++ +  A GL +LH     T 
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEY 657
              AI HRD+KS NIL+ +N    +AD GL+ +  D     +  A     G   Y+ PE 
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 658 LTKQ------QLTEKSDVYSFGVVMFEI 679
           L         +  +++D+Y+ G+V +EI
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 599 TGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 210
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 256
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 257 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 305

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 270
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 271 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 319

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 75  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 599 TGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 216
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 262
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 263 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 311

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG+V+RG  R E +VAVK   ++  +    FR  EI      RH +++  I   +
Sbjct: 11  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADN 67
Query: 550 ERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
           + N    ++ ++ +Y E+G+L D+L   N  +++    +++ +  A GL +LH     T 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEY 657
              AI HRD+KS NIL+ +N    +AD GL+ +  D     +  A     G   Y+ PE 
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 658 LTKQ------QLTEKSDVYSFGVVMFEI 679
           L         +  +++D+Y+ G+V +EI
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 77
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 78  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 131 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 76
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 130 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 75
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 76  DNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIA 128
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 129 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGYCD 549
           IG G FG+V+RG  R E +VAVK   ++  +    FR  EI      RH +++  I   +
Sbjct: 14  IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADN 70
Query: 550 ERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
           + N    ++ ++ +Y E+G+L D+L   N  +++    +++ +  A GL +LH     T 
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEY 657
              AI HRD+KS NIL+ +N    +AD GL+ +  D     +  A     G   Y+ PE 
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 658 LTKQ------QLTEKSDVYSFGVVMFEI 679
           L         +  +++D+Y+ G+V +EI
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 599 TGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ-----DIYRASYYRKGGCAMLPV 210
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 256
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 257 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 305

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGY-- 547
           +G G +G+V+RG  + E  VAVK   ++  +  + FR TE+      RH +++  I    
Sbjct: 16  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEK--SWFRETELYNTVMLRHENILGFIASDM 72
Query: 548 --CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
                  ++ +I  Y E G+L D+L  +   ++S    L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQ 129
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVK-GSFGYLDPEYL 658
              AI HRD+KS NIL+ +N    +AD GL+ +     +Q  V    + G+  Y+ PE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 659 TKQQLTE------KSDVYSFGVVMFEI 679
            +    +      + D+++FG+V++E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 485 FSESLVIGIGGFGKVYRGVL-RDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           F++   IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ    ++ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
              G   +  ++ II EY+  G+  D L       L   +   I     +GL YLH+   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK 140
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              IHRD+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE + +  
Sbjct: 141 ---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
              K+D++S G+   E+  G P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 201
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 247
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 248 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 296

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 472 RFPFVAIQEATDN-FSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEF 526
           ++ ++  Q  T N F +  V+G GGFG+V    +R   K+     +++   +  +G A  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 527 RTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY---ASNFP-SLSWRK 582
             E ++L +   R +VSL    + ++ + ++   M  G LK H+Y    + FP + +   
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 583 RLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV 642
             EIC G    L  LH    + I++RD+K  NILLD++   +++D GL+   P+      
Sbjct: 292 AAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 341
Query: 643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
                G+ GY+ PE +  ++ T   D ++ G +++E++ G+
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 485 FSESLVIGIGGFGKVY--RGVLRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHR 539
           FS+   IG G FG VY  R V R+   VA+K+    G QS++   +   E+  L + RH 
Sbjct: 56  FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           + +   G     +   ++ EY   G+  D L     P L   +   +  GA +GL YLH+
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS 172
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY-- 657
            +   +IHRDVK+ NILL E  + K+ DFG + I         +    G+  ++ PE   
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 223
Query: 658 -LTKQQLTEKSDVYSFGVVMFEILCGRP 684
            + + Q   K DV+S G+   E+   +P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFR-TEIEMLSQFRHRHLVSLIGY-- 547
           +G G +G+V+RG  + E  VAVK   ++  +  + FR TE+      RH +++  I    
Sbjct: 16  VGKGRYGEVWRGSWQGEN-VAVKIFSSRDEK--SWFRETELYNTVMLRHENILGFIASDM 72
Query: 548 --CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
                  ++ +I  Y E G+L D+L  +   ++S    L I +  A GL +LH     T 
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFGTQ 129
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAVK-GSFGYLDPEYL 658
              AI HRD+KS NIL+ +N    +AD GL+ +     +Q  V    + G+  Y+ PE L
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 659 TKQQLTE------KSDVYSFGVVMFEI 679
            +    +      + D+++FG+V++E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 99
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 100 DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 152
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 153 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELM 238

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 599 TGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 175 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 226
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 272
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 273 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 321

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 255
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 256 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 10/202 (4%)
Query: 485 FSESLVIGIGGFGKVYRGVL-RDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           F++   IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
              G   +  ++ II EY+  G+  D L       L   +   I     +GL YLH+   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK 125
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              IHRD+K+AN+LL E+   K+ADFG++    D  Q   +T V   F ++ PE + +  
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-TQIKRNTFVGTPF-WMAPEVIKQSA 180
Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
              K+D++S G+   E+  G P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K +     D       K+  K    + HQ   +   EI +     H+H+V   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 87
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R +I +G      YLH    
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRNR- 141
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L+E+L  K+ DFGL +K+  D ++      + G+  Y+ PE L+K+
Sbjct: 142 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKK 196
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + DV+S G +M+ +L G+P  + S  +E
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 228

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 209
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 255
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 256 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 80
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 81  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 133
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 134 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELM 219

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTE 529
           P + I+   ++F    ++G G FGKV+    +   +     A+K+        +     E
Sbjct: 8   PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 530 IEMLS-QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
             +LS  + H  L  +      +  +  + EY+  G L  H+ + +   LS         
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATF 122
Query: 589 GAAR---GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
            AA    GL +LH+   K I++RD+K  NILLD++   K+ADFG+ K   ++     +  
Sbjct: 123 YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNX 177
Query: 646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
             G+  Y+ PE L  Q+     D +SFGV+++E+L G+
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 84
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 85  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 137
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 138 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELM 223

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 121/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 599 TGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 236
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 237 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 282
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 283 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 331

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 491 IGIGGFGKVYRGVLRDETKVAV-KRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +G G FGKVY+   ++   +A  K   T+S + L ++  EIE+L+   H ++V L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
              ++ I+ E+   G + D +       L+  +   +C      L++LH+   K IIHRD
Sbjct: 79  HDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRD 134
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE---- 665
           +K+ N+L+      ++ADFG+S    +L       +  G+  ++ PE +  + + +    
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 192
Query: 666 -KSDVYSFGVVMFEI 679
            K+D++S G+ + E+
Sbjct: 193 YKADIWSLGITLIEM 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 76
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 77  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 130 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 81
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 82  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 135 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 485 FSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGL-AEFRTEIEMLSQFRHR 539
           F E+L  G G F +V   VL +E       AVK    ++ +G  +    EI +L + +H 
Sbjct: 26  FKETL--GTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           ++V+L    +  N + ++ + +  G L D +    F   + +    +       ++YLH 
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGF--YTEKDASTLIRQVLDAVYYLHR 138
Query: 600 GSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
                I+HRD+K  N+L    DE     ++DFGLSK+    D   V +   G+ GY+ PE
Sbjct: 139 ---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPE 192
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            L ++  ++  D +S GV+ + +LCG P
Sbjct: 193 VLAQKPYSKAVDCWSIGVIAYILLCGYP 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 77
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 78  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 131 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K +     D       K+  K    + HQ   +   EI +     H+H+V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R +I +G      YLH    
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRNR- 137
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L+E+L  K+ DFGL +K+  D ++      + G+  Y+ PE L+K+
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKK 192
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + DV+S G +M+ +L G+P  + S  +E
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 77
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 78  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 131 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 77
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 78  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 130
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 131 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 491 IGIGGFGKVYRGVLRDETKVAV-KRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +G G FGKVY+   ++   +A  K   T+S + L ++  EIE+L+   H ++V L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
              ++ I+ E+   G + D +       L+  +   +C      L++LH+   K IIHRD
Sbjct: 87  HDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRD 142
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE---- 665
           +K+ N+L+      ++ADFG+S    +L       +  G+  ++ PE +  + + +    
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD 200
Query: 666 -KSDVYSFGVVMFEI 679
            K+D++S G+ + E+
Sbjct: 201 YKADIWSLGITLIEM 215

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 472 RFPFVAIQEATDN-FSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEF 526
           ++ ++  Q  T N F +  V+G GGFG+V    +R   K+     +++   +  +G A  
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 527 RTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY---ASNFP-SLSWRK 582
             E ++L +   R +VSL    + ++ + ++   M  G LK H+Y    + FP + +   
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 583 RLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV 642
             EIC G    L  LH    + I++RD+K  NILLD++   +++D GL+   P+      
Sbjct: 292 AAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 341
Query: 643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
                G+ GY+ PE +  ++ T   D ++ G +++E++ G+
Sbjct: 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 485 FSESLVIGIGGFGKVYRGVL-RDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           F++   IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ    ++ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
              G   +  ++ II EY+  G+  D L       L   +   I     +GL YLH+   
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK 125
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              IHRD+K+AN+LL E+   K+ADFG++  G   D         G+  ++ PE + +  
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
              K+D++S G+   E+  G P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 24/169 (14%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   EI +L    H +++ L    +++    ++ E+ E G L        F  +  R + 
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--------FEQIINRHKF 143
Query: 585 EICIGA------ARGLHYLHTGSTKAIIHRDVKSANILLDEN---LMAKVADFGLSKIGP 635
           + C  A        G+ YLH  +   I+HRD+K  NILL+     L  K+ DFGLS    
Sbjct: 144 DECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF-- 198
Query: 636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
              + +      G+  Y+ PE L K++  EK DV+S GV+M+ +LCG P
Sbjct: 199 -FSKDYKLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K +     D       K+  K    + HQ   +   EI +     H+H+V   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R +I +G      YLH    
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGC----QYLHRNR- 137
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L+E+L  K+ DFGL +K+  D ++      + G+  Y+ PE L+K+
Sbjct: 138 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKTLCGTPNYIAPEVLSKK 192
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + DV+S G +M+ +L G+P  + S  +E
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 38/226 (16%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +F E  +IG GGFG+V++   R + K  V R    +++   +   E++ L++  H ++V 
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNE---KAEREVKALAKLDHVNIVH 69
Query: 544 LIGYCD-----------------------------ERNEMIIIYEYMENGTLKDHLYASN 574
             G  D                             +   + I  E+ + GTL+  +    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG 634
              L     LE+     +G+ Y+H   +K +IHRD+K +NI L +    K+ DFGL    
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLV--- 183
Query: 635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             L      T  KG+  Y+ PE ++ Q   ++ D+Y+ G+++ E+L
Sbjct: 184 TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           DNF   + IG G  G V    +R   K VAVK+   +  Q       E+ ++  ++H ++
Sbjct: 154 DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +       +E+ ++ E++E G L D +  +    ++  +   +C+   + L  LH   
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA-- 265
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            + +IHRD+KS +ILL  +   K++DFG  +++  ++ +      + G+  ++ PE +++
Sbjct: 266 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISR 321
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                + D++S G+++ E++ G P
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDGEP 345

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 68
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 69  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 121
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 122 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELM 207

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 118/269 (43%), Gaps = 32/269 (11%)
Query: 491 IGIGGFGK-VYRGVLRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G FGK +      D  +  +K       S +   E R E+ +L+  +H ++V     
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +E   + I+ +Y E G L   + A         + L+  +     L ++H    + I+H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILH 148
Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEK 666
           RD+KS NI L ++   ++ DFG++++   L+ T  ++ A  G+  YL PE    +    K
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPYYLSPEICENKPYNNK 205
Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           SD+++ G V++E+   +                      E G ++++V   ++G   P S
Sbjct: 206 SDIWALGCVLYELCTLKHAF-------------------EAGSMKNLVLKIISGSFPPVS 246
Query: 727 LN---KFVEIAEKCLAQCGIDRPSMGDVL 752
           L+       +  +   +   DRPS+  +L
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRH 540
           D++    VIG G    V        + KVA+KR   +  Q  + E   EI+ +SQ  H +
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKD---HLYASNFPS---LSWRKRLEICIGAARGL 594
           +VS       ++E+ ++ + +  G++ D   H+ A        L       I      GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVSTAVKGSFG 651
            YLH       IHRDVK+ NILL E+   ++ADFG+S     G D+ +  V     G+  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 652 YLDPEYLTKQQLTE-KSDVYSFGVVMFEILCG 682
           ++ PE + + +  + K+D++SFG+   E+  G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 118/254 (46%), Gaps = 32/254 (12%)
Query: 477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
           A+++    F    ++G G +G+VY+G      ++A  +    +     E + EI ML ++
Sbjct: 18  ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKY 77
Query: 537 -RHRHLVSLIGYCDERN------EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
             HR++ +  G   ++N      ++ ++ E+   G++ D +  +   +L       IC  
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--HVSTAVK 647
             RGL +LH      +IHRD+K  N+LL EN   K+ DFG+S     LD+T    +T + 
Sbjct: 138 ILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFI- 190
Query: 648 GSFGYLDPEYLTKQQLTE-----KSDVYSFGVVMFEILCGRP-----------VIDPSLP 691
           G+  ++ PE +   +  +     KSD++S G+   E+  G P            + P  P
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250
Query: 692 REKVNLVEWAMKCQ 705
             ++   +W+ K Q
Sbjct: 251 APRLKSKKWSKKFQ 264

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 119/266 (44%), Gaps = 30/266 (11%)
Query: 491 IGIGGFGKVYRGVLRDETK--VAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G FG+VY+G+  + TK  VA+K     ++   + + + EI +LSQ    ++    G 
Sbjct: 27  IGKGSFGEVYKGI-DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             +  ++ II EY+  G+  D L       L       I     +GL YLH+      IH
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERK---IH 139
Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+K+AN+LL E    K+ADFG++  G   D         G+  ++ PE + +     K+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 668 DVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ-IKPDS 726
           D++S G+   E+  G P      P   + L+                 PTL GQ  KP  
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------PKNSPPTLEGQHSKP-- 243
Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDVL 752
              F E  E CL +    RP+  ++L
Sbjct: 244 ---FKEFVEACLNKDPRFRPTAKELL 266

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 485 FSESLVIGIGGFGKVY--RGVLRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRHR 539
           FS+   IG G FG VY  R V R+   VA+K+    G QS++   +   E+  L + RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           + +   G     +   ++ EY   G+  D L     P L   +   +  GA +GL YLH+
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLHS 133
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY-- 657
            +   +IHRDVK+ NILL E  + K+ DFG + I         +    G+  ++ PE   
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 184
Query: 658 -LTKQQLTEKSDVYSFGVVMFEILCGRP 684
            + + Q   K DV+S G+   E+   +P
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           DNF   + IG G  G V    +R   K VAVK+   +  Q       E+ ++  ++H ++
Sbjct: 34  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +       +E+ ++ E++E G L D +  +    ++  +   +C+   + L  LH   
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA-- 145
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            + +IHRD+KS +ILL  +   K++DFG  +++  ++ +      + G+  ++ PE +++
Sbjct: 146 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISR 201
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                + D++S G+++ E++ G P
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDGEP 225

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 37/233 (15%)
Query: 477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF 536
           +++ A+D F E  V+G G FG+V +     +++    +    + + L+   +E+ +L+  
Sbjct: 1   SLRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASL 59
Query: 537 RHRHLVSLIGYCDERNEMI-------------IIYEYMENGTLKDHLYASNFPSLS---W 580
            H+++V       ER   +             I  EY EN TL D +++ N        W
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQ 639
           R   +I       L Y+H+   + IIHR++K  NI +DE+   K+ DFGL+K +   LD 
Sbjct: 120 RLFRQIL----EALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 640 THVS-----------TAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEIL 680
             +            T+  G+  Y+  E L       EK D YS G++ FE +
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 107/212 (50%), Gaps = 11/212 (5%)
Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
            V++ +    ++    IG G  G VY  + +    +VA+++   Q          EI ++
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
            + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGY 652
           L +LH+     +IHRD+KS NILL  +   K+ DFG  ++I P  +Q+  S  V G+  +
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMV-GTPYW 182
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE +T++    K D++S G++  E++ G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 32/227 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK------VAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           +N     V+G G FGKV        +K      VAVK    ++     E   +E++M++Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL------YASNFPSLSWRKRLE--- 585
              H ++V+L+G C     + +I+EY   G L ++L      ++ +      +KRLE   
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 586 ----------ICIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
                     +C     A+G+ +L     K+ +HRD+ + N+L+    + K+ DFGL++ 
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
                   V    +    ++ PE L +   T KSDV+S+G++++EI 
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 108/212 (50%), Gaps = 11/212 (5%)
Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
            V++ +    ++    IG G  G VY  + +    +VA+++   Q          EI ++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
            + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + 
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 129
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGY 652
           L +LH+     +IHR++KS NILL  +   K+ DFG  ++I P  +Q+  ST V G+  +
Sbjct: 130 LEFLHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 183
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE +T++    K D++S G++  E++ G P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           DNF   + IG G  G V    +R   K VAVK+   +  Q       E+ ++  ++H ++
Sbjct: 32  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +       +E+ ++ E++E G L D +  +    ++  +   +C+   + L  LH   
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA-- 143
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            + +IHRD+KS +ILL  +   K++DFG  +++  ++ +      + G+  ++ PE +++
Sbjct: 144 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISR 199
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                + D++S G+++ E++ G P
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDGEP 223

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           DNF   + IG G  G V    +R   K VAVK+   +  Q       E+ ++  ++H ++
Sbjct: 23  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +       +E+ ++ E++E G L D +  +    ++  +   +C+   + L  LH   
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA-- 134
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            + +IHRD+KS +ILL  +   K++DFG  +++  ++ +      + G+  ++ PE +++
Sbjct: 135 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISR 190
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                + D++S G+++ E++ G P
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGEP 214

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 107/212 (50%), Gaps = 11/212 (5%)
Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
            V++ +    ++    IG G  G VY  + +    +VA+++   Q          EI ++
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
            + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 128
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGY 652
           L +LH+     +IHRD+KS NILL  +   K+ DFG  ++I P  +Q+  S  V G+  +
Sbjct: 129 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSEMV-GTPYW 182
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE +T++    K D++S G++  E++ G P
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 15/212 (7%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRH 540
           D++    VIG G    V        + KVA+KR   +  Q  + E   EI+ +SQ  H +
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKD---HLYASNFPS---LSWRKRLEICIGAARGL 594
           +VS       ++E+ ++ + +  G++ D   H+ A        L       I      GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVSTAVKGSFG 651
            YLH       IHRDVK+ NILL E+   ++ADFG+S     G D+ +  V     G+  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 652 YLDPEYLTKQQLTE-KSDVYSFGVVMFEILCG 682
           ++ PE + + +  + K+D++SFG+   E+  G
Sbjct: 187 WMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 107/212 (50%), Gaps = 11/212 (5%)
Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
            V++ +    ++    IG G  G VY  + +    +VA+++   Q          EI ++
Sbjct: 13  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 72
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
            + ++ ++V+ +      +E+ ++ EY+  G+L D +  +    +   +   +C    + 
Sbjct: 73  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQA 129
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGY 652
           L +LH+     +IHRD+KS NILL  +   K+ DFG  ++I P  +Q+  S  V G+  +
Sbjct: 130 LEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSXMV-GTPYW 183
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE +T++    K D++S G++  E++ G P
Sbjct: 184 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D        KG       
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 296
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 297 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           DNF   + IG G  G V    +R   K VAVK+   +  Q       E+ ++  ++H ++
Sbjct: 77  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +       +E+ ++ E++E G L D +  +    ++  +   +C+   + L  LH   
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA-- 188
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            + +IHRD+KS +ILL  +   K++DFG  +++  ++ +      + G+  ++ PE +++
Sbjct: 189 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISR 244
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                + D++S G+++ E++ G P
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDGEP 268

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           DNF   + IG G  G V    +R   K VAVK+   +  Q       E+ ++  ++H ++
Sbjct: 27  DNF---IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +       +E+ ++ E++E G L D +  +    ++  +   +C+   + L  LH   
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHA-- 138
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            + +IHRD+KS +ILL  +   K++DFG  +++  ++ +      + G+  ++ PE +++
Sbjct: 139 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR---RKXLVGTPYWMAPELISR 194
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                + D++S G+++ E++ G P
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDGEP 218

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +F E  +IG GGFG+V++   R + K   +KR    + +       E++ L++  H ++V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIV 67
Query: 543 SLIGYCD----------------ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEI 586
              G  D                +   + I  E+ + GTL+  +       L     LE+
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
                +G+ Y+H+   K +I+RD+K +NI L +    K+ DFGL      L         
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLV---TSLKNDGKRXRS 181
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           KG+  Y+ PE ++ Q   ++ D+Y+ G+++ E+L
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 490 VIGIGGFGKVYRGV-------LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           V+G G FG VY+G+       ++    + V R  T S +   E   E  +++     ++ 
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVS 82
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C   + + ++ + M  G L DH+   N   L  +  L  C+  A+G+ YL     
Sbjct: 83  RLLGIC-LTSTVQLVTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYLEDVR- 139
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYLTKQ 661
             ++HRD+ + N+L+      K+ DFGL+++  D+D+T   +   K    ++  E + ++
Sbjct: 140 --LVHRDLAARNVLVKSPNHVKITDFGLARLL-DIDETEYHADGGKVPIKWMALESILRR 196
Query: 662 QLTEKSDVYSFGVVMFEIL 680
           + T +SDV+S+GV ++E++
Sbjct: 197 RFTHQSDVWSYGVTVWELM 215

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI + +   H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+F H+++V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D        KG       
Sbjct: 176 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 227
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 273
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 274 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 322

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 71
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 72  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 124
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
            G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 125 EGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELM 210

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           DN     +IG G +G VY+G L DE  VAVK     + Q     +  I  +    H ++ 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIA 70
Query: 543 SLIG-----YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
             I        D R E +++ EY  NG+L  +L   +  +  W     +     RGL YL
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 598 HTGSTK------AIIHRDVKSANILLDENLMAKVADFGLS------KIGPDLDQTHVSTA 645
           HT   +      AI HRD+ S N+L+  +    ++DFGLS      ++    ++ + + +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 646 VKGSFGYLDPEYLT-------KQQLTEKSDVYSFGVVMFEIL 680
             G+  Y+ PE L         +   ++ D+Y+ G++ +EI 
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 484 NFSESLVIGIGGFGKVYRG-VLRDETKVAVKRGGT---QSHQGLAEFRTEIEMLSQFRHR 539
           NF     IG G F +VYR   L D   VA+K+         +  A+   EI++L Q  H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLK---DHLYASN--FPSLS-WRKRLEICIGAARG 593
           +++       E NE+ I+ E  + G L     H        P  + W+  +++C      
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC----SA 148
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L ++H+   + ++HRD+K AN+ +    + K+ D GL +      +T  + ++ G+  Y+
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYM 203
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEI 679
            PE + +     KSD++S G +++E+
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 491 IGIGGFGKVYRGVLRDETKV--AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FGKVY+   + ET V  A K   T+S + L ++  EI++L+   H ++V L+   
Sbjct: 45  LGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
              N + I+ E+   G +   +     P L+  +   +C      L+YLH      IIHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDNK---IIHR 159
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE--- 665
           D+K+ NIL   +   K+ADFG+S       Q   S    G+  ++ PE +  +   +   
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 666 --KSDVYSFGVVMFEI 679
             K+DV+S G+ + E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 491 IGIGGFGKVYRGVLRDETKV--AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FGKVY+   + ET V  A K   T+S + L ++  EI++L+   H ++V L+   
Sbjct: 45  LGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
              N + I+ E+   G +   +     P L+  +   +C      L+YLH      IIHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDNK---IIHR 159
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE--- 665
           D+K+ NIL   +   K+ADFG+S       Q   S    G+  ++ PE +  +   +   
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDRPY 217
Query: 666 --KSDVYSFGVVMFEI 679
             K+DV+S G+ + E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 73  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 25/233 (10%)
Query: 456 KEGHISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKV----A 511
           KEG+   + SS+++G            DNF    V+G G FGKV    +++   +     
Sbjct: 7   KEGNGIGVNSSNRLG-----------IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV 55
Query: 512 VKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL 570
           +K+        +    TE  +LS  R H  L  L       + +  + E++  G L  H+
Sbjct: 56  LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 571 YASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG 629
             S  F     R      I A   L +LH    K II+RD+K  N+LLD     K+ADFG
Sbjct: 116 QKSRRFDEARARFYAAEIISA---LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
           + K G  +     +    G+  Y+ PE L +       D ++ GV+++E+LCG
Sbjct: 170 MCKEG--ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 75  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+  H+++V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 599 TGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 210
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 211 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 256
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 257 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 305

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 78
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 79  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 131
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFG +K+    ++ + +   K    
Sbjct: 132 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELM 217

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 120/292 (41%), Gaps = 47/292 (16%)
Query: 491 IGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG+VY G +          +VAVK      S Q   +F  E  ++S+  H+++V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLH 598
            IG   +     I+ E M  G LK  L       S   SL+    L +    A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 599 TGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---- 651
                  IHRD+ + N LL       +AK+ DFG+++     D    S   KG       
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAMLPV 224
Query: 652 -YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
            ++ PE   +   T K+D +SFGV+++EI     +  PS   ++V              L
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV--------------L 270
Query: 711 EDIVDPTLTGQIKP--DSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           E +   T  G++ P  +       I  +C      DRP+   +L  +EY  Q
Sbjct: 271 EFV---TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 319

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+  G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 81
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 82  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 135 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 472
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 473 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 564

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEI 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   ++ V
Sbjct: 142 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 195
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++  ++ SD+++ G ++++++ G P
Sbjct: 196 -GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLP 232

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKDKNII 473
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 474 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 530
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 531 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 76
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFG +K+    ++ + +   K    
Sbjct: 130 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 76
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C      +I+ + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 77  DNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFG +K+    ++ + +   K    
Sbjct: 130 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDE---TKVAVK----RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E    K+ V     R  T S +   E   E  +++  
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREAT-SPKANKEILDEAYVMASV 108
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 109 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 161
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 162 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELM 247

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K Y     D       KV  K    + HQ   +  TEI +     + H+V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 108
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R  I     +G+ YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR- 162
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L++++  K+ DFGL +KI  D ++      + G+  Y+ PE L K+
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPNYIAPEVLCKK 217
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + D++S G +++ +L G+P  + S  +E
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 108
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 109 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 165
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 166 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 114
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 115 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ 171
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 172 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 477 AIQEATDNFSESL-VIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           A+   T N  E L ++G G FGKV     +   R      +K+    +   +A   TE  
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENR 61
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA- 590
           +L   RH  L +L       + +  + EY   G L  HL      S   R R     GA 
Sbjct: 62  VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAE 117
Query: 591 -ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
               L YLH  S K +++RD+K  N++LD++   K+ DFGL K G  +          G+
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGT 173
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
             YL PE L         D +  GVVM+E++CGR
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K Y     D       KV  K    + HQ   +  TEI +     + H+V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 108
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R  I     +G+ YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR- 162
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L++++  K+ DFGL +KI  D ++      + G+  Y+ PE L K+
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEVLCKK 217
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + D++S G +++ +L G+P  + S  +E
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 490 VIGIGGFGKVYR------GVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FGKV+          R    + V +  T   +     + E ++L +  H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHYLHTGST 602
           L        ++ +I +++  G L   L     F     +  L     A   LH L     
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL----- 145
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             II+RD+K  NILLDE    K+ DFGLSK    +D    + +  G+  Y+ PE + ++ 
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 663 LTEKSDVYSFGVVMFEILCG 682
            T+ +D +SFGV+MFE+L G
Sbjct: 203 HTQSADWWSFGVLMFEMLTG 222

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 130
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 131 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 74  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 130
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 131 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 14/196 (7%)
Query: 491 IGIGGFGKVYRGVLRDETKV--AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G G FGKVY+   + ET V  A K   T+S + L ++  EI++L+   H ++V L+   
Sbjct: 45  LGDGAFGKVYKAQNK-ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
              N + I+ E+   G +   +     P L+  +   +C      L+YLH      IIHR
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHDNK---IIHR 159
Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE--- 665
           D+K+ NIL   +   K+ADFG+S    +           G+  ++ PE +  +   +   
Sbjct: 160 DLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPY 217
Query: 666 --KSDVYSFGVVMFEI 679
             K+DV+S G+ + E+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 14/207 (6%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           + F    ++G G FGKV     +   R      +K+    +   +A   TE  +L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      S   R R     GA     L Y
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAEIVSALDY 263
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH  S K +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 264 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPE 319
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 72  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 128
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 129 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 185
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 186 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFG +K+    ++ + +   K    
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+  G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 81
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 82  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 135 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 76
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 77  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 129
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFG +K+    ++ + +   K    
Sbjct: 130 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+  G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 74
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 75  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 127
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELM 213

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 490 VIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           ++G G FGKV     +   R      +K+    +   +A   TE  +L   RH  L +L 
Sbjct: 158 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 217
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHYLHTGSTK 603
                 + +  + EY   G L  HL      S   R R     GA     L YLH  S K
Sbjct: 218 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAEIVSALDYLH--SEK 271
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE L     
Sbjct: 272 NVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFCGTPEYLAPEVLEDNDY 329
Query: 664 TEKSDVYSFGVVMFEILCGR 683
               D +  GVVM+E++CGR
Sbjct: 330 GRAVDWWGLGVVMYEMMCGR 349

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 490 VIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           ++G G FGKV     +   R      +K+    +   +A   TE  +L   RH  L +L 
Sbjct: 17  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 76
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHYLHTGSTK 603
                 + +  + EY   G L  HL      S   R R     GA     L YLH  S K
Sbjct: 77  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAEIVSALDYLH--SEK 130
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE L     
Sbjct: 131 NVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGTPEYLAPEVLEDNDY 188
Query: 664 TEKSDVYSFGVVMFEILCGR 683
               D +  GVVM+E++CGR
Sbjct: 189 GRAVDWWGLGVVMYEMMCGR 208

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 23/209 (11%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
            F +  V+G G FG VY+G+   E +     VA+K  R  T S +   E   E  +++  
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV 81
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPS---LSWRKRLEICIGAA 591
            + H+  L+G C   + + +I + M  G L D++  +  N  S   L+W      C+  A
Sbjct: 82  DNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 134
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +G++YL     + ++HRD+ + N+L+      K+ DFG +K+    ++ + +   K    
Sbjct: 135 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           ++  E +  +  T +SDV+S+GV ++E++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 114
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 115 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 171
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 172 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   ++ V
Sbjct: 143 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 196
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 197 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 110
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 111 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 490 VIGIGGFGKVYRGVLRDETK----VAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FG VY G   D+ +     A+K        Q +  F  E  ++    H ++++L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 545 IGYCDERNEMI-IIYEYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGST 602
           IG       +  ++  YM +G L   + +    P++  +  +   +  ARG+ YL   + 
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---AE 142
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD----QTHVSTAVKGSFGYLDPEYL 658
           +  +HRD+ + N +LDE+   KVADFGL++   D +    Q H    +   +  L  E L
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL--ESL 200
Query: 659 TKQQLTEKSDVYSFGVVMFEILC-GRPV---IDP 688
              + T KSDV+SFGV+++E+L  G P    IDP
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP 234

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 81/155 (52%), Gaps = 7/155 (4%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           E   E  ++ Q  + ++V +IG C+  + M+++ E  E G L  +L  +    +  +  +
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNII 120
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           E+    + G+ YL   +    +HRD+ + N+LL     AK++DFGLSK +  D +     
Sbjct: 121 ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFE 678
           T  K    +  PE +   + + KSDV+SFGV+M+E
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 490 VIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           ++G G FGKV     +   R      +K+    +   +A   TE  +L   RH  L +L 
Sbjct: 15  LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 74
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHYLHTGSTK 603
                 + +  + EY   G L  HL      S   R R     GA     L YLH  S K
Sbjct: 75  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAEIVSALDYLH--SEK 128
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE L     
Sbjct: 129 NVVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKXFCGTPEYLAPEVLEDNDY 186
Query: 664 TEKSDVYSFGVVMFEILCGR 683
               D +  GVVM+E++CGR
Sbjct: 187 GRAVDWWGLGVVMYEMMCGR 206

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K Y     D       KV  K    + HQ   +  TEI +     + H+V   
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 108
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R  I     +G+ YLH    
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR- 162
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L++++  K+ DFGL +KI  D ++      + G+  Y+ PE L K+
Sbjct: 163 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLCKK 217
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + D++S G +++ +L G+P  + S  +E
Sbjct: 218 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 85/159 (53%), Gaps = 11/159 (6%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIII-YEYMENGTLKDHLYA-SNFPSLSWRKRLEI 586
           E +++S+  H   V L  +C + +E +     Y +NG L  ++    +F     R     
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 145
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTA 645
            + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  
Sbjct: 146 IVSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           V G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 200 V-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 237

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 490 VIGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           V+G G F +V+    R   K+ A+K          +    EI +L + +H ++V+L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 549 DERNEMIIIYEYMENGTLKDHL-----YASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           +      ++ + +  G L D +     Y     SL  ++ L         + YLH     
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------AVKYLHEN--- 125
Query: 604 AIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            I+HRD+K  N+L    +EN    + DFGLSK    ++Q  + +   G+ GY+ PE L +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTPGYVAPEVLAQ 181
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
           +  ++  D +S GV+ + +LCG P
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYP 205

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 93
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + +++  E            I
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 587 CIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 154 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 211 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 246

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 41/260 (15%)
Query: 455 VKEGHISAIFSSSKIGY-----RFPFVA--IQEATDNFSESLVIGIGGFGKVYR----GV 503
           +K G++S +    ++       R P+ A   +   D       +G G FG+V      G+
Sbjct: 29  LKTGYLSIVMDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI 88
Query: 504 LRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN-EMI 555
            +  T   VAVK    G T S H+ L    +E+++L     H ++V+L+G C +    ++
Sbjct: 89  DKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 145
Query: 556 IIYEYMENGTLKDHLYASNFPSLSWRKRLE------------ICIG--AARGLHYLHTGS 601
           +I E+ + G L  +L +     + ++   E            IC     A+G+ +L   +
Sbjct: 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---A 202
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           ++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A +    ++ PE +  
Sbjct: 203 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-RLPLKWMAPETIFD 261
Query: 661 QQLTEKSDVYSFGVVMFEIL 680
           +  T +SDV+SFGV+++EI 
Sbjct: 262 RVYTIQSDVWSFGVLLWEIF 281

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 91
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   E            I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 587 CIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 209 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKR---------GGTQSHQGLAEFRTEIEML 533
           D +  S  +G G  G+V     R   K    R         G  +         TEIE+L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC----IG 589
            +  H  ++ +  + D  +  I++ E ME G L D +  +       R +   C      
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK------RLKEATCKLYFYQ 247
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               + YLH      IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   +
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 301
Query: 647 KGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE L            D +S GV++F  L G P
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 144
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 145 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 198
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 199 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 235

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKR---------GGTQSHQGLAEFRTEIEML 533
           D +  S  +G G  G+V     R   K    R         G  +         TEIE+L
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC----IG 589
            +  H  ++ +  + D  +  I++ E ME G L D +  +       R +   C      
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK------RLKEATCKLYFYQ 261
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               + YLH      IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   +
Sbjct: 262 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 315
Query: 647 KGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE L            D +S GV++F  L G P
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 356

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 82
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   E            I
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 587 CIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 200 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKR--------GGTQSHQGLAEFRTEIEML 533
           D +  S  +G G  G+V     R   K VA+K         G  +         TEIE+L
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC----IG 589
            +  H  ++ +  + D  +  I++ E ME G L D +  +       R +   C      
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK------RLKEATCKLYFYQ 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               + YLH      IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   +
Sbjct: 122 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 175
Query: 647 KGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE L            D +S GV++F  L G P
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 216

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 142 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 140 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV 193
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 491 IGIGGFGKVYRGVLRDET-----KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G GGF K Y     D       KV  K    + HQ   +  TEI +     + H+V   
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGFH 92
Query: 546 GYCDERNEMIIIYEYMENGTLKD---HLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           G+ ++ + + ++ E     +L +      A   P   +  R  I     +G+ YLH    
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLHNNR- 146
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             +IHRD+K  N+ L++++  K+ DFGL +KI  D ++      + G+  Y+ PE L K+
Sbjct: 147 --VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVLCKK 201
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
             + + D++S G +++ +L G+P  + S  +E
Sbjct: 202 GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 233

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 490 VIGIGGFGKVYR------GVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FGKV+          R    + V +  T   +     + E ++L +  H  +V 
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHYLHTGST 602
           L        ++ +I +++  G L   L     F     +  L     A   LH L     
Sbjct: 92  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL----- 146
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             II+RD+K  NILLDE    K+ DFGLSK    +D    + +  G+  Y+ PE + ++ 
Sbjct: 147 -GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 663 LTEKSDVYSFGVVMFEILCG 682
            T+ +D +SFGV+MFE+L G
Sbjct: 204 HTQSADWWSFGVLMFEMLTG 223

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 142 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 196 -GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLP 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKR--------GGTQSHQGLAEFRTEIEML 533
           D +  S  +G G  G+V     R   K VA+K         G  +         TEIE+L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC----IG 589
            +  H  ++ +  + D  +  I++ E ME G L D +  +       R +   C      
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK------RLKEATCKLYFYQ 122
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               + YLH      IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 176
Query: 647 KGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE L            D +S GV++F  L G P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 490 VIGIGGFGKVYR------GVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FGKV+          R    + V +  T   +     + E ++L +  H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHYLHTGST 602
           L        ++ +I +++  G L   L     F     +  L     A   LH L     
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL----- 145
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             II+RD+K  NILLDE    K+ DFGLSK    +D    + +  G+  Y+ PE + ++ 
Sbjct: 146 -GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 663 LTEKSDVYSFGVVMFEILCG 682
            T+ +D +SFGV+MFE+L G
Sbjct: 203 HTQSADWWSFGVLMFEMLTG 222

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKR--------GGTQSHQGLAEFRTEIEML 533
           D +  S  +G G  G+V     R   K VA+K         G  +         TEIE+L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC----IG 589
            +  H  ++ +  + D  +  I++ E ME G L D +  +       R +   C      
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK------RLKEATCKLYFYQ 122
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               + YLH      IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 176
Query: 647 KGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE L            D +S GV++F  L G P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 12/200 (6%)
Query: 490 VIGIGGFGKVYRGVLRDE-----TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           VIG G FGKV     + E      KV  K+   +  +          +L   +H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
                  +++  + +Y+  G L  HL       L  R R       A  L YLH+ +   
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARF-YAAEIASALGYLHSLN--- 159
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           I++RD+K  NILLD      + DFGL K   +++    ++   G+  YL PE L KQ   
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 665 EKSDVYSFGVVMFEILCGRP 684
              D +  G V++E+L G P
Sbjct: 218 RTVDWWCLGAVLYEMLYGLP 237

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 33/216 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 92
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRK---------RLE--IC 587
           ++V+L+G C +    +++I E+ + G L  +L +     + ++           LE  IC
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 588 IG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVST 644
                A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 210 A-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 30/213 (14%)
Query: 491 IGIGGFGKVYR----GVLRDETK--VAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 91
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE--------ICIG- 589
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   +        IC   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 590 -AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVK 647
             A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A +
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-R 207
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
               ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK--VAVKRGGTQSHQGLAEFRT---EIEMLSQFR 537
           D+F     IG G FGKV   V +++TK   A+K    Q      E R    E++++    
Sbjct: 15  DHFEILRAIGKGSFGKVC-IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H  LV+L     +  +M ++ + +  G L+ HL   N        +L IC      L YL
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFIC-ELVMALDYL 131
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                + IIHRD+K  NILLDE+    + DF ++ + P   Q    T + G+  Y+ PE 
Sbjct: 132 QN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEM 185
Query: 658 LTKQQLTEKS---DVYSFGVVMFEILCGR 683
            + ++    S   D +S GV  +E+L GR
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 142 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 142
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 143 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 196
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 197 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 233

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKR--------GGTQSHQGLAEFRTEIEML 533
           D +  S  +G G  G+V     R   K VA+K         G  +         TEIE+L
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC----IG 589
            +  H  ++ +  + D  +  I++ E ME G L D +  +       R +   C      
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK------RLKEATCKLYFYQ 122
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               + YLH      IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   +
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 176
Query: 647 KGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE L            D +S GV++F  L G P
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 140 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 142 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 140 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 82
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   E            I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 587 C--IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 200 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           D F +  V+G GGFG+V+   ++   K+     + +   +  +G      E ++L++   
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHY 596
           R +VSL    + + ++ ++   M  G ++ H+Y    + P     + +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + II+RD+K  N+LLD++   +++D GL+ +     QT  +    G+ G++ PE
Sbjct: 305 LHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPE 359
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L  ++     D ++ GV ++E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 172
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 173 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 226
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E    +E    CQ  
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE----LELMFGCQVE 282
Query: 708 G 708
           G
Sbjct: 283 G 283

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 32/221 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK-VAVKR--------GGTQSHQGLAEFRTEIEML 533
           D +  S  +G G  G+V     R   K VA+K         G  +         TEIE+L
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC----IG 589
            +  H  ++ +  + D  +  I++ E ME G L D +  +       R +   C      
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK------RLKEATCKLYFYQ 128
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               + YLH      IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   +
Sbjct: 129 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTL 182
Query: 647 KGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRP 684
            G+  YL PE L            D +S GV++F  L G P
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 223

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 140 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 194 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 142 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 195
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 196 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 83/158 (52%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   ++ V
Sbjct: 139 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 192
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 193 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           D F +  V+G GGFG+V+   ++   K+     + +   +  +G      E ++L++   
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHY 596
           R +VSL    + + ++ ++   M  G ++ H+Y    + P     + +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + II+RD+K  N+LLD++   +++D GL+ +     QT  +    G+ G++ PE
Sbjct: 305 LHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPE 359
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L  ++     D ++ GV ++E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G  G+V   V R  E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHYLHTGSTK 603
            E N   +  EY   G L D              R+E  IG     A R  H L  G   
Sbjct: 74  REGNIQYLFLEYCSGGELFD--------------RIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 604 ----AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  Y+ PE L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 660 KQQL-TEKSDVYSFGVVMFEILCGR-PVIDPS 689
           +++   E  DV+S G+V+  +L G  P   PS
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 93/177 (52%), Gaps = 10/177 (5%)
Query: 509 KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD 568
           +VAVK+   +  Q       E+ ++  + H ++V +       +E+ ++ E++E G L D
Sbjct: 72  QVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD 131
Query: 569 HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF 628
            +  +    ++  +   +C+   R L YLH    + +IHRD+KS +ILL  +   K++DF
Sbjct: 132 IVTHTR---MNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDF 185
Query: 629 GL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           G  +++  ++ +      + G+  ++ PE +++     + D++S G+++ E++ G P
Sbjct: 186 GFCAQVSKEVPK---RKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           D F +  V+G GGFG+V+   ++   K+     + +   +  +G      E ++L++   
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHY 596
           R +VSL    + + ++ ++   M  G ++ H+Y    + P     + +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + II+RD+K  N+LLD++   +++D GL+ +     QT  +    G+ G++ PE
Sbjct: 305 LHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPE 359
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L  ++     D ++ GV ++E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 91
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   E            I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 587 CIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 209 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 119 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 173 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 209

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 113/218 (51%), Gaps = 25/218 (11%)
Query: 477 AIQEATDNF---SESLVIGIGGFGKVYRGVLRDET----KVAVKRGGTQSHQGLAEFRTE 529
           A Q A ++F   S++ ++G G FG+V++    +ET    K+A K   T+  +   E + E
Sbjct: 80  AKQGAVNSFYTVSKTEILGGGRFGQVHKC---EETATGLKLAAKIIKTRGMKDKEEVKNE 136
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EI 586
           I +++Q  H +L+ L    + +N+++++ EY++ G L D +   ++        L   +I
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVST 644
           C G  R +H ++      I+H D+K  NIL    +    K+ DFGL++     ++  V+ 
Sbjct: 197 CEGI-RHMHQMY------ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249
Query: 645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
              G+  +L PE +    ++  +D++S GV+ + +L G
Sbjct: 250 ---GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 119
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 120 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 174 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 210

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           D F +  V+G GGFG+V+   ++   K+     + +   +  +G      E ++L++   
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICIGAARGLHY 596
           R +VSL    + + ++ ++   M  G ++ H+Y    + P     + +        GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + II+RD+K  N+LLD++   +++D GL+ +     QT  +    G+ G++ PE
Sbjct: 305 LHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTK-TKGYAGTPGFMAPE 359
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L  ++     D ++ GV ++E++  R
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 116
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 117 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 171 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 207

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 132/279 (47%), Gaps = 56/279 (20%)
Query: 494 GGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ--FRHRHLVSLIGYCDER 551
           G FG V++  L ++  VAVK    Q  Q    +++E E+ S    +H +L+  I   ++R
Sbjct: 26  GRFGCVWKAQLMNDF-VAVKIFPLQDKQS---WQSEREIFSTPGMKHENLLQFIA-AEKR 80
Query: 552 N-----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT------- 599
                 E+ +I  + + G+L D+L  +    ++W +   +    +RGL YLH        
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 600 -GSTKAIIHRDVKSANILLDENLMAKVADFGLS---KIGPDLDQTHVSTAVKGSFGYLDP 655
            G   +I HRD KS N+LL  +L A +ADFGL+   + G     TH      G+  Y+ P
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYMAP 194
Query: 656 EYLT-----KQQLTEKSDVYSFGVVMFEIL--CGR---PVIDPSLPREKVNLVEWAMKCQ 705
           E L      ++    + D+Y+ G+V++E++  C     PV +  LP E           +
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFE-----------E 243
Query: 706 ETGQ---LEDIVDPTLTGQIKP---DSLNKFVEIAEKCL 738
           E GQ   LE++ +  +  +++P   D   K   +A+ C+
Sbjct: 244 EIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCV 282

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 118 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 172 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           D   + +V+G G +G VY G  L ++ ++A+K    +  +       EI +    +H+++
Sbjct: 22  DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHY 596
           V  +G   E   + I  E +  G+L   L +   P     K  E  IG        GL Y
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIGFYTKQILEGLKY 137
Query: 597 LHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSK----IGPDLDQTHVSTAVKGSFG 651
           LH      I+HRD+K  N+L++  + + K++DFG SK    I P       +    G+  
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQ 188
Query: 652 YLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRP 684
           Y+ PE + K  +   + +D++S G  + E+  G+P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 32/215 (14%)
Query: 491 IGIGGFGKVYR----GVLRDETKVAV-----KRGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   V     K G T S H+ L    +E+++L     H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 93
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKR--------LEICIG- 589
           ++V+L+G C +    +++I E+ + G L  +L +     + ++          LE  I  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 590 ---AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTA 645
               A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 211 -RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 137
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 138 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 191
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E    +E    CQ  
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE----LELMFGCQVE 247
Query: 708 GQLEDIVDPTLTGQIKPDSLNKF 730
           G   D  +     +     LNKF
Sbjct: 248 G---DAAETPPRPRTPGRPLNKF 267

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 91
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   E            I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 587 CIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 209 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 111 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 164
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E    +E    CQ  
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE----LELMFGCQVE 220
Query: 708 G 708
           G
Sbjct: 221 G 221

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 111 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 164
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E    +E    CQ  
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE----LELMFGCQVE 220
Query: 708 G 708
           G
Sbjct: 221 G 221

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 123
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 124 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 178 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 214

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 9/158 (5%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEIC 587
           E +++S+  H   V L     +  ++     Y +NG L  ++    +F     R      
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 138
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLDQTHVSTAV 646
           + A   L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+  P+  Q   +  V
Sbjct: 139 VSA---LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 192
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            G+  Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 193 -GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 490 VIGIGGFGKVY--RGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           V+G GG+GKV+  R V    T      KV  K    ++ +  A  + E  +L + +H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNF----PSLSWRKRLEICIGAARGLHYL 597
           V LI       ++ +I EY+  G L   L          +  +   + + +G      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H    K II+RD+K  NI+L+     K+ DFGL K    +    V+    G+  Y+ PE 
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEI 192
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ 705
           L +       D +S G +M+++L G P   P     +   ++  +KC+
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAP---PFTGENRKKTIDKILKCK 237

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 118/282 (41%), Gaps = 54/282 (19%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVK------RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           IG G F  VY+G L  ET V V       R  T+S +    F+ E E L   +H ++V  
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSER--QRFKEEAEXLKGLQHPNIVRF 90
Query: 545 IGYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSL----SWRKRLEICIGAARGLHY 596
               +     +  ++++ E   +GTLK +L       +    SW      C    +GL +
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGLQF 144
Query: 597 LHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           LHT  T  IIHRD+K  NI +       K+ D GL+     L +   + AV G+  +  P
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFXAP 199
Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
           E   +++  E  DVY+FG    E            P           +CQ   Q+   V 
Sbjct: 200 EXY-EEKYDESVDVYAFGXCXLEXATS------EYP---------YSECQNAAQIYRRV- 242
Query: 716 PTLTGQIKPDSLNKFV-----EIAEKCLAQCGIDRPSMGDVL 752
              T  +KP S +K       EI E C+ Q   +R S+ D+L
Sbjct: 243 ---TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 82
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   E            I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 587 CIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 200 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           D   + +V+G G +G VY G  L ++ ++A+K    +  +       EI +    +H+++
Sbjct: 8   DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIG-----AARGLHY 596
           V  +G   E   + I  E +  G+L   L +   P     K  E  IG        GL Y
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIGFYTKQILEGLKY 123
Query: 597 LHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSK----IGPDLDQTHVSTAVKGSFG 651
           LH      I+HRD+K  N+L++  + + K++DFG SK    I P       +    G+  
Sbjct: 124 LHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP------CTETFTGTLQ 174
Query: 652 YLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRP 684
           Y+ PE + K  +   + +D++S G  + E+  G+P
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 209

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 491 IGIGGFGKVYR----GVLRDET--KVAVK---RGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   VAVK    G T S H+ L    +E+++L     H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 82
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------------I 586
           ++V+L+G C +    +++I E+ + G L  +L +     + ++   E            I
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 587 CIG--AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVS 643
           C     A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D     
Sbjct: 143 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            A +    ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 200 DA-RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 235

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 111 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 164
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E    +E    CQ  
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE----LELMFGCQVE 220
Query: 708 G 708
           G
Sbjct: 221 G 221

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 14/181 (7%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 111 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 164
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E    +E    CQ  
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE----LELMFGCQVE 220
Query: 708 G 708
           G
Sbjct: 221 G 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 490 VIGIGGFGKVY--RGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           V+G GG+GKV+  R V    T      KV  K    ++ +  A  + E  +L + +H  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNF----PSLSWRKRLEICIGAARGLHYL 597
           V LI       ++ +I EY+  G L   L          +  +   + + +G      +L
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H    K II+RD+K  NI+L+     K+ DFGL K    +    V+    G+  Y+ PE 
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEI 192
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ 705
           L +       D +S G +M+++L G P   P     +   ++  +KC+
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAP---PFTGENRKKTIDKILKCK 237

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHL 541
           D++     +G G FG V+R   R        +     H+   E  R EI+ +S  RH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V+L    ++ NEM++IYE+M  G L + + A     +S  + +E      +GL ++H  +
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 602 TKAIIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
               +H D+K  NI+     +   K+ DFGL+     LD         G+  +  PE   
Sbjct: 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 660 KQQLTEKSDVYSFGVVMFEILCG 682
            + +   +D++S GV+ + +L G
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   R      +++    +   +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      +   R R     GA     L Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARF---YGAEIVSALEY 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   + +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPE 175
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 32/237 (13%)
Query: 477 AIQEATD------NFSESLVIGIGGFGKVY--RGVLRD-ETKVAVKRGGTQSHQGLAEFR 527
           +I  ATD      N+     IG G F KV   R VL   E  V +      +   L +  
Sbjct: 3   SITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 528 TEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEI 586
            E+ ++    H ++V L    +    + ++ EY   G + D+L A         R +   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVS 643
            + A +  H       K I+HRD+K+ N+LLD ++  K+ADFG S    +G  LD     
Sbjct: 123 IVSAVQYCH------QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLD----- 171
Query: 644 TAVKGSFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
               GS  Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 172 -TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 10/203 (4%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHL 541
           D++     +G G FG V+R   R        +     H+   E  R EI+ +S  RH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V+L    ++ NEM++IYE+M  G L + + A     +S  + +E      +GL ++H  +
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 602 TKAIIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
               +H D+K  NI+     +   K+ DFGL+     LD         G+  +  PE   
Sbjct: 170 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 660 KQQLTEKSDVYSFGVVMFEILCG 682
            + +   +D++S GV+ + +L G
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   R      +++    +   +A   TE  +L   RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      +   R R     GA     L Y
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARF---YGAEIVSALEY 123
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   + +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 124 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPE 178
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   R      +++    +   +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      +   R R     GA     L Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARF---YGAEIVSALEY 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   + +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFCGTPEYLAPE 175
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   R      +++    +   +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      +   R R     GA     L Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARF---YGAEIVSALEY 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   + +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPE 175
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   R      +++    +   +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      +   R R     GA     L Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFT-EERARF---YGAEIVSALEY 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   + +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPE 175
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   R      +++    +   +A   TE  +L   RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      +   R R     GA     L Y
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARF---YGAEIVSALEY 125
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   + +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 126 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPE 180
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVY----RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   R      +++    +   +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA--ARGLHY 596
             L +L       + +  + EY   G L  HL      +   R R     GA     L Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-RARF---YGAEIVSALEY 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+   + +++RD+K  N++LD++   K+ DFGL K G  +          G+  YL PE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKXFCGTPEYLAPE 175
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR 683
            L         D +  GVVM+E++CGR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK---VS 120
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   RGL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 121 IAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 174
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E
Sbjct: 175 GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKE 220

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 30/213 (14%)
Query: 491 IGIGGFGKVYR----GVLRDETKVAV-----KRGGTQS-HQGLAEFRTEIEMLSQF-RHR 539
           +G G FG+V      G+ +  T   V     K G T S H+ L    +E+++L     H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHL 91
Query: 540 HLVSLIGYCDERN-EMIIIYEYMENGTLKDHLYASNFPSLSWRK------RLEICIG--- 589
           ++V+L+G C +    +++I E+ + G L  +L +     + ++        LE  I    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 590 -AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVK 647
             A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A +
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA-R 207
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
               ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 108/226 (47%), Gaps = 15/226 (6%)
Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQGLAEFRT-EIEMLSQFRH 538
           ++  F +   +G G +  VY+G+ +     VA+K     S +G       EI ++ + +H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLK--DHLYASNFP---SLSWRKRLEICIGAARG 593
            ++V L       N++ +++E+M+N   K  D     N P    L+  K  +  +   +G
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQG 120
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L + H      I+HRD+K  N+L+++    K+ DFGL++       T  S  V  +  Y 
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYR 175
Query: 654 DPEYLTKQQLTEKS-DVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
            P+ L   +    S D++S G ++ E++ G+P+   +   E++ L+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRG---GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G +G+  +   + + K+ V +    G+ +        +E+ +L + +H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 548 CDERNE--MIIIYEYMENGTL--------KDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
             +R    + I+ EY E G L        K+  Y      L    +L +   A +  H  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL---ALKECHRR 130
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ-THVSTAVKGSFGYLDPE 656
             G    ++HRD+K AN+ LD     K+ DFGL++I   L+  T  + A  G+  Y+ PE
Sbjct: 131 SDGG-HTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKAFVGTPYYMSPE 186
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            + +    EKSD++S G +++E+    P
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMP 214

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 37/272 (13%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKR---GGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLI 545
           +G G +G V++ + R   +V AVK+       S      FR EI +L++   H ++V+L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 546 GY--CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
                D   ++ ++++YME  T    +  +N   L    +  +     + + YLH+G   
Sbjct: 76  NVLRADNDRDVYLVFDYME--TDLHAVIRANI--LEPVHKQYVVYQLIKVIKYLHSG--- 128
Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDL-------------------DQTHVST 644
            ++HRD+K +NILL+     KVADFGLS+   ++                   D   + T
Sbjct: 129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 645 AVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK 703
               +  Y  PE L    + T+  D++S G ++ EILCG+P+   S    ++  +   + 
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248
Query: 704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAE 735
                 +E I  P     I  +SL + VEI +
Sbjct: 249 FPSNEDVESIQSPFAKTMI--ESLKEKVEIRQ 278

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 107/227 (47%), Gaps = 27/227 (11%)
Query: 491 IGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL----- 544
           +G GG G V+  V  D + +VA+K+      Q +     EI+++ +  H ++V +     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 545 ---------IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
                    +G   E N + I+ EYME             P L    RL       RGL 
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETDLAN---VLEQGPLLEEHARL-FMYQLLRGLK 134
Query: 596 YLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKI-GPDLDQT-HVSTAVKGSFGY 652
           Y+H+ +   ++HRD+K AN+ ++ E+L+ K+ DFGL++I  P      H+S  +   + Y
Sbjct: 135 YIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW-Y 190
Query: 653 LDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
             P   L+    T+  D+++ G +  E+L G+ +   +   E++ L+
Sbjct: 191 RSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   H  LV L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWR-KRLEICIGAARGLHYLHTGST 602
                  + +  + EY+  G L  H+      P    R    EI +     L+YLH    
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHE--- 171
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + II+RD+K  N+LLD     K+ D+G+ K G  L     ++   G+  Y+ PE L  + 
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTFCGTPNYIAPEILRGED 229
Query: 663 LTEKSDVYSFGVVMFEILCGRPVID 687
                D ++ GV+MFE++ GR   D
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  V +      +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + ++ EY   G + D+L A         R +    + A +  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD ++  K+ADFG S     G  LD      A  G+  
Sbjct: 130 H------QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------AFCGAPP 177
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  + +      +   L +   E+ ++  
Sbjct: 11  QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 70
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + +I EY   G + D+L A         R +    + A +  
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD ++  K+ADFG S    +G  LD      A  G+  
Sbjct: 131 H------QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD------AFCGAPP 178
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRG---GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G +G+  +   + + K+ V +    G+ +        +E+ +L + +H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 548 CDERNE--MIIIYEYMENGTL--------KDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
             +R    + I+ EY E G L        K+  Y      L    +L +   A +  H  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL---ALKECHRR 130
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
             G    ++HRD+K AN+ LD     K+ DFGL++I  + D +   T V G+  Y+ PE 
Sbjct: 131 SDGG-HTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFV-GTPYYMSPEQ 187
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + +    EKSD++S G +++E+    P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMP 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 110
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 111 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 164
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
           G+  Y+ PE L     + +SD++S G+ + E+  GR  I P   +E
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 117/245 (47%), Gaps = 26/245 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKR-----GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G FG V+   L +E    ++R        +S   + +   EIE+L    H +++ + 
Sbjct: 30  LGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNF--PSLSWRKRLEICIGAARGLHYLHTGSTK 603
              ++ + M I+ E  E G L + + ++     +LS     E+       L Y H   ++
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQ 143
Query: 604 AIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            ++H+D+K  NIL  +   +   K+ DFGL+++         ST   G+  Y+ PE   K
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVF-K 199
Query: 661 QQLTEKSDVYSFGVVMFEILCG-RPVIDPSLP--REKVNLVE--WAMKCQE-TGQLEDIV 714
           + +T K D++S GVVM+ +L G  P    SL   ++K    E  +A++C+  T Q  D++
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259
Query: 715 DPTLT 719
              LT
Sbjct: 260 KQMLT 264

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQF-RH 538
           +F    VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWR-KRLEICIGAARGLHY 596
             LV L       + +  + EY+  G L  H+      P    R    EI +     L+Y
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNY 125
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + II+RD+K  N+LLD     K+ D+G+ K G  L     ++   G+  Y+ PE
Sbjct: 126 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPE 180
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
            L  +      D ++ GV+MFE++ GR   D
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVA------VKRGGTQSHQGLAEFRTEIEM 532
           Q  +D +     +G G +G+V   + +D+   A      +K+    +         E+ +
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAV 74
Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR 592
           L Q  H +++ L  + +++    ++ E    G L D +        S      I      
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLS 132
Query: 593 GLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLS---KIGPDLDQTHVSTAV 646
           G  YLH  +   I+HRD+K  N+LL+    + + K+ DFGLS   ++G  + +       
Sbjct: 133 GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL----- 184
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
            G+  Y+ PE L K+   EK DV+S GV+++ +LCG P       +E +  VE
Sbjct: 185 -GTAYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 235

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQF-RH 538
           +F    VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWR-KRLEICIGAARGLHY 596
             LV L       + +  + EY+  G L  H+      P    R    EI +     L+Y
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNY 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH    + II+RD+K  N+LLD     K+ D+G+ K G  L     ++   G+  Y+ PE
Sbjct: 122 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPE 176
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
            L  +      D ++ GV+MFE++ GR   D
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSL 544
           VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   H  LV L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWR-KRLEICIGAARGLHYLHTGST 602
                  + +  + EY+  G L  H+      P    R    EI +     L+YLH    
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA----LNYLHE--- 139
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + II+RD+K  N+LLD     K+ D+G+ K G  L     ++   G+  Y+ PE L  + 
Sbjct: 140 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSXFCGTPNYIAPEILRGED 197
Query: 663 LTEKSDVYSFGVVMFEILCGRPVID 687
                D ++ GV+MFE++ GR   D
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  V +      +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + ++ EY   G + D+L A         R +    + A +  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD ++  K+ADFG S     G  LD+        GS  
Sbjct: 130 H------QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE------FCGSPP 177
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF---------RTEIEM 532
           +D F     +G G    VYR           K+ GTQ    L            RTEI +
Sbjct: 52  SDFFEVESELGRGATSIVYR----------CKQKGTQKPYALKVLKKTVDKKIVRTEIGV 101
Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR 592
           L +  H +++ L    +   E+ ++ E +  G L D +    +   S R   +       
Sbjct: 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILE 159
Query: 593 GLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            + YLH      I+HRD+K  N+L      +   K+ADFGLSKI   ++   +   V G+
Sbjct: 160 AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGT 213
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            GY  PE L       + D++S G++ + +LCG
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  V +      +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + ++ EY   G + D+L A         R +    + A +  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD ++  K+ADFG S     G  LD         GS  
Sbjct: 130 H------QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPP 177
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 485 FSESLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           F+ESL  G G F K+++GV R+        ET+V +K    ++H+  +E F     M+S+
Sbjct: 12  FNESL--GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSK 68
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGL 594
             H+HLV   G C   +E I++ E+++ G+L  +L  + N  ++ W  +LE+    A  +
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAM 126
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAV-KGSFGY 652
           H+L   +   +IH +V + NILL      K  +    K+  P +  T +   + +    +
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 653 LDPEYL-TKQQLTEKSDVYSFGVVMFEILCG 682
           + PE +   + L   +D +SFG  ++EI  G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 491 IGIGGFGKVYRGVLRDETK----VAVKRGGTQSHQGLAEFRTEIEM-----LSQFRHRHL 541
           IG G +GKV++   RD       VA+KR   Q+ +      T  E+     L  F H ++
Sbjct: 19  IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 542 VSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
           V L   C     D   ++ +++E+++   L  +L     P +      ++     RGL +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+     ++HRD+K  NIL+  +   K+ADFGL++I          T+V  +  Y  PE
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 189
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            L +       D++S G +  E+   +P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  V +      +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + ++ EY   G + D+L A         R +    + A +  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD ++  K+ADFG S     G  LD         GS  
Sbjct: 130 H------QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPP 177
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQGLAEFRTEIEM----- 532
           AT  +     IG+G +G VY+   RD      VA+K     + +      T  E+     
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 533 LSQFRHRHLVSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
           L  F H ++V L+  C     D   ++ +++E+++   L+ +L  +  P L      ++ 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
               RGL +LH      I+HRD+K  NIL+      K+ADFGL++I            V 
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVV 172
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            +  Y  PE L +       D++S G +  E+   +P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 210

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 87/164 (53%), Gaps = 20/164 (12%)
Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL---KDHLYA--SNFPSLS 579
           +F+ E+++++  ++ + ++  G     +E+ IIYEYMEN ++    ++ +    N+    
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 580 WRKRLEICIGAA-RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
             + ++  I +      Y+H  + K I HRDVK +NIL+D+N   K++DFG S       
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGES------- 199
Query: 639 QTHVSTAVKGSFG---YLDPEYLTKQQLTE--KSDVYSFGVVMF 677
           +  V   +KGS G   ++ PE+ + +      K D++S G+ ++
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 484 NFSESLVIGIGGFGKVY--RGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           N+     IG G F KV   R +L   E  V +      +   L +   E+ ++    H +
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V L    +    + ++ EY   G + D+L A       W K  E      + +  +   
Sbjct: 68  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-----GWMKEKEARAKFRQIVSAVQYC 122
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFGYLDPE- 656
             K I+HRD+K+ N+LLD ++  K+ADFG S     G  LD         GS  Y  PE 
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPPYAAPEL 176
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 213

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 485 FSESLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQ 535
           F+ESL  G G F K+++GV R+        ET+V +K    ++H+  +E F     M+S+
Sbjct: 12  FNESL--GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSK 68
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGL 594
             H+HLV   G C   +E I++ E+++ G+L  +L  + N  ++ W  +LE+    A  +
Sbjct: 69  LSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAM 126
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAV-KGSFGY 652
           H+L   +   +IH +V + NILL      K  +    K+  P +  T +   + +    +
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPW 183
Query: 653 LDPEYL-TKQQLTEKSDVYSFGVVMFEILCG 682
           + PE +   + L   +D +SFG  ++EI  G
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  V +      +   L +   E+ ++  
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKV 69
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + ++ EY   G + D+L A         R +    + A +  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD ++  K+ADFG S     G  LD         GS  
Sbjct: 130 H------QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD------TFCGSPP 177
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 100/229 (43%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  + +      +   L +   E+ ++  
Sbjct: 8   QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKI 67
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + +I EY   G + D+L A         R +    + A +  
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 127
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD ++  K+ADFG S    +G  LD         GS  
Sbjct: 128 H------QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD------TFCGSPP 175
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 218

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQGLAEFRTEIEM----- 532
           AT  +     IG+G +G VY+   RD      VA+K     + +      T  E+     
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 533 LSQFRHRHLVSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
           L  F H ++V L+  C     D   ++ +++E+++   L+ +L  +  P L      ++ 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
               RGL +LH      I+HRD+K  NIL+      K+ADFGL++I            V 
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVV 172
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            +  Y  PE L +       D++S G +  E+   +P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 26/230 (11%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVA------VKRGGTQSHQGLAEFRTEIEMLSQ 535
           +D +     +G G +G+V   + +D+   A      +K+    +         E+ +L Q
Sbjct: 3   SDRYQRVKKLGSGAYGEVL--LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQ 60
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
             H +++ L  + +++    ++ E    G L D +        S      I      G  
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVIMKQVLSGTT 118
Query: 596 YLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLS---KIGPDLDQTHVSTAVKGS 649
           YLH  +   I+HRD+K  N+LL+    + + K+ DFGLS   ++G  + +        G+
Sbjct: 119 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL------GT 169
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
             Y+ PE L K+   EK DV+S GV+++ +LCG P       +E +  VE
Sbjct: 170 AYYIAPEVLRKK-YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 491 IGIGGFGKVYRGVLRDETK----VAVKRGGTQSHQGLAEFRTEIEM-----LSQFRHRHL 541
           IG G +GKV++   RD       VA+KR   Q+ +      T  E+     L  F H ++
Sbjct: 19  IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 542 VSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
           V L   C     D   ++ +++E+++   L  +L     P +      ++     RGL +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+     ++HRD+K  NIL+  +   K+ADFGL++I          T+V  +  Y  PE
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 189
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            L +       D++S G +  E+   +P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 490 VIGIGGFGKVYRG---VLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           ++G G FG+V +    + + E  V V    +  ++  +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             ++ +   I+ E    G L D +        S      I      G+ Y+H  +   I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 607 HRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTK 660
           HRD+K  NILL+   ++   K+ DFGLS           +T +K   G   Y+ PE L +
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC------FQQNTKMKDRIGTAYYIAPEVL-R 196
Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
               EK DV+S GV+++ +L G P
Sbjct: 197 GTYDEKCDVWSAGVILYILLSGTP 220

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +IG G FG+VY G    E  + +      +   L  F+ E+    Q RH ++V  +G C 
Sbjct: 40  LIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
               + II    +  TL   +  +    L   K  +I     +G+ YLH    K I+H+D
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIVKGMGYLH---AKGILHKD 155
Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK---GSFGYLDPEYLT------- 659
           +KS N+  D N    + DFGL  I   L        ++   G   +L PE +        
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 660 --KQQLTEKSDVYSFGVVMFEI 679
             K   ++ SDV++ G + +E+
Sbjct: 215 EDKLPFSKHSDVFALGTIWYEL 236

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 491 IGIGGFGKVYRGVLRD-----ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +G G +G+V   + RD     E  + + R  + S    ++   E+ +L    H +++ L 
Sbjct: 45  LGSGAYGEVL--LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 546 GYCDERNEMIIIYEYMENGTLKDHL-YASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
            + +++    ++ E  + G L D + +   F  +       I      G+ YLH  +   
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD---AAVIIKQVLSGVTYLHKHN--- 156
Query: 605 IIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
           I+HRD+K  N+LL+   ++ + K+ DFGLS +  +  Q  +   + G+  Y+ PE L K+
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERL-GTAYYIAPEVLRKK 213
Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
              EK DV+S GV++F +L G P       +E +  VE
Sbjct: 214 -YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQGLAEFRTEIEM----- 532
           AT  +     IG+G +G VY+   RD      VA+K     + +      T  E+     
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRR 59
Query: 533 LSQFRHRHLVSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
           L  F H ++V L+  C     D   ++ +++E+++   L+ +L  +  P L      ++ 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
               RGL +LH      I+HRD+K  NIL+      K+ADFGL++I            V 
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVV 172
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            +  Y  PE L +       D++S G +  E+   +P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 210

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 491 IGIGGFGKVYRGVLRDETK----VAVKRGGTQSHQGLAEFRTEIEM-----LSQFRHRHL 541
           IG G +GKV++   RD       VA+KR   Q+ +      T  E+     L  F H ++
Sbjct: 19  IGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 542 VSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
           V L   C     D   ++ +++E+++   L  +L     P +      ++     RGL +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH+     ++HRD+K  NIL+  +   K+ADFGL++I          T+V  +  Y  PE
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 189
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            L +       D++S G +  E+   +P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPL 218

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 27/222 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQ------GLAEFRTEIE 531
           AT  +     IG+G +G VY+   RD      VA+K     +         ++  R E+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVA 63
Query: 532 MLSQ---FRHRHLVSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKR 583
           +L +   F H ++V L+  C     D   ++ +++E+++   L+ +L  +  P L     
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
            ++     RGL +LH      I+HRD+K  NIL+      K+ADFGL++I          
Sbjct: 123 KDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMAL 176
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
           T V  +  Y  PE L +       D++S G +  E+   +P+
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 218

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 491 IGIGGFGKVYRGVLR----DETKVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG V RG           VAVK  +    S  + + +F  E+  +    HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHT 599
           L G       M ++ E    G+L D L          +LS        +  A G+ YL  
Sbjct: 80  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 131
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYL 658
             +K  IHRD+ + N+LL    + K+ DFGL +  P  D  +V     K  F +  PE L
Sbjct: 132 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 659 TKQQLTEKSDVYSFGVVMFEI 679
             +  +  SD + FGV ++E+
Sbjct: 191 KTRTFSHASDTWMFGVTLWEM 211

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT---EIEMLSQFRHRHLVSLIGY 547
           IG G +G V++   RD  ++   +   +S       +    EI ML Q +H +LV+L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 548 CDERNEMIIIYEYMENGTLKD-HLYASNFP-----SLSWRKRLEICIGAARGLHYLHTGS 601
              +  + +++EY ++  L +   Y    P     S++W+          + +++ H  +
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHKHN 122
Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKI--GP-DLDQTHVSTAVKGSFGYLDPEYL 658
               IHRDVK  NIL+ ++ + K+ DFG +++  GP D     V+T       Y  PE L
Sbjct: 123 C---IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELL 174
Query: 659 T-KQQLTEKSDVYSFGVVMFEILCGRPV 685
               Q     DV++ G V  E+L G P+
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGVPL 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 50/237 (21%)
Query: 474 PFVAIQEAT----DNFSESLVIGIGGFGKVYRGVLRDE-------TKVAVKRGGTQSHQG 522
           P + +Q +T    D +    V+G G FG+V   + +D+        KV  KR   Q    
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDK 70
Query: 523 LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRK 582
            +  R E+++L Q  H +++ L  + +++    ++ E    G L D + +        RK
Sbjct: 71  ESLLR-EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--------RK 121
Query: 583 RLEICIGAAR-------GLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSK 632
           R    + AAR       G+ Y+H      I+HRD+K  N+LL+   ++   ++ DFGLS 
Sbjct: 122 RFS-EVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS- 176
Query: 633 IGPDLDQTHVSTAVK-----GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  TH   + K     G+  Y+ PE L      EK DV+S GV+++ +L G P
Sbjct: 177 -------THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP 225

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 480 EATDNFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAE--FRTEIEMLSQF 536
           ++ + +    ++G G +G V +   +D  + VA+K+        + +     EI++L Q 
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS-LSWRKRLEICIGAARGLH 595
           RH +LV+L+  C ++    +++E++++  L D      FP+ L ++   +       G+ 
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDD---LELFPNGLDYQVVQKYLFQIINGIG 138
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           + H+ +   IIHRD+K  NIL+ ++ + K+ DFG ++      + +       +  Y  P
Sbjct: 139 FCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAP 193
Query: 656 EYLTKQQLTEKS-DVYSFGVVMFEILCGRPV 685
           E L       K+ DV++ G ++ E+  G P+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/177 (24%), Positives = 90/177 (50%), Gaps = 10/177 (5%)
Query: 509 KVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKD 568
           +VAVK    +  Q       E+ ++  ++H ++V +        E+ ++ E+++ G L D
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD 131
Query: 569 HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF 628
            +       L+  +   +C    + L YLH    + +IHRD+KS +ILL  +   K++DF
Sbjct: 132 IVSQVR---LNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 629 GL-SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           G  ++I  D+ +      + G+  ++ PE +++     + D++S G+++ E++ G P
Sbjct: 186 GFCAQISKDVPK---RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRG---GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G +G+  +   + + K+ V +    G+ +        +E+ +L + +H ++V     
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 548 CDERNE--MIIIYEYMENGTL--------KDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
             +R    + I+ EY E G L        K+  Y      L    +L +   A +  H  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL---ALKECHRR 130
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
             G    ++HRD+K AN+ LD     K+ DFGL++I  + D+      V G+  Y+ PE 
Sbjct: 131 SDGG-HTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDEDFAKEFV-GTPYYMSPEQ 187
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + +    EKSD++S G +++E+    P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMP 214

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 50/237 (21%)
Query: 474 PFVAIQEAT----DNFSESLVIGIGGFGKVYRGVLRDE-------TKVAVKRGGTQSHQG 522
           P + +Q +T    D +    V+G G FG+V   + +D+        KV  KR   Q    
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDK 93
Query: 523 LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRK 582
            +  R E+++L Q  H +++ L  + +++    ++ E    G L D + +        RK
Sbjct: 94  ESLLR-EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--------RK 144
Query: 583 RLEICIGAAR-------GLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSK 632
           R    + AAR       G+ Y+H      I+HRD+K  N+LL+   ++   ++ DFGLS 
Sbjct: 145 RFS-EVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS- 199
Query: 633 IGPDLDQTHVSTAVK-----GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  TH   + K     G+  Y+ PE L      EK DV+S GV+++ +L G P
Sbjct: 200 -------THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP 248

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK------VAVKRGGTQSHQGLAEFR----TEIEM 532
           +N+    ++G G    V R + +   K      + V  GG+ S + + E R     E+++
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 533 LSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGA 590
           L +   H +++ L    +      ++++ M+ G L D+L           RK +   +  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
              LH L+      I+HRD+K  NILLD+++  K+ DFG S     LD      +V G+ 
Sbjct: 137 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLRSVCGTP 187
Query: 651 GYLDPEYLTKQQ------LTEKSDVYSFGVVMFEILCGRP 684
            YL PE +            ++ D++S GV+M+ +L G P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 50/237 (21%)
Query: 474 PFVAIQEAT----DNFSESLVIGIGGFGKVYRGVLRDE-------TKVAVKRGGTQSHQG 522
           P + +Q +T    D +    V+G G FG+V   + +D+        KV  KR   Q    
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDK 94
Query: 523 LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRK 582
            +  R E+++L Q  H +++ L  + +++    ++ E    G L D + +        RK
Sbjct: 95  ESLLR-EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--------RK 145
Query: 583 RLEICIGAAR-------GLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSK 632
           R    + AAR       G+ Y+H      I+HRD+K  N+LL+   ++   ++ DFGLS 
Sbjct: 146 RFS-EVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS- 200
Query: 633 IGPDLDQTHVSTAVK-----GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  TH   + K     G+  Y+ PE L      EK DV+S GV+++ +L G P
Sbjct: 201 -------THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP 249

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 113
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D+  ++    
Sbjct: 114 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFV 167
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
           G+  Y+ PE L     + +SD++S G+ + E+  GR
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 18/235 (7%)
Query: 459 HISAIFSSSKIGYRFPFV--AIQEATDNFSESLVIGIGGFGKVYRGVLRD---ETKVAVK 513
           H++++    ++G    F+  A  + +DN+     +G G F  V R V +    E    + 
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 514 RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS 573
                S +   +   E  +  + +H ++V L     E +   ++++ +  G L + + A 
Sbjct: 63  NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 574 NFPSLSWRKRLEICIGAA-RGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFG 629
            F S         CI      + Y H+     I+HR++K  N+LL    +    K+ADFG
Sbjct: 123 EFYS---EADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L+    D +  H      G+ GYL PE L K   ++  D+++ GV+++ +L G P
Sbjct: 177 LAIEVNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 490 VIGIGGFGKVYRG---VLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           ++G G FG+V +    + + E  V V    +  ++  +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             ++ +   I+ E    G L D +        S      I      G+ Y+H  +   I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 607 HRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
           HRD+K  NILL+   ++   K+ DFGLS       Q        G+  Y+ PE L +   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 664 TEKSDVYSFGVVMFEILCGRP 684
            EK DV+S GV+++ +L G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTP 220

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 491 IGIGGFGKVYRGVLR----DETKVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG V RG           VAVK  +    S  + + +F  E+  +    HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHT 599
           L G       M ++ E    G+L D L          +LS        +  A G+ YL  
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 127
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYL 658
             +K  IHRD+ + N+LL    + K+ DFGL +  P  D  +V     K  F +  PE L
Sbjct: 128 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 659 TKQQLTEKSDVYSFGVVMFEI 679
             +  +  SD + FGV ++E+
Sbjct: 187 KTRTFSHASDTWMFGVTLWEM 207

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 50/237 (21%)
Query: 474 PFVAIQEAT----DNFSESLVIGIGGFGKVYRGVLRDE-------TKVAVKRGGTQSHQG 522
           P + +Q +T    D +    V+G G FG+V   + +D+        KV  KR   Q    
Sbjct: 19  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDK 76
Query: 523 LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRK 582
            +  R E+++L Q  H +++ L  + +++    ++ E    G L D + +        RK
Sbjct: 77  ESLLR-EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--------RK 127
Query: 583 RLEICIGAAR-------GLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSK 632
           R    + AAR       G+ Y+H      I+HRD+K  N+LL+   ++   ++ DFGLS 
Sbjct: 128 RFS-EVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS- 182
Query: 633 IGPDLDQTHVSTAVK-----GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  TH   + K     G+  Y+ PE L      EK DV+S GV+++ +L G P
Sbjct: 183 -------THFEASKKMKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP 231

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 490 VIGIGGFGKVYRG---VLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           ++G G FG+V +    + + E  V V    +  ++  +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             ++ +   I+ E    G L D +        S      I      G+ Y+H  +   I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IV 143
Query: 607 HRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
           HRD+K  NILL+   ++   K+ DFGLS       Q        G+  Y+ PE L +   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-RGTY 199
Query: 664 TEKSDVYSFGVVMFEILCGRP 684
            EK DV+S GV+++ +L G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTP 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 529 EIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
           E+++L +    ++V   G      E+ I  E+M+ G+L   L  A   P     K   + 
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VS 129
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           I   +GL YL       I+HRDVK +NIL++     K+ DFG+S  G  +D   ++ +  
Sbjct: 130 IAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 183
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
           G+  Y+ PE L     + +SD++S G+ + E+  GR
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 491 IGIGGFGKVYRGVLRDET----KVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG V RG     +     VAVK  +    S  + + +F  E+  +    HR+L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHT 599
           L G       M ++ E    G+L D L          +LS        +  A G+ YL  
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 137
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYL 658
             +K  IHRD+ + N+LL    + K+ DFGL +  P  D  +V     K  F +  PE L
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 659 TKQQLTEKSDVYSFGVVMFEI 679
             +  +  SD + FGV ++E+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEM 217

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 491 IGIGGFGKVYRGVLR----DETKVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG V RG           VAVK  +    S  + + +F  E+  +    HR+L+ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHT 599
           L G       M ++ E    G+L D L          +LS        +  A G+ YL  
Sbjct: 80  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 131
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYL 658
             +K  IHRD+ + N+LL    + K+ DFGL +  P  D  +V     K  F +  PE L
Sbjct: 132 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190
Query: 659 TKQQLTEKSDVYSFGVVMFEI 679
             +  +  SD + FGV ++E+
Sbjct: 191 KTRTFSHASDTWMFGVTLWEM 211

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 83
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 84  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 143
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 144 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 197
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 198 GPEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 37  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 91
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 92  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 151
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 152 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 205
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYP 231

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 491 IGIGGFGKVYRGVLR----DETKVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG V RG           VAVK  +    S  + + +F  E+  +    HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHT 599
           L G       M ++ E    G+L D L          +LS        +  A G+ YL  
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 127
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYL 658
             +K  IHRD+ + N+LL    + K+ DFGL +  P  D  +V     K  F +  PE L
Sbjct: 128 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 659 TKQQLTEKSDVYSFGVVMFEI 679
             +  +  SD + FGV ++E+
Sbjct: 187 KTRTFSHASDTWMFGVTLWEM 207

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 26/197 (13%)
Query: 495 GFGKVYRGVLRDETKVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERN 552
           G GK Y        K   KR  + S +G++  E   E+ +L + RH ++++L    + + 
Sbjct: 28  GTGKEY------AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81
Query: 553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKS 612
           ++++I E +  G L D L      SL+  +  +       G+HYLH+   K I H D+K 
Sbjct: 82  DVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKP 136
Query: 613 ANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTE 665
            NI LLD+N+     K+ DFG++       +       K  FG   ++ PE +  + L  
Sbjct: 137 ENIMLLDKNVPNPRIKLIDFGIAH------KIEAGNEFKNIFGTPEFVAPEIVNYEPLGL 190
Query: 666 KSDVYSFGVVMFEILCG 682
           ++D++S GV+ + +L G
Sbjct: 191 EADMWSIGVITYILLSG 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 26/197 (13%)
Query: 495 GFGKVYRGVLRDETKVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERN 552
           G GK Y        K   KR  + S +G++  E   E+ +L + RH ++++L    + + 
Sbjct: 35  GTGKEYAA------KFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 88
Query: 553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKS 612
           ++++I E +  G L D L      SL+  +  +       G+HYLH+   K I H D+K 
Sbjct: 89  DVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKP 143
Query: 613 ANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTE 665
            NI LLD+N+     K+ DFG++       +       K  FG   ++ PE +  + L  
Sbjct: 144 ENIMLLDKNVPNPRIKLIDFGIAH------KIEAGNEFKNIFGTPEFVAPEIVNYEPLGL 197
Query: 666 KSDVYSFGVVMFEILCG 682
           ++D++S GV+ + +L G
Sbjct: 198 EADMWSIGVITYILLSG 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 26/229 (11%)
Query: 479 QEATDNFSESLVIGIGGFGKVY--RGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           Q    N+     IG G F KV   R +L   E  V +      +   L +   E+ +   
Sbjct: 10  QPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKV 69
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGL 594
             H ++V L    +    + ++ EY   G + D+L A         R +    + A +  
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYC 129
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKGSFG 651
           H       K I+HRD+K+ N+LLD +   K+ADFG S     G  LD      A  G+  
Sbjct: 130 H------QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD------AFCGAPP 177
Query: 652 YLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           Y  PE +  K+    + DV+S GV+++ ++ G      SLP +  NL E
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK------VAVKRGGTQSHQGLAEFR----TEIEM 532
           +N+    ++G G    V R + +   K      + V  GG+ S + + E R     E+++
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 533 LSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGA 590
           L +   H +++ L    +      ++++ M+ G L D+L           RK +   +  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
              LH L+      I+HRD+K  NILLD+++  K+ DFG S     LD       V G+ 
Sbjct: 124 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTP 174
Query: 651 GYLDPEYLTKQQ------LTEKSDVYSFGVVMFEILCGRP 684
            YL PE +            ++ D++S GV+M+ +L G P
Sbjct: 175 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 76
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 77  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 136
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 137 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 190
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 191 GPEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 75
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 76  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 135
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 136 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 189
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 82
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 83  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 142
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 143 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 196
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK------VAVKRGGTQSHQGLAEFR----TEIEM 532
           +N+    ++G G    V R + +   K      + V  GG+ S + + E R     E+++
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 533 LSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGA 590
           L +   H +++ L    +      ++++ M+ G L D+L           RK +   +  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
              LH L+      I+HRD+K  NILLD+++  K+ DFG S     LD       V G+ 
Sbjct: 137 ICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTP 187
Query: 651 GYLDPEYLTKQQ------LTEKSDVYSFGVVMFEILCGRP 684
            YL PE +            ++ D++S GV+M+ +L G P
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 81
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 82  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 141
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 142 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 195
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 196 GPEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 121
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 235
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYP 261

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 15/214 (7%)
Query: 477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQ----SHQGLAEFRTEIEM 532
            +Q   +++    VIG G FG+V     +   KV   +  ++         A F  E ++
Sbjct: 69  GLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR 592
           ++      +V L     +   + ++ EYM  G L + +   + P   W K        A 
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAK-----FYTAE 182
Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
            +  L    +  +IHRDVK  N+LLD++   K+ADFG      +    H  TAV G+  Y
Sbjct: 183 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDY 241
Query: 653 LDPEYLTKQ----QLTEKSDVYSFGVVMFEILCG 682
           + PE L  Q        + D +S GV +FE+L G
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLS 534
           +NF    V+G G +GKV+  R +   +T      KV  K    Q  +     RTE ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 535 QFRHRHLVSLIGYC-DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKR-----LEICI 588
             R    +  + Y      ++ +I +Y+  G L        F  LS R+R     ++I +
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--------FTHLSQRERFTEHEVQIYV 165
Query: 589 GA-ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           G     L +LH      II+RD+K  NILLD N    + DFGLSK     D+T  +    
Sbjct: 166 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFC 221
Query: 648 GSFGYLDPEYLT--KQQLTEKSDVYSFGVVMFEILCG 682
           G+  Y+ P+ +        +  D +S GV+M+E+L G
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 509 KVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL 566
           K   KR    S +G++  E   E+ +L Q  H ++++L    + R ++++I E +  G L
Sbjct: 43  KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---M 622
            D L      SLS  +          G++YLHT   K I H D+K  NI LLD+N+    
Sbjct: 103 FDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157
Query: 623 AKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            K+ DFGL+    D          K  FG   ++ PE +  + L  ++D++S GV+ + +
Sbjct: 158 IKLIDFGLAHEIED------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 680 LCG 682
           L G
Sbjct: 212 LSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 509 KVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL 566
           K   KR    S +G++  E   E+ +L Q  H ++++L    + R ++++I E +  G L
Sbjct: 43  KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---M 622
            D L      SLS  +          G++YLHT   K I H D+K  NI LLD+N+    
Sbjct: 103 FDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157
Query: 623 AKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            K+ DFGL+    D          K  FG   ++ PE +  + L  ++D++S GV+ + +
Sbjct: 158 IKLIDFGLAHEIED------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 680 LCG 682
           L G
Sbjct: 212 LSG 214

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           +DN+     +G G F  V R V +    E    +      S +   +   E  +  + +H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA-RGLHYL 597
            ++V L     E +   ++++ +  G L + + A  F S         CI      + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---EADASHCIQQILESIAYC 121
Query: 598 HTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
           H+     I+HR++K  N+LL    +    K+ADFGL+    D +  H      G+ GYL 
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLS 175
Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           PE L K   ++  D+++ GV+++ +L G P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 18/211 (8%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGLAE---FRTEIEMLSQFRH 538
           ++F    VIG G FG+V    L++  KV A+K          AE   FR E ++L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHY 596
           + + +L     + N + ++ +Y   G L   L  +    P    R  L   + A   +H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           LH       +HRD+K  NIL+D N   ++ADFG S +    D T  S+   G+  Y+ PE
Sbjct: 194 LH------YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 657 YLT-----KQQLTEKSDVYSFGVVMFEILCG 682
            L      K +   + D +S GV M+E+L G
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSA 613
           ++II E ME G L   +      + + R+  EI       + +LH+ +   I HRDVK  
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 157
Query: 614 NILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
           N+L    +++ + K+ DFG +K   +  Q  + T     + Y+ PE L  ++  +  D++
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMW 213
Query: 671 SFGVVMFEILCGRP--------VIDPSLPREKVNL-------VEWAMKCQETGQLEDIV- 714
           S GV+M+ +LCG P         I P + R ++ L        EW+   ++  QL  ++ 
Sbjct: 214 SLGVIMYILLCGFPPFYSNTGQAISPGMKR-RIRLGQYGFPNPEWSEVSEDAKQLIRLLL 272
Query: 715 --DPT 717
             DPT
Sbjct: 273 KTDPT 277

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 77
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 191
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 509 KVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL 566
           K   KR    S +G++  E   E+ +L Q  H ++++L    + R ++++I E +  G L
Sbjct: 43  KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---M 622
            D L      SLS  +          G++YLHT   K I H D+K  NI LLD+N+    
Sbjct: 103 FDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157
Query: 623 AKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            K+ DFGL+    D          K  FG   ++ PE +  + L  ++D++S GV+ + +
Sbjct: 158 IKLIDFGLAHEIED------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 680 LCG 682
           L G
Sbjct: 212 LSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 509 KVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL 566
           K   KR    S +G++  E   E+ +L Q  H ++++L    + R ++++I E +  G L
Sbjct: 43  KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---M 622
            D L      SLS  +          G++YLHT   K I H D+K  NI LLD+N+    
Sbjct: 103 FDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157
Query: 623 AKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            K+ DFGL+    D          K  FG   ++ PE +  + L  ++D++S GV+ + +
Sbjct: 158 IKLIDFGLAHEIED------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 680 LCG 682
           L G
Sbjct: 212 LSG 214

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           +DN+     +G G F  V R V +    E    +      S +   +   E  +  + +H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA-RGLHYL 597
            ++V L     E +   ++++ +  G L + + A  F S         CI      + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---EADASHCIQQILESIAYC 121
Query: 598 HTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
           H+     I+HR++K  N+LL    +    K+ADFGL+    D +  H      G+ GYL 
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLS 175
Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           PE L K   ++  D+++ GV+++ +L G P
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYP 205

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 509 KVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL 566
           K   KR    S +G++  E   E+ +L Q  H ++++L    + R ++++I E +  G L
Sbjct: 43  KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL 102
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---M 622
            D L      SLS  +          G++YLHT   K I H D+K  NI LLD+N+    
Sbjct: 103 FDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157
Query: 623 AKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            K+ DFGL+    D          K  FG   ++ PE +  + L  ++D++S GV+ + +
Sbjct: 158 IKLIDFGLAHEIED------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 680 LCG 682
           L G
Sbjct: 212 LSG 214

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 73  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 127
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 128 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 187
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 188 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 241
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 242 GPEKYDKSCDMWSLGVIMYILLCGYP 267

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           +DN+     +G G F  V R V +    E    +      S +   +   E  +  + +H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA-RGLHYL 597
            ++V L     E +   ++++ +  G L + + A  F S         CI      + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS---EADASHCIQQILESIAYC 120
Query: 598 HTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
           H+     I+HR++K  N+LL    +    K+ADFGL+    D +  H      G+ GYL 
Sbjct: 121 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLS 174
Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           PE L K   ++  D+++ GV+++ +L G P
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVGYP 204

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 29/185 (15%)
Query: 554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSA 613
           ++II E ME G L   +      + + R+  EI       + +LH+ +   I HRDVK  
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 138
Query: 614 NILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVY 670
           N+L    +++ + K+ DFG +K   +  Q  + T     + Y+ PE L  ++  +  D++
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPY-YVAPEVLGPEKYDKSCDMW 194
Query: 671 SFGVVMFEILCGRP--------VIDPSLPREKVNL-------VEWAMKCQETGQLEDIV- 714
           S GV+M+ +LCG P         I P + R ++ L        EW+   ++  QL  ++ 
Sbjct: 195 SLGVIMYILLCGFPPFYSNTGQAISPGMKR-RIRLGQYGFPNPEWSEVSEDAKQLIRLLL 253
Query: 715 --DPT 717
             DPT
Sbjct: 254 KTDPT 258

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 77
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 191
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D++S GV+M+ +LCG P
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 26/197 (13%)
Query: 495 GFGKVYRGVLRDETKVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERN 552
           G GK Y        K   KR    S +G++  E   E+ +L + RH ++++L    + + 
Sbjct: 49  GTGKEY------AAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 102
Query: 553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKS 612
           ++++I E +  G L D L      SL+  +  +       G+HYLH+   K I H D+K 
Sbjct: 103 DVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKP 157
Query: 613 ANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTE 665
            NI LLD+N+     K+ DFG++       +       K  FG   ++ PE +  + L  
Sbjct: 158 ENIMLLDKNVPNPRIKLIDFGIAH------KIEAGNEFKNIFGTPEFVAPEIVNYEPLGL 211
Query: 666 KSDVYSFGVVMFEILCG 682
           ++D++S GV+ + +L G
Sbjct: 212 EADMWSIGVITYILLSG 228

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 491 IGIGGFGKVYRGVLRDET----KVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG V RG     +     VAVK  +    S  + + +F  E+  +    HR+L+ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHT 599
           L G       M ++ E    G+L D L          +LS        +  A G+ YL  
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 137
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYL 658
             +K  IHRD+ + N+LL    + K+ DFGL +  P  D   V     K  F +  PE L
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196
Query: 659 TKQQLTEKSDVYSFGVVMFEI 679
             +  +  SD + FGV ++E+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEM 217

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 21/201 (10%)
Query: 491 IGIGGFGKVYRGVLRDET----KVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHRHLVS 543
           +G G FG V RG     +     VAVK  +    S  + + +F  E+  +    HR+L+ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHT 599
           L G       M ++ E    G+L D L          +LS        +  A G+ YL  
Sbjct: 76  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS-----RYAVQVAEGMGYL-- 127
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYL 658
             +K  IHRD+ + N+LL    + K+ DFGL +  P  D   V     K  F +  PE L
Sbjct: 128 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186
Query: 659 TKQQLTEKSDVYSFGVVMFEI 679
             +  +  SD + FGV ++E+
Sbjct: 187 KTRTFSHASDTWMFGVTLWEM 207

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 40/222 (18%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDE-------TKVAVKRGGTQSHQGLAEFRTEIEMLS 534
           +D +    V+G G FG+V   + +D+        KV  KR   Q     +  R E+++L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLR-EVQLLK 81
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
           Q  H ++  L  + +++    ++ E    G L D + +        RKR    + AAR +
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--------RKRFS-EVDAARII 132
Query: 595 HYLHTGST----KAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
             + +G T      I+HRD+K  N+LL+   ++   ++ DFGLS        TH   + K
Sbjct: 133 RQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASKK 184
Query: 648 -----GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                G+  Y+ PE L      EK DV+S GV+++ +L G P
Sbjct: 185 XKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP 225

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LKD + AS    +             +GL +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 119 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 75
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 76  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 135
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG--YLDPE 656
              I HRDVK  N+L      N + K+ DFG +K     + T  ++  +  +   Y+ PE
Sbjct: 136 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----ETTSHNSLTEPCYTPYYVAPE 187
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            L  ++  +  D++S GV+M+ +LCG P
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 27/219 (12%)
Query: 481 ATDNFSESLVIGIGGFGKVYRGV--LRDETKVAVKRGGTQSHQ----GLAEFRTEIEMLS 534
           + D +     +G G +G+VY+ +  + +ET VA+KR   +  +    G A    E+ +L 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNET-VAIKRIRLEHEEEGVPGTA--IREVSLLK 88
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
           + +HR+++ L       + + +I+EY EN   K   Y    P +S R           G+
Sbjct: 89  ELQHRNIIELKSVIHHNHRLHLIFEYAENDLKK---YMDKNPDVSMRVIKSFLYQLINGV 145
Query: 595 HYLHTGSTKAIIHRDVKSANILL-----DENLMAKVADFGLSK-IGPDLDQ-THVSTAVK 647
           ++ H   ++  +HRD+K  N+LL      E  + K+ DFGL++  G  + Q TH      
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--- 199
Query: 648 GSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
            +  Y  PE L   +  +   D++S   +  E+L   P+
Sbjct: 200 -TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL 237

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 491 IGIGGFGKVYR----GVLRDETK--VAVKRGGTQSHQGLAE-FRTEIEMLSQF-RHRHLV 542
           +G G FGKV      G+++ +    VAVK     +H    E   +E+++LS    H ++V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSL--------SWRKRLEI 586
           +L+G C      ++I EY   G L + L         +   P++             L  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               A+G+ +L   ++K  IHRD+ + NILL    + K+ DFGL++   +     V    
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +    ++ PE +     T +SDV+S+G+ ++E+ 
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVS 543
           +G   FGKVY+G L           VA+K    ++   L  EFR E  + ++ +H ++V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------LSWRKRLEICIG 589
           L+G   +   + +I+ Y  +G L + L   +  S              L     + +   
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A G+ YL   S+  ++H+D+ + N+L+ + L  K++D GL +     D   +       
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +   + +  SD++S+GVV++E+ 
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 491 IGIGGFGKVYR----GVLRDETK--VAVKRGGTQSHQGLAE-FRTEIEMLSQF-RHRHLV 542
           +G G FGKV      G+++ +    VAVK     +H    E   +E+++LS    H ++V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSL--------SWRKRLEI 586
           +L+G C      ++I EY   G L + L         +   P++             L  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               A+G+ +L   ++K  IHRD+ + NILL    + K+ DFGL++   +     V    
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +    ++ PE +     T +SDV+S+G+ ++E+ 
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 491 IGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGL-AEFRTEIEMLSQFRHRHLVS 543
           +G   FGKVY+G L           VA+K    ++   L  EFR E  + ++ +H ++V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSLSWRKRLE------ICIG 589
           L+G   +   + +I+ Y  +G L + L          S     + +  LE      +   
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            A G+ YL   S+  ++H+D+ + N+L+ + L  K++D GL +     D   +       
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +   + +  SD++S+GVV++E+ 
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHL 541
           +F     +G GGFG V+    + D+   A+KR    + +   E    E++ L++  H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 542 VSLIGYCDERNE------------MIIIYEYMENGTLKDHLYASNFPSLSWRKR---LEI 586
           V       E+N             + I  +      LKD  + +   ++  R+R   L I
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD--WMNGRCTIEERERSVCLHI 123
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHVSTA 645
            +  A  + +LH+   K ++HRD+K +NI    + + KV DFGL + +  D ++  V T 
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 646 VK---------GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +          G+  Y+ PE +     + K D++S G+++FE+L
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++ +  LKD + AS    +             +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 122 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++ +  LKD + AS    +             +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 121 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 491 IGIGGFGKVYR----GVLRDETK--VAVKRGGTQSHQGLAE-FRTEIEMLSQF-RHRHLV 542
           +G G FGKV      G+++ +    VAVK     +H    E   +E+++LS    H ++V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSL--------SWRKRLEI 586
           +L+G C      ++I EY   G L + L         +   P++             L  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               A+G+ +L   ++K  IHRD+ + NILL    + K+ DFGL++   +     V    
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +    ++ PE +     T +SDV+S+G+ ++E+ 
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 491 IGIGGFGKVYR----GVLRDETK--VAVKRGGTQSHQGLAE-FRTEIEMLSQF-RHRHLV 542
           +G G FGKV      G+++ +    VAVK     +H    E   +E+++LS    H ++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSL--------SWRKRLEI 586
           +L+G C      ++I EY   G L + L         +   P++             L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               A+G+ +L   ++K  IHRD+ + NILL    + K+ DFGL++   +     V    
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +    ++ PE +     T +SDV+S+G+ ++E+ 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 491 IGIGGFGKVYR----GVLRDETK--VAVKRGGTQSHQGLAE-FRTEIEMLSQF-RHRHLV 542
           +G G FGKV      G+++ +    VAVK     +H    E   +E+++LS    H ++V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSL--------SWRKRLEI 586
           +L+G C      ++I EY   G L + L         +   P++             L  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
               A+G+ +L   ++K  IHRD+ + NILL    + K+ DFGL++   +     V    
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           +    ++ PE +     T +SDV+S+G+ ++E+ 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAE---FRT---EIEMLSQFRHRHLVSL 544
           +G G F  VY+   ++  ++   +     H+  A+    RT   EI++L +  H +++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           +     ++ + +++++ME     + +   N   L+        +   +GL YLH      
Sbjct: 78  LDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HW 132
Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           I+HRD+K  N+LLDEN + K+ADFGL+K     ++ +    V  +  Y  PE L   ++ 
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARMY 190
Query: 665 EKS-DVYSFGVVMFEILCGRPVI 686
               D+++ G ++ E+L   P +
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFL 213

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 491 IGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQG--LAEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +  VY+G  +  +  VA+K    +  +G      R E+ +L   +H ++V+L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 68
Query: 548 CDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
                 + +++EY++   LK +L    N  ++   K         RGL Y H    + ++
Sbjct: 69  IHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHR---QKVL 122
Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTE 665
           HRD+K  N+L++E    K+ADFGL++      +T+ +  V  +  Y  P+ L      + 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYST 180
Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           + D++  G + +E+  GRP+   S   E+++ +
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     IG G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 82  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 138 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 191
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 88/183 (48%), Gaps = 20/183 (10%)
Query: 509 KVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTL 566
           K   KR    S +G+   E   E+ +L Q  H ++++L    + R ++++I E +  G L
Sbjct: 43  KFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL 102
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---M 622
            D L      SLS  +          G++YLHT   K I H D+K  NI LLD+N+    
Sbjct: 103 FDFLAQKE--SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPH 157
Query: 623 AKVADFGLSKIGPDLDQTHVSTAVKGSFG---YLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
            K+ DFGL+    D          K  FG   ++ PE +  + L  ++D++S GV+ + +
Sbjct: 158 IKLIDFGLAHEIED------GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 680 LCG 682
           L G
Sbjct: 212 LSG 214

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 480 EATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQ 535
           E  +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
             H ++V L+      N++ +++E++    LK  + AS    +             +GL 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           + H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  P
Sbjct: 125 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 656 EYLTKQQLTEKS-DVYSFGVVMFEILCGR 683
           E L   +    + D++S G +  E++  R
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 84  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR--- 193
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 75  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 130
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 131 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 184
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 185 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +D +     IG+G + +  R V +        +   +S +  +E   EIE+L ++ +H +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE---EIEILLRYGQHPN 82
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +++L    D+   + ++ E M  G L D +    F   S R+   +     + + YLH+ 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHS- 139
Query: 601 STKAIIHRDVKSANIL-LDEN---LMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
             + ++HRD+K +NIL +DE+      ++ DFG +K     +   ++     +F  + PE
Sbjct: 140 --QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPE 195
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCG 682
            L +Q   E  D++S G++++ +L G
Sbjct: 196 VLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 84  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR--- 193
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 74  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 129
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 130 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 183
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 184 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 100 HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 155
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 156 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR--- 209
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 210 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 73  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 183 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 84  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR--- 193
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 74  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 129
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 130 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 183
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 184 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 480 EATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQ 535
           E  +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKE 65
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
             H ++V L+      N++ +++E++    LK  + AS    +             +GL 
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           + H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  P
Sbjct: 125 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 179
Query: 656 EYLTK-QQLTEKSDVYSFGVVMFEILCGR 683
           E L   +  +   D++S G +  E++  R
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           +D +     IG+G + +  R V +        +   +S +  +E   EIE+L ++ +H +
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE---EIEILLRYGQHPN 82
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +++L    D+   + ++ E M  G L D +    F   S R+   +     + + YLH+ 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEYLHS- 139
Query: 601 STKAIIHRDVKSANIL-LDEN---LMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
             + ++HRD+K +NIL +DE+      ++ DFG +K     +   ++     +F  + PE
Sbjct: 140 --QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF--VAPE 195
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCG 682
            L +Q   E  D++S G++++ +L G
Sbjct: 196 VLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 79  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 135 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 188
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 87  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 142
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 143 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 196
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 197 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 84  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 140 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 193
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 194 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 89  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 144
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 145 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 198
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 199 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 73  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 183 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 82  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 138 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 191
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 79  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 135 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 188
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 82  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 138 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 191
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V     ++   K+AVK+        +   RT  E+ +L 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 106 HMKHENVIGLLDVFTPATSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 161
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 162 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 215
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L         D++S G +M E+L GR
Sbjct: 216 --WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 82  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 137
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 138 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 191
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 192 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 76  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 131
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 132 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 185
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 186 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 89  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 144
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 145 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 198
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 199 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 89  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 144
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 145 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 198
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 199 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 97  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 152
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 153 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 206
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 207 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 96  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 151
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 152 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 205
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 206 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 79  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 135 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 188
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 88  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 143
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 144 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 197
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 198 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 83  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 139 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 192
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 100 HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 155
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 156 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 209
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 210 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 659 TKQQLTEKS-DVYSFGVVMFEILCGR 683
              +    + D++S G +  E++  R
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 88  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 143
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 144 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR--- 197
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 198 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 83  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 139 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 192
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 97  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 152
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 153 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 206
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 207 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 96  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 151
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 152 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 205
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 206 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH 120
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALK-----XLQDCPKARREVELHWRASQCPHIVRIV 121
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 122 DVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSIN 181
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K         ++T     + Y+ PE L
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPY-YVAPEVL 235
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +  D +S GV+ + +LCG P
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYP 261

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 83  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 139 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 192
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D     V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 120 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 174
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 79  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 134
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 135 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR--- 188
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 189 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++    +L       +  
Sbjct: 73  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIY 128
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--- 182
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 183 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 174
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL +   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 174
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 125 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 179
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH-QGLAEFRT-EIEMLSQF 536
           Q   + + +   +G G +G VY+        VA+KR    +  +G+      EI +L + 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++VSLI        + +++E+ME    K  +   N   L   +         RG+ +
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKK--VLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H      I+HRD+K  N+L++ +   K+ADFGL++      +++    V  +  Y  P+
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPD 189
Query: 657 YLT-KQQLTEKSDVYSFGVVMFEILCGRPVI-----DPSLPR 692
            L   ++ +   D++S G +  E++ G+P+      D  LP+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 122 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 121 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 121 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 175
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 65  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 122
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 123 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 176
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 123 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 177
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 122 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 174
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLR------------DETKVAVKRGGTQSHQGLAE 525
           I    ++FS   +IG GGFG+VY G  +            D+ ++ +K+G T +   L E
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNE 238
Query: 526 FRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWR-KR 583
            R  + ++S      +V +       +++  I + M  G L  HL     F     R   
Sbjct: 239 -RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 297
Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
            EI +G    L ++H    + +++RD+K ANILLDE+   +++D GL+    D  +    
Sbjct: 298 AEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPH 347
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
            +V G+ GY+ PE L K    + S D +S G ++F++L G
Sbjct: 348 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLR------------DETKVAVKRGGTQSHQGLAE 525
           I    ++FS   +IG GGFG+VY G  +            D+ ++ +K+G T +   L E
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNE 239
Query: 526 FRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWR-KR 583
            R  + ++S      +V +       +++  I + M  G L  HL     F     R   
Sbjct: 240 -RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298
Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
            EI +G    L ++H    + +++RD+K ANILLDE+   +++D GL+    D  +    
Sbjct: 299 AEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPH 348
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
            +V G+ GY+ PE L K    + S D +S G ++F++L G
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 102/222 (45%), Gaps = 15/222 (6%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH-QGLAEFRT-EIEMLSQF 536
           Q   + + +   +G G +G VY+        VA+KR    +  +G+      EI +L + 
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++VSLI        + +++E+ME    K  +   N   L   +         RG+ +
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKK--VLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H      I+HRD+K  N+L++ +   K+ADFGL++      +++    V  +  Y  P+
Sbjct: 135 CHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPD 189
Query: 657 YLT-KQQLTEKSDVYSFGVVMFEILCGRPVI-----DPSLPR 692
            L   ++ +   D++S G +  E++ G+P+      D  LP+
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 65  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 122
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 123 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 176
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 121 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 175
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 120 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 83  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 138
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T    
Sbjct: 139 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR--- 192
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 193 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 120 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 59
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 173
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 122 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 176
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEIL 174
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHR 539
           + +F    ++G G +G V     +   ++   +      + L   RT  EI++L  F+H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 540 HLVSLIGY-----CDERNEMIIIYEYMENGTLK---------DHLYASNFPSLSWRKRLE 585
           +++++         +  NE+ II E M+    +         DH+    + +L       
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL------- 122
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---------GPD 636
                 R +  LH GS   +IHRD+K +N+L++ N   KV DFGL++I          P 
Sbjct: 123 ------RAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 637 LDQTHVSTAVKGSFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             Q+ ++  V   + Y  PE  LT  + +   DV+S G ++ E+   RP+
Sbjct: 174 GQQSGMTEXVATRW-YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 93/185 (50%), Gaps = 14/185 (7%)
Query: 504 LRDETKVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM 561
           L+   K   KR    S +G++  +   E+ +L + +H ++++L    + + ++I+I E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDEN 620
             G L D L      SL+  +  E       G++YLH+     I H D+K  NI LLD N
Sbjct: 97  AGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRN 151
Query: 621 L---MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMF 677
           +     K+ DFGL+     +D  +    + G+  ++ PE +  + L  ++D++S GV+ +
Sbjct: 152 VPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 678 EILCG 682
            +L G
Sbjct: 209 ILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++    LK  + AS    +             +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 122 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ D+GL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 515 GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE--MIIIYEYMENGTLKDHLYA 572
           G  Q    + +   EI +L +  H ++V L+   D+ NE  + +++E +  G +   +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEV 128
Query: 573 SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK 632
                LS  +         +G+ YLH    + IIHRD+K +N+L+ E+   K+ADFG+S 
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 633 IGPDLDQTHVSTAVKGSFGYLDPEYL--TKQQLTEKS-DVYSFGVVMFEILCGR-PVID 687
                D    +T   G+  ++ PE L  T++  + K+ DV++ GV ++  + G+ P +D
Sbjct: 186 EFKGSDALLSNTV--GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 73  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 128
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D     V+T    
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR--- 182
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 183 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLR------------DETKVAVKRGGTQSHQGLAE 525
           I    ++FS   +IG GGFG+VY G  +            D+ ++ +K+G T +   L E
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNE 239
Query: 526 FRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWR-KR 583
            R  + ++S      +V +       +++  I + M  G L  HL     F     R   
Sbjct: 240 -RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298
Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
            EI +G    L ++H    + +++RD+K ANILLDE+   +++D GL+    D  +    
Sbjct: 299 AEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPH 348
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
            +V G+ GY+ PE L K    + S D +S G ++F++L G
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 31/220 (14%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLR------------DETKVAVKRGGTQSHQGLAE 525
           I    ++FS   +IG GGFG+VY G  +            D+ ++ +K+G T +   L E
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLA---LNE 239
Query: 526 FRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWR-KR 583
            R  + ++S      +V +       +++  I + M  G L  HL     F     R   
Sbjct: 240 -RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298
Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS 643
            EI +G    L ++H    + +++RD+K ANILLDE+   +++D GL+    D  +    
Sbjct: 299 AEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPH 348
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
            +V G+ GY+ PE L K    + S D +S G ++F++L G
Sbjct: 349 ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK-RGGTQSHQGLAEFRTEIEMLSQFRHR 539
           +NF +   IG G +G VY  R  L  E     K R  T++    +    EI +L +  H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           ++V L+      N++ +++E++    LK  + AS    +             +GL + H+
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L 
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 176
Query: 660 K-QQLTEKSDVYSFGVVMFEILCGR 683
             +  +   D++S G +  E++  R
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 10/205 (4%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK-RGGTQSHQGLAEFRTEIEMLSQFRHR 539
           +NF +   IG G +G VY  R  L  E     K R  T++    +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           ++V L+      N++ +++E++    LK  + AS    +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L 
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 175
Query: 660 K-QQLTEKSDVYSFGVVMFEILCGR 683
             +  +   D++S G +  E++  R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E+++   LK  + AS    +             +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 122 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D     V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++ +  LK  + AS    +             +GL +
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 122 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 176
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 490 VIGIGGFGKVYRGVLRDET--KVAVKRGGTQSH----QGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G +GKV + VL  ET  + AVK    +       G A  + EI++L + RH++++ 
Sbjct: 12  LLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 544 LIG--YCDERNEMIIIYEYMENGT--LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           L+   Y +E+ +M ++ EY   G   + D +    FP           I    GL YLH+
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID---GLEYLHS 127
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
              + I+H+D+K  N+LL      K++  G+++              +GS  +  PE   
Sbjct: 128 ---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 660 KQQLTE--KSDVYSFGVVMFEILCG 682
                   K D++S GV ++ I  G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D     V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 93/185 (50%), Gaps = 14/185 (7%)
Query: 504 LRDETKVAVKRGGTQSHQGLA--EFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM 561
           L+   K   KR    S +G++  +   E+ +L + +H ++++L    + + ++I+I E +
Sbjct: 37  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 96
Query: 562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANI-LLDEN 620
             G L D L      SL+  +  E       G++YLH+     I H D+K  NI LLD N
Sbjct: 97  AGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRN 151
Query: 621 L---MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMF 677
           +     K+ DFGL+     +D  +    + G+  ++ PE +  + L  ++D++S GV+ +
Sbjct: 152 VPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 678 EILCG 682
            +L G
Sbjct: 209 ILLSG 213

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 12/208 (5%)
Query: 481 ATDNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           + +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H ++V L+      N++ +++E++ +  LK  + AS    +             +GL +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
            H+     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE
Sbjct: 120 CHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPE 174
Query: 657 YLTK-QQLTEKSDVYSFGVVMFEILCGR 683
            L   +  +   D++S G +  E++  R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 97  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 152
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D     V+T    
Sbjct: 153 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR--- 206
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 207 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 43/230 (18%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHR 539
           + +F    ++G G +G V     +   ++   +      + L   RT  EI++L  F+H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 540 HLVSLIGY-----CDERNEMIIIYEYMENGTLK---------DHLYASNFPSLSWRKRLE 585
           +++++         +  NE+ II E M+    +         DH+    + +L       
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL------- 122
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---------GPD 636
                 R +  LH GS   +IHRD+K +N+L++ N   KV DFGL++I          P 
Sbjct: 123 ------RAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 637 LDQTHVSTAVKGSFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             Q+ ++  V   + Y  PE  LT  + +   DV+S G ++ E+   RP+
Sbjct: 174 GQQSGMTEYVATRW-YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 48/227 (21%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEI------------- 530
           +F+  +V+G G FGKV          +   R GT+    +   + ++             
Sbjct: 20  DFNFLMVLGKGSFGKV----------MLADRKGTEELYAIKILKKDVVIQDDDVECTMVE 69
Query: 531 -EMLSQFRHRHLVSLIGYCDER-NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
             +L+       ++ +  C +  + +  + EY+  G L  H+       +   K  +   
Sbjct: 70  KRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-----QVGKFKEPQAVF 124
Query: 589 GAAR---GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
            AA    GL +LH    + II+RD+K  N++LD     K+ADFG+ K        H+   
Sbjct: 125 YAAEISIGLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMMDG 174
Query: 646 VK-----GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVID 687
           V      G+  Y+ PE +  Q   +  D +++GV+++E+L G+P  D
Sbjct: 175 VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGLAE---FRTEIEML 533
           +Q   ++F    VIG G FG+V    +++  ++ A+K          AE   FR E ++L
Sbjct: 85  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 144
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAA 591
                + + +L     + N + ++ +Y   G L   L  +    P    R  +   + A 
Sbjct: 145 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 204
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             +H LH       +HRD+K  N+LLD N   ++ADFG S +  + D T  S+   G+  
Sbjct: 205 DSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPD 257
Query: 652 YLDPEYLTKQQ-----LTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKCQ 705
           Y+ PE L   +        + D +S GV M+E+L G  P    SL      ++    + Q
Sbjct: 258 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ 317
Query: 706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID 744
               + D+ +         D + + +   E+ L Q GI+
Sbjct: 318 FPSHVTDVSEEA------KDLIQRLICSRERRLGQNGIE 350

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 38/218 (17%)
Query: 491 IGIGGFGKV--YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           +G GGF  V    G L D    A+KR      Q   E + E +M   F H +++ L+ YC
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 549 ----DERNEMIIIYEYMENGTLKDHLY----ASNFPSLSWRKRLEICIGAARGLHYLHTG 600
                 ++E  ++  + + GTL + +       NF  L+  + L + +G  RGL  +H  
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF--LTEDQILWLLLGICRGLEAIH-- 151
Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--HVS-----------TAVK 647
             K   HRD+K  NILL +     + D G       ++Q   HV             A +
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLG------SMNQACIHVEGSRQALTLQDWAAQR 204
Query: 648 GSFGYLDPEYLTKQQ---LTEKSDVYSFGVVMFEILCG 682
            +  Y  PE  + Q    + E++DV+S G V++ ++ G
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 20/216 (9%)
Query: 479 QEATDNFSES-LVIGIGGFGKVYRGV-----LRDETKVAVKRGGTQSHQGLA--EFRTEI 530
           QE  D++ ++   +G G F  V +       L+   K   KR    S +G++  +   E+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA 590
            +L + +H ++++L    + + ++I+I E +  G L D L      SL+  +  E     
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE--SLTEEEATEFLKQI 123
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANI-LLDENL---MAKVADFGLSKIGPDLDQTHVSTAV 646
             G++YLH+     I H D+K  NI LLD N+     K+ DFGL+     +D  +    +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNI 177
Query: 647 KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            G+  ++ PE +  + L  ++D++S GV+ + +L G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 18/216 (8%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLRDETKV-AVKRGGTQSHQGLAE---FRTEIEML 533
           +Q   ++F    VIG G FG+V    +++  ++ A+K          AE   FR E ++L
Sbjct: 69  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 128
Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAA 591
                + + +L     + N + ++ +Y   G L   L  +    P    R  +   + A 
Sbjct: 129 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 188
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             +H LH       +HRD+K  N+LLD N   ++ADFG S +  + D T  S+   G+  
Sbjct: 189 DSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPD 241
Query: 652 YLDPEYLTKQQ-----LTEKSDVYSFGVVMFEILCG 682
           Y+ PE L   +        + D +S GV M+E+L G
Sbjct: 242 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 12/206 (5%)
Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRH 538
           +NF +   IG G +G VY  R  L  E  VA+K  R  T++    +    EI +L +  H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            ++V L+      N++ +++E++    LK  + AS    +             +GL + H
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     ++HRD+K  N+L++     K+ADFGL++      +T+    V  +  Y  PE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 174
Query: 659 TK-QQLTEKSDVYSFGVVMFEILCGR 683
              +  +   D++S G +  E++  R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQ---GLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FG+V++   R    KVA+K+   ++ +    +   R EI++L   +H ++V+LI 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 547 YCDER--------NEMIIIYEYMEN---GTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
            C  +          + +++++ E+   G L + L       +  ++ +++ +    GL+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLY 139
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-------GPDLDQTHVSTAVKG 648
           Y+H      I+HRD+K+AN+L+  + + K+ADFGL++         P+     V T    
Sbjct: 140 YIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT---- 192
Query: 649 SFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
              Y  PE L  ++      D++  G +M E+    P++  +  + ++ L+
Sbjct: 193 -LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 11/99 (11%)
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVK 647
           ARG+ +L   S++  IHRD+ + NILL EN + K+ DFGL++     PD  +       +
Sbjct: 209 ARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR---KGDTR 262
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRP 684
               ++ PE +  +  + KSDV+S+GV+++EI  L G P
Sbjct: 263 LPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP 301

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETK------VAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           TD++     +G G F  V R V +  T+      +  K+   + HQ L     E  +   
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER---EARICRL 86
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA-RGL 594
            +H ++V L     E     ++++ +  G L + + A  + S         CI      +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS---EADASHCIHQILESV 143
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENL---MAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           +++H      I+HRD+K  N+LL         K+ADFGL+       Q     A  G+ G
Sbjct: 144 NHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA--GTPG 198
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE L K    +  D+++ GV+++ +L G P
Sbjct: 199 YLSPEVLRKDPYGKPVDIWACGVILYILLVGYP 231

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           TD +     IG+G +    R + +        +   +S +   E   EIE+L ++ +H +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPN 77
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +++L    D+   + ++ E M+ G L D +    F   S R+   +     + + YLH  
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHA- 134
Query: 601 STKAIIHRDVKSANIL-LDEN---LMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
             + ++HRD+K +NIL +DE+      ++ DFG +K     +   ++     +F  + PE
Sbjct: 135 --QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF--VAPE 190
Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCG 682
            L +Q      D++S GV+++ +L G
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
           +I +   + L +LH  S  ++IHRDVK +N+L++     K+ DFG+S     L  +   T
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDSVAKT 211
Query: 645 AVKGSFGYLDPEY----LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW 700
              G   Y+ PE     L ++  + KSD++S G+ M E+   R   D            W
Sbjct: 212 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SW 260
Query: 701 AMKCQETGQLEDIVDPTLTGQIKPDSLN-KFVEIAEKCLAQCGIDRPSMGDVL 752
               Q+  Q+ +   P    Q+  D  + +FV+   +CL +   +RP+  +++
Sbjct: 261 GTPFQQLKQVVEEPSP----QLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 309

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLI 545
           S ++G G + KV   V L++  + AVK    Q+    +    E+E L Q + +++++ LI
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
            + ++     +++E ++ G++  H+        + R+   +    A  L +LHT   K I
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQK--HFNEREASRVVRDVAAALDFLHT---KGI 132
Query: 606 IHRDVKSANILLD--ENLM-AKVADFGLSKIGPDLDQTHVS------TAVKGSFGYLDPE 656
            HRD+K  NIL +  E +   K+ DF L   G  L+ +         T   GS  Y+ PE
Sbjct: 133 AHRDLKPENILCESPEKVSPVKICDFDLGS-GMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 657 YLT--KQQLT---EKSDVYSFGVVMFEILCGRP 684
            +     Q T   ++ D++S GVV++ +L G P
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYP 224

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 43/230 (18%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHR 539
           + +F    ++G G +G V     +   ++   +      + L   RT  EI++L  F+H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 540 HLVSLIGY-----CDERNEMIIIYEYMENGTLK---------DHLYASNFPSLSWRKRLE 585
           +++++         +  NE+ II E M+    +         DH+    + +L       
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL------- 122
Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---------GPD 636
                 R +  LH GS   +IHRD+K +N+L++ N   KV DFGL++I          P 
Sbjct: 123 ------RAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 637 LDQTHVSTAVKGSFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
             Q+ +   V   + Y  PE  LT  + +   DV+S G ++ E+   RP+
Sbjct: 174 GQQSGMVEFVATRW-YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGS 649
           A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A +  
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-RLP 256
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 287

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGS 649
           A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A +  
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-RLP 258
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+  FGL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGS 649
           A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A +  
Sbjct: 208 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-RLP 263
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 294

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 55/91 (60%), Gaps = 5/91 (5%)
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGS 649
           A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++ I  D D      A +  
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA-RLP 265
Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             ++ PE +  +  T +SDV+SFGV+++EI 
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 296

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQ---GLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FG+V++   R    KVA+K+   ++ +    +   R EI++L   +H ++V+LI 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 83
Query: 547 YCDER--------NEMIIIYEYMEN---GTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
            C  +          + +++++ E+   G L + L       +  ++ +++ +    GL+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLY 138
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-------GPDLDQTHVSTAVKG 648
           Y+H      I+HRD+K+AN+L+  + + K+ADFGL++         P+     V T    
Sbjct: 139 YIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT---- 191
Query: 649 SFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
              Y  PE L  ++      D++  G +M E+    P++  +  + ++ L+
Sbjct: 192 -LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ D GL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQ---GLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FG+V++   R    KVA+K+   ++ +    +   R EI++L   +H ++V+LI 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 547 YCDER--------NEMIIIYEYMEN---GTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
            C  +          + +++++ E+   G L + L       +  ++ +++ +    GL+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLY 139
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-------GPDLDQTHVSTAVKG 648
           Y+H      I+HRD+K+AN+L+  + + K+ADFGL++         P+     V T    
Sbjct: 140 YIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT---- 192
Query: 649 SFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
              Y  PE L  ++      D++  G +M E+    P++  +  + ++ L+
Sbjct: 193 -LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ D GL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ DF L++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/231 (23%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 491 IGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQ---GLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FG+V++   R    KVA+K+   ++ +    +   R EI++L   +H ++V+LI 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIE 84
Query: 547 YCDERNE--------MIIIYEYMEN---GTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
            C  +          + +++++ E+   G L + L       +  ++ +++ +    GL+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQMLLN---GLY 139
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-------GPDLDQTHVSTAVKG 648
           Y+H      I+HRD+K+AN+L+  + + K+ADFGL++         P+     V T    
Sbjct: 140 YIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVT---- 192
Query: 649 SFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
              Y  PE L  ++      D++  G +M E+    P++  +  + ++ L+
Sbjct: 193 -LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDE-TKVAVK---RGGTQSHQGLA--EFRTEIEMLSQF 536
           D +    VIG G F  V R + R+   + AVK        S  GL+  + + E  +    
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTL---------KDHLYASNFPSLSWRKRLEIC 587
           +H H+V L+        + +++E+M+   L            +Y+    S   R+ LE  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-- 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLS-KIGPDLDQTHVS 643
                 L Y H  +   IIHRDVK  N+LL   + +   K+ DFG++ ++G   +   V+
Sbjct: 142 -----ALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG---ESGLVA 190
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
               G+  ++ PE + ++   +  DV+  GV++F +L G
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 478 IQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLS 534
           I E  + +     +G G +G V      +   +VAVK+        +   RT  E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICI 588
             +H +++ L+        +    E   +  L  HL  ++  ++   ++L       +  
Sbjct: 77  HMKHENVIGLLDVFTPARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 132
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              RGL Y+H+     IIHRD+K +N+ ++E+   K+ D GL++   D    +V+T    
Sbjct: 133 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR--- 186
Query: 649 SFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGR 683
              Y  PE  L      +  D++S G +M E+L GR
Sbjct: 187 --WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 35/178 (19%)
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-----KIGPDLDQ 639
           +I +   + L +LH  S  ++IHRDVK +N+L++     K+ DFG+S      +  D+D 
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID- 169
Query: 640 THVSTAVKGSFGYLDPEY----LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV 695
                   G   Y+ PE     L ++  + KSD++S G+ M E+   R   D        
Sbjct: 170 -------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD-------- 214
Query: 696 NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLN-KFVEIAEKCLAQCGIDRPSMGDVL 752
               W    Q+  Q+ +   P    Q+  D  + +FV+   +CL +   +RP+  +++
Sbjct: 215 ---SWGTPFQQLKQVVEEPSP----QLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 48/302 (15%)
Query: 484 NFSESLVIGIGGFGK-VYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +F    V+G G  G  VYRG+  D   VAVKR   +     +    E+++L +    H  
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPEC---FSFADREVQLLRE-SDEHPN 79
Query: 543 SLIGYCDERNEMIIIYEYME----NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            +  +C E++     ++Y+       TL++++   +F  L     + +      GL +LH
Sbjct: 80  VIRYFCTEKDRQ---FQYIAIELCAATLQEYVEQKDFAHLGLEP-ITLLQQTTSGLAHLH 135
Query: 599 TGSTKAIIHRDVKSANILLDE-----NLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGY 652
           + +   I+HRD+K  NIL+        + A ++DFGL  K+          + V G+ G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 653 LDPEYLT---KQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPRE-KVNLVEWAMKCQET 707
           + PE L+   K+  T   D++S G V + ++  G      SL R+  + L   ++ C   
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252
Query: 708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL-----WNLEYALQLQ 762
            + ED++                 E+ EK +A     RPS   VL     W+LE  LQ  
Sbjct: 253 EKHEDVIA---------------RELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFF 297
Query: 763 GD 764
            D
Sbjct: 298 QD 299

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+      QG A    E++++ +  H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIV 76
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            L             Y +  +G  KD +Y +      P+  +R      R +  +     
Sbjct: 77  RLR------------YFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYV 124
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 178
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 476 VAIQEATDNFSESLVIGIGGFG--KVYRGVLRDETKVAVK---RGGTQSHQGLAEFRTEI 530
           + I   +D +     IG G FG  ++ R  L  E  VAVK   RG           + EI
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDEN----VQREI 67
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIG 589
                 RH ++V           + II EY   G L + +  A  F     R   +  + 
Sbjct: 68  INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVK 647
              G+ Y H+     I HRD+K  N LLD +     K+ DFG SK    L     ST   
Sbjct: 128 ---GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV-- 178
Query: 648 GSFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGR-PVIDPSLPRE 693
           G+  Y+ PE L +Q+   K +DV+S GV ++ +L G  P  DP  PR+
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
           +I +   + L+  H      IIHRD+K +NILLD +   K+ DFG+S     L  +   T
Sbjct: 129 KITLATVKALN--HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKT 183
Query: 645 AVKGSFGYLDPEYL----TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW 700
              G   Y+ PE +    ++Q    +SDV+S G+ ++E+  GR       P  K N V  
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR------FPYPKWNSV-- 235
Query: 701 AMKCQETGQLEDIVD---PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                   QL  +V    P L+   + +    F+     CL +    RP   ++L
Sbjct: 236 ------FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 491 IGIGGFGKVYRGVL-RDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLIGY 547
           +G G +G V   V  R   KVA+K+        L   R   E+ +L   RH +++ L+  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 548 ------CDERNEMIIIYEYM--ENGTLKDHLYASNFPSLSWRKRLEICI-GAARGLHYLH 598
                  D+  +  ++  +M  + G L  H             R++  +    +GL Y+H
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE-------DRIQFLVYQMLKGLRYIH 145
Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY- 657
                 IIHRD+K  N+ ++E+   K+ DFGL++     D       V  +  Y  PE  
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMXGXVV--TRWYRAPEVI 197
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGR 683
           L   + T+  D++S G +M E++ G+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+      QG A    E++++ +  H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIV 76
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            L             Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 77  RLR------------YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 178
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 36/235 (15%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKR------GGTQSHQGLAEFRTEIEMLS 534
           T  F E   IG G FG V++ V R D    A+KR      G       L E      +L 
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 64
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE---ICIGAA 591
           Q  H H+V       E + M+I  EY   G+L D + + N+  +S+ K  E   + +   
Sbjct: 65  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 121
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA-------DFGLSKIGPDL-DQTHVS 643
           RGL Y+H+ S   ++H D+K +NI +    +   A       D+  +K+   + D  HV+
Sbjct: 122 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 178
Query: 644 TAVKGSFGYLDPEYLTKQQLTE------KSDVYSFGVVMFEILCGRPVIDPSLPR 692
                     D  +L  + L E      K+D+++  + +       P     LPR
Sbjct: 179 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEP-----LPR 228

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+      QG A    E++++ +  H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQGKAFKNRELQIMRKLDHCNIV 76
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            L             Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 77  RLR------------YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 178
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 13/107 (12%)
Query: 584 LEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL-SKIGPDLDQTHV 642
           L I I  A  + +LH+   K ++HRD+K +NI    + + KV DFGL + +  D ++  V
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 643 STAVK---------GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
            T +          G+  Y+ PE +     + K D++S G+++FE+L
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 491 IGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G G  G+V++   R    V     ++R G +          ++ +L      ++V   G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCPYIVQCFG 91
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
                 ++ I  E M  GT  + L       +  R   ++ +   + L+YL       +I
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVI 147
Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL-----TKQ 661
           HRDVK +NILLDE    K+ DFG+S    D D+    +A  G   Y+ PE +     TK 
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGISGRLVD-DKAKDRSA--GCAAYMAPERIDPPDPTKP 204
Query: 662 QLTEKSDVYSFGVVMFEILCGR 683
               ++DV+S G+ + E+  G+
Sbjct: 205 DYDIRADVWSLGISLVELATGQ 226

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVK--RGGTQSHQGLAEFRTEI 530
           + I   +D +     IG G FG V R ++RD+     VAVK    G +  + +   + EI
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFG-VAR-LMRDKQANELVAVKYIERGEKIDENV---KREI 66
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIG 589
                 RH ++V           + I+ EY   G L + +  A  F     R   +  I 
Sbjct: 67  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 126
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVK 647
              G+ Y H      + HRD+K  N LLD +     K+ADFG SK    +  +   +AV 
Sbjct: 127 ---GVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLKIADFGYSKAS--VLHSQPKSAV- 177
Query: 648 GSFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGR-PVIDPSLPR 692
           G+  Y+ PE L K++   K +DV+S GV ++ +L G  P  DP  P+
Sbjct: 178 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           TD +     IG+G +    R + +        +   +S +   E   EIE+L ++ +H +
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE---EIEILLRYGQHPN 77
Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +++L    D+   + ++ E  + G L D +    F   S R+   +     + + YLH  
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHA- 134
Query: 601 STKAIIHRDVKSANIL-LDEN---LMAKVADFGLSK---IGPDLDQTHVSTAVKGSFGYL 653
             + ++HRD+K +NIL +DE+      ++ DFG +K       L  T   TA      ++
Sbjct: 135 --QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTA-----NFV 187
Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
            PE L +Q      D++S GV+++  L G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A GL +L +   K II+RD+K  N++LD     K+ADFG+ K   ++     +    G+ 
Sbjct: 452 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 506
Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
            Y+ PE +  Q   +  D ++FGV+++E+L G+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           +G G +G V   Y   LR   KVAVK+        +   RT  E+ +L   +H +++ L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 546 GY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
                    ++ +E+ ++   M  G   +++  S   +LS      +     RGL Y+H+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQ--ALSDEHVQFLVYQLLRGLKYIHS 149
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE-YL 658
                IIHRD+K +N+ ++E+   ++ DFGL++   +    +V+T       Y  PE  L
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGR 683
                 +  D++S G +M E+L G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQ----SHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           VIG G FG+V     +   KV   +  ++         A F  E ++++      +V L 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
               +   + ++ EYM  G L + +   + P    R      + A   +H      +   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH------SMGF 194
Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ---- 661
           IHRDVK  N+LLD++   K+ADFG              TAV G+  Y+ PE L  Q    
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 253
Query: 662 QLTEKSDVYSFGVVMFEILCG 682
               + D +S GV ++E+L G
Sbjct: 254 YYGRECDWWSVGVFLYEMLVG 274

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQ----SHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           VIG G FG+V     +   KV   +  ++         A F  E ++++      +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
               +   + ++ EYM  G L + +   + P    R      + A   +H      +   
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH------SMGF 189
Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ---- 661
           IHRDVK  N+LLD++   K+ADFG              TAV G+  Y+ PE L  Q    
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 248
Query: 662 QLTEKSDVYSFGVVMFEILCG 682
               + D +S GV ++E+L G
Sbjct: 249 YYGRECDWWSVGVFLYEMLVG 269

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           A GL +L +   K II+RD+K  N++LD     K+ADFG+ K   ++     +    G+ 
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTP 185
Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
            Y+ PE +  Q   +  D ++FGV+++E+L G+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 541 LVSLIGYCDERNEMIIIYEYME-----------NGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E ME            G L++ L  S F    W+      + 
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 125
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 126 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 175
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 8/96 (8%)
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKG 648
           RGL Y+H+     +IHRD+K +N+L++EN   K+ DFG+++     P   Q  ++  V  
Sbjct: 170 RGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 649 SFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGR 683
            + Y  PE  L+  + T+  D++S G +  E+L  R
Sbjct: 227 RW-YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 36/235 (15%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKR------GGTQSHQGLAEFRTEIEMLS 534
           T  F E   IG G FG V++ V R D    A+KR      G       L E      +L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 66
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE---ICIGAA 591
           Q  H H+V       E + M+I  EY   G+L D + + N+  +S+ K  E   + +   
Sbjct: 67  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 123
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA-------DFGLSKIGPDL-DQTHVS 643
           RGL Y+H+ S   ++H D+K +NI +    +   A       D+  +K+   + D  HV+
Sbjct: 124 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 644 TAVKGSFGYLDPEYLTKQQLTE------KSDVYSFGVVMFEILCGRPVIDPSLPR 692
                     D  +L  + L E      K+D+++  + +       P     LPR
Sbjct: 181 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPR 230

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 36/235 (15%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKR------GGTQSHQGLAEFRTEIEMLS 534
           T  F E   IG G FG V++ V R D    A+KR      G       L E      +L 
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 66
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE---ICIGAA 591
           Q  H H+V       E + M+I  EY   G+L D + + N+  +S+ K  E   + +   
Sbjct: 67  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 123
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA-------DFGLSKIGPDL-DQTHVS 643
           RGL Y+H+ S   ++H D+K +NI +    +   A       D+  +K+   + D  HV+
Sbjct: 124 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 180
Query: 644 TAVKGSFGYLDPEYLTKQQLTE------KSDVYSFGVVMFEILCGRPVIDPSLPR 692
                     D  +L  + L E      K+D+++  + +       P     LPR
Sbjct: 181 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPR 230

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 36/235 (15%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKR------GGTQSHQGLAEFRTEIEMLS 534
           T  F E   IG G FG V++ V R D    A+KR      G       L E      +L 
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-VLG 68
Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE---ICIGAA 591
           Q  H H+V       E + M+I  EY   G+L D + + N+  +S+ K  E   + +   
Sbjct: 69  Q--HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI-SENYRIMSYFKEAELKDLLLQVG 125
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA-------DFGLSKIGPDL-DQTHVS 643
           RGL Y+H+ S   ++H D+K +NI +    +   A       D+  +K+   + D  HV+
Sbjct: 126 RGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 644 TAVKGSFGYLDPEYLTKQQLTE------KSDVYSFGVVMFEILCGRPVIDPSLPR 692
                     D  +L  + L E      K+D+++  + +       P     LPR
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPR 232

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           +G G +G V   Y   LR   KVAVK+        +   RT  E+ +L   +H +++ L+
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 546 GY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
                    ++ +E+ ++   M  G   +++      +LS      +     RGL Y+H+
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQ--ALSDEHVQFLVYQLLRGLKYIHS 141
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE-YL 658
                IIHRD+K +N+ ++E+   ++ DFGL++   +    +V+T       Y  PE  L
Sbjct: 142 A---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 193
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGR 683
                 +  D++S G +M E+L G+
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 15/201 (7%)
Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQ----SHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           VIG G FG+V     +   KV   +  ++         A F  E ++++      +V L 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
               +   + ++ EYM  G L + +   + P    R      + A   +H      +   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIH------SMGF 194
Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ---- 661
           IHRDVK  N+LLD++   K+ADFG              TAV G+  Y+ PE L  Q    
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 253
Query: 662 QLTEKSDVYSFGVVMFEILCG 682
               + D +S GV ++E+L G
Sbjct: 254 YYGRECDWWSVGVFLYEMLVG 274

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 8/96 (8%)
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK---IGPDLDQTHVSTAVKG 648
           RGL Y+H+     +IHRD+K +N+L++EN   K+ DFG+++     P   Q  ++  V  
Sbjct: 169 RGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 649 SFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGR 683
            + Y  PE  L+  + T+  D++S G +  E+L  R
Sbjct: 226 RW-YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVK---RGGTQSHQGLAEFRTE 529
           + I   +D +     IG G FG V R ++RD+     VAVK   RG   +    A  + E
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFG-VAR-LMRDKQSNELVAVKYIERGEKIA----ANVKRE 65
Query: 530 IEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICI 588
           I      RH ++V           + I+ EY   G L + +  A  F     R   +  I
Sbjct: 66  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 125
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAV 646
               G+ Y H      + HRD+K  N LLD +     K+ DFG SK      Q   +   
Sbjct: 126 S---GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 177
Query: 647 KGSFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGR-PVIDPSLPR 692
            G+  Y+ PE L K++   K +DV+S GV ++ +L G  P  DP  P+
Sbjct: 178 -GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 491 IGIGGFGKVYR--GVLRDETKVA----VKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G F  V R   VL  +   A     K+   + HQ L     E  +    +H ++V L
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL---EREARICRLLKHPNIVRL 86
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
                E     +I++ +  G L + + A  + S         CI   + L  +       
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS---EADASHCI--QQILEAVLHCHQMG 141
Query: 605 IIHRDVKSANILLDENL---MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
           ++HRD+K  N+LL   L     K+ADFGL+       Q     A  G+ GYL PE L K 
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKD 199
Query: 662 QLTEKSDVYSFGVVMFEILCGRP 684
              +  D+++ GV+++ +L G P
Sbjct: 200 PYGKPVDLWACGVILYILLVGYP 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 19/212 (8%)
Query: 482 TDNFSESLVIGIGGFGKVYR------GVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           TD +     +G G F  V R      G       +  K+   + HQ L     E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL---EREARICRL 59
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
            +H ++V L     E     ++++ +  G L + + A  + S         CI   + L 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS---EADASHCI--QQILE 114
Query: 596 YLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
            ++      I+HRD+K  N+LL    +    K+ADFGL+ I    DQ        G+ GY
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGY 172
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE L K    +  D+++ GV+++ +L G P
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYP 204

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 26  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 81
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 82  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 136
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 137 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 190
Query: 658 LTKQQLTEKSDVYSFGVVMFEILC------GRPVID 687
           +      E  D++S G +M E++C      GR  ID
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 226

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 37  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 92
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 93  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 147
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 148 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 201
Query: 658 LTKQQLTEKSDVYSFGVVMFEILC------GRPVID 687
           +      E  D++S G +M E++C      GR  ID
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 237

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 92
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 93  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 152
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 153 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 206
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 207 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 250

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +G V   +  R   KVA+K+     QS         E+ +L   +H +++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 548 CDERNEMIIIYE-YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
               + +   Y+ Y+    ++  L        S  K   +     +GL Y+H+     ++
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA---GVV 148
Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG---SFGYLDPEY-LTKQQ 662
           HRD+K  N+ ++E+   K+ DFGL++        H    + G   +  Y  PE  L+   
Sbjct: 149 HRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 663 LTEKSDVYSFGVVMFEILCGR 683
             +  D++S G +M E+L G+
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 98
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 159 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 212
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     IG G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTIGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EYM  G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    KVADFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 19/201 (9%)
Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           +G G +G V   +  R   KVA+K+     QS         E+ +L   +H +++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 548 CDERNEMIIIYE-YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
               + +   Y+ Y+    ++  L        S  K   +     +GL Y+H+     ++
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA---GVV 166
Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG---SFGYLDPEY-LTKQQ 662
           HRD+K  N+ ++E+   K+ DFGL++        H    + G   +  Y  PE  L+   
Sbjct: 167 HRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 663 LTEKSDVYSFGVVMFEILCGR 683
             +  D++S G +M E+L G+
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 98
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 159 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 212
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 213 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 256

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     IG G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTIGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EYM  G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    KVADFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 100
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 101 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 160
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 161 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 214
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 215 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 258

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 23/214 (10%)
Query: 482 TDNFSESLVIGIGGFGKVYRGVL------RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           TD +     IG G F  V R V            +  K+   + HQ L     E  +   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKL---EREARICRL 59
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG-- 593
            +H ++V L     E     ++++ +  G L + + A  + S         CI       
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS---EADASHCIQQILEAV 116
Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENL---MAKVADFGLSKIGPDLDQTHVSTAVKGSF 650
           LH    G    ++HRD+K  N+LL         K+ADFGL+ I    DQ        G+ 
Sbjct: 117 LHCHQMG----VVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTP 170
Query: 651 GYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           GYL PE L K+   +  D+++ GV+++ +L G P
Sbjct: 171 GYLSPEVLRKEAYGKPVDIWACGVILYILLVGYP 204

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 102
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 103 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 162
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 163 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 216
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 217 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 260

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 143
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 144 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 203
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 204 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 257
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 258 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 301

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 19/212 (8%)
Query: 482 TDNFSESLVIGIGGFGKVYR------GVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ 535
           TD +     +G G F  V R      G       +  K+   + HQ L     E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
            +H ++V L     E     ++++ +  G L + + A  + S         CI   + L 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS---EADASHCI--QQILE 114
Query: 596 YLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
            ++      I+HRD+K  N+LL    +    K+ADFGL+ I    DQ        G+ GY
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGY 172
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L PE L K    +  D+++ GV+++ +L G P
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYP 204

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 485 FSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT-EIEMLSQFRHRHLVS 543
           ++   VIG G FG V++  L +  +VA+K+           F+  E++++   +H ++V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVD 96
Query: 544 LIGYC----DERNEMI--IIYEYMENGTLKDHLYASNFPSLSWRKRLEICI-GAARGLHY 596
           L  +     D+++E+   ++ EY+     +   + +          +++ +    R L Y
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 597 LHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           +H   +  I HRD+K  N+LLD  + + K+ DFG +KI   L     + +   S  Y  P
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI---LIAGEPNVSXICSRYYRAP 210
Query: 656 EYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           E +      T   D++S G VM E++ G+P+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HRDVK  NIL+  +  A + DFG++    D   T +   V G+  Y  PE  ++   T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 667 SDVYSFGVVMFEILCGRP 684
           +D+Y+   V++E L G P
Sbjct: 216 ADIYALTCVLYECLTGSP 233

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 88/181 (48%), Gaps = 37/181 (20%)
Query: 529 EIEMLSQFRHRHLVSL----IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL 584
           EI +L + +H +++SL    + + D +  + ++++Y E+     H+   +  S + +K +
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRK--VWLLFDYAEHDLW--HIIKFHRASKANKKPV 123
Query: 585 EICIGAAR--------GLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLSK 632
           ++  G  +        G+HYLH      ++HRD+K ANIL+     E    K+AD G ++
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 633 I--GP-----DLDQTHVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRP 684
           +   P     DLD   V      +F Y  PE L   +  T+  D+++ G +  E+L   P
Sbjct: 181 LFNSPLKPLADLDPVVV------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
Query: 685 V 685
           +
Sbjct: 235 I 235

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 23/205 (11%)
Query: 491 IGIGGFGKVYR--GVLRDETKVAV----KRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           +G G F  V R   VL  +   A+    K+   + HQ L     E  +    +H ++V L
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLKHPNIVRL 75
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG--LHYLHTGST 602
                E     +I++ +  G L + + A  + S         CI       LH    G  
Sbjct: 76  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYS---EADASHCIQQILEAVLHCHQMG-- 130
Query: 603 KAIIHRDVKSANILLDENL---MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
             ++HR++K  N+LL   L     K+ADFGL+       Q     A  G+ GYL PE L 
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLR 186
Query: 660 KQQLTEKSDVYSFGVVMFEILCGRP 684
           K    +  D+++ GV+++ +L G P
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYP 211

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           +G G +G V   Y   LR   KVAVK+        +   RT  E+ +L   +H +++ L+
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 546 GY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
                    ++ +E+ ++   M  G   +++      +LS      +     RGL Y+H+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQ--ALSDEHVQFLVYQLLRGLKYIHS 149
Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE-YL 658
                IIHRD+K +N+ ++E+   ++ DFGL++   +    +V+T       Y  PE  L
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIML 201
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGR 683
                 +  D++S G +M E+L G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 140
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 141 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 190
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 69
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 70  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 129
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 130 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 183
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 184 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 227

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 40/213 (18%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSH-QGLAEFRT-EIEMLSQFRHRHLVSLIGYC 548
           IG G +G VY+         A+K+   +   +G+      EI +L + +H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR-------------GLH 595
             +  +++++E+++                  +K L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG--PDLDQTHVSTAVKGSFGYL 653
           Y H    + ++HRD+K  N+L++     K+ADFGL++    P    TH       +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 654 DPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
            P+ L   ++ +   D++S G +  E++ G P+
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 76
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 77  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 136
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 137 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 190
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 234

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 76
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 77  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 136
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 137 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 190
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 72
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 73  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 132
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 133 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 186
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 187 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 230

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 154
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 155 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 204
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 122 AVRHCH------NXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 171
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 40/213 (18%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSH-QGLAEFRT-EIEMLSQFRHRHLVSLIGYC 548
           IG G +G VY+         A+K+   +   +G+      EI +L + +H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR-------------GLH 595
             +  +++++E+++                  +K L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG--PDLDQTHVSTAVKGSFGYL 653
           Y H    + ++HRD+K  N+L++     K+ADFGL++    P    TH       +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 654 DPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
            P+ L   ++ +   D++S G +  E++ G P+
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPL 200

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 83
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 84  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 143
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 144 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 197
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 198 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 241

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 154
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 155 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 204
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 153
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 154 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 203
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGY 547
           V+G G   +V   + L    + AVK    Q     +    E+EML Q + HR+++ LI +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 548 CDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
            +E +   +++E M  G++  H++   +F  L     ++     A  L +LH    K I 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLH---NKGIA 133
Query: 607 HRDVKSANILLDE-NLMA--KVADFGL-SKIGPDLDQTHVST----AVKGSFGYLDPEYL 658
           HRD+K  NIL +  N ++  K+ DFGL S I  + D + +ST       GS  Y+ PE +
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 659 -----TKQQLTEKSDVYSFGVVMFEILCGRP 684
                      ++ D++S GV+++ +L G P
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 141
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 142 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 191
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 40/213 (18%)
Query: 491 IGIGGFGKVYRGVLRDETKVAVKRGGTQSH-QGLAEFRT-EIEMLSQFRHRHLVSLIGYC 548
           IG G +G VY+         A+K+   +   +G+      EI +L + +H ++V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR-------------GLH 595
             +  +++++E+++                  +K L++C G                G+ 
Sbjct: 70  HTKKRLVLVFEHLDQDL---------------KKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG--PDLDQTHVSTAVKGSFGYL 653
           Y H    + ++HRD+K  N+L++     K+ADFGL++    P    TH       +  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYR 167
Query: 654 DPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPV 685
            P+ L   ++ +   D++S G +  E++ G P+
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 153
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 154 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 203
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 140
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 141 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 190
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 154
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 155 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 204
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 153
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 154 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 203
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 154
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 155 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 204
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 153
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 154 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 203
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 126
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 127 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 176
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 141
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 142 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 191
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 168
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 169 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 218
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 77
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 78  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 137
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 138 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 191
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 192 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 235

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 168
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 169 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 218
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 125
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 126 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 175
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 126
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 127 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 176
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 75
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 126
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 127 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 176
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT---EIEMLSQFRHR 539
           D +    +IG G +G V     + E +V   +   +  + L + +    EI +L++  H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 540 HLVSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEI---CIGAA 591
           H+V ++        ++ +E+ ++ E      + D  +   F +  +   L I        
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLE------IADSDFKKLFRTPVYLTELHIKTLLYNLL 166
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-------------IGPDLD 638
            G+ Y+H+     I+HRD+K AN L++++   KV DFGL++             I P  D
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 639 QTHVST---------AVKG---SFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEIL 680
             ++ T          + G   +  Y  PE  L ++  TE  DV+S G +  E+L
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD--LDQTHVSTAVKGSFGYLDP 655
           H+     IIHRD+K +NI++  +   K+ DFGL++      + +  V T       Y  P
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAP 194
Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILC------GRPVID 687
           E +      E  D++S G +M E++C      GR  ID
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYID 232

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 141
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 142 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 191
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT------EIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 160
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 161 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 210
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 64
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 178
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFRH--RH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 173
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 174 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 223
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 485 FSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           FSE  V+ +   G+VY   + ++  + +KRG          FR E ++L     R +  L
Sbjct: 74  FSEVAVVKMKQTGQVYAMKIMNKWDM-LKRGEVSC------FREERDVLVNGDRRWITQL 126
Query: 545 IGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
                + N + ++ EY   G L   L  +    P+   R  L   + A   +H L     
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL----- 181
Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL---- 658
              +HRD+K  NILLD     ++ADFG S +    D T  S    G+  YL PE L    
Sbjct: 182 -GYVHRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 659 ---TKQQLTEKSDVYSFGVVMFEILCGR 683
                     + D ++ GV  +E+  G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 35/177 (19%)
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-----KIGPDLDQ 639
           +I +   + L +LH  S  ++IHRDVK +N+L++     K  DFG+S      +  D+D 
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID- 196
Query: 640 THVSTAVKGSFGYLDPEY----LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV 695
                   G   Y  PE     L ++  + KSD++S G+   E+   R   D        
Sbjct: 197 -------AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYD-------- 241
Query: 696 NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLN-KFVEIAEKCLAQCGIDRPSMGDV 751
               W    Q+  Q+ +   P    Q+  D  + +FV+   +CL +   +RP+  ++
Sbjct: 242 ---SWGTPFQQLKQVVEEPSP----QLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 291

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 68
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 69  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 128
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 129 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 182
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 183 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 226

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +++++ VIG G FG VY+  L D  ++   +   Q                +F++R L  
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--------------KRFKNREL-Q 66
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA--- 591
           ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +      
Sbjct: 67  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 126
Query: 592 -------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVS 643
                  R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   +
Sbjct: 127 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPN 180
Query: 644 TAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
            +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 181 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 223

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 44/224 (19%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  + VA+K+               +    +F++R L 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---------------VLQDKRFKNREL- 64
Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA-- 591
            ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +     
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 592 --------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHV 642
                   R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEP 178
Query: 643 STAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           + +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 122 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 171
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 121
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 122 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 171
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 124
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 125 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 174
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT-EIEMLSQFRHRHLV 542
           +++++ VIG G FG VY+  L D  ++   +   Q  +    F+  E++++ +  H ++V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIV 76
Query: 543 SLIGY---CDERNEMI---IIYEYMENGTLKDHLYAS----NFPSLSWRKRLEICIGAAR 592
            L  +     E+ +++   ++ +Y+     +   + S      P +  +  +       R
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM---YQLFR 133
Query: 593 GLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
            L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   + +   S  
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPNVSXICSRY 187
Query: 652 YLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
           Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+  
Sbjct: 39  MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 96
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    
Sbjct: 97  RPFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 154
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 155 QVIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 206
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           DFGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 207 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +++++ VIG G FG VY+  L D  ++   +   Q                +F++R L  
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--------------KRFKNREL-Q 65
Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWR-----KRLEICIGAA--- 591
           ++   D  N + + Y +  +G  KD +Y +      P   +R      R +  +      
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 592 -------RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVS 643
                  R L Y+H+     I HRD+K  N+LLD +  + K+ DFG +K    L +   +
Sbjct: 126 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPN 179
Query: 644 TAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPV 685
            +   S  Y  PE +      T   DV+S G V+ E+L G+P+
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 41/215 (19%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFR------TEIEMLSQFR--HRH 540
           ++G GGFG VY G+ + D   VA+K           E         E+ +L +       
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 97
Query: 541 LVSLIGYCDERNEMIIIYE-----------YMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           ++ L+ + +  +  ++I E             E G L++ L  S F    W+      + 
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF----WQ-----VLE 148
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQTHVSTAVKG 648
           A R  H         ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G
Sbjct: 149 AVRHCH------NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDG 198
Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCG 682
           +  Y  PE++   +   +S  V+S G+++++++CG
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     IG G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTIGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    KVADFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 99/227 (43%), Gaps = 24/227 (10%)
Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVK--RGGTQSHQGLAEFRTEI 530
           + I   +D +     IG G FG V R ++RD+     VAVK    G +  + +   + EI
Sbjct: 11  LPIMHDSDRYELVKDIGSGNFG-VAR-LMRDKQSNELVAVKYIERGEKIDENV---KREI 65
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIG 589
                 RH ++V           + I+ EY   G L + +  A  F     R   +  I 
Sbjct: 66  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 125
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVK 647
              G+ Y H      + HRD+K  N LLD +     K+ DFG SK      Q   +    
Sbjct: 126 ---GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--- 176
Query: 648 GSFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGR-PVIDPSLPR 692
           G+  Y+ PE L K++   K +DV+S GV ++ +L G  P  DP  P+
Sbjct: 177 GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 223

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD--LDQTHVSTAVKGSFGYLDP 655
           H+     IIHRD+K +NI++  +   K+ DFGL++      + +  V T       Y  P
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-----YRAP 194
Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILC------GRPVID 687
           E +      E  D++S G +M E++C      GR  ID
Sbjct: 195 EVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYID 232

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 41/206 (19%)
Query: 488 SLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLI 545
           S V+G+G  GKV +    R + K A+K       Q   + R E+E+     +  H+V ++
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIV 77
Query: 546 GYCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
              +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+ +
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 602 TKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              I HRDVK  N+L      N + K+ DFG +K                          
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------------------ET 170
Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
           T ++  +  D++S GV+M+ +LCG P
Sbjct: 171 TGEKYDKSCDMWSLGVIMYILLCGYP 196

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 33  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 88
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 143
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 144 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 197
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+  
Sbjct: 39  MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 96
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    
Sbjct: 97  RPFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 154
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 155 QVIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 206
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           DFGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 207 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 43/242 (17%)
Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQSHQGLAEFRTEI 530
           + A+ + ++ F     IG G F  VY    +     E K+A+K     SH        E+
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP--IRIAAEL 70
Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIII-YEYMENGTLKDHLYASNFPSLSWRKRLEICIG 589
           + L+    +  V  + YC  +N+ ++I   Y+E+ +  D L      SLS+++  E  + 
Sbjct: 71  QCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLN 125
Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMA-KVADFGLSKIGPD------------ 636
             + L  +H      I+HRDVK +N L +  L    + DFGL++   D            
Sbjct: 126 LFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSE 182
Query: 637 -----LDQTHVSTAVK---------GSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILC 681
                  Q   S  +          G+ G+  PE LTK    T   D++S GV+   +L 
Sbjct: 183 AQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242
Query: 682 GR 683
           GR
Sbjct: 243 GR 244

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSH-QGL-AEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G +G V++   R+  + VA+KR       +G+ +    EI +L + +H+++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
                ++ +++E+ +   LK +  + N   L             +GL + H+   + ++H
Sbjct: 70  LHSDKKLTLVFEFCDQD-LKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+K  N+L++ N   K+A+FGL++      + + +  V  +  Y  P+ L   +L   S
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182
Query: 668 -DVYSFGVVMFEIL-CGRPV 685
            D++S G +  E+   GRP+
Sbjct: 183 IDMWSAGCIFAELANAGRPL 202

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 110/247 (44%), Gaps = 38/247 (15%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+  
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    
Sbjct: 59  RPFQNQTHAKRA-YR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLX 116
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 117 QVIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL------ 680
           DFGL++       + + T    +  Y  PE +      E  D++S G +M E++      
Sbjct: 169 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 681 CGRPVID 687
            GR  ID
Sbjct: 226 PGRDYID 232

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+  
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    
Sbjct: 59  RPFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 116
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 117 QVIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           DFGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 169 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 465 SSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG- 516
           S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+   
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 60
Query: 517 ---TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTLK 567
               Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    +
Sbjct: 61  PFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ 118
Query: 568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD 627
                 +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ D
Sbjct: 119 VIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170
Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           FGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 171 FGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+  
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    
Sbjct: 59  RPFQNQTHAKRA-YR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 116
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 117 QVIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           DFGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 169 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 604 AIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            ++HRD+K  N+L    ++NL  K+ DFG +++ P  +Q   +     +  Y  PE L +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQ 183
Query: 661 QQLTEKSDVYSFGVVMFEILCGR 683
               E  D++S GV+++ +L G+
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 465 SSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG- 516
           S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+   
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 59
Query: 517 ---TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTLK 567
               Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    +
Sbjct: 60  PFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ 117
Query: 568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD 627
                 +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ D
Sbjct: 118 VIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169
Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           FGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 170 FGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 465 SSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG- 516
           S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+   
Sbjct: 1   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 58
Query: 517 ---TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTLK 567
               Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    +
Sbjct: 59  PFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ 116
Query: 568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD 627
                 +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ D
Sbjct: 117 VIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 168
Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           FGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 169 FGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 106/233 (45%), Gaps = 32/233 (13%)
Query: 465 SSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG- 516
           S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+   
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 60
Query: 517 ---TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTLK 567
               Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    +
Sbjct: 61  PFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ 118
Query: 568 DHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD 627
                 +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ D
Sbjct: 119 VIQMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170
Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
           FGL++       + + T    +  Y  PE +      E  D++S G +M E++
Sbjct: 171 FGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 42  DQFERIRTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY   G +  HL        S         
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL--RRIGRFSEPHARFYAA 149
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    KVADFG +K          +  + G
Sbjct: 150 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCG 201
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 178
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ +  M K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 98/200 (49%), Gaps = 12/200 (6%)
Query: 491 IGIGGFGKVYRGVLRDETK-VAVKRGGTQSH-QGL-AEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G +G V++   R+  + VA+KR       +G+ +    EI +L + +H+++V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
                ++ +++E+ +   LK +  + N   L             +GL + H+   + ++H
Sbjct: 70  LHSDKKLTLVFEFCDQD-LKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS---RNVLH 124
Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+K  N+L++ N   K+ADFGL++      + + +  V  +  Y  P+ L   +L   S
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYSTS 182
Query: 668 -DVYSFGVVMFEIL-CGRPV 685
            D++S G +  E+    RP+
Sbjct: 183 IDMWSAGCIFAELANAARPL 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 93
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 150
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ +  M K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 151 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKVVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 93
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 94  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 150
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ +  M K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 151 SDLKPANFLIVDG-MLKLIDFGIANQMQPDXXXV-VKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 20  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 77
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 78  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 134
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ +  M K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 135 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRE 192
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 193 NGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 178
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ + ++ K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 179 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRE 236
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDE-TKVAVK---RGGTQSHQGLA--EFRTEIEMLSQF 536
           D +    VIG G F  V R + R+   + AVK        S  GL+  + + E  +    
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTL---------KDHLYASNFPSLSWRKRLEIC 587
           +H H+V L+        + +++E+M+   L            +Y+    S   R+ LE  
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-- 143
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLS-KIGPDLDQTHVS 643
                 L Y H  +   IIHRDVK   +LL   + +   K+  FG++ ++G   +   V+
Sbjct: 144 -----ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG---ESGLVA 192
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
               G+  ++ PE + ++   +  DV+  GV++F +L G
Sbjct: 193 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 121
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 178
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ + ++ K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 179 SDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV-VKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDE-TKVAVK---RGGTQSHQGLA--EFRTEIEMLSQF 536
           D +    VIG G F  V R + R+   + AVK        S  GL+  + + E  +    
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTL---------KDHLYASNFPSLSWRKRLEIC 587
           +H H+V L+        + +++E+M+   L            +Y+    S   R+ LE  
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE-- 141
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLS-KIGPDLDQTHVS 643
                 L Y H  +   IIHRDVK   +LL   + +   K+  FG++ ++G   +   V+
Sbjct: 142 -----ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG---ESGLVA 190
Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
               G+  ++ PE + ++   +  DV+  GV++F +L G
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 17  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 74
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 131
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ +  M K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 132 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGY 547
           V+G G   +V   + L    + AVK    Q     +    E+EML Q + HR+++ LI +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 548 CDERNEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
            +E +   +++E M  G++  H++   +F  L     ++     A  L +LH    K I 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLH---NKGIA 133
Query: 607 HRDVKSANILLDE-NLMA--KVADFGL-SKIGPDLDQTHVST----AVKGSFGYLDPEYL 658
           HRD+K  NIL +  N ++  K+ DF L S I  + D + +ST       GS  Y+ PE +
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 659 -----TKQQLTEKSDVYSFGVVMFEILCGRP 684
                      ++ D++S GV+++ +L G P
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKVVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +      G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S GV+M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKVVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +      G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S GV+M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  VL  +  VA+K+       Q+H   A +R E+ ++    H++++S
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIS 80
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ ++ E M+    +      +   +S+     +C     G+ +L
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 135
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 136 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 189
Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           +      E  D++S G +M E++
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 34  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIG 89
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +C     G+ +L
Sbjct: 90  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 144
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + +      +  Y  PE 
Sbjct: 145 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYYRAPEV 198
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  VL  +  VA+K+       Q+H   A +R E+ ++    H++++S
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIS 81
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ ++ E M+    +      +   +S+     +C     G+ +L
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 136
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 137 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 190
Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           +      E  D++S G +M E++
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMV 213

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 28/203 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  VL  +  VA+K+       Q+H   A +R E+ ++    H++++S
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKCVNHKNIIS 81
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ ++ E M+    +      +   +S+     +C     G+ +L
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHL 136
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 137 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 190
Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           +      E  D++S G +M E++
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 491 IGIGGFGKVYRGVLRDETKV-AVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GG  KV++ VL ++ ++ A+K    +   +Q L  +R EI  L++ + +H   +I  
Sbjct: 16  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ-QHSDKIIRL 73
Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D       IY  ME G +  + +     S+   +R          +H +H      I+H
Sbjct: 74  YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVH 130
Query: 608 RDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
            D+K AN L+ +  M K+ DFG++ ++ PD     V  +  G+  Y+ PE +     + +
Sbjct: 131 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV-VKDSQVGTVNYMPPEAIKDMSSSRE 188
Query: 667 S-----------DVYSFGVVMFEILCGR 683
           +           DV+S G +++ +  G+
Sbjct: 189 NGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 23/183 (12%)
Query: 510 VAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYE 559
           VAVK+       Q+H   A +R E+ +L    H++++SL+         +E  ++ ++ E
Sbjct: 50  VAVKKLSRPFQNQTHAKRA-YR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 107
Query: 560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE 619
            M+    +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  
Sbjct: 108 LMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKS 159
Query: 620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEI 679
           +   K+ DFGL++         + T    +  Y  PE +      E  D++S G +M E+
Sbjct: 160 DCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 216
Query: 680 LCG 682
           + G
Sbjct: 217 VKG 219

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 109/247 (44%), Gaps = 38/247 (15%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+  
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    
Sbjct: 59  RPFQNQTHAKRA-YR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLX 116
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +      G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 117 QVIQMELDHERMSY-----LLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL------ 680
           DFGL++       + + T    +  Y  PE +      E  D++S G +M E++      
Sbjct: 169 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 681 CGRPVID 687
            GR  ID
Sbjct: 226 PGRDYID 232

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 490 VIGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           VIG G FG+V   Y   +     + + R   + H+  AE   EI +L   R +       
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQ------- 153
Query: 547 YCDERNEMIIIYEYMENGTLKDH------LYASNFPSLSWRKRLE------ICIGAARGL 594
             D+ N M +I+  +EN T ++H      L + N   L  + + +      +   A   L
Sbjct: 154 --DKDNTMNVIH-MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
             L       IIH D+K  NILL +   +  KV DFG S      +   V T ++  F Y
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTXIQSRF-Y 265
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVI 686
             PE +   +     D++S G ++ E+L G P++
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 35/214 (16%)
Query: 490 VIGIGGFGKV---YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           VIG G FG+V   Y   +     + + R   + H+  AE   EI +L   R +       
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQ------- 153
Query: 547 YCDERNEMIIIYEYMENGTLKDH------LYASNFPSLSWRKRLE------ICIGAARGL 594
             D+ N M +I+  +EN T ++H      L + N   L  + + +      +   A   L
Sbjct: 154 --DKDNTMNVIH-MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
             L       IIH D+K  NILL +   +  KV DFG S      +   V T ++  F Y
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTXIQSRF-Y 265
Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVI 686
             PE +   +     D++S G ++ E+L G P++
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 84/207 (40%), Gaps = 16/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET--KVAVKRGGTQSHQGLAEFR---TEIEMLSQFR 537
           D F     +G G FG+V   V   ET    A+K    Q    L E      E  +L    
Sbjct: 41  DQFERIKTLGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
              LV L     + + + ++ EY   G +  HL        S                YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     +I+RD+K  N+++D+    KV DFGL+K          +  + G+  YL PE 
Sbjct: 158 HSLD---LIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  +   +  D ++ GV+++E+  G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 491 IGIGGFGKVYRGVLRDET---KVAVKRGGTQSHQGLAEFRTE-IEMLSQFRHRHLVSLIG 546
           +G G FG+V+R  ++D+    + AVK+        L  FR E +   +      +V L G
Sbjct: 66  VGRGSFGEVHR--MKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
              E   + I  E +E G+L   +       L   + L     A  GL YLHT   + I+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT---RRIL 172
Query: 607 HRDVKSANILL-DENLMAKVADFGLS-KIGPDLDQTHVSTA--VKGSFGYLDPEYLTKQQ 662
           H DVK+ N+LL  +   A + DFG +  + PD     + T   + G+  ++ PE +  + 
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 663 LTEKSDVYSFGVVMFEILCG 682
              K D++S   +M  +L G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNG 252

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++  D +    +IG G FG+V +   R E +    +        L + + E+ +L +  +
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL-ELMN 108
Query: 539 RH-------LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +H       +V L  +   RN + +++E M +  L D L  +NF  +S     +      
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILL--DENLMAKVADFGLS-KIGPDLDQTHVSTAVKG 648
             L +L T    +IIH D+K  NILL   +    K+ DFG S ++G  + Q      ++ 
Sbjct: 168 TALLFLATPEL-SIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX-----IQS 221
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            F Y  PE L         D++S G ++ E+  G P+
Sbjct: 222 RF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 491 IGIGGFGKVYRGVLRDET---KVAVKRGGTQSHQGLAEFRTE-IEMLSQFRHRHLVSLIG 546
           +G G FG+V+R  ++D+    + AVK+        L  FR E +   +      +V L G
Sbjct: 82  VGRGSFGEVHR--MKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYG 133
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
              E   + I  E +E G+L   +       L   + L     A  GL YLHT   + I+
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT---RRIL 188
Query: 607 HRDVKSANILL-DENLMAKVADFGLS-KIGPDLDQTHVSTA--VKGSFGYLDPEYLTKQQ 662
           H DVK+ N+LL  +   A + DFG +  + PD     + T   + G+  ++ PE +  + 
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 248
Query: 663 LTEKSDVYSFGVVMFEILCG 682
              K D++S   +M  +L G
Sbjct: 249 CDAKVDIWSSCCMMLHMLNG 268

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 80
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 81  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 138
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+DE    +V DFG +K          +  + G+  
Sbjct: 139 LTFEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 190
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 223

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQGLAE-FRTEIE 531
           + I   +D +     IG G FG V R ++RD+     VAVK    +  + + E  + EI 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFG-VAR-LMRDKQSNELVAVKY--IERGEKIDENVKREII 67
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGA 590
                RH ++V           + I+ EY   G L + +  A  F     R   +  I  
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS- 126
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVKG 648
             G+ Y H      + HRD+K  N LLD +     K+  FG SK      Q   +    G
Sbjct: 127 --GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV---G 178
Query: 649 SFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGR-PVIDPSLPR 692
           +  Y+ PE L K++   K +DV+S GV ++ +L G  P  DP  P+
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 109/247 (44%), Gaps = 38/247 (15%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      +     IG G  G V   Y  VL  +  VA+K+  
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ ++    H++++SL+         +E  ++ ++ E M+    
Sbjct: 59  RPFQNQTHAKRA-YR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLX 116
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +      G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 117 QVIQMELDHERMSY-----LLYQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL------ 680
           DFGL++       + + T    +  Y  PE +      E  D++S G +M E++      
Sbjct: 169 DFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 225
Query: 681 CGRPVID 687
            GR  ID
Sbjct: 226 PGRDYID 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 486 SESLVIGIGGFGKVYRGVLRDET---KVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHL 541
           +  L +G G FG+V+R  + D+    + AVK+        L  FR E  M  +      +
Sbjct: 96  THQLRLGRGSFGEVHR--MEDKQTGFQCAVKK------VRLEVFRAEELMACAGLTSPRI 147
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V L G   E   + I  E +E G+L   +       L   + L     A  GL YLH+  
Sbjct: 148 VPLYGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHS-- 203
Query: 602 TKAIIHRDVKSANILL-DENLMAKVADFGLS-KIGPDLDQTHVSTA--VKGSFGYLDPEY 657
            + I+H DVK+ N+LL  +   A + DFG +  + PD     + T   + G+  ++ PE 
Sbjct: 204 -RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEV 262
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +  +    K DV+S   +M  +L G
Sbjct: 263 VLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 114
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 172
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 173 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPE 224
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 93
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPE 203
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 21/200 (10%)
Query: 491 IGIGGFGKVYRGVLRDET---KVAVKRGGTQSHQGLAEFRTE-IEMLSQFRHRHLVSLIG 546
           +G G FG+V+R  ++D+    + AVK+        L  FR E +   +      +V L G
Sbjct: 80  LGRGSFGEVHR--MKDKQTGFQCAVKK------VRLEVFRVEELVACAGLSSPRIVPLYG 131
Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
              E   + I  E +E G+L   +       L   + L     A  GL YLHT   + I+
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHT---RRIL 186
Query: 607 HRDVKSANILL-DENLMAKVADFGLS-KIGPDLDQTHVSTA--VKGSFGYLDPEYLTKQQ 662
           H DVK+ N+LL  +   A + DFG +  + PD     + T   + G+  ++ PE +  + 
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 663 LTEKSDVYSFGVVMFEILCG 682
              K D++S   +M  +L G
Sbjct: 247 CDAKVDIWSSCCMMLHMLNG 266

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 93
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPE 203
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 21/205 (10%)
Query: 486 SESLVIGIGGFGKVYRGVLRDET---KVAVKRGGTQSHQGLAEFRTEIEM-LSQFRHRHL 541
           +  L +G G FG+V+R  + D+    + AVK+        L  FR E  M  +      +
Sbjct: 77  THQLRLGRGSFGEVHR--MEDKQTGFQCAVKK------VRLEVFRAEELMACAGLTSPRI 128
Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V L G   E   + I  E +E G+L   +       L   + L     A  GL YLH+  
Sbjct: 129 VPLYGAVREGPWVNIFMELLEGGSLGQLVKEQG--CLPEDRALYYLGQALEGLEYLHS-- 184
Query: 602 TKAIIHRDVKSANILL-DENLMAKVADFGLS-KIGPDLDQTHVSTA--VKGSFGYLDPEY 657
            + I+H DVK+ N+LL  +   A + DFG +  + PD     + T   + G+  ++ PE 
Sbjct: 185 -RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEV 243
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +  +    K DV+S   +M  +L G
Sbjct: 244 VLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 34  DQFERIKTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 83
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 141
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 142 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 193
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 42  DQFERIKTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 149
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 150 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 42  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 149
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K       T     + G
Sbjct: 150 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCG 201
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/308 (22%), Positives = 132/308 (42%), Gaps = 60/308 (19%)
Query: 490 VIGIGGFGKVYRG-VLRDETKVAVK---RGGTQSHQGLAEFRT---EIEMLSQFR----H 538
           ++G GGFG V+ G  L D  +VA+K   R        L++  T   E+ +L +      H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 539 RHLVSLIGYCDERNEMIIIYEY-MENGTLKDHLYASNF----PSLSWRKRLEICIGAARG 593
             ++ L+ + + +   +++ E  +    L D++         PS   R      + A + 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---RCFFGQVVAAIQH 154
Query: 594 LHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
            H      ++ ++HRD+K  NIL+D     AK+ DFG       L      T   G+  Y
Sbjct: 155 CH------SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA----LLHDEPYTDFDGTRVY 204
Query: 653 LDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE 711
             PE++++ Q     + V+S G+++++++CG       +P E+                +
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCG------DIPFERD---------------Q 243
Query: 712 DIVDPTL--TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSS 769
           +I++  L     + PD       +  +CLA     RPS+ ++L  L+  +Q   ++   +
Sbjct: 244 EILEAELHFPAHVSPDC----CALIRRCLAPKPSSRPSLEEIL--LDPWMQTPAEDVPLN 297
Query: 770 PKGETSSP 777
           P     +P
Sbjct: 298 PSKGGPAP 305

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 42  DQFERIKTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 149
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 150 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 42  DQFERIKTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 149
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 150 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++  D +    +IG G FG+V +   R E +    +        L + + E+ +L +  +
Sbjct: 31  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL-ELMN 89
Query: 539 RH-------LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +H       +V L  +   RN + +++E M +  L D L  +NF  +S     +      
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 148
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILL--DENLMAKVADFGLS-KIGPDLDQTHVSTAVKG 648
             L +L T    +IIH D+K  NILL   +    K+ DFG S ++G  + Q      ++ 
Sbjct: 149 TALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX-----IQS 202
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            F Y  PE L         D++S G ++ E+  G P+
Sbjct: 203 RF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 27  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 76
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 134
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K       T     + G
Sbjct: 135 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCG 186
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 222

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 476 VAIQEATDNFSESLVIGIGGFGKVYRGVLRDETK---VAVKRGGTQSHQGLAE-FRTEIE 531
           + I   +D +     IG G FG V R ++RD+     VAVK    +  + + E  + EI 
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFG-VAR-LMRDKQSNELVAVKY--IERGEKIDENVKREII 67
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGA 590
                RH ++V           + I+ EY   G L + +  A  F     R   +  I  
Sbjct: 68  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS- 126
Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVKG 648
             G+ Y H      + HRD+K  N LLD +     K+  FG SK      Q   +    G
Sbjct: 127 --GVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV---G 178
Query: 649 SFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGR-PVIDPSLPR 692
           +  Y+ PE L K++   K +DV+S GV ++ +L G  P  DP  P+
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 19/137 (13%)
Query: 552 NEMIIIYEYMENGTLKDHLYASNFPSL----SWRKRLEICIGAARGLHYLHTGSTKAIIH 607
           +E+I+I EY   G     +++   P L    S    + +      G++YLH  +   I+H
Sbjct: 102 SEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVH 154
Query: 608 RDVKSANILLDENLM---AKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            D+K  NILL         K+ DFG+S KIG   +   +     G+  YL PE L    +
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----MGTPEYLAPEILNYDPI 210
Query: 664 TEKSDVYSFGVVMFEIL 680
           T  +D+++ G++ + +L
Sbjct: 211 TTATDMWNIGIIAYMLL 227

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 42  DQFERIKTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY   G +  HL        S         
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAA 149
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+++D+    KV DFG +K          +  + G
Sbjct: 150 QIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCG 201
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 31/228 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 93
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
           YL PE +  +   +  D ++ GV+++E+  G P   P    E + + E
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADEPIQIYE 248

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 28/205 (13%)
Query: 491 IGIGGFGKV---YRGVLRDETKVAVKRGG----TQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           IG G  G V   Y  +L  E  VA+K+       Q+H   A +R E+ ++    H++++ 
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRA-YR-ELVLMKVVNHKNIIG 87
Query: 544 LIGY------CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           L+         +E  ++ I+ E M+    +      +   +S+     +      G+ +L
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-----LLYQMLVGIKHL 142
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE 
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 196
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCG 682
           +      E  D++S G +M E++ G
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++  D +    +IG G FG+V +   R E +    +        L + + E+ +L +  +
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL-ELMN 108
Query: 539 RH-------LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +H       +V L  +   RN + +++E M +  L D L  +NF  +S     +      
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILL--DENLMAKVADFGLS-KIGPDLDQTHVSTAVKG 648
             L +L T    +IIH D+K  NILL   +    K+ DFG S ++G  + Q      ++ 
Sbjct: 168 TALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX-----IQS 221
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV 685
            F Y  PE L         D++S G ++ E+  G P+
Sbjct: 222 RF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 62  DQFERIKTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 111
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 169
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 170 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 221
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 84/207 (40%), Gaps = 16/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET--KVAVKRGGTQSHQGLAEFR---TEIEMLSQFR 537
           D F     +G G FG+V   V   ET    A+K    Q    L E      E  +L    
Sbjct: 41  DQFERIKTLGTGSFGRVML-VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
              LV L     + + + ++ EY   G +  HL        S                YL
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     +I+RD+K  N+++D+    +V DFGL+K          +  + G+  YL PE 
Sbjct: 158 HSLD---LIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  +   +  D ++ GV+++E+  G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 464 FSSSKIGYRFPFVAIQEAT----DNFSESLVIGIGGFGKV---YRGVLRDETKVAVKRGG 516
            S SK+  +F  V + ++T      + +   IG G  G V   +  VL     VAVK+  
Sbjct: 1   MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLG--INVAVKKLS 58
Query: 517 ----TQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY------CDERNEMIIIYEYMENGTL 566
                Q+H   A +R E+ +L    H++++SL+         +E  ++ ++ E M+    
Sbjct: 59  RPFQNQTHAKRA-YR-ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 116
Query: 567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA 626
           +      +   +S+     +C     G+ +LH+     IIHRD+K +NI++  +   K+ 
Sbjct: 117 QVIHMELDHERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168
Query: 627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG 682
           DFGL++         + T    +  Y  PE +         D++S G +M E++ G
Sbjct: 169 DFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 34  DQFERIKTLGTGSFGRV----------MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN 83
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC 587
                       LV L     + + + ++ EY+  G +  HL     F     R      
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 143
Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           +     LH L       +I+RD+K  N+L+D+    +V DFG +K          +  + 
Sbjct: 144 VLTFEYLHSLD------LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLC 192
Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           G+  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 42  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 149
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 150 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 201
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 93
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 16/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET--KVAVKRGGTQSHQGLAEFR---TEIEMLSQFR 537
           D F     +G G FG+V   V   ET    A+K    Q    L +      E  +L    
Sbjct: 41  DQFERIKTLGTGSFGRVML-VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
              LV L     + + + ++ EY+  G +  HL        S                YL
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  +   +  D ++ GV+++E+  G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 107/239 (44%), Gaps = 55/239 (23%)
Query: 484 NFSESL--------VIGIGGFGKV-YRGVLRDETKVAVKRGGTQSHQGLAEF----RTEI 530
           NF +SL        ++G G  G V ++G  +    VAVKR        L +F      EI
Sbjct: 8   NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKRM-------LIDFCDIALMEI 59
Query: 531 EMLSQFRHRHLVSLIGYCDER-NEMIIIYEYMENGTLKDHLYASNF--PSLSWRKR---L 584
           ++L++    H   +  YC E  +  + I   + N  L+D + + N    +L  +K    +
Sbjct: 60  KLLTE-SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-------------ENLMAKVADFGLS 631
            +    A G+ +LH+     IIHRD+K  NIL+              ENL   ++DFGL 
Sbjct: 119 SLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 632 KIGPDLDQTHVSTAVK---GSFGYLDPEYL-------TKQQLTEKSDVYSFGVVMFEIL 680
           K   D  Q+   T +    G+ G+  PE L       TK++LT   D++S G V + IL
Sbjct: 176 K-KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 16/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET--KVAVKRGGTQSHQGLAEFR---TEIEMLSQFR 537
           D F     +G G FG+V   V   ET    A+K    Q    L +      E  +L    
Sbjct: 41  DQFERIKTLGTGSFGRVML-VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
              LV L     + + + ++ EY+  G +  HL        S                YL
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  +   +  D ++ GV+++E+  G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 16/207 (7%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDET--KVAVKRGGTQSHQGLAEFR---TEIEMLSQFR 537
           D F     +G G FG+V   V   ET    A+K    Q    L +      E  +L    
Sbjct: 41  DQFERIKTLGTGSFGRVML-VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
              LV L     + + + ++ EY+  G +  HL        S                YL
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  YL PE 
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  +   +  D ++ GV+++E+  G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 93
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY   G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+++D+    KV DFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 93
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 34/216 (15%)
Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEF-RTEIEMLSQFRHR-- 539
           D F     +G G FG+V          + VK   T +H  +    + ++  L Q  H   
Sbjct: 41  DQFERIKTLGTGSFGRV----------MLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 540 -----------HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
                       LV L     + + + ++ EY+  G +  HL        S         
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFSEPHARFYAA 148
Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
                  YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 200
Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +  YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 28/213 (13%)
Query: 483 DNFSESLVIGIGGFGKV-----------YRGVLRDETKVAVKRGGTQSHQGLAEFRTEIE 531
           D F     +G G FG+V           Y   + D+ KV   +   Q    L E R    
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK---QIEHTLNEKR---- 93
Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +L       LV L     + + + ++ EY+  G +  HL        S            
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIV 151
Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
               YLH+     +I+RD+K  N+L+D+    +V DFG +K          +  + G+  
Sbjct: 152 LTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPE 203
Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE +  +   +  D ++ GV+++E+  G P
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	820
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-135
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-131
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-87
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-69
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-68
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-67
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-67
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-67
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-65
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-65
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-63
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-63
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-57
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-54
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-48
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-48
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-47
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-46
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-46
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-46
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-45
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-45
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-45
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-45
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	9e-45
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-44
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-44
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-44
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-44
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-44
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-44
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-44
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-43
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-43
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-43
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-43
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-43
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-42
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-42
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-42
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-41
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-41
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-41
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-41
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-40
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-40
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-39
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-39
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-39
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-39
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-39
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-38
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-38
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-38
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-36
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-36
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-33
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-30
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-29
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-29
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-29
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-29
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-29
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-28
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-28
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-27
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-27
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-26
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	1e-26
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	1e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-26
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-23
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-20
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-18
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	8e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-16
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-15
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-15
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-14
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  557 bits (1439), Expect = 0.0
 Identities = 196/304 (64%), Positives = 230/304 (75%), Gaps = 5/304 (1%)

Query: 461 SAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH 520
           S+ +      YR P V ++EAT+NF    +IG G FGKVY+GVLRD  KVA+KR   +S 
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS 76

Query: 521 QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--L 578
           QG+ EF TEIE LS  RH HLVSLIG+CDERNEMI+IY+YMENG LK HLY S+ P+  +
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136

Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
           SW +RLEICIGAARGLHYLHT    AIIHRDVKS NILLDEN + K+ DFG+SK G +LD
Sbjct: 137 SWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193

Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
           QTH+ST VKG+ GY+DPEY  K +LTEKSDVYSFGVV+FE+LC R  I  SLPRE VNL 
Sbjct: 194 QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA 758
           EWA++    GQLE IVDP L  +I+P+SL KF + A KCLA    DRPSMGDVLW LEYA
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

Query: 759 LQLQ 762
           L+LQ
Sbjct: 314 LRLQ 317

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  402 bits (1035), Expect = e-135
 Identities = 103/298 (34%), Positives = 163/298 (54%), Gaps = 20/298 (6%)

Query: 472 RFPFVAIQEATDNFSESL------VIGIGGFGKVYRGVLRDETKVAVKR----GGTQSHQ 521
            F F  ++  T+NF E         +G GGFG VY+G + + T VAVK+        + +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72

Query: 522 GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY-ASNFPSLSW 580
              +F  EI+++++ +H +LV L+G+  + +++ ++Y YM NG+L D L      P LSW
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132

Query: 581 RKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT 640
             R +I  GAA G+++LH       IHRD+KSANILLDE   AK++DFGL++      QT
Sbjct: 133 HMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW 700
            +++ + G+  Y+ PE L   ++T KSD+YSFGVV+ EI+ G P +D    RE   L++ 
Sbjct: 190 VMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDI 246

Query: 701 AMKC-QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY 757
             +   E   +ED +D  +       S+     +A +CL +    RP +  V   L+ 
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  394 bits (1015), Expect = e-131
 Identities = 120/290 (41%), Positives = 177/290 (61%), Gaps = 6/290 (2%)

Query: 472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGL-AEFRTEI 530
           RF    +Q A+DNFS   ++G GGFGKVY+G L D T VAVKR   +  QG   +F+TE+
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 531 EMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--ASNFPSLSWRKRLEICI 588
           EM+S   HR+L+ L G+C    E +++Y YM NG++   L     + P L W KR  I +
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
           G+ARGL YLH      IIHRDVK+ANILLDE   A V DFGL+K+      THV+TAV+G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTTAVRG 197

Query: 649 SFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR--EKVNLVEWAMKCQE 706
           + G++ PEYL+  + +EK+DV+ +GV++ E++ G+   D +     + V L++W     +
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

Query: 707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
             +LE +VD  L G  K + + + +++A  C     ++RP M +V+  LE
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  278 bits (712), Expect = 5e-87
 Identities = 77/314 (24%), Positives = 124/314 (39%), Gaps = 31/314 (9%)

Query: 465 SSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLA 524
           S   +G       +   +       V   G FG V++  L +E  VAVK    Q  Q   
Sbjct: 10  SGVDLGTEN----LYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSW- 63

Query: 525 EFRTEIEMLSQFRHRHLVSLIGYCDERN----EMIIIYEYMENGTLKDHLYASNFPSLSW 580
           +   E+  L   +H +++  IG          ++ +I  + E G+L D L       +SW
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSW 120

Query: 581 RKRLEICIGAARGLHYLHT-------GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
            +   I    ARGL YLH        G   AI HRD+KS N+LL  NL A +ADFGL+  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 634 GPDLDQTHVSTAVKGSFGYLDPEYL-----TKQQLTEKSDVYSFGVVMFEILCGRPVIDP 688
                    +    G+  Y+ PE L      ++    + D+Y+ G+V++E+       D 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 689 SLPREKVNLVEWAMKCQETGQLEDIV-----DPTLTGQIKPDS-LNKFVEIAEKCLAQCG 742
            +    +   E   +      ++++V      P L    +  + +    E  E+C     
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 743 IDRPSMGDVLWNLE 756
             R S G V   + 
Sbjct: 301 EARLSAGCVGERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  231 bits (591), Expect = 1e-69
 Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 22/270 (8%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            IG G FG V+R      + VAVK         + + EF  E+ ++ + RH ++V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             +   + I+ EY+  G+L   L+ S     L  R+RL +    A+G++YLH      I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIV 161

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HR++KS N+L+D+    KV DFGLS++      +  S +  G+  ++ PE L  +   EK
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           SDVYSFGV+++E+   +       P   +N  +             +       +I  + 
Sbjct: 220 SDVYSFGVILWELATLQ------QPWGNLNPAQVVA---------AVGFKCKRLEIPRNL 264

Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
             +   I E C       RPS   ++  L 
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  228 bits (584), Expect = 1e-68
 Identities = 76/307 (24%), Positives = 138/307 (44%), Gaps = 28/307 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           V+G G FG V +   R +  VA+K+  ++S      F  E+  LS+  H ++V L G C 
Sbjct: 15  VVGRGAFGVVCKAKWRAKD-VAIKQIESESE--RKAFIVELRQLSRVNHPNIVKLYGAC- 70

Query: 550 ERNEMIIIYEYMENGTLKDHLYAS-NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
             N + ++ EY E G+L + L+ +   P  +    +  C+  ++G+ YLH+   KA+IHR
Sbjct: 71  -LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 609 DVKSANILLDENLM-AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           D+K  N+LL       K+ DFG +      D     T  KGS  ++ PE       +EK 
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184

Query: 668 DVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSL 727
           DV+S+G++++E++  R       P +++    +        ++   V       +  +  
Sbjct: 185 DVFSWGIILWEVITRR------KPFDEIGGPAF--------RIMWAVHNGTRPPLIKNLP 230

Query: 728 NKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ--LQGDEGKSSPKGETSSPNNHSHSQT 785
                +  +C ++    RPSM +++  + + ++     DE    P   +  P      + 
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEP 290

Query: 786 GVSNTEF 792
            V   EF
Sbjct: 291 YVDFAEF 297

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  224 bits (573), Expect = 2e-67
 Identities = 82/271 (30%), Positives = 138/271 (50%), Gaps = 23/271 (8%)

Query: 491 IGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           IG G FG VY+G    +  VAVK       + Q L  F+ E+ +L + RH +++  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
                + I+ ++ E  +L  HL+AS       +K ++I    ARG+ YLH    K+IIHR
Sbjct: 90  TAPQ-LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL---TE 665
           D+KS NI L E+   K+ DFGL+        +H    + GS  ++ PE +  Q     + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 666 KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           +SDVY+FG+V++E++ G+      LP   +N  +  ++    G L     P L+ +++ +
Sbjct: 205 QSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLS----PDLS-KVRSN 253

Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
              +   +  +CL +   +RPS   +L  +E
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  225 bits (574), Expect = 5e-67
 Identities = 73/337 (21%), Positives = 124/337 (36%), Gaps = 45/337 (13%)

Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
             DN     +IG G +G VY+G L +   VAVK     + Q     +  I  +    H +
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLDERP-VAVKVFSFANRQNFINEK-NIYRVPLMEHDN 68

Query: 541 LVSLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
           +   I        D R E +++ EY  NG+L  +L      +  W     +     RGL 
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLA 125

Query: 596 YLHT------GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI------GPDLDQTHVS 643
           YLHT          AI HRD+ S N+L+  +    ++DFGLS            ++ + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 644 TAVKGSFGYLDPEYL-------TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVN 696
            +  G+  Y+ PE L         +   ++ D+Y+ G++ +EI      + P     +  
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 697 LVEWAMKCQE--TGQLEDIVD-----PTLTGQIKPDS--LNKFVEIAEKCLAQCGIDRPS 747
           +              ++ +V      P      K +S  +    E  E C  Q    R +
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 748 MGDVLWNLEYALQLQGDEGKSSPKGETSSPNNHSHSQ 784
                  +    +L         + ++ SP  H H  
Sbjct: 306 AQXAEERMA---ELM----MIWERNKSVSPTAHHHHH 335

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  222 bits (567), Expect = 8e-67
 Identities = 50/274 (18%), Positives = 113/274 (41%), Gaps = 31/274 (11%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +     G++++G  +    + VK  +    S +   +F  E   L  F H +++ ++G 
Sbjct: 17  KLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 548 CDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
           C         +I  +M  G+L + L+      +   + ++  +  ARG+ +LHT     I
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL-- 663
               + S ++++DE++ A+++   +         +  S     +  ++ PE L K+    
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKKPEDT 187

Query: 664 -TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI 722
               +D++SF V+++E++         +P   ++ +E  MK         +    L   I
Sbjct: 188 NRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMK---------VALEGLRPTI 232

Query: 723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
            P       ++ + C+ +    RP    ++  LE
Sbjct: 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  217 bits (554), Expect = 6e-65
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKR----GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           +IGIGGFGKVYR     +  VAVK           Q +   R E ++ +  +H ++++L 
Sbjct: 14  IIGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
           G C +   + ++ E+   G L   L       +     +   +  ARG++YLH  +   I
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 606 IHRDVKSANILLDE--------NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           IHRD+KS+NIL+ +        N + K+ DFGL++      +T   +A  G++ ++ PE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYAWMAPEV 185

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT 717
           +     ++ SDV+S+GV+++E+L G       +P   ++ +  A           +    
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVA---------YGVAMNK 230

Query: 718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
           L   I       F ++ E C       RPS  ++L  L 
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  217 bits (554), Expect = 9e-65
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 39/283 (13%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVKR-------GGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            IG GGFG V++G L  D++ VA+K        G T+  +   EF+ E+ ++S   H ++
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V L G     N   ++ E++  G L   L     P + W  +L + +  A G+ Y+    
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQN-Q 141

Query: 602 TKAIIHRDVKSANILLDE-----NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
              I+HRD++S NI L        + AKVADFGLS+        H  + + G+F ++ PE
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPE 196

Query: 657 YLTKQQL--TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA-MKCQETGQLEDI 713
            +  ++   TEK+D YSF ++++ IL G        P        +      +   +  I
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGE------GP--------FDEYSYGKIKFINMI 242

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
            +  L   I  D   +   + E C +     RP    ++  L 
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  214 bits (548), Expect = 2e-63
 Identities = 70/311 (22%), Positives = 117/311 (37%), Gaps = 49/311 (15%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           +IG G FG+VY G    E  VA++       +   L  F+ E+    Q RH ++V  +G 
Sbjct: 40  LIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
           C     + II    +  TL   +  +    L   K  +I     +G+ YLH    K I+H
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 608 RDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVSTAVKGSFGYLDPEYLTKQQL- 663
           +D+KS N+  D      + DFGL  I        +        G   +L PE + +    
Sbjct: 154 KDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 664 --------TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNL--VEWAMKCQETGQLEDI 713
                   ++ SDV++ G + +E+           P +      + W M    TG   ++
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAEAIIWQM---GTGMKPNL 263

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGE 773
               +  +I         +I   C A    +RP+   ++  LE   +L   +        
Sbjct: 264 SQIGMGKEIS--------DILLFCWAFEQEERPTFTKLMDMLE---KLP--KRNRRL--- 307

Query: 774 TSSPNNHSHSQ 784
            S P +   S 
Sbjct: 308 -SHPGHFWKSA 317

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  213 bits (545), Expect = 4e-63
 Identities = 74/312 (23%), Positives = 121/312 (38%), Gaps = 31/312 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           V+G G FG+  +   R+  + + +K       +    F  E++++    H +++  IG  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +   +  I EY++ GTL+  +  S      W +R+      A G+ YLH+     IIHR
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLD------------QTHVSTAVKGSFGYLDPE 656
           D+ S N L+ EN    VADFGL+++  D                     V G+  ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP 716
            +  +   EK DV+SFG+V+ EI+         LPR     +           +   +D 
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------NVRGFLDR 242

Query: 717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKGETSS 776
                  P+    F  I  +C       RPS   +   LE             P+ E   
Sbjct: 243 Y----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298

Query: 777 PNNHSHSQTGVS 788
                  + G S
Sbjct: 299 RGFWETYRRGES 310

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  198 bits (505), Expect = 3e-57
 Identities = 70/293 (23%), Positives = 114/293 (38%), Gaps = 35/293 (11%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC- 548
            IG G +G+V+ G  R E  VAVK   T          TEI      RH +++  I    
Sbjct: 44  QIGKGRYGEVWMGKWRGEK-VAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADI 101

Query: 549 ---DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT-----G 600
                  ++ +I +Y ENG+L D+L      +L  +  L++   +  GL +LHT      
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH--VSTAVKGSFGYLDPE-- 656
              AI HRD+KS NIL+ +N    +AD GL+                  G+  Y+ PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218

Query: 657 ----YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED 712
                    Q    +D+YSFG++++E+             +    + +          ED
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPYHDLVPSDPSYED 274

Query: 713 IVD--------PTLTGQIKPDS-LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
           + +        P+   +   D  L +  ++  +C A     R +   V   L 
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  196 bits (500), Expect = 6e-57
 Identities = 65/295 (22%), Positives = 114/295 (38%), Gaps = 39/295 (13%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEM--LSQFRHRHLVSLIGY 547
            +G G +G+V+RG  + E  VAVK     S +    +  E E+      RH +++  I  
Sbjct: 15  CVGKGRYGEVWRGSWQGEN-VAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 548 C----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT---- 599
                    ++ +I  Y E G+L D+L      +L     L I +  A GL +LH     
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 600 -GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV--STAVKGSFGYLDPE 656
                AI HRD+KS NIL+ +N    +AD GL+ +           +    G+  Y+ PE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 657 ------YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
                  +      ++ D+++FG+V++E+             +      +          
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK----PPFYDVVPNDPSF 243

Query: 711 EDIVD--------PTLTGQIKPDS-LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
           ED+          P +  +   D  L    ++ ++C  Q    R +   +   L 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  190 bits (485), Expect = 2e-54
 Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 29/290 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC- 548
            IG G FG+V+RG  R E  VAVK   ++  +       EI      RH +++  I    
Sbjct: 49  SIGKGRFGEVWRGKWRGEE-VAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 106

Query: 549 ---DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK-- 603
                  ++ ++ +Y E+G+L D+L   N  +++    +++ +  A GL +LH       
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 604 ---AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH--VSTAVKGSFGYLDPEYL 658
              AI HRD+KS NIL+ +N    +AD GL+        T         G+  Y+ PE L
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223

Query: 659 ------TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED 712
                    +  +++D+Y+ G+V +EI   R  I       ++   +         ++  
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 282

Query: 713 IVD-----PTLTGQIKPDS-LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
           +V      P +  + +    L    +I  +C    G  R +   +   L 
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  173 bits (440), Expect = 9e-48
 Identities = 77/271 (28%), Positives = 126/271 (46%), Gaps = 25/271 (9%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            IG G FG+V+ G LR D T VAVK  R         A+F  E  +L Q+ H ++V LIG
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
            C ++  + I+ E ++ G     L  +    L  +  L++   AA G+ YL    +K  I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HRD+ + N L+ E  + K++DFG+S+   D          +    +  PE L   + + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 667 SDVYSFGVVMFEIL-CGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPD 725
           SDV+SFG++++E    G        P   ++  +     ++ G+L     P L     PD
Sbjct: 296 SDVWSFGILLWETFSLGA------SPYPNLSNQQTREFVEKGGRLP---CPELC----PD 342

Query: 726 SLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
           ++     + E+C A     RPS   +   L+
Sbjct: 343 AV---FRLMEQCWAYEPGQRPSFSTIYQELQ 370

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  170 bits (432), Expect = 9e-48
 Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 26/201 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FG+V+ G     TKVAVK  + G+ S      F  E  ++ Q +H+ LV L   
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAV 76

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             +    II  EYMENG+L D L   +   L+  K L++    A G+ ++     +  IH
Sbjct: 77  VTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS--------TAVKGSFGYLDPEYLT 659
           RD+++ANIL+ + L  K+ADFGL+++  D + T           TA         PE + 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA---------PEAIN 183

Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
               T KSDV+SFG+++ EI+
Sbjct: 184 YGTFTIKSDVWSFGILLTEIV 204

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  173 bits (441), Expect = 3e-47
 Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 10/193 (5%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L   
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 247

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             E    I+  EYM  G+L D L       L   + +++    A G+ Y+        +H
Sbjct: 248 VSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+++ANIL+ ENL+ KVADFGL+++  D ++       K    +  PE     + T KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 668 DVYSFGVVMFEIL 680
           DV+SFG+++ E+ 
Sbjct: 363 DVWSFGILLTELT 375

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  166 bits (424), Expect = 8e-47
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 26/201 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FG V  G  + +  VAVK  + G+ S     EF  E + + +  H  LV   G 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
           C +   + I+ EY+ NG L ++L  S+   L   + LE+C     G+ +L    +   IH
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS--------TAVKGSFGYLDPEYLT 659
           RD+ + N L+D +L  KV+DFG+++   D               +A         PE   
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA---------PEVFH 178

Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
             + + KSDV++FG++M+E+ 
Sbjct: 179 YFKYSSKSDVWAFGILMWEVF 199

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  173 bits (440), Expect = 2e-46
 Identities = 63/193 (32%), Positives = 100/193 (51%), Gaps = 10/193 (5%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FG+V+ G     T+VA+K  + GT S +    F  E +++ + RH  LV L   
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 330

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             E    I+  EYM  G+L D L       L   + +++    A G+ Y+        +H
Sbjct: 331 VSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+++ANIL+ ENL+ KVADFGL+++  D ++       K    +  PE     + T KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 668 DVYSFGVVMFEIL 680
           DV+SFG+++ E+ 
Sbjct: 446 DVWSFGILLTELT 458

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  165 bits (420), Expect = 3e-46
 Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 26/201 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            IG G FG V+ G   ++ KVA+K  R G  S +   +F  E E++ +  H  LV L G 
Sbjct: 15  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGV 71

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
           C E+  + ++ E+ME+G L D+L  +     +    L +C+    G+ YL       +IH
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS--------TAVKGSFGYLDPEYLT 659
           RD+ + N L+ EN + KV+DFG+++   D   T  +         +         PE  +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS---------PEVFS 178

Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
             + + KSDV+SFGV+M+E+ 
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVF 199

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  165 bits (421), Expect = 3e-46
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 26/201 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FG V  G  R +  VA+K  + G+ S     EF  E +++    H  LV L G 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGV 87

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
           C ++  + II EYM NG L ++L          ++ LE+C      + YL    +K  +H
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS--------TAVKGSFGYLDPEYLT 659
           RD+ + N L+++  + KV+DFGLS+   D + T           +          PE L 
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---------PEVLM 194

Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
             + + KSD+++FGV+M+EI 
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIY 215

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  170 bits (432), Expect = 1e-45
 Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 10/194 (5%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            +G G +G+VY GV +     VAVK  +  T   +   EF  E  ++ + +H +LV L+G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 283

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
            C       II E+M  G L D+L   N   +S    L +    +  + YL     K  I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HR++ + N L+ EN + KVADFGLS++    D        K    +  PE L   + + K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 667 SDVYSFGVVMFEIL 680
           SDV++FGV+++EI 
Sbjct: 400 SDVWAFGVLLWEIA 413

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  164 bits (418), Expect = 2e-45
 Identities = 66/198 (33%), Positives = 106/198 (53%), Gaps = 12/198 (6%)

Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           +IG G  G+V  G LR     +  VA+K  + G    Q   +F +E  ++ QF H +++ 
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNIIR 114

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G        +I+ EYMENG+L   L  ++    +  + + +  G   G+ YL   S  
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + N+L+D NL+ KV+DFGLS+ +  D D  + +T  K    +  PE +  + 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 663 LTEKSDVYSFGVVMFEIL 680
            +  SDV+SFGVVM+E+L
Sbjct: 231 FSSASDVWSFGVVMWEVL 248

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  164 bits (418), Expect = 2e-45
 Identities = 75/313 (23%), Positives = 122/313 (38%), Gaps = 34/313 (10%)

Query: 490 VIGIGGFGKVYRGVLR-----DETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +G G FG V               VAVK     G    +   +F+ EI++L       +
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFI 86

Query: 542 VSLIGYCDERNE--MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           V   G         + ++ EY+ +G L+D L   +   L   + L       +G+ YL  
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYL-- 143

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYL 658
             ++  +HRD+ + NIL++     K+ADFGL+K +  D D   V    +    +  PE L
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 659 TKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMKCQET-GQLEDIVD 715
           +    + +SDV+SFGVV++E+   C +     +     +               LE+   
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE--- 259

Query: 716 PTLTGQI--KPDSLNKFV-EIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKSSPKG 772
               GQ    P +    V E+ + C A    DRPS   +   L+    L           
Sbjct: 260 ----GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD---MLWSGSRGCETHA 312

Query: 773 ETSSPNNHSHSQT 785
            T+ P    HS +
Sbjct: 313 FTAHPEGKHHSLS 325

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  167 bits (425), Expect = 4e-45
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FG+V+       TKVAVK  + G+ S +    F  E  ++   +H  LV L   
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKLVKLHAV 251

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             +    II  E+M  G+L D L +         K ++     A G+ ++     +  IH
Sbjct: 252 VTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 608 RDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKS 667
           RD+++ANIL+  +L+ K+ADFGL+++  D ++       K    +  PE +     T KS
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAPEAINFGSFTIKS 366

Query: 668 DVYSFGVVMFEI--LCGRP 684
           DV+SFG+++ EI      P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  163 bits (416), Expect = 6e-45
 Identities = 51/198 (25%), Positives = 101/198 (51%), Gaps = 13/198 (6%)

Query: 490 VIGIGGFGKVYRGVLRD-----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           V+G G FG VY+G+        +  VA+K  R  T       E   E  +++   + H+ 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHVC 80

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C   + + +I + M  G L D++   +  ++  +  L  C+  A+G++YL     
Sbjct: 81  RLLGIC-LTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---ED 135

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    ++  E +  + 
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 663 LTEKSDVYSFGVVMFEIL 680
            T +SDV+S+GV ++E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  162 bits (412), Expect = 7e-45
 Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 10/194 (5%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            +G G +G+VY GV +     VAVK  +  T   +   EF  E  ++ + +H +LV L+G
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLG 76

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
            C       II E+M  G L D+L   N   +S    L +    +  + YL     K  I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HRD+ + N L+ EN + KVADFGLS++    D        K    +  PE L   + + K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

Query: 667 SDVYSFGVVMFEIL 680
           SDV++FGV+++EI 
Sbjct: 193 SDVWAFGVLLWEIA 206

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  162 bits (412), Expect = 9e-45
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG VY G   D      + A+K     T   Q +  F  E  ++    H ++++
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 544 LIGYCDERNEMI-IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           LIG       +  ++  YM +G L   + +    + + +  +   +  ARG+ YL   + 
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYL---AE 142

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL-----DPEY 657
           +  +HRD+ + N +LDE+   KVADFGL++   D+      +  +     L       E 
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWTALES 199

Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           L   + T KSDV+SFGV+++E+L
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELL 222

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  162 bits (412), Expect = 9e-45
 Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 17/229 (7%)

Query: 490 VIGIGGFGKVYRGVL-----RDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FGKV              +VAVK  +  +  +  +A+ + EIE+L    H ++V
Sbjct: 28  DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHENIV 86

Query: 543 SLIGYC--DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
              G C  D  N + +I E++ +G+LK++L   N   ++ +++L+  +   +G+ YL   
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL--- 142

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLT 659
            ++  +HRD+ + N+L++     K+ DFGL+K I  D +   V         +  PE L 
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202

Query: 660 KQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMKCQE 706
           + +    SDV+SFGV + E+   C       +L  + +      M    
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  164 bits (417), Expect = 1e-44
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 12/198 (6%)

Query: 490 VIGIGGFGKVYRGVL----RDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FG+V  G L    + E  VA+K  + G    Q   +F  E  ++ QF H +++ 
Sbjct: 52  VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNIIR 110

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L G   +   ++I+ EYMENG+L   L   +    +  + + +  G A G+ YL   S  
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL---SDM 166

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + NIL++ NL+ KV+DFGL + +  D +  + +   K    +  PE +  ++
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 663 LTEKSDVYSFGVVMFEIL 680
            T  SDV+S+G+V++E++
Sbjct: 227 FTSASDVWSYGIVLWEVM 244

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  162 bits (413), Expect = 1e-44
 Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 31/208 (14%)

Query: 490 VIGIGGFGKVYRGVLRD-----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           VIG G FG+VY+G+L+      E  VA+K  + G    Q   +F  E  ++ QF H +++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-RVDFLGEAGIMGQFSHHNII 109

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L G   +   M+II EYMENG L   L        S  + + +  G A G+ YL   + 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL---AN 165

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS----------TAVKGSFGY 652
              +HRD+ + NIL++ NL+ KV+DFGLS++  D  +   +          TA       
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA------- 218

Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEIL 680
             PE ++ ++ T  SDV+SFG+VM+E++
Sbjct: 219 --PEAISYRKFTSASDVWSFGIVMWEVM 244

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  161 bits (410), Expect = 1e-44
 Identities = 62/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG VY G L D    +   AVK     T     +++F TE  ++  F H +++S
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 544 LIGYC-DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           L+G C       +++  YM++G L++ +      + + +  +   +  A+G+ YL   ++
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYL---AS 146

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL-----DPEY 657
           K  +HRD+ + N +LDE    KVADFGL++   D+      +    +   L       E 
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           L  Q+ T KSDV+SFGV+++E++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELM 226

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  161 bits (409), Expect = 2e-44
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 490 VIGIGGFGKVYRGVLR---DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
            +G G FG V +G  +       VAVK  +          E   E  ++ Q  + ++V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG C+  + M+++ E  E G L  +L  +    +  +  +E+    + G+ YL       
Sbjct: 84  IGICEAESWMLVM-EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYL---EESN 137

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            +HRD+ + N+LL     AK++DFGLSK +  D +     T  K    +  PE +   + 
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 664 TEKSDVYSFGVVMFEIL 680
           + KSDV+SFGV+M+E  
Sbjct: 198 SSKSDVWSFGVLMWEAF 214

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  160 bits (408), Expect = 2e-44
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 489 LVIGIGGFGKVYRGVLR---DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           + +G G FG V +GV R    +  VA+K  + GT+      E   E +++ Q  + ++V 
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVR 74

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           LIG C     M+++ E    G L   L       +      E+    + G+ YL     K
Sbjct: 75  LIGVCQAEALMLVM-EMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL---EEK 129

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +HRD+ + N+LL     AK++DFGLSK +G D       +A K    +  PE +  ++
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189

Query: 663 LTEKSDVYSFGVVMFEIL 680
            + +SDV+S+GV M+E L
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  160 bits (408), Expect = 2e-44
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 30/201 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            IG G FG V  G  R   KVAVK  +    +      F  E  +++Q RH +LV L+G 
Sbjct: 28  TIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 82

Query: 548 C-DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             +E+  + I+ EYM  G+L D+L +     L     L+  +     + YL        +
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS-------TAVKGSFGYLDPEYLT 659
           HRD+ + N+L+ E+ +AKV+DFGL+K   +   T  +       TA         PE L 
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTA---------PEALR 187

Query: 660 KQQLTEKSDVYSFGVVMFEIL 680
           +++ + KSDV+SFG++++EI 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIY 208

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  160 bits (408), Expect = 2e-44
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 13/199 (6%)

Query: 490 VIGIGGFGKVYRGVLR----DETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FG V RG           VAVK          + + +F  E+  +    HR+L+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L G        ++  E    G+L D L   +             +  A G+ YL    +
Sbjct: 85  RLYGVVLTPPMKMVT-ELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL---ES 139

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
           K  IHRD+ + N+LL    + K+ DFGL + +  + D   +    K  F +  PE L  +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 662 QLTEKSDVYSFGVVMFEIL 680
             +  SD + FGV ++E+ 
Sbjct: 200 TFSHASDTWMFGVTLWEMF 218

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  158 bits (403), Expect = 9e-44
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
            IG G FG V++G+          VA+K  +  T       +F  E   + QF H H+V 
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVK 80

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           LIG   E    II+ E    G L+  L      SL     +      +  L YL    +K
Sbjct: 81  LIGVITENPVWIIM-ELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL---ESK 135

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF--GYLDPEYLTKQ 661
             +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE +  +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 662 QLTEKSDVYSFGVVMFEIL 680
           + T  SDV+ FGV M+EIL
Sbjct: 193 RFTSASDVWMFGVCMWEIL 211

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  161 bits (409), Expect = 1e-43
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G FG VY G L D    +   AVK     T     +++F TE  ++  F H +++S
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 544 LIGYC-DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           L+G C       +++  YM++G L++ +      + + +  +   +  A+G+ +L   ++
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFL---AS 210

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL-----DPEY 657
           K  +HRD+ + N +LDE    KVADFGL++   D+      +    +   L       E 
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALES 267

Query: 658 LTKQQLTEKSDVYSFGVVMFEIL 680
           L  Q+ T KSDV+SFGV+++E++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELM 290

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  158 bits (402), Expect = 2e-43
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 19/230 (8%)

Query: 490 VIGIGGFGKVYRGVLR-----DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FG V               VAVK  +  T+ H    +F  EIE+L   +H ++V
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIV 74

Query: 543 SLIGYC--DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
              G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLT 659
            TK  IHRD+ + NIL++     K+ DFGL+K +  D +   V    +    +  PE LT
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 660 KQQLTEKSDVYSFGVVMFEIL--CGRPVIDPSLPREKVNLV-EWAMKCQE 706
           + + +  SDV+SFGVV++E+     +    P+     +    +  M    
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  157 bits (400), Expect = 2e-43
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 17/199 (8%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G FG+VY GV  +    +  VAVK  +          +F +E  ++    H H+V 
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-KEKFMSEAVIMKNLDHPHIVK 77

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           LIG  +E    II+ E    G L  +L   N  SL     +   +   + + YL    + 
Sbjct: 78  LIGIIEEEPTWIIM-ELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYL---ESI 132

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF--GYLDPEYLTKQ 661
             +HRD+   NIL+      K+ DFGLS+    ++      A        ++ PE +  +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 662 QLTEKSDVYSFGVVMFEIL 680
           + T  SDV+ F V M+EIL
Sbjct: 190 RFTTASDVWMFAVCMWEIL 208

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  159 bits (403), Expect = 2e-43
 Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 29/212 (13%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G FG V    L+       KVAVK  +    +   + EF  E   + +F H H+  
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89

Query: 544 LIGYC------DERNEMIIIYEYMENGTLKDHLYAS----NFPSLSWRKRLEICIGAARG 593
           L+G              ++I  +M++G L   L AS    N  +L  +  +   +  A G
Sbjct: 90  LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           + YL   S++  IHRD+ + N +L E++   VADFGLS+    +         +G    L
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSG--DYYRQGCASKL 201

Query: 654 -----DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
                  E L     T  SDV++FGV M+EI+
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  162 bits (411), Expect = 3e-43
 Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 20/196 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            IG G FG V  G  R   KVAVK  +    +      F  E  +++Q RH +LV L+G 
Sbjct: 200 TIGKGEFGDVMLGDYRG-NKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGV 254

Query: 548 CDERNEMI-IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             E    + I+ EYM  G+L D+L +     L     L+  +     + YL        +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST--AVKGSFGYLDPEYLTKQQLT 664
           HRD+ + N+L+ E+ +AKV+DFGL+K   +   T  +    VK    +  PE L +++ +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVK----WTAPEALREKKFS 364

Query: 665 EKSDVYSFGVVMFEIL 680
            KSDV+SFG++++EI 
Sbjct: 365 TKSDVWSFGILLWEIY 380

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  157 bits (400), Expect = 5e-43
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 28/211 (13%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           ++G G FG V  G L+       KVAVK  +    S + + EF +E   +  F H +++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100

Query: 544 LIGYCDERN-----EMIIIYEYMENGTLKDHLYAS----NFPSLSWRKRLEICIGAARGL 594
           L+G C E +     + ++I  +M+ G L  +L  S        +  +  L+  +  A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL- 653
            YL   S +  +HRD+ + N +L +++   VADFGLSK    +         +G    + 
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYR--QGRIAKMP 212

Query: 654 ----DPEYLTKQQLTEKSDVYSFGVVMFEIL 680
                 E L  +  T KSDV++FGV M+EI 
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  158 bits (401), Expect = 6e-43
 Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 490 VIGIGGFGKVYRGVLRD-----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           V+G G FG VY+G+        +  VA+K  R  T       E   E  +++   + H+ 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-NKEILDEAYVMASVDNPHVC 80

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C      +I  + M  G L D++   +  ++  +  L  C+  A+G++YL     
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYL---ED 135

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    ++  E +  + 
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 663 LTEKSDVYSFGVVMFEIL 680
            T +SDV+S+GV ++E++
Sbjct: 196 YTHQSDVWSYGVTVWELM 213

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (400), Expect = 6e-43
 Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 19/230 (8%)

Query: 490 VIGIGGFGKVYRGVL-----RDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FG V               VAVK  +  T+ H    +F  EIE+L   +H ++V
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIV 105

Query: 543 SLIGYC--DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
              G C    R  + +I EY+  G+L+D+L   +   +   K L+      +G+ YL   
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLT 659
            TK  IHRD+ + NIL++     K+ DFGL+K +  D +   V    +    +  PE LT
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 660 KQQLTEKSDVYSFGVVMFEIL--CGRPVIDPSLPREKVNLVEWA-MKCQE 706
           + + +  SDV+SFGVV++E+     +    P+     +   +   M    
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  157 bits (399), Expect = 9e-43
 Identities = 49/198 (24%), Positives = 97/198 (48%), Gaps = 13/198 (6%)

Query: 490 VIGIGGFGKVYRGVLRD-----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           V+G G FG V++GV        +  V +K     +            +  +    H H+V
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-FQAVTDHMLAIGSLDHAHIV 78

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L+G C   +  ++  +Y+  G+L DH+   +  +L  +  L   +  A+G++YL     
Sbjct: 79  RLLGLCPGSSLQLVT-QYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYL---EE 133

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             ++HR++ + N+LL      +VADFG++ + P  D+  + +  K    ++  E +   +
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 663 LTEKSDVYSFGVVMFEIL 680
            T +SDV+S+GV ++E++
Sbjct: 194 YTHQSDVWSYGVTVWELM 211

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  155 bits (393), Expect = 3e-42
 Identities = 73/271 (26%), Positives = 115/271 (42%), Gaps = 40/271 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            IG G F  VY+G+  + T  VA    +    +      F+ E EML   +H ++V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 547 Y----CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
                   +  ++++ E M +GTLK   Y   F  +  +     C    +GL +LHT  T
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKT--YLKRFKVMKIKVLRSWCRQILKGLQFLHT-RT 149

Query: 603 KAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             IIHRD+K  NI +       K+ D GL+ +      +     V G+  ++ PE   ++
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKA-VIGTPEFMAPEMY-EE 204

Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ 721
           +  E  DVY+FG+ M E+        P           ++ +CQ   Q+   V    T  
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEY---P-----------YS-ECQNAAQIYRRV----TSG 245

Query: 722 IKPDSLNK-----FVEIAEKCLAQCGIDRPS 747
           +KP S +K       EI E C+ Q   +R S
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  156 bits (396), Expect = 3e-42
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 37/215 (17%)

Query: 490 VIGIGGFGKVYRGVLRD---ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RHRHLVS 543
           VIG G FG+V +  ++        A+K  +    S     +F  E+E+L +   H ++++
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHL--------------YASNFPSLSWRKRLEICIG 589
           L+G C+ R  + +  EY  +G L D L                S   +LS ++ L     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
            ARG+ YL   S K  IHRD+ + NIL+ EN +AK+ADFGLS+     +       VK +
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQE-----VYVKKT 199

Query: 650 FGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
            G L       E L     T  SDV+S+GV+++EI
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  155 bits (394), Expect = 4e-42
 Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 19/229 (8%)

Query: 490 VIGIGGFGKVYRGVLRDETK-----VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G FGKV               VAVK  +         + ++ EI++L    H H++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-RSGWKQEIDILRTLYHEHII 96

Query: 543 SLIGYCDERNE--MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
              G C++     + ++ EY+  G+L+D+L      S+   + L        G+ YLH  
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA- 152

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLT 659
             +  IHRD+ + N+LLD + + K+ DFGL+K +    +   V         +  PE L 
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210

Query: 660 KQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMKCQE 706
           + +    SDV+SFGV ++E+   C      P+   E + + +  M    
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  154 bits (392), Expect = 9e-42
 Identities = 78/294 (26%), Positives = 116/294 (39%), Gaps = 49/294 (16%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +G G FG+VY G +          +VAVK             +F  E  ++S+F H+++
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLMEALIISKFNHQNI 95

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHL-----YASNFPSLSWRKRLEICIGAARGLHY 596
           V  IG   +     I+ E M  G LK  L       S   SL+    L +    A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 597 LHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L        IHRD+ + N LL       +AK+ DFG+++              KG    L
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGCAML 207

Query: 654 -----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMKCQE 706
                 PE   +   T K+D +SFGV+++EI  L   P   PS   ++V      ++   
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV------LEFVT 259

Query: 707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           +G   D   P       P  +     I  +C      DRP+   +L  +EY  Q
Sbjct: 260 SGGRMDP--PKNC----PGPVY---RIMTQCWQHQPEDRPNFAIILERIEYCTQ 304

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  152 bits (387), Expect = 1e-41
 Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 37/213 (17%)

Query: 490 VIGIGGFGKVYRGVLRD--------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHR 539
            +G G F K+++GV R+        ET+V +K      +++     F     M+S+  H+
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHK 72

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           HLV   G C   +E I++ E+++ G+L  +L   N   ++   +LE+    A  +H+L  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-- 129

Query: 600 GSTKAIIHRDVKSANILLD--------ENLMAKVADFGLSKIGPDLDQTHVS---TAVKG 648
                +IH +V + NILL              K++D G+S      D             
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP--- 185

Query: 649 SFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEIL 680
                 PE +   + L   +D +SFG  ++EI 
Sbjct: 186 ------PECIENPKNLNLATDKWSFGTTLWEIC 212

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  152 bits (386), Expect = 2e-41
 Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 38/224 (16%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +G   FGKVY+G L           VA+K  +          EFR E  + ++ +H ++
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNV 74

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHL--------------YASNFPSLSWRKRLEIC 587
           V L+G   +   + +I+ Y  +G L + L                +   +L     + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
              A G+ YL   S+  ++H+D+ + N+L+ + L  K++D GL +   ++          
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAA--DYYKL 186

Query: 648 GSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRP 684
                L      PE +   + +  SD++S+GVV++E+     +P
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  160 bits (405), Expect = 3e-41
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)

Query: 490 VIGIGGFGKVYRGVLRD----ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
            IG G FG V++G+          VA+K  +  T       +F  E   + QF H H+V 
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIVK 455

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           LIG   E    II+ E    G L+  L      SL     +      +  L YL    +K
Sbjct: 456 LIGVITENPVWIIM-ELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF--GYLDPEYLTKQ 661
             +HRD+ + N+L+  N   K+ DFGLS+    ++ +    A KG     ++ PE +  +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 662 QLTEKSDVYSFGVVMFEIL 680
           + T  SDV+ FGV M+EIL
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  152 bits (386), Expect = 4e-41
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 32/218 (14%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +G G FG VY GV +       ET+VA+K       S +   EF  E  ++ +F   H+
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHV 90

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHL--------YASNFPSLSWRKRLEICIGAARG 593
           V L+G   +    ++I E M  G LK +L                S  K +++    A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           + YL   +    +HRD+ + N ++ E+   K+ DFG+++   D+ +T      KG  G L
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYET--DYYRKGGKGLL 202

Query: 654 -----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRP 684
                 PE L     T  SDV+SFGVV++EI  L  +P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  158 bits (401), Expect = 6e-41
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 12/197 (6%)

Query: 490 VIGIGGFGKVYRGVLR---DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
            +G G FG V +GV R    +  VA+K  + GT+      E   E +++ Q  + ++V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-TEEMMREAQIMHQLDNPYIVRL 401

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG C     M+++ E    G L   L       +      E+    + G+ YL     K 
Sbjct: 402 IGVCQAEALMLVM-EMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            +HR++ + N+LL     AK++DFGLSK +G D       +A K    +  PE +  ++ 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 664 TEKSDVYSFGVVMFEIL 680
           + +SDV+S+GV M+E L
Sbjct: 517 SSRSDVWSYGVTMWEAL 533

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  152 bits (387), Expect = 1e-40
 Identities = 78/294 (26%), Positives = 116/294 (39%), Gaps = 49/294 (16%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +G G FG+VY G +          +VAVK             +F  E  ++S+F H+++
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLMEALIISKFNHQNI 136

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHL-----YASNFPSLSWRKRLEICIGAARGLHY 596
           V  IG   +     I+ E M  G LK  L       S   SL+    L +    A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 597 LHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L        IHRD+ + N LL       +AK+ DFG+++              KG    L
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAML 248

Query: 654 -----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNLVEWAMKCQE 706
                 PE   +   T K+D +SFGV+++EI  L   P   PS   ++V      ++   
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY--PSKSNQEV------LEFVT 300

Query: 707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           +G   D   P       P  +     I  +C      DRP+   +L  +EY  Q
Sbjct: 301 SGGRMDP--PKNC----PGPVY---RIMTQCWQHQPEDRPNFAIILERIEYCTQ 345

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  151 bits (383), Expect = 2e-40
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 38/223 (17%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +G G FGKV+     +      +  VAVK  +  ++S +   +F+ E E+L+  +H+H+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTMLQHQHI 105

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHL-------------YASNFPSLSWRKRLEICI 588
           V   G C E   +++++EYM +G L   L                    L   + L +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
             A G+ YL   +    +HRD+ + N L+ + L+ K+ DFG+S+     D         G
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VG 217

Query: 649 SFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRP 684
               L      PE +  ++ T +SDV+SFGVV++EI     +P
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  149 bits (378), Expect = 4e-40
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 44/225 (19%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +G G FGKV +            T VAVK  +    S   L +  +E  +L Q  H H+
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHV 88

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYAS----------------------NFPSLS 579
           + L G C +   +++I EY + G+L+  L  S                      +  +L+
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
               +      ++G+ YL   +   ++HRD+ + NIL+ E    K++DFGLS+   D+ +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR---DVYE 202

Query: 640 THVSTAVKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
                 VK S G +       E L     T +SDV+SFGV+++EI
Sbjct: 203 EDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  148 bits (377), Expect = 4e-40
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 39/223 (17%)

Query: 491 IGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +G G FGKV+     +      +  VAVK  +  T + +   +F+ E E+L+  +H H+V
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 80

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHL--------------YASNFPSLSWRKRLEICI 588
              G C + + +I+++EYM++G L   L                     L   + L I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
             A G+ YL   +++  +HRD+ + N L+  NL+ K+ DFG+S+     D         G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----VG 192

Query: 649 SFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRP 684
               L      PE +  ++ T +SDV+SFGV+++EI     +P
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  149 bits (378), Expect = 1e-39
 Identities = 79/309 (25%), Positives = 140/309 (45%), Gaps = 60/309 (19%)

Query: 490 VIGIGGFGKVYRGVLRD--------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RH 538
            +G G FG+V                  VAVK  +    + + L++  +E+EM+    +H
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKH 146

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS--------------NFPSLSWRKRL 584
           +++++L+G C +   + +I EY   G L+++L A                   ++++  +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
                 ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++     D  ++  
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 258

Query: 645 AVKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRPVIDPSLPREKVNL 697
             K + G L      PE L  +  T +SDV+SFGV+M+EI  L G P   P +P E++  
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PGIPVEEL-- 314

Query: 698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFV-EIAEKCLAQCGIDRPSMGDVLWNLE 756
                K  + G   D          KP +    +  +   C       RP+   ++ +L+
Sbjct: 315 ----FKLLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360

Query: 757 YALQLQGDE 765
             L L  +E
Sbjct: 361 RILTLTTNE 369

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  148 bits (375), Expect = 2e-39
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 39/220 (17%)

Query: 490 VIGIGGFGKVYRGVLRD--------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RH 538
            +G G FG+V                  VAVK  +    + + L++  +E+EM+    +H
Sbjct: 42  PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKH 100

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYAS--------------NFPSLSWRKRL 584
           +++++L+G C +   + +I EY   G L+++L A                   ++++  +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
                 ARG+ YL   +++  IHRD+ + N+L+ EN + K+ADFGL++     D  ++  
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212

Query: 645 AVKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
             K + G L      PE L  +  T +SDV+SFGV+M+EI
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  147 bits (374), Expect = 2e-39
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 35/216 (16%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
            +G G FGKV               KVAVK  +             +E++++S   +H +
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHEN 111

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHL------------YASNFPSLSWRKRLEICI 588
           +V+L+G C     +++I EY   G L + L            +A    + S R  L    
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
             A+G+ +L   ++K  IHRDV + N+LL    +AK+ DFGL++     D  + S  +  
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVK 223

Query: 649 SFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
               L      PE +     T +SDV+S+G++++EI
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  146 bits (371), Expect = 4e-39
 Identities = 54/220 (24%), Positives = 89/220 (40%), Gaps = 39/220 (17%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
            +G G FGKV                VAVK  +             +E+++LS    H +
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMN 88

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHL----------------YASNFPSLSWRKRL 584
           +V+L+G C      ++I EY   G L + L                   +  +L     L
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
                 A+G+ +L   ++K  IHRD+ + NILL    + K+ DFGL++   D+       
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYV 202

Query: 645 AVKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
                   L      PE +     T +SDV+S+G+ ++E+
Sbjct: 203 --VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  146 bits (370), Expect = 5e-39
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 38/219 (17%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
            +G G FG+V                VAVK  + G  +H       +E+++L     H +
Sbjct: 34  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLN 92

Query: 541 LVSLIGYC-DERNEMIIIYEYMENGTLKDHL--------------YASNFPSLSWRKRLE 585
           +V+L+G C      +++I E+ + G L  +L                     L+    + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
                A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++   D+ +      
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYKDPDYV- 205

Query: 646 VKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
            +     L      PE +  +  T +SDV+SFGV+++EI
Sbjct: 206 -RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  146 bits (371), Expect = 9e-39
 Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 44/225 (19%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
           V+G G FGKV               +VAVK  +             +E++M++Q   H +
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHEN 110

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHL---------------------YASNFPSLS 579
           +V+L+G C     + +I+EY   G L ++L                        +   L+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
           +   L      A+G+ +L     K+ +HRD+ + N+L+    + K+ DFGL++   D+  
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMS 224

Query: 640 THVSTAVKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
                 V      L      PE L +   T KSDV+S+G++++EI
Sbjct: 225 DSN--YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (369), Expect = 2e-38
 Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 38/280 (13%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHR 539
           + +     IG G FGK        D  +  +K       S +   E R E+ +L+  +H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           ++V      +E   + I+ +Y E G L   + A         + L+  +     L ++H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HVSTAVKGSFGYLDPEYL 658
              + I+HRD+KS NI L ++   ++ DFG++++   L+ T  ++ A  G+  YL PE  
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNSTVELARACIGTPYYLSPEIC 197

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL 718
             +    KSD+++ G V++E+   +         E  ++    +K         I+    
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH------AFEAGSMKNLVLK---------II---- 238

Query: 719 TGQIKP------DSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           +G   P        L   V    +   +   DRPS+  +L
Sbjct: 239 SGSFPPVSLHYSYDLRSLV---SQLFKRNPRDRPSVNSIL 275

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  144 bits (365), Expect = 4e-38
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 46/232 (19%)

Query: 490 VIGIGGFGKVYRGVLRD------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            IG G FG+V++            T VAVK  +    S    A+F+ E  ++++F + ++
Sbjct: 54  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNI 112

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYAS----------------------NFPSLS 579
           V L+G C     M +++EYM  G L + L +                         P LS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
             ++L I    A G+ YL   S +  +HRD+ + N L+ EN++ K+ADFGLS+   ++  
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR---NIYS 226

Query: 640 THVSTAVKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI--LCGRP 684
                        +      PE +   + T +SDV+++GVV++EI     +P
Sbjct: 227 A--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  145 bits (367), Expect = 6e-38
 Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 39/220 (17%)

Query: 490 VIGIGGFGKVYRGVLRD--------ETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RH 538
            +G G FG+V                TKVAVK  +    + + L++  +E+EM+    +H
Sbjct: 76  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKH 134

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--------------YASNFPSLSWRKRL 584
           +++++L+G C +   + +I EY   G L+++L                +    LS +  +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST 644
                 ARG+ YL   ++K  IHRD+ + N+L+ E+ + K+ADFGL++     D  H+  
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246

Query: 645 AVKGSFGYL-----DPEYLTKQQLTEKSDVYSFGVVMFEI 679
             K + G L      PE L  +  T +SDV+SFGV+++EI
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  143 bits (362), Expect = 1e-37
 Identities = 46/220 (20%), Positives = 93/220 (42%), Gaps = 32/220 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK-----------------RGGTQSHQGLAEFRTEIEM 532
            +  G F K+     +D    A+K                            +F+ E+++
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 533 LSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA-- 590
           ++  ++ + ++  G     +E+ IIYEYMEN ++            ++   + I +    
Sbjct: 97  ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 591 ----ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
                    Y+H  + K I HRDVK +NIL+D+N   K++DFG S+   D     +  + 
Sbjct: 157 IKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSR 211

Query: 647 KGSFGYLDPEYLTKQQLT--EKSDVYSFGVVMFEILCGRP 684
            G++ ++ PE+ + +      K D++S G+ ++ +     
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  140 bits (354), Expect = 3e-37
 Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 48/287 (16%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +F E  +IG GGFG+V++     D     +KR    +     +   E++ L++  H ++
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66

Query: 542 VSLIGYCDERNEMI----------------IIYEYMENGTLKDHLYASNFPSLSWRKRLE 585
           V   G  D  +                   I  E+ + GTL+  +       L     LE
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTA 645
           +     +G+ Y+H+   K +I+RD+K +NI L +    K+ DFGL      L      T 
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTR 180

Query: 646 VKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ 705
            KG+  Y+ PE ++ Q   ++ D+Y+ G+++ E+L            E            
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-----CDTAFETSKFFTDLRD-- 233

Query: 706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
             G + DI D      ++            K L++   DRP+  ++L
Sbjct: 234 --GIISDIFDKKEKTLLQ------------KLLSKKPEDRPNTSEIL 266

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (356), Expect = 4e-37
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G GGF  V     L D    A+KR      Q   E + E +M   F H +++ L+ YC
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 549 ----DERNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGST 602
                 ++E  ++  + + GTL + +         L+  + L + +G  RGL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGP-------DLDQTHVSTAVKGSFGYLDP 655
           K   HRD+K  NILL +     + D G                      A + +  Y  P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 656 EYLTKQQ---LTEKSDVYSFGVVMFEILCGRP 684
           E  + Q    + E++DV+S G V++ ++ G  
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  139 bits (353), Expect = 1e-36
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 22/210 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKR--GGTQSHQGLAEFRTEIEMLSQFRH--RHLVSLI 545
            IG GG  KV++ +   +   A+K        +Q L  +R EI  L++ +     ++ L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
            Y      + ++ E   N  L   L      S+   +R          +H +H      I
Sbjct: 95  DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT------ 659
           +H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE +       
Sbjct: 149 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 660 -----KQQLTEKSDVYSFGVVMFEILCGRP 684
                K +++ KSDV+S G +++ +  G+ 
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  139 bits (352), Expect = 1e-36
 Identities = 62/279 (22%), Positives = 115/279 (41%), Gaps = 30/279 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFRH 538
            NF     IG G F +VYR   L D   VA+K+         +  A+   EI++L Q  H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLHY 596
            +++       E NE+ I+ E  + G L   +  +      +  R   +  +     L +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VSTAVKGSFGYLDP 655
           +H+   + ++HRD+K AN+ +    + K+ D GL +           + ++ G+  Y+ P
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSP 205

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLP--REKVNLVEWAMKCQETGQLEDI 713
           E + +     KSD++S G +++E+   +       P   +K+NL     K +     +  
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQS------PFYGDKMNLYSLCKKIE-----QCD 254

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
             P  +     + L + V     C+      RP +  V 
Sbjct: 255 YPPLPSDHYSEE-LRQLV---NMCINPDPEKRPDVTYVY 289

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  138 bits (349), Expect = 2e-36
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 34/240 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIG 546
           +G GG   VY         KVA+K      +  +  L  F  E+   SQ  H+++VS+I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             +E +   ++ EY+E  TL +++  S+ P LS    +        G+ + H      I+
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI-ESHGP-LSVDTAINFTNQILDGIKHAHD---MRIV 133

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HRD+K  NIL+D N   K+ DFG++K   +   T  +  + G+  Y  PE    +   E 
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATDEC 192

Query: 667 SDVYSFGVVMFEILCGRP------------------------VIDPSLPREKVNLVEWAM 702
           +D+YS G+V++E+L G P                         +   +P+   N++  A 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  137 bits (348), Expect = 2e-36
 Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 35/283 (12%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHR 539
           +++     IG G +G+  +     D   +  K    G+ +        +E+ +L + +H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 540 HLVSLIG-YCDERNEMIIIY-EYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLH 595
           ++V       D  N  + I  EY E G L   +         L     L +       L 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 596 YLHT--GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HVSTAVKGSFGY 652
             H        ++HRD+K AN+ LD     K+ DFGL++I   L+     +    G+  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---LNHDTSFAKTFVGTPYY 182

Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED 712
           + PE + +    EKSD++S G +++E+    P      P    +  E A K +E      
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMP------PFTAFSQKELAGKIRE------ 230

Query: 713 IVDPTLTGQIKPDSL---NKFVEIAEKCLAQCGIDRPSMGDVL 752
                  G+ +       ++  EI  + L      RPS+ ++L
Sbjct: 231 -------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 266

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  138 bits (350), Expect = 5e-36
 Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 22/210 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKR--GGTQSHQGLAEFRTEIEMLSQFRH--RHLVSLI 545
            IG GG  KV++ +   +   A+K        +Q L  +R EI  L++ +     ++ L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
            Y      + ++ E   N  L   L      S+   +R          +H +H      I
Sbjct: 76  DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL------- 658
           +H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE +       
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 659 ----TKQQLTEKSDVYSFGVVMFEILCGRP 684
               +K +++ KSDV+S G +++ +  G+ 
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  137 bits (347), Expect = 5e-36
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 40/232 (17%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
             +F E  V+G G FG+V +     D    A+K+    + + L+   +E+ +L+   H++
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQY 63

Query: 541 LVSLIG-YCDERNEMI------------IIYEYMENGTLKDHLYASNFPS---LSWRKRL 584
           +V     + + RN +             I  EY ENGTL D +++ N        WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI----------- 633
           +I       L Y+H+   + IIHRD+K  NI +DE+   K+ DFGL+K            
Sbjct: 124 QIL----EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 634 --GPDLDQTHVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCG 682
                    ++++A+ G+  Y+  E L       EK D+YS G++ FE++  
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  138 bits (349), Expect = 2e-35
 Identities = 51/217 (23%), Positives = 92/217 (42%), Gaps = 36/217 (16%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKR--GGTQSHQGLAEFRTEIEMLSQFRH--RHLVSLI 545
            IG GG  KV++ +   +   A+K        +Q L  +R EI  L++ +     ++ L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLS-------WRKRLEICIGAARGLHYLH 598
            Y      + ++ E   N  L   L      S+        W+  LE        +H +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLE-------AVHTIH 172

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
                 I+H D+K AN L+ +  M K+ DFG++        + V  +  G+  Y+ PE +
Sbjct: 173 ---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 659 -----------TKQQLTEKSDVYSFGVVMFEILCGRP 684
                      +K +++ KSDV+S G +++ +  G+ 
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  134 bits (340), Expect = 3e-35
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G GGF K +       +   A K   +          +   EI +     H+H+V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL-EICIGAAR--------GLHYL 597
           + ++ + + ++ E     +L +            RK L E     AR        G  YL
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEP---EARYYLRQIVLGCQYL 131

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPE 656
           H      +IHRD+K  N+ L+E+L  K+ DFGL+ K+  D ++  V     G+  Y+ PE
Sbjct: 132 HR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE 185

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            L+K+  + + DV+S G +M+ +L G+P
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  135 bits (341), Expect = 3e-35
 Identities = 48/209 (22%), Positives = 83/209 (39%), Gaps = 19/209 (9%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQ-FRH 538
            +F     +G G +G+V++     D    AVK      +  +  A    E+    +  +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFP-SLSWRKRLEICIGAARGLH 595
              V L    +E   + +  E     +L+ H   + ++ P +  W    +        L 
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTL----LALA 171

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           +LH+   + ++H DVK ANI L      K+ DFGL      L         +G   Y+ P
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE---LGTAGAGEVQEGDPRYMAP 225

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           E L +      +DV+S G+ + E+ C   
Sbjct: 226 ELL-QGSYGTAADVFSLGLTILEVACNME 253

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  135 bits (341), Expect = 6e-35
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G GGF K +       +   A K   +          +   EI +     H+H+V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL-EICIGAAR--------GLHYL 597
           + ++ + + ++ E     +L +            RK L E     AR        G  YL
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEP---EARYYLRQIVLGCQYL 157

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSFGYLDPE 656
           H      +IHRD+K  N+ L+E+L  K+ DFGL+ K+  D ++  V     G+  Y+ PE
Sbjct: 158 HR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE 211

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            L+K+  + + DV+S G +M+ +L G+P
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKP 239

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  133 bits (336), Expect = 2e-34
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 37/244 (15%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIG 546
           +G GG  +V+    LRD   VAVK  R            FR E +  +   H  +V++  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 547 YCDERNEMIIIY----EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
             +       +     EY++  TL+D +  +  P ++ ++ +E+   A + L++ H    
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGP-MTPKRAIEVIADACQALNFSHQ--- 134

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVST-AVKGSFGYLDPEYLTKQ 661
             IIHRDVK ANI++      KV DFG+++   D   +   T AV G+  YL PE     
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194

Query: 662 QLTEKSDVYSFGVVMFEILCGRP-----------------------VIDPSLPREKVNLV 698
            +  +SDVYS G V++E+L G P                            L  +   +V
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVV 254

Query: 699 EWAM 702
             A+
Sbjct: 255 LKAL 258

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  132 bits (335), Expect = 2e-34
 Identities = 51/241 (21%), Positives = 89/241 (36%), Gaps = 36/241 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETK---VAVK--RGGTQSHQGLAE-FRTEIEMLSQFRHRHLVS 543
           ++G GG G VY     D  +   VA+K       S        + E     + +  H+V 
Sbjct: 41  LVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           +  + +   ++ +    +    L   L     P L+  + + I       L   H     
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML-RRQGP-LAPPRAVAIVRQIGSALDAAHA---A 153

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
              HRDVK  NIL+  +  A + DFG++    D   T +   V G+  Y+ PE  ++   
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHA 212

Query: 664 TEKSDVYSFGVVMFEILCGRP----------------------VIDPSLPREKVNLVEWA 701
           T ++D+Y+   V++E L G P                       + P +P     ++   
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARG 272

Query: 702 M 702
           M
Sbjct: 273 M 273

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  132 bits (333), Expect = 3e-34
 Identities = 62/298 (20%), Positives = 108/298 (36%), Gaps = 52/298 (17%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRH 540
            +F     +G GGFG V+      D+   A+KR           +   E++ L++  H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 541 LVSLIGYCDERNEMI------------IIYEYMENGTLKDHLYASN-FPSLSWRKRLEIC 587
           +V       E+N               I  +      LKD +              L I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI----------GPDL 637
           +  A  + +LH+   K ++HRD+K +NI    + + KV DFGL                +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNL 697
                 T   G+  Y+ PE +     + K D++S G+++FE+L   P    S   E+V  
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--P---FSTQMERVRT 236

Query: 698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAE---KCLAQCGIDRPSMGDVL 752
                       L D+ +     +  P    K+          L+   ++RP   +++
Sbjct: 237 ------------LTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  130 bits (328), Expect = 1e-33
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 18/204 (8%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           V+G G +G VY G  L ++ ++A+K    +  +       EI +    +H+++V  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA-----ARGLHYLHTGSTK 603
            E   + I  E +  G+L   L  S +  L   K  E  IG        GL YLH     
Sbjct: 89  SENGFIKIFMEQVPGGSLSA-LLRSKWGPL---KDNEQTIGFYTKQILEGLKYLH---DN 141

Query: 604 AIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
            I+HRD+K  N+L++  + + K++DFG SK    ++    +    G+  Y+ PE + K  
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGP 199

Query: 663 L--TEKSDVYSFGVVMFEILCGRP 684
               + +D++S G  + E+  G+P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP 223

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  129 bits (327), Expect = 1e-33
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 27/206 (13%)

Query: 490 VIGIGGFGKVYRGVLRDETK--VAVK-------RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
            +G G FG VY    + ++K  +A+K             HQ     R E+E+ S  RH +
Sbjct: 16  PLGKGKFGNVYLAREK-QSKFILALKVLFKAQLEKAGVEHQ----LRREVEIQSHLRHPN 70

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FP-SLSWRKRLEICIGAARGLHYLH 598
           ++ L GY  +   + +I EY   GT+   L   + F    +     E+       L Y H
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA----NALSYCH 126

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +   K +IHRD+K  N+LL      K+ADFG S   P   +T       G+  YL PE +
Sbjct: 127 S---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLC-GTLDYLPPEMI 179

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             +   EK D++S GV+ +E L G+P
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGKP 205

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  129 bits (327), Expect = 3e-33
 Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 23/212 (10%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGY 547
           ++G G    V+RG  +      A+K     S     +    E E+L +  H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 548 CDERN--EMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
            +E      ++I E+   G+L   L   SN   L   + L +      G+++L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 605 IIHRDVKSANILL----DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           I+HR++K  NI+     D   + K+ DFG ++    L+      ++ G+  YL P+   +
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189

Query: 661 QQL--------TEKSDVYSFGVVMFEILCGRP 684
             L            D++S GV  +    G  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  128 bits (324), Expect = 3e-33
 Identities = 60/206 (29%), Positives = 90/206 (43%), Gaps = 27/206 (13%)

Query: 490 VIGIGGFGKVYRGVLRDETK--VAVK-------RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
            +G G FG VY    + + K  +A+K             HQ     R EIE+ S  RH +
Sbjct: 21  PLGKGKFGNVYLAREK-QNKFIMALKVLFKSQLEKEGVEHQ----LRREIEIQSHLRHPN 75

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FP-SLSWRKRLEICIGAARGLHYLH 598
           ++ +  Y  +R  + ++ E+   G L   L     F    S     E+    A  LHY H
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL----ADALHYCH 131

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
               + +IHRD+K  N+L+      K+ADFG S   P   +        G+  YL PE +
Sbjct: 132 E---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMC---GTLDYLPPEMI 184

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             +   EK D++  GV+ +E L G P
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMP 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  127 bits (322), Expect = 6e-33
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G G F  VYR   +    +VA+K   +        +   + E+++  Q +H  ++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGA------ARGLHYLHTG 600
           Y ++ N + ++ E   NG +  +L           K                G+ YLH+ 
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNR-------VKPFSENEARHFMHQIITGMLYLHS- 130

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
               I+HRD+  +N+LL  N+  K+ADFGL+       + H +    G+  Y+ PE  T+
Sbjct: 131 --HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIATR 186

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
                +SDV+S G + + +L GRP
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRP 210

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (323), Expect = 4e-32
 Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 23/212 (10%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGY 547
           ++G G    V+RG  +      A+K     S     +    E E+L +  H+++V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 548 CDERN--EMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
            +E      ++I E+   G+L   L   SN   L   + L +      G+++L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 605 IIHRDVKSANILL----DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
           I+HR++K  NI+     D   + K+ DFG ++    L+      ++ G+  YL P+   +
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---LEDDEQFVSLYGTEEYLHPDMYER 189

Query: 661 QQL--------TEKSDVYSFGVVMFEILCGRP 684
             L            D++S GV  +    G  
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  128 bits (324), Expect = 6e-32
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 19/206 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYC 548
           V+G G  G +    + D   VAVKR   +          E+++L +   H +++      
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVIRYFCTE 87

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
            +R    I  E     TL++++   +F +    + + +      GL +LH   +  I+HR
Sbjct: 88  KDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---SLNIVHR 142

Query: 609 DVKSANILLDE-----NLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYL---T 659
           D+K  NIL+        + A ++DFGL K +          + V G+ G++ PE L    
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202

Query: 660 KQQLTEKSDVYSFGVVMFEILC-GRP 684
           K+  T   D++S G V + ++  G  
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSH 228

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (318), Expect = 1e-31
 Identities = 40/234 (17%), Positives = 74/234 (31%), Gaps = 29/234 (12%)

Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDET------KVAVKRGGTQSHQGLAEF- 526
           P    Q  +       ++G G F +VY     D        K  +K    Q      EF 
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK---VQKPANPWEFY 112

Query: 527 --RTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL---YASNFPSLSWR 581
                +E L        +        +N  +++ E    GTL + +     +    +   
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL-----------DENLMAKVADFGL 630
             +   +     +  +H      IIH D+K  N +L           D +    + D G 
Sbjct: 173 LVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           S       +  + TA   + G+   E L+ +    + D +     ++ +L G  
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (328), Expect = 2e-31
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGY 547
            +G GGFG V R + +D   +VA+K+   +      E +  EI+++ +  H ++VS    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 548 CDERNEM------IIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTG 600
            D   ++      ++  EY E G L+ +L    N   L       +    +  L YLH  
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 601 STKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
               IIHRD+K  NI+L    + L+ K+ D G +K    LDQ  + T   G+  YL PE 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGELCTEFVGTLQYLAPEL 194

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L +++ T   D +SFG + FE + G  
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFR 221

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  124 bits (312), Expect = 4e-31
 Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 15/199 (7%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
           +G G FG+V+R    +   + AVK+   +  +       E+   +      +V L G   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 120

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
           E   + I  E +E G+L   +       L   + L     A  GL YLH   T+ I+H D
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGD 175

Query: 610 VKSANILLDEN-LMAKVADFGLSKIGPDLDQTHVSTA---VKGSFGYLDPEYLTKQQLTE 665
           VK+ N+LL  +   A + DFG +                 + G+  ++ PE +  +    
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235

Query: 666 KSDVYSFGVVMFEILCGRP 684
           K D++S   +M  +L G  
Sbjct: 236 KVDIWSSCCMMLHMLNGCH 254

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  124 bits (312), Expect = 6e-31
 Identities = 29/300 (9%), Positives = 64/300 (21%), Gaps = 54/300 (18%)

Query: 490 VIGIGGFGKVYRGVLRDE-TKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
            + +G    V+     +     A+K    G   S   L          ++          
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 546 GYC--------------------------DERNEMIIIYEYMENGTLKD-----HLYASN 574
                                              +++        L+            
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187

Query: 575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG 634
                      +     R    L +   K ++H      N+ +  +    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 635 PDLDQTHVSTAVKGSFGYLDPEYLT--KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR 692
                            Y   E+L       T   + +  G+ ++ + C         P 
Sbjct: 245 GTRGPASSVPV-----TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 693 EKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            K +    +++   T  L       L     PD +   +    + L      R    + +
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPL-----PDFVKTLI---GRFLNFDRRRRLLPLEAM 351

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  127 bits (321), Expect = 1e-30
 Identities = 44/237 (18%), Positives = 82/237 (34%), Gaps = 42/237 (17%)

Query: 490 VIGIGGFGKVYRGVLRDET----KVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
            I  GG G +Y     D       V +K     +   +  A    E + L++  H  +V 
Sbjct: 87  CIAHGGLGWIYLA--LDRNVNGRPVVLKGLVH-SGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 544 L--IGYCDERNEMIIIY---EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
           +       +R+   + Y   EY+   +LK          L   + +   +     L YLH
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH 199

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     +++ D+K  NI+L E    K+ D G       ++       + G+ G+  PE +
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS---RINSF---GYLYGTPGFQAPE-I 248

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP-------------VIDPSLPREKVNLVEWAM 702
            +   T  +D+Y+ G  +  +    P                         L+  A+
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAI 305

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  120 bits (304), Expect = 3e-30
 Identities = 52/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           V+G G F +V+    R      A+K          +    EI +L + +H ++V+L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           +      ++ + +  G L D +        + +    +       + YLH      I+HR
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHE---NGIVHR 130

Query: 609 DVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           D+K  N+L    +EN    + DFGLSK+        +STA  G+ GY+ PE L ++  ++
Sbjct: 131 DLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTAC-GTPGYVAPEVLAQKPYSK 186

Query: 666 KSDVYSFGVVMFEILCGRP 684
             D +S GV+ + +LCG P
Sbjct: 187 AVDCWSIGVITYILLCGYP 205

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  124 bits (313), Expect = 3e-30
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 20/222 (9%)

Query: 474 PFVAIQEATDNFSESL----VIGIGGFGKVYRGVLR-DETKVAVK---RGGTQSHQGLAE 525
           P + +Q +T  FS+      V+G G FG+V     +    + AVK   +   +       
Sbjct: 13  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES 72

Query: 526 FRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE 585
              E+++L Q  H +++ L  + +++    ++ E    G L D + +      S      
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAAR 130

Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHV 642
           I      G+ Y+H      I+HRD+K  N+LL    ++   ++ DFGLS      + +  
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKK 184

Query: 643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                G+  Y+ PE L      EK DV+S GV+++ +L G P
Sbjct: 185 MKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCP 225

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  119 bits (300), Expect = 5e-30
 Identities = 59/297 (19%), Positives = 104/297 (35%), Gaps = 54/297 (18%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR--GGTQSHQGLAEFRTEIEMLSQ-FR 537
           T  F E   IG G FG V++ V   D    A+KR                E+   +   +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLH 595
           H H+V       E + M+I  EY   G+L D +             +  ++ +   RGL 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 596 YLHTGSTKAIIHRDVKSANILLDEN-------------------LMAKVADFGLSKIGPD 636
           Y+H+    +++H D+K +NI +                      +M K+ D G       
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182

Query: 637 LDQTHVSTAVKGSFGYLDPEYLT-KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV 695
             +       +G   +L  E L        K+D+++  + +       P     LPR   
Sbjct: 183 --RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-----LPR--- 232

Query: 696 NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           N  +W    Q  G+L     P +   +  +   + +   +  +      RPS   ++
Sbjct: 233 NGDQWHEIRQ--GRL-----PRIPQVLSQE-FTELL---KVMIHPDPERRPSAMALV 278

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (307), Expect = 6e-30
 Identities = 31/237 (13%), Positives = 65/237 (27%), Gaps = 48/237 (20%)

Query: 490 VIGIGGFGKVYRGVLRDET---KVAVK---RGGTQSHQGLAEFRTEIEMLSQFR------ 537
           V+G             D+       V             + + + E+  L   R      
Sbjct: 85  VLGQEDPYAYLEA--TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 538 ----------------HRHLVSLIGYCDERNEMIIIYEYM----ENGTLKDHL-----YA 572
                                 +I    +  +M ++  +         L+        ++
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 573 SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK 632
           S   SL    RL++ +   R L  LH      ++H  ++  +I+LD+     +  F    
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ-----LTEKSDVYSFGVVMFEILCGRP 684
                  + +               L   Q     +T   D ++ G+ ++ I C   
Sbjct: 260 RDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  121 bits (306), Expect = 1e-29
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 24/210 (11%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK--------RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
            +G G  G+V     R    KVA++         G  +         TEIE+L +  H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           ++ +  + D  +   I+ E ME G L D +  +    L               + YLH  
Sbjct: 202 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLH-- 256

Query: 601 STKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
               IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   + G+  YL PE 
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 312

Query: 658 LTKQQL---TEKSDVYSFGVVMFEILCGRP 684
           L            D +S GV++F  L G P
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYP 342

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (309), Expect = 1e-29
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 26/212 (12%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVK-------------RGGTQSHQGLAEFRTEIEMLSQ 535
            +G G +G+V     +   ++ A+K                    +   E   EI +L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
             H +++ L    +++    ++ E+ E G L + +   +           I      G+ 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGIC 160

Query: 596 YLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
           YLH      I+HRD+K  NILL   +  L  K+ DFGLS       + +      G+  Y
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYY 214

Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           + PE L K++  EK DV+S GV+M+ +LCG P
Sbjct: 215 IAPEVL-KKKYNEKCDVWSCGVIMYILLCGYP 245

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  122 bits (308), Expect = 1e-29
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 19/221 (8%)

Query: 474 PFVAIQEATDNFSESL----VIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEF 526
           P + I     + SE       +G G +G+V     +    + A+K       S    ++ 
Sbjct: 24  PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKL 83

Query: 527 RTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEI 586
             E+ +L    H +++ L  + +++    ++ E  + G L D +        +      I
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVI 141

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVS 643
                 G+ YLH      I+HRD+K  N+LL   +++ + K+ DFGLS +    +     
Sbjct: 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKM 195

Query: 644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
               G+  Y+ PE L +++  EK DV+S GV++F +L G P
Sbjct: 196 KERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYP 235

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (298), Expect = 3e-29
 Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 45/296 (15%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G  G V++   +    V A K            +   E+++L +    ++V   G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 548 CDERNEMIIIYEYMENGTLKDHL-YASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
                E+ I  E+M+ G+L   L  A   P     K   + I   +GL YL       I+
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYLR--EKHKIM 154

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HRDVK +NIL++     K+ DFG+S     L  +  ++ V G+  Y+ PE L     + +
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANSFV-GTRSYMSPERLQGTHYSVQ 210

Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG------------------ 708
           SD++S G+ + E+  GR  I P   +E   +    ++                       
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270

Query: 709 ---------QLEDIVD---PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                     L+ IV+   P L   +       FV    KCL +   +R  +  ++
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV---NKCLIKNPAERADLKQLM 323

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (297), Expect = 4e-29
 Identities = 45/218 (20%), Positives = 82/218 (37%), Gaps = 24/218 (11%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGY 547
           V+  GGF  VY    +    + A+KR  +   +       E+  + +   H ++V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 548 C-------DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHT 599
                   D      ++   +  G L + L    +   LS    L+I     R + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI---GPDLDQTHVSTAVK-------GS 649
                IIHRD+K  N+LL      K+ DFG +      PD   +    A+         +
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 650 FGYLDPE---YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             Y  PE     +   + EK D+++ G +++ +   + 
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  116 bits (293), Expect = 4e-29
 Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 13/199 (6%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            IG G +G+V   V +    + A K+      + +  F+ EIE++    H +++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           ++  ++ ++ E    G L + +               I       + Y H      + HR
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---KLNVAHR 130

Query: 609 DVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           D+K  N L      +   K+ DFGL+          +     G+  Y+ P+ L +     
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVL-EGLYGP 186

Query: 666 KSDVYSFGVVMFEILCGRP 684
           + D +S GV+M+ +LCG P
Sbjct: 187 ECDEWSAGVMMYVLLCGYP 205

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (301), Expect = 5e-29
 Identities = 57/225 (25%), Positives = 91/225 (40%), Gaps = 38/225 (16%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYC 548
           ++G G  G V          VAVKR              EI++L++   H +++      
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNVIRYYCSE 78

Query: 549 DERNEMIIIYEYMENGTLKD-----HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
                + I  E      L+D     ++   N         + +    A G+ +LH   + 
Sbjct: 79  TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134

Query: 604 AIIHRDVKSANILLD-------------ENLMAKVADFGLSKI---GPDLDQTHVSTAVK 647
            IIHRD+K  NIL+              ENL   ++DFGL K    G    +T+++    
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS- 193

Query: 648 GSFGYLDPEYL-------TKQQLTEKSDVYSFGVVMFEILC-GRP 684
           G+ G+  PE L       TK++LT   D++S G V + IL  G+ 
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  117 bits (295), Expect = 6e-29
 Identities = 62/211 (29%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 490 VIGIGGFGKVYRGVLRDET--KVAVK--------RGGTQSHQGLAEFRTEIEMLSQFRHR 539
            +G G  G+V     R +T  KVA+K         G  +         TEIE+L +  H 
Sbjct: 17  TLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
            ++ +  + D  +   I+ E ME G L D +  +    L               + YLH 
Sbjct: 76  CIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH- 131

Query: 600 GSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
                IIHRD+K  N+LL   +E+ + K+ DFG SKI   L +T +   + G+  YL PE
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186

Query: 657 YLT---KQQLTEKSDVYSFGVVMFEILCGRP 684
            L            D +S GV++F  L G P
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  118 bits (298), Expect = 6e-29
 Identities = 47/198 (23%), Positives = 93/198 (46%), Gaps = 10/198 (5%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G G FG V+R V +        K   T         + EI +++Q  H  L++L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           +++ EM++I E++  G L D + A ++  +S  + +     A  GL ++H     +I+H 
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH---EHSIVHL 173

Query: 609 DVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           D+K  NI+    +    K+ DFGL+     L+   +      +  +  PE + ++ +   
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPVGFY 230

Query: 667 SDVYSFGVVMFEILCGRP 684
           +D+++ GV+ + +L G  
Sbjct: 231 TDMWAIGVLGYVLLSGLS 248

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  117 bits (295), Expect = 9e-29
 Identities = 46/206 (22%), Positives = 82/206 (39%), Gaps = 16/206 (7%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK-----RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           VIG G F  V R + R+   + AVK     +  +       + + E  +    +H H+V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           L+        + +++E+M+   L   +          S              L Y H   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--- 147

Query: 602 TKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              IIHRDVK   +LL   + +   K+  FG++    +         V G+  ++ PE +
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRV-GTPHFMAPEVV 205

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
            ++   +  DV+  GV++F +L G  
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCL 231

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  116 bits (292), Expect = 9e-29
 Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 35/217 (16%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
              ++    IG G  G VY  + +    +VA+++   Q          EI ++ + ++ +
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICIGAARGL 594
           +V+ +      +E+ ++ EY+  G+L D         +     ++      +C    + L
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTD---------VVTETCMDEGQIAAVCRECLQAL 129

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQ--THVST----AVK 647
            +LH+     +IHRD+KS NILL  +   K+ DFG   +I P+  +  T V T    A  
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA-- 184

Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  PE +T++    K D++S G++  E++ G P
Sbjct: 185 -------PEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (292), Expect = 9e-29
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 26/216 (12%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
            + +     +G G FGKVY+          A K   T+S + L ++  EIE+L+   H +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V L+G      ++ I+ E+   G +   +       L+  +   +C      L++LH+ 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHS- 135

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQ--THVST----AVKGSFGYL 653
             K IIHRD+K+ N+L+      ++ADFG+S K    L +  + + T    A        
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMA-------- 185

Query: 654 DPEYLTKQQLTE-----KSDVYSFGVVMFEILCGRP 684
            PE +  + + +     K+D++S G+ + E+    P
Sbjct: 186 -PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  115 bits (291), Expect = 9e-29
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 20/204 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK-----RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
            +G G F  V R V +    + A K     +   +  Q L     E  +  + +H ++V 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL---EREARICRKLQHPNIVR 69

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L     E +   ++++ +  G L + + A      S              + Y H+    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHS---N 124

Query: 604 AIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            I+HR++K  N+LL    +    K+ADFGL+     ++ +       G+ GYL PE L K
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKK 181

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
              ++  D+++ GV+++ +L G P
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYP 205

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  117 bits (294), Expect = 1e-28
 Identities = 54/276 (19%), Positives = 96/276 (34%), Gaps = 53/276 (19%)

Query: 459 HISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVK---- 513
           H     SS +    F   ++ E    +     IG G +G V   +        A+K    
Sbjct: 2   HHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNK 61

Query: 514 -RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYA 572
            +    + + +   +TE+ ++ +  H ++  L    ++   + ++ E    G L D L  
Sbjct: 62  NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121

Query: 573 SNFPSLSWRKRLEICIG-------------------------------AAR-------GL 594
               S        +                                   +         L
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181

Query: 595 HYLHTGSTKAIIHRDVKSANILL--DENLMAKVADFGLSKI--GPDLDQTHVSTAVKGSF 650
           HYLH    + I HRD+K  N L   +++   K+ DFGLSK     +  + +  T   G+ 
Sbjct: 182 HYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238

Query: 651 GYLDPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
            ++ PE L  T +    K D +S GV++  +L G  
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  119 bits (299), Expect = 2e-28
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           ++G G FG+V +   R  + + AVK        ++  +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             ++ +   I+ E    G L D +        S      I      G+ Y+H      I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIV 143

Query: 607 HRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
           HRD+K  NILL   +++   K+ DFGLS       Q        G+  Y+ PE L +   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 664 TEKSDVYSFGVVMFEILCGRP 684
            EK DV+S GV+++ +L G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTP 220

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (292), Expect = 3e-28
 Identities = 33/241 (13%), Positives = 68/241 (28%), Gaps = 55/241 (22%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFR-------- 537
           V+G                    V             + + + E+  L   R        
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 538 -----------------HRHLVSLIGYCDERNEMIIIYEYM----ENGTLKDHL--YASN 574
                             + ++ +     +   +   + Y        T  + L  ++S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG 634
             SL    RL++ +   R L  LH      ++H  ++  +I+LD+     +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 635 PDLDQTHVSTAVKGSFGYLDPEYL-----------TKQQLTEKSDVYSFGVVMFEILCGR 683
               +         S G+  PE              +  +T   D ++ G+V++ I C  
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 684 P 684
            
Sbjct: 311 L 311

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  114 bits (288), Expect = 3e-28
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 14/202 (6%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            +G G FG V+    R    +  +K     +S   + +   EIE+L    H +++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFP--SLSWRKRLEICIGAARGLHYLHTGSTKAI 605
            ++ + M I+ E  E G L + + ++     +LS     E+       L Y H   ++ +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHV 145

Query: 606 IHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           +H+D+K  NIL      +   K+ DFGL+++         ST   G+  Y+ PE   K+ 
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVF-KRD 201

Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
           +T K D++S GVVM+ +L G  
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCL 223

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  116 bits (292), Expect = 3e-28
 Identities = 53/237 (22%), Positives = 102/237 (43%), Gaps = 22/237 (9%)

Query: 459 HISAIFSSSKIGYRFPFVAIQEA--TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVK-- 513
           H++++    ++G    F+       +DN+     +G G F  V R V +    + A K  
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62

Query: 514 ---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL 570
              +   +  Q L     E  +  + +H ++V L     E +   ++++ +  G L + +
Sbjct: 63  NTKKLSARDFQKL---EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 119

Query: 571 YASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVAD 627
            A      S              + Y H+     I+HR++K  N+LL    +    K+AD
Sbjct: 120 VARE--FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLAD 174

Query: 628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           FGL+     ++ +       G+ GYL PE L K   ++  D+++ GV+++ +L G P
Sbjct: 175 FGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP 228

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  114 bits (288), Expect = 4e-28
 Identities = 51/217 (23%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
                  + IG G  G V          +VAVK    +  Q       E+ ++  ++H +
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICIGAARGL 594
           +V +        E+ ++ E+++ G L D         +  + RL       +C    + L
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD---------IVSQVRLNEEQIATVCEAVLQAL 154

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQ--THVST----AVK 647
            YLH    + +IHRD+KS +ILL  +   K++DFG   +I  D+ +  + V T    A  
Sbjct: 155 AYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA-- 209

Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  PE +++     + D++S G+++ E++ G P
Sbjct: 210 -------PEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  114 bits (287), Expect = 4e-28
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 490 VIGIGGFGKVYRGVLRDET--KVAVK---------RGGTQSHQGLAEFRTEIEMLSQ-FR 537
           ++G G    V R + +  T  + AVK             +  +       E+++L +   
Sbjct: 24  ILGRGVSSVVRRCIHK-PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H +++ L    +      ++++ M+ G L D+L       LS ++  +I       +  L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 140

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H      I+HRD+K  NILLD+++  K+ DFG S     LD       V G+  YL PE 
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEI 194

Query: 658 L------TKQQLTEKSDVYSFGVVMFEILCGRP 684
           +            ++ D++S GV+M+ +L G P
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  113 bits (286), Expect = 9e-28
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 19/206 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK------RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G F  V +   +    + A K         ++      E   E+ +L Q  H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +L    + R ++++I E +  G L D L       LS  +          G++YLH   T
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH---T 133

Query: 603 KAIIHRDVKSANILL----DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           K I H D+K  NI+L          K+ DFGL+     ++       + G+  ++ PE +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIV 190

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             + L  ++D++S GV+ + +L G  
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGAS 216

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (285), Expect = 9e-28
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 13/206 (6%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH 540
            + F     +G G +G VY+ +       VA+K+   +    L E   EI ++ Q    H
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V   G   +  ++ I+ EY   G++ D +      +L+  +   I     +GL YLH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHF- 143

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV--STAVKGSFGYLDPEYL 658
                IHRD+K+ NILL+    AK+ADFG++     L  T    +T + G+  ++ PE +
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDTMAKRNTVI-GTPFWMAPEVI 197

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
            +      +D++S G+   E+  G+P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKP 223

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  111 bits (281), Expect = 2e-27
 Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 32/221 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G+G FGKV  G       KVAVK   R   +S   + + + EI+ L  FRH H++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GLHYLH 598
                 +  ++ EY+  G L D++            R+E     AR         + Y H
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICK--------HGRVEE--MEARRLFQQILSAVDYCH 128

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
                 ++HRD+K  N+LLD ++ AK+ADFGLS +  D +    S    GS  Y  PE +
Sbjct: 129 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVI 182

Query: 659 TKQQLT-EKSDVYSFGVVMFEILCGR-PVIDPSLP--REKV 695
           + +     + D++S GV+++ +LCG  P  D  +P   +K+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  111 bits (281), Expect = 2e-27
 Identities = 47/206 (22%), Positives = 93/206 (45%), Gaps = 19/206 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK------RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G F  V +   +    + A K         ++      E   E+ +L + RH +++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +L    + + ++++I E +  G L D L       L+  +  +       G+HYLH   +
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLH---S 126

Query: 603 KAIIHRDVKSANILL----DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           K I H D+K  NI+L      N   K+ DFG++     ++  +    + G+  ++ PE +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEIV 183

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             + L  ++D++S GV+ + +L G  
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGAS 209

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (286), Expect = 2e-27
 Identities = 48/204 (23%), Positives = 99/204 (48%), Gaps = 10/204 (4%)

Query: 484 NFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
             S++ ++G G FG+V++        K+A K   T+  +   E + EI +++Q  H +L+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L    + +N+++++ EY++ G L D +   ++ +L+    +        G+ ++H    
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMH---Q 205

Query: 603 KAIIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
             I+H D+K  NIL    +    K+ DFGL++               G+  +L PE +  
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARR---YKPREKLKVNFGTPEFLAPEVVNY 262

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
             ++  +D++S GV+ + +L G  
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLS 286

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (286), Expect = 2e-27
 Identities = 57/309 (18%), Positives = 98/309 (31%), Gaps = 60/309 (19%)

Query: 492 GIGGFGKVYRGV-LRDETKVAVKRG--GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
           G      V           V V+R      S++ +   + E+ +   F H ++V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICIGAARGLHYLHTGST 602
              NE+ ++  +M  G+ KD L  ++F        +       I  G  + L Y+H    
Sbjct: 96  IADNELWVVTSFMAYGSAKD-LICTHFM-----DGMNELAIAYILQGVLKALDYIHH--- 146

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQTHVSTAVKGSF-G---YLDPEY 657
              +HR VK+++IL+  +    ++    +  +     +  V             +L PE 
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 658 LTKQQL--TEKSDVYSFGV-------------------VMFEILCGRPVIDPSLPREKVN 696
           L +       KSD+YS G+                   ++ E L G     P L      
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV---PCLLDTSTI 263

Query: 697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNK-------------FVEIAEKCLAQCGI 743
             E              +  +LT      S                F    E+CL +   
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323

Query: 744 DRPSMGDVL 752
            RPS   +L
Sbjct: 324 ARPSASTLL 332

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  113 bits (285), Expect = 2e-27
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 490 VIGIGGFGKVYRGVLRDET--KVAVK-------RGGTQSHQGLAE-FRTEIEMLSQ-FRH 538
           VIG G    V R V R  T  + AVK       R   +  + + E  R E  +L Q   H
Sbjct: 101 VIGRGVSSVVRRCVHR-ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            H+++LI   +  + M ++++ M  G L D+L       LS ++   I       + +LH
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLH 217

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
                 I+HRD+K  NILLD+N+  +++DFG S     L+       + G+ GYL PE L
Sbjct: 218 A---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLRELCGTPGYLAPEIL 271

Query: 659 TKQQL------TEKSDVYSFGVVMFEILCGRP 684
                       ++ D+++ GV++F +L G P
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  113 bits (285), Expect = 2e-27
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 19/206 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK------RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G F  V +   +    + A K         ++      E   E+ +L Q  H +++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +L    + R ++++I E +  G L D L       LS  +          G++YLH   T
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLH---T 133

Query: 603 KAIIHRDVKSANILL----DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           K I H D+K  NI+L          K+ DFGL+     ++       + G+  ++ PE +
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIV 190

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             + L  ++D++S GV+ + +L G  
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGAS 216

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  116 bits (292), Expect = 3e-27
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 16/226 (7%)

Query: 467 SKIGYRFPFVAIQEATDNFSESL----VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQ 521
             I  ++    ++   D+  +       +G G FG V+R   R      A K   T    
Sbjct: 137 FDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES 196

Query: 522 GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR 581
                R EI+ +S  RH  LV+L    ++ NEM++IYE+M  G L + +   +   +S  
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSED 255

Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLD 638
           + +E      +GL ++H       +H D+K  NI+      N + K+ DFGL+     LD
Sbjct: 256 EAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAH---LD 308

Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                    G+  +  PE    + +   +D++S GV+ + +L G  
Sbjct: 309 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 354

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  111 bits (280), Expect = 3e-27
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 15/201 (7%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQG--LAEFRTEIEMLSQFRHRHLVSLIG 546
           ++G G FG+V +   R  + + AVK     S +    +    E+E+L +  H +++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
             ++ +   I+ E    G L D +        S      I      G+ Y+H      I+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMH---KHNIV 143

Query: 607 HRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
           HRD+K  NILL   +++   K+ DFGLS       Q        G+  Y+ PE L +   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 664 TEKSDVYSFGVVMFEILCGRP 684
            EK DV+S GV+++ +L G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTP 220

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  111 bits (279), Expect = 3e-27
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V    E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GLHYLHTG 600
            E N   +  EY   G L D +             +      A+        G+ YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLHG- 123

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYLT 659
               I HRD+K  N+LLDE    K++DFGL+ +    ++  + +    G+  Y+ PE L 
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 660 KQQLT-EKSDVYSFGVVMFEILCGR 683
           +++   E  DV+S G+V+  +L G 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  111 bits (280), Expect = 3e-27
 Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 50/277 (18%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
            IG G FG+V++G+  R +  VA+K     ++   + + + EI +LSQ    ++    G 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE-----ICIGAARGLHYLHTGST 602
             +  ++ II EY+  G+  D L              E     I     +GL YLH+   
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEPGPLD--------ETQIATILREILKGLDYLHS--- 137

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF-G---YLDPEYL 658
           +  IHRD+K+AN+LL E+   K+ADFG++       Q   +   + +F G   ++ PE +
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAG------QLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD--- 715
            +     K+D++S G+   E+  G P      P  +++     MK      L  I     
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEP------PHSELH----PMKV-----LFLIPKNNP 236

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           PTL G      L +FV   E CL +    RP+  ++L
Sbjct: 237 PTLEGNYSKP-LKEFV---EACLNKEPSFRPTAKELL 269

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  111 bits (279), Expect = 5e-27
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 17/208 (8%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           VIG G    V        + KVA+KR    +    + E   EI+ +SQ  H ++VS    
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICIGAARGLHYLHTGS 601
              ++E+ ++ + +  G++ D +             L+      I      GL YLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-- 139

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFG----LSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
               IHRDVK+ NILL E+   ++ADFG    L+  G         T V G+  ++ PE 
Sbjct: 140 -NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197

Query: 658 LTKQQL-TEKSDVYSFGVVMFEILCGRP 684
           + + +    K+D++SFG+   E+  G  
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAA 225

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (280), Expect = 5e-27
 Identities = 45/252 (17%), Positives = 90/252 (35%), Gaps = 46/252 (18%)

Query: 519 SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNF--- 575
           S   +     +I  +  F  ++ V  +     +  + I  +      LKD +        
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 576 --PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
               +     ++I       + +LH+   K ++HRD+K +NI    + + KV DFGL   
Sbjct: 161 REHGVCLHIFIQIA----EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 634 ----------GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR 683
                        +      T   G+  Y+ PE +     + K D++S G+++FE+L   
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS- 272

Query: 684 PVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAE---KCLAQ 740
                S   E+V +            + D+ +     +       K+ +        L+ 
Sbjct: 273 ----FSTQMERVRI------------ITDVRN----LKFPLLFTQKYPQEHMMVQDMLSP 312

Query: 741 CGIDRPSMGDVL 752
              +RP   D++
Sbjct: 313 SPTERPEATDII 324

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  111 bits (280), Expect = 5e-27
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 31/220 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG G F KV     +    +VA+K       +   L +   E+ ++    H ++V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GLHYLHT 599
            +    + +I EY   G + D+L A          R++     AR         + Y H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVA--------HGRMKE--KEARSKFRQIVSAVQYCHQ 132

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
              K I+HRD+K+ N+LLD ++  K+ADFG S          +     G+  Y  PE   
Sbjct: 133 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFC-GAPPYAAPELFQ 186

Query: 660 KQQLT-EKSDVYSFGVVMFEILCGR-PVIDPSLP--REKV 695
            ++    + DV+S GV+++ ++ G  P    +L   RE+V
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (278), Expect = 7e-27
 Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 36/228 (15%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK----RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
           ++G G +GKV   +      + AVK    +   +   G A  + EI++L + RH++++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 545 --IGYCDERNEMIIIYEYMENGT--LKDHLYASNFPSLSWRKRLEICIGAAR-------- 592
             + Y +E+ +M ++ EY   G   + D +           KR  +C   A         
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------EKRFPVC--QAHGYFCQLID 120

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGY 652
           GL YLH+   + I+H+D+K  N+LL      K++  G+++              +GS  +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 653 LDPEYLTKQQLTE--KSDVYSFGVVMFEILCGR-PVIDPSLPR--EKV 695
             PE           K D++S GV ++ I  G  P    ++ +  E +
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  111 bits (279), Expect = 8e-27
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 15/200 (7%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGY 547
            +G G F    + V +      AVK     S +  A  + EI  L     H ++V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKLHEV 74

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             ++    ++ E +  G L + +        S  +   I       + ++H      ++H
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHD---VGVVH 129

Query: 608 RDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           RD+K  N+L    ++NL  K+ DFG +++ P  +Q  + T    +  Y  PE L +    
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELLNQNGYD 187

Query: 665 EKSDVYSFGVVMFEILCGRP 684
           E  D++S GV+++ +L G+ 
Sbjct: 188 ESCDLWSLGVILYTMLSGQV 207

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  113 bits (285), Expect = 9e-27
 Identities = 48/204 (23%), Positives = 82/204 (40%), Gaps = 19/204 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK-----RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
            +G G F  V R V      + A       +   + HQ L     E  +    +H ++V 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRLLKHPNIVR 74

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L     E     +I++ +  G L + + A      S              + + H     
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ---M 129

Query: 604 AIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            ++HR++K  N+LL    +    K+ADFGL+      +Q        G+ GYL PE L K
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFA-GTPGYLSPEVLRK 187

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
               +  D+++ GV+++ +L G P
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYP 211

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  110 bits (278), Expect = 1e-26
 Identities = 44/202 (21%), Positives = 88/202 (43%), Gaps = 19/202 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK----RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL 544
            +G G FG V+R V    +     K    +G  Q        + EI +L+  RHR+++ L
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-----VLVKKEISILNIARHRNILHL 66

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
               +   E+++I+E++    + + +  S F  L+ R+ +         L +LH   +  
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLH---SHN 122

Query: 605 IIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           I H D++  NI+     +   K+ +FG ++    L        +  +  Y  PE      
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQHDV 179

Query: 663 LTEKSDVYSFGVVMFEILCGRP 684
           ++  +D++S G +++ +L G  
Sbjct: 180 VSTATDMWSLGTLVYVLLSGIN 201

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score =  106 bits (266), Expect = 1e-26
 Identities = 31/185 (16%), Positives = 62/185 (33%), Gaps = 23/185 (12%)

Query: 211 ALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAP 270
           A + +  VN GG+      DV    +  D    +      +     I+        N   
Sbjct: 3   ADKVIWAVNAGGESH---VDVHGIHYRKDPLEGRVGRASDYGMKLPILR------SNPED 53

Query: 271 RDVYGTATIVNSGSDPNSNVNVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSR 330
           + +Y T           +  +  ++  +    E+++   F ++YF       F+V +N  
Sbjct: 54  QVLYQTERY--------NEDSFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGH 105

Query: 331 SAQLDFDLHKLPSYAAGNPYYMDF-ITRESDNPKLHVSIGRSTLVDTFP-----NAILNG 384
           +   D D+     ++  +   +   I +   + +  VS     L   F      N  +  
Sbjct: 106 TVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCA 165

Query: 385 LEIMK 389
           L IMK
Sbjct: 166 LFIMK 170

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174

 Score = 77.3 bits (190), Expect = 1e-16
 Identities = 26/172 (15%), Positives = 54/172 (31%), Gaps = 23/172 (13%)

Query: 33  YLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFT 92
           + ++ G  ++       +  D        +S   + +       S+     LY T R   
Sbjct: 8   WAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPIL---RSNPEDQVLYQTERYNE 64

Query: 93  GPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDY--QSQEGS--- 147
               Y   IK++  + + L F              F V     T++KD     + G    
Sbjct: 65  DSFGYDIPIKEEGEYVLVLKFAEVYFAQSQQKV--FDVRVNGHTVVKDLDIFDRVGHSTA 122

Query: 148 -------SVKEYSLNI------ASDRLVLSFTPFANSFAFINALEVISLPDE 186
                  S+K+  L++       + +L + F         + AL ++    +
Sbjct: 123 HDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNPKVCALFIMKGTAD 174

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  110 bits (277), Expect = 1e-26
 Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 33/230 (14%)

Query: 481 ATDNFSESL---------VIGIGGFGKVYRGVLRDET--KVAVKRGGTQSHQGLAEFRTE 529
           +TD+FS            V+G G   +V   +    T  + AVK    Q     +    E
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFRE 60

Query: 530 IEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICI 588
           +EML Q + HR+++ LI + +E +   +++E M  G++  H++       +  +   +  
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQ 118

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKI------GPDLDQ 639
             A  L +LH    K I HRD+K  NIL    ++    K+ DF L            +  
Sbjct: 119 DVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 640 THVSTAVKGSFGYLDPEYLTKQQLTEKS-----DVYSFGVVMFEILCGRP 684
             + T   GS  Y+ PE +              D++S GV+++ +L G P
Sbjct: 176 PELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  110 bits (277), Expect = 1e-26
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 19/205 (9%)

Query: 490 VIGIGGFGKVYRGVLRDET--KVAVK----RGGTQSHQGLAEFRTEIEMLSQFRHR-HLV 542
            +G G F  V + + +  T  + A K    R   Q  +  AE   EI +L   +    ++
Sbjct: 36  ELGRGKFAVVRQCISK-STGQEYAAKFLKKRRRGQDCR--AEILHEIAVLELAKSCPRVI 92

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +L    +  +E+I+I EY   G +           +S    + +      G++YLH    
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ--- 149

Query: 603 KAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
             I+H D+K  NILL         K+ DFG+S+    +        + G+  YL PE L 
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEILN 206

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRP 684
              +T  +D+++ G++ + +L    
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTS 231

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 2e-26
 Identities = 46/206 (22%), Positives = 91/206 (44%), Gaps = 19/206 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVK------RGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G F  V +   +    + A K         ++      +   E+ +L + +H +++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +L    + + ++I+I E +  G L D L       L+  +  E       G++YLH   +
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLH---S 132

Query: 603 KAIIHRDVKSANILL----DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
             I H D+K  NI+L          K+ DFGL+     +D  +    + G+  ++ PE +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIV 189

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
             + L  ++D++S GV+ + +L G  
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGAS 215

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (275), Expect = 2e-26
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSLIGYC 548
           +G G +G+V   V    E  VAVK    +      E  + EI +     H ++V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GLHYLHTG 600
            E N   +  EY   G L D +             +      A+        G+ YLH  
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEP--------DIGMPE--PDAQRFFHQLMAGVVYLHG- 123

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV-STAVKGSFGYLDPEYLT 659
               I HRD+K  N+LLDE    K++DFGL+ +    ++  + +    G+  Y+ PE L 
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLK 180

Query: 660 KQQLT-EKSDVYSFGVVMFEILCGR 683
           +++   E  DV+S G+V+  +L G 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (273), Expect = 4e-26
 Identities = 72/306 (23%), Positives = 130/306 (42%), Gaps = 44/306 (14%)

Query: 465 SSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGL 523
           S ++        A+++    F    ++G G +G+VY+G  ++     A+K          
Sbjct: 6   SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEE 64

Query: 524 AEFRTEIEMLSQF-RHRHLVSLIG------YCDERNEMIIIYEYMENGTLKDHLYASNFP 576
            E + EI ML ++  HR++ +  G           +++ ++ E+   G++ D +  +   
Sbjct: 65  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 124

Query: 577 SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD 636
           +L       IC    RGL +LH      +IHRD+K  N+LL EN   K+ DFG+S     
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA---Q 178

Query: 637 LDQTHV--STAVKGSFGYLDPEYLTKQQLTE-----KSDVYSFGVVMFEILCGRPVIDPS 689
           LD+T    +T + G+  ++ PE +   +  +     KSD++S G+   E+  G P     
Sbjct: 179 LDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP----- 232

Query: 690 LPREKVNLVEWAMKCQETGQLEDIVD---PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP 746
            P   ++     M+      L  I     P L  +        F+   E CL +    RP
Sbjct: 233 -PLCDMH----PMR-----ALFLIPRNPAPRLKSKKWSKKFQSFI---ESCLVKNHSQRP 279

Query: 747 SMGDVL 752
           +   ++
Sbjct: 280 ATEQLM 285

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (272), Expect = 5e-26
 Identities = 58/276 (21%), Positives = 102/276 (36%), Gaps = 38/276 (13%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIEML-SQFRHRHLVSLIG 546
            +G G  G+V++    +    +AVK+   + + +       +++++       ++V   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 547 YCDERNEMIIIYEYMENGTLKD-HLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI 605
                 ++ I  E M     K         P     K   + +   + L+YL       +
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK---MTVAIVKALYYLK--EKHGV 146

Query: 606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           IHRDVK +NILLDE    K+ DFG+S     L          G   Y+ PE +     T+
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGR---LVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 666 -----KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD---PT 717
                ++DV+S G+ + E+  G+                   +      L  ++    P 
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKT---------DFE-----VLTKVLQEEPPL 249

Query: 718 LTGQIK-PDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           L G +        FV   + CL +    RP    +L
Sbjct: 250 LPGHMGFSGDFQSFV---KDCLTKDHRKRPKYNKLL 282

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  108 bits (273), Expect = 5e-26
 Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 28/233 (12%)

Query: 467 SKIGYRFPFVAIQEATDNFSE-----SLVIGIGGFGKVYRGVLRDET--KVAVKRGGTQS 519
              G    F   +      ++       V+G+G  GKV     R  T  K A+K      
Sbjct: 8   HSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHR-RTGQKCALK-----L 61

Query: 520 HQGLAEFRTEIEMLSQF-RHRHLVSLIG-YCDERNEMIIIY---EYMENGTLKDHLYASN 574
                + R E++   Q     H+V ++  Y +  +    +    E ME G L   +    
Sbjct: 62  LYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121

Query: 575 FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLS 631
             + + R+  EI       + +LH+     I HRDVK  N+L    +++ + K+ DFG +
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178

Query: 632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           K      Q  + T    +  Y+ PE L  ++  +  D++S GV+M+ +LCG P
Sbjct: 179 KE---TTQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  109 bits (274), Expect = 5e-26
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G G    VYR   +  +   A+K       +     RTEI +L +  H +++ L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           +   E+ ++ E +  G L D +        S R   +        + YLH      I+HR
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHE---NGIVHR 172

Query: 609 DVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTE 665
           D+K  N+L      +   K+ADFGLSKI   ++   +   V G+ GY  PE L       
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTVCGTPGYCAPEILRGCAYGP 229

Query: 666 KSDVYSFGVVMFEILCGRP 684
           + D++S G++ + +LCG  
Sbjct: 230 EVDMWSVGIITYILLCGFE 248

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  111 bits (278), Expect = 9e-26
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 32/221 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G+G FGKV  G       KVAVK   R   +S   + + R EI+ L  FRH H++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GLHYLH 598
                +++ ++ EY+  G L D++            RL+     +R        G+ Y H
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICK--------NGRLDE--KESRRLFQQILSGVDYCH 133

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
                 ++HRD+K  N+LLD ++ AK+ADFGLS +  D +    S    GS  Y  PE +
Sbjct: 134 R---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVI 187

Query: 659 TKQQLT-EKSDVYSFGVVMFEILCGR-PVIDPSLP--REKV 695
           + +     + D++S GV+++ +LCG  P  D  +P   +K+
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  107 bits (270), Expect = 1e-25
 Identities = 50/215 (23%), Positives = 89/215 (41%), Gaps = 39/215 (18%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR------GGTQSHQGLAEFRTEIEMLSQFRHR--H 540
           ++G GGFG VY G+ + D   VA+K                     E+ +L +       
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 541 LVSLIGYCDERNEMIIIYEYMEN-GTLKDHLYASNFPSLSWRKRL-EICIGAAR------ 592
           ++ L+ + +  +  ++I E  E    L D +          R  L E     AR      
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITE--------RGALQE---ELARSFFWQV 158

Query: 593 --GLHYLHTGSTKAIIHRDVKSANILLDENLM-AKVADFGLSKIGPDLDQTHVSTAVKGS 649
              + + H      ++HRD+K  NIL+D N    K+ DFG   +  D   T  +    G+
Sbjct: 159 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GT 211

Query: 650 FGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGR 683
             Y  PE++   +     + V+S G+++++++CG 
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (270), Expect = 2e-25
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 34/218 (15%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFR 537
              FS+   IG G FG VY    +R+   VA+K+    G QS++   +   E+  L + R
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H + +   G     +   ++ EY   G+  D L   +   L   +   +  GA +GL YL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFG----LSKIGPDLDQTHVST----AVKGS 649
           H+     +IHRDVK+ NILL E  + K+ DFG    ++        + V T    A    
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMA---- 218

Query: 650 FGYLDPE---YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                PE    + + Q   K DV+S G+   E+   +P
Sbjct: 219 -----PEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (267), Expect = 2e-25
 Identities = 49/217 (22%), Positives = 95/217 (43%), Gaps = 41/217 (18%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR------GGTQSHQGLAEFRTEIEMLSQFR----H 538
           ++G GGFG V+ G  L D  +VA+K        G            E+ +L +      H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGT-LKDHLYASNFPSLSWRKRL-EICIGAAR---- 592
             ++ L+ + + +   +++ E       L D++          +  L E   G +R    
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE--------KGPLGE---GPSRCFFG 146

Query: 593 ----GLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
                + + H+   + ++HRD+K  NIL+D     AK+ DFG   +  D      +    
Sbjct: 147 QVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD- 199

Query: 648 GSFGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGR 683
           G+  Y  PE++++ Q     + V+S G+++++++CG 
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  105 bits (265), Expect = 3e-25
 Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 45/280 (16%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVKR-GGTQSHQGLAEFRTEIEM-LSQFRHRHLVSLIG 546
            +G G +G V +         +AVKR   T + Q       ++++ +        V+  G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICIGAARGLHYLHTG 600
                 ++ I  E M + +L D  Y          + +       I +   + L +LH  
Sbjct: 74  ALFREGDVWICMELM-DTSL-DKFYKQVIDK---GQTIPEDILGKIAVSIVKALEHLH-- 126

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE---- 656
           S  ++IHRDVK +N+L++     K+ DFG+S     L          G   Y+ PE    
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKPYMAPERINP 183

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
            L ++  + KSD++S G+ M E+   R P      P +               QL+ +V+
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------------QLKQVVE 228

Query: 716 ---PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
              P L           F     +CL +   +RP+  +++
Sbjct: 229 EPSPQLPADKFSAEFVDFT---SQCLKKNSKERPTYPELM 265

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  110 bits (276), Expect = 3e-25
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 20/211 (9%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           + F +  V+G GGFG+V    +R   K+ A K   +   +  +G A    E ++L +   
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 539 RHLVSLIGYCDERNEMI-IIYEYMENGTLKDHLYASNFPSLS-WRKRL---EICIGAARG 593
           R +VSL  Y  E  + + ++   M  G LK H+Y          R      EIC G    
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG---- 298

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L  LH    + I++RD+K  NILLD++   +++D GL+   P+         V G+ GY+
Sbjct: 299 LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYM 352

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE +  ++ T   D ++ G +++E++ G+ 
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQS 383

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  106 bits (268), Expect = 3e-25
 Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 33/221 (14%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           +G G FGKV      + + KVA+K   R   +          EI  L   RH H++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GLHYLH 598
                 +++++ EY   G L D++          +KR+       R         + Y H
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVE--------KKRMTE--DEGRRFFQQIICAIEYCH 125

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
                 I+HRD+K  N+LLD+NL  K+ADFGLS I  D +    S    GS  Y  PE +
Sbjct: 126 R---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVI 179

Query: 659 TKQQLT-EKSDVYSFGVVMFEILCGR-PVIDPSLP--REKV 695
             +     + DV+S G+V++ +L GR P  D  +P   +KV
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  105 bits (265), Expect = 8e-25
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIE-MLSQFRHRHLVSLIGY 547
            IG+G +    R + +    + AVK               EIE +L   +H ++++L   
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            D+   + ++ E M+ G L D +    F   S R+   +     + + YLH    + ++H
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEYLHA---QGVVH 139

Query: 608 RDVKSANILL---DENLMA-KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
           RD+K +NIL      N  + ++ DFG +K     +   + T    +  ++ PE L +Q  
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPC-YTANFVAPEVLERQGY 197

Query: 664 TEKSDVYSFGVVMFEILCGRP 684
               D++S GV+++ +L G  
Sbjct: 198 DAACDIWSLGVLLYTMLTGYT 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (263), Expect = 1e-24
 Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 39/279 (13%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRTEIE-MLSQFRHRHLVSLIG 546
            IG G +G V + V       +AVKR   T   +   +   +++ ++      ++V   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLE------ICIGAARGLHYLHTG 600
                 +  I  E M + +  D  Y   +  L     +       I +   + L++L   
Sbjct: 89  ALFREGDCWICMELM-STSF-DKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLK-- 142

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE---- 656
               IIHRD+K +NILLD +   K+ DFG+S     L  +   T   G   Y+ PE    
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ---LVDSIAKTRDAGCRPYMAPERIDP 199

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD- 715
             ++Q    +SDV+S G+ ++E+  GR       P  K N V   +          +V  
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRF------PYPKWNSVFDQLTQ--------VVKG 245

Query: 716 --PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
             P L+   + +    F+     CL +    RP   ++L
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  108 bits (271), Expect = 1e-24
 Identities = 53/213 (24%), Positives = 100/213 (46%), Gaps = 21/213 (9%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           D F +  V+G GGFG+V+   ++   K+ A K   +   +  +G      E ++L++   
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 539 RHLVSLIGYCDERNEMI-IIYEYMENGTLKDHLYASNFPSLSW---RKRL---EICIGAA 591
           R +VSL  Y  E    + ++   M  G ++ H+Y  +  +  +   R      +I  G  
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG-- 301

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             L +LH    + II+RD+K  N+LLD++   +++D GL+                G+ G
Sbjct: 302 --LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPG 354

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           ++ PE L  ++     D ++ GV ++E++  R 
Sbjct: 355 FMAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  107 bits (269), Expect = 3e-24
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 33/218 (15%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK---------RGGTQSHQGLAEFRTEIEM 532
           ++FS   +IG GGFG+VY     D  K+ A+K         + G      L E R  + +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA--LNE-RIMLSL 245

Query: 533 LSQFRHRHLVSLIGYCDERNEMI-IIYEYMENGTLKDHLYAS-NFPSLSWRKRL---EIC 587
           +S      +V +  Y     + +  I + M  G L  HL     F       R    EI 
Sbjct: 246 VSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA--DMRFYAAEII 302

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
           +G    L ++H    + +++RD+K ANILLDE+   +++D GL+       + H   +V 
Sbjct: 303 LG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPH--ASV- 351

Query: 648 GSFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCGRP 684
           G+ GY+ PE L K    + S D +S G ++F++L G  
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  101 bits (255), Expect = 7e-24
 Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 57/242 (23%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK--------------------------RGGTQSHQGL 523
           IG G +G V       D T  A+K                           G  Q    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 524 AEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII--IYEYMENGTLKDHLYASNFPSLSWR 581
            +   EI +L +  H ++V L+   D+ NE  +  ++E +  G + +         +   
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME---------VPTL 131

Query: 582 KRLEICIGAAR--------GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
           K L      AR        G+ YLH    + IIHRD+K +N+L+ E+   K+ADFG+S  
Sbjct: 132 KPLS--EDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186

Query: 634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT---EKSDVYSFGVVMFEILCGR-PVIDPS 689
               D   +S  V G+  ++ PE L++ +     +  DV++ GV ++  + G+ P +D  
Sbjct: 187 FKGSD-ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

Query: 690 LP 691
           + 
Sbjct: 245 IM 246

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  102 bits (257), Expect = 7e-24
 Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 41/215 (19%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK--------RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           +G G FG V+  V      +V VK                 L +   EI +LS+  H ++
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 542 VSLIGYCDERNEMIIIYEYMENGT-LKDHLYASNFPSLSWRKRLEICIGAAR-------- 592
           + ++   + +    ++ E   +G  L   +            RL+     A         
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--------HPRLDE--PLASYIFRQLVS 141

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS---KIGPDLDQTHVSTAVKGS 649
            + YL     K IIHRD+K  NI++ E+   K+ DFG +   + G         T   G+
Sbjct: 142 AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY-----TFC-GT 192

Query: 650 FGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGR 683
             Y  PE L        + +++S GV ++ ++   
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  102 bits (257), Expect = 9e-24
 Identities = 63/218 (28%), Positives = 86/218 (39%), Gaps = 36/218 (16%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
           IG G FG          +  VAVK   RG           + EI      RH ++V    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRFKE 83

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAAR--------GLHYLH 598
                  + II EY   G L + +            R       AR        G+ Y H
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICN--------AGRFSE--DEARFFFQQLLSGVSYCH 133

Query: 599 TGSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           +     I HRD+K  N LLD +     K+ DFG SK      Q    + V G+  Y+ PE
Sbjct: 134 S---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE 187

Query: 657 YLTKQQLT-EKSDVYSFGVVMFEILCGR-PVIDPSLPR 692
            L +Q+   + +DV+S GV ++ +L G  P  DP  PR
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (256), Expect = 2e-23
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 23/213 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           D+F     IG G FGKV      D  K+ A+K   +        +     E++++    H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 539 RHLVSLIGYC--DERNEMIIIYEYMENGTLKDHLY-ASNFPSLSWRKRLEIC-IGAARGL 594
             LV+L  Y   DE + M ++ + +  G L+ HL    +F       +L IC +  A  L
Sbjct: 75  PFLVNLW-YSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKE--ETVKLFICELVMA--L 128

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD 654
            YL     + IIHRD+K  NILLDE+    + DF ++ + P   Q    T + G+  Y+ 
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMA 182

Query: 655 PEYLTKQQLTEKS---DVYSFGVVMFEILCGRP 684
           PE  + ++    S   D +S GV  +E+L GR 
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (250), Expect = 2e-23
 Identities = 33/265 (12%), Positives = 74/265 (27%), Gaps = 56/265 (21%)

Query: 490 VIGIGGFGKVYRGVLRDET---KVAVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
             G     + ++    D     +VA+      G      L E  +    LS+     +  
Sbjct: 38  FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-TGST 602
           ++     R   +++ E++  G+L++    S     S    +      A      H  G  
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG-- 149

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +       + + +  +    +A        PD +                        
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYPA---TMPDANP----------------------- 181

Query: 663 LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI 722
              + D+   G  ++ +L  R  +  +  R  +          E       ++P     I
Sbjct: 182 ---QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEP---ADI 228

Query: 723 KPDSLNKFVEIAEKCLAQCGIDRPS 747
             D   +   +A + +   G  R +
Sbjct: 229 DRDIPFQISAVAARSVQGDGGIRSA 253

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (252), Expect = 2e-23
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 27/215 (12%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK--------RGGTQSHQGLAEFRTEIEML 533
           ++F    ++G G F  V        ++  A+K        +     +        E +++
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPY-----VTRERDVM 84

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIG 589
           S+  H   V L     +  ++     Y +NG L  ++     F       R    EI   
Sbjct: 85  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE--TCTRFYTAEIVSA 142

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
               L YLH    K IIHRD+K  NILL+E++  ++ DFG +K+     +   + +  G+
Sbjct: 143 ----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             Y+ PE LT++   + SD+++ G ++++++ G P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 230

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  101 bits (254), Expect = 4e-23
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGY 547
           V+G+G  GKV +   +  + K A+K       Q   + R E+E+  +  +  H+V ++  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 123

Query: 548 CDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
            +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+    
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 180

Query: 604 AIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            I HRDVK  N+L      N + K+ DFG +K         ++T    +  Y+ PE L  
Sbjct: 181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC-YTPYYVAPEVLGP 237

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
           ++  +  D++S GV+M+ +LCG P
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYP 261

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.8 bits (236), Expect = 9e-21
 Identities = 53/213 (24%), Positives = 83/213 (38%), Gaps = 30/213 (14%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           VIG G F +V    ++   +V A+K   +        ++ FR E ++L     R +  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127

Query: 546 GYC--DERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRL---EICIGAARGLHYLH 598
            +   DE   + ++ EY   G L   L  +    P+     R    EI +     +  +H
Sbjct: 128 -FAFQDENY-LYLVMEYYVGGDLLTLLSKFGERIPAE--MARFYLAEIVMA----IDSVH 179

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
                  +HRD+K  NILLD     ++ADFG               AV G+  YL PE L
Sbjct: 180 R---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEIL 235

Query: 659 TKQQLTEKSDVY-------SFGVVMFEILCGRP 684
                   +  Y       + GV  +E+  G+ 
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 28/218 (12%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    VIG G FG+V    L++  KV A+K   +         A FR E ++L     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 539 RHLVSLIGYC--DERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRL---EICIGAA 591
           + + +L  Y   D+ N + ++ +Y   G L   L  +    P      R    E+ I   
Sbjct: 134 KWITTLH-YAFQDDNN-LYLVMDYYVGGDLLTLLSKFEDRLPEE--MARFYLAEMVIA-- 187

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             +  +H       +HRD+K  NIL+D N   ++ADFG      +      S AV G+  
Sbjct: 188 --IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPD 241

Query: 652 YLDPEYLTKQQLTEKS-----DVYSFGVVMFEILCGRP 684
           Y+ PE L   +  +       D +S GV M+E+L G  
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 93.6 bits (233), Expect = 3e-20
 Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 24/213 (11%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           + F    ++G G FGKV     +   +      +K+    +   +A   TE  +L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 539 RHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIGAA 591
             L +L  Y     +R   ++  EY   G L  HL     F     R R    EI     
Sbjct: 208 PFLTALK-YSFQTHDRLCFVM--EYANGGELFFHLSRERVFSE--DRARFYGAEIVSA-- 260

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             L YLH  S K +++RD+K  N++LD++   K+ DFGL K G     T       G+  
Sbjct: 261 --LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPE 314

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           YL PE L         D +  GVVM+E++CGR 
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.8 bits (231), Expect = 3e-20
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 25/208 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVK---RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLI 545
           VIG G FG+V     +   KV A+K   +         A F  E ++++      +V L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 546 GYC--DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAARGLHYLHTG 600
            Y   D+R  + ++ EYM  G L + +   + P      R    E+ +     L  +H+ 
Sbjct: 136 -YAFQDDRY-LYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTAEVVLA----LDAIHS- 186

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
                IHRDVK  N+LLD++   K+ADFG              TAV G+  Y+ PE L  
Sbjct: 187 --MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKS 243

Query: 661 QQLTEK----SDVYSFGVVMFEILCGRP 684
           Q          D +S GV ++E+L G  
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDT 271

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 91.2 bits (227), Expect = 7e-20
 Identities = 50/217 (23%), Positives = 86/217 (39%), Gaps = 35/217 (16%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKR--GGTQSHQGLAEF-------RT--EIEMLSQFRH 538
            I  G +G V  GV  +   VA+KR        + +          R   EI +L+ F H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 539 RHLVSLI-----GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGA 590
            +++ L            +++ ++ E M    L   ++           +     I    
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL--- 144

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQT-HVSTAVKG 648
             GLH LH      ++HRD+   NILL +N    + DF L+ +   D ++T +V+     
Sbjct: 145 -LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW-- 198

Query: 649 SFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRP 684
              Y  PE  +  +  T+  D++S G VM E+   + 
Sbjct: 199 ---YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 89.2 bits (222), Expect = 3e-19
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 51/225 (22%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI- 545
           ++G G +G V           VA+K+         A  RT  EI++L  F+H +++++  
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL-RTLREIKILKHFKHENIITIFN 76

Query: 546 ----GYCDERNEMIIIYEYME--------NGTLKD-H----LYASNFPSLSWRKRLEICI 588
                  +  NE+ II E M+           L D H    +Y             +   
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY-------------QTL- 122

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKG 648
              R +  LH  +   +IHRD+K +N+L++ N   KV DFGL++I  +    +     + 
Sbjct: 123 ---RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 649 SFG--------YLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           S          Y  PE  LT  + +   DV+S G ++ E+   RP
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 88.9 bits (221), Expect = 5e-19
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 44/228 (19%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQF 536
           +    ++    IG G +G V       ++ +VA+K+     HQ   + RT  EI++L +F
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRF 82

Query: 537 RHRHLVSLI-----GYCDERNEMIIIYEYME--------NGTLKD-H----LYASNFPSL 578
           RH +++ +         ++  ++ I+ + ME           L + H    LY       
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY------- 135

Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDL 637
                 +I     RGL Y+H+ +   ++HRD+K +N+LL+     K+ DFGL+++  PD 
Sbjct: 136 ------QIL----RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182

Query: 638 DQTHVSTAVKGSFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           D T   T    +  Y  PE  L  +  T+  D++S G ++ E+L  RP
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 88.1 bits (219), Expect = 6e-19
 Identities = 49/215 (22%), Positives = 83/215 (38%), Gaps = 32/215 (14%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK--------RGGTQSHQGLAEFRTEIEML 533
           D F     +G G FG+V     ++     A+K        +     H        E  +L
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-----LNEKRIL 95

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIG 589
                  LV L     + + + ++ EY+  G +  HL     F       R    +I + 
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP--HARFYAAQIVLT 153

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
                 YLH+     +I+RD+K  N+L+D+    +V DFG +K       T   T     
Sbjct: 154 ----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---- 202

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
              L PE +  +   +  D ++ GV+++E+  G P
Sbjct: 203 -EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 87.6 bits (218), Expect = 7e-19
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLS 534
           + F    V+G GG+GKV+  R V    T      KV  K    ++ +  A  + E  +L 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 535 QFRHRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICI 588
           + +H  +V LI Y      +  +I+  EY+  G L   L                 EI +
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLIL--EYLSGGELFMQLEREGIFMED-TACFYLAEISM 132

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVK 647
                L +LH    K II+RD+K  NI+L+     K+ DFGL K    D   TH      
Sbjct: 133 A----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH------ 179

Query: 648 GSF-G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            +F G   Y+ PE L +       D +S G +M+++L G P
Sbjct: 180 -TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 87.3 bits (217), Expect = 1e-18
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV     +   +      +++    +   +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 539 RHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAAR 592
             L +L  Y     +R  +  + EY   G L  HL      +   R R    EI      
Sbjct: 65  PFLTALK-YAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEE-RARFYGAEIVSA--- 117

Query: 593 GLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG-PDLDQTHVSTAVKGSF- 650
            L YLH+   + +++RD+K  N++LD++   K+ DFGL K G  D            +F 
Sbjct: 118 -LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-------TFC 166

Query: 651 G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           G   YL PE L         D +  GVVM+E++CGR 
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 86.8 bits (216), Expect = 1e-18
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 33/211 (15%)

Query: 490 VIGIGGFGKVY---RGVLRDETKV-AVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVS 543
           V+G G FGKV+   +    D  ++ A+K  +  T   +     + E ++L +  H  +V 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 544 LIGYC---DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAARGLHYL 597
           L  Y    + +  +I+  +++  G L   L      +     +    E+ +     L +L
Sbjct: 91  LH-YAFQTEGKLYLIL--DFLRGGDLFTRLSKEVMFTEE-DVKFYLAELALA----LDHL 142

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSF-G---YL 653
           H+     II+RD+K  NILLDE    K+ DFGLSK   D ++         SF G   Y+
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---A---YSFCGTVEYM 193

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            PE + ++  T+ +D +SFGV+MFE+L G  
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 87.8 bits (218), Expect = 1e-18
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 43/227 (18%)

Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT-EIEMLSQFR 537
           ++    ++   VIG G FG V++  L +  +VA+K+      Q    F+  E++++   +
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK----VLQD-KRFKNRELQIMRIVK 90

Query: 538 HRHLVSLIGY----CDERNEMII--IYEYMENGTLK---DHLYASN--FPSLSWRKRL-E 585
           H ++V L  +     D+++E+ +  + EY+   T+     H        P L  +  + +
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 586 ICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA-KVADFGLSKI-GPDLDQTH-V 642
           +     R L Y+H   +  I HRD+K  N+LLD      K+ DFG +KI          +
Sbjct: 150 LL----RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 643 ST----AVKGSFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            +    A         PE        T   D++S G VM E++ G+P
Sbjct: 203 CSRYYRA---------PELIFGATNYTTNIDIWSTGCVMAELMQGQP 240

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 48/220 (21%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQ 535
           E    +     +G G +G V   +  R   KVA+K+       +  A+ R   E+ +L  
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-RAYRELLLLKH 79

Query: 536 FRHRHLVSLI------GYCDERNEMIIIYEYME---NGTLKDHLYASNFPSLSWRKRLEI 586
            +H +++ L+             +  ++  +M+      +           L +    ++
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY----QM 135

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH-VSTA 645
                +GL Y+H+     ++HRD+K  N+ ++E+   K+ DFGL++   D + T  V T 
Sbjct: 136 L----KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTR 187

Query: 646 VKGSFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                 Y  PE  L+     +  D++S G +M E+L G+ 
Sbjct: 188 W-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.4 bits (215), Expect = 2e-18
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 32/215 (14%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV-AVK--------RGGTQSHQGLAEFRTEIEML 533
            +F     +G G FG+V+    R   +  A+K        R     H        E  ML
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-----NDERLML 60

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIG 589
           S   H  ++ + G   +  ++ +I +Y+E G L   L  S  FP+     +    E+C+ 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP--VAKFYAAEVCLA 118

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
               L YLH+   K II+RD+K  NILLD+N   K+ DFG +K  PD+  T   T     
Sbjct: 119 ----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP---- 167

Query: 650 FGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             Y+ PE ++ +   +  D +SFG++++E+L G  
Sbjct: 168 -DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 32/220 (14%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQ 535
                +     IG G  G V        E  VA+K+      +Q  A+ R   E+ ++  
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-RAYRELVLMKC 80

Query: 536 FRHRHLVSLI------GYCDERNEMIIIYEYME---NGTLKDHLYASNFPSLSWRKRLEI 586
             H++++ L+         +E  ++ I+ E M+      ++  L       L ++     
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ----- 135

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQT-HVST 644
                 G+ +LH+     IIHRD+K +NI++  +   K+ DFGL+   G     T +V T
Sbjct: 136 ---MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 189

Query: 645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  Y  PE +      E  D++S G +M E++ G  
Sbjct: 190 RY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.5 bits (214), Expect = 3e-18
 Identities = 36/162 (22%), Positives = 70/162 (43%), Gaps = 13/162 (8%)

Query: 523 LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRK 582
             + +  +  +     R L S+       +   +  + + +   ++         L+   
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194

Query: 583 RLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV 642
            +      A+G+ +L   +++  IHRD+ + NILL E  + K+ DFGL++     D    
Sbjct: 195 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKD 246

Query: 643 STAVKGSFGYLD-----PEYLTKQQLTEKSDVYSFGVVMFEI 679
              V+     L      PE +  +  T +SDV+SFGV+++EI
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 70.3 bits (172), Expect = 6e-13
 Identities = 37/184 (20%), Positives = 68/184 (36%), Gaps = 27/184 (14%)

Query: 490 VIGIGGFGKVYRGVL------RDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF-RHRH 540
            +G G FG+V                VAVK  + G  +H       +E+++L     H +
Sbjct: 29  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLN 87

Query: 541 LVSLIGYC-DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           +V+L+G C      +++I E+ + G L  +L           KR E      +G  +   
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGARFRQG 138

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                 I  D+K     +  +  +  + F   K   D+++             L  ++LT
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE-------DLYKDFLT 191

Query: 660 KQQL 663
            + L
Sbjct: 192 LEHL 195

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 42/230 (18%)

Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRT--EIEMLSQ 535
           ++  D F    + G G FG V  G  +     VA+K+            R    ++ L+ 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK--VIQDPRFR-NRELQIMQDLAV 75

Query: 536 FRHRHLVSLIGY-----CDERNEM--IIIYEYMENGTLKDHL--YASNFPSLSWR-KRL- 584
             H ++V L  Y       +R ++   ++ EY+ + TL      Y     +      ++ 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134

Query: 585 --EICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKI-GPDLDQT 640
             ++     R +  LH  S   + HRD+K  N+L++  +   K+ DFG +K   P     
Sbjct: 135 LFQLI----RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 641 H-VST----AVKGSFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRP 684
             + +    A         PE     Q  T   D++S G +  E++ G P
Sbjct: 190 AYICSRYYRA---------PELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.5 bits (210), Expect = 5e-18
 Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 43/214 (20%)

Query: 491 IGIGGFGKVYRGVLRD-ET--KVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           IG G +G V++   R+ +T   VA+K+        + +     EI ML Q +H +LV+L+
Sbjct: 11  IGEGSYGVVFKC--RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 546 GYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRL-EICIGAARGLHYLHTGST 602
                +  + +++EY ++ T+   L  Y    P    +    +      + +++ H    
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL----QAVNFCHK--- 120

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VST----AVKGSFGYLDP 655
              IHRDVK  NIL+ ++ + K+ DFG +++  GP       V+T    +         P
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRS---------P 171

Query: 656 EYLTKQQLTEKS-----DVYSFGVVMFEILCGRP 684
           E L    + +       DV++ G V  E+L G P
Sbjct: 172 ELL----VGDTQYGPPVDVWAIGCVFAELLSGVP 201

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 86.3 bits (214), Expect = 7e-18
 Identities = 52/249 (20%), Positives = 90/249 (36%), Gaps = 65/249 (26%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           +IG G +G VY       E  VA+K+           + R   EI +L++ +  +++ L 
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-RILREITILNRLKSDYIIRLY 91

Query: 546 -----GYCDERNEMIIIYEYME---------NGTLKD-H----LYASNFPSLSWRKRLEI 586
                    + +E+ I+ E  +            L + H    LY              +
Sbjct: 92  DLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY-------------NL 138

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV 646
                 G +++H      IIHRD+K AN LL+++   KV DFGL++       T++   +
Sbjct: 139 L----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 647 KGSFGYLDPEYLTKQQLTE--------------------KS-DVYSFGVVMFEILCGRPV 685
           + +          K+QLT                     KS D++S G +  E+L     
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

Query: 686 IDPSLPREK 694
                    
Sbjct: 252 HINDPTNRF 260

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 86.1 bits (213), Expect = 9e-18
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 32/220 (14%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQ 535
                +     IG G  G V        +  VA+K+      +Q  A+ R   E+ ++  
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKC 117

Query: 536 FRHRHLVSLI------GYCDERNEMIIIYEYME---NGTLKDHLYASNFPSLSWRKRLEI 586
             H++++SL+         +E  ++ ++ E M+      ++  L       L ++     
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM---- 173

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-KIGPDLDQT-HVST 644
                 G+ +LH+     IIHRD+K +NI++  +   K+ DFGL+   G     T +V T
Sbjct: 174 ----LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVT 226

Query: 645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                  Y  PE +      E  D++S G +M E++  + 
Sbjct: 227 RY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 41/204 (20%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIE-MLSQFRHRHLVSLIG- 546
           V+G+G  GKV +   +  + K A+K       Q   + R E+E      +  H+V ++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79

Query: 547 YCDERNEMIIIY---EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           Y +       +    E ++ G L   +      + + R+  EI       + YLH+    
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 136

Query: 604 AIIHRDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            I HRDVK  N+L      N + K+ DFG +                        E  T 
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFA-----------------------KE-TTG 172

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
           ++  +  D++S GV+M+ +LCG P
Sbjct: 173 EKYDKSCDMWSLGVIMYILLCGYP 196

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 52/229 (22%), Positives = 95/229 (41%), Gaps = 50/229 (21%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQ 535
           E    + +   +G G +G V   V  R   KVA+K+       +  A+ R   E+ +L  
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAYRELRLLKH 80

Query: 536 FRHRHLVSLI------GYCDERNEMIIIYEYME--------NGTLKDH-----LYASNFP 576
            RH +++ L+         D+  +  ++  +M         +  L +      +Y     
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY----- 135

Query: 577 SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD 636
                   ++     +GL Y+H      IIHRD+K  N+ ++E+   K+ DFGL++    
Sbjct: 136 --------QML----KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180

Query: 637 LDQTHVSTAVKGSFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRP 684
               +V T       Y  PE  L   + T+  D++S G +M E++ G+ 
Sbjct: 181 EMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.8 bits (210), Expect = 2e-17
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 32/222 (14%)

Query: 479 QEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRT-EIEMLSQF 536
           +    +++++ VIG G FG VY+  L D    VA+K+           F+  E++++ + 
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQD---KRFKNRELQIMRKL 104

Query: 537 RHRHLVSLIGY----CDERNEMII--IYEYMENGTLK---DHLYASN--FPSLSWRKRL- 584
            H ++V L  +     ++++E+ +  + +Y+   T+     H   +    P +  +  + 
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA-KVADFGLSKIGPDLDQTHVS 643
           ++     R L Y+H+     I HRD+K  N+LLD +    K+ DFG +K    L +   +
Sbjct: 164 QLF----RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPN 213

Query: 644 TAVKGSFGYLDPEY-LTKQQLTEKSDVYSFGVVMFEILCGRP 684
            +   S  Y  PE        T   DV+S G V+ E+L G+P
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 84.9 bits (210), Expect = 2e-17
 Identities = 42/204 (20%), Positives = 77/204 (37%), Gaps = 49/204 (24%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI 545
           +IG G +G V       ++  VA+K+           + R   EI +L++  H H+V ++
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-RILREIAILNRLNHDHVVKVL 118

Query: 546 -----GYCDERNEMIIIYEYME---------NGTLKD-H----LYASNFPSLSWRKRLEI 586
                   ++ +E+ ++ E  +            L + H    LY              +
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY-------------NL 165

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS-----KIGPDLDQTH 641
                 G+ Y+H+     I+HRD+K AN L++++   KV DFGL+         +     
Sbjct: 166 L----VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

Query: 642 VSTAVKGSFGYLDPEYLTKQQLTE 665
                  +          K+QLT 
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTG 242

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 38/213 (17%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQ-FRHRHLVSL 544
           VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   H  LV L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 545 IGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIGAARGLHYL 597
              C   + R   +I  EY+  G L  H+      P      R    EI +     L+YL
Sbjct: 76  H-SCFQTESRLFFVI--EYVNGGDLMFHMQRQRKLPEE--HARFYSAEISLA----LNYL 126

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSF-G--- 651
           H    + II+RD+K  N+LLD     K+ D+G+ K  + P  D T        +F G   
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS-------TFCGTPN 175

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           Y+ PE L  +      D ++ GV+MFE++ GR 
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 67/234 (28%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLI- 545
            +G GG G V+  V    + +VA+K+          +     EI+++ +  H ++V +  
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVK-HALREIKIIRRLDHDNIVKVFE 75

Query: 546 -------------GYCDERNEMIIIYEYME--------NGTL-KDH----LYASNFPSLS 579
                        G   E N + I+ EYME         G L ++H    +Y        
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY-------- 127

Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSK-IGPDL 637
                ++     RGL Y+H+ +   ++HRD+K AN+ ++ E+L+ K+ DFGL++ + P  
Sbjct: 128 -----QLL----RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 638 DQTHVSTAVKGSFGYLD------PE-YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                 +        L       P   L+    T+  D+++ G +  E+L G+ 
Sbjct: 176 SHKGHLS------EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 57/221 (25%)

Query: 491 IGIGGFGKVYRGVLRD-ETK--VAVKRGGTQSHQGLAEFRT-------------EIEMLS 534
           +G G +G V +   R+ +T   VA+K+           F               EI++L 
Sbjct: 33  VGEGSYGMVMKC--RNKDTGRIVAIKK-----------FLESDDDKMVKKIAMREIKLLK 79

Query: 535 QFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHL--YASNFPSLSWRKRL-EICIGAA 591
           Q RH +LV+L+  C ++    +++E++++ T+ D L  + +       +K L +I     
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII---- 134

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VST---- 644
            G+ + H+     IIHRD+K  NIL+ ++ + K+ DFG ++    P       V+T    
Sbjct: 135 NGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191

Query: 645 AVKGSFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCGRP 684
           A         PE L       K+ DV++ G ++ E+  G P
Sbjct: 192 A---------PELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 84.7 bits (209), Expect = 5e-17
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 38/220 (17%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQ-FR 537
            +F+  +V+G G FGKV     +   ++     +K+        +     E  +L+   +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400

Query: 538 HRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIGA 590
              L  L   C    +R   ++  EY+  G L  H+     F            EI IG 
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVM--EYVNGGDLMYHIQQVGRFKEP--HAVFYAAEIAIG- 454

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKG 648
              L +L +   K II+RD+K  N++LD     K+ADFG+ K  I      T        
Sbjct: 455 ---LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTK------- 500

Query: 649 SF-G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +F G   Y+ PE +  Q   +  D ++FGV+++E+L G+ 
Sbjct: 501 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.8 bits (205), Expect = 6e-17
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 38/213 (17%)

Query: 490 VIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQ-FRHRHLVSL 544
           VIG G + KV    L+   ++     VK+      + +   +TE  +  Q   H  LV L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118

Query: 545 IGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIGAARGLHYL 597
              C   + R   +I  EY+  G L  H+      P      R    EI +     L+YL
Sbjct: 119 H-SCFQTESRLFFVI--EYVNGGDLMFHMQRQRKLPEE--HARFYSAEISLA----LNYL 169

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGSF-G--- 651
           H    + II+RD+K  N+LLD     K+ D+G+ K  + P  D T        +F G   
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS-------TFCGTPN 218

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           Y+ PE L  +      D ++ GV+MFE++ GR 
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 82.4 bits (204), Expect = 8e-17
 Identities = 57/236 (24%), Positives = 107/236 (45%), Gaps = 61/236 (25%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR-GGTQSHQGLAEFRT--EIEMLSQFR-HRHLVSL 544
            +G G +G V++ +  R    VAVK+      +   A+ RT  EI +L++   H ++V+L
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-RTFREIMILTELSGHENIVNL 74

Query: 545 --IGYCDERNEMIIIYEYME--------NGTLKD-H----LYASNFPSLSWRKRLEICIG 589
             +   D   ++ ++++YME           L+  H    +Y             ++   
Sbjct: 75  LNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY-------------QLI-- 119

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGS 649
             + + YLH+G    ++HRD+K +NILL+     KVADFGLS+   ++ +   +  +  +
Sbjct: 120 --KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 650 FGYLDP--------EY------------LTKQQLTEKSDVYSFGVVMFEILCGRPV 685
               +         +Y            L   + T+  D++S G ++ EILCG+P+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 82.0 bits (203), Expect = 8e-17
 Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 43/226 (19%)

Query: 483 DNFSESLVIGIGGFGKVY--RGVLRDET------KVAVKRGGTQSHQGLAEFRTEIEMLS 534
           +NF    V+G G +GKV+  R +   +T      KV  K    Q  +     RTE ++L 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 535 QFRHRH-LVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EI 586
             R    LV+L  Y    + +  +I+  +Y+  G L  HL     F       ++   EI
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLIL--DYINGGELFTHLSQRERFTEH--EVQIYVGEI 168

Query: 587 CIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVST 644
            +     L +LH      II+RD+K  NILLD N    + DFGLSK  +  + ++ +   
Sbjct: 169 VLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY--- 218

Query: 645 AVKGSF-G---YLDPEYLTKQQL--TEKSDVYSFGVVMFEILCGRP 684
                F G   Y+ P+ +        +  D +S GV+M+E+L G  
Sbjct: 219 ----DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.0 bits (203), Expect = 9e-17
 Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 50/229 (21%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQ-SHQGLAEFRT--EIEMLSQ 535
           E  + +     +G G +G V      +   +VAVK+          A+ RT  E+ +L  
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKH 84

Query: 536 FRHRHLVSLI------GYCDERNEMIIIYEYME---------NGTLKDH----LYASNFP 576
            +H +++ L+         +E N++ ++   M               DH    +Y     
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY----- 139

Query: 577 SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD 636
                   +I     RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D
Sbjct: 140 --------QIL----RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

Query: 637 LDQTHVSTAVKGSFGYLDPE-YLTKQQLTEKSDVYSFGVVMFEILCGRP 684
               +V+T       Y  PE  L      +  D++S G +M E+L GR 
Sbjct: 185 EMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 36/219 (16%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQ-FR 537
            +F+  +V+G G FGKV     +   ++     +K+        +     E  +L+   +
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 538 HRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRL---EICIGAA 591
              L  L   C    +R   ++  EY+  G L  H+                 EI IG  
Sbjct: 80  PPFLTQLH-SCFQTMDRLYFVM--EYVNGGDLMYHIQQVGRFKEP-HAVFYAAEIAIG-- 133

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKGS 649
             L +L +   K II+RD+K  N++LD     K+ADFG+ K  I      T        +
Sbjct: 134 --LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-VTTK-------T 180

Query: 650 F-G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           F G   Y+ PE +  Q   +  D ++FGV+++E+L G+ 
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 64/227 (28%), Positives = 89/227 (39%), Gaps = 66/227 (29%)

Query: 490 VIGIGGFGKVYRGVLRDETKV-AVK--------RGGTQSHQGLAEFRTEIE---MLSQFR 537
           VIG G FGKV     + E    AVK        +   + H          E   +L   +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH-------IMSERNVLLKNVK 97

Query: 538 HRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHL-------------YASNFPSLSWR 581
           H  LV L  +     ++   ++  +Y+  G L  HL             YA+        
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVL--DYINGGELFYHLQRERCFLEPRARFYAA-------- 146

Query: 582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH 641
              EI       L YLH+     I++RD+K  NILLD      + DFGL K   + + T 
Sbjct: 147 ---EIASA----LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST- 195

Query: 642 VSTAVKGSF-G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             T    +F G   YL PE L KQ      D +  G V++E+L G P
Sbjct: 196 --T---STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 39/227 (17%)

Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETK--VAVKRGGTQSHQ-GLAEF-----RTEI- 530
           AT  +     IG+G +G VY+   RD  +   VA+K     +   G         R E+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVA 63

Query: 531 --EMLSQFRHRHLVSLI-----GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWR-- 581
               L  F H ++V L+        D   ++ +++E+++   L+ +L  +  P L     
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122

Query: 582 KRL--EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-GPDLD 638
           K L  +      RGL +LH      I+HRD+K  NIL+      K+ADFGL++I    + 
Sbjct: 123 KDLMRQFL----RGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175

Query: 639 QTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
            T  V T       Y  PE L +       D++S G +  E+   +P
Sbjct: 176 LTPVVVT-----LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 38/220 (17%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQ-FR 537
           ++F    ++G G FGKV+    +   +     A+K+        +     E  +LS  + 
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 538 HRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIGA 590
           H  L  +        E    ++  EY+  G L  H+ + + F     R      EI +G 
Sbjct: 77  HPFLTHMF-CTFQTKENLFFVM--EYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILG- 130

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKG 648
              L +LH+   K I++RD+K  NILLD++   K+ADFG+ K  +  D  +T+       
Sbjct: 131 ---LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTN------- 176

Query: 649 SF-G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +F G   Y+ PE L  Q+     D +SFGV+++E+L G+ 
Sbjct: 177 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 38/220 (17%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKV----AVKRGGTQSHQGLAEFRTEIEMLSQ-FR 537
           DNF    V+G G FGKV    +++   +     +K+        +    TE  +LS    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82

Query: 538 HRHLVSLIGYC---DERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRL---EICIGA 590
           H  L  L   C    +R   ++  E++  G L  H+  S  F     R R    EI    
Sbjct: 83  HPFLTQLF-CCFQTPDRLFFVM--EFVNGGDLMFHIQKSRRFDEA--RARFYAAEIISA- 136

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK--IGPDLDQTHVSTAVKG 648
              L +LH    K II+RD+K  N+LLD     K+ADFG+ K  I      T        
Sbjct: 137 ---LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-VTTA------- 182

Query: 649 SF-G---YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +F G   Y+ PE L +       D ++ GV+++E+LCG  
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.6 bits (192), Expect = 8e-16
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 44/214 (20%)

Query: 491 IGIGGFGKVYRGVLRDETK--VAVKR-------GGTQSHQGLAEFRT---EIEMLSQFRH 538
           IG G +G VY+   ++      A+K+        G  S        T   EI +L + +H
Sbjct: 10  IGEGTYGVVYKA--QNNYGETFALKKIRLEKEDEGIPS--------TTIREISILKELKH 59

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRL--EICIGAARGLH 595
            ++V L      +  +++++E+++   LK  L            K    ++      G+ 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLL----NGIA 114

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VSTAVKGSFGY 652
           Y H    + ++HRD+K  N+L++     K+ADFGL++    P    TH + T       Y
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT-----LWY 166

Query: 653 LDPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
             P+ L  +K+  T   D++S G +  E++ G P
Sbjct: 167 RAPDVLMGSKKYSTT-IDIWSVGCIFAEMVNGTP 199

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.0 bits (193), Expect = 1e-15
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 44/214 (20%)

Query: 491 IGIGGFGKVYRGVLRDETK--VAVKR-------GGTQSHQGLAEFRT---EIEMLSQFRH 538
           +G G +G VY+   +D     VA+KR        G  S        T   EI +L +  H
Sbjct: 29  VGEGTYGVVYKA--KDSQGRIVALKRIRLDAEDEGIPS--------TAIREISLLKELHH 78

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRL--EICIGAARGLH 595
            ++VSLI        + +++E+ME   LK  L  +      S  K    ++     RG+ 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLL----RGVA 133

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VSTAVKGSFGY 652
           + H      I+HRD+K  N+L++ +   K+ADFGL++    P    TH V T       Y
Sbjct: 134 HCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVT-----LWY 185

Query: 653 LDPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
             P+ L  +K+  T   D++S G +  E++ G+P
Sbjct: 186 RAPDVLMGSKKYSTS-VDIWSIGCIFAEMITGKP 218

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.2 bits (191), Expect = 2e-15
 Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 53/231 (22%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK--VAVKRGGTQSHQGLAEFRTEIE--------- 531
             +     IG G +GKV++          VA+KR            R +           
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR-----------VRVQTGEEGMPLSTI 59

Query: 532 -------MLSQFRHRHLVSLI-----GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLS 579
                   L  F H ++V L         D   ++ +++E+++   L  +L     P + 
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118

Query: 580 WR--KRL--EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI-G 634
               K +  ++     RGL +LH+     ++HRD+K  NIL+  +   K+ADFGL++I  
Sbjct: 119 TETIKDMMFQLL----RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

Query: 635 PDLDQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
             +  T  V T       Y  PE L +       D++S G +  E+   +P
Sbjct: 172 FQMALTSVVVT-----LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 27/208 (12%)

Query: 491 IGIGGFGKVYRGVLRD-ETK--VAVKRGGTQSHQGLAEFRT---EIEMLSQFRHRHLVSL 544
           +G G +  VY+G   +  T   VA+K     S +G     T   EI ++ + +H ++V L
Sbjct: 13  LGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTP--STAIREISLMKELKHENIVRL 68

Query: 545 IGYCDERNEMIIIYEYMEN---GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
                  N++ +++E+M+N     +      +    L             +GL + H   
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-- 126

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VSTAVKGSFGYLDPEYL 658
              I+HRD+K  N+L+++    K+ DFGL++    P    +  V T       Y  P+ L
Sbjct: 127 -NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT-----LWYRAPDVL 180

Query: 659 --TKQQLTEKSDVYSFGVVMFEILCGRP 684
             ++   T   D++S G ++ E++ G+P
Sbjct: 181 MGSRTYSTS-IDIWSCGCILAEMITGKP 207

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK--VAVKRGGTQSHQGLAEFRT---EIEMLSQFR 537
           + + +   +G G +  VY+G  +  T   VA+K    +  +G     T   E+ +L   +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSK-LTDNLVALKEIRLEHEEGAP--CTAIREVSLLKDLK 58

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRLEICIGAARGLHY 596
           H ++V+L         + +++EY++   LK +L       ++   K     +   RGL Y
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL--LRGLAY 115

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VSTAVKGSFGYL 653
            H    + ++HRD+K  N+L++E    K+ADFGL++    P     + V T       Y 
Sbjct: 116 CHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVT-----LWYR 167

Query: 654 DPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
            P+ L  +    T+  D++  G + +E+  GRP
Sbjct: 168 PPDILLGSTDYSTQ-IDMWGVGCIFYEMATGRP 199

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 76.8 bits (190), Expect = 3e-15
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 40/214 (18%)

Query: 491 IGIGGFGKVYRGVLRD-ETK--VAVKR----GGTQSHQGLAEFRT---EIEMLSQFRHRH 540
           +G G F  VY+   RD  T   VA+K+      +++  G+   RT   EI++L +  H +
Sbjct: 18  LGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPN 73

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRLEICIGAARGLHYLHT 599
           ++ L+     ++ + +++++ME   L+  +  ++   + S  K   +     +GL YLH 
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMT--LQGLEYLH- 129

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI--GPDLDQTH-VST----AVKGSFGY 652
                I+HRD+K  N+LLDEN + K+ADFGL+K    P+   TH V T    A       
Sbjct: 130 --QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRA------- 180

Query: 653 LDPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
             PE L   +       D+++ G ++ E+L   P
Sbjct: 181 --PELLFGARMYGVG-VDMWAVGCILAELLLRVP 211

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.1 bits (190), Expect = 4e-15
 Identities = 50/257 (19%), Positives = 92/257 (35%), Gaps = 76/257 (29%)

Query: 482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRT---EIEMLSQFR 537
           +  +S    +G G FG V      +   + A+K+        L + R    E++++    
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLD 58

Query: 538 HRHLVSLIGY--------------------------------------CDERNEMIIIYE 559
           H +++ L+ Y                                        +   + +I E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 560 YMENGTLKDHLYASNFPSLSWRKRLE----------ICIGAARGLHYLHTGSTKAIIHRD 609
           Y+ + TL   L +         + +           +     R + ++H+     I HRD
Sbjct: 119 YVPD-TLHKVLKSFI----RSGRSIPMNLISIYIYQLF----RAVGFIHSLG---ICHRD 166

Query: 610 VKSANILLDENLMA-KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE-YLTKQQLTEKS 667
           +K  N+L++      K+ DFG +K    L  +  S A   S  Y  PE  L   + T   
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKK---LIPSEPSVAYICSRFYRAPELMLGATEYTPSI 223

Query: 668 DVYSFGVVMFEILCGRP 684
           D++S G V  E++ G+P
Sbjct: 224 DLWSIGCVFGELILGKP 240

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 51/232 (21%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRD-ETK--VAVKRGGTQSHQGLAEFRT----EIEMLSQ 535
             + +   IG G FG+V++   R  +T   VA+K+           F      EI++L  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKA--RHRKTGQKVALKK--VLMENEKEGFPITALREIKILQL 72

Query: 536 FRHRHLVSLIG--------YCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRL-- 584
            +H ++V+LI         Y   +  + +++++ E+  L   L       +LS  KR+  
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131

Query: 585 EICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI------GPDLD 638
            +      GL+Y+H      I+HRD+K+AN+L+  + + K+ADFGL++            
Sbjct: 132 MLL----NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 639 QTH-VSTAVKGSFGYLDPEYLTKQQLTEKS-----DVYSFGVVMFEILCGRP 684
            T+ V T       Y  PE L    L E+      D++  G +M E+    P
Sbjct: 185 YTNRVVT-----LWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRSP 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 52/225 (23%), Positives = 93/225 (41%), Gaps = 42/225 (18%)

Query: 487 ESLVIGIGGFGKVYRGVLRDET---KVAVKR----GGTQSHQGLAEFRTEIEMLSQFRHR 539
           E   +G G +G VY+   +D       A+K+    G + S         EI +L + +H 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHP 78

Query: 540 HLVSLIGYCDERNEMII--IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA------ 591
           +++SL        +  +  +++Y E+  L   +    F   S   +  + +         
Sbjct: 79  NVISLQKVFLSHADRKVWLLFDYAEH-DLWHII---KFHRASKANKKPVQLPRGMVKSLL 134

Query: 592 ----RGLHYLHTGSTKAIIHRDVKSANILLDENLMA----KVADFGLSKI--GPDLDQTH 641
                G+HYLH      ++HRD+K ANIL+          K+AD G +++   P      
Sbjct: 135 YQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 642 VSTAVKGSFGYLDPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
           +   V  +F Y  PE L   +   T+  D+++ G +  E+L   P
Sbjct: 192 LDPVVV-TFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEP 234

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 45/217 (20%)

Query: 491 IGIGGFGKVYRGVLRD-ETK--VAVKR-------GGTQSHQGLAEFRT---EIEMLSQFR 537
           +G G +G+VY+    D  T   VA+KR        G           T   E+ +L + +
Sbjct: 42  LGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPG--------TAIREVSLLKELQ 91

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           HR+++ L       + + +I+EY EN  LK ++  +   S+   K     +    G+++ 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL--INGVNFC 148

Query: 598 HTGSTKAIIHRDVKSANILLDENLMA-----KVADFGLSKI--GPDLDQTH-VSTAVKGS 649
           H   ++  +HRD+K  N+LL  +  +     K+ DFGL++    P    TH + T     
Sbjct: 149 H---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT----- 200

Query: 650 FGYLDPEYL--TKQQLTEKSDVYSFGVVMFEILCGRP 684
             Y  PE L  ++   T   D++S   +  E+L   P
Sbjct: 201 LWYRPPEILLGSRHYSTS-VDIWSIACIWAEMLMKTP 236

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 72.3 bits (178), Expect = 9e-14
 Identities = 46/216 (21%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR- 537
              D++     +G G + +V+  + + +  KV VK       +   + + EI++L   R 
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRG 89

Query: 538 HRHLVSL--IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLS---WRKRL-EICIGAA 591
             ++++L  I          +++E++ N   K       + +L+    R  + EI     
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEIL---- 140

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIG-PDLDQTH-VSTAVKG 648
           + L Y H+     I+HRDVK  N+++D E+   ++ D+GL++   P  +    V++    
Sbjct: 141 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195

Query: 649 SFGYLDPEYLTKQQLTEKS-DVYSFGVVMFEILCGR 683
              +  PE L   Q+ + S D++S G ++  ++  +
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.0 bits (175), Expect = 1e-13
 Identities = 39/158 (24%), Positives = 77/158 (48%), Gaps = 34/158 (21%)

Query: 491 IGIGGFGKVYRGVLRD-ETK--VAVKR-------GGTQSHQGLAEFRT---EIEMLSQFR 537
           IG G +G V++   ++ ET   VA+KR        G  S        +   EI +L + +
Sbjct: 10  IGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPS--------SALREICLLKELK 59

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP-SLSWRKRL--EICIGAARGL 594
           H+++V L        ++ +++E+ +   LK +  + N        K    ++     +GL
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL----KGL 114

Query: 595 HYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK 632
            + H   ++ ++HRD+K  N+L++ N   K+A+FGL++
Sbjct: 115 GFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.5 bits (156), Expect = 1e-10
 Identities = 69/470 (14%), Positives = 139/470 (29%), Gaps = 142/470 (30%)

Query: 350 YYMDFITRESDNPKLHVSIGRSTLVDTFPNAILNGLEIMKINNSRGDFDVAESTSPKSSK 409
           ++MDF T E              ++  F +A ++  +           DV +      SK
Sbjct: 5   HHMDFETGEHQ-------YQYKDILSVFEDAFVDNFDC---------KDVQDMPKSILSK 48

Query: 410 TRVGLIVGVASGSCISVGLALVLVLLCRRRNRLAR----GHLKADEQFAV----KEGHIS 461
             +  I+   S   +S G   +   L  ++  + +      L+ + +F +     E    
Sbjct: 49  EEIDHIIM--SKDAVS-GTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQP 105

Query: 462 AIFSSSKIGYR---------FP--FVAIQEATDNFSESL----------VIGIGGFGKVY 500
           ++ +   I  R         F    V+  +      ++L          + G+ G GK  
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-- 163

Query: 501 RGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII--- 557
              +  +           S++   +   +I  L+          +  C+    ++ +   
Sbjct: 164 -TWVALDV--------CLSYKVQCKMDFKIFWLN----------LKNCNSPETVLEMLQK 204

Query: 558 --YEYMENGT-LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSAN 614
             Y+   N T   DH         S +  L   + +    + L       ++  +V++A 
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL-------LVLLNVQNAK 257

Query: 615 ILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGV 674
                       +    KI   L    ++T  K    +L     T   L   S   +   
Sbjct: 258 AW-------NAFNLS-CKI---L----LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 675 VMFEILCGRPVID---PSLPRE--KVNLVEWAM---------------KCQETGQLEDIV 714
           V   +L     +D     LPRE    N    ++               K     +L  I+
Sbjct: 303 VK-SLL--LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359

Query: 715 DPTLTGQIKPDSLNK-------F---VEIAEKCLAQCGIDRPSMGDVLWN 754
           + +L   ++P    K       F     I    L+           ++W 
Sbjct: 360 ESSLN-VLEPAEYRKMFDRLSVFPPSAHIPTILLS-----------LIWF 397

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.0 bits (147), Expect = 1e-09
 Identities = 64/420 (15%), Positives = 126/420 (30%), Gaps = 115/420 (27%)

Query: 16  SVLCLVSVSTAFDPVDNYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISIN-ASLN 74
           + +       A D   +Y + C          ++F         N +SP+ +      L 
Sbjct: 164 TWV-------ALDVCLSYKVQC------KMDFKIFWL----NLKNCNSPETVLEMLQKLL 206

Query: 75  SISSGNY-SRLYHTARIFTGPSNYSFSIKKQARHFIRLHFFP----FVHETYNMSTAK-F 128
                N+ SR  H++ I         SI+ + R  ++   +      +    N      F
Sbjct: 207 YQIDPNWTSRSDHSSNI---KLRIH-SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAF 262

Query: 129 SVSSQSFTLI--KDYQSQEGSSVKEYSLNIASDRLVLSFTPFANSFAFINALEVISLPDE 186
           ++S +   L+  +  Q  +  S    + +I+ D   ++ TP       +  L+    P +
Sbjct: 263 NLSCK--ILLTTRFKQVTDFLSAATTT-HISLDHHSMTLTPDEVKSLLLKYLDCR--PQD 317

Query: 187 LIPQSAKTIDPQGSSTGNQSLQRQALETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHS 246
           L P+   T +P            + L  +A      +D        W  W     ++   
Sbjct: 318 L-PREVLTTNP------------RRLSIIAESI---RDGLAT----WDNW----KHVNCD 353

Query: 247 NLVMFVSNTSIVNFTDSVTENIAP---RDVYGTATIVNSGSD-PNSNVNVTWNFDVDP-- 300
            L   +  +S+          + P   R ++   ++    +  P   +++ W  DV    
Sbjct: 354 KLTTIIE-SSL--------NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWF-DVIKSD 403

Query: 301 -----------------GFEFLVRFHFCDIYF------NNISSLAFNVYINSRSAQLDFD 337
                              E  +      IY        N  +L     ++  +    FD
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIP--SIYLELKVKLENEYAL-HRSIVDHYNIPKTFD 460

Query: 338 LHKL-PSYAAGNPYYMDFITRESDNPKLHVS-IGRSTLVDTFPNAILNGLEIM--KINNS 393
              L P Y     Y+   I         H+  I     +  F    L+    +  KI + 
Sbjct: 461 SDDLIPPYLDQ--YFYSHIGH-------HLKNIEHPERMTLFRMVFLD-FRFLEQKIRHD 510

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.6 bits (151), Expect = 2e-10
 Identities = 33/199 (16%), Positives = 55/199 (27%), Gaps = 53/199 (26%)

Query: 481 ATDNFSESLVIGIGGFGKVYRGVLRDETKVAVK--------RGGTQSHQGLAEFRTEIEM 532
            T+       IG G FG+V++ +  D T VA+K               +   E   EI +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 533 L-----------------SQFRHRHLV------SLIGYCDE----------------RNE 553
                                   H V       L+   D                  ++
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSA 613
           + I+ E+   G   + +        S      I       L       +    HRD+   
Sbjct: 137 LFIVLEFEFGGIDLEQM---RTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWG 191

Query: 614 NILLDENLMAKVADFGLSK 632
           N+LL +  + K+      K
Sbjct: 192 NVLLKKTSLKKLHYTLNGK 210

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 46/224 (20%), Positives = 92/224 (41%), Gaps = 37/224 (16%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFR--------- 537
            +G G F  V+    + + T VA+K  RG     +       EI++L +           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82

Query: 538 --HRHLVSLIGYCDERNE----MIIIYEYM-ENGTLKDHLYASNFPSLSWRKRLEICIGA 590
               H++ L+ + + +      +++++E + EN  L   +       +      +I    
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLIYVKQISKQL 140

Query: 591 ARGLHYLHTGSTKAIIHRDVKSANILLDE------NLMAKVADFGLSKIGPDLDQTHVST 644
             GL Y+H      IIH D+K  N+L++        +  K+AD G +    +    H + 
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE----HYTN 194

Query: 645 AVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDP 688
           +++    Y  PE L        +D++S   ++FE++ G  + +P
Sbjct: 195 SIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 62.1 bits (151), Expect = 4e-10
 Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 25/207 (12%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHR------ 539
           VIG G FG+V +    +    VA+K  R   + H Q       EI +L   R +      
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNTM 159

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           +++ ++     RN + + +E +    L + +  + F   S     +      + L  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218

Query: 600 GSTKAIIHRDVKSANILLDENLMA--KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                IIH D+K  NILL +   +  KV DFG S      +   V T ++  F Y  PE 
Sbjct: 219 NR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRF-YRAPEV 270

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           +   +     D++S G ++ E+L G P
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGYP 297

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 23/207 (11%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHR------ 539
           +IG G FG+V +     ++  VA+K  +       Q       E+ +L            
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKY 116

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           ++V L  +   RN + +++E +    L D L  +NF  +S     +        L +L T
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 600 GSTKAIIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
                IIH D+K  NILL   +    K+ DFG S          +   ++  F Y  PE 
Sbjct: 176 PELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQSRF-YRSPEV 229

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRP 684
           L         D++S G ++ E+  G P
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 46/279 (16%), Positives = 92/279 (32%), Gaps = 54/279 (19%)

Query: 491 IGIGGFGKVYRGV---------LRDETKVAVK----RGGTQSHQGLAEFRTEIEMLSQFR 537
                 G +Y               + K ++K     G   + Q   +   +   +++++
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 538 HRHLVSLIG---------YCDERNEMIIIYEYMENGT-LKDHLYASNFPSLSWRKRLEIC 587
             +   L+          + D+   +++    +  G  L+  L  S    LS R  L++ 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVL--PSL--GRSLQSALDVSPKHVLSERSVLQVA 165

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV--ADFGLSKIGPDLDQTHVS-- 643
                 L +LH       +H +V + NI +D    ++V  A +G +         HV+  
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHVAYV 221

Query: 644 -TAVKGSFGYLDPEY------LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV- 695
             +     G  D E+            + +SD+ S G  M + L G       LP     
Sbjct: 222 EGSRSPHEG--DLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYG------FLPWTNCL 272

Query: 696 --NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVE 732
                    K +   +    V P        ++L K+++
Sbjct: 273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLK 311

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 52/273 (19%), Positives = 83/273 (30%), Gaps = 87/273 (31%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR--------HRHL 541
           +G G F  V+    ++ +  VA+K   +  H        EI +L   R           +
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103

Query: 542 VSLIGY-----------CDERNEMIIIYEYM-ENGTLKDHLYASNFPSLSWRKRLEICIG 589
           V L+             C       +++E +  +  L   +  SN+  L      +I   
Sbjct: 104 VQLLDDFKISGVNGTHIC-------MVFEVLGHH--LLKWIIKSNYQGLPLPCVKKIIQQ 154

Query: 590 AARGLHYLHTGSTKAIIHRDVKSANILL-------------------------------- 617
             +GL YLH  +   IIH D+K  NILL                                
Sbjct: 155 VLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 618 -----------------DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
                             E L  K+AD G +          + T       Y   E L  
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIG 267

Query: 661 QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
                 +D++S   + FE+  G  + +P    E
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 48/224 (21%), Positives = 83/224 (37%), Gaps = 37/224 (16%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSH-QGLAEFRTEIEMLSQFRHR-----H 540
            +G G FG+V     + ++   AVK  R   +           E ++L + ++      +
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK----IEADILKKIQNDDINNNN 97

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V   G     + M +I+E +   +L + +  +N+           CI   + L+YL   
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV--STAVK----GSFGYLD 654
           S   + H D+K  NILLD+    K              Q +   ST +K    G   +  
Sbjct: 157 S---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213

Query: 655 --------------PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                         PE +        SD++SFG V+ E+  G  
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 43/224 (19%), Positives = 80/224 (35%), Gaps = 41/224 (18%)

Query: 490 VIGIGGFGKVYRGV--LRDETKVAVK--RGGTQ-SHQGLAEFRTEIEMLSQFRHR----- 539
            +G G FGKV   +   R +++VA+K  R   +           EI +L + + +     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENK 81

Query: 540 -HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
              V +  + +    M I +E +      + L  +NF          +       L +LH
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK----GSFGYLD 654
                 + H D+K  NIL   +    + +   S     +     +T+++    GS  +  
Sbjct: 141 ENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK----NTSIRVADFGSATFDH 193

Query: 655 --------------PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                         PE + +    +  DV+S G ++FE   G  
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 35/148 (23%), Positives = 62/148 (41%), Gaps = 14/148 (9%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRH-RHLVSLIGY 547
           IG G FG +Y G  +    +VA+K    ++ H  L     E ++    +    + ++   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---HIESKIYKMMQGGVGIPTIRWC 73

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             E +  +++ E +  G   + L+       S +  L +       + Y+H+   K  IH
Sbjct: 74  GAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIH 128

Query: 608 RDVKSANILLDENLMAK---VADFGLSK 632
           RDVK  N L+          + DFGL+K
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 30/150 (20%), Positives = 56/150 (37%), Gaps = 16/150 (10%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRH-RHLVSLIGY 547
           IG G FG ++ G  L +  +VA+K    +S    L   R E            + ++  +
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL---RDEYRTYKLLAGCTGIPNVYYF 74

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             E    +++ + +  G   + L        S +            +  +H    K++++
Sbjct: 75  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 129

Query: 608 RDVKSANILLDENLMAK-----VADFGLSK 632
           RD+K  N L+            V DFG+ K
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 32/167 (19%), Positives = 62/167 (37%), Gaps = 32/167 (19%)

Query: 491 IGIGGFGKVYRGVLRDET------KVAVKRGGTQSHQGLAEFRT-----EIEMLSQFRHR 539
           IG GGFG +Y   +             VK   + +     E +      + E + ++   
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 540 HLVSLIGYC------------DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEIC 587
             +  +G                   MI+  +    G+    +Y +N    S +  L++ 
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIM--DRF--GSDLQKIYEANAKRFSRKTVLQLS 158

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV--ADFGLSK 632
           +     L Y+H       +H D+K++N+LL+     +V   D+GL+ 
Sbjct: 159 LRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 40/224 (17%), Positives = 81/224 (36%), Gaps = 41/224 (18%)

Query: 490 VIGIGGFGKVYRGV--LRDETKVAVK--RGGTQ-SHQGLAEFRTEIEMLSQFRHR----- 539
            +G G FGKV   +        VAVK  +   +          +EI++L           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR----SEIQVLEHLNTTDPNST 76

Query: 540 -HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
              V ++ + +    + I++E +   +  D +  + F         ++     + +++LH
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK----GSFGYLD 654
           +     + H D+K  NIL  ++   +  +  + +    L     +  +K    GS  Y D
Sbjct: 136 SNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI----NPDIKVVDFGSATYDD 188

Query: 655 --------------PEYLTKQQLTEKSDVYSFGVVMFEILCGRP 684
                         PE +     ++  DV+S G ++ E   G  
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 33/148 (22%), Positives = 68/148 (45%), Gaps = 14/148 (9%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFR-HRHLVSLIGY 547
           IG G FG++Y G  ++   +VA+K    ++ H  L     E ++    +    + ++  +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL---LYESKIYRILQGGTGIPNVRWF 71

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             E +  +++ + +  G   + L+      LS +  L +       + ++H+   K+ +H
Sbjct: 72  GVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLH 126

Query: 608 RDVKSANILLDENLMAK---VADFGLSK 632
           RD+K  N L+     A    + DFGL+K
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 35/166 (21%), Positives = 57/166 (34%), Gaps = 33/166 (19%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRG--GTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGY 547
           IG GGFG +Y         K A        Q +  L    +E++   +   +  +     
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL---FSELKFYQRVAKKDCIKKWIE 101

Query: 548 CDERNEMII--IYEYMENGTLKDHLYASNF-------PSLS----WRKR------LEICI 588
             + + + I   Y     G  +    +  F         L               L++ I
Sbjct: 102 RKQLDYLGIPLFYGS---GLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158

Query: 589 GAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV--ADFGLSK 632
                L Y+H       +H D+K+AN+LL      +V  AD+GLS 
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 14/149 (9%)

Query: 491 IGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH-RHLVSLIGYC 548
           IG G FG++  G  L     VA+K    +S         E     Q      +  +  + 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYFG 74

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
                  ++ E +  G   + L+     + S +  L I I     + Y+H+   K +I+R
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYR 129

Query: 609 DVKSANILL--DENLMAKVA---DFGLSK 632
           DVK  N L+    N   +V    DF L+K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAK 158

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	820
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.9
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.76
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.51
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.48
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.8
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.73
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.51
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.38
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.04
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.99
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.93
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.86
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.81
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.8
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.47
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.85
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.49
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.48
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.34
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.48

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-52  Score=454.28  Aligned_cols=260  Identities=27%  Similarity=0.430  Sum_probs=212.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...++||+|+||.||+|++.      +++.||||++........++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677789999999999999875      367899999988777788899999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC-------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          557 IYEYMENGTLKDHLYASN-------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      |||||++|+|.++|+...             ..+++|.++++|+.|+|+||+|||   +++||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997643             246999999999999999999999   6899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||+++.....+.........||+.|||||++.+..++.++|||||||+||||+| |+.||......+.   ...+.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i~  274 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---IDCIT  274 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HHHHH
Confidence            9999999987654444444456789999999999999999999999999999999999 8999976543322   22211


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                          .+.         ....+..++.++.+|+.+||+.||++||+|.||++.|+.+.+.
T Consensus       275 ----~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          275 ----QGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ----HTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----cCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                111         0123445678899999999999999999999999999988764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-52  Score=450.92  Aligned_cols=260  Identities=28%  Similarity=0.434  Sum_probs=219.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...+.||+|+||+||+|++.      ++..||||++........++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45778889999999999999874      367899999988777778899999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC-----------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeE
Q 003436          557 IYEYMENGTLKDHLYASN-----------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl  625 (820)
                      |||||++|+|.++|+..+           ...++|.++++|+.|+|.||+|||   +++||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997642           357999999999999999999999   689999999999999999999999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHh
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      +|||+|+.....+.........||+.|||||++.++.++.++|||||||+||||+| |++||......+.   ...+.  
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~~i~--  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IECIT--  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHH--
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH--
Confidence            99999986544333333445679999999999999999999999999999999999 8999976543322   22211  


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                        .+..         ...+..++.++.+|+.+||+.||++||++.||++.|+.+.+.
T Consensus       245 --~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          245 --QGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             --HTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --cCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence              1111         123446678899999999999999999999999999887654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.1e-52  Score=446.82  Aligned_cols=254  Identities=23%  Similarity=0.362  Sum_probs=212.2

Q ss_pred             CccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      +...++||+|+||+||+|++.      +++.||||++.... ....++|.+|+.+|++++|||||+++|+|.+++.++||
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            556679999999999999973      46789999986543 34467899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          558 YEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      ||||++|+|.++|....              ...++|.++++|+.|+|+||+|||   +++||||||||+||||++++.+
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~  184 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV  184 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence            99999999999997532              235999999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||+++.....+.........||++|||||++.++.++.++|||||||+||||+| |++||......+   +.+.+ 
T Consensus       185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~i-  260 (308)
T 4gt4_A          185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEMI-  260 (308)
T ss_dssp             EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHHH-
T ss_pred             EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH-
Confidence            9999999986544333334455679999999999999999999999999999999998 899997654332   22222 


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                         ..+..         ...+.+++..+.+|+.+||+.||++||+|.||++.|+.
T Consensus       261 ---~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          261 ---RNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             ---HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---HcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               11111         12345677889999999999999999999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-51  Score=438.27  Aligned_cols=259  Identities=28%  Similarity=0.516  Sum_probs=206.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCC--CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      +++...++||+|+||+||+|++++  .||||.++.  ......++|.+|+++|++++|||||+++|+|.+ +.++|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            457778899999999999999764  489998754  345567889999999999999999999999865 568999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      |++|+|.++|+... ..++|.++++|+.|+|.||+|||   +++||||||||+||||++++.+||+|||+|+........
T Consensus       113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999997653 46999999999999999999999   689999999999999999999999999999876543333


Q ss_pred             cccccccCCccccCcccccc---CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          641 HVSTAVKGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .......||+.|||||++.+   ..++.++|||||||+||||+||++||......+..  ..    ....+    ...|.
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~----~~~~~----~~~p~  258 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IF----MVGRG----YASPD  258 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HH----HHHTT----CCCCC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HH----HHhcC----CCCCC
Confidence            44456789999999999964   35899999999999999999999999754433221  11    11111    11121


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      + .....+++..+.+|+.+||+.+|++||||.||++.|+.+.
T Consensus       259 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          259 L-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             S-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             c-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            1 1334567788999999999999999999999999998664

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-49  Score=434.77  Aligned_cols=264  Identities=23%  Similarity=0.357  Sum_probs=217.6

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCC-CceeeEEeEeec-C
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRH-RHLVSLIGYCDE-R  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~-~  551 (820)
                      ..++|...++||+|+||.||+|++.+      ++.||||++.... ....++|.+|+++|.+++| ||||+++|+|.+ +
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            34678899999999999999999753      3579999976543 4456789999999999965 899999999966 4


Q ss_pred             ceEEEEEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          552 NEMIIIYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      +.+++|||||++|+|.++|+...              ...++|.+++.++.|+|+||+|||   +++||||||||+||||
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  218 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceee
Confidence            57899999999999999997532              245899999999999999999999   7899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~  696 (820)
                      ++++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |++||......+.  
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~--  296 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--  296 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            9999999999999997654333334456679999999999999999999999999999999998 8999975443221  


Q ss_pred             HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      +..    ....+.         ....+..++.++.+++.+||+.||++|||+.|++++|+.+++..
T Consensus       297 ~~~----~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          297 FCR----RLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             HHH----HHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             HHH----HHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            111    111111         11233456678999999999999999999999999999988754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.3e-49  Score=430.60  Aligned_cols=251  Identities=23%  Similarity=0.375  Sum_probs=206.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|...+.||+|+||+||+|+.. +++.||||++...  .....+.|.+|+++|++|+|||||++++++.+++.++||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            67999999999999999999976 5899999987543  34556789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ||++|+|.++|.......+++.++..|+.|++.||+|||   +++||||||||+||||++++.+||+|||+|+....  .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--T  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH--H
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC--C
Confidence            999999999998776667899999999999999999999   78999999999999999999999999999986432  1


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      ....+..+||+.|||||++.+..++.++|||||||+||||+||++||......+..   .   ... .+...        
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~---~---~i~-~~~~~--------  243 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV---L---KII-SGSFP--------  243 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H---HHH-HTCCC--------
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---H---HHH-cCCCC--------
Confidence            12234567999999999999999999999999999999999999999765433221   1   111 11111        


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+...+.++.+|+.+||+.||++||++.|++++
T Consensus       244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1223455778999999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.1e-48  Score=422.37  Aligned_cols=258  Identities=23%  Similarity=0.245  Sum_probs=211.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .+.|...++||+|+||.||+|++. .|+.||||+++....     +.+|+.+|++++|||||++++++.+++.++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356788889999999999999986 588999999764422     24699999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~~~~~  639 (820)
                      |++|+|.++|...+  .+++.++..++.|++.||+|||   +++||||||||+||||+.++ .+||+|||+|+.......
T Consensus       132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999997654  6999999999999999999999   78999999999999999887 699999999987543221


Q ss_pred             c---cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          640 T---HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       640 ~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .   ......+||+.|||||++.+..++.++|||||||+||||+||++||......+....   +..  ....       
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---i~~--~~~~-------  274 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK---IAS--EPPP-------  274 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH---HHH--SCCG-------
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HHc--CCCC-------
Confidence            1   122346799999999999999999999999999999999999999976544332211   111  1100       


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                        ....++.++..+.+++.+||+.||.+|||+.|+++.|..+++...
T Consensus       275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence              112344566789999999999999999999999999998877544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-48  Score=422.45  Aligned_cols=270  Identities=25%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc----eEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN----EMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV~E  559 (820)
                      ++...++||+|+||+||+|+++ |+.||||++...... ...+..|+..+.+++|||||+++|+|.+.+    .++||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            4666789999999999999984 789999998654322 122344566667889999999999997653    6899999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcC-----CCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG-----STKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~-----~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ||++|+|.++|+..   .++|.++++++.|+|+||+|||+.     ..++||||||||+||||++++.+||+|||+|+..
T Consensus        82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            99999999999764   599999999999999999999953     2348999999999999999999999999999865


Q ss_pred             CCCCCc--cccccccCCccccCccccccC------CCCCcceeeehhhhHHHHhcCCCCCCCCCchh----hh----hHH
Q 003436          635 PDLDQT--HVSTAVKGSFGYLDPEYLTKQ------QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE----KV----NLV  698 (820)
Q Consensus       635 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~----~~----~l~  698 (820)
                      ......  .......||+.|||||++.+.      .++.++|||||||+||||+||++|+......+    ..    ...
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            432221  122345799999999999764      47789999999999999999987764322111    00    001


Q ss_pred             HHHHHhhccCccccccCccccCC-CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQ-IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      +........    ...+|.+... ...+++..+.+|+.+||+.||++||||.||++.|+++.+.+
T Consensus       239 ~~~~~~~~~----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          239 EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHHhc----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            111111111    1122222211 12356778999999999999999999999999999887644

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-48  Score=425.34  Aligned_cols=250  Identities=21%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++.++||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999986 58999999876554444567889999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++...   .+++.++..++.|++.||+|||   +++||||||||+||||+.++.+||+|||+|+.....  ..
T Consensus       154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~  225 (346)
T 4fih_A          154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP  225 (346)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SC
T ss_pred             CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC--CC
Confidence            999999999764   5999999999999999999999   789999999999999999999999999999865432  22


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....+||+.|||||++.+..++.++|||||||+||||++|++||......+....   +..    .     ..+.+  .
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---i~~----~-----~~~~~--~  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRD----N-----LPPRL--K  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH----S-----SCCCC--S
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---HHc----C-----CCCCC--C
Confidence            33457899999999999999999999999999999999999999976543332211   111    1     01111  1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......++.+|+.+||+.||++||++.|++++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            123455778999999999999999999998864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.2e-48  Score=411.56  Aligned_cols=245  Identities=26%  Similarity=0.432  Sum_probs=197.0

Q ss_pred             ccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec----CceEEEEE
Q 003436          486 SESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE----RNEMIIIY  558 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  558 (820)
                      ...++||+|+||.||+|++. .+..||+|++...  .....+.|.+|+++|++++|||||++++++..    +..++|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45568999999999999986 4789999986432  34456789999999999999999999999854    35689999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc--EEeccCCCCcEEEc-CCCCeeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA--IIHRDVKSANILLD-ENLMAKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--iiHrDIkp~NIll~-~~~~~kl~DFGla~~~~  635 (820)
                      |||++|+|.++|....  .+++..+..++.|++.||+|||   +++  ||||||||+||||+ +++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999997653  6999999999999999999999   555  99999999999997 47999999999998643


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .    ......+||+.|||||++.+ .++.++|||||||+||||+||++||........  +..   . ...+...    
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~---~-i~~~~~~----  248 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR---R-VTSGVKP----  248 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH---H-HTTTCCC----
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH---H-HHcCCCC----
Confidence            2    22345689999999999865 699999999999999999999999965432211  111   1 1111111    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +    ..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus       249 ~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          249 A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0    1122334568899999999999999999999863

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.6e-48  Score=415.59  Aligned_cols=249  Identities=21%  Similarity=0.319  Sum_probs=210.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..++||+|+||+||+|+.. +++.||||.+...   .....+.+.+|+++|++++|||||++++++.+++.++|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999976 5889999987532   2234577999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      |||++|+|.++|...+  .+++.++..++.|++.||+|||   +++|+||||||+||||++++.+||+|||+|+......
T Consensus       112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999997653  6999999999999999999999   7899999999999999999999999999999765434


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ........+||+.|||||++.+..++.++||||+||+||||+||++||......+.   ...+.    .+..        
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~----~~~~--------  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI---FAKII----KLEY--------  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HTCC--------
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----cCCC--------
Confidence            44445567899999999999999999999999999999999999999976543222   11111    1111        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                        .++.....++.+|+.+||+.||++||++.|++.
T Consensus       252 --~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             --CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence              122334567889999999999999999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=426.98  Aligned_cols=250  Identities=21%  Similarity=0.374  Sum_probs=210.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +.|+..++||+|+||.||+|+.. .|+.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56899999999999999999986 58999999986655555567899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++...   .+++.++..++.|++.||+|||   +++||||||||+||||+.++.+||+|||+|+.....  ..
T Consensus       231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--~~  302 (423)
T 4fie_A          231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VP  302 (423)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS--CC
T ss_pred             CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC--Cc
Confidence            999999998754   4899999999999999999999   789999999999999999999999999999865432  22


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|++||......+....   +..    .     ..+.+  .
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~---i~~----~-----~~~~~--~  368 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRD----N-----LPPRL--K  368 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH----S-----CCCCC--S
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---HHc----C-----CCCCC--c
Confidence            33457899999999999999999999999999999999999999976543332211   111    1     11111  1


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......++.+|+.+||+.||++||++.|++++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            123445678999999999999999999998864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-46  Score=397.84  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=192.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||+||+|+.. +++.||||.+...   .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999975 5899999986533   2334567999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+ +|+|.+++....  .+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+..... 
T Consensus        93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence            999 689999997653  6999999999999999999999   789999999999999999999999999999864432 


Q ss_pred             CccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        ......+||+.|||||++.+..+ +.++||||+||++|||+||++||......+.   .+.+    ..+..       
T Consensus       166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~---~~~i----~~~~~-------  229 (275)
T 3hyh_A          166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL---FKNI----SNGVY-------  229 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCC-------
T ss_pred             --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HcCCC-------
Confidence              22345689999999999998876 5799999999999999999999975433221   1111    11111       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .++.....++.+++.+||+.||++|||+.|++++
T Consensus       230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               1223345678899999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-47  Score=406.87  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=197.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|+..+.||+|+||+||+|+..    .++.||||.+....  ......+.+|+++|++++|||||++++++.+++.+++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56999999999999999999863    36789999875432  2223468889999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |||||++|+|.++|....  .+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+....
T Consensus       104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999997654  6999999999999999999999   78999999999999999999999999999986433


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .  .......+||+.|||||++.+..++.++|||||||+||||+||++||......+...   .+.    .+..      
T Consensus       179 ~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---~i~----~~~~------  243 (304)
T 3ubd_A          179 H--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT---MIL----KAKL------  243 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----HCCC------
T ss_pred             C--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH---HHH----cCCC------
Confidence            2  122345689999999999999999999999999999999999999997654333211   111    1111      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCH-----HHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM-----GDVLW  753 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl~  753 (820)
                          .++...+.++.+++.+||+.||++||++     .|+++
T Consensus       244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                1233455678999999999999999984     55554

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.4e-46  Score=404.34  Aligned_cols=290  Identities=67%  Similarity=1.120  Sum_probs=257.6

Q ss_pred             CCCCHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec
Q 003436          471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE  550 (820)
Q Consensus       471 ~~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  550 (820)
                      .++++.++..++++|...+.||+|+||.||+|++++++.||||+.........+.+.+|++++++++||||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            45666777788999999999999999999999988899999999887776777889999999999999999999999999


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNF--PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                      .+..++||||+++|+|.+++.....  ..++|.+++.++.|++.||+|||   ..+|+||||||+||+++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999976543  35999999999999999999999   689999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      |+++...............||..|+|||++.+..++.++||||||+++|||++|+.||....+.+......|.......+
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  263 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG  263 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence            99986544333333445668999999999999999999999999999999999999998777777777788877777777


Q ss_pred             ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       709 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      .+..++++.+.....++++..+.+++.+||+.||++||++.|+++.|+.++.++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence            8888888888888888999999999999999999999999999999999987654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.9e-45  Score=393.04  Aligned_cols=250  Identities=22%  Similarity=0.372  Sum_probs=188.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc--------
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN--------  552 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--------  552 (820)
                      ++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35889999999999999999976 58899999876443 345578999999999999999999999986543        


Q ss_pred             ----eEEEEEeeccCCchhhHhhhcCC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          553 ----EMIIIYEYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       553 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                          .+++|||||++|+|.+++..... ...++..++.|+.|++.||+|||   +++|+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                37899999999999999976542 34567778999999999999999   78999999999999999999999999


Q ss_pred             ccccccCCCCCCc----------cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhH
Q 003436          628 FGLSKIGPDLDQT----------HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNL  697 (820)
Q Consensus       628 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l  697 (820)
                      ||+|+........          ...+..+||+.|||||++.+..++.++|||||||++|||++   ||...  .+....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHH
Confidence            9999865432211          11234579999999999999999999999999999999997   55421  111111


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ..   . ........         ........+.+++.+||+.||++||++.|+++
T Consensus       237 ~~---~-~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          237 LT---D-VRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH---H-HHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH---H-HhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11   1 11111110         01122345678999999999999999999886

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-43  Score=385.34  Aligned_cols=286  Identities=42%  Similarity=0.722  Sum_probs=246.7

Q ss_pred             CCCCHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChh-hHHHHHHHHHHHHcCCCCceeeEEeEee
Q 003436          471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCD  549 (820)
Q Consensus       471 ~~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~  549 (820)
                      ..+++.++..++++|...++||+|+||.||+|+..+++.||||++...... ....+.+|++++++++||||++++++|.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            568889999999999999999999999999999888999999997654322 2336899999999999999999999999


Q ss_pred             cCceEEEEEeeccCCchhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          550 ERNEMIIIYEYMENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       550 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                      ..+..++||||+++|+|.+++....  ...++|..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999997653  34599999999999999999999953334999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCC--chhhhhHHHHHHHhh
Q 003436          628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSL--PREKVNLVEWAMKCQ  705 (820)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~--~~~~~~l~~~~~~~~  705 (820)
                      ||+++..... .........||..|+|||++.+..++.++||||||+++|||++|+.||....  ........+|.....
T Consensus       178 fg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          178 FGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             CccccccCcc-cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            9999865432 2233445669999999999999999999999999999999999999996321  123345667777777


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      ....+..+.+..+........+..+.+++.+||+.+|.+||++.||+++|+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            7778888888888888888999999999999999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=393.33  Aligned_cols=263  Identities=21%  Similarity=0.310  Sum_probs=203.8

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec------Cce
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE------RNE  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~  553 (820)
                      ++|+..++||+|+||.||+|+.. .|+.||||++...  .....+.+.+|+++|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999976 5899999987643  33445778999999999999999999998753      367


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ++||||||+ |+|.+++...  ..+++.++..++.|++.||+|||   +++||||||||+|||++.++.+||+|||+|+.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999996 7899999754  47999999999999999999999   78999999999999999999999999999986


Q ss_pred             CCCCC--CccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          634 GPDLD--QTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       634 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      .....  ........+||+.|||||++.+. .++.++||||+||+++||++|++||......+....+.   ........
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~---~~~g~p~~  284 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM---MVLGTPSP  284 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH---HHHCCCCG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHH---HhcCCCCh
Confidence            53321  22234457899999999998875 56999999999999999999999998665444332221   11111000


Q ss_pred             cc---c-----------cCcccc---CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 ED---I-----------VDPTLT---GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~---~-----------~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..   +           ..+...   ....+....++.+|+.+||+.||.+|||+.|++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00   0           000000   00111234678899999999999999999998864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.3e-42  Score=381.32  Aligned_cols=265  Identities=24%  Similarity=0.319  Sum_probs=199.3

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  554 (820)
                      ...++|+..++||+|+||+||+|+.+    .++.||+|++.....  ..++.+|+++|+.+ +||||+++++++.+++..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999864    367899998765433  35678999999998 699999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeecccccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLSKI  633 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla~~  633 (820)
                      ++||||+++|+|.+++.     .+++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999983     4899999999999999999999   7999999999999999876 7999999999985


Q ss_pred             CCCCCCc--------------------------cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCC
Q 003436          634 GPDLDQT--------------------------HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVI  686 (820)
Q Consensus       634 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~  686 (820)
                      .......                          ...+..+||+.|+|||++.+. .++.++||||+||+++||+||++||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            4332110                          112345799999999999775 5899999999999999999999999


Q ss_pred             CCCCch-hhhhHHH----------HHHHhhccC---------ccc---------cccCcccc---------CCCChhhHH
Q 003436          687 DPSLPR-EKVNLVE----------WAMKCQETG---------QLE---------DIVDPTLT---------GQIKPDSLN  728 (820)
Q Consensus       687 ~~~~~~-~~~~l~~----------~~~~~~~~~---------~~~---------~~~d~~l~---------~~~~~~~~~  728 (820)
                      ...... +....+.          +........         ...         ....|.+.         .........
T Consensus       248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~  327 (361)
T 4f9c_A          248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD  327 (361)
T ss_dssp             SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred             CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence            654332 1111110          000000000         000         00000000         011123346


Q ss_pred             HHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          729 KFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       729 ~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ++.+|+.+||+.||++|||+.|++++
T Consensus       328 ~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          328 EAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            78899999999999999999998863

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-41  Score=376.63  Aligned_cols=264  Identities=27%  Similarity=0.462  Sum_probs=218.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc--------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR--------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER  551 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  551 (820)
                      .++|...+.||+|+||.||+|++.        .+..||||.+... .....+.+.+|+++|+++ +||||++++++|...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            357888999999999999999863        3567999998654 344567899999999999 899999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCC--------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      +..++||||+++|+|.+++.....              ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            999999999999999999976532              35899999999999999999999   7899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~  696 (820)
                      +.++.+||+|||+++...............+|..|+|||++.+..++.++|||||||++|||++ |+.||......+.. 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~-  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence            9999999999999986554333333344567889999999999999999999999999999999 99998755433221 


Q ss_pred             HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                        ...    ..+.         ....+..++..+.+++.+||+.+|.+||++.|+++.|+.++.+..+
T Consensus       316 --~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~  368 (370)
T 2psq_A          316 --KLL----KEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  368 (370)
T ss_dssp             --HHH----HTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             --HHH----hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence              111    1111         1123345667899999999999999999999999999999876544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.5e-42  Score=400.70  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=210.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...+.||+|+||.||+|+.+ .|+.||+|.+........+.+.+|+++|++++||||+++++++.+.+.++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            367999999999999999999986 5889999998776666677899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC--CCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN--LMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~--~~~kl~DFGla~~~~~~~  638 (820)
                      |++|+|.++|.... ..+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+..... 
T Consensus       236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            99999999986543 46999999999999999999999   7899999999999999754  89999999999875432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        ......+||+.|||||++.+..++.++||||+||+||||++|++||......+....   +.    .....  +++  
T Consensus       311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~---i~----~~~~~--~~~--  377 (573)
T 3uto_A          311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN---VK----SCDWN--MDD--  377 (573)
T ss_dssp             --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HH----TTCCC--CCS--
T ss_pred             --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH---HH----hCCCC--CCc--
Confidence              223456799999999999999999999999999999999999999976544332211   11    11100  011  


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .........+.+|+.+||+.||.+||++.|++++
T Consensus       378 --~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             --GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              1112344678899999999999999999999874

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-41  Score=394.58  Aligned_cols=249  Identities=23%  Similarity=0.295  Sum_probs=200.8

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC------ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ------SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~------~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|+..++||+|+||.||+|+.. .|+.||+|.+...      ..........++.+++.++|||||++++++.+.+.++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999986 5889999986432      1112223344567778889999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      ||||||+||+|.++|...+  .+++..+..++.||+.||+|||   +++||||||||+||||+.+|.+||+|||+|+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999997654  6999999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ..    .....+||+.|||||++.+ ..++.++|+|||||+||||++|++||......+...+......    ..     
T Consensus       344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~~-----  410 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----MA-----  410 (689)
T ss_dssp             SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----CC-----
T ss_pred             CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----CC-----
Confidence            32    2335689999999999964 5799999999999999999999999975433222222211111    10     


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                           ..++.....++.+|+.+||+.||.+|++     +.|++++
T Consensus       411 -----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          411 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                 1123344567899999999999999998     6777654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-40  Score=358.18  Aligned_cols=281  Identities=36%  Similarity=0.652  Sum_probs=231.0

Q ss_pred             CCCCHHHHHHHhcCCccc------eeEeeecceEEEEEEEcCccEEEEEeCCCC----ChhhHHHHHHHHHHHHcCCCCc
Q 003436          471 YRFPFVAIQEATDNFSES------LVIGIGGFGKVYRGVLRDETKVAVKRGGTQ----SHQGLAEFRTEIEMLSQFRHRH  540 (820)
Q Consensus       471 ~~~~~~~l~~at~~f~~~------~~LG~G~fG~Vykg~~~~~~~vavK~~~~~----~~~~~~~f~~Ei~~l~~l~H~n  540 (820)
                      ..|++.++..++++|...      ++||+|+||.||+|+. +++.||||++...    .....+.+.+|++++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            568999999999999887      8999999999999987 5788999986532    2344678999999999999999


Q ss_pred             eeeEEeEeecCceEEEEEeeccCCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       541 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                      |+++++++.+.+..++||||+++|+|.+++.... ...++|..++.++.|++.||+|||   +.+|+||||||+||++++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence            9999999999999999999999999999997532 356999999999999999999999   789999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE  699 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~  699 (820)
                      ++.+||+|||+++...............||..|+|||.+.+ .++.++||||||+++|||++|++||......+..  ..
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~  245 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LD  245 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--TH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--HH
Confidence            99999999999986554333333445679999999998865 5899999999999999999999999765433221  11


Q ss_pred             HHHHhh-ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          700 WAMKCQ-ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       700 ~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      +..... ....+.+.+++.+ .......+..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            111111 1223444445444 2445677889999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=363.99  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=214.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|...++||+|+||.||+|.+. +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56888899999999999999986 57899999887777777889999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.... ..++|.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus        90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999997643 46999999999999999999999   7899999999999999999999999999998654322111


Q ss_pred             ------------ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          642 ------------VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       642 ------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                                  ......||+.|+|||++.+..++.++||||||+++|||++|..|+............          .
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~----------~  235 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----------N  235 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------C
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------h
Confidence                        111457999999999999999999999999999999999999888654332211000          0


Q ss_pred             cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       710 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      .....+.    ..+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       236 ~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          236 VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0000001    12234445688999999999999999999999999988653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-41  Score=369.67  Aligned_cols=268  Identities=27%  Similarity=0.356  Sum_probs=210.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc----eEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN----EMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV  557 (820)
                      .++|...++||+|+||.||+|++. ++.||||++..... ....+..|+.+|++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            357889999999999999999876 68899999865433 3345667999999999999999999997643    47999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC----------cEEeccCCCCcEEEcCCCCeeEee
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK----------AIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~----------~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                      |||+++|+|.+++...   .++|.+++.++.|++.||+|||   +.          +|+||||||+|||++.++.+||+|
T Consensus       101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            9999999999999764   4999999999999999999999   56          999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHH----
Q 003436          628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV----  698 (820)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~----  698 (820)
                      ||+++...............||..|+|||++.+     ..++.++|||||||++|||+||+.||............    
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            999986554333333445679999999999976     45677899999999999999999999754332221111    


Q ss_pred             ------HHHHHhhccCccccccCccccCC-CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          699 ------EWAMKCQETGQLEDIVDPTLTGQ-IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       699 ------~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                            ++...... ...    .+.+... ....++..+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus       255 ~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          255 QHPSLEDMQEVVVH-KKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             SSCCHHHHHHHHTT-SCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             cCCchhhhhhhhhc-ccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                  11111111 111    1111111 12245677999999999999999999999999999887653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-40  Score=361.53  Aligned_cols=259  Identities=30%  Similarity=0.450  Sum_probs=205.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...++||+|+||.||+|+. .++.||||++....  ....++|.+|+++|++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            45788999999999999999987 47789999865443  4456789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCc--EEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKA--IIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+++|+|.+++..... ..+++.+++.++.|++.||+|||   +.+  |+||||||+|||++.++.+||+|||+++....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999999976432 24899999999999999999999   677  99999999999999999999999999975432


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .  ........||..|+|||++.+..++.++||||||+++|||++|+.||......+.....   ..   ...       
T Consensus       192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~---~~---~~~-------  256 (309)
T 3p86_A          192 T--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV---GF---KCK-------  256 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---HH---SCC-------
T ss_pred             c--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---cCC-------
Confidence            1  11233467999999999999999999999999999999999999999765433222111   10   000       


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                        ....+......+.+++.+||+.+|.+||++.++++.|+.++..
T Consensus       257 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          257 --RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             --CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence              1123344557799999999999999999999999999988754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=362.94  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=212.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...++||+|+||.||+|++.    .+..||||++... .....+.|.+|+++|++++||||+++++++.+++..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999985    3456999987654 445567899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999996543 46999999999999999999999   789999999999999999999999999999865442


Q ss_pred             CC-ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          638 DQ-THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       638 ~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .. ........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+....   +    ..+       
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---~----~~~-------  270 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---V----EEG-------  270 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---H----HTT-------
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---H----HcC-------
Confidence            22 122233456788999999999999999999999999999999 9999975543322111   1    111       


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                        .....+..++..+.+++.+||+.+|.+||++.++++.|+.++...
T Consensus       271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence              011223455678999999999999999999999999999987654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.9e-41  Score=372.15  Aligned_cols=260  Identities=26%  Similarity=0.450  Sum_probs=203.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...++||+|+||.||+|++.    .+..||||++... .....++|.+|+++|++++||||++++++|.+.+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57889999999999999999975    4678999998654 344567899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999997543 46999999999999999999999   689999999999999999999999999999865432


Q ss_pred             CCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          638 DQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       638 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.   ...+    ..+       
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i----~~~-------  266 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAV----DEG-------  266 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHH----HTT-------
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC-------
Confidence            211 11222345788999999999999999999999999999998 9999875543221   1111    111       


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                        .....+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       267 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          267 --YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             --EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             --CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence              111223355678999999999999999999999999999987644

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.2e-41  Score=373.66  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=212.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...+.||+|+||.||+|++. +++.||||.+.... ....++|.+|+++|++++||||++++++|..++..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            346888899999999999999987 68899999876543 3445678999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.......
T Consensus       193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999997543 35899999999999999999999   78999999999999999999999999999986433211


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+..   +.+    ..+.         
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~---~~~----~~~~---------  332 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFV----EKGG---------  332 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH---HHH----HTTC---------
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC---------
Confidence            111122335778999999999999999999999999999998 99998755432221   111    1111         


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ....+..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            1122344567899999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.1e-40  Score=358.03  Aligned_cols=262  Identities=21%  Similarity=0.316  Sum_probs=216.9

Q ss_pred             CCCCHHHHHHHhcC----------CccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC
Q 003436          471 YRFPFVAIQEATDN----------FSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR  539 (820)
Q Consensus       471 ~~~~~~~l~~at~~----------f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~  539 (820)
                      ..+++.+++.+++.          |...++||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            45788888888875          667789999999999999987 6899999998766666677899999999999999


Q ss_pred             ceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       540 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                      ||+++++++...+..++||||+++|+|.+++...   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTL  176 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECC
Confidence            9999999999999999999999999999998643   5999999999999999999999   689999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE  699 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~  699 (820)
                      ++.+||+|||+++......  .......||..|+|||++.+..++.++||||||+++|||++|+.||......+.   ..
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~  251 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK  251 (321)
T ss_dssp             TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH
T ss_pred             CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence            9999999999998654321  123456799999999999999999999999999999999999999975543221   11


Q ss_pred             HHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          700 WAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       700 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....    .     ..+.+  .........+.+++.+||+.||++||++.|++++
T Consensus       252 ~~~~----~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          252 RLRD----S-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHH----S-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhc----C-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111    1     11111  1122345678999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=367.79  Aligned_cols=265  Identities=27%  Similarity=0.455  Sum_probs=219.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc--------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR--------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER  551 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  551 (820)
                      .++|...++||+|+||.||+|+..        .+..||||++... .....+.+.+|+++++++ +||||++++++|..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            357888999999999999999863        2467999987654 345567899999999999 999999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          552 NEMIIIYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      +..++||||+++|+|.+++....              ...+++.+++.|+.|++.||+|||   +.+|+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999998654              245999999999999999999999   6899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~  696 (820)
                      ++++.+||+|||+++...............+|..|+|||++.+..++.++|||||||+++||++ |+.||......+.  
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~--  302 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  302 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            9999999999999986554333333445567899999999999999999999999999999999 9999875543221  


Q ss_pred             HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCCC
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDE  765 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~  765 (820)
                       .+.+    ..+.         ....+..+..++.+++.+||+.+|++||++.|+++.|+.+.......
T Consensus       303 -~~~~----~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          303 -FKLL----KEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             -HHHH----HTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             -HHHH----HcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence             1111    1111         11223345678999999999999999999999999999998766443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3e-40  Score=355.83  Aligned_cols=251  Identities=23%  Similarity=0.369  Sum_probs=209.5

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...++||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            467999999999999999999964 6889999987655555567789999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.+++...   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  170 (297)
T 3fxz_A           99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (297)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence            9999999999765   4899999999999999999999   6899999999999999999999999999998654322  


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....      ...+. .       ..
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~-~-------~~  236 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT-P-------EL  236 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS-C-------CC
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC-C-------CC
Confidence            2234467999999999999999999999999999999999999999755433221111      11110 0       01


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+......+.+++.+||+.||++||++.|++++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1233455778999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.9e-40  Score=350.09  Aligned_cols=256  Identities=29%  Similarity=0.456  Sum_probs=212.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...+.||+|+||.||+|+..+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            46888899999999999999998888999999765433 34678999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..... ....
T Consensus        89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  163 (269)
T 4hcu_A           89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  163 (269)
T ss_dssp             TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc-cccc
Confidence            999999996543 46899999999999999999999   789999999999999999999999999999864331 1122


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....+|..|+|||.+.+..++.++||||||++++||++ |+.||......+..   ...   .. +         ....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~---~~~---~~-~---------~~~~  227 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDI---ST-G---------FRLY  227 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHH---HT-T---------CCCC
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH---HHH---hc-C---------ccCC
Confidence            234457788999999999999999999999999999999 89999765433221   111   11 1         0011


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .+......+.+++.+|++.+|++||++.+++++|+++.+
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            122345678999999999999999999999999998865

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.3e-40  Score=355.65  Aligned_cols=261  Identities=28%  Similarity=0.412  Sum_probs=216.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|...+.||+|+||.||+|...      ++..||||.+... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            456888999999999999999862      3578999997654 345567899999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCC----------------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCC
Q 003436          555 IIIYEYMENGTLKDHLYASNF----------------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKS  612 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp  612 (820)
                      ++||||+++|+|.+++.....                      ..+++.+++.++.|++.||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999976432                      34899999999999999999999   68999999999


Q ss_pred             CcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCc
Q 003436          613 ANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLP  691 (820)
Q Consensus       613 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~  691 (820)
                      +||++++++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986554333333344567889999999999999999999999999999999 9999976544


Q ss_pred             hhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          692 REKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       692 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      .+....   .    ..+.         ....+...+..+.+++.+||+.||.+||++.++++.|+.++..
T Consensus       259 ~~~~~~---~----~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ERLFNL---L----KTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGHHHH---H----HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHH---h----hcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            332211   1    1111         1122334567899999999999999999999999999988763

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1e-40  Score=368.65  Aligned_cols=269  Identities=23%  Similarity=0.341  Sum_probs=216.8

Q ss_pred             HHHHHHHhcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEe
Q 003436          475 FVAIQEATDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIG  546 (820)
Q Consensus       475 ~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g  546 (820)
                      ........++|...++||+|+||.||+|++.      +++.||||++... .....+.+.+|++++.++ +||||+++++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            3444455678999999999999999999842      3578999998654 344567899999999999 7999999999


Q ss_pred             EeecCc-eEEEEEeeccCCchhhHhhhcCC--------------------------------------------------
Q 003436          547 YCDERN-EMIIIYEYMENGTLKDHLYASNF--------------------------------------------------  575 (820)
Q Consensus       547 ~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------  575 (820)
                      +|.+.+ ..++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            987755 48999999999999999976432                                                  


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          576 --------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       576 --------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                                    ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence                          12899999999999999999999   7899999999999999999999999999998654433333


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......||..|+|||++.+..++.++||||||+++|||++ |+.||......+..  ...    ...+.         ..
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~----~~~~~---------~~  315 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKEGT---------RM  315 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHH----HHHTC---------CC
T ss_pred             hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHH----HHcCC---------CC
Confidence            4445678999999999999999999999999999999998 99999755433211  111    11111         11


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ..+......+.+++.+||+.+|.+||++.|++++|+.+++.
T Consensus       316 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          316 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            12234456789999999999999999999999999998764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3e-40  Score=360.79  Aligned_cols=257  Identities=24%  Similarity=0.391  Sum_probs=205.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc----EEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET----KVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...++||+|+||.||+|++.. ++    +||+|.+... .....++|.+|+.++++++||||++++++|..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            468889999999999999999653 33    4688887543 3345678999999999999999999999998754 789


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999997654 46999999999999999999999   68999999999999999999999999999986554


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........+|..|+|||++.+..++.++|||||||++|||++ |+.||......+.....   .    .+       
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~----~~-------  235 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---E----KG-------  235 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---H----TT-------
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH---H----cC-------
Confidence            333333444567889999999999999999999999999999999 99999765443322111   1    11       


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                        .....+..+...+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       236 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          236 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              0112234556789999999999999999999999999988765

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.8e-41  Score=361.82  Aligned_cols=265  Identities=26%  Similarity=0.379  Sum_probs=209.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-----CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-----DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~  555 (820)
                      ++|+..++||+|+||.||+|++.     +++.||||++........+.|.+|++++++++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            56888999999999999999852     5789999998877777778999999999999999999999998553  4589


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999997653 35899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh---------hhhHHHHHHHhh
Q 003436          636 DLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE---------KVNLVEWAMKCQ  705 (820)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~---------~~~l~~~~~~~~  705 (820)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.......         ............
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            32211 22233457788999999999999999999999999999999998875321110         000000111111


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .         .......+..++..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       246 ~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          246 K---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             H---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             h---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            1         111122344567889999999999999999999999999998865

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-40  Score=381.01  Aligned_cols=257  Identities=26%  Similarity=0.408  Sum_probs=212.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...++||+|+||.||+|.++++..||||++.... ...+.|.+|+++|++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            45688889999999999999999888899999987544 34678999999999999999999999986 56789999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.......+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~  340 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYT  340 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH-HHH
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC-cee
Confidence            9999999997654446899999999999999999999   689999999999999999999999999999865431 111


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......++..|+|||++....++.++|||||||+||||+| |+.||......+..   ..+..    +.         ..
T Consensus       341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~----~~---------~~  404 (454)
T 1qcf_A          341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALER----GY---------RM  404 (454)
T ss_dssp             TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHHH----TC---------CC
T ss_pred             ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----CC---------CC
Confidence            1233456789999999999999999999999999999999 99999755433221   11111    10         01


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+..++..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus       405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            1234566789999999999999999999999999987654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-40  Score=361.52  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=214.8

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN  552 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  552 (820)
                      ...++|...+.||+|+||.||+|+..+      ++.||||.+... .....+.|.+|++++++++||||++++++|.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            345789999999999999999999853      478999998754 3445678999999999999999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcC----------------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccC
Q 003436          553 EMIIIYEYMENGTLKDHLYASN----------------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV  610 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDI  610 (820)
                      ..++||||+++|+|.+++....                      ...+++.+++.++.|++.||+|||   +.+|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            9999999999999999997642                      156999999999999999999999   789999999


Q ss_pred             CCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCC
Q 003436          611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPS  689 (820)
Q Consensus       611 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~  689 (820)
                      ||+|||++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999975433222222334568899999999999999999999999999999999 99998754


Q ss_pred             CchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          690 LPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       690 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ...+.   ...    ...+...         ..+..++..+.+++.+||+.+|.+||++.++++.|+++.+
T Consensus       281 ~~~~~---~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          281 AHEEV---IYY----VRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             CHHHH---HHH----HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ChHHH---HHH----HhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            33221   111    1111111         1233456789999999999999999999999999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=369.27  Aligned_cols=262  Identities=27%  Similarity=0.386  Sum_probs=213.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|...++||+|+||.||+|++.      .+..||||++... ......++.+|+.++++++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888999999999999999953      3568999997644 4555678999999999999999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcC-----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---CeeEee
Q 003436          556 IIYEYMENGTLKDHLYASN-----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---MAKVAD  627 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---~~kl~D  627 (820)
                      +||||+++|+|.+++....     ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999997643     245999999999999999999999   78999999999999998544   599999


Q ss_pred             ccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhc
Q 003436          628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.   ...+.    
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---~~~i~----  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVT----  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHH----
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----
Confidence            999974322222222334568899999999999999999999999999999998 9999976543322   11111    


Q ss_pred             cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       707 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      .+.         ....+..++..+.+++.+||+.+|.+||++.++++.|+.+.+...
T Consensus       301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            111         111233456779999999999999999999999999998876443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.7e-40  Score=373.40  Aligned_cols=251  Identities=29%  Similarity=0.427  Sum_probs=209.7

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc-eEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-EMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-~~~lV~E~~  561 (820)
                      ++|...++||+|+||.||+|.+. ++.||||.+....  ..+.|.+|+++|++++||||++++++|.+.. ..++||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            46788899999999999999986 6789999987543  4578999999999999999999999986654 799999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....    
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            9999999998776556899999999999999999999   789999999999999999999999999999853321    


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                       .....++..|+|||.+.+..++.++|||||||++|||+| |+.||......+..   ..+    ..+.         ..
T Consensus       343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i----~~~~---------~~  405 (450)
T 1k9a_A          343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRV----EKGY---------KM  405 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---HHH----HTTC---------CC
T ss_pred             -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC---------CC
Confidence             122357889999999999999999999999999999998 99998755433321   111    1111         11


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            2334567889999999999999999999999999998765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.6e-40  Score=381.72  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=215.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...++||+|+||.||+|++.. +..||||.+..... ..++|.+|+++|++++||||++++++|...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            3458888899999999999999875 78899999875433 467899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      |++|+|.+++.......+++..++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++...... .
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-Y  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-E
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-e
Confidence            99999999998766667999999999999999999999   7899999999999999999999999999998654321 1


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .......++..|+|||++.+..++.++|||||||+||||+| |+.||......+.   .+.+.    .         ...
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~----~---------~~~  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE----K---------DYR  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH----T---------TCC
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----c---------CCC
Confidence            22234456789999999999999999999999999999999 8899876543322   11111    1         111


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      ...+..++..+.+|+.+||+.+|.+||++.++++.|+.+.
T Consensus       438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1234456678999999999999999999999999998664

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.2e-40  Score=347.15  Aligned_cols=257  Identities=27%  Similarity=0.415  Sum_probs=212.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...+.||+|+||.||+|..+++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            456888999999999999999999888999999765433 3467899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YV  160 (268)
T ss_dssp             TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EE
T ss_pred             CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hh
Confidence            9999999997643 35899999999999999999999   7899999999999999999999999999998654422 22


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......+|..|+|||.+.+..++.++||||||++++||++ |+.||......+...      .... +.  .       .
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~-~~--~-------~  224 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQ-GH--R-------L  224 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHT-TC--C-------C
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH------HHHc-CC--C-------C
Confidence            2334556788999999999999999999999999999999 999997554332211      1111 10  0       0


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+...+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus       225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            1122334678999999999999999999999999976643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.1e-40  Score=357.81  Aligned_cols=264  Identities=28%  Similarity=0.416  Sum_probs=199.4

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcCcc----EEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRDET----KVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~~~----~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      ..++|...+.||+|+||.||+|++....    .||||.+...  .....+.+.+|++++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            3467999999999999999999976432    7999987654  345568899999999999999999999999776655


Q ss_pred             ------EEEEeeccCCchhhHhhhcC----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCee
Q 003436          555 ------IIIYEYMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAK  624 (820)
Q Consensus       555 ------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~k  624 (820)
                            ++|+||+++|+|.+++....    ...+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999996532    225899999999999999999999   68999999999999999999999


Q ss_pred             EeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHH
Q 003436          625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |++||......+...   ... 
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~~~-  253 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---YLI-  253 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHH-
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---HHh-
Confidence            999999986544333333344567889999999999999999999999999999999 899997654433211   111 


Q ss_pred             hhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                        ...          ....+...+..+.+++.+||+.||.+||++.++++.|++++....
T Consensus       254 --~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          254 --GGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             --TTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             --cCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence              110          012233455789999999999999999999999999999987544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-39  Score=356.17  Aligned_cols=267  Identities=17%  Similarity=0.180  Sum_probs=214.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+|+.. +++.||||.+.....  .+.+.+|+++++++ +||||+++++++..++..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            57889999999999999999974 688999998654332  24578999999999 999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC-----eeEeeccccccCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM-----AKVADFGLSKIGP  635 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~-----~kl~DFGla~~~~  635 (820)
                      + +++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++...
T Consensus        87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            9 99999999764 347999999999999999999999   689999999999999998887     9999999998654


Q ss_pred             CCCCcc-----ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          636 DLDQTH-----VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       636 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ......     ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.................
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            322211     124567999999999999999999999999999999999999999865443333222222111111000


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEG  766 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~  766 (820)
                      .         ......+ ++.+++.+|++.+|.+||++.++++.|+++....+...
T Consensus       242 ~---------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~  287 (330)
T 2izr_A          242 E---------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMF  287 (330)
T ss_dssp             H---------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             H---------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCC
Confidence            0         0111234 89999999999999999999999999998887655433

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.7e-40  Score=354.25  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=216.3

Q ss_pred             hcCCccceeEeeecceEEEEEEE------cCccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL------RDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~  553 (820)
                      .++|...+.||+|+||.||+|++      ..++.||+|++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35688899999999999999985      246789999876543 34467899999999999 99999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          554 MIIIYEYMENGTLKDHLYASNF----------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      .++||||+++|+|.+++.....                ..+++.+++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976542                25899999999999999999999   6899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~  696 (820)
                      +.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||++++||++ |+.||......... 
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence            9999999999999986554333333344567889999999999999999999999999999999 99998755432211 


Q ss_pred             HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                       ......    +         .....+...+..+.+++.+||+.||.+||++.|+++.|++++...
T Consensus       258 -~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          258 -YKMIKE----G---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             -HHHHHH----T---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -HHHhcc----C---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence             111111    1         011122345577999999999999999999999999999987653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.2e-40  Score=375.77  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=207.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...++||+|+||.||+|.++++..||||.+.... ...++|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            34578888999999999999999888889999987544 235689999999999999999999999976 6789999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.......+++.+++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++...... ..
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  336 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-ee
Confidence            9999999997654456999999999999999999999   7899999999999999999999999999998654321 11


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..   ..+    ..+.         ..
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i----~~~~---------~~  400 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQV----ERGY---------RM  400 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHH----HTTC---------CC
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC---------CC
Confidence            2233457889999999999999999999999999999999 89998755433221   111    1110         11


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+..++..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            2234566789999999999999999999999999987654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-39  Score=351.05  Aligned_cols=261  Identities=25%  Similarity=0.404  Sum_probs=208.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCC---CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGT---QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...+.||+|+||.||+|+.. .++.||+|.+..   ......+.|.+|+.++++++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            356889999999999999999976 578999997633   3345567899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999997653  6899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      . ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.      ....... ..     +.
T Consensus       165 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-~~-----~~  231 (294)
T 4eqm_A          165 S-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-SV-----PN  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-CC-----CC
T ss_pred             c-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-cC-----CC
Confidence            1 1222345699999999999999999999999999999999999999976543221      1111111 11     11


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHHh
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRP-SMGDVLWNLEYALQ  760 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~~~  760 (820)
                      .........+..+.+++.+|++.+|.+|| ++.++.+.|+.++.
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            11122334567899999999999999998 89999988876544

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.5e-40  Score=348.96  Aligned_cols=258  Identities=28%  Similarity=0.415  Sum_probs=210.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...+.||+|+||.||+|.+.++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            457888999999999999999999888999999775433 2467899999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..... ...
T Consensus       102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  176 (283)
T 3gen_A          102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYT  176 (283)
T ss_dssp             TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH-HHH
T ss_pred             CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc-ccc
Confidence            9999999997632 35999999999999999999999   789999999999999999999999999999865431 111


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+....   ..    .+         ...
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~----~~---------~~~  240 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IA----QG---------LRL  240 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HH----TT---------CCC
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH---Hh----cc---------cCC
Confidence            2233457788999999999999999999999999999998 9999975543322111   11    11         011


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ..+......+.+++.+||+.+|.+||++.++++.|+++...
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            11233456789999999999999999999999999988753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=9.9e-40  Score=356.80  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=207.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .++|...+.||+|+||.||+|++. +++.||||++...  .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            457999999999999999999984 6899999986533  3455678899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            9999999999997653  5899999999999999999999   789999999999999999999999999999754332 


Q ss_pred             CccccccccCCccccCccccccCCCC-CcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .......||+.|+|||++.+..+. .++|||||||+++||++|+.||......+....   +    ..+..       
T Consensus       168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i----~~~~~-------  231 (328)
T 3fe3_A          168 --GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER---V----LRGKY-------  231 (328)
T ss_dssp             --CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H----HHCCC-------
T ss_pred             --CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH---H----HhCCC-------
Confidence              223456799999999999888765 799999999999999999999976543322111   1    11111       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ..+......+.+++.+||+.||.+||++.|++++
T Consensus       232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               1223345678899999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.1e-39  Score=354.99  Aligned_cols=264  Identities=27%  Similarity=0.459  Sum_probs=216.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc--------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR--------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER  551 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~--------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  551 (820)
                      .++|...+.||+|+||.||+|++.        ++..||+|++... .....+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467889999999999999999873        4678999997654 344567899999999999 899999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCC--------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      +..++||||+++|+|.+++.....              ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999976532              34899999999999999999999   7899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~  696 (820)
                      +.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.. 
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-  269 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  269 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH-
Confidence            9999999999999986554333333344567889999999999999999999999999999999 99998755332221 


Q ss_pred             HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                        ....    .+..         ...+..++..+.+++.+||+.+|.+||++.|+++.|+.++.....
T Consensus       270 --~~~~----~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          270 --KLLK----EGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             --HHHH----HTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             --HHHh----cCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence              1111    1110         112334557799999999999999999999999999999887654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-40  Score=359.45  Aligned_cols=253  Identities=25%  Similarity=0.349  Sum_probs=204.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57899999999999999999987 688999998654332 2346688999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus        87 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            9999999998654  35999999999999999999999   789999999999999999999999999999865432333


Q ss_pred             cccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....|...    ...         
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~----~~~---------  227 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----KTY---------  227 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT----CTT---------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc----ccc---------
Confidence            33345679999999999987765 789999999999999999999997543321 111222111    000         


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..........+.+++.+||+.||.+||++.|++++
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            01112345678899999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-40  Score=359.84  Aligned_cols=264  Identities=25%  Similarity=0.369  Sum_probs=211.6

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      ..++|...+.||+|+||.||+|++.      .+..||||.+.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3467899999999999999999962      45689999876432 33457789999999999 8999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCC---------------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCC
Q 003436          553 EMIIIYEYMENGTLKDHLYASNF---------------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVK  611 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIk  611 (820)
                      ..++||||+++|+|.+++.....                     ..+++.+++.++.|++.||+|||   +.+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976532                     24899999999999999999999   7899999999


Q ss_pred             CCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCC
Q 003436          612 SANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSL  690 (820)
Q Consensus       612 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~  690 (820)
                      |+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999986543333233344567889999999999999999999999999999998 999997654


Q ss_pred             chhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          691 PREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       691 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      .....  ....    ..+         .....+..++..+.+++.+||+.||.+||++.++++.|+.++...
T Consensus       280 ~~~~~--~~~~----~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDANF--YKLI----QNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSHHH--HHHH----HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHHHH--HHHH----hcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            32211  1111    111         111223345678999999999999999999999999999876543

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.9e-39  Score=345.39  Aligned_cols=267  Identities=16%  Similarity=0.191  Sum_probs=214.6

Q ss_pred             hcCCccceeEeeecceEEEEEEE-cCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...+.||+|+||.||+|+. .+++.||||.+.....  .+.+.+|+++++++ +|+|++++++++.+....++|+|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            35689999999999999999996 4688999998654322  24578899999999 79999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC-----eeEeeccccccC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM-----AKVADFGLSKIG  634 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~-----~kl~DFGla~~~  634 (820)
                      |+ +++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++..
T Consensus        87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99 999999997653 45999999999999999999999   789999999999999987766     999999999865


Q ss_pred             CCCCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          635 PDLDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       635 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      ......     .......||..|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            432221     123456799999999999999999999999999999999999999976543332222222211111111


Q ss_pred             cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       710 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                      ..+         .....+..+.+++.+||+.+|.+||++.++++.|+++......
T Consensus       242 ~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          242 LRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             HHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence            111         1123457799999999999999999999999999998875443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-39  Score=345.91  Aligned_cols=259  Identities=29%  Similarity=0.429  Sum_probs=212.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.. +..++|+||++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence            5688899999999999999999888899999876543 235788999999999999999999999864 56899999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.......+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++...... ...
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  166 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTA  166 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EEC
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-ccc
Confidence            999999997544346899999999999999999999   7899999999999999999999999999998654321 122


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+.   ....    ..+.         ...
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~----~~~~---------~~~  230 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNL----ERGY---------RMV  230 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----HTTC---------CCC
T ss_pred             ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHH----hccc---------CCC
Confidence            234457889999999998899999999999999999999 8999875433221   1111    1110         011


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      .+...+..+.+++.+|++.+|++||++.++++.|+.+.....
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            223455789999999999999999999999999999876543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7e-40  Score=357.44  Aligned_cols=257  Identities=23%  Similarity=0.365  Sum_probs=205.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc----EEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET----KVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...++||+|+||.||+|++.. ++    +|++|.+.... ....+.+.+|+.++++++||||++++++|. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            468888999999999999999753 33    37888764332 333456788999999999999999999986 466899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            99999999999999754 246899999999999999999999   68999999999999999999999999999997655


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.....   .    .+..     
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~----~~~~-----  235 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---E----KGER-----  235 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---H----TTCB-----
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---H----cCCC-----
Confidence            444444455678889999999999999999999999999999999 99999765433322111   1    1110     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                          ...+..+...+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       236 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          236 ----LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ----CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ----CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                11122334467889999999999999999999999988754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-39  Score=344.39  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=201.5

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|...+.||+|+||.||+|++..    +..||+|..... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            3568889999999999999999753    456999987653 3445678999999999999999999999985 456889


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999997543 46899999999999999999999   68999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .. ........+++.|+|||.+.+..++.++||||||+++|||++ |++||......+..   ..+.    .+..     
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~----~~~~-----  235 (281)
T 1mp8_A          169 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIE----NGER-----  235 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHH----TTCC-----
T ss_pred             cc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHH----cCCC-----
Confidence            22 112233457789999999999999999999999999999996 99999765443321   1111    1110     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                          ...+..++..+.+++.+||+.+|.+||++.|+++.|+.+++..
T Consensus       236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          236 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                1123455678999999999999999999999999999987643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.4e-39  Score=346.23  Aligned_cols=260  Identities=29%  Similarity=0.417  Sum_probs=218.4

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ..++|...+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            45678889999999999999999875 7789999876543 345789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999998876677999999999999999999999   7899999999999999999999999999998654322 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ........+|..|+|||.+.+..++.++||||||++++||++ |++||......+....   ...             ..
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~---~~~-------------~~  229 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEK-------------DY  229 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHT-------------TC
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---Hhc-------------cC
Confidence            223334567889999999999999999999999999999999 8999876543322211   111             01


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ....+...+..+.+++.+|++.+|.+||++.++++.|+.+.+.
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            1122344567899999999999999999999999999988764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.9e-39  Score=340.03  Aligned_cols=251  Identities=20%  Similarity=0.304  Sum_probs=207.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+++ ++.+|||.+...  .....+.|.+|++++++++||||+++++++...  +..++|+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            46888999999999999999986 778999987644  345567899999999999999999999999876  7889999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc--EEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA--IIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||+++|+|.+++.......+++.+++.++.|++.||+|||   +.+  ++||||||+||+++.++.++|+|||++.... 
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999998766567999999999999999999999   677  9999999999999999999999999875422 


Q ss_pred             CCCccccccccCCccccCccccccCCCCC---cceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTE---KSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                            .....||+.|+|||.+.+...+.   ++||||||+++|||++|+.||......+..      ......+     
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~-----  227 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG------MKVALEG-----  227 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH------HHHHHSC-----
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH------HHHHhcC-----
Confidence                  12346899999999998765554   799999999999999999999754332211      1111111     


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                          .....+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          228 ----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                111233445678999999999999999999999999998763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-39  Score=341.96  Aligned_cols=253  Identities=28%  Similarity=0.481  Sum_probs=196.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCCh----hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH----QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...++||+|+||.||+|++. ++.+|||.......    ...+.+.+|++++++++||||+++++++..++..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            357888999999999999999975 78899998754332    3357789999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC--------CCCeeEeecc
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE--------NLMAKVADFG  629 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~--------~~~~kl~DFG  629 (820)
                      |||+++++|.+++..   ..+++..++.++.|++.||+|||+....+|+||||||+|||++.        ++.+||+|||
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999999854   36899999999999999999999422223999999999999986        7789999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      +++.....    ......||..|+|||.+.+..++.++||||||++++||++|+.||..........      ....   
T Consensus       162 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~---  228 (271)
T 3dtc_A          162 LAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVAM---  228 (271)
T ss_dssp             C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHT---
T ss_pred             cccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhhc---
Confidence            99754332    1224568999999999999999999999999999999999999997543322111      1001   


Q ss_pred             cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       710 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                            .......+..++..+.+++.+|++.+|.+||++.|+++.|+.
T Consensus       229 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          229 ------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                  111112334556789999999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4e-39  Score=340.41  Aligned_cols=256  Identities=30%  Similarity=0.444  Sum_probs=211.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...+.||+|+||.||+|+..+++.||+|.+..... ..+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            46888899999999999999998888999999765433 34678999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +++|.+++.... ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..... ....
T Consensus        87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            999999997643 46899999999999999999999   789999999999999999999999999999864331 1112


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+.   ....    ..+.         ...
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~i----~~~~---------~~~  225 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDI----STGF---------RLY  225 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH----HTTC---------CCC
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH---HHHH----hcCC---------cCC
Confidence            233457789999999998999999999999999999999 8999875433221   1111    1110         011


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .+......+.+++.+|++.+|.+||++.++++.|+++.+
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            122345678999999999999999999999999998865

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=346.43  Aligned_cols=272  Identities=19%  Similarity=0.267  Sum_probs=213.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc--eEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN--EMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~  558 (820)
                      ++|...++||+|+||.||+|+... ++.||||++.... ....+.+.+|+++|++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            468889999999999999999874 8899999876433 234577889999999999999999999987655  789999


Q ss_pred             eeccCCchhhHhhhcCC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE----cCCCCeeEeecccccc
Q 003436          559 EYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLSKI  633 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll----~~~~~~kl~DFGla~~  633 (820)
                      ||+++|+|.+++..... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976432 34999999999999999999999   7899999999999999    7888899999999986


Q ss_pred             CCCCCCccccccccCCccccCccccc--------cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh-hhhHHHHHHHh
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLT--------KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE-KVNLVEWAMKC  704 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~-~~~l~~~~~~~  704 (820)
                      .....   ......||..|+|||++.        +..++.++|||||||++|||++|+.||....... ...........
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            54322   223456999999999986        5788999999999999999999999997543322 22222211111


Q ss_pred             hccCcccccc-----------CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          705 QETGQLEDIV-----------DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       705 ~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .....+..+.           +-.............+.+++.+||+.||++||++.|++++..+...
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            1111111100           0011123455777889999999999999999999999999876643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.6e-39  Score=348.90  Aligned_cols=264  Identities=22%  Similarity=0.308  Sum_probs=204.6

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ..++|...++||+|+||.||+|+..+++.||+|++....  ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            346789999999999999999999889999999876433  223567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||++ |+|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        99 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-  172 (311)
T 3niz_A           99 EFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-  172 (311)
T ss_dssp             ECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred             cCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence            9998 58888886543 46899999999999999999999   789999999999999999999999999999865422 


Q ss_pred             CccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc---cccc-
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ---LEDI-  713 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~-  713 (820)
                       ........||..|+|||++.+ ..++.++|||||||+++||++|++||......+.....   ........   .... 
T Consensus       173 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 -VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI---FSILGTPNPREWPQVQ  248 (311)
T ss_dssp             -CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH---HHHHCCCCTTTSGGGT
T ss_pred             -cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHHCCCChHHhhhhh
Confidence             122334568999999999876 56899999999999999999999999765544332221   11111100   0000 


Q ss_pred             ------------cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 ------------VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                  .+........+....++.+++.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                        00000001112344678899999999999999999999863

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.1e-39  Score=346.49  Aligned_cols=264  Identities=24%  Similarity=0.369  Sum_probs=202.5

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHc--CCCCceeeEEeEeec----CceEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ--FRHRHLVSLIGYCDE----RNEMI  555 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~~~----~~~~~  555 (820)
                      .++|...++||+|+||.||+|++ +++.||||++...   ..+.+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            45789999999999999999988 5788999997643   33556677777766  799999999998644    35689


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCC-----CCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS-----TKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~-----~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      +||||+++|+|.+++...   .+++..+++++.|++.||+|||...     +++|+||||||+|||++.++.+||+|||+
T Consensus        83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            999999999999999543   6999999999999999999999321     57999999999999999999999999999


Q ss_pred             cccCCCCCCcc--ccccccCCccccCccccccC------CCCCcceeeehhhhHHHHhcC----------CCCCCCCCch
Q 003436          631 SKIGPDLDQTH--VSTAVKGSFGYLDPEYLTKQ------QLTEKSDVYSFGVVMFEILCG----------RPVIDPSLPR  692 (820)
Q Consensus       631 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvll~ElltG----------~~p~~~~~~~  692 (820)
                      ++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ++||....+.
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            97543322111  12334799999999999876      566799999999999999999          7777544332


Q ss_pred             hhhhHHHHHHHhhccCccccccCcccc-CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          693 EKVNLVEWAMKCQETGQLEDIVDPTLT-GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       693 ~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                      ... .............     .+.+. ......++..+.+++.+||+.||++||++.|+++.|+++
T Consensus       240 ~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          240 DPS-FEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCC-HHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             Ccc-hhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            211 1111111111111     11111 112235678899999999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-39  Score=359.04  Aligned_cols=277  Identities=16%  Similarity=0.202  Sum_probs=212.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCChhhH-----------HHHHHHHHHHHcCCCCceee
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQSHQGL-----------AEFRTEIEMLSQFRHRHLVS  543 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~nIv~  543 (820)
                      ..++|...++||+|+||.||+|.+..      ++.||||.+........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34579999999999999999999865      36899998765543211           12345666777888999999


Q ss_pred             EEeEeecC----ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-
Q 003436          544 LIGYCDER----NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-  618 (820)
Q Consensus       544 l~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-  618 (820)
                      +++++...    ...++||||+ +++|.+++... ...+++.+++.|+.|++.||+|||   +.+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            99998664    4589999999 99999999764 346999999999999999999999   68999999999999998 


Q ss_pred             -CCCCeeEeeccccccCCCCCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCch
Q 003436          619 -ENLMAKVADFGLSKIGPDLDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR  692 (820)
Q Consensus       619 -~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~  692 (820)
                       .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999865432111     1123455999999999999999999999999999999999999999753322


Q ss_pred             hhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCCCCCC
Q 003436          693 EKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEGKS  768 (820)
Q Consensus       693 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~~~  768 (820)
                      ..  ...+.... ....+.+++++.+.   ...++.++.+++.+|++.+|.+||++.++++.|+.++...+.....
T Consensus       268 ~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~  337 (364)
T 3op5_A          268 PK--YVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG  337 (364)
T ss_dssp             HH--HHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HH--HHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence            21  11111111 11223334443332   1244577999999999999999999999999999998866554433

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.7e-39  Score=345.96  Aligned_cols=256  Identities=27%  Similarity=0.468  Sum_probs=202.1

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|...++||+|+||.||+|+.. ++.||+|++...  ...+.|.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            46888899999999999999985 678999997643  345789999999999999999999999874  4799999999


Q ss_pred             CCchhhHhhhcCC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC-eeEeeccccccCCCCCCc
Q 003436          563 NGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM-AKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       563 ~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~-~kl~DFGla~~~~~~~~~  640 (820)
                      +|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++....    
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~----  158 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----  158 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence            9999999976542 35789999999999999999999543389999999999999988886 79999999975332    


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                       ......||..|+|||++.+..++.++||||||++++||++|+.||........ . ..|...   .+..     +    
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~---~~~~-----~----  223 (307)
T 2eva_A          159 -HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWAVH---NGTR-----P----  223 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHHHH---TTCC-----C----
T ss_pred             -ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHHHh---cCCC-----C----
Confidence             12234689999999999999999999999999999999999999975432211 1 111111   1111     1    


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      ......+..+.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus       224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            122344567899999999999999999999999999887654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4e-39  Score=353.15  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=206.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+++.. +++.||+|.+...   .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57899999999999999999986 5889999987543   2234567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence            9999999999997653  6899999999999999999999   789999999999999999999999999999853321 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                       ........||+.|+|||++.+..++.++|||||||++|||++|++||......+..   +.+.    .+..        
T Consensus       159 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i~----~~~~--------  222 (337)
T 1o6l_A          159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---ELIL----MEEI--------  222 (337)
T ss_dssp             -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCC--------
T ss_pred             -CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH---HHHH----cCCC--------
Confidence             12234567999999999999999999999999999999999999999754332211   1111    1110        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                        .++......+.+++.+||+.||++||     ++.|++++
T Consensus       223 --~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              12234456789999999999999999     89998775

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.1e-40  Score=356.67  Aligned_cols=275  Identities=23%  Similarity=0.344  Sum_probs=213.9

Q ss_pred             cCCccceeEeeecceEEEEEEE-----cCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEee--cCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVL-----RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD--ERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~  555 (820)
                      ++|...+.||+|+||.||++++     ..++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688899999999999999984     357889999988777777788999999999999999999999885  556789


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999997643 25899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          636 DLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ..... .......+|..|+|||++.+..++.++||||||++++||++|+.|+........ ....+.........+.+.+
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFL-RMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHCC----CCHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhh-hhcccccccccHHHHHHHh
Confidence            32221 123345688899999999999999999999999999999999998753221100 0000000000000011111


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      ........+..++..+.+++.+||+.||.+||++.|+++.|+.+....
T Consensus       258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            111222334566788999999999999999999999999998886543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=352.85  Aligned_cols=258  Identities=24%  Similarity=0.393  Sum_probs=203.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc----EEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET----KVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...++||+|+||.||+|++.. ++    +|++|.+... .....+.+.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            568999999999999999999753 33    3578876433 3445678999999999999999999999998755 789


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999997653 46899999999999999999999   78999999999999999999999999999986544


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........+|..|+|||++.+..++.++|||||||++|||++ |++||......+.....   .    .+.      
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~----~~~------  236 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---E----KGE------  236 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---H----TTC------
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---H----cCC------
Confidence            333333344567889999999999999999999999999999999 99999765443322111   1    110      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                         ....+..++..+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus       237 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          237 ---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence               1122334567799999999999999999999999999988753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=378.96  Aligned_cols=257  Identities=28%  Similarity=0.438  Sum_probs=212.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      .++|...++||+|+||.||+|+++++..||||++.... ...++|.+|+++|++++||||++++++|.+ +..++|||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            34578888999999999999999888889999987543 235689999999999999999999999976 6789999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.++|.......+++.+++.|+.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++..... ...
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  419 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYT  419 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH-HHH
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC-cee
Confidence            9999999997654456899999999999999999999   789999999999999999999999999999865431 111


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+..   +.+    ..+.         ..
T Consensus       420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~---~~i----~~~~---------~~  483 (535)
T 2h8h_A          420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQV----ERGY---------RM  483 (535)
T ss_dssp             TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH---HHH----HTTC---------CC
T ss_pred             cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH----HcCC---------CC
Confidence            1233457789999999999999999999999999999999 89998755433221   111    1110         11


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+..++..+.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus       484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            2234566789999999999999999999999999987654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=347.81  Aligned_cols=261  Identities=30%  Similarity=0.479  Sum_probs=206.0

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...++||+|+||.||+|++..     +..||||.+... .......+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456678899999999999998753     346999987654 34455679999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999997643 46999999999999999999999   68999999999999999999999999999986543


Q ss_pred             CCC-ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          637 LDQ-THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       637 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ...+    ..+.     
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~~----~~~~-----  267 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAI----NDGF-----  267 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHH----HTTC-----
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHHH----HCCC-----
Confidence            221 111223456789999999999999999999999999999999 9999865433221   1111    1110     


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                          ....+..++..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus       268 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          268 ----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             ----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             ----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                011223456789999999999999999999999999999876543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.6e-39  Score=353.72  Aligned_cols=265  Identities=26%  Similarity=0.371  Sum_probs=214.5

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER  551 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~  551 (820)
                      ...++|...+.||+|+||.||+|....      ...||+|.+.... ....+.+.+|+++++++ +||||+++++++...
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345789999999999999999999753      2479999876543 34567899999999999 899999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcC------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          552 NEMIIIYEYMENGTLKDHLYASN------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                      +..++||||+++|+|.+++....            ...+++..++.++.|++.||+|||   +.+|+||||||+|||++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECC
Confidence            99999999999999999997532            346899999999999999999999   689999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHH
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLV  698 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~  698 (820)
                      ++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||+| |++||.........  .
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~  277 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--Y  277 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--H
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--H
Confidence            99999999999985433222223334567889999999999999999999999999999999 88998754432211  1


Q ss_pred             HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      .....    +         .....+..++..+.+++.+||+.+|.+||++.++++.|+++.+..
T Consensus       278 ~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          278 KLVKD----G---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhc----C---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            11111    1         011122334567899999999999999999999999999887643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=339.33  Aligned_cols=261  Identities=26%  Similarity=0.407  Sum_probs=212.5

Q ss_pred             cCCccce-eEeeecceEEEEEEEc---CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESL-VIGIGGFGKVYRGVLR---DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...+ .||+|+||.||+|++.   .+..||||.+... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999864   5778999997654 345577899999999999999999999999 45668999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+++++|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999998643 346999999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          638 DQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       638 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+..   ...    ..+.      
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~i----~~~~------  230 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFI----EQGK------  230 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHH----HTTC------
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHH----hcCC------
Confidence            221 11233457899999999998899999999999999999998 99999765433221   111    1111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                         ....+..++..+.+++.+||+.+|.+||++.++++.|+.++.....
T Consensus       231 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          231 ---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence               1123345567899999999999999999999999999999875543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.9e-39  Score=349.16  Aligned_cols=269  Identities=23%  Similarity=0.348  Sum_probs=216.6

Q ss_pred             HHHHHHhcCCccceeEeeecceEEEEEEE------cCccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeE
Q 003436          476 VAIQEATDNFSESLVIGIGGFGKVYRGVL------RDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGY  547 (820)
Q Consensus       476 ~~l~~at~~f~~~~~LG~G~fG~Vykg~~------~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~  547 (820)
                      .......++|...+.||+|+||.||+|++      .+++.||||.+.... ....+.+.+|++++.++ +||||++++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            33444567899999999999999999985      246789999876543 34557899999999999 79999999999


Q ss_pred             eecCc-eEEEEEeeccCCchhhHhhhcCC--------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCC
Q 003436          548 CDERN-EMIIIYEYMENGTLKDHLYASNF--------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKS  612 (820)
Q Consensus       548 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp  612 (820)
                      +...+ ..++|+||+++|+|.+++.....              ..+++.+++.++.|++.||+|||   +.+|+||||||
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp  176 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  176 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCcc
Confidence            87654 58999999999999999976542              22889999999999999999999   68999999999


Q ss_pred             CcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCc
Q 003436          613 ANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLP  691 (820)
Q Consensus       613 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~  691 (820)
                      +||+++.++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus       177 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          177 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             ceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            999999999999999999986544333333345568899999999999999999999999999999998 9999875443


Q ss_pred             hhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          692 REKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       692 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      .+.  .....    ..+..         ...+......+.+++.+||+.+|.+||++.|++++|+.+++..
T Consensus       257 ~~~--~~~~~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          257 DEE--FCRRL----KEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             SHH--HHHHH----HHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hHH--HHHHh----ccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            221  11111    11110         1122334567899999999999999999999999999988754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.3e-39  Score=350.99  Aligned_cols=271  Identities=24%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             CccceeEeeecceEEEEEEEc-----CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceEEE
Q 003436          485 FSESLVIGIGGFGKVYRGVLR-----DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEMII  556 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~~-----~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~l  556 (820)
                      |...++||+|+||.||++.+.     +++.||||++.... ....+.+.+|+++|++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998753     57889999976543 4456789999999999999999999999976  467899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++...   .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            99999999999999765   3899999999999999999999   78999999999999999999999999999987654


Q ss_pred             CCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .... .......+|..|+|||.+.+..++.++||||||++++||++|+.||...... ......+.........+.+.++
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-FLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-HHHHHCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh-hhhhhcccccchhHHHHHHHHh
Confidence            3221 2233456888999999999999999999999999999999999988643211 0000000000000000111111


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      .......+..++..+.+++.+||+.+|.+||++.|+++.|+.+.+..
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            12222334456678999999999999999999999999999887643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-38  Score=344.71  Aligned_cols=265  Identities=28%  Similarity=0.436  Sum_probs=204.0

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER  551 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  551 (820)
                      +....++|...++||+|+||.||+|++..    +..||+|.+...  .....+.+.+|++++++++||||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            33445678889999999999999998653    458999987644  345567899999999999999999999999765


Q ss_pred             c-----eEEEEEeeccCCchhhHhhhc----CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC
Q 003436          552 N-----EMIIIYEYMENGTLKDHLYAS----NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM  622 (820)
Q Consensus       552 ~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~  622 (820)
                      .     ..++|+||+++|+|.+++...    ....+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence            5     359999999999999998542    3356999999999999999999999   789999999999999999999


Q ss_pred             eeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHH
Q 003436          623 AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWA  701 (820)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~  701 (820)
                      +||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |++||......+..   ...
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~  262 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---DYL  262 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HHH
Confidence            99999999986543322233344567889999999999999999999999999999999 88888755433221   111


Q ss_pred             HHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          702 MKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       702 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      .    .+.         ....+...+..+.+++.+||+.+|.+||++.++++.|+.+++.
T Consensus       263 ~----~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          263 L----HGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             H----TTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H----cCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1    111         0112334557899999999999999999999999999998764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.1e-39  Score=342.69  Aligned_cols=262  Identities=20%  Similarity=0.298  Sum_probs=202.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH--QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...+.||+|+||.||+|+...++.+|+|++.....  ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999998889999998764432  2346788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++ +|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (288)
T ss_dssp             CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence            985 9999887543 46899999999999999999999   7899999999999999999999999999997543211  


Q ss_pred             cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc---ccc----
Q 003436          641 HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ---LED----  712 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~----  712 (820)
                      .......||..|+|||++.+ ..++.++|||||||+++||++|++||......+....   .........   ...    
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR---IFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGS
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHHCCCChhhchhhhcc
Confidence            12234568999999999976 4589999999999999999999999976543322211   111111100   000    


Q ss_pred             -ccCcccc-------CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 -IVDPTLT-------GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 -~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..++...       ..........+.+++.+||+.||++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0111110       11123456778999999999999999999999863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.7e-39  Score=353.40  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=205.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh------hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH------QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|...+.||+|+||.||+++.. +++.+|+|.+.....      ...+.+.+|+.+|++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467899999999999999999986 588999997654322      1357789999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC----CeeEeeccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL----MAKVADFGL  630 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~----~~kl~DFGl  630 (820)
                      ++||||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999654  36999999999999999999999   78999999999999998776    799999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|++||......+..   ..+.    .+..
T Consensus       166 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~---~~i~----~~~~  235 (361)
T 2yab_A          166 AHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANIT----AVSY  235 (361)
T ss_dssp             CEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHH----TTCC
T ss_pred             ceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH----hcCC
Confidence            9865432   1233467999999999999999999999999999999999999999765432221   1111    1110


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .  .++..    .......+.+++.+||..||.+||++.|++++
T Consensus       236 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 D--FDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             C--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             C--CCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0  01111    11334678899999999999999999999863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-39  Score=352.04  Aligned_cols=265  Identities=25%  Similarity=0.408  Sum_probs=214.8

Q ss_pred             HHHHHhcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEee
Q 003436          477 AIQEATDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCD  549 (820)
Q Consensus       477 ~l~~at~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~  549 (820)
                      +.+...++|...+.||+|+||.||+|+..      .++.||+|.+.... ......+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            33445678999999999999999999865      36789999876543 344567999999999999999999999999


Q ss_pred             cCceEEEEEeeccCCchhhHhhhcC--------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC
Q 003436          550 ERNEMIIIYEYMENGTLKDHLYASN--------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL  621 (820)
Q Consensus       550 ~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~  621 (820)
                      +.+..++||||+++|+|.+++....        ...+++.++++++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCC
Confidence            9999999999999999999997532        245799999999999999999999   68999999999999999999


Q ss_pred             CeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHH
Q 003436          622 MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEW  700 (820)
Q Consensus       622 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~  700 (820)
                      .+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.||......+.   ...
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~  252 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRF  252 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---HHH
Confidence            999999999975433222222334457889999999999999999999999999999999 8888865433221   111


Q ss_pred             HHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          701 AMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       701 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .    ..+..         ...+..++..+.+++.+||+.+|.+||++.|+++.|++.+.
T Consensus       253 ~----~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          253 V----MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             H----HTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H----HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1    11111         11233456779999999999999999999999999977643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-38  Score=339.01  Aligned_cols=259  Identities=25%  Similarity=0.378  Sum_probs=208.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|...+.||+|+||.||+|++.+    +..||+|..... .....+.|.+|++++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4678899999999999999998653    346999987654 344567899999999999999999999998754 5689


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999997643 45899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .. ........++..|+|||++.+..++.++||||||+++|||++ |+.||......+..   .....    +..     
T Consensus       166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~~----~~~-----  232 (281)
T 3cc6_A          166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLEK----GDR-----  232 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHHH----TCC-----
T ss_pred             cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHhc----CCC-----
Confidence            22 112234557889999999999999999999999999999998 99999755433322   11111    100     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                          ...+..++..+.+++.+||+.+|.+||++.|+++.|+.+.+..
T Consensus       233 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          233 ----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                0112334567899999999999999999999999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-39  Score=354.61  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=201.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCC--CChhhHHHHHHHHHHHHcCCC--CceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFRH--RHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...+.||+|+||.||++...+++.||||++..  ......+.+.+|+++|.+++|  +||+++++++..+...++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            356889999999999999999998899999998653  345556789999999999976  9999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      || +.+|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++.....
T Consensus        88 ~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             Ee-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            99 5688999999865  36899999999999999999999   68999999999999997 678999999999865543


Q ss_pred             CCccccccccCCccccCcccccc-----------CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTK-----------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......     ..      
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~------  229 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SK------  229 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HH------
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HH------
Confidence            33333445679999999999865           678999999999999999999999996433211     11      


Q ss_pred             cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       707 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                         +..++++......+......+.+++.+||+.||.+||++.|++++-.
T Consensus       230 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          230 ---LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             ---HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ---HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence               11112222222334444567899999999999999999999998754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-38  Score=339.70  Aligned_cols=252  Identities=29%  Similarity=0.493  Sum_probs=203.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhh-------HHHHHHHHHHHHcCCCCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQG-------LAEFRTEIEMLSQFRHRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~-------~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  553 (820)
                      .++|...+.||+|+||.||+|++. +++.||+|++.......       .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367889999999999999999985 68899999875433211       167899999999999999999999997665 


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc--EEeccCCCCcEEEcCCCC-----eeEe
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA--IIHRDVKSANILLDENLM-----AKVA  626 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--iiHrDIkp~NIll~~~~~-----~kl~  626 (820)
                       ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+  |+||||||+|||++.++.     +||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence             69999999999999886543 46999999999999999999999   677  999999999999987776     9999


Q ss_pred             eccccccCCCCCCccccccccCCccccCcccc--ccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL--TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      |||+++....     ......||..|+|||++  ....++.++||||||+++|||++|+.||......+.. ......  
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~--  243 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMIR--  243 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHHH--
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHHh--
Confidence            9999974322     23446799999999998  4556789999999999999999999999755433221 111111  


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                       ..         ......+..++..+.+++.+||+.||.+||++.|+++.|++
T Consensus       244 -~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 -EE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -HS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -cc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             11         11122334556789999999999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.5e-39  Score=342.34  Aligned_cols=260  Identities=31%  Similarity=0.559  Sum_probs=198.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...++||+|+||.||+|+..+  .+|+|.+...  .....+.|.+|++++++++||||+++++++. ....++|+|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence            4568899999999999999998754  4899976543  4455678999999999999999999999764 456899999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus       100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999996543 46999999999999999999999   78999999999999999999999999999976543233


Q ss_pred             ccccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          640 THVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ........||..|+|||.+.   +..++.++||||||+++|||++|+.||......+.  +.+...    .+...    +
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~----~~~~~----~  245 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVG----RGSLS----P  245 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHH----HTSCC----C
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhc----ccccC----c
Confidence            33334567999999999986   56788899999999999999999999976543322  111111    11111    1


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      .+ ......++..+.+++.+||+.+|.+||++.++++.|+++.
T Consensus       246 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          246 DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            11 1223456678999999999999999999999999998764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-39  Score=351.13  Aligned_cols=244  Identities=23%  Similarity=0.290  Sum_probs=194.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||+||+|++. +++.||||++...  .......+..|+..+.++ +||||++++++|.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999987 6899999986543  334445566666666655 8999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+ +++|.+++.... ..++|.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence            999 679999887654 46999999999999999999999   689999999999999999999999999998865332 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......||+.|+|||++.+ .++.++|||||||++|||++|..++....        .|.  ....+..    .+. 
T Consensus       211 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~--~~~~~~~----~~~-  272 (311)
T 3p1a_A          211 --GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQ--QLRQGYL----PPE-  272 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHH--HHTTTCC----CHH-
T ss_pred             --CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHH--HHhccCC----Ccc-
Confidence              22334569999999999876 78999999999999999999976553211        111  0111111    111 


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                         ........+.+++.+||+.||++||++.|+++
T Consensus       273 ---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 ---FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               11234567899999999999999999999986

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-39  Score=349.18  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=205.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh------hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH------QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|...+.||+|+||.||+++.. +++.||+|.+.....      ...+.+.+|+.+|++++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356889999999999999999986 578999997643321      2357899999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC----CeeEeeccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL----MAKVADFGL  630 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~----~~kl~DFGl  630 (820)
                      ++||||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999654  46999999999999999999999   78999999999999998877    899999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|++||......+....   ....  ....
T Consensus       165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~--~~~~  236 (326)
T 2y0a_A          165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN---VSAV--NYEF  236 (326)
T ss_dssp             CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH---HHHT--CCCC
T ss_pred             CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HHhc--CCCc
Confidence            98654321   22345799999999999999999999999999999999999999976543322111   1110  0000


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          .+    .........+.+++.+||+.||.+||++.|++++
T Consensus       237 ----~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          237 ----ED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----CH----HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----Cc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                00    0112334678899999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=343.61  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh--------------------------hhHHHHHHHHHHHH
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH--------------------------QGLAEFRTEIEMLS  534 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--------------------------~~~~~f~~Ei~~l~  534 (820)
                      .++|...+.||+|+||.||+|+.. +++.||||.+.....                          ...+.+.+|+++|+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357899999999999999999975 578899998644321                          12356889999999


Q ss_pred             cCCCCceeeEEeEeec--CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCC
Q 003436          535 QFRHRHLVSLIGYCDE--RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKS  612 (820)
Q Consensus       535 ~l~H~nIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp  612 (820)
                      +++||||+++++++..  .+..++||||+++++|.+++..   ..+++.++..++.|++.||+|||   +.+|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            9999999999999976  5688999999999999886543   36999999999999999999999   68999999999


Q ss_pred             CcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCC---CCCcceeeehhhhHHHHhcCCCCCCCC
Q 003436          613 ANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTEKSDVYSFGVVMFEILCGRPVIDPS  689 (820)
Q Consensus       613 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SfGvll~ElltG~~p~~~~  689 (820)
                      +|||++.++.+||+|||+++......  .......||+.|+|||++.+..   .+.++|||||||++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999998654322  2234467999999999997765   478899999999999999999999754


Q ss_pred             CchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          690 LPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       690 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....   +..   .. ......        .......+..+.+++.+||+.||++||++.|++++
T Consensus       244 ~~~~---~~~---~~-~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 RIMC---LHS---KI-KSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SHHH---HHH---HH-HHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             cHHH---HHH---HH-hcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            3221   111   11 111110        01112345678999999999999999999999764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-39  Score=348.54  Aligned_cols=253  Identities=18%  Similarity=0.274  Sum_probs=207.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+++|++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467899999999999999999986 47889999876543 3456788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC--CCCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE--NLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~--~~~~kl~DFGla~~~~~~~  638 (820)
                      +++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus        83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            99999999996543 46899999999999999999999   789999999999999987  789999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......||+.|+|||++.+..++.++|||||||++|||++|++||......+..   ..+..    +...  .++..
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~----~~~~--~~~~~  226 (321)
T 1tki_A          158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII---ENIMN----AEYT--FDEEA  226 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHHH----TCCC--CCHHH
T ss_pred             --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH---HHHHc----CCCC--CChhh
Confidence              2233457899999999999988999999999999999999999999765433221   11111    1100  00000


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                          ....+.++.+++.+||+.||.+||++.|++++-
T Consensus       227 ----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          227 ----FKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             ----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence                113346789999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-38  Score=342.34  Aligned_cols=275  Identities=26%  Similarity=0.367  Sum_probs=208.8

Q ss_pred             CCCHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC--CCCceeeEEeEee
Q 003436          472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF--RHRHLVSLIGYCD  549 (820)
Q Consensus       472 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l--~H~nIv~l~g~~~  549 (820)
                      ..+........++|...++||+|+||.||+|+.. ++.||||++....   ...+..|.+++..+  +||||+++++++.
T Consensus        26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~  101 (337)
T 3mdy_A           26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADI  101 (337)
T ss_dssp             SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             CCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence            3455555556688999999999999999999986 7899999875332   34455666666655  8999999999987


Q ss_pred             cC----ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC--------cEEeccCCCCcEEE
Q 003436          550 ER----NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK--------AIIHRDVKSANILL  617 (820)
Q Consensus       550 ~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~--------~iiHrDIkp~NIll  617 (820)
                      ..    ...++||||+++|+|.+++...   .+++.+++.++.|++.||+|||   ..        +|+||||||+|||+
T Consensus       102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          102 KGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             ESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             cCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEE
Confidence            76    6889999999999999999764   5999999999999999999999   55        99999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCcc--ccccccCCccccCccccccCCCCCc------ceeeehhhhHHHHhcC-------
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTH--VSTAVKGSFGYLDPEYLTKQQLTEK------SDVYSFGVVMFEILCG-------  682 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~k------sDV~SfGvll~ElltG-------  682 (820)
                      +.++.+||+|||+++.........  ......||..|+|||++.+...+.+      +|||||||++|||++|       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999997544322111  1224579999999999988776665      9999999999999999       


Q ss_pred             ---CCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC-CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          683 ---RPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ-IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       683 ---~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                         +.|+......... ... ...........    +.+... ....++.++.+++.+||+.||.+||++.|+++.|+.+
T Consensus       256 ~~~~~p~~~~~~~~~~-~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPS-YED-MREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             CCCCCTTTTTSCSSCC-HHH-HHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCCc-hhh-hHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence               5565433222111 011 11111111111    111111 1236778899999999999999999999999999998


Q ss_pred             Hhhc
Q 003436          759 LQLQ  762 (820)
Q Consensus       759 ~~~~  762 (820)
                      .+..
T Consensus       330 ~~~~  333 (337)
T 3mdy_A          330 SESQ  333 (337)
T ss_dssp             HHTT
T ss_pred             Hhhc
Confidence            7754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-38  Score=342.76  Aligned_cols=263  Identities=24%  Similarity=0.394  Sum_probs=207.9

Q ss_pred             cCCccceeEeeecceEEEEEEE-----cCccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC--ceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVL-----RDETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER--NEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~  554 (820)
                      +.|+..++||+|+||.||+|++     ..++.||+|++.... ....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588889999999999999984     357899999876443 33457899999999999999999999999776  668


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            99999999999999996543 45899999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCch---------hhhhHHHHHHHh
Q 003436          635 PDLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR---------EKVNLVEWAMKC  704 (820)
Q Consensus       635 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~---------~~~~l~~~~~~~  704 (820)
                      ...... .......||..|+|||.+.+..++.++||||||++++||++|+.|+......         ........... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT-  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH-
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH-
Confidence            543221 2233456888999999999999999999999999999999999876422100         00011111111 


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      ..         .......+...+..+.+++.+||+.||.+||++.++++.|+.++
T Consensus       256 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LK---------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HH---------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             Hh---------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11         11111233456678999999999999999999999999998875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=373.68  Aligned_cols=260  Identities=25%  Similarity=0.400  Sum_probs=207.7

Q ss_pred             CCccce-eEeeecceEEEEEEEc---CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          484 NFSESL-VIGIGGFGKVYRGVLR---DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++...+ .||+|+||.||+|.+.   ++..||||++.... ....++|.+|+++|++++||||++++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999875   46789999987543 3456889999999999999999999999976 5689999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus       415 E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             ECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            999999999999754 346999999999999999999999   7899999999999999999999999999998654322


Q ss_pred             Cc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          639 QT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       639 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .. .......++..|+|||++.+..++.++|||||||+||||++ |+.||......+..   ..+    ..+.       
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i----~~~~-------  556 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFI----EQGK-------  556 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HHH----HTTC-------
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HcCC-------
Confidence            11 11223346789999999999999999999999999999998 99999765443322   111    1111       


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                        ....+..++..+.+|+.+||+.+|++||++.++++.|+.+......
T Consensus       557 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          557 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             --CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             --CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence              1123345678899999999999999999999999999998765443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5e-39  Score=355.55  Aligned_cols=272  Identities=21%  Similarity=0.281  Sum_probs=212.4

Q ss_pred             CCCHHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-----CCceeeEE
Q 003436          472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-----HRHLVSLI  545 (820)
Q Consensus       472 ~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----H~nIv~l~  545 (820)
                      .+++.+.....++|...++||+|+||.||+|+.. +++.||||++... ....+.+..|++++++++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            4455555556788999999999999999999985 5788999997643 344567788999999996     99999999


Q ss_pred             eEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC------
Q 003436          546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE------  619 (820)
Q Consensus       546 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~------  619 (820)
                      +++...+..++||||+ +++|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 899999998877667999999999999999999999   789999999999999975      


Q ss_pred             -------------------CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHh
Q 003436          620 -------------------NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL  680 (820)
Q Consensus       620 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ell  680 (820)
                                         ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                               789999999999864332     23457899999999999999999999999999999999


Q ss_pred             cCCCCCCCCCchhhhhHHHHHH---------HhhccCccccccCccccCCCC--------------------hhhHHHHH
Q 003436          681 CGRPVIDPSLPREKVNLVEWAM---------KCQETGQLEDIVDPTLTGQIK--------------------PDSLNKFV  731 (820)
Q Consensus       681 tG~~p~~~~~~~~~~~l~~~~~---------~~~~~~~~~~~~d~~l~~~~~--------------------~~~~~~l~  731 (820)
                      +|+.||......+.........         ...............+....+                    ......+.
T Consensus       254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~  333 (360)
T 3llt_A          254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC  333 (360)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred             HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence            9999997655443322221110         000000000000000000000                    01125678


Q ss_pred             HHHHHHhhcCCCCCCCHHHHHH
Q 003436          732 EIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       732 ~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      +++.+||+.||++||++.|+++
T Consensus       334 ~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          334 DFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhcCChhhCCCHHHHhc
Confidence            9999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-38  Score=353.67  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=208.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...+.||+|+||.||+|+.. +++.+|+|.+..........+.+|+++|++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999986 5788999988766666667899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC--CCCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE--NLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~--~~~~kl~DFGla~~~~~~~  638 (820)
                      +++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++......
T Consensus       130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            99999999986542 46999999999999999999999   789999999999999974  5789999999998654321


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                         ......||+.|+|||++.+..++.++|||||||++|||++|++||......+.   ...+..    ...      ..
T Consensus       206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~---~~~i~~----~~~------~~  269 (387)
T 1kob_A          206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVKR----CDW------EF  269 (387)
T ss_dssp             ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHH----CCC------CC
T ss_pred             ---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH---HHHHHh----CCC------CC
Confidence               22345799999999999999999999999999999999999999976543222   111111    110      01


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...........+.+++.+||+.||.+||++.|++++
T Consensus       270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            111223445678999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=354.50  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=201.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  555 (820)
                      ..++|...++||+|+||.||+|+.. +++.||+|++...   .....+.+..|.++|..+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999986 4789999987543   223456688999999988 7999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       101 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999997653  5899999999999999999999   7899999999999999999999999999998533


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..  .......+||+.|+|||++.+..++.++|||||||++|||++|++||......+....   +.    .+..     
T Consensus       176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~---i~----~~~~-----  241 (353)
T 3txo_A          176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA---IL----NDEV-----  241 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH----HCCC-----
T ss_pred             cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH---HH----cCCC-----
Confidence            21  2223456799999999999999999999999999999999999999976543322111   11    1110     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCH------HHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM------GDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~------~evl~~  754 (820)
                           .++......+.+++.+||+.+|.+||++      .|++++
T Consensus       242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                 1223345678899999999999999998      666653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-38  Score=356.08  Aligned_cols=252  Identities=23%  Similarity=0.344  Sum_probs=201.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCC--CChhhHHHHHHHHHHHHcCC--CCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFR--HRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||++....++.||||++..  ......+.+.+|+++|++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            45899999999999999999988899999998643  34556688999999999996  599999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      | +.+++|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++......
T Consensus       136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            9 66889999997654  6899999999999999999999   78999999999999995 5899999999998654433


Q ss_pred             CccccccccCCccccCcccccc-----------CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK-----------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|++||.......     ....     
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~-----  278 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLH-----  278 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHH-----
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHH-----
Confidence            2223345679999999999865           468899999999999999999999996543211     1111     


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                          .++++......+......+.+++.+||+.||.+||++.|++++-
T Consensus       279 ----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          279 ----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             ----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                11222222223333456789999999999999999999999764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.6e-39  Score=345.07  Aligned_cols=250  Identities=23%  Similarity=0.397  Sum_probs=203.8

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-c-------cEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-E-------TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~-------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      ++|...+.||+|+||.||+|+... +       ..||+|.+........+.+.+|++++++++||||+++++++..++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            568888999999999999998764 2       46999998776666778899999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC--------eeEe
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM--------AKVA  626 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~--------~kl~  626 (820)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.        +||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999997643 34899999999999999999999   789999999999999998887        9999


Q ss_pred             eccccccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCC-CCCCCCCchhhhhHHHHHHHh
Q 003436          627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~-~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      |||+++....      .....||..|+|||++.+ ..++.++||||||+++|||++|. +|+.........   ..   .
T Consensus       164 Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~---~~---~  231 (289)
T 4fvq_A          164 DPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL---QF---Y  231 (289)
T ss_dssp             CCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HH---H
T ss_pred             cCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH---HH---h
Confidence            9999864322      123457889999999987 77999999999999999999965 444432221111   11   1


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ....            ..+......+.+++.+||+.||.+||++.++++.|+.++.
T Consensus       232 ~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          232 EDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1111            1111223457899999999999999999999999987755

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.2e-39  Score=347.62  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=196.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce----
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE----  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~----  553 (820)
                      .++|...++||+|+||.||+|+.. +++.||||++...   .......+.+|++++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            357899999999999999999974 6889999987654   33445678999999999999999999999866543    


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||||+++|+|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            499999999999999997653  6899999999999999999999   68999999999999999999999999999986


Q ss_pred             CCCCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          634 GPDLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       634 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ....... .......||..|+|||++.+..++.++||||||+++|||++|+.||......+..      .......... 
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~-  238 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPIP-  238 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCCC-
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCCC-
Confidence            5432211 2223456899999999999999999999999999999999999999765432211      1111111100 


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         +.   ......+..+.+++.+||+.||.+||+..+++..
T Consensus       239 ---~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          239 ---PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             ---HH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             ---cc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence               00   0112345678999999999999999976666543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.9e-39  Score=340.31  Aligned_cols=253  Identities=29%  Similarity=0.418  Sum_probs=202.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-ceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-NEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~  560 (820)
                      .++|...+.||+|+||.||+|..+ ++.||||.+....  ..+.+.+|++++++++||||+++++++.+. +..++|+||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            356889999999999999999875 7889999976543  457789999999999999999999997544 578999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.+++.......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            99999999997654445889999999999999999999   789999999999999999999999999998754321   


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                        .....++..|+|||.+.+..++.++||||||++++||++ |+.||......+..   ..    ...+         ..
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~----~~~~---------~~  232 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PR----VEKG---------YK  232 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HH----HTTT---------CC
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HhcC---------CC
Confidence              223457889999999999999999999999999999998 99998755332211   11    1111         11


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ...+...+..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus       233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            122345567899999999999999999999999999988653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=357.67  Aligned_cols=254  Identities=20%  Similarity=0.273  Sum_probs=206.2

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ..++|...++||+|+||.||++... +++.+|+|.+....  ....+.+.+|+++|++++||||+++++++.+++..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4567999999999999999999875 57889999865433  34456789999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeeccccccC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIG  634 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFGla~~~  634 (820)
                      |||+++|+|.+.+....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++   +++.+||+|||+++..
T Consensus        89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            99999999999997654  5999999999999999999999   78999999999999998   4688999999999765


Q ss_pred             CCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|++||......+..   ..+    ..+...   
T Consensus       164 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~---~~i----~~~~~~---  231 (444)
T 3soa_A          164 EGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY---QQI----KAGAYD---  231 (444)
T ss_dssp             CTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHH----HHTCCC---
T ss_pred             cCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH---HHH----HhCCCC---
Confidence            4322  2223467999999999999999999999999999999999999999754332221   111    111111   


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ............+.+++.+||+.||.+||++.|++++
T Consensus       232 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          232 ---FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               0011112345678999999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2e-38  Score=354.81  Aligned_cols=270  Identities=21%  Similarity=0.270  Sum_probs=206.4

Q ss_pred             hcCCccceeEeee--cceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIG--GFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G--~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|...++||+|  +||.||+|+.. +++.||||++...  .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4569999999999  99999999987 5889999986543  34456778899999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |||||++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999998776667999999999999999999999   78999999999999999999999999999864322


Q ss_pred             CCC-----ccccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhH-HHHHHH-hhcc
Q 003436          637 LDQ-----THVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNL-VEWAMK-CQET  707 (820)
Q Consensus       637 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l-~~~~~~-~~~~  707 (820)
                      ...     ........||..|+|||++.+  ..++.++|||||||++|||++|++||......+.... ...... ....
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            111     111223468999999999987  6799999999999999999999999975443322110 000000 0000


Q ss_pred             ------------------Ccccccc---Ccc------ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 ------------------GQLEDIV---DPT------LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ------------------~~~~~~~---d~~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                        ..+.+..   .+.      ............+.+++.+||+.||.+||++.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                              0000000   000      0001223345678999999999999999999999865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-38  Score=344.44  Aligned_cols=245  Identities=27%  Similarity=0.379  Sum_probs=204.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56889999999999999999986 58899999865331   123567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            9999999999997653  6899999999999999999999   78999999999999999999999999999986433  


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                         ......||+.|+|||++.+..++.++|||||||++|||++|++||......+..   .   .... +..        
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~---~i~~-~~~--------  220 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY---E---KILN-AEL--------  220 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H---HHHH-CCC--------
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H---HHHh-CCC--------
Confidence               123467999999999999999999999999999999999999999754332211   1   1111 110        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                        .++.....++.+++.+|++.+|.+||     ++.|++++
T Consensus       221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence              12233456789999999999999999     88888754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.6e-38  Score=338.08  Aligned_cols=270  Identities=19%  Similarity=0.261  Sum_probs=208.8

Q ss_pred             HhcCCccceeEeeecceEEEEEEE-cCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEe-ecCceEEEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC-DERNEMIIIY  558 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~  558 (820)
                      ..++|...+.||+|+||.||+|+. .+++.||||.......  .+.+.+|++++++++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999997 4688999997543322  23578899999999988877777665 6677889999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE---cCCCCeeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll---~~~~~~kl~DFGla~~~~  635 (820)
                      ||+ +++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+   ++++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 999999987543 36999999999999999999999   7899999999999999   789999999999998654


Q ss_pred             CCCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          636 DLDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       636 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      .....     .......||..|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            32221     1223567999999999999999999999999999999999999999765433322222211111111100


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEG  766 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~  766 (820)
                      .         ......+..+.+++.+|++.+|++||++.++++.|+.+.+..+...
T Consensus       240 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~  286 (296)
T 4hgt_A          240 E---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  286 (296)
T ss_dssp             H---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred             h---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence            0         0112234679999999999999999999999999999988665433

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.9e-38  Score=337.18  Aligned_cols=263  Identities=21%  Similarity=0.294  Sum_probs=202.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..++||+|+||.||+|+.. +++.||+|++...  .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            56889999999999999999986 5788999986533  33445778899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++ +|.+.+.... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--  154 (292)
T ss_dssp             CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--
T ss_pred             cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--
Confidence            9975 6666655432 46999999999999999999999   689999999999999999999999999999865422  


Q ss_pred             ccccccccCCccccCccccccCC-CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC---cc---cc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQ-LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG---QL---ED  712 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~---~~  712 (820)
                      ........||..|+|||++.+.. ++.++|||||||+++||++|+.|+........  ............   ..   .+
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcc
Confidence            12233457899999999997765 79999999999999999998877543332211  111111111110   00   00


Q ss_pred             ccC---------ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 IVD---------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 ~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+         ........+.....+.+++.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000         000112223456788999999999999999999999863

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.9e-38  Score=350.04  Aligned_cols=253  Identities=22%  Similarity=0.319  Sum_probs=206.5

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ..++|...+.||+|+||.||+|+.. +++.||+|.+...  .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999986 5789999986543  344567899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC---CCeeEeeccccccC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN---LMAKVADFGLSKIG  634 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~---~~~kl~DFGla~~~  634 (820)
                      |||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|||+++..
T Consensus       107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999999998654  36899999999999999999999   6899999999999999764   45999999999865


Q ss_pred             CCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|++||......+   +...+.    .+...   
T Consensus       182 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~----~~~~~---  248 (362)
T 2bdw_A          182 NDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIK----AGAYD---  248 (362)
T ss_dssp             TTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HTCCC---
T ss_pred             cCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----hCCCC---
Confidence            432   12234679999999999999999999999999999999999999997543322   111111    11110   


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .........+..+.+++.+||+.||.+||++.|++++
T Consensus       249 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               0001112345678999999999999999999998765

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-38  Score=347.00  Aligned_cols=262  Identities=27%  Similarity=0.396  Sum_probs=208.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|...+.||+|+||.||+|++.      ++..||||.+... ......++.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            467999999999999999999843      4678999997644 345567899999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCC-----CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEe
Q 003436          555 IIIYEYMENGTLKDHLYASNF-----PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVA  626 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~  626 (820)
                      ++||||+++|+|.+++.....     ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++   ++..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999986542     45899999999999999999999   78999999999999998   45569999


Q ss_pred             eccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhh
Q 003436          627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      |||+++...............+|..|+|||++.+..++.++||||||+++|||+| |+.||......+   ..+...   
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~---  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFVT---  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH---
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHHh---
Confidence            9999975433222222334567899999999999999999999999999999998 889987543322   111111   


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                       .+..         ...+..++..+.+++.+||+.+|.+||++.++++.|+.+.+..
T Consensus       260 -~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          260 -SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             -TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence             1110         1122345577899999999999999999999999999887644

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2e-38  Score=354.54  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=199.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|...++||+|+||.||+++... ++.+|+|++...   .....+.+..|..+|.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4579999999999999999999874 778999986533   223345678899999887 89999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999997653  6999999999999999999999   78999999999999999999999999999985332


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh--hhHHHHHHHhhccCcccccc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK--VNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~  714 (820)
                      .  .......+||+.|+|||++.+..++.++|||||||++|||++|++||......+.  ....++.........+    
T Consensus       206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  279 (396)
T 4dc2_A          206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  279 (396)
T ss_dssp             T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred             C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence            1  2233456899999999999999999999999999999999999999964322111  1111111111111111    


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                            .++......+.+++.+||+.||.+||++
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                  2233455678999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.9e-38  Score=337.91  Aligned_cols=259  Identities=28%  Similarity=0.446  Sum_probs=204.8

Q ss_pred             cCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEe-ecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYC-DERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~l  556 (820)
                      .+|...++||+|+||.||+|++.+    ...+|+|..... .....+.+.+|++++++++||||++++++| ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457888899999999999999653    235889987643 345567899999999999999999999986 45567899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus       105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999653 346899999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCC--ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          637 LDQ--THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       637 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ...  ........+|..|+|||.+.+..++.++||||||++++||++ |.+|+......+.   ......    +.    
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~~~----~~----  249 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQ----GR----  249 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHHHT----TC----
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHHhc----CC----
Confidence            221  122334567889999999999999999999999999999999 5566654332221   111111    10    


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                           ....+..++..+.+++.+||+.+|.+||++.|+++.|+.+...
T Consensus       250 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          250 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                 0011233456799999999999999999999999999998764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=351.86  Aligned_cols=269  Identities=16%  Similarity=0.191  Sum_probs=210.6

Q ss_pred             cCCccceeEeeecceEEEEEEEcC---------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceee----------
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD---------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVS----------  543 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~---------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~----------  543 (820)
                      ++|...+.||+|+||.||+|+...         ++.||+|.....     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            578999999999999999999864         788999987644     35788999999999999987          


Q ss_pred             -----EEeEeec-CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          544 -----LIGYCDE-RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       544 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                           +++++.. +...++||||+ +++|.+++.......+++.+++.++.|++.||+|||   +.+|+||||||+|||+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 6677765 67889999999 999999998764457999999999999999999999   6899999999999999


Q ss_pred             cCCC--CeeEeeccccccCCCCCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCC
Q 003436          618 DENL--MAKVADFGLSKIGPDLDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSL  690 (820)
Q Consensus       618 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~  690 (820)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999865432111     11234579999999999999999999999999999999999999997543


Q ss_pred             chhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 003436          691 PREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGDEG  766 (820)
Q Consensus       691 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~~~  766 (820)
                      .... .+.........  ......++..   .....+..+.+++.+||+.||.+||++.++++.|+++++..+...
T Consensus       273 ~~~~-~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  342 (352)
T 2jii_A          273 PNTE-DIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP  342 (352)
T ss_dssp             TCHH-HHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred             cCHH-HHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence            2211 11111111111  1111111111   011335779999999999999999999999999999987665433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6e-38  Score=336.58  Aligned_cols=267  Identities=19%  Similarity=0.272  Sum_probs=210.5

Q ss_pred             hcCCccceeEeeecceEEEEEEE-cCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEe-ecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC-DERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~-~~~~~~~lV~E  559 (820)
                      .++|...+.||+|+||.||+|+. .+++.||||.+......  +++.+|++++++++|++++..+.++ .+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999997 46889999986544322  4688999999999988877666665 66677899999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE---cCCCCeeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll---~~~~~~kl~DFGla~~~~~  636 (820)
                      |+ +++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+   ++++.+||+|||+++....
T Consensus        86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            99 899999997443 46999999999999999999999   7899999999999999   5889999999999986544


Q ss_pred             CCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          637 LDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       637 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      ....     .......||..|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence            2221     11245679999999999999999999999999999999999999997644332222222111111100000


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                               ......+..+.+++.+||+.+|.+||++.++++.|+++.+..+.
T Consensus       241 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          241 ---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             ---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ---------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                     01123446799999999999999999999999999998876544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=346.75  Aligned_cols=269  Identities=25%  Similarity=0.371  Sum_probs=199.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHH--HHcCCCCceeeEEeEe-----ecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEM--LSQFRHRHLVSLIGYC-----DERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~--l~~l~H~nIv~l~g~~-----~~~~~~  554 (820)
                      .++|...++||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++||||+++++.+     ......
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            35789999999999999999987 57899999875433   2344455555  4458999999999854     233467


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC---------cEEeccCCCCcEEEcCCCCeeE
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK---------AIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~---------~iiHrDIkp~NIll~~~~~~kl  625 (820)
                      ++||||+++|+|.+++....   .++..++.++.|++.||+|||   +.         +|+||||||+|||++.++.+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            89999999999999997653   589999999999999999999   56         9999999999999999999999


Q ss_pred             eeccccccCCCCCC------ccccccccCCccccCcccccc-------CCCCCcceeeehhhhHHHHhcCCCCCCCCCch
Q 003436          626 ADFGLSKIGPDLDQ------THVSTAVKGSFGYLDPEYLTK-------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR  692 (820)
Q Consensus       626 ~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~  692 (820)
                      +|||+++.......      ........||..|+|||++.+       ..++.++|||||||++|||++|+.|+......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999986543211      112234569999999999976       46778999999999999999997665433221


Q ss_pred             hhh--hH---------HHHHHHhhccCccccccCccccCC--CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          693 EKV--NL---------VEWAMKCQETGQLEDIVDPTLTGQ--IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       693 ~~~--~l---------~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      ...  ..         .............    .+.+...  ....++..+.+++.+||+.||++||++.|+++.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            110  00         0000111111111    1111111  12346678999999999999999999999999999998


Q ss_pred             hhcCC
Q 003436          760 QLQGD  764 (820)
Q Consensus       760 ~~~~~  764 (820)
                      ..-..
T Consensus       318 ~~~~~  322 (336)
T 3g2f_A          318 MIWER  322 (336)
T ss_dssp             HCCCC
T ss_pred             HHHHh
Confidence            75544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=344.42  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=201.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-----hhhHHHHHHHHHHHHcCC---CCceeeEEeEeecC
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-----HQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDER  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~  551 (820)
                      .+++|+..++||+|+||.||+|+.. +++.||+|++....     ......+.+|++++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999974 57899999864221     111245667777777664   99999999998765


Q ss_pred             c-----eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEe
Q 003436          552 N-----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVA  626 (820)
Q Consensus       552 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~  626 (820)
                      .     ..++|+||++ |+|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5799999997 69999998876667999999999999999999999   6899999999999999999999999


Q ss_pred             eccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc
Q 003436          627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      |||+++.....   .......||..|+|||++.+..++.++|||||||++|||++|++||......+.............
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999865332   223446789999999999999999999999999999999999999976554333221111100000


Q ss_pred             cCccccc-------cCcc---ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          707 TGQLEDI-------VDPT---LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       707 ~~~~~~~-------~d~~---l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...+...       ..+.   ......++....+.+++.+||+.||++||++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0000000       0000   0001112445778999999999999999999999863

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.8e-38  Score=337.10  Aligned_cols=259  Identities=25%  Similarity=0.346  Sum_probs=208.3

Q ss_pred             hcCCccce-eEeeecceEEEEEEEc---CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          482 TDNFSESL-VIGIGGFGKVYRGVLR---DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       482 t~~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      .++|...+ .||+|+||.||+|.+.   .++.||||.+....  ....+++.+|++++++++||||+++++++ +.+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35677777 9999999999999653   46789999876443  33467899999999999999999999999 556789


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        94 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999999764  35899999999999999999999   6899999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          636 DLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.   ....    ..+..   
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~---  238 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAML----EKGER---  238 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----HTTCC---
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----HcCCC---
Confidence            32221 11223456789999999999899999999999999999999 9999976543221   1111    11111   


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                            ...+..++..+.+++.+||+.||.+||++.++++.|+.++...
T Consensus       239 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          239 ------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                  1223455678999999999999999999999999999987654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.6e-38  Score=345.50  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             hcCCccceeEeeecceEEEEEEE----cCccEEEEEeCCCCC----hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL----RDETKVAVKRGGTQS----HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~  553 (820)
                      .++|...++||+|+||.||+++.    ..++.+|+|++....    ......+.+|+++|++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            35799999999999999999997    468899999876432    2334568899999999999999999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999997653  5889999999999999999999   68999999999999999999999999999975


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ....  ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+..   ..+..    ..    
T Consensus       171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~----~~----  237 (327)
T 3a62_A          171 SIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI---DKILK----CK----  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHH----TC----
T ss_pred             cccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHh----CC----
Confidence            3321  12233467999999999999999999999999999999999999999755432211   11111    10    


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                            ...+......+.+++.+||+.+|.+||     ++.|++++
T Consensus       238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                  112334457789999999999999999     67777764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=352.72  Aligned_cols=259  Identities=27%  Similarity=0.437  Sum_probs=198.6

Q ss_pred             CCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-CceEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-RNEMIII  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV  557 (820)
                      .|...++||+|+||.||+|++.+    ...||||.+... .....++|.+|+.++++++||||++++++|.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            46667899999999999999742    246899987643 34556789999999999999999999998754 5678999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999996543 46899999999999999999999   789999999999999999999999999999854332


Q ss_pred             CC--ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          638 DQ--THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       638 ~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ..  ........+|..|+|||++.+..++.++|||||||++|||++ |.+||......+.   .....    .+..    
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~~----~~~~----  314 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLL----QGRR----  314 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHHH----TTCC----
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHHH----cCCC----
Confidence            21  112234567889999999999999999999999999999999 6677765433222   11111    1110    


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                           ...+..++..+.+++.+||+.+|++||++.|+++.|+.+....
T Consensus       315 -----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          315 -----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                 0112345678999999999999999999999999999987644

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=340.83  Aligned_cols=265  Identities=23%  Similarity=0.328  Sum_probs=201.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|...++||+|+||.||+|+... ++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            578899999999999999999864 8899999865433  3345778899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-  156 (311)
T ss_dssp             CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence            99999999987654  36899999999999999999999   7899999999999999999999999999998654321 


Q ss_pred             ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH--------HhhccC-c
Q 003436          640 THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM--------KCQETG-Q  709 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~-~  709 (820)
                       .......||..|+|||++.+ ..++.++||||||++++||++|++||......+.........        ...... .
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence             12234568999999999976 678999999999999999999999997665444332221110        000000 0


Q ss_pred             cc--cccCccccCC---CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 LE--DIVDPTLTGQ---IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 ~~--~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..  .+.++.....   ..+.....+.+++.+||+.||.+||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00  0001100000   012345678999999999999999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-38  Score=360.88  Aligned_cols=263  Identities=23%  Similarity=0.280  Sum_probs=209.2

Q ss_pred             HHHHHHHhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCCCCceeeEEeEeec
Q 003436          475 FVAIQEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFRHRHLVSLIGYCDE  550 (820)
Q Consensus       475 ~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  550 (820)
                      +.+++..+++|...++||+|+||+||+|++.. ++.||+|++.....   ...+.+.+|+.++.+++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34555667899999999999999999999875 78899998653211   112348899999999999999999999999


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      .+..++|||||++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999997632 46999999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      ++..... .........||+.|+|||++.     ...++.++|||||||++|||++|++||......+....+   ....
T Consensus       222 a~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i---~~~~  297 (437)
T 4aw2_A          222 CLKLMED-GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI---MNHK  297 (437)
T ss_dssp             CEECCTT-SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHH
T ss_pred             hhhcccC-CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh---hhcc
Confidence            9865432 222334467999999999997     567899999999999999999999999765433322111   1100


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCC--CCCHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID--RPSMGDVLWN  754 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~  754 (820)
                      .....     |.    ........+.+++.+||..+|++  ||++.|++++
T Consensus       298 ~~~~~-----p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          298 ERFQF-----PT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHCCC-----CS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ccccC-----Cc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            00001     11    11234567889999999888877  9999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-39  Score=350.59  Aligned_cols=265  Identities=26%  Similarity=0.384  Sum_probs=211.5

Q ss_pred             cCCccceeEeeecceEEEEEEE-----cCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc--eEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVL-----RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN--EMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~-----~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~  555 (820)
                      ++|...+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            4688899999999999999984     357899999988777777788999999999999999999999986644  689


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|+||+++++|.+++.... ..+++.+++.++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus       121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999997653 45899999999999999999999   6899999999999999999999999999998654


Q ss_pred             CCCCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh---------hhhHHHHHHHhh
Q 003436          636 DLDQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE---------KVNLVEWAMKCQ  705 (820)
Q Consensus       636 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~---------~~~l~~~~~~~~  705 (820)
                      ..... .......++..|+|||.+.+..++.++||||||++++||+||+.|+......-         ........... 
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  275 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL-  275 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH-
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH-
Confidence            43221 11233457788999999999999999999999999999999998875321000         00000000111 


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                              +........+..++..+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus       276 --------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          276 --------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             --------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------hhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                    11111112234566789999999999999999999999999998865

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4e-38  Score=346.53  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=201.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...++||+|+||.||+++.. +++.||+|.+...   .....+.+.+|..++.++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56889999999999999999986 4788999986533   344567788999999988 899999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999997653  6899999999999999999999   789999999999999999999999999999853321


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh--hhHHHHHHHhhccCccccccC
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK--VNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~d  715 (820)
                        ........||+.|+|||++.+..++.++|||||||++|||++|++||......+.  ................     
T Consensus       164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  236 (345)
T 3a8x_A          164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  236 (345)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred             --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence              1223456799999999999999999999999999999999999999964321110  0111111111111111     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                           .++......+.+++.+||+.||.+||++
T Consensus       237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 -----RIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 1233455678999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-38  Score=335.57  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=206.4

Q ss_pred             CCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE-EEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM-III  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~-~lV  557 (820)
                      .|...++||+|+||.||+|++.+    +..+|+|..... .....+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35566899999999999998643    236999987643 345567899999999999999999999999766555 999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+.+|+|.+++... ...+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999753 356899999999999999999999   689999999999999999999999999999854332


Q ss_pred             C--CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCC-CCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          638 D--QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       638 ~--~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      .  .........++..|+|||.+.+..++.++||||||+++|||++|. +|+......+   .......    +.     
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~----~~-----  245 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQ----GR-----  245 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHT----TC-----
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhc----CC-----
Confidence            1  112223456789999999999999999999999999999999965 4444333222   1111111    10     


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                          ....+...+..+.+++.+||+.+|.+||++.++++.|+++....
T Consensus       246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                01122344567999999999999999999999999999987654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.3e-39  Score=348.69  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=197.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc-------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN-------  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~-------  552 (820)
                      .++|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            356889999999999999999987 68899999875433 345678999999999999999999999885543       


Q ss_pred             --------------------------------------------------eEEEEEeeccCCchhhHhhhcCC-CCCCHH
Q 003436          553 --------------------------------------------------EMIIIYEYMENGTLKDHLYASNF-PSLSWR  581 (820)
Q Consensus       553 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~  581 (820)
                                                                        ..++||||+++|+|.+++..... ...++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999976542 346777


Q ss_pred             HHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc----------cccccccCCcc
Q 003436          582 KRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT----------HVSTAVKGSFG  651 (820)
Q Consensus       582 ~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  651 (820)
                      .++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999   789999999999999999999999999999865443211          12234579999


Q ss_pred             ccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHH
Q 003436          652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFV  731 (820)
Q Consensus       652 y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  731 (820)
                      |+|||++.+..++.++|||||||++|||++|..|+.     +.......    ........         ........+.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~----~~~~~~~~---------~~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITD----VRNLKFPL---------LFTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHH----HHTTCCCH---------HHHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHH----hhccCCCc---------ccccCChhHH
Confidence            999999999999999999999999999999876532     11111111    11111110         1123345678


Q ss_pred             HHHHHHhhcCCCCCCCHHHHHHH
Q 003436          732 EIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       732 ~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +++.+||+.||++||++.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            99999999999999999999863

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.7e-38  Score=350.54  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=203.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-----SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ++|...+.||+|+||.||+|+.. +++.||||.+...     .....+.+.+|++++++++||||+++++++.+++..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46899999999999999999976 5889999986422     11235778999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC---eeEeecccc
Q 003436          557 IYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM---AKVADFGLS  631 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~---~kl~DFGla  631 (820)
                      ||||+++|+|.+.+...  ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999999888653  2345899999999999999999999   789999999999999976554   999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      +......  .......||+.|+|||++.+..++.++|||||||++|||++|++||.....    .+.....    .+...
T Consensus       181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~----~~~~~  250 (351)
T 3c0i_A          181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGII----KGKYK  250 (351)
T ss_dssp             EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHH----HTCCC
T ss_pred             eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHH----cCCCC
Confidence            8654321  223345799999999999999999999999999999999999999975321    1111111    11110


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .++...    ......+.+++.+||+.||++||++.|++++
T Consensus       251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              011100    1234678999999999999999999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.3e-39  Score=351.30  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=204.8

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      .....++|...++||+|+||.||+|+.+ +++.||+|.+....   ....+.+..|.+++..+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3445678999999999999999999986 57899999875431   22346678899999877 9999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++||||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            9999999999999999997643  5899999999999999999999   7899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      .....  ........||+.|+|||++.+..++.++|||||||++|||++|++||......+..   ..+.    .+.   
T Consensus       167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i~----~~~---  234 (345)
T 1xjd_A          167 ENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF---HSIR----MDN---  234 (345)
T ss_dssp             CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCC---
T ss_pred             hcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHH----hCC---
Confidence            53321  12234567999999999999999999999999999999999999999765432221   1111    111   


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHH-HHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMG-DVLW  753 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl~  753 (820)
                         +    .++......+.+++.+||+.+|.+||++. ++++
T Consensus       235 ---~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 ---P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ---C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence               1    12233456789999999999999999997 6654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.5e-39  Score=359.31  Aligned_cols=259  Identities=22%  Similarity=0.276  Sum_probs=207.1

Q ss_pred             HHHHHhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc
Q 003436          477 AIQEATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN  552 (820)
Q Consensus       477 ~l~~at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  552 (820)
                      +++...++|...++||+|+||.||+|+... ++.+|+|++....   ....+.+.+|+++++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            344556789999999999999999999874 7889999864321   111234788999999999999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++||||+++|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence            999999999999999999754   4899999999999999999999   7899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccCC----CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ----LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      ...... ........||+.|+|||++.+..    ++.++|||||||++|||++|++||......+....+   .....  
T Consensus       217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i---~~~~~--  290 (410)
T 3v8s_A          217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI---MNHKN--  290 (410)
T ss_dssp             ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HTHHH--
T ss_pred             eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH---Hhccc--
Confidence            654322 22234567999999999998765    889999999999999999999999765433221111   10000  


Q ss_pred             ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCC--CCCHHHHHHHH
Q 003436          709 QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGID--RPSMGDVLWNL  755 (820)
Q Consensus       709 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPs~~evl~~L  755 (820)
                      .+.   -|     ........+.+++.+||+.+|.+  ||++.|++++-
T Consensus       291 ~~~---~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          291 SLT---FP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             HCC---CC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             ccc---CC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            000   00     11234467899999999988988  99999998763

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-38  Score=351.17  Aligned_cols=249  Identities=25%  Similarity=0.329  Sum_probs=204.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+++... ++.||+|.+....   ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            568999999999999999999764 7889999864321   233567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        95 e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             CCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999999999764  36999999999999999999999   789999999999999999999999999999865432 


Q ss_pred             CccccccccCCccccCcccccc---CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                        .......||+.|+|||++.+   ..++.++|||||||++|||++|++||.................    .       
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~-------  235 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----T-------  235 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----C-------
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----c-------
Confidence              22345679999999999964   4589999999999999999999999975443332222221111    0       


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCC-HHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-MGDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-~~evl~  753 (820)
                         ...++......+.+++.+||+.+|.+||+ +.++++
T Consensus       236 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 ---VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               01223345578999999999999999998 666654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-38  Score=343.40  Aligned_cols=264  Identities=20%  Similarity=0.335  Sum_probs=191.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457888899999999999999976 57899999875433 2234678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcC----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          560 YMENGTLKDHLYASN----FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      |++ |+|.+++....    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 69999886532    245899999999999999999999   7899999999999999999999999999998653


Q ss_pred             CCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC---ccc
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG---QLE  711 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~  711 (820)
                      ...  .......||..|+|||++.+ ..++.++|||||||++|||++|++||......+.....   .......   ...
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI---FDIMGTPNESLWP  234 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCTTTCG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCChhHhh
Confidence            221  12234568999999999976 46899999999999999999999999765543332211   1111100   000


Q ss_pred             cc-----cCccc------------cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DI-----VDPTL------------TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~-----~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+     ..+.+            ...........+.+++.+||+.||++||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            00     00000            001112344678999999999999999999998864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=352.77  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             ccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccCC
Q 003436          486 SESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENG  564 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~g  564 (820)
                      ...++||+|+||.||+|+.. +++.||+|++........+++.+|+++|++++||||+++++++.+.+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            34568999999999999975 58899999987776667788999999999999999999999999999999999999999


Q ss_pred             chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE--cCCCCeeEeeccccccCCCCCCccc
Q 003436          565 TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL--DENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       565 sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++......   .
T Consensus       172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~  244 (373)
T 2x4f_A          172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K  244 (373)
T ss_dssp             EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred             cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence            9999887543 35899999999999999999999   7899999999999999  567899999999998654322   2


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...  . +...    ...  ..+    ..
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~-i~~~----~~~--~~~----~~  311 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN--N-ILAC----RWD--LED----EE  311 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H-HHHT----CCC--SCS----GG
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHhc----cCC--CCh----hh
Confidence            234569999999999999999999999999999999999999997654332211  1 1110    000  000    11


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .......+.+++.+||+.+|.+||++.|++++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            12345678999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.5e-38  Score=346.60  Aligned_cols=255  Identities=16%  Similarity=0.188  Sum_probs=208.0

Q ss_pred             HHhcCCccceeEeeecceEEEEEE------EcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC---CCceeeEEeEeec
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGV------LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDE  550 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~------~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~  550 (820)
                      ...++|...++||+|+||.||+|+      ...++.||||++....   ..++..|++++.+++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345679999999999999999994      3457899999987654   356778888888886   9999999999999


Q ss_pred             CceEEEEEeeccCCchhhHhhhc---CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC--------
Q 003436          551 RNEMIIIYEYMENGTLKDHLYAS---NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE--------  619 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~--------  619 (820)
                      .+..++||||+++|+|.+++...   ....++|.+++.|+.|++.||+|||   +.+|+||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCcccc
Confidence            99999999999999999999752   2356999999999999999999999   789999999999999998        


Q ss_pred             ---CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhh
Q 003436          620 ---NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVN  696 (820)
Q Consensus       620 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~  696 (820)
                         ++.+||+|||+++...............||..|+|||++.+..++.++|||||||++|||+||+.||.......   
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence               89999999999975433233344456779999999999999999999999999999999999999885321110   


Q ss_pred             HHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCC-CCHHHHHHHHHHHHhh
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDR-PSMGDVLWNLEYALQL  761 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Ps~~evl~~L~~~~~~  761 (820)
                                 ..    .+..+.. .  ...+.+.+++..|++.+|.+| |++.++.+.|+..++.
T Consensus       293 -----------~~----~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 -----------CK----PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -----------EE----ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----------ee----echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                       00    1111111 1  234567889999999999998 6899999999888764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-37  Score=340.24  Aligned_cols=279  Identities=25%  Similarity=0.382  Sum_probs=216.5

Q ss_pred             CCCCHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHc--CCCCceeeEEeEe
Q 003436          471 YRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ--FRHRHLVSLIGYC  548 (820)
Q Consensus       471 ~~~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~nIv~l~g~~  548 (820)
                      ...++.......++|...+.||+|+||.||+|+.. ++.||||.+...   ..+.+..|++++..  ++||||+++++++
T Consensus        30 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           30 SGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             SSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             CCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            45666666777789999999999999999999984 789999997543   34677889999987  7999999999999


Q ss_pred             ecCc----eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCC-----CCcEEeccCCCCcEEEcC
Q 003436          549 DERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS-----TKAIIHRDVKSANILLDE  619 (820)
Q Consensus       549 ~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~-----~~~iiHrDIkp~NIll~~  619 (820)
                      ....    ..++|+||+++|+|.+++...   .+++.+++.++.|++.||+|||...     +.+|+||||||+|||++.
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence            8775    789999999999999999764   5899999999999999999999321     478999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCcc--ccccccCCccccCccccccC------CCCCcceeeehhhhHHHHhcC---------
Q 003436          620 NLMAKVADFGLSKIGPDLDQTH--VSTAVKGSFGYLDPEYLTKQ------QLTEKSDVYSFGVVMFEILCG---------  682 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvll~ElltG---------  682 (820)
                      ++.+||+|||+++.........  ......||..|+|||++.+.      .++.++||||||+++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            9999999999997644322111  22345799999999999765      344789999999999999999         


Q ss_pred             -CCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC-CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          683 -RPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ-IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       683 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                       +.||......+. ....+...... ...    .+.+... ...+++..+.+++.+||+.+|.+||++.+++++|+.+.+
T Consensus       263 ~~~p~~~~~~~~~-~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          263 YQLPYYDLVPSDP-SVEEMRKVVCE-QKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             CCCTTTTTSCSSC-CHHHHHHHHTT-SCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCccccCcCcc-cHHHHHHHHHH-HHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence             667654322111 11111111111 111    1111111 123667889999999999999999999999999999876


Q ss_pred             hc
Q 003436          761 LQ  762 (820)
Q Consensus       761 ~~  762 (820)
                      ..
T Consensus       337 ~~  338 (342)
T 1b6c_B          337 QE  338 (342)
T ss_dssp             TT
T ss_pred             Hh
Confidence            53

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3e-38  Score=336.36  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=203.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...+.||+|+||.||+|+... +..||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            4678999999999999999999764 6789999864322   22346788999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++....  .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999997653  5899999999999999999999   789999999999999999999999999998653321


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                          ......|+..|+|||.+.+..++.++||||||++++||++|+.||......+.....   .    ..         
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~----~~---------  222 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---S----RV---------  222 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---H----HT---------
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH---H----hC---------
Confidence                223457899999999999999999999999999999999999999755432221111   0    00         


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                       ....+......+.+++.+||+.+|.+||++.|++++-
T Consensus       223 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          223 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             -CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence             0112333456788999999999999999999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.9e-38  Score=348.31  Aligned_cols=245  Identities=21%  Similarity=0.304  Sum_probs=205.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+++|++++||||+++++++.+....++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999986 58899999865332   233567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999997653  5899999999999999999999   789999999999999999999999999999865331 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          .....||+.|+|||++.+..++.++|||||||++|||++|++||......+..   +.+    ..+..        
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~i----~~~~~--------  255 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---EKI----VSGKV--------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCCC--------
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH---HHH----HcCCC--------
Confidence                23457999999999999999999999999999999999999999765432211   111    11111        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                        .++......+.+++.+||+.||.+||+     +.|++++
T Consensus       256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence              122344577899999999999999998     7887764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.4e-38  Score=340.73  Aligned_cols=262  Identities=21%  Similarity=0.306  Sum_probs=201.8

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ..++|...++||+|+||.||+|+.. +++.||+|.+...   .....+.+.+|++++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999976 5788999987643   23345789999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++++|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999997653  6899999999999999999999   68999999999999999999999999999976443


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......   ...    ...... ..   .+
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~~~~~-~~---~~  254 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMG----AHINQA-IP---RP  254 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHH----HHHHSC-CC---CG
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHH----HHhccC-CC---Cc
Confidence            211 1223456899999999999999999999999999999999999999754221   111    111110 00   00


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHHhhc
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-SMGDVLWNLEYALQLQ  762 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~~~~~  762 (820)
                         ....+..+..+.+++.+||+.+|++|| ++.++++.|+.++...
T Consensus       255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence               112234456789999999999999999 9999999998876544

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.1e-38  Score=343.62  Aligned_cols=258  Identities=29%  Similarity=0.457  Sum_probs=207.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccE--EEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETK--VAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~--vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...+.||+|+||.||+|+... +..  +++|++... .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            568999999999999999999763 443  488876542 334456789999999999 899999999999999999999


Q ss_pred             EeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          558 YEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      |||+++|+|.+++....              ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997643              246999999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||+++....   ........++..|+|||++.+..++.++||||||+++|||++ |+.||......+.      ..
T Consensus       182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE  252 (327)
T ss_dssp             EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HH
T ss_pred             EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------HH
Confidence            9999999974321   111233457889999999999899999999999999999998 9999975533221      11


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                      .. ..+         .....+...+..+.+++.+||+.+|.+||++.++++.|+.++...
T Consensus       253 ~~-~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          253 KL-PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HG-GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             Hh-hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            11 111         011223345678999999999999999999999999999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.5e-38  Score=347.00  Aligned_cols=250  Identities=23%  Similarity=0.309  Sum_probs=204.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  555 (820)
                      ..++|...++||+|+||.||+|+... ++.||+|.+....   ....+.+..|.++|..+ +||||+++++++...+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            34689999999999999999999874 7889999865431   23356788999999988 8999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999997653  5899999999999999999999   7899999999999999999999999999998533


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..  ........||+.|+|||++.+..++.++|||||||++|||++|++||......+.   .+.+.   . ...     
T Consensus       173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~~~i~---~-~~~-----  238 (353)
T 2i0e_A          173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---FQSIM---E-HNV-----  238 (353)
T ss_dssp             CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH---H-CCC-----
T ss_pred             cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH---HHHHH---h-CCC-----
Confidence            21  1223456799999999999999999999999999999999999999976543221   11111   1 111     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                           .++......+.+++.+||+.+|.+||+     +.+++++
T Consensus       239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 123345577899999999999999995     4666554

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=343.40  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=205.4

Q ss_pred             hcCCccceeEeeecceEEEEEEE-cCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEee----cCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL-RDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD----ERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~-~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~----~~~~~~l  556 (820)
                      .++|...+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            45789999999999999999997 468899999877666677788999999999999999999999986    3457899


Q ss_pred             EEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          557 IYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      |+||+++|+|.+++...  ....+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999999753  3457999999999999999999999   689999999999999999999999999998754


Q ss_pred             CCCCCcc-------ccccccCCccccCccccccCC---CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          635 PDLDQTH-------VSTAVKGSFGYLDPEYLTKQQ---LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       635 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      .......       ......||..|+|||.+.+..   ++.++||||||+++|||++|+.||........ .......  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~--  261 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALAVQ--  261 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHHHH--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHHhh--
Confidence            3211100       012345799999999987553   68999999999999999999999853111000 1111000  


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                       .          ..........+..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus       262 -~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          262 -N----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             -C----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             -c----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence             0          0011112344577999999999999999999999999998663

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6e-38  Score=371.73  Aligned_cols=250  Identities=25%  Similarity=0.377  Sum_probs=202.0

Q ss_pred             eeEeeecceEEEEEEEc---CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLR---DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||.||+|.+.   .++.||||++....  ....++|.+|+++|++++||||++++++|.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999764   46789999876533  3446789999999999999999999999965 458899999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC-ccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ-THV  642 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~-~~~  642 (820)
                      |+|.+++...  ..+++.+++.|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus       454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9999999754  36899999999999999999999   78999999999999999999999999999986543222 122


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....+|..|+|||++.+..++.++|||||||+||||++ |+.||......+....       ...+.         ...
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~~~---------~~~  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGE---------RMG  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC---------CCC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------CCC
Confidence            334457889999999999999999999999999999998 9999976544322111       11111         112


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .+..++..+.+++.+||+.||++||++.+|++.|+....
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            334566889999999999999999999999999998764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-38  Score=338.97  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=205.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec---------
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE---------  550 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~---------  550 (820)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3456899999999999999999986 68899999876544    346789999999999999999998754         


Q ss_pred             -------CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          551 -------RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       551 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                             ....++||||+++|+|.+++.......+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   455899999999999999998765567999999999999999999999   6899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      ||+|||+++......   ......||..|+|||.+.+..++.++||||||+++|||++|..|+..     ...   ....
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~---~~~~  230 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSK---FFTD  230 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHH---HHHH
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHH---HHHH
Confidence            999999998654322   22345689999999999999999999999999999999999877631     111   1111


Q ss_pred             hhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                       ...+.            .+...+..+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus       231 -~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          231 -LRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             -HHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             -hhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence             11111            1223345688999999999999999999999999877543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-38  Score=351.56  Aligned_cols=273  Identities=19%  Similarity=0.262  Sum_probs=213.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc--eEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN--EMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~--~~~lV~  558 (820)
                      ++|...++||+|+||.||+|++.. ++.||||++.... ....+.+.+|+++|++++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            468889999999999999999874 8899999876433 234577889999999999999999999987655  789999


Q ss_pred             eeccCCchhhHhhhcCC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE----cCCCCeeEeecccccc
Q 003436          559 EYMENGTLKDHLYASNF-PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVADFGLSKI  633 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~-~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll----~~~~~~kl~DFGla~~  633 (820)
                      ||+++|+|.+++..... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999976432 34999999999999999999999   7899999999999999    7788899999999986


Q ss_pred             CCCCCCccccccccCCccccCcccccc--------CCCCCcceeeehhhhHHHHhcCCCCCCCCCchh-hhhHHHHHHHh
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTK--------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE-KVNLVEWAMKC  704 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~-~~~l~~~~~~~  704 (820)
                      ....   .......||..|+|||++.+        ..++.++|||||||++|||++|+.||....... ......-....
T Consensus       166 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            5432   22234579999999999865        567889999999999999999999996543221 11221111111


Q ss_pred             hccCcccccc-----------CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          705 QETGQLEDIV-----------DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       705 ~~~~~~~~~~-----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      .....+..+.           +..............+.+++.+||+.||++||++.++++.++.++..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            1111111000           00111234467778899999999999999999999999999888753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.1e-37  Score=337.32  Aligned_cols=265  Identities=21%  Similarity=0.303  Sum_probs=203.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCC---CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGT---QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...+.||+|+||.||+|... +++.||+|++..   ......+.+.+|++++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            357999999999999999999975 688999998764   2345567899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          558 YEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||+++|+|.+++..  .....+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864  23456899999999999999999999   7899999999999999999999999999987543


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...  .......|+..|+|||++.+..++.++||||||+++|||++|+.||.......    ....... .......   
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~-~~~~~~~---  257 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKI-EQCDYPP---  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHHH-HTTCSCC---
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHHh-hcccCCC---
Confidence            321  12234568999999999999999999999999999999999999986432211    1111111 1111111   


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcCC
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQGD  764 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~~  764 (820)
                           ......+..+.+++.+||+.||.+||++.++++.|+++......
T Consensus       258 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          258 -----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             -----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence                 11123456789999999999999999999999999988765543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.7e-38  Score=362.01  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=196.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...++||+|+||.||+|+.. +++.||||.+...   .......+.+|+++|++++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999976 5789999986532   333456788899999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCC-CcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST-KAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~-~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||   + .+|+||||||+|||++.++.+||+|||+++....
T Consensus       227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999999997653  6899999999999999999999   5 7899999999999999999999999999985332


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+....   +..    ...      
T Consensus       302 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---i~~----~~~------  366 (446)
T 4ejn_A          302 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL---ILM----EEI------  366 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHH----CCC------
T ss_pred             C--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH---HHh----CCC------
Confidence            1  2223456799999999999999999999999999999999999999975543222111   110    100      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                          .++......+.+++.+||+.||.+||     ++.|++++
T Consensus       367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                12234456789999999999999999     99999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.9e-38  Score=347.61  Aligned_cols=248  Identities=24%  Similarity=0.342  Sum_probs=203.6

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57889999999999999999974 67899999864321   122357889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+ +|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-
T ss_pred             ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-
Confidence            999 789999887653  6999999999999999999999   789999999999999999999999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+..               ..+... 
T Consensus       162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~~-  223 (336)
T 3h4j_B          162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNSC-  223 (336)
T ss_dssp             --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCSS-
T ss_pred             --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHcC-
Confidence              22334579999999999988776 78999999999999999999999654322110               011000 


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                       ....+......+.+++.+||+.||.+||++.|++++-.
T Consensus       224 -~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          224 -VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             -CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             -CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence             11223345577899999999999999999999987643

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.6e-38  Score=331.97  Aligned_cols=251  Identities=20%  Similarity=0.305  Sum_probs=205.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...++||+|+||.||+|+... +..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            4568999999999999999999875 678999987655455567899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE---cCCCCeeEeeccccccCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll---~~~~~~kl~DFGla~~~~~~  637 (820)
                      +++++|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++......
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            99999999987653  5899999999999999999999   7899999999999999   78899999999999865432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .   ......||..|+|||.+.+. ++.++||||||++++||++|+.||......+....   .    ..+...   .+.
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~----~~~~~~---~~~  228 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK---I----REGTFT---FPE  228 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H----HHCCCC---CCH
T ss_pred             c---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH---H----HhCCCC---CCc
Confidence            2   22345699999999998654 89999999999999999999999976543222111   1    111100   000


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .........+.+++.+|++.+|.+||++.+++++
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          229 ---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0001234678999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=345.01  Aligned_cols=259  Identities=19%  Similarity=0.277  Sum_probs=192.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEe--------ecC
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYC--------DER  551 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~--------~~~  551 (820)
                      ..+|...++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++. ||||+++++++        ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457889999999999999999975 57899999887666677788999999999996 99999999998        344


Q ss_pred             ceEEEEEeeccCCchhhHhhh-cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc--EEeccCCCCcEEEcCCCCeeEeec
Q 003436          552 NEMIIIYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKA--IIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                      ...++|+||++ |+|.+++.. .....+++.+++.++.|++.||+|||   ..+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            56899999996 799998865 23346999999999999999999999   677  999999999999999999999999


Q ss_pred             cccccCCCCCCcc----------ccccccCCccccCcccc---ccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh
Q 003436          629 GLSKIGPDLDQTH----------VSTAVKGSFGYLDPEYL---TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV  695 (820)
Q Consensus       629 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~  695 (820)
                      |+++.........          ......||..|+|||++   .+..++.++||||||+++|||++|+.||........ 
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-  261 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-  261 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence            9998654322111          11134589999999998   567789999999999999999999999864321110 


Q ss_pred             hHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          696 NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       696 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                                        ................+.+++.+||+.+|.+||++.|+++.|+.+.....
T Consensus       262 ------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          262 ------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                              00011111112233457899999999999999999999999998876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.7e-38  Score=346.24  Aligned_cols=261  Identities=21%  Similarity=0.251  Sum_probs=202.2

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-----ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-----SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER  551 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  551 (820)
                      +....++|...+.||+|+||.||+|+.. ++..||+|.+...     .....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            5567788999999999999999999975 5778999976432     234567899999999999999999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 003436          552 NEMIIIYEYMENGTLKDHLYASN--------------------------------------FPSLSWRKRLEICIGAARG  593 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~l~i~~~ia~g  593 (820)
                      +..++||||+++|+|.+++....                                      ...+++..+..++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999985210                                      1123567788999999999


Q ss_pred             hhhhhcCCCCcEEeccCCCCcEEEcCCC--CeeEeeccccccCCCCCC--ccccccccCCccccCcccccc--CCCCCcc
Q 003436          594 LHYLHTGSTKAIIHRDVKSANILLDENL--MAKVADFGLSKIGPDLDQ--THVSTAVKGSFGYLDPEYLTK--QQLTEKS  667 (820)
Q Consensus       594 L~yLH~~~~~~iiHrDIkp~NIll~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~t~ks  667 (820)
                      |+|||   +.+|+||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   68999999999999998766  899999999985432211  112345679999999999975  6789999


Q ss_pred             eeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC
Q 003436          668 DVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS  747 (820)
Q Consensus       668 DV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs  747 (820)
                      ||||||+++|||++|+.||......+...      ...... .. ...     .........+.+++.+||+.+|.+||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~-~~-~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKK-LC-FEN-----PNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCC-CC-TTS-----GGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcc-cc-cCC-----cccccCCHHHHHHHHHHcCCChhHCCC
Confidence            99999999999999999997654332211      111110 00 000     111234567899999999999999999


Q ss_pred             HHHHHHH
Q 003436          748 MGDVLWN  754 (820)
Q Consensus       748 ~~evl~~  754 (820)
                      +.+++++
T Consensus       325 ~~~~l~h  331 (345)
T 3hko_A          325 AMRALQH  331 (345)
T ss_dssp             HHHHHHS
T ss_pred             HHHHhcC
Confidence            9999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=5.7e-38  Score=345.95  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=190.7

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ..++|...+.||+|+||.||+|+... ++.||||.+....  ..+.+.+|+++|++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            45679999999999999999999874 7789999876443  34678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---CCCeeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---~~~~kl~DFGla~~~~~  636 (820)
                      |+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++....
T Consensus       129 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          129 LVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             CCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             eCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            99999999998754  35899999999999999999999   689999999999999975   89999999999986433


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  ...   .. ......     
T Consensus       204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i-~~~~~~-----  269 (349)
T 2w4o_A          204 Q---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RI-LNCEYY-----  269 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HH-HTTCCC-----
T ss_pred             c---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HH-HhCCCc-----
Confidence            1   222346789999999999999999999999999999999999999865433221  111   11 111110     


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                       ............+.+++.+||+.||++||++.|+++
T Consensus       270 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 -FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             011122345577899999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=355.68  Aligned_cols=262  Identities=21%  Similarity=0.251  Sum_probs=207.4

Q ss_pred             HHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeec
Q 003436          475 FVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE  550 (820)
Q Consensus       475 ~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  550 (820)
                      +.+++...++|...++||+|+||.||+++.+ +++.||+|++....   ....+.+.+|.+++.+++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            3444556788999999999999999999986 58899999875321   1223457899999999999999999999999


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      .+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999997643 36899999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccc-------cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHH
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLT-------KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      ++...... ........||+.|+|||++.       ...++.++|||||||++|||++|++||......+....+   ..
T Consensus       209 a~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i---~~  284 (412)
T 2vd5_A          209 CLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI---VH  284 (412)
T ss_dssp             CEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HT
T ss_pred             heeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHH---Hh
Confidence            98654322 22233467999999999997       357899999999999999999999999765433321111   10


Q ss_pred             hhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCC---CCHHHHHHH
Q 003436          704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDR---PSMGDVLWN  754 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Ps~~evl~~  754 (820)
                      ......     -|.    .....+.++.+++.+||. +|.+|   |++.|++++
T Consensus       285 ~~~~~~-----~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          285 YKEHLS-----LPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHCC-----CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             cccCcC-----CCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            000000     011    122345678999999998 99998   688888764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.5e-37  Score=329.92  Aligned_cols=252  Identities=22%  Similarity=0.318  Sum_probs=206.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .++|...+.||+|+||.||+|... +++.||+|++...  .....+.+.+|++++++++||||+++++++...+..++|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467899999999999999999976 4789999986432  3445678899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC---eeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM---AKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~---~kl~DFGla~~~~  635 (820)
                      ||+++++|.+.+....  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            9999999999887653  5899999999999999999999   789999999999999976655   9999999997654


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..   .......||..|+|||.+.+..++.++||||||++++||++|+.||......+....   ..    .+...    
T Consensus       160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~----~~~~~----  225 (284)
T 3kk8_A          160 DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ---IK----AGAYD----  225 (284)
T ss_dssp             SS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH----HTCCC----
T ss_pred             cC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHH---HH----hcccc----
Confidence            32   122345799999999999999999999999999999999999999975443222111   11    11110    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ............+.+++.+||+.+|.+||++.|++++
T Consensus       226 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 --YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             --CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              0001112345678999999999999999999999885

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.3e-38  Score=345.40  Aligned_cols=247  Identities=27%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      +.|...+.||+|+||.||+|+.. +++.||||++....   ....+++.+|+++|++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888899999999999999974 68899999875432   334567999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||++ |+|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....  
T Consensus       134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            9997 68888886443 46899999999999999999999   68999999999999999999999999999976432  


Q ss_pred             CccccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          639 QTHVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                          .....||+.|+|||++.   +..++.++|||||||++|||++|++||......+..      .......      .
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~------~  270 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE------S  270 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC------C
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC------C
Confidence                22457999999999984   567899999999999999999999998654332211      1111111      1


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      +.+   ........+.+++.+||+.+|++||++.+++++.
T Consensus       271 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          271 PAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            111   1223456788999999999999999999998754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.7e-38  Score=349.13  Aligned_cols=255  Identities=22%  Similarity=0.240  Sum_probs=195.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...++||+|+||.||+++.. .++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999987 688999998754332 235688999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC--eeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM--AKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~--~kl~DFGla~~~~~~~  638 (820)
                      +++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++....  
T Consensus        98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            99999999997643  5999999999999999999999   789999999999999987765  99999999974322  


Q ss_pred             CccccccccCCccccCccccccCCCCCc-ceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEK-SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                       ........||+.|+|||++.+..++.+ +|||||||++|||++|+.||.........  .........         ..
T Consensus       171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~---------~~  238 (361)
T 3uc3_A          171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILS---------VK  238 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHT---------TC
T ss_pred             -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhc---------CC
Confidence             112234569999999999988877665 89999999999999999999754332211  111111111         00


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      ............+.+++.+||+.+|.+||++.|++++-.
T Consensus       239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            000111133467899999999999999999999998643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.3e-38  Score=341.02  Aligned_cols=262  Identities=20%  Similarity=0.256  Sum_probs=208.0

Q ss_pred             CHHHHHHHhcCCccc-eeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcC-CCCceeeEEeEe
Q 003436          474 PFVAIQEATDNFSES-LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYC  548 (820)
Q Consensus       474 ~~~~l~~at~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~  548 (820)
                      .+...+...+.|... ++||+|+||.||+|+.. +++.||+|.+...  .......+.+|+.++.++ +||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            334455556667776 88999999999999986 5889999986543  233467889999999999 469999999999


Q ss_pred             ecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---CCCeeE
Q 003436          549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---NLMAKV  625 (820)
Q Consensus       549 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---~~~~kl  625 (820)
                      ...+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||   ..+|+||||||+|||++.   ++.+||
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEE
Confidence            99999999999999999999997666667999999999999999999999   789999999999999987   789999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      +|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.....   ... 
T Consensus       176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~~~-  248 (327)
T 3lm5_A          176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---SQV-  248 (327)
T ss_dssp             CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHT-
T ss_pred             eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---Hhc-
Confidence            9999998654321   223457999999999999999999999999999999999999999765433221111   110 


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       .        ..............+.+++.+||+.||.+||++.+++++
T Consensus       249 -~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 -N--------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -C--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -c--------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             0        011112223455778999999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=346.49  Aligned_cols=265  Identities=18%  Similarity=0.183  Sum_probs=199.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCCChh-----------hHHHHHHHHHHHHcCCCCceeeEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQSHQ-----------GLAEFRTEIEMLSQFRHRHLVSLIG  546 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~~~~-----------~~~~f~~Ei~~l~~l~H~nIv~l~g  546 (820)
                      .++|...++||+|+||.||+|+..    .+..+|+|+.......           ..+.+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357889999999999999999986    5678999986554321           1134678889999999999999999


Q ss_pred             Eeec----CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-
Q 003436          547 YCDE----RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-  621 (820)
Q Consensus       547 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-  621 (820)
                      ++..    ....++||||+ +++|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            9877    77899999999 999999997654  7999999999999999999999   68999999999999998877 


Q ss_pred             -CeeEeeccccccCCCCCC-----ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh
Q 003436          622 -MAKVADFGLSKIGPDLDQ-----THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV  695 (820)
Q Consensus       622 -~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~  695 (820)
                       .+||+|||+++.......     ........||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             999999999986532111     11124457999999999999999999999999999999999999999643221111


Q ss_pred             hHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          696 NLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       696 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                       ..........  .+........   .....+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       270 -~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          270 -VQTAKTNLLD--ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             -HHHHHHHHHH--TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             -HHHHHHhhcc--cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence             1111111100  1111000000   0114456899999999999999999999999988654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=332.53  Aligned_cols=253  Identities=21%  Similarity=0.316  Sum_probs=203.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC----hhhHHHHHHHHHHHHcCCCCceeeEEeEe--ecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS----HQGLAEFRTEIEMLSQFRHRHLVSLIGYC--DERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~  554 (820)
                      .++|...+.||+|+||.||++... +++.+|+|.+....    ....+.+.+|++++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            467999999999999999999975 57899999875432    23457899999999999999999999998  455688


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++||||++++ |.+++.......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 888887766667999999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCCccccccccCCccccCccccccCC--CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      .............||..|+|||++.+..  .+.++||||||++++||++|+.||......+..   +   . ...+..  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~-i~~~~~--  230 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF---E---N-IGKGSY--  230 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---H---H-HHHCCC--
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH---H---H-HhcCCC--
Confidence            4433333334567999999999997644  478999999999999999999999754322211   1   1 111111  


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                              ..+..+...+.+++.+||+.||.+||++.|++++-
T Consensus       231 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          231 --------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             --------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             --------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                    12334557789999999999999999999999763

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.8e-37  Score=355.54  Aligned_cols=266  Identities=18%  Similarity=0.251  Sum_probs=210.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC-CceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH-RHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...++||+|+||.||+|+.. +++.||||........  +++..|+++++.++| +++..+..++.+.+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            367899999999999999999974 5889999975543322  357889999999987 566666667778888999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE---cCCCCeeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll---~~~~~~kl~DFGla~~~~~  636 (820)
                      |+ +++|.+++.... ..+++.+++.|+.||+.||+|||   ..+|+||||||+||||   +.++.+||+|||+++....
T Consensus        84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 999999997543 46999999999999999999999   7899999999999999   6899999999999986544


Q ss_pred             CCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          637 LDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       637 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      ....     .......||..|+|||++.+..++.++|||||||+||||++|+.||.......................+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            2221     11235679999999999999999999999999999999999999997655433333332222211111111


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      .+         ...++.++.+++.+||+.+|++||++.+|++.|+.++...+
T Consensus       239 ~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          239 AL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            11         12335679999999999999999999999999999876443

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7e-38  Score=332.48  Aligned_cols=254  Identities=25%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|+|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            356899999999999999999986 58899999865332 3345788999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999999998643  36899999999999999999999   78999999999999999999999999999976433222


Q ss_pred             ccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      ........|+..|+|||.+.+..+ +.++||||||++++||++|+.||....... .....|...   ....        
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~---~~~~--------  228 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK---KTYL--------  228 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT---CTTS--------
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc---cccc--------
Confidence            222345678999999999987765 789999999999999999999997544321 112222110   0000        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .........+.+++.+||+.||.+||++.|++++
T Consensus       229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          229 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence              0112345678899999999999999999998763

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-38  Score=350.66  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=195.3

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecC--ce
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDER--NE  553 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~  553 (820)
                      ...++|...++||+|+||.||+|.+. +++.||||++...  .....+.+.+|+.+|.++. ||||+++++++...  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34678999999999999999999975 5889999987532  3455677889999999997 99999999998644  37


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++|||||+ |+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            899999997 6999998763   5899999999999999999999   78999999999999999999999999999986


Q ss_pred             CCCCC-------------------CccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchh
Q 003436          634 GPDLD-------------------QTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE  693 (820)
Q Consensus       634 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~  693 (820)
                      .....                   .....+...||+.|+|||++.+ ..++.++|||||||+++||++|++||......+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  238 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN  238 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            43211                   1112234579999999999976 678999999999999999999999997655433


Q ss_pred             hhhHHHHHHHhhccCcccc---ccC------------------ccccC------------CCChhhHHHHHHHHHHHhhc
Q 003436          694 KVNLVEWAMKCQETGQLED---IVD------------------PTLTG------------QIKPDSLNKFVEIAEKCLAQ  740 (820)
Q Consensus       694 ~~~l~~~~~~~~~~~~~~~---~~d------------------~~l~~------------~~~~~~~~~l~~l~~~Cl~~  740 (820)
                      ....+.   ..........   +..                  .....            .....+...+.+++.+||+.
T Consensus       239 ~~~~i~---~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          239 QLERII---GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHH---HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHH---HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            322211   1111000000   000                  00000            00113456789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 003436          741 CGIDRPSMGDVLWN  754 (820)
Q Consensus       741 dp~~RPs~~evl~~  754 (820)
                      ||.+|||+.|++++
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999998864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.1e-38  Score=362.92  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=209.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...++||+|+||.||+|+.. +++.||+|++....   ......+.+|+++|++++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999986 58899999875321   22346688999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999998766567999999999999999999999   689999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh-hHHHHHHHhhccCccccccCc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV-NLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|++||......... .+......    .        
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~--------  404 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----V--------  404 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----C--------
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----c--------
Confidence            1   223457999999999999999999999999999999999999999765332111 11111111    0        


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                        ...++......+.+++.+||+.||.+||     ++.|++++
T Consensus       405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              0122334457789999999999999999     67888764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.4e-38  Score=339.91  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=205.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh------hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH------QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|...+.||+|+||.||+|+.. +++.||+|.+.....      ...+.+.+|++++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456899999999999999999986 578999997644321      1357899999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC----CeeEeeccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL----MAKVADFGL  630 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~----~~kl~DFGl  630 (820)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999754  36899999999999999999999   68999999999999999887    799999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ++......   ......||..|+|||++.+..++.++||||||++++||++|+.||......+...   ...    ....
T Consensus       166 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~----~~~~  235 (321)
T 2a2a_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NIT----SVSY  235 (321)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH---HHH----TTCC
T ss_pred             ceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHH----hccc
Confidence            98654321   2234569999999999999999999999999999999999999997554322211   111    1000


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ..++..    ....+..+.+++.+||+.||.+||++.|++++
T Consensus       236 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 --DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              001111    12334678999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.4e-38  Score=342.68  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=179.9

Q ss_pred             ceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEeeccCCc
Q 003436          488 SLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      .++||+|+||.||+++.. +++.||||++...   ....+.+|+.+++++. ||||+++++++.++...++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            368999999999999986 5789999987532   3467788999999997 9999999999999999999999999999


Q ss_pred             hhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---CeeEeeccccccCCCCCCccc
Q 003436          566 LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---MAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       566 L~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~  642 (820)
                      |.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||+++......  ..
T Consensus        93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~  165 (325)
T 3kn6_A           93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP  165 (325)
T ss_dssp             HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence            99999765  36999999999999999999999   78999999999999997665   89999999998654321  22


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||.....................+...      .....
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccc
Confidence            334568999999999999999999999999999999999999997543321111111111111111110      00001


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ......++.+++.+||+.||.+||++.|+++
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            1234567899999999999999999998875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.7e-37  Score=348.44  Aligned_cols=253  Identities=23%  Similarity=0.348  Sum_probs=193.8

Q ss_pred             cCCccc-eeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHH-cCCCCceeeEEeEeec----CceEE
Q 003436          483 DNFSES-LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLS-QFRHRHLVSLIGYCDE----RNEMI  555 (820)
Q Consensus       483 ~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~----~~~~~  555 (820)
                      ++|... ++||+|+||.||+++.. +++.||||++...     ..+.+|++++. ..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999986 5788999987532     45678888874 4589999999998865    56789


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---CCCeeEeeccccc
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---NLMAKVADFGLSK  632 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---~~~~kl~DFGla~  632 (820)
                      +||||+++|+|.+++.......+++.++..|+.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998766567999999999999999999999   689999999999999987   7899999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh-hHHHHHHHhhccCccc
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV-NLVEWAMKCQETGQLE  711 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~  711 (820)
                      .....   .......||..|+|||++.+..++.++|||||||++|||++|++||......... .....+.    .+...
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~  285 (400)
T 1nxk_A          213 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYE  285 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCC
T ss_pred             ccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCccc
Confidence            64331   1233567899999999999999999999999999999999999999754332211 1111111    11110


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                            +..........++.+++.+||+.||.+||++.|++++-.
T Consensus       286 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          286 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence                  000111234567899999999999999999999998643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.4e-38  Score=334.76  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=203.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEee--cCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD--ERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~--~~~~~~l  556 (820)
                      .++|...+.||+|+||.||+++.. +++.||+|.+...  .....+.+.+|++++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357889999999999999999986 5788999986543  3455678999999999999999999999874  4678999


Q ss_pred             EEeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc-----EEeccCCCCcEEEcCCCCeeEeecc
Q 003436          557 IYEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKA-----IIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~-----iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                      ||||+++|+|.+++...  ....+++.+++.++.|++.||+|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999753  2345999999999999999999999   556     9999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      +++.....  ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......+   +....    ..+.
T Consensus       162 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i----~~~~  232 (279)
T 2w5a_A          162 LARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKI----REGK  232 (279)
T ss_dssp             HHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTC
T ss_pred             hheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHH----hhcc
Confidence            99864432  112234568999999999999999999999999999999999999997653322   11111    1111


Q ss_pred             cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       710 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ..         ..+...+..+.+++.+||+.+|.+||++.|+++.+
T Consensus       233 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          233 FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            11         12234557799999999999999999999999754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-37  Score=332.34  Aligned_cols=250  Identities=24%  Similarity=0.334  Sum_probs=197.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+++.. ++..+|+|++.... ....+.+.+|+++|++++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56889999999999999999976 57889999865432 33467889999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE---cCCCCeeEeeccccccCC
Q 003436          561 MENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGP  635 (820)
Q Consensus       561 ~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll---~~~~~~kl~DFGla~~~~  635 (820)
                      +++|+|.+++...  ....+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998653  2356999999999999999999999   7899999999999999   456889999999997643


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..   .......||..|+|||.+. ..++.++||||||++++||++|+.||......+.....   ..  ...       
T Consensus       179 ~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~---~~--~~~-------  242 (285)
T 3is5_A          179 SD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA---TY--KEP-------  242 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH--CCC-------
T ss_pred             Cc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh---cc--CCc-------
Confidence            32   2233456899999999985 56899999999999999999999999765432221111   10  000       


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                       ... .........+.+++.+||+.||++||++.|+++
T Consensus       243 -~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 -NYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -ccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000 001123467889999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=331.70  Aligned_cols=249  Identities=24%  Similarity=0.392  Sum_probs=184.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            457899999999999999999974 68899999875322   12246789999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999987542 46899999999999999999999   689999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      ..  ......||..|+|||.+.+..++.++||||||++++||++|++||......+..               ..+....
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~  228 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLAD  228 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSC
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhcc
Confidence            11  122456899999999999999999999999999999999999999754322211               0000000


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                        ...+......+.+++.+||+.||++||++.++++
T Consensus       229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              0122334567899999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.6e-37  Score=330.05  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=205.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+.. ++..||+|.+....   ....+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56889999999999999999986 46789999864321   122467899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            9999999999997653  5899999999999999999999   789999999999999999999999999998754331 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                         ......|+..|+|||.+.+..++.++||||||++++||++|+.||......+...      ... ..      +   
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~-~~------~---  228 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIV-NV------D---  228 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH-TT------C---
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHh-cc------c---
Confidence               1234568999999999999999999999999999999999999997543322111      111 11      0   


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                       ..++......+.+++.+|++.+|.+||++.+++++-
T Consensus       229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence             112334456789999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=330.04  Aligned_cols=252  Identities=22%  Similarity=0.359  Sum_probs=200.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      +|....+||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3556669999999999999975 578899998776665666789999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeeccccccCCCCCCc
Q 003436          563 NGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       563 ~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||+++......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            999999997653 345778999999999999999999   689999999999999987 8999999999998654321  


Q ss_pred             cccccccCCccccCccccccCC--CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQ--LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      .......|+..|+|||++.+..  ++.++||||||+++|||++|+.||......... ...  ....           ..
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~~~~-----------~~  243 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--VGMF-----------KV  243 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--HHHH-----------CC
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--hccc-----------cc
Confidence            1223456899999999997653  789999999999999999999998643221111 100  0000           00


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....+......+.+++.+||+.||++||++.+++++
T Consensus       244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            112334455778999999999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-37  Score=333.71  Aligned_cols=259  Identities=25%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC--c--cEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD--E--TKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~--~--~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .++|...++||+|+||.||+|++..  +  ..||||.+...   .....+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3568899999999999999998642  2  36899987643   2345678999999999999999999999998765 8


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||+++|+|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            89999999999999997643 35899999999999999999999   689999999999999999999999999999865


Q ss_pred             CCCCCcc-ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          635 PDLDQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       635 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ....... ......+|..|+|||++.+..++.++||||||++++||++ |+.||......+.   ..   .......   
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~---~~~~~~~---  242 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LH---KIDKEGE---  242 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---HHHTSCC---
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH---HH---HHHccCC---
Confidence            4432211 2234567889999999999899999999999999999999 9999975543221   11   1111110   


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                            ........+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus       243 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 ------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                  011223456789999999999999999999999999987754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=343.48  Aligned_cols=265  Identities=22%  Similarity=0.375  Sum_probs=197.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhh-HHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+|+.. +++.||+|++....... ...+.+|+++|++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            56889999999999999999986 67899999876443221 22456799999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++ |+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  .
T Consensus        82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T  154 (324)
T ss_dssp             CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--c
Confidence            97 59999887653 46899999999999999999999   789999999999999999999999999999854322  1


Q ss_pred             cccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC----
Q 003436          641 HVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD----  715 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----  715 (820)
                      .......||..|+|||++.+ ..++.++|||||||+++||++|++||......+................+.....    
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence            22234568999999999876 5689999999999999999999999976654433222211110000011111100    


Q ss_pred             -----ccccC----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 -----PTLTG----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 -----~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                           +....    ...+.....+.+++.+||+.||.+||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                 00000    0112334678899999999999999999999874

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9e-38  Score=343.29  Aligned_cols=253  Identities=22%  Similarity=0.361  Sum_probs=202.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|...+.||+|+||.||+++.. +++.||+|.+.....    .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457899999999999999999986 578999998754432    235688888888 79999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC----CCeeEeeccccccCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN----LMAKVADFGLSKIGP  635 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~----~~~kl~DFGla~~~~  635 (820)
                      |+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+.++    +.+||+|||+++...
T Consensus        97 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           97 LMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            999999999997643  6899999999999999999999   7899999999999998443    359999999998654


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|++||..........+...+    ..+...    
T Consensus       172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~----  241 (342)
T 2qr7_A          172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS----  241 (342)
T ss_dssp             CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC----
T ss_pred             CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc----
Confidence            322  2233467899999999999888999999999999999999999999754322222222211    111111    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                        +...........+.+++.+||+.||++||++.+++++-
T Consensus       242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence              11122234557789999999999999999999998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.4e-37  Score=333.78  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=204.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...+.||+|+||.||+++.. +++.||+|.+........+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            456889999999999999999986 6889999987655444456788999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE---cCCCCeeEeeccccccCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll---~~~~~~kl~DFGla~~~~~~  637 (820)
                      +++++|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+||++   ++++.+||+|||+++.... 
T Consensus        88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-  161 (304)
T 2jam_A           88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-  161 (304)
T ss_dssp             CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred             CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence            99999999987653  5899999999999999999999   6899999999999999   7889999999999875332 


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                         .......||..|+|||.+.+..++.++||||||++++||++|+.||......+.   ....    ..+...      
T Consensus       162 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i----~~~~~~------  225 (304)
T 2jam_A          162 ---GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL---FEKI----KEGYYE------  225 (304)
T ss_dssp             ---BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH----HHCCCC------
T ss_pred             ---CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHH----HcCCCC------
Confidence               122335689999999999999999999999999999999999999975433221   1111    111110      


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .........+..+.+++.+||+.||.+||++.|++++
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111223455779999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-37  Score=331.63  Aligned_cols=246  Identities=23%  Similarity=0.346  Sum_probs=200.5

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ..++|...+.||+|+||.||+|+.. +++.||+|++...  ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999986 6889999986543  334567788999999999 99999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---------------
Q 003436          557 IYEYMENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---------------  619 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---------------  619 (820)
                      ||||+++|+|.+++....  ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997642  246899999999999999999999   789999999999999984               


Q ss_pred             ----CCCeeEeeccccccCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          620 ----NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       620 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                          ...+||+|||+++.....      ....||..|+|||.+.+. .++.++||||||++++||++|++++....   .
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence                448999999999865432      223589999999999766 66789999999999999999997764321   1


Q ss_pred             hhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          695 VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       695 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ..    ....+..         ...+......+.+++.+||+.||.+||++.|++++
T Consensus       237 ---~~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 ---WH----EIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ---HH----HHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---HH----HHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence               00    0111111         12233455779999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-37  Score=340.98  Aligned_cols=266  Identities=20%  Similarity=0.295  Sum_probs=194.8

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh--hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH--QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ...++|...++||+|+||.||+|+.. +++.||||++.....  ...+.+.+|++++++++||||+++++++..++..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34568999999999999999999975 678999998765432  234668899999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE-----cCCCCeeEeecccc
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL-----DENLMAKVADFGLS  631 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll-----~~~~~~kl~DFGla  631 (820)
                      ||||++ |+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+     ++++.+||+|||++
T Consensus       111 v~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999998 59999997654  5899999999999999999999   6899999999999999     45556999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      +.....  ........||..|+|||++.+. .++.++|||||||+++||++|++||......+.................
T Consensus       185 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            854321  1122345689999999999874 5899999999999999999999999765443322111100000000000


Q ss_pred             ccc-------------cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          711 EDI-------------VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       711 ~~~-------------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ...             ....+..........++.+++.+||+.||.+||++.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000             0000000001123467889999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.3e-37  Score=332.42  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=207.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .+.|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356889999999999999999975 57899999865433 3456789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++..   ..+++.+++.++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++...... 
T Consensus       101 ~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  173 (303)
T ss_dssp             CCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred             eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence            9999999999864   35899999999999999999999   6899999999999999999999999999997654321 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                       .......||..|+|||.+.+..++.++||||||++++||++|++|+......+..   ....    ...     .+   
T Consensus       174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~----~~~-----~~---  237 (303)
T 3a7i_A          174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIP----KNN-----PP---  237 (303)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHH----HSC-----CC---
T ss_pred             -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhh----cCC-----CC---
Confidence             1223457899999999999999999999999999999999999998754332211   1111    111     11   


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                       ......+..+.+++.+||+.+|.+||++.+++++..
T Consensus       238 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          238 -TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             -CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             -CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence             122344567899999999999999999999998654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.1e-37  Score=331.16  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...+.||+|+||.||+++..+ ++.+|+|.+...   .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            3568889999999999999999874 678999976432   344567889999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+++++|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999887643  6899999999999999999999   689999999999999999999999999999865422


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .  .......||..|+|||.+.+..++.++||||||++++||++|+.||......+...      .. .....       
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~-~~~~~-------  232 (294)
T 2rku_A          169 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RI-KKNEY-------  232 (294)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH-HTTCC-------
T ss_pred             c--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-hhccC-------
Confidence            1  12334568999999999999999999999999999999999999997654322111      11 11110       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                         ..+......+.+++.+||+.+|++||++.|++++-
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence               12233446788999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-37  Score=354.30  Aligned_cols=247  Identities=27%  Similarity=0.423  Sum_probs=205.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+.. +++.||||.+....   ....+.+.+|+++|+.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999986 68899999875332   123467899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-  169 (476)
T 2y94_A           96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  169 (476)
T ss_dssp             ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence            999999999999654  36999999999999999999999   789999999999999999999999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+.   ..   .. ..+..       
T Consensus       170 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~---~i-~~~~~-------  233 (476)
T 2y94_A          170 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL---FK---KI-CDGIF-------  233 (476)
T ss_dssp             --CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH---HH---HH-HTTCC-------
T ss_pred             --ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH---HH---HH-hcCCc-------
Confidence              22334579999999999988765 7899999999999999999999975433221   11   11 11110       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ..+......+.+++.+||+.||.+||++.|++++
T Consensus       234 ---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 ---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence               1122344678999999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.1e-38  Score=346.42  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=205.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+|+.. ++..||+|++... .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            56889999999999999999987 5788999987654 344567899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      +++|+|.+++....  .+++..+..++.+++.||+|||   .. +|+||||||+|||++.++.+||+|||+++....   
T Consensus       113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---  184 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  184 (360)
T ss_dssp             CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---
Confidence            99999999997653  5899999999999999999999   54 899999999999999999999999999864321   


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHH-----------------
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM-----------------  702 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~-----------------  702 (820)
                       .......||..|+|||++.+..++.++|||||||+++||++|+.||......+.........                 
T Consensus       185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          185 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             -HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             -ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence             12234578999999999999999999999999999999999999997654332211110000                 


Q ss_pred             ------HhhccCcccc----ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          703 ------KCQETGQLED----IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       703 ------~~~~~~~~~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                            .........+    +................+.+++.+||+.||.+||++.|++++-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                  0000000000    0000000011123456789999999999999999999998864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-37  Score=330.56  Aligned_cols=251  Identities=21%  Similarity=0.322  Sum_probs=201.8

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|...+.||+|+||.||+++.. +++.+|+|.+....      ....+.+.+|++++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46888999999999999999987 58899999754332      123678999999999999999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC----CeeEeecccc
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL----MAKVADFGLS  631 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~----~~kl~DFGla  631 (820)
                      +||||+++++|.+++....  .+++.+++.++.|++.||+|||   +.+++||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            9999999999999997643  6899999999999999999999   78999999999999998877    8999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      +......   ......|+..|+|||++.+..++.++||||||++++||++|+.||......+....   .    ......
T Consensus       160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~----~~~~~~  229 (283)
T 3bhy_A          160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN---I----SAVNYD  229 (283)
T ss_dssp             EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---H----HTTCCC
T ss_pred             eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH---h----HhcccC
Confidence            8654321   12345689999999999999999999999999999999999999976543221111   0    000000


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .++.    .....+..+.+++.+|++.+|.+||++.|++++
T Consensus       230 --~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          230 --FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             --CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             --Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence              0000    112334678999999999999999999999984

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.8e-37  Score=337.29  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=206.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...+.||+|+||.||+++..+ ++.+|+|.+...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            3568889999999999999999874 678999976432   344567889999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++++|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            99999999999887643  6899999999999999999999   689999999999999999999999999999865422


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .  .......||..|+|||++.+..++.++||||||+++|||++|+.||......+...      .. .....       
T Consensus       195 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~-~~~~~-------  258 (335)
T 2owb_A          195 G--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RI-KKNEY-------  258 (335)
T ss_dssp             T--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH-HHTCC-------
T ss_pred             c--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HH-hcCCC-------
Confidence            1  12334578999999999999999999999999999999999999997554322111      11 01110       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                         ..+......+.+++.+||+.||.+||++.|++++-
T Consensus       259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence               11223446788999999999999999999998753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.7e-38  Score=341.05  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=197.6

Q ss_pred             cCCccc-eeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSES-LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      +.|... ++||+|+||.||+|+.. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456663 68999999999999965 6889999997665555567899999999985 79999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC---eeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM---AKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~---~kl~DFGla~~~~~  636 (820)
                      |+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||+++....
T Consensus        92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999997653  6899999999999999999999   689999999999999988765   99999999875432


Q ss_pred             CCC-----ccccccccCCccccCcccccc-----CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh--------hHH
Q 003436          637 LDQ-----THVSTAVKGSFGYLDPEYLTK-----QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV--------NLV  698 (820)
Q Consensus       637 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~--------~l~  698 (820)
                      ...     ........||..|+|||++.+     ..++.++|||||||++|||++|++||......+..        ...
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            111     111223469999999999975     56899999999999999999999999764322100        000


Q ss_pred             HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .........+... . ...    ........+.+++.+||+.||.+||++.|++++
T Consensus       247 ~~~~~~i~~~~~~-~-~~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          247 NMLFESIQEGKYE-F-PDK----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHCCCC-C-CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhccCcc-c-Cch----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000111111110 0 000    001234678999999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.1e-37  Score=330.43  Aligned_cols=247  Identities=26%  Similarity=0.422  Sum_probs=197.5

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec----CceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE----RNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~l  556 (820)
                      .|...+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|++++++++||||+++++++..    +...++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            3677779999999999999976 4678999976432  34556789999999999999999999998754    456899


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc--EEeccCCCCcEEEc-CCCCeeEeecccccc
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA--IIHRDVKSANILLD-ENLMAKVADFGLSKI  633 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--iiHrDIkp~NIll~-~~~~~kl~DFGla~~  633 (820)
                      ||||+++|+|.+++...  ..+++..++.++.|++.||+|||   +.+  |+||||||+|||++ +++.+||+|||++..
T Consensus       107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999999999764  35899999999999999999999   667  99999999999997 789999999999975


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ....    ......||..|+|||.+. ..++.++||||||++++||++|+.||........  ..   ... ..+.... 
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~---~~~-~~~~~~~-  249 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY---RRV-TSGVKPA-  249 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---HHH-TTTCCCG-
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HH---HHH-hccCCcc-
Confidence            4332    223456899999999886 4589999999999999999999999975433221  11   111 1111110 


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                             ..+......+.+++.+||+.+|.+||++.|++++
T Consensus       250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                   1122234578999999999999999999999863

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-37  Score=339.27  Aligned_cols=266  Identities=21%  Similarity=0.292  Sum_probs=199.2

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChh-----hHHHHHHHHHHHHcCCCCceeeEEeEeecCc
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ-----GLAEFRTEIEMLSQFRHRHLVSLIGYCDERN  552 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  552 (820)
                      ....++|...+.||+|+||.||+|+.. +++.||||++......     ..+.+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344578999999999999999999976 4889999987643221     1246889999999999999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++|+||+++ +|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            99999999985 8888886543 46899999999999999999999   7899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC---
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG---  708 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  708 (820)
                      ......  .......||..|+|||++.+. .++.++|||||||++|||++|++|+......+....   ........   
T Consensus       161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~---i~~~~~~~~~~  235 (346)
T 1ua2_A          161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEE  235 (346)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTT
T ss_pred             eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHcCCCChh
Confidence            654322  223446789999999999764 589999999999999999999999876543332211   11111111   


Q ss_pred             ccccc---cCccccC---C-----CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 QLEDI---VDPTLTG---Q-----IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ~~~~~---~d~~l~~---~-----~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...+.   .+.....   .     ........+.+++.+||+.||.+||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            01000   0000000   0     012345789999999999999999999999875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.4e-38  Score=342.26  Aligned_cols=265  Identities=22%  Similarity=0.376  Sum_probs=202.1

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|...++||+|+||.||+|+... ++.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            568899999999999999999864 789999976433  33445678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       105 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          105 FVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             CCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence            99999998876543  35999999999999999999999   7899999999999999999999999999997543321 


Q ss_pred             ccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH---------HHhhccCc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA---------MKCQETGQ  709 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~  709 (820)
                       .......||..|+|||++.+. .++.++|||||||++|||++|++||......+........         ........
T Consensus       179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence             222345689999999999775 7899999999999999999999999765443322111100         00000111


Q ss_pred             cccccCccccC-----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 LEDIVDPTLTG-----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 ~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ......+.+..     ...+..+..+.+++.+||+.||.+||++.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11111111111     1112446789999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-37  Score=342.47  Aligned_cols=257  Identities=23%  Similarity=0.349  Sum_probs=197.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------c
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------N  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  552 (820)
                      .++|...+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+++|++++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467899999999999999999985 5889999987543  344467889999999999999999999998765      3


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++||||+ +++|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            469999999 88999998763   5899999999999999999999   7899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC---
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG---  708 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  708 (820)
                      ....     ..+...+|..|+|||++.+ ..++.++|||||||+++||++|++||......+....+.   ......   
T Consensus       177 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~---~~~g~~~~~  248 (367)
T 1cm8_A          177 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM---KVTGTPPAE  248 (367)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HHHCCCCHH
T ss_pred             cccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HhcCCCCHH
Confidence            6432     1234578999999999987 689999999999999999999999997654433221111   100000   


Q ss_pred             ---------------ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 ---------------QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ---------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                     .+.......+ ....+.....+.+++.+||+.||.+||++.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          249 FVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                           0000000011 11223445778999999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-38  Score=353.37  Aligned_cols=242  Identities=15%  Similarity=0.161  Sum_probs=190.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCC---CChhhHHHHHHHH---HHHHcCCCCceeeEE-------eE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGT---QSHQGLAEFRTEI---EMLSQFRHRHLVSLI-------GY  547 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~---~~~~~~~~f~~Ei---~~l~~l~H~nIv~l~-------g~  547 (820)
                      .++|...+.||+|+||.||+|++. +++.||||++..   ......+.|.+|+   ++|++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999999964 589999998752   3344567899999   555566899999998       55


Q ss_pred             eecCc-----------------eEEEEEeeccCCchhhHhhhcC-----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcE
Q 003436          548 CDERN-----------------EMIIIYEYMENGTLKDHLYASN-----FPSLSWRKRLEICIGAARGLHYLHTGSTKAI  605 (820)
Q Consensus       548 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~i  605 (820)
                      +...+                 ..++||||+ +|+|.+++....     ...++|..++.|+.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 689999997532     123456889999999999999999   6899


Q ss_pred             EeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccC-----------CCCCcceeeehhh
Q 003436          606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-----------QLTEKSDVYSFGV  674 (820)
Q Consensus       606 iHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~SfGv  674 (820)
                      +||||||+|||++.++.+||+|||+++....     ......| ..|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985322     2334567 999999999887           8999999999999


Q ss_pred             hHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          675 VMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       675 ll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ++|||++|+.||......+.               ...+..      .....+..+.+++.+||+.||.+||++.|++++
T Consensus       302 il~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHSSCCC------CC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHCCCCCcccccccc---------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99999999999864322111               111111      112345678999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-38  Score=345.39  Aligned_cols=255  Identities=23%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             hcCCccceeEeeecceEEEEEEE----cCccEEEEEeCCCCC----hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL----RDETKVAVKRGGTQS----HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~----~~~~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      .++|...++||+|+||.||+++.    ..++.||||++....    ....+.+.+|+++|+++ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            35799999999999999999997    368899999875432    12335677899999999 6999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++||||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            9999999999999999997653  6899999999999999999999   6899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ..... .........||..|+|||++.+  ..++.++|||||||++|||++|+.||.........  ..........   
T Consensus       208 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~---  281 (355)
T 1vzo_A          208 EFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS---  281 (355)
T ss_dssp             ECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC---
T ss_pred             ecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc---
Confidence            64331 2222334679999999999985  35789999999999999999999999754322211  1111111110   


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWNL  755 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~L  755 (820)
                              ....+......+.+++.+||+.||.+||     ++.|++++.
T Consensus       282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                    0122344557789999999999999999     899998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.8e-37  Score=339.31  Aligned_cols=268  Identities=22%  Similarity=0.331  Sum_probs=201.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeec--------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--------  550 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------  550 (820)
                      .++|...++||+|+||.||+|+.. +++.||+|++....  ......+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            357999999999999999999985 68899999865433  2234578899999999999999999999876        


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      .+..++||||+++ +|.+.+.... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            4568999999975 7877776543 46999999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCC--ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          631 SKIGPDLDQ--THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       631 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      ++.......  ........||+.|+|||++.+ ..++.++|||||||+++||++|++||......+..............
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            986543221  222344678999999999876 46899999999999999999999999876544333222211111111


Q ss_pred             CccccccCccccC-------C-CC-hh------hHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 GQLEDIVDPTLTG-------Q-IK-PD------SLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ~~~~~~~d~~l~~-------~-~~-~~------~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ......-+.....       . .. .+      ....+.+++.+||+.||++||++.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1011100000000       0 00 00      13457899999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.3e-38  Score=346.95  Aligned_cols=247  Identities=28%  Similarity=0.362  Sum_probs=193.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHH-HHcCCCCceeeEEeEeecCceEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEM-LSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~-l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .++|...++||+|+||.||+++.+. ++.+|+|.+....   ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3579999999999999999999874 7889999865332   2334556677776 577899999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999997653  5889999999999999999999   78999999999999999999999999999985322


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .  ........||+.|+|||++.+..++.++|||||||++|||++|++||......+..   +   .... ..+      
T Consensus       192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~---~---~i~~-~~~------  256 (373)
T 2r5t_A          192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY---D---NILN-KPL------  256 (373)
T ss_dssp             C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH---H---HHHH-SCC------
T ss_pred             C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---H---HHHh-ccc------
Confidence            1  12234567999999999999999999999999999999999999999754332211   1   1111 110      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL  752 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl  752 (820)
                          .++......+.+++.+||+.||.+||++.+.+
T Consensus       257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                12234456789999999999999999986433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-37  Score=335.55  Aligned_cols=265  Identities=24%  Similarity=0.349  Sum_probs=189.1

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34578999999999999999999865 57899999876543 33456788999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhh------cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          558 YEYMENGTLKDHLYA------SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~------~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      |||+++++|.+++..      .....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999864      12346899999999999999999999   689999999999999999999999999999


Q ss_pred             ccCCCCCC---ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc
Q 003436          632 KIGPDLDQ---THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET  707 (820)
Q Consensus       632 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~  707 (820)
                      +.......   ........||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...   .  .. . 
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~--~~-~-  241 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---L--TL-Q-  241 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---H--HH-T-
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---H--Hh-c-
Confidence            76443211   112234568999999999976 568999999999999999999999997654332211   1  11 1 


Q ss_pred             CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ......................+.+++.+||+.||.+||++.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11111101001112223445678999999999999999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.4e-37  Score=351.61  Aligned_cols=262  Identities=20%  Similarity=0.255  Sum_probs=196.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------c
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------N  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  552 (820)
                      .++|...++||+|+||.||+|+.. .++.||||++...  .....+.+.+|+++|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467999999999999999999976 5788999987543  345567889999999999999999999998554      4


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++|||||++ +|.+.+..    .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            67999999976 56666643    4899999999999999999999   6899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH-----------
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA-----------  701 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~-----------  701 (820)
                      ....   ....+...||+.|+|||++.+..++.++|||||||+++||++|++||......+....+...           
T Consensus       213 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          213 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            6433   12234567999999999999999999999999999999999999999765433322111000           


Q ss_pred             -----HHhhcc-Cc-----cccccCccccCCC---ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          702 -----MKCQET-GQ-----LEDIVDPTLTGQI---KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       702 -----~~~~~~-~~-----~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                           ....+. ..     +.......+....   ......++.+|+.+||+.||++|||+.|++++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000000 00     0000000000000   01125678999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.5e-37  Score=349.13  Aligned_cols=202  Identities=24%  Similarity=0.312  Sum_probs=176.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC------CCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF------RHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l------~H~nIv~l~g~~~~~~~~  554 (820)
                      ..+|...++||+|+||.||+|+.. .++.||||++... ....+++.+|+++++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            456899999999999999999876 4789999998654 34456778899888877      577999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC--eeEeeccccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM--AKVADFGLSK  632 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~--~kl~DFGla~  632 (820)
                      ++||||++ ++|.+++.......+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||+++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 69999998877677999999999999999999999   689999999999999999887  9999999997


Q ss_pred             cCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE  693 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~  693 (820)
                      ....     ......||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus       251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            5432     1234578999999999999999999999999999999999999997665433

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.6e-37  Score=333.96  Aligned_cols=263  Identities=19%  Similarity=0.312  Sum_probs=207.2

Q ss_pred             hcCCccceeEeeecceEEEEEEE-c-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc------eeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVL-R-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH------LVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~-~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~  553 (820)
                      .++|...+.||+|+||.||+|.. . +++.||||.+... ....+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            35789999999999999999987 3 5789999997644 344577889999999997765      9999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC--------------
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE--------------  619 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~--------------  619 (820)
                      .++||||+ +++|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 899999998776667999999999999999999999   789999999999999987              


Q ss_pred             -----CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          620 -----NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       620 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                           ++.+||+|||+++.....     .....||..|+|||++.+..++.++|||||||++|||++|++||......+.
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 678999999999864321     2345789999999999999999999999999999999999999976554433


Q ss_pred             hhHHHHHHHh--------hccCcc------------------ccccCccc-cCCCChhhHHHHHHHHHHHhhcCCCCCCC
Q 003436          695 VNLVEWAMKC--------QETGQL------------------EDIVDPTL-TGQIKPDSLNKFVEIAEKCLAQCGIDRPS  747 (820)
Q Consensus       695 ~~l~~~~~~~--------~~~~~~------------------~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs  747 (820)
                      ..........        ......                  .....+.. ...........+.+++.+||+.||.+||+
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            2222111100        000000                  00000000 01123345678999999999999999999


Q ss_pred             HHHHHHH
Q 003436          748 MGDVLWN  754 (820)
Q Consensus       748 ~~evl~~  754 (820)
                      +.|++++
T Consensus       323 ~~ell~h  329 (339)
T 1z57_A          323 LREALKH  329 (339)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=341.43  Aligned_cols=243  Identities=20%  Similarity=0.296  Sum_probs=201.6

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  551 (820)
                      ..++|...+.||+|+||.||+|+.. +++.||||.+....        ....+.+.+|+++|++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4567999999999999999999965 57889999865432        11334677899999999999999999999999


Q ss_pred             ceEEEEEeeccCC-chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          552 NEMIIIYEYMENG-TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       552 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      +..++||||+.+| +|.+++....  .+++..+..|+.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            9999999999877 9999987543  6999999999999999999999   78999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      ++......   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....                  
T Consensus       177 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------  235 (335)
T 3dls_A          177 AAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------  235 (335)
T ss_dssp             CEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred             ceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence            98654322   2234569999999999988876 8899999999999999999999863210                  


Q ss_pred             cccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 LEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ......  ..+......+.+++.+||+.+|++||++.+++++
T Consensus       236 ---~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ---TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000000  1122345678999999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-37  Score=343.35  Aligned_cols=270  Identities=21%  Similarity=0.275  Sum_probs=202.6

Q ss_pred             CHHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCC-----------hhhHHHHHHHHHHHHcCCCCcee
Q 003436          474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS-----------HQGLAEFRTEIEMLSQFRHRHLV  542 (820)
Q Consensus       474 ~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~-----------~~~~~~f~~Ei~~l~~l~H~nIv  542 (820)
                      ...++....++|...++||+|+||.||+|...++..||||++....           ....+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            3467788889999999999999999999998889999999864321           22347899999999999999999


Q ss_pred             eEEeEee-----cCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE
Q 003436          543 SLIGYCD-----ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL  617 (820)
Q Consensus       543 ~l~g~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll  617 (820)
                      ++++++.     .....++||||++ |+|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            9999983     3346899999998 6888888754 346999999999999999999999   6899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVN  696 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~  696 (820)
                      +.++.+||+|||+++.....   .......||..|+|||++.+ ..++.++|||||||++|||++|+.||......+...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999753321   22334568999999999877 678999999999999999999999997654333221


Q ss_pred             HHHHHHHhhccCcc-----------ccccCcccc-------CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          697 LVEWAMKCQETGQL-----------EDIVDPTLT-------GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       697 l~~~~~~~~~~~~~-----------~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..   .........           .+.....+.       ....+.....+.+++.+||+.||.+||++.|++++
T Consensus       245 ~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          245 KI---VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HH---HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH---HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11   111110000           000000000       01122345678999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.5e-37  Score=343.75  Aligned_cols=263  Identities=22%  Similarity=0.276  Sum_probs=204.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC--------CCceeeEEeEee---
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR--------HRHLVSLIGYCD---  549 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~nIv~l~g~~~---  549 (820)
                      .++|...++||+|+||.||+|+.. +++.||||++... ....+.+.+|+++|++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467999999999999999999875 5788999998644 344577899999999985        788999999987   


Q ss_pred             -cCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEcCCC------
Q 003436          550 -ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLDENL------  621 (820)
Q Consensus       550 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~~~~------  621 (820)
                       .....++||||+ +++|.+.+.......+++.++..++.|++.||+|||   ++ +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             567899999999 667777776665567999999999999999999999   56 999999999999998775      


Q ss_pred             -------------------------------------------CeeEeeccccccCCCCCCccccccccCCccccCcccc
Q 003436          622 -------------------------------------------MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL  658 (820)
Q Consensus       622 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  658 (820)
                                                                 .+||+|||+++.....     .....||..|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       8999999999864321     2345789999999999


Q ss_pred             ccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh---hHHHHHHHhhcc-------------------CccccccCc
Q 003436          659 TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV---NLVEWAMKCQET-------------------GQLEDIVDP  716 (820)
Q Consensus       659 ~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~---~l~~~~~~~~~~-------------------~~~~~~~d~  716 (820)
                      .+..++.++|||||||++|||++|+.||......+..   ............                   +.+..+.+.
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            9999999999999999999999999999765432211   111111111100                   000000000


Q ss_pred             cc---------cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TL---------TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l---------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..         ....+......+.+|+.+||+.||++||++.|++++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00         012345667789999999999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.2e-36  Score=335.39  Aligned_cols=258  Identities=27%  Similarity=0.368  Sum_probs=206.6

Q ss_pred             HHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--------hhhHHHHHHHHHHHHcC-CCCceeeEE
Q 003436          476 VAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--------HQGLAEFRTEIEMLSQF-RHRHLVSLI  545 (820)
Q Consensus       476 ~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l-~H~nIv~l~  545 (820)
                      .......++|...+.||+|+||.||+|++. +|+.||||.+....        ....+.+.+|+++++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556678999999999999999999986 68999999765432        12245688999999999 799999999


Q ss_pred             eEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeE
Q 003436          546 GYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKV  625 (820)
Q Consensus       546 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl  625 (820)
                      +++...+..++||||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999999999999754  36899999999999999999999   689999999999999999999999


Q ss_pred             eeccccccCCCCCCccccccccCCccccCcccccc------CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH
Q 003436          626 ADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE  699 (820)
Q Consensus       626 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~  699 (820)
                      +|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||........   ..
T Consensus       242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---LR  315 (365)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH
T ss_pred             EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---HH
Confidence            9999998654321   2234679999999999863      3588999999999999999999999975432221   11


Q ss_pred             HHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          700 WAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       700 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....    +.... ..+.     ....+..+.+++.+||+.||++||++.|++++
T Consensus       316 ~i~~----~~~~~-~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          316 MIME----GQYQF-SSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHH----TCCCC-CHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHh----CCCCC-CCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111    11100 0000     01234668999999999999999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7e-37  Score=349.90  Aligned_cols=267  Identities=22%  Similarity=0.296  Sum_probs=187.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-----Cce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-----RNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-----~~~  553 (820)
                      .++|...++||+|+||.||+|+.. +++.||||++...  .....+.+.+|+++|++++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999976 5789999987543  34456789999999999999999999999843     357


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||||+ +|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 47999988654  36999999999999999999999   78999999999999999999999999999986


Q ss_pred             CCCCCCc-------------------------cccccccCCccccCcccc-ccCCCCCcceeeehhhhHHHHhc------
Q 003436          634 GPDLDQT-------------------------HVSTAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILC------  681 (820)
Q Consensus       634 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvll~Ellt------  681 (820)
                      .......                         ...+...||+.|+|||++ ....++.++|||||||+||||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            5422110                         122345789999999986 56679999999999999999999      


Q ss_pred             -----CCCCCCCCCch-----------------hhhhHHHHHHHhhccCccc--------------cccCcccc---CCC
Q 003436          682 -----GRPVIDPSLPR-----------------EKVNLVEWAMKCQETGQLE--------------DIVDPTLT---GQI  722 (820)
Q Consensus       682 -----G~~p~~~~~~~-----------------~~~~l~~~~~~~~~~~~~~--------------~~~d~~l~---~~~  722 (820)
                           |+++|......                 ...+....+..........              ..+.....   ...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 55555332210                 0001111111111100000              00000000   011


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+.....+.+|+.+||+.||++||++.|++++
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            12345778999999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.9e-37  Score=355.39  Aligned_cols=247  Identities=22%  Similarity=0.358  Sum_probs=203.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+++.. +++.||+|++....   ....+.+..|+++|++++||||+++++++......++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999986 58899999875332   223567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcC--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          559 EYMENGTLKDHLYASN--FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~--~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ||+++|+|.+++....  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            9999999999997643  456999999999999999999999   78999999999999999999999999999986543


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh-hhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK-VNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|++||........ ..+..   .... ..      
T Consensus       342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~i~~-~~------  409 (543)
T 3c4z_A          342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RVLE-QA------  409 (543)
T ss_dssp             TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---HHHH-CC------
T ss_pred             CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---HHhh-cc------
Confidence            22  122345799999999999999999999999999999999999999976432211 11111   1111 10      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                          ..++......+.+++.+||+.||.+||++
T Consensus       410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             ----cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                12233455778999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=337.14  Aligned_cols=261  Identities=25%  Similarity=0.398  Sum_probs=202.3

Q ss_pred             CCHHHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeec
Q 003436          473 FPFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDE  550 (820)
Q Consensus       473 ~~~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~  550 (820)
                      +.+.++....++|...+.||+|+||.||+|+.. +++.||||.+..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            334445566788999999999999999999985 688999998754432 346788999999999 89999999999866


Q ss_pred             ------CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCee
Q 003436          551 ------RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAK  624 (820)
Q Consensus       551 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~k  624 (820)
                            .+..++||||+++|+|.+++.......+++..++.++.|++.||+|||   ..+|+||||||+||+++.++.+|
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEE
Confidence                  467899999999999999998765567999999999999999999999   68999999999999999999999


Q ss_pred             EeeccccccCCCCCCccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH
Q 003436          625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE  699 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~  699 (820)
                      |+|||++.......  .......||..|+|||++.     +..++.++|||||||++|||++|+.||......+...   
T Consensus       170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---  244 (326)
T 2x7f_A          170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF---  244 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---
T ss_pred             EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH---
Confidence            99999987543211  1223456899999999987     5678999999999999999999999996544322111   


Q ss_pred             HHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          700 WAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       700 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .... ...     +.+   .....+..+.+++.+||+.+|.+||++.+++++
T Consensus       245 ---~~~~-~~~-----~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          245 ---LIPR-NPA-----PRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ---HHHH-SCC-----CCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---Hhhc-Ccc-----ccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0111 111     111   122345678999999999999999999999874

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.9e-37  Score=332.77  Aligned_cols=260  Identities=22%  Similarity=0.341  Sum_probs=202.6

Q ss_pred             HHHHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCC--CChhhHHHHHHHHHHHHcCC--CCceeeEEeEeec
Q 003436          475 FVAIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFR--HRHLVSLIGYCDE  550 (820)
Q Consensus       475 ~~~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~  550 (820)
                      +..+....++|...+.||+|+||.||+++..+++.||||.+..  ......+.+.+|++++.+++  |+||+++++++..
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   99 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   99 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence            3334445677999999999999999999998899999998653  34556688999999999997  5999999999999


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccc
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGL  630 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGl  630 (820)
                      .+..++||| +.+++|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+
T Consensus       100 ~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~  172 (313)
T 3cek_A          100 DQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGI  172 (313)
T ss_dssp             SSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred             CCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeeccc
Confidence            999999999 66889999997653  6899999999999999999999   68999999999999996 48999999999


Q ss_pred             cccCCCCCCccccccccCCccccCcccccc-----------CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTK-----------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE  699 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~  699 (820)
                      ++...............||..|+|||.+.+           ..++.++||||||+++|||++|+.||........     
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----  247 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----  247 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----
Confidence            986544322222334578999999999875           4788899999999999999999999965432211     


Q ss_pred             HHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          700 WAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       700 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      ....         +.++......+......+.+++.+||+.||.+||++.|++++-
T Consensus       248 ~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          248 KLHA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HHHH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHH---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            1111         1122222223334456789999999999999999999999764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.1e-37  Score=325.45  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=196.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+.. +++.||||.+....   ....+.+.+|++++++++||||+++++++...+..++|+
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999986 68899999865332   223567889999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++....  .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...... 
T Consensus        91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-  164 (276)
T ss_dssp             ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence            9999999999997653  5899999999999999999999   689999999999999999999999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        .......|+..|+|||.+.+..+ +.++||||||++++||++|+.||......+.   .+...    .+..       
T Consensus       165 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~----~~~~-------  228 (276)
T 2h6d_A          165 --EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKIR----GGVF-------  228 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH----HCCC-------
T ss_pred             --cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhh----cCcc-------
Confidence              12234568999999999987765 6899999999999999999999975432221   11111    1100       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ..+......+.+++.+||+.||.+||++.|++++
T Consensus       229 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 ---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               1123345678999999999999999999999885

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.1e-37  Score=332.18  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=199.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|+..+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|++++++++||||+++++++...+..++|+||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467899999999999999999987 4788999988766666678899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++++|.+++.... ..+++.++..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++.....  ..
T Consensus        98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  171 (302)
T 2j7t_A           98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TL  171 (302)
T ss_dssp             CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--cc
Confidence            99999999887543 35899999999999999999999   68999999999999999999999999998753211  01


Q ss_pred             cccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .......||..|+|||++.     +..++.++||||||+++|||++|+.|+......+..      ...... .....  
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-~~~~~--  242 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKS-DPPTL--  242 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHS-CCCCC--
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhcc-CCccc--
Confidence            1122356899999999983     667899999999999999999999998755432211      111111 11000  


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                           ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 112344567899999999999999999999875

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-37  Score=342.76  Aligned_cols=262  Identities=20%  Similarity=0.269  Sum_probs=198.4

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-------
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-------  550 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-------  550 (820)
                      ....++|...++||+|+||.||+|+.. +++.||||++.....    ...+|+++|+.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999999975 688999998754432    22469999999999999999999843       


Q ss_pred             -------------------------------CceEEEEEeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhh
Q 003436          551 -------------------------------RNEMIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYL  597 (820)
Q Consensus       551 -------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yL  597 (820)
                                                     ....++||||++ |+|.+.+..  .....+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999998 588887764  3345799999999999999999999


Q ss_pred             hcCCCCcEEeccCCCCcEEEc-CCCCeeEeeccccccCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhh
Q 003436          598 HTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVV  675 (820)
Q Consensus       598 H~~~~~~iiHrDIkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvl  675 (820)
                      |   +.+|+||||||+|||++ +++.+||+|||+++......   ......+|..|+|||++.+. .++.++|||||||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   78999999999999997 68999999999998654322   22345689999999998765 58999999999999


Q ss_pred             HHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC----------ccccccCcc-----ccCCCChhhHHHHHHHHHHHhhc
Q 003436          676 MFEILCGRPVIDPSLPREKVNLVEWAMKCQETG----------QLEDIVDPT-----LTGQIKPDSLNKFVEIAEKCLAQ  740 (820)
Q Consensus       676 l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~  740 (820)
                      ++||++|++||......+.....  +. .....          ...+..-+.     ....++...+..+.+++.+||+.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i--~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  308 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRI--IQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY  308 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHH--HH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHH--HH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence            99999999999865443322111  11 00000          001110011     11112334567799999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 003436          741 CGIDRPSMGDVLWN  754 (820)
Q Consensus       741 dp~~RPs~~evl~~  754 (820)
                      +|.+||++.|++++
T Consensus       309 dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          309 EPDLRINPYEAMAH  322 (383)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=328.18  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=201.2

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ..++|...+.||+|+||.||+|+.. +++.||+|.+....  ..+.+.+|++++++++||||+++++++...+..++|+|
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999986 48899999876443  34678899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+++++|.+++... ...+++.+++.++.+++.||+|||   ..+++||||||+||+++.++.+||+|||+++...... 
T Consensus       105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  179 (314)
T 3com_A          105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-  179 (314)
T ss_dssp             CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence            99999999998643 246899999999999999999999   7899999999999999999999999999997643321 


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                       .......|+..|+|||.+.+..++.++||||||+++|||++|+.||..........      .... ...     +.. 
T Consensus       180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~-~~~-----~~~-  245 (314)
T 3com_A          180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF------MIPT-NPP-----PTF-  245 (314)
T ss_dssp             -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH-SCC-----CCC-
T ss_pred             -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhc-CCC-----ccc-
Confidence             12234568999999999999999999999999999999999999997543322111      1101 100     000 


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+......+.+++.+||+.||.+||++.+++++
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             1122345678999999999999999999999874

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.4e-37  Score=329.66  Aligned_cols=252  Identities=23%  Similarity=0.294  Sum_probs=188.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .++|+..+.||+|+||.||+|+.. +++.||+|++.... .. ..+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467899999999999999999975 68899999876542 22 2334445555688889999999999999999999999


Q ss_pred             eeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      ||++ |+|.+++..  .....+++..++.++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 588888754  23457999999999999999999999   56 99999999999999999999999999997643


Q ss_pred             CCCCccccccccCCccccCcccc----ccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYL----TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      ..   .......||..|+|||++    .+..++.++||||||++++||++|+.||........ .+..    ......  
T Consensus       162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~~~~--  231 (290)
T 3fme_A          162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQ----VVEEPS--  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHH----HHHSCC--
T ss_pred             cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHH----HhccCC--
Confidence            32   122334689999999996    566789999999999999999999999975322211 1111    111110  


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          +   .......+..+.+++.+||+.+|++||++.|++++
T Consensus       232 ----~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          232 ----P---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             ----C---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ----C---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                0   01122345678999999999999999999999884

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1e-36  Score=331.91  Aligned_cols=264  Identities=23%  Similarity=0.328  Sum_probs=203.9

Q ss_pred             HhcCCccceeEeeecceEEEEEEE--cCccEEEEEeCCCCC--hhhHHHHHHHHHHHHcC---CCCceeeEEeEee----
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVL--RDETKVAVKRGGTQS--HQGLAEFRTEIEMLSQF---RHRHLVSLIGYCD----  549 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~--~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~----  549 (820)
                      +.++|...+.||+|+||.||+|+.  .+++.||+|++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999998  357889999764321  11123456677777666   8999999999986    


Q ss_pred             -cCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          550 -ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       550 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                       .....++|+||++ |+|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             5678899999998 69999998776667999999999999999999999   689999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      |+++....   ........||..|+|||++.+..++.++||||||+++|||++|++||......+...   .........
T Consensus       165 g~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~  238 (326)
T 1blx_A          165 GLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLP  238 (326)
T ss_dssp             CSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCC
T ss_pred             cccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHcCCC
Confidence            99975432   122344678999999999999999999999999999999999999997654433221   111111100


Q ss_pred             ---cccc-c------cC---ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 ---QLED-I------VD---PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ---~~~~-~------~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .+.. .      ..   ..............+.+++.+||+.||.+||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               0000 0      00   000012223456788999999999999999999999863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-37  Score=339.27  Aligned_cols=259  Identities=22%  Similarity=0.331  Sum_probs=205.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChh-----------------hHHHHHHHHHHHHcCCCCceeeE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQ-----------------GLAEFRTEIEMLSQFRHRHLVSL  544 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~-----------------~~~~f~~Ei~~l~~l~H~nIv~l  544 (820)
                      .++|...+.||+|+||.||+|+. +++.||+|.+......                 ..+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35799999999999999999999 8899999986432211                 12789999999999999999999


Q ss_pred             EeEeecCceEEEEEeeccCCchhhH------hhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCC-CcEEeccCCCCcEEE
Q 003436          545 IGYCDERNEMIIIYEYMENGTLKDH------LYASNFPSLSWRKRLEICIGAARGLHYLHTGST-KAIIHRDVKSANILL  617 (820)
Q Consensus       545 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~-~~iiHrDIkp~NIll  617 (820)
                      ++++.+.+..++||||+++|+|.++      +.......+++..++.++.|++.||+|||   + .+|+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999999      65544567999999999999999999999   5 899999999999999


Q ss_pred             cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccC-CCCC-cceeeehhhhHHHHhcCCCCCCCCCchhhh
Q 003436          618 DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTE-KSDVYSFGVVMFEILCGRPVIDPSLPREKV  695 (820)
Q Consensus       618 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~SfGvll~ElltG~~p~~~~~~~~~~  695 (820)
                      +.++.+||+|||+++.....    ......|+..|+|||.+.+. .++. ++||||||++++||++|+.||.......  
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  259 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--  259 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence            99999999999999864332    23456789999999999877 6666 9999999999999999999997654311  


Q ss_pred             hHHHHHHHhhccCcccccc------Ccc---ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          696 NLVEWAMKCQETGQLEDIV------DPT---LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       696 ~l~~~~~~~~~~~~~~~~~------d~~---l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ......    ..+......      .+.   ............+.+++.+||+.||.+||++.|++++
T Consensus       260 ~~~~~i----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 ELFNNI----RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHH----TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHH----hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111111    111111000      000   0001113456788999999999999999999999873

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-37  Score=347.63  Aligned_cols=199  Identities=26%  Similarity=0.360  Sum_probs=166.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  553 (820)
                      .++|...++||+|+||.||+|+.. +++.||||++...  .....+.+.+|+++|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467999999999999999999976 4788999987643  344567899999999999999999999998766     57


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||||++ |+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999996 6999998654  46999999999999999999999   78999999999999999999999999999986


Q ss_pred             CCCCCCc--------------------cccccccCCccccCcccc-ccCCCCCcceeeehhhhHHHHhcCCCCC
Q 003436          634 GPDLDQT--------------------HVSTAVKGSFGYLDPEYL-TKQQLTEKSDVYSFGVVMFEILCGRPVI  686 (820)
Q Consensus       634 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SfGvll~ElltG~~p~  686 (820)
                      .......                    ...+...||..|+|||++ ....++.++|||||||+++||++|..|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            5432211                    123456799999999986 5667999999999999999999854443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.2e-37  Score=342.82  Aligned_cols=255  Identities=10%  Similarity=0.018  Sum_probs=184.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcC--CCCceeeEE-------eEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQF--RHRHLVSLI-------GYC  548 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l--~H~nIv~l~-------g~~  548 (820)
                      ..+|...++||+|+||.||+|++. +++.||||++....   ....+.+.+|+++++.|  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999976 68899999876543   23456677885444444  699988755       333


Q ss_pred             ecC-----------------ceEEEEEeeccCCchhhHhhhcCCCCCCHHHH------HHHHHHHHHHhhhhhcCCCCcE
Q 003436          549 DER-----------------NEMIIIYEYMENGTLKDHLYASNFPSLSWRKR------LEICIGAARGLHYLHTGSTKAI  605 (820)
Q Consensus       549 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------l~i~~~ia~gL~yLH~~~~~~i  605 (820)
                      ...                 ...++||||++ |+|.+++.... ..+.+..+      +.++.|++.||+|||   +.+|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGL  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence            222                 34899999999 89999997642 23466666      788899999999999   7899


Q ss_pred             EeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCC
Q 003436          606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGR  683 (820)
Q Consensus       606 iHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~  683 (820)
                      +||||||+|||++.++.+||+|||+++....     ......+|..|+|||++.+  ..++.++|||||||++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999986432     1113457799999999987  78999999999999999999999


Q ss_pred             CCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          684 PVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       684 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .||....+.....        .............+........+..+.+++.+||+.||++||++.+++++
T Consensus       291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9997653321110        00000011111111112223556789999999999999999999999763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-36  Score=362.26  Aligned_cols=259  Identities=28%  Similarity=0.390  Sum_probs=208.5

Q ss_pred             HhcCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ..++|...+.||+|+||.||+|++..    +..||+|+.... .....+.|.+|+.+|++++||||+++++++.+ +..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence            34678889999999999999999753    457999987654 34455789999999999999999999999854 5689


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999997543 45899999999999999999999   6899999999999999999999999999998654


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ... ........+|+.|+|||++.+..++.++|||||||++|||++ |++||......+.   ...+..    +..    
T Consensus       543 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~i~~----~~~----  610 (656)
T 2j0j_A          543 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIEN----GER----  610 (656)
T ss_dssp             C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHH----TCC----
T ss_pred             CCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHc----CCC----
Confidence            322 122234457889999999999999999999999999999997 9999875543322   111111    110    


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                           ...+..++..+.+++.+||+.||.+||++.++++.|+.+++.
T Consensus       611 -----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          611 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                 112345567899999999999999999999999999988754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-36  Score=324.37  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=204.4

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---------hhhHHHHHHHHHHHHcCC-CCceeeEEeEee
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---------HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCD  549 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~  549 (820)
                      ..++|...+.||+|+||.||+|+.. +++.||||.+....         ....+.+.+|++++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999986 57899999875432         123467889999999995 999999999999


Q ss_pred             cCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       550 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                      .++..++|+||+++++|.+++...  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999999764  36899999999999999999999   7899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccc------cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHH
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLT------KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      +++......   ......|+..|+|||++.      ...++.++||||||++++||++|+.||......+.   ..... 
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~-  242 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIM-  242 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH-
T ss_pred             chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH---HHHHh-
Confidence            998654321   223456899999999985      45688999999999999999999999975433221   11111 


Q ss_pred             hhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                         .+...      .........+..+.+++.+||+.||.+||++.|+++
T Consensus       243 ---~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 ---SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ---HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---cCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence               11110      001111345577999999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.2e-37  Score=348.46  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=192.1

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--------hhhHHHHHHHHHHHHcCCCCceeeEEeEeec
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE  550 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~  550 (820)
                      ...++|...++||+|+||.||+|... +++.||||.+....        ......+.+|+++|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            34678999999999999999999976 47899999864321        1222358899999999999999999999865


Q ss_pred             CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC---CCeeEee
Q 003436          551 RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN---LMAKVAD  627 (820)
Q Consensus       551 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~---~~~kl~D  627 (820)
                       +..++||||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEee
Confidence             4579999999999999988654  46999999999999999999999   6899999999999999654   4599999


Q ss_pred             ccccccCCCCCCccccccccCCccccCcccccc---CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      ||+++....   ........||+.|+|||++.+   ..++.++|||||||++|||++|++||........  +....   
T Consensus       286 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i---  357 (419)
T 3i6u_A          286 FGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI---  357 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH---
T ss_pred             cccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH---
Confidence            999986543   222345679999999999853   5788899999999999999999999975432211  11111   


Q ss_pred             hccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..+....  .+..    .......+.+++.+||+.||++||++.|++++
T Consensus       358 -~~~~~~~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 -TSGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -HTTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -hcCCCCC--Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             1111100  0000    11335678999999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.1e-36  Score=337.64  Aligned_cols=263  Identities=22%  Similarity=0.334  Sum_probs=203.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  554 (820)
                      .++|...++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++|.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999976 57889999876443 44457899999999999999999999998654     468


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||++ |+|.+++...   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999997 5999988754   5899999999999999999999   789999999999999999999999999999865


Q ss_pred             CCCCC-ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc--
Q 003436          635 PDLDQ-THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL--  710 (820)
Q Consensus       635 ~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--  710 (820)
                      ..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||......+......   ........  
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~  255 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQED  255 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH---HHHCSCCHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH---HHhCCCCHHH
Confidence            43211 111234579999999998754 458999999999999999999999997665443322211   10000000  


Q ss_pred             -cc------------ccCccc--cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 -ED------------IVDPTL--TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 -~~------------~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..            ...+..  .....+.....+.+++.+||+.||.+||++.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             00            000000  000112345678999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.6e-37  Score=352.11  Aligned_cols=251  Identities=23%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .++|...++||+|+||.||+|+.. .+..+|+|.+....  ......+.+|+++|++++||||++++++|.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456899999999999999999986 57889999865432  233567899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---CCCeeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---NLMAKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---~~~~kl~DFGla~~~~  635 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            9999999999887653  5899999999999999999999   789999999999999975   4569999999998654


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ..   .......||+.|+|||++. ..++.++|||||||++|||++|++||......+....+   .    .+...  .+
T Consensus       191 ~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---~----~~~~~--~~  257 (494)
T 3lij_A          191 NQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV---E----KGKYT--FD  257 (494)
T ss_dssp             TT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H----HTCCC--CC
T ss_pred             CC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H----hCCCC--CC
Confidence            32   2233467999999999986 56899999999999999999999999765443322111   1    11111  00


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...    ....+..+.+++.+||+.+|.+||++.|++++
T Consensus       258 ~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          258 SPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             SGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             chh----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            000    12344678899999999999999999999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=334.52  Aligned_cols=262  Identities=24%  Similarity=0.383  Sum_probs=196.7

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEee------------
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD------------  549 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~------------  549 (820)
                      ++|...+.||+|+||.||+|+... ++.||+|++........+.+.+|++++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            578899999999999999999875 8899999987777777888999999999999999999999873            


Q ss_pred             --cCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-CCCCeeEe
Q 003436          550 --ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVA  626 (820)
Q Consensus       550 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-~~~~~kl~  626 (820)
                        +....++||||++ |+|.+++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++ +++.+||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence              4467899999998 699999864   35899999999999999999999   78999999999999997 67799999


Q ss_pred             eccccccCCCCCC-ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh
Q 003436          627 DFGLSKIGPDLDQ-THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC  704 (820)
Q Consensus       627 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~  704 (820)
                      |||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.....   ...
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~---~~~  240 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI---LES  240 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHH
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHh
Confidence            9999986533211 112233457899999998865 67899999999999999999999999765443222111   000


Q ss_pred             hcc---C-------ccccccCcccc------CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QET---G-------QLEDIVDPTLT------GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~~---~-------~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...   .       .+.........      ....+.....+.+++.+||+.||.+||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            000   0       00000000000      01112345779999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.9e-37  Score=353.67  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=205.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|...++||+|+||.||+++.. +++.||||++...   .....+.+.+|+++|++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356889999999999999999986 6889999986432   234467899999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE---cCCCCeeEeeccccccC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL---DENLMAKVADFGLSKIG  634 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll---~~~~~~kl~DFGla~~~  634 (820)
                      +||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  179 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF  179 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred             EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence            99999999999987643  6999999999999999999999   6899999999999999   56789999999999865


Q ss_pred             CCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ....   ......||+.|+|||++.+ .++.++|||||||++|||++|++||......+..   ..+.    .+....  
T Consensus       180 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~----~~~~~~--  246 (484)
T 3nyv_A          180 EASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---KKVE----KGKYTF--  246 (484)
T ss_dssp             CCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH----HCCCCC--
T ss_pred             cccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHH----cCCCCC--
Confidence            4322   2234569999999999876 6899999999999999999999999765433221   1111    111110  


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                          ........+..+.+++.+||+.+|.+||++.|++++-
T Consensus       247 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          247 ----ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             ----CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             ----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence                0001123456789999999999999999999999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.7e-36  Score=350.97  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=202.4

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-------------hhHHHHHHHHHHHHcCCCCceeeEEe
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-------------QGLAEFRTEIEMLSQFRHRHLVSLIG  546 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-------------~~~~~f~~Ei~~l~~l~H~nIv~l~g  546 (820)
                      ..++|...++||+|+||.||+|+.. +++.+|+|.+.....             ...+.+.+|+++|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999986 478899998653321             23567899999999999999999999


Q ss_pred             EeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC---Ce
Q 003436          547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL---MA  623 (820)
Q Consensus       547 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~---~~  623 (820)
                      ++.++...++||||+++|+|.+++....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            9999999999999999999999987653  5999999999999999999999   78999999999999998775   69


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      ||+|||+++.....   .......||+.|+|||++. ..++.++|||||||++|||++|++||......+....+     
T Consensus       189 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-----  259 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV-----  259 (504)
T ss_dssp             EECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred             EEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----
Confidence            99999999865432   2233457999999999987 46899999999999999999999999765443322111     


Q ss_pred             hhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                        ..+...  .+...    ....+..+.+++.+||+.||.+||++.|++++-
T Consensus       260 --~~~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          260 --EKGKYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             --HHCCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --HcCCCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence              111110  00000    012346789999999999999999999998753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.1e-37  Score=341.36  Aligned_cols=258  Identities=23%  Similarity=0.360  Sum_probs=185.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------c
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------N  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~  552 (820)
                      .++|...+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+++|++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            367899999999999999999965 5889999997543  344567889999999999999999999998654      5


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++|+|++ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 6899998865   36999999999999999999999   7899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc--
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ--  709 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  709 (820)
                      ....     ..+...||..|+|||++.+ ..++.++|||||||+++||++|++||......+....+   ........  
T Consensus       181 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i---~~~~g~p~~~  252 (367)
T 2fst_X          181 HTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAE  252 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCCHH
T ss_pred             cccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHH
Confidence            5432     1234578999999999977 68899999999999999999999999765443322211   11111000  


Q ss_pred             -cccccCc-------ccc--C-----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 -LEDIVDP-------TLT--G-----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 -~~~~~d~-------~l~--~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       +..+...       .+.  .     .........+.+|+.+||+.||.+||++.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence             0000000       000  0     0011334678999999999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.2e-36  Score=334.77  Aligned_cols=263  Identities=21%  Similarity=0.275  Sum_probs=193.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCC--CChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGT--QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN------  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  552 (820)
                      .++|...+.||+|+||.||+|+.. .++.||||++..  ......+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357899999999999999999976 578899998654  23445678899999999999999999999987654      


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ..++||||++ |+|.+.+..    .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999997 578888753    4899999999999999999999   6899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH---------H---
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE---------W---  700 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~---------~---  700 (820)
                      .....   .......||..|+|||++.+..++.++|||||||+++||++|+.||......+......         +   
T Consensus       176 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            54321   12334578999999999999999999999999999999999999997654322211100         0   


Q ss_pred             ----HHHhhcc-Cc-----cccccCccccCCC---ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          701 ----AMKCQET-GQ-----LEDIVDPTLTGQI---KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       701 ----~~~~~~~-~~-----~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                          ....... ..     +.+..........   .......+.+++.+||+.||.+|||+.|++++-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                0000000 00     0000000000000   112356789999999999999999999998863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.1e-36  Score=327.03  Aligned_cols=257  Identities=18%  Similarity=0.252  Sum_probs=200.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeec--CceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDE--RNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~  558 (820)
                      ++|...++||+|+||.||+|+.. +++.||||.+....   .+.+.+|++++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            56889999999999999999874 67899999986544   367889999999997 9999999999987  66789999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDL  637 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~~~  637 (820)
                      ||+++++|.+++.     .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.....
T Consensus       113 e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999999884     3889999999999999999999   78999999999999999766 8999999999865432


Q ss_pred             CCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh--------hccC
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC--------QETG  708 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~  708 (820)
                      .   ......|+..|+|||.+.+ ..++.++|||||||+++||++|+.||........ .+.......        ....
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHh
Confidence            2   2234568999999999977 6789999999999999999999999865433211 111100000        0000


Q ss_pred             c------cccc--------cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 Q------LEDI--------VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ~------~~~~--------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .      ..+.        ................+.+++.+||+.||.+||++.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0      0000        00011111222356789999999999999999999999874

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-36  Score=343.06  Aligned_cols=259  Identities=22%  Similarity=0.291  Sum_probs=195.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC------ceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER------NEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~  555 (820)
                      .+|...++||+|+||.||+|++. +++.||||++.....    .+.+|+++|++++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35888899999999999999986 588999998754322    234699999999999999999988432      2367


Q ss_pred             EEEeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-CCeeEeeccccc
Q 003436          556 IIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-LMAKVADFGLSK  632 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-~~~kl~DFGla~  632 (820)
                      +||||+++ +|.+.+..  .....+++..+..++.|+++||+|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999985 66665543  23457999999999999999999999   7899999999999999955 678999999998


Q ss_pred             cCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhc-----
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE-----  706 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~-----  706 (820)
                      ......   ......||..|+|||++.+. .++.++|||||||++|||++|++||......+..  .+.......     
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTREQ  280 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHH
Confidence            654321   12345789999999999765 7899999999999999999999999765433322  111111000     


Q ss_pred             ----cCccccccCccccC-----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          707 ----TGQLEDIVDPTLTG-----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       707 ----~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          .....+...+.+..     .+......++.+|+.+||+.||.+||++.|++++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                01111111111111     1223445789999999999999999999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-36  Score=350.88  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=203.0

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ..++|...++||+|+||.||+++.. +++.||||++...  .......+.+|+++|++++||||+++++++......++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3466999999999999999999986 6889999986432  122357789999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeeccccccC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIG  634 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFGla~~~  634 (820)
                      +||+++|+|.+.+....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++   .++.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999999887653  6899999999999999999999   78999999999999994   5668999999999865


Q ss_pred             CCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ...   .......||+.|+|||++.+ .++.++|||||||++|||++|++||......+....   +.    .+....  
T Consensus       175 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~----~~~~~~--  241 (486)
T 3mwu_A          175 QQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR---VE----TGKYAF--  241 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH----HTCCCS--
T ss_pred             CCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----hCCCCC--
Confidence            432   22334579999999999875 589999999999999999999999976543322211   11    111110  


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +    ..........+.+++.+||+.+|.+||++.+++++
T Consensus       242 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             C----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             C----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0    00112345678999999999999999999999975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.2e-36  Score=341.15  Aligned_cols=260  Identities=21%  Similarity=0.294  Sum_probs=194.8

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc------eEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN------EMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------~~~l  556 (820)
                      .+|...++||+|+||.||+|++..+..+|+|++......    ..+|+++|+.++||||+++++++...+      ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468889999999999999999987777999986443221    236999999999999999999985433      3789


Q ss_pred             EEeeccCCchhhHhh-hcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-CCCCeeEeeccccccC
Q 003436          557 IYEYMENGTLKDHLY-ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIG  634 (820)
Q Consensus       557 V~E~~~~gsL~~~l~-~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-~~~~~kl~DFGla~~~  634 (820)
                      ||||++++.+..... ......+++..+..++.|+++||+|||   +.+|+||||||+|||++ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999998754444332 223457999999999999999999999   78999999999999998 7999999999999865


Q ss_pred             CCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh--------
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ--------  705 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~--------  705 (820)
                      ....   ......||..|+|||++.+. .++.++|||||||++|||++|++||......+.....  .....        
T Consensus       193 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i--~~~~g~p~~~~~~  267 (394)
T 4e7w_A          193 IAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI--IKVLGTPSREQIK  267 (394)
T ss_dssp             CTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCHHHHH
T ss_pred             cCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHHhCCCCHHHHH
Confidence            3322   22345689999999998765 5899999999999999999999999765443322111  11000        


Q ss_pred             ------ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          706 ------ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       706 ------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                            .......+....+...+......++.+++.+||+.||.+||++.|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                  0000000000001111223355789999999999999999999999874

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.1e-36  Score=329.79  Aligned_cols=263  Identities=20%  Similarity=0.288  Sum_probs=204.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC--ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc------eeeEEeEeecCce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD--ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH------LVSLIGYCDERNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~--~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------Iv~l~g~~~~~~~  553 (820)
                      .++|...+.||+|+||.||+|+...  ++.||+|.+... ....+.+.+|++++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4679999999999999999999753  368999998643 344567889999999998766      8999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE----------------
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL----------------  617 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll----------------  617 (820)
                      .++||||+ +++|.+++.......+++.++..++.|++.||+|||   +.+|+||||||+|||+                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 677878887766567999999999999999999999   7899999999999999                


Q ss_pred             ---cCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          618 ---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       618 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                         +.++.+||+|||+++....     ......||..|+|||++.+..++.++|||||||++|||++|++||......+.
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               6688999999999986432     12345799999999999999999999999999999999999999986554333


Q ss_pred             hhHHHHHHHhhc-----cCcccc-ccCc-------------------c--ccCCCChhhHHHHHHHHHHHhhcCCCCCCC
Q 003436          695 VNLVEWAMKCQE-----TGQLED-IVDP-------------------T--LTGQIKPDSLNKFVEIAEKCLAQCGIDRPS  747 (820)
Q Consensus       695 ~~l~~~~~~~~~-----~~~~~~-~~d~-------------------~--l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs  747 (820)
                      ............     ...... ....                   .  ............+.+++.+||+.||.+||+
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            222211100000     000000 0000                   0  000112234568999999999999999999


Q ss_pred             HHHHHHH
Q 003436          748 MGDVLWN  754 (820)
Q Consensus       748 ~~evl~~  754 (820)
                      +.|++++
T Consensus       328 ~~e~l~h  334 (355)
T 2eu9_A          328 LAEALLH  334 (355)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.3e-35  Score=331.15  Aligned_cols=207  Identities=26%  Similarity=0.329  Sum_probs=176.7

Q ss_pred             HHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CC-----ceeeEEeEeecC
Q 003436          479 QEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HR-----HLVSLIGYCDER  551 (820)
Q Consensus       479 ~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----nIv~l~g~~~~~  551 (820)
                      ....++|...++||+|+||.||+|+.. +++.||||++... ....+++..|+++++.++ |+     +++++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            344678999999999999999999976 5788999998643 344567888999998885 44     499999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc--CCCCeeEeecc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD--ENLMAKVADFG  629 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~--~~~~~kl~DFG  629 (820)
                      +..++||||++ |+|.+++.......+++..+..++.|++.||+|||.. ..+|+||||||+|||++  .++.+||+|||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            99999999996 5999999887666799999999999999999999942 46899999999999994  57889999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE  693 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~  693 (820)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|++||......+
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~  265 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD  265 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99865321     234578999999999999999999999999999999999999998655433

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-36  Score=362.16  Aligned_cols=249  Identities=23%  Similarity=0.304  Sum_probs=205.2

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEE
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~  555 (820)
                      ..++|...++||+|+||.||+|+.. +++.||||++...   .....+.+..|.++|..+ +||+|+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3568999999999999999999986 4778999987532   123346678899999988 7999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      |||||+++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+++...
T Consensus       419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            9999999999999998654  6999999999999999999999   7899999999999999999999999999998543


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...  .......||+.|+|||++.+..++.++|||||||+||||++|++||......+..   +   .... ..      
T Consensus       494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~---~---~i~~-~~------  558 (674)
T 3pfq_A          494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---Q---SIME-HN------  558 (674)
T ss_dssp             CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHHS-SC------
T ss_pred             cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH---H---HHHh-CC------
Confidence            221  2234568999999999999999999999999999999999999999765432221   1   1111 11      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCH-----HHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM-----GDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~-----~evl~  753 (820)
                          ..++.....++.+|+.+||+.||.+||++     .||++
T Consensus       559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                12333455778999999999999999997     55554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.7e-36  Score=325.31  Aligned_cols=253  Identities=26%  Similarity=0.379  Sum_probs=197.0

Q ss_pred             HhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC
Q 003436          481 ATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER  551 (820)
Q Consensus       481 at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~  551 (820)
                      ..++|...+.||+|+||.||+|+.. +++.||||.+....        ......+.+|+++|++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999976 47889999865432        12234588999999999999999999998765


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC---eeEeec
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM---AKVADF  628 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~---~kl~DF  628 (820)
                      . .++||||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence            5 89999999999999988654  46899999999999999999999   789999999999999987654   999999


Q ss_pred             cccccCCCCCCccccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      |+++.....   .......||..|+|||++.   ...++.++|||||||++|||++|+.||........  +......  
T Consensus       162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~--  234 (322)
T 2ycf_A          162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS--  234 (322)
T ss_dssp             TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH--
T ss_pred             ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh--
Confidence            999865331   2223456899999999974   56789999999999999999999999975433211  1111111  


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        +...  ..+..    .......+.+++.+||+.||.+||++.+++++
T Consensus       235 --~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          235 --GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence              1110  00111    11335678999999999999999999999853

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.9e-36  Score=332.15  Aligned_cols=263  Identities=23%  Similarity=0.323  Sum_probs=201.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~~  554 (820)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467999999999999999999986 58899999876443 34456788999999999999999999988654     678


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccC
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ++|+||++ |+|.+++...   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999997 6999998763   5899999999999999999999   689999999999999999999999999999865


Q ss_pred             CCCCCcc--------ccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          635 PDLDQTH--------VSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       635 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      .......        ......||..|+|||++.+ ..++.++|||||||+++||++|++||......+.....   ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~  239 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGII  239 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHH
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHHh
Confidence            4321111        1223568999999998764 67899999999999999999999999765433222111   1111


Q ss_pred             ccCc----cccccCc----------cc----cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          706 ETGQ----LEDIVDP----------TL----TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       706 ~~~~----~~~~~d~----------~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....    ...+..+          ..    .....+.....+.+++.+||+.||.+||++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1000    0000000          00    000112445678999999999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.7e-36  Score=330.97  Aligned_cols=255  Identities=20%  Similarity=0.336  Sum_probs=197.7

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce------
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE------  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~------  553 (820)
                      ++|...+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++++++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            56888899999999999999976 5889999987543  33446788999999999999999999999977653      


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||||++ ++|.+++..    .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            499999997 688887742    4899999999999999999999   68999999999999999999999999999975


Q ss_pred             CCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC----
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG----  708 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~----  708 (820)
                      ...     ......+|..|+|||++.+ ..++.++|||||||+++||++|+.||......+.....   .......    
T Consensus       176 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~  247 (353)
T 3coi_A          176 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVPGTEF  247 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH---HHHHCBCCHHH
T ss_pred             CCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCCHHH
Confidence            432     1234568999999999877 67899999999999999999999999765433221111   1100000    


Q ss_pred             --------------ccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 --------------QLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 --------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                    .+.....+.+ ....+.....+.+++.+||+.||.+||++.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                          0000000001 12233556789999999999999999999999864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.6e-36  Score=335.51  Aligned_cols=257  Identities=20%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE----
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM----  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~----  554 (820)
                      .++|...+.||+|+||.||+|+.. +++.||||++...  .....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            357888999999999999999976 5889999987643  344467889999999999999999999999877654    


Q ss_pred             --EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          555 --IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       555 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                        ++||||++ ++|.+.+.    ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence              99999997 68888773    24899999999999999999999   6899999999999999999999999999997


Q ss_pred             cCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc--
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ--  709 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--  709 (820)
                      ....     ......||..|+|||++.+ ..++.++|||||||+++||++|+.||......+.....   ........  
T Consensus       193 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~~~~~~~~~  264 (371)
T 4exu_A          193 HADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI---LKVTGVPGTE  264 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHH
T ss_pred             cccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCcHH
Confidence            5432     2234568999999999987 78999999999999999999999999765433222111   11000000  


Q ss_pred             -cccc-----------cCccccC---CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 -LEDI-----------VDPTLTG---QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 -~~~~-----------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ...+           +......   ...+.....+.+++.+||+.||.+||++.|++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence             0000           0000000   0112345778999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.5e-36  Score=331.83  Aligned_cols=262  Identities=19%  Similarity=0.281  Sum_probs=201.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-----------CCceeeEEeEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-----------HRHLVSLIGYCDE  550 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~  550 (820)
                      ++|...+.||+|+||.||+|+.. +++.||||.+... ....+.+.+|++++++++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57899999999999999999974 6889999997643 344567889999999886           8999999999876


Q ss_pred             Cc----eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEc------C
Q 003436          551 RN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLD------E  619 (820)
Q Consensus       551 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~------~  619 (820)
                      .+    ..++||||+ +++|.+++.......+++..+..++.|++.||+|||   +. +|+||||||+|||++      .
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcC
Confidence            54    789999999 899999998766667999999999999999999999   66 999999999999994      4


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchh----hh
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE----KV  695 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~----~~  695 (820)
                      .+.+||+|||+++....     ......||..|+|||++.+..++.++|||||||++|||++|+.||.......    ..
T Consensus       174 ~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            45899999999986432     1234578999999999999999999999999999999999999997543221    11


Q ss_pred             hHHHHHHHhhc------------------cCccccccCcc---------ccCCCChhhHHHHHHHHHHHhhcCCCCCCCH
Q 003436          696 NLVEWAMKCQE------------------TGQLEDIVDPT---------LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSM  748 (820)
Q Consensus       696 ~l~~~~~~~~~------------------~~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~  748 (820)
                      .+.........                  .+.+..+....         -...++......+.+++.+||+.||.+||++
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            11111110000                  00000000000         0113445677889999999999999999999


Q ss_pred             HHHHHH
Q 003436          749 GDVLWN  754 (820)
Q Consensus       749 ~evl~~  754 (820)
                      .|++++
T Consensus       329 ~ell~h  334 (373)
T 1q8y_A          329 GGLVNH  334 (373)
T ss_dssp             HHHHTC
T ss_pred             HHHhhC
Confidence            999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.6e-36  Score=322.35  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=194.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec----------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE----------  550 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----------  550 (820)
                      .++|...+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|++++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457899999999999999999975 688999998753 34456789999999999999999999998754          


Q ss_pred             ---CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          551 ---RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       551 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                         ....++|+||+++|+|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence               457899999999999999997643 45788999999999999999999   68999999999999999999999999


Q ss_pred             ccccccCCCCCC------------ccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhh
Q 003436          628 FGLSKIGPDLDQ------------THVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK  694 (820)
Q Consensus       628 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~  694 (820)
                      ||+++.......            ........||..|+|||.+.+. .++.++||||||+++|||++   |+...  .+.
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER  234 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence            999986432110            1122345689999999999764 78999999999999999998   33211  111


Q ss_pred             hhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          695 VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       695 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .....   ... ..      ...+........+..+.+++.+||+.||.+||++.+++++
T Consensus       235 ~~~~~---~~~-~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 VNILK---KLR-SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHH---HHH-ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHH---hcc-cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            11111   111 11      1112223445566778999999999999999999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.8e-37  Score=332.70  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=200.4

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ...++|...++||+|+||.||+|+..+  .+|+|.+....  ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345678899999999999999998764  48899865432  23345678899999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      +||+++++|.+++.... ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++ ++.+||+|||+++.....
T Consensus       108 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             CBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999996543 46899999999999999999999   68999999999999998 679999999998754321


Q ss_pred             C---CccccccccCCccccCcccccc---------CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          638 D---QTHVSTAVKGSFGYLDPEYLTK---------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       638 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      .   .........|+..|+|||.+.+         ..++.++||||||+++|||++|+.||......+..      ... 
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~-  255 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII------WQM-  255 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH------HHH-
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHh-
Confidence            1   1122234568999999999864         45788999999999999999999999755432211      111 


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ..+..     +.+.   ....+..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus       256 ~~~~~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          256 GTGMK-----PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HTTCC-----CCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ccCCC-----CCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            11111     1111   112345688999999999999999999999999876553

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.5e-36  Score=328.31  Aligned_cols=255  Identities=22%  Similarity=0.307  Sum_probs=176.1

Q ss_pred             HhcCCccce-eEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec----CceE
Q 003436          481 ATDNFSESL-VIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE----RNEM  554 (820)
Q Consensus       481 at~~f~~~~-~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~  554 (820)
                      ..++|...+ +||+|+||.||+|+.. +++.||||++.... .   ...+....++.++||||+++++++..    +...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            346788854 6999999999999987 58899999875432 1   12223334567799999999999865    4568


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---CCCeeEeecccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---NLMAKVADFGLS  631 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---~~~~kl~DFGla  631 (820)
                      ++||||+++|+|.+++.......+++.+++.++.|++.||+|||   ..+|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998776667999999999999999999999   689999999999999976   456999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      +.....    ......||+.|+|||++.+..++.++||||||+++|||++|+.||............   ......+.  
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~--  249 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQ--  249 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhccc--
Confidence            854321    223456899999999999999999999999999999999999999654322211000   00000000  


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                          ..............+.+++.+||+.||.+||++.|++++-
T Consensus       250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                0011111234567789999999999999999999999854

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.9e-36  Score=325.85  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=181.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHH-HHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIE-MLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~-~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|...+.||+|+||.||+|... +++.||||++... ......++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            56888899999999999999986 5889999987544 3344456666666 6777899999999999999999999999


Q ss_pred             eccCCchhhHhhh---cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          560 YMENGTLKDHLYA---SNFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       560 ~~~~gsL~~~l~~---~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      |+++ +|.+++..   .....+++..+..++.|++.||+|||   .. +|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 88877753   23457999999999999999999999   56 99999999999999999999999999997643


Q ss_pred             CCCCccccccccCCccccCcccc----ccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYL----TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      ..   .......||..|+|||++    .+..++.++||||||+++|||++|+.||.......     +...      ...
T Consensus       178 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~------~~~  243 (327)
T 3aln_A          178 DS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLT------QVV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C------CCC
T ss_pred             cc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHH------HHh
Confidence            32   122334689999999998    46678999999999999999999999986432110     0000      011


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....+.+...........+.+++.+||+.||.+||++.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            1111122222223456789999999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.2e-36  Score=331.80  Aligned_cols=273  Identities=19%  Similarity=0.229  Sum_probs=193.2

Q ss_pred             HHHHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce-
Q 003436          476 VAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE-  553 (820)
Q Consensus       476 ~~l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-  553 (820)
                      .......++|...++||+|+||.||+|+.. +++.||||++.... .....+.+|++.+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            456677889999999999999999999986 58899999864432 223456778888999999999999999865433 


Q ss_pred             ------EEEEEeeccCCchhhHhhh--cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCee
Q 003436          554 ------MIIIYEYMENGTLKDHLYA--SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAK  624 (820)
Q Consensus       554 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~k  624 (820)
                            .++||||+++ +|.+.+..  .....+++..+..++.|++.||+|||. ++.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  7899999986 55544432  234568999999999999999999993 2578999999999999986 89999


Q ss_pred             EeeccccccCCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHH--
Q 003436          625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWA--  701 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~--  701 (820)
                      |+|||+++......   ......||..|+|||++.+. .++.++|||||||++|||++|++||......+........  
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            99999998654322   22345689999999998665 4899999999999999999999999865543322211100  


Q ss_pred             -------HHhhccCccccccC------ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          702 -------MKCQETGQLEDIVD------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       702 -------~~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                             .............+      ..............+.+++.+||+.||.+||++.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   00000000000000      000112223456789999999999999999999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=338.49  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=181.9

Q ss_pred             Ccc-ceeEeeecceEEEEEEEc---CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEe--ecCceEEEEE
Q 003436          485 FSE-SLVIGIGGFGKVYRGVLR---DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC--DERNEMIIIY  558 (820)
Q Consensus       485 f~~-~~~LG~G~fG~Vykg~~~---~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~--~~~~~~~lV~  558 (820)
                      |.. .++||+|+||.||+|+..   .++.||+|++.....  ...+.+|+++|++++||||+++++++  ......++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            554 447999999999999976   467899999865432  24678999999999999999999998  4567899999


Q ss_pred             eeccCCchhhHhhhc-------CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEE----cCCCCeeEee
Q 003436          559 EYMENGTLKDHLYAS-------NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILL----DENLMAKVAD  627 (820)
Q Consensus       559 E~~~~gsL~~~l~~~-------~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll----~~~~~~kl~D  627 (820)
                      ||++ |+|.+++...       ....+++..+..|+.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9997 5888877532       1235999999999999999999999   7899999999999999    7789999999


Q ss_pred             ccccccCCCCCC-ccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchh------hhhHHH
Q 003436          628 FGLSKIGPDLDQ-THVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE------KVNLVE  699 (820)
Q Consensus       628 FGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~------~~~l~~  699 (820)
                      ||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++|++||.......      ......
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            999986543211 1223346789999999999874 58999999999999999999999996543210      001111


Q ss_pred             HHHHhhccC---cccccc-------------Ccccc--------CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          700 WAMKCQETG---QLEDIV-------------DPTLT--------GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       700 ~~~~~~~~~---~~~~~~-------------d~~l~--------~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+.......   .+..+.             .....        ..........+.+|+.+||+.||.+|||+.|++++
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111111100   000000             00000        00001113567899999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.5e-36  Score=318.54  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=203.0

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      ...++|...++||+|+||.||+|+.. +++.||+|.+...  .....+.+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34567999999999999999999986 5889999986432  23346788999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC---CCeeEeecccccc
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN---LMAKVADFGLSKI  633 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~---~~~kl~DFGla~~  633 (820)
                      |+||+++++|.+++....  .+++.+++.++.|++.||+|||   ..+++||||||+||+++.+   +.+||+|||+++.
T Consensus        99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999999887653  5899999999999999999999   6899999999999999654   4799999999986


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      .....   ......|+..|+|||.+.+ .++.++||||||++++||++|+.||......+.   ....    ..+.... 
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~----~~~~~~~-  241 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRV----ETGKYAF-  241 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCCCCC-
T ss_pred             ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHH----HcCCCCC-
Confidence            54321   1223458899999999875 489999999999999999999999976543221   1111    1111110 


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       +..    .....+..+.+++.+||+.+|.+||++.|+++.
T Consensus       242 -~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          242 -DLP----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -CSG----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -Cch----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence             000    012334678999999999999999999999974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.4e-36  Score=322.44  Aligned_cols=245  Identities=22%  Similarity=0.399  Sum_probs=191.9

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh------hhHHHHHHHHHHHHcC----CCCceeeEEe
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH------QGLAEFRTEIEMLSQF----RHRHLVSLIG  546 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l----~H~nIv~l~g  546 (820)
                      .....++|...++||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999875 578999998765432      1223456799999988    8999999999


Q ss_pred             EeecCceEEEEEee-ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-CCCCee
Q 003436          547 YCDERNEMIIIYEY-MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAK  624 (820)
Q Consensus       547 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-~~~~~k  624 (820)
                      ++...+..++|+|+ +++++|.+++....  .+++.+++.++.|++.||+|||   +.+|+||||||+||+++ +++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 88999999997653  5899999999999999999999   68999999999999998 889999


Q ss_pred             EeeccccccCCCCCCccccccccCCccccCccccccCCCC-CcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHH
Q 003436          625 VADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT-EKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMK  703 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~  703 (820)
                      |+|||+++.....    ......|+..|+|||++.+..+. .++||||||+++|||++|+.||....     ...     
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~-----  246 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL-----  246 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-----
T ss_pred             EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh-----
Confidence            9999999865432    22345689999999999877664 58999999999999999999986321     000     


Q ss_pred             hhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          704 CQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       704 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        . ..          ...+......+.+++.+||+.+|++||++.|++++
T Consensus       247 --~-~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          247 --E-AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --H-TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --h-hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0 00          01223445678999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-35  Score=335.54  Aligned_cols=251  Identities=23%  Similarity=0.278  Sum_probs=187.5

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEeecc
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      .|...++||+|+||+||.+...+++.||||++...   ..+.+.+|+++|.++ +||||+++++++.+++..++||||++
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            34556789999999998776667899999987543   235678899999886 89999999999999999999999995


Q ss_pred             CCchhhHhhhcCCCC-----CCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCC-------------CCee
Q 003436          563 NGTLKDHLYASNFPS-----LSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDEN-------------LMAK  624 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~-----l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~-------------~~~k  624 (820)
                       |+|.+++.......     .++..++.++.|++.||+|||   +.+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             69999997654211     234456889999999999999   7899999999999999653             5899


Q ss_pred             EeeccccccCCCCCCcc--ccccccCCccccCcccccc-------CCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhh
Q 003436          625 VADFGLSKIGPDLDQTH--VSTAVKGSFGYLDPEYLTK-------QQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREK  694 (820)
Q Consensus       625 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~  694 (820)
                      |+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......+ 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999998754422111  1234579999999999975       678999999999999999999 899986543322 


Q ss_pred             hhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          695 VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       695 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .   .......   ..     +.+..........++.+++.+||+.||.+||++.++++
T Consensus       248 ~---~i~~~~~---~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S---NIIRGIF---SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---HHHHTCC---CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHhcCCC---Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1   1111100   11     11111123456688999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.7e-36  Score=325.80  Aligned_cols=245  Identities=22%  Similarity=0.400  Sum_probs=198.8

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh------hhHHHHHHHHHHHHcCC--CCceeeEEeEe
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH------QGLAEFRTEIEMLSQFR--HRHLVSLIGYC  548 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~  548 (820)
                      .....++|...++||+|+||.||+|+.. +++.||||.+.....      ...+.+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            3344578999999999999999999865 578999998643321      12245678999999996  59999999999


Q ss_pred             ecCceEEEEEeeccC-CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc-CCCCeeEe
Q 003436          549 DERNEMIIIYEYMEN-GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD-ENLMAKVA  626 (820)
Q Consensus       549 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~-~~~~~kl~  626 (820)
                      ...+..++|+|++.+ ++|.+++....  .+++..++.++.|++.||+|||   +.+|+||||||+|||++ +++.+||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            999999999999986 89999997643  6899999999999999999999   78999999999999998 78999999


Q ss_pred             eccccccCCCCCCccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          627 DFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       627 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      |||+++.....    ......||..|+|||++.+..+ +.++||||||+++|||++|+.||....     ..   .    
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~---~----  256 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI---I----  256 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH---H----
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh---h----
Confidence            99999865432    2234568999999999987765 688999999999999999999986321     00   0    


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      . +..          ......+..+.+++.+||+.+|++||++.|+++.
T Consensus       257 ~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          257 R-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             H-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0 000          1122345678999999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=317.76  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=180.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hh-hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQ-GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~-~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... .. ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            356888999999999999999986 58899999875443 22 2334455556788889999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCC-cEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK-AIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~-~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      ||+ ++.+..++. .....+++..+..++.|++.||+|||   .. +|+||||||+||+++.++.+||+|||+++.....
T Consensus       104 e~~-~~~~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKK-RMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-SEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 445544443 33356899999999999999999999   54 8999999999999999999999999999754332


Q ss_pred             CCccccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                         .......||..|+|||++.     ...++.++||||||+++|||++|+.||.......  ....   ..... ..  
T Consensus       179 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---~~~~~-~~--  247 (318)
T 2dyl_A          179 ---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EVLT---KVLQE-EP--  247 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHH---HHHHS-CC--
T ss_pred             ---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HHHH---HHhcc-CC--
Confidence               1223456899999999994     5578899999999999999999999997533221  1111   11111 10  


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         +.+  ......+..+.+++.+||+.||.+||++.+++++
T Consensus       248 ---~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 ---PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ---CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               001  0112345678999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-35  Score=330.74  Aligned_cols=250  Identities=26%  Similarity=0.321  Sum_probs=187.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ..+|...++||+|+||+||.....+++.||||++......   .+.+|+++|+++ +||||+++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            3468888999999999966555567899999997654332   356799999999 799999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-----CCCeeEeeccccccCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-----NLMAKVADFGLSKIGP  635 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-----~~~~kl~DFGla~~~~  635 (820)
                      ++ |+|.+++..... .+.+.+++.++.|++.||+|||   +.+|+||||||+|||++.     ...+||+|||+++...
T Consensus       100 ~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            96 699999976542 3555677899999999999999   789999999999999943     3468899999998654


Q ss_pred             CCCC-ccccccccCCccccCccccc---cCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          636 DLDQ-THVSTAVKGSFGYLDPEYLT---KQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       636 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      .... ........||+.|+|||++.   ...++.++|||||||+++||++ |++||.........       ........
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~~  247 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACSL  247 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCCC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCCc
Confidence            3221 12234567999999999997   4567889999999999999999 88888543322110       11111111


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      . .    +  .........+.+++.+||+.||.+||++.|+++
T Consensus       248 ~-~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 D-C----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             T-T----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-c----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0 0    0  112234566889999999999999999999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.9e-35  Score=348.52  Aligned_cols=240  Identities=19%  Similarity=0.283  Sum_probs=193.8

Q ss_pred             hcCCccceeEeeecceEEEEEEEc--CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCce-----
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR--DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNE-----  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~--~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~-----  553 (820)
                      .++|...++||+|+||.||+|++.  +++.||||++... .......+.+|+++|++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            367999999999999999999986  5789999987643 34556788999999999999999999999977655     


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||||+++++|.+++..    .++|.+++.|+.|++.||+|||   +.+|+||||||+|||++++ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999987754    6999999999999999999999   7899999999999999886 999999999986


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ....      ....||+.|+|||++.+.. +.++|||||||+++||++|.+|+.......                +.  
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~--  285 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP--  285 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC--
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc--
Confidence            5432      3456999999999997654 899999999999999999988875321100                00  


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-SMGDVLWNLEYAL  759 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~~  759 (820)
                           ...........+.+++.+||+.||.+|| ++.++...|...+
T Consensus       286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                 0000112235788999999999999999 5666766666654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-34  Score=308.56  Aligned_cols=234  Identities=14%  Similarity=0.117  Sum_probs=185.8

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|...+.||+|+||.||+|+... ++.||||.+....   ....+.|.+|+.++.+++||||+++++++.+++..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            569999999999999999999864 8899999976543   344578999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++++|.+++...    ....++.+|+.|++.||+|||   +.+|+||||||+|||++.++.+||+++|         
T Consensus       111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~---------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA---------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred             EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence            999999999998532    355678999999999999999   7899999999999999999999997443         


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                                   |++       .++.++|||||||++|||+||+.||......+.....       . .....  .+..
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~-~~~~~--~~~~  224 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------E-RDTAG--QPIE  224 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------C-BCTTS--CBCC
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------H-HHhcc--CCCC
Confidence                         333       3688999999999999999999999765432211000       0 00000  0000


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      ........+..+.+++.+||+.||.+| ++.|+++.|+++.....
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            001223455779999999999999999 99999999998876443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.1e-35  Score=341.54  Aligned_cols=268  Identities=25%  Similarity=0.342  Sum_probs=205.6

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec------Cce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE------RNE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~  553 (820)
                      .++|...++||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            367999999999999999999975 5889999987654 44556789999999999999999999998765      677


Q ss_pred             EEEEEeeccCCchhhHhhhcC-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCC---eeEeecc
Q 003436          554 MIIIYEYMENGTLKDHLYASN-FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLM---AKVADFG  629 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~---~kl~DFG  629 (820)
                      .++||||+++|+|.+++.... ...+++..++.++.+++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999997643 346899999999999999999999   689999999999999987665   9999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      +++.....   .......||..|+|||.+.+..++.++||||||+++|||++|+.||......     ..|.........
T Consensus       170 ~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred             cccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence            99865432   2234467999999999999999999999999999999999999999754221     112111111111


Q ss_pred             cccccCc------------cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHH-----HHHHHHHHHh
Q 003436          710 LEDIVDP------------TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGD-----VLWNLEYALQ  760 (820)
Q Consensus       710 ~~~~~d~------------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~e-----vl~~L~~~~~  760 (820)
                      .......            ..........+..+.+++.+||+.||++||++.+     ..+.++.++.
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0000000            1112344567889999999999999999999988     4566666654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-34  Score=326.08  Aligned_cols=242  Identities=16%  Similarity=0.148  Sum_probs=181.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh---hhHHHHHHHHHHHHcCCC-Ccee--------------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH---QGLAEFRTEIEMLSQFRH-RHLV--------------  542 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H-~nIv--------------  542 (820)
                      +.+|...++||+|+||.||+|++. +++.||||++.....   ...+.|.+|+.+++.++| +|..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999965 588999998763322   235789999999999987 2211              


Q ss_pred             -e------EEeEeec-----CceEEEEEeeccCCchhhHhh-----hcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcE
Q 003436          543 -S------LIGYCDE-----RNEMIIIYEYMENGTLKDHLY-----ASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAI  605 (820)
Q Consensus       543 -~------l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~i  605 (820)
                       .      +..++..     ....+++|+++ +++|.+++.     ......++|..++.|+.|++.||+|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence             1      1111111     12356777765 689999885     223345889999999999999999999   7899


Q ss_pred             EeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCcccc----------ccCCCCCcceeeehhhh
Q 003436          606 IHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL----------TKQQLTEKSDVYSFGVV  675 (820)
Q Consensus       606 iHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~SfGvl  675 (820)
                      +||||||+|||++.++.+||+|||+++....     ......| ..|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            9999999999999999999999999885432     1344567 999999999          55678899999999999


Q ss_pred             HHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          676 MFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       676 l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +|||++|+.||......+.               ...++..      ....+..+.+++.+||+.+|++||++.++++.
T Consensus       307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999999975432211               1111110      11334679999999999999999998887543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.2e-33  Score=304.36  Aligned_cols=229  Identities=23%  Similarity=0.378  Sum_probs=181.1

Q ss_pred             hcCCccc-eeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHH-HcCCCCceeeEEeEeec----CceE
Q 003436          482 TDNFSES-LVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEML-SQFRHRHLVSLIGYCDE----RNEM  554 (820)
Q Consensus       482 t~~f~~~-~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l-~~l~H~nIv~l~g~~~~----~~~~  554 (820)
                      .++|... ++||+|+||.||++... +++.||+|++...     ..+.+|++++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3557776 68999999999999975 5789999987532     4567888888 56699999999999876    6788


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---CCCeeEeecccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---NLMAKVADFGLS  631 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---~~~~kl~DFGla  631 (820)
                      ++||||+++|+|.+++.......+++.+++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998876667999999999999999999999   789999999999999988   789999999998


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      +...                        +..++.++|||||||++|||++|+.||.........           .....
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~  212 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKT  212 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHH
Confidence            6422                        234678999999999999999999999654321100           00000


Q ss_pred             cccCccccCCCC----hhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHH
Q 003436          712 DIVDPTLTGQIK----PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNL  755 (820)
Q Consensus       712 ~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L  755 (820)
                      .+.....  ..+    ......+.+++.+||+.||.+||++.|++++-
T Consensus       213 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          213 RIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             SSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            0000000  111    23457799999999999999999999999753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=1.6e-33  Score=308.43  Aligned_cols=243  Identities=19%  Similarity=0.200  Sum_probs=182.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCC--------hhhHHHHHHHHHHHHcCC---------CCceeeE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS--------HQGLAEFRTEIEMLSQFR---------HRHLVSL  544 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~---------H~nIv~l  544 (820)
                      .++|...++||+|+||.||+|+. .++.||||++....        ....+.+.+|+++|++++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688899999999999999998 57899999865432        233477889999999886         7777776


Q ss_pred             EeEe-----------------ec-------------CceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHh
Q 003436          545 IGYC-----------------DE-------------RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL  594 (820)
Q Consensus       545 ~g~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL  594 (820)
                      .+.+                 .+             .+..++||||+++|+|.+.+..   ..+++.++..++.|++.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            6653                 22             6789999999999987777644   3589999999999999999


Q ss_pred             hhhhcCCCCcEEeccCCCCcEEEcCCC--------------------CeeEeeccccccCCCCCCccccccccCCccccC
Q 003436          595 HYLHTGSTKAIIHRDVKSANILLDENL--------------------MAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLD  654 (820)
Q Consensus       595 ~yLH~~~~~~iiHrDIkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  654 (820)
                      +|||+  +.+|+||||||+|||++.++                    .+||+|||+++....       ....||..|+|
T Consensus       175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~a  245 (336)
T 2vuw_A          175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMD  245 (336)
T ss_dssp             HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTC
T ss_pred             HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccC
Confidence            99992  37899999999999999887                    999999999986432       13479999999


Q ss_pred             ccccccCCCCCcceeeehhhh-HHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHH
Q 003436          655 PEYLTKQQLTEKSDVYSFGVV-MFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEI  733 (820)
Q Consensus       655 PE~~~~~~~t~ksDV~SfGvl-l~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  733 (820)
                      ||++.+.. +.++||||++++ .+++++|..|+.....  ...+.+   ........    ..............++.++
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~---~~~~~~~~----~~~~~~~~~~~~s~~~~dl  315 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTD---KMLKQMTF----KTKCNTPAMKQIKRKIQEF  315 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHH---HHHHTCCC----SSCCCSHHHHHHHHHHHHH
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHH---hhhhhhcc----CcccchhhhhhcCHHHHHH
Confidence            99998776 899999998777 7788889888731100  000111   11100000    0111111223567889999


Q ss_pred             HHHHhhcCCCCCCCHHHHH
Q 003436          734 AEKCLAQCGIDRPSMGDVL  752 (820)
Q Consensus       734 ~~~Cl~~dp~~RPs~~evl  752 (820)
                      +.+||+.+     |+.|++
T Consensus       316 i~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          316 HRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHGGGSS-----SHHHHH
T ss_pred             HHHHhccC-----CHHHHH
Confidence            99999866     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=9.1e-28  Score=280.48  Aligned_cols=184  Identities=19%  Similarity=0.099  Sum_probs=128.2

Q ss_pred             EeeecceEEEEEEE-cCccEEEEEeCCCC----------ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEEE
Q 003436          491 IGIGGFGKVYRGVL-RDETKVAVKRGGTQ----------SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       491 LG~G~fG~Vykg~~-~~~~~vavK~~~~~----------~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      .+.|+.|.+.+++- --|+.++||.+...          .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45566665554432 23677888875432          123356799999999999 7999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||++|++|.++|....  +++..   +|+.||+.||+|||   +++||||||||+||||++++.+||+|||+|+......
T Consensus       322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            9999999999997653  45543   58899999999999   7999999999999999999999999999998654322


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCC
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV  685 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p  685 (820)
                        ......+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence              22345679999999999976 467789999999999988776543

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.93  E-value=4.7e-27  Score=231.22  Aligned_cols=155  Identities=17%  Similarity=0.175  Sum_probs=117.9

Q ss_pred             eeeEEeecCCcccCCCCCccccccccCccccccCCcceeecCceeeeecCCcccccCchhhhhhhhccCCCCCCCCccee
Q 003436          213 ETVARVNMGGKDVPPQNDVLWRRWVSDDAYLKHSNLVMFVSNTSIVNFTDSVTENIAPRDVYGTATIVNSGSDPNSNVNV  292 (820)
Q Consensus       213 ~~~~R~n~Gg~~~~d~~dr~wr~w~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~vy~TAr~~~~~~~~~~~~~~  292 (820)
                      +++||+||||+.++|   ..||+|.+|..|......+.  . .....+   ...+++|..||||||.++.        ++
T Consensus         5 ~~~~~INcGg~~~~d---~~gr~w~~D~~~~~~g~~~~--~-~~~~~~---~~~~~~~~~lY~TaR~~~~--------~~   67 (174)
T 2jwp_A            5 KVIWAVNAGGESHVD---VHGIHYRKDPLEGRVGRASD--Y-GMKLPI---LRSNPEDQVLYQTERYNED--------SF   67 (174)
T ss_dssp             HEEEEEEETSSSEEE---TTTEEECSSCSSTTCCCCCC--C-CTTSCC---SSSCHHHHHTTTCCCCCCS--------CE
T ss_pred             cEEEEEECCCCCccC---CCCCEEcCCcCcccCCcccc--c-ccceEe---cccCCCCchhhhhhccCCC--------Ce
Confidence            579999999999874   46677888976542221111  0 011111   1124588899999997643        89


Q ss_pred             EEEeecCCCCeeEEEEeecceeecccccEEEEEEEccccccCccCccccccccCCCceeeeeeeecC------------C
Q 003436          293 TWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRES------------D  360 (820)
Q Consensus       293 tw~~~~~~~~~y~v~lhFaEi~~~~~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~y~~~~v~~~------------~  360 (820)
                      +|.+||+++|+|+|||||||+.+++.++|+|||||||+++.++|||..+ +++ +.+++++|.+.+.            .
T Consensus        68 tY~f~v~~~G~Y~VrLhF~ei~~~~~~~rvFdV~ing~~~l~~fdi~~~-ag~-~~~~~~~~~~~v~~~~l~i~~~~~~~  145 (174)
T 2jwp_A           68 GYDIPIKEEGEYVLVLKFAEVYFAQSQQKVFDVRVNGHTVVKDLDIFDR-VGH-STAHDEIIPISIKKGKLSVQGEVSTF  145 (174)
T ss_dssp             EEEEECCSCEEEEEEEEEECCSCCCSSSSCEEEEETTEEEEEEECHHHH-HSS-SSCEEEEEEEEEETTEEEETTEEEEC
T ss_pred             EEEEEeCCCeEEEEEEEEeccccCCCCCeEeEEEECCEEeecCcCHHHh-hCC-CeeEEEEEEEEEecCceeeeeeeccc
Confidence            9999999999999999999999988999999999999999999999988 444 5789999887642            3


Q ss_pred             CCceeEEEcccccccCCcccccccceeeec
Q 003436          361 NPKLHVSIGRSTLVDTFPNAILNGLEIMKI  390 (820)
Q Consensus       361 ~~~~~vsl~~s~~~~~~~~~ilNg~EI~~i  390 (820)
                      .+.+.+.+.++.    ...|++||+||++-
T Consensus       146 ~g~L~I~f~p~~----~~~a~inaIEI~~~  171 (174)
T 2jwp_A          146 TGKLSVEFVKGY----YDNPKVCALFIMKG  171 (174)
T ss_dssp             CSEEEEEEECSS----SCSSSEEEEEEESS
T ss_pred             CCeEEEEEeccC----CCCcEEEEEEEEeC
Confidence            456888887652    23799999999874

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.90  E-value=4.2e-25  Score=256.53  Aligned_cols=185  Identities=17%  Similarity=0.194  Sum_probs=143.1

Q ss_pred             ccceeEeeecceEEEEEEEcCccEEEEEeCCCCC---h-----hhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          486 SESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS---H-----QGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~---~-----~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ...++||+|+||.||+|.. .+..+++|+.....   .     ...+.|.+|+++|++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4466899999999999954 45678888643221   1     1235589999999999999999766666677778999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++++|.+++..          ++.++.|+++||+|||   +++|+||||||+|||+++  .+||+|||+++.....
T Consensus       418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            999999999999865          5689999999999999   789999999999999998  9999999999976442


Q ss_pred             CCcc-----ccccccCCccccCcccccc--CCCCCcceeeehhhhHHHHhcCCCCC
Q 003436          638 DQTH-----VSTAVKGSFGYLDPEYLTK--QQLTEKSDVYSFGVVMFEILCGRPVI  686 (820)
Q Consensus       638 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SfGvll~ElltG~~p~  686 (820)
                      ....     ......||+.|||||++..  ..|+..+|+|+..+-.++.+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            1111     1235679999999999987  66888899999998888887776544

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=99.90  E-value=1.9e-23  Score=205.51  Aligned_cols=149  Identities=15%  Similarity=0.174  Sum_probs=115.4

Q ss_pred             cEEEecCCCcccCCCCceeecCCCCcccccCCCCccccccccccCCCCCCccccceeeeeccCceeeEecccCceEEEEE
Q 003436           32 NYLIDCGSFTNTSAGNRVFAADHTSTFTNLSSPQNISINASLNSISSGNYSRLYHTARIFTGPSNYSFSIKKQARHFIRL  111 (820)
Q Consensus        32 ~~~i~cG~~~~~~~~~~~~~~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~t~R~f~~~~~y~~~~~~~~~~~~R~  111 (820)
                      .|+||||+...++.+||+|.+|..+...+..+.........   .....++.+|+|||+|+.+.+|.||+.++|+|+|||
T Consensus         7 ~~~INcGg~~~~d~~gr~w~~D~~~~~~g~~~~~~~~~~~~---~~~~~~~~lY~TaR~~~~~~tY~f~v~~~G~Y~VrL   83 (174)
T 2jwp_A            7 IWAVNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMKLPIL---RSNPEDQVLYQTERYNEDSFGYDIPIKEEGEYVLVL   83 (174)
T ss_dssp             EEEEEETSSSEEETTTEEECSSCSSTTCCCCCCCCTTSCCS---SSCHHHHHTTTCCCCCCSCEEEEEECCSCEEEEEEE
T ss_pred             EEEEECCCCCccCCCCCEEcCCcCcccCCcccccccceEec---ccCCCCchhhhhhccCCCCeEEEEEeCCCeEEEEEE
Confidence            69999998887778999999997643211111000001000   011223679999999999999999999999999999


Q ss_pred             EecCCCCCCCCcccceEEEEeCcEEEEeeccc-----cCCceEEEEEEec-------------cCCcEEEEEeeCCCccc
Q 003436          112 HFFPFVHETYNMSTAKFSVSSQSFTLIKDYQS-----QEGSSVKEYSLNI-------------ASDRLVLSFTPFANSFA  173 (820)
Q Consensus       112 ~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~-----~~~~~~~e~~~~~-------------~~~~~~v~~~~~~~~~~  173 (820)
                      ||++..+.+  .+.+.|||+++|.+++.||+.     ...|+++||.+.+             .++.|.|+|.|...+.|
T Consensus        84 hF~ei~~~~--~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~a  161 (174)
T 2jwp_A           84 KFAEVYFAQ--SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDNP  161 (174)
T ss_dssp             EEECCSCCC--SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCSS
T ss_pred             EEeccccCC--CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCCc
Confidence            999998875  567899999999999999973     3457899998874             56789999999877899


Q ss_pred             eeeeeEEEEcCC
Q 003436          174 FINALEVISLPD  185 (820)
Q Consensus       174 fi~~~e~~~~~~  185 (820)
                      |||+|||++.+-
T Consensus       162 ~inaIEI~~~~~  173 (174)
T 2jwp_A          162 KVCALFIMKGTA  173 (174)
T ss_dssp             SEEEEEEESSCC
T ss_pred             EEEEEEEEeCcc
Confidence            999999998653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=8.7e-22  Score=209.79  Aligned_cols=151  Identities=14%  Similarity=0.083  Sum_probs=120.1

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCCh------------------hhHHHHHHHHHHHHcCCCC
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH------------------QGLAEFRTEIEMLSQFRHR  539 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~------------------~~~~~f~~Ei~~l~~l~H~  539 (820)
                      +......|...+.||+|+||.||+|...+++.||+|.......                  .....+.+|+++|++++| 
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-  163 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-  163 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT-
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC-
Confidence            3334456667789999999999999997789999998754321                  135678999999999994 


Q ss_pred             ceeeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       540 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                        +++.+++.. +..++||||+++|+|.+ +..        .....++.|++.||+|||   +.+|+||||||+|||++ 
T Consensus       164 --~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          164 --LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             --SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred             --CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence              555554433 56699999999999998 421        234579999999999999   78999999999999999 


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCcccccc
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK  660 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  660 (820)
                      ++.+||+|||+++.               +..++|||++.+
T Consensus       228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            99999999999863               234788998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.72  E-value=1.7e-17  Score=174.19  Aligned_cols=137  Identities=17%  Similarity=0.127  Sum_probs=106.0

Q ss_pred             CccceeEeeecceEEEEEEE-cCccE--EEEEeCCCCCh------------------------hhHHHHHHHHHHHHcCC
Q 003436          485 FSESLVIGIGGFGKVYRGVL-RDETK--VAVKRGGTQSH------------------------QGLAEFRTEIEMLSQFR  537 (820)
Q Consensus       485 f~~~~~LG~G~fG~Vykg~~-~~~~~--vavK~~~~~~~------------------------~~~~~f~~Ei~~l~~l~  537 (820)
                      |...+.||+|+||.||+|.. .+|+.  ||||.......                        .....+.+|+.+|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999998 67888  99997543211                        11236889999999998


Q ss_pred             CCce--eeEEeEeecCceEEEEEeeccC-C----chhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccC
Q 003436          538 HRHL--VSLIGYCDERNEMIIIYEYMEN-G----TLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV  610 (820)
Q Consensus       538 H~nI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDI  610 (820)
                      |+++  +.++.+    ...+|||||+.+ |    +|.++...     .++.++..++.|++.||.|||.  ..+|+||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            8754  444442    356899999942 4    66665432     2355678999999999999993  478999999


Q ss_pred             CCCcEEEcCCCCeeEeeccccccC
Q 003436          611 KSANILLDENLMAKVADFGLSKIG  634 (820)
Q Consensus       611 kp~NIll~~~~~~kl~DFGla~~~  634 (820)
                      ||.|||+++  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999998  9999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=2.9e-15  Score=164.14  Aligned_cols=137  Identities=12%  Similarity=0.092  Sum_probs=98.7

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCCh--------------hhHH--------HHHHHHHHHHcCCCCce
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSH--------------QGLA--------EFRTEIEMLSQFRHRHL  541 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~--------------~~~~--------~f~~Ei~~l~~l~H~nI  541 (820)
                      -|...++||+|++|.||+|...+|+.||||..+....              ....        ....|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3788899999999999999998999999997532100              0001        12346666777655443


Q ss_pred             eeEEeEeecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC
Q 003436          542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL  621 (820)
Q Consensus       542 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~  621 (820)
                      ....-+..  ...+|||||+++++|.++...        .....++.|++.+|.+||   ..+||||||||.|||+++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCC
Confidence            22111111  123799999999998765421        234568899999999999   68999999999999998776


Q ss_pred             ----------CeeEeecccccc
Q 003436          622 ----------MAKVADFGLSKI  633 (820)
Q Consensus       622 ----------~~kl~DFGla~~  633 (820)
                                .+.|+||+-+..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence                      389999997653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=4.5e-11  Score=125.14  Aligned_cols=147  Identities=12%  Similarity=0.098  Sum_probs=113.6

Q ss_pred             HHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEE
Q 003436          478 IQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       478 l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~l  556 (820)
                      +....+.|.....++.|+.+.||+.... ++.+++|............+.+|+++|+.+. |..+.++++++...+..++
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            3445567887778888888999998754 5789999865421122245788999999884 6778899999988889999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcC------------------------------------
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG------------------------------------  600 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~------------------------------------  600 (820)
                      ||||++|.+|.+.+.       +......++.+++++|+.||+.                                    
T Consensus        88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999987632       1123457888999999999961                                    


Q ss_pred             --------------------CCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          601 --------------------STKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       601 --------------------~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                                          ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                11569999999999999876667799999765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.06  E-value=2e-10  Score=119.50  Aligned_cols=138  Identities=17%  Similarity=0.113  Sum_probs=99.6

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc--eeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH--LVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++....+.+.|..+.||+....+|..+++|......   ...+..|+.+++.+.+.+  +.++++++..++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3444433333455699999987777889999865432   245778999999886544  55688888888889999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCC---------------------------------------
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS---------------------------------------  601 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~---------------------------------------  601 (820)
                      ++|.+|.  ...     .+   ...++.++++.|..||...                                       
T Consensus        97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            9999884  211     11   2356777777788887421                                       


Q ss_pred             ----------------CCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          602 ----------------TKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       602 ----------------~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                                      ...++|+|++|.||+++++..++|+||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            12399999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.93  E-value=2.4e-09  Score=117.47  Aligned_cols=142  Identities=16%  Similarity=0.246  Sum_probs=107.3

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCC--CCC-hhhHHHHHHHHHHHHcCC--CCceeeEEeEeecC---ceEEEEE
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGG--TQS-HQGLAEFRTEIEMLSQFR--HRHLVSLIGYCDER---NEMIIIY  558 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~--~~~-~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~---~~~~lV~  558 (820)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..++++++++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45678999999999988765 578888765  322 122356788999999996  45688999998776   4589999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCC-------------------------------------
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS-------------------------------------  601 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~-------------------------------------  601 (820)
                      ||++|..+.+..    ...++..++..++.++++.|+.||...                                     
T Consensus       121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            999998875421    234678888999999999999999620                                     


Q ss_pred             ------------------CCcEEeccCCCCcEEEcCCCC--eeEeecccccc
Q 003436          602 ------------------TKAIIHRDVKSANILLDENLM--AKVADFGLSKI  633 (820)
Q Consensus       602 ------------------~~~iiHrDIkp~NIll~~~~~--~kl~DFGla~~  633 (820)
                                        ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999987653  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.76  E-value=3.3e-09  Score=113.61  Aligned_cols=187  Identities=19%  Similarity=0.188  Sum_probs=121.4

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCc--eeeEEeEeecCc---eEEEEEeec
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRH--LVSLIGYCDERN---EMIIIYEYM  561 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~n--Iv~l~g~~~~~~---~~~lV~E~~  561 (820)
                      .+.++.|....||+..    ..+++|+...  ......+.+|+++|+.+. +..  +.+++..+....   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4578999999999853    5688887542  234567889999998883 332  445565554433   347899999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcC-----------------------------------------
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG-----------------------------------------  600 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~-----------------------------------------  600 (820)
                      +|.+|.+....    .++..++..++.++++.|+.||..                                         
T Consensus        99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            99988754332    356667777777777777777741                                         


Q ss_pred             --------------CCCcEEeccCCCCcEEEcC--CCCeeEeeccccccCCCCCCcccccc------------ccCCccc
Q 003436          601 --------------STKAIIHRDVKSANILLDE--NLMAKVADFGLSKIGPDLDQTHVSTA------------VKGSFGY  652 (820)
Q Consensus       601 --------------~~~~iiHrDIkp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~------------~~gt~~y  652 (820)
                                    ....++|+|+++.||++++  +..+.|+||+.+........-.....            .....+.
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1246899999999999988  56688999999875432100000000            0000011


Q ss_pred             cC-ccccccCCCCCcceeeehhhhHHHHhcCCCCC
Q 003436          653 LD-PEYLTKQQLTEKSDVYSFGVVMFEILCGRPVI  686 (820)
Q Consensus       653 ~a-PE~~~~~~~t~ksDV~SfGvll~ElltG~~p~  686 (820)
                      .. |+....  .....+.|+++.+++++.+|++++
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            12 222211  122368999999999999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.37  E-value=3.8e-06  Score=89.81  Aligned_cols=136  Identities=18%  Similarity=0.165  Sum_probs=92.3

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC---ceeeEEeEee-cCceEEEEEeeccC
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR---HLVSLIGYCD-ERNEMIIIYEYMEN  563 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---nIv~l~g~~~-~~~~~~lV~E~~~~  563 (820)
                      .+.++.|....||+.    +..+++|+.  ........+..|+++|+.+.+.   .+.+.+.++. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            457888888999987    566888874  2334456788999999999652   3667777774 45567899999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcC-------------------------------------------
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG-------------------------------------------  600 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~-------------------------------------------  600 (820)
                      .+|.+....    .++..++..++.++++.|+.||+.                                           
T Consensus        98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            888763211    123333333333343333333321                                           


Q ss_pred             --------------CCCcEEeccCCCCcEEEcC---CCC-eeEeecccccc
Q 003436          601 --------------STKAIIHRDVKSANILLDE---NLM-AKVADFGLSKI  633 (820)
Q Consensus       601 --------------~~~~iiHrDIkp~NIll~~---~~~-~kl~DFGla~~  633 (820)
                                    ....++|+|+++.||+++.   ++. ..|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2456899999999999987   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=4.1e-06  Score=87.47  Aligned_cols=135  Identities=18%  Similarity=0.195  Sum_probs=95.4

Q ss_pred             eEeeecce-EEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          490 VIGIGGFG-KVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       490 ~LG~G~fG-~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      .+..|..| .||+.... ++..+++|+....   ...++.+|+..|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556555 68987765 4567888874422   3456788999998884 44477889999888999999999999888


Q ss_pred             hhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhc-----------------------------------------------
Q 003436          567 KDHLYASNFPSLSWRKRLEICIGAARGLHYLHT-----------------------------------------------  599 (820)
Q Consensus       567 ~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~-----------------------------------------------  599 (820)
                      .+.....      ......++.++++.|+-||.                                               
T Consensus       108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            7654321      12233455555555555552                                               


Q ss_pred             --------CCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          600 --------GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       600 --------~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                              .....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    1123489999999999999887778999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=3.4e-06  Score=92.00  Aligned_cols=81  Identities=9%  Similarity=0.018  Sum_probs=56.1

Q ss_pred             ceeE-eeecceEEEEEEEc-------CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCC---CceeeEEeEeecC--
Q 003436          488 SLVI-GIGGFGKVYRGVLR-------DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRH---RHLVSLIGYCDER--  551 (820)
Q Consensus       488 ~~~L-G~G~fG~Vykg~~~-------~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~--  551 (820)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+..|+.+|+.+..   -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3467 77888999988765       26678888754322   0012356778888888843   3577888888665  


Q ss_pred             -ceEEEEEeeccCCchhh
Q 003436          552 -NEMIIIYEYMENGTLKD  568 (820)
Q Consensus       552 -~~~~lV~E~~~~gsL~~  568 (820)
                       +..++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45689999999877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.80  E-value=6e-05  Score=83.44  Aligned_cols=75  Identities=12%  Similarity=0.086  Sum_probs=49.2

Q ss_pred             ceeEeeecceEEEEEEEc-CccEEEEEeCCCCCh-------hhHHHHHHHHHHHHcCCC--C-ceeeEEeEeecCceEEE
Q 003436          488 SLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSH-------QGLAEFRTEIEMLSQFRH--R-HLVSLIGYCDERNEMII  556 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~-------~~~~~f~~Ei~~l~~l~H--~-nIv~l~g~~~~~~~~~l  556 (820)
                      .+.||.|..+.||++... +++.++||.......       .....+..|.++|+.+..  + .+.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            457899999999999764 467899997543211       123456778888887742  3 445666553  334589


Q ss_pred             EEeeccCC
Q 003436          557 IYEYMENG  564 (820)
Q Consensus       557 V~E~~~~g  564 (820)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.73  E-value=0.00014  Score=78.35  Aligned_cols=140  Identities=16%  Similarity=0.225  Sum_probs=79.9

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC--CceeeEEe------EeecCceEEEEEee
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH--RHLVSLIG------YCDERNEMIIIYEY  560 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g------~~~~~~~~~lV~E~  560 (820)
                      +.|+.|..+.||+....++. +++|+.... .   .++..|+.+++.|..  -.+.+++.      +....+..++|+||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTEE-EEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCCC-EEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            45666678899998876654 888887652 2   233345555554431  12333333      11235678999999


Q ss_pred             ccCCchh--------------hHhhhc--CC--C--------CCCHHHHHH-----------------------------
Q 003436          561 MENGTLK--------------DHLYAS--NF--P--------SLSWRKRLE-----------------------------  585 (820)
Q Consensus       561 ~~~gsL~--------------~~l~~~--~~--~--------~l~~~~~l~-----------------------------  585 (820)
                      ++|.++.              ..+|..  ..  +        .-.|...+.                             
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              112211  00  0        123432110                             


Q ss_pred             --HHHHHHHHhhhhhc----------CCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          586 --ICIGAARGLHYLHT----------GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       586 --i~~~ia~gL~yLH~----------~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                        +...+..++++|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              11123345566652          1257899999999999998888999999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.68  E-value=0.00019  Score=75.56  Aligned_cols=79  Identities=19%  Similarity=0.144  Sum_probs=58.3

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC---CceeeEEeEeecCceEEEEEee
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH---RHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .....+.+|.|..+.||+..+.+|+.+++|+...........|..|+..|+.|..   -.+++++++..    -++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~----~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD----RTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET----TEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC----ceEEEEe
Confidence            4556678999999999999999999999998654443333467889999988842   23455665532    3789999


Q ss_pred             ccCCch
Q 003436          561 MENGTL  566 (820)
Q Consensus       561 ~~~gsL  566 (820)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.51  E-value=0.00031  Score=74.99  Aligned_cols=139  Identities=15%  Similarity=0.155  Sum_probs=92.8

Q ss_pred             ccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCceEEEEEeecc
Q 003436          486 SESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ...+.|+.|....+|+... ++..+++|+....   ....|..|+..|+.|.   ...++++++++...+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456789999999999876 4567888875432   3467888999998884   3678889999888888999999999


Q ss_pred             CCchhh-----------HhhhcCC-C-------------------CCCHHHHH---HH--HHH--------------HHH
Q 003436          563 NGTLKD-----------HLYASNF-P-------------------SLSWRKRL---EI--CIG--------------AAR  592 (820)
Q Consensus       563 ~gsL~~-----------~l~~~~~-~-------------------~l~~~~~l---~i--~~~--------------ia~  592 (820)
                      +..+..           .||.... .                   .-+|....   ++  ..+              ++.
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            876521           2232211 0                   12454322   11  111              111


Q ss_pred             H-hhhhhc-CCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          593 G-LHYLHT-GSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       593 g-L~yLH~-~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                      . ...|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 123321 2356899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.38  E-value=0.00064  Score=75.75  Aligned_cols=78  Identities=14%  Similarity=0.194  Sum_probs=48.2

Q ss_pred             CCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccccccc-cCCccccCccccccC---CCCCcceeeehhhhHH
Q 003436          602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAV-KGSFGYLDPEYLTKQ---QLTEKSDVYSFGVVMF  677 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~t~ksDV~SfGvll~  677 (820)
                      ...++|+|+++.|||++.++ ++|+||+.+........  ..... .-...|++|+.....   ......++......+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            67899999999999998776 99999999875432100  00000 011345666554311   1122345567777888


Q ss_pred             HHhcC
Q 003436          678 EILCG  682 (820)
Q Consensus       678 ElltG  682 (820)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.04  E-value=0.0034  Score=67.33  Aligned_cols=142  Identities=11%  Similarity=0.101  Sum_probs=73.7

Q ss_pred             eeEeeecceE-EEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC--CceeeEEeEeecCceEEEEEeeccCCc
Q 003436          489 LVIGIGGFGK-VYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH--RHLVSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       489 ~~LG~G~fG~-Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~nIv~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      +.|+.|+... +|+....++..+++|.......   .++..|+.+++.+..  -.+.+++.++.+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            3465555444 6676554466677776543321   223456666666632  33566777655444  68999997766


Q ss_pred             hhhHhhh---------------------cCC---CCCCHHHHH-------H-------------HHHHHHHHhhhhh---
Q 003436          566 LKDHLYA---------------------SNF---PSLSWRKRL-------E-------------ICIGAARGLHYLH---  598 (820)
Q Consensus       566 L~~~l~~---------------------~~~---~~l~~~~~l-------~-------------i~~~ia~gL~yLH---  598 (820)
                      +.+++..                     ...   +.++.....       .             ....+...++.|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6543321                     100   111111000       0             0001111122221   


Q ss_pred             cCCCCcEEeccCCCCcEEEcCC----CCeeEeeccccccCC
Q 003436          599 TGSTKAIIHRDVKSANILLDEN----LMAKVADFGLSKIGP  635 (820)
Q Consensus       599 ~~~~~~iiHrDIkp~NIll~~~----~~~kl~DFGla~~~~  635 (820)
                      ......++|+|+.+.|||++.+    ..+.|+||+.+....
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            1125689999999999999874    678999999887543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.99  E-value=0.0018  Score=72.33  Aligned_cols=73  Identities=19%  Similarity=0.164  Sum_probs=49.5

Q ss_pred             ceeEeeecceEEEEEEEcC--------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce-eeEEeEeecCceEEEEE
Q 003436          488 SLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL-VSLIGYCDERNEMIIIY  558 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~  558 (820)
                      .+.|+.|....+|+....+        +..+++|+......  ...+..|..+++.|...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3467778889999998753        46788888643211  1345579998888853333 567776653    3899


Q ss_pred             eeccCCch
Q 003436          559 EYMENGTL  566 (820)
Q Consensus       559 E~~~~gsL  566 (820)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.93  E-value=0.0024  Score=67.99  Aligned_cols=157  Identities=8%  Similarity=0.091  Sum_probs=86.4

Q ss_pred             CCHHHHHHHhcCCcc-----ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc--eeeEE
Q 003436          473 FPFVAIQEATDNFSE-----SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH--LVSLI  545 (820)
Q Consensus       473 ~~~~~l~~at~~f~~-----~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--Iv~l~  545 (820)
                      ++..++......|..     .+.|+.|....+|+....++ .+++|......  ...++..|+.++..|....  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            445566666565653     33566688889999887665 57888765421  1134456777777664222  23333


Q ss_pred             eE------eecCceEEEEEeeccCCchhh--------------Hhhhc--C--CCC------CCHHHHHHHH--------
Q 003436          546 GY------CDERNEMIIIYEYMENGTLKD--------------HLYAS--N--FPS------LSWRKRLEIC--------  587 (820)
Q Consensus       546 g~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~--~--~~~------l~~~~~l~i~--------  587 (820)
                      ..      ....+..+++++|++|..+..              .+|..  .  ...      ..|...+.-+        
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      112356789999999865421              12211  1  010      1233211110        


Q ss_pred             ----HHHHHHhhhhhc----CCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          588 ----IGAARGLHYLHT----GSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       588 ----~~ia~gL~yLH~----~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                          ..+.+.++.++.    .....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                113334444432    124679999999999999887666899999765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.86  E-value=0.0036  Score=68.50  Aligned_cols=140  Identities=19%  Similarity=0.189  Sum_probs=82.5

Q ss_pred             eeEeeecceEEEEEEEcC--------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEEEEEe
Q 003436          489 LVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      +.|..|-...+|+....+        +..+++|+..... .......+|.++++.|. +.-..++++.+.++    +|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence            356667778899987642        4678888854322 23455668999998884 22235677776542    9999


Q ss_pred             eccCCchhhH-----------------hhhcC---CCCCC--HHHHHHHHHHHHH-------------------Hhhh--
Q 003436          560 YMENGTLKDH-----------------LYASN---FPSLS--WRKRLEICIGAAR-------------------GLHY--  596 (820)
Q Consensus       560 ~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~l~i~~~ia~-------------------gL~y--  596 (820)
                      |++|.+|..-                 ||...   .....  |.++.++..++..                   .+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665321                 11111   11122  3444444433321                   1222  


Q ss_pred             --hhc-CCCCcEEeccCCCCcEEEcCC----CCeeEeecccccc
Q 003436          597 --LHT-GSTKAIIHRDVKSANILLDEN----LMAKVADFGLSKI  633 (820)
Q Consensus       597 --LH~-~~~~~iiHrDIkp~NIll~~~----~~~kl~DFGla~~  633 (820)
                        |.. .....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              221 234679999999999999876    7899999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.81  E-value=0.0014  Score=69.45  Aligned_cols=137  Identities=15%  Similarity=0.114  Sum_probs=75.7

Q ss_pred             ceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce-eeEEeEeecCceEEEEEeec-cCCc
Q 003436          488 SLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL-VSLIGYCDERNEMIIIYEYM-ENGT  565 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~-~~gs  565 (820)
                      .+.|+.|....+|+.     ..+++|+........ -....|+.+++.+....+ .++++++.+  .-++|+||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence            668999999999998     568888755432211 122457777777643223 466665433  346899999 6655


Q ss_pred             hhhH------------------hhhcCC---CCCCHHHHH-HH-----------------HHHHHHH-hhhhh-cCCCCc
Q 003436          566 LKDH------------------LYASNF---PSLSWRKRL-EI-----------------CIGAARG-LHYLH-TGSTKA  604 (820)
Q Consensus       566 L~~~------------------l~~~~~---~~l~~~~~l-~i-----------------~~~ia~g-L~yLH-~~~~~~  604 (820)
                      |...                  ||....   ...+....+ .+                 +...+.. .+.|. ......
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            5320                  111111   001111111 11                 0011111 11111 123457


Q ss_pred             EEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          605 IIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       605 iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            999999999999 5667789999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.80  E-value=0.012  Score=62.68  Aligned_cols=141  Identities=11%  Similarity=0.110  Sum_probs=81.6

Q ss_pred             eeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCC--ceeeEEeE-----eecCceEEEEEeec
Q 003436          489 LVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR--HLVSLIGY-----CDERNEMIIIYEYM  561 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--nIv~l~g~-----~~~~~~~~lV~E~~  561 (820)
                      ..|+ |....||+....+|+.+++|...... .....+..|..+++.+...  .+++++..     ....+..++|+|++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88889999877777789999875331 1234566788888777422  23444443     12245568899999


Q ss_pred             cCCchhh----H----------hhhc----C---CCCCCHHHH----------------------HHHHHHHHHHhhhhh
Q 003436          562 ENGTLKD----H----------LYAS----N---FPSLSWRKR----------------------LEICIGAARGLHYLH  598 (820)
Q Consensus       562 ~~gsL~~----~----------l~~~----~---~~~l~~~~~----------------------l~i~~~ia~gL~yLH  598 (820)
                      +|.++..    .          +|..    .   ...+++...                      ...+..++..++-+.
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865421    1          1110    0   112232211                      011111222222111


Q ss_pred             -cCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          599 -TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       599 -~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                       ......++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence             11256799999999999999 4 899999988764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.76  E-value=0.0042  Score=69.81  Aligned_cols=74  Identities=12%  Similarity=0.111  Sum_probs=47.4

Q ss_pred             ceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce-eeEEeEeecCceEEEEEeeccCCc
Q 003436          488 SLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL-VSLIGYCDERNEMIIIYEYMENGT  565 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E~~~~gs  565 (820)
                      .+.|+.|-...+|+....+ +..+++|+......... +-..|..+++.|...++ .++++.+..    .+|+||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            3468888889999988765 46788887543221111 11478888888864444 567777642    25999999865


Q ss_pred             h
Q 003436          566 L  566 (820)
Q Consensus       566 L  566 (820)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.47  E-value=0.0057  Score=66.63  Aligned_cols=73  Identities=19%  Similarity=0.185  Sum_probs=43.9

Q ss_pred             eeEeeecceEEEEEEEcCc---------cEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc-eeeEEeEeecCceEEEEE
Q 003436          489 LVIGIGGFGKVYRGVLRDE---------TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH-LVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~---------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~  558 (820)
                      ..|+.|....+|+....++         ..+++|........ ..+...|.++++.+...+ ..++++...    -++|+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence            4677788889999887642         57888875543222 112356888888775333 346665442    26899


Q ss_pred             eeccCCch
Q 003436          559 EYMENGTL  566 (820)
Q Consensus       559 E~~~~gsL  566 (820)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99997654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.49  E-value=0.021  Score=61.50  Aligned_cols=32  Identities=16%  Similarity=0.343  Sum_probs=28.4

Q ss_pred             CCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          602 TKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       602 ~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            46799999999999999888899999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.48  E-value=0.039  Score=54.69  Aligned_cols=101  Identities=16%  Similarity=0.145  Sum_probs=65.7

Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcccc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS  643 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  643 (820)
                      -||.+.|...+ .++++.+++.+|.|.+.+|.-+-.. ... ..+=+.|..|+|..+|.+.+.+ +.+.           
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            47888887554 5799999999999999998776210 001 1233457999999999988763 1110           


Q ss_pred             ccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCC
Q 003436          644 TAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR  683 (820)
Q Consensus       644 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~  683 (820)
                         .....+.|||... ...+.+.=|||+|++||.-+--.
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence               1122356788763 45578889999999999887644

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.34  E-value=0.15  Score=56.54  Aligned_cols=73  Identities=11%  Similarity=0.131  Sum_probs=46.5

Q ss_pred             eeEeeecceEEEEEEEcC--------ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCc-eeeEEeEeecCceEEEEEe
Q 003436          489 LVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRH-LVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-Iv~l~g~~~~~~~~~lV~E  559 (820)
                      +.|..|-...+|+....+        +..+++|+......... +-.+|..+++.+...+ ..++++.+.    -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            456667778899988753        57788888554332211 2246888888774322 345665443    278999


Q ss_pred             eccCCch
Q 003436          560 YMENGTL  566 (820)
Q Consensus       560 ~~~~gsL  566 (820)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.48  E-value=0.64  Score=50.93  Aligned_cols=31  Identities=32%  Similarity=0.432  Sum_probs=25.9

Q ss_pred             CcEEeccCCCCcEEE------cCCCCeeEeecccccc
Q 003436          603 KAIIHRDVKSANILL------DENLMAKVADFGLSKI  633 (820)
Q Consensus       603 ~~iiHrDIkp~NIll------~~~~~~kl~DFGla~~  633 (820)
                      ..++|+|+.+.|||+      +++..++++||..|..
T Consensus       244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            357899999999999      4567899999998753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	820
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-76
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-64
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-63
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-63
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-58
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-52
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-48
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-46
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-43
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-43
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-37
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (631), Expect = 2e-76
 Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 19/270 (7%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
            IG G FG VY+G    +  V +      + Q L  F+ E+ +L + RH +++  +GY  
Sbjct: 15  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74

Query: 550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRD 609
              ++ I+ ++ E  +L  HL+          K ++I    A+G+ YLH    K+IIHRD
Sbjct: 75  A-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129

Query: 610 VKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ---LTEK 666
           +KS NI L E+L  K+ DFGL+ +      +H    + GS  ++ PE +  Q     + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189

Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           SDVY+FG+V++E++ G+       P   +N  +  +     G L   +       ++ + 
Sbjct: 190 SDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRGYLSPDLSK-----VRSNC 238

Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                 +  +CL +   +RP    +L ++E
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 9e-66
 Identities = 76/274 (27%), Positives = 125/274 (45%), Gaps = 21/274 (7%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           +       +G G FG+V+ G     TKVAVK    Q       F  E  ++ Q +H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L     +   + II EYMENG+L D L   +   L+  K L++    A G+ ++     
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           +  IHRD+++ANIL+ + L  K+ADFGL+++  D ++       K    +  PE +    
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186

Query: 663 LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI 722
            T KSDV+SFG+++ EI+    +  P +   +V         Q   +   +V P      
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRMVRP------ 232

Query: 723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
             +   +  ++   C  +   DRP+   +   LE
Sbjct: 233 -DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 9e-65
 Identities = 75/279 (26%), Positives = 125/279 (44%), Gaps = 23/279 (8%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
              +    IG G FG V+ G   ++ KVA+K    +      +F  E E++ +  H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L G C E+  + +++E+ME+G L D+   +     +    L +C+    G+ YL     
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLE---E 119

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
             +IHRD+ + N L+ EN + KV+DFG+++   D DQ   ST  K    +  PE  +  +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSR 178

Query: 663 LTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ 721
            + KSDV+SFGV+M+E+   G+   +     E V  +    +         +  P L   
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKPRLAST 229

Query: 722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
                     +I   C  +   DRP+   +L  L    +
Sbjct: 230 -------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  214 bits (547), Expect = 2e-64
 Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 21/279 (7%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            + +    +G G +G+VY GV +     VAVK    +    + EF  E  ++ + +H +L
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V L+G C       II E+M  G L D+L   N   +S    L +    +  + YL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
            K  IHRD+ + N L+ EN + KVADFGLS++    D        K    +  PE L   
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYN 191

Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ 721
           + + KSDV++FGV+++EI        P +                  Q+ ++++     +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---------------QVYELLEKDYRME 236

Query: 722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
                  K  E+   C      DRPS  ++    E   Q
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 4e-64
 Identities = 72/296 (24%), Positives = 131/296 (44%), Gaps = 27/296 (9%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCD 549
            IG G FG+V+RG  R E +VAVK   ++  +       EI      RH +++  I   +
Sbjct: 10  SIGKGRFGEVWRGKWRGE-EVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67

Query: 550 ERN----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH-----TG 600
           + N    ++ ++ +Y E+G+L D+L      +++    +++ +  A GL +LH     T 
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT--HVSTAVKGSFGYLDPEYL 658
              AI HRD+KS NIL+ +N    +AD GL+        T         G+  Y+ PE L
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 659 ------TKQQLTEKSDVYSFGVVMFEILCGRPVI----DPSLPREKVNLVEWAMKCQETG 708
                    +  +++D+Y+ G+V +EI     +     D  LP   +   + +++     
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 709 QLEDIVDPTLTGQIK-PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG 763
             E  + P +  + +  ++L    +I  +C    G  R +   +   L    Q +G
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 5e-64
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 23/275 (8%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            + +    +G G FG V  G  R +  VA+K    +      EF  E +++    H  LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L G C ++  + II EYM NG L ++L          ++ LE+C      + YL    +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---S 118

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
           K  +HRD+ + N L+++  + KV+DFGLS+   D D+   S   K    +  PE L   +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 663 LTEKSDVYSFGVVMFEIL-CGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ 721
            + KSD+++FGV+M+EI   G+       P E+    E A    +  +L           
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM------PYERFTNSETAEHIAQGLRLYR--------- 222

Query: 722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
               +  K   I   C  +   +RP+   +L N+ 
Sbjct: 223 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 3e-63
 Identities = 72/269 (26%), Positives = 122/269 (45%), Gaps = 27/269 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC- 548
            IG G FG V  G  R   KVAVK    ++      F  E  +++Q RH +LV L+G   
Sbjct: 14  TIGKGEFGDVMLGDYRG-NKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           +E+  + I+ EYM  G+L D+L +     L     L+  +     + YL        +HR
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSD 668
           D+ + N+L+ E+ +AKV+DFGL+K       T      K    +  PE L +++ + KSD
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSD 182

Query: 669 VYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLN 728
           V+SFG++++EI          +P  ++ L +   + ++  +++                 
Sbjct: 183 VWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMD----------APDGCPP 227

Query: 729 KFVEIAEKCLAQCGIDRPSMGDVLWNLEY 757
              E+ + C       RPS   +   LE+
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 3e-63
 Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
           ++    + +G G FG+V+ G     T+VA+K            F  E +++ + RH  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
            L         + I+ EYM  G+L D L       L   + +++    A G+ Y+     
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 603 KAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQ 662
              +HRD+++ANIL+ ENL+ KVADFGL+++  D ++       K    +  PE     +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190

Query: 663 LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI 722
            T KSDV+SFG+++ E+     V  P +                  ++ D V+       
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR---------------EVLDQVERGYRMPC 235

Query: 723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
            P+      ++  +C  +   +RP+   +   LE
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  211 bits (538), Expect = 6e-63
 Identities = 78/306 (25%), Positives = 136/306 (44%), Gaps = 38/306 (12%)

Query: 473 FPFVAIQEATDNFSESL---------VIGIGGFGKVYRGVLRDETK----VAVKR-GGTQ 518
           F F    EA   F++ +         VIG G FG+V  G L+   K    VA+K      
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 519 SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSL 578
           + +   +F +E  ++ QF H +++ L G   +   ++II E+MENG+L D     N    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125

Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
           +  + + +  G A G+ YL        +HRD+ + NIL++ NL+ KV+DFGLS+   D  
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 639 QTHVSTAV---KGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEIL-CGRPVIDPSLPREK 694
                T+    K    +  PE +  ++ T  SDV+S+G+VM+E++  G        P   
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER------PYWD 236

Query: 695 VNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN 754
           +   +     ++  +L              D  +   ++   C  +    RP  G ++  
Sbjct: 237 MTNQDVINAIEQDYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 755 LEYALQ 760
           L+  ++
Sbjct: 287 LDKMIR 292

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 3e-61
 Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 26/286 (9%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRD-----ETKVAVKR-GGTQSHQGLAEFRTEIEMLSQF 536
              +   VIG G FG+VY+G+L+      E  VA+K      + +   +F  E  ++ QF
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            H +++ L G   +   M+II EYMENG L            S  + + +  G A G+ Y
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDP 655
           L        +HRD+ + NIL++ NL+ KV+DFGLS+ +  D + T+ ++  K    +  P
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
           E ++ ++ T  SDV+SFG+VM+E++         L                  ++   ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---------------EVMKAIN 227

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL 761
                    D  +   ++  +C  Q    RP   D++  L+  ++ 
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 4e-61
 Identities = 60/281 (21%), Positives = 115/281 (40%), Gaps = 10/281 (3%)

Query: 478 IQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGL-AEFRTEIEMLSQ 535
           ++   D+F +   +G G  G V++   +     +A K    +    +  +   E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
               ++V   G      E+ I  E+M+ G+L   L  +    +  +   ++ I   +GL 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLT 118

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           YL       I+HRDVK +NIL++     K+ DFG+S    D     ++ +  G+  Y+ P
Sbjct: 119 YLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSP 172

Query: 656 EYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
           E L     + +SD++S G+ + E+  GR  I P   +E   +    ++            
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
           P              + I E          P +   +++LE
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 4e-61
 Identities = 77/309 (24%), Positives = 137/309 (44%), Gaps = 29/309 (9%)

Query: 460 ISAIFSSSKIGYRFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRG 515
           +SA+        +   +       +F+E  VIG G FG VY G L D    +   AVK  
Sbjct: 6   LSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63

Query: 516 GTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIGYC-DERNEMIIIYEYMENGTLKDHLYAS 573
              +  G +++F TE  ++  F H +++SL+G C       +++  YM++G L++ +   
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123

Query: 574 NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
                + +  +   +  A+G+ +L +   K  +HRD+ + N +LDE    KVADFGL++ 
Sbjct: 124 THN-PTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 179

Query: 634 --GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLP 691
               + D  H  T  K    ++  E L  Q+ T KSDV+SFGV+++E++        + P
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APP 234

Query: 692 REKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDV 751
              VN  +  +   +  +L                 +   E+  KC       RPS  ++
Sbjct: 235 YPDVNTFDITVYLLQGRRLLQP----------EYCPDPLYEVMLKCWHPKAEMRPSFSEL 284

Query: 752 LWNLEYALQ 760
           +  +     
Sbjct: 285 VSRISAIFS 293

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 4e-61
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 28/283 (9%)

Query: 481 ATDNFS-ESLVIGIGGFGKVYRGVLR---DETKVAVKRGGTQSHQG-LAEFRTEIEMLSQ 535
             DN     + +G G FG V +GV R    +  VA+K     + +    E   E +++ Q
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
             + ++V LIG C +   ++++ E    G L   L       +      E+    + G+ 
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMK 123

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLD 654
           YL     K  +HRD+ + N+LL     AK++DFGLSK +G D       +A K    +  
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180

Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEIL-CGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
           PE +  ++ + +SDV+S+GV M+E L  G+       P +K+   E     ++  ++E  
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQK------PYKKMKGPEVMAFIEQGKRME-- 232

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                     P+   +   +   C      DRP    V   + 
Sbjct: 233 --------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  206 bits (524), Expect = 6e-61
 Identities = 72/307 (23%), Positives = 125/307 (40%), Gaps = 47/307 (15%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQ 535
           +N      IG G FG+V++            T VAVK      S    A+F+ E  ++++
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY----------------------AS 573
           F + ++V L+G C     M +++EYM  G L + L                       + 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 574 NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
             P LS  ++L I    A G+ YL        +HRD+ + N L+ EN++ K+ADFGLS+ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
               D             ++ PE +   + T +SDV+++GVV++EI          +  E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 694 KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW 753
           +V              +  + D  +      +   +   +   C ++   DRPS   +  
Sbjct: 250 EV--------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 754 NLEYALQ 760
            L+   +
Sbjct: 295 ILQRMCE 301

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-59
 Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 30/271 (11%)

Query: 490 VIGIGGFGKVYRGVLRDETK-VAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            IG G F  VY+G+  + T  VA    +    +      F+ E EML   +H ++V    
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 547 YC----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
                   +  ++++ E M +GTLK +L    F  +  +     C    +GL +LHT + 
Sbjct: 76  SWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQILKGLQFLHTRTP 133

Query: 603 KAIIHRDVKSANILL-DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQ 661
             IIHRD+K  NI +       K+ D GL+     L +   + AV G+  ++ PE   ++
Sbjct: 134 P-IIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEMY-EE 187

Query: 662 QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ 721
           +  E  DVY+FG+ M E+              ++                 +        
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTSGVKPAS 233

Query: 722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
               ++ +  EI E C+ Q   +R S+ D+L
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 5e-59
 Identities = 62/276 (22%), Positives = 110/276 (39%), Gaps = 27/276 (9%)

Query: 487 ESLVIGIGGFGKVYRGVLRDE---TKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
           E   +G G FG V +G  + +     VAVK  +          E   E  ++ Q  + ++
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 542 VSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGS 601
           V +IG C E    +++ E  E G L  +L       +  +  +E+    + G+ YL    
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQVSMGMKYLEE-- 125

Query: 602 TKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
               +HRD+ + N+LL     AK++DFGLSK +  D +     T  K    +  PE +  
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 661 QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG 720
            + + KSDV+SFGV+M+E                    +   +  +  ++  +++     
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYG---------------QKPYRGMKGSEVTAMLEKGERM 229

Query: 721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE 756
                   +  ++   C      +RP    V   L 
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-58
 Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 26/269 (9%)

Query: 490 VIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G G FGKVY+   ++     A K   T+S + L ++  EI++L+   H ++V L+   
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
              N + I+ E+   G +   +     P L+  +   +C      L+YLH      IIHR
Sbjct: 79  YYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 609 DVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL-----TKQQL 663
           D+K+ NIL   +   K+ADFG+S       Q     +  G+  ++ PE +       +  
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192

Query: 664 TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK 723
             K+DV+S G+ + E+    P      P  ++N +   +K  ++           +   K
Sbjct: 193 DYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246

Query: 724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                   +  +KCL +    R +   +L
Sbjct: 247 --------DFLKKCLEKNVDARWTTSQLL 267

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 4e-58
 Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 41/302 (13%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQSHQG-LAEFRTEIEMLSQ 535
           +  S    +G G FGKV                VAVK     +H        +E+++LS 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY----------------ASNFPSL 578
              H ++V+L+G C      ++I EY   G L + L                   +  +L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
                L      A+G+ +L +   K  IHRD+ + NILL    + K+ DFGL++   +  
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
              V    +    ++ PE +     T +SDV+S+G+ ++E+        P +P +     
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255

Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA 758
                     +   ++           +  +  +I + C     + RP+   ++  +E  
Sbjct: 256 ----------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

Query: 759 LQ 760
           + 
Sbjct: 306 IS 307

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 4e-58
 Identities = 78/308 (25%), Positives = 134/308 (43%), Gaps = 44/308 (14%)

Query: 472 RFPFVAIQEATDNFSESLVIGIGGFGKVYRGVLRD---ETKVAVKR-GGTQSHQGLAEFR 527
            +P +      ++     VIG G FG+V +  ++        A+KR     S     +F 
Sbjct: 3   IYPVLDW----NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA 58

Query: 528 TEIEMLSQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP---------- 576
            E+E+L +   H ++++L+G C+ R  + +  EY  +G L D L  S             
Sbjct: 59  GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 118

Query: 577 ----SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK 632
               +LS ++ L      ARG+ YL     K  IHRD+ + NIL+ EN +AK+ADFGLS+
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 175

Query: 633 IGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPR 692
                 +    T  +    ++  E L     T  SDV+S+GV+++EI+          P 
Sbjct: 176 GQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPY 227

Query: 693 EKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
             +   E   K  +  +LE             +  ++  ++  +C  +   +RPS   +L
Sbjct: 228 CGMTCAELYEKLPQGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277

Query: 753 WNLEYALQ 760
            +L   L+
Sbjct: 278 VSLNRMLE 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 7e-58
 Identities = 67/314 (21%), Positives = 125/314 (39%), Gaps = 33/314 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDE-----TKVAVKR-GGTQSHQGLAEFRTEIEMLSQF 536
             F +  V+G G FG VY+G+   E       VA+K      S +   E   E  +++  
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 537 RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHY 596
            + H+  L+G C      +I  + M  G L D+    +  ++  +  L  C+  A+G++Y
Sbjct: 69  DNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDY-VREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 597 LHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPE 656
           L     + ++HRD+ + N+L+      K+ DFGL+K+    ++ + +   K    ++  E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 657 YLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP 716
            +  +  T +SDV+S+GV ++E++         +P                 ++  I++ 
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------------EISSILEK 228

Query: 717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY-------ALQLQGDEGKSS 769
                  P        I  KC       RP   +++             L +QGDE    
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

Query: 770 PKGETSSPNNHSHS 783
           P    S+       
Sbjct: 289 PSPTDSNFYRALMD 302

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 8e-58
 Identities = 68/274 (24%), Positives = 113/274 (41%), Gaps = 30/274 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F     +G G FG VY    +  +  +A+K   +   +      + R E+E+ S  RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            +++ L GY  +   + +I EY   GT+   L          ++        A  L Y H
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCH 123

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
              +K +IHRD+K  N+LL      K+ADFG S   P        T + G+  YL PE +
Sbjct: 124 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMI 176

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL 718
             +   EK D++S GV+ +E L G+P  + +  +E    +      +      D V    
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----SRVEFTFPDFVTE-- 229

Query: 719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                        ++  + L      RP + +VL
Sbjct: 230 ----------GARDLISRLLKHNPSQRPMLREVL 253

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 1e-57
 Identities = 64/303 (21%), Positives = 118/303 (38%), Gaps = 46/303 (15%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQSHQG-LAEFRTEIEMLSQ 535
           +N     V+G G FGKV               +VAVK    ++         +E++M++Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 536 F-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFP------------------ 576
              H ++V+L+G C     + +I+EY   G L ++L +                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 577 ---SLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI 633
               L++   L      A+G+ +L     K+ +HRD+ + N+L+    + K+ DFGL++ 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPRE 693
                   V    +    ++ PE L +   T KSDV+S+G++++EI        P +P +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 694 KVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW 753
                              ++           +  +   I + C A     RPS  ++  
Sbjct: 274 A--------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 754 NLE 756
            L 
Sbjct: 320 FLG 322

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-57
 Identities = 66/280 (23%), Positives = 114/280 (40%), Gaps = 29/280 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHR 539
           +++     IG G +G+  +   + D   +  K    G+ +        +E+ +L + +H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 540 HLVSLIGYCDERNE--MIIIYEYMENGTLKDHL--YASNFPSLSWRKRLEICIGAARGLH 595
           ++V       +R    + I+ EY E G L   +         L     L +       L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 596 YLHTGSTKA--IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
             H  S     ++HRD+K AN+ LD     K+ DFGL++I      T  + A  G+  Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPYYM 181

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
            PE + +    EKSD++S G +++E+    P      P    +  E A K +E G+   I
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP------PFTAFSQKELAGKIRE-GKFRRI 234

Query: 714 VDPTLTGQIKPDSLNK-FVEIAEKCLAQCGIDRPSMGDVL 752
                     P   +    EI  + L      RPS+ ++L
Sbjct: 235 ----------PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  196 bits (499), Expect = 3e-57
 Identities = 69/278 (24%), Positives = 110/278 (39%), Gaps = 33/278 (11%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFR 537
              FS+   IG G FG VY    +R+   VA+K+    G QS++   +   E+  L + R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H + +   G     +   ++ EY                 L   +   +  GA +GL YL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYL 131

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H   +  +IHRDVK+ NILL E  + K+ DFG + I         + +  G+  ++ PE 
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEV 182

Query: 658 L---TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV 714
           +    + Q   K DV+S G+   E+   +P      P   +N +           L  I 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP------PLFNMNAMS---------ALYHIA 227

Query: 715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                          F    + CL +   DRP+   +L
Sbjct: 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 1e-56
 Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 28/282 (9%)

Query: 474 PFVAIQEATDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKR-GGTQSHQGLAEFRTEIE 531
           PFV      +++     +G G +G+V   V R  E  VAVK     ++       + EI 
Sbjct: 2   PFV------EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55

Query: 532 MLSQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +     H ++V   G+  E N   +  EY   G L D +       +             
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLM 113

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
            G+ YLH      I HRD+K  N+LLDE    K++DFGL+ +    ++  +   + G+  
Sbjct: 114 AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170

Query: 652 YLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL 710
           Y+ PE L +++   E  DV+S G+V+  +L G    D      +              + 
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--------------EY 216

Query: 711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            D  +            +  + +  K L +    R ++ D+ 
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-55
 Identities = 73/277 (26%), Positives = 114/277 (41%), Gaps = 28/277 (10%)

Query: 490 VIGIGGFGKVYRGVLRDE----TKVAVKRGGTQSHQGLAE-FRTEIEMLSQFRHRHLVSL 544
            IG G FG V++G+          VA+K     +   + E F  E   + QF H H+V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 545 IGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA 604
           IG   E N + II E    G L+         SL     +      +  L YL +   K 
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTALAYLES---KR 128

Query: 605 IIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
            +HRD+ + N+L+  N   K+ DFGLS+   D    + ++  K    ++ PE +  ++ T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESINFRRFT 187

Query: 665 EKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIK 723
             SDV+ FGV M+EIL  G        P + V   +   + +   +L           + 
Sbjct: 188 SASDVWMFGVCMWEILMHGVK------PFQGVKNNDVIGRIENGERLP----------MP 231

Query: 724 PDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
           P+       +  KC A     RP   ++   L   L+
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 5e-55
 Identities = 63/288 (21%), Positives = 105/288 (36%), Gaps = 30/288 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETK----VAVKR---GGTQSHQGLAEFRTEIEMLSQ 535
            +      +G G FG V RG     +     VAVK          + + +F  E+  +  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
             HR+L+ L G       M ++ E    G+L D     +             +  A G+ 
Sbjct: 68  LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGYLD 654
           YL    +K  IHRD+ + N+LL    + K+ DFGL + +  + D   +    K  F +  
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 655 PEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV 714
           PE L  +  +  SD + FGV ++E+          L   ++              L  I 
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKID 228

Query: 715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ 762
                     D       +  +C A    DRP+   +    ++ L+ Q
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLEAQ 273

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-54
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 33/293 (11%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQ 535
           +  + S  +G G FG VY GV +       ET+VA+K      S +   EF  E  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLY--------ASNFPSLSWRKRLEIC 587
           F   H+V L+G   +    ++I E M  G LK +L                S  K +++ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 588 IGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVK 647
              A G+ YL+       +HRD+ + N ++ E+   K+ DFG+++   + D         
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 648 GSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET 707
               ++ PE L     T  SDV+SFGVV++EI          L  E+V            
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------ 244

Query: 708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
             L  +++  L      +  +   E+   C       RPS  +++ +++  ++
Sbjct: 245 --LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-54
 Identities = 58/279 (20%), Positives = 117/279 (41%), Gaps = 23/279 (8%)

Query: 475 FVAIQEATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEML 533
            V++ +    ++    IG G  G VY  + +    +VA+++   Q          EI ++
Sbjct: 12  IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVM 71

Query: 534 SQFRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
            + ++ ++V+ +      +E+ ++ EY+  G+L D +  +        +   +C    + 
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQA 128

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           L +LH   +  +IHRD+KS NILL  +   K+ DFG         +    + + G+  ++
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWM 183

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI 713
            PE +T++    K D++S G++  E++ G P      P    N +         G  E  
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQ 237

Query: 714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
               L+   +        +   +CL      R S  ++L
Sbjct: 238 NPEKLSAIFR--------DFLNRCLDMDVEKRGSAKELL 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-54
 Identities = 74/303 (24%), Positives = 133/303 (43%), Gaps = 42/303 (13%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR--------DETKVAVKR-GGTQSHQGLAEFRTEIEML 533
           D       +G G FG+V                TKVAVK      + + L++  +E+EM+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 534 SQF-RHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPS--------------L 578
               +H+++++L+G C +   + +I EY   G L+++L A   P               L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 579 SWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD 638
           S +  +      ARG+ YL +   K  IHRD+ + N+L+ E+ + K+ADFGL++    +D
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV 698
               +T  +    ++ PE L  +  T +SDV+SFGV+++EI        P +P E     
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 244

Query: 699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA 758
                     +L  ++          +  N+   +   C       RP+   ++ +L+  
Sbjct: 245 ----------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

Query: 759 LQL 761
           + L
Sbjct: 295 VAL 297

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 9e-54
 Identities = 57/274 (20%), Positives = 108/274 (39%), Gaps = 26/274 (9%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G F  V     L    + A+K   +        +     E +++S+  H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
              V L     +  ++     Y +NG L  ++      S                L YLH
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
               K IIHRD+K  NILL+E++  ++ DFG +K+     +   + +  G+  Y+ PE L
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL 718
           T++   + SD+++ G ++++++ G P      P    N      K  +       ++   
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLP------PFRAGNEYLIFQKIIK-------LEYDF 229

Query: 719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
             +  P       ++ EK L      R    ++ 
Sbjct: 230 PEKFFPK----ARDLVEKLLVLDATKRLGCEEME 259

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  182 bits (463), Expect = 8e-52
 Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 23/266 (8%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G G FG V+R   R      A K   T         R EI+ +S  RH  LV+L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           ++ NEM++IYE+M  G L + +   +   +S  + +E      +GL ++H       +H 
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMH---ENNYVHL 148

Query: 609 DVKSANILL--DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           D+K  NI+     +   K+ DFGL+     LD         G+  +  PE    + +   
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205

Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +D++S GV+ + +L G        P    N  E     +         D  +        
Sbjct: 206 TDMWSVGVLSYILLSGLS------PFGGENDDETLRNVKS-------CDWNMDDSAFSGI 252

Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDVL 752
                +   K L      R ++   L
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQAL 278

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-50
 Identities = 64/301 (21%), Positives = 115/301 (38%), Gaps = 40/301 (13%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKR-GGTQSHQGLAEFRTEIEMLSQ 535
           D       +G G FG+V                VAVK      +H       +E+++L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 536 FRHRH-LVSLIGYCDERNEMI-IIYEYMENGTLKDHLYASNFPS--------------LS 579
             H   +V+L+G C +    + +I E+ + G L  +L +                   L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 580 WRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ 639
               +      A+G+ +L +   +  IHRD+ + NILL E  + K+ DFGL++       
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE 699
                  +    ++ PE +  +  T +SDV+SFGV+++EI           P   V + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDE 244

Query: 700 WAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL 759
              +  + G      D          +  +  +    C       RP+  +++ +L   L
Sbjct: 245 EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295

Query: 760 Q 760
           Q
Sbjct: 296 Q 296

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  177 bits (450), Expect = 6e-50
 Identities = 54/266 (20%), Positives = 111/266 (41%), Gaps = 23/266 (8%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G G FG V+R V          K   T         + EI +++Q  H  L++L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           +++ EM++I E++  G L D + A ++  +S  + +     A  GL ++H     +I+H 
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EHSIVHL 151

Query: 609 DVKSANILLD--ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           D+K  NI+ +  +    K+ DFGL+     L+   +      +  +  PE + ++ +   
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +D+++ GV+ + +L G     P    + +  ++   +C          D           
Sbjct: 209 TDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRC----------DWEFDEDAFSSV 255

Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDVL 752
             +  +  +  L +    R ++ D L
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDAL 281

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  171 bits (434), Expect = 1e-48
 Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 28/285 (9%)

Query: 482 TDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR---GGTQSHQGLAEFRTEIEMLSQFR 537
           +D +    ++G GG  +V+    LR    VAVK       +       FR E +  +   
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 538 HRHLVSLIGYCDERNE----MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H  +V++    +          I+ EY++  TL+D ++      ++ ++ +E+   A + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQA 123

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGY 652
           L++ H      IIHRDVK ANI++      KV DFG+++ I    +    + AV G+  Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 653 LDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED 712
           L PE      +  +SDVYS G V++E+L G P      P    + V  A +         
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVRE----- 229

Query: 713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-SMGDVLWNLE 756
             DP                +  K LA+   +R  +  ++  +L 
Sbjct: 230 --DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 1e-48
 Identities = 61/331 (18%), Positives = 122/331 (36%), Gaps = 44/331 (13%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            +G G FG V+R V    +     K    +        + EI +L+  RHR+++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHR 608
           +   E+++I+E++    + + +  S F  L+ R+ +         L +LH   +  I H 
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLH---SHNIGHF 126

Query: 609 DVKSANILLD--ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           D++  NI+     +   K+ +FG ++    L        +  +  Y  PE      ++  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
           +D++S G +++ +L G     P L      ++E  M            + T   +   + 
Sbjct: 184 TDMWSLGTLVYVLLSGIN---PFLAETNQQIIENIMNA----------EYTFDEEAFKEI 230

Query: 727 LNKFVEIAEKCLAQCGIDRPSMGDVL---W-----------------NLEYALQLQGDEG 766
             + ++  ++ L +    R +  + L   W                 +  Y   L   + 
Sbjct: 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL 290

Query: 767 KSSPKGETSSPNNHSHSQTGVSNTEFSTASV 797
                    S      SQ GVS  +   AS+
Sbjct: 291 NMVVSAARISCGGAIRSQKGVSVAKVKVASI 321

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (421), Expect = 2e-46
 Identities = 61/268 (22%), Positives = 110/268 (41%), Gaps = 26/268 (9%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQG-LAEFRTEIEMLSQFRHRHLVSLIGY 547
           V+G G F +V      R +  VA+K    ++ +G       EI +L + +H ++V+L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
            +    + +I + +  G L D +    F   + R    +       + YLH      I+H
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLH---DLGIVH 130

Query: 608 RDVKSANILL---DENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLT 664
           RD+K  N+L    DE+    ++DFGLSK+    D   V +   G+ GY+ PE L ++  +
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 665 EKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKP 724
           +  D +S GV+ + +LCG P      P    N  +   +  +        +         
Sbjct: 188 KAVDCWSIGVIAYILLCGYP------PFYDENDAKLFEQILKA-------EYEFDSPYWD 234

Query: 725 DSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
           D  +   +     + +    R +    L
Sbjct: 235 DISDSAKDFIRHLMEKDPEKRFTCEQAL 262

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (418), Expect = 2e-46
 Identities = 60/287 (20%), Positives = 115/287 (40%), Gaps = 38/287 (13%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKR---------GGTQSHQGLAEFRTEIEM 532
           +N+    ++G G    V R +      + AVK             +  +       E+++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 533 LSQFR-HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           L +   H +++ L    +      ++++ M+ G L D+L  +   +LS ++  +I     
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALL 120

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
             +  LH      I+HRD+K  NILLD+++  K+ DFG S     LD       V G+  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPS 174

Query: 652 YLDPEYLT------KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ 705
           YL PE +            ++ D++S GV+M+ +L G P   P   R+++ ++   M   
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---PFWHRKQMLMLRMIMSG- 230

Query: 706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                    +         D  +   ++  + L      R +  + L
Sbjct: 231 ---------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (408), Expect = 1e-44
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 14/206 (6%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
            +F     +G G FG+V+    R +    A+K   +      + +     E  MLS   H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
             ++ + G   +  ++ +I +Y+E G L   L  S        K     +     L YLH
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV--CLALEYLH 121

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +   K II+RD+K  NILLD+N   K+ DFG +K  PD+  T       G+  Y+ PE +
Sbjct: 122 S---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEVV 173

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
           + +   +  D +SFG++++E+L G  
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYT 199

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-44
 Identities = 59/277 (21%), Positives = 109/277 (39%), Gaps = 29/277 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVK---RGGTQSHQGLAEFRTEIEMLS-QFR 537
           ++F    ++G G FGKV+    +      A+K   +        +     E  +LS  + 
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 538 HRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
           H  L  +      +  +  + EY+  G L  H+ + +       +          GL +L
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFL 119

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H   +K I++RD+K  NILLD++   K+ADFG+ K     D         G+  Y+ PE 
Sbjct: 120 H---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT 717
           L  Q+     D +SFGV+++E+L G+    P   +++  L                 +P 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS---PFHGQDEEELFHSIRMD----------NPF 221

Query: 718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN 754
               ++ +      ++  K   +    R  +   +  
Sbjct: 222 YPRWLEKE----AKDLLVKLFVREPEKRLGVRGDIRQ 254

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 7e-44
 Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 29/285 (10%)

Query: 490 VIGIGGFGKVYRGVLRDETK--VAVK--RGGTQSHQGLAEFRTEIE---MLSQFRHRHLV 542
            IG G +GKV++          VA+K  R  T           E+     L  F H ++V
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 543 SLIGYC-----DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYL 597
            L   C     D   ++ +++E+++      +L     P +      ++     RGL +L
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 598 HTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           H+     ++HRD+K  NIL+  +   K+ADFGL++I          T+V  +  Y  PE 
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPEV 186

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLV----------EWAMKCQET 707
           L +       D++S G +  E+   +P+   S   +++  +          +W       
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 708 GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            Q           +   D      ++  KCL      R S    L
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 1e-43
 Identities = 52/285 (18%), Positives = 109/285 (38%), Gaps = 20/285 (7%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHR 539
           +NF +   IG G +G VY+   +     VA+K  R  T++    +    EI +L +  H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
           ++V L+      N++ +++E++    LK  + AS    +             +GL + H+
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
                ++HRD+K  N+L++     K+ADFGL++    +     +  V   +       L 
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD---- 715
            +  +   D++S G +  E++  R +       +++  +   +   +      +      
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 716 --------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                        ++ P        +  + L      R S    L
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (399), Expect = 1e-43
 Identities = 51/284 (17%), Positives = 96/284 (33%), Gaps = 26/284 (9%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYC 548
            IG G FG +Y G  +    +VA+K    ++     +   E ++    +    +  I +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 549 -DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             E +  +++ E +         + S     S +  L +       + Y+H+   K  IH
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIH 126

Query: 608 RDVKSANIL---LDENLMAKVADFGLSKIGPDLD-----QTHVSTAVKGSFGYLDPEYLT 659
           RDVK  N L     +  +  + DFGL+K   D           +  + G+  Y       
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 660 KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT 719
             + + + D+ S G V+     G           K    E   + + +  +E        
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV------- 239

Query: 720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG 763
             +     ++F      C +    D+P    +          QG
Sbjct: 240 --LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (404), Expect = 1e-43
 Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 31/275 (11%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRD-ETKVAVK---RGGTQSHQGLAEFRTE---IEMLSQ 535
           ++FS   +IG GGFG+VY     D     A+K   +   +  QG      E   + ++S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 536 FRHRHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLH 595
                +V +       +++  I + M  G L  HL      S +  +     I    GL 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLE 121

Query: 596 YLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDP 655
           ++H    + +++RD+K ANILLDE+   +++D GL+    D  +     A  G+ GY+ P
Sbjct: 122 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKK-PHASVGTHGYMAP 174

Query: 656 EYL-TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV 714
           E L         +D +S G ++F++L G         ++K  +    +            
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------- 224

Query: 715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMG 749
              L     P+       + E  L +    R    
Sbjct: 225 AVELPDSFSPE----LRSLLEGLLQRDVNRRLGCL 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  156 bits (395), Expect = 2e-43
 Identities = 44/284 (15%), Positives = 104/284 (36%), Gaps = 20/284 (7%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRH 540
           + +     IG G +G VY+         A+K  R   +     +    EI +L + +H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           +V L      +  +++++E+++    K          L         +    G+ Y H  
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH-- 117

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
             + ++HRD+K  N+L++     K+ADFGL++    +     +  +   +       +  
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 661 QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD----- 715
           ++ +   D++S G +  E++ G P+       +++  +   +    +    ++ +     
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 716 -------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                  P              +++  K L      R +    L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  155 bits (393), Expect = 6e-43
 Identities = 41/283 (14%), Positives = 86/283 (30%), Gaps = 28/283 (9%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHR-HLVSLIGY 547
            IG G FG ++ G  L +  +VA+K           + R E            + ++  +
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 548 CDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIH 607
             E    +++ + +  G   + L        S +            +  +H    K++++
Sbjct: 70  GQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124

Query: 608 RDVKSANILLDENLM-----AKVADFGLSKIGPDLD-----QTHVSTAVKGSFGYLDPEY 657
           RD+K  N L+            V DFG+ K   D              + G+  Y+    
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 658 LTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT 717
              ++ + + D+ + G V    L G                E   + +++  L ++    
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC--- 241

Query: 718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ 760
                      +F +             P    +       L+
Sbjct: 242 ------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 7e-43
 Identities = 63/295 (21%), Positives = 124/295 (42%), Gaps = 28/295 (9%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAE-FRTEIEMLSQFR 537
           +    ++    IG G +G V       ++ +VA+K+     HQ   +    EI++L +FR
Sbjct: 5   DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64

Query: 538 HRHLVSLIGYCD----ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
           H +++ +         E+ + + +  ++    L   L       LS            RG
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRG 121

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK-IGPDLDQTHVSTAVKGSFGY 652
           L Y+H+     ++HRD+K +N+LL+     K+ DFGL++   PD D T   T    +  Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 653 LDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE 711
             PE +   +  T+  D++S G ++ E+L  RP+       +++N +   +       L 
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 712 DIV--------------DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            I+              +     ++ P++ +K +++ +K L      R  +   L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 8e-43
 Identities = 57/281 (20%), Positives = 116/281 (41%), Gaps = 25/281 (8%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVKR----GGTQSHQGLAE-FRTEIEMLSQFRHRHLVS 543
            +G G F  VY+   +     VA+K+      +++  G+      EI++L +  H +++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 544 LIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
           L+     ++ + +++++ME          S   + S  K     +   +GL YLH     
Sbjct: 65  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKA--YMLMTLQGLEYLH---QH 119

Query: 604 AIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL 663
            I+HRD+K  N+LLDEN + K+ADFGL+K     ++ +  T    +  Y  PE L   ++
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGARM 177

Query: 664 -TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD------- 715
                D+++ G ++ E+L   P +      +++  +   +      Q  D+         
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 716 ----PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                     I   + +  +++ +         R +    L
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 8e-43
 Identities = 58/272 (21%), Positives = 111/272 (40%), Gaps = 29/272 (10%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQ-FRHRHLVSLIGY 547
           V+G+G  GKV +    R + K A+K       Q   + R E+E+  +  +  H+V ++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 548 CD----ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTK 603
            +     R  ++I+ E ++ G L   +      + + R+  EI       + YLH+    
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130

Query: 604 AIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
            I HRDVK  N+L      N + K+ DFG +K     +          +  Y+ PE L  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGP 187

Query: 661 QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG 720
           ++  +  D++S GV+M+ +LCG P      P    + +  +   +   ++     P    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP------PFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
               + +   +      L      R ++ + +
Sbjct: 242 SEVSEEVKMLI---RNLLKTEPTQRMTITEFM 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-41
 Identities = 54/274 (19%), Positives = 110/274 (40%), Gaps = 32/274 (11%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR------GGTQSHQGLAEFRTEIEMLSQFRHRHLV 542
            +G G F  V +        + A K         ++      +   E+ +L + +H +++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 543 SLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGST 602
           +L    + + ++I+I E +  G L D L      SL+  +  E       G++YLH   +
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLH---S 131

Query: 603 KAIIHRDVKSANILLDEN----LMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
             I H D+K  NI+L +        K+ DFGL+     +D  +    + G+  ++ PE +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIV 188

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL 718
             + L  ++D++S GV+ + +L G         +E +  V               V+   
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------------VNYEF 235

Query: 719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
             +   ++     +   + L +    R ++ D L
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-40
 Identities = 55/291 (18%), Positives = 110/291 (37%), Gaps = 30/291 (10%)

Query: 483 DNFSESLVIGIGGFGKVYRGVLRDE-TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL 541
            +++++ VIG G FG VY+  L D    VA+K+      Q       E++++ +  H ++
Sbjct: 20  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQDKRFKNRELQIMRKLDHCNI 75

Query: 542 VSLIGYCDERNE------MIIIYEYMENGTLKDHL-YASNFPSLSWRKRLEICIGAARGL 594
           V L  +     E      + ++ +Y+     +    Y+    +L             R L
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 595 HYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
            Y+H+     I HRD+K  N+LLD +  + K+ DFG +K     +     + +   +   
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAM----------- 702
                     T   DV+S G V+ E+L G+P+       +++  +   +           
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 703 -KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                  +   I     T   +P +  + + +  + L      R +  +  
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 2e-40
 Identities = 53/274 (19%), Positives = 103/274 (37%), Gaps = 42/274 (15%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKR------GGTQSHQGLAEFRTEIEMLSQFRHRH-- 540
           ++G GGFG VY G+ + D   VA+K                     E+ +L +       
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 541 LVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
           ++ L+ + +  +  ++I E  E               L               + + H  
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCH-- 127

Query: 601 STKAIIHRDVKSANILLDENLM-AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLT 659
               ++HRD+K  NIL+D N    K+ DFG   +  D     V T   G+  Y  PE++ 
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIR 182

Query: 660 KQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL 718
             +     + V+S G+++++++CG     P    E++   +   + + + + + ++    
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDI---PFEHDEEIIRGQVFFRQRVSSECQHLI---- 235

Query: 719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
                             CLA    DRP+  ++ 
Sbjct: 236 ----------------RWCLALRPSDRPTFEEIQ 253

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 50/281 (17%), Positives = 103/281 (36%), Gaps = 26/281 (9%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            IG G +G V++   R     VA+K  R         +    EI +L + +H+++V L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 547 YCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAII 606
                 ++ +++E+ +    K     +        K         +GL + H+   + ++
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLLKGLGFCHS---RNVL 123

Query: 607 HRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEK 666
           HRD+K  N+L++ N   K+A+FGL++    +     S  V   +          +  +  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 667 SDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDS 726
            D++S G +  E+      + P    +  + ++   +   T   E     T     KP  
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 727 LNK---------------FVEIAEKCLAQCGIDRPSMGDVL 752
           +                   ++ +  L    + R S  + L
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 1e-38
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 11/206 (5%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           ++F    ++G G FGKV            A+K   +    +   +A   TE  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
             L +L       + +  + EY   G L  HL  S     +  +           L YLH
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLH 122

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +   + +++RD+K  N++LD++   K+ DFGL K G     T       G+  YL PE L
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVL 177

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRP 684
                    D +  GVVM+E++CGR 
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 3e-38
 Identities = 60/292 (20%), Positives = 119/292 (40%), Gaps = 34/292 (11%)

Query: 490 VIGIGGFGKVYRGVLR-DETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            IG G FG+V++   R    KVA+K      +          EI++L   +H ++V+LI 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 547 YCDE--------RNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
            C          +  + +++++ E+             +LS  KR  +      GL+Y+H
Sbjct: 77  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQMLLNGLYYIH 134

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVS--TAVKGSFGYLDPE 656
                 I+HRD+K+AN+L+  + + K+ADFGL++       +  +  T    +  Y  PE
Sbjct: 135 RNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 657 YLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD 715
            L  ++      D++  G +M E+    P++  +  + ++ L+             ++ +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 716 PTLTGQIKPDSLNK---------------FVEIAEKCLAQCGIDRPSMGDVL 752
             L  +++     K                +++ +K L      R    D L
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 5e-37
 Identities = 61/287 (21%), Positives = 110/287 (38%), Gaps = 36/287 (12%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            +G G +G V   V  R   KVA+K      QS         E+ +L   RH +++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 547 YC------DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
                   D+  +  ++  +M  GT    L       L   +   +     +GL Y+H  
Sbjct: 85  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHA- 139

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
               IIHRD+K  N+ ++E+   K+ DFGL++       + ++  V   +       L  
Sbjct: 140 --AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILNW 193

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP---------------VIDPSLPREKVNLVEWAMKCQ 705
            + T+  D++S G +M E++ G+                 +  + P E V  ++      
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 253

Query: 706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
               L ++        I  ++    V + EK L      R + G+ L
Sbjct: 254 YMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (353), Expect = 6e-37
 Identities = 48/227 (21%), Positives = 87/227 (38%), Gaps = 17/227 (7%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVK---RGGTQSHQGLAEFRTEIEMLSQFRH 538
           D F     +G G FG+V            A+K   +      + +     E  +L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 539 RHLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
             LV L     + + + ++ EY+  G +  HL        S                YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 599 TGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYL 658
           +     +I+RD+K  N+L+D+    +V DFG +K       T     + G+   L PE +
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210

Query: 659 TKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ 705
             +   +  D ++ GV+++E+  G P   P    + + + E  +  +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVSGK 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-32
 Identities = 58/279 (20%), Positives = 94/279 (33%), Gaps = 32/279 (11%)

Query: 483 DNFSESLVIGIGGFGKVYRGVL----RDETKVAVK----RGGTQSHQGLAEFRTEIEMLS 534
           +NF    V+G G +GKV+              A+K        Q  +     RTE ++L 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 535 QFRHR-HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARG 593
             R    LV+L        ++ +I +Y+  G L  HL      +        + I     
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138

Query: 594 LHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
           +  L       II+RD+K  NILLD N    + DFGLSK     +               
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198

Query: 654 DPEYLTKQQ-LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED 712
                       +  D +S GV+M+E+L G         +                   +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---------------SQAE 243

Query: 713 IVDPTLTGQIK-PDSLNK-FVEIAEKCLAQCGIDRPSMG 749
           I    L  +   P  ++    ++ ++ L +    R   G
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 3e-31
 Identities = 57/295 (19%), Positives = 109/295 (36%), Gaps = 32/295 (10%)

Query: 480 EATDNFSESLVIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQF 536
           E  + +     +G G +G V      +   +VAVK      QS         E+ +L   
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 537 RHRHLVSLIGYCDERN-----EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAA 591
           +H +++ L+              + +  ++      D         L+      +     
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHVQFLIYQIL 131

Query: 592 RGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFG 651
           RGL Y+H+     IIHRD+K +N+ ++E+   K+ DFGL++   D    +V+T     + 
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WY 184

Query: 652 YLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE 711
                 L      +  D++S G +M E+L GR +   +   +++ L+   +       L+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 712 DIVDPTLTGQIK--------------PDSLNKFVEIAEKCLAQCGIDRPSMGDVL 752
            I   +    I+                +    V++ EK L      R +    L
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-30
 Identities = 43/204 (21%), Positives = 84/204 (41%), Gaps = 20/204 (9%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVK--RGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIG 546
            IG G  G V        +  VA+K      Q+         E+ ++    H++++SL+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 547 YC------DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG 600
                   +E  ++ ++ E M+    +          L   +   +      G+ +LH+ 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHS- 137

Query: 601 STKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTK 660
               IIHRD+K +NI++  +   K+ DFGL++       + + T    +  Y  PE +  
Sbjct: 138 --AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 192

Query: 661 QQLTEKSDVYSFGVVMFEILCGRP 684
               E  D++S G +M E++  + 
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKI 216

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  120 bits (302), Expect = 2e-30
 Identities = 40/213 (18%), Positives = 86/213 (40%), Gaps = 20/213 (9%)

Query: 483 DNFSESLVIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRH 540
           D++     +G G + +V+  + + +  KV VK           + + EI++L   R   +
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91

Query: 541 LVSLIGYCDERNE--MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLH 598
           +++L     +       +++E++ N   K         +L+            + L Y H
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH 146

Query: 599 TGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEY 657
           +     I+HRDVK  N+++D E+   ++ D+GL++                S  +  PE 
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPEL 200

Query: 658 LTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPS 689
           L   Q+     D++S G ++  ++  +      
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  109 bits (273), Expect = 2e-26
 Identities = 39/233 (16%), Positives = 82/233 (35%), Gaps = 19/233 (8%)

Query: 490 VIGIGGFGKVYRGV-LRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH---------- 538
            +G G F  V+    + + T VA+K               EI++L +             
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 539 -RHLVSLIGYCDERNE---MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGL 594
             H++ L+ + + +      +++   +    L   +       +      +I      GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 595 HYLHTGSTKAIIHRDVKSANILLD-ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYL 653
            Y+H      IIH D+K  N+L++  +    +    ++ +G         T    +  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 654 DPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQE 706
            PE L        +D++S   ++FE++ G  + +P          +   +  E
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 84.1 bits (207), Expect = 3e-19
 Identities = 27/153 (17%), Positives = 49/153 (32%), Gaps = 19/153 (12%)

Query: 490 VIGIGGFGKVYRGVLRDETKVAVK--RGGTQS--------HQGLAEFRTEIEMLSQFRHR 539
           ++G G    V+        +  VK  + G  S          G   F       ++   R
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 540 HLVSLIGYCDERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT 599
            L  L G       +  +Y +  N  L + + A     +      E+       +   + 
Sbjct: 67  ALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120

Query: 600 GSTKAIIHRDVKSANILLDENLMAKVADFGLSK 632
              + I+H D+   N+L+ E     + DF  S 
Sbjct: 121 --HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	820
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.35
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.86
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.22
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.0
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.94
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	94.92
d2o14a1	146	Hypothetical protein YxiM {Bacillus subtilis [TaxI	91.79

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=415.78  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=203.5

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|+..+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            4688889999999999999999888899999987543 335789999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++.... ..++|..++.|+.|+|.||+|||   +++|+||||||+|||+++++.+||+|||+++....... ..
T Consensus        84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS  158 (263)
T ss_dssp             TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence            999999987543 46899999999999999999999   78999999999999999999999999999986544222 22


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcC-CCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCG-RPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....||..|+|||++.+..++.++|||||||++|||+|+ ++|+......+   +.+.+..    +.         ...
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~----~~---------~~~  222 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDIST----GF---------RLY  222 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHH----TC---------CCC
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHh----cC---------CCC
Confidence            3345789999999999999999999999999999999995 55554332222   2221111    10         011


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .+..++.++.+++.+||+.||++||+|.||+++|+++.+
T Consensus       223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            223455788999999999999999999999999998865

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=417.24  Aligned_cols=260  Identities=29%  Similarity=0.519  Sum_probs=206.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||+||+|++++  .||||++...  .....+.|.+|+++|++++||||++++|++.+ +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            568888899999999999998754  5999987543  45567889999999999999999999999865 568999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.+++.... ..++|.+++.|+.|+|+||+|||   +++|+||||||+||||++++.+||+|||+|+........
T Consensus        85 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          85 CEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999997544 46999999999999999999999   689999999999999999999999999999876544344


Q ss_pred             cccccccCCccccCccccccC---CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ---QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .......||+.|||||++.+.   .++.++|||||||+||||+||+.||......+...  ..+.....        .|.
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~--------~p~  230 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYL--------SPD  230 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTSC--------CCC
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCCC--------CCc
Confidence            444567899999999999643   57899999999999999999999997654332211  11111111        111


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      + ......+++.+.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus       231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1 12334566789999999999999999999999999998765

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-49  Score=420.53  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=202.2

Q ss_pred             CCccceeEeeecceEEEEEEEcC-c---cEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRD-E---TKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~-~---~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      +|+..++||+|+||+||+|++.. +   ..||||++... .....++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            34556799999999999999753 2   35889987643 4555678999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      |||++|+|.+++.... ..++|.++++|+.|+|+||+|||   +++|+||||||+||||+.++.+||+|||+++......
T Consensus       107 Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         107 EFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             ECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999887543 46999999999999999999999   7899999999999999999999999999998654422


Q ss_pred             Ccc---ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          639 QTH---VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       639 ~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ...   ......||+.|||||.+.++.++.++|||||||+||||+| |++||......+.   ...+.    .+.     
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~---~~~i~----~~~-----  250 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---INAIE----QDY-----  250 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH----TTC-----
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH---HHHHH----cCC-----
Confidence            211   1123457899999999999999999999999999999998 8999875543322   22111    110     


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                          ....+.+++..+.+|+.+||+.||++||+|.||++.|+++++.
T Consensus       251 ----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                1123345678899999999999999999999999999988764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=414.58  Aligned_cols=256  Identities=29%  Similarity=0.424  Sum_probs=211.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|+..++||+|+||.||+|++++++.||||++.... ...++|.+|+++|++++||||++++|+|.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            4688889999999999999999988999999986543 345789999999999999999999998865 56789999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++.......++|.++++|+.|+|+||+|||   +++|+||||||+||||++++.+||+|||+|+..... ....
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~  166 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTA  166 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEEC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-cccc
Confidence            999999887655556999999999999999999999   689999999999999999999999999999876542 2233


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCC-CCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPV-IDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....||+.|+|||++.+..++.++|||||||++|||+||..| +......+   +...+.    .+.         ...
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~----~~~---------~~~  230 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLE----RGY---------RMV  230 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHH----TTC---------CCC
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----hcC---------CCC
Confidence            3456799999999999999999999999999999999996554 44332221   111111    110         111


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .+..++.++.+|+.+||+.+|++||||.||++.|+....
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            233456789999999999999999999999999988654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-49  Score=419.61  Aligned_cols=259  Identities=29%  Similarity=0.430  Sum_probs=216.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEcC-ccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...++||+|+||+||+|++.+ ++.||||++.... ...++|.+|+++|++++||||++++|+|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            4568888999999999999999874 7889999986543 3457899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.+++.......++|..++.|+.|+|.||+|||   +++|+||||||+||||++++.+||+|||+++..... ..
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~  170 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TY  170 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-SS
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-Cc
Confidence            99999999998877778999999999999999999999   689999999999999999999999999999875442 22


Q ss_pred             cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      .......|+..|+|||++.+..++.++|||||||++|||++|+.|+........  +.+.+    ..+         ...
T Consensus       171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i----~~~---------~~~  235 (287)
T d1opja_         171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----EKD---------YRM  235 (287)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----HTT---------CCC
T ss_pred             eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH----hcC---------CCC
Confidence            333445689999999999999999999999999999999997766543332221  11111    111         112


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+..++.++.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2344566789999999999999999999999999987643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=401.00  Aligned_cols=253  Identities=28%  Similarity=0.419  Sum_probs=212.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|+..++||+|+||+||+|++++++.||||++..... ..++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57888999999999999999998888999998765433 34789999999999999999999999999999999999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|.+++.... ..+++..+++++.|+|+||+|||   +.+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS  157 (258)
T ss_dssp             TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred             CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence            999999976543 46899999999999999999999   6899999999999999999999999999998654432 223


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....||..|+|||.+.+..++.++|||||||++|||+| |+.||......+...      . ...+.         ...
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~------~-i~~~~---------~~~  221 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------H-IAQGL---------RLY  221 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH------H-HHTTC---------CCC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH------H-HHhCC---------CCC
Confidence            344679999999999999999999999999999999998 788987654333211      1 11111         112


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEY  757 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~  757 (820)
                      .+..++.++.+++.+||+.+|++|||+.+++++|.+
T Consensus       222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            233455789999999999999999999999998853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=405.75  Aligned_cols=260  Identities=29%  Similarity=0.472  Sum_probs=205.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcCc-----cEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDE-----TKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~-----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      +.|+..++||+|+||.||+|+++..     ..||||++... ......+|.+|+++|++++||||++++|+|.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4578888999999999999997642     46999987644 34455689999999999999999999999999999999


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      |+||+++|+|.+++.... ..++|.++++++.|++.||+|||   +++|+||||||+||||+.++.+||+|||+++....
T Consensus        87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999998876543 46999999999999999999999   78999999999999999999999999999986544


Q ss_pred             CCC-ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQ-THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ... ........||..|||||++.++.++.++|||||||++|||++|..|+.......  .+.+.+.    .+       
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~~i~----~~-------  229 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIN----DG-------  229 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHH----TT-------
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHHHHh----cc-------
Confidence            222 222334568999999999999999999999999999999999765544332221  1122111    11       


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                        .....+..++..+.+|+.+||+.+|++||+|.||++.|+.+++.
T Consensus       230 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         230 --FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             --CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence              11223445667899999999999999999999999999988764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-48  Score=407.52  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=204.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|+..++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56899999999999999999986 58899999875433 23346789999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +++|+|.++|...  ..+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus        85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999999998643  46999999999999999999999   789999999999999999999999999999876543333


Q ss_pred             cccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      .......||+.|||||++.+..+ +.++|||||||++|||++|++||......... ...+    ......         
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~----~~~~~~---------  225 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW----KEKKTY---------  225 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH----HTTCTT---------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH----hcCCCC---------
Confidence            44456789999999999988776 67899999999999999999999754332211 1111    111100         


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      .........++.+++.+||+.||++|||+.|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0111234467889999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-47  Score=404.16  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=210.9

Q ss_pred             cCCccce-eEeeecceEEEEEEEc---CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESL-VIGIGGFGKVYRGVLR---DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~-~LG~G~fG~Vykg~~~---~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      +++...+ +||+|+||.||+|.++   ++..||||++... .....++|.+|+++|++++||||++++|+|.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4455666 4999999999999864   3457999987654 34557889999999999999999999999965 468999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      ||||++|+|.+++...+ ..+++.++++++.|+|.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999886443 46999999999999999999999   789999999999999999999999999999876543


Q ss_pred             CCc-cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          638 DQT-HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       638 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ... .......||+.|+|||++.+..++.++|||||||++|||+| |++||......+.   ...    ...+..     
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~~----i~~~~~-----  230 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAF----IEQGKR-----  230 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHH----HHTTCC-----
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcCCC-----
Confidence            322 22334568999999999999999999999999999999998 8999976543322   111    112211     


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                          ...++.++.++.+|+.+||+.+|++||++.+|++.|+....
T Consensus       231 ----~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         231 ----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             ----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                12344566789999999999999999999999999988764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=402.16  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=203.1

Q ss_pred             eeEeeecceEEEEEEEcC---ccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeeccC
Q 003436          489 LVIGIGGFGKVYRGVLRD---ETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYMEN  563 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~---~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~  563 (820)
                      ++||+|+||+||+|.+.+   ++.||||++...  +....++|.+|+++|++++||||++++|+|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998753   468999987543  23345789999999999999999999999965 457899999999


Q ss_pred             CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc-cc
Q 003436          564 GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT-HV  642 (820)
Q Consensus       564 gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~  642 (820)
                      |+|.+++....  .++|.++++|+.|+|.||+|||   +++|+||||||+||||+.++.+||+|||+++........ ..
T Consensus        92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999997653  6999999999999999999999   689999999999999999999999999999875543222 22


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      .....||+.|||||.+.+..++.++|||||||++|||+| |++||......+.   ...+    ..+.         ...
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~~i----~~~~---------~~~  230 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAML----EKGE---------RMG  230 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHH----HTTC---------CCC
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HHHH----HcCC---------CCC
Confidence            334578999999999999999999999999999999998 8999976543322   1111    1111         112


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .+..++.++.+|+.+||+.||++||++.+|++.|+....
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            334566789999999999999999999999999887653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=400.29  Aligned_cols=246  Identities=27%  Similarity=0.409  Sum_probs=207.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46889999999999999999986 5789999986532   1233567899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            9999999999997654  6999999999999999999999   789999999999999999999999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                         ......||+.|||||++.+..++.++|||||||+||||++|++||......+....       .....         
T Consensus       160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~-------i~~~~---------  220 (263)
T d2j4za1         160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-------ISRVE---------  220 (263)
T ss_dssp             ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------HHTTC---------
T ss_pred             ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCC---------
Confidence               22346799999999999999999999999999999999999999976543322111       11111         


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ..++...++++.+++.+||+.||++|||+.|++++
T Consensus       221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence             11233455778999999999999999999999863

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=412.97  Aligned_cols=256  Identities=25%  Similarity=0.383  Sum_probs=208.8

Q ss_pred             cCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  554 (820)
                      ++|+..++||+|+||+||+|++..      ...||||++... .......|.+|+.+|.++ +|||||+++++|.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            568889999999999999999753      236899986543 334456789999999998 899999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCC---------------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCC
Q 003436          555 IIIYEYMENGTLKDHLYASNF---------------------PSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSA  613 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~  613 (820)
                      ++|||||++|+|.++|.....                     ..++|.+++.++.|++.||+|||   +++|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            999999999999999976432                     35899999999999999999999   689999999999


Q ss_pred             cEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCch
Q 003436          614 NILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPR  692 (820)
Q Consensus       614 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~  692 (820)
                      |||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |++||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986554433334445678999999999999999999999999999999998 89999754433


Q ss_pred             hhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHH
Q 003436          693 EKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLE  756 (820)
Q Consensus       693 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~  756 (820)
                      +..  ...    .+.+         .....+..++.++.+|+.+||+.+|++|||+.||+++|.
T Consensus       274 ~~~--~~~----~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ANF--YKL----IQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHH--HHH----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH--HHH----HhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            221  111    1111         111234456678999999999999999999999999985

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-47  Score=403.04  Aligned_cols=250  Identities=23%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      ++|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++||||+++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46999999999999999999975 58899999876554455678999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++...   .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+......  .
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~  171 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence            999999988654   5899999999999999999999   7899999999999999999999999999998654322  2


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQ  721 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  721 (820)
                      ......||+.|+|||++.+..++.++|||||||++|||++|++||......+...      .....+.      +.  -.
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~------~~--~~  237 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------PE--LQ  237 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS------CC--CS
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC------CC--CC
Confidence            2345679999999999999999999999999999999999999997554332211      1111111      00  11


Q ss_pred             CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          722 IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       722 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+......+.+++.+||+.||.+||++.|++++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            223455778999999999999999999998753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=403.55  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=206.1

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeecc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYME  562 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~  562 (820)
                      ++|+..+.||+|+||.||+|++++++.||||++.... ...+.|.+|+.+|++++||||++++|+|.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4688999999999999999999988899999986543 345789999999999999999999999965 56789999999


Q ss_pred             CCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCccc
Q 003436          563 NGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTHV  642 (820)
Q Consensus       563 ~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  642 (820)
                      +|+|..++.......++|.+++.|+.|+|.||+|||   ..+|+||||||+||||++++.+||+|||+++...... ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTA  170 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-cee
Confidence            999999988765567999999999999999999999   6899999999999999999999999999998654322 223


Q ss_pred             cccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccCCC
Q 003436          643 STAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTGQI  722 (820)
Q Consensus       643 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  722 (820)
                      .....||+.|+|||++.++.++.++|||||||++|||+||..|+.......  .....+..    +         .....
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i~~----~---------~~~~~  235 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVER----G---------YRMPC  235 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT----T---------CCCCC
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHh----c---------CCCCC
Confidence            344678999999999999999999999999999999999765544332221  11222111    1         11123


Q ss_pred             ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          723 KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       723 ~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      +..+++++.+++.+||+.||++||+|.+|++.|+....
T Consensus       236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence            44566789999999999999999999999998887543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-47  Score=400.26  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=195.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec--CceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--RNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--~~~~~lV  557 (820)
                      ++|+..+.||+|+||.||+|+.. +|+.||||.+...  .....+.+.+|+++|++++||||+++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999976 5889999987544  34456779999999999999999999999854  4568999


Q ss_pred             EeeccCCchhhHhhhc--CCCCCCHHHHHHHHHHHHHHhhhhhcCC--CCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          558 YEYMENGTLKDHLYAS--NFPSLSWRKRLEICIGAARGLHYLHTGS--TKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~--~~~~l~~~~~l~i~~~ia~gL~yLH~~~--~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      |||+++|+|.+++...  ....+++.+++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998642  3457999999999999999999999521  23599999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ....  ........||+.|||||++.+..++.++|||||||++|||+||++||......+.   ...    ...+...  
T Consensus       164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~~----i~~~~~~--  232 (269)
T d2java1         164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGK----IREGKFR--  232 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHH----HHHTCCC--
T ss_pred             cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HHH----HHcCCCC--
Confidence            5432  2223456799999999999999999999999999999999999999975443221   111    1112111  


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                             ..+...+.++.+++.+||+.||.+|||+.|+++
T Consensus       233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   122344567899999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-47  Score=404.91  Aligned_cols=261  Identities=27%  Similarity=0.423  Sum_probs=214.8

Q ss_pred             HHhcCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc
Q 003436          480 EATDNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN  552 (820)
Q Consensus       480 ~at~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~  552 (820)
                      -..++|+..+.||+|+||+||+|++.      +++.||||++.... ....++|.+|+++|++++||||++++++|...+
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            34567999999999999999999975      35789999987544 344678999999999999999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcC----------------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccC
Q 003436          553 EMIIIYEYMENGTLKDHLYASN----------------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDV  610 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDI  610 (820)
                      ..++|+||+++|+|.++|....                      ...++|.+++.|+.|+|.||+|||   +++||||||
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDl  166 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  166 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEE
Confidence            9999999999999999996432                      235899999999999999999999   789999999


Q ss_pred             CCCcEEEcCCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCC-CCCCCC
Q 003436          611 KSANILLDENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-PVIDPS  689 (820)
Q Consensus       611 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~-~p~~~~  689 (820)
                      ||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +|+...
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            9999999999999999999998654433334445567899999999999999999999999999999999996 566654


Q ss_pred             CchhhhhHHHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHH
Q 003436          690 LPREKVNLVEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYAL  759 (820)
Q Consensus       690 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~  759 (820)
                      ...+..   ..+    ..+...         ..+..++.++.+|+.+||+.+|++||||.||++.|+++.
T Consensus       247 ~~~e~~---~~v----~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         247 AHEEVI---YYV----RDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CHHHHH---HHH----HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CHHHHH---HHH----HcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            433322   211    122111         223455678999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=400.42  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=208.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~  561 (820)
                      +.|+..+.||+|+||.||+|+.. +++.||||++........+.|.+|+++|++++||||+++++++.+.+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45888899999999999999976 57899999987666666788999999999999999999999999999999999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.+++.... ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+....  ...
T Consensus        92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~  165 (288)
T d2jfla1          92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQ  165 (288)
T ss_dssp             TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH--HHH
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC--Ccc
Confidence            9999999886543 36999999999999999999999   78999999999999999999999999999975322  111


Q ss_pred             ccccccCCccccCccccc-----cCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          642 VSTAVKGSFGYLDPEYLT-----KQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      ......||+.|+|||++.     +..++.++|||||||++|||+||++||....+.+...   .+.   . +....    
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---~i~---~-~~~~~----  234 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---KIA---K-SEPPT----  234 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHH---H-SCCCC----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---HHH---c-CCCCC----
Confidence            233567999999999984     4568999999999999999999999997654433221   111   1 11111    


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         ...+...+.++.+++.+||+.||.+|||+.|++++
T Consensus       235 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         235 ---LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             ---CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               11223455788999999999999999999998763

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=394.59  Aligned_cols=251  Identities=29%  Similarity=0.429  Sum_probs=202.3

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-CceEEEEEeec
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-RNEMIIIYEYM  561 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~  561 (820)
                      ++|+..++||+|+||.||+|+++ +..||||+++...  ..++|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45778889999999999999985 6789999986543  34789999999999999999999999854 46789999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCcc
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQTH  641 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  641 (820)
                      ++|+|.++|.......++|..+++|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....     
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----  155 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----  155 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC-----
Confidence            9999999997665456899999999999999999999   78999999999999999999999999999985432     


Q ss_pred             ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCccccC
Q 003436          642 VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLTG  720 (820)
Q Consensus       642 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  720 (820)
                      ......+|..|+|||++.+..++.++|||||||++|||+| |++|+......+   +..++.    .+         ...
T Consensus       156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~----~~---------~~~  219 (262)
T d1byga_         156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KG---------YKM  219 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT----TT---------CCC
T ss_pred             CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cC---------CCC
Confidence            1233468899999999999999999999999999999998 678776543332   222221    11         112


Q ss_pred             CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          721 QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       721 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      ..+..++.++.+|+.+||+.||.+||||.+++++|+++..
T Consensus       220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            2344556789999999999999999999999999988754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=392.42  Aligned_cols=244  Identities=26%  Similarity=0.432  Sum_probs=195.9

Q ss_pred             ccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec----CceEEEEE
Q 003436          486 SESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE----RNEMIIIY  558 (820)
Q Consensus       486 ~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~  558 (820)
                      +..++||+|+||+||+|++. +++.||+|++...  .....+.|.+|+++|++++||||+++++++..    +..+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            44568999999999999986 4788999986533  34556789999999999999999999999854    45689999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCc--EEeccCCCCcEEEc-CCCCeeEeeccccccCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKA--IIHRDVKSANILLD-ENLMAKVADFGLSKIGP  635 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~--iiHrDIkp~NIll~-~~~~~kl~DFGla~~~~  635 (820)
                      ||+++|+|.+++....  .+++.++..++.|++.||+|||   +++  |+||||||+|||++ +++.+||+|||+++...
T Consensus        92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999997653  6899999999999999999999   555  99999999999996 57899999999998643


Q ss_pred             CCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      .    .......||+.|||||++.+ .++.++|||||||++|||++|+.||......+.  +..   . ...+...    
T Consensus       167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~---~-i~~~~~~----  231 (270)
T d1t4ha_         167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR---R-VTSGVKP----  231 (270)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH---H-HTTTCCC----
T ss_pred             C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH---H-HHcCCCC----
Confidence            2    22345679999999999865 599999999999999999999999965432221  111   1 1111111    


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      +    ..+.....++.+++.+||+.||++|||+.|+++
T Consensus       232 ~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1    112233456889999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-46  Score=399.94  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=207.1

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc----EEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET----KVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l  556 (820)
                      .+|+..++||+|+||+||+|++.. |+    +||+|++... .....++|.+|+++|++++||||++++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358999999999999999999753 33    6899987543 345578899999999999999999999999875 5678


Q ss_pred             EEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCC
Q 003436          557 IYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~  636 (820)
                      ++||+.+|+|.+++... ...+++..+++++.|+|.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999988765 356999999999999999999999   68999999999999999999999999999997655


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccC
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD  715 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  715 (820)
                      ...........||..|+|||++.++.++.++|||||||+||||+| |++||......+....+   .    .+.      
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~----~~~------  230 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---E----KGE------  230 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---H----HTC------
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---H----cCC------
Confidence            444444445678999999999999999999999999999999998 78888765443322211   1    111      


Q ss_pred             ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          716 PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       716 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                         ....++.++..+.+|+.+||+.+|.+||++.|+++.|+.+..
T Consensus       231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence               112334566789999999999999999999999999988754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=399.11  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=205.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..++||+|+||+||+|+.. +++.||||.+...   .....+.+.+|+++|++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999985 5889999986532   1233567999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+++|+|.+++...+  .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+......
T Consensus        88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999987654  6999999999999999999999   7899999999999999999999999999998765433


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                      .........||+.|+|||++.+..++.++|||||||++|||++|++||......+..   ..+    ..+..        
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~---~~i----~~~~~--------  227 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF---QKI----IKLEY--------  227 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HTTCC--------
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH---HHH----HcCCC--------
Confidence            334445567999999999999999999999999999999999999999765432221   111    11111        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        .++.....++.+|+.+||+.||.+|||+.|++..
T Consensus       228 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 --DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             --CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence              1233445678999999999999999999997654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-46  Score=405.37  Aligned_cols=265  Identities=23%  Similarity=0.342  Sum_probs=205.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .++|+..++||+|+||+||+|+.. +++.||+|++... .....+++.+|+++|++++||||++++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999976 5789999987544 33445789999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ||++|+|.+++.+..  .+++..+..++.|++.||+|||+  .++|+||||||+|||+++++.+||+|||+|+....   
T Consensus        85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  157 (322)
T ss_dssp             CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred             cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---
Confidence            999999999997654  59999999999999999999993  24899999999999999999999999999985422   


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHH-HHHh--------hccC--
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW-AMKC--------QETG--  708 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~-~~~~--------~~~~--  708 (820)
                       .......||+.|+|||++.+..++.++||||+||+++||++|+.||......+....... ....        ....  
T Consensus       158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence             223356899999999999999999999999999999999999999976543221100000 0000        0000  


Q ss_pred             ------------cccc----ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 ------------QLED----IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ------------~~~~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                  ...+    +...............++.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                        0000    000000000011234678899999999999999999999885

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=390.04  Aligned_cols=257  Identities=28%  Similarity=0.393  Sum_probs=201.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|+..+.||+|+||.||+|++..    +..||||.+... .....+.|.+|+++|++++||||++++|+|.+ +..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence            568888999999999999998753    356889987644 34456789999999999999999999999964 678999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      |||+++|+|.+++.... ..+++.+++.++.|+++||+|||   +++|+||||||+||++++++.+||+|||+++.....
T Consensus        86 ~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999876543 46899999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                       .........||+.|+|||++.+..++.++|||||||++|||+| |++|+......+..   ..+.    .+..      
T Consensus       162 -~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~~i~----~~~~------  227 (273)
T d1mp8a_         162 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIE----NGER------  227 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHH----TTCC------
T ss_pred             -cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---HHHH----cCCC------
Confidence             2223345678999999999999999999999999999999998 88998765543322   2111    1111      


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                         ...++.++..+.+|+.+||+.||++|||+.||++.|+.+++.
T Consensus       228 ---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         228 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               123345667899999999999999999999999999988764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.6e-45  Score=399.50  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=210.9

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+++|++++||||+++++++.+++..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 5889999998877777778899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc--CCCCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD--ENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~--~~~~~kl~DFGla~~~~~~~  638 (820)
                      |++|+|.+++.... ..+++.++..|+.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+++..... 
T Consensus       105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            99999999986543 36999999999999999999999   78999999999999995  4688999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......||+.|||||++.+..++.++|||||||++|||++|+.||......+....   +...  ....        
T Consensus       180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~---i~~~--~~~~--------  244 (350)
T d1koaa2         180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN---VKSC--DWNM--------  244 (350)
T ss_dssp             --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHT--CCCS--------
T ss_pred             --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHhC--CCCC--------
Confidence              223456799999999999999999999999999999999999999975543322211   1110  1011        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...........+.+++.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111112345678999999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-45  Score=393.63  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=203.9

Q ss_pred             cCCccceeEeeecceEEEEEEEcC------ccEEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecC-ce
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD------ETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDER-NE  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~------~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~-~~  553 (820)
                      ++|...++||+|+||.||+|++..      ++.||||++... .....+.+..|..++.++ +|+||+.+++++.+. ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            568889999999999999999642      468999997643 344567788898888877 689999999998654 56


Q ss_pred             EEEEEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC
Q 003436          554 MIIIYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE  619 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~  619 (820)
                      .++|||||++|+|.++|....              ...++|.+++.++.|++.||+|||   +++|+||||||+||||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECC
Confidence            899999999999999997542              235899999999999999999999   789999999999999999


Q ss_pred             CCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCC-CCCCCCCchhhhhHH
Q 003436          620 NLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLV  698 (820)
Q Consensus       620 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~-~p~~~~~~~~~~~l~  698 (820)
                      ++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. +||......+.  +.
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~  247 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC  247 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence            9999999999998765544444445678999999999999999999999999999999999975 56754432221  11


Q ss_pred             HHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          699 EWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       699 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                          .....+..         ...+..++.++.+++.+||+.||++|||+.|++++|+.+++.
T Consensus       248 ----~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         248 ----RRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             ----HHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                11111111         122344567899999999999999999999999999998764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-46  Score=397.95  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=192.4

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .+.|+..++||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466899999999999999999986 57899999875433 2234568899999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeeccccccCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPD  636 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFGla~~~~~  636 (820)
                      ||++|+|.++|...  ..+++.++..++.|++.||+|||   +++|+||||||+|||+.   +++.+||+|||+++....
T Consensus        88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999764  36999999999999999999999   78999999999999994   578999999999986433


Q ss_pred             CCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          637 LDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       637 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                      .   .......||+.|||||++.+..++.++|||||||++|||++|++||......+.   ...+.    .+.      .
T Consensus       163 ~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i~----~~~------~  226 (307)
T d1a06a_         163 G---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FEQIL----KAE------Y  226 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH----TTC------C
T ss_pred             C---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHh----ccC------C
Confidence            2   223346799999999999999999999999999999999999999975433221   11111    111      1


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..........+.++.+++.+||+.||.+|||+.|++++
T Consensus       227 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         227 EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11112233455778999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-45  Score=394.97  Aligned_cols=245  Identities=26%  Similarity=0.375  Sum_probs=201.9

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      .|+..+.||+|+||.||+|+.. +++.||||++....   ....+.|.+|+++|++++||||+++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4889999999999999999975 57889999865432   3445779999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ||++|+|..++...  ..+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+....   
T Consensus        96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            99999997766544  36999999999999999999999   78999999999999999999999999999985432   


Q ss_pred             ccccccccCCccccCcccccc---CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCc
Q 003436          640 THVSTAVKGSFGYLDPEYLTK---QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDP  716 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  716 (820)
                         .....||+.|||||++.+   ..++.++|||||||++|||++|++||......+..      ..... +..     +
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~-~~~-----~  232 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NES-----P  232 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SCC-----C
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-CCC-----C
Confidence               234579999999999864   46899999999999999999999999754332211      11111 111     1


Q ss_pred             cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          717 TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       717 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      .+   .....++.+.+++.+||+.||.+|||+.|++++
T Consensus       233 ~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         233 AL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            11   122345678999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=389.96  Aligned_cols=260  Identities=28%  Similarity=0.458  Sum_probs=211.4

Q ss_pred             cCCccceeEeeecceEEEEEEEcC--------ccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCc
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD--------ETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERN  552 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~--------~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~  552 (820)
                      ++|...+.||+|+||.||+|+...        +..||||++.... .....++.+|...+.++ +||||++++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            458888999999999999998642        3479999986554 34567899999999888 8999999999999999


Q ss_pred             eEEEEEeeccCCchhhHhhhcC--------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc
Q 003436          553 EMIIIYEYMENGTLKDHLYASN--------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD  618 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~  618 (820)
                      ..++||||+++|+|.++|....              ...+++.++++++.|+|.||+|||   +.+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            9999999999999999997543              246899999999999999999999   78999999999999999


Q ss_pred             CCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhH
Q 003436          619 ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNL  697 (820)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l  697 (820)
                      .++.+||+|||+++...............+|+.|+|||.+.++.++.++|||||||++|||++ |++||......+.   
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~---  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH---
Confidence            999999999999987655444444556679999999999999999999999999999999998 6788865443221   


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      .+.    ...+.         ....+..++.++.+|+.+||+.||.+|||+.||++.|++++.+
T Consensus       247 ~~~----i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         247 FKL----LKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHH----HHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH----HHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            111    11111         1122334567899999999999999999999999999998765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=387.40  Aligned_cols=256  Identities=25%  Similarity=0.355  Sum_probs=200.1

Q ss_pred             cCCccceeEeeecceEEEEEEEcC----ccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD----ETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~----~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|+..+.||+|+||.||+|++..    ...||||++...   .....++|.+|+++|++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            568889999999999999998753    247899987543   34456789999999999999999999999976 4678


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +||||+++|+|.+++.... ..+++..++.++.|+|.||+|||   +++|+||||||+||||+.++.+||+|||+++...
T Consensus        87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            9999999999999887543 35999999999999999999999   6899999999999999999999999999999765


Q ss_pred             CCCCcc-ccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhHHHHHHHhhccCccccc
Q 003436          636 DLDQTH-VSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNLVEWAMKCQETGQLEDI  713 (820)
Q Consensus       636 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  713 (820)
                      ...... ......|+..|+|||.+.+..++.++|||||||++|||+| |++||......+.   ..++.   +.+.    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i~---~~~~----  232 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKID---KEGE----  232 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHH---TSCC----
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHHHH---hCCC----
Confidence            433222 2334568889999999999999999999999999999998 8999875433322   22221   1111    


Q ss_pred             cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHH
Q 003436          714 VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYA  758 (820)
Q Consensus       714 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~  758 (820)
                           ....+...+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus       233 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 1122334557899999999999999999999999988765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.1e-45  Score=397.00  Aligned_cols=253  Identities=21%  Similarity=0.284  Sum_probs=211.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+++|++++||||+++++++.+++.+++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999975 5899999998776666677889999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc--CCCCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD--ENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~--~~~~~kl~DFGla~~~~~~~  638 (820)
                      |++|+|.+++... ...+++.++..|+.|++.||+|||   +.+|+||||||+||||+  .++.+||+|||+|+..... 
T Consensus       108 ~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         108 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             CCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            9999999877543 346999999999999999999999   78999999999999997  6789999999999875432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......||+.|+|||++.+..++.++|||||||++|||+||++||......+..   ..+..    +.      ...
T Consensus       183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~~i~~----~~------~~~  247 (352)
T d1koba_         183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL---QNVKR----CD------WEF  247 (352)
T ss_dssp             --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH----CC------CCC
T ss_pred             --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----CC------CCC
Confidence              2234567999999999999999999999999999999999999999765433221   11111    11      111


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ........+.++.+|+.+||+.||.+|||+.|++++
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112223455778999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-45  Score=391.89  Aligned_cols=261  Identities=24%  Similarity=0.367  Sum_probs=215.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~  554 (820)
                      ++|+..++||+|+||.||+|++.      .++.||||++.... .....+|.+|+.+++++ +||||++++|+|.+++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            56888899999999999999863      35789999987544 34556799999999999 699999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcC----------------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc
Q 003436          555 IIIYEYMENGTLKDHLYASN----------------FPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD  618 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~  618 (820)
                      ++|||||++|+|.+++....                ...+++.++++++.|+|+||+|||   +++++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            99999999999999997643                235899999999999999999999   78999999999999999


Q ss_pred             CCCCeeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhc-CCCCCCCCCchhhhhH
Q 003436          619 ENLMAKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILC-GRPVIDPSLPREKVNL  697 (820)
Q Consensus       619 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~Ellt-G~~p~~~~~~~~~~~l  697 (820)
                      .++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |++|+......+..  
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~--  257 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--  257 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            999999999999997665444445556789999999999999999999999999999999999 55555443332221  


Q ss_pred             HHHHHHhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          698 VEWAMKCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       698 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ...+.    .+         .....+...+..+.+|+.+||+.||++||+|.|++++|++.+..
T Consensus       258 ~~~i~----~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMIK----EG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHH----HT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHh----cC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            11111    11         11122334567899999999999999999999999999987654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=389.23  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=205.7

Q ss_pred             ceeEeeecceEEEEEEEcCc----cEEEEEeCCC-CChhhHHHHHHHHHHHHcCCCCceeeEEeEeec-CceEEEEEeec
Q 003436          488 SLVIGIGGFGKVYRGVLRDE----TKVAVKRGGT-QSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE-RNEMIIIYEYM  561 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~~----~~vavK~~~~-~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~-~~~~~lV~E~~  561 (820)
                      .++||+|+||+||+|++.++    ..||||++.. ......++|.+|+++|++++||||++++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            45899999999999997542    3589998764 455567889999999999999999999999865 56899999999


Q ss_pred             cCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC--
Q 003436          562 ENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ--  639 (820)
Q Consensus       562 ~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~--  639 (820)
                      ++|+|.+++... ...+++..+++++.|+|.||.|||   +.+|+||||||+||||++++.+||+|||+++.......  
T Consensus       112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            999999988754 346789999999999999999999   78999999999999999999999999999986544322  


Q ss_pred             ccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTLT  719 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  719 (820)
                      ........||..|+|||.+.+..++.++||||||+++|||+||+.|+......  ..+..++..    +..         
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~----g~~---------  252 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQ----GRR---------  252 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----TCC---------
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc----CCC---------
Confidence            22233467899999999999999999999999999999999988776543221  122222211    111         


Q ss_pred             CCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhh
Q 003436          720 GQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQL  761 (820)
Q Consensus       720 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~  761 (820)
                      ...+..++..+.+|+.+||+.||++||+|.||+++|+.+++.
T Consensus       253 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            112234567899999999999999999999999999988763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-45  Score=390.43  Aligned_cols=258  Identities=29%  Similarity=0.449  Sum_probs=207.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcC-cc--EEEEEeCCCC-ChhhHHHHHHHHHHHHcC-CCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRD-ET--KVAVKRGGTQ-SHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~-~~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|+..++||+|+||.||+|++++ +.  .||||++... .....++|.+|+++|+++ +||||++++|+|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            568888999999999999999864 33  5788876433 344567899999999999 799999999999999999999


Q ss_pred             EeeccCCchhhHhhhc--------------CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCe
Q 003436          558 YEYMENGTLKDHLYAS--------------NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMA  623 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~  623 (820)
                      |||+++|+|.++|+..              ....++|.++++++.|+|.||+|||   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999754              2357999999999999999999999   7899999999999999999999


Q ss_pred             eEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCC-CCCCCCCchhhhhHHHHHH
Q 003436          624 KVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAM  702 (820)
Q Consensus       624 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~-~p~~~~~~~~~~~l~~~~~  702 (820)
                      ||+|||+++.....   .......||..|+|||.+.+..++.++|||||||++|||++|. +|+......+   +.+.+ 
T Consensus       167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i-  239 (309)
T d1fvra_         167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL-  239 (309)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHG-
T ss_pred             EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHH-
Confidence            99999999854321   1122456899999999999999999999999999999999976 5665433222   11111 


Q ss_pred             HhhccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhc
Q 003436          703 KCQETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQ  762 (820)
Q Consensus       703 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~  762 (820)
                         ..+.         ....+..++.++.+|+.+||+.||++||+|.||++.|+.+++..
T Consensus       240 ---~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         240 ---PQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             ---GGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ---HhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence               1111         11233456678999999999999999999999999999987643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=386.78  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=206.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC------hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS------HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEM  554 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~  554 (820)
                      .+.|+..+.||+|+||+||+|+.. +|+.||||++....      ....+.|.+|+++|++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357899999999999999999985 58899999764321      22367899999999999999999999999999999


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC----CeeEeeccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL----MAKVADFGL  630 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~----~~kl~DFGl  630 (820)
                      ++|||||++|+|.+++....  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999997653  6999999999999999999999   78999999999999998776    599999999


Q ss_pred             cccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          631 SKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       631 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...   .+.    ....
T Consensus       164 a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~---~i~----~~~~  233 (293)
T d1jksa_         164 AHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA---NVS----AVNY  233 (293)
T ss_dssp             CEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH----TTCC
T ss_pred             hhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH---HHH----hcCC
Confidence            9865432   22345678999999999999999999999999999999999999997654332211   111    1110


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                            ..........+..+.+++.+||+.||.+|||+.|++++
T Consensus       234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00001112345678899999999999999999999863

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=389.07  Aligned_cols=259  Identities=26%  Similarity=0.398  Sum_probs=213.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc------CccEEEEEeCCCC-ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR------DETKVAVKRGGTQ-SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~------~~~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|...+.||+|+||.||+|.+.      .++.||||++... .......|.+|++++++++||||++++|+|..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            56788899999999999999874      3578999998654 3445567999999999999999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhc--------CCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEee
Q 003436          556 IIYEYMENGTLKDHLYAS--------NFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVAD  627 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~D  627 (820)
                      +||||+++|+|.+++...        ....++|..+++++.|+|+||+|||   .++|+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            999999999999998643        2245799999999999999999999   68999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCC-CCCCCCCchhhhhHHHHHHHhhc
Q 003436          628 FGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGR-PVIDPSLPREKVNLVEWAMKCQE  706 (820)
Q Consensus       628 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~-~p~~~~~~~~~~~l~~~~~~~~~  706 (820)
                      ||+++...............||+.|+|||.+.+..++.++||||||+++|||+||+ +|+......+..      ... .
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~------~~i-~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFV-M  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH------HHH-H
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH------HHH-H
Confidence            99998655444434445567899999999999999999999999999999999985 666543322221      111 1


Q ss_pred             cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHh
Q 003436          707 TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQ  760 (820)
Q Consensus       707 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~  760 (820)
                      .+...         ..+..++..+.+++.+||+.+|.+||||.+|++.|++.++
T Consensus       250 ~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             hCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11111         1233556789999999999999999999999999876543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-45  Score=390.59  Aligned_cols=269  Identities=25%  Similarity=0.355  Sum_probs=201.6

Q ss_pred             CCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHH--HHHHHHcCCCCceeeEEeEeecCc----eEEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRT--EIEMLSQFRHRHLVSLIGYCDERN----EMIII  557 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~--Ei~~l~~l~H~nIv~l~g~~~~~~----~~~lV  557 (820)
                      .|...++||+|+||.||+|++ +|+.||||++....   .+++..  |+..+.+++||||++++|+|.+.+    .+++|
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            456677999999999999997 47899999876433   234444  444556789999999999997643    68999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcC-----CCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTG-----STKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~-----~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ||||++|+|.++|+..   .++|.++++++.|+|.||+|||+.     ..++|+||||||+||||++++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999999864   599999999999999999999953     24799999999999999999999999999998


Q ss_pred             cCCCCCCc--cccccccCCccccCccccccC------CCCCcceeeehhhhHHHHhcCCCCCCCCCchhh----h----h
Q 003436          633 IGPDLDQT--HVSTAVKGSFGYLDPEYLTKQ------QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK----V----N  696 (820)
Q Consensus       633 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~----~----~  696 (820)
                      ........  .......||+.|+|||++.+.      .++.++|||||||+||||+||.+|+......+.    .    .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            65432221  123456799999999998764      367799999999999999999887643221110    0    0


Q ss_pred             HHHHHHHhhccCccccccCccccCCC-ChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          697 LVEWAMKCQETGQLEDIVDPTLTGQI-KPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       697 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      ..+........+.    .+|.+.... ..+.+..+.+|+.+||+.||++|||+.||++.|+++.+..+
T Consensus       237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            1111111111111    122221111 23456779999999999999999999999999998877654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.3e-44  Score=377.13  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=203.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc----e
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN----E  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~  553 (820)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+...   .....+.|.+|+++|++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            356899999999999999999975 6889999987543   3444668999999999999999999999986543    4


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++||||+++|+|.+++...+  .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++..+|+|||.++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            789999999999999887654  6999999999999999999999   78999999999999999999999999999875


Q ss_pred             CCCCC-CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          634 GPDLD-QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       634 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ..... .........||+.|+|||++.+..++.++|||||||++|||+||++||....+.+..      .........  
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~--  232 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI--  232 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC--
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCC--
Confidence            43322 222334567999999999999999999999999999999999999999755433221      111111111  


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCC-CHHHHHHHHHHH
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRP-SMGDVLWNLEYA  758 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~evl~~L~~~  758 (820)
                           ......+..+.++.+++.+||+.||.+|| ++.++++.|..+
T Consensus       233 -----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         233 -----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                 11112234557899999999999999999 899998888765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-44  Score=385.07  Aligned_cols=245  Identities=25%  Similarity=0.356  Sum_probs=205.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56899999999999999999985 5889999987532   2234577999999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      |||++|+|..++....  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999887654  5788899999999999999999   799999999999999999999999999999875432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          .....||+.|||||++.+..++.++|||||||+||||++|+.||......+....      .. .+.         
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~-~~~---------  217 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------IL-NAE---------  217 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HH-HCC---------
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH------HH-cCC---------
Confidence                2346899999999999999999999999999999999999999976543322111      11 111         


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                       ..+++..+.++.+++.+||+.||.+||     ++.+++++
T Consensus       218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence             112334456789999999999999996     88888764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-44  Score=386.86  Aligned_cols=249  Identities=24%  Similarity=0.317  Sum_probs=207.7

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      .++|+..++||+|+||.||+|+.. +++.||||++...   .....+.+.+|+++|++++||||+++++++.+.+.+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            357999999999999999999975 6899999987532   223457789999999999999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      ||||++|+|.+++....  .+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999987654  6889999999999999999999   789999999999999999999999999999865432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                      .  ......+||+.|+|||++.+..++.++|||||||++|||++|++||......+.   ....    ..+.+       
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~---~~~i----~~~~~-------  222 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELI----LMEEI-------  222 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHCCC-------
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH---HHHH----hcCCC-------
Confidence            2  223456899999999999999999999999999999999999999976543322   1111    11111       


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                         .++.....++.+++.+||+.||.+||+     +.|++++
T Consensus       223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence               123344567889999999999999995     7777764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-43  Score=373.09  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=205.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---------hhhHHHHHHHHHHHHcCC-CCceeeEEeEeecC
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---------HQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDER  551 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---------~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~  551 (820)
                      ++|+..+.||+|+||+||+|+.. +++.+|||++....         ....+.+.+|+.+|++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57899999999999999999975 68899999864432         112346889999999997 99999999999999


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      +..+||||||++|+|.++|....  .+++.++..++.|++.||+|||   .++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhe
Confidence            99999999999999999997654  6999999999999999999999   789999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCccccCcccccc------CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhh
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTK------QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQ  705 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~  705 (820)
                      +.....   ...+...||..|+|||.+.+      ..++.++||||+||+++||++|+.||......+....       .
T Consensus       158 ~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~-------i  227 (277)
T d1phka_         158 CQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM-------I  227 (277)
T ss_dssp             EECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------H
T ss_pred             eEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH-------H
Confidence            875432   22345679999999999863      3568899999999999999999999986543322111       1


Q ss_pred             ccCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          706 ETGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       706 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..+...      .........++++.+++.+||+.+|++||++.|++++
T Consensus       228 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            111111      1111223455789999999999999999999998763

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7e-43  Score=383.50  Aligned_cols=249  Identities=24%  Similarity=0.297  Sum_probs=200.2

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHH---HHHHHHHcCCCCceeeEEeEeecCceEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFR---TEIEMLSQFRHRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~---~Ei~~l~~l~H~nIv~l~g~~~~~~~~~  555 (820)
                      ++|+..++||+|+||.||+|+.. +|+.||||++....   ......+.   .|+++++.++||||+++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999976 58999999864321   11222333   4577778889999999999999999999


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      +|||||++|+|.++|....  .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999997653  6889999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccccc
Q 003436          636 DLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIV  714 (820)
Q Consensus       636 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  714 (820)
                      ..    ......||+.|+|||++.. ..++.++|||||||+||||+||++||......+...+..    .....      
T Consensus       159 ~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~------  224 (364)
T d1omwa3         159 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTM------  224 (364)
T ss_dssp             SS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSC------
T ss_pred             CC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccC------
Confidence            32    2334679999999999964 568999999999999999999999997654433222111    11000      


Q ss_pred             CccccCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHHH
Q 003436          715 DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLWN  754 (820)
Q Consensus       715 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~~  754 (820)
                          ....+...+.++.+++.+||+.||.+||+     +.|++++
T Consensus       225 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 ----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                01223345567899999999999999999     5777754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-43  Score=384.35  Aligned_cols=245  Identities=21%  Similarity=0.304  Sum_probs=205.9

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC---ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ---SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~  558 (820)
                      ++|+..+.||+|+||.||+|++. +|+.||||++...   .....+.+.+|+++|++++||||+++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999986 5899999986532   1233567899999999999999999999999999999999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~  638 (820)
                      ||+.+|+|.+++....  .+++.++..++.|++.||+|||   +++||||||||+|||++.++.+||+|||+|+..... 
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999997654  6999999999999999999999   789999999999999999999999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                          .....||+.|||||++.+..++.++|||||||++|||+||++||......+..   ..+    ..+..        
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i----~~~~~--------  255 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY---EKI----VSGKV--------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHH----HHCCC--------
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH---HHH----hcCCC--------
Confidence                23467999999999999999999999999999999999999999755332211   111    11111        


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCC-----CHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRP-----SMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~evl~~  754 (820)
                        ..+.....++.+++.+||+.||.+|+     ++.+++++
T Consensus       256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence              12234456789999999999999994     88998863

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=381.36  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=199.6

Q ss_pred             hcCCccce-eEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcC-CCCceeeEEeEeec----CceE
Q 003436          482 TDNFSESL-VIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQF-RHRHLVSLIGYCDE----RNEM  554 (820)
Q Consensus       482 t~~f~~~~-~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~  554 (820)
                      .++|...+ +||+|+||.||+|+.. +++.||||++...     +.+.+|++++.++ +||||+++++++.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788765 6999999999999975 5889999987532     4567899987655 89999999998854    4678


Q ss_pred             EEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC---CCCeeEeecccc
Q 003436          555 IIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE---NLMAKVADFGLS  631 (820)
Q Consensus       555 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~---~~~~kl~DFGla  631 (820)
                      ++|||||++|+|.++|.......+++.++..|+.|++.||+|||   +.+|+||||||+|||+++   ++.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998766667999999999999999999999   789999999999999975   567999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      +......   ......||+.|+|||++.+..++.++|||||||+||||+||++||......+..   .........+.. 
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~-  234 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQY-  234 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCC-
Confidence            8654422   234567999999999999999999999999999999999999999654322211   111111111110 


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                           .+..........++.+|+.+||+.||.+||++.|++++
T Consensus       235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                 00111112445779999999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-43  Score=374.34  Aligned_cols=258  Identities=21%  Similarity=0.258  Sum_probs=196.6

Q ss_pred             cceeEeeecceEEEEEEEc-CccEEEEEeCCCCChh-----hHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          487 ESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQ-----GLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .+++||+|+||+||+|+.. +++.||||++......     ..+.+.+|+++|++++||||+++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999999976 5889999987644322     124688999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      ++++++..++..  ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--  154 (299)
T d1ua2a_          82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--  154 (299)
T ss_dssp             CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred             hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--
Confidence            998877766543  346889999999999999999999   7899999999999999999999999999998654322  


Q ss_pred             cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccC----
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVD----  715 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----  715 (820)
                      .......||+.|+|||++.+. .++.++|||||||++|||+||++||......+....+   .............+    
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---FETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCCTTTSSSTTSS
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---HHhcCCCChhhccchhcc
Confidence            222345799999999998654 5799999999999999999999999765544332221   11111111000000    


Q ss_pred             --ccccCC--------CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          716 --PTLTGQ--------IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       716 --~~l~~~--------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                        ......        ........+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence              000000        011334678999999999999999999999863

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=379.19  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=203.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC---hhhHHHHHHHHHHHH-cCCCCceeeEEeEeecCceEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS---HQGLAEFRTEIEMLS-QFRHRHLVSLIGYCDERNEMIII  557 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~---~~~~~~f~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV  557 (820)
                      ++|...++||+|+||+||+|+.. +++.||||++....   ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999986 58899999875321   233456677777765 68999999999999999999999


Q ss_pred             EeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCC
Q 003436          558 YEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       558 ~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~  637 (820)
                      ||||++|+|.+++....  .+++.++..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999997654  5889999999999999999999   789999999999999999999999999999864432


Q ss_pred             CCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCcc
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPT  717 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  717 (820)
                        ....+...||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+       ..+.      + 
T Consensus       157 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------~~~~------~-  220 (320)
T d1xjda_         157 --DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------RMDN------P-  220 (320)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHCC------C-
T ss_pred             --cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-------HcCC------C-
Confidence              22334567999999999999999999999999999999999999999765433321111       1111      1 


Q ss_pred             ccCCCChhhHHHHHHHHHHHhhcCCCCCCCHH-HHHH
Q 003436          718 LTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMG-DVLW  753 (820)
Q Consensus       718 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-evl~  753 (820)
                         .++...+.++.+|+.+||+.||.+||++. ++++
T Consensus       221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence               12233456789999999999999999995 6754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=375.29  Aligned_cols=252  Identities=18%  Similarity=0.275  Sum_probs=206.3

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      .++|...+.||+|+||+||+|+.. +++.||||.+...... ...+.+|+++|++++||||+++++++.+++.+++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467899999999999999999986 5788999998765433 45688999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC--CCCeeEeeccccccCCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE--NLMAKVADFGLSKIGPDLD  638 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~--~~~~kl~DFGla~~~~~~~  638 (820)
                      |++|+|.+++.... ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.  ...+||+|||+++..... 
T Consensus        83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            99999999996543 36899999999999999999999   789999999999999974  458999999999865432 


Q ss_pred             CccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccccCccc
Q 003436          639 QTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDIVDPTL  718 (820)
Q Consensus       639 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  718 (820)
                        .......+|+.|+|||.+.+..++.++|||||||++|||++|++||......+...   .+..    +...  .+...
T Consensus       158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~---~i~~----~~~~--~~~~~  226 (321)
T d1tkia_         158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE---NIMN----AEYT--FDEEA  226 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHH----TCCC--CCHHH
T ss_pred             --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh----CCCC--CChhh
Confidence              22334578999999999999999999999999999999999999997654332211   1111    1100  00000


Q ss_pred             cCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          719 TGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       719 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          ......++.+++.+||+.||.+||++.|++++
T Consensus       227 ----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         227 ----FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                11234668899999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-42  Score=368.61  Aligned_cols=266  Identities=20%  Similarity=0.293  Sum_probs=202.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..++||+|+||+||+|+.. +++.||||++....  ....+.+.+|+++|++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999975 68899999875433  2335688999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      |+.+ ++.+++.......+++.++..++.|++.||+|||   +.+||||||||+|||++.++.+||+|||+|+...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9975 5556665555567999999999999999999999   7899999999999999999999999999998654322 


Q ss_pred             ccccccccCCccccCccccccCC-CCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccccc-cCcc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQ-LTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLEDI-VDPT  717 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~d~~  717 (820)
                       .......||+.|+|||.+.... .+.++|||||||++|||++|+.||......+......-............. ..+.
T Consensus       157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence             2234457999999999886655 588999999999999999999999765433322111000000000000000 0000


Q ss_pred             ccCC-----------CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          718 LTGQ-----------IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       718 l~~~-----------~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ....           ..+....++.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000           011234678899999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.1e-42  Score=366.81  Aligned_cols=264  Identities=18%  Similarity=0.249  Sum_probs=202.2

Q ss_pred             cCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCC--hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS--HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||+||+|++++++.||||++....  ....+.+.+|+++|++++||||+++++++...+..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5789999999999999999999999999999976543  22357899999999999999999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCCc
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQT  640 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~~  640 (820)
                      +.++.+..+....  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......  
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--  154 (286)
T d1ob3a_          82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--  154 (286)
T ss_dssp             CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence            9877766665433  47999999999999999999999   6899999999999999999999999999998654321  


Q ss_pred             cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc------cc
Q 003436          641 HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE------DI  713 (820)
Q Consensus       641 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~~  713 (820)
                      .......+++.|+|||.+.+. .++.++|||||||+++||++|+.||......+..................      ..
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            122344688999999998754 57999999999999999999999997654433322211111000000000      00


Q ss_pred             ------cCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          714 ------VDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       714 ------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                            ..+.............+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0000001122334567899999999999999999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=365.53  Aligned_cols=240  Identities=23%  Similarity=0.413  Sum_probs=195.4

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC------hhhHHHHHHHHHHHHcCC--CCceeeEEeEeecCce
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS------HQGLAEFRTEIEMLSQFR--HRHLVSLIGYCDERNE  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~  553 (820)
                      ++|...++||+|+||.||+|+.. +++.||||++....      .....++.+|+.+|++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            56889999999999999999975 68999999864321      111234678999999986  8999999999999999


Q ss_pred             EEEEEeeccC-CchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-CCCeeEeecccc
Q 003436          554 MIIIYEYMEN-GTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-NLMAKVADFGLS  631 (820)
Q Consensus       554 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-~~~~kl~DFGla  631 (820)
                      .++||||+.+ +++.+++....  .+++.++..++.|++.||+|||   +++|+||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 57777776543  6999999999999999999999   789999999999999985 579999999999


Q ss_pred             ccCCCCCCccccccccCCccccCccccccCCC-CCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          632 KIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQL-TEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       632 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      +....    ...+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     ...        .+..
T Consensus       159 ~~~~~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~--------~~~~  221 (273)
T d1xwsa_         159 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII--------RGQV  221 (273)
T ss_dssp             EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH--------HCCC
T ss_pred             eeccc----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh--------hccc
Confidence            86433    22345679999999999987765 577899999999999999999996421     000        0110


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                                .++...+.++.+++.+||+.||++|||+.|++++
T Consensus       222 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 ----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             ----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                      1222345678999999999999999999999863

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=363.87  Aligned_cols=266  Identities=21%  Similarity=0.297  Sum_probs=199.0

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-C-ccEEEEEeCCCC--ChhhHHHHHHHHHHHHcC---CCCceeeEEeEee-----
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-D-ETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQF---RHRHLVSLIGYCD-----  549 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~-~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l---~H~nIv~l~g~~~-----  549 (820)
                      .++|+..++||+|+||+||+|++. . ++.||||++...  .......+.+|+++|+.|   +||||++++++|.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999974 3 567999986432  122223456677776655   7999999999984     


Q ss_pred             cCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecc
Q 003436          550 ERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFG  629 (820)
Q Consensus       550 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFG  629 (820)
                      .....++++||++++.+.... ......+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence            345789999999987765443 344467999999999999999999999   7899999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc
Q 003436          630 LSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ  709 (820)
Q Consensus       630 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  709 (820)
                      +++....   ........||+.|+|||++.+..++.++||||+||++|||++|++||....+.+................
T Consensus       162 ~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         162 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            9875432   2334567899999999999999999999999999999999999999986654433222211110000000


Q ss_pred             ccc-------cc---CccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 LED-------IV---DPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 ~~~-------~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ...       ..   .+...........+.+.+|+.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000       00   0000011223445678899999999999999999998864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.3e-40  Score=355.20  Aligned_cols=265  Identities=16%  Similarity=0.202  Sum_probs=211.0

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCC-CceeeEEeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRH-RHLVSLIGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E~  560 (820)
                      ++|...++||+|+||.||+|++. +++.||||.+.....  .+++.+|+++++.++| +|++.+++++.++...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57899999999999999999976 588999998644322  2456789999999965 8999999999999999999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcC-----CCCeeEeeccccccCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDE-----NLMAKVADFGLSKIGP  635 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~-----~~~~kl~DFGla~~~~  635 (820)
                      + +++|.+++.... ..+++.++..++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9 689999886543 46899999999999999999999   899999999999999964     5789999999998754


Q ss_pred             CCCCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcc
Q 003436          636 DLDQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQL  710 (820)
Q Consensus       636 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  710 (820)
                      .....     .......||+.|||||++.+..++.++|||||||++|||+||+.||..............+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            32211     1233467999999999999999999999999999999999999999765443332222222211111111


Q ss_pred             ccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          711 EDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       711 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                      .+         ....+++++.+++..|++.+|.+||+++.+.+.|+++++..+
T Consensus       238 ~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~  281 (293)
T d1csna_         238 RE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  281 (293)
T ss_dssp             HH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence            11         122345678999999999999999999999999998876443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-40  Score=354.32  Aligned_cols=265  Identities=19%  Similarity=0.239  Sum_probs=201.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeE-EeEeecCceEEEEEee
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSL-IGYCDERNEMIIIYEY  560 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l-~g~~~~~~~~~lV~E~  560 (820)
                      ++|+..+.||+|+||.||+|++. +++.||||.+.....  .+++..|++++++++|+|++.. .++..+++..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46889999999999999999975 588999998654432  2457889999999987765555 4555777888999999


Q ss_pred             ccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEc---CCCCeeEeeccccccCCCC
Q 003436          561 MENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLD---ENLMAKVADFGLSKIGPDL  637 (820)
Q Consensus       561 ~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~---~~~~~kl~DFGla~~~~~~  637 (820)
                      +. ++|.+.+.... ..+++.+++.++.|++.||+|||   +++|+||||||+|||++   .+..+||+|||+|+.....
T Consensus        85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            94 56666655433 46999999999999999999999   78999999999999985   4568999999999875442


Q ss_pred             CCc-----cccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCcccc
Q 003436          638 DQT-----HVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLED  712 (820)
Q Consensus       638 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  712 (820)
                      ...     .......||+.|||||.+.+..++.++|||||||++|||+||+.||......+.................. 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-  238 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-  238 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh-
Confidence            221     12345679999999999999999999999999999999999999997654433322221111110000111 


Q ss_pred             ccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHHHHHHHhhcC
Q 003436          713 IVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWNLEYALQLQG  763 (820)
Q Consensus       713 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~L~~~~~~~~  763 (820)
                              .....++.++.+++.+|++.+|.+||++.++.+.|+.+....+
T Consensus       239 --------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         239 --------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             --------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             --------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence                    1122445778999999999999999999999999988766443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-40  Score=357.25  Aligned_cols=267  Identities=21%  Similarity=0.303  Sum_probs=197.5

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec--------C
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE--------R  551 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~--------~  551 (820)
                      ++|+..++||+|+||+||+|+.. +++.||||++...  .....+++.+|+++|++++|||++++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67999999999999999999975 6899999986533  23345778999999999999999999998755        3


Q ss_pred             ceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccc
Q 003436          552 NEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLS  631 (820)
Q Consensus       552 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla  631 (820)
                      +..++||||++++.+.....  ....++...+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            46899999998877665443  3346888999999999999999999   789999999999999999999999999999


Q ss_pred             ccCCCCCCc--cccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccC
Q 003436          632 KIGPDLDQT--HVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETG  708 (820)
Q Consensus       632 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~  708 (820)
                      +........  .......||+.|+|||++.+. .++.++|||||||+++||++|++||....+.+...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            865432221  222345799999999998765 68999999999999999999999997655443333222211111000


Q ss_pred             ccccccCccccC------CCCh---------hhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          709 QLEDIVDPTLTG------QIKP---------DSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       709 ~~~~~~d~~l~~------~~~~---------~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ............      ....         .....+.+|+.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            011100000000      0000         112456789999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-40  Score=361.01  Aligned_cols=261  Identities=21%  Similarity=0.266  Sum_probs=195.6

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCceeeEEeEeec------CceEEE
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE------RNEMII  556 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~~~l  556 (820)
                      +|...++||+|+||+||+|++. .++.||||++.....    .+.+|+++|++++||||+++++++..      ...++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4888889999999999999986 588999998755432    23469999999999999999999843      235789


Q ss_pred             EEeeccCCchhhHhhh-cCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccC
Q 003436          557 IYEYMENGTLKDHLYA-SNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIG  634 (820)
Q Consensus       557 V~E~~~~gsL~~~l~~-~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~  634 (820)
                      |||||+++.+..+... .....+++.++..++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987655444432 23457999999999999999999999   79999999999999998765 8999999999865


Q ss_pred             CCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHH---------HHHh
Q 003436          635 PDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEW---------AMKC  704 (820)
Q Consensus       635 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~---------~~~~  704 (820)
                      ....   ......||..|+|||.+.+ ..++.++||||+||++|||++|++||......+.......         ....
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            4322   2234579999999998865 5789999999999999999999999976654333221110         0000


Q ss_pred             hc---cCccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 QE---TGQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 ~~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      ..   ......................++.+|+.+||+.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   000111110111111223445678999999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-40  Score=359.75  Aligned_cols=260  Identities=22%  Similarity=0.335  Sum_probs=195.5

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc------
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN------  552 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~------  552 (820)
                      .++|+..++||+|+||+||+|+.. +++.||||++...  .....+.+.+|+++|++++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            357899999999999999999976 5899999997643  3445678999999999999999999999987654      


Q ss_pred             eEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          553 EMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       553 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      .+++||||+ +.+|..++...   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            579999999 56777776543   5999999999999999999999   7899999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHh-------
Q 003436          633 IGPDLDQTHVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKC-------  704 (820)
Q Consensus       633 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~-------  704 (820)
                      ....     ..+...||+.|+|||.+.+ ..++.++||||+||+++||++|++||......+...........       
T Consensus       170 ~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            6433     2345679999999999876 45789999999999999999999999766433322211111000       


Q ss_pred             -hcc-------CccccccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          705 -QET-------GQLEDIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       705 -~~~-------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                       ...       ..+.+.....+ ..........+.+|+.+||+.||.+|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             000       00000000000 01122334678899999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-40  Score=359.11  Aligned_cols=267  Identities=21%  Similarity=0.324  Sum_probs=198.2

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCC-hhhHHHHHHHHHHHHcCCCCceeeEEeEeecCc----eEE
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQS-HQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERN----EMI  555 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~  555 (820)
                      +++|+..++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            356889999999999999999975 68999999986543 445678999999999999999999999986543    234


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCC
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGP  635 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~  635 (820)
                      ++++++.+|+|.+++...   .+++..+..++.|++.||+|||   +++||||||||+|||+++++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            555667799999999754   5899999999999999999999   7899999999999999999999999999998654


Q ss_pred             CCCC-ccccccccCCccccCcccccc-CCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCc----
Q 003436          636 DLDQ-THVSTAVKGSFGYLDPEYLTK-QQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQ----  709 (820)
Q Consensus       636 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----  709 (820)
                      .... ........||+.|+|||++.. ..++.++||||+||+++||++|++||......+................    
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            3222 122345679999999999844 5678999999999999999999999976554333222111100000000    


Q ss_pred             ----ccc--ccCccccC----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          710 ----LED--IVDPTLTG----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       710 ----~~~--~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          ...  ...+....    ...+....++.+++.+||+.||.+||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000  00000000    0011223568899999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=344.76  Aligned_cols=265  Identities=19%  Similarity=0.265  Sum_probs=204.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecCceEEEEEe
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E  559 (820)
                      ++|+..++||+|+||+||+|++. +++.||||+++..  .....+++.+|+.+|++++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999975 6788999986433  34456889999999999999999999999999999999999


Q ss_pred             eccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeeccccccCCCCCC
Q 003436          560 YMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKIGPDLDQ  639 (820)
Q Consensus       560 ~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~~~~~~~  639 (820)
                      ++.+++|..++...  ..+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccccc--cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99999998877544  46889999999999999999999   78999999999999999999999999999986543222


Q ss_pred             ccccccccCCccccCccccccCC-CCCcceeeehhhhHHHHhcCCCCCCCCCch-hhhhHHHHHHHhhccCcc---cccc
Q 003436          640 THVSTAVKGSFGYLDPEYLTKQQ-LTEKSDVYSFGVVMFEILCGRPVIDPSLPR-EKVNLVEWAMKCQETGQL---EDIV  714 (820)
Q Consensus       640 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SfGvll~ElltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~---~~~~  714 (820)
                        ......++..|+|||.+.... ++.++|||||||+++||++|+.|+...... +.................   ....
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence              223345778899999987664 689999999999999999999886543322 222111111100000000   0000


Q ss_pred             C---------ccccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          715 D---------PTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       715 d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                      +         ..-...........+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0         000112223445678899999999999999999998763

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=352.36  Aligned_cols=252  Identities=23%  Similarity=0.279  Sum_probs=201.3

Q ss_pred             cCCccceeEeeecceEEEEEEEc----CccEEEEEeCCCC----ChhhHHHHHHHHHHHHcCCC-CceeeEEeEeecCce
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR----DETKVAVKRGGTQ----SHQGLAEFRTEIEMLSQFRH-RHLVSLIGYCDERNE  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~----~~~~vavK~~~~~----~~~~~~~f~~Ei~~l~~l~H-~nIv~l~g~~~~~~~  553 (820)
                      ++|+..++||+|+||+||+|+..    .|+.||||.+...    .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56999999999999999999863    3789999986532    12234568899999999976 899999999999999


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .++|+||+.+|+|.+++....  .++......++.|++.||+|||   +.+|+||||||+||||+.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999997664  4678888999999999999999   78999999999999999999999999999986


Q ss_pred             CCCCCCccccccccCCccccCccccccC--CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhccCccc
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQ--QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQETGQLE  711 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  711 (820)
                      ..... ........|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+......  .... ..   
T Consensus       179 ~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~-~~---  251 (322)
T d1vzoa_         179 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRIL-KS---  251 (322)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHH-HC---
T ss_pred             hcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhcc-cC---
Confidence            54322 2223446799999999999754  47889999999999999999999997654433222111  1110 00   


Q ss_pred             cccCccccCCCChhhHHHHHHHHHHHhhcCCCCCCC-----HHHHHH
Q 003436          712 DIVDPTLTGQIKPDSLNKFVEIAEKCLAQCGIDRPS-----MGDVLW  753 (820)
Q Consensus       712 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~evl~  753 (820)
                             ....+.....++.+++.+||+.||.+||+     ++|+++
T Consensus       252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                   01223345678999999999999999995     778875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-38  Score=344.46  Aligned_cols=257  Identities=17%  Similarity=0.244  Sum_probs=197.1

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeec--CceEEEEE
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDE--RNEMIIIY  558 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~--~~~~~lV~  558 (820)
                      ++|+..++||+|+||+||+|+.. +++.||||++....   .+++.+|+++|++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999975 68899999976543   467889999999995 9999999999864  45689999


Q ss_pred             eeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC-CeeEeeccccccCCCC
Q 003436          559 EYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL-MAKVADFGLSKIGPDL  637 (820)
Q Consensus       559 E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~-~~kl~DFGla~~~~~~  637 (820)
                      ||+++++|..+.     ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999997764     35899999999999999999999   78999999999999998654 6999999999865432


Q ss_pred             CCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhh-hHH----------HHHHHhh
Q 003436          638 DQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKV-NLV----------EWAMKCQ  705 (820)
Q Consensus       638 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~-~l~----------~~~~~~~  705 (820)
                      .   ......+|..|+|||.+.+. .++.++||||+||+++||++|+.||......... ...          .|.....
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         184 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            2   23456789999999998765 4799999999999999999999998755432211 100          1111100


Q ss_pred             ccC--ccccccCc--------cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHH
Q 003436          706 ETG--QLEDIVDP--------TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLW  753 (820)
Q Consensus       706 ~~~--~~~~~~d~--------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~  753 (820)
                      ...  ........        ............++.+|+.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000  00000000        0111112234567899999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-38  Score=345.27  Aligned_cols=261  Identities=20%  Similarity=0.256  Sum_probs=190.8

Q ss_pred             cCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeec------Cce
Q 003436          483 DNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE------RNE  553 (820)
Q Consensus       483 ~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~------~~~  553 (820)
                      ++|+..++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.+|++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999986 5899999987533  34556678999999999999999999999853      468


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      +++||||+.++.+ +.+.    ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            8999999976544 4443    35899999999999999999999   78999999999999999999999999999885


Q ss_pred             CCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHH---------HH---
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVE---------WA---  701 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~---------~~---  701 (820)
                      ...   ....+...+|+.|+|||++.+..++.++||||+||+++||++|++||.............         +.   
T Consensus       169 ~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         169 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            433   223345678999999999999999999999999999999999999997554322211110         00   


Q ss_pred             ----HHhhcc-Cc-----cccccCccccCC---CChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          702 ----MKCQET-GQ-----LEDIVDPTLTGQ---IKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       702 ----~~~~~~-~~-----~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                          ...... ..     ............   ........+.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                000000 00     000111111111   112345678999999999999999999999865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-39  Score=350.08  Aligned_cols=262  Identities=20%  Similarity=0.301  Sum_probs=196.1

Q ss_pred             hcCCccceeEeeecceEEEEEEEc-CccEEEEEeCCCC--ChhhHHHHHHHHHHHHcCCCCceeeEEeEeecC-----ce
Q 003436          482 TDNFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQ--SHQGLAEFRTEIEMLSQFRHRHLVSLIGYCDER-----NE  553 (820)
Q Consensus       482 t~~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~~~~-----~~  553 (820)
                      .++|+..++||+|+||+||+|+.. +++.||||++...  +....+.+.+|+++|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            457999999999999999999975 6899999997644  344556789999999999999999999998533     34


Q ss_pred             EEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          554 MIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       554 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      .+++++|+.+|+|.+++...   .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            46777888899999998543   5999999999999999999999   78999999999999999999999999999874


Q ss_pred             CCCCCCccccccccCCccccCccccccC-CCCCcceeeehhhhHHHHhcCCCCCCCCCchhhhhHHHHHHHhhcc-----
Q 003436          634 GPDLDQTHVSTAVKGSFGYLDPEYLTKQ-QLTEKSDVYSFGVVMFEILCGRPVIDPSLPREKVNLVEWAMKCQET-----  707 (820)
Q Consensus       634 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~~~l~~~~~~~~~~-----  707 (820)
                      ..     .......||..|+|||.+.+. .++.++|||||||+++||++|++||...........+.........     
T Consensus       171 ~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         171 TD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             CT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             cC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            32     223456789999999987665 4689999999999999999999999765433322221110000000     


Q ss_pred             ---CccccccCc--cccC----CCChhhHHHHHHHHHHHhhcCCCCCCCHHHHHHH
Q 003436          708 ---GQLEDIVDP--TLTG----QIKPDSLNKFVEIAEKCLAQCGIDRPSMGDVLWN  754 (820)
Q Consensus       708 ---~~~~~~~d~--~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~evl~~  754 (820)
                         .........  ....    .........+.+|+.+||+.||.+|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence               000000000  0000    0011234668899999999999999999999864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.9e-34  Score=312.68  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=191.1

Q ss_pred             CCccceeEeeecceEEEEEEEc-CccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-----------CCceeeEEeEeecC
Q 003436          484 NFSESLVIGIGGFGKVYRGVLR-DETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-----------HRHLVSLIGYCDER  551 (820)
Q Consensus       484 ~f~~~~~LG~G~fG~Vykg~~~-~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~nIv~l~g~~~~~  551 (820)
                      +|...++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++|++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4888999999999999999975 68999999987543 33467788999998875           57899999887543


Q ss_pred             --ceEEEEEeeccCCc-hhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCC------C
Q 003436          552 --NEMIIIYEYMENGT-LKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENL------M  622 (820)
Q Consensus       552 --~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~------~  622 (820)
                        ...+++++++..+. ............+++..+..++.|++.||+|||+  ..+|+||||||+|||++.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence              45566777665544 3333444555678999999999999999999994  47899999999999997655      3


Q ss_pred             eeEeeccccccCCCCCCccccccccCCccccCccccccCCCCCcceeeehhhhHHHHhcCCCCCCCCCchhh----hhHH
Q 003436          623 AKVADFGLSKIGPDLDQTHVSTAVKGSFGYLDPEYLTKQQLTEKSDVYSFGVVMFEILCGRPVIDPSLPREK----VNLV  698 (820)
Q Consensus       623 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SfGvll~ElltG~~p~~~~~~~~~----~~l~  698 (820)
                      +|++|||.+.....     ......||+.|+|||++.+..++.++||||+||+++||++|+.||........    ..+.
T Consensus       171 ~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         171 IKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            99999999875432     22346799999999999999999999999999999999999999875432211    1111


Q ss_pred             HHHHHhhc-------cC-ccccccC---------c----------cccCCCChhhHHHHHHHHHHHhhcCCCCCCCHHHH
Q 003436          699 EWAMKCQE-------TG-QLEDIVD---------P----------TLTGQIKPDSLNKFVEIAEKCLAQCGIDRPSMGDV  751 (820)
Q Consensus       699 ~~~~~~~~-------~~-~~~~~~d---------~----------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev  751 (820)
                      ..+..+..       .. ......+         .          ............++.+|+.+||+.||.+|||+.|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            11111100       00 0000000         0          00112345667889999999999999999999999


Q ss_pred             HHH
Q 003436          752 LWN  754 (820)
Q Consensus       752 l~~  754 (820)
                      +++
T Consensus       326 L~H  328 (362)
T d1q8ya_         326 VNH  328 (362)
T ss_dssp             HTC
T ss_pred             hcC
Confidence            764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=2e-21  Score=192.29  Aligned_cols=163  Identities=15%  Similarity=0.136  Sum_probs=120.7

Q ss_pred             cceeEeeecceEEEEEEEcCccEEEEEeCCCCC------------------hhhHHHHHHHHHHHHcCCCCceeeEEeEe
Q 003436          487 ESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQS------------------HQGLAEFRTEIEMLSQFRHRHLVSLIGYC  548 (820)
Q Consensus       487 ~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~------------------~~~~~~f~~Ei~~l~~l~H~nIv~l~g~~  548 (820)
                      ..++||+|+||.||+|+..+|+.||||..+...                  ......+..|+..+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            457999999999999999889999999754211                  01123456788999999999999988664


Q ss_pred             ecCceEEEEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhcCCCCcEEeccCCCCcEEEcCCCCeeEeec
Q 003436          549 DERNEMIIIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHTGSTKAIIHRDVKSANILLDENLMAKVADF  628 (820)
Q Consensus       549 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~~~~~~iiHrDIkp~NIll~~~~~~kl~DF  628 (820)
                      .    .+++|||+++..+.+         ++.....+++.|++++|+|||   ..+|+||||||+|||++++ .++|+||
T Consensus        84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            2    379999999876543         344556789999999999999   7899999999999999865 5899999


Q ss_pred             cccccCCCCCCccccccccCCccccCc------cccccCCCCCcceeeehhhhHH
Q 003436          629 GLSKIGPDLDQTHVSTAVKGSFGYLDP------EYLTKQQLTEKSDVYSFGVVMF  677 (820)
Q Consensus       629 Gla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~ksDV~SfGvll~  677 (820)
                      |+|+........          .|...      |. -.+.+..++|+||..--++
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            999754322110          11110      11 1356788999999865443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.35  E-value=6.9e-07  Score=90.41  Aligned_cols=149  Identities=11%  Similarity=0.113  Sum_probs=98.3

Q ss_pred             HHHHHhcCCccceeEeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC-CCceeeEEeEeecCceEE
Q 003436          477 AIQEATDNFSESLVIGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR-HRHLVSLIGYCDERNEMI  555 (820)
Q Consensus       477 ~l~~at~~f~~~~~LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~  555 (820)
                      +++...++|...+..+.+.-..||+... +++.+++|+...........+.+|...+..+. +--+.+++.++..++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4556666776655444344468998764 45567788765444333445677888887774 444677888888888899


Q ss_pred             EEEeeccCCchhhHhhhcCCCCCCHHHHHHHHHHHHHHhhhhhc------------------------------------
Q 003436          556 IIYEYMENGTLKDHLYASNFPSLSWRKRLEICIGAARGLHYLHT------------------------------------  599 (820)
Q Consensus       556 lV~E~~~~gsL~~~l~~~~~~~l~~~~~l~i~~~ia~gL~yLH~------------------------------------  599 (820)
                      +||+++++.++.+.....       ....+++.++++.|+.||+                                    
T Consensus        87 lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            999999998876543211       1122234444444444442                                    


Q ss_pred             --------------------CCCCcEEeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          600 --------------------GSTKAIIHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       600 --------------------~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                                          .....++|+|+.|.|||++++...-|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                1133589999999999999877677999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.86  E-value=2.9e-05  Score=77.54  Aligned_cols=75  Identities=16%  Similarity=0.117  Sum_probs=53.9

Q ss_pred             eEeeecc-eEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCC--CCceeeEEeEeecCceEEEEEeeccCCch
Q 003436          490 VIGIGGF-GKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFR--HRHLVSLIGYCDERNEMIIIYEYMENGTL  566 (820)
Q Consensus       490 ~LG~G~f-G~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~gsL  566 (820)
                      .+..|.. ..||+...+++..+++|........   .+..|+..|+.+.  .-.+.++++++.+++..++|||++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3444543 6789998888888899976544332   3566777777663  33467788888888889999999998766


Q ss_pred             h
Q 003436          567 K  567 (820)
Q Consensus       567 ~  567 (820)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.22  E-value=0.00047  Score=73.48  Aligned_cols=77  Identities=12%  Similarity=0.081  Sum_probs=48.6

Q ss_pred             ceeEeeecceEEEEEEEcC-ccEEEEEeCCCC-------ChhhHHHHHHHHHHHHcCC---CCceeeEEeEeecCceEEE
Q 003436          488 SLVIGIGGFGKVYRGVLRD-ETKVAVKRGGTQ-------SHQGLAEFRTEIEMLSQFR---HRHLVSLIGYCDERNEMII  556 (820)
Q Consensus       488 ~~~LG~G~fG~Vykg~~~~-~~~vavK~~~~~-------~~~~~~~f~~Ei~~l~~l~---H~nIv~l~g~~~~~~~~~l  556 (820)
                      .+.||.|....||+....+ ++.++||.-.+.       ......+...|.+.|+.+.   ...+++++.++.  ...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence            3468999999999998754 568889963321       1112234456888777662   245667776654  34578


Q ss_pred             EEeeccCCch
Q 003436          557 IYEYMENGTL  566 (820)
Q Consensus       557 V~E~~~~gsL  566 (820)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.36  E-value=0.005  Score=63.37  Aligned_cols=134  Identities=12%  Similarity=0.136  Sum_probs=78.1

Q ss_pred             eEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce--eeEEe-----EeecCceEEEEEeeccCCchhh-
Q 003436          497 GKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL--VSLIG-----YCDERNEMIIIYEYMENGTLKD-  568 (820)
Q Consensus       497 G~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~-  568 (820)
                      -.||+...++|+.+++|..+... ...+++..|...+..|....+  +..+.     ....++..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            57999999999999999865442 234667788888887753222  11111     1234566788999998754311 


Q ss_pred             ---H----------hhh----cC---CCCCCHHH----------------------HHHHHHHHHHHhhh-hhcCCCCcE
Q 003436          569 ---H----------LYA----SN---FPSLSWRK----------------------RLEICIGAARGLHY-LHTGSTKAI  605 (820)
Q Consensus       569 ---~----------l~~----~~---~~~l~~~~----------------------~l~i~~~ia~gL~y-LH~~~~~~i  605 (820)
                         .          ++.    ..   ...+++..                      ....+..+...+.- +......++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               0          111    00   11122211                      11222223222221 122235689


Q ss_pred             EeccCCCCcEEEcCCCCeeEeecccccc
Q 003436          606 IHRDVKSANILLDENLMAKVADFGLSKI  633 (820)
Q Consensus       606 iHrDIkp~NIll~~~~~~kl~DFGla~~  633 (820)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.00  E-value=0.012  Score=62.08  Aligned_cols=72  Identities=19%  Similarity=0.169  Sum_probs=48.0

Q ss_pred             eeEeeecceEEEEEEEcCc--------cEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce-eeEEeEeecCceEEEEEe
Q 003436          489 LVIGIGGFGKVYRGVLRDE--------TKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL-VSLIGYCDERNEMIIIYE  559 (820)
Q Consensus       489 ~~LG~G~fG~Vykg~~~~~--------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~E  559 (820)
                      +.|+.|-.-.+|+....++        ..|+++...... . .-...+|..+++.+.-.++ .++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4677788889999887543        346666544222 2 2344578888888853344 477887754    68999


Q ss_pred             eccCCch
Q 003436          560 YMENGTL  566 (820)
Q Consensus       560 ~~~~gsL  566 (820)
                      |+++.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987655

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.94  E-value=0.026  Score=57.21  Aligned_cols=157  Identities=8%  Similarity=0.043  Sum_probs=81.9

Q ss_pred             CCHHHHHHHhcCCcccee-----EeeecceEEEEEEEcCccEEEEEeCCCCChhhHHHHHHHHHHHHcCCCCce--eeEE
Q 003436          473 FPFVAIQEATDNFSESLV-----IGIGGFGKVYRGVLRDETKVAVKRGGTQSHQGLAEFRTEIEMLSQFRHRHL--VSLI  545 (820)
Q Consensus       473 ~~~~~l~~at~~f~~~~~-----LG~G~fG~Vykg~~~~~~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~nI--v~l~  545 (820)
                      .+-.+++....+|...++     |..|---+.|+.+.++|+ +++|+......  .++...|++++..|.+.++  ...+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            455677877888866443     334555778998877654 78887543221  2334456666666643222  1111


Q ss_pred             e------EeecCceEEEEEeeccCCchhh--------------Hhhhc----CC----CCCC-H----------------
Q 003436          546 G------YCDERNEMIIIYEYMENGTLKD--------------HLYAS----NF----PSLS-W----------------  580 (820)
Q Consensus       546 g------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~----~~l~-~----------------  580 (820)
                      .      +...++....++.++.+.....              .++..    ..    .... |                
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      1122345666777776543211              01100    00    0000 0                


Q ss_pred             HHHHHHHHHHHHHhhhhh-cCCCCcEEeccCCCCcEEEcCCCCeeEeeccccc
Q 003436          581 RKRLEICIGAARGLHYLH-TGSTKAIIHRDVKSANILLDENLMAKVADFGLSK  632 (820)
Q Consensus       581 ~~~l~i~~~ia~gL~yLH-~~~~~~iiHrDIkp~NIll~~~~~~kl~DFGla~  632 (820)
                      ......+......+.-.+ .....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            011122222222222222 1236789999999999999988777899999874

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=94.92  E-value=0.12  Score=45.78  Aligned_cols=81  Identities=14%  Similarity=0.210  Sum_probs=64.9

Q ss_pred             cCceeeEecccCceEEEEEEecCCCCCCCCcccceEEEEeCcEEEEeeccccCCceEEEEEEeccCCcEEEEEeeCC-Cc
Q 003436           93 GPSNYSFSIKKQARHFIRLHFFPFVHETYNMSTAKFSVSSQSFTLIKDYQSQEGSSVKEYSLNIASDRLVLSFTPFA-NS  171 (820)
Q Consensus        93 ~~~~y~~~~~~~~~~~~R~~f~~~~~~~~~~~~~~f~v~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~v~~~~~~-~~  171 (820)
                      ....|.++| +.|.|-|+++|-.         ....++.+.|...+.++.+  ...-+.|.|++.++.|+|-|.... ..
T Consensus        63 ~~~~f~v~v-PnG~Y~Vtv~~Gd---------~~~~~~~~eg~~~~~~~~g--~~~~~~~~V~VtDG~L~l~ft~~~~G~  130 (146)
T d2o14a1          63 SNNTFNVDL-PNGLYEVKVTLGN---------TARASVAAEGVFQVINMTG--DGAEDTFQIPVTDGQLNLLVTEGKAGT  130 (146)
T ss_dssp             CSCCEEEEC-CSEEEEEEEEESS---------CSEEEEEETTEEEEEEEES--TTCEEEEEEEECSSEEEEEEEESSTTS
T ss_pred             CCceEEEEC-CCCeEEEEEEEec---------CCCccEEEeeEEeccccCC--ccEEEEEEEEEECCeEEEEEecCCCCC
Confidence            345688888 5789999999884         2346788999888888843  344577899999999999998665 67


Q ss_pred             cceeeeeEEEEcCC
Q 003436          172 FAFINALEVISLPD  185 (820)
Q Consensus       172 ~~fi~~~e~~~~~~  185 (820)
                      .|=||+|||.++++
T Consensus       131 ~~~in~l~I~~~~d  144 (146)
T d2o14a1         131 AFTLSALKIKKLSD  144 (146)
T ss_dssp             CCEEEEEEEEEEES
T ss_pred             ccEEEEEEEEeccc
Confidence            89999999998765

>d2o14a1 b.18.1.32 (A:14-159) Hypothetical protein YxiM {Bacillus subtilis [TaxId: 1423]}

class: All beta proteins
fold: Galactose-binding domain-like
superfamily: Galactose-binding domain-like
family: YxiM N-terminal domain-like
domain: Hypothetical protein YxiM
species: Bacillus subtilis [TaxId: 1423]

Probab=91.79  E-value=0.18  Score=44.62  Aligned_cols=79  Identities=18%  Similarity=0.222  Sum_probs=53.2

Q ss_pred             eeEEEeecCCCCeeEEEEeecceeecccccEEEEEEEccccccCccCccccccccCCCceeeeeeeecCCCCceeEEEc-
Q 003436          291 NVTWNFDVDPGFEFLVRFHFCDIYFNNISSLAFNVYINSRSAQLDFDLHKLPSYAAGNPYYMDFITRESDNPKLHVSIG-  369 (820)
Q Consensus       291 ~~tw~~~~~~~~~y~v~lhFaEi~~~~~~~R~FdI~in~~~~~~~~di~~~~~~~~~~~~y~~~~v~~~~~~~~~vsl~-  369 (820)
                      ...|.++++ ||.|.|.++|.|..       ..++.+.|.....     ..    .+......|+|.+.+ +.+.+.+. 
T Consensus        64 ~~~f~v~vP-nG~Y~Vtv~~Gd~~-------~~~~~~eg~~~~~-----~~----~g~~~~~~~~V~VtD-G~L~l~ft~  125 (146)
T d2o14a1          64 NNTFNVDLP-NGLYEVKVTLGNTA-------RASVAAEGVFQVI-----NM----TGDGAEDTFQIPVTD-GQLNLLVTE  125 (146)
T ss_dssp             SCCEEEECC-SEEEEEEEEESSCS-------EEEEEETTEEEEE-----EE----ESTTCEEEEEEEECS-SEEEEEEEE
T ss_pred             CceEEEECC-CCeEEEEEEEecCC-------CccEEEeeEEecc-----cc----CCccEEEEEEEEEEC-CeEEEEEec
Confidence            456999996 79999999999953       2367777765443     12    123335667787776 66766542 


Q ss_pred             -ccccccCCcccccccceeeeccC
Q 003436          370 -RSTLVDTFPNAILNGLEIMKINN  392 (820)
Q Consensus       370 -~s~~~~~~~~~ilNg~EI~~i~~  392 (820)
                       ....     .+.||++||-++.+
T Consensus       126 ~~~G~-----~~~in~l~I~~~~d  144 (146)
T d2o14a1         126 GKAGT-----AFTLSALKIKKLSD  144 (146)
T ss_dssp             SSTTS-----CCEEEEEEEEEEES
T ss_pred             CCCCC-----ccEEEEEEEEeccc
Confidence             2223     67899999988754